PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, YL; Song, WH				Wu, Yili; Song, Weihong			Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis	FASEB JOURNAL			English	Article						Down syndrome; Alzheimer's disease	SYNDROME CRITICAL REGION; DOWN-SYNDROME; INHIBITS CALCINEURIN; EXPRESSION PATTERNS; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; CASPASE ACTIVATION; GENE-EXPRESSION; MESSENGER-RNA; DSCR1 ADAPT78	Abnormal expression of regulator of calcineurin 1 (RCAN1) has been implicated in Alzheimer's disease (AD) and Down's syndrome (DS). There are two major isoforms of RCAN1, isoforms 1 and 4. RCAN1 isoform 1 is predominantly expressed in the brain, particularly in neurons. In this report, we showed that there are two translation start codons in RCAN1 exon 1 serving as a functional translation initiation site to generate a longer 41-kDa isoform 1 (RCAN1.1L) and a shorter 31-kDa isoform 1 (RCAN1.1S). The first translation initiation site has higher translation efficiency than the downstream second one, and the translation initiation of two AUG sites is by a Cap-dependent mechanism. Short-term expression of RCAN1.1L protected SH-SY5Y cells from oxidative stress-induced apoptosis by inhibiting caspase-3 activation. However, long-term accumulation of RCAN1.1L in SH-SY5Y cells promoted oxidative stress-induced apoptosis via caspase-3 activation, and terminal deoxynucleotidyl transferase dUTP nick end labeling assay showed that the apoptosis ratio was increased to 499.03 +/- 47.56% in SH-1.1L cells compared with 283.93 +/- 28.66% in control cells. Furthermore, we found that RCAN1.1L is significantly elevated in the AD brains and patients with DS. RCAN1.1S is expressed at a low level in both human cells and brain tissues. Our results defined the regulatory mechanism underlying RCAN1 expression and the roles of RCAN1.1 in oxidative stress-induced neurodegeneration in AD and DS pathogenesis.-Wu, Y., Song, W. Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J. 27, 208-221 (2013). www.fasebj.org	[Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing 400014, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China; [Wu, Yili; Song, Weihong] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Townsend Family Labs, Vancouver, BC V6T 1Z3, Canada	Chongqing Medical University; Chongqing Medical University; University of British Columbia	Song, WH (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Townsend Family Labs, 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017	Song, Weihong/0000-0001-9928-889X; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR) [TAD-117948]; National Natural Science Foundation of China (NSFC) [81161120498]; Arthur & June Willms Fellowships	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Arthur & June Willms Fellowships	The authors thank Drs. Philip Ly and Fang Cai for technical assistance. The authors thank the University of Maryland Brain and Tissue Bank for Developmental Disorders for AD and control brain tissues. This work was supported by Canadian Institutes of Health Research (CIHR) aging pilot grant and operating grant TAD-117948, and National Natural Science Foundation of China (NSFC) grant 81161120498. W. S. is the holder of the Tier 1 Canada Research Chair in Alzheimer's Disease. Y. W. was the recipient of the Arthur & June Willms Fellowships.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Bertoni-Freddari C, 2009, ANN NY ACAD SCI, V1171, P18, DOI 10.1111/j.1749-6632.2009.04886.x; Casadei R, 2003, GENE, V321, P185, DOI 10.1016/S0378-1119(03)00835-7; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Dierssen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017010; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ermak G, 2012, J BIOL CHEM, V287, P14088, DOI 10.1074/jbc.M111.305342; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kim Y, 2009, J NEUROCHEM, V111, P344, DOI 10.1111/j.1471-4159.2009.06318.x; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Liu SC, 2008, EUR J NEUROSCI, V28, P1980, DOI 10.1111/j.1460-9568.2008.06497.x; Liu ZA, 2012, NEUROCHEM RES, V37, P1420, DOI 10.1007/s11064-012-0726-0; Lukiw WJ, 2010, MOL NEUROBIOL, V42, P10, DOI 10.1007/s12035-010-8126-4; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Minami T, 2009, J CLIN INVEST, V119, P2257, DOI 10.1172/JCI35738; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Ryeom S, 2009, J CRANIOFAC SURG, V20, P595, DOI 10.1097/SCS.0b013e3181927f47; Saeki M, 2007, J BIOL CHEM, V282, P11786, DOI 10.1074/jbc.M609347200; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shou Y, 2004, BIOCHEM J, V379, P805, DOI 10.1042/BJ20031107; Sobrado M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-48; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; SONG WH, 1995, NUCLEIC ACIDS RES, V23, P3609, DOI 10.1093/nar/23.17.3609; Springer JE, 2000, J NEUROSCI, V20, P7246; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Takuma Kazuhiro, 2009, Folia Pharmacologica Japonica, V134, P180; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Ventoso I, 1998, J BIOL CHEM, V273, P27960, DOI 10.1074/jbc.273.43.27960; WYCKOFF EE, 1990, P NATL ACAD SCI USA, V87, P9529, DOI 10.1073/pnas.87.24.9529; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yoshida NL, 2002, BIOCHEM BIOPH RES CO, V293, P1254; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9; Zhou WH, 2006, MOL CELL BIOL, V26, P3353, DOI 10.1128/MCB.26.9.3353-3364.2006	64	56	58	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					208	221		10.1096/fj.12-213124	http://dx.doi.org/10.1096/fj.12-213124			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038757				2022-12-25	WOS:000313103200020
J	Harriger, L; van den Heuvel, MP; Sporns, O				Harriger, Logan; van den Heuvel, Martijn P.; Sporns, Olaf			Rich Club Organization of Macaque Cerebral Cortex and Its Role in Network Communication	PLOS ONE			English	Article							SMALL-WORLD; FUNCTIONAL CONNECTIVITY; COGNITIVE NEUROSCIENCE; BRAIN; CONSCIOUSNESS; ARCHITECTURE; INFORMATION; PROJECTIONS; CONNECTOME; COLLATION	Graph-theoretical analysis of brain connectivity data has revealed significant features of brain network organization across a range of species. Consistently, large-scale anatomical networks exhibit highly nonrandom attributes including an efficient small world modular architecture, with distinct network communities that are interlinked by hub regions. The functional importance of hubs motivates a closer examination of their mutual interconnections, specifically to examine the hypothesis that hub regions are more densely linked than expected based on their degree alone, i.e. forming a central rich club. Extending recent findings of rich club topology in the cat and human brain, this report presents evidence for the existence of rich club organization in the cerebral cortex of a non-human primate, the macaque monkey, based on a connectivity data set representing a collation of numerous tract tracing studies. Rich club regions comprise portions of prefrontal, parietal, temporal and insular cortex and are widely distributed across network communities. An analysis of network motifs reveals that rich club regions tend to form star-like configurations, indicative of their central embedding within sets of nodes. In addition, rich club nodes and edges participate in a large number of short paths across the network, and thus contribute disproportionately to global communication. As rich club regions tend to attract and disperse communication paths, many of the paths follow a characteristic pattern of first increasing and then decreasing node degree. Finally, the existence of non-reciprocal projections imposes a net directional flow of paths into and out of the rich club, with some regions preferentially attracting and others dispersing signals. Overall, the demonstration of rich club organization in a non-human primate contributes to our understanding of the network principles underlying neural connectivity in the mammalian brain, and further supports the hypothesis that rich club regions and connections have a central role in global brain communication.	[Harriger, Logan; Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [van den Heuvel, Martijn P.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [van den Heuvel, Martijn P.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands	Indiana University System; Indiana University Bloomington; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; van den Heuvel, Martijn/AFR-3213-2022	Sporns, Olaf/0000-0001-7265-4036; van den Heuvel, Martijn/0000-0003-1570-1195	JS McDonnell Foundation; Rudolf Magnus Institute of Neuroscience	JS McDonnell Foundation; Rudolf Magnus Institute of Neuroscience	OS acknowledges support from the JS McDonnell Foundation. MP acknowledges support from the Rudolf Magnus Institute of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Averbeck BB, 2009, J NEUROPHYSIOL, V102, P1911, DOI 10.1152/jn.00519.2009; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezgin G, 2012, NEUROIMAGE, V62, P67, DOI 10.1016/j.neuroimage.2012.04.013; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Paxinos G., 2000, RHESUS MONKEY BRAIN; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; Shanahan M., 2012, EMBODIMENT INNER LIF, P1, DOI 10.1093/acprof:oso/9780199226559.001.0001; Shanahan M, 2012, PHILOS T R SOC B, V367, P2704, DOI 10.1098/rstb.2012.0128; Shanahan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036579; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2016, NETWORKS BRAIN; Sporns O, 2012, DISCOVERING HUMAN CO; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Telesford QK, 2011, BRAIN CONNECT, V1, P295, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Zamora-Lopez G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00083; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhao M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046225; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	77	201	202	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46497	10.1371/journal.pone.0046497	http://dx.doi.org/10.1371/journal.pone.0046497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029538	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900176
J	Lindberg, OR; Persson, A; Brederlau, A; Shabro, A; Kuhn, HG				Lindberg, Olle R.; Persson, Asa; Brederlau, Anke; Shabro, Aidin; Kuhn, Hans Georg			EGF-Induced Expansion of Migratory Cells in the Rostral Migratory Stream	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ADULT SUBVENTRICULAR ZONE; OLFACTORY-BULB; ERM PROTEINS; STEM-CELLS; RADIXIN; NEURONS; NEUROGENESIS; FOREBRAIN; BRAIN	The presence of neural stem cells in the adult brain is currently widely accepted and efforts are made to harness the regenerative potential of these cells. The dentate gyrus of the hippocampal formation, and the subventricular zone (SVZ) of the anterior lateral ventricles, are considered the main loci of adult neurogenesis. The rostral migratory stream (RMS) is the structure funneling SVZ progenitor cells through the forebrain to their final destination in the olfactory bulb. Moreover, extensive proliferation occurs in the RMS. Some evidence suggest the presence of stem cells in the RMS, but these cells are few and possibly of limited differentiation potential. We have recently demonstrated the specific expression of the cytoskeleton linker protein radixin in neuroblasts in the RMS and in oligodendrocyte progenitors throughout the brain. These cell populations are greatly altered after intracerebroventricular infusion of epidermal growth factor (EGF). In the current study we investigate the effect of EGF infusion on the rat RMS. We describe a specific increase of radixin(+)/Olig2(+) cells in the RMS. Negative for NG2 and CNPase, these radixin+/Olig2(+) cells are distinct from typical oligodendrocyte progenitors. The expanded Olig2(+) population responds rapidly to EGF and proliferates after only 24 hours along the entire RMS, suggesting local activation by EGF throughout the RMS rather than migration from the SVZ. In addition, the radixin+/Olig2(+) progenitors assemble in chains in vivo and migrate in chains in explant cultures, suggesting that they possess migratory properties within the RMS. In summary, these results provide insight into the adaptive capacity of the RMS and point to an additional stem cell source for future brain repair strategies.	[Lindberg, Olle R.; Persson, Asa; Brederlau, Anke; Shabro, Aidin; Kuhn, Hans Georg] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Kuhn, HG (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	georg.kuhn@neuro.gu.se	Kuhn, Hans-Georg/L-8127-2014	Kuhn, Hans-Georg/0000-0003-4247-5613; Lindberg, Olle/0000-0001-5646-2501	Swedish Medical Research Council [VR-M 2011-3113]; Swedish Childhood Cancer Foundation [PROJ10/044, NBCNSDoktBidr09/007]; The Swedish Parkinson's Disease Association; Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond; Rune oct Ulla Amlovs Stiftelse; Stiftelsen Edit Jacobsons Donationsfond; Stroke-Riksforbundet; Vastra Gotaland regional funds for biomedical research [ALFGBG-146341]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Childhood Cancer Foundation(European Commission); The Swedish Parkinson's Disease Association; Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond; Rune oct Ulla Amlovs Stiftelse; Stiftelsen Edit Jacobsons Donationsfond; Stroke-Riksforbundet; Vastra Gotaland regional funds for biomedical research	This work was supported by grants from the Swedish Medical Research Council (VR-M 2011-3113), the Swedish Childhood Cancer Foundation (PROJ10/044 and NBCNSDoktBidr09/007, Vastra Gotaland regional funds for biomedical research (ALFGBG-146341), The Swedish Parkinson's Disease Association, Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond, Rune oct Ulla Amlovs Stiftelse, Stiftelsen Edit Jacobsons Donationsfond and Stroke-Riksforbundet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Chazal G, 2000, J NEUROSCI, V20, P1446; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lindberg OR, 2012, STEM CELLS DEV, V21, P1356, DOI 10.1089/scd.2011.0275; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pencea V, 2003, J COMP NEUROL, V463, P402, DOI 10.1002/cne.10746; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Tang PT, 2007, FEBS LETT, V581, P1103, DOI 10.1016/j.febslet.2007.02.013; Thomas LB, 1996, GLIA, V17, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	32	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46380	10.1371/journal.pone.0046380	http://dx.doi.org/10.1371/journal.pone.0046380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029503	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900150
J	Roucher, C; Rogier, C; Dieye-Ba, F; Sokhna, C; Tall, A; Trape, JF				Roucher, Clementine; Rogier, Christophe; Dieye-Ba, Fambaye; Sokhna, Cheikh; Tall, Adama; Trape, Jean-Francois			Changing Malaria Epidemiology and Diagnostic Criteria for Plasmodium falciparum Clinical Malaria	PLOS ONE			English	Article							PYROGENIC THRESHOLD; HOLOENDEMIC AREA; CASE DEFINITIONS; AFRICA; TRANSMISSION; MORTALITY; CHILDREN; INTENSE; FEVER; PARASITEMIA	Background: In tropical Africa, where malaria is highly endemic, low grade infections are asymptomatic and the diagnosis of clinical malaria is usually based on parasite density. Here we investigate how changes in malaria control and endemicity modify diagnostic criteria of Plasmodium falciparum attacks. Methods and Findings: Parasitological and clinical data from the population of Dielmo, Senegal, monitored during 20 years, are analyzed in a random-effect logistic regression model to investigate the relationship between the level of parasitemia and risk of fever. Between 1990 and 2010, P. falciparum prevalence in asymptomatic persons declined from 85% to 1% in children 0-3 years and from 34% to 2% in adults >= 50 years. Thresholds levels of parasitemia for attributing fever episodes to malaria decreased by steps in relation to control policies. Using baseline threshold during following periods underestimated P. falciparum attacks by 9.8-20.2% in children and 18.9-40.2% in adults. Considering all fever episodes associated with malaria parasites as clinical attacks overestimated P. falciparum attacks by 42.2-68.5% in children and 45.9-211.7% in adults. Conclusions: Malaria control modifies in all age-groups the threshold levels of parasitemia to be used for the assessment of malaria morbidity and to guide therapeutic decisions. Even under declining levels of malaria endemicity, the parasite density method must remain the reference method for distinguishing malaria from other causes of fever and assessing trends in the burden of malaria.	[Roucher, Clementine; Dieye-Ba, Fambaye; Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, UMR 198, Dakar, Senegal; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo 101, Madagascar; [Rogier, Christophe; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol, UMR 198, BP 1386, Dakar, Senegal.	jean-francois.trape@ird.fr	ROGIER, Christophe/C-2550-2008		Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)	Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)(Ministry of Research, France)	The Dielmo project was funded by the Institut Pasteur of Paris, the Institut Pasteur of Dakar, the Institut de Recherche pour le Developpement (IRD, formerly ORSTOM) and received grants from the Ministry of Cooperation and the Ministry of Research (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], FOC SEN PROGR IMP SE; BASSETT MT, 1991, J TROP MED HYG, V94, P65; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; BRUCECHWATT LJ, 1952, ANN TROP MED PARASIT, V46, P173, DOI 10.1080/00034983.1952.11685522; Ceesay SJ, 2008, LANCET, V373, P58; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Dicko A, 2005, TROP MED INT HEALTH, V10, P550, DOI 10.1111/j.1365-3156.2005.01418.x; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Kitchen SF, 1949, MALARIOLOGY; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P479; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Ogbonna A, 2008, T ROY SOC TROP MED H, V102, P621, DOI 10.1016/j.trstmh.2008.03.024; RICHARD A, 1988, ANN SOC BELG MED TR, V68, P317; Robert V., 2003, Bulletin de la Societe de Pathologie Exotique, V96, P6; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 2001, Med Trop (Mars), V61, P27; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Trape JF, 2012, J INFECT DIS, V205, P672, DOI 10.1093/infdis/jir805; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; TRAPE JF, 1987, AM J EPIDEMIOL, V126, P193, DOI 10.1093/aje/126.2.193; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P435, DOI 10.1016/0035-9203(85)90054-9; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Vial L, 2006, LANCET, V368, P37, DOI 10.1016/S0140-6736(06)68968-X; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25	34	50	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46188	10.1371/journal.pone.0046188	http://dx.doi.org/10.1371/journal.pone.0046188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029433	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900106
J	Tai, K; Quintino, L; Isaksson, C; Gussing, F; Lundberg, C				Tai, Khalid; Quintino, Luis; Isaksson, Christina; Gussing, Fredrik; Lundberg, Cecilia			Destabilizing Domains Mediate Reversible Transgene Expression in the Brain	PLOS ONE			English	Article							REGULATED GENE-EXPRESSION; NEUROTROPHIC FACTOR; LENTIVIRAL VECTORS; PARKINSONS-DISEASE; PROTEIN STABILITY; TETRACYCLINE; DELIVERY; THERAPY; SYSTEM; CELLS	Regulating transgene expression in vivo by delivering oral drugs has been a long-time goal for the gene therapy field. A novel gene regulating system based on targeted proteasomal degradation has been recently developed. The system is based on a destabilizing domain (DD) of the Escherichia coli dihydrofolate reductase (DHFR) that directs fused proteins to proteasomal destruction. Creating YFP proteins fused to destabilizing domains enabled TMP based induction of YFP expression in the brain, whereas omission of TMP resulted in loss of YFP expression. Moreover, induction of YFP expression was dose dependent and at higher TMP dosages, induced YFP reached levels comparable to expression of unregulated transgene., Transgene expression could be reversibly regulated using the DD system. Importantly, no adverse effects of TMP treatment or expression of DD-fusion proteins in the brain were observed. To show proof of concept that destabilizing domains derived from DHFR could be used with a biologically active molecule, DD were fused to GDNF, which is a potent neurotrophic factor of dopamine neurons. N-terminal placement of the DD resulted in TMP-regulated release of biologically active GDNF. Our findings suggest that TMP-regulated destabilizing domains can afford transgene regulation in the brain. The fact that GDNF could be regulated is very promising for developing future gene therapies (e.g. for Parkinson's disease) and should be further investigated.	[Tai, Khalid; Quintino, Luis; Isaksson, Christina; Gussing, Fredrik; Lundberg, Cecilia] Lund Univ, CNS Gene Therapy Unit, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Lund, Sweden	Lund University	Lundberg, C (corresponding author), Lund Univ, CNS Gene Therapy Unit, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Lund, Sweden.	Cecilia.Lundberg@med.lu.se	Quintino, Luis/D-3122-2014	Quintino, Luis/0000-0002-3040-6074; Lundberg, Cecilia/0000-0002-6959-2564	Swedish Research Council [2010-4496, 2007-8626]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (grants #2010-4496 and #2007-8626, www.vr.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer P, 2001, TRENDS NEUROSCI, V24, P533, DOI 10.1016/S0166-2236(00)01899-3; Anderson PO, 2001, HDB CLIN DRUG DATA; Arvidsson A, 2003, NEUROBIOL DIS, V14, P542, DOI 10.1016/j.nbd.2003.08.002; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BARLING RWA, 1978, J ANTIMICROB CHEMOTH, V4, P203, DOI 10.1093/jac/4.3.203; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Cress DE, 2008, EXP NEUROL, V209, P30, DOI 10.1016/j.expneurol.2007.08.015; Georgievska B, 2004, HUM GENE THER, V15, P934, DOI 10.1089/hum.2004.15.934; Ginhoux F, 2004, MOL THER, V10, P279, DOI 10.1016/j.ymthe.2004.05.012; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guo ZS, 2008, TRENDS MOL MED, V14, P410, DOI 10.1016/j.molmed.2008.07.003; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kordower JH, 2008, EXP NEUROL, V209, P34, DOI 10.1016/j.expneurol.2007.08.001; Nielsen TT, 2009, J GENE MED, V11, P559, DOI 10.1002/jgm.1333; Pollock R, 2000, P NATL ACAD SCI USA, V97, P13221, DOI 10.1073/pnas.230446297; Rang H.P., 2003, PHARMACOLOGY; Regulier E, 2002, HUM GENE THER, V13, P1981, DOI 10.1089/10430340260355383; Rungoe C, 2010, PEDIATR BLOOD CANCER, V55, P304, DOI 10.1002/pbc.22423; Stieger K, 2009, ADV DRUG DELIVER REV, V61, P527, DOI 10.1016/j.addr.2008.12.016; Suter DM, 2006, SWISS MED WKLY, V136, P413; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Vogel R, 2008, HUM GENE THER, V19, P167, DOI 10.1089/hum.2007.125; Xiao H, 2002, J NEUROCHEM, V82, P801, DOI 10.1046/j.1471-4159.2002.00993.x; Zywiel MG, 2011, INT ORTHOP, V35, P37, DOI 10.1007/s00264-010-0992-x	25	30	34	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46269	10.1371/journal.pone.0046269	http://dx.doi.org/10.1371/journal.pone.0046269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029456	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900120
J	Son, NHP; Ananthakrishnan, R; Yu, SQ; Khan, RS; Jiang, HF; Ji, RP; Akashi, H; Li, Q; O'Shea, K; Homma, S; Goldberg, IJ; Ramasamy, R				Son, Ni-Huiping; Ananthakrishnan, Radha; Yu, Shuiqing; Khan, Raffay S.; Jiang, Hongfeng; Ji, Ruiping; Akashi, Hirokazu; Li, Qing; O'Shea, Karen; Homma, Shunichi; Goldberg, Ira J.; Ramasamy, Ravichandran			Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACTIVATED RECEPTOR-ALPHA; CARDIAC-HYPERTROPHY; PPAR-ALPHA; REPERFUSION INJURY; POLYOL PATHWAY; RAT HEARTS; LIPOTOXIC CARDIOMYOPATHY; DIABETIC COMPLICATIONS; GLUCOSE-METABOLISM	Aldose reductase (AR), an enzyme mediating the first step in the polyol pathway of glucose metabolism, is associated with complications of diabetes mellitus and increased cardiac ischemic injury. We investigated whether deleterious effects of AR are due to its actions specifically in cardiomyocytes. We created mice with cardiac specific expression of human AR (hAR) using the a-myosin heavy chain (MHC) promoter and studied these animals during aging and with reduced fatty acid (FA) oxidation. hAR transgenic expression did not alter cardiac function or glucose and FA oxidation gene expression in young mice. However, cardiac overexpression of hAR caused cardiac dysfunction in older mice. We then assessed whether hAR altered heart function during ischemia reperfusion. hAR transgenic mice had greater infarct area and reduced functional recovery than non-transgenic littermates. When the hAR transgene was crossed onto the PPAR alpha knockout background, another example of greater heart glucose oxidation, hAR expressing mice had increased heart fructose content, cardiac fibrosis, ROS, and apoptosis. In conclusion, overexpression of hAR in cardiomyocytes leads to cardiac dysfunction with aging and in the setting of reduced FA and increased glucose metabolism. These results suggest that pharmacological inhibition of AR will be beneficial during ischemia and in some forms of heart failure.	[Ananthakrishnan, Radha; O'Shea, Karen; Ramasamy, Ravichandran] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Son, Ni-Huiping; Yu, Shuiqing; Khan, Raffay S.; Jiang, Hongfeng; Ji, Ruiping; Akashi, Hirokazu; Li, Qing; Homma, Shunichi; Goldberg, Ira J.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	New York University; Columbia University	Ramasamy, R (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	ramasr02@nyumc.org	jiang, hongfeng/I-6188-2013	Ramasamy, Ravichandran/0000-0002-3666-3346	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087945, T32HL007343, P01HL054591, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Ananthakrishnan R, 2011, EXP GERONTOL, V46, P762, DOI 10.1016/j.exger.2011.05.001; Ananthakrishnan R, 2009, AM J PHYSIOL-HEART C, V296, pH333, DOI 10.1152/ajpheart.01012.2008; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; COLLIER A, 1991, BRIT J HOSP MED, V45, P38; Crowder CM, 2009, SCIENCE, V324, P343, DOI 10.1126/science.1173278; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; GABBAY KH, 1966, SCIENCE, V151, P209, DOI 10.1126/science.151.3707.209; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; Guellich A, 2007, AM J PHYSIOL-HEART C, V293, pH93, DOI 10.1152/ajpheart.00037.2007; HERS HG, 1956, BIOCHIM BIOPHYS ACTA, V22, P202, DOI 10.1016/0006-3002(56)90247-5; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; KINOSHITA JH, 1979, METABOLISM, V28, P462, DOI 10.1016/0026-0495(79)90057-X; Kloner RA, 2008, CIRCULATION, V117, P2423, DOI 10.1161/CIRCULATIONAHA.107.697979; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Li Q, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-33; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Major CD, 1999, DIABETES, V48, P1372, DOI 10.2337/diabetes.48.7.1372; MARKUS HB, 1983, BIOCHEM MED METAB B, V29, P31, DOI 10.1016/0006-2944(83)90051-0; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 2003, TXB DIABETES MELLITU, P55; Sena S, 2009, J MOL CELL CARDIOL, V46, P910, DOI 10.1016/j.yjmcc.2009.02.014; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Trueblood N, 1998, AM J PHYSIOL-HEART C, V275, pH75, DOI 10.1152/ajpheart.1998.275.1.H75; Vedantham S, 2011, ARTERIOSCL THROM VAS, V31, P1805, DOI 10.1161/ATVBAHA.111.226902; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; VIVALDI MT, 1985, AM J PATHOL, V121, P522; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801	50	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46549	10.1371/journal.pone.0046549	http://dx.doi.org/10.1371/journal.pone.0046549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029549	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500108
J	Blenda, A; Fang, DD; Rami, JF; Garsmeur, O; Luo, F; Lacape, JM				Blenda, Anna; Fang, David D.; Rami, Jean-Francois; Garsmeur, Olivier; Luo, Feng; Lacape, Jean-Marc			A High Density Consensus Genetic Map of Tetraploid Cotton That Integrates Multiple Component Maps through Molecular Marker Redundancy Check	PLOS ONE			English	Article							X GOSSYPIUM-BARBADENSE; SIMPLE SEQUENCE REPEAT; LINKAGE MAP; GENOME STRUCTURE; RICH REGIONS; SSR MARKERS; HIRSUTUM; QTL; IDENTIFICATION; CONSTRUCTION	A consensus genetic map of tetraploid cotton was constructed using six high-density maps and after the integration of a sequence-based marker redundancy check. Public cotton SSR libraries (17,343 markers) were curated for sequence redundancy using 90% as a similarity cutoff. As a result, 20% of the markers (3,410) could be considered as redundant with some other markers. The marker redundancy information had been a crucial part of the map integration process, in which the six most informative interspecific Gossypium hirsutum xG. barbadense genetic maps were used for assembling a high density consensus (HDC) map for tetraploid cotton. With redundant markers being removed, the HDC map could be constructed thanks to the sufficient number of collinear non-redundant markers in common between the component maps. The HDC map consists of 8,254 loci, originating from 6,669 markers, and spans 4,070 cM, with an average of 2 loci per cM. The HDC map presents a high rate of locus duplications, as 1,292 markers among the 6,669 were mapped in more than one locus. Two thirds of the duplications are bridging homoeologous A(T) and D-T chromosomes constitutive of allopolyploid cotton genome, with an average of 64 duplications per A(T)/D-T chromosome pair. Sequences of 4,744 mapped markers were used for a mutual blast alignment (BBMH) with the 13 major scaffolds of the recently released Gossypium raimondii genome indicating high level of homology between the diploid D genome and the tetraploid cotton genetic map, with only a few minor possible structural rearrangements. Overall, the HDC map will serve as a valuable resource for trait QTL comparative mapping, map-based cloning of important genes, and better understanding of the genome structure and evolution of tetraploid cotton.	[Rami, Jean-Francois; Garsmeur, Olivier; Lacape, Jean-Marc] CIRAD, UMR AGAP, Montpellier, France; [Garsmeur, Olivier] Clemson Univ, Sch Comp, Clemson, SC USA; [Blenda, Anna] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Blenda, Anna] Erskine Coll, Dept Biol, Due West, SC USA; [Fang, David D.] ARS, Cotton Fiber Biosci Res Unit, USDA, SRRC, New Orleans, LA USA	CIRAD; Universite de Montpellier; Clemson University; Clemson University; United States Department of Agriculture (USDA)	Lacape, JM (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	marc.lacape@cirad.fr	Lacape, JM/Y-1806-2019; Lacape, Jean-Marc/B-4326-2008; FANG, DAVID/AAV-5774-2020; Blenda, Anna/J-9915-2019	Lacape, Jean-Marc/0000-0003-0891-8329; FANG, DAVID/0000-0003-0036-5459; Blenda, Anna/0000-0001-7669-3120				Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Lopez-Lavalle LAB, 2011, GENOME, V54, P779, DOI [10.1139/G11-037, 10.1139/g11-037]; BRUBAKER CL, 1994, AM J BOT, V81, P1309, DOI 10.2307/2445407; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Campbell BT, 2009, EUPHYTICA, V169, P285, DOI 10.1007/s10681-009-9917-4; Chen X, 2010, J COMPUT BIOL, V17, P1561, DOI 10.1089/cmb.2009.0268; Claverie M, 2012, THEOR APPL GENET, V124, P665, DOI 10.1007/s00122-011-1738-x; Cone KC, 2002, PLANT PHYSIOL, V130, P1598, DOI 10.1104/pp.012245; Desai A, 2006, GENOME, V49, P336, DOI 10.1139/G05-116; Gill KS, 1996, GENETICS, V144, P1883; Gill KS, 1996, GENETICS, V143, P1001; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Gutierrez OA, 2009, MOL BREEDING, V23, P693, DOI 10.1007/s11032-009-9266-y; Han ZG, 2006, THEOR APPL GENET, V112, P430, DOI 10.1007/s00122-005-0142-9; Hinze LL, 2012, CROP SCI, V52, P222, DOI 10.2135/cropsci2011.04.0202; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lacape JM, 2003, GENOME, V46, P612, DOI [10.1139/G03-050, 10.1139/g03-050]; Lagercrantz U, 1996, GENETICS, V144, P1903; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Lin ZX, 2009, EUPHYTICA, V166, P35, DOI 10.1007/s10681-008-9822-2; Luo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035261; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Nguyen TB, 2004, THEOR APPL GENET, V109, P167, DOI 10.1007/s00122-004-1612-1; Percival A. E., 1990, Advances in Agronomy, V44, P225, DOI 10.1016/S0065-2113(08)60823-8; REINISCH AJ, 1994, GENETICS, V138, P829; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; SCHMIDT R, 1995, SCIENCE, V270, P480, DOI 10.1126/science.270.5235.480; Shappley ZW, 1998, THEOR APPL GENET, V97, P756, DOI 10.1007/s001220050952; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stelly D. M., 1993, P BELTW COTT C NEW O, P1545; Truco MJ, 2007, THEOR APPL GENET, V115, P735, DOI 10.1007/s00122-007-0599-9; Ulloa M, 2002, THEOR APPL GENET, V104, P200, DOI 10.1007/s001220100739; Veyrieras JB, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-49; Waghmare VN, 2005, THEOR APPL GENET, V111, P665, DOI 10.1007/s00122-005-2032-6; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wang XF, 2006, GENOME, V49, P1393, DOI 10.1139/G06-113; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Xiao J, 2009, J COTTON SCI, V13, P75; Yu J, 2010, GENOMICS, V95, P230, DOI 10.1016/j.ygeno.2010.02.001; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y	52	82	92	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45739	10.1371/journal.pone.0045739	http://dx.doi.org/10.1371/journal.pone.0045739			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029214	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700064
J	Khan, AH; Lin, A; Smith, DJ				Khan, Arshad H.; Lin, Andy; Smith, Desmond J.			Discovery and Characterization of Human Exonic Transcriptional Regulatory Elements	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; CONSERVED ELEMENTS; CODING REGION; PPAR-ALPHA; ENHANCER; GENOME; IDENTIFICATION; CHROMATIN; PROMOTER; SPECIFICITY	We sought exonic transcriptional regulatory elements by shotgun cloning human cDNA fragments into luciferase reporter vectors and measuring the resulting expression levels in liver cells. We uncovered seven regulatory elements within coding regions and three within 3' untranslated regions (UTRs). Two of the putative regulatory elements were enhancers and eight were silencers. The regulatory elements were generally but not consistently evolutionarily conserved and also showed a trend toward decreased population diversity. Furthermore, the exonic regulatory elements were enriched in known transcription factor binding sites (TFBSs) and were associated with several histone modifications and transcriptionally relevant chromatin. Evidence was obtained for bidirectional cis-regulation of a coding region element within a tubulin gene, TUBA1B, by the transcription factors PPARA and RORA. We estimate that hundreds of exonic transcriptional regulatory elements exist, an unexpected finding that highlights a surprising multi-functionality of sequences in the human genome.	[Khan, Arshad H.; Lin, Andy; Smith, Desmond J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	DSmith@mednet.ucla.edu						Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barthel KKB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002184; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bolotin E, 2010, HEPATOLOGY, V51, P642, DOI 10.1002/hep.23357; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006; Chen HP, 2008, GENOMICS, V92, P292, DOI 10.1016/j.ygeno.2008.07.009; Chiquet M, 1998, EUR J BIOCHEM, V257, P362, DOI 10.1046/j.1432-1327.1998.2570362.x; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hsu MH, 1998, J BIOL CHEM, V273, P27988, DOI 10.1074/jbc.273.43.27988; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kleinjan DA, 2004, DEV BIOL, V265, P462, DOI 10.1016/j.ydbio.2003.09.011; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLellan AS, 2006, AM J PHYSIOL-CELL PH, V291, pC300, DOI 10.1152/ajpcell.00345.2005; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ohoka N, 2009, MOL ENDOCRINOL, V23, P759, DOI 10.1210/me.2008-0277; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Raichur S, 2010, NUCLEIC ACIDS RES, V38, P4296, DOI 10.1093/nar/gkq180; SHACHTER NS, 1993, J LIPID RES, V34, P1699; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tzameli I, 1996, J BIOL CHEM, V271, P8402, DOI 10.1074/jbc.271.14.8402; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46098	10.1371/journal.pone.0046098	http://dx.doi.org/10.1371/journal.pone.0046098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029400	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700114
J	Li, J; Qu, XD; He, XY; Duan, L; Wu, GJ; Bi, DX; Deng, ZX; Liu, W; Ou, HY				Li, Jing; Qu, Xudong; He, Xinyi; Duan, Lian; Wu, Guojun; Bi, Dexi; Deng, Zixin; Liu, Wen; Ou, Hong-Yu			ThioFinder: A Web-Based Tool for the Identification of Thiopeptide Gene Clusters in DNA Sequences	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BIOSYNTHESIS; PEPTIDE; THIOSTREPTON; ALIGNMENT	Thiopeptides are a growing class of sulfur-rich, highly modified heterocyclic peptides that are mainly active against Gram-positive bacteria including various drug-resistant pathogens. Recent studies also reveal that many thiopeptides inhibit the proliferation of human cancer cells, further expanding their application potentials for clinical use. Thiopeptide biosynthesis shares a common paradigm, featuring a ribosomally synthesized precursor peptide and conserved posttranslational modifications, to afford a characteristic core system, but differs in tailoring to furnish individual members. Identification of new thiopeptide gene clusters, by taking advantage of increasing information of DNA sequences from bacteria, may facilitate new thiopeptide discovery and enrichment of the unique biosynthetic elements to produce novel drug leads by applying the principle of combinatorial biosynthesis. In this study, we have developed a web-based tool ThioFinder to rapidly identify thiopeptide biosynthetic gene cluster from DNA sequence using a profile Hidden Markov Model approach. Fifty-four new putative thiopeptide biosynthetic gene clusters were found in the sequenced bacterial genomes of previously unknown producing microorganisms. ThioFinder is fully supported by an open-access database ThioBase, which contains the sufficient information of the 99 known thiopeptides regarding the chemical structure, biological activity, producing organism, and biosynthetic gene (cluster) along with the associated genome if available. The ThioFinder website offers researchers a unique resource and great flexibility for sequence analysis of thiopeptide biosynthetic gene clusters. ThioFinder is freely available at http://db-mml.sjtu.edu.cn/ThioFinder/.	[Li, Jing; He, Xinyi; Wu, Guojun; Bi, Dexi; Deng, Zixin; Ou, Hong-Yu] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Qu, Xudong; Duan, Lian; Liu, Wen] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Ou, HY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	wliu@mail.sioc.ac.cn; hyou@sjtu.edu.cn	Qu, Xudong/E-1778-2016; OU, Hong-Yu/O-5208-2019; Wu, Guuojun/AHB-4249-2022	Qu, Xudong/0000-0002-3301-8536; OU, Hong-Yu/0000-0001-9439-1660; Wu, Guuojun/0000-0002-7910-2813; Bi, Dexi/0000-0001-9325-8868; Duan, Lian/0000-0002-8266-717X	National Natural Science Foundation of China; Ministry of Science and Technology of China; Ministry of Education of China [NCET-10-0572]; Shanghai Jiaotong University; Shanghai Municipality	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Shanghai Jiaotong University; Shanghai Municipality	This study was supported in part by grants from the National Natural Science Foundation of China; the Ministry of Science and Technology of China (973 and 863 Programs); the Program for New Century Excellent Talents in University, Ministry of Education of China [NCET-10-0572]; the Chen Xing Young Scholars Program, Shanghai Jiaotong University; and Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt HD, 2009, ANGEW CHEM INT EDIT, V48, P6770, DOI 10.1002/anie.200901808; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Baumann S, 2010, J AM CHEM SOC, V132, P6973, DOI 10.1021/ja909317n; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; Brown LCW, 2009, P NATL ACAD SCI USA, V106, P2549, DOI [10.1073/pnas.0900008105, 10.1073/pnas.0900008106]; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Ding Y, 2010, MOL BIOSYST, V6, P1180, DOI 10.1039/c005121g; Duan L, 2012, CHEM BIOL, V19, P443, DOI 10.1016/j.chembiol.2012.02.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelhardt K, 2010, APPL ENVIRON MICROB, V76, P7093, DOI 10.1128/AEM.01442-10; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hegde NS, 2011, NAT CHEM, V3, P829, DOI 10.1038/nchem.1162; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2011, J AM CHEM SOC, V133, P2852, DOI 10.1021/ja1111173; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Morris RP, 2009, J AM CHEM SOC, V131, P5946, DOI 10.1021/ja900488a; SMITH TM, 1993, J CHEM SOC CHEM COMM, P1612, DOI 10.1039/c39930001612; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sundararajan VS, 2012, NUCLEIC ACIDS RES, V40, pD1108, DOI 10.1093/nar/gkr1063; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Velasquez JE, 2011, CURR OPIN CHEM BIOL, V15, P11, DOI 10.1016/j.cbpa.2010.10.027; Walsh CT, 2010, J BIOL CHEM, V285, P27525, DOI 10.1074/jbc.R110.135970; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang J, 2010, APPL ENVIRON MICROB, V76, P2335, DOI 10.1128/AEM.01790-09; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Young TS, 2011, P NATL ACAD SCI USA, V108, P13053, DOI 10.1073/pnas.1110435108; Yu Y, 2010, J AM CHEM SOC, V132, P16324, DOI 10.1021/ja106571g; Yu Y, 2009, ACS CHEM BIOL, V4, P855, DOI 10.1021/cb900133x; Zhang Q, 2011, J BIOL CHEM, V286, P21287, DOI 10.1074/jbc.M111.224832; Zhang Q, 2011, NAT CHEM BIOL, V7, P154, DOI [10.1038/nchembio.512, 10.1038/NCHEMBIO.512]	38	30	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45878	10.1371/journal.pone.0045878	http://dx.doi.org/10.1371/journal.pone.0045878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029291	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700083
J	Li, RW; Wan, B; Zhou, J; Wang, YL; Luo, T; Gu, XT; Chen, F; Yu, L				Li, Ruwei; Wan, Bo; Zhou, Jun; Wang, Yingli; Luo, Ting; Gu, Xiuting; Chen, Fang; Yu, Long			APC/C-Cdh1 Targets Brain-Specific Kinase 2 (BRSK2) for Degradation via the Ubiquitin-Proteasome Pathway	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; ACTIVATED PROTEIN-KINASE; AMPK-RELATED KINASES; NEURONAL POLARIZATION; DIRECT BINDING; SAD-1 KINASE; CELL-CYCLE; KEN BOX; MITOSIS; YEAST	Studies of brain-specific kinase 2 (BRSK2), an AMP-activated protein kinase (AMPK)-related kinase, and its homologs suggest that they are multifunctional regulators of cell-cycle progression. BRSK2, which contains a ubiquitin-associated (UBA) domain, is polyubiquitinated in cells. However, the regulatory mechanisms and exact biological function of BRSK2 remain unclear. Herein, we show that BRSK2 co-localizes with the centrosomes during mitosis. We also demonstrate that BRSK2 protein levels fluctuate during the cell cycle, peaking during mitosis and declining in G1 phase. Furthermore, Cdh1, rather than Cdc20, promotes the degradation of BRSK2 in vivo. Consistent with this finding, knock-down of endogenous Cdh1 blocks BRSK2 degradation during the G1 phase. The conserved KEN box of BRSK2 is required for anaphase-promoting complex/cyclosome-Cdh1 (APC/C-Cdh1)-dependent degradation. Additionally, overexpression of either BRSK2(WT) or BRSK2(Delta KEN) increases the percentage of cells in G2/M. Thus, our results provide the first evidence that BRSK2 regulates cell-cycle progression controlled by APC/C-Cdh1 through the ubiquitin-proteasome pathway.	[Li, Ruwei; Wan, Bo; Zhou, Jun; Wang, Yingli; Luo, Ting; Gu, Xiuting; Chen, Fang; Yu, Long] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Yu, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Zhou, Jun/J-3035-2015; Wan, Bo/AAE-6352-2021; Chen, Fang/F-4325-2019	Chen, Fang/0000-0003-3108-8204	National Key Sci-Tech Special Project of China [2008ZX10002-020, 2008ZX10002-021]; National Natural Science Foundation of China [30872947]; National Natural Science Foundation for Young Scholar of China [81101810]	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scholar of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Key Sci-Tech Special Project of China (2008ZX10002-020, 2008ZX10002-021), http://www.nmp.gov.cn/, National Natural Science Foundation of China (30872947) and the National Natural Science Foundation for Young Scholar of China (grant no. 81101810), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; Bright NJ, 2008, J BIOL CHEM, V283, P14946, DOI 10.1074/jbc.M710381200; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Chen XY, 2012, J BIOL CHEM, V287, P30368, DOI 10.1074/jbc.M112.375618; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lu R, 2004, J BIOL CHEM, V279, P31164, DOI 10.1074/jbc.M404728200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller M, 2010, J CELL SCI, V123, P286, DOI 10.1242/jcs.058230; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Pfleger CM, 2000, GENE DEV, V14, P655; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simpson-Lavy KJ, 2009, CELL CYCLE, V8, P3003; Stanchi F, 2001, YEAST, V18, P69, DOI 10.1002/1097-0061(200101)18:1<69::AID-YEA647>3.0.CO;2-H; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Vazquez-Martin A, 2011, CELL CYCLE, V10, P1295, DOI 10.4161/cc.10.8.15342; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zhou J, 2012, BIOCHEM BIOPH RES CO, V422, P647, DOI 10.1016/j.bbrc.2012.05.045; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	37	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45932	10.1371/journal.pone.0045932	http://dx.doi.org/10.1371/journal.pone.0045932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029325	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800123
J	Eckrich, T; Varakina, K; Johnson, SL; Franz, C; Singer, W; Kuhn, S; Knipper, M; Holley, MC; Marcotti, W				Eckrich, Tobias; Varakina, Ksenya; Johnson, Stuart L.; Franz, Christoph; Singer, Wibke; Kuhn, Stephanie; Knipper, Marlies; Holley, Matthew C.; Marcotti, Walter			Development and Function of the Voltage-Gated Sodium Current in Immature Mammalian Cochlear Inner Hair Cells	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; ACTION-POTENTIALS; GENE-EXPRESSION; CENTRAL NEURONS; RIBBON SYNAPSE; IONIC CURRENTS; NA+ CHANNELS; RAT UTRICLE; DEPENDENCE; NERVE	Inner hair cells (IHCs), the primary sensory receptors of the mammalian cochlea, fire spontaneous Ca2+ action potentials before the onset of hearing. Although this firing activity is mainly sustained by a depolarizing L-type (Ca(V)1.3) Ca2+ current (I-Ca), IHCs also transiently express a large Na+ current (I-Na). We aimed to investigate the specific contribution of I-Na to the action potentials, the nature of the channels carrying the current and whether the biophysical properties of I-Na differ between low-and high-frequency IHCs. We show that I-Na is highly temperature-dependent and activates at around -60 mV, close to the action potential threshold. Its size was larger in apical than in basal IHCs and between 5% and 20% should be available at around the resting membrane potential (-55 mV/-60 mV). However, in vivo the availability of I-Na could potentially increase to >60% during inhibitory postsynaptic potential activity, which transiently hyperpolarize IHCs down to as far as -70 mV. When IHCs were held at -60 mV and I-Na elicited using a simulated action potential as a voltage command, we found that I-Na contributed to the subthreshold depolarization and upstroke of an action potential. We also found that I-Na is likely to be carried by the TTX-sensitive channel subunits Na(V)1.1 and Na(V)1.6 in both apical and basal IHCs. The results provide insight into how the biophysical properties of I-Na in mammalian cochlear IHCs could contribute to the spontaneous physiological activity during cochlear maturation in vivo.	[Eckrich, Tobias; Johnson, Stuart L.; Kuhn, Stephanie; Holley, Matthew C.; Marcotti, Walter] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Varakina, Ksenya; Franz, Christoph; Singer, Wibke; Knipper, Marlies] Univ Tubingen, Dept Otolaryngol, Tubingen Hearing Res Ctr, Tubingen, Germany	University of Sheffield; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Holley, MC (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.c.holley@sheffield.ac.uk; w.marcotti@sheffield.ac.uk		, Stephanie/0000-0001-6633-9478; Holley, Matthew/0000-0001-9547-1953	Wellcome Trust [088719, 091895]; Royal Society; Deutsche Forschungsgemeinschaft DFG [Kni 316-4-1]; Royal Society University Research Fellowship	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Royal Society University Research Fellowship(Royal Society of London)	This work was supported by The Wellcome Trust (088719 and 091895) and The Royal Society to W. M. and Deutsche Forschungsgemeinschaft DFG Kni 316-4-1 to M. K. W. M. and S.L.J. are supported by Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chabbert C, 2003, J PHYSIOL-LONDON, V553, P113, DOI 10.1113/jphysiol.2003.043034; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; EVANS MG, 1987, BIOPHYS J, V52, P649, DOI 10.1016/S0006-3495(87)83256-3; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Glowatzki E, 2008, CURR OPIN NEUROBIOL, V18, P389, DOI 10.1016/j.conb.2008.09.006; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008; Johnson SL, 2008, J PHYSIOL-LONDON, V586, P1029, DOI 10.1113/jphysiol.2007.145219; Johnson SL, 2007, J PHYSIOL-LONDON, V583, P631, DOI 10.1113/jphysiol.2007.136630; Johnson SL, 2011, NAT NEUROSCI, V14, P711, DOI 10.1038/nn.2803; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Knipper M, 1998, DEVELOPMENT, V125, P3709; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Lennan GWT, 1999, PFLUG ARCH EUR J PHY, V438, P40, DOI 10.1007/s004240050877; Li GQ, 2010, AM J PHYSIOL-REG I, V298, pR351, DOI 10.1152/ajpregu.00460.2009; Marcotti W, 2004, J PHYSIOL-LONDON, V560, P691, DOI 10.1113/jphysiol.2004.072868; Marcotti W, 2003, J PHYSIOL-LONDON, V552, P743, DOI 10.1113/jphysiol.2003.043612; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Masetto S, 2003, J NEUROPHYSIOL, V90, P1266, DOI 10.1152/jn.01157.2002; Milburn T, 1995, RECEPTOR CHANNEL, V3, P201; Moody WJ, 2005, PHYSIOL REV, V85, P883, DOI 10.1152/physrev.00017.2004; MULLER M, 1991, HEARING RES, V56, P1, DOI 10.1016/0378-5955(91)90147-2; Nouvian R, 2007, J PHYSIOL-LONDON, V584, P535, DOI 10.1113/jphysiol.2007.139675; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Oliver D, 1997, PFLUG ARCH EUR J PHY, V434, P772, DOI 10.1007/s004240050464; Pineda RH, 2006, DEVELOPMENT, V133, P3827, DOI 10.1242/dev.02559; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Richardson PJ, 2000, J NEUROCHEM, V74, P839, DOI 10.1046/j.1471-4159.2000.740839.x; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; SUGIHARA I, 1989, J NEUROPHYSIOL, V62, P1330, DOI 10.1152/jn.1989.62.6.1330; Vega-Saenz de Miera E, 1997, P NATL ACAD SCI USA, V94, P7059; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WITT CM, 1994, J NEUROPHYSIOL, V72, P1037, DOI 10.1152/jn.1994.72.2.1037; Wooltorton JRA, 2007, J NEUROPHYSIOL, V97, P1684, DOI 10.1152/jn.00649.2006; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	46	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45732	10.1371/journal.pone.0045732	http://dx.doi.org/10.1371/journal.pone.0045732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029208	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000309388400126
J	Maia, MF; Abonuusum, A; Lorenz, LM; Clausen, PH; Bauer, B; Garms, R; Kruppa, T				Maia, Marta Ferreira; Abonuusum, Ayimbire; Lorenz, Lena Maria; Clausen, Peter-Henning; Bauer, Burkhard; Garms, Rolf; Kruppa, Thomas			The Effect of Deltamethrin-treated Net Fencing around Cattle Enclosures on Outdoor-biting Mosquitoes in Kumasi, Ghana	PLOS ONE			English	Article							BLOOD-FEEDING BEHAVIOR; ANOPHELES-ARABIENSIS; PASSIVE ZOOPROPHYLAXIS; MALARIA VECTOR; PYRETHROID INSECTICIDES; BIOKO ISLAND; TSETSE-FLIES; GAMBIAE; TRANSMISSION; PREVENTION	Classic vector control strategies target mosquitoes indoors as the main transmitters of malaria are indoor-biting and resting mosquitoes. However, the intensive use of insecticide-treated bed-nets (ITNs) and indoor residual spraying have put selective pressure on mosquitoes to adapt in order to obtain human blood meals. Thus, early-evening and outdoor vector activity is becoming an increasing concern. This study assessed the effect of a deltamethrin-treated net (100 mg/m(2)) attached to a one-meter high fence around outdoor cattle enclosures on the number of mosquitoes landing on humans. Mosquitoes were collected from four cattle enclosures: Pen A - with cattle and no net; B - with cattle and protected by an untreated net; C - with cattle and protected by a deltamethrin-treated net; D - no cattle and no net. A total of 3217 culicines and 1017 anophelines were collected, of which 388 were Anopheles gambiae and 629 An. ziemanni. In the absence of cattle nearly 3 times more An. gambiae (p<0.0001) landed on humans. The deltamethrin-treated net significantly reduced (nearly three-fold, p<0.0001) culicine landings inside enclosures. The sporozoite rate of the zoophilic An. ziemanni, known to be a secondary malaria vector, was as high as that of the most competent vector An. gambiae; raising the potential of zoophilic species as secondary malaria vectors. After deployment of the ITNs a deltamethrin persistence of 9 months was observed despite exposure to African weather conditions. The outdoor use of ITNs resulted in a significant reduction of host-seeking culicines inside enclosures. Further studies investigating the effectiveness and spatial repellence of ITNs around other outdoor sites, such as bars and cooking areas, as well as their direct effect on vector-borne disease transmission are needed to evaluate its potential as an appropriate outdoor vector control tool for rural Africa.	[Maia, Marta Ferreira; Lorenz, Lena Maria] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Maia, Marta Ferreira] Ifakara Hlth Inst, Bagamoyo, Pwani Region, Tanzania; [Abonuusum, Ayimbire] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Garms, Rolf; Kruppa, Thomas] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Clausen, Peter-Henning; Bauer, Burkhard] Free Univ Berlin, Fac Vet Med, Inst Parasitol & Trop Vet Med, Berlin, Germany	University of London; London School of Hygiene & Tropical Medicine; Ifakara Health Institute; Kumasi Center for Collaborative Research; Bernhard Nocht Institut fur Tropenmedizin; Free University of Berlin	Maia, MF (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Marta.Maia@lshtm.ac.uk	Maia, Marta/I-6003-2019	Maia, Marta/0000-0003-3302-5610; Lorenz, Lena/0000-0002-4724-1421	Vestergaard Frandsen Co.; Vestergaard Frandsen	Vestergaard Frandsen Co.; Vestergaard Frandsen	The study was funded by Vestergaard Frandsen Co. (www.vestergaard-frandsen.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Flight expenses to Kumasi, construction of the animal enclosures and provision of the experimental nets was sponsored by the Vestergaard Frandsen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abonuusum A, 2011, PARASITOL RES, V108, P1465, DOI 10.1007/s00436-010-2195-1; Afrane YA, 2004, ACTA TROP, V89, P125, DOI 10.1016/j.actatropica.2003.06.001; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; ArredondoJimenez JI, 1997, MED VET ENTOMOL, V11, P87, DOI 10.1111/j.1365-2915.1997.tb00294.x; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BAUER B, 1992, TROP MED PARASITOL, V43, P41; Bauer B, 2006, TROP ANIM HEALTH PRO, V38, P29, DOI 10.1007/s11250-006-4343-2; BAUER B, 1995, TROP MED PARASITOL, V46, P183; Bauer B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001343; Bogh C, 2002, T ROY SOC TROP MED H, V96, P593, DOI 10.1016/S0035-9203(02)90320-2; Bogh C, 2001, J MED ENTOMOL, V38, P822, DOI 10.1603/0022-2585-38.6.822; BOUMA M, 1995, T ROY SOC TROP MED H, V89, P351, DOI 10.1016/0035-9203(95)90004-7; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; CHANDLER JA, 1975, T ROY SOC TROP MED H, V69, P415, DOI 10.1016/0035-9203(75)90200-X; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Darriet F, 2000, B SOC PATHOL EXOT, V93, P131; Fornadel CM, 2010, AM J TROP MED HYG, V83, P848, DOI 10.4269/ajtmh.2010.10-0242; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Githeko AK, 1996, EXP PARASITOL, V82, P306, DOI 10.1006/expr.1996.0038; Hewitt S, 1999, TROP MED INT HEALTH, V4, P481, DOI 10.1046/j.1365-3156.1999.00433.x; HEWITT S, 1994, MED VET ENTOMOL, V8, P160, DOI 10.1111/j.1365-2915.1994.tb00156.x; Hill N, 2007, BMJ, V55; Hlatshwayo M, 2005, ONDERSTEPOORT J VET, V72, P245; Kawaguchi I, 2004, P ROY SOC B-BIOL SCI, V271, P301, DOI 10.1098/rspb.2003.2575; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Maia M, 2010, PARASITOL RES, V106, P1307, DOI 10.1007/s00436-010-1796-z; Manh CD, 2010, MAL J, V9; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Pates HV, 2001, B ENTOMOL RES, V91, P289, DOI 10.1079/BER200198; R Development Core Team website, 2011, R LANG ENV STAT COMP; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Riehle MM, 2011, SCIENCE, V331, P596, DOI 10.1126/science.1196759; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Saul A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-32; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Tirados I, 2006, MED VET ENTOMOL, V20, P425, DOI 10.1111/j.1365-2915.2006.652.x; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39	42	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45794	10.1371/journal.pone.0045794	http://dx.doi.org/10.1371/journal.pone.0045794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029245	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000309388400130
J	Kitazume, S; Yoshihisa, A; Yamaki, T; Oikawa, M; Tachida, Y; Ogawa, K; Imamaki, R; Hagiwara, Y; Kinoshita, N; Takeishi, Y; Furukawa, K; Tomita, N; Arai, H; Iwata, N; Saido, T; Yamamoto, N; Taniguchi, N				Kitazume, Shinobu; Yoshihisa, Akiomi; Yamaki, Takayoshi; Oikawa, Masayoshi; Tachida, Yuriko; Ogawa, Kazuko; Imamaki, Rie; Hagiwara, Yoshiaki; Kinoshita, Noriaki; Takeishi, Yasuchika; Furukawa, Katsutoshi; Tomita, Naoki; Arai, Hiroyuki; Iwata, Nobuhisa; Saido, Takaomi; Yamamoto, Naomasa; Taniguchi, Naoyuki			Soluble Amyloid Precursor Protein 770 Is Released from Inflamed Endothelial Cells and Activated Platelets A NOVEL BIOMARKER FOR ACUTE CORONARY SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; CEREBRAL THROMBOSIS; BETA PRODUCTION; ANGIOPATHY; APP; PATHOGENESIS; PERSPECTIVE; INHIBITION; MECHANISMS	Most Alzheimer disease (AD) patients show deposition of amyloid beta (A beta) peptide in blood vessels as well as the brain parenchyma. We previously found that vascular endothelial cells express amyloid beta precursor protein (APP) 770, a different APP isoform from neuronal APP695, and produce A beta. Since the soluble APP cleavage product, sAPP, is considered to be a possible marker for AD diagnosis, sAPP has been widely measured as a mixture of these variants. We hypothesized that measurement of the endothelial APP770 cleavage product in patients separately from that of neuronal APP695 would enable discrimination between endothelial and neurological dysfunctions. Using our newly developed ELISA system for sAPP770, we observed that inflammatory cytokines significantly enhanced sAPP770 secretion by endothelial cells. Furthermore, we unexpectedly found that sAPP770 was rapidly released from activated platelets. We also found that cerebrospinal fluid mainly contained sAPP695, while serum mostly contained sAPP770. Finally, to test our hypothesis that sAPP770 could be an indicator for endothelial dysfunction, we applied our APP770 ELISA to patients with acute coronary syndrome (ACS), in which endothelial injury and platelet activation lead to fibrous plaque disruption and thrombus formation. Development of a biomarker is essential to facilitate ACS diagnosis in clinical practice. The results revealed that ACS patients had significantly higher plasma sAPP770 levels. Furthermore, in myocardial infarction model rats, an increase in plasma sAPP preceded the release of cardiac enzymes, currently used markers for acute myocardial infarction. These findings raise the possibility that sAPP770 can be a useful biomarker for ACS.	[Kitazume, Shinobu; Imamaki, Rie; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Yoshihisa, Akiomi; Yamaki, Takayoshi; Oikawa, Masayoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut Cardiol & Hematol, Fukushima 9601295, Japan; [Hagiwara, Yoshiaki; Kinoshita, Noriaki] Immunobiol Labs Co Ltd, Dept Biol Sci, Fujioka, Gunma 3750005, Japan; [Furukawa, Katsutoshi; Tomita, Naoki; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Div Brain Sci, Dept Geriatr & Gerontol,Aoba Ku, Sendai, Miyagi 9808575, Japan; [Iwata, Nobuhisa; Saido, Takaomi] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Yamamoto, Naomasa] Ohu Univ, Sch Pharmaceut Sci, Dept Biochem, Koriyama, Fukushima 9638611, Japan	RIKEN; Fukushima Medical University; Immuno-Biological Laboratories Co. Ltd.; Tohoku University; RIKEN	Kitazume, S (corresponding author), RIKEN, Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	shinobuk@riken.jp	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Taniguchi, Naoyuki/I-4182-2014; Taniguchi, Naoyuki/A-7086-2016	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Taniguchi, Naoyuki/0000-0001-5889-5968; 	Systems Glycobiology Research Project; strategic programs for RD of RIKEN; Ministry of Education, Science, Sports and Culture of Japan; Takeda Science Foundation	Systems Glycobiology Research Project; strategic programs for RD of RIKEN; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the Systems Glycobiology Research Project and from the strategic programs for R&D of RIKEN (to N. T.), a Grant-in Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (to N. T. and S. K.), and a grant from the Takeda Science Foundation (to S. K.).	ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; BUSH AI, 1990, J BIOL CHEM, V265, P15977; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Esiri MM, 1999, LANCET, V354, P919, DOI 10.1016/S0140-6736(99)02355-7; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; GLENNER GG, 1981, ANN PATHOL, V1, P120; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; Han BH, 2008, J NEUROSCI, V28, P13542, DOI 10.1523/JNEUROSCI.4686-08.2008; Jagust WJ, 1998, NEUROLOGY, V51, P1009, DOI 10.1212/WNL.51.4.1009; Kim ML, 2008, J NEUROSCI, V28, P12052, DOI 10.1523/JNEUROSCI.2913-08.2008; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; MANDYBUR TI, 1975, NEUROLOGY, V25, P120, DOI 10.1212/WNL.25.2.120; Maruyama M, 2004, ARCH NEUROL-CHICAGO, V61, P716, DOI 10.1001/archneur.61.5.716; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PROHOVNIK I, 1988, NEUROLOGY, V38, P931, DOI 10.1212/WNL.38.6.931; SCHMAIER AH, 1993, J CLIN INVEST, V92, P2540, DOI 10.1172/JCI116863; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Tachida Y, 2008, J NEUROCHEM, V104, P1387, DOI 10.1111/j.1471-4159.2007.05127.x; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; VANNOSTRAND WE, 1990, SCIENCE, V248, P745, DOI 10.1126/science.2110384; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wu GX, 2011, J NEUROSCI RES, V89, P822, DOI 10.1002/jnr.22618; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Xu F, 2009, J NEUROSCI, V29, P5666, DOI 10.1523/JNEUROSCI.0095-09.2009; Yaoita H, 2002, CIRCULATION, V105, P975, DOI 10.1161/hc0802.104503; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102	36	39	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40817	40825		10.1074/jbc.M112.398578	http://dx.doi.org/10.1074/jbc.M112.398578			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23033480	hybrid, Green Published			2022-12-25	WOS:000311448800069
J	Liang, JL; Huang, W; Yu, XY; Ashraf, A; Wary, KK; Xu, MF; Millard, RW; Ashraf, M; Wang, YG				Liang, Jialiang; Huang, Wei; Yu, Xiyong; Ashraf, Atif; Wary, Kishore K.; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang			Suicide Gene Reveals the Myocardial Neovascularization Role of Mesenchymal Stem Cells Overexpressing CXCR4 (MSCCXCR4)	PLOS ONE			English	Article							MARROW-DERIVED CELLS; ETS-BINDING-SITES; CARDIAC-FUNCTION; PROGENITOR CELLS; INFARCTED MYOCARDIUM; ENDOTHELIAL-CELLS; IN-VITRO; HYPOXIA; EXPRESSION; REPAIR	Background: Our previous studies indicated that MSCCXCR4 improved cardiac function after myocardial infarction (MI). This study was aimed to investigate the specific role of MSCCXCR4 in neovascularization of infarcted myocardium using a suicide gene approach. Methods: MSCs were transduced with either lentivirus-null vector/GFP (MSCNull as control) or vector encoding for overexpressing CXCR4/GFP. The MSC derived-endothelial cell (EC) differentiation was assessed by a tube formation assay, Dil-ac-LDL uptake, EC marker expression, and VE-cadherin promoter activity assay. Gene expression was analyzed by quantitative RT-PCR or Western blot. The suicide gene approach was under the control of VE-cadherin promoter. In vivo studies: Cell patches containing MSCNull or MSCCXCR4 were transduced with suicide gene and implanted into the myocardium of MI rat. Rats received either ganciclovir (GCV) or vehicle after cell implantation. After one month, the cardiac functional changes and neovascularization were assessed by echocardiography, histological analysis, and micro-CT imaging. Results: The expression of VEGF-A and HIF-1 alpha was significantly higher in MSCCXCR4 as compared to MSCNull under hypoxia. Additionally, MSCCXCR4 enhanced new vessel formation and EC differentiation, as well as STAT3 phosphorylation under hypoxia. STAT3 participated in the transcription of VE-cadherin in MSCCXCR4 under hypoxia, which was inhibited by WP1066 (a STAT3 inhibitor). In addition, GCV specifically induced death of ECs with suicide gene activation. In vivo studies: MSCCXCR4 implantation promoted cardiac functional restoration, reduced infarct size, improved cardiac remodeling, and enhanced neovascularization in ischemic heart tissue. New vessels derived from MSCCXCR4 were observed at the injured heart margins and communicated with native coronary arteries. However, the derived vessel networks were reduced by GCV, reversing improvement of cardiac function. Conclusion: The transplanted MSCCXCR4 enhanced neovascularization after MI by boosting release of angiogenic factors and increasing the potential of endothelial differentiation.	[Liang, Jialiang; Huang, Wei; Ashraf, Atif; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang] Univ Cincinnati, Med Ctr, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Liang, Jialiang; Huang, Wei; Ashraf, Atif; Xu, Meifeng; Millard, Ronald W.; Ashraf, Muhammad; Wang, Yigang] Univ Cincinnati, Med Ctr, Coll Med, Dept Pharmacol & Cell Biophys, Cincinnati, OH 45267 USA; [Liang, Jialiang; Yu, Xiyong] So Med Univ, Guangdong Acad Med Sci, Guangdong Gen Hosp, Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Wary, Kishore K.] Univ Illinois, Dept Pharmacol, Chicago, IL USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	yi-gang.wang@uc.edu	Ashraf, Muhammad/ABB-3463-2021; HUANG, WEI/A-4639-2013; LIANG, JIALIANG/L-5865-2015	LIANG, JIALIANG/0000-0001-8033-741X; Huang, Wei/0000-0003-3046-4220; Liang, Jialiang/0000-0002-1556-7195; Wary, Kishore/0000-0001-8851-8565	National Institutes of Health [HL081859, HL089824, HL110740, HL-080686, R37HL-074272]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081859, R01HL089824, R01HL110740, R01HL079356, R37HL074272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health grants HL081859, HL089824, and HL110740 (to YW); HL-080686 and R37HL-074272 (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shoshan J, 2008, STEM CELLS, V26, P2634, DOI 10.1634/stemcells.2008-0369; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Dai B, 2011, J AM COLL CARDIOL, V58, P2118, DOI 10.1016/j.jacc.2011.06.062; Davani S, 2003, CIRCULATION, V108, P253, DOI 10.1161/01.cir.0000089186.09692.fa; Eun LY, 2010, BIOCHEM BIOPH RES CO, V402, P272, DOI 10.1016/j.bbrc.2010.10.013; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gory S, 1998, J BIOL CHEM, V273, P6750, DOI 10.1074/jbc.273.12.6750; Gory S, 1999, BLOOD, V93, P184, DOI 10.1182/blood.V93.1.184.401a20_184_192; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang CY, 2011, AM J PHYSIOL-HEART C, V301, pH1496, DOI 10.1152/ajpheart.00365.2011; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Huber P, 1996, GENOMICS, V32, P21, DOI 10.1006/geno.1996.0072; Iwakura T, 2011, J MOL CELL CARDIOL, V51, P207, DOI 10.1016/j.yjmcc.2011.04.013; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mavria G, 2001, GENE THER, V8, P913, DOI 10.1038/sj.gt.3301483; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; MULLEN CA, 1994, PHARMACOL THERAPEUT, V63, P199, DOI 10.1016/0163-7258(94)90046-9; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Perry TE, 2009, CARDIOVASC RES, V84, P317, DOI 10.1093/cvr/cvp215; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Rivard A, 1998, MOL MED, V4, P429, DOI 10.1007/BF03401749; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shabbir A, 2010, AM J PHYSIOL-HEART C, V299, pH1428, DOI 10.1152/ajpheart.00488.2010; Venkatesan S, 2003, MOL BIOL CELL, V14, P3305, DOI 10.1091/mbc.e02-11-0714; Walshe TE, 2008, ANNU REV PATHOL-MECH, V3, P615, DOI 10.1146/annurev.pathmechdis.3.121806.151501; Wang YG, 2010, AM J PHYSIOL-HEART C, V298, pH275, DOI 10.1152/ajpheart.00765.2009; Xu J, 2008, J CELL MOL MED, V12, P2395, DOI 10.1111/j.1582-4934.2008.00266.x; Yin LY, 2012, CIRC RES, V110, P241, DOI 10.1161/CIRCRESAHA.111.250126; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhang DS, 2010, AM J PHYSIOL-HEART C, V299, pH1339, DOI 10.1152/ajpheart.00592.2010; Zhang YY, 2004, STEM CELLS, V22, P1015, DOI 10.1634/stemcells.22-6-1015; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463; Ziegelhoeffer T, 2004, CIRC RES, V94, P230, DOI 10.1161/01.RES.0000110419.50982.1C	44	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46158	10.1371/journal.pone.0046158	http://dx.doi.org/10.1371/journal.pone.0046158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029422	Green Published, gold			2022-12-25	WOS:000309973900102
J	Mokudai, T; Nakamura, K; Kanno, T; Niwano, Y				Mokudai, Takayuki; Nakamura, Keisuke; Kanno, Taro; Niwano, Yoshimi			Presence of Hydrogen Peroxide, a Source of Hydroxyl Radicals, in Acid Electrolyzed Water	PLOS ONE			English	Article							OXIDIZING WATER; HYPOCHLOROUS ACID; ESCHERICHIA-COLI; SPIN-RESONANCE; BACTERICIDAL ACTIVITY; DISINFECTION; SCAVENGERS; INHIBITION; PHOTOLYSIS; EFFICIENCY	Background: Acid electrolyzed water (AEW), which is produced through the electrolysis of dilute sodium chloride (NaCl) or potassium chloride solution, is used as a disinfectant in various fields because of its potent antimicrobial activity. The hydroxyl radical, an oxygen radical species, is often suggested as a putative active ingredient for AEW antimicrobial activity. Methodology/Principal Findings: The aim of the present study is to detect hydroxyl radicals in AEW. The hydroxyl radicals in AEW prepared under different conditions were determined using an electron spin resonance (ESR) technique. A signal from 5,5-dimethyl-1-pyrroline N-oxide (DMPO)-OH, an adduct of DMPO and the hydroxyl radical, was detected in AEW prepared by double or triple electrolyses of 1% NaCl but not of 0.1% NaCl solution. Then the presence of hydrogen peroxide as a proposed source of hydroxyl radicals was examined using a combination of ESR and a Fenton reaction. The DMPO-OH signal was clearly detected, even in AEW prepared by single electrolysis of 0.1% NaCl solution, when ferrous sulfate was added to induce a Fenton reaction, indicating the presence of hydrogen peroxide in the AEW. Since sodium formate, a hydroxyl radical scavenger, did not affect the bactericidal activity of AEW, it is concluded that the radical is unlikely to contribute to the antimicrobial activity of AEW, although a small amount of the radical is produced from hydrogen peroxide. Dimethyl sulfoxide, the other hydroxyl radical scavenger used in the present study, canceled the bactericidal activity of AEW, accompanied by complete depletion of free available chlorine, suggesting that hypochlorous acid is probably a major contributor to the antimicrobial activity. Conclusions: It is strongly suggested that although hydrogen peroxide is present in AEW as a source of hydroxyl radicals, the antimicrobial activity of AEW does not depend on these radicals.	[Mokudai, Takayuki; Nakamura, Keisuke; Kanno, Taro; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan	Tohoku University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan.	y.niwano@m.tohoku.ac.jp	MOKUDAI, TAKAYUKI/AAK-1541-2020; Mokudai, Takayuki/M-1029-2018; Niwnao, Yoshimi/Z-3593-2019	MOKUDAI, TAKAYUKI/0000-0003-4628-6908; Mokudai, Takayuki/0000-0003-4628-6908; 	Ministry of Education, Science, Sports and Culture, Japan [23590144]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 23590144, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haq MM, 2005, FOOD SCI TECHNOL RES, V11, P135, DOI 10.3136/fstr.11.135; ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548; [Anonymous], 1985, STANDARD METHODS EXA, P309; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; BECKING LGMB, 1960, J GEOL, V68, P243, DOI 10.1086/626659; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Cao W, 2009, INT J FOOD MICROBIOL, V130, P88, DOI 10.1016/j.ijfoodmicro.2008.12.021; Fabrizio KA, 2004, MEAT SCI, V68, P463, DOI 10.1016/j.meatsci.2004.04.013; Feliciano L, 2012, J FOOD SCI, V77, pM182, DOI 10.1111/j.1750-3841.2012.02633.x; Guentzel JL, 2008, FOOD MICROBIOL, V25, P36, DOI 10.1016/j.fm.2007.08.003; Handojo A, 2009, J FOOD PROTECT, V72, P1315, DOI 10.4315/0362-028X-72.6.1315; Herskind C, 1988, RADIAT RES, V1114, P28; Hotta K, 2000, J JPN SOC INTENSIVE, V7, P97; HURST JK, 1991, EUR J BIOCHEM, V202, P1275, DOI 10.1111/j.1432-1033.1991.tb16500.x; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Kiura H, 2002, J MICROBIOL METH, V49, P285, DOI 10.1016/S0167-7012(01)00385-2; Lee JH, 2004, J GASTROEN HEPATOL, V19, P897, DOI 10.1111/j.1440-1746.2004.03375.x; Lu ZH, 2010, J FOOD PROTECT, V73, P483, DOI 10.4315/0362-028X-73.3.483; Nagamatsu Y, 2001, Dent Mater J, V20, P148; Nakagawara S, 1998, ANAL SCI, V14, P691, DOI 10.2116/analsci.14.691; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Nisola GM, 2011, J ENVIRON SCI HEAL A, V46, P263, DOI 10.1080/10934529.2011.535428; Northcutt J, 2007, POULTRY SCI, V86, P2239, DOI 10.1093/ps/86.10.2239; Oomori T, 2000, ANAL SCI, V16, P365, DOI 10.2116/analsci.16.365; PANGANAMALA RV, 1976, PROSTAGLANDINS, V11, P599, DOI 10.1016/0090-6980(76)90063-0; Park YB, 2009, J FOOD SCI, V74, pM185, DOI 10.1111/j.1750-3841.2009.01139.x; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Rahman SME, 2011, FOOD MICROBIOL, V28, P484, DOI 10.1016/j.fm.2010.10.006; Rahman SME, 2010, INT J FOOD MICROBIOL, V139, P147, DOI 10.1016/j.ijfoodmicro.2010.03.020; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rodriguez-Garcia O, 2011, J FOOD PROTECT, V74, P1552, DOI 10.4315/0362-028X.JFP-11-047; Sharma RR, 2003, INT J FOOD MICROBIOL, V86, P231, DOI 10.1016/S0168-1605(02)00549-4; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; SIES H, 1992, ANN NY ACAD SCI, V669, P7; Stan SD, 2005, J AGR FOOD CHEM, V53, P4906, DOI 10.1021/jf047918k; SUTHANTHIRAN M, 1984, NATURE, V307, P276, DOI 10.1038/307276a0; Tanaka N, 2000, ARTIF ORGANS, V24, P921, DOI 10.1046/j.1525-1594.2000.06611.x; Tsuchiya K, 2004, J FUNCTIONAL WATER, V2, P75; WINTERBOURN CC, 1987, FREE RADICAL BIO MED, V3, P33, DOI 10.1016/0891-5849(87)90037-2; Yonemori S, 1997, NIPPON KAGAKU KAISHI, P497, DOI 10.1246/nikkashi.1997.497	41	31	30	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46392	10.1371/journal.pone.0046392	http://dx.doi.org/10.1371/journal.pone.0046392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029505	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900152
J	Nalbandian, A; Llewellyn, KJ; Kitazawa, M; Yin, HZ; Badadani, M; Khanlou, N; Edwards, R; Nguyen, C; Mukherjee, J; Mozaffar, T; Watts, G; Weiss, J; Kimonis, VE				Nalbandian, Angele; Llewellyn, Katrina J.; Kitazawa, Masashi; Yin, Hong Z.; Badadani, Mallikarjun; Khanlou, Negar; Edwards, Robert; Christopher Nguyen; Mukherjee, Jogeshwar; Mozaffar, Tahseen; Watts, Giles; Weiss, John; Kimonis, Virginia E.			The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; PAGET-DISEASE; FRONTOTEMPORAL DEMENTIA; CELL-DEATH; BONE; MUTATIONS; AUTOPHAGY; FAMILY; MITOCHONDRIA	Valosin containing protein (VCP) mutations are the cause of hereditary inclusion body myopathy, Paget's disease of bone, frontotemporal dementia (IBMPFD). VCP gene mutations have also been linked to 2% of isolated familial amyotrophic lateral sclerosis (ALS). VCP is at the intersection of disrupted ubiquitin proteasome and autophagy pathways, mechanisms responsible for the intracellular protein degradation and abnormal pathology seen in muscle, brain and spinal cord. We have developed the homozygous knock-in VCP mouse (VCPR155H/R155H) model carrying the common R155H mutations, which develops many clinical features typical of the VCP-associated human diseases. Homozygote VCPR155H/R155H mice typically survive less than 21 days, exhibit weakness and myopathic changes on EMG. MicroCT imaging of the bones reveal non-symmetrical radiolucencies of the proximal tibiae and bone, highly suggestive of PDB. The VCPR155H/R155H mice manifest prominent muscle, heart, brain and spinal cord pathology, including striking mitochondrial abnormalities, in addition to disrupted autophagy and ubiquitin pathologies. The VCPR155H/R155H homozygous mouse thus represents an accelerated model of VCP disease and can be utilized to elucidate the intricate molecular mechanisms involved in the pathogenesis of VCP-associated neurodegenerative diseases and for the development of novel therapeutic strategies.	[Nalbandian, Angele; Llewellyn, Katrina J.; Badadani, Mallikarjun; Christopher Nguyen; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Kitazawa, Masashi] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA USA; [Yin, Hong Z.; Mozaffar, Tahseen; Weiss, John] Univ Calif Irvine, Dept Neurol Anat & Neurobiol, Irvine, CA USA; [Khanlou, Negar] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Edwards, Robert] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Mukherjee, Jogeshwar] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Mozaffar, Tahseen] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA; [Watts, Giles] Univ E Anglia, Dept Cell Biol & Biochem, Norwich NR4 7TJ, Norfolk, England	University of California System; University of California Irvine; University of California System; University of California Merced; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of East Anglia	Kimonis, VE (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	vkimonis@uci.edu	weiss, john/B-4283-2008; Mukherjee, Jogeshwar/O-1320-2013; Mozaffar, Tahseen/AAE-6971-2020; Kitazawa, Masashi/AAI-1721-2021	weiss, john/0000-0001-9323-7813; Mukherjee, Jogeshwar/0000-0003-1009-877X; Kitazawa, Masashi/0000-0003-2165-8197	National Institutes of Health (NIH) [AR050236]; Muscular Dystrophy Association (MDA) [175682]; National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR054695];  [NS36548]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054695, R01AR050236, K99AR054695, R21AR063360, R56AR050236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant AR050236 and Muscular Dystrophy Association (MDA) 175682 to VK; and NS36548 to JW; and National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS) grant AR054695 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon Y, 2012, NEUROBIOL AGING; Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Brettschneider J, 2012, ACTA NEUROPATHOL; Calvo AFB, 2012, CARIES RES, V46, P31, DOI 10.1159/000335125; CUSTER SK, 2010, HUM MOL GENET; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Garner TP, 2011, BIOCHEMISTRY-US, V50, P4665, DOI 10.1021/bi200079n; Gomes L. C., 2012, BIOCH BIOPHYS ACTA; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Heinen C, 2010, FEBS LETT, V584, P1585, DOI 10.1016/j.febslet.2010.03.018; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376; Kimonis V., 2007, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Leigh PN, 2010, NAT REV NEUROL, V6, P191, DOI 10.1038/nrneurol.2010.33; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nalbandian A, 2012, MUSCLE NERV IN PRESS; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Shi Z, 2012, EUR J NEUROL, V19, P501, DOI 10.1111/j.1468-1331.2011.03575.x; Spina S, 2008, FASEB J, V22, P5854; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Viassolo V, 2008, CLIN GENET; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yin H, 2012, CELL DEATH IN PRESS	51	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46308	10.1371/journal.pone.0046308	http://dx.doi.org/10.1371/journal.pone.0046308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029473	Green Published, gold			2022-12-25	WOS:000309973900130
J	Zhang, LB; Wang, KZ; Zhao, FL; Hu, WP; Chen, JJ; Lanza, GM; Shen, BZ; Zhang, B				Zhang, Lingbo; Wang, Kezheng; Zhao, Falin; Hu, Weiping; Chen, Junjie; Lanza, Gregory M.; Shen, Baozhong; Zhang, Bin			Near Infrared Imaging of EGFR of Oral Squamous Cell Carcinoma in Mice Administered Arsenic Trioxide	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACUTE PROMYELOCYTIC LEUKEMIA; INDUCED APOPTOSIS; CANCER CELLS; EXPRESSION; XENOGRAFTS; METASTASIS; ACTIVATION; RESISTANCE; INHIBITION	Background: The effectiveness of near-infrared imaging (NIR) interrogation of epidermal growth factor receptor (EGFR) expression as a sensitive biomarker of oral squamous cell carcinoma (OSCC) response to arsenic trioxide therapy was studied in mice. Material and Methods: A431 OSCC in vitro were exposed to 0 mu M, 0.5 mu M, 2.5 mu M, or 5 mu M of As2O3 for 0 h, 24 h, 48 h and 72 h. Confocal microscopy and flow cytometry confirmed EGFR expression and demonstrated a sensitivity dose-related signal decline with As2O3 treatment. Next, mice with pharynx-implanted A431 cells received As2O3 i.p. every 48 h at 0.0, 0.5, 2.5, or 5 mg/kg/day (n = 6/group) from day 0 to 10. An intravenous NIR probe, EGF-Cy5.5, was injected at baseline and on days 4, 8, and 12 for dynamic NIR imaging. Tumor volume and body weights were measured three times weekly. Results: In vitro, A431 EGFR expression was well appreciated in the controls and decreased (p<0.05) with increasing As2O3 dose and treatment duration. In vivo EGFR NIR tumor signal intensity decreased (p<0.05) in As2O3 treated groups versus controls from days 4 to 12, consistent with increasing dosage. Tumor volume diminished in a dose-related manner while body weight was unaffected. Immunohistochemical staining of excised tumors confirmed that EGFR expression was reduced by As2O3 treatment in a dose responsive pattern. Conclusion: This study demonstrates for the first time that OSCC can be interrogated in vivo by NIR molecular imaging of the EGFR and that this biomarker is effective for the longitudinal assessment of OSCC response to As2O3 treatment.	[Wang, Kezheng; Shen, Baozhong] Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Wang, Kezheng; Shen, Baozhong] Harbin Med Univ, Mol Imaging Ctr, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China; [Zhang, Lingbo; Hu, Weiping; Zhang, Bin] Harbin Med Univ, Dept Stomatol, Inst Hard Tissue Dev & Regenerat, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China; [Zhao, Falin] Hangzhou Normal Univ, Sch Hlth Management, Hangzhou, Zhejiang, Peoples R China; [Chen, Junjie; Lanza, Gregory M.] Washington Univ, Div Cardiol, Sch Med, St Louis, MO USA; [Chen, Junjie; Lanza, Gregory M.] Washington Univ, C TRAIN, Sch Med, St Louis, MO USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Hangzhou Normal University; Washington University (WUSTL); Washington University (WUSTL)	Shen, BZ (corresponding author), Harbin Med Univ, Dept Radiol, Affiliated Hosp 4, Harbin, Heilongjiang, Peoples R China.	baozhongshen@gmail.com; zhangbinhmu@gmail.com			National Natural Science Foundation of China [81170960, 81130028, 30970807, 30570527]; International Cooperation and Exchanges Program of the National Ministry of Science and Technology [2009DFB30040]; Foundation of Department of Science and Technology of Heilongjiang Province [GC12C303-2]; National Natural Science Foundation for Young Scholars of China [81101086]; China Postdoctoral Science Foundation [20100471020]; Medical Scientific Research Foundation of Heilongjiang Province Health Department [2010-156]; National Institutes of Health [CA119342, CA154737, HL094470, HL073646, HL078631, HL113392, AR056468, NS073457]; DOD [CA100623]; NATIONAL CANCER INSTITUTE [R01CA154737, R21CA100623, U54CA119342] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113392, R01HL078631, R01HL094470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS073457] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Program of the National Ministry of Science and Technology; Foundation of Department of Science and Technology of Heilongjiang Province; National Natural Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical Scientific Research Foundation of Heilongjiang Province Health Department; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge grant support from the National Natural Science Foundation of China (81170960, 81130028, 30970807 and 30570527) (for BZ, BS), the International Cooperation and Exchanges Program of the National Ministry of Science and Technology (2009DFB30040) (for BS), Foundation of Department of Science and Technology of Heilongjiang Province (GC12C303-2) (for BZ), the National Natural Science Foundation for Young Scholars of China (81101086) (for KW), China Postdoctoral Science Foundation (20100471020) (for KW) and Medical Scientific Research Foundation of Heilongjiang Province Health Department (2010-156) (for KW), and the National Institutes of Health (CA119342, CA154737, HL094470, HL073646, HL078631, HL113392, AR056468, NS073457) and DOD (CA100623) (for GML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Science Foundation of China: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm; The International Cooperation and Exchanges Program of the National Ministry of Science and Technology http://www.most.gov.cn/eng/cooperation/; Foundation of Department of Science and Technology of Heilongjiang Province: http://210.76.36.142/kjt/tztg/200902/t20090210_98480.htm; National Natural Science Foundation for Young Scholars of China: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0106.htm; China Postdoctoral Science Foundation: http://www.chinapostdoctor.org.cn/V3/Program/Main.aspx; Medical Scientific Research Foundation of Heilongjiang Province Health Department: www.hljwst.gov.cn/; NIH: http://www.nih.gov/; DOD: http://www.defense.gov/.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Atkins D, 2004, J HISTOCHEM CYTOCHEM, V52, P893, DOI 10.1369/jhc.3A6195.2004; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Cantor KP, 2007, TOXICOL APPL PHARM, V222, P252, DOI 10.1016/j.taap.2007.01.026; Chen X, 2009, ONCOL REP, V22, P73, DOI 10.3892/or_00000408; Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956; Chou YH, 2011, TOXICOL LETT, V203, P147, DOI 10.1016/j.toxlet.2011.03.017; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Gee MS, 2008, RADIOLOGY, V248, P925, DOI 10.1148/radiol.2482071496; Gleysteen JP, 2008, HEAD NECK-J SCI SPEC, V30, P782, DOI 10.1002/hed.20782; Huang HS, 2006, J BIOMED SCI, V13, P113, DOI 10.1007/s11373-005-9040-z; Jhala DD, 2008, FOOD CHEM TOXICOL, V46, P1138, DOI 10.1016/j.fct.2007.11.009; Ke S, 2003, CANCER RES, V63, P7870; Konkimalla VB, 2007, EXPERT REV ANTICANC, V7, P317, DOI 10.1586/14737140.7.3.317; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Laimer K, 2007, ORAL ONCOL, V43, P193, DOI 10.1016/j.oraloncology.2006.02.009; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Liu ZM, 2006, CELL SIGNAL, V18, P244, DOI 10.1016/j.cellsig.2005.04.006; Maeda H, 2001, CANCER RES, V61, P5432; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Nitin N, 2009, NEOPLASIA, V11, P542, DOI 10.1593/neo.09188; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Oyen WJG, 2009, NAT REV CLIN ONCOL, V6, P609, DOI 10.1038/nrclinonc.2009.139; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Rosenthal EL, 2006, LARYNGOSCOPE, V116, P1636, DOI 10.1097/01.mlg.0000232513.19873.da; Sarkis SA, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-13; SHIN DM, 1994, CANCER RES, V54, P3153; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Tichauer K. M, 2011, MOL IMAGING BIOL; Tsai CW, 2010, ANTICANCER RES, V30, P3655; Vernhet L, 2001, BIOCHEM PHARMACOL, V61, P1387, DOI 10.1016/S0006-2952(01)00606-2; Wang KZ, 2009, ACTA RADIOL, V50, P1095, DOI 10.3109/02841850903008800; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Withrow KP, 2008, TECHNOL CANCER RES T, V7, P61, DOI 10.1177/153303460800700108; Yeh KY, 2011, HEAD NECK-J SCI SPEC, V33, P734, DOI 10.1002/hed.21535; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	38	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46255	10.1371/journal.pone.0046255	http://dx.doi.org/10.1371/journal.pone.0046255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029451	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900117
J	Caugant, DA; Kristiansen, PA; Wang, X; Mayer, LW; Taha, MK; Ouedraogo, R; Kandolo, D; Bougoudogo, F; Sow, S; Bonte, L				Caugant, Dominique A.; Kristiansen, Paul A.; Wang, Xin; Mayer, Leonard W.; Taha, Muhamed-Kheir; Ouedraogo, Rasmata; Kandolo, Denis; Bougoudogo, Flabou; Sow, Samba; Bonte, Laurence			Molecular Characterization of Invasive Meningococcal Isolates from Countries in the African Meningitis Belt before Introduction of a Serogroup A Conjugate Vaccine	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; BURKINA-FASO; W135; DISEASE; EPIDEMIC; EMERGENCE; OUTBREAK; STRAIN; NIGER	Background: The serogroup A conjugate meningococcal vaccine, MenAfriVac, was introduced in mass vaccination campaigns in December 2010 in Burkina Faso, Mali and Niger. In the coming years, vaccination will be extended to other African countries at risk of epidemics. To document the molecular characteristics of disease-causing meningococcal strains circulating in the meningitis belt of Africa before vaccine introduction, the World Health Organization Collaborating Centers on Meningococci in Europe and United States established a common strain collection of 773 isolates from cases of invasive meningococcal disease collected between 2004 and 2010 from 13 sub-Saharan countries. Methodology: All isolates were characterized by multilocus sequence typing, and 487 (62%) were also analyzed for genetic variation in the surface antigens PorA and FetA. Antibiotic susceptibility was tested for part of the collection. Principal Findings: Only 19 sequence types (STs) belonging to 6 clonal complexes were revealed. ST-5 clonal complex dominated with 578 (74.8%) isolates. All ST-5 complex isolates were remarkably homogeneous in their PorA (P1.20,9) and FetA (F3-1) and characterized the serogroup A strains which have been responsible for most epidemics during this time period. Sixty-eight (8.8%) of the 773 isolates belonged to the ST-11 clonal complex which was mainly represented by serogroup W135, while an additional 38 (4.9%) W135 isolates belonged to the ST-175 complex. Forty-eight (6.2%) serogroup X isolates from West Africa belonged to the ST-181 complex, while serogroup X cases in Kenya and Uganda were caused by an unrelated clone, ST-5403. Serogroup X, ST-181, emerged in Burkina Faso before vaccine introduction. Conclusions: In the seven years preceding introduction of a new serogroup A conjugate vaccine, serogroup A of the ST-5 clonal complex was identified as the predominant disease-causing strain.	[Caugant, Dominique A.; Kristiansen, Paul A.] Norwegian Inst Publ Hlth, WHO Collaborating Ctr Reference & Res Meningococc, Oslo, Norway; [Caugant, Dominique A.] Univ Oslo, Fac Med, Oslo, Norway; [Wang, Xin; Mayer, Leonard W.] Ctr Dis Control & Prevent, WHO Collaborating Ctr Prevent & Control Epidem Me, Atlanta, GA USA; [Taha, Muhamed-Kheir] Inst Pasteur, WHO Collaborating Ctr Reference & Res Meningococc, Paris, France; [Ouedraogo, Rasmata] Ctr Hosp Univ Pediat Charles de Gaulle, Lab Reference Meningite, Ouagadougou, Burkina Faso; [Kandolo, Denis] WHO Inter Country Support Team W Africa, Ouagadougou, Burkina Faso; [Bougoudogo, Flabou] INRSP, Bamako, Mali; [Sow, Samba] CVD, Bamako, Mali; [Bonte, Laurence] Med Sans Frontieres, Support Logist, Paris, France	Norwegian Institute of Public Health (NIPH); University of Oslo; Centers for Disease Control & Prevention - USA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders	Caugant, DA (corresponding author), Norwegian Inst Publ Hlth, WHO Collaborating Ctr Reference & Res Meningococc, Oslo, Norway.	dominique.caugant@fhi.no	, dcaugant/AAH-6843-2019	, dcaugant/0000-0003-2765-9844	Norwegian Institute of Public Health; Institute Pasteur; Centres for Disease Control and Prevention	Norwegian Institute of Public Health; Institute Pasteur; Centres for Disease Control and Prevention	The work was supported by the Norwegian Institute of Public Health, Institute Pasteur and Centres for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJELLO GW, 1984, J CLIN MICROBIOL, V20, P55, DOI 10.1128/JCM.20.1.55-58.1984; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P306; Bai XL, 2010, EXPERT REV VACCINES, V9, P1203, DOI 10.1586/ERV.10.116; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Collard JM, 2010, EMERG INFECT DIS, V16, P1496, DOI 10.3201/eid1609.100510; CRAVEN DE, 1978, J CLIN MICROBIOL, V7, P410; Delrieu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019513; DENIS F, 1982, LANCET, V2, P1335; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Katz LS, 2009, NUCLEIC ACIDS RES, V37, pW606, DOI 10.1093/nar/gkp288; Koumare B, 2007, VACCINE, V25, pA37, DOI 10.1016/j.vaccine.2007.04.038; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; Lapeyssonnie L., 1963, B WHO              S, V28, P3; Materu S, 2007, EMERG INFECT DIS, V13, P944, DOI 10.3201/eid1306.070042; Mayer LW, 2002, J INFECT DIS, V185, P1596, DOI 10.1086/340414; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; Nicolas P, 2006, Med Trop (Mars), V66, P494; Nicolas P, 2005, J CLIN MICROBIOL, V43, P5129, DOI 10.1128/JCM.43.10.5129-5135.2005; Nicolas P, 1996, Med Trop (Mars), V56, P203; Ouedraogo-Traore R, 2002, SCAND J INFECT DIS, V34, P804, DOI 10.1080/0036554021000026949; Pollard A. J., 2003, EMERG INFECT DIS, V9, P1503; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; REINGOLD AL, 1985, LANCET, V2, P114; Riou J-Y, 1996, B WORLD HEALTH ORGAN, V74, P1996; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170	34	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46019	10.1371/journal.pone.0046019	http://dx.doi.org/10.1371/journal.pone.0046019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029368	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500056
J	Ogawa, T; Kawashima, N; Ogata, T; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Ogata, Toru; Nakazawa, Kimitaka			Limited Transfer of Newly Acquired Movement Patterns across Walking and Running in Humans	PLOS ONE			English	Article							RUN TRANSITION SPEED; ELECTRICAL-STIMULATION; REDUCED-GRAVITY; MOTOR TASK; LOCOMOTION; LIMB; CEREBELLUM; NETWORKS; DYNAMICS; PHASE	The two major modes of locomotion in humans, walking and running, may be regarded as a function of different speed (walking as slower and running as faster). Recent results using motor learning tasks in humans, as well as more direct evidence from animal models, advocate for independence in the neural control mechanisms underlying different locomotion tasks. In the current study, we investigated the possible independence of the neural mechanisms underlying human walking and running. Subjects were tested on a split-belt treadmill and adapted to walking or running on an asymmetrically driven treadmill surface. Despite the acquisition of asymmetrical movement patterns in the respective modes, the emergence of asymmetrical movement patterns in the subsequent trials was evident only within the same modes (walking after learning to walk and running after learning to run) and only partial in the opposite modes (walking after learning to run and running after learning to walk) (thus transferred only limitedly across the modes). Further, the storage of the acquired movement pattern in each mode was maintained independently of the opposite mode. Combined, these results provide indirect evidence for independence in the neural control mechanisms underlying the two locomotive modes.	[Ogawa, Tetsuya; Kawashima, Noritaka; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Ogawa, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan.	ogawa-tetsuya@rehab.go.jp	Ogata, Toru/ADC-3560-2022	Ogata, Toru/0000-0001-9011-8640	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grand-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to T. Ogawa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JL, 2008, J EXP BIOL, V211, P1281, DOI 10.1242/jeb.011932; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BERKOWITZ A, 1994, J NEUROSCI, V14, P5105; Budick SA, 2000, J EXP BIOL, V203, P2565; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; FARLEY CT, 1992, J APPL PHYSIOL, V73, P2709, DOI 10.1152/jappl.1992.73.6.2709; HODGSON JA, 1994, MED SCI SPORT EXER, V26, P1491; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Ito S, 1998, BIOL CYBERN, V78, P337, DOI 10.1007/s004220050438; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Kram R, 1997, J EXP BIOL, V200, P821; Lam T, 2003, J NEUROPHYSIOL, V89, P1920, DOI 10.1152/jn.01030.2002; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Ogawa T, 2011, SOC NUER ABSTR; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHIK ML, 1966, BIOPHYS-USSR, V11, P756; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292	27	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46349	10.1371/journal.pone.0046349	http://dx.doi.org/10.1371/journal.pone.0046349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029490	Green Published, gold			2022-12-25	WOS:000309517500093
J	Arsic, B; Zhu, Y; Heinrichs, DE; McGavin, MJ				Arsic, Benjamin; Zhu, Yue; Heinrichs, David E.; McGavin, Martin J.			Induction of the Staphylococcal Proteolytic Cascade by Antimicrobial Fatty Acids in Community Acquired Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							CATABOLIC MOBILE ELEMENT; GRAM-POSITIVE BACTERIA; PEPTIDE-SENSING SYSTEM; METALLOPROTEASE AUREOLYSIN; NASAL CARRIAGE; ANALYSIS REVEALS; SERINE-PROTEASE; GENOME SEQUENCE; IMMUNE EVASION; SKIN SURFACE	Community acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and the USA300 strain of CA-MRSA in particular, are known for their rapid community transmission, and propensity to cause aggressive skin and soft tissue infections. To assess factors that contribute to these hallmark traits of CA-MRSA, we evaluated how growth of USA300 and production of secreted virulence factors was influenced on exposure to physiologic levels of unsaturated free fatty acids that would be encountered on the skin or anterior nares, which represent the first sites of contact with healthy human hosts. There was a sharp threshold between sub-inhibitory and inhibitory concentrations, such that 100 mu M sapienic acid (C16:1) and linoleic acid (C18:1) were sufficient to prevent growth after 24 h incubation, while 25 mM allowed unrestricted growth, and 50 mM caused an approximate 10-12 h lag, followed by unimpeded exponential growth. Conversely, saturated palmitic or stearic acids did not affect growth at 100 mu M. Although growth was not affected by 25 mM sapienic or linoleic acid, these and other unsaturated C16 and C18 fatty acids, but not their saturated counterparts, promoted robust production of secreted proteases comprising the Staphylococcal proteolytic cascade. This trait was also manifested to varying degrees in other CA-MRSA, and in genetically diverse methicillin susceptible S. aureus strains. Therefore, induction of the Staphylococcal proteolytic cascade by unsaturated fatty acids is another feature that should now be evaluated as a potential contributing factor in the aggressive nature of skin and soft tissue infections caused by USA300, and as a general virulence mechanism of S. aureus.	[Arsic, Benjamin; Zhu, Yue; Heinrichs, David E.; McGavin, Martin J.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Heinrichs, David E.; McGavin, Martin J.] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	McGavin, MJ (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	martin.mcgavin@schulich.uwo.ca	Heinrichs, David/ABD-5702-2021	McGavin, Martin/0000-0001-5955-0689; Heinrichs, David/0000-0002-7217-2456	Natural Sciences and Engineering Research Council of Canada Discovery Grants; Western University Schulich School of Medicine and Dentistry internal award	Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Western University Schulich School of Medicine and Dentistry internal award	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grants (http://www.nserc-crsng.gc.ca) and Western University Schulich School of Medicine and Dentistry internal award (http://www.schulich.uwo.ca/research) to MJM and DEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; AYORA S, 1994, J BACTERIOL, V176, P3218, DOI 10.1128/jb.176.11.3218-3223.1994; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Beaufort N, 2008, BIOCHEM J, V410, P157, DOI 10.1042/BJ20070650; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Clarke SR, 2007, CELL HOST MICROBE, V1, P199, DOI 10.1016/j.chom.2007.04.005; Cole AM, 2001, CLIN DIAGN LAB IMMUN, V8, P1064, DOI 10.1128/CDLI.8.6.1064-1069.2001; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Do TQ, 2008, J IMMUNOL, V181, P4177, DOI 10.4049/jimmunol.181.6.4177; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Elie-Turenne MC, 2010, INFECT CONT HOSP EP, V31, P574, DOI 10.1086/652525; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gonzalez DJ, 2012, J BIOL CHEM, V287, P13889, DOI 10.1074/jbc.M112.349860; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Gyenis L, 2011, J PROTEOME RES, V10, P4887, DOI 10.1021/pr2008994; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Holtfreter S, 2009, CLIN VACCINE IMMUNOL, V16, P1607, DOI 10.1128/CVI.00263-09; Howden BP, 2008, ANTIMICROB AGENTS CH, V52, P3755, DOI 10.1128/AAC.01613-07; Imamura T, 2005, J EXP MED, V201, P1669, DOI 10.1084/jem.20042041; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kies S, 2001, INFECT IMMUN, V69, P7933, DOI 10.1128/IAI.69.12.7933-7936.2001; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948; Lai YP, 2007, MOL MICROBIOL, V63, P497, DOI 10.1111/j.1365-2958.2006.05540.x; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Massimi I, 2002, J BIOL CHEM, V277, P41770, DOI 10.1074/jbc.M207162200; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; McGavin MJ, 2012, FRONTIERS CELLULAR I, V2; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; MILLER SJ, 1988, ARCH DERMATOL, V124, P209, DOI 10.1001/archderm.124.2.209; Montgomery CP, 2009, INFECT IMMUN, V77, P2650, DOI 10.1128/IAI.00256-09; Moore PCL, 2002, J MED MICROBIOL, V51, P516, DOI 10.1099/0022-1317-51-6-516; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nickerson N, 2010, MOL MICROBIOL, V75, P161, DOI 10.1111/j.1365-2958.2009.06974.x; Nickerson NN, 2008, MOL MICROBIOL, V69, P1530, DOI 10.1111/j.1365-2958.2008.06384.x; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; Ohbayashi T, 2011, MICROBIOL-SGM, V157, P786, DOI 10.1099/mic.0.044503-0; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Pynnonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002104; Rice K, 2001, INFECT IMMUN, V69, P159, DOI 10.1128/IAI.69.1.159-169.2001; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; SHRYOCK TR, 1992, J MED MICROBIOL, V36, P288, DOI 10.1099/00222615-36-4-288; Sieprawska-Lupa M, 2004, ANTIMICROB AGENTS CH, V48, P4673, DOI 10.1128/AAC.48.12.4673-4679.2004; Sivaraman K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-433; Stefaniak AB, 2006, TOXICOL IN VITRO, V20, P1265, DOI 10.1016/j.tiv.2006.05.011; Takigawa H, 2005, DERMATOLOGY, V211, P240, DOI 10.1159/000087018; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wille JJ, 2003, SKIN PHARMACOL APPL, V16, P176, DOI 10.1159/000069757; Yeung M, 2011, MICROBES INFECT, V13, P189, DOI 10.1016/j.micinf.2010.10.023; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	85	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45952	10.1371/journal.pone.0045952	http://dx.doi.org/10.1371/journal.pone.0045952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029337	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700095
J	Gnjidic, D; Stanaway, FF; Cumming, R; Waite, L; Blyth, F; Naganathan, V; Handelsman, DJ; Le Couteur, DG				Gnjidic, Danijela; Stanaway, Fiona F.; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Handelsman, David J.; Le Couteur, David G.			Mild Cognitive Impairment Predicts Institutionalization among Older Men: A Population-Based Cohort Study	PLOS ONE			English	Article							NURSING-HOME PLACEMENT; URINARY-INCONTINENCE; ALZHEIMERS-DISEASE; CARE HOMES; SHORT-FORM; DEMENTIA; ADMISSION; DIAGNOSIS; HEALTH; RELIABILITY	Background: There is a lack of evidence on the contribution of mild cognitive impairment (MCI) to institutionalization in older adults. This study aimed to evaluate a range of risk factors including MCI of institutionalization in older men. Methods: Men aged >= 70 years (n = 1705), participating in the Concord Health and Ageing in Men Project, Sydney, Australia were studied. Participants completed self-reported questionnaires and underwent comprehensive clinical assessments during 2005-2007. Institutionalization was defined as entry into a nursing home facility or hostel at any time over an average of 5 years of follow-up. Cox regression analysis was conducted to generate hazard ratios (HR) with 95% confidence intervals (CI). Results: A total of 125 (7.3%) participants were institutionalized. Piecewise Cox proportional models were generated and divided at 3.4 years (1250 days) of follow-up due to violation of the proportional hazards assumption for the association between MCI and institutionalization (chi(2) = 6.44, p = 0.01). Dementia, disability in Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL), poor grip strength, few social interactions, being a Non-English speaking immigrant and age were predictive of institutionalization during both time periods, whereas MCI (HR = 4.39, 95% CI 2.17-8.87) only predicted institutionalization in the period beyond 3.4 years of follow-up. Being married (HR = 0.42, 95% CI: 0.24-0.72) was protective only during the period after 3.4 years of follow-up. Discussion: In this study, the strongest predictors of institutionalization were dementia, MCI, ADL and IADL disability. MCI was not a predictor of early institutionalization but became a significant predictor beyond 3.4 years of follow-up.	[Gnjidic, Danijela] Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia; [Gnjidic, Danijela] Royal N Shore Hosp, Dept Aged Care, Sydney, NSW, Australia; [Gnjidic, Danijela; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Handelsman, David J.; Le Couteur, David G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Gnjidic, Danijela; Stanaway, Fiona F.; Cumming, Robert; Waite, Louise; Blyth, Fiona; Naganathan, Vasi; Le Couteur, David G.] Concord Hosp, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Handelsman, David J.; Le Couteur, David G.] Concord Hosp, ANZAC Res Inst, Sydney, NSW, Australia; [Stanaway, Fiona F.; Cumming, Robert] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Gnjidic, Danijela] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	Royal North Shore Hospital; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Sydney; Concord Repatriation General Hospital; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney	Gnjidic, D (corresponding author), Royal N Shore Hosp, Dept Clin Pharmacol, Sydney, NSW, Australia.	danijela.gnjidic@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016; Handelsman, David/AAR-9580-2021	Handelsman, David/0000-0002-4200-7476; Naganathan, Vasikaran/0000-0001-7243-0796; Waite, Louise/0000-0001-9056-6996; Le Couteur, David/0000-0002-4227-5817	Australian National Health and Medical Research Council (NHMRC) [301916]; Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation; Geoff and Elaine Penney Ageing Research Unit	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sydney Medical School Foundation; Ageing and Alzheimer's Research Foundation; Geoff and Elaine Penney Ageing Research Unit	The CHAMP study is funded by the Australian National Health and Medical Research Council (NHMRC Project Grant No. 301916), Sydney Medical School Foundation and Ageing and Alzheimer's Research Foundation. The authors gratefully acknowledge the funding support from the Geoff and Elaine Penney Ageing Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW) AIoHaW, 2011, DRUG STAT SER, V26; AIHW (Australian Institute of Health and Welfare), 2011, AG CAR STAT SER, V35; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Busse A, 2006, BRIT J PSYCHIAT, V189, P399, DOI 10.1192/bjp.bp.105.014779; Byrne LMT, 1998, J CLIN EXP NEUROPSYC, V20, P286, DOI 10.1076/jcen.20.2.286.1176; Chan DC, 2003, J GERONTOL A-BIOL, V58, P548; Chukwujama O, 2011, NEW ENGL J MED, V365, P1358, DOI 10.1056/NEJMc1108238; Cohen-Mansfield J, 2011, ARCH GERONTOL GERIAT, V53, P309, DOI 10.1016/j.archger.2010.12.009; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cumming RG, 2009, INT J EPIDEMIOL, V38, P374, DOI 10.1093/ije/dyn071; Dudas RB, 2005, AM J GERIAT PSYCHIAT, V13, P218, DOI 10.1176/appi.ajgp.13.3.218; Dunn J E, 1993, J Aging Health, V5, P194, DOI 10.1177/089826439300500203; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Gibson D., 2001, PROJECTIONS OLDER IM; Gnjidic D, 2012, CLIN PHARMACOL THER, V91, P521, DOI 10.1038/clpt.2011.258; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Grundy E, 2007, AGE AGEING, V36, P424, DOI 10.1093/ageing/afm067; Guo MX, 2012, J NEUROL SCI, V312, P39, DOI 10.1016/j.jns.2011.08.026; HE W, 2005, CURRENT POPULATION R, P23; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Holroyd-Leduc JM, 2004, J AM GERIATR SOC, V52, P712, DOI 10.1111/j.1532-5415.2004.52207.x; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; LIEBERMAN MA, 1991, GERONTOLOGIST, V31, P371, DOI 10.1093/geront/31.3.371; Lord SR, 1996, ARCH PHYS MED REHAB, V77, P232, DOI 10.1016/S0003-9993(96)90103-3; Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; McCallum J, 2005, AUSTRALAS J AGEING, V24, P169, DOI 10.1111/j.1741-6612.2005.00116.x; McCann M, 2011, AGE AGEING, V40, P358, DOI 10.1093/ageing/afr031; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rowland JT, 2004, INT PSYCHOGERIATR, V118, P111; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tuokko H, 2003, ARCH NEUROL-CHICAGO, V60, P577, DOI 10.1001/archneur.60.4.577; Turcotte Martin., 2007, PORTRAIT SENIORS CAN; Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wechsler D, 1987, WMS R WECHSLER MEMOR; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46061	10.1371/journal.pone.0046061	http://dx.doi.org/10.1371/journal.pone.0046061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029389	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700111
J	Lo, JC; Groeger, JA; Santhi, N; Arbon, EL; Lazar, AS; Hasan, S; von Schantz, M; Archer, SN; Dijk, DJ				Lo, June C.; Groeger, John A.; Santhi, Nayantara; Arbon, Emma L.; Lazar, Alpar S.; Hasan, Sibah; von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan			Effects of Partial and Acute Total Sleep Deprivation on Performance across Cognitive Domains, Individuals and Circadian Phase	PLOS ONE			English	Article							NEUROBEHAVIORAL FUNCTION; SUSTAINED ATTENTION; WORKING-MEMORY; TIME AWAKE; SHORT-FORM; ONE NIGHT; PER3; POLYMORPHISM; RESTRICTION; HEALTH	Background: Cognitive performance deteriorates during extended wakefulness and circadian phase misalignment, and some individuals are more affected than others. Whether performance is affected similarly across cognitive domains, or whether cognitive processes involving Executive Functions are more sensitive to sleep and circadian misalignment than Alertness and Sustained Attention, is a matter of debate. Methodology/Principal Findings: We conducted a 2 x 12-day laboratory protocol to characterize the interaction of repeated partial and acute total sleep deprivation and circadian phase on performance across seven cognitive domains in 36 individuals (18 males; mean +/- SD of age = 27.6 +/- 4.0 years). The sample was stratified for the rs57875989 polymorphism in PER3, which confers cognitive susceptibility to total sleep deprivation. We observed a deterioration of performance during both repeated partial and acute total sleep deprivation. Furthermore, prior partial sleep deprivation led to poorer cognitive performance in a subsequent total sleep deprivation period, but its effect was modulated by circadian phase such that it was virtually absent in the evening wake maintenance zone, and most prominent during early morning hours. A significant effect of PER3 genotype was observed for Subjective Alertness during partial sleep deprivation and on n-back tasks with a high executive load when assessed in the morning hours during total sleep deprivation after partial sleep loss. Overall, however, Subjective Alertness and Sustained Attention were more affected by both partial and total sleep deprivation than other cognitive domains and tasks including n-back tasks of Working Memory, even when implemented with a high executive load. Conclusions/Significance: Sleep loss has a primary effect on Sleepiness and Sustained Attention with much smaller effects on challenging Working Memory tasks. These findings have implications for understanding how sleep debt and circadian rhythmicity interact to determine waking performance across cognitive domains and individuals.	[Lo, June C.; Groeger, John A.; Santhi, Nayantara; Arbon, Emma L.; Lazar, Alpar S.; Hasan, Sibah; von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England; [Groeger, John A.] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England; [von Schantz, Malcolm; Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Hull; University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England.	d.j.dijk@surrey.ac.uk	von Schantz, Malcolm/C-5962-2014; Groeger, John/AAK-2799-2020; Groeger, John/AAQ-8187-2021; Groeger, John/B-5671-2014	von Schantz, Malcolm/0000-0002-9911-9436; Groeger, John/0000-0002-3582-1058; Lazar, Alpar/0000-0003-3147-8229; Santhi, Nayantara/0000-0003-4568-1447	AFOSR [FA9550-08-1-0080]	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was funded by AFOSR award FA9550-08-1-0080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1994, PERCEPT MOTOR SKILL, V79, P287, DOI 10.2466/pms.1994.79.1.287; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; ARTHUR W, 1994, EDUC PSYCHOL MEAS, V54, P394, DOI 10.1177/0013164494054002013; BABKOFF H, 1988, Q J EXP PSYCHOL-A, V40, P737, DOI 10.1080/14640748808402296; BADDELEY AD, 1968, PSYCHON SCI, V10, P341; Balkin TJ, 2004, J SLEEP RES, V13, P219, DOI 10.1111/j.1365-2869.2004.00407.x; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Braver TS, 2010, CURR OPIN NEUROBIOL, V20, P242, DOI 10.1016/j.conb.2010.03.002; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brown JW, 2009, ENCY NEUROSCIENCE, P93; Buysse D J, 1989, Psychiatry Res, V28, P193; Cain SW, 2011, BRAIN COGNITION, V76, P37, DOI 10.1016/j.bandc.2011.03.005; Cajochen C, 1999, AM J PHYSIOL-REG I, V277, pR640, DOI 10.1152/ajpregu.1999.277.3.R640; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Czeisler CA, 1985, SLEEP RES, V14, P295; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Dinges DF, 1997, SLEEP, V20, P267; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 2005, SLEEP, V28, P1059; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2011, P NATL ACAD SCI USA, V108, P15602, DOI 10.1073/pnas.1010666108; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; FRITH CD, 1973, Q J EXP PSYCHOL, V25, P253, DOI 10.1080/14640747308400345; Goel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005874; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gonzalez MMC, 2006, SLEEP, V29, P1327, DOI 10.1093/sleep/29.10.1327; Graw P, 2004, PHYSIOL BEHAV, V80, P695, DOI 10.1016/j.physbeh.2003.12.004; Groeger JA, 2004, J SLEEP RES, V13, P359, DOI 10.1111/j.1365-2869.2004.00418.x; Groeger JA, 2008, SLEEP, V31, P1159; Groeger JA, 2011, BEHAV NEUROSCI, V125, P252, DOI 10.1037/a0022692; Habeck C, 2004, COGNITIVE BRAIN RES, V18, P306, DOI 10.1016/j.cogbrainres.2003.10.019; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Harrison Y, 2000, SLEEP, V23, P1067; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Harrison Y, 2007, NEUROPSYCHOLOGIA, V45, P1966, DOI 10.1016/j.neuropsychologia.2006.12.012; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jones KHS, 2007, J SLEEP RES, V16, P12, DOI 10.1111/j.1365-2869.2007.00561.x; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Klerman EB, 2008, CURR BIOL, V18, P1118, DOI 10.1016/j.cub.2008.06.047; Lazar AS, 2012, CHRONOBIOL INT, V29, P131, DOI 10.3109/07420528.2011.641193; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Luckhaupt SE, 2010, SLEEP, V33, P149, DOI 10.1093/sleep/33.2.149; Macmillan N. A., 2005, DETECTION THEORY USE; Macmillan NA, 1996, PSYCHON B REV, V3, P164, DOI 10.3758/BF03212415; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Miller E.K., 2009, ENCYCL NEUROSCI, V4, P99; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Pilcher JJ, 2007, AVIAT SPACE ENVIR MD, V78, pB15; POLLACK I, 1964, PSYCHON SCI, V1, P125, DOI 10.3758/BF03342823; Rechtschaffen A, 1968, NATL I HLTH PUBLICAT; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rogers NL, 2008, J SLEEP RES, V17, P406, DOI 10.1111/j.1365-2869.2008.00681.x; Rupp TL, 2012, SLEEP, V35, P1163, DOI 10.5665/sleep.2010; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Tucker AM, 2010, SLEEP, V33, P47, DOI 10.1093/sleep/33.1.47; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; Van Dongen HPA, 2001, CHRONOBIOL INT, V18, P85, DOI 10.1081/CBI-100001178; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Vandierendonck A, 1998, Q J EXP PSYCHOL-A, V51, P197, DOI 10.1080/713755748; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WYATT JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zhou X, 2011, SLEEP, V34, P931, DOI 10.5665/SLEEP.1130	85	207	209	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45987	10.1371/journal.pone.0045987	http://dx.doi.org/10.1371/journal.pone.0045987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029352	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700100
J	Dutta, D; Williamson, CD; Cole, NB; Donaldson, JG				Dutta, Dipannita; Williamson, Chad D.; Cole, Nelson B.; Donaldson, Julie G.			Pitstop 2 Is a Potent Inhibitor of Clathrin-Independent Endocytosis	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; TERMINAL DOMAIN; SMALL MOLECULES; PATHWAY; PROTEINS; DYNAMIN; CARGO; CELLS; ENDOSOMES	Clathrin independent endocytosis (CIE) is a form of endocytosis present in all cells that mediates the entry of nutrients, macromolecules and membrane proteins into cells. When compared to clathrin-dependent endocytosis (CDE), however, much less is known about the machinery involved in forming CIE endosomes. One way to distinguish CIE from CDE has been to deplete cells of coat proteins involved in CDE such as clathrin or the dynamin GTPase, leading to a block of CDE but not CIE. A drawback of such genetic manipulations is that depletion of proteins important for mediating CDE over a period of days can have complex indirect effects on cellular function. The identification of chemical compounds that specifically and rapidly block CDE or CIE would facilitate the determination of whether a process involved CDE or CIE. To date, all of those compounds have targeted CDE. Dynasore and the dynoles specifically target and block dynamin activity thus inhibiting CDE but not most forms of CIE. Recently, a new compound called pitstop 2 was identified as an inhibitor of the interaction of amphiphysin with the amino terminal domain of clathrin, and shown to inhibit CDE in cells. Here we show that pitstop 2 is also a potent inhibitor of CIE. The effects of pitstop 2 are not restricted to inhibition of clathrin since knockdown of clathrin fails to rescue the inhibition of endocytosis of CIE proteins by the drug. Thus pitstop 2 has additional cellular targets besides the amino terminal domain of clathrin and thus cannot be used to distinguish CIE from CDE.	[Dutta, Dipannita; Williamson, Chad D.; Cole, Nelson B.; Donaldson, Julie G.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Donaldson, JG (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	donaldsonj@helix.nih.gov			Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) [HL006060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006130] Funding Source: NIH RePORTER	Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the Intramural Research Program in the National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH), HL006060. http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole NB, 2012, ACS CHEM BIOL, V7, P464, DOI 10.1021/cb2004252; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Eyster CA, 2009, TRAFFIC, V10, P590, DOI 10.1111/j.1600-0854.2009.00894.x; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Zhao XH, 2001, J CELL SCI, V114, P353	27	126	130	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45799	10.1371/journal.pone.0045799	http://dx.doi.org/10.1371/journal.pone.0045799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029248	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800098
J	Tochigi, M; Nishida, A; Shimodera, S; Oshima, N; Inoue, K; Okazaki, Y; Sasaki, T				Tochigi, Mamoru; Nishida, Atsushi; Shimodera, Shinji; Oshima, Norihito; Inoue, Ken; Okazaki, Yuji; Sasaki, Tsukasa			Irregular Bedtime and Nocturnal Cellular Phone Usage as Risk Factors for Being Involved in Bullying: A Cross-Sectional Survey of Japanese Adolescents	PLOS ONE			English	Article							PEER-VICTIMIZATION; ELEMENTARY-SCHOOL; CHILDHOOD; ASSOCIATION; POPULATION; SCHEDULES; PRESCHOOL; SYMPTOMS; CHILDREN; BEHAVIOR	Purpose: A number of studies have tried to identify risk factors for being involved in bullying in order to help developing preventive measures; however, to our knowledge, no study has investigated the effect of nocturnal lifestyle behavior such as sleep pattern or cellular phone usage. In the present study, we aimed to investigate the relationship between school bullying and sleep pattern or nocturnal cellular phone usage in adolescents. The effect of school size on school bullying was also examined. Methods: Data from the cross-sectional survey of psychopathologies conducted for 19,436 Japanese students from 45 public junior high schools (7th-9th grade) and 28 senior high schools (10th-12th grade) were analyzed. Results: Bullying status was significantly associated with irregular bedtime (OR = 1.23 and 1.41 for pure bullies and bully-victims, respectively) and e-mail exchange or calling after lights-out (OR = 1.53 and 1.31 for pure bullies and bully-victims, respectively) after controlling domestic violence and substance usage. In addition, school size was significantly associated with the increased risk of bullying in junior high school students (OR = 1.13 for bully-victims). Conclusions: The present results suggested that sleep pattern and nocturnal cellular phone usage might be risk factors for being involved in school bullying in adolescents. Although further accumulation of data is needed, progressive trend towards nocturnal lifestyle and increasing usage of cellular phone might impair the well-being of adolescents. School-based interventions for lifestyle including sleep pattern and cellular phone usage may be encouraged to reduce school bullying.	[Shimodera, Shinji] Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan; [Tochigi, Mamoru] Univ Tokyo, Dept Neuropsychiat, Grad Sch Med, Tokyo, Japan; [Nishida, Atsushi] Tokyo Inst Psychiat, Dept Schizophrenia Res, Tokyo, Japan; [Oshima, Norihito; Sasaki, Tsukasa] Univ Tokyo, Off Mental Hlth Support, Tokyo, Japan; [Inoue, Ken] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Dept Hlth Educ, Grad Sch Educ, Tokyo, Japan	Kochi University; University of Tokyo; Tokyo Institute of Psychiatry; University of Tokyo; Fujita Health University; University of Tokyo	Shimodera, S (corresponding author), Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan.	shimodes@kochi-u.ac.jp	Andoh, Akira/AAB-9303-2022		Ministry of Health, Labor and Welfare of Japan [H19-kokoro-ippan-012]; Grants-in-Aid for Scientific Research [22791158] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant from the Ministry of Health, Labor and Welfare of Japan (#H19-kokoro-ippan-012) and the Grant-in-aid from the Research Group for Schizophrenia in Japan (AN). AN also acknowledges the support from the Research Group for Schizophrenia in Japan, Award for Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; Barker ED, 2008, ARCH GEN PSYCHIAT, V65, P1185, DOI 10.1001/archpsyc.65.10.1185; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; DAHL R, 1995, PRINCIPLES PRACTICE, V2, P19; Doi Y, 2003, PSYCHIAT CLIN NEUROS, V57, P379, DOI 10.1046/j.1440-1819.2003.01135.x; GOLDBERG DP, 1976, BRIT J PSYCHIAT, V129, P61, DOI 10.1192/bjp.129.1.61; Harada T, 2004, SLEEP BIOL RHYTHMS, V2, P97; Hawker DSJ, 2000, J CHILD PSYCHOL PSYC, V41, P441, DOI 10.1111/1469-7610.00629; Hodges EVE, 1997, DEV PSYCHOL, V33, P1032, DOI 10.1037//0012-1649.33.6.1032; Kaneita Y, 2007, J CLIN PSYCHIAT, V68, P1426, DOI 10.4088/JCP.v68n0916; Kumpulainen K, 2000, CHILD ABUSE NEGLECT, V24, P1567, DOI 10.1016/S0145-2134(00)00210-6; Ladd GW, 2003, CHILD DEV, V74, P1344, DOI 10.1111/1467-8624.00611; National Institute for Educational Policy Research, 2010, FOLL UP SURV BULL 20; Olweus D., 1999, NATURE SCH BULLYING, P7; Sasazawa Y, 1991, JPN J SCH HLTH S, V41, P638; Sasazawa Y, 2001, JPN J SCH HLTH S, V42, P23; Schreier A, 2009, ARCH GEN PSYCHIAT, V66, P527, DOI 10.1001/archgenpsychiatry.2009.23; Schwartz D, 2000, DEV PSYCHOL, V36, P646, DOI 10.1037//0012-1649.36.5.646; Shields A, 2001, J CLIN CHILD PSYCHOL, V30, P349, DOI 10.1207/S15374424JCCP3003_7; Snyder J, 2003, CHILD DEV, V74, P1881, DOI 10.1046/j.1467-8624.2003.00644.x; Solbere ME, 2007, BRIT J EDUC PSYCHOL, V77, P441, DOI 10.1348/000709906X105689; Sourander A, 2000, CHILD ABUSE NEGLECT, V24, P873, DOI 10.1016/S0145-2134(00)00146-0; Takasu NN, 2012, SLEEP BIOL RHYTHMS, V10, P84, DOI 10.1111/j.1479-8425.2011.00524.x; Turagabeci AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001585; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Wever R.A., 1979, CIRCADIAN SYSTEM MAN; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yokomaku A, 2008, CHRONOBIOL INT, V25, P549, DOI 10.1080/07420520802261705	28	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45736	10.1371/journal.pone.0045736	http://dx.doi.org/10.1371/journal.pone.0045736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PP	23029211	Green Published, gold			2022-12-25	WOS:000309388400127
J	Graziano, V; Luo, GB; Blainey, PC; Perez-Berna, AJ; Mcgrath, WJ; Flint, SJ; Martin, CS; Xie, XS; Mangel, WF				Graziano, Vito; Luo, Guobin; Blainey, Paul C.; Perez-Berna, Ana J.; Mcgrath, William J.; Flint, S. Jane; San Martin, Carmen; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space II. ADENOVIRUS PROTEINASE IS ACTIVATED IN AN UNUSUAL ONE-DIMENSIONAL BIOCHEMICAL REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; TRANSPORT; COFACTORS; VIRION; TYPE-2; HEXON	Late in an adenovirus infection, the viral proteinase (AVP) becomes activated to process virion precursor proteins used in virus assembly. AVP is activated by two cofactors, the viral DNA and pVIc, an 11-amino acid peptide originating from the C terminus of the precursor protein pVI. There is a conundrum in the activation of AVP in that AVP and pVI are sequence-independent DNA-binding proteins with nM equilibrium dissociation constants such that in the virus particle, they are predicted to be essentially irreversibly bound to the viral DNA. Here, we resolve that conundrum by showing that activation of AVP takes place on the one-dimensional contour of DNA. In vitro, pVI, a substrate, slides on DNA via one-dimensional diffusion, D-1 = 1.45 x 10(6) bp(2)/s, until it binds to AVP also on the same DNA molecule. AVP, partially activated by being bound to DNA, excises pVIc, which binds to the AVP molecule that cut it out. pVIc then forms a disulfide bond with AVP forming the fully active AVP-pVIc complex bound to DNA. In vivo, in heat-disrupted immature virus, AVP was also activated by pVI in DNA-dependent reactions. This activation mechanism illustrates a new paradigm for virion maturation and a new way, by sliding on DNA, for bimolecular complexes to form among proteins not involved in DNA metabolism.	[Graziano, Vito; Mcgrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Luo, Guobin; Blainey, Paul C.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Perez-Berna, Ana J.; San Martin, Carmen] CSIC, CNB, Dept Macromol Struct, E-28049 Madrid, Spain; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Harvard University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Princeton University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	San Martín, Carmen/A-4074-2010; Perez-Berna, Ana/G-2789-2016	San Martín, Carmen/0000-0001-9799-175X; Blainey, Paul/0000-0002-4889-8783; Perez-Berna, Ana/0000-0003-4145-532X; McGrath, William/0000-0002-9375-624X	National Institutes of Health [R01AI41599, GM037705]; National Institutes of Health; National Science Foundation; Ministerio de Ciencia e Innovacion of Spain [BFU2010-16382, FIS2010-10552-E]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI41599 (to W. F. M.) and GM037705 (to S. J. F.) and the National Institutes of Health Director's Pioneer Award and a National Science Foundation grant (to X. S. X.). This work was also supported by Grants BFU2010-16382 and FIS2010-10552-E from the Ministerio de Ciencia e Innovacion of Spain (to C. S. M.); The recipient of a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion of Spain.	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2002, BIOCHEMISTRY-US, V41, P430, DOI 10.1021/bi015150g; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flint S.J., 2000, PRINCIPLES VIROLOGY; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; MATTHEWS DA, 1995, J GEN VIROL, V76, P1959, DOI 10.1099/0022-1317-76-8-1959; MATTHEWS DA, 1994, J GEN VIROL, V75, P3365, DOI 10.1099/0022-1317-75-12-3365; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; Ramakrishnan V, 1997, CRIT REV EUKAR GENE, V7, P215, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.20; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614	33	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2068	2080		10.1074/jbc.M112.407312	http://dx.doi.org/10.1074/jbc.M112.407312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043137	Green Published, hybrid			2022-12-25	WOS:000313751400058
J	Fan, LL; Xu, CR; Wang, CM; Tao, JY; Ho, C; Jiang, LJ; Gui, B; Huang, S; Evert, M; Calvisi, DF; Chen, X				Fan, Lingling; Xu, Chuanrui; Wang, Chunmei; Tao, Junyan; Ho, Coral; Jiang, Lijie; Gui, Bing; Huang, Shiang; Evert, Matthias; Calvisi, Diego F.; Chen, Xin			Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development	PLOS ONE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; HEPATOCELLULAR-CARCINOMA; INK4A-ARF LOCUS; OVAL CELLS; PROLIFERATION; TUMORIGENESIS; GROWTH; MICE; RAT	Bmi1 is a polycomb group transcriptional repressor and it has been implicated in regulating self-renewal and proliferation of many types of stem or progenitor cells. In addition, Bmi1 has been shown to function as an oncogene in multiple tumor types. In this study, we investigated the functional significance of Bmi1 in regulating hepatic oval cells, the major type of bipotential progenitor cells in adult liver, as well as the role of Bmi1 during hepatocarcinogenesis using Bmi1 knockout mice. We found that loss of Bmi1 significantly restricted chemically induced oval cell expansion in the mouse liver. Concomitant deletion of Ink4a/Arf in Bmi1 deficient mice completely rescued the oval cell expansion phenotype. Furthermore, ablation of Bmi1 delayed hepatocarcinogenesis induced by AKT and Ras co-expression. This antineoplastic effect was accompanied by the loss of hepatic oval cell marker expression in the liver tumor samples. In summary, our data demonstrated that Bmi1 is required for hepatic oval cell expansion via deregulating the Ink4a/Arf locus in mice. Our study also provides the evidence, for the first time, that Bmi1 expression is required for liver cancer development in vivo, thus representing a promising target for innovative treatments against human liver cancer.	[Fan, Lingling; Wang, Chunmei; Tao, Junyan; Ho, Coral; Jiang, Lijie; Gui, Bing; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Fan, Lingling; Huang, Shiang] Huazhong Univ Sci & Technol, Ctr Stem Cell Res & Applicat, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Chuanrui] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430074, Peoples R China; [Evert, Matthias; Calvisi, Diego F.] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Ernst Moritz Arndt Universitat Greifswald	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	xin.chen@ucsf.edu	Wang, Chunmei/J-2423-2013; tao, junyan/C-6919-2015	Wang, Chunmei/0000-0003-4615-0517; 	National Institutes of Health [R01CA136606, P30DK026743]; NATIONAL CANCER INSTITUTE [R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grant R01CA136606 to X.C., and P30DK026743 to the University of California San Francisco Liver Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz L, 2012, CELL CYCLE, V11, P65, DOI 10.4161/cc.11.1.18097; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FAKTOR V M, 1990, Ontogenez, V21, P625; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1002/hep.1840220433; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023; Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Preisegger KH, 1999, LAB INVEST, V79, P103; Pritchard MT, 2010, AM J PATHOL, V176, P2743, DOI 10.2353/ajpath.2010.091186; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wu XZ, 2006, J GASTROEN HEPATOL, V21, P1093, DOI 10.1111/j.1440-1746.2006.04485.x; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zheng D, 2006, AM J PATHOL, V169, P2066, DOI 10.2353/ajpath.2006.060211	52	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46472	10.1371/journal.pone.0046472	http://dx.doi.org/10.1371/journal.pone.0046472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029524	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900165
J	Makondo, E; Bell, TG; Kramvis, A				Makondo, Euphodia; Bell, Trevor G.; Kramvis, Anna			Genotyping and Molecular Characterization of Hepatitis B Virus from Human Immunodeficiency Virus-Infected Individuals in Southern Africa	PLOS ONE			English	Article							BASIC CORE PROMOTER; PRE-S DELETION; ANTIRETROVIRAL THERAPY; CLINICAL-SIGNIFICANCE; HIV COINFECTION; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE-RESISTANCE; VIRAL REPLICATION; BLOOD-TRANSFUSION; HBV COINFECTION	Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) are hyperendemic in sub-Saharan Africa. The HBV genotypes prevailing in HIV-infected Africans are unknown. Our aim was to determine the HBV genotypes in HIV-infected participants and to identify clinically significant HBV mutations. From 71 HBV DNA(+ve) HIV-infected participants, 49 basic core promoter/precore (BCP/PC) and 29 complete S regions were successfully sequenced. Following phylogenetic analysis of 29 specimens in the complete S region, 28 belonged to subgenotype A1 and one to D3. Mutations affecting HBeAg expression at the transcriptional (1762T1764A), translational (Kozak 1809-1812, initiation 1814-1816, G1896A with C1858T), or post translational levels (G1862T), were responsible for the high HBeAg-negativity observed. The G1862T mutation occurred only in subgenotype A1 isolates, which were found in one third (7/21) of HBsAg(-ve) participants, but in none of the 18 HBsAg(+ve) participants (p<0.05). Pre-S deletion mutants were detected in four HBsAg(+ve) and one HBsAg(-ve) participant/s. The following mutations occurred significantly more frequently in HBV isolated in this study than in strains of the same cluster of the phylogenetic tree: ps1F25L, ps1V88L/A; ps2Q10R, ps2 R48K/T, ps2A53V and sQ129R/H, sQ164A/V/G/D, sV168A and sS174N (p<0.05). ps1I48V/T occurred more frequently in females than males (p<0.05). Isolates with sV168A occurred more frequently in participants with viral loads.200 IU per ml (p<0.05) and only sS174N occurred more frequently in HBsAg(-ve) than in HBsAg(+ve) individuals (p<0.05). Prior to initiation of ART, ten percent, 3 of 29 isolates sequenced, had drug resistance mutations rtV173L, rtL180M+rtM204V and rtV214A, respectively. This study has provided important information on the molecular characteristics of HBV in HIV-infected southern Africans prior to ART initiation, which has important clinical relevance in the management of HBV/HIV co-infection in our unique setting.	[Makondo, Euphodia; Bell, Trevor G.; Kramvis, Anna] Univ Witwatersrand, Hepatitis Virus Div Res Programme, Dept Internal Med, Johannesburg, South Africa	University of Witwatersrand	Kramvis, A (corresponding author), Univ Witwatersrand, Hepatitis Virus Div Res Programme, Dept Internal Med, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	Bell, Trevor Graham/B-7388-2016	Bell, Trevor Graham/0000-0003-2630-7513; Kramvis, Anna/0000-0001-6006-3765	South African Medical Research Council; National Research Foundation (NRF) [65530]; National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF; Belgium Technical Cooperation Fellowship; PRF; Deutsch Forschungsgemeinschaft (German Research Foundation); Cancer Association of South Africa	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF; Belgium Technical Cooperation Fellowship; PRF; Deutsch Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Cancer Association of South Africa	This study was supported by grants received from the South African Medical Research Council and the National Research Foundation (NRF; GUN#65530) awarded to AK. TGB received bursaries from the National Bioinformatics Network, Poliomyelitis Research Foundation (PRF) and NRF. EM received a Belgium Technical Cooperation Fellowship and bursaries from the NRF and PRF. Research was supported by funding from Deutsch Forschungsgemeinschaft (German Research Foundation) and the Cancer Association of South Africa. The funders had no role in study design, data collection and analysis, decision to publish.	Acar A, 2010, BRAZ J INFECT DIS, V14, P41, DOI 10.1590/S1413-86702010000100009; Ahn SH, 2003, GASTROENTEROLOGY, V125, P1370, DOI 10.1016/j.gastro.2003.07.016; Allain JP, 2009, HEPATOLOGY, V49, P1868, DOI 10.1002/hep.22879; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Audsley J, 2009, HIV MED, V10, P229, DOI 10.1111/j.1468-1293.2008.00675.x; Audsley J, 2010, VIROLOGY, V405, P539, DOI 10.1016/j.virol.2010.06.038; Baptista M, 1999, HEPATOLOGY, V29, P946, DOI 10.1002/hep.510290336; Barth RE, 2011, J MED VIROL, V83, P929, DOI 10.1002/jmv.22026; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015; BOTHA JF, 1984, LANCET, V1, P1210; Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Buckwold VE, 1997, J GEN VIROL, V78, P2055, DOI 10.1099/0022-1317-78-8-2055; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; CARMAN WF, 1989, LANCET, V2, P588; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CY, 2008, HEPATOL RES, V38, P580, DOI 10.1111/j.1872-034X.2007.00315.x; Chen WN, 2000, EUR J CLIN INVEST, V30, P787; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; DIBISCEGLIE AM, 1985, J MED VIROL, V16, P337, DOI 10.1002/jmv.1890160406; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Firnhaber C, 2012, INT J INFECT DIS, V16, pE268, DOI 10.1016/j.ijid.2011.12.007; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Gous N, 2010, ANTIVIR THER, V15, P61, DOI 10.3851/IMP1487; Gunther S, 1998, J CLIN MICROBIOL, V36, P531; Gutierrez C, 2004, J MED VIROL, V73, P200, DOI 10.1002/jmv.20076; Henke-Gendo C, 2008, J INFECT DIS, V198, P1620, DOI 10.1086/592987; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hou JL, 2002, J GEN VIROL, V83, P2291, DOI 10.1099/0022-1317-83-9-2291; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Iacomi F, 2009, J MED VIROL, V81, P1151, DOI 10.1002/jmv.21505; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; Kim HS, 1997, J GEN VIROL, V78, P1083, DOI 10.1099/0022-1317-78-5-1083; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottilil S, 2005, INDIAN J MED RES, V121, P424; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2007, HEPATOL RES, V37, pS27, DOI 10.1111/j.1872-034X.2007.00100.x; Laras A, 1998, J VIRAL HEPATITIS, V5, P241, DOI 10.1046/j.1365-2893.1998.00109.x; Lin CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-17; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; Nicholas K.B., 1997, GENEDOC ANAL VISUALI; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Osiowy C, 2010, J MED VIROL, V82, P942, DOI 10.1002/jmv.21758; PASTORE G, 1988, J HEPATOL, V7, P164, DOI 10.1016/S0168-8278(88)80478-1; Paulij WP, 1999, J GEN VIROL, V80, P2121, DOI 10.1099/0022-1317-80-8-2121; Quarleri J, 2007, AIDS RES HUM RETROV, V23, P525, DOI 10.1089/aid.2006.0172; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Selabe SG, 2009, J MED VIROL, V81, P996, DOI 10.1002/jmv.21479; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; VENTO S, 1989, LANCET, V2, P108; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; XIA X, 2000, DATA ANAL MOL BIOL E; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zhang D, 2012, BMC INFECT DIS, V10, P271; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	91	34	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46345	10.1371/journal.pone.0046345	http://dx.doi.org/10.1371/journal.pone.0046345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029487	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900140
J	Park, SH; Sim, WY; Min, BH; Yang, SS; Khademhosseini, A; Kaplan, DL				Park, Sang-Hyug; Sim, Woo Young; Min, Byoung-Hyun; Yang, Sang Sik; Khademhosseini, Ali; Kaplan, David L.			Chip-Based Comparison of the Osteogenesis of Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells under Mechanical Stimulation	PLOS ONE			English	Article							HUMAN OSTEOBLAST PROLIFERATION; EXTRACELLULAR-MATRIX; STROMAL CELLS; SHEAR-STRESS; DIFFERENTIATION; EXPRESSION; INTEGRIN; STRAIN; PERFUSION; PROTEIN	Adipose tissue-derived stem cells (ASCs) are considered as an attractive stem cell source for tissue engineering and regenerative medicine. We compared human bone marrow-derived mesenchymal stem cells (hMSCs) and hASCs under dynamic hydraulic compression to evaluate and compare osteogenic abilities. A novel micro cell chip integrated with microvalves and microscale cell culture chambers separated from an air-pressure chamber was developed using microfabrication technology. The microscale chip enables the culture of two types of stem cells concurrently, where each is loaded into cell culture chambers and dynamic compressive stimulation is applied to the cells uniformly. Dynamic hydraulic compression (1 Hz, 1 psi) increased the production of osteogenic matrix components (bone sialoprotein, oateopontin, type I collagen) and integrin (CD11b and CD31) expression from both stem cell sources. Alkaline phosphatase and Alrizarin red staining were evident in the stimulated hMSCs, while the stimulated hASCs did not show significant increases in staining under the same stimulation conditions. Upon application of mechanical stimulus to the two types of stem cells, integrin (beta 1) and osteogenic gene markers were upregulated from both cell types. In conclusion, stimulated hMSCs and hASCs showed increased osteogenic gene expression compared to non-stimulated groups. The hMSCs were more sensitive to mechanical stimulation and more effective towards osteogenic differentiation than the hASCs under these modes of mechanical stimulation.	[Park, Sang-Hyug; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Park, Sang-Hyug] Jungwon Univ, Dept Biomed Engn, Goesan Eup, Chungbuk, South Korea; [Sim, Woo Young; Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA; [Sim, Woo Young; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Min, Byoung-Hyun] Ajou Univ, Dept Orthopead Surg, Sch Med, Suwon 441749, South Korea; [Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Tufts University; Jungwon University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ajou University; Ajou University; Ajou University; Harvard University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Khademhosseini, Ali/A-9435-2010	Khademhosseini, Ali/0000-0002-2692-1524; Min, Byoung-Hyun/0000-0001-8928-414X; Khademhosseini, Ali/0000-0001-6322-8852	National Institutes of Health [EB003210, EB002520, EB008392]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003210, R01EB008392, P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Support from the National Institutes of Health [EB003210 (DLK), EB002520 (DLK) and EB008392 (AK)] for these studies is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arihiro K, 2001, PATHOL INT, V51, P100, DOI 10.1046/j.1440-1827.2001.01164.x; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F; CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001; Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Globus R K, 1995, ASGSB Bull, V8, P19; Hanson AD, 2009, ANN BIOMED ENG, V37, P955, DOI 10.1007/s10439-009-9648-7; Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y; Hebert E, 2000, BIOSCIENCE REP, V20, P213, DOI 10.1023/A:1026484722248; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045001; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Jagodzinski M, 2008, J BIOMECH, V41, P1885, DOI 10.1016/j.jbiomech.2008.04.001; Jagodzinski M, 2004, Eur Cell Mater, V7, P35; Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim K, 2010, BIOCHIP J, V4, P148, DOI 10.1007/s13206-010-4210-0; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068; Ogawa Rei, 2006, Curr Stem Cell Res Ther, V1, P13, DOI 10.2174/157488806775269043; Park SH, 2006, TISSUE ENG, V12, P3107, DOI 10.1089/ten.2006.12.3107; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Qi MC, 2009, INT J ORAL SCI, V1, P143, DOI 10.4248/IJOS.09021; RAMBAUT PC, 1985, LANCET, V2, P1050; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Shav D, 2010, ANN NY ACAD SCI, V1188, P25, DOI 10.1111/j.1749-6632.2009.05079.x; Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m; SIMKIN A, 1987, CALCIFIED TISSUE INT, V40, P59, DOI 10.1007/BF02555706; Szeszel MK, 2005, J HISTOCHEM CYTOCHEM, V53, P753, DOI 10.1369/jhc.4A6600.2005; Tani-Ishii N, 2002, J PERIODONTAL RES, V37, P184, DOI 10.1034/j.1600-0765.2002.00610.x; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Ward DF, 2007, STEM CELLS DEV, V16, P467, DOI 10.1089/scd.2007.0034; Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	58	83	90	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46689	10.1371/journal.pone.0046689	http://dx.doi.org/10.1371/journal.pone.0046689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029565	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900199
J	Stempler, S; Ruppin, E				Stempler, Shiri; Ruppin, Eytan			Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer's Disease	PLOS ONE			English	Article							BRAIN; ASTROCYTES; PATHOLOGY	Alterations in gene expression resulting from Alzheimer's disease have received considerable attention in recent years. Although expression has been investigated separately in whole brain tissue, in astrocytes and in neurons, a rigorous comparative study quantifying the relative utility of these sources in predicting the progression of Alzheimer's disease has been lacking. Here we analyze gene expression from neurons, astrocytes and whole tissues across different brain regions, and compare their ability to predict Alzheimer's disease progression by building pertaining classification models based on gene expression sets annotated to different biological processes. Remarkably, we find that predictions based on neuronal gene expression are significantly more accurate than those based on astrocyte or whole tissue expression. The findings explicate the central role of neurons, particularly as compared to glial cells, in the pathogenesis of Alzheimer's disease, and emphasize the importance of measuring gene expression in the most relevant (pathogenically 'proximal') single cell types.	[Stempler, Shiri; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Stempler, S (corresponding author), Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.	shirist2@post.tau.ac.il; ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	Israeli Science Foundation; Tel Aviv University	Israeli Science Foundation(Israel Science Foundation); Tel Aviv University	This work was supported by a grant from the Israeli Science Foundation to E.R. S.S gratefully acknowledges the support of the Josef Sagol fellowship for brain research at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chow N, 1998, P NATL ACAD SCI USA, V95, P9620, DOI 10.1073/pnas.95.16.9620; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Galvin JE, 2004, NEUROCHEM RES, V29, P1041, DOI 10.1023/B:NERE.0000023592.53769.4d; Ginsberg SD, 2011, NEUROBIOL DIS; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2010, NEUROBIOL AGING, V31, P549, DOI 10.1016/j.neurobiolaging.2008.05.013; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Simpson JE, 2011, NEUROBIOL AGING; Stahlberg A, 2011, EXPERT REV MOL DIAGN, V11, P735, DOI [10.1586/erm.11.60, 10.1586/ERM.11.60]; Stahlberg A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1182; Stempler S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.003; van der Flier WM, 2011, LANCET NEUROL, V10, P280, DOI 10.1016/S1474-4422(10)70306-9; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45879	10.1371/journal.pone.0045879	http://dx.doi.org/10.1371/journal.pone.0045879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029292	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900060
J	Constantino, FC; Pinggera, L; Paranamana, S; Kashino, M; Chait, M				Constantino, Francisco Cervantes; Pinggera, Leyla; Paranamana, Supathum; Kashino, Makio; Chait, Maria			Detection of Appearing and Disappearing Objects in Complex Acoustic Scenes	PLOS ONE			English	Article							AUDITORY-CORTEX; AUDIOVISUAL LINKS; CHANGE-BLINDNESS; ONSET RESPONSES; CHANGE DEAFNESS; FREQUENCY; ASYMMETRIES; INCREMENTS; PERCEPTION; DECREMENTS	The ability to detect sudden changes in the environment is critical for survival. Hearing is hypothesized to play a major role in this process by serving as an "early warning device," rapidly directing attention to new events. Here, we investigate listeners' sensitivity to changes in complex acoustic scenes-what makes certain events "pop-out" and grab attention while others remain unnoticed? We use artificial "scenes" populated by multiple pure-tone components, each with a unique frequency and amplitude modulation rate. Importantly, these scenes lack semantic attributes, which may have confounded previous studies, thus allowing us to probe low-level processes involved in auditory change perception. Our results reveal a striking difference between "appear" and "disappear" events. Listeners are remarkably tuned to object appearance: change detection and identification performance are at ceiling; response times are short, with little effect of scene-size, suggesting a pop-out process. In contrast, listeners have difficulty detecting disappearing objects, even in small scenes: performance rapidly deteriorates with growing scene-size; response times are slow, and even when change is detected, the changed component is rarely successfully identified. We also measured change detection performance when a noise or silent gap was inserted at the time of change or when the scene was interrupted by a distractor that occurred at the time of change but did not mask any scene elements. Gaps adversely affected the processing of item appearance but not disappearance. However, distractors reduced both appearance and disappearance detection. Together, our results suggest a role for neural adaptation and sensitivity to transients in the process of auditory change detection, similar to what has been demonstrated for visual change detection. Importantly, listeners consistently performed better for item addition (relative to deletion) across all scene interruptions used, suggesting a robust perceptual representation of item appearance.	[Constantino, Francisco Cervantes; Pinggera, Leyla; Paranamana, Supathum; Chait, Maria] Univ London Imperial Coll Sci Technol & Med, Ear Inst, London, England; [Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Imperial College London; Nippon Telegraph & Telephone Corporation	Chait, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ear Inst, London, England.	m.chait@ucl.ac.uk	Cervantes Constantino, Francisco/AAA-1200-2020	Cervantes Constantino, Francisco/0000-0002-7393-3579; Chait, Maria/0000-0002-7808-3593	Deafness Research United Kingdom; Wellcome Trust [093292/Z/10/Z]	Deafness Research United Kingdom; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by a Deafness Research United Kingdom (http://www.deafnessresearch.org.uk/) fellowship, and a Wellcome Trust project grant (093292/Z/10/Z) to MC. MK is employed by NTT Communication Science Laboratories, NTT Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREGMAN AS, 1994, J ACOUST SOC AM, V96, P2694, DOI 10.1121/1.411277; Chait M, 2008, BRAIN RES, V1213, P78, DOI 10.1016/j.brainres.2008.03.050; Cole GG, 2010, Q J EXP PSYCHOL, V63, P147, DOI 10.1080/17470210902853522; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; Demany L, 2008, PSYCHOL SCI, V19, P85, DOI 10.1111/j.1467-9280.2008.02050.x; DeWeese M, 1998, NEURAL COMPUT, V10, P1179, DOI 10.1162/089976698300017403; Eramudugolla R, 2005, CURR BIOL, V15, P1108, DOI 10.1016/j.cub.2005.05.051; Erviti M, 2011, J ACOUST SOC AM, V129, P3837, DOI 10.1121/1.3589257; Fishman YI, 2009, HEARING RES, V254, P64, DOI 10.1016/j.heares.2009.04.010; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Gregg MK, 2008, J EXP PSYCHOL HUMAN, V34, P974, DOI 10.1037/0096-1523.34.4.974; Gregg MK, 2012, NEUROIMAGE, V62, P113, DOI 10.1016/j.neuroimage.2012.04.057; Hartmann WM, 2006, J ACOUST SOC AM, V120, P2142, DOI 10.1121/1.2228476; Kubovy M., 1981, PERCEPTUAL ORG; Macmillan N. A., 2005, DETECTION THEORY USE; Mazza V, 2007, NEUROPSYCHOLOGIA, V45, P514, DOI 10.1016/j.neuropsychologia.2006.02.010; McAnally KI, 2010, J EXP PSYCHOL HUMAN, V36, P994, DOI 10.1037/a0016895; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Moore BCJ, 1997, J ACOUST SOC AM, V102, P2954, DOI 10.1121/1.420350; Moore BCJ, 1999, J ACOUST SOC AM, V106, P3539, DOI 10.1121/1.428207; Moshitch D, 2006, J NEUROPHYSIOL, V95, P3756, DOI 10.1152/jn.00822.2005; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; Pavani F, 2008, PERCEPT PSYCHOPHYS, V70, P619, DOI 10.3758/PP.70.4.619; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; Phillips DP, 2002, HEARING RES, V167, P192, DOI 10.1016/S0378-5955(02)00393-3; PLACK CJ, 1990, J ACOUST SOC AM, V87, P2178, DOI 10.1121/1.399185; Qin L, 2007, J NEUROPHYSIOL, V97, P3421, DOI 10.1152/jn.00184.2007; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Scholl B, 2010, NEURON, V65, P412, DOI 10.1016/j.neuron.2010.01.020; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Simons DJ, 2002, CONSCIOUS COGN, V11, P78, DOI 10.1006/ccog.2001.0533; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; SUMMERFIELD Q, 1987, J ACOUST SOC AM, V81, P700, DOI 10.1121/1.394838; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Wolfe JM, 2001, PERCEPT PSYCHOPHYS, V63, P381, DOI 10.3758/BF03194406; Yamashiro K, 2009, EUR J NEUROSCI, V30, P125, DOI 10.1111/j.1460-9568.2009.06790.x; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	41	34	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46167	10.1371/journal.pone.0046167	http://dx.doi.org/10.1371/journal.pone.0046167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23029426	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500069
J	Perlis, RH; Ruderfer, D; Hamilton, SP; Ernst, C				Perlis, Roy H.; Ruderfer, Douglas; Hamilton, Steven P.; Ernst, Carl			Copy Number Variation in Subjects with Major Depressive Disorder Who Attempted Suicide	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PSYCHIATRIC-DISORDERS; RISK; METAANALYSIS; RECURRENT; BEHAVIOR	Background: Suicide is one of the top ten leading causes of death in North America and represents a major public health burden, partcularly for people with Major Depressive disorder (MD). Many studies have suggested that suicidal behavior runs in families, however, identification of genomic loci that drive this efffect remain to be identified. Methodology/Principal Findings: Using subjects collected as part of STAR*D, we genotyped 189 subjects with MD with history of a suicide attempt and 1073 subjects with Major Depressive disorder that had never attempted suicide. Copy Number Variants (CNVs) were called in Birdsuite and analyzed in PLINK. We found a set of CNVs present in the suicide attempter group that were not present in in the non-attempter group including in SNTG2 and MACROD2 - two brain expressed genes previously linked to psychopathology; however, these results failed to reach genome-wide signifigance. Conclusions: These data suggest potential CNVs to be investigated further in relation to suicide attempts in MD using large sample sizes.	[Ernst, Carl] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Perlis, Roy H.; Ruderfer, Douglas; Ernst, Carl] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	McGill University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco	Ernst, C (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	carl.ernst@mcgill.ca	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Hamilton, Steven/0000-0001-8106-6260	American Foundation for Suicide Prevention; Canada Research Chair in Psychiatric Genetics; Proteus Biomedical	American Foundation for Suicide Prevention; Canada Research Chair in Psychiatric Genetics; Proteus Biomedical	This work was funded by a Young Investigator grant from the American Foundation for Suicide Prevention to CE. CE receives salary support from a Canada Research Chair in Psychiatric Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CE, DR, and SH have declared that no competing interests exist RP has received research support from Proteus Biomedical. RP has consulted or advised for Genomind; Proteus Biomedical; RIDVentures. RP has a financial interest in Concordant Rater Systems. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Brent DA, 2002, ARCH GEN PSYCHIAT, V59, P801, DOI 10.1001/archpsyc.59.9.801; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Mondimore FM, 2006, AM J PSYCHIAT, V163, P1554, DOI 10.1176/appi.ajp.163.9.1554; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Munafo MR, 2006, GENES BRAIN BEHAV, V5, P3, DOI 10.1111/j.1601-183X.2006.00188.x; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Weissman M, 2009, ANN EPIDEMIOL, V19, P264, DOI 10.1016/j.annepidem.2009.01.021	23	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46315	10.1371/journal.pone.0046315	http://dx.doi.org/10.1371/journal.pone.0046315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029476	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500088
J	Talmont, F; Mouledous, L; Boue, J; Mollereau, C; Dietrich, G				Talmont, Franck; Mouledous, Lionel; Boue, Jerome; Mollereau, Catherine; Dietrich, Gilles			Denatured G-Protein Coupled Receptors as Immunogens to Generate Highly Specific Antibodies	PLOS ONE			English	Article							MU-OPIOID-RECEPTOR; NEUROBLASTOMA SH-SY5Y CELLS; 3RD EXTRACELLULAR LOOPS; MORPHINE-LIKE ACTIVITY; NATURAL HUMAN-IGG; PICHIA-PASTORIS; FUNCTIONAL EXPRESSION; ADRENERGIC-RECEPTORS; SYSTEM; MICE	G-protein coupled receptors (GPCRs) play a major role in a number of physiological and pathological processes. Thus, GPCRs have become the most frequent targets for development of new therapeutic drugs. In this context, the availability of highly specific antibodies may be decisive to obtain reliable findings on localization, function and medical relevance of GPCRs. However, the rapid and easy generation of highly selective anti-GPCR antibodies is still a challenge. Herein, we report that highly specific antibodies suitable for detection of GPCRs in native and unfolded forms can be elicited by immunizing animals against purified full length denatured recombinant GPCRs. Contrasting with the currently admitted postulate, our study shows that an active and well-folded GPCR is not required for the production of specific anti-GPCR antibodies. This new immunizing strategy validated with three different human GPCR (m-opioid, k-opioid, neuropeptide FF2 receptors) might be generalized to other members of the GPCR family.	[Talmont, Franck; Mouledous, Lionel; Mollereau, Catherine] IPBS, CNRS, Toulouse, France; [Talmont, Franck; Mouledous, Lionel; Boue, Jerome; Mollereau, Catherine; Dietrich, Gilles] Univ Toulouse 3, F-31062 Toulouse, France; [Boue, Jerome; Dietrich, Gilles] Fac Med Toulouse, INSERM, U1043, Ctr Physiopathol Toulouse Purpan, F-31073 Toulouse, France; [Boue, Jerome; Dietrich, Gilles] CNRS, U5282, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Talmont, F (corresponding author), IPBS, CNRS, Toulouse, France.	franck.talmont@ipbs.fr	Dietrich, Gilles/AAC-2119-2020	Dietrich, Gilles/0000-0002-2232-1716; Mollereau, Catherine/0000-0003-1543-5624; Mouledous, Lionel/0000-0002-7675-3493	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paul Sabatier, Toulouse III	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paul Sabatier, Toulouse III	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), and the Universite Paul Sabatier, Toulouse III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirregoitia E, 2006, J CLIN ENDOCR METAB, V91, P4969, DOI 10.1210/jc.2006-0599; Asada H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-24; Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Beermann S, 2011, N-S ARCH PHARMACOL, V385, P125; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bockaert J, 2004, CURR OPIN DRUG DISC, V7, P649; Boue J, 2012, PAIN, V153, P485, DOI 10.1016/j.pain.2011.11.013; Boue J, 2011, J IMMUNOL, V186, P5078, DOI 10.4049/jimmunol.1003335; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Dietrich G, 1998, J NEUROCHEM, V70, P2106; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Huang LL, 2005, J MOL RECOGNIT, V18, P327, DOI 10.1002/jmr.735; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; KAZMI SMI, 1987, MOL PHARMACOL, V32, P109; Kivell BM, 2004, DEV BRAIN RES, V149, P9, DOI 10.1016/j.devbrainres.2003.11.012; Koutsopoulos S, 2012, CHEM SOC REV, V41, P1721, DOI 10.1039/c1cs15180k; Lu XY, 2009, N-S ARCH PHARMACOL, V379, P417, DOI 10.1007/s00210-009-0394-z; Mace G, 2002, BLOOD, V100, P3261, DOI 10.1182/blood-2002-01-0055; Mace G, 1999, J BIOL CHEM, V274, P20079, DOI 10.1074/jbc.274.29.20079; Mace G, 1999, EUR J IMMUNOL, V29, P997, DOI 10.1002/(SICI)1521-4141(199903)29:03<997::AID-IMMU997>3.0.CO;2-1; Mancia F, 2007, P NATL ACAD SCI USA, V104, P4303, DOI 10.1073/pnas.0700301104; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Muller I, 2008, J MEMBRANE BIOL, V223, P49, DOI 10.1007/s00232-008-9112-x; Muller I, 2010, APPL BIOCHEM BIOTECH, V160, P2175, DOI 10.1007/s12010-009-8715-8; Niwa H, 2012, BRIT J ANAESTH, V108, P530, DOI 10.1093/bja/aes015; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Singh S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-28; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Tansky MF, 2007, P NATL ACAD SCI USA, V104, P10691, DOI 10.1073/pnas.0703394104	44	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46348	10.1371/journal.pone.0046348	http://dx.doi.org/10.1371/journal.pone.0046348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029489	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500092
J	Zhang, R; Yao, FY; Gao, F; Abou-Samra, AB				Zhang, Ren; Yao, Fayi; Gao, Feng; Abou-Samra, Abdul B.			Nrac, a Novel Nutritionally-Regulated Adipose and Cardiac-Enriched Gene	PLOS ONE			English	Article							UNITED-STATES; OBESITY; ENDOCRINE; TISSUE; PREVALENCE; OVERWEIGHT; ADIPOCYTE; CHILDREN; TRENDS; CHINA	Obesity increases the risk of multiple diseases, such as type 2 diabetes and coronary heart diseases, and therefore the current obesity epidemic poses a major public health issue. Therapeutic approaches are urgently needed to treat obesity as well as its complications. Plasma-membrane proteins with restricted tissue distributions are attractive drug targets, because of their accessibility to various drug delivery mechanisms and potentially alleviated side effects. To identify genes involved in metabolism, we performed RNA-Seq on fat in mice treated with a high-fat diet or fasting. Here we show that the gene A530016L24Rik (human ortholog C14orf180), named Nrac, is a novel nutritionally-regulated adipose and cardiac-enriched gene. Nrac is expressed specifically and abundantly in fat and the heart. Both fasting and obesity reduced Nrac expression in white adipose tissue, and fasting reduced its expression in brown fat. Nrac is localized to the plasma membrane, and highly induced during adipocyte differentiation. Nrac is therefore a novel adipocyte marker and has potential functions in metabolism.	[Zhang, Ren; Yao, Fayi; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Ctr Mol Med, Detroit, MI 48202 USA; [Zhang, Ren; Yao, Fayi; Abou-Samra, Abdul B.] Wayne State Univ, Sch Med, Genet & Endocrine Div, Detroit, MI USA; [Gao, Feng] Tianjin Univ, Dept Phys, Tianjin 300072, Peoples R China	Wayne State University; Wayne State University; Tianjin University	Zhang, R (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med, Detroit, MI 48202 USA.	rzhang@med.wayne.edu	Abou-Samra, Abdul/ABE-8723-2020; Gao, Feng/C-9913-2009	Gao, Feng/0000-0002-9563-3841; Abou-Samra, Abdul/0000-0001-8735-1142	Wayne State University [176412]; National Natural Science Foundation of China [90408028, 31171238, 30800642, 10747150]	Wayne State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was supported in part by a fund (176412) from Wayne State University to R.Z. and by the National Natural Science Foundation of China (Grant Nos. 90408028, 31171238, 30800642 and 10747150) to F.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Gupta RK, 2011, CELL METAB, V14, P739, DOI 10.1016/j.cmet.2011.11.007; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Virtanen KA, 2009, NEW ENGL J MED, V361, P1123; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46254	10.1371/journal.pone.0046254	http://dx.doi.org/10.1371/journal.pone.0046254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029450	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500077
J	Kothari, H; Rao, LVM; Vankayalapati, R; Pendurthi, UR				Kothari, Hema; Rao, L. Vijaya Mohan; Vankayalapati, Ramakrishna; Pendurthi, Usha R.			Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROTEASE-ACTIVATED RECEPTORS; PROCOAGULANT ACTIVITY; COAGULATION; FIBRINOLYSIS; MONOCYTES; GROWTH; GENES; INFLAMMATION; HEMOSTASIS	A number of earlier studies reported the occurrence of thrombotic complications, particularly disseminated intravascular coagulation and deep vein thrombosis, in tuberculosis (TB) patients. The aberrant expression of tissue factor (TF), the primary activator of coagulation cascade, is known to be responsible for thrombotic disorders in many diseases including bacterial infections. Further, expression of TF by cells of the monocyte/macrophage lineage is also shown to contribute to the development and progression of local and systemic inflammatory reactions. In the present study, we have investigated whether Mycobacterium tuberculosis (Mtb) infection induces TF expression in macrophages, and various host and pathogenic factors responsible for TF expression. We have tested the effect of live virulent Mtb H37Rv, gamma-irradiated Mtb H37Rv (gamma-Mtb) and various components derived from Mtb H37Rv on TF expression in macrophages. The data presented in the manuscript show that both live virulent Mtb and gamma-Mtb treatments markedly increased TF activity in macrophages, predominantly in the CD14(+) macrophages. Detailed studies using gamma-Mtb showed that the increased TF activity in macrophages following Mtb treatment is the result of TF transcriptional activation. The signaling pathways of TF induction by Mtb appears to be distinct from that of LPS-induced TF expression. Mtb-mediated TF expression is dependent on cooperation of CD14/TLR2/TLR4 and probably yet another unknown receptor/cofactor. Mtb cell wall core components, mycolyl arabinogalactan peptidoglycan (mAGP), phosphatidylinositol mannoside-6 (PIM6) and lipomannan (LM) were identified as factors responsible for induction of TF in the order of mAGP > PIM6 > LM. A direct contact between bacteria and macrophage and not Mtb-released soluble factors is critical for TF induction by Mtb. In summary, our data show that Mtb induces TF expression in macrophages and Mtb signaling pathways that elicit TF induction require cooperation of multiple receptors, co-receptors/co-factors including Toll-like receptors. The importance of TF in granuloma formation and containment of Mtb is discussed.	[Kothari, Hema; Rao, L. Vijaya Mohan; Pendurthi, Usha R.] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA; [Vankayalapati, Ramakrishna] Univ Texas Hlth Ctr Tyler, Ctr Pulm & Infect Dis Control, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Kothari, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX USA.	Hema.Kothari@uthct.edu			American Heart Association, Texas; NIH/NHLBI [HL58869, HL65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058869, R01HL065500] Funding Source: NIH RePORTER	American Heart Association, Texas(American Heart Association); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was primarily supported by a post-doctoral fellowship award from American Heart Association, Texas affiliate to Hema Kothari. L.V.M.R and U.R.P. are partly supported by NIH/NHLBI grants HL58869 and HL65500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2007, BLOOD, V109, P5251, DOI 10.1182/blood-2006-10-051334; Ameixa C, 2002, INFECT IMMUN, V70, P4743, DOI 10.1128/IAI.70.8.4743-4746.2002; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; BEHLING CA, 1993, ANN CLIN LAB SCI, V23, P256; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; Carraway MS, 2003, AM J RESP CRIT CARE, V167, P1200, DOI 10.1164/rccm.200204-287OC; Chu AJ, 2005, ARCH BIOCHEM BIOPHYS, V440, P123, DOI 10.1016/j.abb.2005.06.005; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; DELPRETE G, 1995, BLOOD, V86, P250, DOI 10.1182/blood.V86.1.250.bloodjournal861250; Dhiman R, 2011, J IMMUNOL; DRAKE TA, 1989, J CELL BIOL, V109, P389, DOI 10.1083/jcb.109.1.389; DRAKE TA, 1993, AM J PATHOL, V142, P1458; El Fekih Leila, 2009, Tunis Med, V87, P328; Garcia-Perez BE, 2011, IMMUNOBIOLOGY, V216, P925, DOI 10.1016/j.imbio.2011.01.004; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Franco RF, 2000, BLOOD, V96, P554; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Garcia-Perez BE, 1970, UNDERSTANDING TUBERC; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Jung YJ, 2002, J EXP MED, V196, P991, DOI 10.1084/jem.20021186; Lang IM, 1996, HUM PATHOL, V27, P423, DOI 10.1016/S0046-8177(96)90118-5; LEATHAM EW, 1995, BRIT HEART J, V73, P10; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; LYBERG T, 1982, INFECT IMMUN, V38, P855, DOI 10.1128/IAI.38.3.855-859.1982; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Mehta PK, 2006, MICROB PATHOGENESIS, V41, P119, DOI 10.1016/j.micpath.2006.05.002; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; Moller ASW, 2001, THROMB RES, V102, P273, DOI 10.1016/S0049-3848(01)00248-1; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Osterud B, 1998, BLOOD COAGUL FIBRIN, V9, pS9; Osterud B, 1995, HYPERCOAG STS, P1; Pawlinski R, 2004, THROMB HAEMOSTASIS, V92, P444, DOI 10.1160/TH04-05-0309; Pawlinski R, 2004, BLOOD, V103, P1342, DOI 10.1182/blood-2003-09-3051; Pawlinski R, 2010, THROMB RES, V125, pS70, DOI 10.1016/j.thromres.2010.01.042; Pendurthi UR, 1997, ARTERIOSCL THROM VAS, V17, P940, DOI 10.1161/01.ATV.17.5.940; Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RICKLES FR, 1973, J CLIN INVEST, V52, P1427, DOI 10.1172/JCI107316; Rindi L, 1999, BIOCHEM BIOPH RES CO, V258, P94, DOI 10.1006/bbrc.1999.0591; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; SCHEIBENBOGEN C, 1992, HAEMOSTASIS, V22, P173; SCHWAGER I, 1994, BLOOD, V83, P152, DOI 10.1182/blood.V83.1.152.bloodjournal831152; SELVARAJ P, 1994, EUR RESPIR J, V7, P1227, DOI 10.1183/09031936.94.07071227; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Silver RF, 2009, AM J RESP CELL MOL, V40, P491, DOI 10.1165/rcmb.2008-0219OC; Spira A, 2003, AM J RESP CELL MOL, V29, P545, DOI 10.1165/rcmb.2002-0310OC; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; STEIN DS, 1990, SOUTHERN MED J, V83, P60, DOI 10.1097/00007611-199001000-00019; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; TANNENBAUM SH, 1986, J IMMUNOL, V137, P1532; Taubman MB, 1997, THROMB HAEMOSTASIS, V78, P200; Taylor F B Jr, 1994, New Horiz, V2, P555; Taylor FB, 1998, BLOOD, V91, P1609, DOI 10.1182/blood.V91.5.1609.1609_1609_1615; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; Turken O, 2002, INT J TUBERC LUNG D, V6, P927; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; Wang J, 1999, J CLIN INVEST, V103, P1023, DOI 10.1172/JCI6224; Wang JY, 2005, THROMB HAEMOSTASIS, V93, P729, DOI 10.1160/TH04-09-0562; Welty-wolf KE, 2000, AM J RESP CRIT CARE, V161, pA517; Williams Julie C, 2012, Front Biosci (Elite Ed), V4, P358; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	79	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45700	10.1371/journal.pone.0045700	http://dx.doi.org/10.1371/journal.pone.0045700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029190	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700059
J	Huff, DD; Lindley, ST; Wells, BK; Chai, F				Huff, David D.; Lindley, Steven T.; Wells, Brian K.; Chai, Fei			Green Sturgeon Distribution in the Pacific Ocean Estimated from Modeled Oceanographic Features and Migration Behavior	PLOS ONE			English	Article							ACIPENSER-MEDIROSTRIS; SPECIES DISTRIBUTIONS; TROPHIC DYNAMICS; PREDICTION; VARIABILITY; CALIFORNIA; HOTSPOTS; SYSTEM; RIVER; FIELD	The green sturgeon (Acipenser medirostris), which is found in the eastern Pacific Ocean from Baja California to the Bering Sea, tends to be highly migratory, moving long distances among estuaries, spawning rivers, and distant coastal regions. Factors that determine the oceanic distribution of green sturgeon are unclear, but broad-scale physical conditions interacting with migration behavior may play an important role. We estimated the distribution of green sturgeon by modeling species-environment relationships using oceanographic and migration behavior covariates with maximum entropy modeling (MaxEnt) of species geographic distributions. The primary concentration of green sturgeon was estimated from approximately 41-51.5 degrees N latitude in the coastal waters of Washington, Oregon, and Vancouver Island and in the vicinity of San Francisco and Monterey Bays from 36-37 degrees N latitude. Unsuitably cold water temperatures in the far north and energetic efficiencies associated with prevailing water currents may provide the best explanation for the range-wide marine distribution of green sturgeon. Independent trawl records, fisheries observer records, and tagging studies corroborated our findings. However, our model also delineated patchily distributed habitat south of Monterey Bay, though there are few records of green sturgeon from this region. Green sturgeon are likely influenced by countervailing pressures governing their dispersal. They are behaviorally directed to revisit natal freshwater spawning rivers and persistent overwintering grounds in coastal marine habitats, yet they are likely physiologically bounded by abiotic and biotic environmental features. Impacts of human activities on green sturgeon or their habitat in coastal waters, such as bottom-disturbing trawl fisheries, may be minimized through marine spatial planning that makes use of high-quality species distribution information.	[Huff, David D.; Lindley, Steven T.; Wells, Brian K.] Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA; [Huff, David D.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Chai, Fei] Univ Maine, Sch Marine Sci, Orono, ME USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; University of Maine System; University of Maine Orono	Huff, DD (corresponding author), Natl Ocean & Atmospher Adm, SW Fisheries Sci Ctr, Fisheries Ecol Div, Santa Cruz, CA USA.	david.huff@noaa.gov	Lindley, Steven T/G-3997-2014; Huff, David/A-8166-2008	Lindley, Steven T/0000-0001-9556-0411; Huff, David/0000-0001-9061-7685	National Oceanic and Atmospheric Administration; California Current Integrated Ecosystem Assessment Program; Species of Concern Program; NASA Grant [NNX09AU39G]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); California Current Integrated Ecosystem Assessment Program; Species of Concern Program; NASA Grant(National Aeronautics & Space Administration (NASA))	The authors' research was supported by funds from the National Oceanic and Atmospheric Administration, California Current Integrated Ecosystem Assessment Program (http://www.st.nmfs.noaa.gov/iea/index.html), a Species of Concern Program (http://www.nmfs.noaa.gov/pr/species/concern/grant.htm) grant to S.T.L. and by NASA Grant number NNX09AU39G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PB, 2007, ENVIRON BIOL FISH, V79, P339, DOI 10.1007/s10641-006-9062-z; Al-Humaidhi A. W., 2012, OBSERVED ESTIMATED T; Auad G, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001987; Bellman M.A., 2010, OBSERVED ESTIMATED T; Bidigare RR, 2009, J PLANKTON RES, V31, P1131, DOI 10.1093/plankt/fbp064; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; BRINK KH, 1991, J GEOPHYS RES-OCEANS, V96, P14637, DOI 10.1029/91JC01206; BRINKHURST RO, 1991, CONT SHELF RES, V11, P737, DOI 10.1016/0278-4343(91)90077-J; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; Chai F, 2009, J OCEANOGR, V65, P703, DOI 10.1007/s10872-009-0061-5; Colway Christa, 2007, Northwestern Naturalist, V88, P188, DOI 10.1898/1051-1733(2007)88[188:CROTGS]2.0.CO;2; Commerce Do, 2008, END THREAT WILDL PLA, P52084; CRAWFORD WR, 1991, CONT SHELF RES, V11, P669, DOI 10.1016/0278-4343(91)90073-F; Cross Jeffrey N., 1993, P459; Dewees CM, 1984, CALIFORNIA COOPERATI, V25, P68; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Erickson DL, 2007, AM FISH S S, V56, P197; Erickson DL, 2007, ENVIRON BIOL FISH, V79, P255, DOI 10.1007/s10641-006-9072-x; Erickson DL, 2011, COMMUNICATION; Favorite F., 1976, INT N PACIFIC FISHER, V187; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hastie T., 2009, SPRINGER SERIES STAT, Vxxii; Hendy IL, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000965; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; Huff DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025156; Huff DD, 2005, N AM J FISH MANAGE, V25, P346, DOI 10.1577/M03-231.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kelly JT, 2012, ENVIRON BIOL FISH, V93, P151, DOI 10.1007/s10641-011-9898-8; Klimley AP, 1985, BIOL WHITE SHARK, P15; Krige DG, 1967, J S AFR I MIN METALL, V67, P21; LARGE WG, 1982, J PHYS OCEANOGR, V12, P464, DOI 10.1175/1520-0485(1982)012<0464:SALHFM>2.0.CO;2; Levings C. D., 1980, FJORD OCEANOGRAPHY, P515; Lindley ST, 2008, T AM FISH SOC, V137, P182, DOI 10.1577/T07-055.1; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu G, 2009, ICES J MAR SCI, V66, P420, DOI 10.1093/icesjms/fsn219; Lucas B.G, 2007, ECOSYSTEM OVERVIEW P; Mayfield RB, 2004, T AM FISH SOC, V133, P961, DOI 10.1577/T02-144.1; McLain D.R., 1983, California Cooperative Oceanic Fisheries Investigations Reports, V24, P165; MCNAB BK, 2002, PHYSL ECOLOGY VERTEB, V27; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Mora EA, 2009, J APPL ICHTHYOL, V25, P39, DOI 10.1111/j.1439-0426.2009.01297.x; [National Oceanic and Atmospheric Administration Commerce Do], 2010, ENV ASS PROP APPL PR, V101; [National Oceanic and Atmospheric Administration Commerce Do], 2007, NOAA FISH NAM PAN EX; Nur N, 2011, ECOL APPL, V21, P2241, DOI 10.1890/10-1460.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Polovina JJ, 2008, PROG OCEANOGR, V77, P217, DOI 10.1016/j.pocean.2008.03.011; Ranasinghe JA, 2011, HABITAT RELATED BENT; Ready J, 2010, ECOL MODEL, V221, P467, DOI 10.1016/j.ecolmodel.2009.10.025; Rosales-Casian JA, 2009, CAL COOP OCEAN FISH, V50, P169; Scott JM, 2002, PREDICTING SPECIES O, Vxvii; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; Springer AM, 1996, FISH OCEANOGR, V5, P205, DOI 10.1111/j.1365-2419.1996.tb00118.x; Stabeno PJ, 2001, FISH OCEANOGR, V10, P81, DOI 10.1046/j.1365-2419.2001.00157.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P519, DOI 10.1046/j.1439-0426.2002.00413.x; Sydeman WJ, 2006, DEEP-SEA RES PT II, V53, P247, DOI 10.1016/j.dsr2.2006.03.001; Thomson R.E., 1981, CANADIAN SPECIAL PUB, P291; Ware D.M., 1989, CAN SPEC PUBL FISH A, V108, P359; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Welch DW, 2002, OCEANOL ACTA, V25, P243, DOI 10.1016/S0399-1784(02)01206-9; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Xiu P., 2011, J GEOPHYS RES OCEANS, V116; Xiu P, 2012, DEEP-SEA RES PT I, V63, P102, DOI 10.1016/j.dsr.2012.01.006; Xiu P, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005657; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhang HM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027086	71	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45852	10.1371/journal.pone.0045852	http://dx.doi.org/10.1371/journal.pone.0045852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029274	Green Submitted, gold, Green Published			2022-12-25	WOS:000309392800105
J	Pan, JC; Bahar, AA; Syed, H; Ren, DC				Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng			Reverting Antibiotic Tolerance of Pseudomonas aeruginosa PAO1 Persister Cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one	PLOS ONE			English	Article							BIOFILM FORMATION; ESCHERICHIA-COLI; INHIBITION; RESISTANCE; BACTERIA; ELEMENTS; TOXINS; GROWTH; RIDDLE; RNAS	Background: Bacteria are well known to form dormant persister cells that are tolerant to most antibiotics. Such intrinsic tolerance also facilitates the development of multidrug resistance through acquired mechanisms. Thus persister cells are a promising target for developing more effective methods to control chronic infections and help prevent the development of multidrug-resistant bacteria. However, control of persister cells is still an unmet challenge. Methodology/Principal Findings: We show in this report that (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one (BF8) can restore the antibiotic susceptibility of Pseudomonas aeruginosa PAO1 persister cells at growth non-inhibitory concentrations. Persister control by BF8 was found to be effective against both planktonic and biofilm cells of P. aeruginosa PAO1. Interestingly, although BF8 is an inhibitor of quorum sensing (QS) in Gram-negative bacteria, the data in this study suggest that the activities of BF8 to revert antibiotic tolerance of P. aeruginosa PAO1 persister cells is not through QS inhibition and may involve other targets. Conclusion: BF8 can sensitize P. aeruginosa persister cells to antibiotics.	[Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng] Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA; [Pan, Jiachuan; Bahar, Ali Adem; Syed, Haseeba; Ren, Dacheng] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY USA; [Ren, Dacheng] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Ren, Dacheng] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University; Syracuse University; Syracuse University; Syracuse University	Ren, DC (corresponding author), Syracuse Univ, Dept Biomed & Chem Engn, Syracuse, NY 13244 USA.	dren@syr.edu			U.S. National Science Foundation [CAREER-1055644, EFRI-1137186]	U.S. National Science Foundation(National Science Foundation (NSF))	The studies described in this work were supported by the U.S. National Science Foundation (CAREER-1055644 and EFRI-1137186, http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bomberger JM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001325; Brazas MD, 2005, ANTIMICROB AGENTS CH, V49, P3222, DOI 10.1128/AAC.49.8.3222-3227.2005; Chen CY, 2003, J MICROBIOL METH, V55, P475, DOI 10.1016/S0167-7012(03)00194-5; Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Duo M, 2010, APPL MICROBIOL BIOT, V85, P1551, DOI 10.1007/s00253-009-2174-6; Gefen O, 2009, FEMS MICROBIOL REV, V33, P704, DOI 10.1111/j.1574-6976.2008.00156.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Goodrich AF, 1999, RNA, V5, P972, DOI 10.1017/S1355838299990398; Han Y, 2008, BIOORG MED CHEM LETT, V18, P1006, DOI 10.1016/j.bmcl.2007.12.032; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hou S, 2009, INHIBITING MICROBIAL, P6; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; LaFleur MD, 2010, ANTIMICROB AGENTS CH, V54, P39, DOI 10.1128/AAC.00860-09; Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mukamolova GV, 1998, P NATL ACAD SCI USA, V95, P8916, DOI 10.1073/pnas.95.15.8916; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Niepa THR, 2012, BIOMATERIALS, V33, P7356, DOI 10.1016/j.biomaterials.2012.06.092; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Pabdee AB, 1959, J MOL BIOL, V1, P156; Pan JC, 2009, EXPERT OPIN THER PAT, V19, P1581, DOI 10.1517/13543770903222293; Pearson H, 2002, NATURE, V418, P469, DOI 10.1038/418469b; Ren DC, 2001, ENVIRON MICROBIOL, V3, P731, DOI 10.1046/j.1462-2920.2001.00249.x; Sambrook J, 2001, MOL CLONING LAB MANU; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; TAYLOR PC, 1983, ANTIMICROB AGENTS CH, V23, P142, DOI 10.1128/AAC.23.1.142; Wang R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00144	43	50	51	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45778	10.1371/journal.pone.0045778	http://dx.doi.org/10.1371/journal.pone.0045778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029239	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900099
J	Roberts, IN; Lam, XT; Miranda, H; Kieselbach, T; Funk, C				Roberts, Irma N.; Lam, Xuan Tam; Miranda, Helder; Kieselbach, Thomas; Funk, Christiane			Degradation of PsbO by the Deg Protease HhoA Is Thioredoxin Dependent	PLOS ONE			English	Article							MANGANESE-STABILIZING PROTEIN; SYNECHOCYSTIS-SP PCC-6803; OXYGEN-EVOLVING COMPLEX; II REACTION-CENTER; CHLOROPLAST THYLAKOID LUMEN; SP STRAIN PCC-6803; PHOTOSYSTEM-II; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; DISULFIDE BOND	The widely distributed members of the Deg/HtrA protease family play an important role in the proteolysis of misfolded and damaged proteins. Here we show that the Deg protease rHhoA is able to degrade PsbO, the extrinsic protein of the Photosystem II (PSII) oxygenq-evolving complex in Synechocystis sp. PCC 6803 and in spinach. PsbO is known to be stable in its oxidized form, but after reduction by thioredoxin it became a substrate for recombinant HhoA (rHhoA). rHhoA cleaved reduced eukaryotic (specifically, spinach) PsbO at defined sites and created distinct PsbO fragments that were not further degraded. As for the corresponding prokaryotic substrate (reduced PsbO of Synechocystis sp. PCC 6803), no PsbO fragments were observed. Assembly to PSII protected PsbO from degradation. For Synechocystis sp. PCC 6803, our results show that HhoA, HhoB, and HtrA are localized in the periplasma and/or at the thylakoid membrane. In agreement with the idea that PsbO could be a physiological substrate for Deg proteases, part of the cellular fraction of the three Deg proteases of Synechocystis sp. PCC 6803 (HhoA, HhoB, and HtrA) was detected in the PSIIq-enriched membrane fraction.	[Funk, Christiane] Umea Univ, Dept Chem, Umea, Sweden; Umea Univ, Umea Plant Sci Ctr, Umea, Sweden	Umea University; Umea University	Funk, C (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	Christiane.Funk@chem.umu.se	Kieselbach, Thomas/O-6023-2015; Funk, Christiane/AAO-6041-2021	Kieselbach, Thomas/0000-0001-5577-2938; Funk, Christiane/0000-0002-7897-4038; Roberts, Irma/0000-0003-4896-7782	Swedish Energy Agency [2009-000928]; Royal Swedish Academy of Sciences [312-3820-06]; Lawsky Foundation; Umea University	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Royal Swedish Academy of Sciences; Lawsky Foundation; Umea University	This work was supported by grants of the Swedish Energy Agency (2009-000928 to CF), the Royal Swedish Academy of Sciences (312-3820-06 to CF), the Lawsky Foundation (to XTL) and Umea University (to CF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARELLANO JB, 1994, PHYSIOL PLANTARUM, V91, P369, DOI 10.1111/j.1399-3054.1994.tb02962.x; Balmer Y, 2006, ANTIOXID REDOX SIGN, V8, P1829, DOI 10.1089/ars.2006.8.1829; Barker M, 2006, J BIOL CHEM, V281, P30347, DOI 10.1074/jbc.M601064200; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betts SD, 1996, BBA-BIOENERGETICS, V1274, P135, DOI 10.1016/0005-2728(96)00023-0; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; BURNAP RL, 1994, BIOCHEMISTRY-US, V33, P13712, DOI 10.1021/bi00250a023; Chassin Y, 2002, PLANT PHYSIOL, V130, P857, DOI 10.1104/pp.007922; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; De Las Rivas J, 2004, PHOTOSYNTH RES, V81, P329, DOI 10.1023/B:PRES.0000036889.44048.e4; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; ETTINGER WF, 1991, J CELL BIOL, V115, P321, DOI 10.1083/jcb.115.2.321; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fulda S, 2000, EUR J BIOCHEM, V267, P5900, DOI 10.1046/j.1432-1327.2000.01642.x; Funk C, 2001, FAMILY DEG HTR PROTE, pS8; GORLACH J, 1993, PLANT CELL PHYSIOL, V34, P497; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hall M, 2010, PROTEOMICS, V10, P987, DOI 10.1002/pmic.200900654; Hashimoto A, 1996, FEBS LETT, V391, P29; Hauske P, 2009, MOL BIOSYST, V5, P980, DOI 10.1039/b902089f; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Henmi T, 2004, PLANT CELL PHYSIOL, V45, P243, DOI 10.1093/pcp/pch027; Huang F, 2006, PROTEOMICS, V6, P910, DOI 10.1002/pmic.200500114; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huesgen PF, 2005, PHYSIOL PLANTARUM, V123, P413, DOI 10.1111/j.1399-3054.2005.00458.x; Huesgen PF, 2007, J BACTERIOL, V189, P6611, DOI 10.1128/JB.00883-07; Huesgen PF, 2011, BIOCHEM J, V435, P733, DOI 10.1042/BJ20102131; Hutchison RS, 1998, BIOCHEMISTRY-US, V37, P5643, DOI 10.1021/bi9724467; IRRGANG KD, 1995, J BIOL CHEM, V270, P17588, DOI 10.1074/jbc.270.29.17588; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Kaneko T, 1996, DNA Res, V3, P109; Kapri-Pardes E, 2007, PLANT CELL, V19, P1039, DOI 10.1105/tpc.106.046573; Karamoko M, 2011, PLANT CELL, V23, P4462, DOI 10.1105/tpc.111.089680; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; Kieselbach T, 2003, PHYSIOL PLANTARUM, V119, P337, DOI 10.1034/j.1399-3054.2003.00199.x; Kieselbach T, 1998, J BIOL CHEM, V273, P6710, DOI 10.1074/jbc.273.12.6710; Kieselbach T, 2000, FEBS LETT, V480, P271, DOI 10.1016/S0014-5793(00)01890-1; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2010, CHINESE SCI BULL, V55, P3145, DOI 10.1007/s11434-010-4042-2; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; Lu YK, 2005, PLANT CELL PHYSIOL, V46, P1944, DOI 10.1093/pcp/pci209; Lundin B, 2007, BBA-BIOENERGETICS, V1767, P500, DOI 10.1016/j.bbabio.2006.10.009; Lydakis-Simantiris N, 1999, BIOCHEMISTRY-US, V38, P404, DOI 10.1021/bi981847z; Marchand C, 2004, PROTEOMICS, V4, P2696, DOI 10.1002/pmic.200400805; Marchand C, 2006, PROTEOMICS, V6, P6528, DOI 10.1002/pmic.200600443; Mata-Cabana A, 2007, PROTEOMICS, V7, P3953, DOI 10.1002/pmic.200700410; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIYAO M, 1984, FEBS LETT, V170, P350, DOI 10.1016/0014-5793(84)81342-3; Nikitina J, 2008, PHOTOSYNTH RES, V98, P391, DOI 10.1007/s11120-008-9327-9; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk M, 2004, PHYS CHEM CHEM PHYS, V6, P4878, DOI 10.1039/b407316a; PALOMARES R, 1993, EUR J BIOCHEM, V217, P345, DOI 10.1111/j.1432-1033.1993.tb18252.x; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Popelkova H, 2003, PHOTOSYNTH RES, V77, P21, DOI 10.1023/A:1024970926655; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Shutova T, 2005, BIOCHEMISTRY-US, V44, P15182, DOI 10.1021/bi0512750; Silva P, 2002, PHILOS T R SOC B, V357, P1461, DOI 10.1098/rstb.2002.1146; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Spence E, 2003, MOL MICROBIOL, V48, P1481, DOI 10.1046/j.1365-2958.2003.03519.x; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Stroher E, 2008, PHYSIOL PLANTARUM, V133, P566, DOI 10.1111/j.1399-3054.2008.01103.x; Sun XW, 2007, PLANT CELL, V19, P1347, DOI 10.1105/tpc.106.049510; Sun XW, 2010, PLANT J, V62, P240, DOI 10.1111/j.1365-313X.2010.04140.x; Sun XW, 2010, PLANT PHYSIOL, V152, P1263, DOI 10.1104/pp.109.150722; Suorsa M, 2007, PHOTOSYNTH RES, V93, P89, DOI 10.1007/s11120-007-9154-4; TANAKA S, 1989, BIOCHEMISTRY-US, V28, P7188, DOI 10.1021/bi00444a009; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; WALES R, 1989, PLANT MOL BIOL, V12, P439, DOI 10.1007/BF00017583; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wong JH, 2004, PHYTOCHEMISTRY, V65, P1629, DOI 10.1016/j.phytochem.2004.05.010; Wyman AJ, 2005, PHOTOSYNTH RES, V85, P359, DOI 10.1007/s11120-005-7385-9; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Zak E, 2001, P NATL ACAD SCI USA, V98, P13443, DOI 10.1073/pnas.241503898; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	81	19	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45713	10.1371/journal.pone.0045713	http://dx.doi.org/10.1371/journal.pone.0045713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029195	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388400123
J	Chen, HM; Zheng, CX; Gao, Q; Ge, YC; Liu, ZH				Chen, Hui-Mei; Zheng, Chun-Xia; Gao, Qing; Ge, Yong-Chun; Liu, Zhi-Hong			Heart-Type Fatty Acid Binding Protein Is Associated with Proteinuria in Obesity	PLOS ONE			English	Article							RENAL LIPID-METABOLISM; DIABETIC-NEPHROPATHY; GLOMERULOPATHY; INSIGHTS; INJURY; MICE; GLOMERULOSCLEROSIS; HYPERTENSION; ALBUMINURIA; DAMAGE	Rationale: Lipid metabolism contributes to the formation of obesity-related glomerulopathy (ORG). Heart-type fatty acid binding protein (H-FABP or FABP3) is involved in lipid metabolism and was predicted to relate to renal lesions in obesity. Methods: A total of 28 patients with ORG were investigated, and renal tissue from 7 kidney donors served as controls. Db/db mice with albuminuria were treated with Simvastatin for 12 weeks. Results: Immunohistochemistry demonstrated the H-FABP staining in glomerular and tubular areas of patients with ORG, and the percentage of H-FABP in the glomerular area was significantly higher than in controls (15.8 +/- 1.62 versus 4.51 +/- 0.56%, P<0.001). Moreover, H-FABP expression correlated with proteinuria, high-density lipoprotein (HDL) cholesterol, waist circumference and the homeostatic model assessment-insulin resistance (HOMA-IR) among patients with ORG. Enhanced expression of H-FABP was also detected in the db/db mice, and expression increased from 8 to 20 weeks of age and was weakly related to increased albuminuria (r = 0.433; P = 0.020). Furthermore, H-FABP was co-localized with synaptopodin and demonstrated a podocyte pattern distribution. After Simvastation treatment, the urine albumin levels decreased with lipid levels and H-FABP expression in the glomeruli. The expression of H-FABP was related to Simvastatin treatment, albuminuria and triglycerides, while it was only linked with triglycerides and albuminuria (r = 0.643, P = 0.036). Conclusions: This study confirmed an association of H-FABP with the pathogenesis of clinical and experimental ORG, and suggests that such a process might be related to podocytes and lipid dysmetabolism.	[Chen, Hui-Mei; Zheng, Chun-Xia; Gao, Qing; Ge, Yong-Chun; Liu, Zhi-Hong] Nanjing Univ, Res Inst Nephrol, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing University	Chen, HM (corresponding author), Nanjing Univ, Res Inst Nephrol, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	chenhuimei@nju.edu.cn; zhihong-liu@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726; Chen, Huimei/0000-0001-7788-1334	National Natural Science Foundation of China [30800546, 81070579]; Doctoral Foundation of Education Ministry of China [200802841008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Education Ministry of China	This work was supported by the National Natural Science Foundation of China (grant number: 30800546, 81070579) and the Doctoral Foundation of Education Ministry of China (grant number: 200802841008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco S, 2005, AM J HYPERTENS, V18, P557, DOI 10.1016/j.amjhyper.2004.10.034; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; Chen HM, 2006, AM J KIDNEY DIS, V48, P772, DOI 10.1053/j.ajkd.2006.07.025; Chen HM, 2011, J RENAL NUTR, V21, P309, DOI 10.1053/j.jrn.2010.06.019; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kimura H, 1999, KIDNEY INT, V56, pS159; Kramer H, 2009, DIABETES CARE, V32, P851, DOI 10.2337/dc08-2059; Kume S, 2007, J AM SOC NEPHROL, V18, P2715, DOI 10.1681/ASN.2007010089; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Mayrhofer C, 2009, AM J PATHOL, V174, P1191, DOI 10.2353/ajpath.2009.080654; Negishi K, 2007, KIDNEY INT, V72, P348, DOI 10.1038/sj.ki.5002304; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Praga M, 2001, NEPHROL DIAL TRANSPL, V16, P1790, DOI 10.1093/ndt/16.9.1790; Praga M, 2002, NEPHROL DIAL TRANSPL, V17, P1157, DOI 10.1093/ndt/17.7.1157; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Raz I, 2011, DIABETES CARE, V34, pS99, DOI 10.2337/dc11-s201; Sharma K, 2009, KIDNEY INT, V76, P145, DOI 10.1038/ki.2009.137; Sheridan AM, 1996, KIDNEY INT, V49, P88, DOI 10.1038/ki.1996.12; Stieger N, 2011, DIABETES-METAB RES, V27, P207, DOI 10.1002/dmrr.1164; Tanimoto M, 2004, METABOLISM, V53, P1473, DOI 10.1016/j.metabol.2004.06.016; Tran HA, 2004, J CLIN ENDOCR METAB, V89, P6358, DOI 10.1210/jc.2004-1174; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	28	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45691	10.1371/journal.pone.0045691	http://dx.doi.org/10.1371/journal.pone.0045691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029183	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900168
J	Christel, CJ; Schaer, R; Wang, SY; Henzi, T; Kreiner, L; Grabs, D; Schwaller, B; Lee, A				Christel, Carl J.; Schaer, Raphael; Wang, Shiyi; Henzi, Thomas; Kreiner, Lisa; Grabs, Detlev; Schwaller, Beat; Lee, Amy			Calretinin Regulates Ca2+-dependent Inactivation and Facilitation of Ca(v)2.1 Ca2+ Channels through a Direct Interaction with the alpha(1)2.1 Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESYNAPTIC CALCIUM CURRENT; PROTEIN-INTERACTION SITE; CA2+/CALMODULIN-DEPENDENT FACILITATION; SPLICE VARIANTS; GRANULE CELLS; BINDING; IDENTIFICATION; CALMODULIN; MODULATION; PARVALBUMIN	Voltage-gated Ca(v)2.1 Ca2+ channels undergo dual modulation by Ca2+, Ca2+-dependent inactivation (CDI), and Ca2+-dependent facilitation (CDF), which can influence synaptic plasticity in the nervous system. Although the molecular determinants controlling CDI and CDF have been the focus of intense research, little is known about the factors regulating these processes in neurons. Here, we show that calretinin (CR), a Ca2+-binding protein highly expressed in subpopulations of neurons in the brain, inhibits CDI and enhances CDF by binding directly to alpha(1)2.1. Screening of a phage display library with CR as bait revealed a highly basic CR-binding domain (CRB) present in multiple copies in the cytoplasmic linker between domains II and III of alpha(1)2.1. In pulldown assays, CR binding to fusion proteins containing these CRBs was largely Ca2+-dependent. alpha(1)2.1 coimmunoprecipitated with CR antibodies from transfected cells and mouse cerebellum, which confirmed the existence of CR-Ca(v)2.1 complexes in vitro and in vivo. In HEK293T cells, CR significantly decreased Ca(v)2.1 CDI and increased CDF. CR binding to alpha(1)2.1 was required for these effects, because they were not observed upon substitution of the II-III linker of alpha(1)2.1 with that from the Ca(v)1.2 alpha(1) subunit (alpha(1)1.2), which lacks the CRBs. In addition, coexpression of a protein containing the CRBs blocked the modulatory action of CR, most likely by competing with CR for interactions with alpha(1)2.1. Our findings highlight an unexpected role for CR in directly modulating effectors such as Ca(v)2.1, which may have major consequences for Ca2+ signaling and neuronal excitability.	[Schaer, Raphael; Henzi, Thomas; Grabs, Detlev; Schwaller, Beat] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Otolaryngol, Iowa City, IA 52242 USA; [Christel, Carl J.; Wang, Shiyi; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Kreiner, Lisa] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	University of Fribourg; University of Iowa; University of Iowa; University of Iowa; Emory University	Schwaller, B (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	beat.schwaller@unifr.ch; amy-lee@uiowa.edu	Wang, Shiyi/AAC-9354-2019	Schwaller, Beat/0000-0002-8277-7555; Wang, Shiyi/0000-0003-3433-3025; Lee, Amy/0000-0001-8021-0443	National Institutes of Health [DC009433, R01 HL087120, T32007121]; Carver Research Program of Excellence award; Swiss National Science Foundation [113518, 130680]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Research Program of Excellence award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants DC009433 and R01 HL087120 (to A. L.) and T32007121 (to C. J. C.). This work was also supported by a Carver Research Program of Excellence award (to A. L.) and Swiss National Science Foundation Grants 113518 and 130680 (to B. S.).	ANDRESSEN C, 1993, CELL TISSUE RES, V271, P181, DOI 10.1007/BF00318606; AUGUSTINE GJ, 1986, J PHYSIOL-LONDON, V381, P619, DOI 10.1113/jphysiol.1986.sp016347; Bearzatto B, 2006, FASEB J, V20, P380, DOI 10.1096/fj.05-3785fje; Berggard T, 2002, J BIOL CHEM, V277, P16662, DOI 10.1074/jbc.M200415200; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Chaudhuri D, 2005, J NEUROSCI, V25, P8282, DOI 10.1523/JNEUROSCI.2253-05.2005; Chaudhuri D, 2004, J NEUROSCI, V24, P6334, DOI 10.1523/JNEUROSCI.1712-04.2004; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dino MR, 1999, J NEUROCYTOL, V28, P99, DOI 10.1023/A:1007072105919; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gall D, 2003, J NEUROSCI, V23, P9320; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; Kreiner L, 2010, J NEUROPHYSIOL, V103, P371, DOI 10.1152/jn.00635.2009; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; KUZNICKI J, 1995, BIOCHEM J, V308, P607; Lautermilch NJ, 2005, J NEUROSCI, V25, P7062, DOI 10.1523/JNEUROSCI.0447-05.2005; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lin KH, 2012, J NEUROSCI, V32, P1261, DOI 10.1523/JNEUROSCI.3838-11.2012; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Marini AM, 1997, BRAIN RES BULL, V42, P279, DOI 10.1016/S0361-9230(96)00263-8; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Rajapaksha WRAKJS, 2008, J BIOL CHEM, V283, P15997, DOI 10.1074/jbc.M710544200; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Schiffmann SN, 1999, P NATL ACAD SCI USA, V96, P5257, DOI 10.1073/pnas.96.9.5257; Schwaller B, 2004, ANTICANCER RES, V24, P4003; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Schwaller B., 2007, HDB NEUROCHEMISTRY M, P197, DOI 10.1007/978-0-387-30379-6_5.; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Soong TW, 2002, J NEUROSCI, V22, P10142; STARR TVB, 1991, P NATL ACAD SCI USA, V88, P5621, DOI 10.1073/pnas.88.13.5621; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WINSKY L, 1995, J NEUROCHEM, V65, P381; Zamponi GW, 2003, J PHARMACOL SCI, V92, P79	58	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406363	http://dx.doi.org/10.1074/jbc.M112.406363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033479	Green Published, hybrid			2022-12-25	WOS:000311233800045
J	Besirli, CG; Zheng, QD; Reed, DM; Zacks, DN				Besirli, Cagri G.; Zheng, Qiong-Duon; Reed, David M.; Zacks, David N.			ERK-Mediated Activation of Fas Apoptotic Inhibitory Molecule 2 (Faim2) Prevents Apoptosis of 661W Cells in a Model of Detachment-Induced Photoreceptor Cell Death	PLOS ONE			English	Article							PHOSPHORYLATION; EXPRESSION; LIFEGUARD; NEURONS; PATHWAY; TUMORS	In this study, we examined the role of Fas apoptotic inhibitory molecule 2 (Faim2), an inhibitor of the Fas signaling pathway, and its regulation by stress kinase signaling during Fas-mediated apoptosis of 661W cells, an immortalized photoreceptor-like cell line Treatment of 661W cells with a Fas-activating antibody led to increased levels of Faim2. Both ERK and JNK stress kinase pathways were activated in Fas-treated 661W cells, but only the inhibition of the ERK pathway reduced the levels of Faim2. Blocking the ERK pathway using a pharmacological inhibitor increased the susceptibility of 661W cells to Fas-induced caspase activation and apoptosis. When the levels of Faim2 were reduced in 661W cells by siRNA knockdown, Fas activating antibody treatment resulted in earlier and more robust caspase activation, and increased cell death. These results demonstrate that Faim2 acts as a neuroprotectant during Fas-mediated apoptosis of 661W cells. The expression of Faim2 is triggered, at least in part, by Fas-receptor activation and subsequent ERK signaling. Our findings identify a novel protective pathway that auto-regulates Fas-induced photoreceptor apoptosis in vitro. Modulation of this pathway to increase Faim2 expression may be a potential therapeutic option to prevent photoreceptor death.	[Besirli, Cagri G.; Zheng, Qiong-Duon; Reed, David M.; Zacks, David N.] Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zacks, DN (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA.	davzacks@umich.edu	Zacks, David/I-4394-2013; Reed, David M/S-7063-2019; Reed, David Millard/AFQ-5520-2022	Reed, David M/0000-0002-4772-6138; Zacks, David/0000-0001-8592-5165; Besirli, Cagri/0000-0001-7154-2024	Michigan Eye Bank and Transplantation Center; NEI [R01-020823]; Departmental Core Center for Vision Research [NEI-EY-07003]; Heed Ophthalmic Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY020823] Funding Source: NIH RePORTER	Michigan Eye Bank and Transplantation Center; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Departmental Core Center for Vision Research; Heed Ophthalmic Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Michigan Eye Bank and Transplantation Center (DNZ); NEI R01-020823 (DNZ); and Departmental Core Center for Vision Research NEI-EY-07003. CGB is supported by The Heed Ophthalmic Foundation Fellowship. DMR is partially supported by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Beier CP, 2005, J NEUROSCI, V25, P6765, DOI 10.1523/JNEUROSCI.1700-05.2005; Besirli CG, 2011, INVEST OPHTH VIS SCI, V52, P4193, DOI 10.1167/iovs.10-7090; Besirli CG, 2010, INVEST OPHTH VIS SCI, V51, P2177, DOI 10.1167/iovs.09-4439; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; de Mendoza TH, 2011, P NATL ACAD SCI USA, V108, P17189, DOI 10.1073/pnas.1114226108; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Reimers K, 2006, INT J MOL MED, V18, P729; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Ross WH, 2002, EYE, V16, P440, DOI 10.1038/sj.eye.6700192; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zacks DN, 2007, ARCH OPHTHALMOL-CHIC, V125, P1389, DOI 10.1001/archopht.125.10.1389; Zacks David N, 2009, Trans Am Ophthalmol Soc, V107, P343; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598	26	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46664	10.1371/journal.pone.0046664	http://dx.doi.org/10.1371/journal.pone.0046664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029562	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900196
J	Coutellier, L; Beraki, S; Ardestani, PM; Saw, NL; Shamloo, M				Coutellier, Laurence; Beraki, Simret; Ardestani, Pooneh Memar; Saw, Nay Lui; Shamloo, Mehrdad			Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders	PLOS ONE			English	Article							MICE LACKING; PREPULSE INHIBITION; SYNAPSE DEVELOPMENT; PERIRHINAL CORTEX; SCHIZOPHRENIA; MEMORY; HIPPOCAMPUS; BEHAVIOR; PROTEIN; PAS	Npas4 is a transcription factor, which is highly expressed in the brain and regulates the formation and maintenance of inhibitory synapses in response to excitatory synaptic activity. A deregulation of the inhibitory-excitatory balance has been associated with a variety of human developmental disorders such as schizophrenia and autism. However, not much is known about the role played by inhibitory synapses and inhibitory pathways in the development of nervous system disorders. We hypothesized that alterations in the inhibitory pathways induced by the absence of Npas4 play a major role in the expression of the symptoms observed in psychiatric disorders. To test this hypothesis we tested mice lacking the transcription factor (Npas4 knock-out mice (Npas4-KO)) in a battery of behavioral assays focusing on general activity, social behaviors, and cognitive functions. Npas4-KO mice are hyperactive in a novel environment, spend less time exploring an unfamiliar ovariectomized female, spend more time avoiding an unfamiliar male during a first encounter, show higher social dominance than their WT littermates, and display pre-pulse inhibition, working memory, long-term memory, and cognitive flexibility deficits. These behavioral deficits may replicate schizophrenia-related symptomatology such as social anxiety, hyperactivity, and cognitive and sensorimotor gating deficits. Immunohistochemistry analyses revealed that Npas4 expression is induced in the hippocampus after a social encounter and that Npas4 regulates the expression of c-Fos in the CA1 and CA3 regions of the hippocampus after a cognitive task. Our results suggest that Npas4 may play a major role in the regulation of cognitive and social functions in the brain with possible implications for developmental disorders such as schizophrenia and autism.	[Coutellier, Laurence; Beraki, Simret; Ardestani, Pooneh Memar; Saw, Nay Lui; Shamloo, Mehrdad] Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA	Stanford University	Shamloo, M (corresponding author), Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA.	mshamloo@stanford.edu	Coutellier, Laurence/AAH-6706-2020	Coutellier, Laurence/0000-0001-9331-8701	National Institute of Neurological Disorders and Stroke P30 center core grant [NS069375-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke P30 center core grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Neurological Disorders and Stroke P30 center core grant (NS069375-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Breuillaud L, 2012, BIOL PSYCHI IN PRESS; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; Fendt M, 2011, BEHAV BRAIN RES, V217, P1, DOI 10.1016/j.bbr.2010.09.022; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gaffan EA, 2000, BEHAV NEUROSCI, V114, P18, DOI 10.1037/0735-7044.114.1.18; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gould GG, 2011, J NEUROCHEM, V116, P291, DOI 10.1111/j.1471-4159.2010.07104.x; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guidotti G, 2012, NEUROPSYCHOPHARMACOL, V37, P746, DOI 10.1038/npp.2011.252; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Homberg JR, 2007, PSYCHOPHARMACOLOGY, V195, P175, DOI 10.1007/s00213-007-0895-8; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; KIM JS, 1980, NEUROSCI LETT, V20, P379, DOI 10.1016/0304-3940(80)90178-0; Klar AJS, 2004, GENETICS, V167, P1833, DOI 10.1534/genetics.104.028217; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Machaalani R, 2002, BRAIN RES, V951, P293, DOI 10.1016/S0006-8993(02)03175-X; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Yamada K, 2004, AM J MED GENET B, V127B, P11, DOI 10.1002/ajmg.b.20166; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	55	84	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46604	10.1371/journal.pone.0046604	http://dx.doi.org/10.1371/journal.pone.0046604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029555	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900189
J	Hayashi, T; Yao, SY; Crain, B; Chan, M; Tawatao, RI; Gray, C; Vuong, L; Lao, F; Cottam, HB; Carson, DA; Corr, M				Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Chan, Michael; Tawatao, Rommel I.; Gray, Christine; Vuong, Linda; Lao, Fitzgerald; Cottam, Howard B.; Carson, Dennis A.; Corr, Maripat			Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN DENDRITIC CELLS; MULTIPLE-SCLEROSIS; AGONIST 852A; IFN-GAMMA; T-CELLS; RESPONSES; ENCEPHALOMYELITIS; PROLIFERATION; DEMYELINATION	The Toll-like receptors (TLR) have been advocated as attractive therapeutic targets because TLR signaling plays dual roles in initiating adaptive immune responses and perpetuating inflammation. Paradoxically, repeated stimulation of bone marrow mononuclear cells with a synthetic TLR7 ligand 9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine (called 1V136) leads to subsequent TLR hyporesponsiveness. Further studies on the mechanism of action of this pharmacologic agent demonstrated that the TLR7 ligand treatment depressed dendritic cell activation, but did not directly affect T cell function. To verify this mechanism, we utilized experimental allergic encephalitis (EAE) as an in vivo T cell dependent autoimmune model. Drug treated SJL/J mice immunized with proteolipid protein (PLP)(139-151) peptide had attenuated disease severity, reduced accumulation of mononuclear cells in the central nervous system (CNS), and limited demyelination, without any apparent systemic toxicity. Splenic T cells from treated mice produced less cytokines upon antigenic rechallenge. In the spinal cords of 1V136-treated EAE mice, the expression of chemoattractants was also reduced, suggesting innate immune cell hyposensitization in the CNS. Indeed, systemic 1V136 did penetrate the CNS. These experiments indicated that repeated doses of a TLR7 ligand may desensitize dendritic cells in lymphoid organs, leading to diminished T cell responses. This treatment strategy might be a new modality to treat T cell mediated autoimmune diseases.	[Corr, Maripat] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hayashi, Tomoko; Yao, Shiyin; Crain, Brian; Chan, Michael; Tawatao, Rommel I.; Gray, Christine; Vuong, Linda; Lao, Fitzgerald; Cottam, Howard B.; Carson, Dennis A.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Corr, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mcorr@ucsd.edu		Vuong, Linda/0000-0001-5253-3712	Telormedix (Bioggio, Switzerland); Arthritis Foundation; United States National Institutes of Health [CA23100, HHSN272200900034C]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER	Telormedix (Bioggio, Switzerland); Arthritis Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from Telormedix (Bioggio, Switzerland), the Arthritis Foundation (MC) and by CA23100 and HHSN272200900034C (DAC) from the United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chan M, 2011, BIOCONJUGATE CHEM, V22, P445, DOI 10.1021/bc1004813; Chan M, 2009, BIOCONJUGATE CHEM, V20, P1194, DOI 10.1021/bc900054q; Chang YC, 2005, SOUTH MED J, V98, P914, DOI 10.1097/01.SMJ.0000176712.01491.98; Craft N, 2005, J IMMUNOL, V175, P1983, DOI 10.4049/jimmunol.175.3.1983; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Doran A, 2005, DRUG METAB DISPOS, V33, P165, DOI 10.1124/dmd.104.001230; Dumitru CD, 2009, CANCER IMMUNOL IMMUN, V58, P575, DOI 10.1007/s00262-008-0581-7; Dummer R, 2008, CLIN CANCER RES, V14, P856, DOI 10.1158/1078-0432.CCR-07-1938; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Fearon DT, 1996, SCIENCE, V272, P50, DOI 10.1126/science.272.5258.50; Fleming CJ, 2004, BRIT J DERMATOL, V151, P485, DOI 10.1111/j.1365-2133.2004.05983.x; Forward NA, 2010, J LEUKOCYTE BIOL, V87, P117, DOI 10.1189/jlb.0908559; Hayashi T, 2001, INFECT IMMUN, V69, P6156, DOI 10.1128/IAI.69.10.6156-6164.2001; Hayashi T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/262394; Hayashi T, 2009, P NATL ACAD SCI USA, V106, P2764, DOI 10.1073/pnas.0813037106; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; Inglefield JR, 2008, J INTERF CYTOK RES, V28, P253, DOI 10.1089/jir.2007.0097; Ito T, 2002, J EXP MED, V195, P1507, DOI 10.1084/jem.20020207; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Kurimoto A, 2004, BIOORGAN MED CHEM, V12, P1091, DOI 10.1016/j.bmc.2003.12.008; Lee J, 2006, P NATL ACAD SCI USA, V103, P1828, DOI 10.1073/pnas.0510801103; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lombardi V, 2009, J IMMUNOL, V182, P3372, DOI 10.4049/jimmunol.0801969; Marta M, 2008, EUR J IMMUNOL, V38, P565, DOI 10.1002/eji.200737187; Merson TD, 2010, NEUROMOL MED, V12, P99, DOI 10.1007/s12017-010-8112-z; Milo R, 2011, J NEUROIMMUNOL, V231, P23, DOI 10.1016/j.jneuroim.2010.10.021; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Purdon CH, 2004, CRIT REV THER DRUG, V21, P97, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i2.20; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Touil T, 2006, J IMMUNOL, V177, P7505, DOI 10.4049/jimmunol.177.11.7505; Weiner HL, 2004, ARCH NEUROL-CHICAGO, V61, P1613, DOI 10.1001/archneur.61.10.1613; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	47	18	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45860	10.1371/journal.pone.0045860	http://dx.doi.org/10.1371/journal.pone.0045860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029281	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900059
J	Schallner, N; Fuchs, M; Schwer, CI; Loop, T; Buerkle, H; Lagreze, WA; van Oterendorp, C; Biermann, J; Goebel, U				Schallner, Nils; Fuchs, Matthias; Schwer, Christian I.; Loop, Torsten; Buerkle, Hartmut; Lagreze, Wolf Alexander; van Oterendorp, Christian; Biermann, Julia; Goebel, Ulrich			Postconditioning with Inhaled Carbon Monoxide Counteracts Apoptosis and Neuroinflammation in the Ischemic Rat Retina	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REPERFUSION LUNG INJURY; HEAT-SHOCK RESPONSE; CARDIOPULMONARY BYPASS; GANGLION-CELLS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MULLER CELLS; MICROGLIA; PATHWAY	Purpose: Ischemia and reperfusion injury (I/R) of neuronal structures and organs is associated with increased morbidity and mortality due to neuronal cell death. We hypothesized that inhalation of carbon monoxide (CO) after I/R injury ('postconditioning') would protect retinal ganglion cells (RGC). Methods: Retinal I/R injury was performed in Sprague-Dawley rats (n = 8) by increasing ocular pressure (120 mmHg, 1 h). Rats inhaled room air or CO (250 ppm) for 1 h immediately following ischemia or with 1.5 and 3 h latency. Retinal tissue was harvested to analyze Bcl-2, Bax, Caspase-3, HO-1 expression and phosphorylation of the nuclear transcription factor (NF)-kappa B, p38 and ERK-1/2 MAPK. NF-kappa B activation was determined and inhibition of ERK-1/2 was performed using PD98059 (2 mg/kg). Densities of fluorogold prelabeled RGC were analyzed 7 days after injury. Microglia, macrophage and Muller cell activation and proliferation were evaluated by Iba-1, GFAP and Ki-67 staining. Results: Inhalation of CO after I/R inhibited Bax and Caspase-3 expression (Bax: 1.9 +/- 0.3 vs. 1.4 +/- 0.2, p = 0.028; caspase-3: 2.0 +/- 0.2 vs. 1.5 +/- 0.1, p = 0.007; mean +/- S.D., fold induction at 12 h), while expression of Bcl-2 was induced (1.2 +/- 0.2 vs. 1.6 +/- 0.2, p = 0.001; mean +/- S. D., fold induction at 12 h). CO postconditioning suppressed retinal p38 phosphorylation (p = 0.023 at 24 h) and induced the phosphorylation of ERK-1/2 (p < 0.001 at 24 h). CO postconditioning inhibited the expression of HO-1. The activation of NF-kappa B, microglia and Muller cells was potently inhibited by CO as well as immigration of proliferative microglia and macrophages into the retina. CO protected I/R-injured RGC with a therapeutic window at least up to 3 h (n = 8; RGC/mm(2); mean +/- S.D.: 1255 +/- 327 I/R only vs. 1956 +/- 157 immediate CO treatment, vs. 1830 +/- 109 1.5 h time lag and vs. 1626 +/- 122 3 h time lag; p < 0.001). Inhibition of ERK-1/2 did not counteract the CO effects (RGC/mm(2) : 1956 +/- 157 vs. 1931 +/- 124, mean +/- S.D., p = 0.799). Conclusion: Inhaled CO, administered after retinal ischemic injury, protects RGC through its strong anti-apoptotic and antiinflammatory effects.	[Schallner, Nils; Fuchs, Matthias; Schwer, Christian I.; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich] Univ Med Ctr Freiburg Breisgau, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Lagreze, Wolf Alexander; van Oterendorp, Christian; Biermann, Julia] Univ Eye Hosp, Univ Med Ctr, Freiburg, Germany	University of Freiburg	Schallner, N (corresponding author), Univ Med Ctr Freiburg Breisgau, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	nils.schallner@uniklinik-freiburg.de	Buerkle, Hartmut/I-5785-2014; Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016	Göbel, Ulrich/0000-0002-9991-3226	departmental funding; German Research Foundation (DFG); Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''	departmental funding; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''	This work was supported by departmental funding. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE LA, 1991, CANCER RES, V51, P974; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; GELLER SF, 1995, INVEST OPHTH VIS SCI, V36, P737; Goebel U, 2009, BRIT J ANAESTH, V103, P173, DOI 10.1093/bja/aep087; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Goebel U, 2011, ANESTH ANALG, V112, P282, DOI 10.1213/ANE.0b013e318203f591; Graham BL, 2002, AM J RESP CRIT CARE, V165, P1504, DOI 10.1164/rccm.2108071; Guo YL, 2001, J CELL BIOCHEM, V82, P556, DOI 10.1002/jcb.1180; Jaissle GB, 2011, GRAEF ARCH CLIN EXP, V249, P183, DOI 10.1007/s00417-010-1470-2; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; Kamphuis W, 2007, MOL VIS, V13, P1020; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kohno H, 2006, GRAEF ARCH CLIN EXP, V244, P90, DOI 10.1007/s00417-005-0030-7; Lewis G, 1999, AM J OPHTHALMOL, V128, P165, DOI 10.1016/S0002-9394(99)00103-8; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Marra C, 2011, J NEUROIMMUNOL, V233, P120, DOI 10.1016/j.jneuroim.2010.12.008; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Nakanishi Y, 2006, EXP EYE RES, V83, P1108, DOI 10.1016/j.exer.2006.05.018; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Takeuchi A, 2000, AM J RESP CRIT CARE, V161, P1816, DOI 10.1164/ajrccm.161.6.9907038; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Weber J, 1998, STROKE, V29, P2076, DOI 10.1161/01.STR.29.10.2076; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537; Wong GY, 2000, ANESTHESIOLOGY, V92, P425, DOI 10.1097/00000542-200002000-00024; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	49	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46479	10.1371/journal.pone.0046479	http://dx.doi.org/10.1371/journal.pone.0046479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029526	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900167
J	Solt, LA; Kamenecka, TM; Burris, TP				Solt, Laura A.; Kamenecka, Theodore M.; Burris, Thomas P.			LXR-Mediated Inhibition of CD4(+) T Helper Cells	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ROR-GAMMA-T; X-RECEPTOR AGONIST; ADOPTIVE TRANSFER; INTERFERON-GAMMA; GENE-EXPRESSION; DIFFERENTIATION; BET; INDUCTION; LINEAGE	T(H)17 cells, which require the expression of both retinoic acid receptor-related orphan receptors alpha and gamma t (ROR alpha and ROR gamma t) for full differentiation and function, have been implicated as major effectors in the pathogenesis of inflammatory and autoimmune diseases. We recently demonstrated that the Liver X Receptor (LXR) agonist, T0901317 (T09), also displays high-affinity ROR alpha and ROR gamma inverse activity, potentially explaining its effectiveness in various T(H)17-mediated autoimmune disease models. However, recent studies suggest that in conjunction with the RORs, LXR mediates a negative regulatory effect on T(H)17 cell differentiation. Since T09 acts on both LXRs and RORs, it presents as a valuable tool to understand how compounds with mixed pharmacology affect potential pathological cell types. Therefore, using T09, we investigated the mechanism by which the LXRs and RORs affect T(H)17 cell differentiation and function. Here we demonstrate that T09 activity at ROR alpha and gamma, not LXR, is facilitating the inhibition of T(H)17 cell differentiation and function. We also demonstrate that LXR activity inhibits the differentiation and function of T(H)1, T(H)2 and iT(reg) cells. Finally, T09 inhibited T cell proliferation and induced cell death. These data help explain much of the efficacy of T09 in inflammatory models and suggest that the generation of synthetic ligands with graded, combined LXR and ROR activity may hold utility in the treatment of inflammatory and autoimmune diseases where targeting both T(H)17 and T(H)1 cells is required.	[Solt, Laura A.; Kamenecka, Theodore M.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [R01DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health R01DK080201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO DG, 1989, CELL IMMUNOL, V124, P132, DOI 10.1016/0008-8749(89)90117-2; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; CHRIST M, 1993, IMMUNOLOGY, V78, P455; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Ferber IA, 1996, J IMMUNOL, V156, P5; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; MCDONALD AH, 1988, J IMMUNOL, V140, P1132; Nath N, 2006, IMMUNOLOGY, V118, P384, DOI 10.1111/j.1365-2567.2006.02385.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Tamauchi H, 2004, INT IMMUNOL, V16, P179, DOI 10.1093/intimm/dxh026; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Waldburger KE, 1996, AM J PATHOL, V148, P375; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yura M, 2001, J AUTOIMMUN, V17, P17, DOI 10.1006/jaut.2001.0520; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zuercher WJ, 2010, J MED CHEM, V53, P3412, DOI 10.1021/jm901797p	47	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46615	10.1371/journal.pone.0046615	http://dx.doi.org/10.1371/journal.pone.0046615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029557	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900191
J	Sulaeman, S; Hernould, M; Schaumann, A; Coquet, L; Bolla, JM; De, E; Tresse, O				Sulaeman, Sheiam; Hernould, Mathieu; Schaumann, Annick; Coquet, Laurent; Bolla, Jean-Michel; De, Emmanuelle; Tresse, Odile			Enhanced Adhesion of Campylobacter jejuni to Abiotic Surfaces Is Mediated by Membrane Proteins in Oxygen-Enriched Conditions	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; ELONGATION-FACTOR TU; BIOFILM FORMATION; ESCHERICHIA-COLI; C-JEJUNI; BINDING PROTEIN; IDENTIFICATION; ADHERENCE; PROTEOMICS; VIRULENCE	Campylobacter jejuni is responsible for the major foodborne bacterial enteritis in humans. In contradiction with its fastidious growth requirements, this microaerobic pathogen can survive in aerobic food environments, suggesting that it must employ a variety of protection mechanisms to resist oxidative stress. For the first time, C. jejuni 81-176 inner and outer membrane subproteomes were analyzed separately using two-dimensional protein electrophoresis (2-DE) of oxygen-acclimated cells and microaerobically grown cells. LC-MS/MS analyses successfully identified 42 and 25 spots which exhibited a significantly altered abundance in the IMP-enriched fraction and in the OMP-enriched fraction, respectively, in response to oxidative conditions. These spots corresponded to 38 membrane proteins that could be grouped into different functional classes: (i) transporters, (ii) chaperones, (iii) fatty acid metabolism, (iv) adhesion/virulence and (v) other metabolisms. Some of these proteins were up-regulated at the transcriptional level in oxygen-acclimated cells as confirmed by qRT-PCR. Downstream analyses revealed that adhesion of C. jejuni to inert surfaces and swarming motility were enhanced in oxygen-acclimated cells or paraquat-stressed cells, which could be explained by the higher abundance of membrane proteins involved in adhesion and biofilm formation. The virulence factor CadF, over-expressed in the outer membrane of oxygen-acclimated cells, contributes to the complex process of C. jejuni adhesion to inert surfaces as revealed by a reduction in the capability of C. jejuni 81-176 DCadF cells compared to the isogenic strain. Taken together, these data demonstrate that oxygen-enriched conditions promote the over-expression of membrane proteins involved in both the biofilm initiation and virulence of C. jejuni.	[Sulaeman, Sheiam; Hernould, Mathieu; Tresse, Odile] INRA, SECALIM, UMR1014, F-44026 Nantes, France; [Sulaeman, Sheiam; Hernould, Mathieu; Tresse, Odile] Univ Nantes, LUNAM Univ, Nantes, France; [Schaumann, Annick; Coquet, Laurent; De, Emmanuelle] CNRS, IFRMP23, FR 3038, Mont St Aignan, France; [Schaumann, Annick; Coquet, Laurent; De, Emmanuelle] Univ Rouen, Lab Polymeres Biopolyme Surfaces, UMR 6270, Mont St Aignan, France; [Bolla, Jean-Michel] Univ Aix Marseille, IRBA, Fac Med & Pharm, UMR MD1, Marseille, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; UDICE-French Research Universities; Aix-Marseille Universite	Tresse, O (corresponding author), INRA, SECALIM, UMR1014, F-44026 Nantes, France.	odile.tresse@oniris-nantes.fr	Bolla, Jean Michel/D-3885-2014	Bolla, Jean Michel/0000-0003-3892-4340; COQUET, Laurent/0000-0001-7778-7321; De, Emmanuelle/0000-0002-9564-1649; Tresse, Odile/0000-0001-9833-2510	Pays de la Loire region (France) through the project GENICAMP; Syrian fellowship	Pays de la Loire region (France) through the project GENICAMP(Region Pays de la Loire); Syrian fellowship	This research was funded by the Pays de la Loire region (France) through the project GENICAMP. Sheiam Sulaeman was the recipient of a Syrian fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DWK, 1999, CURR OPIN GASTROEN, V15, P538, DOI 10.1097/00001574-199911000-00015; Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Atack JM, 2008, J BACTERIOL, V190, P5279, DOI 10.1128/JB.00100-08; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Batz B., 2011, RANKING RISKS 10 PAT; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Bieche C, 2012, J PROTEOMICS, V75, P1144, DOI 10.1016/j.jprot.2011.10.028; Boyanova L, 2004, DIAGN MICR INFEC DIS, V49, P71, DOI 10.1016/j.diagmicrobio.2003.12.004; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Brown RN, 2010, J PROTEOME RES, V9, P4454, DOI 10.1021/pr100215h; BURUCOA C, 1995, RES MICROBIOL, V146, P467, DOI 10.1016/0923-2508(96)80292-0; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Corcionivoschi Nicolae, 2007, Bacteriol Virusol Parazitol Epidemiol, V52, P51; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; FISHER MT, 1992, J BIOL CHEM, V267, P1872; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Garenaux A, 2009, CURR MICROBIOL, V58, P134, DOI 10.1007/s00284-008-9289-3; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; GRANT KA, 1995, MICROBIOL-SGM, V141, P1369, DOI 10.1099/13500872-141-6-1369; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Gundogdu O, 2011, J BACTERIOLOGY; HASSAN HM, 1979, J BIOL CHEM, V254, P846; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Jeon B, 2011, J ANTIMICROB CHEMOTH, V66, P79, DOI 10.1093/jac/dkq418; John A, 2011, RES MICROBIOL, V162, P410, DOI 10.1016/j.resmic.2011.02.004; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kaakoush NO, 2007, RES MICROBIOL, V158, P644, DOI 10.1016/j.resmic.2007.07.009; Kim TJ, 2008, APPL ENVIRON MICROB, V74, P5466, DOI 10.1128/AEM.00222-08; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kolberg J, 2008, FEMS IMMUNOL MED MIC, V53, P222, DOI 10.1111/j.1574-695X.2008.00419.x; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Larson CL, 2008, MICROBIOL-SGM, V154, P3835, DOI 10.1099/mic.0.2008/021279-0; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Nachamkin I, 2002, MICROBES INFECT, V4, P399, DOI 10.1016/S1286-4579(02)01553-8; Nikaido E, 2011, MICROBIOL-SGM, V157, P648, DOI 10.1099/mic.0.045757-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Prokhorova TA, 2006, VACCINE, V24, P6446, DOI 10.1016/j.vaccine.2006.05.085; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Scott NE, 2010, PROTEOMICS, V10, P277, DOI 10.1002/pmic.200900440; Seal BS, 2007, J PROTEOME RES, V6, P4582, DOI 10.1021/pr070356a; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Siroy A, 2006, J PROTEOME RES, V5, P3385, DOI 10.1021/pr060372s; SKIRROW MB, 1990, LANCET, V336, P921, DOI 10.1016/0140-6736(90)92282-M; Solis N, 2011, PROTEOMICS, V11, P3169, DOI 10.1002/pmic.201000808; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Sulaeman S, 2010, J APPL MICROBIOL, V108, P1303, DOI 10.1111/j.1365-2672.2009.04534.x; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Vilain S, 2001, ELECTROPHORESIS, V22, P4368, DOI 10.1002/1522-2683(200112)22:20<4368::AID-ELPS4368>3.0.CO;2-9; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yamasaki M, 2004, FEMS MICROBIOL LETT, V235, P57, DOI 10.1016/j.femsle.2004.04.012; Yao RJ, 1997, MOL MICROBIOL, V23, P1021, DOI 10.1046/j.1365-2958.1997.2861650.x; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	79	38	38	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46402	10.1371/journal.pone.0046402	http://dx.doi.org/10.1371/journal.pone.0046402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029510	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900154
J	Mitra, A; Fay, PA; Morgan, JK; Vendura, KW; Versaggi, SL; Riordan, JT				Mitra, Avishek; Fay, Pamela A.; Morgan, Jason K.; Vendura, Khoury W.; Versaggi, Salvatore L.; Riordan, James T.			Sigma Factor N, Liaison to an ntrC and rpoS Dependent Regulatory Pathway Controlling Acid Resistance and the LEE in Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT LEE; O-ANTIGEN-EXPRESSION; RNA-POLYMERASE; PROTEIN SECRETION; SALMONELLA-TYPHIMURIUM; PATHOGENICITY ISLAND; BORRELIA-BURGDORFERI; INTRACELLULAR LEVELS; 2-COMPONENT SYSTEM; SUBUNIT SYNTHESIS	Enterohemorrhagic Escherichia coli (EHEC) is dependent on acid resistance for gastric passage and low oral infectious dose, and the locus of enterocyte effacement (LEE) for intestinal colonization. Mutation of rpoN, encoding sigma factor N (sigma(N)), dramatically alters the growth-phase dependent regulation of both acid resistance and the LEE. This study reports on the determinants of sigma(N)-directed acid resistance and LEE expression, and the underlying mechanism attributable to this phenotype. Glutamate-dependent acid resistance (GDAR) in TW14359 Delta rpoN correlated with increased expression of the gadX-gadW regulatory circuit during exponential growth, whereas upregulation of arginine-dependent acid resistance (ADAR) genes adiA and adiC in TW14359 Delta rpoN did not confer acid resistance by the ADAR mechanism. LEE regulatory (ler), structural (espA and cesT) and effector (tir) genes were downregulated in TW14359 Delta rpoN, and mutation of rpoS encoding sigma factor 38 (sigma(S)) in TW14359 Delta rpoN restored acid resistance and LEE genes to WT levels. Stability, but not the absolute level, of sigma(S) was increased in TW14359 Delta rpoN; however, increased stability was not solely attributable to the GDAR and LEE expression phenotype. Complementation of TW14359 Delta rpoN with a sigma(N) allele that binds RNA polymerase (RNAP) but not DNA, did not restore WT levels of S-sigma stability, gadE, ler or GDAR, indicating a dependence on transcription from a sigma(N) promoter(s) and not RNAP competition for the phenotype. Among a library of sigma(N) enhancer binding protein mutants, only TW14359 Delta ntrC, inactivated for nitrogen regulatory protein NtrC, phenocopied TW14359 Delta rpoN for sigma(S) stability, GDAR and ler expression. The results of this study suggest that during exponential growth, NtrC-sigma(N) regulate GDAR and LEE expression through downregulation of s S at the post-translational level; likely by altering sigma(S) stability or activity. The regulatory interplay between NtrC, other EBPs, and sigma(N)-sigma(S), represents a mechanism by which EHEC can coordinate GDAR, LEE expression and other cellular functions, with nitrogen availability and physiologic stimuli.	[Mitra, Avishek; Fay, Pamela A.; Morgan, Jason K.; Vendura, Khoury W.; Versaggi, Salvatore L.; Riordan, James T.] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Riordan, JT (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol CMMB, Tampa, FL 33620 USA.	jtriordan@usf.edu	Mitra, Avishek/AAA-5628-2021	Mitra, Avishek/0000-0003-0243-2045	University of South Florida	University of South Florida	This research was supported by intramural start-up funds from the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abe P, 1997, INFECT IMMUN, V65, P3547, DOI 10.1128/IAI.65.9.3547-3555.1997; Baik HS, 1996, MICROBIOL-SGM, V142, P3195, DOI 10.1099/13500872-142-11-3195; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Belik A S, 2008, Mol Gen Mikrobiol Virusol, P3; Bergholz TM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-97; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bittner M, 2004, MICROB PATHOGENESIS, V36, P19, DOI 10.1016/j.micpath.2003.08.003; Bittner M, 2002, MICROBIOL-SGM, V148, P3789, DOI 10.1099/00221287-148-12-3789; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; BOHANNON DE, 1991, J BACTERIOL, V173, P4482, DOI 10.1128/JB.173.14.4482-4492.1991; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chart H, 2000, J APPL MICROBIOL, V88, p12S, DOI 10.1111/j.1365-2672.2000.tb05328.x; Claret L, 2002, J MOL BIOL, V321, P185, DOI 10.1016/S0022-2836(02)00600-9; Colland F, 2002, GENES CELLS, V7, P233, DOI 10.1046/j.1365-2443.2002.00517.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Dong T, 2011, MOL MICROBIOL, V79, P375, DOI 10.1111/j.1365-2958.2010.07449.x; Elliott SJ, 1998, MOL MICROBIOL, V28, P1, DOI 10.1046/j.1365-2958.1998.00783.x; Farewell A, 1998, MOL MICROBIOL, V29, P1039, DOI 10.1046/j.1365-2958.1998.00990.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gong SM, 2004, MOL MICROBIOL, V54, P948, DOI 10.1111/j.1365-2958.2004.04312.x; Hartland EL, 1999, MOL MICROBIOL, V32, P151, DOI 10.1046/j.1365-2958.1999.01338.x; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; HENGGEARONIS R, 1992, MOL MICROBIOL, V6, P1877, DOI 10.1111/j.1365-2958.1992.tb01360.x; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Ishihama A, 1990, Adv Biophys, V26, P19, DOI 10.1016/0065-227X(90)90005-E; Iyoda S, 2005, J BACTERIOL, V187, P4086, DOI 10.1128/JB.187.12.4086-4094.2005; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Joslin SN, 2008, J BACTERIOL, V190, P2422, DOI 10.1128/JB.01827-07; Kenny B, 1997, INFECT IMMUN, V65, P2606, DOI 10.1128/IAI.65.7.2606-2612.1997; Krin E, 2010, RES MICROBIOL, V161, P363, DOI 10.1016/j.resmic.2010.04.002; Kwon YM, 1998, APPL ENVIRON MICROB, V64, P3458; Laaberki MH, 2006, INT J MED MICROBIOL, V296, P197, DOI 10.1016/j.ijmm.2006.02.017; LANGE R, 1994, GENE DEV, V8, P1600, DOI 10.1101/gad.8.13.1600; Lease RA, 2004, J BACTERIOL, V186, P6179, DOI 10.1128/JB.186.18.6179-6185.2004; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Ma Z, 2004, J BACTERIOL, V186, P7378, DOI 10.1128/JB.186.21.7378-7389.2004; Ma Z, 2003, J BACTERIOL, V185, P6852, DOI 10.1128/JB.185.23.6852-6859.2003; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Masuda N, 2002, J BACTERIOL, V184, P6225, DOI 10.1128/JB.184.22.6225-6234.2002; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Mead P, 1998, INT C EM INF DIS ATL; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller JH., 1972, EXPT MOL GENETICS; MORTON HJ, 1970, IN VITRO CELL DEV B, V6, P89; Muffler A, 1996, J BACTERIOL, V178, P1607, DOI 10.1128/jb.178.6.1607-1613.1996; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Neupane M, 2011, MICROB PATHOGENESIS, V51, P466, DOI 10.1016/j.micpath.2011.07.009; Noguchi K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010132; Paesold G, 1999, J BACTERIOL, V181, P1264, DOI 10.1128/JB.181.4.1264-1268.1999; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; POWERS JC, 1989, J CELL BIOCHEM, V39, P33, DOI 10.1002/jcb.240390105; Price SB, 2000, APPL ENVIRON MICROB, V66, P632, DOI 10.1128/AEM.66.2.632-637.2000; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Reading NC, 2010, MICROBIOL-SGM, V156, P1167, DOI 10.1099/mic.0.033027-0; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; Riordan JT, 2010, MICROBIOL-SGM, V156, P719, DOI 10.1099/mic.0.032631-0; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; SANKAR P, 1988, J BACTERIOL, V170, P5433, DOI 10.1128/jb.170.12.5433-5439.1988; Sayed AK, 2007, MICROBIOL-SGM, V153, P2584, DOI 10.1099/mic.0.2007/007005-0; Schweder T, 1996, J BACTERIOL, V178, P470, DOI 10.1128/jb.178.2.470-476.1996; Shin S, 2001, MOL MICROBIOL, V41, P1133, DOI 10.1046/j.1365-2958.2001.02570.x; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; StimHerndon KP, 1996, MICROBIOL-UK, V142, P1311, DOI 10.1099/13500872-142-5-1311; Taylor M, 1996, MOL MICROBIOL, V22, P1045, DOI 10.1046/j.1365-2958.1996.01547.x; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x; Tomoyasu T, 2005, FEMS MICROBIOL LETT, V253, P59, DOI 10.1016/j.femsle.2005.09.020; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Wang L, 2001, J BIOL CHEM, V276, P8979, DOI 10.1074/jbc.M009587200; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; Wong ARC, 2011, MOL MICROBIOL, V80, P1420, DOI 10.1111/j.1365-2958.2011.07661.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yona-Nadler C, 2003, MICROBIOL-SGM, V149, P877, DOI 10.1099/mic.0.25970-0; Zgurskaya HI, 1997, MOL MICROBIOL, V24, P643, DOI 10.1046/j.1365-2958.1997.3961742.x; Zhao K, 2010, NUCLEIC ACIDS RES, V38, P1273, DOI 10.1093/nar/gkp1123; Zimmer DP, 2000, P NATL ACAD SCI USA, V97, P14674, DOI 10.1073/pnas.97.26.14674	99	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46288	10.1371/journal.pone.0046288	http://dx.doi.org/10.1371/journal.pone.0046288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029465	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500085
J	Gounder, SS; Kannan, S; Devadoss, D; Miller, CJ; Whitehead, KS; Odelberg, SJ; Firpo, MA; Paine, R; Hoidal, JR; Abel, ED; Rajasekaran, NS				Gounder, Sellamuthu S.; Kannan, Sankaranarayanan; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Firpo, Matthew A.; Paine, Robert, III; Hoidal, John R.; Abel, E. Dale; Rajasekaran, Namakkal S.			Impaired Transcriptional Activity of Nrf2 in Age-Related Myocardial Oxidative Stress Is Reversible by Moderate Exercise Training	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; CARDIOVASCULAR-DISEASE; REACTIVE OXYGEN; CELL-DEATH; ENHANCES SUSCEPTIBILITY; ENDOTHELIAL-CELLS; RECEPTOR FUNCTION; OLD RATS; IN-VIVO; ANTIOXIDANT	Aging promotes accumulation of reactive oxygen/nitrogen species (ROS/RNS) in cardiomyocytes, which leads to contractile dysfunction and cardiac abnormalities. These changes may contribute to increased cardiovascular disease in the elderly. Inducible antioxidant pathways are regulated by nuclear erythroid 2 p45-related factor 2 (Nrf2) through antioxidant response cis-elements (AREs) and are impaired in the aging heart. Whereas acute exercise stress (AES) activates Nrf2 signaling and promotes myocardial antioxidant function in young mice (similar to 2 months), aging mouse (> 23 months) hearts exhibit significant oxidative stress as compared to those of the young. The purpose of this study was to investigate agedependent regulation of Nrf2-antioxidant mechanisms and redox homeostasis in mouse hearts and the impact of exercise. Old mice were highly susceptible to oxidative stress following high endurance exercise stress (EES), but demonstrated increased adaptive redox homeostasis after moderate exercise training (MET; 10m/min, for 45 min/day) for similar to 6 weeks. Following EES, transcription and protein levels for most of the ARE-antioxidants were increased in young mice but their induction was blunted in aging mice. In contrast, 6-weeks of chronic MET promoted nuclear levels of Nrf2 along with its target antioxidants in the aging heart to near normal levels as seen in young mice. These observations suggest that enhancing Nrf2 function and endogenous cytoprotective mechanisms by MET, may combat age-induced ROS/RNS and protect the myocardium from oxidative stress diseases.	[Gounder, Sellamuthu S.; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Rajasekaran, Namakkal S.] Univ Utah, Dept Internal Med, Div Cardiol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Gounder, Sellamuthu S.; Devadoss, Dinesh; Miller, Corey J.; Whitehead, Kevin S.; Odelberg, Shannon J.; Paine, Robert, III; Hoidal, John R.; Rajasekaran, Namakkal S.] Univ Utah, Dept Internal Med, Div Pulm, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Kannan, Sankaranarayanan] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA; [Firpo, Matthew A.] Univ Utah, Dept Gen Surg, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; [Abel, E. Dale] Univ Utah, Dept Internal Med, Div Endocrinol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rajasekaran, NS (corresponding author), Univ Utah, Dept Internal Med, Div Cardiol, Hlth Sci Ctr, Salt Lake City, UT 84112 USA.	Raj.Soorappan@hsc.utah.edu	Devadoss, Dinesh/AAO-7983-2020	Devadoss, Dinesh/0000-0003-0069-1799; Abel, E. Dale/0000-0001-5290-0738	Center on Aging (CoA); Utah - Pilot Grant Program Award; AHA [086501F]; University of Utah Interdisciplinary Seed Grant; Divisions of Cardiology and Pulmonary; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042860] Funding Source: NIH RePORTER	Center on Aging (CoA); Utah - Pilot Grant Program Award; AHA(American Heart Association); University of Utah Interdisciplinary Seed Grant; Divisions of Cardiology and Pulmonary; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a Center on Aging (CoA), Utah - Pilot Grant Program Award, Beginning Grant-In-Aid from the AHA (086501F) and University of Utah Interdisciplinary Seed Grant to Namakkal S. Rajasekaran. Seed funding from the Divisions of Cardiology and Pulmonary also supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EUR HEART J; Asghar M, 2007, AM J PHYSIOL-RENAL, V293, pF914, DOI 10.1152/ajprenal.00272.2007; Baker JM, 2011, FASEB J, V25, P4348, DOI 10.1096/fj.11-189043; Bean JF, 2004, ARCH PHYS MED REHAB, V85, pS31, DOI 10.1016/j.apmr.2004.03.010; Capell BC, 2007, CIRC RES, V101, P13, DOI 10.1161/CIRCRESAHA.107.153692; Chicco AJ, 2005, AM J PHYSIOL-REG I, V289, pR424, DOI 10.1152/ajpregu.00636.2004; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Dreger H, 2009, CARDIOVASC RES, V83, P354, DOI 10.1093/cvr/cvp107; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; George L, 2009, AM J PHYSIOL-RENAL, V297, pF1174, DOI 10.1152/ajprenal.00397.2009; GURWITZ JH, 1991, JAMA-J AM MED ASSOC, V265, P1720, DOI 10.1001/jama.265.13.1720; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Guzik TJ, 2006, DRUG DISCOV TODAY, V11, P524, DOI 10.1016/j.drudis.2006.04.003; Hazzard William R., 1995, Am J Geriatr Cardiol, V4, P16; He XQ, 2009, J MOL CELL CARDIOL, V46, P47, DOI 10.1016/j.yjmcc.2008.10.007; Hirayama A, 2003, FREE RADICAL BIO MED, V34, P1236, DOI 10.1016/S0891-5849(03)00073-X; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Jennings JR, 1997, PSYCHOL AGING, V12, P225, DOI 10.1037/0882-7974.12.2.225; Jialal I, 2003, CIRCULATION, V107, P926, DOI 10.1161/01.CIR.0000048966.26216.4C; Junn E, 2001, J NEUROCHEM, V78, P374, DOI 10.1046/j.1471-4159.2001.00425.x; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, METHOD ENZYMOL, V378, P273; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P332, DOI 10.3109/10799893.2011.607171; Lakatta Edward, 1994, Am J Geriatr Cardiol, V3, P11; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li JQ, 2009, ARTERIOSCL THROM VAS, V29, P1843, DOI 10.1161/ATVBAHA.109.189480; Li MY, 2006, J CELL PHYSIOL, V206, P518, DOI 10.1002/jcp.20496; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; Mitchell C, 2010, TOXICOL LETT, V195, P23, DOI 10.1016/j.toxlet.2010.02.020; Muthusamy VR, 2012, FREE RADIC BIOL MED; Naumann P, 2011, INT J ONCOL, V39, P101, DOI 10.3892/ijo.2011.1025; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Neilan TG, 2006, CIRCULATION, V114, P2325, DOI 10.1161/CIRCULATIONAHA.106.647461; Newsholme P, 2010, CLIN SCI, V118, P341, DOI 10.1042/CS20090433; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rajasekaran NS, 2011, ANTIOXID REDOX SIGN, V14, P957, DOI 10.1089/ars.2010.3587; Rajasekaran NS, 2005, BBA-MOL BASIS DIS, V1741, P103, DOI 10.1016/j.bbadis.2004.11.025; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rhoades DA, 2007, J AM GERIATR SOC, V55, P87, DOI 10.1111/j.1532-5415.2006.01018.x; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Sharma S, 2011, EUR HEART J; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Trivax JE, 2010, J APPL PHYSIOL, V108, P1148, DOI 10.1152/japplphysiol.01151.2009; Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092; Ungvari Z, 2011, AM J PHYSIOL-HEART C, V301, pH363, DOI 10.1152/ajpheart.01134.2010; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Varadharaj S, 2005, ANTIOXID REDOX SIGN, V7, P287, DOI 10.1089/ars.2005.7.287; Weinsaft J W, 2001, Am J Geriatr Cardiol, V10, P348, DOI 10.1111/j.1076-7460.2001.00833.x; Wissler RW, 1996, CIRCULATION, V93, P1608, DOI 10.1161/01.CIR.93.9.1608; Zhang KR, 2007, APOPTOSIS, V12, P1579, DOI 10.1007/s10495-007-0090-8; Zhu H, 2005, FEBS LETT, V579, P3029, DOI 10.1016/j.febslet.2005.04.058	66	124	132	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45697	10.1371/journal.pone.0045697	http://dx.doi.org/10.1371/journal.pone.0045697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029187	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700058
J	Saeed, M; Schwarze, F; Loidl, A; Meraner, J; Lechner, M; Loidl, P				Saeed, Muhammad; Schwarze, Florian; Loidl, Adele; Meraner, Joachim; Lechner, Markus; Loidl, Peter			In Vitro Phosphorylation and Acetylation of the Murine Pocket Protein Rb2/p130	PLOS ONE			English	Article							RETINOBLASTOMA GENE FAMILY; P130; P130/RBL2; CLONING; MEMBER	The retinoblastoma protein (pRb) and the related proteins Rb2/p130 and 107 represent the "pocket protein" family of cell cycle regulators. A key function of these proteins is the cell cycle dependent modulation of E2F-regulated genes. The biological activity of these proteins is controlled by acetylation and phosphorylation in a cell cycle dependent manner. In this study we attempted to investigate the interdependence of acetylation and phosphorylation of Rb2/p130 in vitro. After having identified the acetyltransferase p300 among several acetyltransferases to be associated with Rb2/p130 during S-phase in NIH3T3 cells in vivo, we used this enzyme and the CDK4 protein kinase for in vitro modification of a variety of full length Rb2/p130 and truncated versions with mutations in the acetylatable lysine residues 1079, 128 and 130. Mutation of these residues results in the complete loss of Rb2/p130 acetylation. Replacement of lysines by arginines strongly inhibits phosphorylation of Rb2/p130 by CDK4; the inhibitory effect of replacement by glutamines is less pronounced. Preacetylation of Rb2/p130 strongly enhances CDK4-catalyzed phosphorylation, whereas deacetylation completely abolishes in vitro phosphorylation. In contrast, phosphorylation completely inhibits acetylation of Rb2/p130 by p300. These results suggest a mutual interdependence of modifications in a way that acetylation primes Rb2/p130 for phosphorylation and only dephosphorylated Rb2/p130 can be subject to acetylation. Human papillomavirus 16-E7 protein, which increases acetylation of Rb2/p130 by p300 strongly reduces phosphorylation of this protein by CDK4. This suggests that the balance between phosphorylation and acetylation of Rb2/p130 is essential for its biological function in cell cycle control.	[Saeed, Muhammad; Schwarze, Florian; Loidl, Adele; Meraner, Joachim; Lechner, Markus; Loidl, Peter] Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria	Medical University of Innsbruck	Loidl, P (corresponding author), Innsbruck Med Univ, Bioctr, Div Mol Biol, Innsbruck, Austria.	Peter.Loidl@i-med.ac.at		Schwarze, Florian/0000-0002-1334-1301	Tyrolean Science Foundation (TWF) [TWF 34]	Tyrolean Science Foundation (TWF)	This work was supported by Tyrolean Science Foundation (TWF), TWF 34. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canhoto AJ, 2000, ONCOGENE, V19, P5116, DOI 10.1038/sj.onc.1203893; Chestukhin A, 2002, MOL CELL BIOL, V22, P453, DOI 10.1128/MCB.22.2.453-468.2002; Claudio PP, 1996, CANCER RES, V56, P2003; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Fiorentino FP, 2009, CELL RES, V19, P1044, DOI 10.1038/cr.2009.96; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Hansen K, 1999, ELECTROPHORESIS, V20, P372, DOI 10.1002/(SICI)1522-2683(19990201)20:2<372::AID-ELPS372>3.0.CO;2-R; Hansen K, 2001, EMBO J, V20, P422, DOI 10.1093/emboj/20.3.422; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; MAYOL X, 1993, ONCOGENE, V8, P2561; MAYOL X, 1995, ONCOGENE, V11, P801; Purev E, 2011, J CELL PHYSIOL, V226, P1027, DOI 10.1002/jcp.22418; Roman A, 2006, CELL CYCLE, V5, P567, DOI 10.4161/cc.5.6.2571; Schwarze F, 2010, ONCOGENE, V29, P5755, DOI 10.1038/onc.2010.311; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618	20	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46174	10.1371/journal.pone.0046174	http://dx.doi.org/10.1371/journal.pone.0046174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029429	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700120
J	Lepinay, C; Rigaud, T; Salon, C; Lemanceau, P; Mougel, C				Lepinay, Clementine; Rigaud, Thierry; Salon, Christophe; Lemanceau, Philippe; Mougel, Christophe			Interaction between Medicago truncatula and Pseudomonas fluorescens: Evaluation of Costs and Benefits across an Elevated Atmospheric CO2	PLOS ONE			English	Article							MICROBIAL COMMUNITY; MYCORRHIZA DEVELOPMENT; CARBON-DIOXIDE; DYNAMICS; NITROGEN; RESPONSES; PLANTS; ROOTS; MODEL; SOIL	Soil microorganisms play a key role in both plants nutrition and health. Their relation with plant varies from mutualism to parasitism, according to the balance of costs and benefits for the two partners of the interaction. These interactions involved the liberation of plant organic compounds via rhizodeposition. Modification of atmospheric CO2 concentration may affect rhizodeposition and as a consequence trophic interactions that bind plants and microorganisms. Positive effect of elevated CO2 on plants are rather well known but consequences for micoorganisms and their interactions with plants are still poorly understood. A gnotobiotic system has been developed to study the interaction between Medicago truncatula Jemalong J5 and the mutualistic bacteria Pseudomonas fluorescens strain C7R12 under two atmospheric CO2 concentrations: ambient (365 ppm) versus enriched (750 ppm). Costs and benefits for each partner have been determined over time by measuring plant development and growth, the C and N contents of the various plant parts and the density of the bacteria in rhizosphere compartments. Following the increase in CO2, there was a beneficial effect of P. fluorescens C7R12 on development, vegetative growth, and C/N content of M. truncatula. Concerning plant reproduction, an early seed production was noticed in presence of the bacterial strain combined with increased atmospheric CO2 conditions. Paradoxically, this transient increase in seed production was correlated with a decrease in bacterial density in the rhizosphere soil, revealing a cost of increased CO2 for the bacterial strain. This shift of costs-benefits ratio disappeared later during the plant growth. In conclusion, the increase in CO2 concentration modifies transiently the cost-benefit balance in favor of the plant. These results may be explained either by a competition between the two partners or a change in bacterial physiology. The ecosystem functioning depends on the stability of many plant-microbe associations that abiotic factors can disrupt.	[Lepinay, Clementine; Salon, Christophe; Lemanceau, Philippe; Mougel, Christophe] INRA, UMR Agroecol 1347, F-21034 Dijon, France; [Rigaud, Thierry] Univ Bourgogne, UMR CNRS, CNRS, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Mougel, C (corresponding author), INRA, UMR Agroecol 1347, F-21034 Dijon, France.	christophe.mougel@dijon.inra.fr	Salon, Christophe/AAH-5285-2021; Mougel, Christophe/D-5118-2017; Rigaud, Thierry/ABE-2552-2020; Salon, Christophe/C-3460-2014; Rigaud, Thierry/T-4053-2017	Mougel, Christophe/0000-0001-8675-3115; Rigaud, Thierry/0000-0002-0163-6639; Rigaud, Thierry/0000-0002-0163-6639; Lepinay, Clementine/0000-0003-1330-1550	National Institute for Agricultural Research (INRA Plant Health and Environment division); Regional Council of Burgundy [AIB29000359, AIB 29000427, 29000594]	National Institute for Agricultural Research (INRA Plant Health and Environment division); Regional Council of Burgundy(Region Bourgogne-Franche-Comte)	C.L. was funded by a doctoral grant from National Institute for Agricultural Research (INRA Plant Health and Environment division) and the Regional Council of Burgundy (project no AIB29000359). Grants AIB 29000427 & 29000594 were obtained from the Regional Council of Burgundy for support to intregrated Agrale 6 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Arnone JA, 2000, NEW PHYTOL, V147, P73, DOI 10.1046/j.1469-8137.2000.00685.x; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Bakker PAHM, 2007, EUR J PLANT PATHOL, V119, P241, DOI 10.1007/s10658-007-9114-z; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; BARRAQUIO WL, 1983, CAN J MICROBIOL, V29, P867, DOI 10.1139/m83-141; Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; BLONDON F, 1994, GENOME, V37, P264, DOI 10.1139/g94-037; Briat J.F., 2007, ADV BOT RES, V46, P137, DOI DOI 10.1016/S0065-2296(07)46004-9; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Colebatch G, 2002, NEW PHYTOL, V153, P37, DOI 10.1046/j.0028-646X.2001.00304.x; Cook DR, 1999, CURR OPIN PLANT BIOL, V2, P301, DOI 10.1016/S1369-5266(99)80053-3; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Drigo B, 2008, BIOL FERT SOILS, V44, P667, DOI 10.1007/s00374-008-0277-3; EPARVIER A, 1991, FEMS MICROBIOL ECOL, V86, P177, DOI 10.1111/j.1574-6968.1991.tb04807.x; Finzi AC, 2006, ECOSYSTEMS, V9, P215, DOI 10.1007/s10021-005-0078-6; Huxman TE, 1999, FUNCT ECOL, V13, P769, DOI 10.1046/j.1365-2435.1999.00366.x; Johnstone RA, 2008, J EVOLUTION BIOL, V21, P879, DOI 10.1111/j.1420-9101.2008.01505.x; KING EO, 1954, J LAB CLIN MED, V44, P301; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Kuzyakov Y, 2007, PLANT SOIL, V290, P293, DOI 10.1007/s11104-006-9162-8; Lambers H, 2009, PLANT SOIL, V321, P83, DOI 10.1007/s11104-009-0042-x; LEMANCEAU P, 1992, AGRONOMIE, V12, P413, DOI 10.1051/agro:19920601; LEMANCEAU P, 1988, AGRONOMIE, V8, P243, DOI 10.1051/agro:19880310; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Luo YQ, 1998, GLOBAL CHANGE BIOL, V4, P173, DOI 10.1046/j.1365-2486.1998.00116.x; Moreau D, 2007, PLANT CELL ENVIRON, V30, P213, DOI 10.1111/j.1365-3040.2006.01620.x; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Phillips RL, 2002, OECOLOGIA, V131, P236, DOI 10.1007/s00442-002-0868-x; Pivato B, 2008, FEMS MICROBIOL LETT, V289, P173, DOI 10.1111/j.1574-6968.2008.01391.x; Pivato B, 2009, MYCORRHIZA, V19, P81, DOI 10.1007/s00572-008-0205-2; Pritchard SG, 1999, GLOB CHANGE BIOL, V5, P807, DOI 10.1046/j.1365-2486.1999.00268.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Salon C, 2001, AGRONOMIE, V21, P539, DOI 10.1051/agro:2001143; Sanchez L, 2004, NEW PHYTOL, V161, P855, DOI 10.1046/j.1469-8137.2004.00997.x; Sanhewe AJ, 1996, J EXP BOT, V47, P631, DOI 10.1093/jxb/47.5.631; Stacey G, 2006, CURR OPIN PLANT BIOL, V9, P110, DOI 10.1016/j.pbi.2006.01.005; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thoquet Philippe, 2002, BMC Plant Biology, V2, P1, DOI 10.1186/1471-2229-2-1; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE CP, 1991, ANNU REV PLANT PHYS, V42, P373, DOI 10.1146/annurev.pp.42.060191.002105; Vansuyt G, 2007, MOL PLANT MICROBE IN, V20, P441, DOI 10.1094/MPMI-20-4-0441; Voisin AS, 2003, ANN BOT-LONDON, V91, P539, DOI 10.1093/aob/mcg055; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Williams MA, 2000, PLANT SOIL, V227, P127, DOI 10.1023/A:1026590001307; Woodward FI, 2002, CURR OPIN PLANT BIOL, V5, P207, DOI 10.1016/S1369-5266(02)00253-4; Young ND, 2003, CURR OPIN PLANT BIOL, V6, P199, DOI 10.1016/S1369-5266(03)00006-2; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891; Ziska L.H., 2008, PLANT GROWTH CLIMATE, P17, DOI [10.1002/9780470988695, DOI 10.1002/9780470988695.CH2, DOI 10.1002/9780470988695]	53	4	4	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45740	10.1371/journal.pone.0045740	http://dx.doi.org/10.1371/journal.pone.0045740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029215	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800088
J	Rothenbacher, D; Kleiner, A; Koenig, W; Primatesta, P; Breitling, LP; Brenner, H				Rothenbacher, Dietrich; Kleiner, Andrea; Koenig, Wolfgang; Primatesta, Paola; Breitling, Lutz P.; Brenner, Hermann			Relationship between Inflammatory Cytokines and Uric Acid Levels with Adverse Cardiovascular Outcomes in Patients with Stable Coronary Heart Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK; HYPERURICEMIA; GOUT; METAANALYSIS; ASSOCIATION; BIOMARKERS; COHORT; STROKE	Background: So far it is unclear whether the association between serum uric acid (SUA), inflammatory cytokines and risk of atherosclerosis is causal or an epiphenomenon. The aim of the project is to investigate the independent prognostic relationship of inflammatory markers and SUA levels with adverse cardiovascular outcomes in a patient population with stable coronary heart disease (CHD). Methods: SUA, C-reactive protein (CRP) and interleukin (IL)-6 were measured at baseline in a cohort of 1,056 patients aged 30-70 years with CHD. Cox proportional hazards model was used to determine the prognostic value of these markers on a combined CVD endpoint during eight year follow-up after adjustment for covariates. Results: For 1,056 patients with stable coronary heart disease aged 30-70 years (mean age 58.9 years, SD 8.0) follow-up information and serum measurements were complete and n = 151 patients (incidence 21.1 per 1000 patients years) experienced a fatal or non-fatal CVD event during follow-up (p-value = 0.05 for quartiles of SUA, p = 0.002 for quartiles of CRP, p = 0.13 for quartiles of IL-6 in Kaplan-Meier analysis). After adjustment for age, gender and hospital site the hazard ratio (HR) for SUA increased from 1.37 to 1.65 and 2.27 in the second, third, and top quartile, when compared to the bottom one (p for trend <0.0005). The HR for CRP increased from 0.85 to 0.98 and 1.64 in the respective quartiles (p for trend 0.02). After further adjustment for covariates SUA still showed a clear statistically significant relationship with the outcome (p for trend 0.045), whereas CRP did not (p for trend 0.10). Conclusion: The data suggest that compared to inflammatory markers such as CRP and IL-6 serum uric acid levels may predict future CVD risk in patients with stable CHD with a risk increase even at levels considered normal.	[Rothenbacher, Dietrich; Kleiner, Andrea] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Primatesta, Paola] Novartis Pharma AG, Global Clin Epidemiol, Basel, Switzerland; [Breitling, Lutz P.; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-6900 Heidelberg, Germany	Ulm University; Ulm University; Novartis; Helmholtz Association; German Cancer Research Center (DKFZ)	Rothenbacher, D (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.	dietrich.rothenbacher@uni-ulm.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Koenig, Wolfgang/0000-0002-2064-9603; Rothenbacher, Dietrich/0000-0002-3563-2791	German Federal Ministry of Education and Research [01GD9820/0]; Pitzer Foundation (Bad Nauheim, Germany); Novartis Pharma (Basel, Switzerland)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Pitzer Foundation (Bad Nauheim, Germany); Novartis Pharma (Basel, Switzerland)	The study was supported in part by the German Federal Ministry of Education and Research (#01GD9820/0) and the Pitzer Foundation (Bad Nauheim, Germany). Part of this work was financed by Novartis Pharma (Basel, Switzerland) by an unrestricted grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busso N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2952; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Chen CC, 2011, AM J PHYSIOL-HEART C, V301, pH1107, DOI 10.1152/ajpheart.01071.2010; Chuang SY, 2012, INT J CARDIOL, V154, P316, DOI 10.1016/j.ijcard.2011.06.055; Cook NR, 2010, INT J CLIN PRACT, V64, P1723, DOI 10.1111/j.1742-1241.2010.02469.x; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Filippatos GS, 2011, EUR HEART J, V32, P712, DOI 10.1093/eurheartj/ehq473; Ito H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027817; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martin WJ, 2010, IMMUNOL CELL BIOL, V88, P15, DOI 10.1038/icb.2009.89; Neri L, 2011, AM J KIDNEY DIS, V58, P398, DOI 10.1053/j.ajkd.2011.04.025; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; SORIANO LC, 2011, ARTHRITIS RES THERAP, V0013; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang QL, 2010, ATHEROSCLEROSIS, V211, P342, DOI 10.1016/j.atherosclerosis.2010.02.028	24	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45907	10.1371/journal.pone.0045907	http://dx.doi.org/10.1371/journal.pone.0045907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029307	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800117
J	Ochala, J; Ravenscroft, G; Laing, NG; Nowak, KJ				Ochala, Julien; Ravenscroft, Gianina; Laing, Nigel G.; Nowak, Kristen J.			Nemaline Myopathy-Related Skeletal Muscle alpha-Actin (ACTA1) Mutation, Asp286Gly, Prevents Proper Strong Myosin Binding and Triggers Muscle Weakness	PLOS ONE			English	Article							BETA-TROPOMYOSIN MUTATION; CONTRACTILE FUNCTION; DEFECTIVE REGULATION; SARCOMERE LENGTH; RABBIT PSOAS; FIBERS; ACTIVATION; FORCE; GENE; KINETICS	Many mutations in the skeletal muscle alpha-actin gene (ACTA1) lead to muscle weakness and nemaline myopathy. Despite increasing clinical and scientific interest, the molecular and cellular pathogenesis of weakness remains unclear. Therefore, in the present study, we aimed at unraveling these mechanisms using muscles from a transgenic mouse model of nemaline myopathy expressing the ACTA1 Asp286Gly mutation. We recorded and analyzed the mechanics of membranepermeabilized single muscle fibers. We also performed molecular energy state computations in the presence or absence of Asp286Gly. Results demonstrated that during contraction, the Asp286Gly acts as a "poison-protein'' and according to the computational analysis it modifies the actin-actin interface. This phenomenon is likely to prevent proper myosin crossbridge binding, limiting the fraction of actomyosin interactions in the strong binding state. At the cell level, this decreases the force-generating capacity, and, overall, induces muscle weakness. To counterbalance such negative events, future potential therapeutic strategies may focus on the inappropriate actin-actin interface or myosin binding.	[Ochala, Julien] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Ravenscroft, Gianina; Laing, Nigel G.; Nowak, Kristen J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia	Uppsala University; University of Western Australia	Ochala, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	julien.ochala@neuro.uu.se	Ravenscroft, Gina/H-5695-2014; Ochala, Julien/K-4120-2017	Ravenscroft, Gina/0000-0003-3634-211X; Ochala, Julien/0000-0002-6358-2920; Laing, Nigel/0000-0001-5111-3732	Swedish Research Council [Dnr2009-2277]; Harald och Greta Jeanssons Stiftelse; Australian National Health and Medical Research Council [APP1035955, APP1002147]; Australian Research Council [FT100100734]; A Foundation Building Strength for Nemaline Myopathy	Swedish Research Council(Swedish Research CouncilEuropean Commission); Harald och Greta Jeanssons Stiftelse; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); A Foundation Building Strength for Nemaline Myopathy	This study was supported by grants from the Swedish Research Council (Dnr2009-2277) and Harald och Greta Jeanssons Stiftelse to J.O., from the Australian National Health and Medical Research Council to G.R. (APP1035955) and N.G.L (APP1002147), the Australian Research Council to K.J.N. (FT100100734) and A Foundation Building Strength for Nemaline Myopathy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Bang ML, 2009, FASEB J, V23, P4117, DOI 10.1096/fj.09-137729; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; COOKE R, 1980, BIOCHEMISTRY-US, V19, P2265, DOI 10.1021/bi00551a042; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; Endoh M, 2008, CIRC J, V72, P1915, DOI 10.1253/circj.CJ-08-0838; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; LAING N, 1995, NAT GENET, V10, P249, DOI 10.1038/ng0695-249a; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lehman W, 2008, ADV EXP MED BIOL, V644, P95; Li XC, 2011, BIOPHYS J, V100, P1005, DOI 10.1016/j.bpj.2010.12.3697; Linari M, 2007, BIOPHYS J, V92, P2476, DOI 10.1529/biophysj.106.099549; Lindqvist J, 2012, ACTA NEUROPATHOL, V123, P739, DOI 10.1007/s00401-012-0962-z; Lorenz M, 2010, P NATL ACAD SCI USA, V107, P12529, DOI 10.1073/pnas.1003604107; Malik FI, 2011, J MOL CELL CARDIOL, V51, P454, DOI 10.1016/j.yjmcc.2011.05.006; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Ochala J., 2011, FASEB J; Ochala J, 2008, J PHYSIOL-LONDON, V586, P2993, DOI 10.1113/jphysiol.2008.153650; Ochala J, 2007, J PHYSIOL-LONDON, V581, P1283, DOI 10.1113/jphysiol.2007.129759; Ochala J, 2010, P NATL ACAD SCI USA, V107, P9807, DOI 10.1073/pnas.1001733107; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ravenscroft G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028699; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sanoudou D, 2001, TRENDS MOL MED, V7, P362, DOI 10.1016/S1471-4914(01)02089-5	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45923	10.1371/journal.pone.0045923	http://dx.doi.org/10.1371/journal.pone.0045923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029319	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900112
J	Shukla, V; Zheng, YL; Mishra, SK; Amin, ND; Steiner, J; Grant, P; Kesavapany, S; Pant, HC				Shukla, Varsha; Zheng, Ya-Li; Mishra, Santosh K.; Amin, Niranjana D.; Steiner, Joseph; Grant, Philip; Kesavapany, Sashi; Pant, Harish C.			A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice	FASEB JOURNAL			English	Article						Cdk5 hyperphosphorylation; neurodegeneration; therapeutics	CYCLIN-DEPENDENT KINASE-5; INTERMEDIATE-FILAMENT PROTEINS; AMYLOID-PRECURSOR-PROTEIN; PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; SYNAPTIC PLASTICITY; TRANSGENIC MODEL; BETA-SECRETASE; TAU-PROTEIN; MOUSE MODEL	Alzheimer's disease (AD), one of the leading neurodegenerative disorders of older adults, which causes major socioeconomic burdens globally, lacks effective therapeutics without significant side effects. Besides the hallmark pathology of amyloid plaques and neurofibrillary tangles (NFTs), it has been reported that cyclin-dependent kinase 5 (Cdk5), a critical neuronal kinase, is hyperactivated in AD brains and is, in part, responsible for the above pathology. Here we show that a modified truncated 24-aa peptide (TFP5), derived from the Cdk5 activator p35, penetrates the blood-brain barrier after intraperitoneal injections, inhibits abnormal Cdk5 hyperactivity, and significantly rescues AD pathology (up to 70-80%) in 5XFAD AD model mice. The mutant mice, injected with TFP5 exhibit behavioral rescue, whereas no rescue was observed in mutant mice injected with either saline or scrambled peptide. However, TFP5 does not inhibit cell cycle Cdks or normal Cdk5/p35 activity, and thereby has no toxic side effects (even at 200 mg/kg), a common problem in most current therapeutics for AD. In addition, treated mice displayed decreased inflammation, amyloid plaques, NFTs, cell death, and an extended life by 2 mo. These results suggest TFP5 as a potential therapeutic, toxicity-free candidate for AD.-Shukla, V., Zheng, Y.-L., Mishra, S. K., Amin, N. D., Steiner, J., Grant, P., Kesavapany, S., Pant, H. C. A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice. FASEB J. 27, 174-186 (2013). www.fasebj.org	[Pant, Harish C.] Natl Inst Neurol Disorders & Stroke, Neurochem Lab, NIH, Bethesda, MD 20892 USA; [Steiner, Joseph] Natl Inst Neurol Disorders & Stroke, Neurotherapeut Dev Unit, Bethesda, MD 20892 USA; [Mishra, Santosh K.] Natl Inst Dent & Craniofacial Res, Mol Genet Unit, Lab Sensory Biol, NIH, Bethesda, MD USA; [Zheng, Ya-Li] Ningxia Peoples Hosp, Dept Nephrol, Yinchuan, Peoples R China; [Kesavapany, Sashi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Neurobiol Program, Singapore 117595, Singapore	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National University of Singapore	Pant, HC (corresponding author), Natl Inst Neurol Disorders & Stroke, Neurochem Lab, NIH, 49 Convent Dr,MSC 4479,Bldg 49,Rm 2A28, Bethesda, MD 20892 USA.	panth@ninds.nih.gov	Mishra, Santosh/S-7516-2017	Mishra, Santosh/0000-0001-8616-2606	U.S. National Institutes of Health (NIH), NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003104, ZIANS003134] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Peter Davies (Albert Einstein College of Medicine, Bronx, NY, USA) for the generous gift of Alz-50 antibody. Help from Daniel Abebe (National Institute of Child Health and Human Development, Bethesda, MD, USA) in performing behavior assays is acknowledged. For cell culture studies, rat embryo cortices were provided by Dr. Yanmin Chen [National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA]. This work was supported by the intramural research program of the U.S. National Institutes of Health (NIH), NINDS. A patent application has been filed on behalf of NIH (patent application no. 13/249,003) regarding TFP5 as a potential therapeutic for AD. The authors declare no conflicts of interest. V. S. designed the study, performed the experiments, analyzed the data, and drafted the manuscript; S. K. M. participated in study design and analyzed behavior data; N. D. A. performed the in vitro activity analyses and provided the reagents; P. G. and J. S. contributed to experimental design and reviewed the manuscript; Y. Z. and S. K. performed initial in vitro studies; H. C. P. designed the study, analyzed data, and revised the manuscript.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Angelo M, 2006, J NEUROCHEM, V99, P353, DOI 10.1111/j.1471-4159.2006.04040.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; CORK LC, 1986, J NEUROPATH EXP NEUR, V45, P56, DOI 10.1097/00005072-198601000-00005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Cyr M, 2003, P NATL ACAD SCI USA, V100, P11035, DOI 10.1073/pnas.1831768100; de la Monte S. M., 2000, Journal of Alzheimer's Disease, V2, P261; De Strooper B, 2000, J CELL SCI, V113, P1857; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2002, J NEUROSCI, V22, P3700; Giusti-Rodriguez P, 2011, J NEUROSCI, V31, P15751, DOI 10.1523/JNEUROSCI.3588-11.2011; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guan JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025735; Hawash Ammar H., 2007, Biotechnology Journal, V2, P941, DOI 10.1002/biot.200700093; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Helal CJ, 2004, BIOORG MED CHEM LETT, V14, P5521, DOI 10.1016/j.bmcl.2004.09.006; Ho A, 2001, CANCER RES, V61, P474; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Knockaert M, 2002, J BIOL CHEM, V277, P25493, DOI 10.1074/jbc.M202651200; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; LANGLEY OK, 1988, BRAIN RES, V457, P12, DOI 10.1016/0006-8993(88)90052-2; Lau LF, 2002, J MOL NEUROSCI, V19, P267, DOI 10.1385/JMN:19:3:267; Lau LF, 2003, NEUROSIGNALS, V12, P209, DOI 10.1159/000074622; Lee HP, 2010, EXPERT REV NEUROTHER, V10, P1201, DOI 10.1586/ERN.10.74; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lopez-Tobon A, 2011, REV NEUROSCIENCE, V22, P143, DOI 10.1515/RNS.2011.015; Luque FA, 2009, INT REV NEUROBIOL, V84, P151, DOI 10.1016/S0074-7742(09)00408-5; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Maier M, 2006, J NEUROSCI, V26, P4717, DOI 10.1523/JNEUROSCI.0381-06.2006; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Monaco EA, 2005, FRONT BIOSCI-LANDMRK, V10, P143, DOI 10.2741/1516; Nath R, 2000, BIOCHEM BIOPH RES CO, V274, P16, DOI 10.1006/bbrc.2000.3070; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Ritchie CW, 2004, AM J GERIAT PSYCHIAT, V12, P358, DOI 10.1176/appi.ajgp.12.4.358; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; Royce J., PSYCHOL B, V84, P1098; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; Rudrabhatla P, 2010, FASEB J, V24, P4396, DOI 10.1096/fj.10-157859; Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Smith DS, 2002, TRENDS CELL BIOL, V12, P28, DOI 10.1016/S0962-8924(01)02181-X; Smith Wanli W., 2006, CNS & Neurological Disorders-Drug Targets, V5, P355, DOI 10.2174/187152706784111515; STERNBERGER NH, 1985, P NATL ACAD SCI USA, V82, P4274, DOI 10.1073/pnas.82.12.4274; Takahashi S, 2010, AM J PATHOL, V176, P320, DOI 10.2353/ajpath.2010.081158; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; Tseng HC, 2002, FEBS LETT, V523, P58, DOI 10.1016/S0014-5793(02)02934-4; UEDA K, 1990, J NEUROSCI, V10, P3295; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zheng YL, 2010, J BIOL CHEM, V285, P34202, DOI 10.1074/jbc.M110.134643; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2003, J BIOL CHEM, V278, P24026, DOI 10.1074/jbc.M303079200; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x	71	86	89	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					174	186		10.1096/fj.12-217497	http://dx.doi.org/10.1096/fj.12-217497			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038754	Green Published			2022-12-25	WOS:000313103200017
J	Bernard, JK; McCann, SP; Bhardwaj, V; Washington, MK; Frey, MR				Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Washington, Mary K.; Frey, Mark R.			Neuregulin-4 Is a Survival Factor for Colon Epithelial Cells both in Culture and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; TYROSINE KINASE; ERBB4 ISOFORM; TRANSGENIC MICE; EXPRESSION; APOPTOSIS; FAMILY; PROLIFERATION; TRANSACTIVATION	Expression of the ErbB4 tyrosine kinase is elevated in colonic epithelial cells during inflammatory bowel disease, whereas ErbB4 overexpression in cultured colonocytes blocks TNF-induced apoptosis in a ligand-dependent manner. Together, these observations suggest that ErbB4 induction may be a protective response. However, the effects of ErbB4 signaling in the colonic epithelium in vivo are not known. Furthermore, previous work on ErbB4 used ligands shared with other receptors, raising the question of whether the observed responses are explicitly due to ErbB4. In this study, we used the ErbB4-specific ligand neuregulin-4 (NRG4) to activate ErbB4 and define its role in colonocyte biology. NRG4 treatment, either in cultured cells or in mice, blocked colonic epithelial apoptosis induced by TNF and IFN-gamma. It was also protective in a murine experimental colitis model. NRG4 stimulated phosphorylation of ErbB4 but not other ErbB receptors, indicating that this is a specific response. Furthermore, in contrast to related ligands, NRG4 enhanced cell survival but not proliferation or migration, and stimulated phosphorylation of the anti-apoptotic mediator Akt but not ERK MAPK. Pharmacological inhibition of PI3K/Akt signaling reversed the anti-apoptotic effects of NRG4, confirming the role of this cascade in NRG4-induced cell survival. With regard to the potential clinical importance of this pathway, NRG4 expression was decreased in human inflammatory bowel disease samples and mouse models of colitis, suggesting that activation of ErbB4 is altered in disease. Thus, exogenous NRG4 may be beneficial for disorders in which epithelial apoptosis is part of the pathology.	[Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Frey, Mark R.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Bernard, Jessica K.; McCann, Sean P.; Bhardwaj, Vrinda; Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90089 USA; [Frey, Mark R.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Washington, Mary K.] Vanderbilt Univ, Dept Pathol, Sch Med, Nashville, TN 37332 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; Vanderbilt University	Frey, MR (corresponding author), Childrens Hosp Los Angeles, Saban Res Inst, 4650 Sunset Blvd,MS 137, Los Angeles, CA 90027 USA.	mfrey@chla.usc.edu	bhardwaj, vrinda/V-5234-2019; Frey, Mark/M-1739-2019; Bhardwaj, Vrinda/GLR-1727-2022	Frey, Mark/0000-0002-2561-5402; 	National Institutes of Health [K01DK077956, R03DK090295]; Crohn's and Colitis Foundation of America; Saban Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK077956, R03DK090295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Saban Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK077956 and R03DK090295. This work was also supported by a Senior Research Award from the Crohn's and Colitis Foundation of America and a Research Career Development Award from the Saban Research Institute.	Bongers G, 2012, GASTROENTEROLOGY, V143, P730, DOI 10.1053/j.gastro.2012.05.034; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Edwards J, 2006, CLIN CANCER RES, V12, P123, DOI 10.1158/1078-0432.CCR-05-1445; Egger B, 2000, SCAND J GASTROENTERO, V35, P1181; Erlich S, 2001, NEUROSCIENCE, V107, P353, DOI 10.1016/S0306-4522(01)00350-5; Feng YJ, 2012, ANN NY ACAD SCI, V1258, P71, DOI 10.1111/j.1749-6632.2012.06572.x; Feng YJ, 2012, AM J PHYSIOL-GASTR L, V302, pG236, DOI 10.1152/ajpgi.00142.2011; Frey MR, 2006, EMBO J, V25, P5683, DOI 10.1038/sj.emboj.7601457; Frey MR, 2010, LAB INVEST, V90, P1415, DOI 10.1038/labinvest.2010.117; Frey MR, 2009, GASTROENTEROLOGY, V136, P217, DOI 10.1053/j.gastro.2008.09.023; Frey MR, 2004, J BIOL CHEM, V279, P44513, DOI 10.1074/jbc.M406253200; Harari D, 1999, ONCOGENE, V18, P2681, DOI 10.1038/sj.onc.1202631; Hayes NVL, 2008, ONCOGENE, V27, P715, DOI 10.1038/sj.onc.1210689; Hilliard VC, 2011, AM J PHYSIOL-GASTR L, V301, pG338, DOI 10.1152/ajpgi.00057.2011; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Kainulainen V, 2000, J BIOL CHEM, V275, P8641, DOI 10.1074/jbc.275.12.8641; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Lee JC, 2002, EUR J CANCER, V38, P1065, DOI 10.1016/S0959-8049(02)00004-7; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Memon AA, 2004, BRIT J CANCER, V91, P2034, DOI 10.1038/sj.bjc.6602251; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Rotterud R, 2005, BJU INT, V95, P1344, DOI 10.1111/j.1464-410X.2005.05497.x; Saito T, 2004, ENDOCRINOLOGY, V145, P4232, DOI 10.1210/en.2004-0401; Srinivasan R, 2000, CANCER RES, V60, P1483; Srinivasan R, 1999, CLIN CANCER RES, V5, P2877; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Tovey SM, 2004, BREAST CANCER RES, V6, pR246, DOI 10.1186/bcr783; Veikkolainen V, 2011, CELL CYCLE, V10, P2647, DOI 10.4161/cc.10.16.17194; Vidal GA, 2007, ONCOGENE, V26, P462, DOI 10.1038/sj.onc.1209794; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370	50	35	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.400846	http://dx.doi.org/10.1074/jbc.M112.400846			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033483	Green Published, hybrid			2022-12-25	WOS:000311233800053
J	Glekas, GD; Mulhern, BJ; Kroc, A; Duelfer, KA; Lei, V; Rao, CV; Ordal, GW				Glekas, George D.; Mulhern, Brendan J.; Kroc, Abigail; Duelfer, Keegan A.; Lei, Victor; Rao, Christopher V.; Ordal, George W.			The Bacillus subtilis Chemoreceptor McpC Senses Multiple Ligands Using Two Discrete Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MALTOSE CHEMORECEPTOR; CHEMOTAXIS; COMPLEX; KINASE; ASPARAGINE; METHIONINE; PROTEINS; ENCODES; SYSTEMS	Bacillus subtilis can perform chemotaxis toward all 20 L-amino acids normally found in proteins. Loss of a single chemoreceptor, McpC, was previously found to reduce chemotaxis to 19 of these amino acids. In this study, we investigated the amino acid-sensing mechanism of McpC. We show that McpC alone can support chemotaxis to 17 of these amino acids to varying degrees. Eleven amino acids were found to directly bind the amino-terminal sensing domain of McpC in vitro. Sequence analysis indicates that the McpC sensing domain exhibits a dual Per-Arnt-Sim (PAS) domain structure. Using this structure as a guide, we were able to isolate mutants that suggest that four amino acids (arginine, glutamine, lysine, and methionine) are sensed by an indirect mechanism. We identified four candidate binding lipoproteins associated with amino acid transporters that may function in indirect sensing: ArtP, GlnH, MetQ, and YckB. ArtP was found to bind arginine and lysine; GlnH, glutamine; MetQ, methionine; and YckB, tryptophan. In addition, we found that ArtP, MetQ, and YckB bind the sensing domain of McpC, suggesting that the three participate in the indirect sensing of arginine, lysine, methionine, and possibly tryptophan as well. Taken together, these results further our understanding of amino acid chemotaxis in B. subtilis and gain insight into how a single chemoreceptor is able to sense many amino acids.	[Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Glekas, George D.; Mulhern, Brendan J.; Kroc, Abigail; Duelfer, Keegan A.; Lei, Victor; Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, 600 S Mathews,211 RAL, Urbana, IL 61801 USA.	chris@scs.uiuc.edu; ordal@uiuc.edu			National Institutes of Health [GM054365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054365, R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM054365 (to G. W. O and C. V. R.).	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Auger S, 2002, J BACTERIOL, V184, P5179, DOI 10.1128/JB.184.18.5179-5186.2002; Bunai K, 2004, ELECTROPHORESIS, V25, P141, DOI 10.1002/elps.200305676; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; Chao XJ, 2006, CELL, V124, P561, DOI 10.1016/j.cell.2005.11.046; Garrity LF, 1997, MICROBIOL-UK, V143, P2945, DOI 10.1099/00221287-143-9-2945; Glekas GD, 2010, J BIOL CHEM, V285, P1870, DOI 10.1074/jbc.M109.072108; HANLON DW, 1994, J BIOL CHEM, V269, P14038; HAZELBAUER GL, 1975, J BACTERIOL, V122, P206, DOI 10.1128/JB.122.1.206-214.1975; Hullo MF, 2004, RES MICROBIOL, V155, P80, DOI 10.1016/j.resmic.2003.11.008; Karatan E, 2001, J BIOL CHEM, V276, P43618, DOI 10.1074/jbc.M104955200; KOSSMANN M, 1988, J BACTERIOL, V170, P4516, DOI 10.1128/jb.170.10.4516-4521.1988; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; Muller J, 1997, MICROBIOL-UK, V143, P3231, DOI 10.1099/00221287-143-10-3231; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; ORDAL GW, 1977, J BACTERIOL, V129, P151, DOI 10.1128/JB.129.1.151-155.1977; ORDAL GW, 1977, J BACTERIOL, V129, P156, DOI 10.1128/JB.129.1.156-165.1977; Quentin Y, 1999, J MOL BIOL, V287, P467, DOI 10.1006/jmbi.1999.2624; Sekowska A, 2001, GENOME BIOL, V2; Szurmant H, 2003, J BIOL CHEM, V278, P48611, DOI 10.1074/jbc.M306180200; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; WU LJ, 1991, J BACTERIOL, V173, P4877, DOI 10.1128/jb.173.15.4877-4888.1991; Zhang YH, 1999, P NATL ACAD SCI USA, V96, P939, DOI 10.1073/pnas.96.3.939; Zhang Z, 2010, J MOL BIOL, V400, P335, DOI 10.1016/j.jmb.2010.04.049; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	26	60	62	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413518	http://dx.doi.org/10.1074/jbc.M112.413518			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038252	Green Published, hybrid			2022-12-25	WOS:000311233800013
J	Pena, A; Matilla, I; Martin-Benito, J; Valpuesta, JM; Carrascosa, JL; de la Cruz, F; Cabezon, E; Arechaga, I				Pena, Alejandro; Matilla, Inmaculada; Martin-Benito, Jaime; Valpuesta, Jose M.; Carrascosa, Jose L.; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio			The Hexameric Structure of a Conjugative VirB4 Protein ATPase Provides New Insights for a Functional and Phylogenetic Relationship with DNA Translocases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV SECRETION SYSTEM; BACTERIAL CONJUGATION; ELECTRON-MICROSCOPY; AGROBACTERIUM-TUMEFACIENS; CHROMOSOME SEGREGATION; COMPARATIVE GENOMICS; PLASMID R388; CORE COMPLEX; BINDING; TRWB	VirB4 proteins are ATPases essential for pilus biogenesis and protein transport in type IV secretion systems. These proteins contain a motor domain that shares structural similarities with the motor domains of DNA translocases, such as the VirD4/TrwB conjugative coupling proteins and the chromosome segregation pump FtsK. Here, we report the three-dimensional structure of full-length TrwK, the VirB4 homologue in the conjugative plasmid R388, determined by single-particle electron microscopy. The structure consists of a hexameric double ring with a barrel-shaped structure. The C-terminal half of VirB4 proteins shares a striking structural similarity with the DNA translocase TrwB. Docking the atomic coordinates of the crystal structures of TrwB and FtsK into the EM map revealed a better fit for FtsK. Interestingly, we have found that like TrwB, TrwK is able to bind DNA with a higher affinity for G4 quadruplex structures than for single-stranded DNA. Furthermore, TrwK exerts a dominant negative effect on the ATPase activity of TrwB, which reflects an interaction between the two proteins. Our studies provide new insights into the structure-function relationship and the evolution of these DNA and protein translocases.	[Pena, Alejandro; Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain; [Pena, Alejandro; Matilla, Inmaculada; de la Cruz, Fernando; Cabezon, Elena; Arechaga, Ignacio] UC CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Martin-Benito, Jaime; Valpuesta, Jose M.; Carrascosa, Jose L.] Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Cabezon, E (corresponding author), Univ Cantabria, Dept Biol Mol, Fac Med, Santander 39011, Spain.	cabezone@unican.es; arechagai@unican.es	de la Cruz, Fernando/L-2812-2014; Valpuesta, Jose M/AAA-6002-2019; Arechaga, Ignacio/K-2198-2014; Cabezon, Elena/K-5874-2014; Valpuesta, José M/T-1977-2017	de la Cruz, Fernando/0000-0003-4758-6857; Arechaga, Ignacio/0000-0002-1342-9370; Valpuesta, José M/0000-0001-7468-8053; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Cabezon, Elena/0000-0002-6177-5016; Pena, Alejandro/0000-0001-5674-7064	Ministerio de Economia y Competitividad (MINECO, Spain) [BFU2011-22874, BFU2011-29038, BFU2010-15703, BFU2008-00995/BMC]; European VII Framework Program [FP72009-248919]; MINECO	Ministerio de Economia y Competitividad (MINECO, Spain)(Spanish Government); European VII Framework Program; MINECO(Spanish Government)	This work was supported by Ministerio de Economia y Competitividad (MINECO, Spain) Grants BFU2011-22874 (to E. C. and I. A), BFU2011-29038 (to J. L. C.), BFU2010-15703 (to J. M. V.), BFU2008-00995/BMC, and FP72009-248919 from the European VII Framework Program (to F. C.). This work was also supported by a predoctoral fellowship from the MINECO (to A. P.).	Arechaga I, 2008, J BACTERIOL, V190, P5472, DOI 10.1128/JB.00321-08; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; BERGER BR, 1993, J BACTERIOL, V175, P1723, DOI 10.1128/JB.175.6.1723-1734.1993; Cabezon E, 2006, RES MICROBIOL, V157, P299, DOI 10.1016/j.resmic.2005.12.002; Cabezon E, 2012, CURR OPIN BIOTECH, V23, P537, DOI 10.1016/j.copbio.2011.11.031; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; CROWTHER RA, 1971, J MOL BIOL, V60, P123, DOI 10.1016/0022-2836(71)90452-9; Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x; Dang TAT, 1997, J BACTERIOL, V179, P453, DOI 10.1128/jb.179.2.453-462.1997; Durand E, 2010, J BACTERIOL, V192, P2315, DOI 10.1128/JB.01384-09; Fernandez-Lopez R, 2006, FEMS MICROBIOL REV, V30, P942, DOI 10.1111/j.1574-6976.2006.00042.x; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hishida T, 2004, P NATL ACAD SCI USA, V101, P9573, DOI 10.1073/pnas.0403584101; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kerr JE, 2010, J BACTERIOL, V192, P4923, DOI 10.1128/JB.00557-10; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Li F, 2012, J BACTERIOL, V194, P4041, DOI 10.1128/JB.00648-12; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matilla I, 2010, J BIOL CHEM, V285, P17537, DOI 10.1074/jbc.M109.084137; Middleton R, 2005, P NATL ACAD SCI USA, V102, P1685, DOI 10.1073/pnas.0409399102; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; Pena A, 2011, J BIOL CHEM, V286, P17376, DOI 10.1074/jbc.M110.208942; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rabel C, 2003, J BACTERIOL, V185, P1045, DOI 10.1128/JB.185.3.1045-1058.2003; Ripoll-Rozada J., 2012, REGULATION TYPE 4, P17408; Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102; Vogelmann J, 2011, EMBO J, V30, P2246, DOI 10.1038/emboj.2011.121; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109; Waters V L, 1999, Front Biosci, V4, pD433, DOI 10.2741/Waters; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	42	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.413849	http://dx.doi.org/10.1074/jbc.M112.413849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035111	Green Published, hybrid			2022-12-25	WOS:000311233800060
J	Brand, GD; Magalhaes, MTQ; Tinoco, MLP; Aragao, FJL; Nicoli, J; Kelly, SM; Cooper, A; Bloch, C				Brand, Guilherme D.; Magalhaes, Mariana T. Q.; Tinoco, Maria L. P.; Aragao, Francisco J. L.; Nicoli, Jacques; Kelly, Sharon M.; Cooper, Alan; Bloch, Carlos, Jr.			Probing Protein Sequences as Sources for Encrypted Antimicrobial Peptides	PLOS ONE			English	Article							CIRCULAR-DICHROISM; MODEL MEMBRANES; BIOACTIVE PEPTIDES; TRANSGENIC PLANTS; LIPID-BILAYER; WHEAT GLUTEN; RESISTANCE; PATHOGENS; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HYDROPHOBICITY	Starting from the premise that a wealth of potentially biologically active peptides may lurk within proteins, we describe here a methodology to identify putative antimicrobial peptides encrypted in protein sequences. Candidate peptides were identified using a new screening procedure based on physicochemical criteria to reveal matching peptides within protein databases. Fifteen such peptides, along with a range of natural antimicrobial peptides, were examined using DSC and CD to characterize their interaction with phospholipid membranes. Principal component analysis of DSC data shows that the investigated peptides group according to their effects on the main phase transition of phospholipid vesicles, and that these effects correlate both to antimicrobial activity and to the changes in peptide secondary structure. Consequently, we have been able to identify novel antimicrobial peptides from larger proteins not hitherto associated with such activity, mimicking endogenous and/or exogenous microorganism enzymatic processing of parent proteins to smaller bioactive molecules. A biotechnological application for this methodology is explored. Soybean (Glycine max) plants, transformed to include a putative antimicrobial protein fragment encoded in its own genome were tested for tolerance against Phakopsora pachyrhizi, the causative agent of the Asian soybean rust. This procedure may represent an inventive alternative to the transgenic technology, since the genetic material to be used belongs to the host organism and not to exogenous sources.	[Brand, Guilherme D.; Magalhaes, Mariana T. Q.; Bloch, Carlos, Jr.] Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Tinoco, Maria L. P.; Aragao, Francisco J. L.] Embrapa Recursos Genet & Biotecnol, Lab Transferencia & Expressao Genes, Brasilia, DF, Brazil; [Nicoli, Jacques] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Kelly, Sharon M.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Brand, Guilherme D.; Cooper, Alan] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Minas Gerais; University of Glasgow; University of Glasgow	Bloch, C (corresponding author), Embrapa Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil.	bloch.carlos@gmail.com	Kelly, Sharon/K-4611-2013; Aragão, Francisco J.L./E-6962-2013; Brand, Guilherme/B-5603-2015; Cooper, Alan/F-7813-2011; Bloch, Carlos/S-8375-2019; Nicoli, Jacques R/K-4807-2015	Brand, Guilherme/0000-0002-1615-0009; Cooper, Alan/0000-0001-6709-7343; Nicoli, Jacques R/0000-0003-2390-2608; Torquato Quezado de Magalhaes, Mariana/0000-0003-4912-0233; Kelly, Sharon/0000-0002-3516-1387; Bloch Jr, Carlos/0000-0003-2799-6883	Brazilian National Counsel of Technological and Scientific Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa do DF (FAPDF); UK Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [B20089] Funding Source: researchfish	Brazilian National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do DF (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Brazilian National Counsel of Technological and Scientific Development (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Apoio a Pesquisa do DF (FAPDF). The biological microcalorimetry facilities in Glasgow were originally funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragao FJL, 2000, THEOR APPL GENET, V101, P1, DOI 10.1007/s001220051441; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cunha WG, 2010, PLANT PATHOL, V59, P654, DOI 10.1111/j.1365-3059.2010.02279.x; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Dores RM, 2002, MASS SPECTROM REV, V21, P220, DOI 10.1002/mas.10029; Epand RF, 2010, BIOCHEMISTRY-US, V49, P4076, DOI 10.1021/bi100378m; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Epand RM, 2010, BBA-BIOMEMBRANES, V1798, P1272, DOI 10.1016/j.bbamem.2010.03.012; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; EPAND RM, 1981, BIOCHEMISTRY-US, V20, P4603, DOI 10.1021/bi00519a014; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; FRALEY C, 2006, 504 U WASH DEP STAT; FUKUDOME S, 1993, FEBS LETT, V316, P17, DOI 10.1016/0014-5793(93)81727-H; FUKUDOME S, 1992, FEBS LETT, V296, P107, DOI 10.1016/0014-5793(92)80414-C; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; JAIN MK, 1977, J MEMBRANE BIOL, V34, P157, DOI 10.1007/BF01870299; Jean-Francois F, 2008, BIOCHEMISTRY-US, V47, P6394, DOI 10.1021/bi800448h; Jolliffe, 2002, PRINCIPAL COMPONENT; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Ladokhin AS, 2010, J MEMBRANE BIOL, V236, P247, DOI 10.1007/s00232-010-9291-0; Lata S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S19; Lewis RNAH, 2005, BBA-BIOMEMBRANES, V1668, P203, DOI 10.1016/j.bbamem.2004.12.007; LEWIS RV, 1983, ANNU REV PHARMACOL, V23, P353, DOI 10.1146/annurev.pa.23.040183.002033; MCELHANEY RN, 1982, CHEM PHYS LIPIDS, V30, P229, DOI 10.1016/0009-3084(82)90053-6; Meisel H, 1999, ANTON LEEUW INT J G, V76, P207, DOI 10.1023/A:1002063805780; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V401, P317, DOI 10.1016/0005-2736(75)90233-3; Phelan M, 2009, INT DAIRY J, V19, P643, DOI 10.1016/j.idairyj.2009.06.001; Ponti D, 2003, BIOCHEM J, V370, P121, DOI 10.1042/BJ20021444; Rech EL, 2008, NAT PROTOC, V3, P410, DOI 10.1038/nprot.2008.9; REGOLI D, 1980, PHARMACOL REV, V32, P1; Rivero M, 2012, J BIOTECHNOL, V157, P334, DOI 10.1016/j.jbiotec.2011.11.005; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seto GWJ, 2007, BBA-BIOMEMBRANES, V1768, P2787, DOI 10.1016/j.bbamem.2007.07.018; Shewry PR, 1997, ADV BOT RES, V26, P135, DOI 10.1016/S0065-2296(08)60120-2; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Torrent M, 2012, BIOINFORMATICS, V28, P130, DOI 10.1093/bioinformatics/btr604; Torrent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016968; Tossi A, 2000, BIOPOLYMERS, V55, P4; Vanhoye D, 2003, EUR J BIOCHEM, V270, P2068, DOI 10.1046/j.1432-1033.2003.03584.x; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306; Zhao Q, 1997, BIOPOLYMERS, V43, P75; Zhu WL, 2009, CHEM BIOL DRUG DES, V73, P209, DOI 10.1111/j.1747-0285.2008.00769.x	54	35	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45848	10.1371/journal.pone.0045848	http://dx.doi.org/10.1371/journal.pone.0045848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029273	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000309973900058
J	Doodhi, H; Jana, SC; Devan, P; Mazumdar, S; Ray, K				Doodhi, Harinath; Jana, Swadhin C.; Devan, Pavithra; Mazumdar, Shyamalava; Ray, Krishanu			Biochemical and Molecular Dynamic Simulation Analysis of a Weak Coiled Coil Association between Kinesin-II Stalks	PLOS ONE			English	Article							HETEROTRIMERIC KINESIN; MOTOR PROTEIN; NECK REGION; CHOLINE-ACETYLTRANSFERASE; INTRAFLAGELLAR TRANSPORT; HETERODIMER FORMATION; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; ACCESSORY SUBUNIT; CRYSTAL-STRUCTURE	Definition: Kinesin-2 refers to the family of motor proteins represented by conserved, heterotrimeric kinesin-II and homodimeric Osm3/Kif17 class of motors. Background: Kinesin-II, a microtubule-based anterograde motor, is composed of three different conserved subunits, named KLP64D, KLP68D and DmKAP in Drosophila. Although previous reports indicated that coiled coil interaction between the middle segments of two dissimilar motor subunits established the heterodimer, the molecular basis of the association is still unknown. Methodology/Principal Findings: Here, we present a detailed heterodimeric association model of the KLP64D/68D stalk supported by extensive experimental analysis and molecular dynamic simulations. We find that KLP64D stalk is unstable, but forms a weak coiled coil heteroduplex with the KLP68D stalk when coexpressed in bacteria. Local instabilities, relative affinities between the C-terminal stalk segments, and dynamic long-range interactions along the stalks specify the heterodimerization. Thermal unfolding studies and independent simulations further suggest that interactions between the C-terminal stalk fragments are comparatively stable, whereas the N-terminal stalk reversibly unfolds at ambient temperature. Conclusions/Significance: Results obtained in this study suggest that coiled coil interaction between the C-terminal stalks of kinesin-II motor subunits is held together through a few hydrophobic and charged interactions. The N-terminal stalk segments are flexible and could uncoil reversibly during a motor walk. This supports the requirement for a flexible coiled coil association between the motor subunits, and its role in motor function needs to be elucidated.	[Doodhi, Harinath; Jana, Swadhin C.; Devan, Pavithra; Ray, Krishanu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Mazumdar, Shyamalava] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR)	Ray, K (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	krishanu@tifr.res.in	Mazumdar, Shyamalava/B-5024-2012	Mazumdar, Shyamalava/0000-0002-7375-9267; Doodhi, Harinath/0000-0003-2978-4446; Ray, Krishanu/0000-0001-6406-3199; Jana, Swadhin/0000-0002-8311-3849	Department of Science and Technology (DST) [SR/SO/BB-59/2006]; Tata Institute of Fundamental Research (TIFR) intramural grant; DST Grant	Department of Science and Technology (DST)(Department of Science & Technology (India)); Tata Institute of Fundamental Research (TIFR) intramural grant; DST Grant	The project is jointly supported by a Department of Science and Technology (DST) grant SR/SO/BB-59/2006 to KR as well as a Tata Institute of Fundamental Research (TIFR) intramural grant to KR. PD was supported by a junior research fellowship from the DST Grant. HD and SJ were Research Scholars at TIFR during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bornschlogl T, 2009, P NATL ACAD SCI USA, V106, P6992, DOI 10.1073/pnas.0812620106; Brown JH, 1996, PROTEINS, V26, P134; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Chana M, 2002, J STRUCT BIOL, V137, P206, DOI 10.1006/jsbi.2002.4446; Chana MS, 2005, J PEPT RES, V65, P209, DOI 10.1111/j.1399-3011.2005.00210.x; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; De Marco V, 2003, EMBO REP, V4, P717, DOI 10.1038/sj.embor.embor884; De Marco V, 2001, EMBO J, V20, P3370, DOI 10.1093/emboj/20.13.3370; DECUEVAS M, 1992, J CELL BIOL, V116, P957, DOI 10.1083/jcb.116.4.957; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gratkowski H, 2002, BIOPHYS J, V83, P1613, DOI 10.1016/S0006-3495(02)73930-1; Henson JH, 1997, CELL MOTIL CYTOSKEL, V38, P29, DOI 10.1002/(SICI)1097-0169(1997)38:1<29::AID-CM4>3.0.CO;2-C; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Houston ME, 2002, J PEPT RES, V59, P34, DOI 10.1046/j.1397-002x.2001.10928.x; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; LEHRER SS, 1989, SCIENCE, V246, P926, DOI 10.1126/science.2814515; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Makino T, 2007, BIOCHEMISTRY-US, V46, P9523, DOI 10.1021/bi700291a; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Missimer JH, 2010, PROTEIN SCI, V19, P2462, DOI 10.1002/pro.528; Morii H, 1997, BIOCHEMISTRY-US, V36, P1933, DOI 10.1021/bi962392l; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Muthukrishnan G, 2009, CURR BIOL, V19, P442, DOI 10.1016/j.cub.2009.01.058; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Olufsen M, 2007, J MOL GRAPH MODEL, V26, P124, DOI 10.1016/j.jmgm.2006.10.003; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Ray K, 2006, PHYSICA A, V372, P52, DOI 10.1016/j.physa.2006.05.007; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Romberg L, 1998, J CELL BIOL, V140, P1407, DOI 10.1083/jcb.140.6.1407; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Shimizu Y, 2005, BIOCHEM BIOPH RES CO, V337, P868, DOI 10.1016/j.bbrc.2005.09.126; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Tripet B, 1997, J BIOL CHEM, V272, P8946; van der Spoel D., 2005, GROMACS USER MANUAL; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vukajlovic M, 2011, MOL BIOL CELL, V22, P4279, DOI 10.1091/mbc.E11-02-0112; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Whitby FG, 2000, PROTEINS, V38, P49; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	63	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45981	10.1371/journal.pone.0045981	http://dx.doi.org/10.1371/journal.pone.0045981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029351	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900070
J	Layachi, S; Rogerieux, F; Robidel, F; Lacroix, G; Bayat, S				Layachi, Skander; Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam			Effet of Combined Nitrogen Dioxide and Carbon Nanoparticle Exposure on Lung Function During Ovalbumin Sensitization in Brown Norway Rat	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; METHACHOLINE-INDUCED BRONCHOCONSTRICTION; AIR-POLLUTION; INFLAMMATORY RESPONSES; ANTIGEN INHALATION; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; NO2-EXPOSED RATS; ALLERGIC-ASTHMA; MURINE MODEL	The interaction of particulate and gaseous pollutants in their effects on the severity of allergic inflammation and airway responsiveness are not well understood. We assessed the effect of exposure to NO2 in the presence or absence of repetitive treatment with carbon nanoparticle (CNP) during allergen sensitization and challenges in Borwn-Norway (BN) rat, in order to assess their interactions on lung function and airway responses (AR) to allergen and methacholine (MCH), end-expiratory lung volume (EELV), bronchoalveolar lavage fluid (BALF) cellular content, serum and BALF cytokine levels and histological changes. Animals were divided into the following groups (n = 6): Control; CNP (Degussa-FW2): 13 nm, 0.5 mg/kg instilled intratracheally x3 at 7-day intervals; OVA: ovalbumin-sensitised; OVA+CNP: both sensitized and exposed to CNP. Rats were divided into equal groups exposed either to air or to NO2, 10 ppm, 6 h/d, 5d/wk for 4 weeks. Exposure to NO2, significantly enhanced lung inflammation and airway reactivity, with a significantly larger effect in animals sensitized to allergen, which was related to a higher expression of TH1 and TH2-type cytokines. Conversely, exposure to NO2 in animals undergoing repeated tracheal instillation of CNP alone, increased BALF neutrophilia and enhanced the expression of TH1 cytokines: TNF-alpha and IFN-gamma, but did not show an additive effect on airway reactivity in comparison to NO2 alone. The exposure to NO2 combined with CNP treatment and allergen sensitization however, unexpectedly resulted in a significant decrease in both airway reactivity to allergen and to methacholine, and a reduction in TH2-type cytokines compared to allergen sensitization alone. EELV was significantly reduced with sensitization, CNP treatment or both. These data suggest an immunomodulatory effect of repeated tracheal instillation of CNP on the proinflammatory effects of NO2 exposure in sensitized BN rat. Furthermore, our findings suggest that NO2, CNP and OVA sensitization may significantly slow overall lung growth in parenchymally mature animals.	[Layachi, Skander; Bayat, Sam] Univ Picardie Jules Verne, EA4285, Lab Perinatal & Risques Tox, UMI01,INERIS, Amiens, France; [Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam] Amiens Univ Hosp, Paediat Lung Funct Lab, Dept Paediat Cardiol, Amiens, France; [Rogerieux, Francoise; Robidel, Franck; Lacroix, Ghislaine; Bayat, Sam] Amiens Univ Hosp, Paediat Lung Funct Lab, Dept Resp Med, Amiens, France; Inst Natl Environm Ind & Risques INERIS, Verneuil En Halatte, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de l'Environnement Industriel et des Risques (INERIS)	Bayat, S (corresponding author), Univ Picardie Jules Verne, EA4285, Lab Perinatal & Risques Tox, UMI01,INERIS, Amiens, France.	bayat.sam@chu-amiens.fr	Lacroix, Ghislaine/Q-8005-2018	Lacroix, Ghislaine/0000-0002-3260-8526	European Regional Development Fund via a Picardie Regional Council grant [REG08009]	European Regional Development Fund via a Picardie Regional Council grant	This study was entirely funded by the European Regional Development Fund via a Picardie Regional Council grant #REG08009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Humadi NH, 2002, EXP LUNG RES, V28, P333, DOI 10.1080/01902140290091976; Alberg T, 2011, INHAL TOXICOL, V23, P268, DOI 10.3109/08958378.2011.566898; Alessandrini F, 2006, J ALLERGY CLIN IMMUN, V117, P824, DOI 10.1016/j.jaci.2005.11.046; BADIER M, 1988, J APPL PHYSIOL, V64, P323, DOI 10.1152/jappl.1988.64.1.323; Boland S, 2000, AM J PHYSIOL-LUNG C, V278, pL25, DOI 10.1152/ajplung.2000.278.1.L25; Bolle I, 2008, J APPL PHYSIOL, V104, P1167, DOI 10.1152/japplphysiol.00587.2007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan A. J., 1998, Reviews on Environmental Health, V13, P73; CHITANO P, 1995, EUR RESPIR J, V8, P1357, DOI 10.1183/09031936.95.08081357; Chow WK, 2003, BUILD ENVIRON, V38, P227, DOI 10.1016/S0360-1323(02)00120-8; de Haar C, 2006, CLIN EXP ALLERGY, V36, P1469, DOI 10.1111/j.1365-2222.2006.02586.x; Dong CC, 2005, TOXICOL SCI, V88, P202, DOI 10.1093/toxsci/kfi280; FOLKESSON HG, 1991, J APPL PHYSIOL, V71, P1106, DOI 10.1152/jappl.1991.71.3.1106; Garn H, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-4; Garn H, 2003, AM J RESP CELL MOL, V28, P386, DOI 10.1165/rcmb.4888; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gilmour MI, 1996, FUND APPL TOXICOL, V31, P65, DOI 10.1006/faat.1996.0076; Gilmour PS, 2004, TOXICOL APPL PHARM, V195, P35, DOI 10.1016/j.taap.2003.10.003; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Graham LeRoy M, 2004, Paediatr Respir Rev, V5 Suppl A, pS59, DOI 10.1016/S1526-0542(04)90012-7; Granum B, 2002, TOXICOL SCI, V65, P7, DOI 10.1093/toxsci/65.1.7; Habre W, 2001, ANESTHESIOLOGY, V94, P348, DOI 10.1097/00000542-200102000-00026; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; HEDBERG K, 1989, JAMA-J AM MED ASSOC, V262, P3014; HOLT PG, 1987, IMMUNOLOGY, V60, P97; Hussain I, 2004, CHEST, V126, P198, DOI 10.1378/chest.126.1.198; Inoue K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-106; Janosi TZ, 2006, J APPL PHYSIOL, V101, P454, DOI 10.1152/japplphysiol.00011.2006; KAROL MH, 1994, EUR RESPIR J, V7, P555, DOI 10.1183/09031936.94.07030555; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; KIPS JC, 1992, AM REV RESPIR DIS, V145, P1306, DOI 10.1164/ajrccm/145.6.1306; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; Li XY, 1999, INHAL TOXICOL, V11, P709; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; LIRA SA, 1994, J EXP MED, V180, P2039, DOI 10.1084/jem.180.6.2039; LOHMANNMATTHES ML, 1994, EUR RESPIR J, V7, P1678; MATSUMURA Y, 1970, AM REV RESPIR DIS, V102, P430; Mehrad B, 2002, AM J RESP CRIT CARE, V166, P1263, DOI 10.1164/rccm.200204-367OC; Moreira AP, 2011, J CLIN INVEST, V121, P4420, DOI 10.1172/JCI44999; Mosqueron L, 2002, OCCUP ENVIRON MED, V59, P550, DOI 10.1136/oem.59.8.550; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Oberdorster G, 2000, Res Rep Health Eff Inst, P5; Oberdorster G, 2000, RES REP HLTH EFF I, P75; Park HJ, 2009, INT IMMUNOPHARMACOL, V9, P261, DOI 10.1016/j.intimp.2008.10.021; Pathmanathan S, 2003, OCCUP ENVIRON MED, V60, P892, DOI 10.1136/oem.60.11.892; Pereira CEL, 2007, BRAZ J MED BIOL RES, V40, P1353, DOI 10.1590/S0100-879X2006005000164; Persinger RL, 2002, MOL CELL BIOCHEM, V234, P71, DOI 10.1023/A:1015973530559; Petak F, 1997, J APPL PHYSIOL, V82, P1479, DOI 10.1152/jappl.1997.82.5.1479; PIERSON WE, 1992, J ALLERGY CLIN IMMUN, V90, P557, DOI 10.1016/0091-6749(92)90128-O; Poynter ME, 2006, AM J PHYSIOL-LUNG C, V290, pL144, DOI 10.1152/ajplung.00131.2005; Proust B, 2002, MEDIAT INFLAMM, V11, P251, DOI 10.1080/096293502900000113; Samuelsen M, 2008, TOXICOLOGY, V246, P124, DOI 10.1016/j.tox.2008.01.001; Saric J, 2010, J PROTEOME RES, V9, P2255, DOI 10.1021/pr901019z; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sears BW, 2010, J INFLAMM RES, V3, P105, DOI 10.2147/JIR.S12853; Siddiqui S, 2010, J APPL PHYSIOL, V109, P1170, DOI 10.1152/japplphysiol.01168.2009; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; van de Woestijne KP, 1981, P 28 INT C PHYS SCI, P655, DOI DOI 10.1016/B978-0-08-026823-1.50083-1; van Zijverden M, 2000, TOXICOL APPL PHARM, V168, P131, DOI 10.1006/taap.2000.9013; Vanacker NJ, 2001, AM J RESP CRIT CARE, V163, P674, DOI 10.1164/ajrccm.163.3.2004160; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; Yamashita K, 2009, TOXICOLOGY, V261, P19, DOI 10.1016/j.tox.2009.04.034; Yanagisawa R, 2003, THORAX, V58, P605, DOI 10.1136/thorax.58.7.605	68	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45687	10.1371/journal.pone.0045687	http://dx.doi.org/10.1371/journal.pone.0045687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029182	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900052
J	Vermeij, A; van Beek, AHEA; Rikkert, MGMO; Claassen, JAHR; Kessels, RPC				Vermeij, Anouk; van Beek, Arenda H. E. A.; Rikkert, Marcel G. M. Olde; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.			Effects of Aging on Cerebral Oxygenation during Working-Memory Performance: A Functional Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; PREFRONTAL CORTEX; HEMOGLOBIN OXYGENATION; BLOOD-VOLUME; BRAIN ACTIVATION; TASK; NIRS; STIMULATION; DEPENDENCY; DECREASE	Working memory is sensitive to aging-related decline. Evidence exists that aging is accompanied by a reorganization of the working-memory circuitry, but the underlying neurocognitive mechanisms are unclear. In this study, we examined aging-related changes in prefrontal activation during working-memory performance using functional Near-Infrared Spectroscopy (fNIRS), a noninvasive neuroimaging technique. Seventeen healthy young (21-32 years) and 17 healthy older adults (64-81 years) performed a verbal working-memory task (n-back). Oxygenated and deoxygenated hemoglobin concentration changes were registered by two fNIRS channels located over the left and right prefrontal cortex. Increased working-memory load resulted in worse performance compared to the control condition in older adults, but not in young participants. In both young and older adults, prefrontal activation increased with rising working-memory load. Young adults showed slight right-hemispheric dominance at low levels of working-memory load, while no hemispheric differences were apparent in older adults. Analysis of the time-activation curve during the high working-memory load condition revealed a continuous increase of the hemodynamic response in the young. In contrast to that, a quadratic pattern of activation was found in the older participants. Based on these results it could be hypothesized that young adults were better able to keep the prefrontal cortex recruited over a prolonged period of time. To conclude, already at low levels of working-memory load do older adults recruit both hemispheres, possibly in an attempt to compensate for the observed aging-related decline in performance. Also, our study shows that aging effects on the time course of the hemodynamic response must be taken into account in the interpretation of the results of neuroimaging studies that rely on blood oxygen levels, such as fMRI.	[Vermeij, Anouk; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Vermeij, Anouk; van Beek, Arenda H. E. A.; Rikkert, Marcel G. M. Olde; Claassen, Jurgen A. H. R.; Kessels, Roy P. C.] Radboud Univ Nijmegen, Alzheimer Ctr Nijmegen, Dept Geriatr Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Vermeij, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.vermeij@ger.umcn.nl	Rikkert, M.G.M. Olde/H-8078-2014; Claassen, Jurgen A.H.R./A-9806-2008; Kessels, Roy P.C./D-1902-2010; Vermeij, Anouk/J-5934-2012; Rikkert, Marcel Olde/D-9773-2012	Rikkert, M.G.M. Olde/0000-0003-1397-1677; Claassen, Jurgen A.H.R./0000-0002-1778-8151; Kessels, Roy P.C./0000-0001-9500-9793; 	Donders TopTalent Grant; Netherlands Organisation for Scientific Research (NWO); Alzheimer Nederland [WE03-2010-03]; VIDI innovational grant from NWO [452-08-005]	Donders TopTalent Grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Alzheimer Nederland; VIDI innovational grant from NWO	This project was funded by a Donders TopTalent Grant supported by the Netherlands Organisation for Scientific Research (NWO), awarded to AV and a grant from Alzheimer Nederland (no. WE03-2010-03) awarded to JC. RK was funded by a VIDI innovational grant from the NWO (no. 452-08-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Butti M, 2009, MED PHYS, V36, P4103, DOI 10.1118/1.3190557; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Claassen JAHR, 2006, PHYSIOL MEAS, V27, P255, DOI 10.1088/0967-3334/27/3/004; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Fallgatter AJ, 1997, NEUROSCI LETT, V223, P89, DOI 10.1016/S0304-3940(97)13416-4; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Heekeren HR, 1997, PHILOS T ROY SOC B, V352, P743, DOI 10.1098/rstb.1997.0057; Herrmann MJ, 2007, EUR J NEUROSCI, V26, P2713, DOI 10.1111/j.1460-9568.2007.05921.x; HOCK C, 1995, J CEREBR BLOOD F MET, V15, P1103, DOI 10.1038/jcbfm.1995.137; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; Hoshi Y, 2003, NEUROIMAGE, V20, P1493, DOI 10.1016/S1053-8119(03)00412-9; Jansma JM, 2000, NEUROIMAGE, V12, P688, DOI 10.1006/nimg.2000.0645; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Kwee IL, 2003, J NEUROL, V250, P525, DOI 10.1007/s00415-003-1028-x; Leon-Carrion J, 2007, NEUROSCI LETT, V422, P147, DOI 10.1016/j.neulet.2007.04.087; Leon-Carrion J, 2006, NEUROSCI LETT, V403, P90, DOI 10.1016/j.neulet.2006.04.050; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; LIU H, 1995, MED PHYS, V22, P1209, DOI 10.1118/1.597520; LIU HL, 1995, PHYS MED BIOL, V40, P1983, DOI 10.1088/0031-9155/40/11/015; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; MARIN J, 1995, MECH AGEING DEV, V79, P71, DOI 10.1016/0047-6374(94)01551-V; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Meulenbroek O, 2010, BRAIN RES, V1315, P100, DOI 10.1016/j.brainres.2009.12.011; Missonnier P, 2011, J NEURAL TRANSM, V118, P945, DOI 10.1007/s00702-011-0600-2; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Nagel IE, 2011, J COGNITIVE NEUROSCI, V23, P2030, DOI 10.1162/jocn.2010.21560; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Nyberg L, 2009, SCAND J PSYCHOL, V50, P41, DOI 10.1111/j.1467-9450.2008.00678.x; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Sakatani K, 2006, LIFE SCI, V78, P2734, DOI 10.1016/j.lfs.2005.10.045; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmand B., 1992, NEDERLANDSE LEESTEST; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Tsujii T, 2010, BEHAV BRAIN RES, V210, P178, DOI 10.1016/j.bbr.2010.02.027; van Beek AHEA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.016; Van de Ven MJT, 2001, J CEREBR BLOOD F MET, V21, P110, DOI 10.1097/00004647-200102000-00002; Verhage F., 1964, INTELLIGENTIE LEEFTI; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6	64	69	71	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46210	10.1371/journal.pone.0046210	http://dx.doi.org/10.1371/journal.pone.0046210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029437	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900108
J	Wang, XH; Wu, T; Hu, Y; Marcinkiewicz, M; Qi, SJ; Valderrama-Carvajal, H; Luo, HY; Wu, JP				Wang, Xuehai; Wu, Tao; Hu, Yan; Marcinkiewicz, Martin; Qi, Shijie; Valderrama-Carvajal, Hector; Luo, Hongyu; Wu, Jiangping			Pno1 Tissue-Specific Expression and Its Functions Related to the Immune Responses and Proteasome Activities	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MICE; CELLS; OVEREXPRESSION; MATURATION; PROTEINS; 90S	Pno1 is a protein that plays a role in proteasome and ribosome neogenesis in yeast. So far, its functions in mammalian cells have not been investigated. To understand its function in mammals, we performed in situ hybridization analysis of Pno1 expression in different development stages and generated Pno1 gene knockout (KO) and transgenic (Tg) mice lineages. The results showed early lethality of homozygous Pno1 KO lineage caused, as demonstrated in parallel by ex vivo experiments, by arrest of embryo development before compaction stage. Though, heterozygous (HET) mice with 50% of normal Pno1 mRNA concentration were fertile and showed no obvious anomalies. The lymphoid organs of HET mice were normal in size, weight and cellularity, with normal T and B cell subpopulations. TCR-triggered activation and proliferation of HET T cells were normal. Proteasome activities in HET organs were uncompromised. Tg mice with actin promoter-driven Pno1 expression were also fertile, with no apparent anomalies, although they expressed 2-5-fold higher Pno1 mRNA levels. The lymphoid organs of Tg mice were of normal size, weight and cellularity with normal T and B cell sub-populations. TCR-triggered activation and proliferation of Tg T cells were normal. Tg organs and tissues presented normal proteasome activity as did their wild type counterparts. Tagged Pno1 over-expression in L cells and density gradient fractionation established that Pno1 existed in large complexes with sedimentation rates between 20S and 26S, bigger than mature 26S proteasomes. Pno1 in fractions did not coincide with 40S or 60S ribosome subunits. Our study indicates that Pno1 is essential for cellular functions, but only a small percentage of its normal level is sufficient, and excessive amounts are neither harmful nor useful. The nature of the large complexes it associates with remains to be identified, but it is certain that they are not mature proteasomes or ribosomes.	[Wang, Xuehai; Wu, Tao; Hu, Yan; Qi, Shijie; Valderrama-Carvajal, Hector; Luo, Hongyu; Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada; [Wu, Jiangping] Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Serv Nephrol, Montreal, PQ H2L 4K8, Canada; [Wu, Tao] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Inst Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Marcinkiewicz, Martin] Cytochem Inc, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Zhejiang University	Wu, JP (corresponding author), Hop Notre Dame de Bon Secours, Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Lab Immunol, Montreal, PQ H2L 4K8, Canada.	jianping.wu@umontreal.ca			Canadian Institutes of Health Research [MOP57697, MOP69089, MOP97829]; Heart and Stroke Foundation of Quebec; Jean-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec (FRSQ)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Jean-Louis Levesque Foundation; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP57697 and MOP69089) and H. L. (MOP97829). It was also funded by grants from the Heart and Stroke Foundation of Quebec, the Jean-Louis Levesque Foundation to J.W. In addition, it was supported by a group grant from Fonds de la recherche en sante du Quebec (FRSQ) for Transfusional and Hemovigilance Medical Research to J.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016194; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; Han B, 2007, ARTHRITIS RHEUM-US, V56, P3748, DOI 10.1002/art.22978; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Luo HY, 2011, J BIOL CHEM, V286, P41135, DOI 10.1074/jbc.M111.302596; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Marcinkiewicz M, 2002, J NEUROPATH EXP NEUR, V61, P815, DOI 10.1093/jnen/61.9.915; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Senapin S, 2003, NUCLEIC ACIDS RES, V31, P2524, DOI 10.1093/nar/gkg366; Tone Y, 2002, GENE DEV, V16, P3142, DOI 10.1101/gad.1025602; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; UDEM SA, 1972, J MOL BIOL, V65, P227, DOI 10.1016/0022-2836(72)90279-3; Vanrobays E, 2004, RNA, V10, P645, DOI 10.1261/rna.5162204; Woolls HA, 2011, J BIOL CHEM, V286, P2578, DOI 10.1074/jbc.M110.191494; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645	21	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46093	10.1371/journal.pone.0046093	http://dx.doi.org/10.1371/journal.pone.0046093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029399	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900089
J	Asan; Geng, CY; Chen, Y; Wu, K; Cai, QL; Wang, Y; Lang, YS; Cao, HZ; Yang, HM; Wang, J; Zhang, XQ				Asan; Geng, Chunyu; Chen, Yan; Wu, Kui; Cai, Qingle; Wang, Yu; Lang, Yongshan; Cao, Hongzhi; Yang, Huangming; Wang, Jian; Zhang, Xiuqing			Paired-End Sequencing of Long-Range DNA Fragments for De Novo Assembly of Large, Complex Mammalian Genomes by Direct Intra-Molecule Ligation	PLOS ONE			English	Article							SHORT-READ; STRUCTURAL VARIATION; STRATEGY; MAP; PET	Background: The relatively short read lengths from next generation sequencing (NGS) technologies still pose a challenge for de novo assembly of complex mammal genomes. One important solution is to use paired-end (PE) sequence information experimentally obtained from long-range DNA fragments (>1 kb). Here, we characterize and extend a long-range PE library construction method based on direct intra-molecule ligation (or molecular linker-free circularization) for NGS. Results: We found that the method performs stably for PE sequencing of 2- to 5- kb DNA fragments, and can be extended to 10-20 kb (and even in extremes, up to similar to 35 kb). We also characterized the impact of low quality input DNA on the method, and develop a whole-genome amplification (WGA) based protocol using limited input DNA (<1 mu g). Using this PE dataset, we accurately assembled the YanHuang (YH) genome, the first sequenced Asian genome, into a scaffold N50 size of >2 Mb, which is over100-times greater than the initial size produced with only small insert PE reads(17 kb). In addition, we mapped two 7- to 8- kb insertions in the YH genome using the larger insert sizes of the long-range PE data. Conclusions: In conclusion, we demonstrate here the effectiveness of this long-range PE sequencing method and its use for the de novo assembly of a large, complex genome using NGS short reads.	[Asan; Geng, Chunyu; Chen, Yan; Wu, Kui; Cai, Qingle; Wang, Yu; Lang, Yongshan; Cao, Hongzhi; Yang, Huangming; Wang, Jian; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Beijing Genomics Institute (BGI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	wangjian@genomics.org.cn; zhangxq@genomics.org.cn			National High Technology Research and Development Program of China [2006AA02A302, 2009AA022707]; National Natural Science Foundation of China [30811130531]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High Technology Research and Development Program of China (2006AA02A302, 2009AA022707), and National Natural Science Foundation of China (30811130531). Funding for open access charge: National High Technology Research and Development Program of China (2006AA02A302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Donahue WF, 2007, CURR PROTOC HUM GENE; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Harris R. S., 2007, THESIS PENNSYLVANIA; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2011, NAT BIOTECHNOL, V29, P723, DOI 10.1038/nbt.1904; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	27	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46211	10.1371/journal.pone.0046211	http://dx.doi.org/10.1371/journal.pone.0046211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029438	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500073
J	Bazzigaluppi, P; Ruigrok, T; Saisan, P; De Zeeuw, CI; de Jeu, M				Bazzigaluppi, Paolo; Ruigrok, Tom; Saisan, Payam; De Zeeuw, Chris I.; de Jeu, Marcel			Properties of the Nucleo-Olivary Pathway: An In Vivo Whole-Cell Patch Clamp Study	PLOS ONE			English	Article							INFERIOR OLIVARY NEURONS; MEDIAL ACCESSORY OLIVE; MEMBRANE-POTENTIAL OSCILLATIONS; GAP-JUNCTIONS; CEREBELLAR INHIBITION; GABAERGIC INNERVATION; DECEREBRATE FERRET; DENDRITIC SPINES; GABA(B) BINDING; RAT-BRAIN	The inferior olivary nucleus (IO) forms the gateway to the cerebellar cortex and receives feedback information from the cerebellar nuclei (CN), thereby occupying a central position in the olivo-cerebellar loop. Here, we investigated the feedback input from the CN to the IO in vivo in mice using the whole-cell patch-clamp technique. This approach allows us to study how the CN-feedback input is integrated with the activity of olivary neurons, while the olivo-cerebellar system and its connections are intact. Our results show how IO neurons respond to CN stimulation sequentially with: i) a short depolarization (EPSP), ii) a hyperpolarization (IPSP) and iii) a rebound depolarization. The latter two phenomena can also be evoked without the EPSPs. The IPSP is sensitive to a GABA(A) receptor blocker. The IPSP suppresses suprathreshold and subthreshold activity and is generated mainly by activation of the GABA(A) receptors. The rebound depolarization re-initiates and temporarily phase locks the subthreshold oscillations. Lack of electrotonical coupling does not affect the IPSP of individual olivary neurons, nor the sensitivity of its GABA(A) receptors to blockers. The GABAergic feedback input from the CN does not only temporarily block the transmission of signals through the IO, it also isolates neurons from the network by shunting the junction current and re-initiates the temporal pattern after a fixed time point. These data suggest that the IO not only functions as a cerebellar controlled gating device, but also operates as a pattern generator for controlling motor timing and/or learning.	[Bazzigaluppi, Paolo; Ruigrok, Tom; De Zeeuw, Chris I.; de Jeu, Marcel] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Saisan, Payam] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [De Zeeuw, Chris I.] Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Diego; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	de Jeu, M (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	m.dejeu@erasmusmc.nl		Bazzigaluppi, Paolo/0000-0002-0434-2548	ZonMw [917.96.347]	ZonMw(Netherlands Organization for Health Research and Development)	The present work has been funded by ZonMw Grant 917.96.347 (M.d.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; ANGAUT P, 1989, BRAIN RES, V479, P361, DOI 10.1016/0006-8993(89)91641-7; Bal T, 1997, J NEUROPHYSIOL, V77, P3145, DOI 10.1152/jn.1997.77.6.3145; Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; Bengtsson F, 2004, EUR J NEUROSCI, V20, P2999, DOI 10.1111/j.1460-9568.2004.03789.x; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; BRIDGES RJ, 1989, AM J PHYSIOL, V256, pC902, DOI 10.1152/ajpcell.1989.256.4.C902; Choi S, 2010, J PHYSIOL-LONDON, V588, P3031, DOI 10.1113/jphysiol.2009.184705; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Devor A, 2000, PROG BRAIN RES, V124, P213; Devor A, 2001, J NEUROPHYSIOL, V85, P1686, DOI 10.1152/jn.2001.85.4.1686; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DEZEEUW CI, 1990, J COMP NEUROL, V300, P495, DOI 10.1002/cne.903000405; DEZEEUW CI, 1990, NEUROSCIENCE, V34, P645, DOI 10.1016/0306-4522(90)90171-Y; DEZEEUW CI, 1990, J COMP NEUROL, V300, P478, DOI 10.1002/cne.903000404; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; GRUART A, 1994, EXP BRAIN RES, V101, P173; HESSLOW G, 1986, NEUROSCI LETT, V63, P76, DOI 10.1016/0304-3940(86)90016-9; Hesslow G, 1996, EXP BRAIN RES, V110, P36; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; KIM JH, 1988, NEUROSCIENCE, V25, P475, DOI 10.1016/0306-4522(88)90252-7; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kistler WM, 2002, NEURAL COMPUT, V14, P2597, DOI 10.1162/089976602760407991; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Llinas RR, 2011, J PHYSIOL-LONDON, V589, P3423, DOI 10.1113/jphysiol.2011.207464; Long MA, 2002, J NEUROSCI, V22, P10898; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Park YG, 2010, P NATL ACAD SCI USA, V107, P10731, DOI 10.1073/pnas.1002995107; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Ruigrok TJ, 2010, CEREBELLUM IN PRESS; RUIGROK TJH, 1995, EUR J NEUROSCI, V7, P679, DOI 10.1111/j.1460-9568.1995.tb00672.x; RUIGROK TJH, 1990, J COMP NEUROL, V298, P315, DOI 10.1002/cne.902980305; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; Sangrey T, 2010, EUR J NEUROSCI, V32, P1646, DOI 10.1111/j.1460-9568.2010.07408.x; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; SOTELO C, 1974, J NEUROPHYSIOL, V37, P541, DOI 10.1152/jn.1974.37.3.541; SOTELO C, 1986, J COMP NEUROL, V252, P32, DOI 10.1002/cne.902520103; Svensson P, 2006, EXP BRAIN RES, V168, P241, DOI 10.1007/s00221-005-0086-y; TURGEON SM, 1994, NEUROSCIENCE, V62, P601, DOI 10.1016/0306-4522(94)90392-1; TURGEON SM, 1994, NEUROBIOL AGING, V15, P705, DOI 10.1016/0197-4580(94)90052-3; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; YAROM Y, 1987, J NEUROSCI, V7, P1166; Zeeuw DE CI, 1997, CLIMBING FIBER COLLA	54	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46360	10.1371/journal.pone.0046360	http://dx.doi.org/10.1371/journal.pone.0046360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029495	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500096
J	Kong, C; Samovski, D; Srikanth, P; Wainszelbaum, MJ; Charron, AJ; Liu, JL; Lange, JJ; Chen, PI; Pan, ZQ; Su, X; Stahl, PD				Kong, Chen; Samovski, Dmitri; Srikanth, Priya; Wainszelbaum, Marisa J.; Charron, Audra J.; Liu, Jialiu; Lange, Jeffrey J.; Chen, Pin-I; Pan, Zhen-Qiang; Su, Xiong; Stahl, Philip D.			Ubiquitination and Degradation of the Hominoid-Specific Oncoprotein TBC1D3 Is Mediated by CUL7 E3 Ligase	PLOS ONE			English	Article							COPY NUMBER VARIATION; 3-M SYNDROME; ONCOGENE; PROTEIN; PATHWAY; GROWTH; CANCER; CELLS; MUTATIONS; GENE	Expression of the hominoid-specific TBC1D3 oncoprotein enhances growth factor receptor signaling and subsequently promotes cellular proliferation and survival. Here we report that TBC1D3 is degraded in response to growth factor signaling, suggesting that TBC1D3 expression is regulated by a growth factor-driven negative feedback loop. To gain a better understanding of how TBC1D3 is regulated, we studied the effects of growth factor receptor signaling on TBC1D3 post-translational processing and turnover. Using a yeast two-hybrid screen, we identified CUL7, the scaffolding subunit of the CUL7 E3 ligase complex, as a TBC1D3-interacting protein. We show that CUL7 E3 ligase ubiquitinates TBC1D3 in response to serum stimulation. Moreover, TBC1D3 recruits F-box 8 (Fbw8), the substrate recognition domain of CUL7 E3 ligase, in pull-down experiments and in an in vitro assay. Importantly, alkaline phosphatase treatment of TBC1D3 suppresses its ability to recruit Fbw8, indicating that TBC1D3 phosphorylation is critical for its ubiquitination and degradation. We conclude that serum-and growth factor-stimulated TBC1D3 ubiquitination and degradation are regulated by its interaction with CUL7-Fbw8.	[Kong, Chen; Samovski, Dmitri; Srikanth, Priya; Wainszelbaum, Marisa J.; Charron, Audra J.; Liu, Jialiu; Lange, Jeffrey J.; Chen, Pin-I; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pan, Zhen-Qiang] Icahn Med Inst, Dept Oncol Sci, New York, NY USA; [Su, Xiong] Washington Univ, Sch Med, Ctr Human Nutr, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Washington University (WUSTL)	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	xsu@wustl.edu; pstahl@wustl.edu	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019	Samovski, Dmitri/0000-0002-6860-6688; Srikanth, Priya/0000-0002-9669-0434	National Health Institute [GM086566]; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM086566] Funding Source: NIH RePORTER	National Health Institute; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Health Institute grant GM086566 and a grant from the McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Hanson D, 2011, HORM RES PAEDIAT, V76, P369, DOI 10.1159/000334392; Hanson D, 2011, AM J HUM GENET, V89, P148, DOI 10.1016/j.ajhg.2011.05.028; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; HUEBNER K, 1988, ONCOGENE, V3, P449; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; NAKAMURA T, 1992, ONCOGENE, V7, P733; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pei L, 2002, CANCER RES, V62, P5420; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	25	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46485	10.1371/journal.pone.0046485	http://dx.doi.org/10.1371/journal.pone.0046485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029530	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500104
J	Merlini, E; Luzi, K; Suardi, E; Barassi, A; Cerrone, M; Martinez, JS; Bai, F; D'Eril, GVM; Monforte, AD; Marchetti, G				Merlini, Esther; Luzi, Kety; Suardi, Elisa; Barassi, Alessandra; Cerrone, Maddalena; Martinez, Javier Sanchez; Bai, Francesca; D'Eril, Gian Vico Melzi; Monforte, Antonella D'Arminio; Marchetti, Giulia			T-Cell Phenotypes, Apoptosis and Inflammation in HIV plus Patients on Virologically Effective cART with Early Atherosclerosis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INDIVIDUAL ANTIRETROVIRAL DRUGS; CAROTID-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION; INFECTED PATIENTS; MICROBIAL TRANSLOCATION; HIV-1-INFECTED PATIENTS; REPLICATIVE SENESCENCE	Objective: We investigated the potential relationship between T-cell phenotype, inflammation, endotoxemia, and atherosclerosis evaluated by carotid intima-media thickness (IMT) in a cohort of HIV-positive patients undergoing long-term virologically suppressive combination antiretroviral therapy (cART). Design: We studied 163 patients receiving virologically suppressive cART. Methods: We measured IMT (carotid ultrasound); CD4+/CD8+ T-cell activation (CD38, CD45R0), differentiation (CD127), apoptosis (CD95), and senescence (CD28, CD57) (flow cytometry); plasma sCD14, IL-6, TNF-alpha, sVCAM-1, hs-CRP, anti-CMV IgG (ELISA); LPS (LAL). The results were compared by Mann-Whitney, Kruskal-Wallis or Chi-square tests, and factors associated with IMT were evaluated by multivariable logistic regression. Results: Of 163 patients, 112 demonstrated normal IMT (nIMT), whereas 51 (31.3%) had pathological IMT (pIMT: >= 1 mm). Of the patients with pIMT, 22 demonstrated an increased IMT (iIMT), and 29 were shown to have plaques. These patient groups had comparable nadir and current CD4+, VLs and total length of time on cART. Despite similar proportions of CD38-expressing CD8+ cells (p = .95), pIMT patients exhibited higher activated memory CD8+CD38+CD45R0+ cells (p = .038) and apoptotic CD4+CD95+ (p = .01) and CD8+CD95+ cells (p = .003). In comparison to nIMT patients, iIMT patients tended to have lower numbers of early differentiated CD28+CD57- memory CD4+ (p = .048) and CD28-CD57-CD8+ cells (p = .006), both of which are associated with a higher proliferative potential. Despite no differences in plasma LPS levels, pIMT patients showed significantly higher circulating levels of sCD14 than did nIMT patients (p = .046). No differences in anti-CMV IgG was shown. Although circulating levels of sCD14 seemed to be associated with a risk of ATS in an unadjusted analysis, this effect was lost after adjusting for classical cardiovascular predictors. Conclusions: Despite the provision of full viral suppression by cART, a hyperactivated, pro-apoptotic T-cell profile characterizes HIV-infected patients with early vascular damage, for whom the potential contribution of subclinical endotoxemia and anti-CMV immunity should be investigated further.	[Merlini, Esther; Luzi, Kety; Suardi, Elisa; Cerrone, Maddalena; Martinez, Javier Sanchez; Bai, Francesca; Monforte, Antonella D'Arminio; Marchetti, Giulia] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis & Trop Med, Milan, Italy; [Barassi, Alessandra; D'Eril, Gian Vico Melzi] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Lab Clin Analyses, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan	Marchetti, G (corresponding author), Univ Milan, San Paolo Hosp, Dept Hlth Sci, Clin Infect Dis & Trop Med, Milan, Italy.	giulia.marchetti@unimi.it	Cerrone, Maddalena/AAH-9742-2021; Gori, Andrea/AAC-6078-2022; Cerrone, Maddalena/AAH-1559-2020; Bai, Francesca/K-4823-2018; Marchetti, Giulia/GPX-7655-2022; MARCHETTI, GIULIA CARLA/K-4384-2018	Cerrone, Maddalena/0000-0002-6900-6086; barassi, alessandra/0000-0002-0404-8357; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828				Aiello AE, 2012, J INFECT DIS, V205, P1772, DOI 10.1093/infdis/jis288; Amar J, 2006, J HYPERTENS, V24, P1083, DOI 10.1097/01.hjh.0000226198.44181.0c; Bandres E, 2000, CLIN IMMUNOL, V96, P230, DOI 10.1006/clim.2000.4894; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chung NA, 2003, HEART, V89, P1411, DOI 10.1136/heart.89.12.1411; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hwang SJ, 1997, CIRCULATION, V96, P4219; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mangili A, 2011, ATHEROSCLEROSIS, V214, P468, DOI 10.1016/j.atherosclerosis.2010.11.013; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Nadareishvili ZG, 2004, NEUROLOGY, V63, P1446; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Paulsen M, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-7; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rossi R, 2009, JAIDS-J ACQ IMM DEF, V52, P303, DOI 10.1097/QAI.0b013e3181b18c19; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; SalazarGonzalez JF, 1997, CLIN IMMUNOL IMMUNOP, V84, P36, DOI 10.1006/clin.1997.4364; SALONEN JT, 1993, CIRCULATION, V87, P56; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Stoll LL, 2004, ARTERIOSCL THROM VAS, V24, P2227, DOI 10.1161/01.ATV.0000147534.69062.dc; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Sze DMY, 2001, BLOOD, V98, P2817, DOI 10.1182/blood.V98.9.2817; Vamvakopoulos J, 2003, TRANSPLANTATION, V75, P742, DOI 10.1097/01.TP.0000054929.87347.59; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	53	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46073	10.1371/journal.pone.0046073	http://dx.doi.org/10.1371/journal.pone.0046073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029393	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500061
J	Wajnberg, E; Curty, C; Jervis, M				Wajnberg, Eric; Curty, Christine; Jervis, Mark			Intra-Population Genetic Variation in the Temporal Pattern of Egg Maturation in a Parasitoid Wasp	PLOS ONE			English	Article							TRICHOGRAMMA-MAIDIS PINTUREAU; LIFE-HISTORY EVOLUTION; BODY-SIZE; TRADE-OFFS; ALLOCATION; FECUNDITY; INSECTS; LOAD; TIME; CONSEQUENCES	Parasitoid wasps are taxonomically and biologically extremely diverse. A conceptual framework has recently been developed for understanding life-history evolution and diversification in these animals, and it has confirmed that each of two linked life-history traits - the mode of larval development and the temporal pattern of egg maturation - acts as an organiser of life-history. The framework has been predicated on the assumption that there exists sufficient genetic variation in the latter trait to allow it to be shaped by natural selection. Focusing on the parasitoid wasp Trichogramma brassicae, our aim was to test the validity of that assumption, using established quantitative genetic methods. We demonstrate the existence of a statistically significant degree of intra-population polygenic variation in the temporal pattern of egg production within the wasp population we studied. Furthermore, our results, together with published data on clinal variation in the egg maturation pattern of another species, suggest that intra-specific evolutionary shifts in the temporal pattern of egg maturation of parasitoid wasps can result from a change in allocation to egg production either before, or very shortly after adult emergence, without there being an accompanying change in lifetime fecundity. As well as opening new avenues of research into the reproductive strategies, behaviour, community organisation and biological control potential of parasitoid wasps, this discovery also has implications for studies of life-history evolution and diversification in insects generally.	[Wajnberg, Eric; Curty, Christine] INRA, Sophia Antipolis, France; [Jervis, Mark] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales	INRAE; Cardiff University	Wajnberg, E (corresponding author), INRA, Sophia Antipolis, France.	wajnberg@sophia.inra.fr	Wajnberg, Eric/A-4862-2009	Wajnberg, Eric/0000-0002-6700-7114				Bernstein Carlos, 2008, P129, DOI 10.1002/9780470696200.ch7; BIGLER F, 1987, J APPL ENTOMOL, V104, P340, DOI 10.1111/j.1439-0418.1987.tb00535.x; BLACKBURN TM, 1991, FUNCT ECOL, V5, P65, DOI 10.2307/2389556; BLACKBURN TM, 1991, J ANIM ECOL, V60, P151, DOI 10.2307/5451; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; BRUINS EBAW, 1994, ENTOMOL EXP APPL, V72, P297, DOI 10.1007/BF02383818; Clausen C. P., 1940, ENTOMOPHAGOUS INSECT; Dieckhoff C, 2010, ENTOMOL EXP APPL, V136, P254, DOI 10.1111/j.1570-7458.2010.01024.x; Dixon AFG, 2002, ECOL ENTOMOL, V27, P433, DOI 10.1046/j.1365-2311.2002.00429.x; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2004, EVOL ECOL RES, V6, P993; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Falconer D. S., 1981, INTRO QUANTITATIVE G; Gauld I. D., 1988, HYMENOPTERA; Hajek A.E., 2004, NATURAL ENEMIES INTR; Hassell, 2000, SPATIAL TEMPORAL DYN; Hawkins BA, 1999, OIKOS, V86, P493, DOI 10.2307/3546654; Hawkins BA, 1994, PATTERN PROCESS HOST; Heimpel GE, 1997, OECOLOGIA, V110, P346, DOI 10.1007/s004420050168; HOFFMANN AA, 1988, GENET SEL EVOL, V20, P87, DOI 10.1186/1297-9686-20-1-87; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jervis M.A., 2005, P73, DOI 10.1007/1-4020-2625-0_2; JERVIS MA, 1994, J APPL ENTOMOL, V117, P72, DOI 10.1111/j.1439-0418.1994.tb00709.x; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; Jervis MA, 2004, OIKOS, V107, P449, DOI 10.1111/j.0030-1299.2004.13453.x; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis M, 2011, BIOL J LINN SOC, V104, P443, DOI 10.1111/j.1095-8312.2011.01719.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Jervis MA, 2007, EVOL ECOL, V21, P307, DOI 10.1007/s10682-006-9102-3; Jervis MA, 2007, BIOL J LINN SOC, V90, P293, DOI 10.1111/j.1095-8312.2007.00721.x; Jones TS, 2009, OECOLOGIA, V159, P627, DOI 10.1007/s00442-008-1247-z; Kindlmann P, 2001, J EVOLUTION BIOL, V14, P835, DOI 10.1046/j.1420-9101.2001.00323.x; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Lasalle John, 1993, P1; Lewontin R. C., 1965, P77; Mayhew PJ, 1999, J ANIM ECOL, V68, P906, DOI 10.1046/j.1365-2656.1999.00338.x; Mills NJ, 2000, ECOL ENTOMOL, V25, P315, DOI 10.1046/j.1365-2311.2000.00260.x; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Parsons P.A., 1980, Evolutionary Biology (New York), V13, P175; PINTUREAU B, 1981, AGRONOMIE, V1, P315, DOI 10.1051/agro:19810409; Roff Derek, 2002, pi; Shuker DM, 2007, HEREDITY, V98, P69, DOI 10.1038/sj.hdy.6800897; Stearns S.C., 1992, pi; Thorne AD, 2006, P ROY SOC B-BIOL SCI, V273, P1099, DOI 10.1098/rspb.2005.3416; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; WAJNBERG E, 1989, ENTOMOPHAGA, V34, P397, DOI 10.1007/BF02372479; Wajnberg E, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P19, DOI 10.1079/9780851997353.0019; Wajnberg E, 2004, J ANIM ECOL, V73, P1179, DOI 10.1111/j.0021-8790.2004.00892.x; WAJNBERG E, 1989, ENTOMOL EXP APPL, V53, P177, DOI 10.1007/BF00187999; Wajnberg E, 1999, J ANIM ECOL, V68, P121, DOI 10.1046/j.1365-2656.1999.00270.x; Wajnberg E, 1994, BIOL CONTROL EGG PAR	53	12	13	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45915	10.1371/journal.pone.0045915	http://dx.doi.org/10.1371/journal.pone.0045915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029312	Green Published, Green Accepted, gold			2022-12-25	WOS:000309517500046
J	Heide, J; Mann, SA; Vandenberg, JI				Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.			The Schizophrenia-Associated Kv11.1-3.1 Isoform Results in Reduced Current Accumulation during Repetitive Brief Depolarizations	PLOS ONE			English	Article							HERG POTASSIUM CHANNEL; MOLECULAR-BASIS; ACTIVATION; GENES; KCNH2	Recent genome wide association studies identified a brain and primate specific isoform of a voltage-gated potassium channel, referred to as Kv11.1-3.1, which is significantly associated with schizophrenia. The 3.1 isoform replaces the first 102 amino acids of the most abundant isoform (referred to as Kv11.1-1A) with six unique amino acids. Here we show that the Kv11.1-3.1 isoform has faster rates of channel deactivation but a slowing of the rates of inactivation compared to the Kv11.1-1A isoform. The Kv11.1-3.1 isoform also has a significant depolarizing shift in the voltage-dependence of steady-state inactivation. The consequence of the altered gating kinetics is that there is lower current accumulation for Kv11.1-3.1 expressing cells during repetitive action potential firing compared to Kv11.1-1A expressing cells, which in turn will result in longer lasting trains of action potentials. Increased expression of Kv11.1-3.1 channels in the brain of schizophrenia patients might therefore contribute to disorganized neuronal firing.	[Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Heide, Juliane; Mann, Stefan A.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia; [Heide, Juliane; Vandenberg, Jamie I.] Schizophrenia Res Inst, Darlinghurst, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Mann, Stefan/H-3874-2011; Vandenberg, Jamie I/B-6608-2013	Mann, Stefan/0000-0003-4533-2300; Vandenberg, Jamie I/0000-0002-3859-3716; Heide, Juliane/0000-0001-9395-4724	Schizophrenia Research Institute; St. Vincent's Clinic Foundation; National Health and Medical Research Council [1019693]	Schizophrenia Research Institute; St. Vincent's Clinic Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the Schizophrenia Research Institute (http://www.schizophreniaresearch.org.au/), St. Vincent's Clinic Foundation (http://www.clinic.stvincents.com.au/clinic-foundation), and National Health and Medical Research Council (1019693) (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2010, NATURE, V468, P158, DOI 10.1038/468158a; Atalar F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-27; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Hamilton SP, 2008, AM J PSYCHIAT, V165, P420, DOI 10.1176/appi.ajp.2008.08020218; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2011, WORLD J BIOL PSYCHIA, DOI [10.3109/15622975.15622011.15604350, DOI 10.3109/15622975.15622011.15604350)]; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schmitt A, 2008, EUR ARCH PSY CLIN N, V258, P35, DOI 10.1007/s00406-008-5019-x; Schonherr R, 1996, J PHYSIOL-LONDON, V493, P635, DOI 10.1113/jphysiol.1996.sp021410; Shepard PD, 2007, SCHIZOPHRENIA BULL, V33, P1263, DOI 10.1093/schbul/sbm106; Subbiah RN, 2004, J PHYSIOL-LONDON, V558, P417, DOI 10.1113/jphysiol.2004.062588; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tan Hao-Yang, 2009, Cogn Neuropsychiatry, V14, P277, DOI 10.1080/13546800903091665; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Vandenberg JI, 2012, PHYSIOL REV, V92, P1393, DOI 10.1152/physrev.00036.2011; Vandenberg JI, 2004, EUR BIOPHYS J BIOPHY, V33, P89, DOI 10.1007/s00249-003-0338-3; Walker BD, 1999, BRIT J PHARMACOL, V128, P444, DOI 10.1038/sj.bjp.0702774; Wang DY, 2010, CURR DRUG TARGETS, V11, P1; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637	24	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45624	10.1371/journal.pone.0045624	http://dx.doi.org/10.1371/journal.pone.0045624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029143	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700054
J	Lopez-Rosas, I; Orozco, E; Marchat, LA; Garcia-Rivera, G; Guillen, N; Weber, C; Carrillo-Tapia, E; de la Cruz, OH; Perez-Plasencia, C; Lopez-Camarillo, C				Lopez-Rosas, Itzel; Orozco, Esther; Marchat, Laurence A.; Garcia-Rivera, Guillermina; Guillen, Nancy; Weber, Christian; Carrillo-Tapia, Eduardo; Hernandez de la Cruz, Olga; Perez-Plasencia, Carlos; Lopez-Camarillo, Cesar			mRNA Decay Proteins Are Targeted to poly(A)(+) RNA and dsRNA-Containing Cytoplasmic Foci That Resemble P-Bodies in Entamoeba histolytica	PLOS ONE			English	Article							PROCESSING BODIES; GENE-EXPRESSION; STRESS GRANULES; HUMAN-CELLS; SITES; INTERFERENCE; DEADENYLATION; TRYPANOSOMES; DEGRADATION; STABILITY	In higher eukaryotes, mRNA degradation and RNA-based gene silencing occur in cytoplasmic foci referred to as processing bodies (P-bodies). In protozoan parasites, the presence of P-bodies and their putative role in mRNA decay have yet to be comprehensively addressed. Identification of P-bodies might provide information on how mRNA degradation machineries evolved in lower eukaryotes. Here, we used immunofluorescence and confocal microscopy assays to investigate the cellular localization of mRNA degradation proteins in the human intestinal parasite Entamoeba histolytica and found evidence of the existence of P-bodies. Two mRNA decay factors, namely the EhXRN2 exoribonuclease and the EhDCP2 decapping enzyme, were localized in cytoplasmic foci in a pattern resembling P-body organization. Given that amoebic foci appear to be smaller and less rounded than those described in higher eukaryotes, we have named them "P-body-like structures''. These foci contain additional mRNA degradation factors, including the EhCAF1 deadenylase and the EhAGO2-2 protein involved in RNA interference. Biochemical analysis revealed that EhCAF1 co-immunoprecipitated with EhXRN2 but not with EhDCP2 or EhAGO2-2, thus linking deadenylation to 5'-to-3' mRNA decay. The number of EhCAF1-containing foci significantly decreased after inhibition of transcription and translation with actinomycin D and cycloheximide, respectively. Furthermore, results of RNA-FISH assays showed that (i) EhCAF1 colocalized with poly(A)(+) RNA and (ii) during silencing of the Ehpc4 gene by RNA interference, EhAGO2-2 colocalized with small interfering RNAs in cytoplasmic foci. Our observation of decapping, deadenylation and RNA interference proteins within P-body-like foci suggests that these structures have been conserved after originating in the early evolution of eukaryotic lineages. To the best of our knowledge, this is the first study to report on the localization of mRNA decay proteins within P-body-like structures in E. histolytica. Our findings should open up opportunities for deciphering the mechanisms of mRNA degradation and RNA-based gene silencing in this deep-branching eukaryote.	[Lopez-Rosas, Itzel; Orozco, Esther; Carrillo-Tapia, Eduardo; Hernandez de la Cruz, Olga; Lopez-Camarillo, Cesar] Univ Autonoma Ciudad Mexico, Programa Ciencias Genom, Mexico City, DF, Mexico; [Orozco, Esther; Garcia-Rivera, Guillermina] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico; [Marchat, Laurence A.] Inst Politecn Nacl, Escuela Nacl Med & Homeopatia, Programa Inst Biomed Mol & Red Biotecnol, Mexico City, DF, Mexico; [Guillen, Nancy; Weber, Christian] Inst Pasteur, Unite Biol Cellulaire Parasitisme, Paris, France; [Guillen, Nancy; Weber, Christian] INSERM, U786, Paris, France; [Perez-Plasencia, Carlos] Inst Nacl Canc, Unidad Genom & Secuenciac Masiva, Mexico City, DF, Mexico; [Perez-Plasencia, Carlos] Univ Nacl Autonoma Mexico, Unidad Biomed, Fac Estudios Super Iztacala, Mexico City 04510, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Lopez-Camarillo, C (corresponding author), Univ Autonoma Ciudad Mexico, Programa Ciencias Genom, Mexico City, DF, Mexico.	cesar.lopez@uacm.edu.mx	Perez-Plasencia, Carlos/P-2372-2019; López-Rosas, Itzel/GVU-8431-2022; Lopez-Camarillo, Cesar/I-1946-2019; Weber, Christian/AAW-2153-2020; Marchat, Laurence A./S-8418-2018	Perez-Plasencia, Carlos/0000-0002-8593-8211; Lopez-Camarillo, Cesar/0000-0002-9417-2609; Weber, Christian/0000-0003-4610-8714; Marchat, Laurence A./0000-0003-1615-8614; Hernandez, Olga Nohemi/0000-0003-2623-5329; Lopez-Rosas, Itzel/0000-0003-3864-260X	Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD) [M08-S02]; European community; Autonomous University of Mexico City	Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD); European community(European Commission); Autonomous University of Mexico City	This work was supported by Mexico-France (SEP-CONACYT-ANUIES; ECOS NORD) grant M08-S02 and European community grants. The authors acknowledge Autonomous University of Mexico City for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed M, 2005, EXP PARASITOL, V110, P265, DOI 10.1016/j.exppara.2005.02.023; Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Aizer A, 2008, PRION, V2, P131, DOI 10.4161/pri.2.4.7773; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Chen CYA, 2011, WIRES RNA, V2, P167, DOI 10.1002/wrna.40; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Camarillo C, 2003, J BIOL CHEM, V278, P11273, DOI 10.1074/jbc.M211757200; Lopez-Camarillo C, 2008, GENE, V414, P19, DOI 10.1016/j.gene.2008.01.024; Lopez-Casamichana M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-35; Lykke-Andersen S, 2011, RNA BIOL, V8, P61, DOI 10.4161/rna.8.1.14237; Marchat LA, 2002, CELL MICROBIOL, V4, P725, DOI 10.1046/j.1462-5822.2002.00220.x; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Schwede A, 2008, NUCLEIC ACIDS RES, V36, P3374, DOI 10.1093/nar/gkn108; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; She M, 2008, MOL CELL, V29, P337, DOI 10.1016/j.molcel.2008.01.002; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Solis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008424; Stalder L, 2009, RNA, V15, P1265, DOI 10.1261/rna.1672509; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; TAKIFF HE, 1989, J BACTERIOL, V171, P2581, DOI 10.1128/jb.171.5.2581-2590.1989; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2011, FUTURE MICROBIOL, V6, P103, DOI [10.2217/fmb.10.154, 10.2217/FMB.10.154]; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	45	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45966	10.1371/journal.pone.0045966	http://dx.doi.org/10.1371/journal.pone.0045966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029343	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700098
J	Reed, JR; Stone, MD; Beadnell, TC; Ryu, Y; Griffin, TJ; Schwertfeger, KL				Reed, Johanna R.; Stone, Matthew D.; Beadnell, Thomas C.; Ryu, Yungil; Griffin, Timothy J.; Schwertfeger, Kathryn L.			Fibroblast Growth Factor Receptor 1 Activation in Mammary Tumor Cells Promotes Macrophage Recruitment in a CX3CL1-Dependent Manner	PLOS ONE			English	Article							NF-KAPPA-B; BREAST-CANCER; MOLECULAR CHARACTERIZATION; FRACTALKINE RECEPTOR; CHEMOKINE RECEPTORS; MOUSE MODEL; EXPRESSION; PROGRESSION; MIGRATION; INVOLVEMENT	Tumor formation is an extensive process requiring complex interactions that involve both tumor cell-intrinsic pathways and soluble mediators within the microenvironment. Tumor cells exploit the intrinsic functions of many soluble molecules, including chemokines and their receptors, to regulate pro-tumorigenic phenotypes that are required for growth and progression of the primary tumor. Previous studies have shown that activation of inducible FGFR1 (iFGFR1) in mammary epithelial cells resulted in increased proliferation, migration, and invasion in vitro and tumor formation in vivo. These studies also demonstrated that iFGFR1 activation stimulated recruitment of macrophages to the epithelium where macrophages contributed to iFGFR1-mediated epithelial cell proliferation and angiogenesis. The studies presented here further utilize this model to identify the mechanisms that regulate FGFR1-induced macrophage recruitment. Results from this study elucidate a novel role for the inflammatory chemokine CX3CL1 in FGFR1-induced macrophage migration. Specifically, we illustrate that activation of both the inducible FGFR1 construct in mouse mammary epithelial cells and endogenous FGFR in the triple negative breast cancer cell line, HS578T, leads to expression of the chemokine CX3CL1. Furthermore, we demonstrate that FGFR-induced CX3CL1 is sufficient to recruit CX3CR1-expressing macrophages in vitro. Finally, blocking CX3CR1 in vivo leads to decreased iFGFR1-induced macrophage recruitment, which correlates with decreased angiogenesis. While CX3CL1 is a known target of FGF signaling in the wound healing environment, these studies demonstrate that FGFR activation also leads to induction of CX3CL1 in a tumor setting. Furthermore, these results define a novel role for CX3CL1 in promoting macrophage recruitment during mammary tumor formation, suggesting that the CX3CL1/CX3CR1 axis may represent a potential therapeutic approach for targeting breast cancers associated with high levels of tumor-associated macrophages.	[Reed, Johanna R.; Schwertfeger, Kathryn L.] Univ Minnesota, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Ryu, Yungil; Schwertfeger, Kathryn L.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Beadnell, Thomas C.; Ryu, Yungil; Schwertfeger, Kathryn L.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Schwertfeger, KL (corresponding author), Univ Minnesota, Microbiol Immunol & Canc Biol Grad Program, Minneapolis, MN 55455 USA.	schwe251@umn.edu		Griffin, Timothy/0000-0001-6801-2559	Department of Defense (DOD) [BC100038]; National Institutes of Health/National Cancer Institute (NIH/NCI) [R01CA132837]; NATIONAL CANCER INSTITUTE [R01CA132827, T32CA009138] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was provided by a Department of Defense (DOD) pre-doctoral fellowship BC100038 to JRR and National Institutes of Health/National Cancer Institute (NIH/NCI) R01CA132837 to KLS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Andres G, 2009, J CELL MOL MED, V13, P2083, DOI 10.1111/j.1582-4934.2008.00415.x; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bhavsar PK, 2008, FASEB J, V22, P1807, DOI 10.1096/fj.07-094235; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chandrasekar B, 2003, BIOCHEM J, V373, P547, DOI 10.1042/BJ20030207; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Courjal F, 1997, CANCER RES, V57, P4360; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Das R, 2005, IUBMB LIFE, V57, P441, DOI 10.1080/15216540500159424; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dickson C, 2000, BREAST CANCER RES, V2, P191, DOI 10.1186/bcr53; Ferretti E, 2011, LEUKEMIA, V25, P1268, DOI 10.1038/leu.2011.88; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gil-Bernabe A. M., 2012, BLOOD; Graham K, 2011, CLIN CANCER RES, V17, P236, DOI 10.1158/1078-0432.CCR-10-1369; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Koizumi K, 2009, J IMMUNOL, V183, P7825, DOI 10.4049/jimmunol.0803627; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu Y, 2011, CANCER RES, V71, P6492, DOI 10.1158/0008-5472.CAN-11-1145; Lucas AD, 2001, AM J PATHOL, V158, P855, DOI 10.1016/S0002-9440(10)64034-5; Marchesi F, 2010, J NEUROIMMUNOL, V224, P39, DOI 10.1016/j.jneuroim.2010.05.007; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nevo I, 2009, CANCER LETT, V273, P127, DOI 10.1016/j.canlet.2008.07.029; Park MH, 2012, J SURG ONCOL; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Presta M, 2009, EUR CYTOKINE NETW, V20, P39, DOI 10.1684/ecn.2009.0155; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reed JR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2246; Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083; Schwertfeger KL, 2006, CANCER RES, V66, P5676, DOI 10.1158/0008-5472.CAN-05-3781; Sharpe R, 2011, CLIN CANCER RES, V17, P5275, DOI 10.1158/1078-0432.CCR-10-2727; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Tuck AB, 1997, ARCH PATHOL LAB MED, V121, P578; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; White GE, 2009, BLOOD, V113, P767, DOI 10.1182/blood-2008-11-189860; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812; Yuen T, 2002, METHOD ENZYMOL, V345, P556	60	44	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45877	10.1371/journal.pone.0045877	http://dx.doi.org/10.1371/journal.pone.0045877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029290	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700082
J	Saito, S; Murase, K				Saito, Shigeyoshi; Murase, Kenya			Detection and Early Phase Assessment of Radiation-Induced Lung Injury in Mice Using Micro-CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; MOUSE LUNG; PULMONARY-FIBROSIS; THORACIC IRRADIATION; EMPHYSEMA; DAMAGE; MODEL; CHEMOTHERAPY; RADIOTHERAPY; PNEUMONITIS	Radiation therapy is an important therapeutic modality for thoracic malignancies. However, radiation-induced pulmonary injuries such as radiation pneumonitis and fibrosis are major dose-limiting factors. Previous research shows that micro-computed tomography (micro-CT) can detect radiation-induced lung injuries a few months following irradiation, but studies to assess the early response of lung tissue are lacking. The aim of this study was to determine if micro-CT could be used to detect and assess early-phase radiation-induced lung injury in mice. Twenty-one animals were divided into three groups: normal (n = 7), one day after x-ray exposure (n = 7), and at four days after x-ray exposure (n = 7). The x-ray-exposed groups received a single dose of 20 Gy, to the whole lung. Histology showed enlargements of the air space (Lm: mean chord length) following irradiation. 40.5 +/- 3.8 mu m and 60.0 +/- 6.9 mu m were observed after one and four days, respectively, compared to 26.5 +/- 3.1 mu m in normal mice. Three-dimensional micro-CT images were constructed and histograms of radiodensity Hounsfield Units (HU) - were used to assess changes in mouse lungs. Radiation-induced lung injury was observed in irradiated mice, by the use of two parameters which were defined as shifts in peak HU between -200 to -800 HU (Peak(HU)) and increase in the number of pixels at -1000 HU (Number(-1000)). These parameters were correlated with histological changes. The results demonstrate that micro-CT can be used for the early detection and assessment of structural and histopathological changes resulting from radiation-induced lung injury in mice. Micro-CT has the advantage, over traditional histological techniques, of allowing longitudinal studies of lung disease progression and assessment of the entire lung, while reducing the number of animals required for such studies.	[Saito, Shigeyoshi; Murase, Kenya] Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Osaka, Japan	Osaka University	Saito, S (corresponding author), Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Osaka, Japan.	saito@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [24791299]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (No. 24791299) for Scientific Research (Kakenhi) of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; ADAMSON IYR, 1970, AM J PATHOL, V58, P481; Artaechevarria X, 2011, EUR RADIOL, V21, P954, DOI 10.1007/s00330-010-1982-5; Cha JH, 2009, AM J ROENTGENOL, V193, pW95, DOI [10.2214/AJR.08.1833, 10.2214/AJR.08.2298]; Chen YY, 2002, SEMIN RADIAT ONCOL, V12, P26, DOI 10.1053/srao.2002.31360; Choi YW, 2004, RADIOGRAPHICS, V24, P985, DOI 10.1148/rg.244035160; COGGLE JE, 1986, ENVIRON HEALTH PERSP, V70, P261, DOI 10.2307/3430363; Ding XA, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-24; Downing L, 2010, RADIAT RES, V173, P536, DOI 10.1667/RR1712.1; FIELD SB, 1976, BRIT J RADIOL, V49, P700, DOI 10.1259/0007-1285-49-584-700; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Ford NL, 2009, PHYS MED BIOL, V54, P2121, DOI 10.1088/0031-9155/54/7/018; Froese AR, 2007, EUR RESPIR J, V30, P1082, DOI 10.1183/09031936.00000507; Grutters JPC, 2010, RADIOTHER ONCOL, V95, P32, DOI 10.1016/j.radonc.2009.08.003; Hind M, 2004, EUR RESPIR J, V23, P20, DOI 10.1183/09031936.03.00119103; Ibuki Y, 1997, FREE RADICAL BIO MED, V22, P1029, DOI 10.1016/S0891-5849(96)00500-X; Jackson IL, 2011, RADIAT RES, V175, P510, DOI 10.1667/RR2421.1; Jackson IL, 2010, RADIAT RES, V173, P10, DOI 10.1667/RR1911.1; Jorgensen SM, 1998, AM J PHYSIOL-HEART C, V275, pH1103, DOI 10.1152/ajpheart.1998.275.3.H1103; Kameoka S, 2010, DENTOMAXILLOFAC RAD, V39, P441, DOI 10.1259/dmfr/37174063; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; Kimura T, 2006, INT J RADIAT ONCOL, V66, P483, DOI 10.1016/j.ijrobp.2006.05.008; MAISIN JR, 1970, RADIAT RES, V44, P545, DOI 10.2307/3573214; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; MOOSAVI H, 1977, INT J RADIAT ONCOL, V2, P921, DOI 10.1016/0360-3016(77)90190-0; Nakaya Yoshihiro, 2002, Nihon Hoshasen Gijutsu Gakkai Zasshi, V58, P885; NICHOLAS D, 1985, RADIOTHER ONCOL, V4, P253, DOI 10.1016/S0167-8140(85)80090-6; Okada T, 2010, J RADIAT RES, V51, P355, DOI 10.1269/jrr.10016; Parameswaran H, 2006, J APPL PHYSIOL, V100, P186, DOI 10.1152/japplphysiol.00424.2005; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; PHILLIPS TL, 1975, CANCER, V35, P1678, DOI 10.1002/1097-0142(197506)35:6<1678::AID-CNCR2820350629>3.0.CO;2-K; Postnov AA, 2005, J MICROSC-OXFORD, V220, P70, DOI 10.1111/j.1365-2818.2005.01510.x; Rodt T, 2011, ACTA RADIOL, V52, P75, DOI 10.1258/ar.2010.100059; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Shofer S, 2008, J APPL PHYSIOL, V105, P669, DOI 10.1152/japplphysiol.00980.2007; STEEL GG, 1979, BRIT J RADIOL, V52, P741, DOI 10.1259/0007-1285-52-621-741; Toma Claudia Lucia, 2011, Pneumologia, V60, P40; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239	38	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45960	10.1371/journal.pone.0045960	http://dx.doi.org/10.1371/journal.pone.0045960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029340	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700097
J	Wang, XX; Sharp, AR; Miller, RD				Wang, Xinxin; Sharp, Alana R.; Miller, Robert D.			Early Postnatal B Cell Ontogeny and Antibody Repertoire Maturation in the Opossum, Monodelphis domestica	PLOS ONE			English	Article							SHORT-TAILED OPOSSUM; WALLABY MACROPUS-EUGENII; MARSUPIAL LIGHT-CHAINS; BONE-MARROW; FETAL LIVER; POUCH YOUNG; TRICHOSURUS-VULPECULA; JUNCTIONAL DIVERSITY; NEONATAL PIGLETS; LYMPHOID-TISSUES	Marsupials are a lineage of mammals noted for giving birth to highly altricial young, which complete much of their "fetal" development externally attached to a teat. Postnatal B cell ontogeny and diversity was investigated in a model marsupial species, the gray short-tailed opossum, Monodelphis domestica. The results support the initiation of B cell development late in gestation and progressing into the first two weeks of postnatal life. Transcription of CD79a and CD79b was detected in embryonic tissue prior to birth, while immunoglobulin heavy chain locus transcription was not detected until the first postnatal 24 hours. Transcription of the Ig light chains was not detected until postnatal day 7 at the earliest. The predicted timing of the earliest appearance of mature B cells and completion of gene rearrangements is consistent with previous analyses on the timing of endogenous antibody responses in newborn marsupials. The diversity of early B cell IgH chains is limited, as has been seen in fetal humans and mice, but lacks bias in the gene segments used to encode the variable domains. Newborn light chain diversity is, from the start, comparable to that of the adult, consistent with an earlier hypothesis that light chains contribute extensively to antibody diversity in this species.	[Wang, Xinxin; Sharp, Alana R.; Miller, Robert D.] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA	University of New Mexico	Miller, RD (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.	rdmiller@unm.edu	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Miller, Robert/0000-0002-8479-8819	National Institutes of Health from the Institutional Development Award program [P20 GM103452-09]; National Science Foundation [IOS-0641382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452] Funding Source: NIH RePORTER	National Institutes of Health from the Institutional Development Award program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part the National Institutes of Health grant no. P20 GM103452-09 from the Institutional Development Award program and a National Science Foundation award IOS-0641382. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1999, J IMMUNOL, V162, P6009; Aveskogh M, 1998, EUR J IMMUNOL, V28, P2738, DOI 10.1002/(SICI)1521-4141(199809)28:09<2738::AID-IMMU2738>3.0.CO;2-I; Baker ML, 2005, J IMMUNOL, V174, P5665, DOI 10.4049/jimmunol.174.9.5665; Belov K, 2002, DEV COMP IMMUNOL, V26, P599, DOI 10.1016/S0145-305X(02)00015-0; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Butler JE, 2006, VET RES, V37, P417, DOI 10.1051/vetres:2006009; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Butler JE, 2001, J IMMUNOL, V167, P3239, DOI 10.4049/jimmunol.167.6.3239; Butler JE, 2000, J IMMUNOL, V165, P6999, DOI 10.4049/jimmunol.165.12.6999; DEANE EM, 1984, DEV COMP IMMUNOL, V8, P863, DOI 10.1016/0145-305X(84)90069-7; DECKER DJ, 1991, J IMMUNOL, V146, P350; del Blanco B, 2011, GENET RES, V2011, P1; DERRICKSON EM, 1992, FUNCT ECOL, V6, P57, DOI 10.2307/2389771; Duncan L, 2010, VET IMMUNOL IMMUNOP, V136, P235, DOI 10.1016/j.vetimm.2010.03.013; FADEM BH, 1985, BIOL REPROD, V33, P112, DOI 10.1095/biolreprod33.1.112; FEENEY AJ, 1992, J IMMUNOL, V149, P222; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; ISHINO S, 1991, J VET MED SCI, V53, P877, DOI 10.1292/jvms.53.877; KALMUTZ SE, 1962, NATURE, V193, P851, DOI 10.1038/193851a0; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; LAPLANTE ES, 1969, TRANSPLANTATION, V7, P67, DOI 10.1097/00007890-196901000-00006; LAVIA MF, 1963, SCIENCE, V140, P1219, DOI 10.1126/science.140.3572.1219; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Lucero JE, 1998, J IMMUNOL, V161, P6724; LYNE A. G., 1959, NATURE, V183, P622, DOI 10.1038/183622b0; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MILILI M, 1991, MOL IMMUNOL, V28, P753, DOI 10.1016/0161-5890(91)90118-4; Miller RD, 1999, IMMUNOGENETICS, V50, P329, DOI 10.1007/s002510050609; Miller RD, 1998, J IMMUNOL, V160, P259; Old JM, 2003, J ANAT, V203, P123, DOI 10.1046/j.1469-7580.2003.00207.x; Old JM, 2000, DEV COMP IMMUNOL, V24, P445, DOI 10.1016/S0145-305X(00)00008-2; PALACIOS R, 1992, MOL CELL BIOL, V12, P518, DOI 10.1128/MCB.12.2.518; Parra ZE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-111; Parra ZE, 2009, J IMMUNOL, V182, P154, DOI 10.4049/jimmunol.182.1.154; ROWLANDS DT, 1972, J IMMUNOL, V108, P941; Samollow PB, 2006, AUST J ZOOL, V54, P173, DOI 10.1071/ZO05059; Samples K, 1986, AM J REPROD IMMUNOL, V11, P94; Schelonka RL, 2011, IMMUNOGENETICS, V63, P599, DOI 10.1007/s00251-011-0543-7; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; STANLEY NF, 1972, AUST J EXP BIOL MED, V50, P689, DOI 10.1038/icb.1972.62; Tonnelle C, 1995, ANN NY ACAD SCI, V764, P231; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang XX, 2012, IMMUNOGENETICS, V64, P713, DOI 10.1007/s00251-012-0627-z; Wang XX, 2012, IMMUNOGENETICS, V64, P647, DOI 10.1007/s00251-012-0626-0; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; Yadav M, 1971, AUST J EXP BIOL MED, V49, P322; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45931	10.1371/journal.pone.0045931	http://dx.doi.org/10.1371/journal.pone.0045931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029324	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700089
J	Bizzarro, V; Fontanella, B; Carratu, A; Belvedere, R; Marfella, R; Parente, L; Petrella, A				Bizzarro, Valentina; Fontanella, Bianca; Carratu, Anna; Belvedere, Raffaella; Marfella, Raffaele; Parente, Luca; Petrella, Antonello			Annexin A1 N-Terminal Derived Peptide Ac2-26 Stimulates Fibroblast Migration in High Glucose Conditions	PLOS ONE			English	Article							INDUCED APOPTOSIS; RECEPTOR; ACTIN	Deficient wound healing in diabetic patients is very frequent, but the cellular and molecular causes are poorly defined. In this study, we have evaluated whether Annexin A1 derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions. Using normal human skin fibroblasts WS1 in low glucose (LG) or high glucose (HG) we observed the enrichment of Annexin A1 protein at cell movement structures like lamellipodial extrusions and interestingly, a significant decrease in levels of the protein in HG conditions. The analysis of the translocation of Annexin A1 to cell membrane showed lower levels of Annexin A1 in both membrane pool and supernatants of WS1 cells treated with HG. Wound-healing assays using cell line transfected with Annexin A1 siRNAs indicated a slowing down in migration speed of cells suggesting that Annexin A1 has a role in the migration of WS1 cells. In order to analyze the role of extracellular Annexin A1 in cell migration, we have performed wound-healing assays using Ac2-26 showing that peptide was able to increase fibroblast cell migration in HG conditions. Experiments on the mobilization of intracellular calcium and analysis of p-ERK expression confirmed the activity of the FPR1 following stimulation with the peptide Ac2-26. A wound-healing assay on WS1 cells in the presence of the FPR agonist fMLP, of the FPR antagonist CsH and in the presence of Ac2-26 indicated that Annexin A1 influences fibroblast cell migration under HG conditions acting through FPR receptors whose expression was slightly increased in HG. In conclusion, these data demonstrate that (i) Annexin A1 is involved in migration of WS1 cells, through interaction with FPRs; (ii) N-terminal peptide of Annexin A1 Ac2-26 is able to stimulate direct migration of WS1 cells in high glucose treatment possibly due to the increased receptor expression observed in hyperglycemia conditions.	[Bizzarro, Valentina; Carratu, Anna; Belvedere, Raffaella; Parente, Luca; Petrella, Antonello] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Fontanella, Bianca] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Marfella, Raffaele] Univ Naples 2, Dept Geriatr & Metab Dis, Naples, Italy	University of Salerno; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli	Petrella, A (corresponding author), Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy.	apetrella@unisa.it	Petrella, Antonello/E-7708-2012; Belvedere, Raffaella/ABF-7735-2020; Marfella, Raffaele/AAH-2595-2019	Marfella, Raffaele/0000-0003-3960-9270; PETRELLA, Antonello/0000-0002-6945-5295; BIZZARRO, VALENTINA/0000-0002-5222-0705	University of Salerno (FARB); BCC, Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania	University of Salerno (FARB); BCC, Banca di Credito Cooperativo, Fisciano (Salerno); Fondazione con il Sud; Regione Campania(Regione Campania)	The work conducted in the authors' laboratory and referred to in this paper was funded by University of Salerno (FARB 2009, 2010, 2011), from BCC, Banca di Credito Cooperativo, Fisciano (Salerno), from Fondazione con il Sud, and from Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlvarezMartinez MT, 1997, BBA-PROTEIN STRUCT M, V1339, P331, DOI 10.1016/S0167-4838(97)00018-6; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Ernst S, 2004, J IMMUNOL, V172, P7669, DOI 10.4049/jimmunol.172.12.7669; Festa M, 2009, INT J CANCER, V124, P2728, DOI 10.1002/ijc.24260; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Imajo M, 2006, IUBMB LIFE, V58, P312, DOI 10.1080/15216540600746393; Katanaev VL, 2001, BIOCHEMISTRY-MOSCOW+, V66, P351, DOI 10.1023/A:1010293809553; Kusumawati A, 2000, MICROB PATHOGENESIS, V28, P343, DOI 10.1006/mpat.2000.0354; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Marfella R, 2012, J CLIN ENDOCR METAB, V97, P933, DOI 10.1210/jc.2011-2037; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Morello S, 2008, CANCER BIOL THER, V7, P278, DOI 10.4161/cbt.7.2.5301; Perretti M, 2001, AM J PATHOL, V158, P1969, DOI 10.1016/S0002-9440(10)64667-6; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Prossnitz ER, 1997, PHARMACOL THERAPEUT, V74, P73, DOI 10.1016/S0163-7258(96)00203-3; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; VanCompernolle SE, 2003, J IMMUNOL, V171, P2050, DOI 10.4049/jimmunol.171.4.2050; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62	29	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45639	10.1371/journal.pone.0045639	http://dx.doi.org/10.1371/journal.pone.0045639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029153	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800072
J	Ran, C; Carrias, A; Williams, MA; Capps, N; Dan, BCT; Newton, JC; Kloepper, JW; Ooi, EL; Browdy, CL; Terhune, JS; Liles, MR				Ran, Chao; Carrias, Abel; Williams, Malachi A.; Capps, Nancy; Dan, Bui C. T.; Newton, Joseph C.; Kloepper, Joseph W.; Ooi, Ei L.; Browdy, Craig L.; Terhune, Jeffery S.; Liles, Mark R.			Identification of Bacillus Strains for Biological Control of Catfish Pathogens	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; IMMUNE-RESPONSE; RAINBOW-TROUT; DIETARY SUPPLEMENTATION; CHANNEL CATFISH; PROBIOTICS; SUBTILIS; PARAMETERS; RESISTANCE; INFECTION	Bacillus strains isolated from soil or channel catfish intestine were screened for their antagonism against Edwardsiella ictaluri and Aeromonas hydrophila, the causative agents of enteric septicemia of catfish (ESC) and motile aeromonad septicaemia (MAS), respectively. Twenty one strains were selected and their antagonistic activity against other aquatic pathogens was also tested. Each of the top 21 strains expressed antagonistic activity against multiple aquatic bacterial pathogens including Edwardsiella tarda, Streptococcus iniae, Yersinia ruckeri, Flavobacterium columnare, and/or the oomycete Saprolegnia ferax. Survival of the 21 Bacillus strains in the intestine of catfish was determined as Bacillus CFU/g of intestinal tissue of catfish after feeding Bacillus spore-supplemented feed for seven days followed by normal feed for three days. Five Bacillus strains that showed good antimicrobial activity and intestinal survival were incorporated into feed in spore form at a dose of 8 x 10(7) CFU/g and fed to channel catfish for 14 days before they were challenged by E. ictaluri in replicate. Two Bacillus subtilis strains conferred significant benefit in reducing catfish mortality (P<0.05). A similar challenge experiment conducted in Vietnam with four of the five Bacillus strains also showed protective effects against E. ictaluri in striped catfish. Safety of the four strains exhibiting the strongest biological control in vivo was also investigated in terms of whether the strains contain plasmids or express resistance to clinically important antibiotics. The Bacillus strains identified from this study have good potential to mediate disease control as probiotic feed additives for catfish aquaculture.	[Ran, Chao; Carrias, Abel; Williams, Malachi A.; Capps, Nancy; Liles, Mark R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Dan, Bui C. T.; Ooi, Ei L.] Novus Int Inc, Novus Aqua Res Ctr, Ho Chi Minh City, Vietnam; [Newton, Joseph C.] Auburn Univ, Dept Pathobiol, Auburn, AL 36849 USA; [Kloepper, Joseph W.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Browdy, Craig L.] Novus Int Inc, Charleston, SC USA; [Terhune, Jeffery S.] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University	Liles, MR (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	lilesma@auburn.edu			National Science Foundation; Novus International Inc.	National Science Foundation(National Science Foundation (NSF)); Novus International Inc.	A patent has been submitted for the use of these strains in aquaculture (patent pending). The authors Liles, Terhune, Newton, and Kloepper have been awarded a National Science Foundation grant to support this research. Novus International Inc. has also funded this work at Auburn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture U. D. o., 2003, REF FING CATF HLTH 1; Ai QH, 2011, AQUACULTURE, V317, P155, DOI 10.1016/j.aquaculture.2011.04.036; Aly SM, 2008, FISH SHELLFISH IMMUN, V25, P128, DOI 10.1016/j.fsi.2008.03.013; AUSTIN B, 1995, J FISH DIS, V18, P93, DOI 10.1111/j.1365-2761.1995.tb01271.x; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Casula G, 2002, APPL ENVIRON MICROB, V68, P2344, DOI 10.1128/AEM.68.5.2344-2352.2002; De Silva SS, 2010, AMBIO, V39, P504, DOI 10.1007/s13280-010-0072-x; Farmer B.D., 2004, IMPROVED METHODS ISO; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gildberg A, 1998, AQUACULTURE, V167, P103, DOI 10.1016/S0044-8486(98)00296-8; Gournier-Chateau N., 1994, Les probiotiques en alimentation animale et humaine.; Harikrishnan R, 2003, AQUACULTURE, V221, P41, DOI 10.1016/S0044-8486(03)00023-1; Hawke JP, 2004, DEV AQUAC FISH SCI, V34, P387; HAWKE JP, 1979, J FISH RES BOARD CAN, V36, P1508, DOI 10.1139/f79-219; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hyronimus B, 2000, INT J FOOD MICROBIOL, V61, P193, DOI 10.1016/S0168-1605(00)00366-4; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Jack RW, 1996, APPL ENVIRON MICROB, V62, P2897, DOI 10.1128/AEM.62.8.2897-2903.1996; Joborn A, 1997, J FISH DIS, V20, P383, DOI 10.1046/j.1365-2761.1997.00316.x; Kenny D. S., 1981, Biological control in crop production.: Papers presented at the fifth Annual Symposium held at the Beltsville Agricultural Centre, Maryland, 18-21 May 1980. (Beltsville Symposia in Agricultural Research, 5)., P143; Kumar R, 2008, FISH SHELLFISH IMMUN, V24, P168, DOI 10.1016/j.fsi.2007.10.008; National Committee for Clinical Laboratory Standards, 2012, PERF STAND ANT DISK; Nayak SK, 2007, FISH SHELLFISH IMMUN, V23, P892, DOI 10.1016/j.fsi.2007.02.008; Newaj-Fyzul A, 2007, J APPL MICROBIOL, V103, P1699, DOI 10.1111/j.1365-2672.2007.03402.x; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Phan LT, 2009, AQUACULTURE, V296, P227, DOI 10.1016/j.aquaculture.2009.08.017; Phuong NT, 2010, SUCCESS STORIES IN ASIAN AQUACULTURE, P131, DOI 10.1007/978-90-481-3087-0_7; Pridgeon JW, 2011, J APPL MICROBIOL, V111, P114, DOI 10.1111/j.1365-2672.2011.05030.x; Qiao JQ, 2011, PLASMID, V65, P141, DOI 10.1016/j.plasmid.2010.11.008; Queiroz JF, 1998, J WORLD AQUACULT SOC, V29, P67, DOI 10.1111/j.1749-7345.1998.tb00300.x; Robertson PAW, 2000, AQUACULTURE, V185, P235, DOI 10.1016/S0044-8486(99)00349-X; Salinas I, 2005, FISH SHELLFISH IMMUN, V19, P67, DOI 10.1016/j.fsi.2004.11.007; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Sorokulova I, 2008, CLIN INFECT DIS, V46, pS92, DOI 10.1086/523334; USDA, 2003, REF FOODS CATF HLT 2; Wagner BA, 2002, J AQUAT ANIM HEALTH, V14, P263, DOI 10.1577/1548-8667(2002)014&lt;0263:TEOBDI&gt;2.0.CO;2; Wang YB, 2008, AQUACULTURE, V281, P1, DOI 10.1016/j.aquaculture.2008.06.002; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	38	88	97	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45793	10.1371/journal.pone.0045793	http://dx.doi.org/10.1371/journal.pone.0045793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029244	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800097
J	Yao, J; Zhao, Q; Yuan, Y; Zhang, L; Liu, XM; Yung, WKA; Weinstein, JN				Yao, Jun; Zhao, Qi; Yuan, Ying; Zhang, Li; Liu, Xiaoming; Yung, W. K. Alfred; Weinstein, John N.			Identification of Common Prognostic Gene Expression Signatures with Biological Meanings from Microarray Gene Expression Datasets	PLOS ONE			English	Article							BREAST-CANCER; LUNG-CANCER; PREDICTION; SURVIVAL	Numerous prognostic gene expression signatures for breast cancer were generated previously with few overlap and limited insight into the biology of the disease. Here we introduce a novel algorithm named SCoR (Survival analysis using Cox proportional hazard regression and Random resampling) to apply random resampling and clustering methods in identifying gene features correlated with time to event data. This is shown to reduce overfitting noises involved in microarray data analysis and discover functional gene sets linked to patient survival. SCoR independently identified a common poor prognostic signature composed of cell proliferation genes from six out of eight breast cancer datasets. Furthermore, a sequential SCoR analysis on highly proliferative breast cancers repeatedly identified T/B cell markers as favorable prognosis factors. In glioblastoma, SCoR identified a common good prognostic signature of chromosome 10 genes from two gene expression datasets (TCGA and REMBRANDT), recapitulating the fact that loss of one copy of chromosome 10 (which harbors the tumor suppressor PTEN) is linked to poor survival in glioblastoma patients. SCoR also identified prognostic genes on sex chromosomes in lung adenocarcinomas, suggesting patient gender might be used to predict outcome in this disease. These results demonstrate the power of SCoR to identify common and biologically meaningful prognostic gene expression signatures.	[Yao, Jun; Yung, W. K. Alfred] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Yuan, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Zhang, Li; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Liu, Xiaoming] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Houston, TX USA; [Zhao, Qi] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Johns Hopkins University	Yao, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.	jyao1@mdanderson.org	Liu, Xiaoming/C-2743-2008	Liu, Xiaoming/0000-0001-8285-5528; Zhang, Li/0000-0003-0517-7860; Weinstein, John/0000-0001-9401-6908	National Institutes of Health (NIH) SPORE [5P50127001]; NIH [U24 CA143883]; Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE [U24CA143883, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health (NIH) SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben and Catherine Ivy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the National Institutes of Health (NIH) SPORE grant 5P50127001 and NIH grant U24 CA143883, and by Ben and Catherine Ivy Foundation (http://www.ivyfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badve S, 2009, J CLIN PATHOL, V62, P6, DOI 10.1136/jcp.2008.059899; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Eisen Andrea, 1998, Current Opinion in Oncology, V10, P486, DOI 10.1097/00001622-199811000-00002; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Haibe-Kains B, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-394; Koscielny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000313; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Novello S, 2008, FUTURE ONCOL, V4, P705, DOI 10.2217/14796694.4.5.705; Paggi MG, 2010, CANCER LETT, V298, P1, DOI 10.1016/j.canlet.2010.08.009; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Robinson BM, 2011, J THORAC ONCOL, V6, P1691, DOI 10.1097/JTO.0b013e31822647fd; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorner AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013073; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	25	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45894	10.1371/journal.pone.0045894	http://dx.doi.org/10.1371/journal.pone.0045894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029298	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800113
J	Gjerstorff, MF; Rosner, HI; Pedersen, CB; Greve, KBV; Schmidt, S; Wilson, KL; Mollenhauer, J; Besir, H; Poulsen, FM; Mollegaard, NE; Ditzel, HJ				Gjerstorff, Morten F.; Rosner, Heike I.; Pedersen, Christina B.; Greve, Katrine B. V.; Schmidt, Steffen; Wilson, Katherine L.; Mollenhauer, Jan; Besir, Hueseyin; Poulsen, Flemming M.; Mollegaard, Niels Erik; Ditzel, Henrik J.			GAGE Cancer-Germline Antigens Are Recruited to the Nuclear Envelope by Germ Cell-Less (GCL)	PLOS ONE			English	Article							TO-AUTOINTEGRATION FACTOR; EMERIN IN-VITRO; TRANSCRIPTION FACTOR; INTRINSIC DISORDER; BTB/POZ DOMAIN; PROTEIN FAMILY; EXPRESSION; DROSOPHILA; BINDING; GENE	GAGE proteins are highly similar, primate-specific molecules with unique primary structure and undefined cellular roles. They are restricted to cells of the germ line in adult healthy individuals, but are broadly expressed in a wide range of cancers. In a yeast two-hybrid screen we identified the metazoan transcriptional regulator, Germ cell-less (GCL), as an interaction partner of GAGE12I. GCL directly binds LEM-domain proteins (LAP2 beta, emerin, MAN1) at the nuclear envelope, and we found that GAGE proteins were recruited to the nuclear envelope inner membrane by GCL. Based on yeast two-hybrid analysis and pull-down experiments of GCL polypeptides, GCL residues 209-320 (which includes the BACK domain) were deduced sufficient for association with GAGE proteins. GAGE mRNAs and GCL mRNA were demonstrated in human testis and most types of cancers, and at the protein level GAGE members and GCL were co-expressed in cancer cell lines. Structural studies of GAGE proteins revealed no distinct secondary or tertiary structure, suggesting they are intrinsically disordered. Interestingly GAGE proteins formed stable complexes with dsDNA in vitro at physiological concentrations, and GAGE12I bound several different dsDNA fragments, suggesting sequence-nonspecific binding. Dual association of GAGE family members with GCL at the nuclear envelope inner membrane in cells, and with dsDNA in vitro, implicate GAGE proteins in chromatin regulation in germ cells and cancer cells.	[Gjerstorff, Morten F.; Pedersen, Christina B.; Greve, Katrine B. V.; Schmidt, Steffen; Mollenhauer, Jan; Ditzel, Henrik J.] Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark; [Rosner, Heike I.; Poulsen, Flemming M.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wilson, Katherine L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Mollenhauer, Jan] Univ So Denmark, Lundbeckfonden Ctr Excellence NanoCAN, Odense, Denmark; [Besir, Hueseyin] EMBL Heidelberg, Prot Express & Purificat Core Facil, Heidelberg, Germany; [Mollegaard, Niels Erik] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Ditzel, Henrik J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; University of Copenhagen; Johns Hopkins University; Lundbeckfonden; University of Southern Denmark; European Molecular Biology Laboratory (EMBL); University of Copenhagen; University of Southern Denmark; Odense University Hospital	Gjerstorff, MF (corresponding author), Univ So Denmark, Inst Mol Med, Dept Canc & Inflammat Res, Odense, Denmark.	mgjerstorff@health.sdu.dk	Mollenhauer, Jan/G-4452-2012; Wilson, Katherine/HII-8144-2022	gjerstorff, morten/0000-0002-0845-1952; Ditzel, Henrik J./0000-0003-3927-5135; Mollegaard, Niels Erik/0000-0002-8255-3711; Rosner, Heike Ilona/0000-0002-6201-3195; Besir, Huseyin/0000-0002-7249-4762	Danish Research Council; Danish Cancer Society; National Institutes of Health [RO1 GM48646]; Danish Cancer Research Foundation; Lundbeck Foundation; LeoPharma Research Foundation; Horslev Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048646] Funding Source: NIH RePORTER	Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Cancer Society(Danish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); LeoPharma Research Foundation; Horslev Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Danish Research Council, the Danish Cancer Society, the National Institutes of Health (RO1 GM48646), the Danish Cancer Research Foundation, the Lundbeck Foundation, the LeoPharma Research Foundation, and the Horslev Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Artemenko KA, 2011, ANALYST, V136, P1971, DOI 10.1039/c0an00649a; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Burger HG, 1981, TESTIS; Cilensek ZM, 2002, CANCER BIOL THER, V1, P380; de la Luna S, 1999, EMBO J, V18, P212, DOI 10.1093/emboj/18.1.212; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMIDOV V, 1993, NUCLEIC ACIDS RES, V21, P2103, DOI 10.1093/nar/21.9.2103; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; Gjerstorff MF, 2006, BRIT J CANCER, V94, P1864, DOI 10.1038/sj.bjc.6603163; Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262; Gjerstorff MF, 2007, HUM REPROD, V22, P953, DOI 10.1093/humrep/del494; Gjerstorff MF, 2010, PROTEIN EXPRES PURIF, V73, P217, DOI 10.1016/j.pep.2010.05.010; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Holaska JM, 2006, ANAT REC PART A, V288A, P676, DOI 10.1002/ar.a.20334; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; JONGENS TA, 1992, CELL, V70, P569, DOI 10.1016/0092-8674(92)90427-E; JONGENS TA, 1994, GENE DEV, V8, P2123, DOI 10.1101/gad.8.18.2123; Killen MW, 2011, AM J TRANSL RES, V3, P234; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Kimura T, 1999, BIOCHEM BIOPH RES CO, V262, P223, DOI 10.1006/bbrc.1999.1160; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kota SK, 2010, DEV CELL, V19, P675, DOI 10.1016/j.devcel.2010.10.009; Kular RK, 2009, J INTERF CYTOK RES, V29, P645, DOI 10.1089/jir.2008.0099; Leatherman JL, 2002, CURR BIOL, V12, P1681, DOI 10.1016/S0960-9822(02)01182-X; Liu Y, 2007, GENETICA; Magae J, 1996, J CELL SCI, V109, P1717; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Montes de Oca R, 2011, NUCLEUS, V2; Moore J, 2009, MECH DEVELOP, V126, P503, DOI 10.1016/j.mod.2009.04.002; Nili E, 2001, J CELL SCI, V114, P3297; Prokocimer M, 2006, J STRUCT BIOL, V155, P351, DOI 10.1016/j.jsb.2006.02.016; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Robertson SE, 1999, DEV BIOL, V215, P288, DOI 10.1006/dbio.1999.9453; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; WU CL, 1995, MOL CELL BIOL, V15, P2536; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zeng Y, 2011, J BIOL CHEM, V286, P13985, DOI 10.1074/jbc.M110.210765	55	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45819	10.1371/journal.pone.0045819	http://dx.doi.org/10.1371/journal.pone.0045819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029259	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900104
J	Martin, D; Allagnat, F; Gesina, E; Caille, D; Gjinovci, A; Waeber, G; Meda, P; Haefliger, JA				Martin, David; Allagnat, Florent; Gesina, Emilie; Caille, Dorothee; Gjinovci, Asllan; Waeber, Gerard; Meda, Paolo; Haefliger, Jacques-Antoine			Specific Silencing of the REST Target Genes in Insulin-Secreting Cells Uncovers Their Participation in Beta Cell Survival	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURON-RESTRICTIVE SILENCER; CYTOKINE-INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; UP-REGULATION; REPRESSOR; PHOSPHORYLATION; PROTEIN; BCL-2; CDK5	The absence of the transcriptional repressor RE-1 Silencing Transcription Factor (REST) in insulin-secreting beta cells is a major cue for the specific expression of a large number of genes. These REST target genes were largely ascribed to a function of neurotransmission in a neuronal context, whereas their role in pancreatic beta cells has been poorly explored. To identify their functional significance, we have generated transgenic mice expressing REST in beta cells (RIP-REST mice), and previously discovered that REST target genes are essential to insulin exocytosis. Herein we characterized a novel line of RIP-REST mice featuring diabetes. In diabetic RIP-REST mice, high levels of REST were associated with postnatal beta cell apoptosis, which resulted in gradual beta cell loss and sustained hyperglycemia in adults. Moreover, adenoviral REST transduction in INS-1E cells led to increased cell death under control conditions, and sensitized cells to death induced by cytokines. Screening for REST target genes identified several anti-apoptotic genes bearing the binding motif RE-1 that were downregulated upon REST expression in INS-1E cells, including Gjd2, Mapk8ip1, Irs2, Ptprn, and Cdk5r2. Decreased levels of Cdk5r2 in beta cells of RIP-REST mice further confirmed that it is controlled by REST, in vivo. Using siRNA-mediated knockdown in INS-1E cells, we showed that Cdk5r2 protects beta cells against cytokines and palmitate-induced apoptosis. Together, these data document that a set of REST target genes, including Cdk5r2, is important for beta cell survival.	[Martin, David; Allagnat, Florent; Waeber, Gerard; Haefliger, Jacques-Antoine] CHU Vaudois, Serv Internal Med, Lausanne, Switzerland; [Gesina, Emilie] Ecole Polytech Fed Lausanne, Fac Sci Vie, Lausanne, Switzerland; [Caille, Dorothee; Gjinovci, Asllan; Meda, Paolo] Univ Med Ctr, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Haefliger, JA (corresponding author), CHU Vaudois, Serv Internal Med, Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Allagnat, Florent/AAY-7188-2021; Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017	Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [31003A_138528/1, 310000-109402]; Juvenile Diabetes Research Foundation [1-2007-158]; European Union [BETAIMAGE 222980, IMIDIA, C2008-T7]; National Institutes of Health [HL64232]; Novartis; Octav; Marcella Botnar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064232] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Octav; Marcella Botnar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from The Swiss National Science Foundation [31003A_138528/1; 310000-109402], the Juvenile Diabetes Research Foundation [1-2007-158], the European Union [BETAIMAGE 222980; IMIDIA, C2008-T7], the National Institutes of Health HL64232, the Novartis and the Octav and the Marcella Botnar Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Allagnat F, 2011, CELL DEATH DIFFER, V18, P328, DOI 10.1038/cdd.2010.105; Allison J, 2000, INT IMMUNOL, V12, P9, DOI 10.1093/intimm/12.1.9; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Bonny C, 2000, J BIOL CHEM, V275, P16466, DOI 10.1074/jbc.M908297199; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Cheung ZH, 2008, J NEUROSCI, V28, P4872, DOI 10.1523/JNEUROSCI.0689-08.2008; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Daval M, 2011, DIABETES, V60, P1186, DOI 10.2337/db10-1048; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Endo R, 2009, J BIOL CHEM, V284, P26029, DOI 10.1074/jbc.M109.026443; Haefliger JA, 2003, J CELL SCI, V116, P1463, DOI 10.1242/jcs.00356; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Klee P, CX36 PROTECTS UNPUB; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li BS, 2002, EMBO J, V21, P324, DOI 10.1093/emboj/21.3.324; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Martin Daniel, 2008, P51; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Mziaut H, 2008, P NATL ACAD SCI US; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Richardson SJ, 2009, DIABETOLOGIA, V52, P1686, DOI 10.1007/s00125-009-1410-z; Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/en.141.6.2003; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schuit Frans, 2005, Diabetologia, V48, pR93; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Takahashi S, 2010, AM J PATHOL, V176, P320, DOI 10.2353/ajpath.2010.081158; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; TRIMBLE ER, 1985, ENDOCRINOLOGY, V117, P1246, DOI 10.1210/endo-117-3-1246; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wang CX, 2006, CELL DEATH DIFFER, V13, P1203, DOI 10.1038/sj.cdd.4401804; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631	49	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45844	10.1371/journal.pone.0045844	http://dx.doi.org/10.1371/journal.pone.0045844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029270	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388900106
J	Ramadas, RA; Ewart, SL; Iwakura, Y; Medoff, BD; LeVine, AM				Ramadas, Ravisankar A.; Ewart, Susan L.; Iwakura, Yoichiro; Medoff, Benjamin D.; LeVine, Ann Marie			IL-36 alpha Exerts Pro-Inflammatory Effects in the Lungs of Mice	PLOS ONE			English	Article							NF-KAPPA-B; IL-1 RECEPTOR ANTAGONIST; EPITHELIAL-CELLS; MURINE MODEL; PSEUDOMONAS-AERUGINOSA; MECHANICAL VENTILATION; PULMONARY INFLAMMATION; IL-1-BETA SECRETION; PATTERN-RECOGNITION; INFLUENZA-VIRUS	Interleukin (IL-) 36 cytokines (previously designated as novel IL-1 family member cytokines; IL-1F5-IL-1F10) constitute a novel cluster of cytokines structurally and functionally similar to members of the IL-1 cytokine cluster. The effects of IL-36 cytokines in inflammatory lung disorders remains poorly understood. The current study sought to investigate the effects of IL-36 alpha (IL-1F6) and test the hypothesis that IL-36 alpha acts as a pro-inflammatory cytokine in the lung in vivo. Intratracheal instillation of recombinant mouse IL-36 alpha induced neutrophil influx in the lungs of wild-type C57BL/6 mice and IL-1 alpha beta(-/-) mice in vivo. IL-36 alpha induced neutrophil influx was also associated with increased mRNA expression of neutrophil-specific chemokines CXCL1 and CXCL2 in the lungs of C57BL/6 and IL-1 alpha beta(-/-) mice in vivo. In addition, intratracheal instillation of IL-36 alpha enhanced mRNA expression of its receptor IL-36R in the lungs of C57BL/6 as well as IL-1 alpha beta(-/-) mice in vivo. Furthermore, in vitro incubation of CD11c(+) cells with IL-36 alpha resulted in the generation of neutrophil-specific chemokines CXCL1, CXCL2 as well as TNF alpha. IL-36 alpha increased the expression of the co-stimulatory molecule CD40 and enhanced the ability of CD11c(+) cells to induce CD4(+) T cell proliferation in vitro. Furthermore, stimulation with IL-36 alpha activated NF-kappa B in a mouse macrophage cell line. These results demonstrate that IL-36 alpha acts as a pro-inflammatory cytokine in the lung without the contribution of IL-1 alpha and IL-1 beta. The current study describes the pro-inflammatory effects of IL-36 alpha in the lung, demonstrates the functional redundancy of IL-36 alpha with other agonist cytokines in the IL-1 and IL-36 cytokine cluster, and suggests that therapeutic targeting of IL-36 cytokines could be beneficial in inflammatory lung diseases.	[Ramadas, Ravisankar A.; Medoff, Benjamin D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA; [Ramadas, Ravisankar A.; Medoff, Benjamin D.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Ewart, Susan L.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Iwakura, Yoichiro] Univ Tokyo, Ctr Expt Med & Syst Biol, Tokyo, Japan; [LeVine, Ann Marie] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Michigan State University; University of Tokyo; University of Michigan System; University of Michigan	Ramadas, RA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02115 USA.	rramadas@partners.org; anlevine@med.umich.edu	Iwakura, Yoichiro/E-5457-2011	Iwakura, Yoichiro/0000-0002-9934-5775; Medoff, Benjamin/0000-0002-2558-0449	National Institute of Allergy and Infectious Diseases [1R03AI101366]; National Heart, Lung & Blood Institute [5T32HL007874]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI101366] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung & Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research work was supported by Grants from the National Institute of Allergy and Infectious Diseases 1R03AI101366 (R.A.R) and the National Heart, Lung & Blood Institute 5T32HL007874 (B.D.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar R, 2008, CLIN EXP ALLERGY, V38, P1847, DOI 10.1111/j.1365-2222.2008.03119.x; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; BORISH L, 1992, J IMMUNOL, V149, P3078; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Bry K, 2007, AM J RESP CELL MOL, V36, P32, DOI 10.1165/rcmb.2006-0116OC; Calkins CM, 2002, J ENDOTOXIN RES, V8, P59, DOI 10.1179/096805102125000092; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Choi IW, 2004, INT IMMUNOPHARMACOL, V4, P1817, DOI 10.1016/j.intimp.2004.07.030; Chustz RT, 2011, AM J RESP CELL MOL, V45, P145, DOI 10.1165/rcmb.2010-0075OC; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Desmet C, 2004, J IMMUNOL, V173, P5766, DOI 10.4049/jimmunol.173.9.5766; DeVoti JA, 2008, MOL MED, V14, P608, DOI 10.2119/2008-00060.DeVoti; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1977, P NATL ACAD SCI USA, V74, P4624, DOI 10.1073/pnas.74.10.4624; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Heiman AS, 2005, J INTERF CYTOK RES, V25, P82, DOI 10.1089/jir.2005.25.82; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Howland KC, 2000, J IMMUNOL, V164, P4465, DOI 10.4049/jimmunol.164.9.4465; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jedrzkiewicz S, 2000, AM J PHYSIOL-LUNG C, V279, pL1058, DOI 10.1152/ajplung.2000.279.6.L1058; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Johnson VJ, 2005, J ALLERGY CLIN IMMUN, V116, P851, DOI 10.1016/j.jaci.2005.07.008; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Jones MR, 2005, J IMMUNOL, V175, P7530, DOI 10.4049/jimmunol.175.11.7530; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kugathasan K, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-48; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; LEFF JA, 1994, AM J PHYSIOL, V266, pL2, DOI 10.1152/ajplung.1994.266.1.L2; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manzer R, 2006, AM J RESP CELL MOL, V34, P158, DOI 10.1165/rcmb.2005-0205OC; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martin U, 2009, J IMMUNOL, V183, P4021, DOI 10.4049/jimmunol.0803301; McLellan AD, 1996, EUR J IMMUNOL, V26, P1204, DOI 10.1002/eji.1830260603; Nakae S, 2003, INT IMMUNOL, V15, P483, DOI 10.1093/intimm/dxg054; Nicklin MJH, 2002, GENOMICS, V79, P718, DOI 10.1006/geno.2002.6751; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Perrone LA, 2010, J INFECT DIS, V202, P1161, DOI 10.1086/656365; PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Ramadas RA, 2006, IMMUNOGENETICS, V58, P851, DOI 10.1007/s00251-006-0146-x; Ramadas RA, 2011, AM J RESP CELL MOL, V44, P134, DOI 10.1165/rcmb.2009-0315OC; Ranieri VM, 2000, JAMA-J AM MED ASSOC, V284, P43, DOI 10.1001/jama.284.1.43; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schultz MJ, 2002, AM J PHYSIOL-LUNG C, V282, pL285, DOI 10.1152/ajplung.00461.2000; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Tonnel AB, 2001, INT ARCH ALLERGY IMM, V124, P267, DOI 10.1159/000053729; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; ULICH TR, 1991, AM J PATHOL, V138, P521; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Vigne S, 2011, BLOOD; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wang CC, 2006, GENE THER, V13, P1414, DOI 10.1038/sj.gt.3302798; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; ZHANG Y, 1993, J IMMUNOL, V150, P4188; Zwijnenburg PJG, 2003, J IMMUNOL, V170, P4724, DOI 10.4049/jimmunol.170.9.4724	76	68	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45784	10.1371/journal.pone.0045784	http://dx.doi.org/10.1371/journal.pone.0045784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029241	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900100
J	Sato, Y; Morimoto, K; Kubo, T; Yanagihara, K; Seyama, T				Sato, Yuichiro; Morimoto, Kinjiro; Kubo, Takanori; Yanagihara, Kazuyoshi; Seyama, Toshio			High Mannose-Binding Antiviral Lectin PFL from Pseudomonas fluorescens Pf0-1 Promotes Cell Death of Gastric Cancer Cell MKN28 via Interaction with alpha 2-Integrin	PLOS ONE			English	Article							IN-VITRO; INTEGRIN; GLYCOSYLATION; SPECIFICITY; ADHESION; GLYCANS	Novel anti-HIV lectin family which shows a strict binding specificity for high mannose glycans has been found in lower organisms. The bacterial orthologue has been identified in the genome of Pseudomonas fluorescens Pf0-1 and the gene coding a putative lectin was cloned, expressed in Escherichia coli and purified by one step gel filtration. Glycan array screening of the recombinant lectin, termed PFL, has revealed that PFL preferentially recognizes high mannose glycans with alpha 1-3 Man that was highly exposed at the D2 position. In contrast, masking of this alpha 1-3 Man with alpha 1-2 Man dramatically impaired lectin-carbohydrate interactions. Reducing terminal disaccharide, GlcNAc-GlcNAc of high mannose glycans was also essential for PFL-binding. PFL showed a potent anti-influenza virus activity by inhibiting the virus entry into cells at doses of low nanomolar concentration. At micromolar concentration or higher, PFL showed a cytotoxicity accompanying loss of the cell adhesion against human gastric cancer MKN28 cells. The cell surface molecule to which PFL bound was coprecipitated with biotin-labeled PFL and identified as integrin alpha 2 by peptide mass fingerprinting using MALDI-TOF mass spectrometry. Intriguingly, upon treatment with exogenous PFL, integrin alpha 2 on the cell surface underwent rapid internalization to the cytoplasm and accumulated to perinuclear region, together with the bound PFL. The resulting loss of cell adherence would trigger a signaling pathway that induced anoikis-like cell death. These events were effectively inhibited by pretreatment of PFL with mannnan, indicating the involvement of high mannose glycans on PFL-induced cell death that was triggered by PFL-integrin alpha 2 interactions.	[Sato, Yuichiro; Morimoto, Kinjiro] Yasuda Womens Univ, Fac Pharm, Dept Med Pharm, Hiroshima, Japan; [Kubo, Takanori; Yanagihara, Kazuyoshi; Seyama, Toshio] Yasuda Womens Univ, Fac Pharm, Dept Life Sci, Hiroshima, Japan		Sato, Y (corresponding author), Yasuda Womens Univ, Fac Pharm, Dept Med Pharm, Hiroshima, Japan.	sato-y@yasuda-u.ac.jp		Kubo, Takanori/0000-0002-7609-7094	Japan Society for the Promotion of Science (JSPS) [24790101]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported in part by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (Grant number 24790101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Botos I, 2005, PROG BIOPHYS MOL BIO, V88, P233, DOI 10.1016/j.pbiomolbio.2004.05.001; Chang CP, 2007, HEPATOLOGY, V45, P286, DOI 10.1002/hep.21509; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Fukuda Y, 2006, ANTI-CANCER DRUG, V17, P943, DOI 10.1097/01.cad.0000224458.13651.b4; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Hori K, 2007, GLYCOBIOLOGY, V17, P479, DOI 10.1093/glycob/cwm007; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Liao WR, 2003, J IND MICROBIOL BIOT, V30, P433, DOI 10.1007/s10295-003-0068-7; Litynska A, 2002, ACTA BIOCHIM POL, V49, P491; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; MirShekari SY, 1997, J BIOL CHEM, V272, P4027, DOI 10.1074/jbc.272.7.4027; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; Petrossian K, 2007, ACTA HISTOCHEM, V109, P491, DOI 10.1016/j.acthis.2007.05.004; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Rintanen N, 2012, MOL BIOL CELL, V23, P448, DOI 10.1091/mbc.E11-06-0548; Sanchez-Ruderisch H, 2011, CELL DEATH DIFFER, V18, P806, DOI 10.1038/cdd.2010.148; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Sato Y, 2011, J BIOL CHEM, V286, P19446, DOI 10.1074/jbc.M110.216655; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315	28	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45922	10.1371/journal.pone.0045922	http://dx.doi.org/10.1371/journal.pone.0045922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029318	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900111
J	Vaughan, VC; Sullivan-Gunn, M; Hinch, E; Martin, P; Lewandowski, PA				Vaughan, Vanessa C.; Sullivan-Gunn, Melanie; Hinch, Edward; Martin, Peter; Lewandowski, Paul A.			Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia	PLOS ONE			English	Article							XANTHINE-OXIDASE INHIBITORS; PROTEOLYSIS-INDUCING FACTOR; N-3 FATTY-ACIDS; PROTEIN-DEGRADATION; OXIDATIVE STRESS; EXPRESSION; ALLOPURINOL; CATABOLISM; INDEXES; PATHWAY	Cancer cachexia is a wasting condition, driven by systemic inflammation and oxidative stress. This study investigated eicosapentaenoic acid (EPA) in combination with oxypurinol as a treatment in a mouse model of cancer cachexia. Mice with cancer cachexia were randomized into 4 treatment groups (EPA (0.4 g/kg/day), oxypurinol (1 mmol/L ad-lib), combination, or control), and euthanized after 29 days. Analysis of oxidative damage to DNA, mRNA analysis of pro-oxidant, antioxidant and proteolytic pathway components, along with enzyme activity of pro- and antioxidants were completed on gastrocnemius muscle. The control group displayed earlier onset of tumor compared to EPA and oxypurinol groups (P<0.001). The EPA group maintained body weight for an extended duration (20 days) compared to the oxypurinol (5 days) and combination (8 days) groups (P<0.05). EPA (18.2 +/- 3.2 pg/ml) and combination (18.4 +/- 3.7 pg/ml) groups had significantly higher 8-OH-dG levels than the control group (12.9 +/- 1.4 pg/ml, P <= 0.05) indicating increased oxidative damage to DNA. mRNA levels of GPx1, MURF1 and MAFbx were higher following EPA treatment compared to control (P <= 0.05). Whereas oxypurinol was associated with higher GPx1, MnSOD, CAT, XDH, MURF1, MAFbx and UbB mRNA compared to control (P <= 0.05). Activity of total SOD was higher in the oxypurinol group (32.2 +/- 1.5 U/ml) compared to control (27.0 +/- 1.3 U/ml, P<0.01), GPx activity was lower in the EPA group (8.76 +/- 2.0 U/ml) compared to control (14.0 +/- 1.9 U/ml, P<0.05), and catalase activity was lower in the combination group (14.4 +/- 2.8 U/ml) compared to control (20.9 +/- 2.0 U/ml, P<0.01). There was no change in XO activity. The increased rate of weight decline in mice treated with oxypurinol indicates that XO may play a protective role during the progression of cancer cachexia, and its inhibition is detrimental to outcomes. In combination with EPA, there was little significant improvement from control, indicating oxypurinol is unlikely to be a viable treatment compound in cancer cachexia.	[Vaughan, Vanessa C.; Hinch, Edward; Martin, Peter; Lewandowski, Paul A.] Deakin Univ, Sch Med, Waurn Ponds, Australia; [Sullivan-Gunn, Melanie] Victoria Univ, Sch Biomed & Hlth Sci, Melbourne, Vic 8001, Australia	Deakin University; Victoria University	Lewandowski, PA (corresponding author), Deakin Univ, Sch Med, Waurn Ponds, Australia.	paul.lewandowski@deakin.edu.au	Sullivan-Gunn, Melanie/U-4785-2019; Vaughan, Vanessa/AAB-6176-2019; Martin, Peter/R-6302-2017	Vaughan, Vanessa/0000-0003-3879-2448; Martin, Peter/0000-0002-1214-5149; SULLIVAN-GUNN, MELANIE/0000-0003-4099-5439	Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency; State Government of Victoria, Australia; Bellberry Support Scholarship through Bellberry Ltd.	Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency; State Government of Victoria, Australia; Bellberry Support Scholarship through Bellberry Ltd.	VV is the recipient of the Victorian Cancer Agency Palliative and Supportive Care Scholarship through the Victorian Cancer Agency funded by the State Government of Victoria, Australia, and the Bellberry Support Scholarship through Bellberry Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles J M, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS39, DOI 10.1016/j.ejon.2005.09.006; Barber MD, 2001, NUTRITION, V17, P751, DOI 10.1016/S0899-9007(01)00631-1; Barreiro E, 2005, FEBS LETT, V579, P1646, DOI 10.1016/j.febslet.2005.02.017; BECK SA, 1991, CANCER RES, V51, P6089; Biondo PD, 2008, J NUTR BIOCHEM, V19, P787, DOI 10.1016/j.jnutbio.2008.02.003; Bossola M, 2003, ANN SURG, V237, P384, DOI 10.1097/00000658-200303000-00013; Day RO, 2007, CLIN PHARMACOKINET, V46, P623, DOI 10.2165/00003088-200746080-00001; de Palma L, 2008, JOINT BONE SPINE, V75, P53, DOI 10.1016/j.jbspin.2007.04.019; DEBY C, 1981, BIOCHEM PHARMACOL, V30, P2243, DOI 10.1016/0006-2952(81)90094-0; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Fearon KCH, 2006, J CLIN ONCOL, V24, P3401, DOI 10.1200/JCO.2005.04.5724; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardman WE, 2004, J NUTR, V134, p3427S, DOI 10.1093/jn/134.12.3427S; Hashimoto M, 1999, LIPIDS, V34, P1297, DOI 10.1007/s11745-999-0481-6; Kaynar H, 2005, CANCER LETT, V227, P133, DOI 10.1016/j.canlet.2004.12.005; Khal J, 2005, BRIT J CANCER, V93, P774, DOI 10.1038/sj.bjc.6602780; Li M, 2011, ENVIRON TOXICOL, V26, P217, DOI 10.1002/tox.20546; Mantovani G, 2003, J MOL MED-JMM, V81, P664, DOI 10.1007/s00109-003-0476-1; Meneshian A, 2002, MICROCIRCULATION, V9, P161, DOI 10.1038/sj.mn.7800136; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Penna F, 2011, J CACHEXIA SARCOPENI, V2, P95, DOI 10.1007/s13539-011-0028-4; Russell ST, 2007, CELL SIGNAL, V19, P1797, DOI 10.1016/j.cellsig.2007.04.003; Russell ST, 2005, PROSTAG LEUKOTR ESS, V72, P409, DOI 10.1016/j.plefa.2005.03.002; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Skipworth RJE, 2007, CLIN NUTR, V26, P667, DOI 10.1016/j.clnu.2007.03.011; Springer J, 2009, J CARD FAIL, V15, pS22, DOI 10.1016/j.cardfail.2009.06.381; Stehr SN, 2006, CLIN CHIM ACTA, V373, P1, DOI 10.1016/j.cca.2006.04.024; Sullivan-Gunn M, 2011, BRIT J CANCER, V104, P1055, DOI 10.1038/bjc.2011.35; Sullivan-Gunn MJ, 2011, J CACHEXIA SARCOPENI, V2, P181, DOI 10.1007/s13539-011-0037-3; TATE GA, 1988, ARTHRITIS RHEUM, V31, P1543, DOI 10.1002/art.1780311211; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; Tijerina Amanda J, 2004, Dimens Crit Care Nurs, V23, P237, DOI 10.1097/00003465-200411000-00001; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van Norren K, 2009, BRIT J CANCER, V100, P713, DOI 10.1038/sj.bjc.6604905; Whitehouse AS, 2001, CANCER RES, V61, P3604; Wyke SM, 2005, BRIT J CANCER, V92, P711, DOI 10.1038/sj.bjc.6602402	36	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45900	10.1371/journal.pone.0045900	http://dx.doi.org/10.1371/journal.pone.0045900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029301	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388900109
J	Yang, YW; Wang, Z; Ren, LL; Wang, W; Vernet, G; Paranhos-Baccala, G; Jin, Q; Wang, JW				Yang, Yaowu; Wang, Zhong; Ren, Lili; Wang, Wei; Vernet, Guy; Paranhos-Baccala, Glaucia; Jin, Qi; Wang, Jianwei			Influenza A/H1N1 2009 Pandemic and Respiratory Virus Infections, Beijing, 2009-2010	PLOS ONE			English	Article							A H1N1 VIRUS; CLINICAL CHARACTERISTICS; TRACT INFECTION; ADULTS; EPIDEMIOLOGY; RHINOVIRUSES; CIRCULATION; PREVALENCE; CHINA	To determine the role of the pandemic influenza A/H1N1 2009 (A/H1N1 2009pdm) in acute respiratory tract infections (ARTIs) and its impact on the epidemic of seasonal influenza viruses and other common respiratory viruses, nasal and throat swabs taken from 7,776 patients with suspected viral ARTIs from 2006 through 2010 in Beijing, China were screened by real-time PCR for influenza virus typing and subtyping and by multiplex or single PCR tests for other common respiratory viruses. We observed a distinctive dual peak pattern of influenza epidemic during the A/H1N1 2009pdm in Beijing, China, which was formed by the A/H1N1 2009pdm, and a subsequent influenza B epidemic in year 2009/2010. Our analysis also shows a small peak formed by a seasonal H3N2 epidemic prior to the A/H1N1 2009pdm peak. Parallel detection of multiple respiratory viruses shows that the epidemic of common respiratory viruses, except human rhinovirus, was delayed during the pandemic of the A/H1N1 2009pdm. The H1N1 2009pdm mainly caused upper respiratory tract infections in the sampled patients; patients infected with H1N1 2009pdm had a higher percentage of cough than those infected with seasonal influenza or other respiratory viruses. Our findings indicate that A/H1N1 2009pdm and other respiratory viruses except human rhinovirus could interfere with each other during their transmission between human beings. Understanding the mechanisms and effects of such interference is needed for effective control of future influenza epidemics.	[Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, CAMS Fondat Merieux, Beijing 100730, Peoples R China; [Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Chinese Acad Med Sci, Inst Pathogen Biol, Christophe Merieux Lab, CAMS Fondat Merieux, Beijing 100730, Peoples R China; [Yang, Yaowu; Ren, Lili; Wang, Wei; Jin, Qi; Wang, Jianwei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Vernet, Guy; Paranhos-Baccala, Glaucia] Fondat Merieux, Lyon, France; [Wang, Zhong] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Yang, Yaowu] China Natl Accreditat Serv Conform Assessment CNA, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, CAMS Fondat Merieux, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; wangjw28@163.com	Wang, Jianwei/AAW-9499-2020; Wang, Jianwei/W-5916-2019	Wang, Jianwei/0000-0002-1116-4559; 	National Basic Research Program (973 Program) of China [2010CB534003]; National Key Technologies RD Program; National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China [2009ZX10004-206]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program); National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China	This work was supported by the National Basic Research Program (973 Program) of China (2010CB534003), the National Key Technologies R&D Program, the National Major S & T Project for the Control and Prevention of Major Infectious Diseases in China (2009ZX10004-206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; Casalegno JS, 2010, EURO SURVEILL, V15; Centers for Disease Control and Prevention, 2009, FLU ACT SURV 2008 20; Centers for Disease Control and Prevention, 2010, FLU ACT SURV 2009 20; Centers for Disease Control and Prevention, 2009, 2007 08 US INFLUENZA; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Dai XQ, 2012, BIOMED ENVIRON SCI, V25, P61, DOI 10.3967/0895-3988.2012.01.009; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; del Rio C, 2010, T AM CLIN CLIMAT ASS, V121, P138; del Rio Carlos, 2010, Trans Am Clin Climatol Assoc, V121, P128; Deng LH, 2012, J ZHEJIANG UNIV-SC B, V13, P49, DOI 10.1631/jzus.B1100168; European Centre for Disease Prevention and Control, 2010, WEEKL INFL SURV OV A; European Centre for Disease Prevention and Control, 2010, INFL SURV EUR 2008 0; European Centre for Disease Prevention and Control, 2009, WEEKL INFL SURV OV M; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Guo L, 2012, EUR J CLIN MICROBIOL, V31, P1051, DOI 10.1007/s10096-011-1406-8; Hsieh YH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-332; Jacobson J, 2010, AM J NURS, V110, P22, DOI 10.1097/01.NAJ.0000389664.17370.d9; Li JG, 2012, J INFECTION, V64, P96, DOI 10.1016/j.jinf.2011.10.011; Mak GC, 2012, INFLUENZA OTHER RESP, V6, pe6, DOI 10.1111/j.1750-2659.2011.00323.x; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Patel M, 2010, BRIT J ANAESTH, V104, P128, DOI 10.1093/bja/aep375; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Raoult D, 2011, SCIENCE, V331, P144, DOI 10.1126/science.331.6014.144-c; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Ren LL, 2011, J MED VIROL, V83, P291, DOI 10.1002/jmv.21956; Santa-Olalla Peralta P, 2010, EUROSURVEILLANCE, V15; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Wang X, 2011, EPIDEMIOL INFECT, V139, P1551, DOI 10.1017/S0950268810002694; WHO, 2010, GLOB AL RESP GAR PAN; World Health Organization, 2011, SUMM REV 2010 2011 N; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xiang ZC, 2010, J INFECTION, V61, P289, DOI 10.1016/j.jinf.2010.07.001; Yang YW, 2010, J VIROL METHODS, V167, P37, DOI 10.1016/j.jviromet.2010.03.007; Yang ZF, 2012, JPN J INFECT DIS, V65, P208, DOI 10.7883/yoken.65.208	40	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45807	10.1371/journal.pone.0045807	http://dx.doi.org/10.1371/journal.pone.0045807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029253	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900102
J	Walsh, CJ; Fletcher, TD; Burns, MJ				Walsh, Christopher J.; Fletcher, Tim D.; Burns, Matthew J.			Urban Stormwater Runoff: A New Class of Environmental Flow Problem	PLOS ONE			English	Article							HYDROLOGIC ALTERATION; STREAM ECOLOGY; LAND-COVER; WATER; CATCHMENT; MANAGEMENT; URBANIZATION; MECHANISM; BEHAVIOR; LESSONS	Environmental flow assessment frameworks have begun to consider changes to flow regimes resulting from land-use change. Urban stormwater runoff, which degrades streams through altered volume, pattern and quality of flow, presents a problem that challenges dominant approaches to stormwater and water resource management, and to environmental flow assessment. We used evidence of ecological response to different stormwater drainage systems to develop methods for input to environmental flow assessment. We identified the nature of hydrologic change resulting from conventional urban stormwater runoff, and the mechanisms by which such hydrologic change is prevented in streams where ecological condition has been protected. We also quantified the increase in total volume resulting from urban stormwater runoff, by comparing annual streamflow volumes from undeveloped catchments with the volumes that would run off impervious surfaces under the same rainfall regimes. In catchments with as little as 5-10% total imperviousness, conventional stormwater drainage, associated with poor in-stream ecological condition, reduces contributions to baseflows and increases the frequency and magnitude of storm flows, but in similarly impervious catchments in which streams retain good ecological condition, informal drainage to forested hillslopes, without a direct piped discharge to the stream, results in little such hydrologic change. In urbanized catchments, dispersed urban stormwater retention measures can potentially protect urban stream ecosystems by mimicking the hydrologic effects of informal drainage, if sufficient water is harvested and kept out of the stream, and if discharged water is treated to a suitable quality. Urban stormwater is a new class of environmental flow problem: one that requires reduction of a large excess volume of water to maintain riverine ecological integrity. It is the best type of problem, because solving it provides an opportunity to solve other problems such as the provision of water for human use.	[Walsh, Christopher J.; Fletcher, Tim D.] Univ Melbourne, Dept Resource Management & Geog, Parkville, Vic 3052, Australia; [Fletcher, Tim D.; Burns, Matthew J.] Monash Univ, Dept Civil Engn, Clayton, Vic 3800, Australia; [Fletcher, Tim D.; Burns, Matthew J.] Monash Univ, Monash Water Liveabil, Clayton, Vic 3800, Australia	University of Melbourne; Monash University; Monash University	Walsh, CJ (corresponding author), Univ Melbourne, Dept Resource Management & Geog, Parkville, Vic 3052, Australia.	cwalsh@unimelb.edu.au	Walsh, Christopher/B-2552-2009; Fletcher, Tim/AAB-8356-2019	Walsh, Christopher/0000-0002-4181-6722; Fletcher, Tim/0000-0001-8819-5567	Melbourne Water; Australian Research Council's; Linkage Projects scheme [LP0883610]; Council's Future Fellowship scheme	Melbourne Water; Australian Research Council's(Australian Research Council); Linkage Projects scheme; Council's Future Fellowship scheme	This work was supported by Melbourne Water (www.melbournewater.com.au) and the Australian Research Council's (www.arc.gov.au) Linkage Projects scheme (project number LP0883610) and TDF is supported by the Council's Future Fellowship scheme. The views expressed herein are those of the authors and not necessarily those of the funding bodies. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Other than the acknowledged hydrographic data used in the paper that were collected by Melbourne Water, the funders had no role in data collection.	[Anonymous], 2007, STORMWATER RECYCLING; [Anonymous], 2006, SUST WAT STRAT CENTR; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Australian Bureau of Statistics, 2010, POP GROWTH PRES FUT; BOYD MJ, 1993, HYDROLOG SCI J, V38, P463, DOI 10.1080/02626669309492699; Bratieres K, 2008, 11 INT C URB DRAIN I; Brown LR, 2009, J N AM BENTHOL SOC, V28, P1051, DOI 10.1899/08-153.1; Burns MJ, 2012, LANDSCAPE URBAN PLAN, V105, P230, DOI 10.1016/j.landurbplan.2011.12.012; Burns MJ, 2012, 7 INT C WAT SENS URB; Carlson TN, 2000, GLOBAL PLANET CHANGE, V25, P49, DOI 10.1016/S0921-8181(00)00021-7; CHESSMAN BC, 1995, AUST J ECOL, V20, P122, DOI 10.1111/j.1442-9993.1995.tb00526.x; Coutts AM, 2007, J APPL METEOROL CLIM, V46, P477, DOI 10.1175/JAM2462.1; Fletcher TD, 2008, J ENVIRON QUAL, V37, pS116, DOI 10.2134/jeq2007.0411; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; Hamel P, 2011, 12 INT C URB DRAIN I; Harremoes P, 1997, WATER SCI TECHNOL, V35, P11, DOI 10.1016/S0273-1223(97)00180-7; Hatt BE, 2006, J ENVIRON MANAGE, V79, P102, DOI 10.1016/j.jenvman.2005.06.003; Hatt BE, 2004, ENVIRON MANAGE, V34, P112, DOI 10.1007/s00267-004-0221-8; Holman-Dodds JK, 2003, J AM WATER RESOUR AS, V39, P205, DOI 10.1111/j.1752-1688.2003.tb01572.x; Jolly ID, 1997, WATER SALT BALANCES; Kennedy C, 2007, J IND ECOL, V11, P43, DOI 10.1162/jie.2007.1107; Kennen JG, 2008, ECOL MODEL, V211, P57, DOI 10.1016/j.ecolmodel.2007.08.014; King RS, 2011, ECOL APPL, V21, P1659, DOI 10.1890/10-1357.1; Kirchner JW, 2003, HYDROL PROCESS, V17, P871, DOI 10.1002/hyp.5108; Knights D., 2009, STORMW IND ASS NSW V; Konrad CP, 2005, AM FISH S S, V47, P157; Lenoir A., 1996, USE ALGAE MONITORING, P29; Leopold L.B., 1968, HYDROLOGY URBAN LAND, V554; Li H, 2009, J HYDROL ENG, V14, P407, DOI 10.1061/(ASCE)1084-0699(2009)14:4(407); Melbourne Water, 2006, WAT SUPPL DEM STRAT; Mikkelsen PS, 1996, J HYDRAUL RES, V34, P827, DOI 10.1080/00221686.1996.10525034; Mitchell VG, 2008, ENVIRON MODELL SOFTW, V23, P782, DOI 10.1016/j.envsoft.2007.09.006; Mitchell VG, 2006, ENVIRON MANAGE, V37, P589, DOI 10.1007/s00267-004-0252-1; Mitchell VG, 2003, ENVIRON MANAGE, V32, P735, DOI 10.1007/s00267-003-2062-2; Newton D, 2009, 32 HYDR WAT RES S NE, P102; Pagotto C, 2000, WATER RES, V34, P4446, DOI 10.1016/S0043-1354(00)00221-9; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Price K, 2011, PROG PHYS GEOG, V35, P465, DOI 10.1177/0309133311402714; Ragab R, 2003, HYDROL PROCESS, V17, P2409, DOI 10.1002/hyp.1250; Roy AH, 2005, J N AM BENTHOL SOC, V24, P656, DOI 10.1899/0887-3593(2005)024\\[0656:IHAAAM\\]2.0.CO;2; Roy AH, 2008, ENVIRON MANAGE, V42, P344, DOI 10.1007/s00267-008-9119-1; Shuster WD, 2005, URBAN WATER J, V2, P263; TANAKA T, 1988, J HYDROL, V102, P139, DOI 10.1016/0022-1694(88)90095-9; Taylor SL, 2004, FRESHWATER BIOL, V49, P835, DOI 10.1111/j.1365-2427.2004.01225.x; Tourbier J, 2007, ADV URBAN FLOOD MANA, P13; Walsh CJ, 2009, J N AM BENTHOL SOC, V28, P977, DOI 10.1899/08-161.1; Walsh CJ, 2009, J HYDROL ENG, V14, P399, DOI 10.1061/(ASCE)1084-0699(2009)14:4(399); Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI [10.1899/04-020.1, 10.1899/04-028.1]; Wang LZ, 2003, T AM FISH SOC, V132, P825, DOI 10.1577/T02-099; Wenger SJ, 2009, J N AM BENTHOL SOC, V28, P1080, DOI 10.1899/08-186.1; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang L., 1999, 9912 COOP RES CTR CA	53	217	226	5	231	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45814	10.1371/journal.pone.0045814	http://dx.doi.org/10.1371/journal.pone.0045814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029257	gold, Green Published			2022-12-25	WOS:000309388400133
J	Li, BQ; Cai, YD; Feng, KY; Zhao, GJ				Li, Bi-Qing; Cai, Yu-Dong; Feng, Kai-Yan; Zhao, Gui-Jun			Prediction of Protein Cleavage Site with Feature Selection by Random Forest	PLOS ONE			English	Article							PROPROTEIN CONVERTASE CLEAVAGE; PROTEASOME; GENERATION; RECEPTOR; MOTIFS; TOOL	Proteinases play critical roles in both intra and extracellular processes by binding and cleaving their protein substrates. The cleavage can either be non-specific as part of degradation during protein catabolism or highly specific as part of proteolytic cascades and signal transduction events. Identification of these targets is extremely challenging. Current computational approaches for predicting cleavage sites are very limited since they mainly represent the amino acid sequences as patterns or frequency matrices. In this work, we developed a novel predictor based on Random Forest algorithm (RF) using maximum relevance minimum redundancy (mRMR) method followed by incremental feature selection (IFS). The features of physicochemical/biochemical properties, sequence conservation, residual disorder, amino acid occurrence frequency, secondary structure and solvent accessibility were utilized to represent the peptides concerned. Here, we compared existing prediction tools which are available for predicting possible cleavage sites in candidate substrates with ours. It is shown that our method makes much more reliable predictions in terms of the overall prediction accuracy. In addition, this predictor allows the use of a wide range of proteinases.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Bi-Qing] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Feng, Kai-Yan] Beijing Genom Inst, Shenzhen, Peoples R China; [Zhao, Gui-Jun] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai Inst Med Genet, Sch Med, Shanghai 200030, Peoples R China; [Zhao, Gui-Jun] Shanghai Lab Embryo & Reprod Engn, Shanghai, Peoples R China; [Zhao, Gui-Jun] Minist Hlth, Key Lab Embryo Mol Biol, Shanghai, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Beijing Genomics Institute (BGI); Shanghai Jiao Tong University	Cai, YD (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work was supported by the National Basic Research Program of China (2011CB510102, 2011CB510101) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fairlie DP, 2000, J MED CHEM, V43, P1271, DOI 10.1021/jm990315t; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; Holzhutter HG, 1999, J MOL BIOL, V286, P1251, DOI 10.1006/jmbi.1998.2530; Holzhutter HG, 2000, BIOPHYS J, V79, P1196, DOI 10.1016/S0006-3495(00)76374-0; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kohavi R., 1995, INT JOINT C ART INT, V14, P1137, DOI DOI 10.1067/MOD.2000.109031; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Raghunath M, 1999, J CELL SCI, V112, P1093; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Van Damme P, 2008, BIOL CHEM, V389, P371, DOI 10.1515/BC.2008.043; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; WITTEN IH, 2005, DATA MINING PRACTICA; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; You Liwen, 2006, Comput Syst Bioinformatics Conf, P249; Zhang N, 2012, MOL BIOSYSTEMS; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou XW, 2004, MOL CELL PROTEOMICS, V3, P565, DOI 10.1074/mcp.M300123-MCP200	43	34	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45854	10.1371/journal.pone.0045854	http://dx.doi.org/10.1371/journal.pone.0045854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029276	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900171
J	Boiko, N; Kucher, V; Stockand, JD; Eaton, BA				Boiko, Nina; Kucher, Volodymyr; Stockand, James D.; Eaton, Benjamin A.			Pickpocket1 Is an Ionotropic Molecular Sensory Transducer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; CAENORHABDITIS-ELEGANS; MECHANOSENSORY TRANSDUCTION; DROSOPHILA-MELANOGASTER; TRP CHANNELS; C-ELEGANS; DEG/ENAC; NEURONS; SUBUNIT; MEC-4	The molecular transformation of an external stimulus into changes in sensory neuron activity is incompletely described. Although a number of molecules have been identified that can respond to stimuli, evidence that these molecules can transduce stimulation into useful neural activity is lacking. Here we demonstrate that pickpocket1 (ppk1), a Drosophila homolog of mammalian Degenerin/epithelial sodium channels, encodes an acid-sensing sodium channel that conducts a transient depolarizing current in multidendritic sensory neurons of Drosophila melanogaster. Stimulation of Ppk1 is sufficient to bring these sensory neurons to threshold, eliciting a burst of action potentials. The transient nature of the neural activity produced by Ppk1 activation is the result of Ppk1 channel gating properties. This model is supported by the observation of enhanced bursting activity in neurons expressing a gain of function ppk1 mutant harboring the degenerin mutation. These findings demonstrate that Ppk1 can function as an ionotropic molecular sensory transducer capable of transforming the perception of a stimulus into phasic neuronal activity in sensory neurons.	[Boiko, Nina; Kucher, Volodymyr; Stockand, James D.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [RO1 NS062811]; American Heart Association [0640054N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS062811 (to B. A. E.). This work was also supported by American Heart Association Established Investigator Award 0640054N (to J. D. S.).	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Borzan J, 2010, ANESTHESIOLOGY, V113, P647, DOI 10.1097/ALN.0b013e3181eaa58a; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Chatzigeorgiou M, 2010, NAT NEUROSCI, V13, P861, DOI 10.1038/nn.2581; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Darboux I, 1998, BIOCHEM BIOPH RES CO, V246, P210, DOI 10.1006/bbrc.1998.8183; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; GLOOR GB, 1993, GENETICS, V135, P81; Golic KG, 1996, GENETICS, V144, P1693; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hong K, 2000, J NEUROSCI, V20, P2575; HONG KS, 1994, NATURE, V367, P470, DOI 10.1038/367470a0; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sicaeros Beatriz, 2007, J Vis Exp, P226, DOI 10.3791/226; Soll DR, 1995, INT REV CYTOL, V163, P43; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	35	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.411736	http://dx.doi.org/10.1074/jbc.M112.411736			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033486	Green Published, hybrid			2022-12-25	WOS:000311233800056
J	Nishimura, M; Song, WJ				Nishimura, Masataka; Song, Wen-Jie			Temporal Sequence of Visuo-Auditory Interaction in Multiple Areas of the Guinea Pig Visual Cortex	PLOS ONE			English	Article							MULTISENSORY INTERACTIONS; NEURONAL OSCILLATIONS; ANATOMICAL EVIDENCE; OBJECT RECOGNITION; SENSORY CORTICES; STRIATE CORTEX; MACAQUE MONKEY; BARREL CORTEX; IN-VIVO; HUMANS	Recent studies in humans and monkeys have reported that acoustic stimulation influences visual responses in the primary visual cortex (V1). Such influences can be generated in V1, either by direct auditory projections or by feedback projections from extrastriate cortices. To test these hypotheses, cortical activities were recorded using optical imaging at a high spatiotemporal resolution from multiple areas of the guinea pig visual cortex, to visual and/or acoustic stimulations. Visuo-auditory interactions were evaluated according to differences between responses evoked by combined auditory and visual stimulation, and the sum of responses evoked by separate visual and auditory stimulations. Simultaneous presentation of visual and acoustic stimulations resulted in significant interactions in V1, which occurred earlier than in other visual areas. When acoustic stimulation preceded visual stimulation, significant visuo-auditory interactions were detected only in V1. These results suggest that V1 is a cortical origin of visuo-auditory interaction.	[Nishimura, Masataka; Song, Wen-Jie] Kumamoto Univ, Dept Sensory & Cognit Physiol, Grad Sch Med Sci, Kumamoto, Japan	Kumamoto University	Song, WJ (corresponding author), Kumamoto Univ, Dept Sensory & Cognit Physiol, Grad Sch Med Sci, Kumamoto, Japan.	song@kumamoto-u.ac.jp		Song, Wen-Jie/0000-0003-2909-3098; Nishimura, Masataka/0000-0002-3309-458X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23115516]; JSPS [20300112, 22220004, 23659797];  [203900]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows #203900, a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry'' (#23115516) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and JSPS grants (#20300112, #22220004, and #23659797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Clancy B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.007.2010; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; Falchier A, 2002, J NEUROSCI, V22, P5749; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fujita S, 2010, NEUROSCIENCE, V165, P278, DOI 10.1016/j.neuroscience.2009.09.073; FUKUNISHI K, 1992, BIOL CYBERN, V67, P501, DOI 10.1007/BF00198757; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Hall AJ, 2008, EXP BRAIN RES, V190, P413, DOI 10.1007/s00221-008-1485-7; Horikawa J, 1996, J PHYSIOL-LONDON, V497, P629, DOI 10.1113/jphysiol.1996.sp021795; Inui K, 2006, J NEUROPHYSIOL, V96, P775, DOI 10.1152/jn.00103.2006; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kubota M, 2008, NEUROREPORT, V19, P1691, DOI 10.1097/WNR.0b013e32831579ff; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Maeda S, 2001, NEUROSCI LETT, V302, P137, DOI 10.1016/S0304-3940(01)01678-0; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Nishimura M, 2006, NEUROSCI RES, V54, P230, DOI 10.1016/j.neures.2005.12.002; Nishimura M, 2007, J NEUROPHYSIOL, V97, P927, DOI 10.1152/jn.00689.2006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Saitoh K, 2010, NEUROSCI RES, V68, P107, DOI 10.1016/j.neures.2010.06.009; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; SPATZ WB, 1991, EXP BRAIN RES, V84, P495; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; WREE A, 1981, ANAT EMBRYOL, V162, P81, DOI 10.1007/BF00318096; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	52	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46339	10.1371/journal.pone.0046339	http://dx.doi.org/10.1371/journal.pone.0046339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029483	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900136
J	Orenstein, Y; Linhart, C; Shamir, R				Orenstein, Yaron; Linhart, Chaim; Shamir, Ron			Assessment of Algorithms for Inferring Positional Weight Matrix Motifs of Transcription Factor Binding Sites Using Protein Binding Microarray Data	PLOS ONE			English	Article							SIMPLE-MODELS; DISCOVERY; SIMILARITY	The new technology of protein binding microarrays (PBMs) allows simultaneous measurement of the binding intensities of a transcription factor to tens of thousands of synthetic double-stranded DNA probes, covering all possible 10-mers. A key computational challenge is inferring the binding motif from these data. We present a systematic comparison of four methods developed specifically for reconstructing a binding site motif represented as a positional weight matrix from PBM data. The reconstructed motifs were evaluated in terms of three criteria: concordance with reference motifs from the literature and ability to predict in vivo and in vitro bindings. The evaluation encompassed over 200 transcription factors and some 300 assays. The results show a tradeoff between how the methods perform according to the different criteria, and a dichotomy of method types. Algorithms that construct motifs with low information content predict PBM probe ranking more faithfully, while methods that produce highly informative motifs match reference motifs better. Interestingly, in predicting high-affinity binding, all methods give far poorer results for in vivo assays compared to in vitro assays.	[Orenstein, Yaron; Linhart, Chaim; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870; Orenstein, Yaron/0000-0002-3583-3112	European Community [HEALTH-F4-2009-223575]; Israel Science Foundation [802/08]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	European Community(European Commission); Israel Science Foundation(Israel Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University	This study was supported in part by the European Community's Seventh Framework grant [HEALTH-F4-2009-223575] for the TRIREME project; and by the Israel Science Foundation (grant no. 802/08). YO was supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Aparicio Oscar, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1707s23; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Chen XY, 2007, BIOINFORMATICS, V23, pI72, DOI 10.1093/bioinformatics/btm224; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Gordan R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r125; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Jauch R, 2012, BIOCHEM J, V443, P39, DOI 10.1042/BJ20111768; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Li N, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-8; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Morris Q, 2011, NAT BIOTECHNOL, V29, P483, DOI 10.1038/nbt.1892; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Sandve GK, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-11; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Tanaka E, 2011, BIOINFORMATICS, V27, P1603, DOI 10.1093/bioinformatics/btr257; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46145	10.1371/journal.pone.0046145	http://dx.doi.org/10.1371/journal.pone.0046145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029415	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900096
J	Rampal, S; Mahadeva, S; Guallar, E; Bulgiba, A; Mohamed, R; Rahmat, R; Arif, MT; Rampal, L				Rampal, Sanjay; Mahadeva, Sanjiv; Guallar, Eliseo; Bulgiba, Awang; Mohamed, Rosmawati; Rahmat, Ramlee; Arif, Mohamad Taha; Rampal, Lekhraj			Ethnic Differences in the Prevalence of Metabolic Syndrome: Results from a Multi-Ethnic Population-Based Survey in Malaysia	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-COMPOSITION; COMPONENTS; DISEASE; ADULTS	Introduction: The prevalence of metabolic syndrome is increasing disproportionately among the different ethnicities in Asia compared to the rest of the world. This study aims to determine the differences in the prevalence of metabolic syndrome across ethnicities in Malaysia, a multi-ethnic country. Methods: In 2004, we conducted a national cross-sectional population-based study using a stratified two-stage cluster sampling design (N = 17,211). Metabolic syndrome was defined according to the International Diabetes Federation/National Heart, Lung and Blood Institute/American Heart Association (IDF/NHLBI/AHA-2009) criteria. Multivariate models were used to study the independent association between ethnicity and the prevalence of the metabolic syndrome. Results: The overall mean age was 36.9 years, and 50.0% participants were female. The ethnic distribution was 57.0% Malay, 28.5% Chinese, 8.9% Indian and 5.0% Indigenous Sarawakians. The overall prevalence of the metabolic syndrome was 27.5%, with a prevalence of central obesity, raised triglycerides, low high density lipoprotein cholesterol, raised blood pressure and raised fasting glucose of 36.9%, 29.3%, 37.2%, 38.0% and 29.1%, respectively. Among those,40 years, the adjusted prevalence ratios for metabolic syndrome for ethnic Chinese, Indians, and Indigenous Sarawakians compared to ethnic Malay were 0.81 (95% CI 0.67 to 0.96), 1.42 (95% CI 1.19 to 1.69) and 1.37 (95% CI 1.08 to 1.73), respectively. Among those aged >= 40 years, the corresponding prevalence ratios were 0.86 (95% CI 0.79 to 0.92), 1.25 (95% CI 1.15 to 1.36), and 0.94 (95% CI 0.80, 1.11). The P-value for the interaction of ethnicity by age was 0.001. Conclusions: The overall prevalence of metabolic syndrome in Malaysia was high, with marked differences across ethnicities. Ethnic Chinese had the lowest prevalence of metabolic syndrome, while ethnic Indians had the highest. Indigenous Sarawakians showed a marked increase in metabolic syndrome at young ages.	[Rampal, Lekhraj] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Malaysia; [Rampal, Sanjay; Bulgiba, Awang] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Mahadeva, Sanjiv; Mohamed, Rosmawati] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Guallar, Eliseo] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Area Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Rahmat, Ramlee] Minist Hlth, Putrajaya, Malaysia; [Arif, Mohamad Taha] Univ Sarawak Malaysia, Fac Med & Hlth Sci, Sarawak, Malaysia	Universiti Putra Malaysia; Universiti Malaya; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; Johns Hopkins University; Johns Hopkins Medicine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Kementerian Kesihatan Malaysia; University of Malaysia Sarawak	Rampal, L (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Malaysia.	rampal@medic.upm.edu.my	Mahadeva, Sanjiv/E-1711-2011; Rampal, Lekhraj/G-6117-2010; Rampal, Sanjay/B-9691-2010; Guallar, Eliseo/D-3807-2014; Bulgiba, Awang/B-8271-2010	Mahadeva, Sanjiv/0000-0001-5824-0590; Rampal, Sanjay/0000-0002-0105-6407; Guallar, Eliseo/0000-0002-4471-9565; Bulgiba, Awang/0000-0002-5313-0445	Ministry of Science, Technology and Environment (MOSTE) IRPA Project [06-02-04-0000-PR-0041/05-03]	Ministry of Science, Technology and Environment (MOSTE) IRPA Project	The authors are grateful to the Director General of Health, Ministry of Health Malaysia, all the State Directors of Medical and Health Services and their staff for their assistance. This study is part of the National study on Cardio-Vascular Disease Risk Factors and funded by Ministry of Science, Technology and Environment (MOSTE) IRPA Project Grant No. 06-02-04-0000-PR-0041/05-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-854; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bhardwaj S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024362; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P130, DOI 10.4103/0975-3583.70911; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P86, DOI 10.4103/0975-3583.64442; Department of Statistics Malaysia, 2000, POP DISTR BAS DEM CH; Ghosh Arnab, 2010, J Cardiovasc Dis Res, V1, P81, DOI 10.4103/0975-3583.64441; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Health IoP, 2006, NAT HLTH MORB SURV N; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lian CW, 2011, MALAYS J MED SCI, V18, P58; Malik A, 2007, J DIG DIS, V8, P58, DOI 10.1111/j.1443-9573.2007.00286.x; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mohamud WNW, 2011, DIABETES RES CLIN PR, V91, P239, DOI 10.1016/j.diabres.2010.11.025; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Narayanan P, 2011, METAB SYNDR RELAT D, V9, P389, DOI 10.1089/met.2011.0014; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Nuur Amalina A G, 2012, Med J Malaysia, V67, P31; Pandit Kaushik, 2012, Indian J Endocrinol Metab, V16, P44, DOI 10.4103/2230-8210.91187; Polotsky HN, 2010, SEMIN REPROD MED, V28, P426, DOI 10.1055/s-0030-1262902; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Rampal S, 2010, ASIA-PAC J PUBLIC HE, V22, P194, DOI 10.1177/1010539509334816; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tan AKG, 2011, METAB SYNDR RELAT D, V9, P441, DOI 10.1089/met.2011.0031; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Venkataraman R, 2004, AM J CARDIOL, V94, P977, DOI 10.1016/j.amjcard.2004.06.048; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zainuddin LRM, 2011, INT J PREVENTIVE MED, V2, P229	34	72	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46365	10.1371/journal.pone.0046365	http://dx.doi.org/10.1371/journal.pone.0046365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029497	Green Published, gold			2022-12-25	WOS:000309973900144
J	Yao, F; Ariyaratne, PN; Hillmer, AM; Lee, WH; Li, GL; Teo, ASM; Woo, XY; Zhang, ZS; Chen, JQP; Poh, WT; Zawack, KFB; Chan, CS; Leong, ST; Neo, SC; Choi, PSD; Gao, S; Nagarajan, N; Thoreau, H; Shahab, A; Ruan, XA; Cacheux-Rataboul, V; Wei, CL; Bourque, G; Sung, WK; Liu, ET; Ruan, YJ				Yao, Fei; Ariyaratne, Pramila N.; Hillmer, Axel M.; Lee, Wah Heng; Li, Guoliang; Teo, Audrey S. M.; Woo, Xing Yi; Zhang, Zhenshui; Chen, Jieqi P.; Poh, Wan Ting; Zawack, Kelson F. B.; Chan, Chee Seng; Leong, See Ting; Neo, Say Chuan; Choi, Poh Sum D.; Gao, Song; Nagarajan, Niranjan; Thoreau, Herve; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Wei, Chia-Lin; Bourque, Guillaume; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun			Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons	PLOS ONE			English	Article							SHORT-READ; REARRANGEMENT; COMPLEXITY	Structural variations (SVs) contribute significantly to the variability of the human genome and extensive genomic rearrangements are a hallmark of cancer. While genomic DNA paired-end-tag (DNA-PET) sequencing is an attractive approach to identify genomic SVs, the current application of PET sequencing with short insert size DNA can be insufficient for the comprehensive mapping of SVs in low complexity and repeat-rich genomic regions. We employed a recently developed procedure to generate PET sequencing data using large DNA inserts of 10-20 kb and compared their characteristics with short insert (1 kb) libraries for their ability to identify SVs. Our results suggest that although short insert libraries bear an advantage in identifying small deletions, they do not provide significantly better breakpoint resolution. In contrast, large inserts are superior to short inserts in providing higher physical genome coverage for the same sequencing cost and achieve greater sensitivity, in practice, for the identification of several classes of SVs, such as copy number neutral and complex events. Furthermore, our results confirm that large insert libraries allow for the identification of SVs within repetitive sequences, which cannot be spanned by short inserts. This provides a key advantage in studying rearrangements in cancer, and we show how it can be used in a fusion-point-guided-concatenation algorithm to study focally amplified regions in cancer.	[Yao, Fei; Ariyaratne, Pramila N.; Hillmer, Axel M.; Lee, Wah Heng; Li, Guoliang; Teo, Audrey S. M.; Woo, Xing Yi; Zhang, Zhenshui; Chen, Jieqi P.; Poh, Wan Ting; Zawack, Kelson F. B.; Chan, Chee Seng; Leong, See Ting; Neo, Say Chuan; Choi, Poh Sum D.; Nagarajan, Niranjan; Thoreau, Herve; Shahab, Atif; Ruan, Xiaoan; Cacheux-Rataboul, Valere; Wei, Chia-Lin; Bourque, Guillaume; Sung, Wing-Kin; Liu, Edison T.; Ruan, Yijun] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Yao, Fei] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth, Singapore 117595, Singapore; [Gao, Song] Natl Univ Singapore, Ctr Life Sci, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Ruan, Yijun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore	Ruan, YJ (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.	ruanyj@gis.a-star.edu.sg	Hillmer, Axel M/N-2927-2014; Hillmer, Axel M/B-7485-2015; Li, Guoliang/D-8014-2012; Bourque, Guillaume/AFR-2927-2022	Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Li, Guoliang/0000-0003-1601-6640; Bourque, Guillaume/0000-0002-3933-9656; Sung, Wing-Kin/0000-0001-7806-7086; Nagarajan, Niranjan/0000-0003-0850-5604; THOREAU, HERVE/0000-0001-6643-167X	Agency for Science Technology and Research (A*STAR), Singapore; National Cancer Institute (USA) [NCI: 5 R33 CA126996-02]	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Cancer Institute (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Agency for Science Technology and Research (A*STAR), Singapore, and from a grant from the National Cancer Institute (USA) NCI: 5 R33 CA126996-02 (Pair-end-ditag technologies for the complete annotation of fusion genes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000051; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dunn JJ, 2002, GENOME RES, V12, P1756, DOI 10.1101/gr.306102; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Inaki K, 2011, GENOME RES, V21, P676, DOI 10.1101/gr.113225.110; Kidd JM, 2008, GENOME RES, V18, P2016, DOI 10.1101/gr.081786.108; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Nagarajan N, 2009, J COMPUT BIOL, V16, P897, DOI 10.1089/cmb.2009.0005; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shastry BS, 2007, J HUM GENET, V52, P871, DOI 10.1007/s10038-007-0200-z; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wetzel J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-95	33	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46152	10.1371/journal.pone.0046152	http://dx.doi.org/10.1371/journal.pone.0046152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029419	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900099
J	Bhatt, JP; Manish, K; Pandit, MK				Bhatt, Jay P.; Manish, Kumar; Pandit, Maharaj K.			Elevational Gradients in Fish Diversity in the Himalaya: Water Discharge Is the Key Driver of Distribution Patterns	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; HABITAT HETEROGENEITY; ALTITUDINAL RANGE; EASTERN HIMALAYA; BIODIVERSITY; ENERGY; ARALIACEAE; ENDEMISM	Background: Studying diversity and distribution patterns of species along elevational gradients and understanding drivers behind these patterns is central to macroecology and conservation biology. A number of studies on biogeographic gradients are available for terrestrial ecosystems, but freshwater ecosystems remain largely neglected. In particular, we know very little about the species richness gradients and their drivers in the Himalaya, a global biodiversity hotspot. Methodology/Principal Findings: We collated taxonomic and distribution data of fish species from 16 freshwater Himalayan rivers and carried out empirical studies on environmental drivers and fish diversity and distribution in the Teesta river (Eastern Himalaya). We examined patterns of fish species richness along the Himalayan elevational gradients (50-3800 m) and sought to understand the drivers behind the emerging patterns. We used generalized linear models (GLM) and generalized additive models (GAM) to examine the richness patterns; GLM was used to investigate relationship between fish species richness and various environmental variables. Regression modelling involved stepwise procedures, including elimination of collinear variables, best model selection, based on the least Akaike's information criterion (AIC) and the highest percentage of deviance explained (D-2). This maiden study on the Himalayan fishes revealed that total and non-endemic fish species richness monotonously decrease with increasing elevation, while endemics peaked around mid elevations (700-1500 m). The best explanatory model (synthetic model) indicated that water discharge is the best predictor of fish species richness patterns in the Himalayan rivers. Conclusions/Significance: This study, carried out along one of the longest bioclimatic elevation gradients of the world, lends support to Rapoport's elevational rule as opposed to mid domain effect hypothesis. We propose a species-discharge model and contradict species-area model in predicting fish species richness. We suggest that drivers of richness gradients in terrestrial and aquatic ecosystems are likely to be different. These studies are crucial in context of the impacts of unprecedented on-going river regulation on fish diversity and distribution in the Himalaya.	[Bhatt, Jay P.; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India; [Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India	University of Delhi; University of Delhi	Pandit, MK (corresponding author), Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India.	rajkpandit@gmail.com	Manish, Kumar/M-5034-2019; Pandit, Maharaj K/A-4065-2014	Manish, Kumar/0000-0002-0373-0426; Pandit, Maharaj K/0000-0001-6611-560X	Ministry of Environment, Forests & Wildlife, Government of India; NHPC India [J.12011/11/99-IA.I]	Ministry of Environment, Forests & Wildlife, Government of India; NHPC India	The financial support for this study was provided by the Ministry of Environment, Forests & Wildlife, Government of India & NHPC India vide grant No. J.12011/11/99-IA.I sanctioned to MKP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Acharya BK, 2011, ACTA OECOL, V37, P329, DOI 10.1016/j.actao.2011.03.005; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Benke M, 2011, J BIOGEOGR, V38, P2021, DOI 10.1111/j.1365-2699.2011.02527.x; Bhatt J. P., 2005, Aquatic Ecosystem Health & Management, V8, P259, DOI 10.1080/14634980500218274; Bhatt JP, 2010, CURR SCI INDIA, V99, P196; Bhatt JP, 2001, CURR SCI INDIA, V81, P1332; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Chettri B, 2010, ACTA OECOL, V36, P16, DOI 10.1016/j.actao.2009.09.004; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Crawley M.J., 1993, GLIM ECOLOGISTS; Crawley M. J, 2002, STAT COMPUTING INTRO; Dahanukar N, 2004, J BIOGEOGR, V31, P123, DOI 10.1046/j.0305-0270.2003.01016.x; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Fu CZ, 2004, GLOBAL ECOL BIOGEOGR, V13, P543, DOI 10.1111/j.1466-822X.2004.00122.x; Gordon ND, 2005, STREAM HYDROLOGY INT, P429; Griffiths D, 1997, J ANIM ECOL, V66, P49, DOI 10.2307/5963; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hack J.T., 1973, J RES US GEOL SURV, V1, P421; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCullagh P, 1989, GEN LINEAR MODELS; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2009, CONSERV BIOL, V23, P1346, DOI 10.1111/j.1523-1739.2009.01359.x; Pandit MK, 2012, CONSERV BIO IN PRESS; PENNAK RW, 1953, FRESHWATER INVERTEBR; Pimm SL, 2004, SCIENCE, V304, P831, DOI 10.1126/science.1095332; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAINA HS, 1999, FISH FISHERIES HIGHE, P304; Rapoport E. H., 1982, AREOGRAPHY GEOGRAPHI, P269; Schwarz M, 2005, REMOTE SENS ENVIRON, V95, P428, DOI 10.1016/j.rse.2004.12.010; SEEBER L, 1983, TECTONOPHYSICS, V92, P335, DOI 10.1016/0040-1951(83)90201-9; Sharma SK, 2011, PLANT SYST EVOL, V297, P87, DOI 10.1007/s00606-011-0501-8; Sharma SK, 2010, PLANT SYST EVOL, V287, P29, DOI 10.1007/s00606-010-0286-1; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Venables W., 2013, MODERN APPL STAT S, V53, P86; Vetaas OR, 2002, GLOBAL ECOL BIOGEOGR, V11, P291, DOI 10.1046/j.1466-822X.2002.00297.x; Welch PS, 1952, LIMNOLOGICAL METHODS; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wohlgemuth T, 2008, J BIOGEOGR, V35, P1226, DOI 10.1111/j.1365-2699.2008.01884.x; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; YOUNG A., 1974, SLOPE DEV	57	55	57	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46237	10.1371/journal.pone.0046237	http://dx.doi.org/10.1371/journal.pone.0046237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029444	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500074
J	Bloos, F; Sachse, S; Kortgen, A; Pletz, MW; Lehmann, M; Straube, E; Riedemann, NC; Reinhart, K; Bauer, M				Bloos, Frank; Sachse, Svea; Kortgen, Andreas; Pletz, Mathias W.; Lehmann, Marc; Straube, Eberhard; Riedemann, Niels C.; Reinhart, Konrad; Bauer, Michael			Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational Study	PLOS ONE			English	Article							REAL-TIME PCR; BLOOD-STREAM PATHOGENS; SEVERE SEPSIS; ANTIMICROBIAL THERAPY; MULTIPLEX PCR; CARE-UNIT; INFECTIONS; MORTALITY; INITIATION; DIAGNOSIS	Background: Treatment of septic shock relies on appropriate antimicrobial therapy. Current culture based methods deliver final results after days, which may delay potentially lifesaving adjustments in antimicrobial therapy. This study was undertaken to compare PCR with blood culture results under routine conditions regarding 1. impact on antimicrobial therapy, and 2. time to result, in patients with presumed sepsis. Methodology/Principal Findings: This was an observational study in a 50 beds ICU of a university hospital. In 245 patients with suspected sepsis, 311 concomitant blood cultures and blood for multiplex PCR (VYOO (R)) were obtained. 45 of 311 blood cultures (14.5%) and 94 of 311 PCRs (30.1%) were positive. However, blood culture or microbiological sampling from the presumed site of infection rarely confirmed PCR results and vice versa. Median time to positivity and interquartile range were 24.2 (18.0, 27.5) hours for the PCR and 68 (52.2, 88.5) hours for BC (p<0.01). PCR median time to result was dependent on technician availability (53.5 hours on Saturdays, 7.2 hours under optimal logistic conditions). PCR results showed good correlation with procalcitonin (p<0.001). In 34% of patients with positive PCRs antimicrobial therapy was considered inadequate according to assessment of clinical arbitrators including 5 patients with vancomycin-resistant enterococci (VRE), 3 cases with multiresistant staphylococci, and 4 patients with fungi. Conclusions: The results of this observational study support the hypothesis that PCR results are available faster, are more frequently positive, and may result in earlier adjustment of antimicrobial therapy. However, shorter time to result can only be fully exploited when the laboratory is adequately staffed for a 24 hour/7 day service, or when point of care/automated assay systems become available.	[Bloos, Frank; Kortgen, Andreas; Riedemann, Niels C.; Reinhart, Konrad; Bauer, Michael] Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany; [Bloos, Frank; Kortgen, Andreas; Reinhart, Konrad; Bauer, Michael] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Sachse, Svea; Straube, Eberhard] Jena Univ Hosp, Inst Med Microbiol, Jena, Germany; [Pletz, Mathias W.] Jena Univ Hosp, Div Gastroenterol Hepatol & Infect Dis, Jena, Germany; [Lehmann, Marc] SIRS Lab GmbH, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Bauer, M (corresponding author), Jena Univ Hosp, Dept Anesthesiol & Intens Care Therapy, Jena, Germany.	Michael.Bauer@med.uni-jena.de	Pletz, Mathias Wilhelm/H-9782-2019; Bloos, Frank/AAY-8265-2020	Pletz, Mathias Wilhelm/0000-0001-8157-2753; Bloos, Frank/0000-0002-0767-7941; Bauer, Michael/0000-0002-1521-3514	Thuringian Ministry of Education (ProExzellenz-Initiative) [PR 108-2]; Thuringian Foundation for Technology, Innovation, and Research STIFT; German Sepsis Society; SIRS-Lab GmbH	Thuringian Ministry of Education (ProExzellenz-Initiative); Thuringian Foundation for Technology, Innovation, and Research STIFT; German Sepsis Society; SIRS-Lab GmbH	The study was financially supported by the Thuringian Ministry of Education (ProExzellenz-Initiative: PR 108-2, http://www.thueringen.de/de/tmbwk/wissenschaft/zukunftsinitiative/proexzellenz/), the Thuringian Foundation for Technology, Innovation, and Research STIFT (www.stift-thueringen.de), and the German Sepsis Society (www.sepsis-gesellschaft.de). SIRS-Lab GmbH has supplied the VYOO (R)-Kits and personnel to run the PCR. SIRS-Lab GmbH has also financed a prospective study which took place after this study was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, study goals and feasibility issues have been discussed with SIRS-Lab GmbH during the preparation phase of the study.	Bloos F, 2010, INTENS CARE MED, V36, P241, DOI 10.1007/s00134-009-1705-z; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Dupont H, 2011, J ANTIMICROB CHEMOTH, V66, P2379, DOI 10.1093/jac/dkr308; Garey KW, 2006, CLIN INFECT DIS, V43, P25, DOI 10.1086/504810; Hebart H, 2009, BONE MARROW TRANSPL, V43, P553, DOI 10.1038/bmt.2008.355; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2010, CRIT CARE, V14, DOI 10.1186/cc9294; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Lerma FA, 2003, MED CLIN-BARCELONA, V121, P281, DOI 10.1157/13050710; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; MacArthur RD, 2004, CLIN INFECT DIS, V38, P284, DOI 10.1086/379825; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; Mauch H, 1999, MIQ QUALITATSSTANDAR; Micek ST, 2005, PHARMACOTHERAPY, V25, P26, DOI 10.1592/phco.25.1.26.55615; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Pletz MW, 2011, INTENS CARE MED, V37, P1069, DOI 10.1007/s00134-011-2245-x; R Core Team, 2021, R LANG ENV STAT COMP; Sachse S, 2009, J CLIN MICROBIOL, V47, P1050, DOI 10.1128/JCM.02242-08; Sandiumenge A, 2003, INTENS CARE MED, V29, P876, DOI 10.1007/s00134-003-1715-1; Shafazand S, 2002, CHEST, V122, P1727, DOI 10.1378/chest.122.5.1727; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Wellinghausen N, 2009, J MED MICROBIOL, V58, P1106, DOI 10.1099/jmm.0.007906-0; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x	33	63	67	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46003	10.1371/journal.pone.0046003	http://dx.doi.org/10.1371/journal.pone.0046003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029360	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500054
J	Wu, QF; Sun, CC; Lin, HY; Babitt, JL				Wu, Qifang; Sun, Chia Chi; Lin, Herbert Y.; Babitt, Jodie L.			Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs)	PLOS ONE			English	Article							NEURAL-TUBE CLOSURE; HEPCIDIN EXPRESSION; NEOGENIN INTERACTS; IRON OVERLOAD; HEMOJUVELIN; MEMBRANE; INHIBITION; PROMOTES; DRAGON; RECEPTORS	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor beta superfamily that exert their effects via type I and type II serine threonine kinase receptors and the SMAD intracellular signaling pathway to regulate diverse biologic processes. Recently, we discovered that the repulsive guidance molecule (RGM) family, including RGMA, RGMB, and RGMC/hemojuvelin (HJV), function as co-receptors that enhance cellular responses to BMP ligands. Here, we use surface plasmon resonance to quantitate the binding kinetics of RGM proteins for BMP ligands. We show that among the RGMs, HJV exhibits the highest affinity for BMP6, BMP5, and BMP7 with KD 8.1, 17, and 20 nM respectively, versus 28, 33, and 166 nM for RGMB, and 55, 83, and 63 nM for RGMA. Conversely, RGMB exhibits preferential binding to BMP4 and BMP2 with KD 2.6 and 5.5 nM respectively, versus 4.5 and 9.4 nM for HJV, and 14 and 22 nM for RGMA, while RGMA exhibits the lowest binding affinity for most BMPs tested. Among the BMP ligands, RGMs exhibit the highest relative affinity for BMP4 and the lowest relative affinity for BMP7, while none of the RGMs bind to BMP9. Thus, RGMs exhibit preferential binding for distinct subsets of BMP ligands. The preferential binding of HJV for BMP6 is consistent with the functional role of HJV and BMP6 in regulating systemic iron homeostasis. Our data may help explain the mechanism by which BMPs exert cell-context specific effects via a limited number of type I and type II receptors.	[Babitt, Jodie L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Anemia Signaling Res,Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Babitt, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Anemia Signaling Res,Div Nephrol, Boston, MA 02114 USA.	babitt.jodie@mgh.harvard.edu			National Institutes of Health [K08-DK075846, RO1-DK087727, RO1 DK-069533, RO1 DK-071837]; Massachusetts General Hospital; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, K08DK075846, R01DK071837, R01DK087727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health [grant numbers K08-DK075846, RO1-DK087727 (to J.L.B.), RO1 DK-069533, and RO1 DK-071837 (to H.Y.L.)] and a Claflin Distinguished Scholar Award from the Massachusetts General Hospital (to J.L.B.). This work was conducted with support from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [Award #UL1 RR 025758] and financial contributions from Harvard University and its affiliated academic health care centers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Brasse-Lagnel C, 2010, HAEMATOL-HEMATOL J, V95, P2031, DOI 10.3324/haematol.2010.022129; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Celeste AJ, 1994, J BONE MINER RES  S1, V9, pS136; Chen WJ, 2013, HAEMATOLOGICA, V98, P296, DOI 10.3324/haematol.2012.070136; Corradini E, 2010, GASTROENTEROLOGY, V139, P1721, DOI 10.1053/j.gastro.2010.07.044; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2011, BLOOD CELL MOL DIS, V40, P122; Ma CHE, 2011, J NEUROSCI, V31, P18391, DOI 10.1523/JNEUROSCI.4550-11.2011; Maes K, 2010, BLOOD, V116, P3635, DOI 10.1182/blood-2010-03-274571; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Tassew NG, 2012, DEV CELL, V22, P391, DOI 10.1016/j.devcel.2011.11.022; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200	52	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46307	10.1371/journal.pone.0046307	http://dx.doi.org/10.1371/journal.pone.0046307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029472	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500087
J	Chen, C; Yang, G; Geng, XR; Wang, XP; Liu, ZJ; Yang, PC				Chen, Chi; Yang, Gui; Geng, Xiao-Rui; Wang, Xingpeng; Liu, Zhanju; Yang, Ping-Chang			TNFAIP3 Facilitates Degradation of Microbial Antigen SEB in Enterocytes	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; BARRIER ABNORMALITIES; DENDRITIC CELLS; A20 DEFICIENCY; IMMUNE CELLS; TRANSPORT; IGE; SENSITIZATION; PERMEABILITY; ACTIVATION	Background and Aims: The enterocytes have the potential to absorb noxious substances, such as microbial products, from the gut lumen. How the enterocytes process the substances to harmless materials is not fully understood. This study aims to elucidate the role of ubiquitin E3 ligase TNFAIP3 (TNFAIP3) in facilitating the degradation of endocytic microbial products in enterocytes. Methods: Human intestinal epithelial cell line, HT-29 cells, was cultured to monolayers using as an in vitro model to observe the endocytosis and degradation of microbial products, Staphylococcal enterotoxin B (SEB) in epithelial cells. The RNA interference was employed to knock down the TNFAIP3 gene in HT-29 cells to observe the role of TNFAIP3 in the degradation of endocytic SEB. The role of TNFAIP3 in facilitating the endosome/lysosome fusion was observed by immunocytochemistry. Results: Upon the absorption of SEB, the expression of TNFAIP3 was increased in HT-29 cells. Silencing the TNFAIP3 gene in HT-29 cells resulted in a large quantity of SEB to be transported across the HT-29 monolayers to the transwell basal chambers; the transportation was via the intracellular pathway. TNFAIP3 was required in the fusion of SEB-carrying endosomes and lysosomes. Conclusions: TNFAIP3 plays a critical role in the degradation of endocytic SEB in enterocytes.	[Chen, Chi; Wang, Xingpeng; Liu, Zhanju] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Yang, Ping-Chang] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Tongji University; McMaster University	Liu, ZJ (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Shanghai 200092, Peoples R China.	liuzhanju88@126.com; yangp@mcmaster.ca	Yang, Ping-Chang/K-4669-2019		Canadian Institutes of Health Research [191063, 220058, 177843]; Natural Sciences, Engineering Research Council of Canada (NSERC) [371268]; National Natural Science Foundation of China [30971358, 81061120521]; Shanghai Science and Technology Commission [12XD1404000]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences, Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from the Canadian Institutes of Health Research (#191063, #220058 and #177843), Natural Sciences, Engineering Research Council of Canada (NSERC, #371268), the National Natural Science Foundation of China (No. 30971358; No. 81061120521), and Shanghai Science and Technology Commission (No. 12XD1404000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen X, 2010, N AM J MED SCI, V2, P241, DOI 10.4297/najms.2010.2241; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Forbes-Blom E, 2012, CLIN EXP ALLERGY, V42, P305, DOI 10.1111/j.1365-2222.2011.03861.x; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Hasilik A, 2009, INT J CLIN PHARM TH, V47, pS18; Hauri H P, 1991, Semin Cell Biol, V2, P355; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Hovelmeyer N, 2011, EUR J IMMUNOL, V41, P595, DOI 10.1002/eji.201041313; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; Krakauer T, 2010, MIL MED, V175, P917, DOI 10.7205/MILMED-D-10-00148; Li LY, 2009, BBA-MOL CELL RES, V1793, P346, DOI 10.1016/j.bbamcr.2008.09.013; Lu J, 1998, J PHARMACOL EXP THER, V287, P128; Luzio JP, 2009, BIOCHEM SOC T, V37, P21; McKay DM, 1997, J IMMUNOL, V159, P2382; Miyazaki D, 2010, JPN J OPHTHALMOL, V54, P476, DOI 10.1007/s10384-010-0837-6; Moreto M, 2009, J ANIM SCI, V87, pE92, DOI 10.2527/jas.2008-1381; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Perez-Bosque A, 2010, P NUTR SOC, V69, P447, DOI 10.1017/S0029665110001849; Sluyter R, 2002, INT IMMUNOL, V14, P1415, DOI 10.1093/intimm/dxf111; Tu YH, 2009, N AM J MED SCI, V1, P24; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; Yang PC, 1999, J IMMUNOL, V163, P2769; Yang PC, 2005, BMC GASTROENTEROL, V5, DOI 10.1186/1471-230X-5-28; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470; Zhang N, 2011, ALLERGY, V66, P141, DOI 10.1111/j.1398-9995.2010.02448.x	32	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45941	10.1371/journal.pone.0045941	http://dx.doi.org/10.1371/journal.pone.0045941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029332	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700093
J	Liu, QJ; Wu, HW; Wu, LZ; Xie, X; Kong, JL; Ye, XF; Liu, LP				Liu, Quanjun; Wu, Hongwen; Wu, Lingzhi; Xie, Xiao; Kong, Jinglin; Ye, Xiaofeng; Liu, Liping			Voltage-Driven Translocation of DNA through a High Throughput Conical Solid-State Nanopore	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; TRANSPORT; MOLECULES; FABRICATION; NANOTUBES; PROTEINS	Nanopores have become an important tool for molecule detection at single molecular level. With the development of fabrication technology, synthesized solid-state membranes are promising candidate substrates in respect of their exceptional robustness and controllable size and shape. Here, a 30-60 (tip-base) nm conical nanopore fabricated in 100 nm thick silicon nitride (Si3N4) membrane by focused ion beam (FIB) has been employed for the analysis of lambda-DNA translocations at different voltage biases from 200 to 450 mV. The distributions of translocation time and current blockage, as well as the events frequencies as a function of voltage are investigated. Similar to previously published work, the presence and configurations of lambda-DNA molecules are characterized, also, we find that greater applied voltages markedly increase the events rate, and stretch the coiled lambda-DNA molecules into linear form. However, compared to 6-30 nm ultrathin solid-state nanopores, a threshold voltage of 181 mV is found to be necessary to drive DNA molecules through the nanopore due to conical shape and length of the pore. The speed is slowed down similar to 5 times, while the capture radius is similar to 2 fold larger. The results show that the large nanopore in thick membrane with an improved stability and throughput also has the ability to detect the molecules at a single molecular level, as well as slows down the velocity of molecules passing through the pore. This work will provide more motivations for the development of nanopores as a Multi-functional sensor for a wide range of biopolymers and nano materials.	[Liu, Quanjun; Wu, Hongwen; Wu, Lingzhi; Kong, Jinglin; Ye, Xiaofeng; Liu, Liping] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Wu, Lingzhi] Nanjing Univ Posts & Telecommun, Sch Geog & Biol Informat, Nanjing, Jiangsu, Peoples R China; [Xie, Xiao] Southeast Univ, SEU FEI Nanopico Ctr, Key Lab MEMS, Minist Educ, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing University of Posts & Telecommunications; Southeast University - China	Liu, QJ (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.	lqj@seu.edu.cn	liu, li/HGC-0900-2022	Kong, Jinglin/0000-0003-4549-0720	National Natural Science Foundation of China [61071050]; Ministry of Science and Technology of China [2009 DFA32750]; Ministry of Education [200967]; State Key Laboratory of Bioelectronics of Southeast University [2011E14]; China Postdoctoral Science Foundation [20110491339]; Chinese Postdoctoral Fund [2011M500081]; Natural Science Foundation of China [61101056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education; State Key Laboratory of Bioelectronics of Southeast University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Postdoctoral Fund; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for financial support from National Natural Science Foundation of China (61071050); international cooperation project from the Ministry of Science and Technology of China (2009 DFA32750); the Ministry of Education major project(200967); the Open Project of State Key Laboratory of Bioelectronics of Southeast University (2011E14); the China Postdoctoral Science Foundation (20110491339); Chinese Postdoctoral Fund (No. 2011M500081); Natural Science Foundation of China (61101056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2001, ELECTROCHEMICAL METH, P66; Astier Y, 2011, SMALL, V7, P455, DOI 10.1002/smll.201002113; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chen P, 2004, NANO LETT, V4, P2293, DOI 10.1021/nl048654j; Chen P, 2004, NANO LETT, V4, P1333, DOI 10.1021/nl0494001; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/nnano.2009.12, 10.1038/NNANO.2009.12]; Deamer DW, 2000, TRENDS BIOTECHNOL, V18, P147, DOI 10.1016/S0167-7799(00)01426-8; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fan R, 2005, NANO LETT, V5, P1633, DOI 10.1021/nl0509677; Fologea D, 2005, NANO LETT, V5, P1905, DOI 10.1021/nl051199m; Fologea D, 2005, NANO LETT, V5, P1734, DOI 10.1021/nl051063o; Fologea D, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2767206; Fologea D, 2007, ELECTROPHORESIS, V28, P3186, DOI 10.1002/elps.200700047; Gershow M, 2007, NAT NANOTECHNOL, V2, P775, DOI 10.1038/nnano.2007.381; Hall AR, 2011, NANO LETT, V11, P2446, DOI 10.1021/nl200873w; Hall AR, 2010, NAT NANOTECHNOL, V5, P874, DOI [10.1038/nnano.2010.237, 10.1038/NNANO.2010.237]; Harrell CC, 2006, LANGMUIR, V22, P10837, DOI 10.1021/la061234k; He YH, 2011, ACS NANO, V5, P8391, DOI 10.1021/nn203186c; Heng JB, 2005, NANO LETT, V5, P1883, DOI 10.1021/nl0510816; Henrickson SE, 2000, PHYS REV LETT, V85, P3057, DOI 10.1103/PhysRevLett.85.3057; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Kowalczyk SW, 2012, NANO LETT, V12, P1038, DOI 10.1021/nl204273h; Kowalczyk SW, 2010, NANO LETT, V10, P1414, DOI 10.1021/nl100271c; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Lan WJ, 2011, ANAL CHEM, V83, P3840, DOI 10.1021/ac200312n; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Li JL, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454129; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Merchant CA, 2010, NANO LETT, V10, P2915, DOI 10.1021/nl101046t; Mirsaidov U, 2010, NANOTECHNOLOGY, P21; Muthukumar M, 2007, ANNU REV BIOPH BIOM, V36, P435, DOI 10.1146/annurev.biophys.36.040306.132622; Niedzwiecki DJ, 2010, J AM CHEM SOC, V132, P10816, DOI 10.1021/ja1026858; Nkodo AE, 2001, ELECTROPHORESIS, V22, P2424, DOI 10.1002/1522-2683(200107)22:12<2424::AID-ELPS2424>3.0.CO;2-1; Oukhaled A, 2011, ACS NANO, V5, P3628, DOI 10.1021/nn1034795; Pedone D, 2009, ANAL CHEM, V81, P9689, DOI 10.1021/ac901877z; Rosenstein JK, 2012, NAT METHODS, V9, P487, DOI [10.1038/NMETH.1932, 10.1038/nmeth.1932]; Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sen YH, 2009, ANAL BIOANAL CHEM, V394, P437, DOI 10.1007/s00216-008-2529-3; Singer A, 2012, NANO LETT, V12, P1722, DOI 10.1021/nl300372a; Singer A, 2010, NANO LETT, V10, P738, DOI 10.1021/nl100058y; Siwy Z, 2004, J AM CHEM SOC, V126, P10850, DOI 10.1021/ja047675c; Siwy ZS, 2006, ADV FUNCT MATER, V16, P735, DOI 10.1002/adfm.200500471; Skinner GM, 2009, NANO LETT, V9, P2953, DOI 10.1021/nl901370w; Smeets RMM, 2009, NANO LETT, V9, P3089, DOI 10.1021/nl803189k; Smeets RMM, 2006, NANO LETT, V6, P89, DOI 10.1021/nl052107w; Stein DM, 2004, REV SCI INSTRUM, V75, P900, DOI 10.1063/1.1666986; Storm AJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051903; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b; Wanunu M, 2008, BIOPHYS J, V95, P4716, DOI 10.1529/biophysj.108.140475; Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/nnano.2010.202, 10.1038/NNANO.2010.202]; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]; Wanunu M, 2009, NANO LETT, V9, P3498, DOI 10.1021/nl901691v; Wei RS, 2012, NAT NANOTECHNOL, V7, P257, DOI [10.1038/nnano.2012.24, 10.1038/NNANO.2012.24]; Yusko EC, 2011, NAT NANOTECHNOL, V6, P253, DOI 10.1038/nnano.2011.12; Zhang JS, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021906; Zhao Q, 2008, NUCLEIC ACIDS RES, V36, P1532, DOI 10.1093/nar/gkm1017	64	42	45	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46014	10.1371/journal.pone.0046014	http://dx.doi.org/10.1371/journal.pone.0046014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029365	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700106
J	Kac, G; Schlussel, MM; Perez-Escamilla, R; Velasquez-Melendez, G; da Silva, AAM				Kac, Gilberto; Schluessel, Michael M.; Perez-Escamilla, Rafael; Velasquez-Melendez, Gustavo; Moura da Silva, Antonio Augusto			Household Food Insecurity Is Not Associated with BMI for Age or Weight for Height among Brazilian Children Aged 0-60 Months	PLOS ONE			English	Article							OVERWEIGHT STATUS; SCHOOL-CHILDREN; US CHILDREN; OBESITY; INCOME; UNDERWEIGHT; COLOMBIA; FAMILIES	We examined the association between Household Food Insecurity (HFI), weight for height z-score (WHZ) and Body Mass Index for age z-score (BMI-Z) in a representative sample of children 0-60 months of age (n = 3,433) in five Brazilian geographical regions. Data were derived from the 2006-07 Brazilian Demographic and Health Survey. HFI was measured with the Brazilian Food Insecurity Scale. Associations were estimated using multiple linear regression models (beta coefficients and 95% CI) taking into account the complex sampling design. Interaction terms between HFI and geographical region and HFI and child sex and child age were assessed. The weighted prevalence of any level of HFI was 48.6%. Severe food insecurity was more prevalent among children from the North region (16.8%), born from mothers with <4 years of schooling (15.9%) and those from families with >= 3 children (18.8%). The interaction between HFI and geographical region was non-significant for BMI-Z (P = 0.119) and WHZ (P = 0.198). Unadjusted results indicated that HFI was negatively associated with BMI-Z (moderate to severe HFI: beta = -0.19, 95% CI: -0.35 - -0.03, P = 0.047), and WHZ (moderate to severe HFI: beta = -0.26, 95% CI: -0.42 - -0.09, P = 0.009). Estimates lost significance after adjustments for key confounders such as mothers' skin color, mothers' years of schooling, place of household, household income quartiles, mothers' smoking habit, mothers' marital status, number of children 0-60 months in the household, and birth order. HFI is unrelated to weight outcomes among Brazilian children 0-60 months.	[Kac, Gilberto; Schluessel, Michael M.] Univ Fed Rio de Janeiro, Observ Epidemiol Nutr, Inst Nutr Josue Castro, Rio De Janeiro, RJ, Brazil; [Perez-Escamilla, Rafael] Yale Sch Publ Hlth, New Haven, CT USA; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Escola Enfermagem, Dept Enfermagem Materno Infantil Saude Publ, Belo Horizonte, MG, Brazil; [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Maranhao, Brazil	Universidade Federal do Rio de Janeiro; Yale University; Universidade Federal de Minas Gerais; Universidade Federal do Maranhao	Kac, G (corresponding author), Univ Fed Rio de Janeiro, Observ Epidemiol Nutr, Inst Nutr Josue Castro, Rio De Janeiro, RJ, Brazil.	gilberto.kac@gmail.com	Kac, Gilberto/H-6862-2012; Silva, Antonio A M/B-5410-2009	Kac, Gilberto/0000-0001-8603-9077; Silva, Antonio A M/0000-0003-4968-5138	Rio de Janeiro State (FAPERJ)	Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	G. Kac, G. Velasquez-Melendez and A. A. M. Silva are research fellows from the Brazilian National Council for Scientific and Technological Development (CNPq). M. M. Schlussel is research fellow from Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo K, 2001, ARCH PEDIAT ADOL MED, V155, P1161, DOI 10.1001/archpedi.155.10.1161; Alvarado Beatriz Eugenia, 2005, Cad. Saúde Pública, V21, P724, DOI 10.1590/S0102-311X2005000300006; Baig-Ansari N, 2006, FOOD NUTR BULL, V27, P114, DOI 10.1177/156482650602700203; Bhargava A, 2008, BRIT J NUTR, V100, P438, DOI 10.1017/S0007114508894366; Casey PH, 2006, PEDIATRICS, V118, pE1406, DOI 10.1542/peds.2006-0097; dos Santos JV, 2010, CAD SAUDE PUBLICA, V26, P41, DOI 10.1590/S0102-311X2010000100005; Dubois L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-199; Eisenmann JC, 2011, OBES REV, V12, pe73, DOI 10.1111/j.1467-789X.2010.00820.x; Gundersen C, 2009, J NUTR, V139, P1173, DOI 10.3945/jn.109.105361; Hackett M, 2009, REV PANAM SALUD PUBL, V25, P506, DOI 10.1590/S1020-49892009000600006; Institute of Medicine, 2011, HUNG OB UND FOOD INS; Isanaka S, 2007, J NUTR, V137, P2747, DOI 10.1093/jn/137.12.2747; Jones SJ, 2003, ARCH PEDIAT ADOL MED, V157, P780, DOI 10.1001/archpedi.157.8.780; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; Kac G, 2012, PUBLIC HEALTH NUTR, P1; Kac Gilberto, 2003, Cad. Saúde Pública, V19, pS4, DOI 10.1590/S0102-311X2003000700001; Larson NI, 2011, AM J PREV MED, V40, P166, DOI 10.1016/j.amepre.2010.10.028; Antunes MML, 2010, CAD SAUDE PUBLICA, V26, P1642, DOI 10.1590/S0102-311X2010000800017; Metallinos-Katsaras E, 2009, J AM DIET ASSOC, V109, P1790, DOI 10.1016/j.jada.2009.07.007; Monteiro CA, 2002, PUBLIC HEALTH NUTR, V5, P105, DOI 10.1079/PHN2001281; Oh SY, 2003, EUR J CLIN NUTR, V57, P1598, DOI 10.1038/sj.ejcn.1601877; Oliveira Juliana Souza, 2010, Rev. Bras. Saude Mater. Infant., V10, P237, DOI 10.1590/S1519-38292010000200011; Ortiz-Hernandez L, 2007, REV INVEST CLIN, V59, P32; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Perez-Escamilla R, 2012, MODERN NUTR HLTH DIS; Perez-Escamilla R, 2008, REV NUTR, V21, P15; Reis M, 2012, HEALTH ECON, V21, P405, DOI 10.1002/hec.1722; Rose D, 2006, PEDIATRICS, V117, P464, DOI 10.1542/peds.2005-0582; Velasquez-Melendez G, 2011, J NUTR, V141, P898, DOI 10.3945/jn.110.135046; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 1995, PHYS STAT US INT ANT	31	22	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45747	10.1371/journal.pone.0045747	http://dx.doi.org/10.1371/journal.pone.0045747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029220	Green Submitted, gold, Green Published			2022-12-25	WOS:000309392800091
J	Vandergaast, R; Fredericksen, BL				Vandergaast, Rianna; Fredericksen, Brenda L.			West Nile Virus (WNV) Replication Is Independent of Autophagy in Mammalian Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; UNFOLDED PROTEIN RESPONSE; INFECTION; ACTIVATION; MACHINERY; DEGRADATION; INDUCTION; MARKER	Autophagy is a homeostatic process responsible for recycling cytosolic proteins and organelles. Moreover, this pathway contributes to the cell's intrinsic innate defenses. While many viruses have evolved mechanisms to antagonize the antiviral effects of the autophagy pathway, others subvert autophagy to facilitate replication. Here, we have investigated the role of autophagy in West Nile virus (WNV) replication. Experiments in cell lines derived from a variety of sources, including the kidney, liver, skin, and brain, indicated that WNV replication does not upregulate the autophagy pathway. Furthermore, WNV infection did not inhibit rapamycin-induced autophagy, suggesting that WNV does not disrupt the authophagy signaling cascade. Perturbation of the autophagy pathway by depletion of the major autophagy factors Atg5 or Atg7 had no effect on WNV infectious particle production, indicating that WNV does not require a functional autophagy pathway for replication. Taken together, the results of our study provide evidence that WNV, unlike several other viruses of the family Flaviviridae, does not significantly interact with the conventional autophagy pathway in mammalian cells.	[Vandergaast, Rianna; Fredericksen, Brenda L.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Vandergaast, Rianna; Fredericksen, Brenda L.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Fredericksen, BL (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	bfreder@umd.edu			Public Health Service from the National Institute of Allergy and Infectious Diseases [AI083397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083397] Funding Source: NIH RePORTER	Public Health Service from the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant AI083397 from the National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982; Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Estrabaud E, 2011, J HEPATOL, V55, P1150, DOI 10.1016/j.jhep.2011.04.025; Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001; Lin LT, 2010, VIROLOGY, V402, P1, DOI 10.1016/j.virol.2010.03.026; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Mizui T, 2010, J GASTROENTEROL, V45, P195, DOI 10.1007/s00535-009-0132-9; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Orvedahl A, 2008, AUTOPHAGY, V4, P280, DOI 10.4161/auto.5289; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; Sejvar JJ, 2006, REV MED VIROL, V16, P209, DOI 10.1002/rmv.501; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Shrivastava S, 2012, J VIROL; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	47	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45800	10.1371/journal.pone.0045800	http://dx.doi.org/10.1371/journal.pone.0045800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029249	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800099
J	Zhang, JZ; An, Y; Gao, JW; Han, J; Pan, XY; Pan, Y; Tie, L; Li, XJ				Zhang, Jianzhao; An, Yu; Gao, Junwei; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun			Aquaporin-1 Translocation and Degradation Mediates the Water Transportation Mechanism of Acetazolamide	PLOS ONE			English	Article							DOWN-REGULATION; CONCENTRATING ABILITY; MAPK PATHWAYS; CHANNELS; EXPRESSION; PERMEABILITY; PROTEIN; AQP1; TRAFFICKING; MEMBRANE	Background: Diuretic agents are widely used on the treatment of water retention related diseases, among which acetazolamide (AZA) acts originally as a carbonic anhydrase (CA) inhibitor. Aquaporin-1 (AQP1) being located in renal proximal tubules is required for urine concentration. Previously our lab has reported AZA putatively modulated AQP1. Aim of this study is to testify our hypothesis that regulating AQP1 may mediate diuretic effect of AZA. Methodology/Principal Findings: For in vivo study, we utilized Sprague Dawley rats, as well as AQP1 knock-out (AQP1(-/-)) mice to examine urine volume, and human kidney-2 (HK-2) cell line was used for in vitro mechanism study. In our present study we found that AZA decreased CAs activity initially but the activity gradually recovered. Contrarily, diuretic effect was consistently significant. AQP1 protein expression was significantly decreased on day 7 and 14. By utilizing AQP1(-/-) mice, we found diuretic effect of AZA was cancelled on day 14, while urine volume continuously increased in wild-type mice. Surface plasmon resonance (SPR) results indicated AQP1 was physiologically bound by myosin heavy chain (MHC), immunoprecipitation and immunofluorescence results confirmed this protein interaction. In vitro study results proved AZA facilitated AQP1 translocation onto cell membrane by promoting interaction with MHC, dependent on ERK/ myosin light chain kinase (MLCK) pathway activation. MHC inhibitor BDM and ERK inhibitor U0126 both abolished above effect of AZA. Eventually AZA induced AQP1 ubiquitination, while proteasome inhibitor MG132 reversed AZA's down-regulating effect upon AQP1. Conclusions/Significance: Our results identified AZA exerted diuretic effect through an innovative mechanism by regulating AQP1 and verified its inhibitory mechanism was via promoting MHC-dependent translocation onto cell membrane and then ubiquitin mediated degradation, implicating a novel mechanism and target for diuretic agent discovering.	[Zhang, Jianzhao; An, Yu; Gao, Junwei; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhang, Jianzhao; An, Yu; Han, Jing; Pan, Xueyang; Pan, Yan; Tie, Lu; Li, Xuejun] Peking Univ, Inst Syst Biomed, Beijing 100871, Peoples R China	Peking University; Peking University	Li, XJ (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	lixj@bjmu.edu.cn	An, Yu/O-2966-2013; Pan, Xueyang/Y-1641-2019	An, Yu/0000-0002-9678-3382; Pan, Xueyang/0000-0003-4453-4971	National Natural Science Foundation of China [81020108031, 30572202, 30973558, 30772571, 30901815, 30901803]; Ministry of Science and Technology in China [2009ZX09103-144]; Ministry of Education of China [B07001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology in China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81020108031, 30572202, 30973558, 30772571, 30901815, 30901803), the Major Specialized Research Fund from the Ministry of Science and Technology in China (No. 2009ZX09103-144) and Research Fund from Ministry of Education of China (111 Projects No. B07001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1993, AM J PHYSIOL, V265, pF463; Ameli PA, 2012, ACTA NEUROCHIR SUPPL, V113, P59, DOI 10.1007/978-3-7091-0923-6_13; Amlal H, 2001, KIDNEY INT, V60, P1824, DOI 10.1046/j.1523-1755.2001.00995.x; BANKS DA, 1986, EPILEPSIA, V27, P510, DOI 10.1111/j.1528-1157.1986.tb03576.x; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bin K, 2011, HEPATO-GASTROENTEROL, V58, P1502, DOI 10.5754/hge11154; BRION LP, 1988, ANAL BIOCHEM, V175, P289, DOI 10.1016/0003-2697(88)90391-0; Conner MT, 2012, J BIOL CHEM, V287, P11516, DOI 10.1074/jbc.M111.329219; Conner MT, 2010, BIOCHEMISTRY-US, V49, P821, DOI 10.1021/bi902068b; Dantzler WH, 2011, ACTA PHYSIOL, V202, P361, DOI 10.1111/j.1748-1716.2010.02214.x; Gao JW, 2006, ANAL BIOCHEM, V350, P165, DOI 10.1016/j.ab.2006.01.003; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Jiang Q, 2009, INT J MOL MED, V23, P771, DOI 10.3892/ijmm_00000191; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Lee J, 2006, KIDNEY BLOOD PRESS R, V29, P18, DOI 10.1159/000092483; Leitch V, 2001, P NATL ACAD SCI USA, V98, P2894, DOI 10.1073/pnas.041616498; LI XJ, 1994, BIOCHEM MOL BIOL INT, V32, P371; Liu LH, 2011, LUNG, V189, P331, DOI 10.1007/s00408-011-9288-1; Ma B, 2004, ACTA PHARMACOL SIN, V25, P90; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; MA TH, 1993, J BIOL CHEM, V268, P22756; Marinelli RA, 1997, J BIOL CHEM, V272, P12984, DOI 10.1074/jbc.272.20.12984; Marinelli RA, 1999, AM J PHYSIOL-GASTR L, V276, pG280, DOI 10.1152/ajpgi.1999.276.1.G280; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Mubarakshina Borisova MM, 2012, BIOCH BIOPHYS ACTA; Navratilova I, 2011, FUTURE MED CHEM, V3, P1809, DOI [10.4155/fmc.11.128, 10.4155/FMC.11.128]; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nielsen S, 1996, Perit Dial Int, V16 Suppl 1, pS25; NIELSEN S, 1993, J CELL BIOL, V120, P371, DOI 10.1083/jcb.120.2.371; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Noda Y, 2004, J PHARMACOL SCI, V96, P249, DOI 10.1254/jphs.FMJ04004X2; PRESTON GM, 1993, J BIOL CHEM, V268, P17; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Ran X, 2010, HEART VESSELS, V25, P237, DOI 10.1007/s00380-009-1179-5; Sakurada Tsutomu, 2004, Adv Perit Dial, V20, P37; Schnermann J, 1998, P NATL ACAD SCI USA, V95, P9660, DOI 10.1073/pnas.95.16.9660; Sogaard R, 2008, PFLUG ARCH EUR J PHY, V456, P285, DOI 10.1007/s00424-007-0392-2; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Takata K, 2008, HISTOCHEM CELL BIOL, V130, P197, DOI 10.1007/s00418-008-0457-0; Tang S, 2001, AM J KIDNEY DIS, V38, P317, DOI 10.1053/ajkd.2001.26097; Tanimura Y, 2009, J STRUCT BIOL, V166, P16, DOI 10.1016/j.jsb.2008.11.010; Tietz PS, 2006, BIOL CELL, V98, P43, DOI 10.1042/BC20040089; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Verkman AS, 1998, AM J MED SCI, V316, P310, DOI 10.1097/00000441-199811000-00004; Xiang Y, 2004, ACTA PHARMACOL SIN, V25, P812; Yang BX, 2006, FEBS LETT, V580, P6679, DOI 10.1016/j.febslet.2006.11.025; Yool Andrea J, 2002, BMC Physiol, V2, P4, DOI 10.1186/1472-6793-2-4; Yool AJ, 2010, CLIN EXP PHARMACOL P, V37, P403, DOI 10.1111/j.1440-1681.2009.05244.x; Zhao D, 2006, AM J PHYSIOL-RENAL, V291, pF429, DOI 10.1152/ajprenal.00011.2006	52	27	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45976	10.1371/journal.pone.0045976	http://dx.doi.org/10.1371/journal.pone.0045976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029347	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800127
J	Rossaint, J; Berger, C; Van Aken, H; Scheld, HH; Zahn, PK; Rukosujew, A; Zarbock, A				Rossaint, Jan; Berger, Christian; Van Aken, Hugo; Scheld, Hans H.; Zahn, Peter K.; Rukosujew, Andreas; Zarbock, Alexander			Cardiopulmonary Bypass during Cardiac Surgery Modulates Systemic Inflammation by Affecting Different Steps of the Leukocyte Recruitment Cascade	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SOLUBLE ADHESION MOLECULES; E-SELECTIN; NEUTROPHIL ADHESION; INTEGRIN ACTIVATION; SURFACE EXPRESSION; P-SELECTIN; ISCHEMIA-REPERFUSION; RECEPTOR EXPRESSION; CD11B/CD18 MAC-1	Background: It is known that the use of a cardiopulmonary bypass (CPB) during cardiac surgery leads to leukocyte activation and may, among other causes, induce organ dysfunction due to increased leukocyte recruitment into different organs. Leukocyte extravasation occurs in a cascade-like fashion, including capturing, rolling, adhesion, and transmigration. However, the molecular mechanisms of increased leukocyte recruitment caused by CPB are not known. This clinical study was undertaken in order to investigate which steps of the leukocyte recruitment cascade are affected by the systemic inflammation during CPB. Methods: We investigated the effects of CPB on the different steps of the leukocyte recruitment cascade in whole blood from healthy volunteers (n = 9) and patients undergoing cardiac surgery with the use of cardiopulmonary bypass (n = 7) or in off-pump coronary artery bypass-technique (OPCAB, n = 9) by using flow chamber experiments, transmigration assays, and biochemical analysis. Results: CPB abrogated selectin-induced slow leukocyte rolling on E-selectin/ICAM-1 and P-selectin/ICAM-1. In contrast, chemokine-induced arrest and transmigration was significantly increased by CPB. Mechanistically, the abolishment of slow leukocyte rolling was due to disturbances in intracellular signaling with reduced phosphorylation of phospholipase C (PLC) gamma 2, Akt, and p38 MAP kinase. Furthermore, CPB induced an elevated transmigration which was caused by upregulation of Mac-1 on neutrophils. Conclusion: These data suggest that CPB abrogates selectin-mediated slow leukocyte rolling by disturbing intracellular signaling, but that the clinically observed increased leukocyte recruitment caused by CPB is due to increased chemokine-induced arrest and transmigration. A better understanding of the underlying molecular mechanisms causing systemic inflammation after CPB may aid in the development of new therapeutic approaches.	[Rossaint, Jan; Berger, Christian; Van Aken, Hugo; Zarbock, Alexander] Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Scheld, Hans H.; Rukosujew, Andreas] Univ Hosp Munster, Dept Thorac & Cardiovasc Surg, Munster, Germany; [Zahn, Peter K.] Univ Hosp Bergmannsheil Bochum, Dept Anesthesiol Intens Care Med Palliat Care Med, Bochum, Germany	University of Munster; University of Munster; Ruhr University Bochum	Zarbock, A (corresponding author), Univ Hosp Munster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany.	zarbock@uni-muenster.de	Berger, Christian/AAI-6750-2021; Zahn, Peter/AAB-9377-2021	Berger, Christian/0000-0002-9087-7732; Rukosujew, Andreas/0000-0002-0869-1630	DFG ("Deutsche Forschungsgemeinschaft")	DFG ("Deutsche Forschungsgemeinschaft")(German Research Foundation (DFG))	This study was funded by the DFG ("Deutsche Forschungsgemeinschaft"). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman U, 2007, J INFLAMM LOND, V4, P21, DOI DOI 10.1186/1476-9255-4-21; Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9; Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2; Asimakopoulos G, 2001, PERFUSION-UK, V16, P353, DOI 10.1177/026765910101600505; Ben-Abraham R, 2003, PAEDIATR ANAESTH, V13, P655, DOI 10.1046/j.1460-9592.2003.01069.x; Block H, 2012, J EXP MED, V209, P407, DOI 10.1084/jem.20111493; BRAUDE S, 1986, AM REV RESPIR DIS, V134, P867, DOI 10.1164/arrd.1986.134.5.867; Cameron D, 1996, J CARDIOVASC PHARM, V27, pS1; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chesnutt BC, 2006, MICROCIRCULATION, V13, P99, DOI 10.1080/10739680500466376; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Diacovo TG, 1996, BLOOD, V88, P146; DREYER WJ, 1991, CIRCULATION, V84, P400, DOI 10.1161/01.CIR.84.1.400; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; ELLIOTT MJ, 1993, ANN THORAC SURG, V56, P1503, DOI 10.1016/0003-4975(93)90741-Y; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; FORSYTH KD, 1990, J IMMUNOL METHODS, V128, P159, DOI 10.1016/0022-1759(90)90206-B; FREYER DR, 1988, J IMMUNOL, V141, P580; GILLINOV AM, 1994, ANN THORAC SURG, V57, P126, DOI 10.1016/0003-4975(94)90380-8; GLASSER L, 1990, AM J CLIN PATHOL, V93, P662, DOI 10.1093/ajcp/93.5.662; Hambsch J, 2002, ANESTHESIOLOGY, V96, P1078, DOI 10.1097/00000542-200205000-00009; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HIND CRK, 1988, CARDIOVASC RES, V22, P37, DOI 10.1093/cvr/22.1.37; Inoue T, 2003, CIRCULATION, V107, P1757, DOI 10.1161/01.CIR.0000060487.15126.56; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; KUIJPERS TW, 1991, BLOOD, V78, P1105; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Kunkel EJ, 2000, J IMMUNOL, V164, P3301, DOI 10.4049/jimmunol.164.6.3301; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Landis Clive, 2007, J Extra Corpor Technol, V39, P291; Landis RC, 2009, SEMIN CARDIOTHORAC V, V13, P87, DOI 10.1177/1089253209337743; Laudanna C, 2009, WIRES SYST BIOL MED, V1, P116, DOI 10.1002/wsbm.9; Lewis SM, 2009, AM J RESP CELL MOL, V40, P724, DOI 10.1165/rcmb.2008-0252OC; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liangos O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013658; Lo Presti R, 2004, CLIN HEMORHEOL MICRO, V30, P53; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marsik C, 2004, J CLIN IMMUNOL, V24, P62, DOI 10.1023/B:JOCI.0000018064.13793.83; May AE, 2002, BLOOD, V100, P3611, DOI 10.1182/blood-2002-03-0778; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Murphy GJ, 2004, J CARDIAC SURG, V19, P481, DOI 10.1111/j.0886-0440.2004.04101.x; Orr Y, 2007, J LEUKOCYTE BIOL, V82, P1115, DOI 10.1189/jlb.0906545; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Raja SG, 2007, J CARDIAC SURG, V22, P445, DOI 10.1111/j.1540-8191.2007.00447.x; RINDER CS, 1992, BLOOD, V79, P1201; Rinder CS, 2003, ANN THORAC SURG, V75, P899, DOI 10.1016/S0003-4975(02)04490-9; Rosenbloom AJ, 1999, J LEUKOCYTE BIOL, V66, P83, DOI 10.1002/jlb.66.1.83; ROSENBLOOM AJ, 1995, JAMA-J AM MED ASSOC, V274, P58, DOI 10.1001/jama.274.1.58; Rossaint J, 2011, KIDNEY INT, V80, P493, DOI 10.1038/ki.2011.125; SCHLEIFFENBAUM B, 1989, J IMMUNOL, V142, P3537; Schnoor M, 2011, J EXP MED, V208, P1721, DOI 10.1084/jem.20101920; Simon DI, 1997, ARTERIOSCL THROM VAS, V17, P528, DOI 10.1161/01.ATV.17.3.528; Sniecinski RM, 2011, ANESTH ANALG, V113, P1319, DOI 10.1213/ANE.0b013e3182354b7e; Stadtmann A, 2011, EUR J IMMUNOL, V41, P2074, DOI 10.1002/eji.201041196; TELLADO JM, 1993, SURGERY, V113, P624; Urner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033403; VEDDER NB, 1988, J CLIN INVEST, V81, P676, DOI 10.1172/JCI113372; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Warren OJ, 2009, J CARDIOTHOR VASC AN, V23, P223, DOI 10.1053/j.jvca.2008.08.007; Wei MX, 2003, WORLD J SURG, V27, P140, DOI 10.1007/s00268-002-6595-y; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zarbock A, 2012, J MOL MED, V90, P353, DOI 10.1007/s00109-011-0835-2; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zarbock A, 2009, J LEUKOCYTE BIOL, V86, P1119, DOI 10.1189/jlb.0209117; Zarbock A, 2009, MICROCIRCULATION, V16, P31, DOI 10.1080/10739680802350104	75	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45738	10.1371/journal.pone.0045738	http://dx.doi.org/10.1371/journal.pone.0045738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029213	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400128
J	Yeo, ZX; Chan, M; Yap, YS; Ang, P; Rozen, S; Lee, ASG				Yeo, Zhen Xuan; Chan, Maurice; Yap, Yoon Sim; Ang, Peter; Rozen, Steve; Lee, Ann Siew Gek			Improving Indel Detection Specificity of the Ion Torrent PGM Benchtop Sequencer	PLOS ONE			English	Article							COPY-NUMBER; MUTATION; GENOME	The emergence of benchtop sequencers has made clinical genetic testing using next-generation sequencing more feasible. Ion Torrent's PGM (TM) is one such benchtop sequencer that shows clinical promise in detecting single nucleotide variations (SNVs) and microindel variations (indels). However, the large number of false positive indels caused by the high frequency of homopolymer sequencing errors has impeded PGM (TM)'s usage for clinical genetic testing. An extensive analysis of PGM (TM) data from the sequencing reads of the well-characterized genome of the Escherichia coli DH10B strain and sequences of the BRCA1 and BRCA2 genes from six germline samples was done. Three commonly used variant detection tools, SAMtools, Dindel, and GATK's Unified Genotyper, all had substantial false positive rates for indels. By incorporating filters on two major measures we could dramatically improve false positive rates without sacrificing sensitivity. The two measures were: B-Allele Frequency (BAF) and VARiation of the Width of gaps and inserts (VARW) per indel position. A BAF threshold applied to indels detected by UnifiedGenotyper removed similar to 99% of the indel errors detected in both the DH10B and BRCA sequences. The optimum BAF threshold for BRCA sequences was determined by requiring 100% detection sensitivity and minimum false discovery rate, using variants detected from Sanger sequencing as reference. This resulted in 15 indel errors remaining, of which 7 indel errors were removed by selecting a VARW threshold of zero. VARW specific errors increased in frequency with higher read depth in the BRCA datasets, suggesting that homopolymer-associated indel errors cannot be reduced by increasing the depth of coverage. Thus, using a VARW threshold is likely to be important in reducing indel errors from data with higher coverage. In conclusion, BAF and VARW thresholds provide simple and effective filtering criteria that can improve the specificity of indel detection in PGM (TM) data without compromising sensitivity.	[Yeo, Zhen Xuan; Chan, Maurice; Lee, Ann Siew Gek] Natl Canc Ctr Singapore, Div Med Sci, Singapore, Singapore; [Yap, Yoon Sim; Ang, Peter] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Ang, Peter] Gleneagles Med Ctr, Oncocare Canc Ctr, Singapore, Singapore; [Rozen, Steve] Duke NUS Grad Med Sch, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	; Rozen, Steven G./J-5939-2013	Ang, Peter/0000-0002-0482-3069; Rozen, Steven G./0000-0002-4288-0056	SingHealth Foundation [SHF/FG482S/2010]; National Medical Research Council of Singapore [NMRC/1194/2008]	SingHealth Foundation(SingHealth); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This work was supported by a SingHealth Foundation grant (SHF/FG482S/2010) awarded to MC and a grant from the National Medical Research Council of Singapore (NMRC/1194/2008) awarded to ASGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Harismendy O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r124; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Losada L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019054; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Samarakoon U, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-116; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	32	40	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45798	10.1371/journal.pone.0045798	http://dx.doi.org/10.1371/journal.pone.0045798			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029247	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388400132
J	Cahill, KB; Quade, JH; Carleton, KL; Cote, RH				Cahill, Karyn B.; Quade, Jonathan H.; Carleton, Karen L.; Cote, Rick H.			Identification of Amino Acid Residues Responsible for the Selectivity of Tadalafil Binding to Two Closely Related Phosphodiesterases, PDE5 and PDE6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; CATALYTIC SITE; CGMP BINDING; INHIBITORS; POTENCY; ROD; SILDENAFIL; VARDENAFIL; MECHANISM; EFFICACY	The 11 families of the Class I cyclic nucleotide phosphodiesterases (PDEs) are critical for regulation of cyclic nucleotide signaling. PDE5 (important in regulating vascular smooth muscle contraction) and PDE6 (responsible for regulating visual transduction in vertebrate photoreceptors) are structurally similar but have several functional differences whose structural basis is poorly understood. Using evolutionary trace analysis and structural homology modeling in conjunction with site-directed mutagenesis, we have tested the hypothesis that class-specific differences between PDE5 and PDE6 account for the biochemical and pharmacological differences in the two enzyme families. Replacing human PDE5 residues in the M-loop region of the binding site for the PDE5-selective inhibitor tadalafil (Cialis (R)) with the corresponding class-specific cone PDE6 residues (P773E, I778V, E780L, F787W, E796V, D803P, L804M, N806D, I813L, S815K) reduces tadalafil binding affinity to levels characteristic of PDE6. These mutations fail to alter vardenafil (Levitra (R)) affinity for the active site. Class-specific differences in PDE5 versus cone PDE6 that contribute to the accelerated catalytic efficiency of PDE6 were identified but required heterologous expression of full-length PDE5 constructs. Introduction of PDE6 residues into the background of the PDE5 protein sequence often led to loss of catalytic activity and reduced protein solubility, supporting the idea that multiple structural elements of PDE6 are highly susceptible to misfolding during heterologous expression. This work validates the use of PDE5 as a template to identify functional differences between PDE5 and PDE6 that will accelerate efforts to develop the next generation of PDE5-selective inhibitors with fewer adverse side effects resulting from PDE6 inhibition.	[Cahill, Karyn B.; Quade, Jonathan H.; Cote, Rick H.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Carleton, Karen L.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System Of New Hampshire; University of New Hampshire; University System of Maryland; University of Maryland College Park	Cote, RH (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, 46 Coll Rd, Durham, NH 03824 USA.	rick.cote@unh.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Carleton, Karen/0000-0001-6306-5643	National Institutes of Health [R01 EY05798-24]; New Hampshire Agricultural Experiment Station [2482]; NATIONAL EYE INSTITUTE [R01EY005798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Hampshire Agricultural Experiment Station; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY05798-24 (to R. H. C.) Partial funding was provided by the New Hampshire Agricultural Experiment Station; this is Scientific Contribution Number 2482.	Bischoff E, 2004, INT J IMPOT RES, V16, pS11, DOI 10.1038/sj.ijir.3901208; Blount MA, 2004, MOL PHARMACOL, V66, P144, DOI 10.1124/mol.66.1.144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Carleton KL, 2005, J MOL EVOL, V61, P75, DOI 10.1007/s00239-004-0289-z; Chen G, 2008, BIOCHEM PHARMACOL, V75, P1717, DOI 10.1016/j.bcp.2008.01.019; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote R.H., 2006, CYCLIC NUCLEOTIDE PH, DOI DOI 10.1201/9781420020847.CH8; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Cote RH, 2000, METHOD ENZYMOL, V315, P646; D'Amours MR, 1999, MOL PHARMACOL, V55, P508; Francis S, 2006, CYCLIC NUCLEOTIDE PH, P131; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; GILLESPIE PG, 1989, MOL PHARMACOL, V36, P773; Goc A, 2010, J MOL BIOL, V401, P363, DOI 10.1016/j.jmb.2010.06.044; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Granovsky AE, 2001, J BIOL CHEM, V276, P21698, DOI 10.1074/jbc.M100626200; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Kajimura N, 2002, J STRUCT BIOL, V139, P27, DOI 10.1016/S1047-8477(02)00502-6; Kerr NM, 2009, CLIN EXP OPHTHALMOL, V37, P514, DOI 10.1111/j.1442-9071.2009.02070.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laties A, 2006, J SEX MED, V3, P12, DOI 10.1111/j.1743-6109.2005.00194.x; Laties AM, 2009, DRUG SAFETY, V32, P1, DOI 10.2165/00002018-200932010-00001; Lichtarge O, 2010, CURR OPIN STRUC BIOL, V20, P351, DOI 10.1016/j.sbi.2010.04.002; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Piriev N, 2003, MOL VIS, V9, P80; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Supuran CT, 2006, CURR PHARM DESIGN, V12, P3459, DOI 10.2174/138161206778343118; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; White JB, 2004, MOL VIS, V10, P738; Zhang J, 2004, BIOCHEM PHARMACOL, V68, P867, DOI 10.1016/j.bcp.2004.05.015; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257; Zoraghi R, 2007, BIOCHEMISTRY-US, V46, P13554, DOI 10.1021/bi7010702	41	25	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41406	41416		10.1074/jbc.M112.389189	http://dx.doi.org/10.1074/jbc.M112.389189			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23033484	Green Published, hybrid			2022-12-25	WOS:000311887600053
J	Liu, YY; Lv, KS; Li, ZL; Yu, ACH; Chen, JG; Teng, JL				Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Yu, Albert C. H.; Chen, Jianguo; Teng, Junlin			PACSIN1, a Tau-interacting Protein, Regulates Axonal Elongation and Branching by Facilitating Microtubule Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; CULTURED HIPPOCAMPAL-NEURONS; SYNDAPIN-I; DYNAMIC MICROTUBULES; PHOSPHORYLATION; ORGANIZATION; ACTIN; MEMBRANE; ISOFORMS; TUBULIN	Tau is a major member of the neuronal microtubule-associated proteins. It promotes tubulin assembly and stabilizes axonal microtubules. Previous studies have demonstrated that Tau forms cross-bridges between microtubules, with some particles located on cross-bridges, suggesting that some proteins interact with Tau and might be involved in regulating Tau-related microtubule dynamics. This study reports that PACSIN1 interacts with Tau in axon. PACSIN1 blockade results in impaired axonal elongation and a higher number of primary axonal branches in mouse dorsal root ganglia neurons, which is induced by increasing the binding ability of Tau to microtubules. In PACSIN1-blocked dorsal root ganglia neurons, a greater amount of Tau is inclined to accumulate in the central domain of growth cones, and it promotes the stability of the microtubule network. Taken together, these results suggest that PACSIN1 is an important Tau binding partner in regulating microtubule dynamics and forming axonal plasticity.	[Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Chen, Jianguo; Teng, Junlin] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Liu, Yingying; Lv, Kaosheng; Li, Zenglong; Chen, Jianguo; Teng, Junlin] Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Coll Life Sci, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Yu, Albert C. H.] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci,Key Lab Neurosci,Minist Educ, Beijing 100191, Peoples R China; [Yu, Albert C. H.] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci,Key Lab Neurosci,Minist Publ Hl, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University	Chen, JG (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	chenjg@pku.edu.cn; junlinteng@pku.edu.cn			National Natural Science Foundation of China [30670659, 31071177]; Major State Basic Research Development Program of China (973 Program) [2010CB833705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China Grants 30670659 and 31071177 and Major State Basic Research Development Program of China (973 Program) Grant 2010CB833705.	Anggono V, 2006, NAT NEUROSCI, V9, P752, DOI 10.1038/nn1695; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Black MM, 1996, J NEUROSCI, V16, P3601; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Buck KB, 2002, J NEUROSCI, V22, P9358; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Clayton EL, 2009, J NEUROSCI, V29, P7706, DOI 10.1523/JNEUROSCI.1976-09.2009; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Grimm-Gunter EMS, 2008, EXP CELL RES, V314, P1991, DOI 10.1016/j.yexcr.2008.03.015; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; HUGHES GB, 1981, OTOLARYNG HEAD NECK, V89, P767, DOI 10.1177/019459988108900515; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; Kessels MM, 2002, EMBO J, V21, P6083, DOI 10.1093/emboj/cdf604; Kornack DR, 2005, CURR OPIN NEUROBIOL, V15, P58, DOI 10.1016/j.conb.2005.01.009; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Mantych KB, 2001, J NEUROSCI, V21, P6802, DOI 10.1523/JNEUROSCI.21-17-06802.2001; Modregger J, 2000, J CELL SCI, V113, P4511; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; OKABE S, 1990, NATURE, V343, P479, DOI 10.1038/343479a0; Plomann M, 1998, EUR J BIOCHEM, V256, P201, DOI 10.1046/j.1432-1327.1998.2560201.x; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Sergeant N, 2005, BBA-MOL BASIS DIS, V1739, P179, DOI 10.1016/j.bbadis.2004.06.020; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Wagner U, 1996, J CELL SCI, V109, P1537; Wang Q, 2009, P NATL ACAD SCI USA, V106, P12700, DOI 10.1073/pnas.0902974106; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; YU WQ, 1994, J NEUROSCI, V14, P5872	46	22	24	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.403451	http://dx.doi.org/10.1074/jbc.M112.403451			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035120	Green Published, hybrid			2022-12-25	WOS:000311233800059
J	Cosson, P; Marchetti, A; Ravazzola, M; Orci, L				Cosson, Pierre; Marchetti, Anna; Ravazzola, Mariella; Orci, Lelio			Mitofusin-2 Independent Juxtaposition of Endoplasmic Reticulum and Mitochondria: An Ultrastructural Study	PLOS ONE			English	Article							ELECTRON TOMOGRAPHY; COLOCALIZATION; ORGANIZATION; MICROSCOPY; CHANNELS; FUSION; LINE; ER	Besides its role in controlling the morphology of mitochondria, mitofusin-2 has been proposed to tether mitochondria to the endoplasmic reticulum (ER), based largely on light microscopic analysis. In this study we have examined by electron microscopy the organization of ER and mitochondria in cells expressing or not mitofusin-2. Contrary to previous studies, we observed that loss of mitofusin-2 increased ER-mitochondria juxtaposition. These results suggest that mitofusin-2 does not play a critical role in the juxtapostion of ER and mitochondria, and highlight the essential role of ultrastructural analysis to visualize and measure contact between two intracellular compartments.	[Cosson, Pierre; Marchetti, Anna; Ravazzola, Mariella; Orci, Lelio] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland	University of Geneva	Cosson, P (corresponding author), Ctr Med Univ Geneva, Dept Cell Physiol & Metab, Geneva Fac Med, Geneva, Switzerland.	Pierre.Cosson@unige.ch			Swiss National Science Foundation [31003A_135789]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx) to PC (31003A_135789). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; FIORI MG, 1981, NEUROSCIENCE, V6, P461, DOI 10.1016/0306-4522(81)90138-X; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Orci L, 2009, P NATL ACAD SCI USA, V106, P19358, DOI 10.1073/pnas.0911280106; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Santel A, 2001, J CELL SCI, V114, P867; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	23	168	170	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46293	10.1371/journal.pone.0046293	http://dx.doi.org/10.1371/journal.pone.0046293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029466	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900125
J	Donohoe, DR; Wali, A; Brylawski, BP; Bultman, SJ				Donohoe, Dallas R.; Wali, Aminah; Brylawski, Bruna P.; Bultman, Scott J.			Microbial Regulation of Glucose Metabolism and Cell-Cycle Progression in Mammalian Colonocytes	PLOS ONE			English	Article							GUT MICROBIOME; EPITHELIAL-CELLS; ENERGY-METABOLISM; GERM-FREE; INTESTINE; OBESITY; MOUSE; MUTUALISM; ECOLOGY; COLON	A prodigious number of microbes inhabit the human body, especially in the lumen of the gastrointestinal (GI) tract, yet our knowledge of how they regulate metabolic pathways within our cells is rather limited. To investigate the role of microbiota in host energy metabolism, we analyzed ATP levels and AMPK phosphorylation in tissues isolated from germfree and conventionally-raised C57BL/6 mice. These experiments demonstrated that microbiota are required for energy homeostasis in the proximal colon to a greater extent than other segments of the GI tract that also harbor high densities of bacteria. This tissue-specific effect is consistent with colonocytes utilizing bacterially-produced butyrate as their primary energy source, whereas most other cell types utilize glucose. However, it was surprising that glucose did not compensate for butyrate deficiency. We measured a 3.5-fold increase in glucose uptake in germfree colonocytes. However, C-13-glucose metabolic-flux experiments and biochemical assays demonstrated that they shifted their glucose metabolism away from mitochondrial oxidation/CO2 production and toward increased glycolysis/lactate production, which does not yield enough ATPs to compensate. The mechanism responsible for this metabolic shift is diminished pyruvate dehydrogenase (PDH) levels and activity. Consistent with perturbed PDH function, the addition of butyrate, but not glucose, to germfree colonocytes ex vivo stimulated oxidative metabolism. As a result of this energetic defect, germfree colonocytes exhibited a partial block in the G(1)-to-S-phase transition that was rescued by a butyrate-fortified diet. These data reveal a mechanism by which microbiota regulate glucose utilization to influence energy homeostasis and cell-cycle progression of mammalian host cells.	[Donohoe, Dallas R.; Wali, Aminah; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Donohoe, Dallas R.; Wali, Aminah; Bultman, Scott J.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA; [Brylawski, Bruna P.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bultman, SJ (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	Scott_Bultman@med.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Institutes of Health [CA125237]; American Institute of Cancer Research; Prevent Cancer Foundation; NIH [P30-ES10126]; NATIONAL CANCER INSTITUTE [R01CA125237, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute of Cancer Research; Prevent Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (CA125237 to S.J.B.), the American Institute of Cancer Research, and The Prevent Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank V. Madden, S. Ray, and B. Bagnell at the UNC Micrsocopy Services Laboratory for advice with confocal microscopy. We would also like to thank L. Collin at the UNC Biomarker Mass Spectrometry Facility (supported by NIH grant P30-ES10126) for his technical assistance in performing the LC-MS/MS experiments. Finally, we would like to thank the staff of the National Gnotobiotic Resource Center at UNC for maintaining germfree mice.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2000, CURR OPIN MICROBIOL, V3, P79, DOI 10.1016/S1369-5274(99)00055-7; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; KHOURY KA, 1969, J EXP MED, V130, P659, DOI 10.1084/jem.130.3.659; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; ROEDIGER WEW, 1979, GUT, V20, P484, DOI 10.1136/gut.20.6.484; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; SEWELL DL, 1975, AM J PHYSIOL, V228, P526, DOI 10.1152/ajplegacy.1975.228.2.526; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	31	93	96	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46589	10.1371/journal.pone.0046589	http://dx.doi.org/10.1371/journal.pone.0046589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029553	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900187
J	Gao, L; Jiang, T; Guo, J; Liu, Y; Cui, GY; Gu, LZ; Su, LY; Zhang, YD				Gao, Li; Jiang, Teng; Guo, Jun; Liu, Yi; Cui, Guiyun; Gu, Lize; Su, Lingying; Zhang, Yingdong			Inhibition of Autophagy Contributes to Ischemic Postconditioning-Induced Neuroprotection against Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; HYPOXIA-ISCHEMIA; INFARCT SIZE; NEURON DEATH; CELL-DEATH; IN-VIVO; PATHWAYS; STROKE; MODEL; BRAIN	Background: Ischemic postconditioning (IPOC), or relief of ischemia in a stuttered manner, has emerged as an innovative treatment strategy to reduce programmed cell death, attenuate ischemic injuries, and improve neurological outcomes. However, the mechanisms involved have not been completely elucidated. Recent studies indicate that autophagy is a type of programmed cell death that plays elusive roles in controlling neuronal damage and metabolic homeostasis. This study aims to determine the role of autophagy in IPOC-induced neuroprotection against focal cerebral ischemia in rats. Methodology/Principal Findings: A focal cerebral ischemic model with permanent middle cerebral artery (MCA) occlusion plus transient common carotid artery (CCA) occlusion was established. The autophagosomes and the expressions of LC3/Beclin 1/p62 were evaluated for their contribution to the activation of autophagy. We found that autophagy was markedly induced with the upregulation of LC3/Beclin 1 and downregulation of p62 in the penumbra at various time intervals following ischemia. IPOC, performed at the onset of reperfusion, reduced infarct size, mitigated brain edema, inhibited the induction of LC3/Beclin 1 and reversed the reduction of p62 simultaneously. Rapamycin, an inducer of autophagy, partially reversed all the aforementioned effects induced by IPOC. Conversely, autophagy inhibitor 3-methyladenine (3-MA) attenuated the ischemic insults, inhibited the activation of autophagy, and elevated the expression of anti-apoptotic protein Bcl-2, to an extent comparable to IPOC. Conclusions/Significance: The present study suggests that inhibition of the autophagic pathway plays a key role in IPOC-induced neuroprotection against focal cerebral ischemia. Thus, pharmacological inhibition of autophagy may provide a novel therapeutic strategy for the treatment of stroke.	[Gao, Li; Jiang, Teng; Zhang, Yingdong] Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Guo, Jun; Gu, Lize] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Liu, Yi; Su, Lingying] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Cui, Guiyun] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University	Zhang, YD (corresponding author), Nanjing Med Univ, Affiliated Nanjing Hosp 1, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	zhangyingdong@yahoo.com.cn			Medical Science and Technology Development Foundation, Nanjing Department of Health [ZKX09036]	Medical Science and Technology Development Foundation, Nanjing Department of Health	This study was supported by Key Project of Medical Science and Technology Development Foundation, Nanjing Department of Health (NO. ZKX09036, http://www.njh.gov.cn/html/list_83.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bochelen D, 1999, J PHARMACOL EXP THER, V288, P653; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Cui DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035324; Danielisova V, 2009, CELL MOL NEUROBIOL, V29, P871, DOI 10.1007/s10571-009-9369-3; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Ivanes F, 2011, ANTIOXID REDOX SIGN, V14, P811, DOI 10.1089/ars.2010.3354; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kirino T, 2002, J CEREBR BLOOD F MET, V22, P1283, DOI 10.1097/01.WCB.0000040942.89393.88; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Krolikowski JG, 2006, CAN J ANAESTH, V53, P174, DOI 10.1007/BF03021824; Labrande C, 2006, NEUROSCIENCE, V137, P231, DOI 10.1016/j.neuroscience.2005.08.080; Lajoie C, 2009, CAN J PHYSIOL PHARM, V87, P460, DOI [10.1139/Y09-031, 10.1139/y09-031]; Leconte C, 2009, STROKE, V40, P3349, DOI 10.1161/STROKEAHA.109.557314; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Puyal J, 2009, ANN NEUROL, V66, P378, DOI 10.1002/ana.21714; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Tian FF, 2010, AUTOPHAGY, V6, P1107, DOI 10.4161/auto.6.8.13427; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Victor ED, 2006, PATHOPHYSIOL, V13, P119; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; Wagner C, 2010, MOL CELL BIOCHEM, V339, P135, DOI 10.1007/s11010-009-0377-x; Wang JY, 2011, J NEUROPATH EXP NEUR, V70, P314, DOI 10.1097/NEN.0b013e31821352bd; Wang JK, 2010, BRAIN RES, V1357, P142, DOI 10.1016/j.brainres.2010.08.009; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	44	121	138	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46092	10.1371/journal.pone.0046092	http://dx.doi.org/10.1371/journal.pone.0046092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029398	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900088
J	Moustafa, AA; Hewedi, DH; Eissa, AM; Myers, CE; Sadek, HA				Moustafa, Ahmed A.; Hewedi, Doaa H.; Eissa, Abeer M.; Myers, Catherine E.; Sadek, Hisham A.			The Relationship between Associative Learning, Transfer Generalization, and Homocysteine Levels in Mild Cognitive Impairment	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; ALLOSTERIC MODULATION; TREATMENT STRATEGY; RISK-FACTOR; HIPPOCAMPAL; MEMORY; DEMENTIA; DECLINE	Previous studies have shown that high total homocysteine levels are associated with Alzheimer's disease (AD) and mild cognitive impairment (MCI). In this study, we test the relationship between cognitive function and total homocysteine levels in healthy subjects (Global Dementia Rating, CDR = 0) and individuals with MCI (CDR = 0.5). We have used a cognitive task that tests learning and generalization of rules, processes that have been previously shown to rely on the integrity of the striatal and hippocampal regions, respectively. We found that total homocysteine levels are higher in MCI individuals than in healthy controls. Unlike what we expected, we found no difference between MCI subjects and healthy controls in learning and generalization. We conducted further analysis after diving MCI subjects in two groups, depending on their Global Deterioration Scale (GDS) scores: individuals with very mild cognitive decline (vMCD, GDS = 2) and mild cognitive decline (MCD, GDS = 3). There was no difference among the two MCI and healthy control groups in learning performance. However, we found that individuals with MCD make more generalization errors than healthy controls and individuals with vMCD. We found no difference in the number of generalization errors between healthy controls and MCI individuals with vMCD. In addition, interestingly, we found that total homocysteine levels correlate positively with generalization errors, but not with learning errors. Our results are in agreement with prior results showing a link between hippocampal function, generalization performance, and total homocysteine levels. Importantly, our study is perhaps among the first to test the relationship between learning (and generalization) of rules and homocysteine levels in healthy controls and individuals with MCI.	[Moustafa, Ahmed A.] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Moustafa, Ahmed A.] Univ Western Sydney, Marcs Inst Brain & Behav, Sydney, NSW, Australia; [Hewedi, Doaa H.; Eissa, Abeer M.; Sadek, Hisham A.] Ain Shams Univ, Sch Med, Psychogeriatr Res Ctr, Dept Psychiat, Cairo, Egypt; [Myers, Catherine E.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Myers, Catherine E.] New Jersey Hlth Care Syst, NeuroBehav Res Lab, Dept Vet Affairs, E Orange, NJ USA	Western Sydney University; Western Sydney University; Egyptian Knowledge Bank (EKB); Ain Shams University; Rutgers State University Newark; Rutgers State University New Brunswick; New Jersey Department of Health & Senior Services	Moustafa, AA (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia.	a.moustafa@uws.edu.au	Myers, Catherine E./AAU-5804-2020; Eissa, Abeer/GZG-9440-2022; Moustafa, Ahmed/AAM-2836-2021	Myers, Catherine E./0000-0002-2776-4823; Moustafa, Ahmed/0000-0001-5971-273X; Eissa, Abeer/0000-0003-1635-6039				Algaidi SA, 2006, EXP NEUROL, V197, P8, DOI 10.1016/j.expneurol.2005.07.003; Annerbo S, 2005, DEMENT GERIATR COGN, V20, P209, DOI 10.1159/000087297; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Ayesa-Arriola R, 2012, EUR ARCH PSY CLIN N, V262, P557, DOI 10.1007/s00406-012-0302-2; Baydas G, 2005, BRAIN RES, V1046, P187, DOI 10.1016/j.brainres.2005.04.011; BONARDI C, 1993, ANIM LEARN BEHAV, V21, P369, DOI 10.3758/BF03198003; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Chen CS, 2011, AM J GERIAT PSYCHIAT, V19, P618, DOI 10.1097/JGP.0b013e318209ddf1; Christie LA, 2005, NEUROSCI LETT, V373, P119, DOI 10.1016/j.neulet.2004.09.072; Collins AGE, 2012, EUR J NEUROSCI, V35, P1024, DOI 10.1111/j.1460-9568.2011.07980.x; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; DELEON MJ, 1989, LANCET, V2, P672; den Heijer T, 2003, BRAIN, V126, P170, DOI 10.1093/brain/awg006; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; EICHENBAUM H, 1989, BEHAV NEUROSCI, V103, P1207, DOI 10.1037/0735-7044.103.6.1207; EICHENBAUM H, 1988, BEHAV NEUROSCI, V102, P331, DOI 10.1037/0735-7044.102.3.331; Faux NG, 2011, J ALZHEIMERS DIS, V27, P909, DOI 10.3233/JAD-2011-110752; Feng L, 2006, AM J CLIN NUTR, V84, P1506, DOI 10.1093/ajcn/84.6.1506; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frank MJ, 2006, PSYCHOL SCI, V17, P700, DOI 10.1111/j.1467-9280.2006.01769.x; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; Frantzen F, 1998, CLIN CHEM, V44, P311; Ganguly PK, 2008, BRAIN RES, V1226, P192, DOI 10.1016/j.brainres.2008.05.090; Gao L, 2012, NEUROL SCI, V33, P39, DOI 10.1007/s10072-011-0645-x; Garcia A, 2004, J GERONTOL A-BIOL, V59, P1323, DOI 10.1093/gerona/59.12.1323; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Genedani S, 2010, CURR ALZHEIMER RES, V7, P150, DOI 10.2174/156720510790691074; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Grambaite R, 2011, J ALZHEIMERS DIS, V27, P453, DOI 10.3233/JAD-2011-110290; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Ho RCM, 2011, AM J GERIAT PSYCHIAT, V19, P607, DOI 10.1097/JGP.0b013e3181f17eed; Hooshmand B, 2012, J INTERN MED, V271, P204, DOI 10.1111/j.1365-2796.2011.02484.x; Hooshmand B, 2010, NEUROLOGY, V75, P1408, DOI 10.1212/WNL.0b013e3181f88162; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jahanshahi M, 2009, NEUROPSYCHOLOGIA; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Johnson SC, 2007, NEUROPSYCHOL DEV C B, P1; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Krishna R, 2012, COGN BEHAV NEUROL, V25, P7, DOI 10.1097/WNN.0b013e318248ff1b; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Kumaran D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00157; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Macpherson H, 2012, PSYCHOPHARMACOLOGY, V220, P351, DOI 10.1007/s00213-011-2481-3; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Maelicke A, 2000, DEMENT GERIATR COGN, V11, P11, DOI 10.1159/000051227; Matte C, 2009, NEUROSCIENCE, V163, P1039, DOI 10.1016/j.neuroscience.2009.07.023; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McCaddon A, 2001, DEMENT GERIATR COGN, V12, P309, DOI 10.1159/000051275; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Moustafa AA, 2010, BRAIN COGNITION, V74, P132, DOI 10.1016/j.bandc.2010.07.013; Myers CE, 2008, NEUROPSYCHOLOGY, V22, P681, DOI 10.1037/0894-4105.22.5.681; MYERS CE, 1994, BEHAV NEUROSCI, V108, P835, DOI 10.1037/0735-7044.108.5.835; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Narayan SK, 2011, INT PSYCHOGERIATR, V23, P1607, DOI 10.1017/S1041610211000779; Nurk E, 2005, ANN NEUROL, V58, P847, DOI 10.1002/ana.20645; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Pan XC, 2012, EUR J NEUROSCI, V35, P1083, DOI 10.1111/j.1460-9568.2011.07981.x; Perneezky R, 2007, J GERIATR PSYCH NEUR, V20, P84, DOI 10.1177/0891988706297093; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pirchl M, 2010, EUR J NEUROSCI, V32, P1516, DOI 10.1111/j.1460-9568.2010.07434.x; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Prins ND, 2002, NEUROLOGY, V59, P1375, DOI 10.1212/01.WNL.0000032494.05619.93; Rajagopalan P, 2011, NEUROREPORT, V22, P391, DOI 10.1097/WNR.0b013e328346bf85; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P18, DOI 10.1017/S1041610207006394; Reitz C, 2009, DEMENT GERIATR COGN, V27, P11, DOI 10.1159/000182421; Sabri O, 2008, EUR J NUCL MED MOL I, V35, pS30, DOI 10.1007/s00259-007-0701-1; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Seger CA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00066; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Shohamy D, 2006, NEUROPSYCHOLOGIA, V44, P774, DOI 10.1016/j.neuropsychologia.2005.07.013; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Stoub TR, 2006, P NATL ACAD SCI USA, V103, P10041, DOI 10.1073/pnas.0603414103; Tamminen Jakke, 2012, Cognition, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Teunissen C E, 2003, J Nutr Health Aging, V7, P153; Thompson R.F., 1972, TOPICS LEARNING PERF, P105; van den Kommer TN, 2010, NEUROBIOL AGING, V31, P1700, DOI 10.1016/j.neurobiolaging.2008.09.009; van Rossum IA, 2010, J ALZHEIMERS DIS, V20, P881, DOI 10.3233/JAD-2010-091606; Vandenberghe R, 1999, EUR J NEUROSCI, V11, P4037, DOI 10.1046/j.1460-9568.1999.00813.x; Weiner MF, 2009, CURR ALZHEIMER RES, V6, P52, DOI 10.2174/156720509787313952; Wimmer GE, 2012, EUR J NEUROSCI, V35, P1092, DOI 10.1111/j.1460-9568.2012.08017.x; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zhuo JM, 2011, TRENDS PHARMACOL SCI, V32, P562, DOI 10.1016/j.tips.2011.05.003; Zoccolella Stefano, 2006, Current Vascular Pharmacology, V4, P237, DOI 10.2174/157016106777698414	101	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46496	10.1371/journal.pone.0046496	http://dx.doi.org/10.1371/journal.pone.0046496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029537	gold, Green Published			2022-12-25	WOS:000309973900175
J	Nicolau, I; Tian, LL; Menzies, D; Ostiguy, G; Pai, M				Nicolau, Ioana; Tian, Lulu; Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar			Point-of-Care Urine Tests for Smoking Status and Isoniazid Treatment Monitoring in Adult Patients	PLOS ONE			English	Article							ARKANSAS METHOD; DIPSTICK METHOD; ADHERENCE; TUBERCULOSIS; METAANALYSIS; COTININE; TOBACCO	Background: Poor adherence to isoniazid (INH) preventive therapy (IPT) is an impediment to effective control of latent tuberculosis (TB) infection. TB patients who smoke are at higher risk of latent TB infection, active disease, and TB mortality, and may have lower adherence to their TB medications. The objective of our study was to validate IsoScreen and SmokeScreen (GFC Diagnostics, UK), two point-of-care tests for monitoring INH intake and determining smoking status. The tests could be used together in the same individual to help identify patients with a high-risk profile and provide a tailored treatment plan that includes medication management, adherence interventions, and smoking cessation programs. Methodology/Principal Findings: 200 adult outpatients attending the TB and/or the smoking cessation clinic were recruited at the Montreal Chest Institute. Sensitivity and specificity were measured for each test against the corresponding composite reference standard. Test reliability was measured using kappa statistic for intra-rater and inter-rater agreement. Univariate and multivariate logistic regression models were used to explore possible covariates that might be related to false-positive and false-negative test results. IsoScreen had a sensitivity of 93.2% (95% confidence interval [CI] 80.3, 98.2) and specificity of 98.7% (94.8, 99.8). IsoScreen had intra-rater agreement (kappa) of 0.75 (0.48, 0.94) and inter-rater agreement of 0.61 (0.27, 0.90). SmokeScreen had a sensitivity of 69.2% (56.4, 79.8), specificity of 81.6% (73.0, 88.0), intra-rater agreement of 0.77 (0.56, 0.94), and inter-rater agreement of 0.66 (0.42, 0.88). False-positive SmokeScreen tests were strongly associated with INH treatment. Conclusions: IsoScreen had high validity and reliability, whereas SmokeScreen had modest validity and reliability. SmokeScreen tests did not perform well in a population receiving INH due to the association between INH treatment and false-positive SmokeScreen test results. Development of the next generation SmokeScreen assay should account for this potential interference.	[Nicolau, Ioana; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Tian, Lulu] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar] McGill Univ, Ctr Hlth, Div Resp, Montreal, PQ, Canada; [Menzies, Dick; Ostiguy, Gaston; Pai, Madhukar] Montreal Chest Inst, Montreal, PQ, Canada	McGill University; Emory University; Rollins School Public Health; McGill University; McGill University	Pai, M (corresponding author), McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X	Canadian Institutes of Health Research [MOP-89918]; European and Developing Countries Clinical Trials Partnership; CIHR; Fonds de recherche du Quebec - Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European and Developing Countries Clinical Trials Partnership; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR grant MOP-89918) and the European and Developing Countries Clinical Trials Partnership (TB-NEAT grant). MP received a New Investigator Award from CIHR, and a salary award from Fonds de recherche du Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bernert JT, 2005, J ANAL TOXICOL, V29, P814, DOI 10.1093/jat/29.8.814; Chambers KL, 2001, BRIT J BIOMED SCI, V58, P61; Cope G, 1996, CLIN CHIM ACTA, V256, P135, DOI 10.1016/S0009-8981(96)06417-0; ELLARD GA, 1977, J CLIN PATHOL, V30, P84, DOI 10.1136/jcp.30.1.84; Fitzpatrick J, 1999, NICOMETER DETECTS NI; Gariti P, 2002, CANCER EPIDEM BIOMAR, V11, P1123; Guerra RL, 2010, RESP MED, V104, P754, DOI 10.1016/j.rmed.2010.02.001; Hanifa Y, 2007, INT J TUBERC LUNG D, V11, P1232; Hobbs SD, 2005, J VASC SURG, V41, P451, DOI 10.1016/j.jvs.2004.12.039; KILBURN JO, 1972, AM REV RESPIR DIS, V106, P923, DOI 10.1164/arrd.1972.106.6.923; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Meissner PE, 2002, INT J TUBERC LUNG D, V6, P903; Montalto NJ, 2007, CANCER EPIDEM BIOMAR, V16, P1858, DOI 10.1158/1055-9965.EPI-07-0189; Parker Donna R, 2002, Nicotine Tob Res, V4, P305, DOI 10.1080/14622200210142715; Payne CE, 2006, J PLAST RECONSTR AES, V59, P1156, DOI 10.1016/j.bjps.2005.12.053; Schmitz KE, 2010, CLIN NURS RES, V19, P131, DOI 10.1177/1054773810363473; SCHRAUFNAGEL DE, 1990, CHEST, V98, P314, DOI 10.1378/chest.98.2.314; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; StataCorp, 2019, STATA STAT SOFTWARE; Whitfield R, 2004, ANN CLIN BIOCHEM, V41, P411, DOI 10.1258/0004563041731637; WHO, 2011, WHO GLOBAL TUBERCULO; World Health Organization, 2008, WHO REP GLOB TOB EP	25	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45913	10.1371/journal.pone.0045913	http://dx.doi.org/10.1371/journal.pone.0045913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029310	Green Published, gold			2022-12-25	WOS:000309973900064
J	Soh, PN; Witkowski, B; Gales, A; Huyghe, E; Berry, A; Pipy, B; Benoit-Vical, F				Soh, Patrice Njomnang; Witkowski, Benoit; Gales, Amandine; Huyghe, Eric; Berry, Antoine; Pipy, Bernard; Benoit-Vical, Francoise			Implication of Glutathione in the In Vitro Antiplasmodial Mechanism of Action of Ellagic Acid	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTION; MALARIA; CHLOROQUINE; IDENTIFICATION; POTENTIATION; ANTIOXIDANT; EXTRACTS; DRUGS	The search for new antimalarial chemotherapy has become increasingly urgent due to parasite resistance to current drugs. Ellagic acid (EA) is a polyphenol, recently found in various plant products, that has effective antimalarial activity in vitro and in vivo without toxicity. To further understand the antimalarial mechanism of action of EA in vitro, we evaluated the effects of EA, ascorbic acid and N-acetyl-L-cysteine (NAC), alone and/or in combination on the production of reactive oxygen species (ROS) during the trophozoite and schizonte stages of the erythrocytic cycle of P. falciparum. The parasitized erythrocytes were pre-labelled with DCFDA (dichlorofluorescein diacetate). We showed that NAC had no effect on ROS production, contrary to ascorbic acid and EA, which considerably reduced ROS production. Surprisingly, EA reduced the production of the ROS with concentrations (6.6 x 10(-9) - 6.6x10(-6) M) ten-fold lower than ascorbic acid (113x10(-6) M). Additionally, the in vitro drug sensitivity of EA with antioxidants showed that antiplasmodial activity is independent of the ROS production inside parasites, which was confirmed by the additive activity of EA and desferrioxamine. Finally, EA could act by reducing the glutathione content inside the Plasmodium parasite. This was consolidated by the decrease in the antiplasmodial efficacy of EA in the murine model Plasmodium yoelii-high GSH strain, known for its high glutathione content. Given its low toxicity and now known mechanism of action, EA appears as a promising antiplasmodial compound.	[Soh, Patrice Njomnang; Witkowski, Benoit; Benoit-Vical, Francoise] CNRS, Chim Coordinat Lab, F-31077 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Benoit-Vical, Francoise] Univ Toulouse 3, UPS, INPT, LCC, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Berry, Antoine; Benoit-Vical, Francoise] Univ Toulouse 3, Ctr Hosp Univ Toulouse, Serv Parasitol Mycol, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Witkowski, Benoit; Berry, Antoine; Benoit-Vical, Francoise] Univ Toulouse 3, Fac Med Rangueil, F-31062 Toulouse, France; [Gales, Amandine; Berry, Antoine; Pipy, Bernard] Univ Toulouse 3, UMR IRD UPS 152, F-31062 Toulouse, France; [Soh, Patrice Njomnang; Huyghe, Eric] Ctr Hosp Univ Toulouse, Dept Urol & Androl, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Soh, PN (corresponding author), CNRS, Chim Coordinat Lab, 205 Route Narbonne, F-31077 Toulouse, France.	sohnjomnang@yahoo.fr	Benoit-Vical, Francoise/E-3938-2016; Witkowski, Benoit/T-1118-2019; Berry, Antoine/J-9352-2014; Galès, Amandine/M-9066-2014	Benoit-Vical, Francoise/0000-0002-9468-4823; Pipy, Bernard/0000-0001-8060-7029; Berry, Antoine/0000-0002-6626-7766; Huyghe, Eric/0000-0001-9445-4385	French National Research Agency (ANR) [ANR-06-RIB-020]	French National Research Agency (ANR)(French National Research Agency (ANR))	The French National Research Agency (ANR) is acknowledged for financial support (ANR-06-RIB-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banzouzi JT, 2002, J ETHNOPHARMACOL, V81, P399, DOI 10.1016/S0378-8741(02)00121-6; Benoit-Vical F, 2005, IDRUGS, V8, P45; Benoit-Vical F, 2000, ANTIMICROB AGENTS CH, V44, P2836, DOI 10.1128/AAC.44.10.2836-2841.2000; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Bozdech Z, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-23; Deharo E, 2003, BIOCHEM PHARMACOL, V66, P809, DOI 10.1016/S0006-2952(03)00396-4; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Farber PM, 1998, FEBS LETT, V422, P311, DOI 10.1016/S0014-5793(98)00031-3; Fu Y, 2010, CYTOM PART A, V77A, P253, DOI 10.1002/cyto.a.20856; Ginsburg H, 2003, REDOX REP, V8, P276, DOI 10.1179/135100003225002907; Hayeshi R, 2007, FOOD CHEM TOXICOL, V45, P286, DOI 10.1016/j.fct.2006.07.027; KATO M, 1987, J PARASITOL, V73, P1058, DOI 10.2307/3282537; Labieniec M, 2006, CELL BIOL INT, V30, P761, DOI 10.1016/j.cellbi.2006.05.013; Luersen K, 2000, BIOCHEM J, V346, P545, DOI 10.1042/0264-6021:3460545; Meierjohann S, 2002, BIOCHEM J, V368, P761, DOI 10.1042/BJ20020962; Mohamed AF, 2005, MED SCI MONITOR, V11, pBR426; Pradines B, 1996, ANTIMICROB AGENTS CH, V40, P2094, DOI 10.1128/AAC.40.9.2094; Reddy MK, 2007, PLANTA MED, V73, P461, DOI 10.1055/s-2007-967167; Soh PN, 2009, ANTIMICROB AGENTS CH, V53, P1100, DOI 10.1128/AAC.01175-08; Srivastava P, 1999, TROP MED INT HEALTH, V4, P251, DOI 10.1046/j.1365-3156.1999.00387.x; Sturm N, 2009, ANTIMICROB AGENTS CH, V53, P622, DOI 10.1128/AAC.00544-08; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Verotta L, 2001, J NAT PROD, V64, P603, DOI 10.1021/np000306j; WAHLGREN M, 1983, CLIN EXP IMMUNOL, V54, P135; Witkowski B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032620; World Health Organization, 2010, WORLD MAL REP 2010	26	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45906	10.1371/journal.pone.0045906	http://dx.doi.org/10.1371/journal.pone.0045906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029306	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900062
J	Traven, A; Janicke, A; Harrison, P; Swaminathan, A; Seemann, T; Beilharz, TH				Traven, Ana; Jaenicke, Amrei; Harrison, Paul; Swaminathan, Angavai; Seemann, Torsten; Beilharz, Traude H.			Transcriptional Profiling of a Yeast Colony Provides New Insight into the Heterogeneity of Multicellular Fungal Communities	PLOS ONE			English	Article							CELL-WALL INTEGRITY; CANDIDA-ALBICANS BIOFILMS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID HOMEOSTASIS; BIDIRECTIONAL PROMOTERS; CATABOLITE DEGRADATION; DRUG-RESISTANCE; RNA; MITOCHONDRIA	Understanding multicellular fungal structures is important for designing better strategies against human fungal pathogens. For example, the ability to form multicellular biofilms is a key virulence property of the yeast Candida albicans. C. albicans biofilms form on indwelling medical devices and are drug resistant, causing serious infections in hospital settings. Multicellular fungal communities are heterogeneous, consisting of cells experiencing different environments. Heterogeneity is likely important for the phenotypic characteristics of communities, yet it is poorly understood. Here we used colonies of the yeast Saccharomyces cerevisiae as a model fungal multicellular structure. We fractionated the outside colony layers from the cells in the center by FACS, using a Cit1-GFP marker expressed exclusively on the outside. Transcriptomics analysis of the two subpopulations revealed that the outside colony layers are actively growing by fermentative metabolism, while the cells residing on the inside are in a resting state and experience changes to mitochondrial activity. Our data shows several parallels with C. albicans biofilms providing insight into the contributions of heterogeneity to biofilm phenotypes. Hallmarks of C. albicans biofilms - the expression of ribosome and translation functions and activation of glycolysis and ergosterol biosynthesis occur on the outside of colonies, while expression of genes associates with sulfur assimilation is observed in the colony center. Cell wall restructuring occurs in biofilms, and cell wall functions are enriched in both fractions: the outside cells display enrichment of cell wall biosynthesis enzymes and cell wall proteins, while the inside cells express cell wall degrading enzymes. Our study also suggests that noncoding transcription and posttranscriptional mRNA regulation play important roles during growth of yeast in colonies, setting the scene for investigating these pathways in the development of multicellular fungal communities.	[Traven, Ana; Jaenicke, Amrei; Swaminathan, Angavai; Beilharz, Traude H.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Harrison, Paul; Seemann, Torsten] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia	Monash University; Monash University	Traven, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	ana.traven@monash.edu; traude.beilharz@monash.edu	Traven, Ana/H-8174-2017; Beilharz, Traude/O-5457-2019; Harrison, Paul/V-6978-2019; Beilharz, Traude/I-1438-2014; Seemann, Torsten/B-2318-2010	Traven, Ana/0000-0001-6252-3104; Beilharz, Traude/0000-0002-8942-9502; Harrison, Paul/0000-0002-3980-268X; Beilharz, Traude/0000-0002-8942-9502; Seemann, Torsten/0000-0001-6046-610X	Monash University funds	Monash University funds	This work was funded by Monash University funds. T. H. B. is an Australian Research Council fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batova M, 2008, CURR GENET, V53, P313, DOI 10.1007/s00294-008-0187-9; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Bruckner S, 2012, FEMS MICROBIOL REV, V36, P25, DOI 10.1111/j.1574-6976.2011.00275.x; Cap M, 2012, MOL CELL, V46, P436, DOI 10.1016/j.molcel.2012.04.001; Chang YW, 2001, GENETICS, V157, P17; Dagley MJ, 2011, MOL MICROBIOL, V79, P968, DOI 10.1111/j.1365-2958.2010.07503.x; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Fanning S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002585; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Janicke A, 2012, RNA, V18, P1289, DOI 10.1261/rna.031898.111; Khot PD, 2006, ANTIMICROB AGENTS CH, V50, P3708, DOI 10.1128/AAC.00997-06; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lackner DH, 2007, MOL CELL, V26, P145, DOI 10.1016/j.molcel.2007.03.002; Minarikova L, 2001, EXP CELL RES, V271, P296, DOI 10.1006/excr.2001.5379; Murillo LA, 2005, EUKARYOT CELL, V4, P1562, DOI 10.1128/EC.4.9.1562-1573.2005; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Nett JE, 2010, ANTIMICROB AGENTS CH, V54, P3505, DOI 10.1128/AAC.00227-10; Nett JE, 2010, J INFECT DIS, V202, P171, DOI 10.1086/651200; Nett JE, 2009, J INFECT DIS, V200, P307, DOI 10.1086/599838; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Palkova Z, 1997, NATURE, V390, P532, DOI 10.1038/37398; Puig S, 2000, YEAST, V16, P139, DOI 10.1002/(SICI)1097-0061(20000130)16:2<139::AID-YEA512>3.3.CO;2-A; Qu Y, 2012, EUKARYOT CELL, V11, P532, DOI 10.1128/EC.05292-11; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Ramage Gordon, 2012, Int J Microbiol, V2012, P528521, DOI 10.1155/2012/528521; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Shingu-Vazquez M, 2011, EUKARYOT CELL, V10, P1376, DOI 10.1128/EC.05184-11; Singh-Babak SD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002718; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Vachova L, 2004, J BIOL CHEM, V279, P37973, DOI 10.1074/jbc.M404594200; Vachova L, 2009, ENVIRON MICROBIOL, V11, P1866, DOI 10.1111/j.1462-2920.2009.01911.x; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yeater KM, 2007, MICROBIOL-SGM, V153, P2373, DOI 10.1099/mic.0.2007/006163-0; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808	46	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46243	10.1371/journal.pone.0046243	http://dx.doi.org/10.1371/journal.pone.0046243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029448	Green Published, gold			2022-12-25	WOS:000309973900116
J	Vaapil, M; Helczynska, K; Villadsen, R; Petersen, OW; Johansson, E; Beckman, S; Larsson, C; Pahlman, S; Jogi, A				Vaapil, Marica; Helczynska, Karolina; Villadsen, Rene; Petersen, Ole W.; Johansson, Elisabet; Beckman, Siv; Larsson, Christer; Pahlman, Sven; Jogi, Annika			Hypoxic Conditions Induce a Cancer-Like Phenotype in Human Breast Epithelial Cells	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; HUMAN NEUROBLASTOMA-CELLS; EXPRESSION PATTERN; E-CADHERIN; TUMOR CHARACTERISTICS; MOLECULAR-CLONING; GENE-EXPRESSION; STEM-CELLS; MUC1 EMA; ID-1	Introduction: Solid tumors are less oxygenated than their tissue of origin. Low intra-tumor oxygen levels are associated with worse outcome, increased metastatic potential and immature phenotype in breast cancer. We have reported that tumor hypoxia correlates to low differentiation status in breast cancer. Less is known about effects of hypoxia on non-malignant cells. Here we address whether hypoxia influences the differentiation stage of non-malignant breast epithelial cells and potentially have bearing on early stages of tumorigenesis. Methods: Normal human primary breast epithelial cells and immortalized non-malignant mammary epithelial MCF-10A cells were grown in a three-dimensional overlay culture on laminin-rich extracellular matrix for up to 21 days at normoxic or hypoxic conditions. Acinar morphogenesis and expression of markers of epithelial differentiation and cell polarization were analyzed by immunofluorescence, immunohistochemistry, qPCR and immunoblot. Results: In large ductal carcinoma in situ patient-specimens, we find that epithelial cells with high HIF-1 alpha levels and multiple cell layers away from the vasculature are immature compared to well-oxygenated cells. We show that hypoxic conditions impaired acinar morphogenesis of primary and immortalized breast epithelial cells grown ex vivo on laminin-rich matrix. Normoxic cultures formed polarized acini-like spheres with the anticipated distribution of marker proteins associated with mammary epithelial polarization e. g. alpha 6-integrin, laminin 5 and Human Milk Fat Globule/MUC1. At hypoxia, cells were not polarized and the sub-cellular distribution pattern of the marker proteins rather resembled that reported in vivo in breast cancer. The hypoxic cells remained in a mitotic state, whereas proliferation ceased with acinar morphogenesis at normoxia. We found induced expression of the differentiation repressor ID1 in the undifferentiated hypoxic MCF-10A cell structures. Acinar morphogenesis was associated with global histone deacetylation whereas the hypoxic breast epithelial cells showed sustained global histone acetylation, which is generally associated with active transcription and an undifferentiated proliferative state.	[Vaapil, Marica; Helczynska, Karolina; Johansson, Elisabet; Beckman, Siv; Larsson, Christer; Pahlman, Sven; Jogi, Annika] Skane Univ Hosp Malmo, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Vaapil, Marica; Helczynska, Karolina; Johansson, Elisabet; Beckman, Siv; Pahlman, Sven; Jogi, Annika] Lund Univ, CREATE Hlth, Lund, Sweden; [Helczynska, Karolina] Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Villadsen, Rene; Petersen, Ole W.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Biol Dis Anal, Copenhagen, Denmark; [Villadsen, Rene; Petersen, Ole W.] Univ Copenhagen, Danish Stem Cell Ctr, Fac Hlth Sci, Copenhagen, Denmark	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; University of Copenhagen; University of Copenhagen	Jogi, A (corresponding author), Skane Univ Hosp Malmo, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden.	annika.jogi@med.lu.se	Vaapil, Marica/R-4420-2019	Villadsen, Rene/0000-0002-5226-381X; Jogi, Annika/0000-0003-1697-8030; Petersen, Ole William/0000-0003-1691-749X	Swedish Cancer Society; Children's Cancer Foundation of Sweden; Swedish Research Council; SSF Strategic Center for Translational Cancer Research - CREATE Health; BioCARE; Strategic Reasearch Program at Lund University; Hans von Kantzows Stiftelse; Gunnar Nilsson's Cancer Foundation; Jeanssons Foundation; Magnus Bergvall's Foundation; Royal Physiographic Society; Gyllenstiernska Krapperup Foundation; Danish Cancer Society [DP07063, R20-A1149-10-S2]; European Comission [LSHC-CT-2006_037632]; Danish Agency for Science and Technology Innovation [2107-05-0006, 10-092798, 08-045450]; Lundbeck Foundation; Novo Nordic Foundation; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation of Sweden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); SSF Strategic Center for Translational Cancer Research - CREATE Health; BioCARE; Strategic Reasearch Program at Lund University; Hans von Kantzows Stiftelse; Gunnar Nilsson's Cancer Foundation; Jeanssons Foundation; Magnus Bergvall's Foundation; Royal Physiographic Society; Gyllenstiernska Krapperup Foundation; Danish Cancer Society(Danish Cancer Society); European Comission(European CommissionEuropean Commission Joint Research Centre); Danish Agency for Science and Technology Innovation; Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning	Funding provided by Swedish Cancer Society, the Children's Cancer Foundation of Sweden, the Swedish Research Council, the SSF Strategic Center for Translational Cancer Research - CREATE Health, BioCARE, a Strategic Reasearch Program at Lund University, Hans von Kantzows Stiftelse, Gunnar Nilsson's Cancer Foundation, Jeanssons Foundation, Magnus Bergvall's Foundation, The Royal Physiographic Society, Gyllenstiernska Krapperup Foundation. The work from the laboratory of OWP and RV is supported by grants from the Danish Cancer Society (DP07063 and R20-A1149-10-S2), the European Comission (Contract no. LSHC-CT-2006_037632 to EuroCSC), the Danish Agency for Science and Technology Innovation (2107-05-0006 to DANED, 10-092798 to DANSTEM and 08-045450 to Danish-Japanese Cooperative Research), the Lundbeck Foundation, the Novo Nordic Foundation, and Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal BE, 2004, AM J MED GENET C, V129C, P85, DOI 10.1002/ajmg.c.30018; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; BURCHELL J, 1983, J IMMUNOL, V131, P508; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Davis TL, 2001, PROSTATE, V46, P240; de Roos MAJ, 2007, HISTOPATHOLOGY, V51, P227, DOI 10.1111/j.1365-2559.2007.02754.x; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DELAMONTE SM, 1985, AM J PEDIAT HEMATOL, V7, P109; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Manfrin E, 2008, BREAST CANCER RES TR, V107, P371, DOI 10.1007/s10549-007-9569-9; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Pietras A, 2010, CURR TOP MICROBIOL I; PYKE C, 1994, AM J PATHOL, V145, P782; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Singh J, 2001, J BIOL CHEM, V276, P11852, DOI 10.1074/jbc.M006931200; SOULE HD, 1990, CANCER RES, V50, P6075; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; van der Vegt B, 2007, HISTOPATHOLOGY, V51, P322, DOI 10.1111/j.1365-2559.2007.02757.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1	52	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46543	10.1371/journal.pone.0046543	http://dx.doi.org/10.1371/journal.pone.0046543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029547	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900183
J	Dambach, J; Thatje, S; Rodder, D; Basher, Z; Raupach, MJ				Dambach, Johannes; Thatje, Sven; Roedder, Dennis; Basher, Zeenatul; Raupach, Michael J.			Effects of Late-Cenozoic Glaciation on Habitat Availability in Antarctic Benthic Shrimps (Crustacea: Decapoda: Caridea)	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; EASTERN WEDDELL SEA; SOUTHERN-OCEAN; CHORISMUS ANTARCTICUS; CLIMATE-CHANGE; POLAR FRONT; ICE; TEMPERATURE; DISPERSAL; MAXIMUM	Marine invertebrates inhabiting the high Antarctic continental shelves are challenged by disturbance of the seafloor by grounded ice, low but stable water temperatures and variable food availability in response to seasonal sea-ice cover. Though a high diversity of life has successfully adapted to such conditions, it is generally agreed that during the Last Glacial Maximum (LGM) the large-scale cover of the Southern Ocean by multi-annual sea ice and the advance of the continental ice sheets across the shelf faced life with conditions, exceeding those seen today by an order of magnitude. Conditions prevailing at the LGM may have therefore acted as a bottleneck event to both the ecology as well as genetic diversity of today's fauna. Here, we use for the first time specific Species Distribution Models (SDMs) for marine arthropods of the Southern Ocean to assess effects of habitat contraction during the LGM on the three most common benthic caridean shrimp species that exhibit a strong depth zonation on the Antarctic continental shelf. While the shallow-water species Chorismus antarcticus and Notocrangon antarcticus were limited to a drastically reduced habitat during the LGM, the deep-water shrimp Nematocarcinus lanceopes found refuge in the Southern Ocean deep sea. The modeling results are in accordance with genetic diversity patterns available for C. antarcticus and N. lanceopes and support the hypothesis that habitat contraction at the LGM resulted in a loss of genetic diversity in shallow water benthos.	[Dambach, Johannes; Roedder, Dennis] Zool Forschungsmuseum Alexander Koenig, Bonn, Germany; [Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Basher, Zeenatul] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; [Raupach, Michael J.] Deutsch Zentrum Marine Biodiversitatsforsch, Wilhelmshaven, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); NERC National Oceanography Centre; University of Southampton; University of Auckland	Dambach, J (corresponding author), Zool Forschungsmuseum Alexander Koenig, Bonn, Germany.	j.dambach.zfmk@uni-bonn.de	Raupach, Michael J./AAF-7566-2020; Rödder, Dennis/AAT-8644-2021; Raupach, Michael/G-7072-2012	Raupach, Michael J./0000-0001-8299-6697; Rödder, Dennis/0000-0002-6108-1639; Basher, Zeenatul/0000-0002-6439-8324	German Research Foundation (DFG) [RA-1688-2]; New Zealand Government	German Research Foundation (DFG)(German Research Foundation (DFG)); New Zealand Government	This study was funded by the German Research Foundation (DFG, RA-1688-2). The Ross Sea specimens data collected by the cruise TAN0802 (IPY-CAML Voyage), made available through the New Zealand International Polar Year-Census of Antarctic Marine Life Project (Phase 1: So001IPY; Phase 2: IPY2007-01) was funded by the New Zealand Government. The authors gratefully acknowledge project governance by the Ministry of Fisheries Science Team and the Ocean Survey 20/20 CAML Advisory Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Ainley DG, 2012, POLAR BIOL, P1; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Arntz WE, 2006, POLAR BIOL, V29, P83, DOI 10.1007/s00300-005-0047-8; ARNTZ WE, 1991, POLAR BIOL, V11, P169; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; BARNARD K. H., 1950, ANN S AFRICAN MUS, V38, P1; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; BATE CS, 1888, ZOOLOGY, V24, P1, DOI DOI 10.5962/BHL.TITLE.6513; Bauer RT., 2004, REMARKABLE SHRIMPS A; Bigg GR, 2008, P ROY SOC B-BIOL SCI, V275, P163, DOI 10.1098/rspb.2007.1153; Bluhm BA, 2002, CRUSTACEANA, V75, P61, DOI 10.1163/156854002317373528; Bluhm BA, 2001, MAR BIOL, V138, P247, DOI 10.1007/s002270000458; Bortolotto E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-32; BOWMAN AW, 2005, SM SMOOTHING METHODS; Brey T, 1996, ANTARCT SCI, V8, P3, DOI 10.1017/S0954102096000028; Brierley AS, 2002, SCIENCE, V295, P1890, DOI 10.1126/science.1068574; BUSBY J R, 1991, Plant Protection Quarterly, V6, P8; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WWL, 2008, 163 U BRIT COL FISH, V16; CLARKE A, 1982, INT J INVER REP DEV, V5, P71; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; CLARKE A, 1979, MAR BIOL, V55, P111, DOI 10.1007/BF00397306; CLARKE A, 1993, J EXP MAR BIOL ECOL, V168, P189, DOI 10.1016/0022-0981(93)90259-Q; CLARKE A, 1977, J EXP MAR BIOL ECOL, V27, P93, DOI 10.1016/0022-0981(77)90056-9; Dambach J, 2011, AQUAT CONSERV, V21, P92, DOI 10.1002/aqc.1160; DAYTON PK, 1977, SCIENCE, V197, P55, DOI 10.1126/science.197.4298.55; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; DITTRICH B, 1990, NATURWISSENSCHAFTEN, V77, P491, DOI 10.1007/BF01135930; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fraser CI, 2012, TRENDS ECOL EVOL, V1543, P10; Gaines SD, 2003, ECOL APPL, V13, pS32; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Gorny M, 1999, SCI MAR, V63, P367, DOI 10.3989/scimar.1999.63s1367; GORNY M, 1992, POLAR BIOL, V12, P111; Gorny M, 1997, POLAR BIOL, V17, P191, DOI 10.1007/s003000050122; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; GUTT J, 1991, ANTARCT SCI, V3, P363, DOI 10.1017/S0954102091000469; Gutt J, 2012, POLAR RES IN PRESS; Guzmán Guillermo, 2005, Gayana (Concepc.), V69, P285; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Jimenez-Valverde Alberto, 2009, Biodiversity Informatics, V6, P28; KIRKWOOD JM, 1984, ANARE RES NOTES, V11, P1; Komai T, 1996, DEEP SEA SHRIMP CRUS, P179; Lardies MA, 2011, POLAR BIOL, V34, P707, DOI 10.1007/s00300-010-0926-5; Ledoyer M., 1989, Mesogee, V49, P67; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lovrich GA, 2005, SCI MAR, V69, P183, DOI 10.3989/scimar.2005.69s2183; Lumpkin R, 2005, DEEP-SEA RES PT I, V52, P495, DOI 10.1016/j.dsr.2004.09.001; Lumpkin R, 2005, J ATMOS OCEAN TECH, V22, P1403, DOI 10.1175/JTECH1793.1; Macpherson E, 2002, P ROY SOC B-BIOL SCI, V269, P1715, DOI 10.1098/rspb.2002.2091; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mascetti P, 1997, POLAR BIOL, V17, P384, DOI 10.1007/PL00013380; Maxwell J.G.H., 1985, P397; Page TJ, 2002, POLAR BIOL, V25, P818, DOI 10.1007/s00300-002-0414-7; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; Pfeffer G, 1886, JB HAMBURGISCHEN WIS, V4, P44; Phillips S.J., 2004, P 21 INT C MACH LEAR, P655, DOI [DOI 10.1145/1015330.1015412, 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; POSSINGHAM HP, 1990, ECOLOGY, V71, P973, DOI 10.2307/1937366; Praca E, 2008, OCEAN SCI, V4, P49, DOI 10.5194/os-4-49-2008; Raupach MJ, 2010, MAR BIOL, V157, P1783, DOI 10.1007/s00227-010-1451-3; Raupach MJ, 2006, POLAR BIOL, V29, P439, DOI 10.1007/s00300-005-0069-2; Riddle MJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001327; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Smith WO, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004251; Storch V, 2001, POLAR BIOL, V24, P604, DOI 10.1007/s003000100261; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Team R, 2010, R LANG ENV STAT COMP; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; Thatje S, 2005, POLAR BIOL, V28, P290, DOI 10.1007/s00300-004-0687-0; Thatje S, 2004, POLAR BIOL, V27, P195, DOI 10.1007/s00300-003-0583-z; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; Thatje S, 2008, ECOLOGY, V89, P682, DOI 10.1890/07-0498.1; Thornhill DJ, 2008, MOL ECOL, V17, P5104, DOI 10.1111/j.1365-294X.2008.03970.x; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; TIEFENBACHER L, 1990, Spixiana, V13, P117; TIEFENBACHER L, 1990, Spixiana, V13, P229; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; Wittmann A, 2010, POLAR BIOL, V33, P919, DOI 10.1007/s00300-010-0768-1; Yaldwyn J. C., 1965, Monographiae Biologicae, V15, P324; Zarenkov N.A., 1968, BIOL REP SOV ANTARCT, V4, P153	103	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46283	10.1371/journal.pone.0046283	http://dx.doi.org/10.1371/journal.pone.0046283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029463	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000309517500083
J	Fisher, DJ; Fernandez, RE; Adams, NE; Maurelli, AT				Fisher, Derek J.; Fernandez, Reinaldo E.; Adams, Nancy E.; Maurelli, Anthony T.			Uptake of Biotin by Chlamydia Spp. through the Use of a Bacterial Transporter (BioY) and a Host-Cell Transporter (SMVT)	PLOS ONE			English	Article							TRACHOMATIS SEROVAR L2; CHLAMYDOPHILA-ABORTUS; DEVELOPMENTAL CYCLE; MEMBRANE-PROTEINS; PROTEOME ANALYSIS; NICHE ADAPTATION; GENOME SEQUENCE; III SECRETION; COLI; LIGASE	Chlamydia spp. are obligate intracellular Gram-negative bacterial pathogens that cause disease in humans and animals. Minor variations in metabolic capacity between species have been causally linked to host and tissue tropisms. Analysis of the highly conserved genomes of Chlamydia spp. reveals divergence in the metabolism of the essential vitamin biotin with genes for either synthesis (bioF_2ADB) and/or transport (bioY). Streptavidin blotting confirmed the presence of a single biotinylated protein in Chlamydia. As a first step in unraveling the need for divergent biotin acquisition strategies, we examined BioY (CTL0613) from C. trachomatis 434/Bu which is annotated as an S component of the type II energy coupling-factor transporters (ECF). Type II ECFs are typically composed of a transport specific component (S) and a chromosomally unlinked energy module (AT). Intriguingly, Chlamydia lack recognizable AT modules. Using H-3-biotin and recombinant E. coli expressing CTL0613, we demonstrated that biotin was transported with high affinity (a property of Type II ECFs previously shown to require an AT module) and capacity (apparent K(m) of 3.35 nM and V(max) of 55.1 pmol x min(-1) x mg(-1)). Since Chlamydia reside in a host derived membrane vacuole, termed an inclusion, we also sought a mechanism for transport of biotin from the cell cytoplasm into the inclusion vacuole. Immunofluorescence microscopy revealed that the mammalian sodium multivitamin transporter (SMVT), which transports lipoic acid, biotin, and pantothenic acid into cells, localizes to the inclusion. Since Chlamydia also are auxotrophic for lipoic and pantothenic acids, SMVT may be subverted by Chlamydia to move multiple essential compounds into the inclusion where BioY and another transporter(s) would be present to facilitate transport into the bacterium. Collectively, our data validates the first BioY from a pathogenic organism and describes a two-step mechanism by which Chlamydia transport biotin from the host cell into the bacterial cytoplasm.	[Fernandez, Reinaldo E.; Adams, Nancy E.; Maurelli, Anthony T.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Fisher, Derek J.] So Illinois Univ, Dept Microbiol, Carbondale, IL 62901 USA	Uniformed Services University of the Health Sciences - USA; Southern Illinois University System; Southern Illinois University	Maurelli, AT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, F Edward Hebert Sch Med, Bethesda, MD 20814 USA.	anthony.maurelli@usuhs.edu		Maurelli, Anthony/0000-0002-4788-6166; Adams, Nancy/0000-0002-0781-0896; Fisher, Derek/0000-0002-1663-8389	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 AI044033, F32 AI078655-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI078655, R01AI044033] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants R01 AI044033 (ATM) and F32 AI078655-01 (DJF) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Baneke A, 2012, TRAVEL MED INFECT DI; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; Berntsson RP, 2012, P NATL ACAD SCI US; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; DAKSHINAMURTI K, 1963, J BIOL CHEM, V238, P294; Delli-Bovi TA, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-73; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; Elwell CA, 2012, CELL MICROBIOL; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Entcheva P, 2002, APPL ENVIRON MICROB, V68, P2843, DOI 10.1128/AEM.68.6.2843-2848.2002; Finkenwirth F, 2010, BIOCHEM J, V431, P373, DOI 10.1042/BJ20100813; Giles TN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-166; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Guillen-Navarro K, 2005, FEMS MICROBIOL LETT, V250, P209, DOI 10.1016/j.femsle.2005.07.020; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hebbeln P, 2007, P NATL ACAD SCI USA, V104, P2909, DOI 10.1073/pnas.0609905104; Heinzen RA, 1997, INFECT IMMUN, V65, P1088, DOI 10.1128/IAI.65.3.1088-1094.1997; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kuroishi T, 2011, MOL GENET METAB, V104, P537, DOI 10.1016/j.ymgme.2011.08.030; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Lin S, 2011, MOL BIOSYST, V7, P1811, DOI 10.1039/c1mb05022b; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Maurer AP, 2007, PLOS PATHOG, V3, P752, DOI 10.1371/journal.ppat.0030083; McClarty G, 2007, CURR OPIN MICROBIOL, V10, P47, DOI 10.1016/j.mib.2006.12.003; McCoy AJ, 2005, MOL MICROBIOL, V57, P41, DOI 10.1111/j.1365-2958.2005.04661.x; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1411; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; Mock DM, 2005, J NUTR BIOCHEM, V16, P435, DOI 10.1016/j.jnutbio.2005.03.022; Neubauer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029087; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Polyak SW, 2012, APPL MICROBIOL BIOT, V93, P983, DOI 10.1007/s00253-011-3796-z; PRAKASH O, 1974, J BACTERIOL, V120, P785, DOI 10.1128/JB.120.2.785-791.1974; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Purushothaman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016850; Ramaswamy AV, 2010, J BACTERIOL, V192, P6172, DOI 10.1128/JB.00717-10; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Said Hamid M, 2012, Subcell Biochem, V56, P1, DOI 10.1007/978-94-007-2199-9_1; Said HM, 1998, AM J PHYSIOL-CELL PH, V275, pC1365, DOI 10.1152/ajpcell.1998.275.5.C1365; Sait M, 2011, J BACTERIOL, V193, P4276, DOI 10.1128/JB.05290-11; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schneider J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-6; Shaw AC, 2002, PROTEOMICS, V2, P164, DOI 10.1002/1615-9861(200202)2:2<164::AID-PROT164>3.0.CO;2-U; Soriano A, 2006, ANAL BIOCHEM, V349, P268, DOI 10.1016/j.ab.2005.10.044; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Sullivan JT, 2001, MICROBIOL-SGM, V147, P1315, DOI 10.1099/00221287-147-5-1315; Taniguchi Ayumi, 2008, Congenital Anomalies, V48, P57, DOI 10.1111/j.1741-4520.2008.00179.x; ter Beek J, 2011, J BIOL CHEM, V286, P5471, DOI 10.1074/jbc.M110.199224; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Vandahl BB, 2002, METHOD ENZYMOL, V358, P277; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Voigt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035097; WALLER JR, 1965, J BACTERIOL, V90, P853, DOI 10.1128/JB.90.4.853-856.1965; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724; Zempleni Janos, 2008, Expert Rev Endocrinol Metab, V3, P715, DOI 10.1586/17446651.3.6.715; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	76	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46052	10.1371/journal.pone.0046052	http://dx.doi.org/10.1371/journal.pone.0046052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029384	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500059
J	Ai, D; Desjardins-Proulx, P; Chu, CJ; Wang, G				Ai, Dexiecuo; Desjardins-Proulx, Philippe; Chu, Chengjin; Wang, Gang			Immigration, Local Dispersal Limitation, and the Repeatability of Community Composition under Neutral and Niche Dynamics	PLOS ONE			English	Article							BETA-DIVERSITY; SPECIES POOL; COMPETITION; ABUNDANCE; PATTERNS; INVASION; MODEL; PREDICTABILITY; DISSIMILARITY; CONSEQUENCES	Repeatability of community composition has been a critical aspect for community structure, which is closely associated with community stability, predictability, conservation biology and ecological restoration. It has been shown that both immigration and local dispersal limitation can affect the community composition in both neutral and niche model. Hence, we use a spatially explicit individual-based model to investigate the potential influence of immigration rate and strength of local dispersal limitation on repeatability in both neutral and niche models. Similarity measures are used to quantify repeatability. We examine the repeatability of community composition among replicate communities (which means the same community repeats many times), and between niche and neutral replicate communities. We find the correlation between repeatability and immigration rate is positive in the neutral model and an inverted unimodal in the niche model. The correlation between repeatability and local dispersal distance is positive in the niche model and negative in the neutral model. High repeatability between niche communities and neutral communities is observed with high immigration rates or when high local dispersal distance appears in the niche model or low local dispersal distance in the neutral model. Our results show that repeatability of community composition is not only dependent on the types of community models (niche vs. neutrality) but also strongly determined by immigration rates and local dispersal limitation.	[Ai, Dexiecuo; Chu, Chengjin; Wang, Gang] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Desjardins-Proulx, Philippe] Univ Quebec Rimouski, Theoret Ecosyst Ecol Lab, Rimouski, PQ, Canada; [Desjardins-Proulx, Philippe] McGill Univ, Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Desjardins-Proulx, Philippe] Univ Illinois, Coll Engn, Chicago, IL USA	Lanzhou University; University of Quebec; Universite du Quebec a Rimouski; McGill University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wang, G (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	wgmg36@lzu.edu.cn	Chu, Chu/T-6038-2019	Chu, Chengjin/0000-0002-0606-449X	National Natural Science Foundation of China [30970465]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No. 30970465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Brudvig LA, 2008, RESTOR ECOL, V16, P290, DOI 10.1111/j.1526-100X.2007.00317.x; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Davies KF, 2001, ECOLOGY, V82, P1830, DOI 10.1890/0012-9658(2001)082[1830:EOWABP]2.0.CO;2; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gonzalez MT, 2005, INT J PARASITOL, V35, P1369, DOI 10.1016/j.ijpara.2005.07.016; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Holyoak M, 2006, ECOLOGY, V87, P1370, DOI 10.1890/0012-9658(2006)87[1370:REEWNC]2.0.CO;2; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; HUBBELL SP, 1979, SCIENCE, V203, P1299, DOI 10.1126/science.203.4387.1299; Hubbell Stephen P., 2001, V32, pi; Irigoien X, 2011, J PLANKTON RES, V0, P1; Keith AR, 2010, ECOLOGY, V91, P3398, DOI 10.1890/09-1236.1; Laird RA, 2008, ECOLOGY, V89, P237, DOI 10.1890/07-0117.1; LAWTON JH, 1989, J ANIM ECOL, V58, P1021, DOI 10.2307/5139; Lechowicz M.J., 2001, INTEGRATING ECOLOGY, P117; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Loreau M, 1999, AM NAT, V154, P427, DOI 10.1086/303252; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2006, OIKOS, V113, P481, DOI 10.1111/j.2006.0030-1299.14582.x; Palmer MA, 1997, RESTOR ECOL, V5, P291, DOI 10.1046/j.1526-100X.1997.00543.x; PARRISH JAD, 1976, ECOLOGY, V57, P1281, DOI 10.2307/1935052; Poulin R, 2002, INT J PARASITOL, V32, P1235, DOI 10.1016/S0020-7519(02)00109-1; R Development Core Team, 2009, R FDN STAT COMP; Ruiz-Jaen MC, 2005, RESTOR ECOL, V13, P569, DOI 10.1111/j.1526-100X.2005.00072.x; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; Schwilk DW, 2005, ECOL LETT, V8, P272, DOI 10.1111/j.1461-0248.2004.00720.x; SHARIK TL, 1989, AM MIDL NAT, V122, P133, DOI 10.2307/2425690; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Shurin JB, 2000, ECOLOGY, V81, P3074, DOI 10.2307/177402; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Volkov I, 2004, NATURE, V427, P696, DOI 10.1038/427696a; Zhou SR, 2008, ECOLOGY, V89, P248, DOI 10.1890/06-1817.1; Zobel M, 1998, APPL VEG SCI, V1, P55, DOI 10.2307/1479085	56	14	14	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46164	10.1371/journal.pone.0046164	http://dx.doi.org/10.1371/journal.pone.0046164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029424	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700118
J	Quadt, KA; Barfod, L; Andersen, D; Bruun, J; Gyan, B; Hassenkam, T; Ofori, MF; Hviid, L				Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Gyan, Ben; Hassenkam, Tue; Ofori, Michael F.; Hviid, Lars			The Density of Knobs on Plasmodium falciparum-Infected Erythrocytes Depends on Developmental Age and Varies among Isolates	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; ATOMIC-FORCE MICROSCOPE; FAMILY EXPRESSION; VARIANT ANTIGENS; KNOBLESS CLONE; FINE-STRUCTURE; CELL-LINE; SURFACE; CYTOADHERENCE; BLOOD	Background: The virulence of Plasmodium falciparum malaria is related to the parasite's ability to evade host immunity through clonal antigenic variation and tissue-specific adhesion of infected erythrocytes (IEs). The P. falciparum erythrocyte membrane protein 1 (PfEMP1) family expressed on dome-shaped protrusions called knobs on the IE surface is central to both. Differences in receptor specificity and affinity of expressed PfEMP1 are important for IE adhesiveness, but it is not known whether differences in the number and size of the knobs on which the PfEMP1 proteins are expressed also play a role. Therefore, the aim of this study was to provide detailed information on isolate-and time-dependent differences in knob size and density. Methodology/Principal Findings: We used atomic force microscopy to characterize knobs on the surface of P. falciparum-infected erythrocytes. Fourteen ex vivo isolates from Ghanaian children with malaria and 10 P. falciparum isolates selected in vitro for expression of a particular PfEMP1 protein (VAR2CSA) were examined. Knob density increased from similar to 20 h to similar to 35 h post-invasion, with significant variation among isolates. The knob density ex vivo, which was about five-fold higher than following long-term in vitro culture, started to decline within a few months of culture. Although knob diameter and height varied among isolates, we did not observe significant time-dependent variation in these dimensions. Conclusions/Significance: The density of knobs on the P. falciparum-IE surface depends on time since invasion, but is also determined by the infecting isolate in a time-independent manner. This is the first study to quantitatively evaluate knob densities and dimensions on different P. falciparum isolates, to examine ex vivo isolates from humans, and to compare ex vivo and long-term in vitro-cultured isolates. Our findings contribute to the understanding of the interaction between P. falciparum parasites and the infected host.	[Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Hviid, Lars] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol I, Copenhagen, Denmark; [Quadt, Katharina A.; Barfod, Lea; Andersen, Daniel; Bruun, Jonas; Hviid, Lars] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Gyan, Ben; Ofori, Michael F.] Univ Ghana, Noguchi Mem Inst Med Res, Dept Immunol, Legon, Ghana; [Hassenkam, Tue] Univ Copenhagen, Dept Chem, Fac Sci, Nanosci Ctr, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Ghana; University of Copenhagen	Hviid, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol I, Copenhagen, Denmark.	lhviid@sund.ku.dk	Hviid, Lars/G-3705-2012; Hassenkam, Tue/B-8391-2015; Bruun, Jonas/B-3821-2015; Ofori, Michael F/H-9072-2013	Hviid, Lars/0000-0002-1698-4927; Ofori, Michael F/0000-0003-2341-7514; Barfod, Lea/0000-0001-6510-495X	Danish Medical Research Council [271-07-0301]; Danish Consultative Research Committee for Development Research (FFU) [104.Dan.8 I/306]; European Community [242095]; Rigshospitalet Grant [9615.05330]; University of Copenhagen	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Consultative Research Committee for Development Research (FFU); European Community(European Commission); Rigshospitalet Grant; University of Copenhagen	The research leading to these results was funded by Danish Medical Research Council Grant 271-07-0301, Danish Consultative Research Committee for Development Research (FFU) Grant 104.Dan.8 I/306, European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095, Rigshospitalet Grant 9615.05330, and the University of Copenhagen Program of Excellence in membrane topology and quaternary structure of key membrane proteins involved in P. falciparum malaria pathogenesis and immunity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; Armitage P., 1987, STAT METHODS MED RES; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; BARNWELL JW, 1982, J IMMUNOL, V128, P224; BIGGS BA, 1989, EXP PARASITOL, V69, P189, DOI 10.1016/0014-4894(89)90187-2; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; COATNEY GR, 1971, PRIMATE MALARIAS; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; GRUENBERG J, 1983, J CELL BIOL, V97, P795, DOI 10.1083/jcb.97.3.795; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; HO M, 1992, INFECT IMMUN, V60, P2225, DOI 10.1128/IAI.60.6.2225-2228.1992; Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381; Hutchings CL, 2007, MOL MICROBIOL, V65, P1092, DOI 10.1111/j.1365-2958.2007.05850.x; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 2011, EXPERT REV VACCINES, V10, P1405, DOI [10.1586/ERV.11.113, 10.1586/erv.11.113]; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LANGRETH SG, 1985, INFECT IMMUN, V47, P760, DOI 10.1128/IAI.47.3.760-766.1985; LANGRETH SG, 1979, EXP PARASITOL, V48, P213, DOI 10.1016/0014-4894(79)90101-2; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Li Ang, 2010, Br J Haematol, V151, P1, DOI 10.1111/j.1365-2141.2010.08261.x; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACKENSTEDT U, 1989, PARASITOL RES, V75, P528, DOI 10.1007/BF00931161; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; MILLER L H, 1969, American Journal of Tropical Medicine and Hygiene, V18, P860; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; Nagao E, 2008, J STRUCT BIOL, V162, P460, DOI 10.1016/j.jsb.2008.03.005; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; PATTILLO RA, 1968, CANCER RES, V28, P1231; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; TRAGER W, 1966, B WORLD HEALTH ORGAN, V35, P883; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; WHO, 2011, WORLD MALARIA REPORT 2011, P1	45	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45658	10.1371/journal.pone.0045658	http://dx.doi.org/10.1371/journal.pone.0045658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029166	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900088
J	Guo, W; Luo, C; Wang, C; Zhu, Y; Wang, X; Gao, XD; Yao, WB				Guo, Wei; Luo, Cheng; Wang, Chen; Zhu, Yue; Wang, Xin; Gao, Xiangdong; Yao, Wenbing			Protection against Th17 Cells Differentiation by an Interleukin-23 Receptor Cytokine-Binding Homology Region	PLOS ONE			English	Article							ROR-GAMMA-T; AUTOIMMUNE INFLAMMATION; IL-17 PRODUCTION; IL-23; EXPRESSION; DISTINCT; ANTAGONIST; ACTIVATION; ARTHRITIS; PROMOTES	Th17 cells have been reported to produce proinflammatory cytokines like Interleukin-17, IL-22, and regarded as important players in various inflammatory diseases. One of the IL-12 cytokine family cytokines, IL-23, composed of p19 and p40 subunit, is known for its potential to promote Th17 development and IL-17 producing, and the IL-23/IL-17 pathway is considered to be potential therapeutic target for autoimmune inflammation responses. Knockout mice deficient in either IL-23 or IL-17 related genes can suppress the allergic responses. Several IL-23 or IL-17 neutralizing agents are being evaluated in vitro or in vivo to disrupt the IL-23/IL-17 axis. Herein, we report that prokaryotically expressed soluble IL-23 receptor cytokine-binding homology region as an endogenous extracellular receptor analogue could be a natural antagonist against IL-23/IL-17 axis. We provide evidence that IL23R-CHR can bind to IL-23 in a dose-dependent manner in vitro, and block IL-23 signal by IL23R-CHR reducing the ROR gamma t expression, which in turn lowers the expression of IL-17/IL-22, thus protecting naive CD4+ T cells against Th17 development. Together, this study indicates the importance of IL-23 pathway in Th17 development and the negative regulation of Th17 development by IL23R-CHR, and highlights the important roles of the soluble receptor extracellular region in the therapeutic strategy of neutralizing IL-23.	[Guo, Wei; Luo, Cheng; Wang, Chen; Zhu, Yue; Wang, Xin; Gao, Xiangdong; Yao, Wenbing] China Pharmaceut Univ, State Key Lab Nat Med, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Gao, XD (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	xiangdong_gao@yahoo.com.cn; wbyao@cpu.edu.cn	Gao, Xiang/HDO-3543-2022; wang, chen/GWM-9481-2022					Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bouguermouh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005087; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chi W, 2007, J ALLERGY CLIN IMMUN, V119, P1218, DOI 10.1016/j.jaci.2007.01.010; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cornelissen F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2893; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009249; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LAVALLIE ER, 1993, J BIOL CHEM, V268, P23311; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Nikoopour Enayat, 2008, Inflammation & Allergy Drug Targets, V7, P203, DOI 10.2174/187152808785748155; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Serhan C.N., 2010, FUNDAMENTALS INFLAMM, V1st ed, DOI [10.1017/CBO9781139195737, DOI 10.1017/CBO9781139195737]; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Suen KF, 2010, PROTEIN EXPRES PURIF, V71, P96, DOI 10.1016/j.pep.2009.12.015; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, SEMIN IMMUNOL, V19, P351, DOI 10.1016/j.smim.2008.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138	37	13	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45625	10.1371/journal.pone.0045625	http://dx.doi.org/10.1371/journal.pone.0045625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029144	gold, Green Submitted, Green Published			2022-12-25	WOS:000309388400113
J	Barbarulo, A; Iansante, V; Chaidos, A; Naresh, K; Rahemtulla, A; Franzoso, G; Karadimitris, A; Haskard, DO; Papa, S; Bubici, C				Barbarulo, A.; Iansante, V.; Chaidos, A.; Naresh, K.; Rahemtulla, A.; Franzoso, G.; Karadimitris, A.; Haskard, D. O.; Papa, S.; Bubici, C.			Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma	ONCOGENE			English	Article						PARP14; c-Jun N-terminal kinase; survival; multiple myeloma; apoptosis	N-TERMINAL KINASE; GENE-EXPRESSION; CELL-LINES; APOPTOSIS; JNK; LYMPHOMA; PROLIFERATION; SUPPRESSION; ACTIVATION; CARCINOMA	Regulation of cell survival is a key part of the pathogenesis of multiple myeloma (MM). Jun N-terminal kinase (JNK) signaling has been implicated in MM pathogenesis, but its function is unclear. To elucidate the role of JNK in MM, we evaluated the specific functions of the two major JNK proteins, JNK1 and JNK2. We show here that JNK2 is constitutively activated in a panel of MM cell lines and primary tumors. Using loss-of-function studies, we demonstrate that JNK2 is required for the survival of myeloma cells and constitutively suppresses JNK1-mediated apoptosis by affecting expression of poly(ADP-ribose) polymerase (PARP) 14, a key regulator of B-cell survival. Strikingly, we found that PARP14 is highly expressed in myeloma plasma cells and associated with disease progression and poor survival. Overexpression of PARP14 completely rescued myeloma cells from apoptosis induced by JNK2 knockdown, indicating that PARP14 is critically involved in JNK2-dependent survival. Mechanistically, PARP14 was found to promote the survival of myeloma cells by binding and inhibiting JNK1. Moreover, inhibition of PARP14 enhances the sensitization of MM cells to anti-myeloma agents. Our findings reveal a novel regulatory pathway in myeloma cells through which JNK2 signals cell survival via PARP14, and identify PARP14 as a potential therapeutic target in myeloma.	[Barbarulo, A.; Franzoso, G.; Bubici, C.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Inflammat & Signal Transduct, London, England; [Iansante, V.; Papa, S.] Fdn Liver Res, Inst Hepatol, Cell Signalling & Canc Lab, London WC1E 6HX, England; [Chaidos, A.; Rahemtulla, A.; Karadimitris, A.] Imperial Coll Healthcare NHS Trust, Ctr Haematol, London, England; [Chaidos, A.; Naresh, K.; Rahemtulla, A.; Karadimitris, A.; Haskard, D. O.] Univ London Imperial Coll Sci Technol & Med, London, England; [Naresh, K.] Imperial Coll Healthcare NHS Trust, Dept Histopathol, London, England; [Haskard, D. O.] Imperial Coll Healthcare NHS Trust, Natl Heart & Lung Inst, British Heart Fdn, Vasc Sci Unit, London, England	Imperial College London; University of London; University College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; University College London	Papa, S (corresponding author), Fdn Liver Res, Inst Hepatol, Cell Signalling & Canc Lab, 69-75 Chenies Mews, London WC1E 6HX, England.	s.papa@researchinliver.org.uk; c.bubici@imperial.ac.uk	Papa, Salvatore/J-9413-2012; Franzoso, Guido/GRR-8628-2022	Papa, Salvatore/0000-0002-8369-6538; Franzoso, Guido/0000-0002-0778-988X; Naresh, Kikkeri N/0000-0003-3807-3638; Iansante, Valeria/0000-0002-4369-3375; Chaidos, Aristeidis/0000-0003-1453-8576; Bubici, Concetta/0000-0002-8074-4661	NIH [R01 CA084040, R01 CA098583]; Cancer Research UK [C26587/A8839]; Kay Kendall Leukemia Fund [KKL443]; Italian Association for Cancer Research [8557]; Foundation for Liver Research; NATIONAL CANCER INSTITUTE [R01CA084040, R01CA098583] Funding Source: NIH RePORTER; Cancer Research UK [15115] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Kay Kendall Leukemia Fund; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Foundation for Liver Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	We are grateful to S Chokshi, R Williams and J Dyson for critical comments on the manuscript. We also thank D Trono (Ecole Polytechnique Federale de Lausanne, Switzerland) for the pWPI lentiviral vector and M Johns (Imperial College) for the human PARP14 cDNA; H Cooksley, A Riva (Institute of Hepatology), and PM Choy, MH Lam and V Patel (MSc students) for technical support. GF receives funding from NIH grants R01 CA084040 and R01 CA098583 and Cancer Research UK grant C26587/A8839. DOH receives professorial support from the British Heart Foundation. This study was primarily supported by a research grant from Kay Kendall Leukemia Fund (KKL443) to CB, and in part by grants from Italian Association for Cancer Research (Start-up 8557) and the Foundation for Liver Research to S.P.	Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; Anbalagan M, 2012, INT J CANCER, V130, P1967, DOI 10.1002/ijc.26207; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Bost F, 1999, MOL CELL BIOL, V19, P1938; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Chen NY, 2001, CANCER RES, V61, P3908; Cho SH, 2011, P NATL ACAD SCI USA, V108, P15972, DOI 10.1073/pnas.1017082108; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gangopadhyay NN, 2011, CANCER INVEST, V29, P608, DOI 10.3109/07357907.2011.621916; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goenka S, 2007, J BIOL CHEM, V282, P18732, DOI 10.1074/jbc.M611283200; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hideshima T, 2003, ONCOGENE, V22, P8797, DOI 10.1038/sj.onc.1206919; Hideshima T, 2003, BLOOD, V101, P1530, DOI 10.1182/blood-2002-08-2543; Hideshima T, 2003, BLOOD, V101, P703, DOI 10.1182/blood-2002-06-1874; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Kajiguchi T, 2006, CANCER SCI, V97, P540, DOI 10.1111/j.1349-7006.2006.00199.x; Ke HN, 2010, CANCER RES, V70, P3080, DOI 10.1158/0008-5472.CAN-09-2923; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kim KH, 2010, BIOMAT PROP PROD DEV, P149; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Naresh KN, 2006, J CLIN PATHOL, V59, P903, DOI 10.1136/jcp.2004.020610; Nitta RT, 2011, ONCOGENE, V30, P234, DOI 10.1038/onc.2010.414; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2011, NAT REV CLIN ONCOL, V8, P479, DOI 10.1038/nrclinonc.2011.63; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Spanoudakis E, 2009, BLOOD, V113, P2498, DOI 10.1182/blood-2008-06-161281; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Witzig TE, 1999, BRIT J HAEMATOL, V104, P131, DOI 10.1046/j.1365-2141.1999.01136.x; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yanagawa T, 2007, CANCER RES, V67, P8682, DOI 10.1158/0008-5472.CAN-07-1586; Yang YM, 2003, CLIN CANCER RES, V9, P391; Yoon CH, 2012, ONCOGENE, V31, P4655, DOI 10.1038/onc.2011.634; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	53	84	92	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 5	2013	32	36					4231	4242		10.1038/onc.2012.448	http://dx.doi.org/10.1038/onc.2012.448			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045269	Green Accepted			2022-12-25	WOS:000324168000005
J	An, HL; Lu, SQ; Li, JW; Meng, XY; Zhan, Y; Cui, M; Long, M; Zhang, HL; Logothetis, DE				An, Hai-Long; Lu, Shou-Qin; Li, Jun-Wei; Meng, Xuan-Yu; Zhan, Yong; Cui, Meng; Long, Mian; Zhang, Hai-Lin; Logothetis, Diomedes E.			The Cytosolic GH Loop Regulates the Phosphatidylinositol 4,5-Bisphosphate-induced Gating Kinetics of Kir2 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; K+ CHANNEL; CRYSTAL-STRUCTURE; G-PROTEINS; POTASSIUM CHANNELS; STRUCTURAL BASIS; PIP2; ACTIVATION; CONDUCTION; SITES	Inwardly rectifying K+ (Kir) channels set the resting membrane potential and regulate cellular excitability. The activity of Kir channels depends critically on the phospholipid PIP2. The molecular mechanism by which PIP2 regulates Kir channel gating is poorly understood. Here, we utilized a combination of computational and electrophysiological approaches to discern structural elements involved in regulating the PIP2-induced gating kinetics of Kir2 channels. We identify a novel role for the cytosolic GH loop. Mutations that directly or indirectly affect GH loop flexibility (e.g. V223L, E272G, D292G) increase both the on- and especially the off-gating kinetics. These effects are consistent with a model in which competing interactions between the CD and GH loops for the N terminus regulate the gating of the intracellular G loop gate.	[Lu, Shou-Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Lu, Shou-Qin; Long, Mian] Chinese Acad Sci, Inst Mech, Ctr Biomech & Bioengn, Beijing 100190, Peoples R China; [An, Hai-Long; Meng, Xuan-Yu; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [An, Hai-Long; Li, Jun-Wei; Zhan, Yong] Hebei Univ Technol, Inst Biophys, Sch Sci, Tianjin 300401, Peoples R China; [Zhang, Hai-Lin] Hebei Med Univ, Key Lab Pharmacol & Toxicol New Drug, Key Lab Neural & Vasc Biol, Minist Educ,Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS; Virginia Commonwealth University; Hebei University of Technology; Hebei Medical University	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China.	mlong@imech.ac.cn; z.hailin@yahoo.com; delogothetis@vcu.edu	Li, Junwei/B-6936-2019	Li, Junwei/0000-0002-1724-4752	National Institutes of Health [HL059949, S10RR027411]; NSFC (National Natural Science Foundation of China) [11145003, 10975045, C2009000029, 30730031]; 973 Program [2007CB512100, C2009001104]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by grant National Institutes of Health Grant HL059949 (to D.L.). This work was also supported by NSFC (National Natural Science Foundation of China) Grants 11145003 (to H.A.), 10975045 and C2009000029 (to Y.Z.), and 30730031 (to H.Z.) and by 973 Program Grants 2007CB512100 and C2009001104 (to H.Z.). Computations performed at VCU were supported by the Center for High Performance Computing (CHiPC) and by the National Institutes of Health Grant S10RR027411 (to M.C.).	Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Horn R, 2005, SCI STKE, V307, P50; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Kukita F, 2000, J PHYSIOL-LONDON, V522, P357, DOI 10.1111/j.1469-7793.2000.00357.x; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lupyan D, 2010, BIOPHYS J, V98, P240, DOI 10.1016/j.bpj.2009.09.063; MacKerell AD., 1998, ENCY COMPUTATIONAL C, V1, P271; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Mezei M, 2006, J COMPUT AID MOL DES, V20, P97, DOI 10.1007/s10822-006-9039-1; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Mezei M, 2003, J MOL GRAPH MODEL, V21, P463, DOI 10.1016/S1093-3263(02)00203-6; Mezei M, 2010, J COMPUT CHEM, V31, P2658, DOI 10.1002/jcc.21551; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Rodriguez-Menchaca AA, 2012, P NATL ACAD SCI USA, V109, pE2399, DOI 10.1073/pnas.1207901109; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schulte U, 2000, EUR J BIOCHEM, V267, P5837, DOI 10.1046/j.1432-1327.2000.01671.x; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yang JQ, 2010, NEURON, V66, P871, DOI 10.1016/j.neuron.2010.05.009; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	45	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42278	42287		10.1074/jbc.M112.418640	http://dx.doi.org/10.1074/jbc.M112.418640			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23033482	Green Published, hybrid			2022-12-25	WOS:000312103000063
J	Dieteren, CEJ; Koopman, WJH; Swarts, HG; Peters, JGP; Maczuga, P; van Gemst, JJ; Masereeuw, R; Smeitink, JAM; Nijtmans, LGJ; Willems, PHGM				Dieteren, Cindy E. J.; Koopman, Werner J. H.; Swarts, Herman G.; Peters, Janny G. P.; Maczuga, Piotr; van Gemst, Jasper J.; Masereeuw, Rosalinde; Smeitink, Jan A. M.; Nijtmans, Leo G. J.; Willems, Peter H. G. M.			Subunit-specific Incorporation Efficiency and Kinetics in Mitochondrial Complex I Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ENCODED SUBUNITS; ASSEMBLY KINETICS; IDENTIFICATION; SUBCOMPLEXES; DEFECTS; PROTEIN	Studies employing native PAGE suggest that most nDNA-encoded CI subunits form subassemblies before assembling into holo-CI. In addition, in vitro evidence suggests that some subunits can directly exchange in holo-CI. Presently, data on the kinetics of these two incorporation modes for individual CI subunits during CI maintenance are sparse. Here, we used inducible HEK293 cell lines stably expressing AcGFP1-tagged CI subunits and quantified the amount of tagged subunit in mitoplasts and holo-CI by non-native and native PAGE, respectively, to determine their CI incorporation efficiency. Analysis of time courses of induction revealed three subunit-specific patterns. A first pattern, represented by NDUFS1, showed overlapping time courses, indicating that imported subunits predominantly incorporate into holo-CI. A second pattern, represented by NDUFV1, consisted of parallel time courses, which were, however, not quantitatively overlapping, suggesting that imported subunits incorporate at similar rates into holo-CI and CI assembly intermediates. The third pattern, represented by NDUFS3 and NDUFA2, revealed a delayed incorporation into holo-CI, suggesting their prior appearance in CI assembly intermediates and/or as free monomers. Our analysis showed the same maximum incorporation into holo-CI for NDUFV1, NDUFV2, NDUFS1, NDUFS3, NDUFS4, NDUFA2, and NDUFA12 with nearly complete loss of endogenous subunit at 24 h of induction, indicative of an equimolar stoichiometry and unexpectedly rapid turnover. In conclusion, the results presented demonstrate that newly formed nDNA-encoded CI subunits rapidly incorporate into holo-CI in a subunit-specific manner.	[Dieteren, Cindy E. J.; Koopman, Werner J. H.; Swarts, Herman G.; Willems, Peter H. G. M.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Biochem, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.; Maczuga, Piotr; van Gemst, Jasper J.; Smeitink, Jan A. M.; Nijtmans, Leo G. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Cell Biol, NL-6500 HB Nijmegen, Netherlands; [Peters, Janny G. P.; Masereeuw, Rosalinde] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Pharmacol & Toxicol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Willems, PHGM (corresponding author), Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Med Ctr, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.willems@ncmls.ru.nl	Masereeuw, Roos/N-3582-2014; Peters, J.G.P./L-4570-2015; Willems, P.H.G.M./L-4759-2015; Koopman, Werner J.H./AAC-9668-2020; Koopman, Werner J.H./D-3592-2009; Nijtmans, L.G.J./L-4549-2015; Dieteren, Cindy E.J./D-6042-2011; Masereeuw, Roos/I-5276-2016; Smeitink, Jan/C-1351-2013	Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; Masereeuw, Roos/0000-0002-1560-1074; 	Netherlands Organization for Scientific Research [911-02-008]; Radboud University Nijmegen Medical Centre	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Radboud University Nijmegen Medical Centre	This work was supported by the Netherlands Organization for Scientific Research (Grant 911-02-008) and a grant from the Radboud University Nijmegen Medical Centre (to W. J. H. K. and L. G. J. N).	Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bourges I, 2004, BIOCHEM J, V383, P491, DOI 10.1042/BJ20040256; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Dieteren CEJ, 2011, BBA-BIOENERGETICS, V1807, P1624, DOI 10.1016/j.bbabio.2011.09.013; Dieteren CEJ, 2011, P NATL ACAD SCI USA, V108, P8657, DOI 10.1073/pnas.1017581108; Dieteren CEJ, 2009, METHOD ENZYMOL, V456, P133, DOI 10.1016/S0076-6879(08)04407-8; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; HALL RE, 1990, J BIOL CHEM, V265, P16484; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perales-Clemente E, 2010, MOL CELL BIOL, V30, P3038, DOI 10.1128/MCB.00025-10; PILKINGTON SJ, 1991, BIOCHEMISTRY-US, V30, P2166, DOI 10.1021/bi00222a021; Potluri P, 2004, EUR J BIOCHEM, V271, P3265, DOI 10.1111/j.1432-1033.2004.04260.x; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schneider D, 2008, BBA-BIOENERGETICS, V1777, P735, DOI 10.1016/j.bbabio.2008.03.003; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200; Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262; VIDEIRA A, 1989, EUR J BIOCHEM, V181, P493, DOI 10.1111/j.1432-1033.1989.tb14751.x; Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	32	30	32	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41851	41860		10.1074/jbc.M112.391151	http://dx.doi.org/10.1074/jbc.M112.391151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038253	hybrid, Green Published			2022-12-25	WOS:000312103000026
J	Bei, L; Shah, C; Wang, H; Huang, WQ; Roy, R; Eklund, EA				Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.			beta-Catenin Activates the HOXA10 and CDX4 Genes in Myeloid Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMATOPOIETIC-CELLS; BONE-MARROW-CELLS; STEM-CELLS; IN-VITRO; DNA-BINDING; EXPRESSION; LEUKEMIA; TRANSCRIPTION; MLL; DIFFERENTIATION	HoxA10 is a homeodomain transcription factor that is involved in maintenance of the myeloid progenitor population and implicated in myeloid leukemogenesis. Previously, we found that FGF2 and CDX4 are direct target genes of HoxA10 and that HOXA10 is a Cdx4 target gene. We also found that increased production of fibroblast growth factor 2 (Fgf2) by HoxA10-overexpressing myeloid progenitor cells results in activation of beta-catenin in an autocrine manner. In this study, we identify novel cis elements in the CDX4 and HOXA10 genes that are activated by beta-catenin in myeloid progenitor cells. We determine that beta-catenin interacts with these cis elements, identifying both CDX4 and HOXA10 as beta-catenin target genes in this context. We demonstrate that HoxA10-induced CDX4 transcription is influenced by Fgf2-dependent beta-catenin activation. Similarly, Cdx4-induced HOXA10 transcription is influenced by beta-catenin in an Fgf2-dependent manner. Increased expression of a set of Hox proteins, including HoxA10, is associated with poor prognosis in acute myeloid leukemia. Cdx4 contributes to leukemogenesis in Hox-overexpressing acute myeloid leukemia, and increased beta-catenin activity is also associated with poor prognosis. The current studies identify a molecular mechanisms through which increased expression of HoxA10 increases Cdx4 expression by direct CDX4 activation and by Fgf2-induced beta-catenin activity. This results in Cdx4-induced HoxA10-expression, creating a positive feedback mechanism.	[Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Bei, Ling; Shah, Chirag; Wang, Hao; Huang, Weiqi; Roy, Rupali; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch, Dept Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu		Wang, Hao/0000-0003-2131-0377	National Institutes of Health [R01-HL87717]; Veterans Affairs Merit Review; NATIONAL CANCER INSTITUTE [R01CA195642] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL87717. This work was also supported by a Veterans Affairs Merit Review (to E. A. E.).	ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bansal D, 2006, P NATL ACAD SCI USA, V103, P16924, DOI 10.1073/pnas.0604579103; Bei L, 2007, J BIOL CHEM, V282, P16846, DOI 10.1074/jbc.M609744200; Bei L, 2011, J BIOL CHEM, V286, P19047, DOI 10.1074/jbc.M110.213983; Bjornsson JM, 2001, BLOOD, V98, P3301, DOI 10.1182/blood.V98.12.3301; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Eklund EA, 2000, J BIOL CHEM, V275, P20117, DOI 10.1074/jbc.M907915199; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Horton SJ, 2005, CANCER RES, V65, P9245, DOI 10.1158/0008-5472.CAN-05-1691; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kim K, 2000, MOL BIOL CELL, V11, P3509, DOI 10.1091/mbc.11.10.3509; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lawrence HJ, 1997, BLOOD, V89, P1922, DOI 10.1182/blood.V89.6.1922; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Shah CA, 2012, J BIOL CHEM, V287, P18230, DOI 10.1074/jbc.M111.328401; Shah CA, 2011, J BIOL CHEM, V286, P3161, DOI 10.1074/jbc.M110.183251; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wang H, 2009, J BIOL CHEM, V284, P2549, DOI 10.1074/jbc.M804704200; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WILSON EL, 1991, BLOOD, V77, P954	45	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.402172	http://dx.doi.org/10.1074/jbc.M112.402172			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038246	Green Published, hybrid			2022-12-25	WOS:000311233800029
J	Wang, XW; Zhuang, XX; Cao, D; Chu, YJ; Yao, P; Liu, W; Liu, LF; Adams, G; Fang, GW; Dou, Z; Ding, X; Huang, YJ; Wang, DM; Yao, XB				Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Yao, Phil; Liu, Wei; Liu, Lifang; Adams, Gregory; Fang, Guowei; Dou, Zhen; Ding, Xia; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao			Mitotic Regulator SKAP Forms a Link between Kinetochore Core Complex KMN and Dynamic Spindle Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; PLUS-END TRACKING; CENP-E; CHROMOSOME SEGREGATION; ANAPHASE TRANSITION; PROTEIN E; MITOSIS; CHECKPOINT; ATTACHMENT; INTERACTS	Chromosome segregation in mitosis is orchestrated by the dynamic interactions between the kinetochore and spindle microtubules. Our recent study shows that mitotic motor CENP-E cooperates with SKAP to orchestrate an accurate chromosome movement in mitosis. However, it remains elusive how kinetochore core microtubule binding activity KMN (KNL1-MIS12-NDC80) regulates microtubule plus-end dynamics. Here, we identify a novel interaction between MIS13 and SKAP that orchestrates accurate interaction between kinetochore and dynamic spindle microtubules. SKAP physically interacts with MIS13 and specifies kinetochore localization of SKAP. Suppression of MIS13 by small interfering RNA abrogates the kinetochore localization of SKAP. Total internal reflection fluorescence microscopic assays demonstrate that SKAP exhibits an EB1-dependent, microtubule plus-end loading and tracking in vitro. Importantly, SKAP is essential for kinetochore oscillations and dynamics of microtubule plus-ends during live cell mitosis. Based on those findings, we reason that SKAP constitutes a dynamic link between spindle microtubule plus-ends and mitotic chromosomes to achieve faithful cell division.	[Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Liu, Wei; Liu, Lifang; Fang, Guowei; Dou, Zhen; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Chu, Youjun; Liu, Wei; Liu, Lifang; Fang, Guowei; Dou, Zhen; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Univ Sci & Technol China, Hefei 230027, Peoples R China; [Wang, Xiwei; Zhuang, Xiaoxuan; Cao, Dan; Adams, Gregory; Dou, Zhen; Ding, Xia; Huang, Yuejia; Wang, Dongmei; Yao, Xuebiao] Hefei Natl Lab Phys Sci Microscale, Joint Res Grp Cellular Dynam, Anhui Morehouse Sch Med, Hefei 230027, Peoples R China; [Wang, Xiwei; Chu, Youjun; Yao, Phil; Adams, Gregory; Huang, Yuejia] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Yao, Phil] Georgia Inst Technol, Sch Engn, Atlanta, GA 30310 USA; [Liu, Lifang] AF Gen Hosp, Beijing 100036, Peoples R China; [Adams, Gregory; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; University System of Georgia; Georgia Institute of Technology; Beijing University of Chinese Medicine	Wang, DM (corresponding author), Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China.	douzhen@ustc.edu.cn; wangdm@ustc.edu.cn	Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Zhuang, Xiaoxuan/R-7836-2019; liu, li/HGC-0900-2022	Zhuang, Xiaoxuan/0000-0003-4004-5329; Xia, Peng/0000-0002-5419-7756; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, G12RR03034, UL1 RR025008, CA132389]; Chinese 973 Project [2010CB912103, 2012CB917204, 2012CB945002, 2002CB713700]; Chinese Academy of Science [KSCX2-YW-H-10]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010]; Chinese Postdoctoral Fellowship [2012M510210]; Fundamental Research Funds for Central Universities [WK2060190018, WK2340000021]; NATIONAL CANCER INSTITUTE [P20CA132389, R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK115812] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Project(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Fellowship; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, G12RR03034, UL1 RR025008, and CA132389. This work was also supported by Chinese 973 Project Grants 2010CB912103, 2012CB917204, 2012CB945002, and 2002CB713700; Chinese Academy of Science Grant KSCX2-YW-H-10; Anhui Province Key Project Grant 08040102005; International Collaboration Grant 2009DFA31010; Chinese Natural Science Foundation Grants 90508002, 91129714, 31071184, 81270466, 90913016, MOE20113402130010, Chinese Postdoctoral Fellowship 2012M510210; and the Fundamental Research Funds for Central Universities (WK2060190018 and WK2340000021).	Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Dixit R, 2010, METHOD CELL BIOL, V95, P543, DOI 10.1016/S0091-679X(10)95027-9; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; McEwen BF, 2001, MOL BIOL CELL, V12, P2776, DOI 10.1091/mbc.12.9.2776; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Wang HM, 2004, J BIOL CHEM, V279, P54590, DOI 10.1074/jbc.M407588200; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721; ZHAI Y, 1994, J CELL SCI, V107, P881; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	43	35	40	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406652	http://dx.doi.org/10.1074/jbc.M112.406652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035123	Green Published, hybrid			2022-12-25	WOS:000311233800010
J	Lee, YP; Wong, CH; Chan, KS; Lai, SK; Koh, CG; Li, HY				Lee, Yoke-Peng; Wong, Chi-Hang; Chan, Kheng-Sze; Lai, Soak-Kuan; Koh, Cheng-Gee; Li, Hoi-Yeung			In Vivo FRET Imaging Revealed a Regulatory Role of RanGTP in Kinetochore-Microtubule Attachments via Aurora B Kinase	PLOS ONE			English	Article							CHROMOSOME ALIGNMENT; SPINDLE CHECKPOINT; MITOTIC-SPINDLE; MAMMALIAN-CELLS; PROTEIN-KINASE; SOMATIC-CELLS; GTPASE RAN; CENP-E; ANAPHASE; GRADIENT	Under the fluctuating circumstances provided by the innate dynamics of microtubules and opposing tensions resulted from microtubule-associated motors, it is vital to ensure stable kinetochore-microtubule attachments for accurate segregation. However, a comprehensive understanding of how this regulation is mechanistically achieved remains elusive. Using our newly designed live cell FRET time-lapse imaging, we found that post-metaphase RanGTP is crucial in the maintenance of stable kinetochore-microtubule attachments by regulating Aurora B kinase via the NES-bearing Mst1. More importantly, our study demonstrates that by ensuring stable alignment of metaphase chromosomes prior to segregation, RanGTP is indispensible in governing the genomic integrity and the fidelity of cell cycle progression. Our findings suggest an additional role of RanGTP beyond its known function in mitotic spindle assembly during the prometaphase-metaphase transition.	[Lee, Yoke-Peng; Wong, Chi-Hang; Chan, Kheng-Sze; Lai, Soak-Kuan; Koh, Cheng-Gee; Li, Hoi-Yeung] Nanyang Technol Univ, Div Mol & Cell Biol, Sch Biol Sci, Coll Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Koh, CG (corresponding author), Nanyang Technol Univ, Div Mol & Cell Biol, Sch Biol Sci, Coll Sci, Singapore, Singapore.	cgkoh@ntu.edu.sg; hyli@ntu.edu.sg	Wong, Chi Hang/C-6909-2015; Koh, Cheng Gee/A-2215-2011; Wong, Chi Hang/ABE-8673-2021	Wong, Chi Hang/0000-0003-4157-6287; Koh, Cheng Gee/0000-0003-1905-8010; Wong, Chi Hang/0000-0003-4157-6287; Li, Hoi Yeung/0000-0002-8603-1953	Academic Research Council; Ministry of Education, Singapore [RG37/08]; A*STAR, Biomedical Research Council [08/1/22/19/568]	Academic Research Council; Ministry of Education, Singapore(Ministry of Education, Singapore); A*STAR, Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Academic Research Council, Ministry of Education, Singapore (Academic Research Fund AcRF Tier 1, RG37/08) and A*STAR, Biomedical Research Council (BMRC grant 08/1/22/19/568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Anand R, 2008, BIOCHEMISTRY-US, V47, P6719, DOI 10.1021/bi800309m; Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Bamba C, 2002, CURR BIOL, V12, P503, DOI 10.1016/S0960-9822(02)00741-8; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Daum JR, 2011, CURR BIOL, V21, P1018, DOI 10.1016/j.cub.2011.05.032; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Maia AF, 2010, CHROMOSOMA, V119, P405, DOI 10.1007/s00412-010-0265-x; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Malkusch W, 2004, BIOSCIENCE TECHNOLOG, P32; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; NISHITANI H, 1990, J BIOCHEM-TOKYO, V107, P228, DOI 10.1093/oxfordjournals.jbchem.a123031; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Silverman-Gavrila RV, 2006, MOL BIOL CELL, V17, P2069, DOI 10.1091/mbc.E05-10-0991; Stevens D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022969; Sundin LJR, 2011, MOL BIOL CELL, V22, P759, DOI 10.1091/mbc.E10-08-0671; Tatsuka M, 1998, CANCER RES, V58, P4811; Torosantucci L, 2008, MOL BIOL CELL, V19, P1873, DOI 10.1091/mbc.E07-10-1050; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000	39	57	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45836	10.1371/journal.pone.0045836	http://dx.doi.org/10.1371/journal.pone.0045836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029267	gold, Green Published			2022-12-25	WOS:000309973900056
J	Leidner, B; Sheikh, H; Ginges, J				Leidner, Bernhard; Sheikh, Hammad; Ginges, Jeremy			Affective Dimensions of Intergroup Humiliation	PLOS ONE			English	Article							ACTION TENDENCIES; ANGER; SHAME; TERRORISM; REJECTION; VIOLENCE; GUILT; CATEGORIZATION; EMBARRASSMENT; EMOTIONS	Despite the wealth of theoretical claims about the emotion of humiliation and its effect on human relations, there has been a lack of empirical research investigating what it means to experience humiliation. We studied the affective characteristics of humiliation, comparing the emotional experience of intergroup humiliation to two other emotions humiliation is often confused with: anger and shame. The defining characteristics of humiliation were low levels of guilt and high levels of other-directed outrage (like anger and unlike shame), and high levels of powerlessness (like shame and unlike anger). Reasons for the similarities and differences of humiliation with anger and shame are discussed in terms of perceptions of undeserved treatment and injustice. Implications for understanding the behavioral consequences of humiliation and future work investigating the role of humiliation in social life are discussed.	[Leidner, Bernhard] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Sheikh, Hammad; Ginges, Jeremy] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	University of Massachusetts System; University of Massachusetts Amherst; The New School	Leidner, B (corresponding author), Univ Massachusetts, Dept Psychol, Tobin Hall, Amherst, MA 01003 USA.	bleidner@psych.umass.edu	Sheikh, Hammad/AAD-5953-2019	Sheikh, Hammad/0000-0002-5472-4309	Gottlieb Daimler- und Karl Benz-Foundation [02-15/06]; Alliance of Civilizations Media Fund; National Science Foundation [BCS-827313]; Department of Defense Multidisciplinary University Research Initiative [AOR-MURI W911NF-08-1-0301]	Gottlieb Daimler- und Karl Benz-Foundation; Alliance of Civilizations Media Fund; National Science Foundation(National Science Foundation (NSF)); Department of Defense Multidisciplinary University Research Initiative(MURI)	Research reported here as well as the writing of this paper was supported by a Fellowship for Young Scientists of the Gottlieb Daimler- und Karl Benz-Foundation (02-15/06), to Bernhard Leidner, and by grants from the Alliance of Civilizations Media Fund, the National Science Foundation (BCS-827313) and the Department of Defense Multidisciplinary University Research Initiative (AOR-MURI W911NF-08-1-0301) to Jeremy Ginges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Atran S, 2005, NATURE, V437, P630, DOI 10.1038/437620a; Batson CD, 2007, EUR J SOC PSYCHOL, V37, P1272, DOI 10.1002/ejsp.434; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; Beck AT, 1985, ANXIETY DISORDERS PH; Bourgeois KS, 2001, MOTIV EMOTION, V25, P101, DOI 10.1023/A:1010661825137; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BROWNE A, 1993, AM PSYCHOL, V48, P1077, DOI 10.1037/0003-066X.48.10.1077; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Cattell R.B., 1966, HDB MULTIVARIATE EXP; Cohen D, 1996, J PERS SOC PSYCHOL, V70, P945, DOI 10.1037/0022-3514.70.5.945; Coleman P. T., 2007, ANN C INT ASS CONFL; Combs DJY, 2010, BASIC APPL SOC PSYCH, V32, P128, DOI 10.1080/01973531003738379; Duhl L, 1992, J Prim Prev, V12, P243, DOI 10.1007/BF02015517; Ellsworth PC, 2006, EMOTION, V6, P572, DOI 10.1037/1528-3542.6.4.572; Fontan V, 2006, TERROR POLIT VIOLENC, V18, P217, DOI 10.1080/09546550500383266; Gilbert P, 1997, BRIT J MED PSYCHOL, V70, P113, DOI 10.1111/j.2044-8341.1997.tb01893.x; Ginges J, 2008, J COGN CULT, V8, P281, DOI 10.1163/156853708X358182; GREIST JH, 1995, J CLIN PSYCHIAT, V56, P5; Hartling L.M., 1999, J PRIM PREV, V19, P259, DOI [10.1023/A:1022622422521, DOI 10.1023/A:1022622422521]; Hassan N., 2007, ROOTS TERRORISM; Henrich J., BEHAV BRAIN IN PRESS; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Jackson M, 2000, THESIS; Juergensmeyer Mark, 2000, TERROR MIND GOD; Keltner D, 1997, PSYCHOL BULL, V122, P250, DOI 10.1037/0033-2909.122.3.250; Klein D C, 1991, J Prim Prev, V12, P93, DOI 10.1007/BF02015214; Leary MR, 2006, PERS SOC PSYCHOL REV, V10, P111, DOI 10.1207/s15327957pspr1002_2; Leary MR, 1998, J PERS SOC PSYCHOL, V74, P1290, DOI 10.1037/0022-3514.74.5.1290; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; Lindner, 2006, MAKING ENEMIES HUMIL; Lindner E. G., 2002, PEACE CONFLICT J PEA, V8, P125, DOI DOI 10.1207/S15327949PAC0802_02; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mackie D.M., 2015, APA HDB PERSONALITY, P263, DOI [10.1037/14342-010, DOI 10.1037/14342-010]; Mackie D. M., 2009, HDB PREJUDICE STEREO, P285; Mackie DM, 2000, J PERS SOC PSYCHOL, V79, P602, DOI 10.1037//0022-3514.79.4.602; Medin DL, 2004, PSYCHOL REV, V111, P960, DOI 10.1037/0033-295x.111.4.960; Mikula G, 1998, PERS SOC PSYCHOL B, V24, P769, DOI 10.1177/0146167298247009; Miller William Ian, 1993, HUMILIATION OTHER ES; Moghadam A, 2006, STUD CONFL TERROR, V29, P707, DOI 10.1080/10576100600561907; Montada L., 1988, SOC JUSTICE RES, V3, P313, DOI [10.1007/BF01048081, DOI 10.1007/BF01048081]; Mosquera PMR, 2002, J CROSS CULT PSYCHOL, V33, P16, DOI 10.1177/0022022102033001002; Murphy K, 2009, SOC JUSTICE RES, V22, P1, DOI 10.1007/s11211-008-0086-8; Rodriguez Mosquera P, 2008, COGNITION EMOTION, V22, P1471, DOI 10.1080/02699930701822272; Scheff T.J., 1987, ROLE SHAME SYMPTOM F, P109; Scheff Thomas J., 2000, J MUNDANE BEHAV, V1, P303; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; SILVER M, 1986, J THEOR SOC BEHAV, V16, P269, DOI 10.1111/j.1468-5914.1986.tb00080.x; Small DA, 2006, POLIT PSYCHOL, V27, P289, DOI 10.1111/j.1467-9221.2006.00007.x; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Stanton J. M., 2006, 13007 SYR U SCH INF; STEINBERG BS, 1991, POLIT PSYCHOL, V12, P653, DOI 10.2307/3791551; Stern J., 2003, TERROR NAME GOD WHY, DOI [10.2307/20033801, DOI 10.2307/20033801]; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tangney J.P., 1999, HDB COGNITION EMOTIO, P541, DOI DOI 10.1002/0470013494.CH26; Tangney J.P., 2003, SHAME GUILT; Tangney J.P, 2007, SELF CONSCIOUS EMOTI, P310; Tangney JP, 1996, J PERS SOC PSYCHOL, V70, P1256, DOI 10.1037/0022-3514.70.6.1256; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; van Zomeren M, 2004, J PERS SOC PSYCHOL, V87, P649, DOI 10.1037/0022-3514.87.5.649; VOGEL W, 1990, CONTEMP FAM THER, V12, P139, DOI 10.1007/BF00892492; Wallace C., 2004, 13006 SYR U SCH INF; Weiss HM, 1999, J APPL PSYCHOL, V84, P786, DOI 10.1037/0021-9010.84.5.786; Yzerbyt V, 2003, BRIT J SOC PSYCHOL, V42, P533, DOI 10.1348/014466603322595266	67	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46375	10.1371/journal.pone.0046375	http://dx.doi.org/10.1371/journal.pone.0046375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029499	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900146
J	Zhang, H; Yu, CH; Jiang, YP; Peng, C; He, K; Tang, JY; Xin, HL				Zhang, Hong; Yu, Cheng-Hao; Jiang, Yi-Ping; Peng, Cheng; He, Kun; Tang, Jian-Yuan; Xin, Hai-Liang			Protective Effects of Polydatin from Polygonum cuspidatum against Carbon Tetrachloride-Induced Liver Injury in Mice	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; EXTRACT; RATS; ACTIVATION; FIBROSIS; REGENERATION; INFLAMMATION; HEPATITIS; CARCINOMA	Polydatin is one of main compounds in Polygonum cuspidatum, a plant with both medicinal and nutritional value. The possible hepatoprotective effects of polydatin on acute liver injury mice induced by carbon tetrachloride (CCl4) and the mechanisms involved were investigated. Intraperitoneal injection of CCl4 (50 ml/kg) resulted in a significant increase in the levels of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and hepatic malondialdehyde (MDA), also a marked enhancement in the expression of hepatic tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) and nuclearfactor-kappa B (NF-kappa B). On the other hand, decreased glutathione (GSH) content and activities of glutathione transferase (GST), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were observed following CCl4 exposure. Nevertheless, all of these phenotypes were evidently reversed by preadministration of polydatin for 5 continuous days. The mRNA and protein expression levels of hepatic growth factor-beta1 (TGF-beta(1)) were enhanced further by polydatin. These results suggest that polydatin protects mice against CCl4-induced liver injury through antioxidant stress and antiinflammatory effects. Polydatin may be an effective hepatoprotective agent and a promising candidate for the treatment of oxidative stress-and inflammation-related diseases.	[Zhang, Hong; Yu, Cheng-Hao; Peng, Cheng] Chengdu Univ Tradit Chinese Med, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Coll Pharm, Chengdu, Peoples R China; [Zhang, Hong; Jiang, Yi-Ping; He, Kun] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai, Peoples R China; [Tang, Jian-Yuan] State Food & Drug Adm, Ctr Drug Evaluat, Beijing, Peoples R China; [Xin, Hai-Liang] Second Mil Med Univ, Dept Tradit Chinese Med, Changhai Hosp, Shanghai, Peoples R China	Chengdu University of Traditional Chinese Medicine; Naval Medical University; Naval Medical University	Peng, C (corresponding author), Chengdu Univ Tradit Chinese Med, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Coll Pharm, Chengdu, Peoples R China.	pengchengchengdu@126.com; tangjianyuan163@163.com; hailiangxin@163.com		Peng, Cheng/0000-0003-3303-906X; zhang, hong/0000-0002-6191-0046	National Natural Science Foundation of China [81173462]; Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources [2011012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources	This work was supported by the National Natural Science Foundation of China (81173462) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources (2011012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Campo GM, 2008, BRIT J PHARMACOL, V155, P945, DOI 10.1038/bjp.2008.338; Chang JS, 2005, ANTIVIR RES, V66, P29, DOI 10.1016/j.antiviral.2004.12.006; Du J, 2009, PHYTOMEDICINE, V16, P652, DOI 10.1016/j.phymed.2008.10.001; Fakurazi S, 2008, FOOD CHEM TOXICOL, V46, P2611, DOI 10.1016/j.fct.2008.04.018; Fei HongHua, 2008, Journal of Shandong University (Health Sciences), V46, P43; GOLDBERG DM, 1965, GASTROENTEROLOGY, V49, P256; Gopal N, 2008, FITOTERAPIA, V79, P24, DOI 10.1016/j.fitote.2007.07.006; Gross A, 2009, CHEM-BIOL INTERACT, V178, P56, DOI 10.1016/j.cbi.2008.09.025; He YD, 2012, BRIT J DERMATOL, V167, P941, DOI 10.1111/j.1365-2133.2012.10951.x; Huang B, 2010, FOOD CHEM, V120, P873, DOI 10.1016/j.foodchem.2009.11.020; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P41; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Jia XY, 2011, FOOD CHEM, V125, P673, DOI 10.1016/j.foodchem.2010.09.062; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kim HY, 2011, TOXICOLOGY, V282, P104, DOI 10.1016/j.tox.2011.01.017; Kim KW, 2007, VASC PHARMACOL, V47, P99, DOI 10.1016/j.vph.2007.04.007; Li L, 2013, EXP TOXICOL PATHOL, V65, P73, DOI 10.1016/j.etp.2011.06.003; Li RP, 2012, PHYTOMEDICINE, V19, P677, DOI 10.1016/j.phymed.2012.03.002; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Mehmetcik G, 2008, EXP TOXICOL PATHOL, V60, P475, DOI 10.1016/j.etp.2008.04.014; Miao Q, 2011, PHYTOMEDICINE, V19, P8, DOI 10.1016/j.phymed.2011.06.023; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Pan YM, 2007, FOOD CHEM, V105, P1518, DOI 10.1016/j.foodchem.2007.05.039; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; Recknagel R.O., 2020, HEPATOTOXICOLOGY, P401; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; REJ R, 1978, CLIN CHEM, V24, P1971; Rosillo MA, 2011, BIOCHEM PHARMACOL, V82, P737, DOI 10.1016/j.bcp.2011.06.043; Shan B, 2008, FOOD CHEM, V109, P530, DOI 10.1016/j.foodchem.2007.12.064; Shu SY, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-31; Simpson KJ, 1997, J HEPATOL, V27, P1120, DOI 10.1016/S0168-8278(97)80160-2; Singh N, 2008, ENVIRON TOXICOL PHAR, V26, P241, DOI 10.1016/j.etap.2008.05.006; Srivastava A, 2010, FOOD CHEM, V118, P411, DOI 10.1016/j.foodchem.2009.05.014; Taniguchi M, 2004, LIFE SCI, V75, P1539, DOI 10.1016/j.lfs.2004.02.030; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Tung YT, 2009, FOOD CHEM TOXICOL, V47, P1385, DOI 10.1016/j.fct.2009.03.021; Venukumar M R, 2002, Indian J Clin Biochem, V17, P80, DOI 10.1007/BF02867976; Weerachayaphorn J, 2010, J ETHNOPHARMACOL, V129, P254, DOI 10.1016/j.jep.2010.03.026; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Wu JG, 2009, PHYTOMEDICINE, V16, P1033, DOI 10.1016/j.phymed.2009.04.005; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yener Z, 2009, FOOD CHEM TOXICOL, V47, P418, DOI 10.1016/j.fct.2008.11.031; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031157; Zhang RR, 2009, J ETHNOPHARMACOL, V126, P207, DOI 10.1016/j.jep.2009.08.044	48	78	86	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46574	10.1371/journal.pone.0046574	http://dx.doi.org/10.1371/journal.pone.0046574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029551	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900185
J	Zhang, YQ; Pei, XW; Zhang, C; Lu, ZF; Wang, ZX; Jia, SR; Li, WM				Zhang, Yongqiang; Pei, Xinwu; Zhang, Chao; Lu, Zifeng; Wang, Zhixing; Jia, Shirong; Li, Weimin			De Novo Foliar Transcriptome of Chenopodium amaranticolor and Analysis of Its Gene Expression During Virus-Induced Hypersensitive Response	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; RNA-SEQ; DISEASE-RESISTANCE; MOSAIC-VIRUS; ARABIDOPSIS-THALIANA; PLANT IMMUNITY; DEFENSE; CELL; TOOL; IDENTIFICATION	Background: The hypersensitive response (HR) system of Chenopodium spp. confers broad-spectrum virus resistance. However, little knowledge exists at the genomic level for Chenopodium, thus impeding the advanced molecular research of this attractive feature. Hence, we took advantage of RNA-seq to survey the foliar transcriptome of C. amaranticolor, a Chenopodium species widely used as laboratory indicator for pathogenic viruses, in order to facilitate the characterization of the HR-type of virus resistance. Methodology and Principal Findings: Using Illumina HiSeq (TM) 2000 platform, we obtained 39,868,984 reads with 3,588,208,560 bp, which were assembled into 112,452 unigenes (3,847 clusters and 108,605 singletons). BlastX search against the NCBI NR database identified 61,698 sequences with a cut-off E-value above 10(-5). Assembled sequences were annotated with gene descriptions, GO, COG and KEGG terms, respectively. A total number of 738 resistance gene analogs (RGAs) and homology sequences of 6 key signaling proteins within the R proteins-directed signaling pathway were identified. Based on this transcriptome data, we investigated the gene expression profiles over the stage of HR induced by Tobacco mosaic virus and Cucumber mosaic virus by using digital gene expression analysis. Numerous candidate genes specifically or commonly regulated by these two distinct viruses at early and late stages of the HR were identified, and the dynamic changes of the differently expressed genes enriched in the pathway of plant-pathogen interaction were particularly emphasized. Conclusions: To our knowledge, this study is the first description of the genetic makeup of C. amaranticolor, providing deep insight into the comprehensive gene expression information at transcriptional level in this species. The 738 RGAs as well as the differentially regulated genes, particularly the common genes regulated by both TMV and CMV, are suitable candidates which merit further functional characterization to dissect the molecular mechanisms and regulatory pathways of the HR-type of virus resistance in Chenopodium.	[Zhang, Yongqiang; Pei, Xinwu; Zhang, Chao; Wang, Zhixing; Jia, Shirong; Li, Weimin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Lu, Zifeng] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Lanzhou University	Li, WM (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	liwm518@hotmail.com	Pei, Xinwu/AAI-1736-2019; Jia, Shirong/L-8788-2019; pei, xinwu/O-7083-2019	Pei, Xinwu/0000-0001-7828-3037; 	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms [2011ZX08001-002, 2011ZX08004-004]; Special Fund for Agro-scientific Research in the Public Interest [201103026-2]	National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms; Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Major Special Project of China on New Varieties Cultivation for Transgenic Organisms (grant nos. 2011ZX08001-002 and 2011ZX08004-004), and the Special Fund for Agro-scientific Research in the Public Interest (grant no. 201103026-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Caldwell KS, 2009, GENETICS, V181, P671, DOI 10.1534/genetics.108.097279; Canto T, 1999, VIROLOGY, V265, P74, DOI 10.1006/viro.1999.0028; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; CMI/AAB, 1984, DESCR PLANT VIR JUL; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper B, 2001, PLANT J, V26, P339, DOI 10.1046/j.1365-313X.2001.01030.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DAWSON WO, 1986, P NATL ACAD SCI USA, V83, P1832, DOI 10.1073/pnas.83.6.1832; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hou WN, 2011, MOL PLANT PATHOL, V12, P595, DOI 10.1111/J.1364-3703.2010.00696.X; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Lu M, 2001, PLANT CELL, V13, P437, DOI 10.1105/tpc.13.2.437; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pitzschke A., 2009, CURR OPIN PLANT BIOL, V12, P1; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Schmitz I, 1996, VIROLOGY, V226, P281, DOI 10.1006/viro.1996.0656; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Sun Q, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-53; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VISEDO G, 1990, PHYSIOL PLANTARUM, V78, P218; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zheng ZY, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-2; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	69	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45953	10.1371/journal.pone.0045953	http://dx.doi.org/10.1371/journal.pone.0045953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029338	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900067
J	Zou, HS; Gowda, S; Zhou, LJ; Hajeri, S; Chen, GY; Duan, YP				Zou, Huasong; Gowda, Siddarame; Zhou, Lijuan; Hajeri, Subhas; Chen, Gongyou; Duan, Yongping			The Destructive Citrus Pathogen, 'Candidatus Liberibacter asiaticus' Encodes a Functional Flagellin Characteristic of a Pathogen-Associated Molecular Pattern	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; DEFENSE RESPONSE; GREENING DISEASE; PLANT DEFENSE; PERCEPTION; GENES; IDENTIFICATION; ARABIDOPSIS; FLG22; FLS2	Huanglongbing (HLB) is presently the most devastating citrus disease worldwide. As an intracellular plant pathogen and insect symbiont, the HLB bacterium, 'Candidatus Liberibacter asiaticus' (Las), retains the entire flagellum-encoding gene cluster in its significantly reduced genome. Las encodes a flagellin and hook-associated protein (Fla) of 452 amino acids that contains a conserved 22 amino acid domain (flg22) at positions 29 to 50 in the N-terminus. The phenotypic alteration in motility of a Sinorhizobium meliloti mutant lacking the fla genes was partially restored by constitutive expression of Fla(Las). Agrobacterium-mediated transient expression in planta revealed that Fla(Las) induced cell death and callose deposition in Nicotiana benthamiana, and that the transcription of BAK1 and SGT1, which are associated with plant innate immunity, was upregulated. Amino acid substitution experiments revealed that residues 38 (serine) and 39 (aspartate) of Fla(Las) were essential for callose induction. The synthetic flg22(Las) peptide could not induce plant cell death but retained the ability to induce callose deposition at a concentration of 20 mu M or above. This demonstrated that the pathogen-associated molecular pattern (PAMP) activity of flg22 in Las was weaker than those in other well-studied plant pathogenic bacteria. These results indicate that Fla(Las) acts as a PAMP and may play an important role in triggering host plant resistance to the HLB bacteria.	[Zou, Huasong; Zhou, Lijuan; Duan, Yongping] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA; [Gowda, Siddarame; Hajeri, Subhas] Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Lake Alfred, FL USA; [Zhou, Lijuan] Univ Florida, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Zou, Huasong; Chen, Gongyou] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Shanghai Jiao Tong University	Duan, YP (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL USA.	Yongping.Duan@ars.usda.gov	CHEN, Gongyou/AAA-9694-2019; Hajeri, Subhas/E-8180-2018; Zhou, Li/GSE-4531-2022; Zou, Huasong/GLN-3569-2022	CHEN, Gongyou/0000-0003-1979-2880; Hajeri, Subhas/0000-0002-5993-118X; Zou, Huasong/0000-0001-5758-1975	United States Department of Agriculture; Citrus Research and Development Foundation [312, 162]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation	Funding provided by United States Department of Agriculture and Citrus Research and Development Foundation grant #162 and #312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove JM, 2006, J PLANT PATHOL, V88, P7; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cornelis P, 2011, MICROBIOL-SGM, V157, P1251, DOI 10.1099/mic.0.049635-0; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lacomme C, 2008, CURR PROTOC MICROBIO, p16I11; Lin H, 2011, PLOS ONE, V6; Liu Y, 2010, CHINESE SCI BULL, V55, P259, DOI 10.1007/s11434-009-0721-2; Lu HY, 2010, MICROBIOL-SGM, V156, P2092, DOI 10.1099/mic.0.038547-0; Lyle S., 2012, CITRUS DIS HUANGLONG; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Sambrook J, 2001, MOL CLONING LAB MANU; Scharf B, 2001, J BACTERIOL, V183, P5334, DOI 10.1128/JB.183.18.5334-5342.2001; SCHNEIDER H, 1968, PHYTOPATHOLOGY, V58, P1155; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Taguchi F, 2003, PLANT PHYSIOL BIOCH, V41, P165, DOI 10.1016/S0981-9428(02)00018-9; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tsai CH, 2008, BOT STUD, V49, P49; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Zhao XY, 1981, P INT SOC CITRICULTU, V1, P466	42	32	36	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46447	10.1371/journal.pone.0046447	http://dx.doi.org/10.1371/journal.pone.0046447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029520	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900161
J	Xie, XJ; Lu, H; Moorleghen, JJ; Howatt, DA; Rateri, DL; Cassis, LA; Daugherty, A				Xie, Xiaojie; Lu, Hong; Moorleghen, Jessica J.; Howatt, Deborah A.; Rateri, Debra L.; Cassis, Lisa A.; Daugherty, Alan			Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; ATHEROSCLEROTIC LESIONS; MATRIX METALLOPROTEINASES; CLINICAL-TRIAL; INHIBITION; GROWTH; MODEL; LOCALIZATION; DEGENERATION; SUPPRESSION	Background: There is no proven medical approach to attenuating expansion and rupture of abdominal aortic aneurysms (AAAs). One approach that is currently being investigated is the use of doxycycline. Despite being primarily used as an antimicrobial drug, doxycycline has been proposed to function in reducing AAA expansion. Doxycycline is effective in reducing the formation in the most commonly used mouse models of AAAs when administered prior to the initiation of the disease. The purpose of the current study was to determine the effects of doxycycline on established AAAs when it was administered at a dose that produces therapeutic serum concentrations. Methods and Results: LDL receptor (-)/(-) male mice fed a saturated-fat supplemented diet were infused with AngII (1,000 ng/kg/min) via mini-osmotic pumps for 28 days. Upon verification of AAA formation by noninvasive high frequency ultrasonography, mice were stratified based on aortic lumen diameters, and continuously infused with AngII while also administered either vehicle or doxycycline (100 mg/kg/day) in drinking water for 56 days. Administration of doxycycline led to serum drug concentrations of 2.3 +/- 0.6 mu g/ml. Doxycycline administration had no effect on serum cholesterol concentrations and systolic blood pressures. Doxycycline administration did not prevent progressive aortic dilation as determined by temporal measurements of lumen dimensions using high frequency ultrasound. This lack of effect on AAA regression and progression was confirmed at the termination of the study by ex vivo measurements of maximal width of suprarenal aortas and AAA volumes. Also, doxycycline did not reduce AAA rupture. Medial and adventitial remodeling was not overtly changed by doxycycline as determined by immunostaining and histological staining. Conclusions: Doxycycline administration did not influence AngII-induced AAA progression and aortic rupture when administered to mice with established AAAs.	[Xie, Xiaojie; Lu, Hong; Moorleghen, Jessica J.; Howatt, Deborah A.; Rateri, Debra L.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Xie, Xiaojie] Zhejiang Univ, Coll Med, Dept Cardiol,Affiliated Hosp 2, Key Lab Diag & Treatment Cardiovasc Dis Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China; [Cassis, Lisa A.; Daugherty, Alan] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA	University of Kentucky; Zhejiang University; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009; Lu, Hong S./ABH-3929-2020; Lu, Hong Shen/C-4626-2015	Daugherty, Alan/0000-0003-2093-3775; Lu, Hong Shen/0000-0002-0577-2558; Xie, Xiaojie/0000-0001-8421-2737	National Institutes of Health [HL80100, HL70239]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R01HL070239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported by grants from the National Institutes of Health (HL80100 and HL70239). The funders had no role in the study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bartoli MA, 2006, ANN VASC SURG, V20, P228, DOI 10.1007/s10016-006-9017-z; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Choke E, 2005, EUR J VASC ENDOVASC, V30, P227, DOI 10.1016/j.ejvs.2005.03.009; Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Kaito K, 2003, SURG TODAY, V33, P426, DOI 10.1007/s10595-002-2513-0; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2005, SURGERY, V137, P457, DOI 10.1016/j.surg.2004.12.004; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu Hong, 2007, V139, P77; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Mao DL, 1999, BIOCHEM BIOPH RES CO, V261, P904, DOI 10.1006/bbrc.1999.1142; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; NEWMAN KM, 1994, J VASC SURG, V20, P814, DOI 10.1016/S0741-5214(94)70169-5; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Petrinec D, 1996, ANN NY ACAD SCI, V800, P263, DOI 10.1111/j.1749-6632.1996.tb33326.x; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Powell JT, 2011, BRIT J SURG, V98, P609, DOI 10.1002/bjs.7465; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Sho E, 2004, J VASC SURG, V39, P1312, DOI 10.1016/j.jvs.2004.01.036; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Xiong WF, 2009, J BIOL CHEM, V284, P1765, DOI 10.1074/jbc.M806239200; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	42	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46411	10.1371/journal.pone.0046411	http://dx.doi.org/10.1371/journal.pone.0046411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029514	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500102
J	Nagaishi, M; Nobusawa, S; Tanaka, Y; Ikota, H; Yokoo, H; Nakazato, Y				Nagaishi, Masaya; Nobusawa, Sumihito; Tanaka, Yuko; Ikota, Hayato; Yokoo, Hideaki; Nakazato, Yoichi			Slug, Twist, and E-Cadherin as Immunohistochemical Biomarkers in Meningeal Tumors	PLOS ONE			English	Article							SOLITARY FIBROUS TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS SNAIL; CENTRAL-NERVOUS-SYSTEM; CELL-CELL ADHESION; N-CADHERIN; EXPRESSION; CANCER; HEMANGIOPERICYTOMA; MENINGIOMA	The overexpression of Twist and Slug and subsequent down-regulation of E-cadherin facilitate the acquirement of invasive growth properties in cancer cells. It is unclear which of these molecules are expressed in mesenchymal tumors in the central nervous system. Here, we investigated 10 cases each of hemangiopericytoma, solitary fibrous tumor, meningothelial, fibrous, angiomatous, and atypical meningiomas, and 5 cases of anaplastic meningioma for Slug, Twist, E-cadherin, and N-cadherin immunoexpression. Nuclear Slug expression was observed in 9/10 (90%) hemangiopericytomas and 5/10 (50%) solitary fibrous tumors, but not in any meningiomas, except for 1 case. Similarly, nuclear Twist expression was more extensive in hemangiopericytomas and solitary fibrous tumors than meningiomas. In contrast to Slug and Twist, the positive expression of E-cadherin was observed in 39/45 (87%) meningiomas, but not in any hemangiopericytomas or solitary fibrous tumors (P < 0.0001). The fraction of tumor cells expressing E-cadherin in meningeal tumors was negatively correlated to those of Twist (P = 0.004) and Slug (P < 0.0001). The overexpression of Slug and Twist with down-regulation of E-cadherin was characteristic findings in hemangiopericytomas and solitary fibrous tumors, but not in meningiomas. The immunohistochemical profiles of the two tumor groups may be useful as diagnostic markers in cases that present a differential diagnosis challenge.	[Nagaishi, Masaya; Nobusawa, Sumihito; Tanaka, Yuko; Ikota, Hayato; Yokoo, Hideaki; Nakazato, Yoichi] Gunma Univ, Grad Sch Med, Dept Human Pathol, Gunma, Japan	Gunma University	Nakazato, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Human Pathol, Gunma, Japan.	nagaishi-nsu@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [21500335]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (No. 21500335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aamodt R, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/616023; Bisceglia M, 2011, ADV ANAT PATHOL, V18, P356, DOI 10.1097/PAP.0b013e318229c004; Borg M F, 1995, Australas Radiol, V39, P36, DOI 10.1111/j.1440-1673.1995.tb00229.x; Carneiro SS, 1996, AM J CLIN PATHOL, V106, P217, DOI 10.1093/ajcp/106.2.217; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chan JKC, 1997, HISTOPATHOLOGY, V31, P568, DOI 10.1046/j.1365-2559.1997.2400897.x; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Drummond KJ, 2000, J CLIN NEUROSCI, V7, P69, DOI 10.1054/jocn.1998.0153; Fletcher CDMUK, 2002, BONE; GUTHRIE BL, 1989, NEUROSURGERY, V25, P514, DOI 10.1227/00006123-198910000-00003; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; MENA H, 1991, HUM PATHOL, V22, P84, DOI 10.1016/0046-8177(91)90067-Y; Mikami S, 2011, LAB INVEST, V91, P1443, DOI 10.1038/labinvest.2011.111; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Nagaishi M, 2012, BRAIN PATHOL IN PRES; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nikas DC, 1999, ACTA NEUROCHIR, V141, P307, DOI 10.1007/s007010050302; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Pecina-Slaus N, 2010, J CANCER RES CLIN, V136, P695, DOI 10.1007/s00432-009-0708-z; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Perry A, 1997, AM J SURG PATHOL, V21, P1354, DOI 10.1097/00000478-199711000-00010; Rajaram V, 2004, HUM PATHOL, V35, P1413, DOI 10.1016/j.humpath.2004.07.017; Richmond PJM, 1997, CANCER RES, V57, P3189; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Schreider C, 2002, J CELL SCI, V115, P543; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Taylor KM, 2007, CURR OPIN GENET DEV, V17, P326, DOI 10.1016/j.gde.2007.05.012; The WHO, 2020, CLASSIFICATION TUMOU; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu QC, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-119; Zhou KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011231	36	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46053	10.1371/journal.pone.0046053	http://dx.doi.org/10.1371/journal.pone.0046053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029385	gold, Green Published			2022-12-25	WOS:000309554700110
J	Boudreau, E; Labib, S; Bertrand, AT; Decostre, V; Bolongo, PM; Sylvius, N; Bonne, G; Tesson, F				Boudreau, Emilie; Labib, Sarah; Bertrand, Anne T.; Decostre, Valerie; Bolongo, Pierrette M.; Sylvius, Nicolas; Bonne, Gisele; Tesson, Frederique			Lamin A/C Mutants Disturb Sumo1 Localization and Sumoylation in Vitro and in Vivo	PLOS ONE			English	Article							NUCLEAR-ENVELOPE ALTERATIONS; SPATIAL-ORGANIZATION; MUSCULAR-DYSTROPHY; GENE; SMAD4; CARDIOMYOPATHY; TRANSCRIPTION; ACCUMULATION; FIBROBLASTS; MUTATIONS	A-type lamins A and C are nuclear intermediate filament proteins in which mutations have been implicated in multiple disease phenotypes commonly known as laminopathies. A few studies have implicated sumoylation in the regulation of A-type lamins. Sumoylation is a post-translational protein modification that regulates a wide range of cellular processes through the attachment of small ubiquitin-related modifier (sumo) to various substrates. Here we showed that laminopathy mutants result in the mislocalization of sumo1 both in vitro (C2C12 cells overexpressing mutant lamins A and C) and in vivo (primary myoblasts and myopathic muscle tissue from the Lmna(H222P/H222P) mouse model). In C2C12 cells, we showed that the trapping of sumo1 in p.Asp192Gly, p.Gln353Lys, and p.Arg386Lys aggregates of lamin A/C correlated with an increased steady-state level of sumoylation. However, lamin A and C did not appear to be modified by sumo1. Our results suggest that mutant lamin A/C alters the dynamics of sumo1 and thus misregulation of sumoylation may be contributing to disease progression in laminopathies.	[Boudreau, Emilie; Labib, Sarah; Bolongo, Pierrette M.; Sylvius, Nicolas; Tesson, Frederique] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Bertrand, Anne T.; Decostre, Valerie; Bonne, Gisele] INSERM, UMRS 974, Paris, France; [Bertrand, Anne T.; Decostre, Valerie; Bonne, Gisele] Univ Paris 06, Inst Myol, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, UF Cardiogenet & Myogenet, F-75634 Paris, France	University of Ottawa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Tesson, F (corresponding author), Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	FTesson@uottawa.ca	Bertrand, Anne/AAR-6751-2020; Tesson, Frederique/A-3218-2013; Bonne, Gisèle/G-3121-2013	Bonne, Gisèle/0000-0002-2516-3258; Bertrand, Anne/0000-0001-7153-848X; Sylvius, Nicolas/0000-0002-3470-3711	Heart and Stroke Foundation [NA 6628]; Canadian Institutes of Health Research [77685]; Foreign Affairs and International Trade Canada Scholarship; INSERM (Institut national de la sante et de la recherche medicale); Universite Pierre et Marie Curie - Paris 6; Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foreign Affairs and International Trade Canada Scholarship; INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie - Paris 6; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This research was supported by an operating grant (NA 6628) from the Heart and Stroke Foundation (http://www.heartandstroke.on.ca/site/c.pvI3IeNWJwE/b.3581583/k.BE4C/Home.htm) awarded to F. Tesson, an operating grant (77685) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) awarded to F. Tesson, a Foreign Affairs and International Trade Canada Scholarship (http://www.scholarships-bourses.gc.ca/scholarships-bourses/index.aspx?view=d) awarded to E. Boudreau, and INSERM (Institut national de la sante et de la recherche medicale, http://www.inserm.fr/), Universite Pierre et Marie Curie - Paris 6 (http://www.upmc.fr/), the Centre National de la Recherche Scientifique (CNRS, http://www.cnrs.fr/), and the Association Francaise contre les Myopathies (http://www.afm-telethon.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bertrand AT, 2012, HUM MOL GENET, V21, P1037, DOI 10.1093/hmg/ddr534; Brown SC, 2008, BIOCHEM SOC T, V36, P1335, DOI 10.1042/BST0361335; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; De Vos WH, 2011, HUM MOL GENET, V20, P4175, DOI 10.1093/hmg/ddr344; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dutour A, 2011, HUM MOL GENET; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hubner S, 2005, EXP CELL RES, V312, P171, DOI 10.1016/j.yexcr.2005.10.011; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Kang JS, 2008, NAT CELL BIOL, V10, P654, DOI 10.1038/ncb1728; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Liang M, 2004, J BIOL CHEM, V279, P22857, DOI 10.1074/jbc.M401554200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Palancade B, 2008, TRENDS CELL BIOL, V18, P174, DOI 10.1016/j.tcb.2008.02.001; Panse VG, 2006, TRAFFIC, V7, P1311, DOI 10.1111/j.1600-0854.2006.00471.x; Pichler Andrea, 2008, V446, P131, DOI 10.1007/978-1-60327-084-7_9; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sylvius N, 2005, J MED GENET, V42, P639, DOI 10.1136/jmg.2004.023283; Sylvius N, 2008, EXP CELL RES, V314, P2362, DOI 10.1016/j.yexcr.2008.04.017; Sylvius N, 2006, CURR OPIN CARDIOL, V21, P159, DOI 10.1097/01.hco.0000221575.33501.58; Verstraeten VLRM, 2007, CURR MED CHEM, V14, P1231; Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105; Yasugi T, 1996, NUCLEIC ACIDS RES, V24, P2005, DOI 10.1093/nar/24.11.2005; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124; Zhong N, 2005, BIOCHEM BIOPH RES CO, V338, P855, DOI 10.1016/j.bbrc.2005.10.020	43	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45918	10.1371/journal.pone.0045918	http://dx.doi.org/10.1371/journal.pone.0045918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029315	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800120
J	Wang, XY; Tan, LX; Li, Y; Zhang, Y; Zhou, DY; Liu, TQ; Hao, W				Wang, Xuyi; Tan, Linxiang; Li, Yi; Zhang, Yao; Zhou, Dongyi; Liu, Tieqiao; Hao, Wei			HCV and HIV Infection among Heroin Addicts in Methadone Maintenance Treatment (MMT) and Not in MMT in Changsha and Wuhan, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; RISK; EPIDEMIOLOGY	Objective: To compare HCV and HIV infection among heroin addicts in MMT and not in MMT in two large cities in central China. Methods: A total of 541 heroin addicts were recruited from MMT clinics and voluntary detoxification centers in Changsha and Wuhan, China. Structured questionnaires collected data on their socio-demographics, clinical status, risk behaviors, and their knowledge of HIV. Their HIV serostatus and Hepatitis C virus (HCV) serostatus were determined by testing antibodies in blood serum. Results: We observed a higher prevalence of HCV infection among MMT heroin addicts (82.3%) than that in the non-MMT group (50.6%). However, our findings indicated that the heroin addicts in MMT had less drug or sexual HIV/HCV risk behaviors and more knowledge about HIV than non-MMT addicts. The heroin addicts in MMT had a significantly higher percentage of individuals who always used condoms (44.9%) compared with patients in the non-MMT group (14.6%, p = 0.039), and they had more knowledge about HIV than non-MMT individuals (p<.001). The percentage of HIV-positive addicts in the MMT group (0.7%) and non-MMT group (0.8%) were almost same. Conclusion: Our study indicated that the rate of HCV infection among heroin addicts among MMT or non-MMT settings in central China is very high. The non-MMT heroin addicts have higher risk of becoming infected with HCV in the future, while at present they have lower rates of HCV infection than MMT heroin addicts. Although rates of HIV infection among MMT and non-MMT heroin addicts are low now, they are all at great risk of becoming infected with HIV in the future, especially for non-MMT heroin addicts. We should use the MMT sites as a platform to improve the control of HCV and HIV infection in heroin addicts.	[Wang, Xuyi; Tan, Linxiang; Liu, Tieqiao; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Li, Yi; Zhang, Yao] Mental Hlth Ctr Wuhan, Wuhan, Hubei Province, Peoples R China; [Zhou, Dongyi] Psychiat Hosp Changsha, Changsha, Hunan, Peoples R China	Central South University	Hao, W (corresponding author), Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China.	weiaho57@gmail.com	liu, tieqiao/GSE-2327-2022		State Key Program of National Natural Science of China [81130020]; National Key Technology R&D Program of China [2012BAI01B07]; National Key Basic Research and Development Program [2009CB522007]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); National Key Basic Research and Development Program(National Basic Research Program of China)	This work was supported by State Key Program of National Natural Science of China (grant no. 81130020), The National Key Technology R&D Program of China (grant no. 2012BAI01B07), and National Key Basic Research and Development Program (grant no. 2009CB522007) to Wei Hao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER A, 1995, ADDICTION, V90, P545, DOI 10.1111/j.1360-0443.1995.tb02189.x; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2012, AM J DRUG ALCOHOL AB, V38, P140, DOI 10.3109/00952990.2011.643984; Bravo MJ, 2012, INT J DRUG POLICY, VS0955-3959, P00016, DOI [10.1016/j.drugpo.2012.02.002, DOI 10.1016/J.DRUGP0.2012.02.002]; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Fletcher NF, 2012, J VIRAL HEPATITIS, V19, P301, DOI 10.1111/j.1365-2893.2012.01591.x; Gyarmathy VA, 2002, J ACQ IMMUN DEF SYND, V30, P448, DOI [10.1097/00042560-200208010-00011, 10.1097/01.QAI.0000018880.78058.98]; Hagan H, 2007, INT J DRUG POLICY, V18, P341, DOI 10.1016/j.drugpo.2007.01.016; Joseph H, 2000, MT SINAI J MED, V67, P347; Li Ming-qiang, 2007, Harm Reduct J, V4, P8, DOI 10.1186/1477-7517-4-8; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Peles E, 2011, J ADDICT MED, V5, P214, DOI 10.1097/ADM.0b013e31820e13dd; Scheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tang YL, 2007, ADDICTION, V102, P1057, DOI 10.1111/j.1360-0443.2007.01849.x; Wang X, 2011, J NEUROIMMUNE PHARM, V6, P477, DOI 10.1007/s11481-011-9296-1; Willner-Reid J, 2008, J SUBST ABUSE TREAT, V35, P78, DOI 10.1016/j.jsat.2007.08.011; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210	23	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45632	10.1371/journal.pone.0045632	http://dx.doi.org/10.1371/journal.pone.0045632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029149	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800070
J	Zhang, HL; He, J; Li, JS; Tian, D; Gu, LB; Zhou, MX				Zhang, Hailong; He, Jing; Li, Jiansha; Tian, Dan; Gu, Lubing; Zhou, Muxiang			Methylation of RASSF1A gene promoter is regulated by p53 and DAXX	FASEB JOURNAL			English	Article						acute lymphoid leukemia; epigenetic gene silencing; protein-DNA binding	ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR RASSF1A; CELL-CYCLE PROGRESSION; WILD-TYPE P53; BINDING PROTEIN; HUMAN CANCERS; APOPTOSIS; MDM2; EXPRESSION; MUTATIONS	Inactivation of the tumor suppressor Ras-association domain family 1 isoform A (RASSF1A) due to epigenetic silencing occurs in a variety of human cancers, and still largely unknown are the regulators and mechanisms underlying RASSF1A gene promoter methylation. Herein, we report that this methylation is regulated by p53 and death-associated protein 6 (DAXX) in acute lymphoblastic leukemia (ALL). We found that p53 bound to the RASSF1A promoter, recruiting DAXX as well as DNA methyltransferase 1 (DNMT1) for DNA methylation, which subsequently resulted in inactivation of RASSF1A in wild-type p53 ALL cells. Although the presence of p53 was required for the recruitment of DAXX and DNMT1 to the RASSF1A promoter, fluctuation in p53 protein levels did not affect the rates of RASSF1A methylation. Conversely, methylation of RASSF1A promoter was critically controlled by DAXX, as the enforced overexpression of DAXX led to enhanced RASSF1A promoter methylation, whereas inhibition of DAXX reduced RASSF1A methylation. Interestingly, we found that the p53/DAXX-mediated RASSF1A methylation regulated murine double minute 2 (MDM2) protein stability in ALL. Our results reveal a novel function for p53 in the methylation of RASSF1A promoter by its interaction with DAXX. Discovery of this mechanism provides new insight into the interactions among the tumor-related factors p53, RASSF1A, DAXX, and MDM2 in cancer pathogenesis.-Zhang, H., He, J., Li, J., Tian, D., Gu, L., Zhou, M. Methylation of RASSF1A gene promoter is regulated by p53 and DAXX. FASEB J. 27, 232-242 (2013). www.fasebj.org	[Zhang, Hailong; He, Jing; Li, Jiansha; Tian, Dan; Gu, Lubing; Zhou, Muxiang] Emory Univ, Sch Med, Dept Pediat, Div Hematol Oncol, Atlanta, GA 30322 USA	Emory University	Gu, LB (corresponding author), Emory Univ, Sch Med, Div Pediat Hematol Oncol, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	lbgu@emory.edu; mzhou@emory.edu			U.S. National Institutes of Health/National Cancer Institute [R01 CA123490, R01 CA143107]; Leukemia and Lymphoma Society [6033-08]; CURE Childhood Cancer; NATIONAL CANCER INSTITUTE [R01CA143107, R01CA123490] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); CURE Childhood Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge support from U.S. National Institutes of Health/National Cancer Institute grants R01 CA123490 and R01 CA143107 (M. Z.), the Leukemia and Lymphoma Society 6033-08 (M. Z.), and CURE Childhood Cancer (M. Z. and L.G.).	Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang YS, 2009, BIOCHEM BIOPH RES CO, V386, P762, DOI 10.1016/j.bbrc.2009.06.126; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; King TC, 2000, CANCER-AM CANCER SOC, V89, P769, DOI 10.1002/1097-0142(20000815)89:4<769::AID-CNCR8>3.0.CO;2-6; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; PREUDHOMME C, 1995, J CLIN ONCOL, V13, P812, DOI 10.1200/JCO.1995.13.4.812; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Richter AM, 2009, BBA-REV CANCER, V1796, P114, DOI 10.1016/j.bbcan.2009.03.004; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2008, EMBO J, V27, P1863, DOI 10.1038/emboj.2008.115; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Wethkamp N, 2009, J BIOL CHEM, V284, P28783, DOI 10.1074/jbc.M109.041186; Whang YM, 2005, CANCER RES, V65, P3682, DOI 10.1158/0008-5472.CAN-04-2792; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; ZASTAWNY RL, 1993, ONCOGENE, V8, P1529; Zhang XL, 2010, CANCER RES, V70, P9895, DOI 10.1158/0008-5472.CAN-10-1546; Zhou M, 2000, LEUKEMIA, V14, P61, DOI 10.1038/sj.leu.2401619; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	43	30	31	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2013	27	1					232	242		10.1096/fj.12-215491	http://dx.doi.org/10.1096/fj.12-215491			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038753	Green Published			2022-12-25	WOS:000313103200022
J	Park, HJ; Shabashvili, D; Nekorchuk, MD; Shyqyriu, E; Jung, JI; Ladd, TB; Moore, BD; Felsenstein, KM; Golde, TE; Kim, SH				Park, Hyo-Jin; Shabashvili, Daniil; Nekorchuk, Michael D.; Shyqyriu, Eva; Jung, Joo In; Ladd, Thomas B.; Moore, Brenda D.; Felsenstein, Kevin M.; Golde, Todd E.; Kim, Seong-Hun			Retention in Endoplasmic Reticulum 1 (RER1) Modulates Amyloid-beta (A beta) Production by Altering Trafficking of gamma-Secretase and Amyloid Precursor Protein (APP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; HIPPOCAMPAL-NEURONS; COMPLEX COMPONENT; PLASMA-MEMBRANE; GOLGI-APPARATUS; IN-VIVO; PRESENILIN-1	The presence of neuritic plaques containing aggregated amyloid-beta (A beta) peptides in the brain parenchyma is a pathological hallmark of Alzheimer disease (AD). A beta is generated by sequential cleavage of the amyloid beta precursor protein (APP) by beta- and gamma-secretase, respectively. As APP processing to A beta requires transport through the secretory pathway, trafficking of the substrate and access to the secretases are key factors that can influence A beta production (Thinakaran, G., and Koo, E. H. (2008) Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619). Here, we report that retention in endoplasmic reticulum 1 (RER1) associates with gamma-secretase in early secretory compartments and regulates the intracellular trafficking of gamma-secretase. RER1 overexpression decreases both gamma-secretase localization on the cell surface and A beta secretion and conversely RER1 knockdown increases the level of cell surface gamma-secretase and increases A beta secretion. Furthermore, we find that increased RER1 levels decrease mature APP and increase immature APP, resulting in less surface accumulation of APP. These data show that RER1 influences the trafficking and localization of both gamma-secretase and APP, thereby regulating the production and secretion of A beta peptides.	[Park, Hyo-Jin; Jung, Joo In; Ladd, Thomas B.; Moore, Brenda D.; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, Gainesville, FL 32610 USA; [Park, Hyo-Jin; Shabashvili, Daniil; Nekorchuk, Michael D.; Shyqyriu, Eva; Kim, Seong-Hun] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, POB 100159,1275 Ctr Dr, Gainesville, FL 32610 USA.	tgolde@mbi.ufl.edu; skim0925@hotmail.com		Moore, Brenda/0000-0002-9685-6561	National Institutes of Health [AG033138, AG020206]; NIA; NATIONAL INSTITUTE ON AGING [P01AG020206, R01AG033138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG033138 and AG020206 from the NIA.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Boehm J, 1997, J CELL SCI, V110, P991; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DESTROOPER B, 1993, J CELL BIOL, V121, P295, DOI 10.1083/jcb.121.2.295; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Golde TE, 2010, EXP NEUROL, V223, P252, DOI 10.1016/j.expneurol.2009.07.035; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huse JT, 2001, TRAFFIC, V2, P75, DOI 10.1034/j.1600-0854.2001.020201.x; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2005, J BIOL CHEM, V280, P1992, DOI 10.1074/jbc.M412404200; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levites Y, 2006, J CLIN INVEST, V116, P193, DOI 10.1172/JCI25410; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Massaad MJ, 1999, EUR J CELL BIOL, V78, P435, DOI 10.1016/S0171-9335(99)80070-3; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; Pamren A, 2011, J BIOL CHEM, V286, P31153, DOI 10.1074/jbc.C111.235267; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Portelius E., 2006, J NEUROL S1, V66, pS69; Saito Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022108; SATO K, 1995, MOL BIOL CELL, V6, P1459, DOI 10.1091/mbc.6.11.1459; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Suga K, 2009, J BIOCHEM, V146, P905, DOI 10.1093/jb/mvp138; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; VANNOSTRAND WE, 1989, NATURE, V341, P546; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Walter J, 2001, CURR OPIN NEUROBIOL, V11, P585, DOI 10.1016/S0959-4388(00)00253-1; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P8534, DOI 10.1073/pnas.1202691109	69	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40629	40640		10.1074/jbc.M112.418442	http://dx.doi.org/10.1074/jbc.M112.418442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043097	Green Published, hybrid			2022-12-25	WOS:000311448800052
J	Suntharalingam, A; Abisambra, JF; O'Leary, JC; Koren, J; Zhang, B; Joe, MK; Blair, LJ; Hill, SE; Jinwal, UK; Cockman, M; Duerfeldt, AS; Tomarev, S; Blagg, BSJ; Lieberman, RL; Dickey, CA				Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Joe, Myung Kuk; Blair, Laura J.; Hill, Shannon E.; Jinwal, Umesh K.; Cockman, Matthew; Duerfeldt, Adam S.; Tomarev, Stanislav; Blagg, Brian S. J.; Lieberman, Raquel L.; Dickey, Chad A.			Glucose-regulated Protein 94 Triage of Mutant Myocilin through Endoplasmic Reticulum-associated Degradation Subverts a More Efficient Autophagic Clearance Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; OLFACTOMEDIN-HOMOLOGY DOMAIN; CHEMICAL CHAPERONE; POINT MUTANTS; MOUSE MODEL; ER STRESS; GLAUCOMA; APOPTOSIS; RESCUE; GRP94	Clearance of misfolded proteins in the endoplasmic reticulum (ER) is traditionally handled by ER-associated degradation (ERAD), a process that requires retro-translocation and ubiquitination mediated by a luminal chaperone network. Here we investigated whether the secreted, glaucoma-associated protein myocilin was processed by this pathway. Myocilin is typically transported through the ER/Golgi network, but inherited mutations in myocilin lead to its misfolding and aggregation within trabecular meshwork cells, and ultimately, ER stress-induced cell death. Using targeted knockdown strategies, we determined that glucose-regulated protein 94 (Grp94), the ER equivalent of heat shock protein 90 (Hsp90), specifically recognizes mutant myocilin, triaging it through ERAD. The addition of mutant myocilin to the short list of Grp94 clients strengthens the hypothesis that beta-strand secondary structure drives client association with Grp94. Interestingly, the ERAD pathway is incapable of efficiently handling the removal of mutant myocilin, but when Grp94 is depleted, degradation of mutant myocilin is shunted away from ERAD toward a more robust clearance pathway for aggregation-prone proteins, the autophagy system. Thus ERAD inefficiency for distinct aggregation-prone proteins can be subverted by manipulating ER chaperones, leading to more effective clearance by the autophagic/lysosomal pathway. General Hsp90 inhibitors and a selective Grp94 inhibitor also facilitate clearance of mutant myocilin, suggesting that therapeutic approaches aimed at inhibiting Grp94 could be beneficial for patients suffering from some cases of myocilin glaucoma.	[Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Blair, Laura J.; Cockman, Matthew; Dickey, Chad A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Suntharalingam, Amirthaa; Abisambra, Jose F.; O'Leary, John C., III; Koren, John, III; Zhang, Bo; Blair, Laura J.; Cockman, Matthew; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Res Inst, Tampa, FL 33613 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, Tampa, FL 33613 USA; [Joe, Myung Kuk; Tomarev, Stanislav] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Hill, Shannon E.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Duerfeldt, Adam S.; Blagg, Brian S. J.] Univ Kansas, Dept Med Chem, Lawrence, KS 66049 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Georgia; Georgia Institute of Technology; University of Kansas	Dickey, CA (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA.	cdickey@health.usf.edu	Abisambra, Joe/AAP-3269-2020; blagg, brian s j/X-7770-2018; Abisambra, Jose/V-6860-2019	blagg, brian s j/0000-0002-6200-3480; Abisambra, Jose/0000-0001-6341-679X; Koren, John/0000-0002-6017-1763; Blair, Laura/0000-0002-4981-5564	National Institutes of Health [R00AG031291, R01NS073899, R01EY021205]; American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY021205, ZIAEY000318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Grants R00AG031291 (to C. A. D.), R01NS073899 (to C. A. D.), and R01EY021205 (to R. L. L.). This work was also supported by the American Health Assistance Foundation.	Abisambra JF, 2012, J MOL BIOL, V421, P653, DOI 10.1016/j.jmb.2012.02.003; Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Alward WLM, 1998, NEW ENGL J MED, V339, P1298, DOI 10.1056/NEJM199810293391808; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Burns JN, 2011, BIOCHEMISTRY-US, V50, P5824, DOI 10.1021/bi200231x; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Garriga P, 1996, P NATL ACAD SCI USA, V93, P4560, DOI 10.1073/pnas.93.10.4560; Ge J, 2000, CHINESE MED J-PEKING, V113, P195; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hardy KM, 2005, J BIOL CHEM, V280, P28917, DOI 10.1074/jbc.M504803200; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Koga H, 2011, NEUROBIOL DIS, V43, P29, DOI 10.1016/j.nbd.2010.07.006; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liton PB, 2009, AUTOPHAGY, V5, P122, DOI 10.4161/auto.5.1.7304; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Liu YH, 2008, J CELL BIOL, V182, P185, DOI 10.1083/jcb.200709176; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; Perkumas KM, 2007, EXP EYE RES, V84, P209, DOI 10.1016/j.exer.2006.09.020; Rajan RS, 2011, CURR MED CHEM, V18, P1; Resch ZT, 2009, EXP EYE RES, V88, P704, DOI 10.1016/j.exer.2008.08.011; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Rozsa F W, 1998, Mol Vis, V4, P20; Santambrogio L, 2011, AUTOPHAGY, V7, P652, DOI 10.4161/auto.7.6.15287; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Vollrath D, 2006, EXP EYE RES, V82, P1030, DOI 10.1016/j.exer.2005.10.007; Wang L, 2007, MOL VIS, V13, P618; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2012, INVEST OPHTH VIS SCI, V53, P1557, DOI 10.1167/iovs.11-8837; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	65	55	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40661	40669		10.1074/jbc.M112.384800	http://dx.doi.org/10.1074/jbc.M112.384800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035116	Green Published, hybrid			2022-12-25	WOS:000311448800055
J	Zhang, Q; Hunke, C; Yau, YH; Seow, V; Lee, S; Tanner, LB; Guan, XL; Wenk, MR; Fibriansah, G; Chew, PL; Kukkaro, P; Biukovic, G; Shi, PY; Shochat, SG; Gruber, G; Lok, SM				Zhang, Qian; Hunke, Cornelia; Yau, Yin Hoe; Seow, Vernon; Lee, Sumarlin; Tanner, Lukas Bahati; Guan, Xue Li; Wenk, Markus R.; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Biukovic, Goran; Shi, Pei-Yong; Shochat, Susana Geifman; Grueber, Gerhard; Lok, Shee-Mei			The Stem Region of Premembrane Protein Plays an Important Role in the Virus Surface Protein Rearrangement during Dengue Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; PH; PURIFICATION; LIPIDS	Newly assembled dengue viruses (DENV) undergo maturation to become infectious particles. The maturation process involves major rearrangement of virus surface premembrane (prM) and envelope (E) proteins. The prM-E complexes on immature viruses are first assembled as trimeric spikes in the neutral pH environment of the endoplasmic reticulum. When the virus is transported to the low pH environment of the exosomes, these spikes rearrange into dimeric structures, which lie parallel to the virus lipid envelope. The proteins involved in driving this process are unknown. Previous cryoelectron microscopy studies of the mature DENV showed that the prM-stem region (residues 111-131) is membrane-associated and may interact with the E proteins. Here we investigated the prM-stem region in modulating the virus maturation process. The binding of the prM-stem region to the E protein was shown to increase significantly at low pH compared with neutral pH in ELISAs and surface plasmon resonance studies. In addition, the affinity of the prM-stem region for the liposome, as measured by fluorescence correlation spectroscopy, was also increased when pH is lowered. These results suggest that the prM-stem region forms a tight association with the virus membrane and attracts the associated E protein in the low pH environment of exosomes. This will lead to the surface protein rearrangement observed during maturation.	[Zhang, Qian; Seow, Vernon; Lee, Sumarlin; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Lok, Shee-Mei] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Zhang, Qian; Seow, Vernon; Lee, Sumarlin; Fibriansah, Guntur; Chew, Pau Ling; Kukkaro, Petra; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr Bioimaging Sci, Singapore 119077, Singapore; [Hunke, Cornelia; Yau, Yin Hoe; Biukovic, Goran; Shochat, Susana Geifman; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Shi, Pei-Yong] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Tanner, Lukas Bahati; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Guan, Xue Li] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland	National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State University of New York (SUNY) System; Wadsworth Center; National University of Singapore; University of Basel; Swiss Tropical & Public Health Institute	Lok, SM (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, KTP Bldg,8 Coll Rd, Singapore 169857, Singapore.	sheemei.lok@duke-nus.edu.sg	Guan, Xue Li/D-2935-2014; Hoe, YAU Yin/A-2817-2011; Wenk, Markus Rene/D-1441-2014; Fibriansah, Guntur/P-1201-2015	Guan, Xue Li/0000-0002-5189-8178; Hoe, YAU Yin/0000-0001-8136-2393; Fibriansah, Guntur/0000-0002-9990-3335; Lok, Shee-Mei/0000-0003-4631-8041	Duke-NUS Graduate Medical School Block Grant [R913-200-039-304]; Biomedical Research Council [R-913-300-019-304]	Duke-NUS Graduate Medical School Block Grant; Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by Duke-NUS Graduate Medical School Block Grant R913-200-039-304 and Biomedical Research Council Grant R-913-300-019-304 (to S.-M. L.).	ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; DAVISON SC, 1974, BIOCHEMISTRY-US, V140, P461, DOI 10.1042/bj1400461; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Hunke C, 2007, PROTEIN EXPRES PURIF, V53, P378, DOI 10.1016/j.pep.2007.01.009; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wimmer R, 2006, BIOCHEMISTRY-US, V45, P481, DOI 10.1021/bi051876r; World Health Organization, 1997, DENG HAEM FEV DIAGN, P12; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	26	38	40	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40525	40534		10.1074/jbc.M112.384446	http://dx.doi.org/10.1074/jbc.M112.384446			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035113	Green Published, hybrid			2022-12-25	WOS:000311448800043
J	Ma, L; Niknejad, N; Gorn-Hondermann, I; Dayekh, K; Dimitroulakos, J				Ma, Laurie; Niknejad, Nima; Gorn-Hondermann, Ivan; Dayekh, Khalil; Dimitroulakos, Jim			Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MEVALONATE PATHWAY; PROTEIN-KINASE; INDUCED APOPTOSIS; PHASE-I; CANCER; LKB1; TARGETS; PHOSPHORYLATION; SENSITIVITY	Background: Cellular stress responses trigger signaling cascades that inhibit proliferation and protein translation to help alleviate the stress or if the stress cannot be overcome induce apoptosis. In recent studies, we demonstrated the ability of lovastatin, an inhibitor of mevalonate synthesis, to induce the Integrated Stress Response as well as inhibiting epidermal growth factor receptor (EGFR) activation. Methodology/Principal Findings: In this study, we evaluated the effects of lovastatin on the activity of the LKB1/AMPK pathway that is activated upon cellular energy shortage and can interact with the above pathways. In the squamous cell carcinoma (SCC) cell lines SCC9 and SCC25, lovastatin treatment (1-25 mu M, 24 hrs) induced LKB1 and AMPK activation similar to metformin (1-10 mM, 24 hrs), a known inducer of this pathway. Lovastatin treatment impaired mitochondrial function and also decreased cellular ADP/ATP ratios, common triggers of LKB1/AMPK activation. The cytotoxic effects of lovastatin were attenuated in LKB1 null MEFs indicating a role for this pathway in regulating lovastatin-induced cytotoxicity. Of clinical relevance, lovastatin induces synergistic cytotoxicity in combination with the EGFR inhibitor gefitinib. In LKB1 deficient (A549, HeLa) and expressing (SCC9, SCC25) cell lines, metformin enhanced gefitinib cytotoxicity only in LKB1 expressing cell lines while both groups showed synergistic cytotoxic effects with lovastatin treatments. Furthermore, the combination of lovastatin with gefitinib induced a potent apoptotic response without significant induction of autophagy that is often induced during metabolic stress inhibiting cell death. Conclusion/Significance: Thus, targeting multiple metabolic stress pathways including the LKB1/AMPK pathway enhances lovastatin's ability to synergize with gefitinib in SCC cells.	[Ma, Laurie; Niknejad, Nima; Gorn-Hondermann, Ivan; Dayekh, Khalil; Dimitroulakos, Jim] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Dayekh, Khalil; Dimitroulakos, Jim] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Dayekh, Khalil; Dimitroulakos, Jim] Univ Ottawa, Dept Biochem, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Dimitroulakos, J (corresponding author), Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	jdimitroulakos@ohri.ca	Dimitroulakos, Jim/AAK-3398-2020		Canadian Institute of Health Research; Ottawa Regional Cancer Foundation; Prostate Cancer Fight Foundation (Motorcycle Ride for Dad)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation; Prostate Cancer Fight Foundation (Motorcycle Ride for Dad)	Research support from the Canadian Institute of Health Research (J.D.) and the Ottawa Regional Cancer Foundation and the Prostate Cancer Fight Foundation (Motorcycle Ride for Dad) (J.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Boudeau J, 2003, FEBS LETT, V546, P159, DOI 10.1016/S0014-5793(03)00642-2; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chan KKW, 2003, CLIN CANCER RES, V9, P10; CHIACCHIERA F, 2010, CELL CYCLE IN PRESS, P9; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Clendening JW, 2010, P NATL ACAD SCI USA, V107, P15051, DOI 10.1073/pnas.0910258107; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Daiber A, 2010, BBA-BIOENERGETICS, V1797, P897, DOI 10.1016/j.bbabio.2010.01.032; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2001, CLIN CANCER RES, V7, P158; Dimitroulakos J, 1996, NAT MED, V2, P326, DOI 10.1038/nm0396-326; Dimitroulakos J, 2006, CLIN CANCER RES, V12, p4426S, DOI 10.1158/1078-0432.CCR-06-0089; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Herbst RS, 2003, SEMIN ONCOL, V30, P34, DOI 10.1016/S0093-7754(03)00184-2; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huttemann M, 2012, BBA-BIOENERGETICS, V1817, P598, DOI 10.1016/j.bbabio.2011.07.001; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Knox JJ, 2005, EUR J CANCER, V41, P523, DOI 10.1016/j.ejca.2004.12.013; Korade Z, 2010, J LIPID RES, V51, P3259, DOI 10.1194/jlr.M009365; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Lian J, 2008, MOL NUTR FOOD RES, V52, P393, DOI 10.1002/mnfr.200700005; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Mantha AJ, 2005, CLIN CANCER RES, V11, P2398, DOI 10.1158/1078-0432.CCR-04-1951; Marcus AI, 2010, J THORAC ONCOL, V5, P1883, DOI 10.1097/JTO.0b013e3181fbc28a; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Murtola TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039445; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Pawson T, 2002, EUR J CANCER, V38, pS3, DOI 10.1016/S0959-8049(02)80597-4; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; Rosner M, 2008, MUTAT RES-REV MUTAT, V659, P284, DOI 10.1016/j.mrrev.2008.06.001; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; Sinthupibulyakit C, 2010, INT J ONCOL, V37, P1575, DOI 10.3892/ijo_00000811; Thibault A, 1996, CLIN CANCER RES, V2, P483; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Wang AH, 2011, ANN HEMATOL, V90, P917, DOI 10.1007/s00277-011-1175-6; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219	52	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46055	10.1371/journal.pone.0046055	http://dx.doi.org/10.1371/journal.pone.0046055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029387	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900082
J	Murphy, SV; Lim, R; Heraud, P; Cholewa, M; Le Gros, M; de Jonge, MD; Howard, DL; Paterson, D; McDonald, C; Atala, A; Jenkin, G; Wallace, EM				Murphy, Sean V.; Lim, Rebecca; Heraud, Philip; Cholewa, Marian; Le Gros, Mark; de Jonge, Martin D.; Howard, Daryl L.; Paterson, David; McDonald, Courtney; Atala, Anthony; Jenkin, Graham; Wallace, Euan M.			Human Amnion Epithelial Cells Induced to Express Functional Cystic Fibrosis Transmembrane Conductance Regulator	PLOS ONE			English	Article							GENE-THERAPY; CHLORIDE CHANNELS; CFTR	Cystic fibrosis, an autosomal recessive disorder caused by a mutation in a gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), remains a leading cause of childhood respiratory morbidity and mortality. The respiratory consequences of cystic fibrosis include the generation of thick, tenacious mucus that impairs lung clearance, predisposing the individual to repeated and persistent infections, progressive lung damage and shortened lifespan. Currently there is no cure for cystic fibrosis. With this in mind, we investigated the ability of human amnion epithelial cells (hAECs) to express functional CFTR. We found that hAECs formed 3-dimensional structures and expressed the CFTR gene and protein after culture in Small Airway Growth Medium (SAGM). We also observed a polarized CFTR distribution on the membrane of hAECs cultured in SAGM, similar to that observed in polarized airway cells in vivo. Further, hAECs induced to express CFTR possessed functional iodide/chloride (I-/Cl-) ion channels that were inhibited by the CFTR-inhibitor CFTR-172, indicating the presence of functional CFTR ion channels. These data suggest that hAECs may be a promising source for the development of a cellular therapy for cystic fibrosis.	[Murphy, Sean V.; Lim, Rebecca; McDonald, Courtney; Jenkin, Graham; Wallace, Euan M.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Heraud, Philip] Monash Univ, Ctr Biospect, Sch Chem, Melbourne, Vic 3004, Australia; [Cholewa, Marian] Monash Univ, Monash Ctr Synchrotron Sci, Melbourne, Vic 3004, Australia; [Le Gros, Mark] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [de Jonge, Martin D.; Howard, Daryl L.; Paterson, David] Australian Synchrotron, Xray Fluorescence Microscopy, Melbourne, Vic, Australia; [Lim, Rebecca; Jenkin, Graham; Wallace, Euan M.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Atala, Anthony] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Monash University; Monash University; Monash University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Monash University; Wake Forest University; Wake Forest Baptist Medical Center	Wallace, EM (corresponding author), Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	euan.wallace@monash.edu	Cholewa, Marian/C-9474-2011; Wallace, Euan M/K-6774-2015; de Jonge, Martin D/C-3400-2011; Lim, Rebecca/K-5175-2019; Howard, Daryl/E-9107-2013	Wallace, Euan M/0000-0002-4506-5233; de Jonge, Martin D/0000-0001-7731-6175; Lim, Rebecca/0000-0002-0410-497X; Heraud, Philip/0000-0003-4377-9184; Howard, Daryl/0000-0001-6071-2382; McDonald, Courtney/0000-0001-8421-461X; Atala, Anthony/0000-0001-8186-2160	Australian Synchrotron International Synchrotron Access Program; NHMRC Project [606483]; Australian Cystic Fibrosis Research Trust; Victorian Government Operational Inftrastructure Support Program; National Center for Research Resources [5 P41 RR019664-08]; National Institute of General Medical Sciences of the National Institutes of Health [8 P41 GM103445-08]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103445] Funding Source: NIH RePORTER	Australian Synchrotron International Synchrotron Access Program; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Research Trust; Victorian Government Operational Inftrastructure Support Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Australian Synchrotron International Synchrotron Access Program, NHMRC Project Grant 606483, the Australian Cystic Fibrosis Research Trust, the Victorian Government Operational Inftrastructure Support Program, the National Center for Research Resources (5 P41 RR019664-08) and the National Institute of General Medical Sciences (8 P41 GM103445-08) of the National Institutes of Health and the US Department of Energy, Office of Biological and Environmental Research (Contract No. DE-AC02-05CH11231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson TJ, 2008, CURR GENE THER, V8, P201, DOI 10.2174/156652308784746468; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Conese M, 2011, J CYST FIBROS, V10, pS114, DOI 10.1016/S1569-1993(11)60017-9; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Ferrari S, 2002, ADV DRUG DELIVER REV, V54, P1373, DOI 10.1016/S0169-409X(02)00145-X; Griesenbach U, 2004, GENE THER, V11, pS43, DOI 10.1038/sj.gt.3302368; Griesenbach U, 2004, CURR OPIN PULM MED, V10, P542, DOI 10.1097/01.mcp.0000142102.91202.04; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Ito Y, 2000, BIOCHEM BIOPH RES CO, V274, P230, DOI 10.1006/bbrc.2000.3125; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lu M, 2006, J CLIN INVEST, V116, P797, DOI 10.1172/JCI26961; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Murphy S, 2010, CURR PROTOC STEM CEL, V1, p1E61; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Paracchini V, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/575471; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Rosenecker J, 2006, CURR OPIN MOL THER, V8, P439; Stayman JW, 2000, IEEE T MED IMAGING, V19, P601, DOI 10.1109/42.870666; Tang WM, 2004, J BIOMOL SCREEN, V9, P607, DOI 10.1177/1087057104266740; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Walsh DE, 2000, J MEMBRANE BIOL, V177, P209, DOI 10.1007/s002320010004	28	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46533	10.1371/journal.pone.0046533	http://dx.doi.org/10.1371/journal.pone.0046533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029546	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900182
J	Sordelli, MS; Beltrame, JS; Cella, M; Gervasi, MG; Martinez, SP; Burdet, J; Zotta, E; Franchi, AM; Ribeiro, ML				Sordelli, Micaela S.; Beltrame, Jimena S.; Cella, Maximiliano; Gracia Gervasi, Maria; Perez Martinez, Silvina; Burdet, Juliana; Zotta, Elsa; Franchi, Ana M.; Laura Ribeiro, Maria			Interaction between Lysophosphatidic Acid, Prostaglandins and the Endocannabinoid System during the Window of Implantation in the Rat Uterus	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO IMPLANTATION; LYSOPHOSPHOLIPASE-D; CANNABINOID RECEPTOR; NITRIC-OXIDE; DIFFERENTIAL EXPRESSION; PERIIMPLANTATION PERIOD; MOUSE UTERUS; UTERINE; PREGNANCY	Bioactive lipid molecules as lysophosphatidic acid (LPA), prostaglandins (PG) and endocannabinoids are important mediators of embryo implantation. Based on previous published data we became interested in studying the interaction between these three groups of lipid derivatives in the rat uterus during the window of implantation. Thus, we adopted a pharmacological approach in vitro using LPA, DGPP (a selective antagonist of LPA3, an LPA receptor), endocannabinoids' receptor selective antagonists (AM251 and AM630) and non selective (indomethacin) and selective (NS-398) inhibitors of cyclooxygenase-1 and 2 enzymes. Cyclooxygenase isoforms participate in prostaglandins' synthesis. The incubation of the uterus from rats pregnant on day 5 of gestation (implantation window) with LPA augmented the activity and the expression of fatty acid amide hydrolase, the main enzyme involved in the degradation of endocannabinoids in the rodent uteri, suggesting that LPA decreased endocannabinoids' levels during embryo implantation. It has been reported that high endocannabinoids are deleterious for implantation. Also, LPA increased PGE2 production and cyclooxygenase-2 expression. The incubation of LPA with indomethacin or NS-398 reversed the increment in PGE2 production, suggesting that cyclooxygenase-2 was the isoform involved in LPA effect. PGs are important mediators of decidualization and vascularization at the implantation sites. All these effects were mediated by LPA3, as the incubation with DGPP completely reversed LPA stimulatory actions. Besides, we also observed that endocannabinoids mediated the stimulatory effect of LPA on cyclooxygenase-2 derived PGE2 production, as the incubation of LPA with AM251 or AM630 completely reversed LPA effect. Also, LPA augmented via LPA3 decidualization and vascularization markers. Overall, the results presented here demonstrate the participation of LPA3 in the process of implantation through the interaction with other groups of lipid molecules, prostaglandins and endocannabinoids, which prepare the uterine milieu for embryo invasion during the window of implantation.	[Sordelli, Micaela S.; Beltrame, Jimena S.; Laura Ribeiro, Maria] UBA, Fac Med, CONICET, Lab Fisiol & Farmacol Reprod,CEFYBO, Buenos Aires, DF, Argentina; [Cella, Maximiliano; Franchi, Ana M.] UBA, Fac Med, CONICET, Lab Fisiopatol Prenez & Parto,CEFYBO, Buenos Aires, DF, Argentina; [Gracia Gervasi, Maria; Perez Martinez, Silvina] UBA, Fac Med, CONICET, Lab Biol Reprod Mamiferos,CEFYBO, Buenos Aires, DF, Argentina; [Burdet, Juliana; Zotta, Elsa] UBA, Fac Farm & Bioquim, Dept Cs Biol, Catedra Fisiopatol,Lab Fisiopatol Mol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Ribeiro, ML (corresponding author), UBA, Fac Med, CONICET, Lab Fisiol & Farmacol Reprod,CEFYBO, Buenos Aires, DF, Argentina.	marialribeiro@yahoo.com.ar		zotta, elsa/0000-0002-8763-5046; Ribeiro, Maria Laura/0000-0002-3679-0193; Gervasi, Maria Gracia/0000-0002-5468-2700	Proyecto de Investigacion Plurianual (CONICET); Proyecto de Investigacion en Ciencia y Tecnologia (FONCYT)	Proyecto de Investigacion Plurianual (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Proyecto de Investigacion en Ciencia y Tecnologia (FONCYT)	This work was funded by Proyecto de Investigacion Plurianual 2008 (CONICET) and Proyecto de Investigacion en Ciencia y Tecnologia 2006 (FONCYT) to AMF; Proyecto de Investigacion Cientifica y Tecnologica 2010 (FONCYT) to MLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Achache H, 2010, FERTIL STERIL, V94, P1271, DOI 10.1016/j.fertnstert.2009.07.1668; Alexander JS, 1998, AM J PHYSIOL-HEART C, V274, pH115, DOI 10.1152/ajpheart.1998.274.1.H115; BANY BM, 1995, BIOL REPROD, V53, P126, DOI 10.1095/biolreprod53.1.126; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Callegari EA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-3; CAMPBELL WB, 1987, METHOD ENZYMOL, V141, P323, DOI 10.1016/0076-6879(87)41080-X; Cong J, 2006, REPRODUCTION, V131, P139, DOI 10.1530/rep.1.00861; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; English D, 2001, CARDIOVASC RES, V49, P588, DOI 10.1016/S0008-6363(00)00230-3; Gainor JP, 2001, AM J PHYSIOL-HEART C, V281, P1992; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hama K, 2006, LIFE SCI, V79, P1736, DOI 10.1016/j.lfs.2006.06.002; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Iwasawa Y, 2009, AM J REPROD IMMUNOL, V62, P90, DOI 10.1111/j.1600-0897.2009.00715.x; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lim HJ, 2002, VITAM HORM, V64, P43, DOI 10.1016/S0083-6729(02)64002-6; Liszewska E, 2009, ENDOCRINOLOGY, V150, P422, DOI 10.1210/en.2008-0749; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Moore F, 2000, BIOCHEM BIOPH RES CO, V269, P322, DOI 10.1006/bbrc.2000.2290; Motta AB, 1997, PROSTAG LEUKOTR ESS, V56, P265, DOI 10.1016/S0952-3278(97)90569-X; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Paria BC, 1996, MOL REPROD DEV, V45, P183, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;183::AID-MRD11&gt;3.0.CO;2-2; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; PERTWEE R, 1995, LIFE SCI, V56, P1949, DOI 10.1016/0024-3205(95)00175-6; Ribeiro ML, 2005, P NATL ACAD SCI USA, V102, P8048, DOI 10.1073/pnas.0502899102; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Sordelli MS, 2012, EUR J PHARMACOL, V685, P174, DOI 10.1016/j.ejphar.2012.04.034; Sordelli MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018368; Stocco CO, 1998, J ENDOCRINOL, V156, P253, DOI 10.1677/joe.0.1560253; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x; Tokumura A, 1999, BIOL REPROD, V61, P195, DOI 10.1095/biolreprod61.1.195; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; TOKUMURA A, 1986, BIOCHIM BIOPHYS ACTA, V875, P31; TOKUMURA A, 1980, ARCH INT PHARMACOD T, V245, P74; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Wang HB, 2007, PROSTAG OTH LIPID M, V83, P62, DOI 10.1016/j.prostaglandins.2006.09.009; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wei QX, 2009, FERTIL STERIL, V91, P1686, DOI 10.1016/j.fertnstert.2008.02.121; Wodawek-Potocka I, 2009, REPRODUCTION, V137, P95, DOI 10.1530/REP-08-0209; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	54	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46059	10.1371/journal.pone.0046059	http://dx.doi.org/10.1371/journal.pone.0046059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029388	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900083
J	Stanley, R; Snelgrove, PVR; deYoung, B; Gregory, RS				Stanley, Ryan; Snelgrove, Paul V. R.; deYoung, Brad; Gregory, Robert S.			Dispersal Patterns, Active Behaviour, and Flow Environment during Early Life History of Coastal Cold Water Fishes	PLOS ONE			English	Article							COD GADUS-MORHUA; SHANNY ULVARIA-SUBBIFURCATA; CORAL-REEF FISHES; ATLANTIC COD; LARVAL FISH; SPATIAL-PATTERN; LOCOMOTOR MORPHOLOGY; SWIMMING PERFORMANCE; MARINE POPULATIONS; PELAGIC STAGES	During the pelagic larval phase, fish dispersal may be influenced passively by surface currents or actively determined by swimming behaviour. In situ observations of larval swimming are few given the constraints of field sampling. Active behaviour is therefore often inferred from spatial patterns in the field, laboratory studies, or hydrodynamic theory, but rarely are these approaches considered in concert. Ichthyoplankton survey data collected during 2004 and 2006 from coastal Newfoundland show that changes in spatial heterogeneity for multiple species do not conform to predictions based on passive transport. We evaluated the interaction of individual larvae with their environment by calculating Reynolds number as a function of ontogeny. Typically, larvae hatch into a viscous environment in which swimming is inefficient, and later grow into more efficient intermediate and inertial swimming environments. Swimming is therefore closely related to length, not only because of swimming capacity but also in how larvae experience viscosity. Six of eight species sampled demonstrated consistent changes in spatial patchiness and concomitant increases in spatial heterogeneity as they transitioned into more favourable hydrodynamic swimming environments, suggesting an active behavioural element to dispersal. We propose the tandem assessment of spatial heterogeneity and hydrodynamic environment as a potential approach to understand and predict the onset of ecologically significant swimming behaviour of larval fishes in the field.	[Stanley, Ryan; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada; [Stanley, Ryan; Snelgrove, Paul V. R.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Snelgrove, Paul V. R.] Mem Univ Newfoundland, Canada Res Chair Boreal & Cold Ocean Syst, St John, NF, Canada; [deYoung, Brad] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ecol Sci Sect, St John, NF, Canada; [Gregory, Robert S.] Fisheries & Oceans Canada, Ctr Expertise Aquat Habitat Res, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Fisheries & Oceans Canada; Fisheries & Oceans Canada	Stanley, R (corresponding author), Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF, Canada.	rstanley@mun.ca			Natural Sciences and Engieering research Council of Canada; major federal government granting agency for natural sciences in Canada	Natural Sciences and Engieering research Council of Canada; major federal government granting agency for natural sciences in Canada	This study was funded by the Natural Sciences and Engieering research Council of Canada (www.nserc.ca), the major federal government granting agency for natural sciences in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Baumann H, 2003, ICES J MAR SCI, V60, P243, DOI 10.1016/S1054-3139(03)00019-5; BLISS CI, 1953, BIOMETRICS, V9, P176, DOI 10.2307/3001850; Bochdansky AB, 2008, MAR ECOL PROG SER, V367, P239, DOI 10.3354/meps07590; Bode M, 2006, MAR ECOL PROG SER, V308, P17, DOI 10.3354/meps308017; Bradbury IR, 2008, FISH RES, V91, P299, DOI 10.1016/j.fishres.2007.12.006; Bradbury IR, 2003, MAR ECOL PROG SER, V257, P233, DOI 10.3354/meps257233; Bradbury IR, 2001, FISH OCEANOGR, V10, P342, DOI 10.1046/j.1365-2419.2001.00179.x; Bradbury IR, 2001, CAN J FISH AQUAT SCI, V58, P811, DOI 10.1139/cjfas-58-4-811; Bradbury IR, 2000, CAN J FISH AQUAT SCI, V57, P1761, DOI 10.1139/cjfas-57-9-1761; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crowder LB, 2000, B MAR SCI, V66, P799; DAVIDSON FJM, 1995, FISH OCEANOGR, V4, P33, DOI 10.1111/j.1365-2419.1995.tb00059.x; Davidson FJM, 2001, J GEOPHYS RES-OCEANS, V106, P7001, DOI 10.1029/2000JC900052; DEYOUNG B, 1995, ATMOS OCEAN, V33, P135, DOI 10.1080/07055900.1995.9649528; DEYOUNG B, 1993, CAN J FISH AQUAT SCI, V50, P2729, DOI 10.1139/f93-298; Fahay MP., 2007, EARLY STAGES FISHES; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; FRANK KT, 1982, CAN J FISH AQUAT SCI, V39, P991, DOI 10.1139/f82-134; Fuiman LA, 1997, J EXP BIOL, V200, P1745; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Gillis GB, 2003, J EXP BIOL, V206, P1768, DOI 10.1242/jeb.00297; Guan L, 2008, J EXP MAR BIOL ECOL, V360, P31, DOI 10.1016/j.jembe.2008.03.006; Harden Jones F.R., 1968, FISH MIGRATION; Hastings A, 2003, ECOL APPL, V13, pS65; HEWITT R, 1981, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V178, P229; Hjort J., 1914, ICES, V20, P1; Kingsford MJ, 2002, B MAR SCI, V70, P309; LAPRISE R, 1995, MAR ECOL PROG SER, V122, P73, DOI 10.3354/meps122073; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2007, MAR ECOL PROG SER, V349, P255, DOI 10.3354/meps07107; Leis JM, 2007, MAR ECOL PROG SER, V347, P185, DOI 10.3354/meps06977; Leis JM, 2007, MAR BIOL, V153, P103, DOI 10.1007/s00227-007-0794-x; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leis JM, 2009, MAR FRESHWATER RES, V60, P211, DOI 10.1071/MF08186; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2010, FISH LOCOMOTION ECOE, P333; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; MATSUURA Y, 1995, FISH B-NOAA, V93, P172; Maynou F, 2006, FISH OCEANOGR, V15, P390, DOI 10.1111/j.1365-2419.2005.00398.x; MCGURK MD, 1987, ENVIRON BIOL FISH, V20, P81, DOI 10.1007/BF00005288; McHenry MJ, 2006, J MORPHOL, V267, P1099, DOI 10.1002/jmor.10462; Methven DA, 2003, ICES J MAR SCI, V60, P38, DOI 10.1006/jmsc.2002.1315; Muller UK, 1996, REV FISH BIOL FISHER, V6, P353, DOI 10.1007/BF00122586; Papritz A, 1999, SPATIAL STAT REMOTE, P83, DOI [DOI 10.1007/0-306-47647-9_6, 10.1007/0-306-47647-9_6]; Pepin P, 2000, MAR ECOL PROG SER, V204, P199, DOI 10.3354/meps204199; Pepin P, 1997, CAN J FISH AQUAT SCI, V54, P765, DOI 10.1139/cjfas-54-4-765; Pepin P, 2003, FISH OCEANOGR, V12, P19, DOI 10.1046/j.1365-2419.2003.00221.x; Pepin P, 2002, CAN J FISH AQUAT SCI, V59, P105, DOI 10.1139/F01-198; Rose G, 1996, NAFO SCI COUNCIL STU, V96; Schillinger DJ, 2000, PHYS BIOL 2 YO DATA; Snelgrove PVR, 2008, CAN J FISH AQUAT SCI, V65, P159, DOI 10.1139/F07-148; St Germain C, 2007, ZOOPLANKTON SPATIAL, P57; Stabeno PJ, 1996, FISH OCEANOGR, V5, P81, DOI 10.1111/j.1365-2419.1996.tb00084.x; Stanley RRE, 2009, BIOPHYSICAL STUDY CO; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; TANAKA M, 1985, T AM FISH SOC, V114, P471, DOI 10.1577/1548-8659(1985)114<471:FATIMO>2.0.CO;2; TEMPLEMAN W, 1981, Journal of Northwest Atlantic Fishery Science, V2, P21; Tittensor D. P., 2002, ANAL PHYS OCEANOGRAP; Tittensor DP, 2001, ANAL PHYS OCEANOGRAP, P90; von Herbing IH, 2002, J FISH BIOL, V61, P865, DOI 10.1006/jfbi.2002.2118; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Williams PJ, 1996, CAN J FISH AQUAT SCI, V53, P1246, DOI 10.1139/cjfas-53-6-1246; Wroblewski J, 2005, COAST MANAGE, V33, P411, DOI 10.1080/08920750500217930; Yao T, 1986, ATMOS OCEAN, V24, P235, DOI 10.1080/07055900.1986.9649249	69	21	21	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46266	10.1371/journal.pone.0046266	http://dx.doi.org/10.1371/journal.pone.0046266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029455	Green Published, Green Accepted, gold			2022-12-25	WOS:000309973900119
J	Wilson, MJ; Dearden, PK				Wilson, Megan J.; Dearden, Peter K.			Pair-Rule Gene Orthologues Have Unexpected Maternal Roles in the Honeybee (Apis mellifera)	PLOS ONE			English	Article							GROUP-III GENES; SPIDER CUPIENNIUS-SALEI; HOMEODOMAIN PROTEIN FTZ; SHORT-GERM INSECT; FUSHI-TARAZU; EXPRESSION PATTERNS; TRIBOLIUM-CASTANEUM; GAP-LIKE; DROSOPHILA; SEGMENTATION	Pair-rule genes are a class of segmentation genes first identified in Drosophila melanogaster. In Drosophila, these genes act to translate non-periodic information produced by the overlapping patterns of gap gene expression into patterns of gene expression in every other segment. While pair-rule genes are, for the most part, conserved in metazoans, their function in pair-rule patterning is not. Many of these genes do, however, regulate segmentation in arthropods and do so with dual-segment periodicity. Here we examine the expression and function of honeybee orthologues of Drosophila pair-rule genes. Knockdown of the expression of these genes leads to extensive patterning defects, implying that they act in early patterning, as well as segmentation in honeybee embryos. We show that these pair-rule gene orthologues indeed regulate the expression of honeybee maternal and gap genes implying roles in maternal patterning of the honeybee embryo.	[Wilson, Megan J.; Dearden, Peter K.] Univ Otago, Dept Biochem, Lab Evolut & Dev, Natl Res Ctr Growth & Dev & Genet Otago, Dunedin, New Zealand	University of Otago	Dearden, PK (corresponding author), Univ Otago, Dept Biochem, Lab Evolut & Dev, Natl Res Ctr Growth & Dev & Genet Otago, Dunedin, New Zealand.	peter.dearden@otago.ac.nz	Dearden, Peter/B-7607-2008	Dearden, Peter/0000-0001-7790-9675; Wilson, Megan/0000-0003-3425-5071	Royal Society of New Zealand Marsden Grant [UOO0401]	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a Royal Society of New Zealand Marsden Grant to P. K. D. (UOO0401). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binner P, 1997, DEV GENES EVOL, V206, P447, DOI 10.1007/s004270050074; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Choe CP, 2007, DEV BIOL, V302, P281, DOI 10.1016/j.ydbio.2006.09.037; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Davis GK, 2001, DEVELOPMENT, V128, P3445; DAWES R, 1994, DEVELOPMENT, V120, P1561; Dearden PK, 2006, GENOME RES, V16, P1376, DOI 10.1101/gr.5108606; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Dearden PK, 2009, COLD SPRING HARB PRO; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duncan EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-558; DuPraw E., 1967, METHODS DEV BIOL, P183; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; Florence B, 1997, DEVELOPMENT, V124, P839; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; Heffer A, 2010, P NATL ACAD SCI USA, V107, P18040, DOI 10.1073/pnas.1010746107; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; Hughes CL, 2002, DEV BIOL, V247, P47, DOI 10.1006/dbio.2002.0683; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mouchel-Vielh E, 2002, EVOL DEV, V4, P76, DOI 10.1046/j.1525-142X.2002.01063.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Osborne P, 2005, APIDOLOGIE, V36, P113, DOI 10.1051/apido:2004075; Osborne PW, 2005, DEV GENES EVOL, V215, P499, DOI 10.1007/s00427-005-0008-9; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schoppmeier M, 2005, EVOL DEV, V7, P160, DOI 10.1111/j.1525-142X.2005.05018.x; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Tang AH, 2001, DEVELOPMENT, V128, P801; TSAI CC, 1994, DEVELOPMENT, V120, P1671; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; Wilson MJ, 2011, DEVELOPMENT, V138, P3497, DOI 10.1242/dev.067926; Wilson MJ, 2010, DEV BIOL, V339, P200, DOI 10.1016/j.ydbio.2009.12.015; Wilson MJ, 2009, DEV BIOL, V335, P276, DOI 10.1016/j.ydbio.2009.09.002; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	44	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46490	10.1371/journal.pone.0046490	http://dx.doi.org/10.1371/journal.pone.0046490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029534	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900173
J	Xu, Y; Huang, LZ; Fu, S; Wu, JX; Zhou, XP				Xu, Yi; Huang, Lingzhe; Fu, Shuai; Wu, Jianxiang; Zhou, Xueping			Population Diversity of Rice Stripe Virus-Derived siRNAs in Three Different Hosts and RNAi-Based Antiviral Immunity in Laodelphgax striatellus	PLOS ONE			English	Article							ARABIDOPSIS; INTERFERENCE; DEFENSE; POLYMERASE; AMPLIFICATION; COMPLEXES; BIOLOGY; STRAND	Background: Small RNA-mediated gene silencing plays evolutionarily conserved roles in gene regulation and defense against invasive nucleic acids. Virus-derived small interfering RNAs (vsiRNAs) are one of the key elements involved in RNA silencing-based antiviral activities in plant and insect. vsiRNAs produced after viruses infecting hosts from a single kingdom (i.e., plant or animal) are well described. In contrast, vsiRNAs derived from viruses capable of infecting both plants and their insect vectors have not been characterized. Methodology/Principal Findings: We examined Rice stripe virus (RSV)-derived small interfering RNAs in three different hosts, Oryza sativa, Nicotiana benthamiana and a natural RSV transmitting vector Laodelphgax striatellus, through deep sequencing. Our results show that large amounts of vsiRNAs generated in these hosts after RSV infection. The vsiRNAs from N. benthamiana and L. striatellus mapped equally to the genomic-and antigenomic-strand of RSV RNAs. They showed, however, a significant bias in those from O. sativa. Furthermore, our results demonstrate that the number and size distributions of vsiRNAs in the three hosts were very different. In O. sativa and N. benthamiana, most vsiRNAs were mapped to the discrete regions in the RSV genome sequence, and most of the vsiRNAs from these two hosts were generated from RSV genomic RNAs 3 and 4. In contrast, the vsiRNAs identified in L. striatellus distributed uniformly along the whole genome of RSV. We have also shown that silencing Agronaute 2 in L. striatellus enhanced RSV accumulation in this host. Conclusions/Significance: Our study demonstrates that the core RNA-induced gene silencing (RNAi) machinery is present in L. striatellus. We also provide evidence that the RNAi-mediated immunity against RSV is present in L. striatellus. We propose that a common small RNA-mediated virus defense mechanism exists in both helipterum insects and plants, but the vsiRNAs are generated differentially in different hosts.	[Xu, Yi; Huang, Lingzhe; Fu, Shuai; Wu, Jianxiang; Zhou, Xueping] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Xueping] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, JX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	wujx@zju.edu.cn; zzhou@zju.edu.cn		Fu, Shuai/0000-0002-8338-0074	Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; National High Technology Research and Development Program of China (863 Program) [2012AA101505]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (IRT0943) and the National High Technology Research and Development Program of China (863 Program) (2012AA101505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; FALK BW, 1989, VIROLOGY, V173, P338, DOI 10.1016/0042-6822(89)90253-5; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Hamera S, 2012, PLANT J, V69, P104, DOI 10.1111/j.1365-313X.2011.04774.x; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hohn T, 2007, P NATL ACAD SCI USA, V104, P17905, DOI 10.1073/pnas.0709178104; Jiang L, 2012, VIRUS RES, V163, P512, DOI 10.1016/j.virusres.2011.11.016; Li J, 2011, PEST MANAG SCI, V67, P852, DOI 10.1002/ps.2124; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SY, 2011, PLOS ONE, V6; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sun F, 2011, J PHYTOPATHOL, V159, P767, DOI 10.1111/j.1439-0434.2011.01840.x; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang XB, 2010, P NATL ACAD SCI USA, V107, P484, DOI 10.1073/pnas.0904086107; Wei TY, 2009, J GEN VIROL, V90, P1025, DOI 10.1099/vir.0.006858-0; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Xiong RY, 2008, J VIROL, V82, P12304, DOI 10.1128/JVI.01696-08; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036238; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yan F, 2010, ARCH VIROL, V155, P935, DOI 10.1007/s00705-010-0670-8; Yang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016928; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303	47	29	29	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46238	10.1371/journal.pone.0046238	http://dx.doi.org/10.1371/journal.pone.0046238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029445	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900114
J	Zarrabi, N; Prosperi, M; Belleman, RG; Colafigli, M; De Luca, A; Sloot, PMA				Zarrabi, Narges; Prosperi, Mattia; Belleman, Robert G.; Colafigli, Manuela; De Luca, Andrea; Sloot, Peter M. A.			Combining Epidemiological and Genetic Networks Signifies the Importance of Early Treatment in HIV-1 Transmission	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; ANTIRETROVIRAL THERAPY; EVOLUTIONARY DYNAMICS; RECONSTRUCTION; EPIDEMICS; EVENTS; SEX	Inferring disease transmission networks is important in epidemiology in order to understand and prevent the spread of infectious diseases. Reconstruction of the infection transmission networks requires insight into viral genome data as well as social interactions. For the HIV-1 epidemic, current research either uses genetic information of patients' virus to infer the past infection events or uses statistics of sexual interactions to model the network structure of viral spreading. Methods for a reliable reconstruction of HIV-1 transmission dynamics, taking into account both molecular and societal data are still lacking. The aim of this study is to combine information from both genetic and epidemiological scales to characterize and analyse a transmission network of the HIV-1 epidemic in central Italy. We introduce a novel filter-reduction method to build a network of HIV infected patients based on their social and treatment information. The network is then combined with a genetic network, to infer a hypothetical infection transmission network. We apply this method to a cohort study of HIV-1 infected patients in central Italy and find that patients who are highly connected in the network have longer untreated infection periods. We also find that the network structures for homosexual males and heterosexual populations are heterogeneous, consisting of a majority of 'peripheral nodes' that have only a few sexual interactions and a minority of 'hub nodes' that have many sexual interactions. Inferring HIV-1 transmission networks using this novel combined approach reveals remarkable correlations between high out-degree individuals and longer untreated infection periods. These findings signify the importance of early treatment and support the potential benefit of wide population screening, management of early diagnoses and anticipated antiretroviral treatment to prevent viral transmission and spread. The approach presented here for reconstructing HIV-1 transmission networks can have important repercussions in the design of intervention strategies for disease control.	[Zarrabi, Narges; Belleman, Robert G.; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Prosperi, Mattia] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Emerging Pathogens Inst, Gainesville, FL USA; [Prosperi, Mattia; Colafigli, Manuela; De Luca, Andrea] Univ Cattolica Sacro Cuore, Clin Infect Dis, I-00168 Rome, Italy; [De Luca, Andrea] Siena Univ Hosp, Infect Dis Unit, Siena, Italy; [Sloot, Peter M. A.] Natl Res Univ ITMO, St Petersburg, Russia; [Sloot, Peter M. A.] Nanyang Technol Univ, Singapore, Singapore	University of Amsterdam; State University System of Florida; University of Florida; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; ITMO University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zarrabi, N (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	N.Zarrabi@uva.nl	De Luca, Andrea/G-8810-2011; Colafigli, Manuela/K-5167-2018; Sloot, Peter/B-3078-2014	De Luca, Andrea/0000-0002-9561-9193; Colafigli, Manuela/0000-0003-1610-6347; Sloot, Peter/0000-0002-3848-5395	DynaNets project; European Union [233847]; 'Leading Scientist Program' of the Government of the Russian Federation [11.G34.31.0019]	DynaNets project; European Union(European Commission); 'Leading Scientist Program' of the Government of the Russian Federation	This research was partly sponsored by the DynaNets project (www.dynanets.org), European Union grant agreement number 233847, and a grant from the 'Leading Scientist Program' of the Government of the Russian Federation, under contract 11.G34.31.0019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Barcherini S, 1999, INT J EPIDEMIOL, V28, P122, DOI 10.1093/ije/28.1.122; Brancato G, 1997, INT J EPIDEMIOL, V26, P1107, DOI 10.1093/ije/26.5.1107; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown A.L., 2010, 17 C RETR OPP INF; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; Castellano C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00371; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen MS, 2011, NEW ENGL J MED, V365, P1; Csardi N., 2006, INT J COMP SYST, V1695, P1; DeGruttola V, 2011, CLIN INFECT DIS, V52, P1050, DOI 10.1093/cid/cir094; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2004, INFERRING PHYLOGENIE, V266, P418; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Fleischer NL, 2008, J EPIDEMIOL COMMUN H, V62, P842, DOI 10.1136/jech.2007.067371; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Giuliani M, 2005, AIDS, V19, P1429, DOI 10.1097/01.aids.0000180808.27298.af; Glymour M.M., 2006, METHODS SOCIAL EPIDE, P393; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Huson DH, 2010, PHYLOGENETIC NETWORK; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Lemey P, 2006, AIDS REV, V8, P125; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mei S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-118; Metzger VT, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002015; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Phillips KD, 1992, J ASSOC NURSE AIDS C, V7, P57; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; REZZA G, 1994, J ACQ IMMUN DEF SYND, V7, P500; Schneeberger A, 2004, SEX TRANSM DIS, V31, P380, DOI 10.1097/00007435-200406000-00012; Sloot PMA, 2008, INT J COMPUT MATH, V85, P1175, DOI 10.1080/00207160701750583; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Sorensen SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029098; Steel M., 2010, BIOMETRICS, V66, P324, DOI DOI 10.1111/J.1541-0420.2010.01388.X; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thulasiraman K., 1992, GRAPHS THEORY ALGORI, P118; Van de Vijver D, 2006, REVIEWS, V2007, P17; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130	55	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46156	10.1371/journal.pone.0046156	http://dx.doi.org/10.1371/journal.pone.0046156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029421	Green Published, gold			2022-12-25	WOS:000309973900101
J	Beck, ET; He, J; Nelson, MI; Bose, ME; Fan, J; Kumar, S; Henrickson, KJ				Beck, Eric T.; He, Jie; Nelson, Martha I.; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.			Genome Sequencing and Phylogenetic Analysis of 39 Human Parainfluenza Virus Type 1 Strains Isolated from 1997-2010	PLOS ONE			English	Article							HEMAGGLUTININ-NEURAMINIDASE GLYCOPROTEIN; RESPIRATORY SYNCYTIAL VIRUS; POLYMERASE-CHAIN-REACTION; NEWCASTLE-DISEASE VIRUS; SENDAI-VIRUS; RECOMBINANT SEQUENCES; MOLECULAR EVOLUTION; YOUNG-CHILDREN; GENE; IDENTIFICATION	Thirty-nine human parainfluenza type 1 (HPIV-1) genomes were sequenced from samples collected in Milwaukee, Wisconsin from 1997-2010. Following sequencing, phylogenetic analyses of these sequences plus any publicly available HPIV-1 sequences (from GenBank) were performed. Phylogenetic analysis of the whole genomes, as well as individual genes, revealed that the current HPIV-1 viruses group into three different clades. Previous evolutionary studies of HPIV-1 in Milwaukee revealed that there were two genotypes of HPIV-1 co-circulating in 1991 (previously described as HPIV-1 genotypes C and D). The current study reveals that there are still two different HPIV-1 viruses co-circulating in Milwaukee; however, both groups of HPIV-1 viruses are derived from genotype C indicating that genotype D may no longer be in circulation in Milwaukee. Analyses of genetic diversity indicate that while most of the genome is under purifying selection some regions of the genome are more tolerant of mutation. In the 40 HPIV-1 genomes sequenced in this study, the nucleotide sequence of the L gene is the most conserved while the sequence of the P gene is the most variable. Over the entire protein coding region of the genome, 81 variable amino acid residues were observed and as with nucleotide diversity, the P protein seemed to be the most tolerant of mutation (and contains the greatest proportion of non-synonymous to synonymous substitutions) while the M protein appears to be the least tolerant of amino acid substitution.	[Beck, Eric T.; He, Jie; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, Milwaukee, WI 53226 USA; [Beck, Eric T.; He, Jie; Bose, Michael E.; Fan, Jiang; Kumar, Swati; Henrickson, Kelly J.] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA; [Nelson, Martha I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Medical College of Wisconsin; Children's Hospital of Wisconsin; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Henrickson, KJ (corresponding author), Med Coll Wisconsin, Dept Pediat, Midwest Resp Virus Program, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Khenrick@mcw.edu			National Institutes of Health [NIAID U01-AI077988, NIAID U01-AI070428]; Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070428, U01AI077988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin(General Electric); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the National Institutes of Health (NIAID U01-AI077988 and NIAID U01-AI070428) with additional funding provided by the Midwest Respiratory Virus Program; Department of Pediatrics; Medical College of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE MR, 1995, J INFECT DIS, V171, P851, DOI 10.1093/infdis/171.4.851; BOUSSE T, 1995, VIROLOGY, V209, P654, DOI 10.1006/viro.1995.1299; BOUSSE T, 1994, VIROLOGY, V204, P506, DOI 10.1006/viro.1994.1564; Bousse T, 2002, J VIROL, V76, P8244, DOI 10.1128/JVI.76.16.8244-8251.2002; Chambers R, 2009, J GEN VIROL, V90, P1906, DOI 10.1099/vir.0.011700-0; Chong YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000872; Counihan ME, 2001, PEDIATR INFECT DIS J, V20, P646, DOI 10.1097/00006454-200107000-00003; CURRAN J, 1993, J VIROL, V67, P4358, DOI 10.1128/JVI.67.7.4358-4364.1993; Dave VP, 1997, VIRUS GENES, V14, P153; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FALSEY AR, 1991, INFECT CONT HOSP EP, V12, P602; Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Han GZ, 2008, VIROLOGY, V371, P54, DOI 10.1016/j.virol.2007.09.038; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Henrickson KJ, 1997, J INFECT DIS, V176, P867, DOI 10.1086/516533; HENRICKSON KJ, 1994, CLIN INFECT DIS, V18, P770, DOI 10.1093/clinids/18.5.770; Henrickson KJ, 1996, J CLIN MICROBIOL, V34, P695, DOI 10.1128/JCM.34.3.695-700.1996; HENRICKSON KJ, 1992, J INFECT DIS, V166, P995, DOI 10.1093/infdis/166.5.995; HETHERINGTON SV, 1994, J INFECT DIS, V169, P248, DOI 10.1093/infdis/169.2.248; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYN D, 1991, J GEN VIROL, V72, P983, DOI 10.1099/0022-1317-72-4-983; LYN D, 1991, J GEN VIROL, V72, P817, DOI 10.1099/0022-1317-72-4-817; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MATSUOKA Y, 1991, VIROLOGY, V181, P403, DOI 10.1016/0042-6822(91)90514-C; McAuliffe JM, 2004, J VIROL, V78, P2029, DOI 10.1128/JVI.78.4.2029-2036.2004; Mizuta K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-533; Newman JT, 2002, VIRUS GENES, V24, P77, DOI 10.1023/A:1014042221888; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Rassa JC, 1998, VIROLOGY, V247, P274, DOI 10.1006/viro.1998.9266; SMITH JM, 1992, J MOL EVOL, V34, P126; Spann KM, 2003, J VIROL, V77, P11201, DOI 10.1128/JVI.77.20.11201-11211.2003; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; THOMPSON SD, 1987, VIROLOGY, V160, P1, DOI 10.1016/0042-6822(87)90037-7; Yang HT, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-58; Zhang R, 2010, VIRUS RES, V151, P45, DOI 10.1016/j.virusres.2010.03.015; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46048	10.1371/journal.pone.0046048	http://dx.doi.org/10.1371/journal.pone.0046048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029382	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500058
J	Casanova, CM; Sehr, P; Putzker, K; Hentze, MW; Neumann, B; Duncan, KE; Thoma, C				Casanova, Claudia M.; Sehr, Peter; Putzker, Kerstin; Hentze, Matthias W.; Neumann, Beate; Duncan, Kent E.; Thoma, Christian			Automated High-Throughput RNAi Screening in Human Cells Combined with Reporter mRNA Transfection to Identify Novel Regulators of Translation	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INTERNAL RIBOSOME ENTRY; TARGETING TRANSLATION; INITIATION; CANCER; EXPRESSION; VEGF; PHOSPHORYLATION; MECHANISMS; HYPOXIA	Proteins that promote angiogenesis, such as vascular endothelial growth factor (VEGF), are major targets for cancer therapy. Accordingly, proteins that specifically activate expression of factors like VEGF are potential alternative therapeutic targets and may help to combat evasive resistance to angiogenesis inhibitors. VEGF mRNA contains two internal ribosome entry sites (IRESs) that enable selective activation of VEGF protein synthesis under hypoxic conditions that trigger angiogenesis. To identify novel regulators of VEGF IRES-driven translation in human cells, we have developed a high-throughput screening approach that combines siRNA treatment with transfection of a VEGF-IRES reporter mRNA. We identified the kinase MAPK3 as a novel positive regulator of VEGF IRES-driven translation and have validated its regulatory effect on endogenous VEGF. Our automated method is scalable and readily adapted for use with other mRNA regulatory elements. Consequently, it should be a generally useful approach for high-throughput identification of novel regulators of mRNA translation.	[Duncan, Kent E.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany; [Casanova, Claudia M.; Thoma, Christian] Univ Hosp Freiburg, Dept Med 2, Freiburg, Germany; [Casanova, Claudia M.; Sehr, Peter; Putzker, Kerstin; Hentze, Matthias W.; Neumann, Beate; Thoma, Christian] EMBL, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; European Molecular Biology Laboratory (EMBL)	Duncan, KE (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Hamburg, Germany.	kent.duncan@zmnh.uni-hamburg.de; christian.thoma@uniklinik-freiburg.de	Hentze, Matthias W/V-3980-2017	Hentze, Matthias W/0000-0002-4023-7876; Sehr, Peter/0000-0002-4348-5066; Neumann, Beate/0000-0002-6899-502X; Duncan, Kent/0000-0003-4290-2670; Putzker, Kerstin/0000-0001-8375-5908	Deutsche Forschungsgemeinschaft [TH788/3-1, TH788/2-1, TH788/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft to C. T. (TH788/3-1). C. T. is a recipient of a Heisenberg-Fellowship from the Deutsche Forschungsgemeinschaft (TH788/2-1 and TH788/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Danckwardt S, 2011, MOL CELL, V41, P298, DOI 10.1016/j.molcel.2010.12.032; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Ding L, 2012, STEM CELL REV REP, V8, P32, DOI 10.1007/s12015-011-9269-z; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Erfle H, 2008, J BIOMOL SCREEN, V13, P575, DOI 10.1177/1087057108320133; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gingras AC, 2001, GENE DEV, V15, P2852; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holcik M, 2004, CURR CANCER DRUG TAR, V4, P299, DOI 10.2174/1568009043333005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Malina A, 2011, ONCOTARGET, V2, P76; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Puri Nitin, 2008, Nucleic Acids Symp Ser (Oxf), P25, DOI 10.1093/nass/nrn013; Robert F, 2009, EXPERT OPIN THER TAR, V13, P1279, DOI 10.1517/14728220903241625; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021	47	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45943	10.1371/journal.pone.0045943	http://dx.doi.org/10.1371/journal.pone.0045943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029333	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500048
J	Feng, YY; Zhang, M; Zhang, LL; Zhang, T; Ding, JF; Zhuang, YP; Wang, XN; Yang, Z				Feng, Yanye; Zhang, Ming; Zhang, Linlin; Zhang, Ting; Ding, Jianfeng; Zhuang, Yingping; Wang, Xiaoning; Yang, Zhong			An Automatic Refolding Apparatus for Preparative-Scale Protein Production	PLOS ONE			English	Article							GROWTH-FACTOR-I; STRUCTURAL PROTEOMICS; CRYSTAL-STRUCTURE; ARTEMIN; EXPRESSION; STRATEGIES; BINDING; VITRO	Protein refolding is an important process to recover active recombinant proteins from inclusion bodies. Refolding by simple dilution, dialysis and on-column refolding methods are the most common techniques reported in the literature. However, the refolding process is time-consuming and laborious due to the variability of the behavior of each protein and requires a great deal of trial-and-error to achieve success. Hence, there is a need for automation to make the whole process as convenient as possible. In this study, we invented an automatic apparatus that integrated three refolding techniques: varying dilution, dialysis and on-column refolding. We demonstrated the effectiveness of this technology by varying the flow rates of the dilution buffer into the denatured protein and testing different refolding methods. We carried out different refolding methods on this apparatus: a combination of dilution and dialysis for human stromal cell-derived factor 1 (SDF-1/CXCL12) and thioredoxin fused-human artemin protein (Trx-ARTN); dilution refolding for thioredoxin fused-human insulin-like growth factor I protein (Trx-IGF1) and enhanced fluorescent protein (EGFP); and on-column refolding for bovine serum albumin (BSA). The protein refolding processes of these five proteins were preliminarily optimized using the slowly descending denaturants (or additives) method. Using this strategy of decreasing denaturants concentration, the efficiency of protein refolding was found to produce higher quantities of native protein. The standard refolding apparatus configuration can support different operations for different applications; it is not limited to simple dilution, dialysis and on-column refolding techniques. Refolding by slowly decreasing denaturants concentration, followed by concentration or purification on-column, may be a useful strategy for rapid and efficient recovery of active proteins from inclusion bodies. An automatic refolding apparatus employing this flexible strategy may provide a powerful tool for preparative scale protein production.	[Feng, Yanye; Zhang, Ming; Zhang, Ting; Zhuang, Yingping; Wang, Xiaoning] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Biotechnol, Shanghai 200237, Peoples R China; [Feng, Yanye; Zhang, Linlin; Yang, Zhong] Fudan Univ, State Key Lab Genet Engn, Dept Microbiol, Sch Life Sci, Shanghai 200433, Peoples R China; [Ding, Jianfeng] Novoprotein Sci Inc, Dept R&D, Shanghai, Peoples R China	East China University of Science & Technology; Fudan University	Wang, XN (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Sch Biotechnol, Shanghai 200237, Peoples R China.	xnwang88@gmail.com; zhongyang_fudan@163.com			National Basic Research Program of China [2009CB918600]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (No. 2009CB918600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Basu A, 2011, APPL MICROBIOL BIOT, V92, P241, DOI 10.1007/s00253-011-3513-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruinzeel W, 2011, APPL BIOCHEM BIOTECH, V165, P1379, DOI 10.1007/s12010-011-9354-4; Bruinzeel W, 2012, PROTEIN EXPRES PURIF, V81, P25, DOI 10.1016/j.pep.2011.08.028; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Buckle AM, 2005, NAT METHODS, V2, P3, DOI 10.1038/nmeth0105-3; Christendat D, 2000, PROG BIOPHYS MOL BIO, V73, P339, DOI 10.1016/S0079-6107(00)00010-9; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; Cowieson NP, 2006, PROTEOMICS, V6, P1750, DOI 10.1002/pmic.200500056; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039; Jones H, 2006, ORG BIOMOL CHEM, V4, P1223, DOI 10.1039/b517879g; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lange C, 2005, PROTEIN FOLDING HANDBOOK, P1245, DOI 10.1002/9783527619498.ch71; Langenhof M, 2005, J CHROMATOGR A, V1069, P195, DOI 10.1016/j.chroma.2005.01.063; Leland P, 2006, INNOVATION, P1; Li M, 2004, PROTEIN EXPRES PURIF, V33, P1, DOI 10.1016/j.pep.2003.08.023; Luo W X, 2000, Sheng Wu Gong Cheng Xue Bao, V16, P578; Mannall GJ, 2009, BIOTECHNOL BIOENG, V103, P329, DOI 10.1002/bit.22245; Peterson MJ, 2011, J CHEM EDUC, V88, P986, DOI 10.1021/ed100594h; Read EK, 2010, BIOTECHNOL BIOENG, V105, P276, DOI 10.1002/bit.22528; Silvian L, 2006, BIOCHEMISTRY-US, V45, P6801, DOI 10.1021/bi060035x; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V31, P149, DOI 10.1016/S1046-5928(03)00133-5; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Tsumoto K, 2010, CURR PHARM BIOTECHNO, V11, P285, DOI 10.2174/138920110791111979; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981; Yee A, 2003, ACCOUNTS CHEM RES, V36, P183, DOI 10.1021/ar010126g; Zhang L, 2012, ACTA CHIM SINICA, V70, P6	36	4	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45891	10.1371/journal.pone.0045891	http://dx.doi.org/10.1371/journal.pone.0045891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029296	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500044
J	Fukuda, H; Imamura, M; Tanaka, Y; Iwata, M; Hirose, H; Kaku, K; Maegawa, H; Watada, H; Tobe, K; Kashiwagi, A; Kawamori, R; Maeda, S				Fukuda, Hisashi; Imamura, Minako; Tanaka, Yasushi; Iwata, Minoru; Hirose, Hiroshi; Kaku, Kohei; Maegawa, Hiroshi; Watada, Hirotaka; Tobe, Kazuyuki; Kashiwagi, Atsunori; Kawamori, Ryuzo; Maeda, Shiro			A Single Nucleotide Polymorphism within DUSP9 Is Associated with Susceptibility to Type 2 Diabetes in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FASTING PLASMA-GLUCOSE; INSULIN-RESISTANCE; GENETIC-VARIATION; RISK LOCI; REPLICATION; VARIANTS; HOMEOSTASIS; OBESITY; STORAGE	Aims: The DUSP9 locus on chromosome X was identified as a susceptibility locus for type 2 diabetes in a meta-analysis of European genome-wide association studies (GWAS), and GWAS in South Asian populations identified 6 additional single nucleotide polymorphism (SNP) loci for type 2 diabetes. However, the association of these loci with type 2 diabetes have not been examined in the Japanese. We performed a replication study to investigate the association of these 7 susceptibility loci with type 2 diabetes in the Japanese population. Methods: We genotyped 11,319 Japanese participants (8,318 with type 2 diabetes and 3,001 controls) for each of the 7 SNPs-rs5945326 near DUSP9, rs3923113 near GRB14, rs16861329 in ST6GAL1, rs1802295 in VPS26A, rs7178572 in HMG20A, rs2028299 near AP3S2, and rs4812829 in HNF4A-and examined the association of each of these 7 SNPs with type 2 diabetes by using logistic regression analysis. Results: All SNPs had the same direction of effect (odds ratio [OR]>1.0) as in the original reports. One SNP, rs5945326 near DUSP9, was significantly associated with type 2 diabetes at a genome-wide significance level (p = 2.21x10(-8); OR 1.39, 95% confidence interval [CI]: 1.24-1.56). The 6 SNPs derived from South Asian GWAS were not significantly associated with type 2 diabetes in the Japanese population by themselves (p >= 0.007). However, a genetic risk score constructed from 6 South Asian GWAS derived SNPs was significantly associated with Japanese type 2 diabetes (p = 8.69x10(-4), OR = 1.06. 95% CI; 1.03-1.10). Conclusions/interpretation: These results indicate that the DUSP9 locus is a common susceptibility locus for type 2 diabetes across different ethnicities, and 6 loci identified in South Asian GWAS also have significant effect on susceptibility to Japanese type 2 diabetes.	[Fukuda, Hisashi; Imamura, Minako; Maeda, Shiro] RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Hisashi; Tanaka, Yasushi] St Marianna Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Kawasaki, Kanagawa, Japan; [Iwata, Minoru; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 930, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo, Japan; [Kaku, Kohei] Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Dept Internal Med, Kurashiki, Okayama, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Otsu, Shiga 5202192, Japan; [Watada, Hirotaka] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Bunkyo Ku, Tokyo 1138421, Japan; [Watada, Hirotaka; Kawamori, Ryuzo] Juntendo Univ, Grad Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan	RIKEN; Saint Marianna University; University of Toyama; Keio University; Kawasaki Medical School; Shiga University of Medical Science; Juntendo University; Juntendo University	Maeda, S (corresponding author), RIKEN Ctr Genom Med, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan.	smaeda@src.riken.jp	Hirose, Hiroshi/F-8556-2014; Kashiwagi, Atsunori/H-8712-2019	Watada, Hirotaka/0000-0001-5961-1816; Maegawa, Hiroshi/0000-0002-4611-8149	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bao XY, 2012, MOL BIOL REP, V39, P2447, DOI 10.1007/s11033-011-0995-8; Bazuine M, 2004, MOL ENDOCRINOL, V18, P1697, DOI 10.1210/me.2003-0213; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Hayashi T, 2007, DIABETOLOGIA, V50, P980, DOI 10.1007/s00125-007-0618-z; Horikoshi M, 2007, DIABETOLOGIA, V50, P747, DOI 10.1007/s00125-006-0588-6; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Imamura M, 2012, HUM MOL GENET, V10, P1093; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; International Diabetes Federation, 2011, DIABETES ATLAS, V6th; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohshige T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026911; Onuma H, 2010, J HUM GENET, V55, P600, DOI 10.1038/jhg.2010.75; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Yamauchi T, 2010, NAT GENET, V42, P864, DOI 10.1038/ng.660; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	45	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46263	10.1371/journal.pone.0046263	http://dx.doi.org/10.1371/journal.pone.0046263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029454	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500079
J	Guo, HL; Topham, DJ				Guo, Hailong; Topham, David J.			Multiple Distinct Forms of CD8+T Cell Cross-Reactivity and Specificities Revealed after 2009 H1N1 Influenza A Virus Infection in Mice	PLOS ONE			English	Article							CYTOTOXIC LYMPHOCYTES-T; IMMUNITY; PROTECTION; EPITOPES; MEMORY; IDENTIFICATION; NUCLEOPROTEIN; RECOGNITION; VACCINATION; PROMINENT	Influenza primed mice are protected against lethal infection with H1N1 A/CA/04/E3/09 virus, and T depletion and serum transfer studies suggest a T-dependent mechanism. We therefore set out to investigate the quality of the cross-reactive T cell response to CA/E3/09 in mice primed with H3N2 influenza A/Hong Kong/X31 virus. Sequences of the immunodominant nucleoprotein (NP) NP366-374 and acid polymerase (PA) PA224-233 CD8 epitopes from X31 each differ from the CA/E3/09 virus by one amino acid: an M371V substitution at position 6 of the NP peptide, and an S224P substitution at position 1 of the PA peptide, raising questions about the role of these epitopes in protection. PA224-233 peptides from either virus could elicit IFN-gamma spot forming cells from mice infected with X31, indicating cross-reactivity of these two peptides. However, no T cell responses to either PA224-233 peptide were detectable after primary CA/E3/09 infection, suggesting it is cryptic in this virus. In contrast, primary responses to the NP366 peptides were detectable after infection with either virus, but did not cross-react in vitro. Similarly, H2-D-b tetramers of each NP epitope stained CD8+ T cells from each respective virus infection, but did not obviously cross-react. Early after lethal CA/E3/09 challenge, X31 primed mice had enhanced IFN-gamma responses toward both NP366 peptides, as well as recall responses to a set of subdominant NP and PA peptides not detectable after primary X31 infection alone. Furthermore, dual-tetramer staining revealed an expanded population of CD8 T cells reactive to both NP366 variant peptides also not seen after the priming infection alone. These observations demonstrate unusual CD8+ T cell cross-reactivity and specificity are elicited after primary and secondary CA/E3/09 influenza virus infections.	[Guo, Hailong] Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Vaccine Immunol, Rochester, NY 14621 USA; [Topham, David J.] Univ Rochester, Dept Microbiol & Immunol, New York Influenza Ctr Excellence, Rochester, NY USA; [Topham, David J.] Univ Rochester, Aab Inst Biomed Sci, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY USA	Rochester General Hospital; University of Rochester; University of Rochester	Guo, HL (corresponding author), Rochester Gen Hosp, Res Inst, Ctr Infect Dis & Vaccine Immunol, Rochester, NY 14621 USA.	jackguo1234@yahoo.com; david_topham@urmc.rochester.edu		Guo, Hailong/0000-0003-2619-335X	NIH [N01-AI50020, HHSN266200700008C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant N01-AI50020 and NIH grant HHSN266200700008C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreansky S, 2004, INT CONGR SER, V1263, P141, DOI 10.1016/j.ics.2004.01.046; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; BENNINK J, 1978, IMMUNOLOGY, V35, P503; BENNINK JR, 1987, J VIROL, V61, P1098, DOI 10.1128/JVI.61.4.1098-1102.1987; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Boon ACM, 2004, J IMMUNOL, V172, P2453, DOI 10.4049/jimmunol.172.4.2453; Doherty PC, 2009, CLIN PHARMACOL THER, V85, P665, DOI 10.1038/clpt.2009.52; Ellebedy AH, 2010, CLIN VACCINE IMMUNOL, V17, P1998, DOI 10.1128/CVI.00247-10; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Guo HL, 2010, J VIROL, V84, P7750, DOI 10.1128/JVI.00187-10; Haanen JBAG, 1999, J EXP MED, V190, P1319, DOI 10.1084/jem.190.9.1319; Kedzierska K, 2006, IMMUNOL REV, V211, P133, DOI 10.1111/j.0105-2896.2006.00386.x; Kedzierska K, 2008, P NATL ACAD SCI USA, V105, P19408, DOI 10.1073/pnas.0810274105; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Price GE, 2000, J EXP MED, V191, P1853, DOI 10.1084/jem.191.11.1853; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Richards KA, 2010, J IMMUNOL, V185, P4998, DOI 10.4049/jimmunol.1001395; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rubio V, 2003, NAT MED, V9, P1377, DOI 10.1038/nm942; Skountzou I, 2010, J IMMUNOL; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; Theodossis A, 2010, P NATL ACAD SCI USA, V107, P5534, DOI 10.1073/pnas.1000032107; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175; Vitiello A, 1996, J IMMUNOL, V157, P5555; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Woodland DL, 2001, IMMUNOL RES, V24, P53, DOI 10.1385/IR:24:1:53; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	36	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46166	10.1371/journal.pone.0046166	http://dx.doi.org/10.1371/journal.pone.0046166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029425	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500068
J	Hansson, ML; Behmer, S; Ceder, R; Mohammadi, S; Preta, G; Grafstrom, RC; Fadeel, B; Wallberg, AE				Hansson, Magnus L.; Behmer, Stefanie; Ceder, Rebecca; Mohammadi, Sadollah; Preta, Giulio; Grafstrom, Roland C.; Fadeel, Bengt; Wallberg, Annika E.			MAML1 Acts Cooperatively with EGR1 to Activate EGR1-Regulated Promoters: Implications for Nephrogenesis and the Development of Renal Cancer	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR MAML1; DROSOPHILA MASTERMIND; NOTCH COACTIVATOR; P300; COMPLEX; GROWTH; ACETYLATION; REGULATOR; CARCINOMA; APOPTOSIS	Mastermind-like 1 (MAML1) is a transcriptional coregulator of activators in various signaling pathways, such as Notch, p53, myocyte enhancer factor 2C (MEF2C) and beta-catenin. In earlier studies, we demonstrated that MAML1 enhanced p300 acetyltransferase activity, which increased the acetylation of Notch by p300. In this study, we show that MAML1 strongly induced acetylation of the transcription factor early growth response-1 (EGR1) by p300, and increased EGR1 protein expression in embryonic kidney cells. EGR1 mRNA transcripts were also upregulated in the presence of MAML1. We show that MAML1 physically interacted with, and acted cooperatively with EGR1 to increase transcriptional activity of the EGR1 and p300 promoters, which both contain EGR1 binding sites. Bioinformatics assessment revealed a correlation between p300, EGR1 and MAML1 copy number and mRNA alterations in renal clear cell carcinoma and p300, EGR1 and MAML1 gene alterations were associated with increased overall survival. Our findings suggest MAML1 may be a component of the transcriptional networks which regulate EGR1 target genes during nephrogenesis and could also have implications for the development of renal cell carcinoma.	[Hansson, Magnus L.; Behmer, Stefanie; Ceder, Rebecca; Mohammadi, Sadollah; Preta, Giulio; Grafstrom, Roland C.; Fadeel, Bengt; Wallberg, Annika E.] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden	Karolinska Institutet	Wallberg, AE (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden.	Annika.Wallberg@ki.se	Preta, Giulio/AAW-6182-2021; Grafström, Roland C/N-7217-2016; Preta, Giulio/N-7141-2016	Preta, Giulio/0000-0002-8318-4698	Swedish Research Council; Swedish Cancer Society; Swedish Children's Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation	The authors received support from the Swedish Research Council, Swedish Cancer Society and the Swedish Children's Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Guerra MC, 2007, CANCER RES, V67, P8690, DOI 10.1158/0008-5472.CAN-07-1720; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Hansson ML, 2009, NUCLEIC ACIDS RES, V37, P2996, DOI 10.1093/nar/gkp163; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; Kitagawa M, 2001, MOL CELL BIOL, V21, P4337, DOI 10.1128/MCB.21.13.4337-4346.2001; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lindberg MJ, 2010, FASEB J, V24, P2396, DOI 10.1096/fj.09-149401; Liu CT, 1998, CANCER GENE THER, V5, P3; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Pode-Shakked N, 2011, PEDIATR NEPHROL, V26, P1535, DOI 10.1007/s00467-011-1858-1; Popko-Scibor AE, 2011, BIOCHEM BIOPH RES CO, V416, P300, DOI 10.1016/j.bbrc.2011.11.030; RACKLEY RR, 1995, J UROLOGY, V154, P700, DOI 10.1016/S0022-5347(01)67136-2; Ribeiro MSJ, 2009, CURR PROTEIN PEPT SC, V10, P570; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Scharnhorst V, 2000, ONCOGENE, V19, P791, DOI 10.1038/sj.onc.1203390; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; Strefford JC, 2005, CANCER GENET CYTOGEN, V159, P1, DOI 10.1016/j.cancergencyto.2004.09.020; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yu J, 2007, CELL DEATH DIFFER, V14, P436, DOI 10.1038/sj.cdd.4402029; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200	27	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46001	10.1371/journal.pone.0046001	http://dx.doi.org/10.1371/journal.pone.0046001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029358	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500053
J	Kirchhoff, NT; Leef, MJ; Valdenegro, V; Hayward, CJ; Nowak, BF				Kirchhoff, Nicole T.; Leef, Melanie J.; Valdenegro, Victoria; Hayward, Craig J.; Nowak, Barbara F.			Correlation of Humoral Immune Response in Southern Bluefin Tuna, T. maccoyii, with Infection Stage of the Blood Fluke, Cardicola forsteri	PLOS ONE			English	Article							THUNNUS-MACCOYII; SCHISTOSOMA-MANSONI; SANGUINICOLIDAE; DIGENEA; TREMATODA; CASTELNAU; HEALTH	The blood fluke, Cardicola forsteri, is a prevalent infection in ranched southern bluefin tuna. This project aimed to define the timing and intensity of the various developmental stages of C. forsteri within southern bluefin tuna as well as to relate infection to host pathology and immune response. Archival samples from several cohorts of T. maccoyii sampled from 2008 to 2010 were used in this study. The prevalence and intensity of C. forsteri infection was described using heart flushes and histological examination. Humoral immune response, i.e. C. forsteri specific antibody, lysozyme activity, and alternative complement activity, was also described. Based on the validated and detailed C. forsteri infection timeline, relationships between infection events, physiological response, and diagnosis were proposed. Immune response developed concurrently with C. forsteri infection, with the majority of physiological response coinciding with commencing egg production. Further research is needed to confirm the origin of C. forsteri antigen which is responsible for immune response development and how T. maccoyii immune response works against infection. To aide this research, further diagnostic methods for confirmation of infection need to be developed.	[Kirchhoff, Nicole T.; Leef, Melanie J.; Valdenegro, Victoria; Hayward, Craig J.; Nowak, Barbara F.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia; [Hayward, Craig J.] Lincoln Marine Sci Ctr, SARDI Aquat Sci, Port Lincoln, SA, Australia	University of Tasmania	Kirchhoff, NT (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia.	Nicole.Kirchhoff@utas.edu.au	Nowak, Barbara/J-7261-2014; Leef, Melanie/C-6655-2013	Nowak, Barbara/0000-0002-0347-643X; Valdenegro Vega, Victoria/0000-0003-1708-9593	Fisheries Research and Development Corporation, a Australian Government organization	Fisheries Research and Development Corporation, a Australian Government organization	Funding for this project was provided by the Fisheries Research and Development Corporation, a Australian Government organization. This manuscript, its data and conclusions, have been approved by the Australian Southern Bluefin Tuna Industry Association (ASBTIA) research council for publication. No funding was provided by the ASBTIA. Please see www.frdc.com.au for more information about the funders of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken HM, 2006, AQUACULTURE, V254, P40, DOI 10.1016/j.aquaculture.2005.10.013; Aiken H, 2009, AQUACULTURE, V293, P204, DOI 10.1016/j.aquaculture.2009.04.034; Aiken HM, 2007, FISH FISH, V8, P167, DOI 10.1111/j.1467-2679.2007.00248.x; Aiken HM, 2008, FISH SHELLFISH IMMUN, V25, P66, DOI 10.1016/j.fsi.2007.12.010; Arkoosh M.R., 1990, Fish Immunology Technical Communications, P15; Bullard SA, 2004, J PARASITOL, V90, P128, DOI 10.1645/GE-106R; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carrington AC, 2007, FISH SHELLFISH IMMUN, V23, P781, DOI 10.1016/j.fsi.2007.02.006; Colquitt SE, 2001, J FISH DIS, V24, P225, DOI 10.1046/j.1365-2761.2001.00289.x; Colquittt SE, 1999, THESIS U TASMANIA LA; Cox FEG, 1997, INT J PARASITOL, V27, P1147, DOI 10.1016/S0020-7519(97)00112-4; Cribb TH, 2000, T ROY SOC SOUTH AUST, V124, P117; Cribb TH, 2011, INT J PARASITOL, V41, P861, DOI 10.1016/j.ijpara.2011.03.011; Dennis MM, 2011, VET PATHOL, V48, P846, DOI 10.1177/0300985810388524; Deveney MR, 2005, J FISH DIS, V28, P279, DOI 10.1111/j.1365-2761.2005.00629.x; Hayward CJ, 2010, VET PARASITOL, V173, P107, DOI 10.1016/j.vetpar.2010.06.007; HERBERT BW, 1995, INT J PARASITOL, V25, P3, DOI 10.1016/0020-7519(94)00071-U; Kirchhoff NT, 2011, J FISH BIOL, V79, P331, DOI 10.1111/j.1095-8649.2011.03019.x; Kirchhoff NT, 2011, AQUACULTURE, V315, P207, DOI 10.1016/j.aquaculture.2011.02.036; Kirchhoff NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023705; Leef MJ, 2012, AQUACULTURE UNPUB; MCLAREN DJ, 1978, PARASITOLOGY, V77, P313, DOI 10.1017/S0031182000050277; Mladineo I, 2004, B EUR ASSOC FISH PAT, V24, P144; Munday BL, 2003, J FISH DIS, V26, P187, DOI 10.1046/j.1365-2761.2003.00454.x; Nowak B, 2006, B EUR ASSOC FISH PAT, V26, P38; Roberts ML, 2005, PARASITOLOGY, V131, P261, DOI 10.1017/S0031182005007651; Rough K. M., 2000, ILLUSTRATED GUIDE PA; Shirakashi S, 2012, PARASITOLOG IN PRESS; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; TOSSWILL JHC, 1986, T ROY SOC TROP MED H, V80, P435, DOI 10.1016/0035-9203(86)90334-2; van Ede F, 2007, THESIS U TASMANIA LA, P107; Watts M, 2002, J FISH DIS, V25, P191, DOI 10.1046/j.1365-2761.2002.00342.x; Yano T., 1992, TECHNIQUES FISH IMMU, P131; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6	34	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45742	10.1371/journal.pone.0045742	http://dx.doi.org/10.1371/journal.pone.0045742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029217	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500038
J	Villar, D; Ortiz-Barahona, A; Gomez-Maldonado, L; Pescador, N; Sanchez-Cabo, F; Hackl, H; Rodriguez, BAT; Trajanoski, Z; Dopazo, A; Huang, THM; Yan, PS; del Peso, L				Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; Sanchez-Cabo, Fatima; Hackl, Hubert; Rodriguez, Benjamin A. T.; Trajanoski, Zlatko; Dopazo, Ana; Huang, Tim H. M.; Yan, Pearlly S.; del Peso, Luis			Cooperativity of Stress-Responsive Transcription Factors in Core Hypoxia-Inducible Factor Binding Regions	PLOS ONE			English	Article							GENE-EXPRESSION; FACTOR-I; DNA-BINDING; CHROMATIN IMMUNOPRECIPITATION; TRANSACTIVATION DOMAIN; MOLECULAR REGULATION; SIGNALING PATHWAYS; FACTOR 1-ALPHA; PROTEIN-ALPHA; UP-REGULATION	The transcriptional response driven by Hypoxia-inducible factor (HIF) is central to the adaptation to oxygen restriction. Despite recent characterization of genome-wide HIF DNA binding locations and hypoxia-regulated transcripts in different cell types, the molecular bases of HIF target selection remain unresolved. Herein, we combined multi-level experimental data and computational predictions to identify sequence motifs that may contribute to HIF target selectivity. We obtained a core set of bona fide HIF binding regions by integrating multiple HIF1 DNA binding and hypoxia expression profiling datasets. This core set exhibits evolutionarily conserved binding regions and is enriched in functional responses to hypoxia. Computational prediction of enriched transcription factor binding sites identified sequence motifs corresponding to several stress-responsive transcription factors, such as activator protein 1 (AP1), cAMP response element-binding (CREB), or CCAAT-enhancer binding protein (CEBP). Experimental validations on HIF-regulated promoters suggest a functional role of the identified motifs in modulating HIF-mediated transcription. Accordingly, transcriptional targets of these factors are overrepresented in a sorted list of hypoxia-regulated genes. Altogether, our results implicate cooperativity among stress-responsive transcription factors in fine-tuning the HIF transcriptional response.	[Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; del Peso, Luis] Univ Autonoma Madrid, Dept Biochem, Madrid, Spain; [Villar, Diego; Ortiz-Barahona, Amaya; Gomez-Maldonado, Laura; Pescador, Nuria; del Peso, Luis] Inst Invest Biomed Alberto Sols, Madrid, Spain; CNIC, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Villar, D (corresponding author), Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Cambridge, England.	dvillar@iib.uam.es	Dopazo, Ana/N-1159-2014; Villar, Diego/K-8595-2017; Trajanoski, Zlatko/AAT-6703-2021; Hackl, Hubert/B-3168-2018; Sanchez-Cabo, Fatima/N-5030-2014; del Peso, Luis/K-9391-2014; Sanchez-Cabo, Fatima/AAC-5563-2020	Dopazo, Ana/0000-0002-4910-1684; Villar, Diego/0000-0002-8614-6232; Hackl, Hubert/0000-0003-4055-3841; Sanchez-Cabo, Fatima/0000-0003-1881-1664; del Peso, Luis/0000-0003-4014-5688; Sanchez-Cabo, Fatima/0000-0003-1881-1664	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) [SAF2008-03147]; Comunidad Autonoma de Madrid [S-SAL-0311_2006]; 7th Research Framework Programme of the European Union [METOXIA project ref. HEALTH-F2-2009-222741]; Spanish Ministry of Science and Innovation [FPU programme]; European Molecular Biology Organization [Short-Term Fellowships]	Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN); Comunidad Autonoma de Madrid(Comunidad de Madrid); 7th Research Framework Programme of the European Union; Spanish Ministry of Science and Innovation [FPU programme](Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Molecular Biology Organization [Short-Term Fellowships]	This work was supported by Ministerio de Ciencia e Innovacion (Spanish Ministry of Science and Innovation, MICINN) [grant number SAF2008-03147 to L. del P.], Comunidad Autonoma de Madrid [grant number S-SAL-0311_2006 to L. del P.] and the 7th Research Framework Programme of the European Union [grant number METOXIA project ref. HEALTH-F2-2009-222741] to L. del P. D.V. was a recipient of PhD funding from the Spanish Ministry of Science and Innovation [FPU programme] and the European Molecular Biology Organization [Short-Term Fellowships]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; He QY, 2011, NAT GENET, V43, P414, DOI 10.1038/ng.808; Hemberg M, 2011, NUCLEIC ACIDS RES, V39, P7092, DOI 10.1093/nar/gkr404; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090; Ji HK, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl803; Jiang Y, 2005, LEUKEMIA, V19, P1239, DOI 10.1038/sj.leu.2403734; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaplan T, 2012, METHOD CELL BIOL, V110, P263, DOI 10.1016/B978-0-12-388403-9.00011-4; Katada K, 2006, DIGESTION, V73, P89, DOI 10.1159/000094039; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Koslowski M, 2011, ONCOGENE, V30, P876, DOI 10.1038/onc.2010.481; Kovacs KA, 2003, J BIOL CHEM, V278, P36959, DOI 10.1074/jbc.M303147200; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; Laderoute KR, 2005, SEMIN CELL DEV BIOL, V16, P502, DOI 10.1016/j.semcdb.2005.03.005; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liao H, 2007, FASEB J, V21, P935, DOI 10.1096/fj.06-6285com; Liu QY, 2011, MOL CANCER THER, V10, P1113, DOI 10.1158/1535-7163.MCT-10-1010; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miki N, 2004, J BIOL CHEM, V279, P15025, DOI 10.1074/jbc.M313186200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rossler J, 2004, J CELL BIOCHEM, V93, P153, DOI 10.1002/jcb.20133; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sanchez-Elsner T, 2004, J MOL BIOL, V336, P9, DOI 10.1016/j.jmb.2003.12.023; Schodel J, 2012, NAT GENET, V44, P420, DOI 10.1038/ng.2204; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singer GAC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-349; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung FL, 2007, CANCER LETT, V253, P74, DOI 10.1016/j.canlet.2007.01.012; Tacchini L, 2002, BIOCHEM PHARMACOL, V63, P139, DOI 10.1016/S0006-2952(01)00836-X; Tavor S, 2003, J BIOL CHEM, V278, P52651, DOI 10.1074/jbc.M307077200; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Toedling J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000227; Tomancak P, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-115; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Vengellur A, 2003, GENE EXPRESSION, V11, P181, DOI 10.3727/000000003108749062; Vengellur A, 2005, PHYSIOL GENOMICS, V22, P308, DOI 10.1152/physiolgenomics.00045.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger RH, 1998, EUR J BIOCHEM, V253, P771, DOI 10.1046/j.1432-1327.1998.2530771.x; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Zhang W, 1999, J HUM GENET, V44, P293, DOI 10.1007/s100380050163; Zhao XY, 2011, J BIOL CHEM, V286, P36808, DOI 10.1074/jbc.M111.247262	92	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45708	10.1371/journal.pone.0045708	http://dx.doi.org/10.1371/journal.pone.0045708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029193	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700061
J	Yang, S; Li, Q; Zeng, QL; Zhang, JB; Yu, ZI; Liu, ZD				Yang, Sen; Li, Qing; Zeng, Qinglan; Zhang, Jibin; Yu, Ziniu; Liu, Ziduo			Conversion of Solid Organic Wastes into Oil via Boettcherisca peregrine (Diptera: Sarcophagidae) Larvae and Optimization of Parameters for Biodiesel Production	PLOS ONE			English	Article							DEPENDENCE	The feedstocks for biodiesel production are predominantly from edible oils and the high cost of the feedstocks prevents its large scale application. In this study, we evaluated the oil extracted from Boettcherisca peregrine larvae (BPL) grown on solid organic wastes for biodiesel production. The oil contents detected in the BPL converted from swine manure, fermentation residue and the degreased food waste, were 21.7%, 19.5% and 31.1%, respectively. The acid value of the oil is 19.02 mg KOH/g requiring a two-step transesterification process. The optimized process of 12:1 methanol/oil (mol/mol) with 1.5% H2SO4 reacted at 70 degrees C for 120 min resulted in a 90.8% conversion rate of free fatty acid (FFA) by esterification, and a 92.3% conversion rate of triglycerides into esters by alkaline transesterification. Properties of the BPL oil-based biodiesel are within the specifications of ASTM D6751, suggesting that the solid organic waste-grown BPL could be a feasible non-food feedstock for biodiesel production.	[Yang, Sen; Li, Qing; Zhang, Jibin; Yu, Ziniu; Liu, Ziduo] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Li, Qing] Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China; [Zeng, Qinglan] Xianning Vocat Tech Coll, Dept Biol Engn, Xianning, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Liu, ZD (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	lzd@mail.hzau.edu.cn			open project of State Key Laboratory of Huazhong Agricultural University [ALM0810]; China National Natural Sciences Foundation [u1170303]; Genetically Modified Organisms Breeding Major Projects of China [2011ZX08001-001]	open project of State Key Laboratory of Huazhong Agricultural University; China National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects of China	This study was supported by grants from the open project of State Key Laboratory of Huazhong Agricultural University (ALM0810), the China National Natural Sciences Foundation (u1170303), and the Genetically Modified Organisms Breeding Major Projects of China (2011ZX08001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, EN14103; Banks JE, 2008, BIOL CONTROL, V47, P141, DOI 10.1016/j.biocontrol.2008.08.006; Chang KJL, 2011, PHYTOCHEMISTRY, V72, P1460, DOI 10.1016/j.phytochem.2011.04.001; Demirbas A, 2003, ENERG CONVERS MANAGE, V44, P2093, DOI 10.1016/S0196-8904(02)00234-0; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Gan S, 2010, BIORESOURCE TECHNOL, V101, P7338, DOI 10.1016/j.biortech.2010.04.028; GOFF ML, 1991, J FORENSIC SCI, V36, P537; Gui MM, 2008, ENERGY, V33, P1646, DOI 10.1016/j.energy.2008.06.002; Kafuku G, 2010, FUEL, V89, P2556, DOI 10.1016/j.fuel.2010.03.039; Knothe G, 2005, FUEL PROCESS TECHNOL, V86, P1059, DOI 10.1016/j.fuproc.2004.11.002; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Li Q, 2011, J PET ENV BIOTECHN S, VS2; Li Q, 2011, FUEL, V90, P1545, DOI 10.1016/j.fuel.2010.11.016; Li ZX, 2012, APPL ENERG, V94, P349, DOI 10.1016/j.apenergy.2012.01.068; Liu WC, 2007, THEOR POPUL BIOL, V72, P86, DOI 10.1016/j.tpb.2007.01.002; Martindale W, 2008, NAT BIOTECHNOL, V26, P1068, DOI 10.1038/nbt1008-1068; Min X. U., 1999, LUBRICATING OIL, P56; Mongobay, 2006, WHY OIL PALM REPLACI; Neves L, 2008, WASTE MANAGE, V28, P965, DOI 10.1016/j.wasman.2007.03.031; Rezanka T, 2009, PROG LIPID RES, V48, P206, DOI 10.1016/j.plipres.2009.03.003; Rodrigues C, 2011, CRIT REV BIOTECHNOL, P1; Schroeder Hilke, 2003, Leg Med (Tokyo), V5 Suppl 1, pS372; Sharma YC, 2010, FUEL, V89, P1470, DOI 10.1016/j.fuel.2009.10.013; Thoenes P., 2007, BIOFUELS COMMODITY M; Wang Hai-Yang, 2010, Huanjing Kunchong Xuebao, V32, P166; Wu Guo-Xing, 2006, Acta Entomologica Sinica, V49, P22; Zheng L, 2011, RENEW ENERG, V44, P1	27	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45940	10.1371/journal.pone.0045940	http://dx.doi.org/10.1371/journal.pone.0045940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029331	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700092
J	Kusuhara, S; Fukushima, Y; Fukuhara, S; Jakt, LM; Okada, M; Shimizu, Y; Hata, M; Nishida, K; Negi, A; Hirashima, M; Mochizuki, N; Nishikawa, SI; Uemura, A				Kusuhara, Sentaro; Fukushima, Yoko; Fukuhara, Shigetomo; Jakt, Lars Martin; Okada, Mitsuhiro; Shimizu, Yuri; Hata, Masayuki; Nishida, Kohji; Negi, Akira; Hirashima, Masanori; Mochizuki, Naoki; Nishikawa, Shin-Ichi; Uemura, Akiyoshi			Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR; MACULAR DEGENERATION; GENE-EXPRESSION; IDENTIFICATION; SURVIVAL; RANIBIZUMAB; BEVACIZUMAB; MICROARRAYS; RECEPTOR; REVEALS	Background: Drugs inhibiting vascular endothelial growth factor (VEGF) signaling are globally administered to suppress deregulated angiogenesis in a variety of eye diseases. However, anti-VEGF therapy potentially affects the normal functions of retinal neurons and glias which constitutively express VEGF receptor 2. Thus, it is desirable to identify novel drug targets which are exclusively expressed in endothelial cells (ECs). Here we attempted to identify an EC-specific Rho guanine nucleotide exchange factor (GEF) and evaluate its role in retinal angiogenesis. Methodology/Principal Findings: By exploiting fluorescence-activated cell sorting and microarray analyses in conjunction with in silico bioinformatics analyses, we comprehensively identified endothelial genes in angiogenic retinal vessels of postnatal mice. Of 9 RhoGEFs which were highly expressed in retinal ECs, we show that Arhgef15 acted as an EC-specific GEF to mediate VEGF-induced Cdc42 activation and potentiated RhoJ inactivation, thereby promoting actin polymerization and cell motility. Disruption of the Arhgef15 gene led to delayed extension of vascular networks and subsequent reduction of total vessel areas in postnatal mouse retinas. Conclusions/Significance: Our study provides information useful to the development of new means of selectively manipulating angiogenesis without affecting homeostasis in un-targeted tissues; not only in eyes but also in various disease settings such as cancer.	[Kusuhara, Sentaro; Fukushima, Yoko; Jakt, Lars Martin; Okada, Mitsuhiro; Shimizu, Yuri; Nishikawa, Shin-Ichi; Uemura, Akiyoshi] RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan; [Kusuhara, Sentaro; Negi, Akira; Uemura, Akiyoshi] Kobe Univ, Div Ophthalmol, Dept Surg, Grad Sch Med, Kobe, Hyogo 657, Japan; [Fukushima, Yoko; Hata, Masayuki; Hirashima, Masanori; Uemura, Akiyoshi] Kobe Univ, Div Vasc Biol, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Fukushima, Yoko; Nishida, Kohji] Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; [Fukuhara, Shigetomo; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Osaka, Japan	RIKEN; Kobe University; Kobe University; Osaka University; National Cerebral & Cardiovascular Center - Japan	Uemura, A (corresponding author), RIKEN Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan.	auemura@med.kobe-u.ac.jp	Hirashima, Masanori/ABC-9204-2021; Uemura, Akiyoshi/I-7510-2017	Hirashima, Masanori/0000-0002-0190-4381; Uemura, Akiyoshi/0000-0001-5574-5470; Kusuhara, Sentaro/0000-0002-6458-539X; Jakt, Lars Martin/0000-0002-3787-8138; Nishida, Kohji/0000-0001-9069-3610	Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation; Ministry of Education, Culture, Sports, Science and Technology, Japan [22689046]; Japan Science and Technology Agency [AS231Z03014G]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Inamori Foundation; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Mishima Saiichi Commemoration Ophthalmology Study Research Foundation; Grants-in-Aid for Scientific Research [22390040, 22113009, 22689046] Funding Source: KAKEN	Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Inamori Foundation; Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder; Mishima Saiichi Commemoration Ophthalmology Study Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the 'Global Center of Excellence for Education and Research on Signal Transduction Medicine in the Coming Generation' and 'Grants-in-Aid for Young Scientists' (22689046) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and 'Exploratory Research, Feasibility Study Stage, A-STEP' (AS231Z03014G) from the Japan Science and Technology Agency. AU is supported by the Takeda Science Foundation, Mitsubishi Pharma Research Foundation, Inamori Foundation, Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder, and Mishima Saiichi Commemoration Ophthalmology Study Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Jakt LM, 2008, CANCER SCI, V99, P829, DOI 10.1111/j.1349-7006.2008.00767.x; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Mills JC, 2001, NAT CELL BIOL, V3, pE175, DOI 10.1038/35087108; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sato T, 2008, DEVELOPMENT, V135, P755, DOI 10.1242/dev.012708; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uemura A, 2006, J CLIN INVEST, V116, P369, DOI 10.1172/JCI25964; Uemura AK, 2006, EXP CELL RES, V312, P676, DOI 10.1016/j.yexcr.2005.10.030; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Yang XJ, 1996, J NEUROSCI, V16, P6089	36	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45858	10.1371/journal.pone.0045858	http://dx.doi.org/10.1371/journal.pone.0045858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029280	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800108
J	Qiu, N; Xiao, ZS; Cao, L; David, V; Quarles, LD				Qiu, Ni; Xiao, Zhousheng; Cao, Li; David, Valentin; Quarles, Leigh Darryl			Conditional Mesenchymal Disruption of Pkd1 Results in Osteopenia and Polycystic Kidney Disease	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; EXTRARENAL MANIFESTATIONS; INTRACRANIAL ANEURYSMS; EPITHELIAL-CELLS; CRE RECOMBINASE; CYST FORMATION; BONE-FORMATION; STEM-CELLS; MICE; EXPRESSION	Conditional deletion of Pkd1 in osteoblasts using either Osteocalcin(Oc)-Cre or Dmp1-Cre results in defective osteoblast-mediated postnatal bone formation and osteopenia. Pkd1 is also expressed in undifferentiated mesenchyme that gives rise to the osteoblast lineage. To examine the effects of Pkd1 on prenatal osteoblast development, we crossed Pkd1(flox/flox) and Col1a1(3.6)-Cre mice, which has been used to achieve selective inactivation of Pkd1 earlier in the osteoblast lineage. Control Pkd1(flox/flox) and Pkd1(flox/+), heterozygous Col1a1(3.6)-Cre;Pkd1(flox/+) and Pkd1(flox/null), and homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) and Col1a1(3.6)-Cre;Pkd1(flox/null) mice were analyzed at ages ranging from E14.5 to 8-weeks-old. Newborn Col1a1(3.6)Cre;Pkd1(flox/null) mice exhibited defective skeletogenesis in association with a greater reduction in Pkd1 expression in bone. Conditional Col1a1(3.6)-Cre;Pkd1(flox/+) and Col1a1(3.6)-Cre;Pkd1(flox/flox) mice displayed a gene dose-dependent decrease in bone formation and increase in marrow fat at 6 weeks of age. Bone marrow stromal cell and primary osteoblast cultures from homozygous Col1a1(3.6)-Cre;Pkd1(flox/flox) mice showed increased proliferation, impaired osteoblast development and enhanced adipogenesis ex vivo. Unexpectedly, we found evidence for Col1a1(3.6)-Cre mediated deletion of Pkd1 in extraskeletal tissues in Col1a1(3.6)-Cre;Pkd1(flox/flox) mice. Deletion of Pkd1 in mesenchymal precursors resulted in pancreatic and renal, but not hepatic, cyst formation. The non-lethality of Col1a1(3.6)-Cre;Pkd1(flox/flox) mice establishes a new model to study abnormalities in bone development and cyst formation in pancreas and kidney caused by Pkd1 gene inactivation.	[Qiu, Ni; Xiao, Zhousheng; Cao, Li; David, Valentin; Quarles, Leigh Darryl] Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Quarles, LD (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; xiao, zhousheng/0000-0002-3363-5673	National Institute of Diabetes and Digestive and Kidney Diseases [P50-DK057301, R01-DK083303]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R21-AR056794]; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R01DK083303] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants P50-DK057301 (National Institute of Diabetes and Digestive and Kidney Diseases) to James P. Calvet, R21-AR056794 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) to Zhousheng Xiao, and R01-DK083303 (National Institute of Diabetes and Digestive and Kidney Diseases) to L. Darryl Quarles from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiari G, 2012, J MOL MED BERL; Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; CHAUVEAU D, 1994, KIDNEY INT, V45, P1140, DOI 10.1038/ki.1994.151; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Chea SW, 2009, YONSEI MED J, V50, P105, DOI 10.3349/ymj.2009.50.1.105; Deal C, 2009, CURR OPIN RHEUMATOL, V21, P380, DOI 10.1097/BOR.0b013e32832cbc2a; Driscoll JA, 2008, CHEST, V133, P1181, DOI 10.1378/chest.07-2147; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gallagher AR, 2010, ADV CHRONIC KIDNEY D, V17, P118, DOI 10.1053/j.ackd.2010.01.002; Garcia-Gonzalez MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012821; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Guillaume R, 1999, DEV DYNAM, V214, P337, DOI 10.1002/(SICI)1097-0177(199904)214:4<337::AID-AJA6>3.0.CO;2-O; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Hassane S, 2007, ARTERIOSCL THROM VAS, V27, P2177, DOI 10.1161/ATVBAHA.107.149252; Hick AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-66; Horster M, 1997, PFLUG ARCH EUR J PHY, V434, P647, DOI 10.1007/s004240050448; Horster MF, 1999, PHYSIOL REV, V79, P1157, DOI 10.1152/physrev.1999.79.4.1157; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; Housset C, 2005, GASTROEN CLIN BIOL, V29, P861, DOI 10.1016/S0399-8320(05)86361-4; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031; KAEHNY WD, 1991, SEMIN NEPHROL, V11, P661; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Leuenroth SJ, 2008, J AM SOC NEPHROL, V19, P1659, DOI 10.1681/ASN.2008030259; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Malka D, 1998, GUT, V42, P131, DOI 10.1136/gut.42.1.131; Martin ADV, 2012, MOL ENDOCRI IN PRESS; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; OWEN M, 1988, J CELL SCI, P63; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Peczkowska M, 2004, BLOOD PRESSURE, V13, P283, DOI 10.1080/08037050410016492; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Pirson Y, 2010, ADV CHRONIC KIDNEY D, V17, P173, DOI 10.1053/j.ackd.2010.01.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Rickard DJ, 1996, J BONE MINER RES, V11, P312; SCHIEVINK WI, 1992, J AM SOC NEPHROL, V3, P88; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Skala I, 1985, Vnitr Lek, V31, P677; Stuart RO, 2003, KIDNEY INT, V64, P1997, DOI 10.1046/j.1523-1755.2003.00383.x; Togawa H, 2011, AM J PHYSIOL-RENAL, V300, pF511, DOI 10.1152/ajprenal.00038.2010; Torra R, 1997, CLIN NEPHROL, V47, P19; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tulachan SS, 2006, DEV GROWTH DIFFER, V48, P65, DOI 10.1111/j.1440-169x.2006.00846.x; van Gulick JJM, 2011, NETH J MED, V69, P367; Wescott MP, 2009, MOL BIOL CELL, V20, P4838, DOI 10.1091/mbc.E09-03-0203; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xiao Y, 2009, MOL CELL BIOCH; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xu H, 2001, DNA SEQUENCE, V12, P361, DOI 10.3109/10425170109084460; Yamaguchi T, 2010, AM J PHYSIOL-RENAL, V299, pF944, DOI 10.1152/ajprenal.00387.2010; ZEIER M, 1992, KIDNEY INT, V42, P1259, DOI 10.1038/ki.1992.413; Zha LB, 2008, J GENET GENOMICS, V35, P525, DOI 10.1016/S1673-8527(08)60072-7; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020	74	13	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46038	10.1371/journal.pone.0046038	http://dx.doi.org/10.1371/journal.pone.0046038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029375	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800133
J	Qu, ST; Yao, YL; Shang, C; Xue, YX; Ma, J; Li, Z; Liu, YH				Qu, Shengtao; Yao, Yilong; Shang, Chao; Xue, Yixue; Ma, Jun; Li, Zhen; Liu, Yunhui			MicroRNA-330 Is an Oncogenic Factor in Glioblastoma Cells by Regulating SH3GL2 Gene	PLOS ONE			English	Article							DOWN-REGULATION; CANCER-CELLS; EGF RECEPTOR; EXPRESSION; CARCINOMA; GROWTH; METHYLATION; PATHWAY; DISEASE; PROTEIN	MicroRNAs have recently emerged as key regulators of cancers. This study was therefore conducted to investigate the role of miR-330 in biological behaviors of human glioblastoma U87 and U251 cell lines and its molecular mechanism. SH3GL2 gene was identified as the target of miR-330. MiR-330 overexpression was established by transfecting miR-330 precursor into U87 and U251 cells, and its effects on proliferation, migration, invasion, cell cycle and apoptosis were studied. Overexpression of miR-330 can enhance cellular proliferation, promote migration and invasion, activate cell cycle and also inhibit apoptosis in U87 and U251 cells. Collectively, these above-mentioned results suggest that miRNA-330 plays an oncogenic role in human glioblastoma by regulating SH3GL2 gene and might be a new therapeutic target of human glioblastoma.	[Qu, Shengtao; Yao, Yilong; Li, Zhen; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China; [Shang, Chao; Xue, Yixue; Ma, Jun] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Peoples R China; [Shang, Chao; Xue, Yixue; Ma, Jun] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China.	liuyh62@gmail.com			Natural Science Foundation of China [81171131, 81172197, 30973079, 81072056]; special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities [20092104110015, 20102104110009]; Natural Science Foundation of Liaoning Province in China [201102300]; Science and Technology Plan Projects of Liaoning Province in China [2011225020]; Shenyang Science and Technology Plan Projects [F-10-205-1-22, F-10-205-1-37]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities; Natural Science Foundation of Liaoning Province in China(Natural Science Foundation of Liaoning Province); Science and Technology Plan Projects of Liaoning Province in China; Shenyang Science and Technology Plan Projects	This work is supported by grants from Natural Science Foundation of China (Nos. 81171131, 81172197, 30973079, 81072056), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities, (Nos. 20092104110015, 20102104110009), Natural Science Foundation of Liaoning Province in China (No. 201102300), Science and Technology Plan Projects of Liaoning Province in China (No. 2011225020) and Shenyang Science and Technology Plan Projects (Nos. F-10-205-1-22, F-10-205-1-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Hodzic J, 2011, NUCLEOS NUCLEOT NUCL, V30, P1214, DOI 10.1080/15257770.2011.629271; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li CS, 2009, AAPS J, V11, P747, DOI 10.1208/s12248-009-9145-9; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Osterberg L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-368; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Reutens AT, 2002, INT J BIOCHEM CELL B, V34, P1173, DOI 10.1016/S1357-2725(02)00063-8; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Shang C, 2010, PROGR ANATOMICAL SCI, V16, P128; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Shi ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032709; Silber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033844; Sinha S, 2008, ANN SURG ONCOL, V15, P1070, DOI 10.1245/s10434-007-9790-0; Song JY, 2009, CANCER LETT, V283, P135, DOI 10.1016/j.canlet.2009.03.034; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Zhong Xiaomin, 2012, Methods Mol Biol, V822, P295, DOI 10.1007/978-1-61779-427-8_21	35	51	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46010	10.1371/journal.pone.0046010	http://dx.doi.org/10.1371/journal.pone.0046010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029364	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800130
J	Gupta, SK; Shen, CY; Moe, SM; Kamendulis, LM; Goldman, M; Dube, MP				Gupta, Samir K.; Shen, Changyu; Moe, Sharon M.; Kamendulis, Lisa M.; Goldman, Mitchell; Dube, Michael P.			Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; VITAMIN-D; DYSFUNCTION; ASSOCIATION; RISK; HYPERPARATHYROIDISM	Objective: Changes in endothelial function, measured as flow-mediated dilation (FMD) of the brachial artery, has not been systematically assessed beyond 6 months of initiation of antiretroviral therapy (ART) when drug-related effects might offset initial improvements with virologic control. Design: We assessed 6 and 12 month changes in FMD [presented as median (quartile 1, quartile 3)] and circulating HIV and cardiovascular biomarkers in 23 subjects initiating ART. Results: There were no significant changes in FMD at 6 or 12 months overall despite significant increases in CD4 cell count and HDL-C and reductions in HIV RNA level, MCP-1, IP-10, sVCAM-1, sTNFR2, and sCD14. However, there were significant differences (P = 0.04) in the changes in FMD between those receiving efavirenz [N = 12; -3.50% (-4.90%, 0.68%)] vs. protease inhibitors at 12 months [N = 11; 1.50% (-0.86%, 4.56%)]. The differences in changes in FMD between those receiving and not receiving emtricitabine/tenofovir/efavirenz were more pronounced and were significantly different at both 6 and 12 months (P < 0.02 for both). Additional studies showed no significant differences in changes in 25-(OH)-vitamin D, PTH, FGF-23, of F2-isoprostane levels between efavirenz and PI use or between those receiving and not receiving emtricitabine/tenofovir/efavirenz. Conclusion: Efavirenz use was associated with reduced FMD at 12 months compared to PI-based regimens while emtricitabine/tenofovir/efavirenz was associated with reduced FMD at both 6 and 12 months compared to those not receiving this combination. Long-term effects of antiretrovirals on endothelial function may play an important role in the risk of cardiovascular disease in HIV-infected patients.	[Gupta, Samir K.; Goldman, Mitchell] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA; [Shen, Changyu] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN USA; [Moe, Sharon M.] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN USA; [Kamendulis, Lisa M.] Indiana Univ, Dept Environm Hlth, Bloomington, IN USA; [Dube, Michael P.] Univ So Calif, Keck Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90033 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Southern California	Gupta, SK (corresponding author), Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN USA.	sgupta1@iupui.edu	Dubé, Marie-Pierre/B-9364-2008	Dubé, Marie-Pierre/0000-0001-8442-4393	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [R01 HL72711, R01 HL095149]; Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources [RR025761]; Gilead Sciences, Inc.; Merck Co.; Janssen (Tibotec) Therapeutics; Bristol-Myers Squibb; ViiV Healthcare/GlaxoSmithKline; Serono; Genzyme; Shire; Amgen; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072711, R01HL095149] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources; Gilead Sciences, Inc.(Gilead Sciences); Merck Co.(Merck & Company); Janssen (Tibotec) Therapeutics(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Myers Squibb(Bristol-Myers Squibb); ViiV Healthcare/GlaxoSmithKline; Serono; Genzyme(Sanofi-AventisGenzyme Corporation); Shire; Amgen(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [R01 HL72711 and R01 HL095149] and by a Project Development Team within the Indiana Clinical and Translational Sciences Institute NIH/National Center for Research Resources [RR025761]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S.K.G. reports having received unrestricted research grant support from Gilead Sciences, Inc., Merck & Co., and Janssen (Tibotec) Therapeutics and receives consultant fees from Bristol-Myers Squibb. M.P.D. reports research grant support from ViiV Healthcare/GlaxoSmithKline and has received consultant fees from Serono. S.M.M. reports research grants and consulting fees from Genzyme, Shire, and Amgen. All other authors report no conflicts. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bastani NE, 2009, RAPID COMMUN MASS SP, V23, P2885, DOI 10.1002/rcm.4197; Brown TT, 2010, ANTIVIR THER, V15, P425, DOI [10.3851/IMP1502, 10.3851/IMP15021]; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Dekker D, 2011, ARTERIOSCL THROM VAS, V31, P458, DOI 10.1161/ATVBAHA.110.211789; Delaney JAC, 2010, AIDS, V24, P2201, DOI 10.1097/QAD.0b013e32833d2132; Durand M, 2011, JAIDS-J ACQ IMM DEF, V57, P245, DOI 10.1097/QAI.0b013e31821d33a5; Egashira K, 2002, CIRC J, V66, P529, DOI 10.1253/circj.66.529; Ekmekci A, 2009, J ENDOCRINOL INVEST, V32, P611, DOI [10.3275/6400, 10.1007/BF03346518]; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grubb JR, 2006, J INFECT DIS, V193, P1516, DOI 10.1086/503807; Gupta SK, 2007, JAIDS-J ACQ IMM DEF, V45, P596, DOI 10.1097/QAI.0b013e318061d2fa; Gupta SK, 2009, J INFECT DIS, V200, P614, DOI 10.1086/600890; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Jamaluddin MS, 2010, ATHEROSCLEROSIS, V208, P104, DOI 10.1016/j.atherosclerosis.2009.07.029; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Redhage LA, 2009, HIV CLIN TRIALS, V10, P181, DOI 10.1310/hct1003-181; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Stein JH, 2001, CIRCULATION, V104, P257, DOI 10.1161/01.CIR.104.3.257; Suessenbacher A, 2006, VASC MED, V11, P239, DOI 10.1177/1358863x06075006; Tarcin O, 2009, J CLIN ENDOCR METAB, V94, P4023, DOI 10.1210/jc.2008-1212; Torriani FJ, 2008, J AM COLL CARDIOL, V52, P569, DOI 10.1016/j.jacc.2008.04.049; Valgimigli M, 2003, ARCH BIOCHEM BIOPHYS, V420, P255, DOI 10.1016/j.abb.2003.07.006; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478	27	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45716	10.1371/journal.pone.0045716	http://dx.doi.org/10.1371/journal.pone.0045716			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029197	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900092
J	Werkmeister, RM; Palkovits, S; Told, R; Groschl, M; Leitgeb, RA; Garhofer, G; Schmetterer, L				Werkmeister, Rene M.; Palkovits, Stefan; Told, Reinhard; Groeschl, Martin; Leitgeb, Rainer A.; Garhoefer, Gerhard; Schmetterer, Leopold			Response of Retinal Blood Flow to Systemic Hyperoxia as Measured with Dual-Beam Bidirectional Doppler Fourier-Domain Optical Coherence Tomography	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; FLICKER STIMULATION; VESSEL ANALYZER; VELOCITY; GLAUCOMA; VELOCIMETRY; MECHANISM; HUMANS; CELLS; NERVE	Purpose: There is a long-standing interest in the study of retinal blood flow in humans. In the recent years techniques have been established to measure retinal perfusion based on optical coherence tomography (OCT). In the present study we used a technique called dual-beam bidirectional Doppler Fourier-domain optical coherence tomography (FD-OCT) to characterize the effects of 100% oxygen breathing on retinal blood flow. These data were compared to data obtained with a laser Doppler velocimeter (LDV). Methods: 10 healthy subjects were studied on 2 study days. On one study day the effect of 100% oxygen breathing on retinal blood velocities was studied using dual-beam bidirectional Doppler FD-OCT. On the second study day the effect of 100% oxygen breathing on retinal blood velocities was assessed by laser Doppler velocimetry (LDV). Retinal vessel diameters were measured on both study days using a commercially available Dynamic Vessel Analyzer. Retinal blood flow was calculated based on retinal vessel diameters and red blood cell velocity. Results: As expected, breathing of pure oxygen induced a pronounced reduction in retinal vessel diameters, retinal blood velocities and retinal blood flow on both study days (p<0.001). Blood velocity data correlated well between the two methods applied under both baseline as well as under hyperoxic conditions (r=0.98 and r=0.75, respectively). Data as obtained with OCT were, however, slightly higher. Conclusion: A good correlation was found between red blood cell velocity as measured with dual-beam bidirectional Doppler FD-OCT and red blood cell velocity assessed by the laser Doppler method. Dual-beam bidirectional Doppler FD-OCT is a promising approach for studying retinal blood velocities in vivo.	[Werkmeister, Rene M.; Told, Reinhard; Leitgeb, Rainer A.; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Palkovits, Stefan; Told, Reinhard; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Groeschl, Martin] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Technische Universitat Wien	Schmetterer, L (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	leopold.schmetterer@meduniwien.ac.at		Leitgeb, Rainer/0000-0002-0131-4111; Schmetterer, Leopold/0000-0002-7189-1707; Told, Reinhard/0000-0003-2046-7081	Austrian Science Foundation [APP21570FW]; Austrian Research Promotion Agency (FFG) [FA 607A0502]; Christian Doppler Laboratory for Laser Development and their Application in Medicine; Austrian Science Fund (FWF) [P 21570] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG); Christian Doppler Laboratory for Laser Development and their Application in Medicine; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Foundation, project no. APP21570FW, http://www.fwf.ac.at/; Austrian Research Promotion Agency (FFG), project no. FA 607A0502, http://www.ffg.at/en; and Christian Doppler Laboratory for Laser Development and their Application in Medicine, http://www.cdg.ac.at/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute American National Standard for Safe Use of Lasers, 2000, Z136122000 ANSI LAS; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bachmann AH, 2007, OPT EXPRESS, V15, P408, DOI 10.1364/OE.15.000408; Baumann B, 2011, BIOMED OPT EXPRESS, V2, P1539, DOI 10.1364/BOE.2.001539; Bower BA, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772877; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; FEKE GT, 1994, INVEST OPHTH VIS SCI, V35, P2968; FEKE GT, 1989, INVEST OPHTH VIS SCI, V30, P58; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Garcia JPS, 2002, OPHTHALMIC RES, V34, P295, DOI 10.1159/000065600; Garhofer G, 2004, BRIT J OPHTHALMOL, V88, P887, DOI 10.1136/bjo.2003.033548; Garhofer G, 2012, INVEST OPHTH VIS SCI, V53, P698, DOI 10.1167/iovs.11-8624; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Gilmore ED, 2007, INVEST OPHTH VIS SCI, V48, P1744, DOI 10.1167/iovs.06-1016; GRUNWALD JE, 1992, INVEST OPHTH VIS SCI, V33, P356; Grunwald JE, 1996, BRIT J OPHTHALMOL, V80, P327, DOI 10.1136/bjo.80.4.327; Gullstrand A., 1924, HELMHOLTZS TREATISE, V1, P351; Iftimia NV, 2008, OPT EXPRESS, V16, P13624, DOI 10.1364/OE.16.013624; Kiss B, 2002, MICROVASC RES, V64, P75, DOI 10.1006/mvre.2002.2402; Leitgeb RA, 2004, OPT LETT, V29, P171, DOI 10.1364/OL.29.000171; Leitgeb RA, 2003, OPT EXPRESS, V11, P3116, DOI 10.1364/OE.11.003116; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; Logean E, 2000, APPL OPTICS, V39, P2858, DOI 10.1364/AO.39.002858; Logean E, 2003, LASER PHYS, V13, P45; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Michaely R, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2771553; Mozaffarieh M, 2007, SURV OPHTHALMOL, V52, pS174, DOI 10.1016/j.survophthal.2007.08.013; Nagaoka Taiji, 2006, Nippon Ganka Gakkai Zasshi, V110, P872; Nguyen TT, 2009, INVEST OPHTH VIS SCI, V50, P5609, DOI 10.1167/iovs.09-3442; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Pedersen CJ, 2007, OPT LETT, V32, P506, DOI 10.1364/OL.32.000506; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Pemp B, 2010, DIABETES CARE, V33, P2038, DOI 10.2337/dc10-0502; Pemp B, 2010, INVEST OPHTH VIS SCI, V51, P2, DOI 10.1167/iovs.09-3888; Pemp B, 2009, INVEST OPHTH VIS SCI, V50, P4029, DOI 10.1167/iovs.08-3260; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Polska E, 2001, AM J PHYSIOL-HEART C, V280, pH1442, DOI 10.1152/ajpheart.2001.280.4.H1442; Resch H, 2009, ACTA OPHTHALMOL, V87, P4, DOI 10.1111/j.1755-3768.2007.01167.x; RIVA C, 1972, INVEST OPHTH VISUAL, V11, P936; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; RIVA CE, 1981, APPL OPTICS, V20, P117, DOI 10.1364/AO.20.000117; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; RIVA CE, 1983, INVEST OPHTH VIS SCI, V24, P47; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Schmetterer L, 1999, DIABETOLOGIA, V42, P387, DOI 10.1007/s001250051171; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Schmoll T, 2011, BIOMED OPT EXPRESS, V2, P1159, DOI 10.1364/BOE2.001159; Schmoll T, 2009, OPT EXPRESS, V17, P4166, DOI 10.1364/OE.17.004166; Singh ASG, 2010, BIOMED OPT EXPRESS, V1, P1047, DOI 10.1364/BOE.1.001047; Singh ASG, 2011, BIOMED OPT EXPRESS, V2, P1328, DOI 10.1364/BOE.2.001328; Stalmans I, 2011, ACTA OPHTHALMOL, V89, pe609, DOI 10.1111/j.1755-3768.2011.02178.x; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Szkulmowska A, 2008, OPT LETT, V33, P1425, DOI 10.1364/OL.33.001425; Tao YK, 2009, OPT EXPRESS, V17, P4177, DOI 10.1364/OE.17.004177; Tuchin V. V, 2006, OPTICAL CLEARING TIS; Wang Y, 2009, BRIT J OPHTHALMOL, V93, P634, DOI 10.1136/bjo.2008.150276; Wang YM, 2011, BIOMED OPT EXPRESS, V2, P1852, DOI 10.1364/BOE.001852; Wang YM, 2011, INVEST OPHTH VIS SCI, V52, P840, DOI 10.1167/iovs.10-5985; Werkmeister RM, 2008, OPT LETT, V33, P2967, DOI 10.1364/OL.33.002967; Yazdanfar S, 2003, ARCH OPHTHALMOL-CHIC, V121, P235; Yoshida A, 2003, AM J OPHTHALMOL, V135, P356, DOI 10.1016/S0002-9394(02)01949-9; Zhong ZY, 2011, INVEST OPHTH VIS SCI, V52, P4151, DOI 10.1167/iovs.10-6940; Zotter S, 2011, OPT EXPRESS, V19, P1217, DOI 10.1364/OE.19.001217	65	45	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45876	10.1371/journal.pone.0045876	http://dx.doi.org/10.1371/journal.pone.0045876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029289	Green Published, gold, Green Submitted			2022-12-25	WOS:000311313900172
J	Harvey, EL; Menden-Deuer, S				Harvey, Elizabeth L.; Menden-Deuer, Susanne			Predator-Induced Fleeing Behaviors in Phytoplankton: A New Mechanism for Harmful Algal Bloom Formation?	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; DIURNAL VERTICAL MIGRATION; POPULATION-DISTRIBUTIONS; PREY INTERACTIONS; TOXIN PRODUCTION; ECOLOGICAL ROLE; MARINE BIRDS; MICROZOOPLANKTON; GROWTH; EUTROPHICATION	In the plankton, heterotrophic microbes encounter and ingest phytoplankton prey, which effectively removes >50% of daily phytoplankton production in the ocean and influences global primary production and biochemical cycling rates. Factors such as size, shape, nutritional value, and presence of chemical deterrents are known to affect predation pressure. Effects of movement behaviors of either predator or prey on predation pressure, and particularly fleeing behaviors in phytoplankton are thus far unknown. Here, we quantified individual 3D movements, population distributions, and survival rates of the toxic phytoplankton species, Heterosigma akashiwo in response to a ciliate predator and predator-derived cues. We observed predator-induced defense behaviors previously unknown for phytoplankton. Modulation of individual phytoplankton movements during and after predator exposure resulted in an effective separation of predator and prey species. The strongest avoidance behaviors were observed when H. akashiwo co-occurred with an actively grazing predator. Predator-induced changes in phytoplankton movements resulted in a reduction in encounter rate and a 3-fold increase in net algal population growth rate. A spatially explicit population model predicted rapid phytoplankton bloom formation only when fleeing behaviors were incorporated. These model predictions reflected field observations of rapid H. akashiwo harmful algal bloom (HAB) formation in the coastal ocean. Our results document a novel behavior in phytoplankton that can significantly reduce predation pressure and suggests a new mechanism for HAB formation. Phytoplankton behaviors that minimize predatory losses, maximize resource acquisition, and alter community composition and distribution patterns could have major implications for our understanding and predictive capacity of marine primary production and biochemical cycling rates.	[Harvey, Elizabeth L.; Menden-Deuer, Susanne] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Harvey, EL (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	smenden@gso.uri.edu		Menden-Deuer, Susanne/0000-0002-8434-4251	Rhode Island EPSCoR [1004057]; US Department of Agriculture [2008-38420-18737]; Ecology of Harmful Algal Blooms [NA06NOS4780248]; National Science Foundation [0826205]	Rhode Island EPSCoR; US Department of Agriculture(United States Department of Agriculture (USDA)); Ecology of Harmful Algal Blooms; National Science Foundation(National Science Foundation (NSF))	A portion of this work was conducted at the Rhode Island EPSCoR supported Center for Marine Life Science (NSF EPSCoR Grant #1004057). Funding was provided by a Disease in Marine Organisms Fellowship through the US Department of Agriculture (2008-38420-18737 to M. Gomez-Chiarri), an Ecology of Harmful Algal Blooms grant (NA06NOS4780248 to S. Strom and S. Menden-Deuer), and the National Science Foundation (Biological-Oceanography Award 0826205 to S. Menden-Deuer). This is EcoHAB publication number ECO702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bearon RN, 2006, MAR ECOL PROG SER, V306, P153, DOI 10.3354/meps306153; Bearon RN, 2004, LIMNOL OCEANOGR, V49, P607, DOI 10.4319/lo.2004.49.2.0607; BOLLENS SM, 1989, J PLANKTON RES, V11, P1047, DOI 10.1093/plankt/11.5.1047; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; CULLEN JJ, 1981, MAR BIOL, V62, P81, DOI 10.1007/BF00388169; DODSON S, 1988, LIMNOL OCEANOGR, V33, P1431, DOI 10.4319/lo.1988.33.6_part_2.1431; Dolan JR, 2001, J PLANKTON RES, V23, P1009, DOI 10.1093/plankt/23.9.1009; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Dyhrman ST, 2008, HARMFUL ALGAE, V8, P167, DOI 10.1016/j.hal.2008.08.016; Fredrickson KA, 2011, J PHYCOL, V47, P25, DOI 10.1111/j.1529-8817.2010.00942.x; Fredrickson KA, 2009, J PLANKTON RES, V31, P135, DOI 10.1093/plankt/fbn112; Fu F, 2012, MAR ECOL PR IN PRESS; Glibert Patricia M., 2005, Oceanography, V18, P136; Godhantaraman N, 2003, J PLANKTON RES, V25, P465, DOI 10.1093/plankt/25.5.465; Graham SL, 2010, AQUAT MICROB ECOL, V59, P111, DOI 10.3354/ame01391; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Haque SM, 2002, BOT MAR, V45, P356, DOI 10.1515/BOT.2002.036; Harvey EL, 2011, LIMNOL OCEANOGR, V56, P371, DOI 10.4319/lo.2011.56.1.0371; Hershberger PK, 1997, CAN J FISH AQUAT SCI, V54, P2228, DOI 10.1139/cjfas-54-10-2228; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Jakobsen HH, 2006, AQUAT MICROB ECOL, V44, P197, DOI 10.3354/ame044197; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; KAMYKOWSKI D, 1977, LIMNOL OCEANOGR, V22, P148, DOI 10.4319/lo.1977.22.1.0148; Kiorboe T, 2009, MECHANISTIC APPROACH; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lehrter JC, 1999, ESTUARIES, V22, P113, DOI 10.2307/1352932; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Long DL, 2007, PNAS, V104, P10512, DOI DOI 10.1073/PNAS.0611600104; Mcgillicuddy DJ, 2003, J PLANKTON RES, V25, P1131, DOI 10.1093/plankt/25.9.1131; Menden-Deuer S, 2006, LIMNOL OCEANOGR, V51, P109, DOI 10.4319/lo.2006.51.1.0109; Menden-Deuer S, 2010, HARMFUL ALGAE 2008, P98; Rensel JEJ, 2010, HARMFUL ALGAE, V10, P98, DOI 10.1016/j.hal.2010.07.005; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Selander E, 2011, P NATL ACAD SCI USA, V108, P4030, DOI 10.1073/pnas.1011870108; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Smayda T.J., 1998, PHYSL ECOLOGY HARMFU, P113; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; SMAYDA TJ, 1990, TOXIC MARINE PHYTOPLANKTON, P29; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Strom S, J PHYCOL IN PRESS; Strom SL, 2001, MAR BIOL, V138, P355, DOI 10.1007/s002270000461; TAYLOR FJR, 1993, DEV MAR BIO, V3, P705; Taylor G.I., 1921, P LOND MATH SOC, V20, P196, DOI [DOI 10.1112/PLMS/S2-20.1.196, 10.1112/plms/s2-20.1.196]; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; Titelman J, 2001, MAR ECOL PROG SER, V213, P203, DOI 10.3354/meps213203; TOMAS CR, 1978, J PHYCOL, V14, P309, DOI 10.1111/j.1529-8817.1978.tb00303.x; Utermohl V. H., 1931, VERH INT VEREIN THEO, V5, P567, DOI DOI 10.1080/03680770.1931.11898492; Van Dolah FM, 2001, HUM ECOL RISK ASSESS, V7, P1329; Van Donk E, 2007, ECOL INFORM, V2, P112, DOI 10.1016/j.ecoinf.2007.03.002; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; YIN KD, 1995, ESTUAR COAST SHELF S, V40, P505, DOI 10.1006/ecss.1995.0035; Yin KD, 1997, MAR ECOL PROG SER, V161, P173, DOI 10.3354/meps161173	57	41	41	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46438	10.1371/journal.pone.0046438	http://dx.doi.org/10.1371/journal.pone.0046438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029518	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900159
J	Liu, L; Cui, J; Song, CJ; Bian, JS; Sparatore, A; Del Soldato, P; Wang, XY; Yan, CD				Liu, Lei; Cui, Jie; Song, Cheng-Jie; Bian, Jin-Song; Sparatore, Anna; Del Soldato, Piero; Wang, Xin-Yu; Yan, Chang-Dong			H(2)S-Releasing Aspirin Protects against Aspirin-Induced Gastric Injury via Reducing Oxidative Stress	PLOS ONE			English	Article							HYDROGEN-SULFIDE PROTECTS; INHIBITS SUPEROXIDE FORMATION; CYSTATHIONINE GAMMA-LYASE; LOW-DOSE ASPIRIN; GASTROINTESTINAL COMPLICATIONS; SILDENAFIL ACS6; INDUCED DAMAGE; NADPH OXIDASE; RAT; CELLS	The aim of this study was to examine the effect of ACS14, a hydrogen sulfide (H2S)-releasing derivative of aspirin (Asp), on Asp-induced gastric injury. Gastric hemorrhagic lesions were induced by intragastric administration of Asp (200 mg/kg, suspended in 0.5% carboxymethyl cellulose solutions) in a volume of 1 ml/100 g body weight. ACS14 (1, 5 or 10 mg/kg) was given 30 min before the Asp administration. The total area of gastric erosions, H2S concentration and oxidative stress in gastric tissues were measured three hours after administration of Asp. Treatment with Asp (200 mg/kg), but not ACS14 (430 mg/kg, at equimolar doses to 200 mg/kg Asp), for 3 h significantly increased gastric mucosal injury. The damage caused by Asp was reversed by ACS14 at 1-10 mg/kg in a concentration-dependent manner. ACS14 abrogated Asp-induced upregulation of COX-2 expression, but had no effect on the reduced PGE(2) level. ACS14 reversed the decreased H2S concentrations and blood flow in the gastric tissue in Asp-treated rats. Moreover, ACS14 attenuated Asp-suppressed superoxide dismutase-1 (SOD-1) expression and GSH activity, suggesting that ACS14 may stimulate antioxidants in the gastric tissue. ACS14 also obviously inhibited Asp-induced upregulation of protein expression of oxidases including XOD, p47(phox) and p67(phox). In conclusion, ACS14 protects Asp induced gastric mucosal injury by inhibiting oxidative stress in the gastric tissue.	[Wang, Xin-Yu] Shenzhen Second Peoples Hosp, Dept Endocrinol, Shenzhen, Guangdong, Peoples R China; [Liu, Lei; Cui, Jie; Song, Cheng-Jie; Yan, Chang-Dong] Xuzhou Med Coll, Dept Physiol, Xuzhou, Jiangsu, Peoples R China; [Bian, Jin-Song] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, Milan, Italy; [Del Soldato, Piero] CTG Pharma, Milan, Italy	Second People's Hospital of Shenzhen; Xuzhou Medical University; National University of Singapore; University of Milan	Wang, XY (corresponding author), Shenzhen Second Peoples Hosp, Dept Endocrinol, Shenzhen, Guangdong, Peoples R China.	wangxy926@yahoo.com; yancd55@163.com	Sparatore, Anna/J-8634-2015	Sparatore, Anna/0000-0003-2135-2649; Bian, Jinsong/0000-0002-7741-598X	China National Science Fund in Jiangsu Province [BK2009088]; National Natural Science Foundation of China [30873055]	China National Science Fund in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from China National Science Fund in Jiangsu Province (BK2009088) and National Natural Science Foundation of China (30873055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JC, 2004, BRIT J CLIN PHARMACO, V58, P587, DOI 10.1111/j.1365-2125.2004.02198.x; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Blandizzi C, 2008, DRUG AGING, V25, P197, DOI 10.2165/00002512-200825030-00003; Blandizzi C, 2009, PHARMACOL RES, V59, P90, DOI 10.1016/j.phrs.2008.11.004; Brandes RP, 2008, CURR OPIN LIPIDOL, V19, P513, DOI 10.1097/MOL.0b013e32830c91e3; Brzozowski T, 2000, J PHYSIOL PHARMACOL, V51, P751; D'Argenio G, 2008, BRIT J NUTR, V100, P1228, DOI 10.1017/S0007114508988747; Davies NM, 1997, ALIMENT PHARM THERAP, V11, P1101, DOI 10.1046/j.1365-2036.1997.00247.x; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Devai I, 2002, ENVIRON TECHNOL, V23, P319, DOI 10.1080/09593332508618412; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Erdmann K, 2008, BIOCHEM BIOPH RES CO, V368, P937, DOI 10.1016/j.bbrc.2008.02.009; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Fiorucci S, 2002, GASTROENTEROLOGY, V123, P1598, DOI 10.1053/gast.2002.36558; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Giustarini D, 2010, FREE RADICAL BIO MED, V48, P1263, DOI 10.1016/j.freeradbiomed.2010.02.014; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hatazawa R, 2007, AM J PHYSIOL-GASTR L, V293, pG788, DOI 10.1152/ajpgi.00131.2007; Hu LF, 2008, PFLUG ARCH EUR J PHY, V455, P971, DOI 10.1007/s00424-007-0346-8; Hu LF, 2007, J NEUROCHEM, V100, P1121, DOI 10.1111/j.1471-4159.2006.04283.x; Hu LF, 2010, AGING CELL, V9, P135, DOI 10.1111/j.1474-9726.2009.00543.x; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Kimura H, 2010, AMINO ACIDS; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Konturek PC, 2008, J PHYSIOL PHARMACOL, V59, P67; Li JM, 2001, CARDIOVASC RES, V52, P477, DOI 10.1016/S0008-6363(01)00407-2; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Metwally NS, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-8; Mizuno H, 1997, GASTROENTEROLOGY, V112, P387, DOI 10.1053/gast.1997.v112.pm9024292; Muzaffar S, 2008, BRIT J PHARMACOL, V155, P984, DOI 10.1038/bjp.2008.326; Muzaffar S, 2008, J VASC RES, V45, P521, DOI 10.1159/000129686; Naesdall J, 2006, DRUG SAFETY, V29, P119; Osborne NN, 2010, INVEST OPHTH VIS SCI, V51, P284, DOI 10.1167/iovs.09-3999; Osborne NN, 2012, NEUROCHEM INT; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Pohle T, 2001, ALIMENT PHARM THER, V15, P677, DOI 10.1046/j.1365-2036.2001.00975.x; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rossoni G, 2010, EUR J PHARMACOL, V648, P139, DOI 10.1016/j.ejphar.2010.08.039; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sen U, 2011, AM J PHYSIOL-CELL PH, V300, pC155, DOI 10.1152/ajpcell.00143.2010; Shukla N, 2009, BJU INT, V103, P1522, DOI 10.1111/j.1464-410X.2009.08415.x; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Sparatore A, 2009, FREE RADICAL BIO MED, V46, P586, DOI 10.1016/j.freeradbiomed.2008.11.013; Suzuki T, 2008, J PHARMACOL SCI, V106, P469, DOI 10.1254/jphs.FP0071422; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Vacek TP, 2010, AMINO ACIDS, V39, P1161, DOI 10.1007/s00726-010-0550-2; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Wallace JL, 2007, BRIT J PHARMACOL, V152, P421, DOI 10.1038/sj.bjp.0707396; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhang QY, 2004, BIOCHEM BIOPH RES CO, V317, P30, DOI 10.1016/j.bbrc.2004.02.176	61	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46301	10.1371/journal.pone.0046301	http://dx.doi.org/10.1371/journal.pone.0046301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029468	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900127
J	Khan, JA; Bellance, C; Guiochon-Mantel, A; Lombes, M; Loosfelt, H				Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues			Differential Regulation of Breast Cancer-Associated Genes by Progesterone Receptor Isoforms PRA and PRB in a New Bi-Inducible Breast Cancer Cell Line	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; A-ISOFORM; HB-EGF; EXPRESSION; PHOSPHORYLATION; ESTROGEN; AMPHIREGULIN; TRANSCRIPTION; ALPHA	Progesterone receptor isoforms (PRA and PRB) are expressed at equal levels in normal mammary cells. However, alteration in PRA/PRB expression is often observed in aggressive breast cancer suggesting differential contribution of PR isoforms in carcinogenesis. The mechanisms underlying such processes remain to be established mainly due to paucity of appropriate cellular models. To investigate the role of PR isoforms and the impact of imbalanced PRA/PRB ratio in transcriptional regulation, we have generated an original human breast cancer cell line conditionally expressing PRA and/or PRB in dose-dependence of non-steroid inducers. We first focused on PR-dependent transcriptional regulation of the paracrine growth factor gene amphiregulin (AREG) playing important role in cancer. Interestingly, unliganded PRA increases AREG expression, independently of estrogen receptor, yet inhibitable by antiprogestins. We show that functional outcome of epidermal growth factor (EGF) on such regulation is highly dependent on PRA/PRB ratio. Using this valuable model, genome-wide transcriptomic studies allowed us to determine the differential effects of PRA and PRB as a function of hormonal status. We identified a large number of novel PR-regulated genes notably implicated in breast cancer and metastasis and demonstrated that imbalanced PRA/PRB ratio strongly impact their expression predicting poor outcome in breast cancer. In sum, our unique cell-based system strongly suggests that PRA/PRB ratio is a critical determinant of PR target gene selectivity and responses to hormonal/growth factor stimuli. These findings provide molecular support for the aggressive phenotype of breast cancers with impaired expression of PRA or PRB.	[Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues] INSERM, U693, F-94275 Le Kremlin Bicetre, France; [Khan, Junaid A.; Bellance, Catherine; Guiochon-Mantel, Anne; Lombes, Marc; Loosfelt, Hugues] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Guiochon-Mantel, Anne] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Khan, Junaid A.] Univ Agr Faisalabad, Dept Physiol & Pharmacol, Faisalabad, Pakistan	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of Agriculture Faisalabad	Loosfelt, H (corresponding author), INSERM, U693, F-94275 Le Kremlin Bicetre, France.	hugues.loosfelt@u-psud.fr	Khan, Junaid Ali/ABG-6129-2020; Khan, Junaid Ali/ABG-2756-2020; Khan, Junaid/AAE-3522-2019; Lombes, Marc/L-5933-2018; Guiochon-Mantel, Anne S/S-8408-2018	Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; Guiochon-Mantel, Anne S/0000-0003-1737-1409	Institut National de la Sante et de la Recherche Medicale (INSERM) France; Association de la Recherche contre le Cancer (ARC), France; Higher Education Commission, Islamabad, Pakistan; La Ligue Contre le Cancer, France; Conseil Regional de la Martinique	Institut National de la Sante et de la Recherche Medicale (INSERM) France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association de la Recherche contre le Cancer (ARC), France; Higher Education Commission, Islamabad, Pakistan(Higher Education Commission of Pakistan); La Ligue Contre le Cancer, France; Conseil Regional de la Martinique	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM) France (http://www.inserm.fr/), the Association de la Recherche contre le Cancer (ARC), France (http://www.arc-cancer.net). Junaid A. Khan was on study leave from the Department of Physiology and Pharmacology, University of Agriculture, Faisalabad and is a recipient of doctoral scholarship from Higher Education Commission, Islamabad, Pakistan, and a fellowship from La Ligue Contre le Cancer, France (http://www.ligue-cancer.net/). Catherine Bellance got a fellowship from the Conseil Regional de la Martinique (http://www.crmartinique.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafiz HA, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-10; Afhuppe W, 2009, J STEROID BIOCHEM, V113, P105, DOI 10.1016/j.jsbmb.2008.11.015; Amazit L, 2011, MOL ENDOCRINOL, V25, P394, DOI 10.1210/me.2010-0458; Arnett-Mansfield RL, 2001, CANCER RES, V61, P4576; Bagheri-Yarmand R, 2004, DEVELOPMENT, V131, P3469, DOI 10.1242/dev.01213; Bain DL, 2001, J BIOL CHEM, V276, P23825, DOI 10.1074/jbc.M102611200; Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Beck CA, 1996, J BIOL CHEM, V271, P1209, DOI 10.1074/jbc.271.2.1209; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; CHAUCHEREAU A, 1991, J BIOL CHEM, V266, P18280; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Clarke RB, 1997, CANCER RES, V57, P4987; Daniel AR, 2007, MOL ENDOCRINOL, V21, P2890, DOI 10.1210/me.2007-0248; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Daniel AR, 2009, P NATL ACAD SCI USA, V106, P14287, DOI 10.1073/pnas.0905118106; Desruisseau S, 2004, INT J CANCER, V111, P733, DOI 10.1002/ijc.20312; Faivre E, 2005, STEROIDS, V70, P418, DOI 10.1016/j.steroids.2005.02.012; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Graham JD, 1995, J BIOL CHEM, V270, P30693, DOI 10.1074/jbc.270.51.30693; GRAHAM JD, 1995, CANCER RES, V55, P5063; Groshong SD, 1997, MOL ENDOCRINOL, V11, P1593, DOI 10.1210/me.11.11.1593; Hagan CR, 2011, MOL CELL BIOL, V31, P2439, DOI 10.1128/MCB.01246-10; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; HORWITZ KB, 1992, ENDOCR REV, V13, P146, DOI 10.1210/er.13.2.146; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Jacobsen BM, 2003, J MAMMARY GLAND BIOL, V8, P257, DOI 10.1023/B:JOMG.0000010028.48159.84; Jacobsen BM, 2002, J BIOL CHEM, V277, P27793, DOI 10.1074/jbc.M202584200; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan JA, 2011, MOL ENDOCRINOL, V25, P394; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Leo JCL, 2005, INT J CANCER, V117, P561, DOI 10.1002/ijc.21186; Leonhardt SA, 1998, MOL ENDOCRINOL, V12, P1914, DOI 10.1210/me.12.12.1914; Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559; Lin VCL, 1999, CLIN CANCER RES, V5, P395; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mani SK, 2006, MOL ENDOCRINOL, V20, P1322, DOI 10.1210/me.2005-0466; Mani SK, 1996, MOL ENDOCRINOL, V10, P1728, DOI 10.1210/me.10.12.1728; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; McGowan EM, 2004, BREAST CANCER RES TR, V83, P211, DOI 10.1023/B:BREA.0000014041.58977.80; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; Mote PA, 2008, ERNST SCHERING FOUND, V1, P77, DOI 10.1007/2789_2008_076; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Mote PA, 2004, GENE CHROMOSOME CANC, V39, P236, DOI 10.1002/gcc.10321; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; MUSGROVE EA, 1991, MOL CELL BIOL, V11, P5032, DOI 10.1128/MCB.11.10.5032; Narayanan R, 2005, MOL CELL BIOL, V25, P2885, DOI 10.1128/MCB.25.8.2885-2898.2005; Narayanan R, 2005, MOL CELL BIOL, V25, P264, DOI 10.1128/MCB.25.1.264-277.2005; Palli SR, 2003, EUR J BIOCHEM, V270, P1308, DOI 10.1046/j.1432-1033.2003.03501.x; Peng J, 2010, INT J ONCOL, V36, P451, DOI 10.3892/ijo_00000519; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Punglia RS, 2006, CANCER-AM CANCER SOC, V106, P2576, DOI 10.1002/cncr.21919; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Shyamala G, 1998, P NATL ACAD SCI USA, V95, P696, DOI 10.1073/pnas.95.2.696; Smid-Koopman E, 2005, J SOC GYNECOL INVEST, V12, P285, DOI 10.1016/j.jsgi.2005.01.003; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wargon V, 2011, BREAST CANCER RES TR, V126, P319, DOI 10.1007/s10549-010-0908-x; Wargon V, 2009, BREAST CANCER RES TR, V116, P449, DOI 10.1007/s10549-008-0150-y; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015; ZHANG ZM, 1994, ENDOCRINOLOGY, V134, P1089, DOI 10.1210/en.134.3.1089	82	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45993	10.1371/journal.pone.0045993	http://dx.doi.org/10.1371/journal.pone.0045993			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029355	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700102
J	Machida, T; Ishibashi, A; Kirino, A; Sato, J; Kawasaki, S; Niimura, Y; Honjoh, K; Miyamoto, T				Machida, Takeshi; Ishibashi, Akiko; Kirino, Ai; Sato, Jun-ichi; Kawasaki, Shinji; Niimura, Youichi; Honjoh, Ken-ichi; Miyamoto, Takahisa			Chloroplast NADPH-Dependent Thioredoxin Reductase from Chlorella vulgaris Alleviates Environmental Stresses in Yeast Together with 2-Cys Peroxiredoxin	PLOS ONE			English	Article							REACTION-MECHANISM; OXIDATIVE STRESS; REDOX SYSTEM; EXPRESSION; CELLS; PROTECTION; PROTEINS; NTRC	Chloroplast NADPH-dependent thioredoxin reductase (NTRC) catalyzes the reduction of 2-Cys peroxiredoxin (2-Cys Prx) and, thus, probably functions as an antioxidant system. The functions of the enzyme in oxidative and salt stresses have been reported previously. We have previously identified and characterized NTRC in Chlorella vulgaris. In the present study, we isolated a full-length cDNA clone encoding 2-Cys Prx from C. vulgaris and investigated the involvement of Chlorella NTRC/2-Cys Prx system in several environmental stress tolerances by using yeast as a eukaryotic model. Deduced Chlorella 2-Cys Prx was homologous to those of chloroplast 2-Cys Prxs from plants, and two conserved cysteine residues were found in the deduced sequence. Enzyme assay showed that recombinant mature C. vulgaris NTRC (mCvNTRC) transferred electrons from NADPH to recombinant mature C. vulgaris 2-Cys Prx (mCvPrx), and mCvPrx decomposed hydrogen peroxide, tert-butyl hydroperoxide, and peroxynitrite by cooperating with mCvNTRC. Based on the results, the mCvNTRC/mCvPrx antioxidant system was identified in Chlorella. The antioxidant system genes were expressed in yeast separately or coordinately. Stress tolerances of yeast against freezing, heat, and menadione-induced oxidative stresses were significantly improved by expression of mCvNTRC, and the elevated tolerances were more significant when both mCvNTRC and mCvPrx were co-expressed. Our results reveal a novel feature of NTRC: it functions as an antioxidant system with 2-Cys Prx in freezing and heat stress tolerances.	[Machida, Takeshi; Honjoh, Ken-ichi; Miyamoto, Takahisa] Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol, Fukuoka 812, Japan; [Machida, Takeshi] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Japan; [Ishibashi, Akiko; Kirino, Ai] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch Bioresource & Bioenvironm Sci, Fukuoka 812, Japan; [Sato, Jun-ichi; Kawasaki, Shinji; Niimura, Youichi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan	Kyushu University; Fukushima Medical University; Kyushu University; Tokyo University of Agriculture	Honjoh, K (corresponding author), Kyushu Univ, Fac Agr, Grad Sch, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	honjoh@agr.kyushu-u.ac.jp		Kawasaki, Shinji/0000-0001-8225-4431	Japan Society for the Promotion of Science (JSPS) [20580135, 08J02023]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (no. 20580135) from the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/e-grants/index.html). T. Machida was supported by a Grant-in-Aid for JSPS Fellows (no. 08J02023) from JSPS. JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for financial support.	Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Cheong NE, 1999, PLANT MOL BIOL, V40, P825, DOI 10.1023/A:1006271823973; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; FLORENCIO FJ, 1988, ARCH BIOCHEM BIOPHYS, V266, P496, DOI 10.1016/0003-9861(88)90282-2; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; HUPPE HC, 1990, PLANTA, V180, P341, DOI 10.1007/BF01160389; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kim KH, 2010, BIOTECHNOL LETT, V32, P571, DOI 10.1007/s10529-009-0185-0; Kim MD, 2011, PLANT PHYSIOL BIOCH, V49, P891, DOI 10.1016/j.plaphy.2011.04.001; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Machida T, 2008, PLANT SCI, V175, P238, DOI 10.1016/j.plantsci.2008.04.002; Machida T, 2009, BIOSCI BIOTECH BIOCH, V73, P695, DOI 10.1271/bbb.80761; Perez-Ruiz JM, 2009, FEBS LETT, V583, P1399, DOI 10.1016/j.febslet.2009.03.067; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Moon JC, 2006, BIOCHEM BIOPH RES CO, V348, P478, DOI 10.1016/j.bbrc.2006.07.088; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Pulido P, 2009, PLANT J, V57, P132, DOI 10.1111/j.1365-313X.2008.03675.x; Rouhanizadeh M, 2008, METHOD ENZYMOL, V441, P111, DOI 10.1016/S0076-6879(08)01207-X; Sakamoto A, 2003, PLANT J, V33, P841, DOI 10.1046/j.1365-313X.2003.01669.x; Serrato AJ, 2004, J BIOL CHEM, V279, P43821, DOI 10.1074/jbc.M404696200; Stenbaek A, 2008, FEBS LETT, V582, P2773, DOI 10.1016/j.febslet.2008.07.006; Takeda K, 2004, BIOSCI BIOTECH BIOCH, V68, P20, DOI 10.1271/bbb.68.20; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8	29	7	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45988	10.1371/journal.pone.0045988	http://dx.doi.org/10.1371/journal.pone.0045988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029353	gold, Green Submitted, Green Published			2022-12-25	WOS:000309554700101
J	Yanashima, R; Garcia, AA; Aldridge, J; Weiss, N; Hayes, MA; Andrews, JH				Yanashima, Ryan; Garcia, Antonio A.; Aldridge, James; Weiss, Noah; Hayes, Mark A.; Andrews, James H.			Cutting a Drop of Water Pinned by Wire Loops Using a Superhydrophobic Surface and Knife	PLOS ONE			English	Article							LIQUID; ACTUATION; BREAKUP	A water drop on a superhydrophobic surface that is pinned by wire loops can be reproducibly cut without formation of satellite droplets. Drops placed on low-density polyethylene surfaces and Teflon-coated glass slides were cut with superhydrophobic knives of low-density polyethylene and treated copper or zinc sheets, respectively. Distortion of drop shape by the superhydrophobic knife enables a clean break. The driving force for droplet formation arises from the lower surface free energy for two separate drops, and it is modeled as a 2-D system. An estimate of the free energy change serves to guide when droplets will form based on the variation of drop volume, loop spacing and knife depth. Combining the cutting process with an electrofocusing driving force could enable a reproducible biomolecular separation without troubling satellite drop formation.	[Garcia, Antonio A.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Yanashima, Ryan; Weiss, Noah; Hayes, Mark A.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Aldridge, James; Andrews, James H.] Youngstown State Univ, Dept Phys & Astron, Youngstown, OH 44555 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Ohio; Youngstown State University	Garcia, AA (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	tony.garcia@asu.edu			National Science Foundation [CBET 0925100]; National Institutes of Health [1R03AI094193-01, 1R03AI099740-01, 5R21EB010191-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI094193, R03AI099740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB010191] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Science Foundation grant CBET 0925100, and National Institutes of Health grants 1R03AI094193-01, 1R03AI099740-01, and 5R21EB010191-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bormashenko E, 2011, LANGMUIR, V27, P3266, DOI 10.1021/la200258u; BOYS CV, 1959, SOAP BUBBLES THEIR C; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Chuech SG, 2006, INT J NUMER METH FL, V52, P1159, DOI 10.1002/fld.1226; Darhuber AA, 2005, ANNU REV FLUID MECH, V37, P425, DOI 10.1146/annurev.fluid.36.050802.122052; Das TK, 1997, ATOMIZATION SPRAY, V7, P549, DOI 10.1615/AtomizSpr.v7.i5.70; Egatz-Gomez A, 2007, APPL SURF SCI, V254, P330, DOI 10.1016/j.apsusc.2007.07.121; Larmour IA, 2007, ANGEW CHEM INT EDIT, V46, P1710, DOI 10.1002/anie.200604596; Nakajima A, 2011, NPG ASIA MATER, V3, P49, DOI 10.1038/asiamat.2011.55; PAPAGEORGIOU DT, 1995, PHYS FLUIDS, V7, P1529, DOI 10.1063/1.868540; Rayleigh L., 1892, DUBLIN PHILOS MAG J, V34, P145, DOI DOI 10.1080/14786449208620301; Roach P, 2008, SOFT MATTER, V4, P224, DOI 10.1039/b712575p; SCHULKES RMSM, 1994, J FLUID MECH, V278, P83, DOI 10.1017/S0022112094003629; Shapiro B, 2003, J APPL PHYS, V93, P5794, DOI 10.1063/1.1563828; TJAHJADI M, 1992, J FLUID MECH, V243, P297, DOI 10.1017/S0022112092002738; Tomotika S, 1936, PROC R SOC LON SER-A, V153, P0302, DOI 10.1098/rspa.1936.0003; Weiss NG, 2011, LANGMUIR, V27, P494, DOI 10.1021/la104085t; Xue CH, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/3/033002	18	19	19	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45893	10.1371/journal.pone.0045893	http://dx.doi.org/10.1371/journal.pone.0045893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029297	Green Published, gold			2022-12-25	WOS:000309554700086
J	Arendt, JFB; Nexo, E				Arendt, Johan F. B.; Nexo, Ebba			Cobalamin Related Parameters and Disease Patterns in Patients with Increased Serum Cobalamin Levels	PLOS ONE			English	Article							TRANSCOBALAMIN LEVELS; HOLO-TRANSCOBALAMIN; TRANSPORT PROTEINS; VITAMIN-B12; PLASMA; HAPTOCORRIN; FOLATE; QUANTIFICATION; ASSOCIATION; CELLS	Background: Measurement of serum cobalamin levels is routinely used to diagnose cobalamin deficiency. Surprisingly, approximately 15% of patients have high cobalamin levels and no consensus exists regarding the clinical implications. Methods: Hospital-treated patients above 18 years of age referred for serum cobalamin measurement were included in groups of patients [percentage cobalamin supplemented] with low (<200 pmol/L, n = 200 [6%]), normal (200-600, n = 202 [6%]) high (601-1000, n = 217 [27%]) and very high (>1000, n = 199 [53%]) cobalamin levels. Total and cobalamin-saturated (holo) transcobalamin, total haptocorrin, soluble TC receptor, sCD320, and methylmalonic acid were analyzed. Data on diagnoses and medical prescriptions was obtained through medical files and the Aarhus University Prescription Database. Results: Among patients not cobalamin supplemented median total haptocorrin and holo transcobalamin levels were markedly higher in the groups with high/very high cobalamin levels compared to groups with low/normal cobalamin levels. Median total transcobalamin and sCD320 levels were similar across the groups. A number of diagnoses were significantly associated to very high Cbl levels (odds ratio (95% confidence interval)): alcoholism (5.74 (2.76-11.96)), liver disease (8.53 (3.59-20.23)), and cancer (5.48 (2.85-10.55)). Elevated haptocorrin levels were seen in patients with alcoholism, cancer, liver-, renal-, autoimmune-, and bronchopulmonary disease. No clinical associations to sCD320 and total and holo transcobalamin levels were found. Conclusion: In non-supplemented patients, high cobalamin levels were associated to high haptocorrin levels, and several diagnoses, including alcoholism, liver disease and cancer. Our study emphasizes that clinicians should take high serum cobalamin levels into consideration in the diagnostic process.	[Arendt, Johan F. B.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	Aarhus University	Arendt, JFB (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	johan.frederik.berg.arendt@sun.au.dk		Arendt, Johan Frederik Hakonsen/0000-0003-4423-4813; Nexo, Ebba/0000-0001-9406-9081	Faculty of Health, Aarhus University; Danish Medical Research Council; Lundbeck Foundation	Faculty of Health, Aarhus University; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by: the Faculty of Health, Aarhus University (www.health.au.dk); Danish Medical Research Council (www.fi.dk/raad-og-udvalg/det-frie-forskningsraad/om-dff/faglige-raad/sundhed-og-sygdom) and the Lundbeck Foundation (www.lundbeckfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGASAKI T, 1990, BLOOD, V76, P1380; Arendt JFB, 2012, CLIN CHEM LAB MED, V50, P515, DOI 10.1515/CCLM.2011.810; ARNALICH F, 1990, BRIT J RHEUMATOL, V29, P171; ARNALICH F, 1990, J MED, V21, P277; Baker H, 1998, J AM COLL NUTR, V17, P235, DOI 10.1080/07315724.1998.10718752; Boisson F, 1999, CANCER DETECT PREV, V23, P89, DOI 10.1046/j.1525-1500.1999.09914.x; BOUDES P, 1990, LANCET, V335, P1401, DOI 10.1016/0140-6736(90)91279-J; CARMEL R, 1977, CANCER-AM CANCER SOC, V40, P1348, DOI 10.1002/1097-0142(197709)40:3<1348::AID-CNCR2820400352>3.0.CO;2-Q; Carmel R, 2001, CLIN LAB HAEMATOL, V23, P365, DOI 10.1046/j.1365-2257.2001.00134.x; Chiche L, 2008, REV MED INTERNE, V29, P187, DOI 10.1016/j.revmed.2007.07.007; Collin SM, 2010, CANCER EPIDEM BIOMAR, V19, P1632, DOI 10.1158/1055-9965.EPI-10-0180; COLTMAN C A JR, 1975, Medical and Pediatric Oncology, V1, P185, DOI 10.1002/mpo.2950010302; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Ermens AAM, 2003, CLIN BIOCHEM, V36, P585, DOI 10.1016/j.clinbiochem.2003.08.004; FREMONT S, 1991, TUMOR BIOL, V12, P353, DOI 10.1159/000217736; GIMSING P, 1995, LEUKEMIA, V9, P1604; GIMSING P, 1995, BRIT J HAEMATOL, V89, P812; HALL CA, 1984, J LAB CLIN MED, V103, P70; HALL CA, 1964, NATURE, V204, P1207, DOI 10.1038/2041207a0; HALL CA, 1969, J LAB CLIN MED, V73, P60; Hvas AM, 2006, HAEMATOLOGICA, V91, P1506; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lildballe DL, 2011, CLIN CHEM, V57, P1436, DOI 10.1373/clinchem.2011.165944; Lildballe DL, 2009, CLIN CHEM LAB MED, V47, P182, DOI 10.1515/CCLM.2009.047; Lin CY, 2010, NUTR CANCER, V62, P190, DOI 10.1080/01635580903305334; LINDEMANS J, 1989, EXP CELL RES, V184, P449, DOI 10.1016/0014-4827(89)90343-1; Malik ZA, 2009, AIDS, V23, P403, DOI 10.1097/QAD.0b013e32831ef4f7; Morkbak AL, 2005, CLIN CHIM ACTA, V356, P184, DOI 10.1016/j.cccn.2005.01.013; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Nexo E, 2000, CLIN CHEM, V46, P1643; Nexo E, 2002, CLIN CHEM, V48, P561; REMACHA AF, 1993, HAEMATOLOGICA, V78, P84; RULE SAJ, 1994, AM J HEMATOL, V47, P167, DOI 10.1002/ajh.2830470304; VREUGDENHIL G, 1992, J INTERN MED, V231, P547, DOI 10.1111/j.1365-2796.1992.tb00972.x	35	53	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45979	10.1371/journal.pone.0045979	http://dx.doi.org/10.1371/journal.pone.0045979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029349	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800128
J	Lee, YL; Peng, Q; Fong, SW; Chen, ACH; Lee, KF; Ng, EHY; Nagy, A; Yeung, WSB				Lee, Yin Lau; Peng, Qian; Fong, Sze Wan; Chen, Andy C. H.; Lee, Kai Fai; Ng, Ernest H. Y.; Nagy, Andras; Yeung, William S. B.			Sirtuin 1 Facilitates Generation of Induced Pluripotent Stem Cells from Mouse Embryonic Fibroblasts through the miR-34a and p53 Pathways	PLOS ONE			English	Article							REGULATES APOPTOSIS; DNA-DAMAGE; DIFFERENTIATION; EXPRESSION; RESVERATROL; INDUCTION; TROPHOBLAST; DEACETYLASE; ACTIVATION; INHIBITION	Forced-expression of transcription factors can reprogram somatic cells into induced pluripotent stem cells (iPSC). Recent studies show that the reprogramming efficiency can be improved by inclusion of small molecules that regulate chromatin modifying enzymes. We report here that sirtuin 1 (SIRT1), a member of the sirtuin family of NAD(+)-dependent protein deacetylases, is involved in iPSC formation. By using an efficient mouse secondary fibroblast reprogramming system with doxycycline (DOX) inducible Yamanaka's transcription factors delivered by piggyBac (PB) transposition (2 degrees F/1B MEF), we show that SIRT1 knockdown decreased while resveratrol (RSV) increased the efficiency of iPSC formation. The treatments were associated with altered acetylated p53 and its downstream Nanog but not p21 expression. The stimulatory effect was also confirmed by SIRT1 over-expression, which stimulated the formation of colonies with induced Nanog and reduced p21 expression. Furthermore, the effects of RSV and SIRT1 knockdown on reprogramming were most pronounced during the initiation phase of reprogramming. MicroRNA-34a is a known regulator of SIRT1. Its inhibitor increased, while its mimics reduced iPSC formation. The stimulatory effect of SIRT1 during reprogramming was also confirmed in the primary MEF. RSV increased while tenovin-6, a small molecule that activates p53 through SIRT1 inhibition, suppressed reprogramming. In conclusion, SIRT1 enhances iPSC generation, in part, through deacetylation of p53, inhibition of p21 and enhancement of Nanog expression.	[Lee, Yin Lau; Peng, Qian; Fong, Sze Wan; Chen, Andy C. H.; Lee, Kai Fai; Ng, Ernest H. Y.; Yeung, William S. B.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Nagy, Andras] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Hong Kong; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Yeung, WSB (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	wsbyeung@hkucc.hku.hk	Nagy, Andras/G-6465-2013; Lee, Calvin Kai Fai/C-4328-2009; Lee, Yin Lau/C-4639-2009	Nagy, Andras/0000-0003-4311-0413; Ng, Ernest/0000-0002-7688-4557; Lee, Calvin Kai Fai/0000-0001-5957-439X; Lee, Yin Lau/0000-0003-0559-4381	General Research Fund from the Research Grant Council, Hong Kong [HKU775711M]; Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong	General Research Fund from the Research Grant Council, Hong Kong; Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong	This work was supported by the General Research Fund (HKU775711M) from the Research Grant Council, Hong Kong (http://www.ugc.edu.hk/cgi-bin/ugc/search_project.pl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kristina Nagy and Peter Tonge for their input on the study. We also thank the support from the Stem Cell and Regenerative Medicine Consortium (SCRMC), The University of Hong Kong.	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brooks CL, 2008, CANCER CELL, V13, P377, DOI 10.1016/j.ccr.2008.04.009; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Camins A, 2010, BIOCH BIOPHYS ACTA; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Golos TG, 2006, SEMIN REPROD MED, V24, P314, DOI 10.1055/s-2006-952154; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haider UGB, 2002, MOL PHARMACOL, V62, P772, DOI 10.1124/mol.62.4.772; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Honda A, 2010, J BIOL CHEM; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Liang GY, 2010, J BIOL CHEM, V285, P25516, DOI 10.1074/jbc.M110.142059; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nagy K, 2011, STEM CELL REV REP, V7, P693, DOI 10.1007/s12015-011-9239-5; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Olson ER, 2005, AM J PHYSIOL-HEART C, V288, pH1131, DOI 10.1152/ajpheart.00763.2004; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng HF, 2010, J CELL BIOCHEM, V110, P995, DOI 10.1002/jcb.22613; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	56	38	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45633	10.1371/journal.pone.0045633	http://dx.doi.org/10.1371/journal.pone.0045633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029150	Green Published, gold			2022-12-25	WOS:000309392800071
J	Amini, P; Wadden, D; Cahill, F; Randell, E; Vasdev, S; Chen, XH; Gulliver, W; Zhang, WZ; Zhang, HW; Yi, YQ; Sun, G				Amini, Peyvand; Wadden, Danny; Cahill, Farrell; Randell, Edward; Vasdev, Sudesh; Chen, Xihua; Gulliver, Wayne; Zhang, Weizhen; Zhang, Hongwei; Yi, Yanqing; Sun, Guang			Serum Acylated Ghrelin Is Negatively Correlated with the Insulin Resistance In the CODING study	PLOS ONE			English	Article							PLASMA GHRELIN; CIRCULATING GHRELIN; METABOLIC SYNDROME; DIABETES-MELLITUS; HUMANS; GLUCOSE; SENSITIVITY; SECRETION; HOMEOSTASIS; PREVALENCE	Objective: Ghrelin is a 28-amino acid orexigenic peptide synthesized mainly in the stomach. Acute administration of ghrelin has been found to decrease insulin secretion. However, little data is available regarding whether ghrelin contributes to the long-term regulation of insulin resistance at the population level. The aim of this study is to investigate the association between circulating ghrelin and insulin resistance in a large population based study. Design: A total of 2082 CODING study (Complex Diseases in the Newfoundland population: Environment and Genetics) subjects were assessed. Subjects were of at least third generation Newfoundland descent, between the ages of 20 and 79 years, and had no serious metabolic, cardiovascular, or endocrine diseases. Ghrelin was measured with an Enzyme Immunoassay method. Insulin and fasting glucose were measured by Immulite 2500 autoanalyzer and Lx20 clinical chemistry analyzer, respectively. Homeostatic Model Assessment of beta cell function (HOMA-beta) and Insulin Resistance (HOMA-IR) and Quantitative Insulin-sensitivity Check Index (QUICKI) were used for measurement of insulin resistance. Results: Partial correlation analyses showed a significant negative correlation between circulating ghrelin and insulin level and insulin resistance in the entire cohort and also in men and women separately. The aforementioned correlation was independent of age, percentage of trunk fat and HDL-cholesterol. According to menopausal status, only pre-menopausal women revealed negative correlations. Conclusion: Our results suggest that except for postmenopausal women, high circulating ghrelin level is associated with lower insulin resistance in the general population.	[Amini, Peyvand; Wadden, Danny; Cahill, Farrell; Vasdev, Sudesh; Gulliver, Wayne; Zhang, Hongwei; Yi, Yanqing; Sun, Guang] Mem Univ Newfoundland, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada; [Chen, Xihua] Mem Univ Newfoundland, Div Biomed Sci, St John, NF, Canada; [Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Peking University	Sun, G (corresponding author), Mem Univ Newfoundland, Div Med, St John, NF, Canada.	gsun@mun.ca	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798	Canadian Institutes for Health Research (CIHR) [MOP192552]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (CIHR) grant number MOP192552 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Barazzoni R, 2007, J CLIN ENDOCR METAB, V92, P3935, DOI 10.1210/jc.2006-2527; Beaumont NJ, 2003, J BIOL CHEM, V278, P8877, DOI 10.1074/jbc.C200575200; Bennett NR, 2009, CLIN ENDOCRINOL, V70, P408, DOI 10.1111/j.1365-2265.2008.03344.x; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Cano SC, 2012, CNS DRUGS, V26, P281, DOI 10.2165/11599890-000000000-00000; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Chacko SK, 2012, AM J PHYSL ENDOCRINO; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Dezaki K, 2007, DIABETES, V56, P2319, DOI 10.2337/db07-0345; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; International Diabetes Federation (IDF), 2011, GLOB BURD; Kalish GM, 2003, J CLIN ENDOCR METAB, V88, P1646, DOI 10.1210/jc.2002-021375; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Laferrere B, 2011, INT J OBESITY, V35, pS22, DOI 10.1038/ijo.2011.143; Longo KA, 2011, J PHARMACOL EXP THER, V339, P115, DOI 10.1124/jpet.111.183764; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ozgen IT, 2010, J PEDIATR ADOL GYNEC, V23, P285, DOI 10.1016/j.jpag.2010.02.011; Paik KH, 2004, J CLIN ENDOCR METAB, V89, P3885, DOI 10.1210/jc.2003-032137; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Purnell JQ, 2003, J CLIN ENDOCR METAB, V88, P5747, DOI 10.1210/jc.2003-030513; Qader SS, 2005, REGUL PEPTIDES, V128, P51, DOI 10.1016/j.regpep.2004.12.018; Schofield CJ, 2012, DIABET MED; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Soni AC, 2011, MENOPAUSE, V18, P296, DOI 10.1097/gme.0b013e3181f2e611; Sun YX, 2007, NEUROENDOCRINOLOGY, V86, P215, DOI 10.1159/000109094; Tong J, 2010, DIABETES, V59, P2145, DOI 10.2337/db10-0504; Toshinai Koji, 2007, Clin Calcium, V17, P1392; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Vartiainen J, 2010, J ENDOCRINOL INVEST, V33, P496, DOI [10.1007/BF03346631, 10.3275/6861]; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Wells T, 2009, PROG LIPID RES, V48, P257, DOI 10.1016/j.plipres.2009.04.002; WHO, 2006, DEF DIGN DIAB MELL I	40	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45657	10.1371/journal.pone.0045657	http://dx.doi.org/10.1371/journal.pone.0045657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029165	Green Accepted, Green Published, gold			2022-12-25	WOS:000309388900087
J	Sakai, H; Takahara, M; Honjo, NF; Doi, S; Sadato, N; Uchiyama, Y				Sakai, Hiroyuki; Takahara, Miwa; Honjo, Naomi F.; Doi, Shun'ichi; Sadato, Norihiro; Uchiyama, Yuji			Regional Frontal Gray Matter Volume Associated with Executive Function Capacity as a Risk Factor for Vehicle Crashes in Normal Aging Adults	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER-ADULTS; INDIVIDUAL-DIFFERENCES; ATTENTIONAL NETWORKS; ACCIDENT INVOLVEMENT; RESPONSE-INHIBITION; ACTION SELECTION; GO/NO-GO; MEMORY; MRI	Although low executive functioning is a risk factor for vehicle crashes among elderly drivers, the neural basis of individual differences in this cognitive ability remains largely unknown. Here we aimed to examine regional frontal gray matter volume associated with executive functioning in normal aging individuals, using voxel-based morphometry (VBM). To this end, 39 community-dwelling elderly volunteers who drove a car on a daily basis participated in structural magnetic resonance imaging, and completed two questionnaires concerning executive functioning and risky driving tendencies in daily living. Consequently, we found that participants with low executive function capacity were prone to risky driving. Furthermore, VBM analysis revealed that lower executive function capacity was associated with smaller gray matter volume in the supplementary motor area (SMA). Thus, the current data suggest that SMA volume is a reliable predictor of individual differences in executive function capacity as a risk factor for vehicle crashes among elderly persons. The implication of our results is that regional frontal gray matter volume might underlie the variation in driving tendencies among elderly drivers. Therefore, detailed driving behavior assessments might be able to detect early neurodegenerative changes in the frontal lobe in normal aging adults.	[Sakai, Hiroyuki; Uchiyama, Yuji] Toyota Cent Res & Dev Labs Inc, Informat & Elect Res Div, Nagakute, Aichi 48011, Japan; [Takahara, Miwa] Aichi Shukutoku Univ, Dept Human Informat, Nagakute, Aichi, Japan; [Honjo, Naomi F.] Osaka Neurosurg Hosp, Dept Radiol, Takamatsu, Kagawa, Japan; [Doi, Shun'ichi] Kagawa Univ, Div Intelligent Mech Syst Engn, Takamatsu, Kagawa 760, Japan; [Sadato, Norihiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan	Toyota Central R&D Labs Inc; Aichi Shukutoku University; Kagawa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Sakai, H (corresponding author), Toyota Cent Res & Dev Labs Inc, Informat & Elect Res Div, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	sakai@mosk.tytlabs.co.jp	Uchiyama, Yuji/GVS-0186-2022	Uchiyama, Yuji/0000-0003-1581-8668; Sadato, Norihiro/0000-0002-9786-3907	Toyota Central Research and Development Laboratories, Inc.	Toyota Central Research and Development Laboratories, Inc.	This work was carried out under the financial support of Toyota Central Research and Development Laboratories, Inc., which is funded by its stockholding companies (http://www.tytlabs.co.jp/english/comp/outline02.html). The funders had no role in the study design, data collection and analysis, and the decision to publish.	Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ball K, 1993, J Am Optom Assoc, V64, P71; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; de Toledo-Morrell L, 2000, HIPPOCAMPUS, V10, P136, DOI 10.1002/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J; de Winter JCF, 2010, J SAFETY RES, V41, P463, DOI 10.1016/j.jsr.2010.10.007; DEWEER B, 1995, J NEUROL NEUROSUR PS, V58, P590, DOI 10.1136/jnnp.58.5.590; Duarte A, 2006, NEUROSCI LETT, V406, P60, DOI 10.1016/j.neulet.2006.07.029; Elderkin-Thompson V, 2008, NEUROPSYCHOLOGY, V22, P626, DOI 10.1037/0894-4105.22.5.626; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Floden D, 2006, J COGNITIVE NEUROSCI, V18, P1843, DOI 10.1162/jocn.2006.18.11.1843; Forstmann BU, 2008, J COGNITIVE NEUROSCI, V20, P1854, DOI 10.1162/jocn.2008.20122; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Jack CR, 1997, NEUROLOGY, V49, P786, DOI 10.1212/WNL.49.3.786; Kanai R, 2011, NAT REV NEUROSCI, V31, P6620; Kanai R, 2011, CURR BIOL, V21, pR106, DOI [10.1016/j.cub.2010.12.009, 10.1016/j.cub.2011.03.017]; Kanai R, 2010, CURR BIOL, V20, P1626, DOI 10.1016/j.cub.2010.07.027; Kohler S, 1998, NEUROPSYCHOLOGIA, V36, P901, DOI 10.1016/S0028-3932(98)00017-7; Komada Y, 2009, IATSS REV, V34, P106; Kopelman MD, 2001, J NEUROL NEUROSUR PS, V71, P23, DOI 10.1136/jnnp.71.1.23; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; Lucidi F, 2010, ACCIDENT ANAL PREV, V42, P1689, DOI 10.1016/j.aap.2010.04.008; Mesken J, 2002, ERGONOMICS, V45, P469, DOI 10.1080/00140130210129682; Mungas D, 2002, NEUROLOGY, V59, P867, DOI 10.1212/WNL.59.6.867; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; OWSLEY C, 1994, OPTOMETRY VISION SCI, V71, P727, DOI 10.1097/00006324-199412000-00002; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Ozkan T, 2006, ACCIDENT ANAL PREV, V38, P386, DOI 10.1016/j.aap.2005.10.012; Parker D, 2000, ACCIDENT ANAL PREV, V32, P751, DOI 10.1016/S0001-4575(99)00125-6; PARKER D, 1995, ERGONOMICS, V38, P1036, DOI 10.1080/00140139508925170; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Schwebel DC, 2007, J SAFETY RES, V38, P501, DOI 10.1016/j.jsr.2007.04.005; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P382, DOI 10.1162/jocn.2010.21444; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1313, DOI 10.1016/j.neuropsychologia.2004.02.009; Westlye LT, 2011, CEREB CORTEX, V21, P345, DOI 10.1093/cercor/bhq101; Yamagata S, 2005, TWIN RES HUM GENET, V8, P300, DOI 10.1375/1832427054936790	52	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45920	10.1371/journal.pone.0045920	http://dx.doi.org/10.1371/journal.pone.0045920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029316	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388400136
J	Cox, N; Pilling, D; Gomer, RH				Cox, Nehemiah; Pilling, Darrell; Gomer, Richard H.			NaCl Potentiates Human Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM AMYLOID-P; COLONY-STIMULATING FACTORS; DIETARY-SODIUM INTAKE; AMINO-ACID-TRANSPORT; HYPERTONIC SALINE; SALT INTAKE; MONOCYTE DIFFERENTIATION; CIRCULATING FIBROCYTES; PULMONARY-FIBROSIS; CHLORIDE CHANNELS	Excessive NaCl intake is associated with a variety of fibrosing diseases such as renal and cardiac fibrosis. This association has been attributed to increased blood pressure as the result of high NaCl intake. However, studies in patients with high NaCl intake and fibrosis reveal a connection between NaCl intake and fibrosis that is independent of blood pressure. We find that increasing the extracellular concentration of NaCl to levels that may occur in human blood after high-salt intake can potentiate, in serum-free culture conditions, the differentiation of freshly-isolated human monocytes into fibroblast-like cells called fibrocytes. NaCl affects the monocytes directly during their adhesion. Potassium chloride and sodium nitrate also potentiate fibrocyte differentiation. The plasma protein Serum Amyloid P (SAP) inhibits fibrocyte differentiation. High levels of extracellular NaCl change the SAP Hill coefficient from 1.7 to 0.8, and cause a four-fold increase in the concentration of SAP needed to inhibit fibrocyte differentiation by 95%. Together, our data suggest that NaCl potentiates fibrocyte differentiation. NaCl-increased fibrocyte differentiation may thus contribute to NaCl-increased renal and cardiac fibrosis.	[Cox, Nehemiah; Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Cox, Nehemiah/0000-0002-2369-4741; Pilling, Darrell/0000-0002-7413-2773	Texas AM University; NICHD	Texas AM University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by Texas A&M University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The monoclonal antibody M-38 developed by McDonald, J.A was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We thank Sarah Herlihy and Jonathan Phillips for their critical review of the manuscript and the staff at Beutel student health center for drawing blood from volunteers.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; ARCANGELI A, 1993, P NATL ACAD SCI USA, V90, P5858, DOI 10.1073/pnas.90.12.5858; ASHTON N, 1991, J PHYSIOL-LONDON, V435, P533, DOI 10.1113/jphysiol.1991.sp018523; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balgoma D, 2010, J IMMUNOL, V184, P3857, DOI 10.4049/jimmunol.0902883; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Colden-Stanfield M, 1998, AM J PHYSIOL-CELL PH, V275, pC267, DOI 10.1152/ajpcell.1998.275.1.C267; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Farquhar WB, 2005, J APPL PHYSIOL, V99, P1545, DOI 10.1152/japplphysiol.00262.2005; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; FROHLICH ED, 1993, AM J PHYSIOL, V264, pR30, DOI 10.1152/ajpregu.1993.264.1.R30; GILL GV, 1985, J ROY SOC MED, V78, P1009, DOI 10.1177/014107688507801206; Gomer RH, 2009, WOUND REPAIR REGEN, V17, P397, DOI 10.1111/j.1524-475X.2009.00482.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; HAMILTON JA, 1980, J CELL PHYSIOL, V103, P435, DOI 10.1002/jcp.1041030309; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2011, EUR HEART J, V32, P3073, DOI 10.1093/eurheartj/ehr194; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JUNGER WG, 1994, CIRC SHOCK, V42, P190; Kagiyama S, 2007, HYPERTENS RES, V30, P979, DOI 10.1291/hypres.30.979; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kolsen-Petersen JA, 2004, ACTA ANAESTH SCAND, V48, P667, DOI 10.1111/j.1399-6576.2004.00396.x; LINDINGER MI, 1992, AM J PHYSIOL, V262, pR126, DOI 10.1152/ajpregu.1992.262.1.R126; Mantovani A, 1998, INT J CLIN LAB RES, V28, P77, DOI 10.1007/s005990050023; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNCK LK, 1995, GUT, V36, P215, DOI 10.1136/gut.36.2.215; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Reuter S, 2009, CURR HYPERTENS REP, V11, P91, DOI 10.1007/s11906-009-0018-5; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Shapiro L, 1995, P NATL ACAD SCI USA, V92, P12230, DOI 10.1073/pnas.92.26.12230; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shi C, 2006, TRENDS CARDIOVAS MED, V16, P146, DOI 10.1016/j.tcm.2006.03.002; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Strieter Robert M, 2009, Trans Am Clin Climatol Assoc, V120, P49; Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2; Susic D, 2012, CURR OPIN LIPIDOL, V23, P11, DOI 10.1097/MOL.0b013e32834d9c52; TOBIAS JW, 1987, BLOOD, V69, P1265; Wang HA, 2010, J CELL BIOCHEM, V111, P49, DOI 10.1002/jcb.22658; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu HCM, 1998, CIRCULATION, V98, P2621, DOI 10.1161/01.CIR.98.23.2621; YUAN BX, 1991, AM J PHYSIOL, V261, pH1397, DOI 10.1152/ajpheart.1991.261.5.H1397	68	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45674	10.1371/journal.pone.0045674	http://dx.doi.org/10.1371/journal.pone.0045674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029177	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900166
J	Yamada, T; Takeuchi, S; Fujita, N; Nakamura, A; Wang, W; Li, Q; Oda, M; Mitsudomi, T; Yatabe, Y; Sekido, Y; Yoshida, J; Higashiyama, M; Noguchi, M; Uehara, H; Nishioka, Y; Sone, S; Yano, S				Yamada, T.; Takeuchi, S.; Fujita, N.; Nakamura, A.; Wang, W.; Li, Q.; Oda, M.; Mitsudomi, T.; Yatabe, Y.; Sekido, Y.; Yoshida, J.; Higashiyama, M.; Noguchi, M.; Uehara, H.; Nishioka, Y.; Sone, S.; Yano, S.			Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations	ONCOGENE			English	Article						Akt kinase-interacting protein1; EGFR mutation; novel therapeutic target; lung cancer	GROWTH-FACTOR RECEPTOR; ACQUIRED-RESISTANCE; INCREASED SENSITIVITY; SCAFFOLD PROTEINS; DRUG-RESISTANCE; MAPK SCAFFOLD; PHASE-II; INHIBITOR; GEFITINIB; PATHWAY	Despite initial dramatic response, epidermal growth factor receptor (EGFR) mutant lung cancer patients always acquire resistance to EGFR-tyrosine kinase inhibitors (TKIs). Gatekeeper T790M mutation in EGFR is the most prevalent genetic alteration underlying acquired resistance to EGFR-TKI, and EGFR mutant lung cancer cells are reported to be addictive to EGFR/Akt signaling even after acquired T790M mutation. Here, we focused on Akt kinase-interacting protein1 (Aki1), a scaffold protein of PI3K (phosphoinositide 3-kinase)/PDK1 (3-phosphoinositide-dependent protein kinase)/Akt that determines receptor signal selectivity for non-mutated EGFR, and assessed its role in EGFR mutant lung cancer with or without gatekeeper T790M mutation. Cell line-based assays showed that Aki1 constitutively associates with mutant EGFR in lung cancer cells with (H1975) or without (PC-9 and HCC827) T790M gatekeeper mutation. Silencing of Aki1 induced apoptosis of EGFR mutant lung cancer cells. Treatment with Aki1 siRNA dramatically inhibited growth of H1975 cells in a xenograft model. Moreover, silencing of Aki1 further potentiated growth inhibitory effect of new generation EGFR-TKIs against H1975 cells in vitro. Aki1 was frequently expressed in tumor cells of EGFR mutant lung cancer patients (53/56 cases), including those with acquired resistance to EGFR-TKI treatment (7/7 cases). Our data suggest that Aki1 may be a critical mediator of survival signaling from mutant EGFR to Akt, and may therefore be an ideal target for EGFR mutant lung cancer patients, especially those with acquired EGFR-TKI resistance due to EGFR T790M gatekeeper mutation.	[Yamada, T.; Takeuchi, S.; Wang, W.; Li, Q.; Yano, S.] Kanazawa Univ, Canc Res Inst, Div Med Oncol, Kanazawa, Ishikawa 9200934, Japan; [Fujita, N.; Nakamura, A.] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan; [Oda, M.] Kanazawa Univ, Dept Gen & Cardiothorac Surg, Kanazawa, Ishikawa 9200934, Japan; [Mitsudomi, T.] Aichi Canc Ctr Hosp, Dept Thorac Surg, Nagoya, Aichi 464, Japan; [Yatabe, Y.] Aichi Canc Ctr Hosp, Dept Pathol, Nagoya, Aichi 464, Japan; [Sekido, Y.] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Yoshida, J.] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan; [Higashiyama, M.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Osaka, Japan; [Noguchi, M.] Univ Tsukuba, Inst Basic Med Sci, Dept Pathol, Tsukuba, Ibaraki 305, Japan; [Uehara, H.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Mol & Environm Pathol, Tokushima 770, Japan; [Nishioka, Y.; Sone, S.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Resp Med & Rheumatol, Tokushima 770, Japan	Kanazawa University; Japanese Foundation for Cancer Research; Kanazawa University; Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; National Cancer Center - Japan; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of Tsukuba; Tokushima University; Tokushima University	Yamada, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Med Oncol, Takara Machi 13-1, Kanazawa, Ishikawa 9200934, Japan.	tadaakiy@med.kanazawa-u.ac.jp	Yamada, Tadaaki/L-5378-2015; Sekido, Yoshitaka/P-9756-2015; YATABE, Yasushi/J-6461-2014	Yamada, Tadaaki/0000-0002-6945-281X; YATABE, Yasushi/0000-0003-1788-559X; wang, wei/0000-0001-8887-8499; Sekido, Yoshitaka/0000-0002-2428-3848; Mitsudomi, Tetsuya/0000-0001-9860-8505; Yoshida, Junji/0000-0002-1433-9297	Ministry of Health, Labor and Welfare [16-1]; Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790902, 21390256, 22112010]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Dr John D Minna (University of Texas Southwestern Medical Center) and Dr Isaiah J Fidler (MD Anderson Cancer Center, Houston, TX, USA) for kindly provided by H1975 and PC14PE6, respectively. We thank Mrs Takayuki Nakagawa and Kenji Kita (Cancer Research Institute, Kanazawa University) for technical assistance and fruitful discussion. This work was supported in part by the Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare (M Noguchi, 16-1) and was supported by Grants-in-Aid for Cancer Research (T Yamada, 23790902 and S Yano, 21390256) and Scientific Research on Innovative Areas 'Integrative Research on Cancer Microenvironment Network' (S Yano, 22112010) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Janjigian YY, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7525; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Morrison DK, 2001, J CELL SCI, V114, P1609; Mouri A, 2012, J NEUROSCI, V32, P4562, DOI 10.1523/JNEUROSCI.6458-11.2012; Mulloy R, 2007, CANCER RES, V67, P2325, DOI 10.1158/0008-5472.CAN-06-4293; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Sequist LV, 2010, J CLIN ONCOL, V28, P3076, DOI 10.1200/JCO.2009.27.9414; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Yano S, 2000, AM J PATHOL, V157, P1893, DOI 10.1016/S0002-9440(10)64828-6; Yano S, 2008, CANCER RES, V68, P9479, DOI 10.1158/0008-5472.CAN-08-1643; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yu Z, 2007, CANCER RES, V67, P10417, DOI 10.1158/0008-5472.CAN-07-1248; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	38	22	24	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4427	4435		10.1038/onc.2012.446	http://dx.doi.org/10.1038/onc.2012.446			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23045273	Green Submitted			2022-12-25	WOS:000324404200011
J	Baniecki, ML; McGrath, WJ; Mangel, WF				Baniecki, Mary Lynn; McGrath, William J.; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space III. ATOMIC RESOLUTION STRUCTURE OF THE NASCENT FORM OF THE ADENOVIRUS PROTEINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; SEROTYPE-2 PROTEINASE; COFACTOR; PROTEASE; CRYSTALLIZATION; POLYPEPTIDE; ACTIVATION; MECHANISM; SEQUENCE; COMPLEX	The adenovirus proteinase (AVP), the first member of a new class of cysteine proteinases, is essential for the production of infectious virus, and here we report its structure at 0.98 angstrom resolution. AVP, initially synthesized as an inactive enzyme, requires two cofactors for maximal activity: pVIc, an 11-amino acid peptide, and the viral DNA. Comparison of the structure of AVP with that of an active form, the AVP-pVIc complex, reveals why AVP is inactive. Both forms have an alpha + beta fold; the major structural differences between them lie in the beta-sheet domain. In AVP-pVIc, the general base His-54N delta 1 is 3.9 angstrom away from the Cys-122 S gamma, thereby rendering it nucleophilic. In AVP, however, His-54 N delta 1 is 7.0 angstrom away from Cys-122 S gamma, too far away to be able to abstract the proton from Cys-122. In AVP-pVIc, Tyr-84 forms a cation-pi interaction with His-54 that should raise the pK(a) of His-54 and freeze the imidazole ring in the place optimal for forming an ion pair with Cys-122. In AVP, however, Tyr-84 is more than 11 angstrom away from its position in AVP-pVIc. Based on the structural differences between AVP and AVP-pVIc, we present a model that postulates that activation of AVP by pVIc occurs via a 62-amino acid-long activation pathway in which the binding of pVIc initiates contiguous conformational changes, analogous to falling dominos. There is a common pathway that branches into a pathway that leads to the repositioning of His-54 and another pathway that leads to the repositioning of Tyr-84.	[Baniecki, Mary Lynn; McGrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Mangel, WF (corresponding author), Brookhaven Natl Lab, Dept Biol, 50 Bell Ave, Upton, NY 11973 USA.	mangel@bnl.gov		McGrath, William/0000-0002-9375-624X	National Institutes of Health [AI R0141599]; Office of Biological and Environmental Research of the United States Department of Energy [DE-AC0298CH10886]; Brookhaven National Laboratory; Office of Biological and Environmental Research; Office of Basic Energy Sciences of the United States Department of Energy; National Center for Research Resources [P41RR012408]; NIGMS of the National Institutes of Health [P41GM103473]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of the United States Department of Energy(United States Department of Energy (DOE)); Brookhaven National Laboratory(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI R0141599 (to W. F. M.). This work was also supported by the Office of Biological and Environmental Research of the United States Department of Energy under Prime Contract DE-AC0298CH10886 with Brookhaven National Laboratory.; We thank Zbigniew Dauter for advice during data collection and analysis. We also thank Michael Becker and Annie Heroux for assistance in data collection. Data for this study were measured at beam line X-25 of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the United States Department of Energy, and from the National Center for Research Resources (Grant P41RR012408) and the NIGMS (Grant P41GM103473) of the National Institutes of Health. The National Synchrotron Light Source, Brookhaven National Laboratory, is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number DE-AC02-98CH10886.	ANDERSON CW, 1993, PROTEIN EXPRES PURIF, V4, P8, DOI 10.1006/prep.1993.1002; Andres G, 2001, J BIOL CHEM, V276, P780, DOI 10.1074/jbc.M006844200; Ansarah-Sobrinho C, 2004, J VIROL, V78, P6335, DOI 10.1128/JVI.78.12.6335-6343.2004; Baniecki ML, 2002, ACTA CRYSTALLOGR D, V58, P1462, DOI 10.1107/S0907444902008429; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; BLOW DM, 1976, ACCOUNTS CHEM RES, V9, P145, DOI 10.1021/ar50100a004; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Drenth J, 1971, ENZYMES, V3, P485; EDVARDSSON B, 1976, J VIROL, V19, P533, DOI 10.1128/JVI.19.2.533-547.1976; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; KEEFE LJ, 1995, PROTEIN SCI, V4, P1658, DOI 10.1002/pro.5560040826; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; McGrath WJ, 1996, J STRUCT BIOL, V117, P77, DOI 10.1006/jsbi.1996.0072; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; STRAUSS MG, 1990, NUCL INSTRUM METH A, V297, P275, DOI 10.1016/0168-9002(90)91376-M; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; WEBSTER A, 1993, J GEN VIROL, V74, P1415, DOI 10.1099/0022-1317-74-7-1415; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	45	9	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2081	2091		10.1074/jbc.M112.407429	http://dx.doi.org/10.1074/jbc.M112.407429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043139	Green Published, hybrid			2022-12-25	WOS:000313751400059
J	Kraft, AW; Hu, XY; Yoon, H; Yan, P; Xiao, QL; Wang, Y; Gil, SC; Brown, J; Wilhelmsson, U; Restivo, JL; Cirrito, JR; Holtzman, DM; Kim, J; Pekny, M; Lee, JM				Kraft, Andrew W.; Hu, Xiaoyan; Yoon, Hyejin; Yan, Ping; Xiao, Qingli; Wang, Yan; Gil, So Chon; Brown, Jennifer; Wilhelmsson, Ulrika; Restivo, Jessica L.; Cirrito, John R.; Holtzman, David M.; Kim, Jungsu; Pekny, Milos; Lee, Jin-Moo			Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice	FASEB JOURNAL			English	Article						Alzheimer's disease; GFAP; astrogliosis; intermediate filaments; vimentin	FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA-PROTEIN; INTERMEDIATE-FILAMENTS; ALZHEIMERS-DISEASE; A-BETA; REACTIVE ASTROCYTES; MICROGLIAL CELLS; DRIVING-FORCE; MOUSE MODEL; IN-VITRO	The accumulation of aggregated amyloid-beta (A beta) in amyloid plaques is a neuropathological hallmark of Alzheimer's disease (AD). Reactive astrocytes are intimately associated with amyloid plaques; however, their role in AD pathogenesis is unclear. We deleted the genes encoding two intermediate filament proteins required for astrocyte activation-glial fibrillary acid protein (Gfap) and vimentin (Vim)-in transgenic mice expressing mutant human amyloid precursor protein and presenilin-1 (APP/PS1). The gene deletions increased amyloid plaque load: APP/PS1 Gfap(-/-) Vim(-/-) mice had twice the plaque load of APP/PS1 Gfap(+/+) Vim(+/+) mice at 8 and 12 mo of age. APP expression and soluble and interstitial fluid A beta levels were unchanged, suggesting that the deletions had no effect on APP processing or A beta generation. Astrocyte morphology was markedly altered by the deletions: wild-type astrocytes had hypertrophied processes that surrounded and infiltrated plaques, whereas Gfap(-/-) Vim(-/-) astrocytes had little process hypertrophy and lacked contact with adjacent plaques. Moreover, Gfap and Vim gene deletion resulted in a marked increase in dystrophic neurites (2- to 3-fold higher than APP/PS1 Gfap(+/+) Vim(+/+) mice), even after normalization for amyloid load. These results suggest that astrocyte activation limits plaque growth and attenuates plaque-related dystrophic neurites. These activities may require intimate contact between astrocyte and plaque.-Kraft, A. W., Hu, X., Yoon, H., Yan, P., Xiao, Q., Wang, Y., Gil, S. C., Brown, J., Wilhelmsson, U., Restivo, J. L., Cirrito, J. R., Holtzman, D. M., Kim, J., Pekny, M., Lee, J.-M. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 27, 187-198 (2013). www.fasebj.org	[Kraft, Andrew W.; Hu, Xiaoyan; Yoon, Hyejin; Yan, Ping; Xiao, Qingli; Wang, Yan; Gil, So Chon; Brown, Jennifer; Restivo, Jessica L.; Cirrito, John R.; Holtzman, David M.; Kim, Jungsu; Lee, Jin-Moo] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, St Louis, MO 63124 USA; [Wilhelmsson, Ulrika; Pekny, Milos] Univ Gothenburg, Ctr Brain Repair & Rehabil, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol,Sahlgrenska Acad, Gothenburg, Sweden	Washington University (WUSTL); University of Gothenburg	Lee, JM (corresponding author), Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, 660 S Euclid Ave,Campus Box 8111, St Louis, MO 63124 USA.	leejm@wustl.edu	Yoon, Hyejin/AAI-8641-2021; Kim, Jungsu/F-2457-2012; Lee, Jin-Moo/K-2024-2015	Wilhelmsson, Ulrika/0000-0003-3227-2687; Kim, Jungsu/0000-0002-6931-8581; Lee, Jin-Moo/0000-0002-3979-0906	U.S. National Institutes of Health [R01 NS48283, R01 NS67905, P01 NS32636, R37 AG13956, P30NS69329]; Swedish Medical Research Council [11548]; ALF Goteborg; Sten A. Olsson Foundation for Research and Culture; Nano-Net COST Action [BM1002]; EU [237956, 279017]; Frimurare Foundation; Wilhelm and Martina Lundgren's Research Foundation; Hjarnfonden; AFA Insurance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067905, P01NS032636, R01NS048283, P30NS069329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); ALF Goteborg; Sten A. Olsson Foundation for Research and Culture; Nano-Net COST Action(European Cooperation in Science and Technology (COST)); EU(European Commission); Frimurare Foundation; Wilhelm and Martina Lundgren's Research Foundation; Hjarnfonden; AFA Insurance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Alec Zhu for help with PCR, histology, and writing of the manuscript. This work was supported by U.S. National Institutes of Health grants R01 NS48283, R01 NS67905, and P01 NS32636 (to J.-M. L.); R37 AG13956 (to D. M. H.); and P30NS69329 (to J. K.); and grants from the Swedish Medical Research Council (11548), ALF Goteborg, Sten A. Olsson Foundation for Research and Culture, Nano-Net COST Action (BM1002), the EU FP 7 Programs EduGlia (237956) and TargetBraIn (279017), the Frimurare Foundation, Wilhelm and Martina Lundgren's Research Foundation, Hjarnfonden, and AFA Insurance (to M. P.).	Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Askarova S, 2011, NEUROSCIENCE, V199, P375, DOI 10.1016/j.neuroscience.2011.09.038; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bolmont T, 2008, J NEUROSCI, V28, P4283, DOI 10.1523/JNEUROSCI.4814-07.2008; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Burbach GJ, 2004, J NEUROSCI, V24, P2421, DOI 10.1523/JNEUROSCI.5599-03.2004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Cirrito JR, 2003, J NEUROSCI, V23, P8844; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; FRACKOWIAK J, 1992, ACTA NEUROPATHOL, V84, P225; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Grimwood S, 2005, NEUROPHARMACOLOGY, V48, P1002, DOI 10.1016/j.neuropharm.2005.01.016; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hu XY, 2007, EMBO J, V26, P2755, DOI 10.1038/sj.emboj.7601707; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kato S, 1998, PATHOL INT, V48, P332, DOI 10.1111/j.1440-1827.1998.tb03915.x; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Potokar M, 2007, TRAFFIC, V8, P12, DOI 10.1111/j.1600-0854.2006.00509.x; Potokar M, 2010, GLIA, V58, P1208, DOI 10.1002/glia.21000; Szapacs ME, 2004, NEUROBIOL DIS, V16, P572, DOI 10.1016/j.nbd.2004.04.010; Thal DR, 2000, ACTA NEUROPATHOL, V100, P608, DOI 10.1007/s004010000242; Vardjan N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-144; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Wegiel J, 2000, ACTA NEUROPATHOL, V100, P356, DOI 10.1007/s004010000199; Weisman D, 2006, VITAM HORM, V74, P505, DOI 10.1016/S0083-6729(06)74020-1; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Yamaguchi H, 1998, ACTA NEUROPATHOL, V95, P217, DOI 10.1007/s004010050790; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	65	204	210	0	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					187	198		10.1096/fj.12-208660	http://dx.doi.org/10.1096/fj.12-208660			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038755	Green Published			2022-12-25	WOS:000313103200018
J	Mohammad, S; Ozaki, T; Takeuchi, K; Unno, K; Yamoto, K; Morioka, E; Takiguchi, S; Ikeda, M				Mohammad, Shahid; Ozaki, Tomoya; Takeuchi, Kouhei; Unno, Katsuya; Yamoto, Kurumi; Morioka, Eri; Takiguchi, Soichi; Ikeda, Masayuki			Functional Compensation between Cholecystokinin-1 and -2 Receptors in Murine Paraventricular Nucleus Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL VAGAL COMPLEX; CCK-A RECEPTORS; FOOD-INTAKE; SUPRACHIASMATIC NUCLEUS; MOLECULAR-CLONING; RAT NODOSE; EXPRESSION; SATIETY; ORGANIZATION; LACKING	Cholecystokinin (CCK) and its receptor subtypes CCK-1 and -2 have diverse homeostatic functions. CCK-1 and -2 receptors share a common phosphatidylinositol signaling pathway, yet little is known regarding their possible functional coupling. We focused on CCK-mediated Ca2+ signaling in parvocellular paraventricular nucleus (PVN) cells, which control satiety and other autonomic functions. Analysis of mouse hypothalamic slices demonstrated that the general CCK receptor agonist CCK-8s (10 nM) triggered Ca2+ transients most significantly in the posterior subregion of the PVN (PaPo). This 10 nM CCK-8s-induced response was absent in CCK-1 receptor knock-out (CCK1R(-/-)) slices, showing that the response is mediated by CCK-1 receptors. CCK-8s concentrations higher than 30 nM triggered a Ca2+ rise similarly in wild-type and CCK1R(-/-) slices. The large CCK-8s (100 nM)-induced Ca2+ responses in CCK1R(-/-) slices were blocked by a CCK-2 receptor antagonist (CI-988), whereas those in wild-type slices required a mixture of CI-988 and lorglumide (a CCK-1 receptor antagonist) for complete antagonism. Therefore, CCK-1 and -2 receptors may function synergistically in single PaPo neurons and deletion of CCK-1 receptors may facilitate CCK-2 receptor signaling. This hypothesis was supported by results of real-time RT-PCR, immunofluorescence double labeling and Western blotting assays, which indicated CCK-2 receptor overexpression in PaPo neurons of CCK1R(-/-) mice. Furthermore, behavioral studies showed that intraperitoneal injections of lorglumide up-regulated food accesses in wild-type but not in CCK1R(-/-) mice, whereas CI-988 injections up-regulated food accesses in CCK1R(-/-) but not in wild-type mice. Compensatory CCK signaling via CCK-2 receptors in CCK1R(-/-) mice shed light on currently controversial satiety-controlling mechanisms.	[Ikeda, Masayuki] Toyama Univ, Fac Sci, Dept Biol, Grad Sch Innovat Life Sci, Toyama 9308555, Japan; [Takeuchi, Kouhei; Unno, Katsuya; Yamoto, Kurumi; Ikeda, Masayuki] Toyama Univ, Grad Sch Sci & Engn, Toyama 9308555, Japan; [Takiguchi, Soichi] Kyushu Natl Canc Ctr, Inst Clin Res, Minami Ku, Fukuoka 8111395, Japan	University of Toyama; University of Toyama	Ikeda, M (corresponding author), Toyama Univ, Fac Sci, Dept Biol, Grad Sch Innovat Life Sci, Rm B214,3190 Gofuku, Toyama 9308555, Japan.	msikeda@sci.u-toyama.ac.jp		Ikeda, Masayuki/0000-0002-6833-9495; Shahid, Mohammad/0000-0001-5239-7861	Ministry of Education, Culture, Sports, Science, and Technology Japan [22300108]	Ministry of Education, Culture, Sports, Science, and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (22300108) from the Ministry of Education, Culture, Sports, Science, and Technology Japan (to M. I.).	Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Bi S, 2004, ENDOCRINOLOGY, V145, P3873, DOI 10.1210/en.2004-0284; Blevins JE, 2009, BRAIN RES, V1255, P98, DOI 10.1016/j.brainres.2008.12.015; Broberger C, 2001, BRAIN RES, V903, P128, DOI 10.1016/S0006-8993(01)02468-4; Cheng ZJ, 2003, J BIOL CHEM, V278, P52972, DOI 10.1074/jbc.M310090200; CRAWLEY JN, 1991, J PHARMACOL EXP THER, V257, P1076; GIBBS J, 1973, NATURE, V245, P323, DOI 10.1038/245323a0; Guard DB, 2009, BRAIN RES, V1266, P37, DOI 10.1016/j.brainres.2009.02.003; Hashimoto H, 2005, AUTON NEUROSCI-BASIC, V121, P16, DOI 10.1016/j.autneu.2005.05.002; HINKS GL, 1995, NEUROSCIENCE, V68, P765, DOI 10.1016/0306-4522(95)00148-C; HIROSUE Y, 1993, AM J PHYSIOL, V265, pR481, DOI 10.1152/ajpregu.1993.265.3.R481; HONDA T, 1993, MOL CELL NEUROSCI, V4, P143, DOI 10.1006/mcne.1993.1018; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Ikeda M, 2003, EUR J NEUROSCI, V17, P58, DOI 10.1046/j.1460-9568.2003.02427.x; Ivy AC, 1928, AM J PHYSIOL, V86, P599, DOI 10.1152/ajplegacy.1928.86.3.599; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Koutcherov Y, 2000, J COMP NEUROL, V423, P299; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; Lo CM, 2008, AM J PHYSIOL-REG I, V294, pR803, DOI 10.1152/ajpregu.00682.2007; Monnikes H, 2000, DIGESTION, V62, P178, DOI 10.1159/000007811; Monnikes H, 1997, AM J PHYSIOL-REG I, V273, pR2059, DOI 10.1152/ajpregu.1997.273.6.R2059; MORAN TH, 1992, AM J PHYSIOL, V262, pR46, DOI 10.1152/ajpregu.1992.262.1.R46; Moran TH, 1998, AM J PHYSIOL-REG I, V274, pR618, DOI 10.1152/ajpregu.1998.274.3.R618; Muramatsu Y, 2005, BIOCHEM BIOPH RES CO, V331, P1270, DOI 10.1016/j.bbrc.2005.04.040; Ozaki T., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Panicker AK, 1998, AM J PHYSIOL-REG I, V275, pR158, DOI 10.1152/ajpregu.1998.275.1.R158; Raboin SJ, 2008, REGUL PEPTIDES, V150, P73, DOI 10.1016/j.regpep.2008.06.007; Reidelberger RD, 2004, AM J PHYSIOL-REG I, V286, pR1005, DOI 10.1152/ajpregu.00646.2003; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; Shimazoe T, 2008, FASEB J, V22, P1479, DOI 10.1096/fj.07-9372com; Simmons RD, 1999, PHARMACOL BIOCHEM BE, V62, P549, DOI 10.1016/S0091-3057(98)00186-5; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Sorimachi M, 2001, NEUROSCI LETT, V300, P91, DOI 10.1016/S0304-3940(01)01553-1; Stern JE, 2001, J PHYSIOL-LONDON, V537, P161, DOI 10.1111/j.1469-7793.2001.0161k.x; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takiguchi S, 2002, PANCREAS, V24, P276, DOI 10.1097/00006676-200204000-00011; Takiguchi S, 1997, GENE, V197, P169, DOI 10.1016/S0378-1119(97)00259-X; Uchoa ET, 2009, HORM BEHAV, V56, P532, DOI 10.1016/j.yhbeh.2009.09.007; ULRICH CD, 1993, BIOCHEM BIOPH RES CO, V193, P204, DOI 10.1006/bbrc.1993.1610; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; Wang LX, 2000, REGUL PEPTIDES, V92, P79, DOI 10.1016/S0167-0115(00)00153-1; WANK SA, 1992, P NATL ACAD SCI USA, V89, P3125, DOI 10.1073/pnas.89.7.3125; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Washington MC, 2011, PEPTIDES, V32, P272, DOI 10.1016/j.peptides.2010.11.010; Yang L, 2009, J NEUROSCI, V29, P179, DOI 10.1523/JNEUROSCI.4379-08.2009	50	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416214	http://dx.doi.org/10.1074/jbc.M112.416214			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038256	Green Published, hybrid			2022-12-25	WOS:000311233800011
J	Albarrak, SM; Brown, WC; Noh, SM; Reif, KE; Scoles, GA; Turse, JE; Norimine, J; Ueti, MW; Palmer, GH				Albarrak, Saleh M.; Brown, Wendy C.; Noh, Susan M.; Reif, Kathryn E.; Scoles, Glen A.; Turse, Joshua E.; Norimine, Junzo; Ueti, Massaro W.; Palmer, Guy H.			Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity	PLOS ONE			English	Article							MAJOR SURFACE PROTEIN-2; T-LYMPHOCYTE EPITOPES; IDENTIFICATION; RESPONSES; GENOME; RICKETTSIALES; TRANSMISSION; EXPRESSION; EFFICIENCY; VARIANTS	Identification of specific antigens responsible for the ability of complex immunogens to induce protection is a major goal in development of bacterial vaccines. Much of the investigation has focused on highly abundant and highly immunodominant outer membrane proteins. Recently however, genomic and proteomic approaches have facilitated identification of minor components of the bacterial outer membrane that have previously been missed or ignored in immunological analyses. Immunization with Anaplasma marginale outer membranes or a cross-linked surface complex induces protection against bacteremia, however the components responsible for protection within these complex immunogens are unknown. Using outer membrane protein AM779 as a model, we demonstrated that this highly conserved but minor component of the A. marginale surface was immunologically sub-dominant in the context of the outer membrane or surface complex vaccines. Immunologic sub-dominance could be overcome by targeted vaccination with AM779 for T lymphocyte responses but not for antibody responses, suggesting that both abundance and intrinsic immunogenicity determine relative dominance. Importantly, immunization with AM779 supports that once priming is achieved by specific targeting, recall upon infectious challenge is achieved. While immunization with AM779 alone was not sufficient to induce protection, the ability of targeted immunization to prime the immune response to highly conserved but low abundance proteins supports continued investigation into the role of sub-dominant antigens, individually and collectively, in vaccine development for A. marginale and related bacterial pathogens.	[Albarrak, Saleh M.; Reif, Kathryn E.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Brown, Wendy C.; Reif, Kathryn E.; Turse, Joshua E.; Norimine, Junzo; Palmer, Guy H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Noh, Susan M.; Scoles, Glen A.; Ueti, Massaro W.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; Washington State University; United States Department of Agriculture (USDA)	Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	gpalmer@vetmed.wsu.edu	, 0000-0001-7041-1823/B-9144-2014; Albarrak, Saleh/GRO-3447-2022	, 0000-0001-7041-1823/0000-0001-7041-1823; Albarrak, Saleh/0000-0003-4965-6142	National Institutes of Health [AI44005, AIO53692]; Wellcome Trust [GR075800M]; U.S. Department of Agriculture [ARS 5348-32000-033-00D, CSREES 35604-15440]; Saudi Ministry of Higher Education; Infectious Diseases and Microbial Immunology Training Program NIH [T32AI07025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, T32AI007025, R01AI044005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Saudi Ministry of Higher Education; Infectious Diseases and Microbial Immunology Training Program NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI44005 and AIO53692, Wellcome Trust GR075800M, and U.S. Department of Agriculture Grants ARS 5348-32000-033-00D and CSREES 35604-15440. Saleh M. Albarrak was supported by a fellowship from the Saudi Ministry of Higher Education; Joshua E. Turse and Kathryn E. Reif were supported by the Infectious Diseases and Microbial Immunology Training Program NIH T32AI07025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2011, INFECT IMMUN, V79, P1311, DOI 10.1128/IAI.01174-10; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Brown WC, 2003, J IMMUNOL, V170, P3790, DOI 10.4049/jimmunol.170.7.3790; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Brown WC, 2001, J IMMUNOL, V166, P1114, DOI 10.4049/jimmunol.166.2.1114; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P234; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; French DM, 1999, INFECT IMMUN, V67, P5834, DOI 10.1128/IAI.67.11.5834-5840.1999; French DM, 1998, INFECT IMMUN, V66, P1200, DOI 10.1128/IAI.66.3.1200-1207.1998; Gallimore A, 1998, J EXP MED, V187, P1647; Herndon DR, 2010, J BACTERIOL, V192, P379, DOI 10.1128/JB.01330-09; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; MCGUIRE TC, 1984, INFECT IMMUN, V45, P697, DOI 10.1128/IAI.45.3.697-700.1984; MCGUIRE TC, 1991, J CLIN MICROBIOL, V29, P788, DOI 10.1128/JCM.29.4.788-793.1991; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; Norimine J, 2005, IMMUNOGENETICS, V57, P750, DOI 10.1007/s00251-005-0045-6; Oukka M, 1996, J IMMUNOL, V157, P3039; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Palmer GH, 2012, FEMS IMMUNOL MED MIC, V64, P115, DOI 10.1111/j.1574-695X.2011.00878.x; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Scoles GA, 2005, J MED ENTOMOL, V42, P668, DOI 10.1603/0022-2585(2005)042[0668:REOBTO]2.0.CO;2; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Ueti MW, 2009, INFECT IMMUN, V77, P70, DOI 10.1128/IAI.01164-08	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46372	10.1371/journal.pone.0046372	http://dx.doi.org/10.1371/journal.pone.0046372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029498	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900145
J	Lohavanichbutr, P; Houck, J; Doody, DR; Wang, P; Mendez, E; Futran, N; Upton, MP; Holsinger, FC; Schwartz, SM; Chen, C				Lohavanichbutr, Pawadee; Houck, John; Doody, David R.; Wang, Pei; Mendez, Eduardo; Futran, Neal; Upton, Melissa P.; Holsinger, F. Christopher; Schwartz, Stephen M.; Chen, Chu			Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; HUMAN-PAPILLOMAVIRUS; FIELD CANCERIZATION; PROTEOMIC ANALYSIS; RISK-ASSESSMENT; HEAD; HETEROZYGOSITY; SURVIVAL	Oral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide, with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor samples from OSCC patients, 58 uninvolved oral mucosae from OSCC patients and 45 normal oral mucosae from patients without oral cancer, all enrolled at one of the three University of Washington-affiliated medical centers between 2003 to 2008. We found 2,596 probe sets differentially expressed between 167 tumor samples and 45 normal samples. Among 2,596 probe sets, 71 were significantly and consistently up-or down-regulated in the comparison between normal samples and uninvolved oral samples and between uninvolved oral samples and tumor samples. Cox regression analyses showed that 20 of the 71 probe sets were significantly associated with progression-free survival. The risk score for each patient was calculated from coefficients of a Cox model incorporating these 20 probe sets. The hazard ratio (HR) associated with each unit change in the risk score adjusting for age, gender, tumor stage, and high-risk HPV status was 2.7 (95% CI: 2.0-3.8, p = 8.8E-10). The risk scores in an independent dataset of 74 OSCC patients from the MD Anderson Cancer Center was also significantly associated with progression-free survival independent of age, gender, and tumor stage (HR 1.6, 95% CI: 1.1-2.2, p = 0.008). Gene Set Enrichment Analysis showed that the most prominent biological pathway represented by the 71 probe sets was the Integrin cell surface interactions pathway. In conclusion, we identified 71 probe sets in which dysregulation occurred in both uninvolved oral mucosal and cancer samples. Dysregulation of 20 of the 71 probe sets was associated with progression-free survival and was validated in an independent dataset.	[Lohavanichbutr, Pawadee; Houck, John; Doody, David R.; Schwartz, Stephen M.; Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Wang, Pei] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Mendez, Eduardo; Futran, Neal; Chen, Chu] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Mendez, Eduardo] VA Puget Sound Hlth Care Syst, Surg & Perioperat Care Serv, Seattle, WA USA; [Mendez, Eduardo] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Upton, Melissa P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Holsinger, F. Christopher] Univ Texas MD Anderson Canc Ctr, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Schwartz, Stephen M.; Chen, Chu] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle	Chen, C (corresponding author), Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA.	cchen@fhcrc.org		Doody, David/0000-0003-2291-6493; Schwartz, Stephen/0000-0001-7499-8502; Wang, Pei/0000-0002-6890-6453	National Institutes of Health, National Cancer Institute [NIH/NCI 5R01 CA095419]; Fred Hutchinson Cancer Research Center; Cancer Center Support Core Grant [CA16672]; National Cancer Institute [P50 CA97007]; "Clinician Investigator Program in Translational Research" [K12 CA88084]; NIH Loan Repayment Program; Clinical Research Program [2 L30 CA117652-02A1]; THANC Foundation Young Investigator Award in Head and Neck Cancer; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA095419, P30CA015704, P50CA097007] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fred Hutchinson Cancer Research Center; Cancer Center Support Core Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); "Clinician Investigator Program in Translational Research"; NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Research Program; THANC Foundation Young Investigator Award in Head and Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants from the National Institutes of Health, National Cancer Institute (NIH/NCI 5R01 CA095419), and by institutional funds from the Fred Hutchinson Cancer Research Center. The study at the MD Anderson Cancer Center was supported by Cancer Center Support Core Grant CA16672 (Affymetrix Microarray Core Facility; the Bioinformatics Core), Specialized Program of Research Excellence in Head and Neck Cancer Grant P50 CA97007 from the National Cancer Institute, "Clinician Investigator Program in Translational Research" K12 CA88084, NIH Loan Repayment Program, Clinical Research Program 2 L30 CA117652-02A1, and THANC Foundation Young Investigator Award in Head and Neck Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON R, 1994, ONCOGENE, V9, P2077; Araki D, 2002, INT J ONCOL, V20, P355; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Belbin TJ, 2005, ARCH OTOLARYNGOL, V131, P10, DOI 10.1001/archotol.131.1.10; BERGLER W, 1989, ARCH OTO-RHINO-LARYN, V246, P121, DOI 10.1007/BF00456651; Bloching MM, 2008, ONCOL REP, V19, P1373; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chen L, 2005, CANCER GENET CYTOGEN, V159, P37, DOI 10.1016/j.cancergencyto.2004.09.011; Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002; Chiang WF, 2011, ORAL ONCOL, V47, P452, DOI 10.1016/j.oraloncology.2011.03.025; El-Naggar AK, 1998, ONCOGENE, V16, P2983, DOI 10.1038/sj.onc.1201808; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gonzalez-Garcia R, 2009, HEAD NECK-J SCI SPEC, V31, P1168, DOI 10.1002/hed.21088; Hockel A, 2005, CANCER RES, V65, P2997; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Imai FL, 2001, INT J MOL MED, V7, P43; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kale Alka D, 2012, J Oral Maxillofac Pathol, V16, P10, DOI 10.4103/0973-029X.92966; Kannan S, 1996, BRIT J ORAL MAX SURG, V34, P51, DOI 10.1016/S0266-4356(96)90136-9; Kayahara H, 2001, J HUM GENET, V46, P335, DOI 10.1007/s100380170069; Kooren Joel A, 2011, Clin Proteomics, V8, P13, DOI 10.1186/1559-0275-8-13; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Larsen SR, 2009, J ORAL PATHOL MED, V38, P657, DOI 10.1111/j.1600-0714.2009.00797.x; Lazar AD, 1998, CLIN CANCER RES, V4, P2787; Lee CY, 2011, J CELL BIOCHEM, V112, P2549, DOI 10.1002/jcb.23179; Lee DJ, 1997, CLIN CANCER RES, V3, P501; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lo Muzio L, 2006, INT J IMMUNOPATH PH, V19, P675, DOI 10.1177/039463200601900323; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; Mao EJ, 1998, J ORAL PATHOL MED, V27, P297; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Mendez E, 2009, CLIN CANCER RES, V15, P1353, DOI 10.1158/1078-0432.CCR-08-1816; Mishra RC, 1999, EUR J SURG ONCOL, V25, P186, DOI 10.1053/ejso.1998.0624; Mizukoshi E, 2011, HEPATOLOGY, V53, P1206, DOI 10.1002/hep.24149; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Mucke T, 2009, ORAL ONCOL, V45, P687, DOI 10.1016/j.oraloncology.2008.10.011; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; NEES M, 1993, CANCER RES, V53, P4189; Remmerbach TW, 2011, ORAL ONCOL, V47, P278, DOI 10.1016/j.oraloncology.2011.02.005; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun G, 2009, ARTIF CELL BLOOD SUB, V37, P125, DOI 10.1080/10731190902913759; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Thomson PJ, 2002, INT J ORAL MAX SURG, V31, P262, DOI 10.1054/ijom.2002.0220; Uchida K, 2011, ONCOL REP, V26, P463, DOI 10.3892/or.2011.1327; Wang XL, 1999, ONCOGENE, V18, P823, DOI 10.1038/sj.onc.1202318; Wang Y, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-624; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Woolgar JA, 1999, ORAL ONCOL, V35, P257, DOI 10.1016/S1368-8375(98)00113-4; Yamamoto N, 2001, BRIT J CANCER, V84, P754, DOI 10.1054/bjoc.2000.1656; Yamashita Y, 2002, INT J ONCOL, V20, P595; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	63	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46575	10.1371/journal.pone.0046575	http://dx.doi.org/10.1371/journal.pone.0046575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029552	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900186
J	Monadjem, A; Kane, A; Botha, A; Dalton, D; Kotze, A				Monadjem, Ara; Kane, Adam; Botha, Andre; Dalton, Desire; Kotze, Antoinette			Survival and Population Dynamics of the Marabou Stork in an Isolated Population, Swaziland	PLOS ONE			English	Article							LEPTOPTILOS-CRUMENIFERUS; MODELING SURVIVAL; TAG LOSS; RATES; CICONIA; BIOLOGY; MORTALITY; VULTURES; CLIMATE; IMPACT	Investigating the ecology of long lived birds is particularly challenging owing to the time scales involved. Here an analysis is presented of a long term study of the survival and population dynamics of the marabou stork (Leptoptilos crumeniferus), a wide ranging scavenging bird from Sub-Saharan Africa. Using resightings data of tagged nestlings and free flying birds we show that the stork population can be divided into three general life stages with unique survival probabilities and fecundities. Fecundity of the storks is inversely related to rainfall during their breeding season. Corroborative evidence for a metapopulation structure is discussed highlighting the impact of the Swaziland birds on the ecology of the species in the broader region. The importance of tag loss or illegibility over time is highlighted. Clearly, any attempt at conserving a species will require a detailed understanding of its population structure, of the sort examined here.	[Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Kane, Adam] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Zool, Dublin 2, Ireland; [Botha, Andre] Endangered Wildlife Trust, Birds Prey Programme, Modderfontein, South Africa; [Dalton, Desire; Kotze, Antoinette] Natl Zool Gardens South Africa, Pretoria, South Africa; [Dalton, Desire; Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, South Africa	Trinity College Dublin; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State	Monadjem, A (corresponding author), Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini.	ara@uniswa.sz	Monadjem, Ara/K-7279-2014; Botha, Andre/Y-2304-2019; Kane, Adam/H-6449-2013	Monadjem, Ara/0000-0003-1906-4023; Kane, Adam/0000-0002-2830-5338; Botha, Andre/0000-0003-1077-1215; Dalton, Desire Lee/0000-0001-5975-6425				Bamford AJ, 2009, S AFR J WILDL RES, V39, P202, DOI 10.3957/056.039.0201; Barnes K. N., 1998, IMPORTANT BIRD AREAS; Borkhataria RR, 2008, WATERBIRDS, V31, P42, DOI 10.1675/1524-4695(2008)31[42:APMOWS]2.0.CO;2; Botha Andre, 2007, Vulture News, V56, P52; Brown L.H., 1984, P97; Brown LH, 1982, BIRDS AFRICA, VI; Burhnam KP, 1987, AM FISH SOC MONOGR, P5; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAMPBELL B, 1974, DICT BIRDS COLOR; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Diekmann M., 2004, VULTURE NEWS, V51, P34; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hylton RA, 2006, CONDOR, V108, P97, DOI 10.1650/0010-5422(2006)108[0097:EONHOP]2.0.CO;2; Jovani R, 2004, ECOGRAPHY, V27, P611, DOI 10.1111/j.0906-7590.2004.03925.x; KAHL MP, 1966, J ZOOL, V148, P289; KANYAMIBWA S, 1990, IBIS, V132, P27, DOI 10.1111/j.1474-919X.1990.tb01013.x; KANYAMIBWA S, 1993, ORNIS SCAND, V24, P297, DOI 10.2307/3676791; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Monadjem A, 2005, OSTRICH, V76, P45, DOI 10.2989/00306520509485472; Monadjem A, 2013, AFR J ECOL, V51, P87, DOI 10.1111/aje.12009; Monadjem A, 2010, OSTRICH, V81, P85, DOI 10.2989/00306525.2010.488411; Monadjem A, 2008, OSTRICH, V79, P187, DOI 10.2989/OSTRICH.2008.79.2.8.582; Monadjem A, 2009, IBIS, V151, P344, DOI 10.1111/j.1474-919X.2009.00912.x; Mundy PJ., 2003, HONEYGUIDE, V49; Mundy PJ, 1992, VULTURES AFRICA ACOR; Nevoux M, 2008, J ANIM ECOL, V77, P1143, DOI 10.1111/j.1365-2656.2008.01435.x; Pastor J., 2008, MATH ECOLOGY POPULAT, P344; Piper SE, 1999, BIRD STUDY, V46, P230; POMEROY DE, 1977, ARDEA, V65, P1; POMEROY DE, 1978, ARDEA, V66, P1; Postupalsky S., 1973, MANAGEMENT RAPTORS, P21; Reilly T, 1965, OSTRICH, V36, P96; Rotella JJ, 2005, ECOLOGY, V86, P821, DOI 10.1890/04-1193; Ryan, 2005, ROBERTS BIRDS SO AFR, P626; Saether BE, 2006, J ANIM ECOL, V75, P80, DOI 10.1111/j.1365-2656.2005.01023.x; SARRAZIN F, 1994, AUK, V111, P853; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SEBER GAF, 1981, BIOMETRIKA, V68, P211, DOI 10.2307/2335821; Spangenberg JA, 2005, LESLIE LEFKOVITCH MA; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Tarboton WR., 2001, GUIDE NESTS EGGS SO; Tucker AD, 2001, CAN J ZOOL, V79, P2199, DOI 10.1139/cjz-79-12-2199; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHYTE IJ, 1993, OSTRICH, V64, P186	52	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46434	10.1371/journal.pone.0046434	http://dx.doi.org/10.1371/journal.pone.0046434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029517	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900158
J	Saito, Y; Ishii, K; Sakuma, N; Kawasaki, K; Oda, K; Mizusawa, H				Saito, Yoko; Ishii, Kenji; Sakuma, Naoko; Kawasaki, Keiichi; Oda, Keiichi; Mizusawa, Hidehiro			Neural Substrates for Semantic Memory of Familiar Songs: Is There an Interface between Lyrics and Melodies?	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; WORD FORM AREA; SPEECH-PERCEPTION; CORTICAL ORGANIZATION; EXPRESSIVE APHASIA; FUNCTIONAL-ANATOMY; CEREBRAL NETWORKS; MUSIC PERCEPTION; TEMPORAL-LOBES; VOCAL-MUSIC	Findings on song perception and song production have increasingly suggested that common but partially distinct neural networks exist for processing lyrics and melody. However, the neural substrates of song recognition remain to be investigated. The purpose of this study was to examine the neural substrates involved in the accessing "song lexicon'' as corresponding to a representational system that might provide links between the musical and phonological lexicons using positron emission tomography (PET). We exposed participants to auditory stimuli consisting of familiar and unfamiliar songs presented in three ways: sung lyrics (song), sung lyrics on a single pitch (lyrics), and the sung syllable 'la' on original pitches (melody). The auditory stimuli were designed to have equivalent familiarity to participants, and they were recorded at exactly the same tempo. Eleven right-handed nonmusicians participated in four conditions: three familiarity decision tasks using song, lyrics, and melody and a sound type decision task (control) that was designed to engage perceptual and prelexical processing but not lexical processing. The contrasts (familiarity decision tasks versus control) showed no common areas of activation between lyrics and melody. This result indicates that essentially separate neural networks exist in semantic memory for the verbal and melodic processing of familiar songs. Verbal lexical processing recruited the left fusiform gyrus and the left inferior occipital gyrus, whereas melodic lexical processing engaged the right middle temporal sulcus and the bilateral temporo-occipital cortices. Moreover, we found that song specifically activated the left posterior inferior temporal cortex, which may serve as an interface between verbal and musical representations in order to facilitate song recognition.	[Saito, Yoko; Ishii, Kenji; Kawasaki, Keiichi; Oda, Keiichi] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan; [Sakuma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, Tokyo, Japan; [Mizusawa, Hidehiro] Tokyo Med Dent Univ, Dept Neurol Neurol Sci, Grad Sch Med Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental University (TMDU)	Ishii, K (corresponding author), Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan.	ishii@pet.tmig.or.jp			Japan Society for the Promotion of Science [1952353]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (1952353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes F, 2010, MEM COGNITION, V38, P641, DOI 10.3758/MC.38.5.641; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Blumstein SE, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00136.x; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Bozic M, 2010, P NATL ACAD SCI USA, V107, P17439, DOI 10.1073/pnas.1000531107; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cloutman L, 2009, CORTEX, V45, P641, DOI 10.1016/j.cortex.2008.05.013; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; CROWDER RG, 1990, MEM COGNITION, V18, P469, DOI 10.3758/BF03198480; Dalla Bella S, 2003, PERCEPT PSYCHOPHYS, V65, P1019; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; Giraud AL, 2002, NEUROPSYCHOLOGIA, V40, P1562, DOI 10.1016/S0028-3932(02)00023-4; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Groussard M, 2010, NEUROIMAGE, V53, P1301, DOI 10.1016/j.neuroimage.2010.07.013; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 2001, ANN NY ACAD SCI, V930, P179, DOI 10.1111/j.1749-6632.2001.tb05733.x; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hebert S, 2003, BRAIN, V126, P1838, DOI 10.1093/brain/awg186; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; Jeffries KJ, 2003, NEUROREPORT, V14, P749, DOI 10.1097/00001756-200304150-00018; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; Levitin DJ, 2009, ANN NY ACAD SCI, V1156, P211, DOI 10.1111/j.1749-6632.2009.04417.x; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; Nakamura K, 2000, BRAIN, V123, P954, DOI 10.1093/brain/123.5.954; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Obleser J, 2010, CEREB CORTEX, V20, P633, DOI 10.1093/cercor/bhp128; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Peretz I, 2004, MEM COGNITION, V32, P142, DOI 10.3758/BF03195827; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Plailly J, 2007, CEREB CORTEX, V17, P2650, DOI 10.1093/cercor/bhl173; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Purnell-Webb P, 2008, PERCEPT MOTOR SKILL, V106, P927, DOI 10.2466/PMS.106.3.927-957; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Raymer AM, 1997, BRAIN LANG, V58, P137, DOI 10.1006/brln.1997.1786; Saito Y, 2009, JAPANESE J PSYCHOL, V80, P405; Saito Y, 2006, NEUROREPORT, V17, P1893, DOI 10.1097/WNR.0b013e328011519c; Sammler D, 2010, J NEUROSCI, V30, P3572, DOI 10.1523/JNEUROSCI.2751-09.2010; Satoh M, 2006, AM J NEURORADIOL, V27, P1101; Satoh M, 2003, AM J NEURORADIOL, V24, P1843; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schulkind MD, 2004, PERCEPT PSYCHOPHYS, V66, P1351, DOI 10.3758/BF03195003; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Straube T, 2008, NEUROPSYCHOLOGIA, V46, P1505, DOI 10.1016/j.neuropsychologia.2008.01.008; Tranel D, 2005, J COGNITIVE NEUROSCI, V17, P1293, DOI 10.1162/0898929055002508; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Wise RJS, 2000, NEUROPSYCHOLOGIA, V38, P985, DOI 10.1016/S0028-3932(99)00152-9; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	80	12	12	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46354	10.1371/journal.pone.0046354	http://dx.doi.org/10.1371/journal.pone.0046354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029492	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900141
J	Undem, C; Rios, EJ; Maylor, J; Shimoda, LA				Undem, Clark; Rios, Eon J.; Maylor, Julie; Shimoda, Larissa A.			Endothelin-1 Augments Na+/H+ Exchange Activity in Murine Pulmonary Arterial Smooth Muscle Cells via Rho Kinase	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; INTRACELLULAR PH; GROWTH-FACTORS; H+ EXCHANGE; HYPERTENSION; ACTIVATION; PROLIFERATION; MECHANISMS; ANTAGONIST; PREVENTS	Excessive production of endothelin-1 (ET-1), a potent vasoconstrictor, occurs with several forms of pulmonary hypertension. In addition to modulating vasomotor tone, ET-1 can potentiate pulmonary arterial smooth muscle cell (PASMC) growth and migration, both of which contribute to the vascular remodeling that occurs during the development of pulmonary hypertension. It is well established that changes in cell proliferation and migration in PASMCs are associated with alkalinization of intracellular pH (pH(i)), typically due to activation of Na+/H+ exchange (NHE). In the systemic vasculature, ET-1 increases pH(i), Na+/H+ exchange activity and stimulates cell growth via a mechanism dependent on protein kinase C (PKC). These results, coupled with data describing elevated levels of ET-1 in hypertensive animals/humans, suggest that ET-1 may play an important role in modulating pH(i) and smooth muscle growth in the lung; however, the effect of ET-1 on basal pH(i) and NHE activity has yet to be examined in PASMCs. Thus, we used fluorescent microscopy in transiently (3-5 days) cultured rat PASMCs and the pH-sensitive dye, BCECF-AM, to measure changes in basal pH(i) and NHE activity induced by increasing concentrations of ET-1 (10(-10) to 10(-8) M). We found that application of exogenous ET-1 increased pH(i) and NHE activity in PASMCs and that the ET-1-induced augmentation of NHE was prevented in PASMCs pretreated with an inhibitor of Rho kinase, but not inhibitors of PKC. Moreover, direct activation of PKC had no effect on pH(i) or NHE activity in PASMCs. Our results indicate that ET-1 can modulate pH homeostasis in PASMCs via a signaling pathway that includes Rho kinase and that, in contrast to systemic vascular smooth muscle, activation of PKC does not appear to be an important regulator of PASMC pH(i).	[Undem, Clark; Rios, Eon J.; Maylor, Julie; Shimoda, Larissa A.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Shimoda, LA (corresponding author), Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21218 USA.	shimodal@welch.jhu.edu			National Institutes of Health [HL-67919, HL-73859, HL-07963]; American Heart Association [AHA9930255N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073859, K02HL067919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL-67919, HL-73859 and HL-07963) and by a Scientist Development Grant from the American Heart Association (AHA9930255N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALKJAER C, 1988, J PHYSIOL-LONDON, V402, P391, DOI 10.1113/jphysiol.1988.sp017211; Aalkjaer C, 1997, ACTA PHYSIOL SCAND, V161, P557, DOI 10.1046/j.1365-201X.1997.00263.x; Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Aversa CR, 1997, AM J PHYSIOL-LUNG C, V273, pL848, DOI 10.1152/ajplung.1997.273.4.L848; BERK BC, 1990, J BIOL CHEM, V265, P17334; Bialecki RA, 1999, PULM PHARMACOL THER, V12, P303, DOI 10.1006/pupt.1999.0211; Biswas P, 2005, AM J PHYSIOL-RENAL, V288, pF8, DOI 10.1152/ajprenal.00435.2003; BOBIK A, 1991, AM J PHYSIOL, V260, pC581, DOI 10.1152/ajpcell.1991.260.3.C581; BONVALLET ST, 1994, AM J PHYSIOL, V266, pH1327, DOI 10.1152/ajpheart.1994.266.4.H1327; Bouallegue A, 2007, CURR VASC PHARMACOL, V5, P45, DOI 10.2174/157016107779317161; Chen SJ, 1997, J CARDIOVASC PHARM, V29, P713, DOI 10.1097/00005344-199706000-00003; CODY RJ, 1992, CIRCULATION, V85, P504, DOI 10.1161/01.CIR.85.2.504; DANTHULURI NR, 1990, J PHARMACOL EXP THER, V254, P393; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; DICARLO VS, 1995, AM J PHYSIOL-LUNG C, V269, pL690, DOI 10.1152/ajplung.1995.269.5.L690; Ebata S, 1999, KIDNEY INT, V56, P1400, DOI 10.1046/j.1523-1755.1999.00674.x; EDDAHIBI S, 1995, AM J PHYSIOL-HEART C, V268, pH828, DOI 10.1152/ajpheart.1995.268.2.H828; ELTON TS, 1992, AM J PHYSIOL, V263, pR1260, DOI 10.1152/ajpregu.1992.263.6.R1260; Frasch HF, 1999, AM J PHYSIOL-LUNG C, V276, pL304, DOI 10.1152/ajplung.1999.276.2.L304; Galie N, 2004, CARDIOVASC RES, V61, P227, DOI 10.1016/j.cardiores.2003.11.026; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; GRIENDLING KK, 1989, J BIOL CHEM, V264, P8237; GUNTUPALLI J, 1994, AM J PHYSIOL, V266, pF658, DOI 10.1152/ajprenal.1994.266.4.F658; He JQ, 2000, J PHYSIOL-LONDON, V524, P807, DOI 10.1111/j.1469-7793.2000.00807.x; Hersch E, 2004, AM J PHYSIOL-CELL PH, V287, pC1209, DOI 10.1152/ajpcell.00198.2004; Homma N, 2007, J CARDIOVASC PHARM, V50, P697, DOI 10.1097/FJC.0b013e3181593774; HUBEL CA, 1995, BIOCHEM J, V310, P1013, DOI 10.1042/bj3101013; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; JANAKIDEVI K, 1992, AM J PHYSIOL, V263, pC1295, DOI 10.1152/ajpcell.1992.263.6.C1295; Kawanabe Y, 2002, J CARDIOVASC PHARM, V40, P307, DOI 10.1097/00005344-200208000-00016; Koliakos G, 2007, ANN NY ACAD SCI, V1095, P274, DOI 10.1196/annals.1397.031; LAPOINTE MS, 1994, AM J MED SCI, V307, pS9; LI H, 1994, AM J PHYSIOL, V266, pL553, DOI 10.1152/ajplung.1994.266.5.L553; LI HB, 1994, J APPL PHYSIOL, V77, P1451, DOI 10.1152/jappl.1994.77.3.1451; LONCHAMPT MO, 1991, AM J HYPERTENS, V4, P776, DOI 10.1093/ajh/4.9.776; LUCCHESI PA, 1995, CARDIOVASC RES, V29, P172, DOI 10.1016/0008-6363(96)88566-X; Luke T, 2012, AM J PHYSIOL-LUNG C, V302, pL1128, DOI 10.1152/ajplung.00396.2011; LUSCHER TF, 1992, AM REV RESPIR DIS, V146, pS56; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Madden JA, 2001, AM J PHYSIOL-LUNG C, V280, pL264, DOI 10.1152/ajplung.2001.280.2.L264; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; MITSUKA M, 1993, CIRC RES, V73, P269, DOI 10.1161/01.RES.73.2.269; MITSUKA M, 1991, AM J PHYSIOL, V260, pC562, DOI 10.1152/ajpcell.1991.260.3.C562; Mukherjee R, 2006, CIRCULATION, V114, pI308, DOI 10.1161/CIRCULATIONAHA.105.001388; Muto S, 2000, KIDNEY INT, V57, P2319, DOI 10.1046/j.1523-1755.2000.00092.x; Nakanishi K, 1999, LAB INVEST, V79, P1347; NEYLON CB, 1990, CIRC RES, V67, P814, DOI 10.1161/01.RES.67.4.814; Quinn DA, 1996, AM J RESP CELL MOL, V14, P139, DOI 10.1165/ajrcmb.14.2.8630263; QUINN DA, 1991, AM J RESP CELL MOL, V5, P586, DOI 10.1165/ajrcmb/5.6.586; Quinn DA, 1998, AM J RESP CRIT CARE, V157, P1263, DOI 10.1164/ajrccm.157.4.9704106; Raymond MN, 2006, ENDOCRINOLOGY, V147, P5873, DOI 10.1210/en.2006-0291; Rios EJ, 2005, AM J PHYSIOL-LUNG C, V289, pL867, DOI 10.1152/ajplung.00455.2004; Rodriguez-Vita J, 2005, CIRC RES, V97, P125, DOI 10.1161/01.RES.0000174614.74469.83; Rubens C, 2001, CHEST, V120, P1562, DOI 10.1378/chest.120.5.1562; Shimoda L, 1998, AM J PHYSIOL-LUNG C, V274, pL842, DOI 10.1152/ajplung.1998.274.5.L842; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL1115, DOI 10.1152/ajplung.2001.281.5.L1115; STELZNER TJ, 1992, AM J PHYSIOL, V262, pL614, DOI 10.1152/ajplung.1992.262.5.L614; Stenmark KR, 2010, PEDIATR CRIT CARE ME, V11, pS85, DOI 10.1097/PCC.0b013e3181c76db3; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; Touyz RM, 1997, HYPERTENSION, V30, P1440, DOI 10.1161/01.HYP.30.6.1440; WALTER R, 1995, PFLUG ARCH EUR J PHY, V430, P137, DOI 10.1007/BF00373849; Wedgwood S, 2001, AM J PHYSIOL-LUNG C, V281, pL1058, DOI 10.1152/ajplung.2001.281.5.L1058; Weigand L, 2006, AM J PHYSIOL-LUNG C, V290, pL284, DOI 10.1152/ajplung.00449.2004; Woodsome TP, 2006, J CELL SCI, V119, P1769, DOI 10.1242/jcs.02805; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yang XJ, 2007, AM J PHYSIOL-RENAL, V293, pF1054, DOI 10.1152/ajprenal.00295.2007; Yu LY, 2008, AM J RESP CRIT CARE, V177, P1276, DOI 10.1164/rccm.200710-1522OC	70	29	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46303	10.1371/journal.pone.0046303	http://dx.doi.org/10.1371/journal.pone.0046303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029469	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900128
J	Vankemmelbeke, M; O'Shea, P; James, R; Penfold, CN				Vankemmelbeke, Mireille; O'Shea, Paul; James, Richard; Penfold, Christopher N.			Interaction of Nuclease Colicins with Membranes: Insertion Depth Correlates with Bilayer Perturbation	PLOS ONE			English	Article							IMMUNITY PROTEIN RELEASE; OUTER-MEMBRANE; CYTOTOXIC DOMAIN; PHOSPHOLIPID-MEMBRANES; ANTIMICROBIAL PEPTIDES; ENDOPLASMIC-RETICULUM; ENDONUCLEASE TOXIN; ESCHERICHIA-COLI; ALPHA-SARCIN; OMPF PORIN	Background: Protein transport across cellular membranes is an important aspect of toxin biology. Escherichia coli cell killing by nuclease colicins occurs through DNA (DNases) or RNA (RNases) hydrolysis and to this end their cytotoxic domains require transportation across two sets of membranes. In order to begin to unravel the molecular mechanisms underlying the membrane translocation of colicin nuclease domains, we have analysed the membrane association of four DNase domains (E9, a charge reduction E9 mutant, E8, and E7) and one ribosomal RNase domain (E3) using a biomembrane model system. Principal Results: We demonstrate, through the use of large unilamellar vesicles composed of synthetic and E. coli lipids and a membrane surface potential sensor, that the colicin nuclease domains bind anionic membranes only, with micromolar affinity and via a cooperative binding mechanism. The evaluation of the nuclease bilayer insertion depth, through a fluorescence quenching analysis using brominated lipids, indicates that the nucleases locate to differential regions in the bilayer. Colicin DNases target the interfacial region of the lipid bilayer, with the DNase E7 showing the deepest insertion, whereas the ribosomal RNase E3 penetrates into the hydrophobic core region of the bilayer. Furthermore, the membrane association of the DNase E7 and the ribosomal RNase E3 induces vesicle aggregation, lipid mixing and content leakage to a much larger extent than that of the other DNases analysed. Conclusions/Significance: Our results show, for the first time, that after the initial electrostatically driven membrane association, the pleiotropic membrane effects induced by colicin nuclease domains relate to their bilayer insertion depth and may be linked to their in vivo membrane translocation.	[Vankemmelbeke, Mireille; James, Richard; Penfold, Christopher N.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [O'Shea, Paul] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Vankemmelbeke, M (corresponding author), Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England.	mireille.vankemmelbeke@nottingham.ac.uk	James, Richard/B-2252-2009	O'Shea, paul/0000-0001-9313-8313; James, Richard/0000-0002-5086-788X; Penfold, Christopher/0000-0003-3251-5650; Vankemmelbeke, Mireille/0000-0002-8100-813X	Wellcome Trust [082045/B/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Programme grant (082045/B/07/Z) from the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2012, CURR PHARM BIOTECHNO, V13, P1446, DOI 10.2174/138920112800784835; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Alvarez-Garcia E, 2009, ARCH BIOCHEM BIOPHYS, V481, P37, DOI 10.1016/j.abb.2008.10.012; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; Antignani A, 2008, P NATL ACAD SCI USA, V105, P8020, DOI 10.1073/pnas.0711707105; Baboolal TG, 2008, STRUCTURE, V16, P371, DOI 10.1016/j.str.2007.12.023; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chak KF, 1998, PROTEINS, V32, P17, DOI 10.1002/(SICI)1097-0134(19980701)32:1<17::AID-PROT4>3.0.CO;2-B; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duche D, 2006, J BACTERIOL, V188, P8593, DOI 10.1128/JB.00941-06; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; GarinotSchneider C, 1997, MICROBIOL-SGM, V143, P2931, DOI 10.1099/00221287-143-9-2931; GASSET M, 1995, BBA-PROTEIN STRUCT M, V1252, P43, DOI 10.1016/0167-4838(95)00106-5; GASSET M, 1990, BIOCHEM J, V265, P815, DOI 10.1042/bj2650815; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gillor O, 2008, APPL MICROBIOL BIOT, V81, P591, DOI 10.1007/s00253-008-1726-5; Golding C, 1996, BIOCHEMISTRY-US, V35, P10931, DOI 10.1021/bi960905i; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Inoue T, 2011, ANNU REV MICROBIOL, V65, P287, DOI 10.1146/annurev-micro-090110-102855; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacadena J, 2007, FEMS MICROBIOL REV, V31, P212, DOI 10.1111/j.1574-6976.2006.00063.x; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matsuzaki K, 2000, BBA-BIOMEMBRANES, V1467, P219, DOI 10.1016/S0005-2736(00)00223-6; Montalban-Lopez M, 2011, CURR PHARM BIOTECHNO, V12, P1205, DOI 10.2174/138920111796117364; Moreno MR, 2007, BIOCHEMISTRY-US, V46, P10572, DOI 10.1021/bi700911g; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Ng CL, 2010, NAT STRUCT MOL BIOL, V17, P1241, DOI 10.1038/nsmb.1896; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; Ramamurthi KS, 2010, CURR OPIN MICROBIOL, V13, P753, DOI 10.1016/j.mib.2010.09.014; Saeki D, 2008, J COLLOID INTERF SCI, V320, P611, DOI 10.1016/j.jcis.2007.12.002; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Sun J, 2004, EUR BIOPHYS J BIOPHY, V33, P572, DOI 10.1007/s00249-004-0400-9; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Top D, 2012, J BIOL CHEM, V287, P3403, DOI 10.1074/jbc.M111.305268; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van Dalen A, 2004, BBA-MOL CELL RES, V1694, P97, DOI 10.1016/j.bbamcr.2004.03.007; van den Bremer ETJ, 2004, PROTEIN SCI, V13, P1391, DOI 10.1110/ps.03508204; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WALLIS R, 1992, EUR J BIOCHEM, V210, P923, DOI 10.1111/j.1432-1033.1992.tb17496.x; Whittaker SBM, 1998, J BIOMOL NMR, V12, P145, DOI 10.1023/A:1008272928173; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zakharov SD, 2006, BIOCHEMISTRY-US, V45, P10199, DOI 10.1021/bi060694+	74	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46656	10.1371/journal.pone.0046656	http://dx.doi.org/10.1371/journal.pone.0046656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029560	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900194
J	Bennett, RL; Carruthers, AL; Hui, T; Kerney, KR; Liu, XF; May, WS				Bennett, Richard L.; Carruthers, Aubrey L.; Hui, Teng; Kerney, Krystal R.; Liu, Xiangfei; May, W. Stratford, Jr.			Increased Expression of the dsRNA-Activated Protein Kinase PKR in Breast Cancer Promotes Sensitivity to Doxorubicin	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR FUNCTION; UP-REGULATION; RNA; INTERFERON; GENE; CELLS; P53; LEUKEMIA; STRESS	It has been reported that the expression and activity of the interferon-inducible, dsRNA-dependent protein kinase, PKR, is increased in mammary carcinoma cell lines and primary tumor samples. To extend these findings and determine how PKR signaling may affect breast cancer cell sensitivity to chemotherapy, we measured PKR expression by immunohistochemical staining of 538 cases of primary breast cancer and normal tissues. Significantly, PKR expression was elevated in ductal, lobular and squamous cell carcinomas or lymph node metastases but not in either benign tumor specimens or cases of inflammation compared to normal tissues. Furthermore, PKR expression was increased in precancerous stages of mammary cell hyperplasia and dysplasia compared to normal tissues, indicating that PKR expression may be upregulated by the process of tumorigenesis. To test the function of PKR in breast cancer, we generated MCF7, T-47D and MDA-MB-231 breast cancer cell lines with significantly reduced PKR expression by siRNA knockdown. Importantly, while knockdown of PKR expression had no effect on cell proliferation under normal growth conditions, MCF7, T-47D or MDA-MB-231 cells with reduced PKR expression or treated with a small molecule PKR inhibitor were significantly less sensitive to doxorubicin or H2O2-induced toxicity compared to control cells. In addition, the rate of eIF2 alpha phosphorylation following treatment with doxorubicin was delayed in breast cancer cell lines with decreased PKR expression. Significantly, treatment of breast cancer lines with reduced PKR expression with either interferon-alpha, which increases PKR expression, or salubrinal, which increases eIF2 alpha phosphorylation, restored doxorubicin sensitivity to normal levels. Taken together these results indicate that increased PKR expression in primary breast cancer tissues may serve as a biomarker for response to doxorubicin-containing chemotherapy and that future therapeutic approaches to promote PKR expression/activation and eIF2 alpha phosphorylation may be beneficial for the treatment of breast cancer.	[May, W. Stratford, Jr.] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32611 USA; Univ Florida, Univ Florida Shands Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	May, WS (corresponding author), Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL 32611 USA.	smay@ufl.edu	Liu, Xiangfei/F-3708-2017; Bennett, Richard/ABF-9211-2021	Bennett, Richard/0000-0002-0243-2443; Kerney, Krystal/0000-0003-4134-0020	NIH/NHLBI [R01-HL054083]; University of Florida; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054083] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Florida(University of Florida); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant NIH/NHLBI R01-HL054083. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ann Fu and the University of Florida's molecular pathology core for excellent technical assistance. In addition, K. K. was a participant in the University Scholar's Program, and T. H. was a participant in the HHMI-UF Science for Life Program. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund.	Garcia MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023887; BARBER GN, 1993, GENOMICS, V16, P765, DOI 10.1006/geno.1993.1262; Basu S, 1997, CANCER RES, V57, P943; Bennett RL, 2006, BLOOD, V108, P821, DOI 10.1182/blood-2005-11-006817; Bennett RL, 2012, CELL CYCLE, V11, P407, DOI 10.4161/cc.11.2.18999; Beretta L, 1996, ONCOGENE, V12, P1593; BERGER R, 1987, CANCER GENET CYTOGEN, V29, P9, DOI 10.1016/0165-4608(87)90026-4; BERGER R, 1988, CANCER GENET CYTOGEN, V34, P11, DOI 10.1016/0165-4608(88)90161-6; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cuddihy AR, 1999, MOL CELL BIOL, V19, P2475; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Deb A, 2001, EMBO J, V20, P2487, DOI 10.1093/emboj/20.10.2487; DONZE O, 1995, EMBO J, V14, P3828, DOI 10.1002/j.1460-2075.1995.tb00052.x; Gil J, 2001, ONCOGENE, V20, P385, DOI 10.1038/sj.onc.1204109; Haines GK, 1998, TUMOR BIOL, V19, P52, DOI 10.1159/000029974; Hii SI, 2004, INT J CANCER, V109, P329, DOI 10.1002/ijc.11714; Ishii T, 2001, ONCOGENE, V20, P1900, DOI 10.1038/sj.onc.1204267; ITO T, 1994, P NATL ACAD SCI USA, V91, P7455, DOI 10.1073/pnas.91.16.7455; Kim SH, 2002, ONCOGENE, V21, P8741, DOI 10.1038/sj.onc.1205987; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; KIRCHHOFF S, 1995, ONCOGENE, V11, P439; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Kuyama M, 2003, J DERMATOL, V30, P579, DOI 10.1111/j.1346-8138.2003.tb00439.x; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; Murad JM, 2005, BLOOD CELL MOL DIS, V34, P1, DOI 10.1016/j.bcmd.2004.08.025; Nussbaum JM, 2003, CANCER LETT, V196, P207, DOI 10.1016/S0304-3835(03)00276-3; Pataer A, 2010, CLIN CANCER RES, V16, P5522, DOI 10.1158/1078-0432.CCR-10-0753; Peidis P, 2010, CELL DEATH DIFFER, P1; Shir A, 2002, NAT BIOTECHNOL, V20, P895, DOI 10.1038/nbt730; SQUIRE J, 1993, GENOMICS, V16, P768, DOI 10.1006/geno.1993.1263; Tam NWN, 1999, EUR J BIOCHEM, V262, P149, DOI 10.1046/j.1432-1327.1999.00360.x; TANAKA H, 1995, GENE, V153, P283, DOI 10.1016/0378-1119(94)00821-9; Tanaka H, 2000, GENE, V246, P373, DOI 10.1016/S0378-1119(00)00080-9; TANAKA H, 1994, P NATL ACAD SCI USA, V91, P7995, DOI 10.1073/pnas.91.17.7995; Watanabe MAE, 2003, EUR J PHARMACOL, V465, P205, DOI 10.1016/S0014-2999(03)01480-8; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wong AHT, 1997, EMBO J, V16, P1291, DOI 10.1093/emboj/16.6.1291; Wong AHT, 2001, J BIOL CHEM, V276, P13727, DOI 10.1074/jbc.M011240200; Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000	41	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46040	10.1371/journal.pone.0046040	http://dx.doi.org/10.1371/journal.pone.0046040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029376	Green Submitted, gold, Green Published			2022-12-25	WOS:000309554700109
J	Coltri, PP; Oliveira, CC				Coltri, Patricia P.; Oliveira, Carla C.			Cwc24p Is a General Saccharomyces cerevisiae Splicing Factor Required for the Stable U2 snRNP Binding to Primary Transcripts	PLOS ONE			English	Article							PRE-MESSENGER-RNA; DEPENDENT ATPASE; RIBOSOMAL-RNA; PRP2 PROTEIN; BRANCH SITE; 19 COMPLEX; SPLICEOSOME; YEAST; STEP; CORE	Splicing of primary transcripts is an essential process for the control of gene expression. Specific conserved sequences in premature transcripts are important to recruit the spliceosome machinery. The Saccharomyces cerevisiae catalytic spliceosome is composed of about 60 proteins and 5 snRNAs (U1, U2, U4/U6 and U5). Among these proteins, there are core components and regulatory factors, which might stabilize or facilitate splicing of specific substrates. Assembly of a catalytic complex depends on the dynamics of interactions between these proteins and RNAs. Cwc24p is an essential S. cerevisiae protein, originally identified as a component of the NTC complex, and later shown to affect splicing in vivo. In this work, we show that Cwc24p also affects splicing in vitro. We show that Cwc24p is important for the U2 snRNP binding to primary transcripts, co-migrates with spliceosomes, and that it interacts with Brr2p. Additionally, we show that Cwc24p is important for the stable binding of Prp19p to the spliceosome. We propose a model in which Cwc24p is required for stabilizing the U2 association with primary transcripts, and therefore, especially important for splicing of RNAs containing non- consensus branchpoint sequences.	[Coltri, Patricia P.; Oliveira, Carla C.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, CC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	ccoliv@iq.usp.br	Oliveira, Carla C/F-2323-2011; Coltri, Patricia P./E-6294-2014	Oliveira, Carla C/0000-0002-1098-9241; Coltri, Patricia P./0000-0001-8447-7516	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [09/52826-4]; FAPESP fellowship [09/52176-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (09/52826-4 to C.C.O.). P.P.C. was recipient of a FAPESP fellowship (09/52176-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; CHAMPIONARNAUD P, 1994, GENE DEV, V8, P1974, DOI 10.1101/gad.8.16.1974; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Goldfeder MB, 2008, J BIOL CHEM, V283, P2644, DOI 10.1074/jbc.M707885200; Gonzales FA, 2005, J MOL BIOL, V346, P437, DOI 10.1016/j.jmb.2004.11.071; Grainger RJ, 2009, RNA, V15, P2161, DOI 10.1261/rna.1908309; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hirose T, 2003, MOL CELL, V12, P113, DOI 10.1016/S1097-2765(03)00267-3; Hirose T, 2006, MOL CELL, V23, P673, DOI 10.1016/j.molcel.2006.07.011; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Khanna M, 2009, RNA, V15, P2174, DOI 10.1261/rna.1790509; KING DS, 1990, NUCLEIC ACIDS RES, V18, P6559, DOI 10.1093/nar/18.22.6559; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McGrail JC, 2009, NUCLEIC ACIDS RES, V37, P4205, DOI 10.1093/nar/gkp341; Meyer Markus, 2009, Briefings in Functional Genomics & Proteomics, V8, P60, DOI 10.1093/bfgp/elp002; Mishra SK, 2011, NATURE, V474, P173, DOI 10.1038/nature10143; Munding EM, 2010, GENE DEV, V24, P2693, DOI 10.1101/gad.1977410; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Ohrt T, 2012, RNA, V18, P1244, DOI 10.1261/rna.033316.112; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Qiu ZCR, 2011, NUCLEIC ACIDS RES, V39, P3427, DOI 10.1093/nar/gkq1328; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Saha D, 2012, J BIOL CHEM, V287, P5390, DOI 10.1074/jbc.M111.298547; Sambrook J., 2002, MOL CLONING LAB MANU; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Smith DJ, 2008, MOL CELL, V30, P657, DOI 10.1016/j.molcel.2008.04.013; Spingola M, 2004, NUCLEIC ACIDS RES, V32, P1242, DOI 10.1093/nar/gkh281; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Stevens SW, 2002, METHOD ENZYMOL, V351, P200; Tseng CK, 2011, RNA, V17, P145, DOI 10.1261/rna.2459611; Vincenti S, 2007, RNA, V13, P138, DOI 10.1261/rna.251907; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Will CL, 2010, COLD SPRING HARB PER; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; Yeh TC, 2011, MOL CELL BIOL, V31, P43, DOI 10.1128/MCB.00801-10; Zanchin NIT, 1997, MOL CELL BIOL, V17, P5001, DOI 10.1128/MCB.17.9.5001	50	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45678	10.1371/journal.pone.0045678	http://dx.doi.org/10.1371/journal.pone.0045678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029180	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700057
J	Chadwick, AC; Sahoo, D				Chadwick, Alexandra C.; Sahoo, Daisy			Functional Characterization of Newly-Discovered Mutations in Human SR-BI	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; CELLULAR CHOLESTEROL EFFLUX; TERMINAL TRANSMEMBRANE DOMAIN; SELECTIVE LIPID UPTAKE; TRANSPORT IN-VIVO; SCAVENGER RECEPTOR; HDL CHOLESTEROL; PLASMA HDL; EXTRACELLULAR DOMAIN	In rodents, SR-BI has been firmly established as a physiologically relevant HDL receptor that mediates removal of HDL-cholesteryl esters (CE). However, its role in human lipoprotein metabolism is less defined. Recently, two unique point mutations in human SR-BI - S112F or T175A - were identified in subjects with high HDL-cholesterol (HDL-C) levels. We hypothesized that mutation of these conserved residues would compromise the cholesterol-transport functions of SR-BI. To test this hypothesis, S112F- and T175A-SR-BI were generated by site-directed mutagenesis. Cell surface expression was confirmed for both mutant receptors in COS-7 cells upon transient transfection, albeit at lower levels for T175A-SR-BI. Both mutant receptors displayed defective HDL binding, selective uptake of HDL-CE and release of free cholesterol (FC) from cells to HDL. Mutant receptors were also unable to re-organize plasma membrane pools of FC. While these impaired functions were independent of receptor oligomerization, inability of T175A-SR-BI to mediate cholesterol-transport functions could be related to altered N-linked glycosylation status. In conclusion, high HDL-C levels observed in carriers of S112F- or T175A-SRBI mutant receptors are consistent with the inability of these SR-BI receptors to mediate efficient selective uptake of HDL-CE, and suggest that increased plasma HDL concentrations in these settings may not be associated with lower risk of cardiovascular disease.	[Chadwick, Alexandra C.; Sahoo, Daisy] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Div Endocrinol Metab & Clin Nutr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	dsahoo@mcw.edu			National Institutes of Health [NIHR01HL58012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health NIHR01HL58012. http://www.nhlbi.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; Ashida A, 2007, PEDIATR NEPHROL, V22, P670, DOI 10.1007/s00467-006-0388-8; Athyros VG, 2012, J CARDIOVASC MED, V13, P254, DOI 10.2459/JCM.0b013e3283522422; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brunham LR, 2011, CLIN GENET, V79, P575, DOI 10.1111/j.1399-0004.2011.01682.x; Cao GP, 1997, J BIOL CHEM, V272, P33068, DOI 10.1074/jbc.272.52.33068; Connelly MA, 2003, J BIOL CHEM, V278, P25773, DOI 10.1074/jbc.M302820200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Duong M, 2006, ARTERIOSCL THROM VAS, V26, P541, DOI 10.1161/01.ATV.0000203515.25574.19; Feys HB, 2009, BLOOD, V114, P4749, DOI 10.1182/blood-2009-07-230615; Gaidukov L, 2011, J BIOL CHEM, V286, P18452, DOI 10.1074/jbc.M111.229872; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; GLASS C, 1985, J BIOL CHEM, V260, P744; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo L, 2011, J LIPID RES, V52, P2272, DOI 10.1194/jlr.M019091; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; Hewing B, 2012, CURR OPIN LIPIDOL; Hsu LA, 2003, ARTERIOSCL THROM VAS, V23, P1869, DOI 10.1161/01.ATV.0000082525.84814.A9; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Imjeti NS, 2011, MOL BIOL CELL, V22, P4621, DOI 10.1091/mbc.E11-04-0320; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jang DS, 2004, BIOCHEM J, V382, P967, DOI 10.1042/BJ20031871; Ji AL, 2011, ATHEROSCLEROSIS, V217, P106, DOI 10.1016/j.atherosclerosis.2011.03.017; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Ji Y, 1999, J BIOL CHEM, V274, P33398, DOI 10.1074/jbc.274.47.33398; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; Oram JF, 1996, J LIPID RES, V37, P2473; Papale GA, 2011, BIOCHEMISTRY-US, V50, P6245, DOI 10.1021/bi2005625; Papale GA, 2010, ARCH BIOCHEM BIOPHYS, V496, P132, DOI 10.1016/j.abb.2010.02.011; Parathath S, 2004, J BIOL CHEM, V279, P24976, DOI 10.1074/jbc.M402435200; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reaven E, 2004, J LIPID RES, V45, P513, DOI 10.1194/jlr.M300370-JLR200; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Sahoo D, 2007, BBA-MOL CELL BIOL L, V1771, P807, DOI 10.1016/j.bbalip.2006.03.003; Stylianou IM, 2012, CIRC RES, V110, P337, DOI 10.1161/CIRCRESAHA.110.230854; Swarnakar S, 1999, J BIOL CHEM, V274, P29733, DOI 10.1074/jbc.274.42.29733; Trigatti BL, 2000, BBA-MOL CELL BIOL L, V1529, P276, DOI 10.1016/S1388-1981(00)00154-2; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Ueda Y, 1999, J BIOL CHEM, V274, P7165, DOI 10.1074/jbc.274.11.7165; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Wild S, 2008, HEART, V94, P692, DOI 10.1136/hrt.2007.126326; Yancey PG, 2007, J LIPID RES, V48, P1140, DOI 10.1194/jlr.M600539-JLR200; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD; Yvan-Charvet L, 2008, J LIPID RES, V49, P107, DOI 10.1194/jlr.M700200-JLR200; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	70	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45660	10.1371/journal.pone.0045660	http://dx.doi.org/10.1371/journal.pone.0045660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029167	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800073
J	Greliche, N; Zeller, T; Wild, PS; Rotival, M; Schillert, A; Ziegler, A; Deloukas, P; Erdmann, J; Hengstenberg, C; Ouwehand, WH; Samani, NJ; Schunkert, H; Munzel, T; Lackner, KJ; Cambien, F; Goodall, AH; Tiret, L; Blankenberg, S; Tregouet, DA				Greliche, Nicolas; Zeller, Tanja; Wild, Philipp S.; Rotival, Maxime; Schillert, Arne; Ziegler, Andreas; Deloukas, Panos; Erdmann, Jeanette; Hengstenberg, Christian; Ouwehand, Willem H.; Samani, Nilesh J.; Schunkert, Heribert; Munzel, Thomas; Lackner, Karl J.; Cambien, Francois; Goodall, Alison H.; Tiret, Laurence; Blankenberg, Stefan; Tregouet, David-Alexandre		Cardiogenics Consortium	Comprehensive Exploration of the Effects of miRNA SNPs on Monocyte Gene Expression	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HISTONE DEACETYLASE 6; MICRORNA TARGETS; LUNG-CANCER; DISEASES; SUSCEPTIBILITY; BINDING; LOCUS; IDENTIFICATION; PREDICTION	We aimed to assess whether pri-miRNA SNPs (miSNPs) could influence monocyte gene expression, either through marginal association or by interacting with polymorphisms located in 3'UTR regions (3utrSNPs). We then conducted a genome-wide search for marginal miSNPs effects and pairwise miSNPs x 3utrSNPs interactions in a sample of 1,467 individuals for which genome-wide monocyte expression and genotype data were available. Statistical associations that survived multiple testing correction were tested for replication in an independent sample of 758 individuals with both monocyte gene expression and genotype data. In both studies, the hsa-mir-1279 rs1463335 was found to modulate in cis the expression of LYZ and in trans the expression of CNTN6, CTRC, COPZ2, KRT9, LRRFIP1, NOD1, PCDHA6, ST5 and TRAF3IP2 genes, supporting the role of hsa-mir-1279 as a regulator of several genes in monocytes. In addition, we identified two robust miSNPs x 3utrSNPs interactions, one involving HLA-DPB1 rs1042448 and hsa-mir-219-1 rs107822, the second the H1F0 rs1894644 and hsa-mir-659 rs5750504, modulating the expression of the associated genes. As some of the aforementioned genes have previously been reported to reside at disease-associated loci, our findings provide novel arguments supporting the hypothesis that the genetic variability of miRNAs could also contribute to the susceptibility to human diseases.	[Greliche, Nicolas; Rotival, Maxime; Cambien, Francois; Tiret, Laurence; Tregouet, David-Alexandre] Univ Paris 06, INSERM, UMR S 937, Paris, France; [Greliche, Nicolas] Univ Paris 11, Paris, France; [Zeller, Tanja; Blankenberg, Stefan] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Wild, Philipp S.; Munzel, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Schillert, Arne; Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometrie & Stat, D-23538 Lubeck, Germany; [Deloukas, Panos; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Hinxton, England; [Erdmann, Jeanette; Schunkert, Heribert] Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Gen Hosp, Natl Inst Hlth Res Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Dept Clin Chem, Univ Med Ctr, Mainz, Germany; [Tregouet, David-Alexandre] Univ Paris 06, ICAN, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; University of Lubeck; Wellcome Trust Sanger Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Regensburg; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Johannes Gutenberg University of Mainz; UDICE-French Research Universities; Sorbonne Universite	Tregouet, DA (corresponding author), Univ Paris 06, INSERM, UMR S 937, Paris, France.	david.tregouet@upmc.fr	Wild, Philipp S./M-2106-2019; Trégouët, David-Alexandre/P-9210-2019; Greliche, Nicolas/P-4180-2015; Munzel, Thomas/A-2912-2014; Deloukas, Panos/B-2922-2013; Tregouet, David-Alexandre/E-3961-2016; Erdmann, Jeanette/A-4417-2009; Erdmann, Jeanette/P-7513-2014; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; Ziegler, Andreas/G-4246-2012	Trégouët, David-Alexandre/0000-0001-9084-7800; Greliche, Nicolas/0000-0003-0683-2257; Munzel, Thomas/0000-0001-5503-4150; Deloukas, Panos/0000-0001-9251-070X; Erdmann, Jeanette/0000-0002-4486-6231; Ziegler, Andreas/0000-0002-8386-5397; Maouche, Seraya/0000-0001-8186-1635; Matvienko-Sikar, Karen/0000-0003-2777-6581; Nelson, Christopher/0000-0001-8025-2897; Wild, Philipp/0000-0003-4413-9752; Goodall, Alison/0000-0002-7883-9645; Rendon, Augusto/0000-0001-8994-0039; Ouwehand, Willem/0000-0002-7744-1790; Wallace, Chris/0000-0001-9755-1703; Rotival, Maxime/0000-0003-2519-8044; Zeller, Tanja/0000-0003-3379-2641	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'') [AZ 961-386261/733]; Johannes Gutenberg-University of Mainz; Boehringer Ingelheim; PHILIPS Medical Systems; National Genome Network "NGFNplus'' [A3 01GS0833, 01GS0831]; Federal Ministry of Education and Research, Germany [BMBF 01KU0908A]; Agence Nationale de la Recherche, France [ANR 09 GENO 106 01]; European Union [LSHM-CT-2006-037593]; British Heart Foundation; Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; NIHR Cambridge Biomedical Research Centre; Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM); Genomic Network of the Pierre and Marie Curie University (Paris 06); British Heart Foundation [RG/09/012/28096] Funding Source: researchfish	government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation''); Johannes Gutenberg-University of Mainz; Boehringer Ingelheim(Boehringer Ingelheim); PHILIPS Medical Systems; National Genome Network "NGFNplus''; Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Agence Nationale de la Recherche, France(French National Research Agency (ANR)); European Union(European Commission); British Heart Foundation(British Heart Foundation); Leicester NIHR Biomedical Research Unit in Cardiovascular Disease; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM)(Region Ile-de-France); Genomic Network of the Pierre and Marie Curie University (Paris 06); British Heart Foundation(British Heart Foundation)	The Gutenberg Health Study is funded through the government of Rheinland-Pfalz ("Stiftung Rheinland Pfalz fur Innovation'', contract AZ 961-386261/733), the research programs "Wissen schafft Zukunft'' and "Schwerpunkt Vaskulare Pravention'' of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. The present study was supported by the National Genome Network "NGFNplus'' (contract A3 01GS0833 and 01GS0831) and by a joint funding from the Federal Ministry of Education and Research, Germany (contract BMBF 01KU0908A) and from the Agence Nationale de la Recherche, France (contract ANR 09 GENO 106 01) for the project CARDomics. CARDIOGENICS was funded by the European Union FP6 program (LSHM-CT-2006-037593). NJ Samani holds a Chair supported by the British Heart Foundation. Work described in this paper is part of the research portfolio supported by the Leicester NIHR Biomedical Research Unit in Cardiovascular Disease. Collection of the Cardiogenics controls was part supported through the Cambridge Bioresource, which is funded by the NIHR Cambridge Biomedical Research Centre. Statistical analyses benefit from the C2BIG computing centre funded by the Fondation pour la Recherche Medicale, La Region Ile de France (CODDIM) and the Genomic Network of the Pierre and Marie Curie University (Paris 06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barenboim M, 2010, HUM MUTAT, V31, P1223, DOI 10.1002/humu.21349; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castagne R, 2011, GENOMICS, V98, P320, DOI 10.1016/j.ygeno.2011.06.009; Castagne R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023956; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dalmasso C, 2008, GENETICS, V180, P697, DOI 10.1534/genetics.108.089839; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Fernandez-Hernando C, 2011, CURR OPIN LIPIDOL, V22, P86, DOI 10.1097/MOL.0b013e3283428d9d; Fiesel FC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-64; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hughes AE, 2011, AM J HUM GENET; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Inaoka H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-112; Inaoka H, 2007, P NATL ACAD SCI USA, V104, P5020, DOI 10.1073/pnas.0611078104; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kominami S, 2009, J HUM GENET, V54, P108, DOI 10.1038/jhg.2008.15; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leeper NJ, 2011, CIRCULATION, V123, P236, DOI 10.1161/CIRCULATIONAHA.110.003855; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shah S, 2011, CIRC CARDIOVASC GENE; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Slaby O, 2011, J CELL MOL MED; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tian T, 2009, CANCER EPIDEM BIOMAR, V18, P1183, DOI 10.1158/1055-9965.EPI-08-0814; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Verhelst H, 2011, EUR J PAEDIATR NEURO, V15, P163, DOI 10.1016/j.ejpn.2010.07.004; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; ZAMANI MG, 1994, AM J MED GENET, V54, P372, DOI 10.1002/ajmg.1320540417; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhou XD, 2009, ARTHRITIS RHEUM-US, V60, P3807, DOI 10.1002/art.24982	62	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45863	10.1371/journal.pone.0045863	http://dx.doi.org/10.1371/journal.pone.0045863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029284	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309392800110
J	Harrison, WJ; Mattingley, JB; Remington, RW				Harrison, William J.; Mattingley, Jason B.; Remington, Roger W.			Pre-Saccadic Shifts of Visual Attention	PLOS ONE			English	Article							EYE-MOVEMENTS; CORTEX; TARGET; SPACE; FIELD; MODEL	The locations of visual objects to which we attend are initially mapped in a retinotopic frame of reference. Because each saccade results in a shift of images on the retina, however, the retinotopic mapping of spatial attention must be updated around the time of each eye movement. Mathot and Theeuwes [1] recently demonstrated that a visual cue draws attention not only to the cue's current retinotopic location, but also to a location shifted in the direction of the saccade, the "future-field". Here we asked whether retinotopic and future-field locations have special status, or whether cue-related attention benefits exist between these locations. We measured responses to targets that appeared either at the retinotopic or future-field location of a brief, non-predictive visual cue, or at various intermediate locations between them. Attentional cues facilitated performance at both the retinotopic and future-field locations for cued relative to uncued targets, as expected. Critically, this cueing effect also occurred at intermediate locations. Our results, and those reported previously [1], imply a systematic bias of attention in the direction of the saccade, independent of any predictive remapping of attention that compensates for retinal displacements of objects across saccades [2].	[Harrison, William J.; Mattingley, Jason B.; Remington, Roger W.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mattingley, Jason B.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Harrison, WJ (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	willjharri@gmail.com	Mattingley, Jason/J-1537-2014; Harrison, William/C-7131-2018	Mattingley, Jason/0000-0003-0929-9216; Harrison, William/0000-0002-6408-0359	Australian Research Council [DP0666772]; Australia Research Council Laureate Fellowship	Australian Research Council(Australian Research Council); Australia Research Council Laureate Fellowship(Australian Research Council)	This research was funded by an Australian Research Council grant to RWR (DP0666772) and an Australia Research Council Laureate Fellowship to JBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Cavanagh P, 2010, TRENDS COGN SCI, V14, P147, DOI 10.1016/j.tics.2010.01.007; Cutzu F, 2003, VISION RES, V43, P205, DOI 10.1016/S0042-6989(02)00491-1; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Golomb JD, 2008, J NEUROSCI, V28, P10654, DOI 10.1523/JNEUROSCI.2525-08.2008; Golomb JD, 2011, ATTEN PERCEPT PSYCHO, V73, P7, DOI 10.3758/s13414-010-0016-3; Golomb JD, 2010, J NEUROSCI, V30, P10493, DOI 10.1523/JNEUROSCI.1546-10.2010; Golomb JD, 2010, J VISION, V10, DOI 10.1167/10.3.19; HUGHES HC, 1987, NEUROPSYCHOLOGIA, V25, P5, DOI 10.1016/0028-3932(87)90039-X; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mathot S, 2011, PHILOS T R SOC B, V366, P516, DOI 10.1098/rstb.2010.0187; Mathot S, 2010, EXP BRAIN RES, V200, P117, DOI 10.1007/s00221-009-2055-3; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Rizzolatti G, 1987, NEUROPSYCHOLOGIA; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; SHELIGA BM, 1994, EXP BRAIN RES, V98, P507; SHULMAN GL, 1979, J EXP PSYCHOL HUMAN, V5, P522, DOI 10.1037/0096-1523.5.3.522; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Szinte M, 2011, J VISION, V11, DOI 10.1167/11.2.4; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Zirnsak M, 2011, J NEUROSCI, V31, P17887, DOI 10.1523/JNEUROSCI.2465-11.2011; Zirnsak M, 2010, VISION RES, V50, P1328, DOI 10.1016/j.visres.2010.02.002	24	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45670	10.1371/journal.pone.0045670	http://dx.doi.org/10.1371/journal.pone.0045670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029175	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800077
J	Gleiss, S; Kayser, C				Gleiss, Stephanie; Kayser, Christoph			Audio-Visual Detection Benefits in the Rat	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; RHESUS-MONKEYS; VISUAL-PERCEPTION; AUDITORY-STIMULI; LOOMING SIGNALS; REACTION-TIME; SOUND; ENHANCEMENT; INFORMATION; CORTEX	Human psychophysical studies have described multisensory perceptual benefits such as enhanced detection rates and faster reaction times in great detail. However, the neural circuits and mechanism underlying multisensory integration remain difficult to study in the primate brain. While rodents offer the advantage of a range of experimental methodologies to study the neural basis of multisensory processing, rodent studies are still limited due to the small number of available multisensory protocols. We here demonstrate the feasibility of an audio-visual stimulus detection task for rats, in which the animals detect lateralized uni- and multi-sensory stimuli in a two-response forced choice paradigm. We show that animals reliably learn and perform this task. Reaction times were significantly faster and behavioral performance levels higher in multisensory compared to unisensory conditions. This benefit was strongest for dim visual targets, in agreement with classical patterns of multisensory integration, and was specific to task-informative sounds, while uninformative sounds speeded reaction times with little costs for detection performance. Importantly, multisensory benefits for stimulus detection and reaction times appeared at different levels of task proficiency and training experience, suggesting distinct mechanisms inducing these two multisensory benefits. Our results demonstrate behavioral multisensory enhancement in rats in analogy to behavioral patterns known from other species, such as humans. In addition, our paradigm enriches the set of behavioral tasks on which future studies can rely, for example to combine behavioral measurements with imaging or pharmacological studies in the behaving animal or to study changes of integration properties in disease models.	[Gleiss, Stephanie; Kayser, Christoph] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Kayser, Christoph] Bernstein Ctr Computat Neurosci, Tubingen, Germany	Max Planck Society	Kayser, C (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	christoph.kayser@tuebingen.mpg.de	Kayser, Christoph/A-3203-2012	Kayser, Christoph/0000-0001-7362-5704; Kayser, Stephanie/0000-0002-1577-6288	Max Planck Society; Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]	Max Planck Society(Max Planck Society); Bernstein Center for Computational Neuroscience, Tubingen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Max Planck Society and the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Caclin A, 2011, BRAIN RES, V1396, P35, DOI 10.1016/j.brainres.2011.04.016; Calvert G., 2004, HDB MULTISENSORY PRO; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; David N, 2011, AUTISM RES, V4, P383, DOI 10.1002/aur.210; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Doyle MC, 2001, PERCEPTION, V30, P795, DOI 10.1068/p3126; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Ghazanfar AA, 2002, P NATL ACAD SCI USA, V99, P15755, DOI 10.1073/pnas.242469699; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Hirokawa J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025283; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Jeffery KJ, 2007, BEHAV BRAIN RES, V183, P213, DOI 10.1016/j.bbr.2007.06.017; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Leo F, 2011, EXP BRAIN RES, V213, P193, DOI 10.1007/s00221-011-2742-8; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Mahoney JR, 2011, BRAIN RES, V1426, P43, DOI 10.1016/j.brainres.2011.09.017; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Meier P, 2011, J VIS, V11, P22; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; Nelson WT, 1998, HUM FACTORS, V40, P452, DOI 10.1518/001872098779591304; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Peiffer AM, 2007, NEUROREPORT, V18, P1077, DOI 10.1097/WNR.0b013e3281e72ae7; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Romei V, 2009, CURR BIOL, V19, P1799, DOI 10.1016/j.cub.2009.09.027; Sakata S, 2004, EXP BRAIN RES, V159, P409, DOI 10.1007/s00221-004-1962-6; SCHIFF W, 1962, SCIENCE, V136, P982, DOI 10.1126/science.136.3520.982; Schroeder C. E., 2004, COGN PROCESS, V5, P140; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P544, DOI 10.3758/BF03206045; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; STEIN BE, 1978, J NEUROPHYSIOL, V41, P55, DOI 10.1152/jn.1978.41.1.55; Stein BE., 1993, MERGING SENSES; Stevenson RA, 2012, EXP BRAIN RES, V219, P121, DOI 10.1007/s00221-012-3072-1; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383	55	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45677	10.1371/journal.pone.0045677	http://dx.doi.org/10.1371/journal.pone.0045677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029179	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000311313900167
J	Alemu, EA; Lamark, T; Torgersen, KM; Birgisdottir, AB; Larsen, KB; Jain, A; Olsvik, H; Overvatn, A; Kirkin, V; Johansen, T				Alemu, Endalkachew Ashenafi; Lamark, Trond; Torgersen, Knut Martin; Birgisdottir, Aasa Birna; Larsen, Kenneth Bowitz; Jain, Ashish; Olsvik, Hallvard; Overvatn, Aud; Kirkin, Vladimir; Johansen, Terje			ATG8 Family Proteins Act as Scaffolds for Assembly of the ULK Complex SEQUENCE REQUIREMENTS FOR LC3-INTERACTING REGION (LIR) MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; INTERACTING MOTIF; STRUCTURAL BASIS; MAMMALIAN-CELLS; KINASE; LC3; DEGRADATION; P62/SQSTM1; BINDING; IDENTIFICATION	Autophagy is a lysosome-dependent degradation system conserved among eukaryotes. The mammalian Atg1 homologues, Unc-51 like kinase (ULK) 1 and 2, are multifunctional proteins with roles in autophagy, neurite outgrowth, and vesicle transport. The mammalian ULK complex involved in autophagy consists of ULK1, ULK2, ATG13, FIP200, and ATG101. We have used pulldown and peptide array overlay assays to study interactions between the ULK complex and six different ATG8 family proteins. Strikingly, in addition to ULK1 and ULK2, ATG13 and FIP200 interacted with human ATG8 proteins, all with strong preference for the GABARAP subfamily. Similarly, yeast and Drosophila Atg1 interacted with their respective Atg8 proteins, demonstrating the evolutionary conservation of the interaction. Use of peptide arrays allowed precise mapping of the functional LIR motifs, and two-dimensional scans of the ULK1 and ATG13 LIR motifs revealed which substitutions that were tolerated. This information, combined with an analysis of known LIR motifs, provides us with a clearer picture of sequence requirements for LIR motifs. In addition to the known requirements of the aromatic and hydrophobic residues of the core motif, we found the interactions to depend strongly on acidic residues surrounding the central core LIR motifs. A preference for either a hydrophobic residue or an acidic residue following the aromatic residue in the LIR motif is also evident. Importantly, the LIR motif is required for starvation-induced association of ULK1 with autophagosomes. Our data suggest that ATG8 proteins act as scaffolds for assembly of the ULK complex at the phagophore.	[Larsen, Kenneth Bowitz; Jain, Ashish; Olsvik, Hallvard; Overvatn, Aud; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Torgersen, Knut Martin] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Kirkin, Vladimir] Merck KGaA, D-64293 Darmstadt, Germany	UiT The Arctic University of Tromso; University of Oslo; Merck KGaA	Johansen, T (corresponding author), Univ Tromso, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/AAY-1753-2021; Johansen, Terje/N-2971-2015; Larsen, Kenneth/HDO-5510-2022	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Birgisdottir, Asa Birna/0000-0003-1080-3619; Lamark, Trond/0000-0001-6338-3342; Kirkin, Vladimir/0000-0002-8049-3663; Olsvik, Hallvard/0000-0003-3489-7461	FUGE program of the Norwegian Research Council; FRIBIO program of the Norwegian Research Council; Norwegian Cancer Society; Blix Foundation	FUGE program of the Norwegian Research Council; FRIBIO program of the Norwegian Research Council; Norwegian Cancer Society(Norwegian Cancer Society); Blix Foundation	This work was supported in part by grants from the FUGE and FRIBIO programs of the Norwegian Research Council, the Norwegian Cancer Society, and the Blix Foundation (to T. J.).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Chan EY, 2012, ANTIOXID REDOX SIGN, V17, P775, DOI 10.1089/ars.2011.4396; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Le Grand JN, 2011, AUTOPHAGY, V7, P1302, DOI 10.4161/auto.7.11.16723; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Mohrluder J, 2007, BIOCHEMISTRY-US, V46, P14537, DOI 10.1021/bi7018145; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, J BIOL CHEM, V287, P28503, DOI 10.1074/jbc.C112.387514; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Sancho A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034034; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b	55	213	223	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.378109	http://dx.doi.org/10.1074/jbc.M112.378109			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23043107	Green Published, hybrid			2022-12-25	WOS:000311233800001
J	Sanchez-Solana, B; Motwani, M; Li, DQ; Eswaran, J; Kumar, R				Sanchez-Solana, Beatriz; Motwani, Mona; Li, Da-Qiang; Eswaran, Jeyanthy; Kumar, Rakesh			p21-activated Kinase-1 Signaling Regulates Transcription of Tissue Factor and Tissue Factor Pathway Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM-STIMULATED FIBROBLASTS; FACTOR GENE-EXPRESSION; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; ENDOTHELIAL-CELLS; C-JUN; KINASE; PROTEIN; ACTIVATION	Tissue factor (TF) is a cell-surface glycoprotein responsible for initiating the coagulation cascade. Besides its role in homeostasis, studies have shown the implication of TF in embryonic development, cancer-related events, and inflammation via coagulation-dependent and -independent (signaling) mechanisms. Tissue factor pathway inhibitor (TFPI) plays an important role in regulating TF-initiated blood coagulation. Therefore, transcriptional regulation of TF expression and its physiological inhibitor TFPI would allow us to understand the critical step that controls many different processes. From a gene profiling study aimed at identifying differentially regulated genes between wild-type (WT) and p21-activated kinase 1-null (PAK1-KO) mouse embryonic fibroblasts (MEFs), we found TF and TFPI are differentially expressed in the PAK1-KO MEFs in comparison with wild-type MEFs. Based on these findings, we further investigated in this study the transcriptional regulation of TF and TFPI by PAK1, a serine/threonine kinase. We found that the PAK1.c-Jun complex stimulates the transcription of TF and consequently its procoagulant activity. Moreover, PAK1 negatively regulates the expression of TFPI and additionally contributes to increased TF activity. For the first time, this study implicates PAK1 in coagulation processes, through its dual transcriptional regulation of TF and its inhibitor.	[Sanchez-Solana, Beatriz; Motwani, Mona; Li, Da-Qiang; Kumar, Rakesh] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Eswaran, Jeyanthy] George Washington Univ, Sch Med & Hlth Sci, McCormick Prote & Genom Ctr, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwu.edu	Motwani, Mona/AAV-8162-2020; Kumar, Rakesh/ABD-1065-2020	Motwani, Mona/0000-0003-0912-5478; Kumar, Rakesh/0000-0001-7664-0803; Eswaran, Jeyanthy/0000-0003-0260-9517; Sanchez-Solana, Beatriz/0000-0003-1155-5194	National Institutes of Health Grant [CA90970]; McCormick Proteomic and Genomic Center; NATIONAL CANCER INSTITUTE [R01CA090970] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Proteomic and Genomic Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA90970 (to R. K.). This work was also supported by the McCormick Proteomic and Genomic Center.	Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Amirkhosravi A, 2007, SEMIN THROMB HEMOST, V33, P643, DOI 10.1055/s-2007-991531; Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1663; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; BARNES C, 2003, NAT STRUCT BIOL, V31, P10; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; BROWN PH, 1994, ONCOGENE, V9, P791; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; CARSON SD, 1986, THROMB RES, V41, P185, DOI 10.1016/0049-3848(86)90228-8; Carson SD, 1996, BLOOD COAGUL FIBRIN, V7, P303, DOI 10.1097/00001721-199604000-00004; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Contrino J, 1996, NAT MED, V2, P209, DOI 10.1038/nm0296-209; CUI MZ, 1994, ARTERIOSCLER THROMB, V14, P807, DOI 10.1161/01.ATV.14.5.807; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; DRAKE TA, 1989, AM J PATHOL, V134, P1087; FELTS SJ, 1995, BIOCHEMISTRY-US, V34, P12355, DOI 10.1021/bi00038a032; Gorlach A, 2005, THROMB HAEMOSTASIS, V93, P1168, DOI 10.1160/TH05-01-0006; Hembrough TA, 2001, J BIOL CHEM, V276, P12241, DOI 10.1074/jbc.M010395200; Khanna A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017979; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; Li DQ, 2011, P NATL ACAD SCI USA, V108, P8791, DOI 10.1073/pnas.1018389108; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li F, 2002, EMBO REP, V3, P767, DOI 10.1093/embo-reports/kvf157; Li TT, 2011, CARCINOGENESIS, V32, P659, DOI 10.1093/carcin/bgq271; Mackman N, 1996, HAEMOSTASIS, V26, P17; MACKMAN N, 1990, P NATL ACAD SCI USA, V87, P2254, DOI 10.1073/pnas.87.6.2254; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MCVEY JH, 1994, BAILLIERE CLIN HAEM, V7, P469, DOI 10.1016/S0950-3536(05)80094-0; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Molli PR, 2010, J CELL BIOL, V190, P101, DOI 10.1083/jcb.200908050; NEMERSON Y, 1988, BLOOD, V71, P1; Pendurthi UR, 2002, VITAM HORM, V64, P323, DOI 10.1016/S0083-6729(02)64009-9; Rickles FR, 2001, ACTA HAEMATOL-BASEL, V106, P6, DOI 10.1159/000046583; Ruf W, 2011, J THROMB HAEMOST, V9, P306, DOI 10.1111/j.1538-7836.2011.04318.x; Ruf W, 2007, THROMB RES, V120, pS7, DOI 10.1016/S0049-3848(07)70125-1; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Singh RR, 2005, J BIOL CHEM, V280, P18130, DOI 10.1074/jbc.M412607200; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Tanikawa M, 2011, BRIT J CANCER, V104, P1349, DOI 10.1038/bjc.2011.75; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Vadlamudi RK, 2003, CANCER METAST REV, V22, P385, DOI 10.1023/A:1023729130497; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; VANDERPOLL T, 1990, NEW ENGL J MED, V322, P1622, DOI 10.1056/NEJM199006073222302; Versteeg HH, 2006, SEMIN THROMB HEMOST, V32, P24, DOI 10.1055/s-2006-933337; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	54	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.404061	http://dx.doi.org/10.1074/jbc.M112.404061			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038262	hybrid, Green Published			2022-12-25	WOS:000311233800002
J	Arora, G; Mezencev, R; McDonald, JF				Arora, Gaurav; Mezencev, Roman; McDonald, John F.			Human Cells Display Reduced Apoptotic Function Relative to Chimpanzee Cells	PLOS ONE			English	Article							MITOMYCIN-C; NONHUMAN; MITOCHONDRIAL; GENOME; TUMORS	Previously published gene expression analyses suggested that apoptotic function may be reduced in humans relative to chimpanzees and led to the hypothesis that this difference may contribute to the relatively larger size of the human brain and the increased propensity of humans to develop cancer. In this study, we sought to further test the hypothesis that humans maintain a reduced apoptotic function relative to chimpanzees by conducting a series of apoptotic function assays on human, chimpanzee and macaque primary fibroblastic cells. Human cells consistently displayed significantly reduced apoptotic function relative to the chimpanzee and macaque cells. These results are consistent with earlier findings indicating that apoptotic function is reduced in humans relative to chimpanzees.	[McDonald, John F.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	McDonald, JF (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	john.mcdonald@biology.gatech.edu	Mezencev, Roman/O-8489-2019; Mezencev, Roman/A-8573-2009	Mezencev, Roman/0000-0003-4361-7628; McDonald, John F/0000-0002-4263-8155	Georgia Tech Foundation	Georgia Tech Foundation	This work was carried out with the financial support of the Georgia Tech Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora G, 2009, MED HYPOTHESES, V73, P453, DOI 10.1016/j.mehy.2009.03.035; BENIASHVILI DS, 1989, J MED PRIMATOL, V18, P423; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Budd SL, 2000, P NATL ACAD SCI USA, V97, P6161, DOI 10.1073/pnas.100121097; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; de Sousa A., 2007, P291; Deng XM, 2000, P NATL ACAD SCI USA, V97, P1578, DOI 10.1073/pnas.97.4.1578; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Goodman M, 1996, MOL PHYLOGENET EVOL, V5, P269, DOI 10.1006/mpev.1996.0021; Karaman MW, 2003, GENOME RES, V13, P1619, DOI 10.1101/gr.1289803; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; MCCLURE HM, 1973, AM J PHYS ANTHROPOL, V38, P425, DOI 10.1002/ajpa.1330380243; Mezencev R, 2011, J NAT MED-TOKYO, V65, P488, DOI 10.1007/s11418-011-0526-x; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; SEIBOLD HR, 1973, LAB ANIM SCI, V23, P533; Seong GJ, 2005, INVEST OPHTH VIS SCI, V46, P3545, DOI 10.1167/iovs.04-1358; SZYBALSKI W, 1964, FED PROC, V23, P946; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Vallender EJ, 2006, HUM MOL GENET, V15, P3034, DOI 10.1093/hmg/ddl245; Varki A, 2000, GENOME RES, V10, P1065, DOI 10.1101/gr.10.8.1065; Waters DJ, 1998, PROSTATE, V36, P64; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	28	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46182	10.1371/journal.pone.0046182	http://dx.doi.org/10.1371/journal.pone.0046182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029431	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900104
J	Harper, EM; Clark, MS; Hoffman, JI; Philipp, EER; Peck, LS; Morley, SA				Harper, Elizabeth M.; Clark, Melody S.; Hoffman, Joseph I.; Philipp, Eva E. R.; Peck, Lloyd S.; Morley, Simon A.			Iceberg Scour and Shell Damage in the Antarctic Bivalve Laternula elliptica	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; BLUE MUSSEL; OCEAN; CLAM; KING; TEMPERATURE; GROWTH; CALCIFICATION; DISSOLUTION; DIVERSITY	We document differences in shell damage and shell thickness in a bivalve mollusc (Laternula elliptica) from seven sites around Antarctica with differing exposures to ice movement. These range from 60% of the sea bed impacted by ice per year (Hangar Cove, Antarctic Peninsula) to those protected by virtually permanent sea ice cover (McMurdo Sound). Patterns of shell damage consistent with blunt force trauma were observed in populations where ice scour frequently occurs; damage repair frequencies and the thickness of shells correlated positively with the frequency of iceberg scour at the different sites with the highest repair rates and thicker shells at Hangar Cove (74.2% of animals damaged) compared to the other less impacted sites (less than 10% at McMurdo Sound). Genetic analysis of population structure using Amplified Fragment Length Polymorphisms (AFLPs) revealed no genetic differences between the two sites showing the greatest difference in shell morphology and repair rates. Taken together, our results suggest that L. elliptica exhibits considerable phenotypic plasticity in response to geographic variation in physical disturbance.	[Harper, Elizabeth M.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Clark, Melody S.; Peck, Lloyd S.; Morley, Simon A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Hoffman, Joseph I.] Univ Cambridge, Dept Zool, Cambridge CB2 3EQ, England; [Philipp, Eva E. R.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge; University of Kiel	Harper, EM (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	emh21@cam.ac.uk	Harper, Elizabeth M/B-3890-2008; Clark, Melody S/D-7371-2014; Hoffman, Joseph i/K-7725-2012	Harper, Elizabeth M/0000-0002-1092-3867; Clark, Melody S/0000-0002-3442-3824; Hoffman, Joseph i/0000-0001-5895-8949	British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package; Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; University of Bremen; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish; NERC [bas0100025, dml011000] Funding Source: UKRI	British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package; Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; University of Bremen; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was not part of any specific grant but as part of a general research programme between the University of Cambridge and the British Antarctic Survey. SAM, LSP and MSC were supported by the British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package. JH was supported by a Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship. During the sampling period of the Jubany specimens EP was supported by a PhD scholarship from the University of Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IY, 1996, MAR POLLUT BULL, V32, P592, DOI 10.1016/0025-326X(95)00247-K; AHN IY, 1993, J EXP MAR BIOL ECOL, V171, P75, DOI 10.1016/0022-0981(93)90141-A; Ansell AD, 1997, J MOLLUS STUD, V63, P285, DOI 10.1093/mollus/63.2.285; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; ARNAUD P M, 1973, Tethys, V5, P549; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Brandvik PJ, 2009, COLD REG SCI TECHNOL, V55, P160, DOI 10.1016/j.coldregions.2008.06.006; Brey T, 1997, POLAR BIOL, V17, P465, DOI 10.1007/s003000050143; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Cadee GC, 1999, J SEA RES, V41, P149, DOI 10.1016/S1385-1101(98)00042-2; CHECA A, 1993, PALAEOGEOGR PALAEOCL, V100, P309, DOI 10.1016/0031-0182(93)90061-M; Cintra-Buenrostro CE, 2007, J SHELLFISH RES, V26, P221, DOI 10.2983/0730-8000(2007)26[221:TPANMA]2.0.CO;2; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clarke A., 1990, P9; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Day EG, 2000, J EXP MAR BIOL ECOL, V243, P185, DOI 10.1016/S0022-0981(99)00120-3; De Wolf H, 1998, MAR ECOL PROG SER, V163, P155, DOI 10.3354/meps163155; Denny MW, 2010, ANNU REV MAR SCI, V2, P89, DOI 10.1146/annurev-marine-120308-081011; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; GASPAR MB, 1994, J MAR BIOL ASSOC UK, V74, P927, DOI 10.1017/S0025315400090159; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; Guerra C, 2012, AQUAC RES, V43, P756, DOI 10.1111/j.1365-2109.2011.02885.x; Harley CDG, 2009, FUNCT ECOL, V23, P292, DOI 10.1111/j.1365-2435.2008.01496.x; Hoffman JI, 2012, POLAR BIOL, V35, P919, DOI 10.1007/s00300-011-1139-2; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hoffman JI, 2010, MAR BIOL, V157, P765, DOI 10.1007/s00227-009-1360-5; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Jeffreys H., 1961, THEORY PROBABILITY, V3rd ed.; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Kowalewski M., 2002, PALEONTOLOGICAL SOC, V8, P1; Leonard GH, 1999, ECOLOGY, V80, P1; Lesser MP, 2010, COMP BIOCHEM PHYS A, V156, P541, DOI 10.1016/j.cbpa.2010.04.012; Lomovasky BJ, 2005, J SEA RES, V54, P163, DOI 10.1016/j.seares.2005.01.004; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; Maughan PJ, 1996, THEOR APPL GENET, V93, P392, DOI 10.1007/BF00223181; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, POLAR BIOL, V27, P357, DOI 10.1007/s00300-003-0588-7; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; RALPH R, 1977, MAR BIOL, V42, P171, DOI 10.1007/BF00391569; Rodrigues Edson, 2007, Oecologia Brasiliensis, V11, P37; SHANKS AL, 1986, OECOLOGIA, V69, P420, DOI 10.1007/BF00377065; Teske PR, 2007, J MOLLUS STUD, V73, P223, DOI 10.1093/mollus/eym012; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vermeij G.J, 1987, EVOLUTION ESCALATION; Watson S., 2009, THESIS U SOUTHAMPTON; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; Whitlow WL, 2010, MAR ECOL-EVOL PERSP, V31, P418, DOI 10.1111/j.1439-0485.2009.00350.x; Wilk J, 2009, MAR BIOL RES, V5, P155, DOI 10.1080/17451000802279644; ZAMORANO JH, 1986, POLAR BIOL, V6, P139, DOI 10.1007/BF00274876; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	67	43	44	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46341	10.1371/journal.pone.0046341	http://dx.doi.org/10.1371/journal.pone.0046341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029484	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000309973900137
J	Mallegol, J; Duncan, C; Prashar, A; So, J; Low, DE; Terebeznik, M; Guyard, C				Mallegol, Julia; Duncan, Carla; Prashar, Akriti; So, Jannice; Low, Donald E.; Terebeznik, Mauricio; Guyard, Cyril			Essential Roles and Regulation of the Legionella pneumophila Collagen-Like Adhesin during Biofilm Formation	PLOS ONE			English	Article							AUTOINDUCER SYNTHASE LQSA; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LEGIONNAIRES-DISEASE; ESCHERICHIA-COLI; FLOATING BIOFILMS; CYSTIC-FIBROSIS; VIBRIO-CHOLERAE; WATER; REPLICATION	Legionellosis is mostly caused by Legionella pneumophila (Lp) and is defined by a severe respiratory illness with a case fatality rate ranging from 5 to 80%. In a previous study, we showed that a glycosaminoglycan (GAG)-binding adhesin of Lp, named Lcl, is produced during legionellosis and is unique to the L. pneumophila species. Importantly, a mutant depleted in Lcl (Delta lpg2644) is impaired in adhesion to GAGs and epithelial cells and in biofilm formation. Here, we examine the molecular function(s) of Lcl and the transcriptional regulation of its encoding gene during different stages of the biofilm development. We show that the collagen repeats and the C-terminal domains of Lcl are crucial for the production of biofilm. We present evidence that Lcl is involved in the early step of surface attachment but also in intercellular interactions. Furthermore, we address the relationship between Lcl gene regulation during biofilm formation and quorum sensing (QS). In a static biofilm assay, we show that Lcl is differentially regulated during growth phases and biofilm formation. Moreover, we show that the transcriptional regulation of lpg2644, mediated by a prototype of QS signaling homoserine lactone (3OC12-HSL), may play a role during the biofilm development. Thus, transcriptional down-regulation of lpg2644 may facilitate the dispersion of Lp to reinitiate biofilm colonization on a distal surface.	[Mallegol, Julia; Duncan, Carla; So, Jannice; Low, Donald E.; Guyard, Cyril] OAHPP, Toronto, ON, Canada; [Mallegol, Julia; So, Jannice; Low, Donald E.; Guyard, Cyril] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mallegol, Julia; Low, Donald E.; Guyard, Cyril] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Prashar, Akriti; Terebeznik, Mauricio] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Scarborough	Guyard, C (corresponding author), OAHPP, Toronto, ON, Canada.	cyril.guyard@oahpp.ca		, cyril/0000-0002-2721-0097; Prashar, Akriti/0000-0002-1320-362X	Ontario Agency for Health protection and Promotion; Canadian Institutes of Health Research [MOP-102514]; Natural Sciences and Engineering Research Council of Canada; Ontario Association of Medical Laboratories grants	Ontario Agency for Health protection and Promotion; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Association of Medical Laboratories grants	This work was supported by the Ontario Agency for Health protection and Promotion (http://www.oahpp.ca/) and the Canadian Institutes of Health Research (MOP-102514) (http://www.cihr-irsc.gc.ca/). AP and MT are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the Ontario Association of Medical Laboratories grants (http://www.oaml.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Bartram Jamie, 2007, P1; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Benin AL, 2002, CLIN INFECT DIS, V35, P1039, DOI 10.1086/342903; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Carlson HK, 2010, MOL MICROBIOL; Cooper IR, 2010, J HOSP INFECT, V74, P152, DOI 10.1016/j.jhin.2009.07.005; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Declerck P, 2007, CURR MICROBIOL, V55, P435, DOI 10.1007/s00284-007-9006-7; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; Declerck P, 2009, MICROBIOL RES, V164, P593, DOI 10.1016/j.micres.2007.06.001; Duncan C, 2011, INFECT IMMUN, V79, P2168, DOI 10.1128/IAI.01304-10; Dunne WM, 2002, J CLIN MICROBIOL, V40, P3889, DOI 10.1128/JCM.40.11.3889-3893.2002; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hentzer M, 2003, BIODRUGS, V17, P241, DOI 10.2165/00063030-200317040-00003; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hilbi H, 2010, MOL MICROBIOL, V76, P1, DOI 10.1111/j.1365-2958.2010.07086.x; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kimura S, 2009, MICROBIOL-SGM, V155, P1934, DOI 10.1099/mic.0.026641-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; LUCK CP, 2009, INT J SYST EVOL MICR; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Richards JJ, 2009, CHEMBIOCHEM, V10, P2287, DOI 10.1002/cbic.200900317; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Shrout JD, 2012, ENVIRON SCI TECHNOL, V46, P1995, DOI 10.1021/es203933h; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Stout JE, 1997, JAMA-J AM MED ASSOC, V278, P1404, DOI 10.1001/jama.278.17.1404; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; Vandersmissen L, 2010, FEMS MICROBIOL LETT, V306, P168, DOI 10.1111/j.1574-6968.2010.01951.x; Vervaeren H, 2006, FEMS MICROBIOL ECOL, V58, P583, DOI 10.1111/j.1574-6941.2006.00181.x; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087	65	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46462	10.1371/journal.pone.0046462	http://dx.doi.org/10.1371/journal.pone.0046462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029523	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900164
J	Butler, JA; Mishur, RJ; Bokov, AF; Hakala, KW; Weintraub, ST; Rea, SL				Butler, Jeffrey A.; Mishur, Robert J.; Bokov, Alex F.; Hakala, Kevin W.; Weintraub, Susan T.; Rea, Shane L.			Profiling the Anaerobic Response of C. elegans Using GC-MS	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MASS SPECTROMETRY; METABOLISM; EXTRACTION; NEMATODE; YEAST; LIFE; KEGG; RHODOQUINONE; MITOCHONDRIA	The nematode Caenorhabditis elegans is a model organism that has seen extensive use over the last four decades in multiple areas of investigation. In this study we explore the response of the nematode Caenorhabditis elegans to acute anoxia using gas-chromatography mass-spectrometry (GC-MS). We focus on the readily-accessible worm exometabolome to show that C. elegans are mixed acid fermenters that utilize several metabolic pathways in unconventional ways to remove reducing equivalents - including partial reversal of branched-chain amino acid catabolism and a potentially novel use of the glyoxylate pathway. In doing so, we provide detailed methods for the collection and analysis of excreted metabolites that, with minimal adjustment, should be applicable to many other species. We also describe a procedure for collecting highly volatile compounds from C. elegans. We are distributing our mass spectral library in an effort to facilitate wider use of metabolomics.	[Butler, Jeffrey A.; Mishur, Robert J.; Bokov, Alex F.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Butler, Jeffrey A.; Mishur, Robert J.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Hakala, Kevin W.; Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.	reas3@uthscsa.edu	Rea, Shane/F-4073-2014; Bokov, Alex/O-9952-2014	Bokov, Alex/0000-0002-0511-9815	National Institute on Aging; Ellison Medical Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation)	Financial support was provided by the National Institute on Aging and the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HJ, 2008, FEBS LETT, V582, P1661, DOI 10.1016/j.febslet.2008.04.020; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broeckling CD, 2006, ANAL CHEM, V78, P4334, DOI 10.1021/ac0521596; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; COOPER AF, 1971, J NEMATOL, V3, P205; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Falk MJ, 2008, MOL GENET METAB, V93, P388, DOI 10.1016/j.ymgme.2007.11.007; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14; Geier FM, 2011, ANAL CHEM, V83, P3730, DOI 10.1021/ac2001109; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kell DB, 2005, NAT REV MICROBIOL, V3, P557, DOI 10.1038/nrmicro1177; Li HL, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-49; MA YC, 1993, J BIOL CHEM, V268, P20360; Martin FPJ, 2011, J PROTEOME RES, V10, P990, DOI 10.1021/pr100703a; Mas S, 2007, BIOTECHNOL BIOENG, V96, P1014, DOI 10.1002/bit.21194; Mendenhall AR, 2006, GENETICS, V174, P1173, DOI 10.1534/genetics.106.061390; Morrison DJ, 2004, RAPID COMMUN MASS SP, V18, P2593, DOI 10.1002/rcm.1662; ORIORDAN VB, 1990, COMP BIOCHEM PHYS B, V95, P125, DOI 10.1016/0305-0491(90)90258-U; Paik MJ, 2008, BIOMED CHROMATOGR, V22, P450, DOI 10.1002/bmc.966; Paik MJ, 2004, J CHROMATOGR A, V1034, P13, DOI 10.1016/j.chroma.2004.02.032; Peng YJ, 2010, P NATL ACAD SCI USA, V107, P10719, DOI 10.1073/pnas.1005866107; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO J, 2012, R DEV CORE TEAM NLME; Pope GA, 2007, YEAST, V24, P667, DOI 10.1002/yea.1499; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Rea SL, 2010, DEV DISABIL RES REV, V16, P200, DOI 10.1002/ddrr.114; Rea SL, 2005, EXP GERONTOL, V40, P841, DOI 10.1016/j.exger.2005.06.015; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Shepherd T, 2007, METABOLOMICS, V3, P475, DOI 10.1007/s11306-007-0058-2; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Takamiya S, 1999, ARCH BIOCHEM BIOPHYS, V371, P284, DOI 10.1006/abbi.1999.1465; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wylie T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-525; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	40	24	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46140	10.1371/journal.pone.0046140	http://dx.doi.org/10.1371/journal.pone.0046140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029411	gold, Green Published			2022-12-25	WOS:000309517500064
J	Crosby, K; Smith, DR				Crosby, Kate; Smith, David Roy			Does the Mode of Plastid Inheritance Influence Plastid Genome Architecture?	PLOS ONE			English	Article							MATERNAL INHERITANCE; CHLOROPLAST-DNA; PATERNAL INHERITANCE; CYTOPLASMIC INHERITANCE; CELL-CYCLE; NDH GENES; MITOCHONDRIAL; TRANSMISSION; EVOLUTION; ORGANELLAR	Plastid genomes show an impressive array of sizes and compactnesses, but the forces responsible for this variation are unknown. It has been argued that species with small effective genetic population sizes are less efficient at purging excess DNA from their genomes than those with large effective population sizes. If true, one may expect the primary mode of plastid inheritance to influence plastid DNA (ptDNA) architecture. All else being equal, biparentally inherited ptDNAs should have a two-fold greater effective population size than those that are uniparentally inherited, and thus should also be more compact. Here, we explore the relationship between plastid inheritance pattern and ptDNA architecture, and consider the role of phylogeny in shaping our observations. Contrary to our expectations, we found no significant difference in plastid genome size or compactness between ptDNAs that are biparentally inherited relative to those that are uniparentally inherited. However, we also found that there was significant phylogenetic signal for the trait of mode of plastid inheritance. We also found that paternally inherited ptDNAs are significantly smaller (n = 19, p = 0.000001) than those that are maternally, uniparentally (when isogamous), or biparentally inherited. Potential explanations for this observation are discussed.	[Crosby, Kate] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Smith, David Roy] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada	Dalhousie University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia	Crosby, K (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	crosbyk@dal.ca	Smith, David Roy/AAR-1529-2020; Smith, David/L-7910-2015	Smith, David Roy/0000-0001-9560-5210; Smith, David/0000-0001-9560-5210; Crosby, Kate/0000-0003-1860-8367	Natural Sciences and Engineering Research Council of Canada; Izaak Walton Killam Trusts	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Izaak Walton Killam Trusts	DRS is supported by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada and the Izaak Walton Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CR, 1990, CURR GENET, V18, P141, DOI 10.1007/BF00312602; Amane M, 1999, THEOR APPL GENET, V99, P133, DOI 10.1007/s001220051217; Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Azhagiri AK, 2007, PLANT J, V52, P817, DOI 10.1111/j.1365-313X.2007.03278.x; Baack EJ, 2005, NEW PHYTOL, V167, P623, DOI 10.1111/j.1469-8137.2005.01433.x; Baur E., 1909, Z VEREBUNGSL, V1, P330, DOI DOI 10.1007/BF01990603; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BOBLENZ K, 1990, MOL GEN GENET, V220, P489, DOI 10.1007/BF00391760; Bogdanova VS, 2012, THEOR APPL GENET, V124, P1503, DOI 10.1007/s00122-012-1804-z; Bogdanova VS, 2009, THEOR APPL GENET, V118, P801, DOI 10.1007/s00122-008-0940-y; Bouzon Z, 2000, CRYPTOGAMIE ALGOL, V21; Braukmann TWA, 2009, CURR GENET, V55, P323, DOI 10.1007/s00294-009-0249-7; BRAWLEY SH, 1976, J CELL SCI, V20, P255; Carmichael JS, 1995, PLANT CELL, V7, P1975, DOI 10.1105/tpc.7.12.1975; Chen J, 2002, THEOR APPL GENET, V104, P1307, DOI 10.1007/s00122-002-0893-5; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; CONDE MF, 1979, J HERED, V70, P2, DOI 10.1093/oxfordjournals.jhered.a109182; CORRIVEAU JL, 1990, CURR GENET, V17, P327, DOI 10.1007/BF00314880; CORRIVEAU JL, 1989, CURR GENET, V16, P47, DOI 10.1007/BF00411083; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Davis TM, 2010, ACTA HORTIC, V859, P221; DONG J, 1992, J HERED, V83, P419, DOI 10.1093/oxfordjournals.jhered.a111244; Drummond A., 2011, GENEIOUS V5 5; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferguson DJP, 2007, INT J PARASITOL, V37, P33, DOI 10.1016/j.ijpara.2006.10.003; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Gregory TR, 2008, GENOME, V51, P309, DOI 10.1139/G08-003; Guo FL, 2005, PROTOPLASMA, V225, P5, DOI 10.1007/s00709-005-0088-4; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Havey MJ, 1998, THEOR APPL GENET, V97, P122, DOI 10.1007/s001220050875; Hu Z-M, 1995, ACTA BOT SIN, P1; Huang CY, 2003, NATURE, V422, P72, DOI 10.1038/nature01435; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumari M, 2011, PLANT SCI, V180, P628, DOI 10.1016/j.plantsci.2011.01.003; KUROIWA T, 1986, PROTOPLASMA, V133, P85, DOI 10.1007/BF01293191; Latta RG, 1997, GENETICS, V146, P1153; LEE C. L., 1955, BOT GAZ, V117, P79, DOI 10.1086/335894; LEE RW, 1973, MOL GEN GENET, V121, P99, DOI 10.1007/BF00277524; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Lynch M, 2007, ORIGINS GENOME ARCHI; Martinez-Reyna JM, 2001, CROP SCI, V41, P1579, DOI 10.2135/cropsci2001.4151579x; Matsushima R, 2008, PLANT CELL PHYSIOL, V49, P81, DOI 10.1093/pcp/pcm170; McKinnon GE, 2001, GENOME, V44, P831, DOI 10.1139/gen-44-5-831; MEJNARTOWICZ M, 1991, THEOR APPL GENET, V82, P477, DOI 10.1007/BF00588602; Miyamura S, 2010, J PLANT RES, V123, P171, DOI 10.1007/s10265-010-0309-6; MOGENSEN HL, 1988, P NATL ACAD SCI USA, V85, P2594, DOI 10.1073/pnas.85.8.2594; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; MOGENSEN HL, 1985, PROTOPLASMA, V128, P1, DOI 10.1007/BF01273229; Motomura T, 2010, J PLANT RES, V123, P185, DOI 10.1007/s10265-010-0313-x; NEALE DB, 1989, THEOR APPL GENET, V77, P212, DOI 10.1007/BF00266189; Neale DB, 1986, PATERNAL INHERITANCE; Niwa K, 2010, J PHYCOL, V46, P693, DOI 10.1111/j.1529-8817.2010.00853.x; OHBA K, 1971, Silvae Genetica, V20, P101; Olson MS, 2000, P ROY SOC B-BIOL SCI, V267, P1801, DOI 10.1098/rspb.2000.1213; Orme D, 2011, CAPER PACKAGE COMP A; PACINI E, 1992, ANN BOT-LONDON, V70, P179, DOI 10.1093/oxfordjournals.aob.a088455; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Peters AF, 2004, EUR J PHYCOL, V39, P235, DOI 10.1080/09670260410001683241; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Renzaglia KS, 1999, INT J PLANT SCI, V160, P14, DOI 10.1086/314103; Renzaglia KS, 2002, NEW PHYTOL, V154, P159, DOI 10.1046/j.1469-8137.2002.00355.x; Renzaglia KS, 2001, AM J BOT, V88, P1151, DOI 10.2307/3558326; Ruf S, 2001, NAT BIOTECHNOL, V19, P870, DOI 10.1038/nbt0901-870; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; SCHMIT V, 1993, THEOR APPL GENET, V87, P506, DOI 10.1007/BF00215097; Suda S, 2004, PHYCOL RES, V52, P273, DOI 10.1111/j.1440-183.2004.00346.x; SUN GH, 1988, PROTOPLASMA, V144, P185, DOI 10.1007/BF01637252; SUTTON BCS, 1991, THEOR APPL GENET, V82, P242, DOI 10.1007/BF00226220; SZMIDT AE, 1987, PLANT MOL BIOL, V9, P59, DOI 10.1007/BF00017987; Van Droogenbroeck B, 2005, EUPHYTICA, V143, P161, DOI 10.1007/s10681-005-3156-0; Vivek BS, 1999, THEOR APPL GENET, V98, P669, DOI 10.1007/s001220051119; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080; Whittle CA, 2003, P NATL ACAD SCI USA, V100, P4055, DOI 10.1073/pnas.0730639100; Whittle CA, 2002, MOL BIOL EVOL, V19, P938, DOI 10.1093/oxfordjournals.molbev.a004151; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Wills DM, 2005, THEOR APPL GENET, V110, P941, DOI 10.1007/s00122-004-1914-3; Zanmin H, 1996, ACTA BOT SIN, V38; Zhang Q, 2003, PLANT CELL PHYSIOL, V44, P941, DOI 10.1093/pcp/pcg121; Zhong BJ, 2010, MOL BIOL EVOL, V27, P2855, DOI 10.1093/molbev/msq170; Zhong ZR, 2011, MOL GENET GENOMICS, V286, P411, DOI 10.1007/s00438-011-0653-9; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	93	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46260	10.1371/journal.pone.0046260	http://dx.doi.org/10.1371/journal.pone.0046260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029453	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500078
J	Huang, KT; Pavlides, SC; Lecanda, J; Blank, SV; Mittal, KR; Gold, LI				Huang, Kuang-Tzu; Pavlides, Savvas C.; Lecanda, Jon; Blank, Stephanie V.; Mittal, Khushbakhat R.; Gold, Leslie I.			Estrogen and Progesterone Regulate p27kip1 Levels via the Ubiquitin-Proteasome System: Pathogenic and Therapeutic Implications for Endometrial Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; DEPENDENT KINASE INHIBITOR; CELL-CYCLE ARREST; SUBCELLULAR-LOCALIZATION; RECEPTOR-ALPHA; IN-VIVO; P27(KIP1); PHOSPHORYLATION; LIGASE; SKP2	The levels of proteins that control the cell cycle are regulated by ubiquitin-mediated degradation via the ubiquitin-proteasome system (UPS) by substrate-specific E3 ubiquitin ligases. The cyclin-dependent kinase inhibitor, p27kip1 (p27), that blocks the cell cycle in G1, is ubiquitylated by the E3 ligase SCF-Skp2/Cks1 for degradation by the UPS. In turn, Skp2 and Cks1 are ubiquitylated by the E3 ligase complex APC/Cdh1 for destruction thereby maintaining abundant levels of nuclear p27. We previously showed that perpetual proteasomal degradation of p27 is an early event in Type I endometrial carcinogenesis (ECA), an estrogen (E2)-induced cancer. The present studies demonstrate that E2 stimulates growth of ECA cell lines and normal primary endometrial epithelial cells (EECs) and induces MAPK-ERK1/2-dependent phosphorylation of p27 on Thr187, a prerequisite for p27 ubiquitylation by nuclear SCF-Skp2/Cks1 and subsequent degradation. In addition, E2 decreases the E3 ligase [APC]Cdh1 leaving Skp2 and Cks1 intact to cause p27 degradation. Furthermore, knocking-down Skp2 prevents E2-induced p27 degradation and growth stimulation suggesting that the pathogenesis of E2-induced ECA is dependent on Skp2-mediated degradation of p27. Conversely, progesterone (Pg) as an inhibitor of endometrial proliferation increases nuclear p27 and Cdh1 in primary EECs and ECA cells. Pg, also increases Cdh1 binding to APC to form the active E3ligase. Knocking-down Cdh1 obviates Pg-induced stabilization of p27 and growth inhibition. Notably, neither E2 nor Pg affected transcription of Cdh1, Skp2, Cks1 nor p27. These studies provide new insights into hormone regulation of cell proliferation through the UPS. The data implicates that preventing nuclear p27 degradation by blocking Skp2/Cks1-mediated degradation of p27 or increasing Cdh1 to mediate degradation of Skp2-Cks1 are potential strategies for the prevention and treatment of ECA.	[Huang, Kuang-Tzu; Pavlides, Savvas C.; Lecanda, Jon; Gold, Leslie I.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Mittal, Khushbakhat R.; Gold, Leslie I.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Blank, Stephanie V.] NYU, Sch Med, Dept Obstet & Gynecol, New York, NY USA; [Blank, Stephanie V.; Mittal, Khushbakhat R.; Gold, Leslie I.] NYU, Inst Canc, New York, NY USA	New York University; New York University; New York University; New York University	Gold, LI (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	leslie.gold@nyumc.org			National Institutes of Health, National Cancer Institute [R01 CA 89175]; New York University (NYU) Cancer Institute Pilot Project Grant; NATIONAL CANCER INSTITUTE [R01CA089175] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); New York University (NYU) Cancer Institute Pilot Project Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, National Cancer Institute, R01 CA 89175 www.nih.gov (to LIG); and a New York University (NYU) Cancer Institute Pilot Project Grant (to LIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit A, 2011, OBSTET GYN CLIN N AM, V38, P1, DOI 10.1016/j.ogc.2011.02.001; An HJ, 2002, HISTOPATHOLOGY, V41, P437, DOI 10.1046/j.1365-2559.2002.01455.x; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2010, CELL CYCLE, V9, P971, DOI 10.4161/cc.9.5.10914; Benmaamar R, 2005, CELL CYCLE, V4, P1230, DOI 10.4161/cc.4.9.2048; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Boutonnet C, 2010, CELL CYCLE, V9, P975, DOI 10.4161/cc.9.5.10915; BRUNER KL, 1995, P NATL ACAD SCI USA, V92, P7362, DOI 10.1073/pnas.92.16.7362; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cardozo T, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S9; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cunha GR, 2004, ARCH HISTOL CYTOL, V67, P417, DOI 10.1679/aohc.67.417; Daniel AR, 2009, MOL CELL ENDOCRINOL, V308, P47, DOI 10.1016/j.mce.2009.01.004; Dellas A, 2009, CLIN CANCER RES, V15, P2456, DOI 10.1158/1078-0432.CCR-08-1732; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Ellenson LH, 2004, CANCER CELL, V5, P533, DOI 10.1016/j.ccr.2004.05.029; Fujita T, 2009, INT J CANCER, V125, P826, DOI 10.1002/ijc.24399; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hershko D, 2001, CANCER, V91, P1745, DOI 10.1002/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Koos RD, 2011, ENDOCRINOLOGY, V152, P4481, DOI 10.1210/en.2011-1449; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Lacey JV, 2009, MATURITAS, V63, P39, DOI 10.1016/j.maturitas.2009.02.005; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Lecanda J, 2007, CANCER RES, V67, P1007, DOI 10.1158/0008-5472.CAN-06-0235; Lecanda J, 2009, CELL CYCLE, V8, P742, DOI 10.4161/cc.8.5.7871; Li M, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-2; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Mamillapalli R, 2001, CURR BIOL, V11, P263, DOI 10.1016/S0960-9822(01)00065-3; Miyamoto T, 2010, GYNECOL ENDOCRINOL, V26, P220, DOI [10.1080/09513590903215482, 10.3109/09513590903215482]; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nigg EA, 1993, CURR OPIN CELL BIOL, V5, P187, DOI 10.1016/0955-0674(93)90101-U; Nycum LR, 2001, GYNECOL ONCOL, V81, P242, DOI 10.1006/gyno.2001.6144; Parekh TV, 2002, CANCER RES, V62, P2778; Park H, 2011, ARCH GYNECOL OBSTET; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Tang L, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-144; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Watanabe J, 2006, INT J GYNECOL CANCER, V16, P452, DOI 10.1111/j.1525-1438.2006.00418.x; Yu M, 2009, FERTIL STERIL, V92, P2122, DOI 10.1016/j.fertnstert.2009.06.013; Zhang LL, 2009, J CELL BIOCHEM, V106, P553, DOI 10.1002/jcb.22017; Zhou W, 2012, P AM ASS CANC RES, V103	61	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46072	10.1371/journal.pone.0046072	http://dx.doi.org/10.1371/journal.pone.0046072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029392	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500060
J	Kaakinen, M; Ducci, F; Sillanpaa, MJ; Laara, E; Jarvelin, MR				Kaakinen, Marika; Ducci, Francesca; Sillanpaa, Mikko J.; Laara, Esa; Jarvelin, Marjo-Riitta			Associations between Variation in CHRNA5-CHRNA3-CHRNB4, Body Mass Index and Blood Pressure in the Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; ENVIRONMENT INTERACTIONS; SUSCEPTIBILITY LOCUS; EUROPEAN-AMERICANS; PERMUTATION TESTS; GENE-ENVIRONMENT; HEAVY SMOKING; WHOLE-GENOME	Background: The CHRNA5-CHRNA3-CHRNB4 gene cluster on 15q25 has consistently been associated with smoking quantity, nicotine dependence and lung cancer. Recent research also points towards its involvement in cardiovascular homeostasis, but studies in large human samples are lacking, especially on the role of the gene cluster in blood pressure regulation. Methodology/Principal Findings: We studied the associations between 18 single nucleotide polymorphisms (SNPs) in CHRNA5-CHRNA3-CHRNB4 and systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI) in 5402 young adults from the Northern Finland Birth Cohort 1966. We observed some evidence for associations between two SNPs and SBP and between six SNPs and BMI; the evidence for associations with DBP was weaker. The associations with the three phenotypes were driven by different loci with low linkage disequilibrium with each other. The associations appeared more pronounced in smokers, such that the smoking-increasing alleles would predict lower SBP and BMI. Each additional copy of the rs1948 G-allele and the rs950776 A-allele reduced SBP on average by -1.21 (95% CI -2.01, -0.40) mmHg in smokers. The variants associated with BMI included rs2036534, rs6495309, rs1996371, rs6495314, rs4887077 and rs11638372 and had an average effect size of -0.38 (-0.68, -0.08) kg/m(2) per an additional copy of the risk allele in smokers. Formal assessments of interactions provided weaker support for these findings, especially after adjustment for multiple testing. Conclusions: Variation at 15q25 appears to interact with smoking status in influencing SBP and BMI. The genetic loci associated with SBP were in low linkage disequilibrium with those associated with BMI suggesting that the gene cluster might regulate SBP through biological mechanisms that partly differ from those regulating BMI. Further studies in larger samples are needed for more precise evaluation of the possible interactions, and to understand the mechanisms behind.	[Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Ducci, Francesca] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Kaakinen, Marika; Sillanpaa, Mikko J.; Jarvelin, Marjo-Riitta] Bioctr Oulu, Oulu, Finland; [Ducci, Francesca] St Georges Univ London, Div Mental Hlth, London, England; [Sillanpaa, Mikko J.; Laara, Esa] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Biol, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England	University of Oulu; University of London; King's College London; University of Oulu; St Georges University London; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London	Kaakinen, M (corresponding author), Univ Oulu, Inst Hlth Sci, Oulu, Finland.	marika.kaakinen@oulu.fi		Kaakinen, Marika/0000-0002-9228-0462; Sillanpaa, Mikko J./0000-0003-2808-2768; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland {Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)] [104781, 120315, 129418]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission [QLG1-CT-2000-01643]; The National Heart, Lung and Blood Institute [5R01HL087679-02, 1RL1MH083268-01]; The National Institute of Health/The National Institute of Mental Health [5R01MH63706:02]; European Network of Genomic and Genetic Epidemiology (ENGAGE) project [HEALTH-F4-2007-201413]; Medical Research Council, UK [G0500539, G0600705]; Medical Research Council [G0600705, G0801056B] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Academy of Finland {Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)]; University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); The National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); The National Institute of Health/The National Institute of Mental Health; European Network of Genomic and Genetic Epidemiology (ENGAGE) project; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Academy of Finland [project grants 104781, 120315, 129418, Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)], University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission [EURO-BLCS, Framework 5 award QLG1-CT-2000-01643], The National Heart, Lung and Blood Institute [5R01HL087679-02] through the SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED) program [1RL1MH083268-01], The National Institute of Health/The National Institute of Mental Health [5R01MH63706:02], European Network of Genomic and Genetic Epidemiology (ENGAGE) project and grant agreement [HEALTH-F4-2007-201413], and the Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/Public Health Challenges Research Program (SALVE)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Broms U, 2012, NICOTINE TOB RES, V14, P720, DOI 10.1093/ntr/ntr283; Buzkova P, 2011, ANN HUM GENET, V75, P36, DOI 10.1111/j.1469-1809.2010.00572.x; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Cheng PW, 2011, BRIT J PHARMACOL, V163, P1203, DOI 10.1111/j.1476-5381.2010.01124.x; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Grucza RA, 2006, ALCOHOL RES HEALTH, V29, P172; Hindorff L, 2012, CATALOG PUBLISHED GE; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Kim J, 2008, CLIN CHEM LAB MED, V46, P1085, DOI 10.1515/CCLM.2008.230; Landgren S, 2009, BRAIN RES, V1305, pS72, DOI 10.1016/j.brainres.2009.08.026; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Leone A, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/264894; Li YF, 2009, NEUROSCI LETT, V462, P20, DOI 10.1016/j.neulet.2009.06.081; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moore C, 2011, EUR J PHARMACOL, V668, P177, DOI 10.1016/j.ejphar.2011.06.055; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, PLINK 1 06; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2009, R FDN STAT COMP; Rana BK, 2009, J PHARMACOL EXP THER, V331, P419, DOI 10.1124/jpet.109.157271; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thomas DC, 2012, AM J EPIDEMIOL, V175, P203, DOI 10.1093/aje/kwr365; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46557	10.1371/journal.pone.0046557	http://dx.doi.org/10.1371/journal.pone.0046557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029550	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500109
J	Lambertucci, SA; Carrete, M; Donazar, JA; Hiraldo, F				Lambertucci, Sergio A.; Carrete, Martina; Antonio Donazar, Jose; Hiraldo, Fernando			Large-Scale Age-Dependent Skewed Sex Ratio in a Sexually Dimorphic Avian Scavenger	PLOS ONE			English	Article							ANDEAN CONDORS; COMMUNAL ROOSTS; VULTUR-GRYPHUS; HABITAT USE; POPULATION; SIZE; SEGREGATION; COMPETITION; ARGENTINA; PATAGONIA	Age-dependent skewed sex ratios have been observed in bird populations, with adult males generally outnumbering females. This trend is mainly driven by higher female mortality, sometimes associated with anthropogenic factors. Despite the large amount of work on bird sex ratios, research examining the spatial stability of adult sex ratios is extremely scarce. The Andean condor (Vultur gryphus) is the only bird of prey with strong sexual dimorphism favouring males (males are 30% heavier than females). By examining data from most of its South-American range, we show that while the juvenile sex ratio is balanced, or even female-skewed, the sex ratio becomes increasing male-skewed with age, with adult males outnumbering females by >20%, and, in some cases by four times more. This result is consistent across regions and independent of the nature of field data. Reasons for this are unknown but it can be hypothesized that the progressive disappearance of females may be associated with mortality caused by anthropogenic factors. This idea is supported by the asymmetric habitat use by the two sexes, with females scavenging in more humanized areas. Whatever the cause, male-skewed adult sex ratios imply that populations of this endangered scavenger face higher risks of extinction than previously believed.	[Lambertucci, Sergio A.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Carrete, Martina; Antonio Donazar, Jose; Hiraldo, Fernando] CSIC, Estac Biol Donana, Dept Biol Conservac, E-41080 Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar	Carrete, Martina/A-6376-2009; Hiraldo, Fernando/AAA-8314-2019; Carrete, Martina/D-2618-2017	Carrete, Martina/0000-0002-0491-2950; LAMBERTUCCI, SERGIO/0000-0002-2624-2185; Donazar, Jose Antonio/0000-0002-9433-9755	Project BIOCON from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria) [08 126]	Project BIOCON from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria)	Funding was provided through the Project BIOCON 08 126, from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aresco MJ, 2005, BIOL CONSERV, V123, P37, DOI 10.1016/j.biocon.2004.10.006; Brooke MD, 2012, ANIM CONSERV, V15, P466, DOI 10.1111/j.1469-1795.2012.00535.x; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Christe P, 2006, OIKOS, V114, P381, DOI 10.1111/j.2006.0030-1299.15130.x; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; Feijoo J., 1999, REGISTRO NACL CONDOR, V7, P18; FERRER M, 1992, BIOL CONSERV, V60, P57, DOI 10.1016/0006-3207(92)90799-S; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Lambertucci SA, 2009, J RAPTOR RES, V43, P245, DOI 10.3356/JRR-08-108.1; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McGahan J, 1972, THESIS U WISCONSIN U; Ministerio de Ambiente Vivienda y Desarrollo Territorial, 2006, PROGR NAC CONS COND; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Onichimowska Anna., 2012, KONIEC GRY; Orzack SH, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P383, DOI 10.1017/CBO9780511542053.020; Rios-Uzeda B, 2007, J FIELD ORNITHOL, V78, P170, DOI 10.1111/j.1557-9263.2007.00100.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Sarno RJ, 2000, REV CHIL HIST NAT, V73, P3; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Stoks R, 2001, ECOL ENTOMOL, V26, P188, DOI 10.1046/j.1365-2311.2001.00303.x; Wehi PM, 2011, J EVOLUTION BIOL, V24, P2321, DOI 10.1111/j.1420-9101.2011.02366.x; White C.M., 1994, NEW WORLD VULTURES G; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004	35	36	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46347	10.1371/journal.pone.0046347	http://dx.doi.org/10.1371/journal.pone.0046347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029488	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500091
J	Song, ZJ; Song, YL; Yin, J; Shen, Y; Yao, CL; Sun, Z; Jiang, JJ; Zhu, DM; Zhang, Y; Shen, QJ; Gao, L; Tong, CY; Bai, CX				Song, Zhenju; Song, Yuanlin; Yin, Jun; Shen, Yao; Yao, Chenling; Sun, Zhan; Jiang, Jinjun; Zhu, Duming; Zhang, Yong; Shen, Qinjun; Gao, Lei; Tong, Chaoyang; Bai, Chunxue			Genetic Variation in the TNF Gene Is Associated with Susceptibility to Severe Sepsis, but Not with Mortality	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; TRAUMA PATIENTS; ALPHA; POLYMORPHISMS; RISK; MULTICENTER; LYMPHOTOXIN; INFECTION; HAPLOTYPE	Background: Tumor necrosis factor (TNF) and TNF receptor superfamily (TNFR)-mediated immune response play an essential role in the pathogenesis of severe sepsis. Studies examining associations of TNF and lymphotoxin-alpha (LTA) single nucleotide polymorphisms (SNPs) with severe sepsis have produced conflicting results. The objective of this study was to investigate whether genetic variation in TNF, LTA, TNFRSF1A and TNFRSF1B was associated with susceptibility to or death from severe sepsis in Chinese Han population. Methodology/Principal Findings: Ten SNPs in TNF, LTA, TNFRSF1A and TNFRSF1B were genotyped in samples of patients with severe sepsis (n = 432), sepsis (n = 384) and healthy controls (n = 624). Our results showed that rs1800629, a SNP in the promoter region of TNF, was significantly associated with risk for severe sepsis. The minor allele frequency of rs1800629 was significantly higher in severe sepsis patients than that in both healthy controls (P-adj = 0.00046, odds ratio (OR)(adj) = 1.92) and sepsis patients (P-adj = 0.002, ORadj = 1.56). Further, we investigated the correlation between rs1800629 genotypes and TNF-alpha concentrations in peripheral blood mononuclear cells (PBMCs) of healthy volunteers exposed to lipopolysaccharides (LPS) ex vivo, and the association between rs1800629 and TNF-alpha serum levels in severe sepsis patients. After exposure to LPS, the TNF-alpha concentration in culture supernatants of PBMCs was significantly higher in the subjects with AA+AG genotypes than that with GG genotype (P = 0.007). Moreover, in patients with severe sepsis, individuals with AA+AG genotypes had significantly higher TNF-alpha serum concentrations than those with GG genotype (P-adj = 0.02). However, there were no significant associations between SNPs in the four candidate genes and 30 day mortality for patients with severe sepsis. Conclusions/Significance: Our findings suggested that the functional TNF gene SNP rs1800629 was strongly associated with susceptibility to severe sepsis, but not with lethality in Chinese Han population.	[Song, Zhenju; Yin, Jun; Yao, Chenling; Sun, Zhan; Tong, Chaoyang] Fudan Univ, Zhongshan Hosp, Dept Emergency Med, Shanghai 200433, Peoples R China; [Song, Yuanlin; Shen, Yao; Jiang, Jinjun; Zhang, Yong; Shen, Qinjun; Gao, Lei; Bai, Chunxue] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Zhu, Duming] Fudan Univ, Zhongshan Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Tong, CY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Emergency Med, Shanghai 200433, Peoples R China.	tong.chaoyang@zs-hospital.sh.cn; bai.chunxue@zs-hospital.sh.cn	HASAN, AURANGZEB/B-8270-2010; Rasheed, Lubna/S-1841-2019	Rasheed, Lubna/0000-0002-5378-8079; Bai, Chunxue/0000-0001-5798-3130	National Natural Science Foundation of China [30930090, 81000023, 81171837]; Shanghai Committee of Science and Technology [09411960400]; Shanghai Public Health Fund for Distinguished Young Scholars [08GWQ026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Public Health Fund for Distinguished Young Scholars	This work was supported by grants from the Major Program of the National Natural Science Foundation of China (30930090), the National Natural Science Foundation of China (81000023 and 81171837), the Shanghai Committee of Science and Technology (09411960400) and the Shanghai Public Health Fund for Distinguished Young Scholars (08GWQ026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, CRIT CARE MED, V20, P864; Appoloni O, 2001, AM J MED, V110, P486, DOI 10.1016/S0002-9343(01)00656-8; Arcaroli J, 2006, AM J RESP CRIT CARE, V173, P1335, DOI 10.1164/rccm.200603-341OC; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Calvano Jacqueline E, 2003, Surg Infect (Larchmt), V4, P163, DOI 10.1089/109629603766956951; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; Constantin A, 2004, ARTHRITIS RHEUM-US, V50, P742, DOI 10.1002/art.20113; Dahmer Mary K, 2005, Pediatr Crit Care Med, V6, pS61, DOI 10.1097/01.PCC.0000161970.44470.C7; DEBETS JMH, 1989, CRIT CARE MED, V17, P489, DOI 10.1097/00003246-198906000-00001; Douni E, 1998, J EXP MED, V188, P1343, DOI 10.1084/jem.188.7.1343; Duan ZX, 2011, J TRAUMA, V70, P954, DOI 10.1097/TA.0b013e3181e88adf; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Garnacho-Montero J, 2006, CRIT CARE, V10, DOI 10.1186/cc4995; Gordon AC, 2004, GENES IMMUN, V5, P631, DOI 10.1038/sj.gene.6364136; Hamann L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-65; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; Horiuchi T, 2009, RHEUMATOLOGY, V48, P1045, DOI 10.1093/rheumatology/kep166; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Majetschak M, 1999, ANN SURG, V230, P207, DOI 10.1097/00000658-199908000-00011; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menges T, 2008, CRIT CARE MED, V36, P1456, DOI 10.1097/CCM.0B013E318170ABB6; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Moller M, 2010, AM J RESP CRIT CARE, V181, P388, DOI 10.1164/rccm.200905-0678OC; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; O'Keefe GE, 2002, J TRAUMA, V52, P817, DOI 10.1097/00005373-200205000-00001; Pino-Yanes M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013759; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reid CL, 2002, CRIT CARE MED, V30, P2216, DOI 10.1097/00003246-200210000-00007; Secher T, 2009, J IMMUNOL, V182, P7855, DOI 10.4049/jimmunol.0804008; Song Z, CRIT CARE, V15, pR12; Song ZhenJu, 2009, Chinese Journal of Emergency Medicine, V18, P956; Stuber F, 1995, J Inflamm, V46, P42; Tang GJ, 2000, CRIT CARE MED, V28, P2733, DOI 10.1097/00003246-200008000-00008; Teuffel O, 2010, CRIT CARE MED, V38, P276, DOI 10.1097/CCM.0b013e3181b42af0; Tiancha Huang, 2011, Scand J Infect Dis, V43, P436, DOI 10.3109/00365548.2011.562528; Toubiana J, 2010, CRIT CARE MED, V38, P2287, DOI 10.1097/CCM.0b013e3181f9f9c7; Wang SX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-27; Waschke KA, 2005, AM J GASTROENTEROL, V100, P1126, DOI 10.1111/j.1572-0241.2005.40534.x; Zheng X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017987	44	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46113	10.1371/journal.pone.0046113	http://dx.doi.org/10.1371/journal.pone.0046113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029405	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500062
J	Zhao, JX; Zhao, JC; Perlman, S				Zhao, Jingxian; Zhao, Jincun; Perlman, Stanley			Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-gamma, IL-2 and IL-2R	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR; IN-VIVO; DENDRITIC CELLS; TH1 DIFFERENTIATION; REGULATORY CELLS; FOXP3 EXPRESSION; INTERLEUKIN-2; RESPONSES; INFECTION	Complex interactions between effector T cells and Foxp3(+) regulatory T cells (Treg) contribute to clinical outcomes in cancer, and autoimmune and infectious diseases. Previous work showed that IL-12 reversed Treg-mediated suppression of CD4(+) Foxp3(-) T cell (Tconv) proliferation. We and others have also shown that Tregs express T-bet and IFN-gamma at sites of Th1 inflammation and that IL-12 induces IFN-gamma production by Tregs in vitro. To investigate whether loss of immunosuppression occurs when IFN-gamma is expressed by Tregs we treated mouse lymphocyte cultures with IL-12. IFN-gamma expression did not decrease the ability of Tregs to suppress Tconv proliferation. Rather, IL-12 treatment decreased Treg frequency and Foxp3 levels in Tregs. We further showed that IL-12 increased IL-2R expression on Tconv and CD8 T cells, diminished its expression on Tregs and decreased IL-2 production by Tconv and CD8 T cells. Together, these IL-12 mediated changes favored the outgrowth of non-Tregs. Additionally, we showed that treatment with a second cytokine, IL-27, decreased IL-2 expression without augmenting Tconv and CD8 T cell proliferation. Notably, IL-27 only slightly modified levels of IL-2R on non-Treg T cells. Together, these results show that IL-12 has multiple effects that modify the balance between Tregs and non-Tregs and support an important role for relative levels of IL-2R but not for IFN-gamma expression in IL-12-mediated reversal of Treg immunosuppression.	[Zhao, Jingxian; Zhao, Jincun; Perlman, Stanley] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Zhao, Jingxian] Jinan Univ, Inst Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China	University of Iowa; Jinan University	Perlman, S (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	Stanley-Perlman@uiowa.edu	Zhao, Jincun/ABD-8679-2021	Zhao, Jincun/0000-0003-2515-5589; Perlman, Stanley/0000-0003-4213-2354	N.I.H. [RO1 NS36592]; National Multiple Sclerosis Society [RG 2864]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036592] Funding Source: NIH RePORTER	N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the N.I.H. (RO1 NS36592) and the National Multiple Sclerosis Society (RG 2864, http://www.nationalmssociety.org/research/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2006, BLOOD, V107, P2409, DOI 10.1182/blood-2005-06-2399; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Feng T, 2011, GASTROENTEROLOGY, V140, P2031, DOI 10.1053/j.gastro.2011.03.009; FLEMING JO, 1986, J VIROL, V58, P869, DOI 10.1128/JVI.58.3.869-875.1986; Kapil P, 2009, J VIROL, V83, P5978, DOI 10.1128/JVI.00315-09; King IL, 2005, J IMMUNOL, V175, P641, DOI 10.4049/jimmunol.175.2.641; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lazarski CA, 2008, IMMUNITY, V29, P511, DOI 10.1016/j.immuni.2008.09.012; Lemoine FM, 2009, INT J ONCOL, V35, P569, DOI 10.3892/ijo_00000368; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mach N, 2000, CANCER RES, V60, P3239; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Saadoun D, 2011, NEW ENGL J MED, V365, P2067, DOI 10.1056/NEJMoa1105143; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Valenzuela J, 2002, J IMMUNOL, V169, P6842, DOI 10.4049/jimmunol.169.12.6842; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wojno EDT, 2011, J IMMUNOL, V187, P266, DOI 10.4049/jimmunol.1004182; Xing Z, 2001, CELL MOL BIOL, V47, P689; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2009, J LEUKOCYTE BIOL, V86, P1295, DOI 10.1189/jlb.0609445; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; Zhao JX, 2011, J EXP MED, V208, P1571, DOI 10.1084/jem.20110236; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	50	60	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46241	10.1371/journal.pone.0046241	http://dx.doi.org/10.1371/journal.pone.0046241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029447	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500075
J	Entling, MH; Schweiger, O; Bacher, S; Espadaler, X; Hickler, T; Kumschick, S; Woodcock, BA; Nentwig, W				Entling, Martin H.; Schweiger, Oliver; Bacher, Sven; Espadaler, Xavier; Hickler, Thomas; Kumschick, Sabrina; Woodcock, Ben A.; Nentwig, Wolfgang			Species Richness-Environment Relationships of European Arthropods at Two Spatial Grains: Habitats and Countries	PLOS ONE			English	Article							WOODY PLANT RICHNESS; METABOLIC THEORY; VEGETATION DYNAMICS; GLOBAL-MODELS; CLIMATE; DIVERSITY; SCALE; BIODIVERSITY; GRADIENTS; PATTERNS	We study how species richness of arthropods relates to theories concerning net primary productivity, ambient energy, water-energy dynamics and spatial environmental heterogeneity. We use two datasets of arthropod richness with similar spatial extents (Scandinavia to Mediterranean), but contrasting spatial grain (local habitat and country). Samples of ground-dwelling spiders, beetles, bugs and ants were collected from 32 paired habitats at 16 locations across Europe. Species richness of these taxonomic groups was also determined for 25 European countries based on the Fauna Europaea database. We tested effects of net primary productivity (NPP), annual mean temperature (T), annual rainfall (R) and potential evapotranspiration of the coldest month (PETmin) on species richness and turnover. Spatial environmental heterogeneity within countries was considered by including the ranges of NPP, T, R and PETmin. At the local habitat grain, relationships between species richness and environmental variables differed strongly between taxa and trophic groups. However, species turnover across locations was strongly correlated with differences in T. At the country grain, species richness was significantly correlated with environmental variables from all four theories. In particular, species richness within countries increased strongly with spatial heterogeneity in T. The importance of spatial heterogeneity in T for both species turnover across locations and for species richness within countries suggests that the temperature niche is an important determinant of arthropod diversity. We suggest that, unless climatic heterogeneity is constant across sampling units, coarse-grained studies should always account for environmental heterogeneity as a predictor of arthropod species richness, just as studies with variable area of sampling units routinely consider area.	[Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany; [Entling, Martin H.; Bacher, Sven; Kumschick, Sabrina; Nentwig, Wolfgang] Univ Bern, Bern, Switzerland; [Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Bacher, Sven] Univ Fribourg, Ecol & Evolut Unit, CH-1700 Fribourg, Switzerland; [Espadaler, Xavier] Autonomous Univ Barcelona, Anim Biodivers Grp, Ecol Unit, Bellaterra, Spain; [Espadaler, Xavier] Autonomous Univ Barcelona, CREAF, Bellaterra, Spain; [Hickler, Thomas] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Hickler, Thomas] Goethe Univ Frankfurt, Dept Phys Geog, Frankfurt, Germany; [Kumschick, Sabrina] Univ Stellenbosch, Ctr Excellence Invas Biol, Dept Bot & Zool, Matieland, South Africa; [Woodcock, Ben A.] NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England	University of Koblenz & Landau; University of Bern; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Fribourg; Autonomous University of Barcelona; Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Stellenbosch University; UK Centre for Ecology & Hydrology (UKCEH)	Entling, MH (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau Pfalz, Germany.	entling@uni-landau.de	Espadaler, Xavier/F-1898-2011; Woodcock, Ben/F-9199-2010; Entling, Martin H/C-6953-2008; Hickler, Thomas/S-6287-2016; Nentwig, Wolfgang/A-6624-2011; Bacher, Sven/F-5431-2010; Schweiger, Oliver/B-4909-2008	Espadaler, Xavier/0000-0002-7681-5957; Woodcock, Ben/0000-0003-0300-9951; Hickler, Thomas/0000-0002-4668-7552; Bacher, Sven/0000-0001-5147-7165; Schweiger, Oliver/0000-0001-8779-2335; Kumschick, Sabrina/0000-0001-8034-5831	EC FP6 ALARM Project [GOCE-CT-2003-506675]; FP7 SCALES Project [226 852]; MEC-FEDER [CGL2007-64080-C02-01]; Natural Environment Research Council [CEH010021] Funding Source: researchfish	EC FP6 ALARM Project(European Commission); FP7 SCALES Project; MEC-FEDER(Spanish GovernmentEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The sampling and the research of SB, TH, SK, WN and OS were supported by the EC FP6 ALARM Project (GOCE-CT-2003-506675) and the FP7 SCALES Project (grant 226 852). XE was supported by MEC-FEDER CGL2007-64080-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2004, 55 TYND CTR CLIM CHA; [Anonymous], 2010, R LANG ENV STAT COMP; Begon M., 2009, ECOLOGY INDIVIDUALS; Belmaker J, 2011, GLOBAL ECOL BIOGEOGR, V20, P464, DOI 10.1111/j.1466-8238.2010.00615.x; Bivand R., 2020, SPDEP SPATIAL DEPEND; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Cassemiro FAS, 2010, ECOLOGY, V91, P3729, DOI 10.1890/09-1434.1; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Ellenberg H, 2010, VETETATION MITTELEUR; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Entling W, 2010, J BIOGEOGR, V37, P477, DOI 10.1111/j.1365-2699.2009.02216.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Eyre MD, 2005, J BIOGEOGR, V32, P973, DOI 10.1111/j.1365-2699.2005.01258.x; Fauna Europaea Web Service, 2004, FAUN EUR VERS 1 1; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Finch OD, 2008, BIODIVERS CONSERV, V17, P2849, DOI 10.1007/s10531-008-9400-x; Hammen VC, 2010, ENVIRON MONIT ASSESS, V164, P337, DOI 10.1007/s10661-009-0896-7; Hawkins BA, 2006, J BIOGEOGR, V33, P770, DOI 10.1111/j.1365-2699.2006.01452.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hawkins BA, 2007, ECOLOGY, V88, P255, DOI 10.1890/0012-9658(2007)88[255:GMFPWP]2.0.CO;2; Hawkins BA, 2010, J BIOGEOGR, V37, P647, DOI 10.1111/j.1365-2699.2009.02250.x; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hickler T, 2004, ECOLOGY, V85, P519, DOI 10.1890/02-0344; Hickler T, 2006, GLOBAL ECOL BIOGEOGR, V15, P567, DOI 10.1111/j.1466-8238.2006.00254.x; Hickler T, 2012, GLOBAL ECOL BIOGEOGR, V21, P50, DOI 10.1111/j.1466-8238.2010.00613.x; Hickler T, 2009, GLOBAL ECOL BIOGEOGR, V18, P304, DOI 10.1111/j.1466-8238.2009.00455.x; Hill MO, 2000, J APPL ECOL, V37, P3, DOI 10.1046/j.1365-2664.2000.00466.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hortal J, 2011, ECOL LETT, V14, P741, DOI 10.1111/j.1461-0248.2011.01634.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kaspari M, 2004, OECOLOGIA, V140, P407, DOI 10.1007/s00442-004-1607-2; Kaspari M, 2004, ECOLOGY, V85, P1800, DOI 10.1890/03-0682; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Koleff P, 2002, GLOBAL ECOL BIOGEOGR, V11, P363, DOI 10.1046/j.1466-822x.2002.00302.x; Kumschick S, 2009, ECOL ENTOMOL, V34, P748, DOI 10.1111/j.1365-2311.2009.01127.x; Lavers C, 2006, GLOBAL ECOL BIOGEOGR, V15, P213, DOI 10.1111/j.1466-822x.2006.00229.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; O'Brien EM, 2006, J BIOGEOGR, V33, P1868, DOI 10.1111/j.1365-2699.2006.01534.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rosenzweig Michael L., 1993, P52; Rotzer T, 2001, CLIM RES, V18, P249, DOI 10.3354/cr018249; Schoener T.W., 1989, P79; Schuldt A, 2010, BIOL CONSERV, V143, P2747, DOI 10.1016/j.biocon.2010.07.022; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; Smith B, 2001, GLOBAL ECOL BIOGEOGR, V10, P621, DOI 10.1046/j.1466-822X.2001.00256.x; Smith B, 2008, FOREST ECOL MANAG, V255, P3985, DOI 10.1016/j.foreco.2008.03.056; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; TOPPING CJ, 1992, J APPL ECOL, V29, P485, DOI 10.2307/2404516; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; Zaehle S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002395; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3; [No title captured]	66	9	9	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45875	10.1371/journal.pone.0045875	http://dx.doi.org/10.1371/journal.pone.0045875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029288	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000309554700081
J	Kim, JH; Shim, KW; Yoon, YS; Lee, SY; Kim, SS; Oh, SW				Kim, Jung Hwan; Shim, Kyung Won; Yoon, Yeong Sook; Lee, Sang Yeoup; Kim, Sung Soo; Oh, Sang Woo			Cigarette Smoking Increases Abdominal and Visceral Obesity but Not Overall Fatness: An Observational Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; KOREA NATIONAL-HEALTH; BODY-FAT DISTRIBUTION; METABOLIC SYNDROME; WEIGHT-GAIN; WOMEN; MEN; MASS; CONSUMPTION; CESSATION	Background: Cigarette smoking and obesity are leading public health concerns. Both increase the risk for cardiovascular disease, cancer, and metabolic abnormalities. This study was conducted to assess the association between cigarette smoking and different types of obesity. Methodology/Principal Findings: Two hundred eighty-three visitors to university hospitals located in four main provinces of South Korea were participated. All participants were classified as either current/past or never smokers and were divided into quartiles according to the total pack-years. Body mass index, waist circumference, total body fat percentage, and area of visceral and abdominal subcutaneous fat were measured. These results of each groups were compared. Waist circumference, and visceral fat area showed a J- or U-shaped association with total smoking amount during a lifetime. After restricting the analyses to past/current smokers, we found significant dose-dependent associations of smoking pack-years with abdominal and visceral obesity. Overall obesity measured by body mass index and total body fat percentage did not show such associations. Although current smokers clearly showed significant associations, we could not demonstrate these in past smokers, possibly because of the limited sample size. Conclusions/Significance: Although smokers did not show significant difference in mean body mass index than those who never smoked, they showed more metabolically adverse fat distributions with increasing smoking amounts. This finding suggests that smoking is not beneficial for weight control. Therefore, smoking cessation and avoidance of smoking commencement should be addressed as important public health issues in preventing obesity and related complications.	[Oh, Sang Woo] Dongguk Univ, Dept Family Med, Ctr Obes Metab & Clin Nutr, Int Hosp, Gyeonggi Do, South Korea; [Kim, Jung Hwan] Eulji Univ, Dept Family Med, Seoul Eulji Hosp, Seoul, South Korea; [Shim, Kyung Won] Ewha Womans Univ, Dept Family Med, Mokdong Hosp, Seoul, South Korea; [Yoon, Yeong Sook] Inje Univ, Dept Family Med, Ctr Hlth Promot, Ilsan Paik Hosp,Coll Med, Gyeonggi Do, South Korea; [Yoon, Yeong Sook] Inje Univ, Clin Res Ctr, Ilsan Paik Hosp, Coll Med, Gyeonggi Do, South Korea; [Lee, Sang Yeoup] Pusan Natl Univ, Dept Family Med, Coll Med, Pusan, South Korea; [Kim, Sung Soo] Chungnam Natl Univ Hosp, Dept Family Med, Taejon, South Korea	Dongguk University; Eulji University; Ewha Womans University; Inje University; Inje University; Pusan National University; Chungnam National University; Chungnam National University Hospital	Oh, SW (corresponding author), Dongguk Univ, Dept Family Med, Ctr Obes Metab & Clin Nutr, Int Hosp, Gyeonggi Do, South Korea.	osw6021@yahoo.co.kr	Lee, Sang Yeoup/AAV-2125-2020	Yoon, Yeong Sook/0000-0002-9249-2940; Lee, Sang Yeoup/0000-0002-3585-9910; Kim, JungHwan/0000-0001-8984-2914; Oh, Sang Woo/0000-0002-5623-6720	Korean Society for the Study of Obesity (KOSSO)	Korean Society for the Study of Obesity (KOSSO)	SWO was awarded a research grant named "MunSeok fund" by Korean Society for the Study of Obesity (KOSSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamia C, 2004, INT J OBESITY, V28, P1091, DOI 10.1038/sj.ijo.0802697; BARRETTCONNOR E, 1989, ANN INTERN MED, V111, P783, DOI 10.7326/0003-4819-111-10-783; Bedogni G, 2002, EUR J CLIN NUTR, V56, P1143, DOI 10.1038/sj.ejcn.1601466; Bray G A, 1993, Obes Res, V1, P203; Calole C, 2011, BMC PUBLIC HEALTH, V11, P23; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Froom P, 1998, J FAM PRACTICE, V46, P460; Goldman J, 2001, Med Sci Monit, V7, P1280; Hideaki K, 2006, J EXP MED, V280, P123; Jee SH, 2002, OBES RES, V10, P891, DOI 10.1038/oby.2002.122; KHAW KT, 1988, NEW ENGL J MED, V318, P1705, DOI 10.1056/NEJM198806303182601; KOTANI K, 1994, INT J OBESITY, V18, P207; KVIST H, 1986, INT J OBESITY, V10, P53; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Oh SW, 2005, J CLIN ONCOL, V23, P4742, DOI 10.1200/JCO.2005.11.726; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Okura T, 2005, INT J OBESITY, V29, P1259, DOI 10.1038/sj.ijo.0803013; Onat A, 2009, METABOLISM, V58, P963, DOI 10.1016/j.metabol.2009.02.029; Pi-Sunyer FX, 2004, NUTR REV, V62, pS120, DOI 10.1111/j.1753-4887.2004.tb00081.x; Pomerleau C S, 2001, Nicotine Tob Res, V3, P51, DOI 10.1080/14622200020032105; Ribeiro FF, 2003, OBES RES, V11, P1488, DOI 10.1038/oby.2003.199; Sairenchi T, 2004, AM J EPIDEMIOL, V160, P158, DOI 10.1093/aje/kwh183; SEIDELL JC, 1991, AM J EPIDEMIOL, V133, P257, DOI 10.1093/oxfordjournals.aje.a115870; SHIMOKATA H, 1989, JAMA-J AM MED ASSOC, V261, P1169, DOI 10.1001/jama.261.8.1169; STAMFORD BA, 1986, AM J CLIN NUTR, V43, P486, DOI 10.1093/ajcn/43.4.486; WHO, 2000, ASIA PACIFIC PERSPEC; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Yumi M, 2011, OBESITY, V19, P647	28	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45815	10.1371/journal.pone.0045815	http://dx.doi.org/10.1371/journal.pone.0045815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029258	Green Published, gold			2022-12-25	WOS:000309554700075
J	Wu, N; Sulpice, E; Obeid, P; Benzina, S; Kermarrec, F; Combe, S; Gidrol, X				Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier			The miR-17 Family Links p63 Protein to MAPK Signaling to Promote the Onset of Human Keratinocyte Differentiation	PLOS ONE			English	Article							C-JUN; EPIDERMAL MORPHOGENESIS; MESSENGER-RNA; STEM-CELLS; SKIN; PROLIFERATION; EXPRESSION; MICRORNAS; REPRESSION; MIRNAS	The p63 protein plays a key role in regulating human keratinocyte proliferation and differentiation. Although some p63-regulating microRNAs (miRNAs) have been identified in the control of epidermal homeostasis, little is known about miRNAs acting downstream of p63. In this paper, we characterized multiple p63-regulated miRNAs (miR-17, miR-20b, miR-30a, miR-06a, miR-143 and miR-455-3p) and elucidated their roles in the onset of keratinocyte differentiation. We identified RB, p21 and multiple MAPKs as targets of these p63-controlled miRNAs. Upon inhibition of most of these miRNAs, we observed defects in commitment to differentiation that could be reversed by siRNA-mediated silencing of their targets. Furthermore, knockdown of MAPK8 and MAPK9 efficiently restored expression of the early differentiation markers keratin 1 and keratin 10 in p63-silenced primary human keratinocytes. These results highlight new mechanistic roles of multiple miRNAs, particularly the miR-17 family (miR-17, miR-20b and miR-106a), as regulatory intermediates for coordinating p63 with MAPK signaling in the commitment of human mature keratinocytes to early differentiation.	[Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] CEA, Lab Biol Grande Echelle, Grenoble, France; [Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] INSERM, U1038, Grenoble, France; [Wu, Ning; Sulpice, Eric; Obeid, Patricia; Benzina, Sami; Kermarrec, Frederique; Combe, Stephanie; Gidrol, Xavier] Univ Grenoble 1, Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gidrol, X (corresponding author), CEA, Lab Biol Grande Echelle, Grenoble, France.	xavier.gidrol@cea.fr		OBEID, Patricia/0000-0003-3144-0001; Gidrol, Xavier/0000-0002-4233-3749; Sulpice, Eric/0000-0001-7695-0561	CEA; FRM	CEA(French Atomic Energy Commission); FRM(Fondation pour la Recherche Medicale)	Funding provided by CEA (http://dirgre.cea.fr:8000/scripts/home/index.asp) and FRM (http://www.frm.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2008, TRENDS BIOCHEM SCI, V33, P583, DOI 10.1016/j.tibs.2008.09.002; Alameda JP, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.82; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antonini D, 2010, J INVEST DERMATOL, V130, P1249, DOI 10.1038/jid.2009.438; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hara T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.40; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MANNI I, 2009, FASEB J; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Paramio JM, 2000, J BIOL CHEM, V275, P41219, DOI 10.1074/jbc.M004973200; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ruiz S, 2004, DEVELOPMENT, V131, P2737, DOI 10.1242/dev.01148; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Scheel AHJ, 2009, CELL CYCLE, V8, P1426, DOI 10.4161/cc.8.9.8324; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vigano MA, 2006, EMBO J, V25, P5105, DOI 10.1038/sj.emboj.7601375; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Weston CR, 2004, P NATL ACAD SCI USA, V101, P14114, DOI 10.1073/pnas.0406061101; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2010, CELL DEATH DIFFER, V17, P229, DOI 10.1038/cdd.2009.92; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8	49	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45761	10.1371/journal.pone.0045761	http://dx.doi.org/10.1371/journal.pone.0045761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029228	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700066
J	Bro-Jorgensen, J				Bro-Jorgensen, Jakob			Longevity in Bovids Is Promoted by Sociality, But Reduced by Sexual Selection	PLOS ONE			English	Article							NATURAL-POPULATIONS; BODY-SIZE; RED DEER; SENESCENCE; EVOLUTION; DIMORPHISM; COSTS; AGE	Selection on intrinsic lifespan depends on both external factors affecting mortality and inherent tradeoffs in resource allocation between viability traits and other fitness-related traits. Longevity is therefore likely to vary between species in a sex-specific manner due to interspecific and intersexual differences in behavioural ecology. Here I focus on the bovid family to test two central hypotheses on longevity selection using the comparative method: firstly, that a reduction of extrinsic mortality in social species strengthens selection on intrinsic lifespan, and secondly, that mortality costs associated with intense sexual selection lead to shorter intrinsic lifespan. The results show that longevity (i) increases with sociality in both sexes and (ii) decreases with male-biased sexual size-dimorphism, but in males only. These discoveries suggest that sociality, a key ungulate strategy to reduce predation-related mortality, selects for inherently longer-lived organisms, and that strong sexual selection, which is known to compromise survival rates in the wild, can constrain also intrinsic lifespan. The contrasting results for males and females indicate that selection on longevity in the two sexes is partly uncoupled.	Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Dept Evolut Ecol & Behav,Mammalian Behav & Evolut, Liverpool L69 3BX, Neston, England	University of Liverpool	Bro-Jorgensen, J (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Dept Evolut Ecol & Behav,Mammalian Behav & Evolut, Liverpool L69 3BX, Neston, England.	bro@liv.ac.uk						[Anonymous], 2000, LONGEVITY RECORDS LI; AUSTAD SN, 1991, J GERONTOL, V46, pB47, DOI 10.1093/geronj/46.2.B47; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Bro-Jorgensen J, 2008, OIKOS, V117, P729, DOI 10.1111/j.0030-1299.2008.16069.x; Bro-Jorgensen J, 2007, EVOLUTION, V61, P1316, DOI 10.1111/j.1558-5646.2007.00111.x; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Carranza J, 2004, NATURE, V432, P215, DOI 10.1038/nature03004; Carranza J, 2007, AM NAT, V170, P370, DOI 10.1086/519852; Darwin C., 1874, DESCENT MAN SELECTIO; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Harvey P.H., 1991, COMP METHOD EVOLUTIO; JARMAN P, 1983, BIOL REV, V58, P485, DOI 10.1111/j.1469-185X.1983.tb00398.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jones M.L., 1982, Zoologische Garten, V53, P113; Jones Marvin L., 1993, International Zoo Yearbook, V32, P159; Kamilar JM, 2010, BIOL LETTERS, V6, P736, DOI 10.1098/rsbl.2010.0348; Kingdon J, 1997, KINGDON FIELD GUIDE; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; McClave J., 2003, STATISTICS; MEAD J I, 1989, Mammalian Species, P1, DOI 10.2307/3504167; Medawar P., 1952, UNSOLVED PROBLEM BIO; Mysterud A, 2001, P ROY SOC B-BIOL SCI, V268, P911, DOI 10.1098/rspb.2001.1585; Nussey DH, 2009, AM NAT, V174, P342, DOI 10.1086/603615; Orme, 2011, CAPER COMP ANAL PHYL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Barberia FJ, 2007, EVOLUTION, V61, P2811, DOI 10.1111/j.1558-5646.2007.00229.x; Polak J, 2009, BIOL J LINN SOC, V98, P872, DOI 10.1111/j.1095-8312.2009.01294.x; Preston BT, 2011, ECOL LETT, V14, P1017, DOI 10.1111/j.1461-0248.2011.01668.x; Promislow D, 2003, BEHAV GENET, V33, P191, DOI 10.1023/A:1022562103669; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; R Core Team, 2016, R FDN STAT COMP; Rohlf FJ, 2001, EVOLUTION, V55, P2143; Shultz S, 2006, P ROY SOC B-BIOL SCI, V273, P207, DOI 10.1098/rspb.2005.3283; Stearns S.C., 1992, pi; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; Weigl R., 2005, KL SENCKENBERG-REIHE; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams PD, 2006, TRENDS ECOL EVOL, V21, P458, DOI 10.1016/j.tree.2006.05.008	43	12	14	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45769	10.1371/journal.pone.0045769	http://dx.doi.org/10.1371/journal.pone.0045769			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029234	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800095
J	Hamilton, JA; Lacey, DC; Turner, A; de Kok, B; Huynh, J; Scholz, GM				Hamilton, John A.; Lacey, Derek C.; Turner, Amanda; de Kok, Bernard; Huynh, Jennifer; Scholz, Glen M.			Hypoxia Enhances the Proliferative Response of Macrophages to CSF-1 and Their Pro-Survival Response to TNF	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC GROWTH-FACTORS; MARROW-DERIVED MACROPHAGES; RHEUMATOID-ARTHRITIS; KAPPA-B; DNA-SYNTHESIS; MONOCYTE/MACROPHAGE SURVIVAL; NEUTROPHIL SURVIVAL; MURINE MACROPHAGES	In chronic inflammatory lesions there are increased numbers of macrophages with a possible contribution of enhanced survival/proliferation due, for example, to cytokine action; such lesions are often hypoxic. Prior studies have found that culture in low oxygen can promote monocyte/macrophage survival. We show here, using pharmacologic inhibitors, that the hypoxia-induced pro-survival response of macrophages exhibits a dependence on PI3-kinase and mTOR activities but surprisingly is suppressed by Akt and p38 MAPK activities. It was also found that in hypoxia at CSF-1 concentrations, which under normoxic conditions are suboptimal for macrophage proliferation, macrophages can proliferate more strongly with no evidence for alteration in CSF-1 receptor degradation kinetics. TNF promoted macrophage survival in normoxic conditions with an additive effect in hypoxia. The enhanced hypoxia-dependent survival and/or proliferation of macrophages in the presence of CSF-1 or TNF may contribute to their elevated numbers at a site of chronic inflammation.	[Hamilton, John A.; Lacey, Derek C.; Turner, Amanda; de Kok, Bernard; Huynh, Jennifer; Scholz, Glen M.] Univ Melbourne, Dept Med, Royal Melbourne Hosp Parkville, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3010, Australia	Royal Melbourne Hospital; University of Melbourne	Hamilton, JA (corresponding author), Univ Melbourne, Dept Med, Royal Melbourne Hosp Parkville, Arthrit & Inflammat Res Ctr, Melbourne, Vic 3010, Australia.	jahami@unimelb.edu.au		Hamilton, John A/0000-0002-9493-9224; Scholz, Glen/0000-0003-2722-6344	National Health and Medical Research Council of Australia; Cooperative Research Centre for Chronic Inflammatory Diseases	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Chronic Inflammatory Diseases(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by grants from the National Health and Medical Research Council of Australia and the Cooperative Research Centre for Chronic Inflammatory Diseases, and by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia (to JAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Catrina AI, 2005, ARTHRITIS RHEUM-US, V52, P61, DOI 10.1002/art.20764; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003; Chang M, 2009, J LEUKOCYTE BIOL, V85, P947, DOI 10.1189/jlb.0908522; Choi HK, 2011, CELL SIGNAL, V23, P1633, DOI 10.1016/j.cellsig.2011.05.017; Comalada M, 2004, EUR J IMMUNOL, V34, P2257, DOI 10.1002/eji.200425110; Comalada N, 2003, AM J PHYSIOL-CELL PH, V285, pC1235, DOI 10.1152/ajpcell.00228.2003; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Degrossoli A, 2007, EXP BIOL MED, V232, P88; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Elsegood CL, 2009, ARTERIOSCL THROM VAS, V29, P1283, DOI 10.1161/ATVBAHA.108.180778; Fong CC, 2007, TOXICOLOGY, V235, P52, DOI 10.1016/j.tox.2007.03.006; Hamilton JA, 2000, J LEUKOCYTE BIOL, V67, P226, DOI 10.1002/jlb.67.2.226; Hamilton JA, 2003, J LEUKOCYTE BIOL, V73, P702, DOI 10.1189/jlb.0103037; Hamilton JA, 2001, BIOCHEM J, V354, P179, DOI 10.1042/0264-6021:3540179; Hamilton JA, 1998, INT J BIOCHEM CELL B, V30, P271, DOI 10.1016/S1357-2725(97)00111-8; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; HAMILTON JA, 1993, LANCET, V342, P536, DOI 10.1016/0140-6736(93)91653-4; HAMILTON JA, 1986, BIOCHEM BIOPH RES CO, V138, P445, DOI 10.1016/0006-291X(86)90301-3; HAMILTON JA, 1988, J CELL PHYSIOL, V134, P405, DOI 10.1002/jcp.1041340311; Hamilton JA, 2009, ARTHRITIS RHEUM-US, V60, P1210, DOI 10.1002/art.24505; HANNAH S, 1995, FEBS LETT, V372, P233, DOI 10.1016/0014-5793(95)00986-J; HASLETT C, 1994, PHILOS T ROY SOC B, V345, P327, DOI 10.1098/rstb.1994.0113; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Kim HJ, 2008, CANCER LETT, V260, P88, DOI 10.1016/j.canlet.2007.10.030; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lo SZY, 2011, CANCER LETT, V307, P80, DOI 10.1016/j.canlet.2011.03.020; Lombardo E, 2007, J IMMUNOL, V178, P3731, DOI 10.4049/jimmunol.178.6.3731; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Matsui T, 2009, J NUCL MED, V50, P920, DOI 10.2967/jnumed.108.060103; Mazumder B, 2010, J IMMUNOL, V184, P3311, DOI 10.4049/jimmunol.0903778; MESZAROS K, 1987, BIOCHEM BIOPH RES CO, V149, P1, DOI 10.1016/0006-291X(87)91596-8; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Murray J, 2000, J CELL SCI, V113, P337; Murray JT, 2000, INFLAMM RES, V49, P610, DOI 10.1007/s000110050638; Muz B, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2568; Negus RPM, 1998, J LEUKOCYTE BIOL, V63, P758, DOI 10.1002/jlb.63.6.758; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pope RM, 2002, NAT REV IMMUNOL, V2, P527, DOI 10.1038/nri846; Rane MJ, 2001, J BIOL CHEM, V276, P3517, DOI 10.1074/jbc.M005953200; Roiniotis J, 2009, J IMMUNOL, V182, P7974, DOI 10.4049/jimmunol.0804216; RYMSA B, 1990, RES COMMUN CHEM PATH, V68, P263; Sester DP, 2006, J IMMUNOL, V177, P4473, DOI 10.4049/jimmunol.177.7.4473; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; VAIRO G, 1985, BIOCHEM BIOPH RES CO, V132, P430, DOI 10.1016/0006-291X(85)91040-X; Walmsley SR, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2632; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Wang YJ, 2007, AM J RESP CELL MOL, V36, P68, DOI 10.1165/rcmb.2006-0165OC; Xaus J, 2000, BLOOD, V95, P3823; Yun JK, 1997, P NATL ACAD SCI USA, V94, P13903, DOI 10.1073/pnas.94.25.13903	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45853	10.1371/journal.pone.0045853	http://dx.doi.org/10.1371/journal.pone.0045853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029275	Green Published, gold			2022-12-25	WOS:000309388400135
J	Liu, PY; Ge, XM; Ding, HZ; Jiang, HL; Christensen, BM; Li, JY				Liu, Pingyang; Ge, Xiaomei; Ding, Haizhen; Jiang, Honglin; Christensen, Bruce M.; Li, Jianyong			Role of Glutamate Decarboxylase-like Protein 1 (GADL1) in Taurine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ALANINE SUPPLEMENTATION; SULFINIC ACID DECARBOXYLASE; MUSCLE CARNOSINE SYNTHESIS; ESCHERICHIA-COLI; MICE LACKING; GABA; BRAIN; TISSUES; NEUROPROTECTION; DEHYDROGENASE	This manuscript concerns the tissue-specific transcription of mouse and cattle glutamate decarboxylase-like protein 1 (GADL1) and the biochemical activities of human GADL1 recombinant protein. Bioinformatic analysis suggested that GADL1 appears late in evolution, only being found in reptiles, birds, and mammals. RT-PCR determined that GADL1 mRNA is transcribed at high levels in mouse and cattle skeletal muscles and also in mouse kidneys. Substrate screening determined that GADL1, unlike its name implies, has no detectable GAD activity, but it is able to efficiently catalyze decarboxylation of aspartate, cysteine sulfinic acid, and cysteic acid to beta-alanine, hypotaurine, and taurine, respectively. Western blot analysis verified the presence of GADL1 in mouse muscles, kidneys, C2C12 myoblasts, and C2C12 myotubes. Incubation of the supernatant of fresh muscle or kidney extracts with cysteine sulfinic acid resulted in the detection of hypotaurine or taurine in the reaction mixtures, suggesting the possible involvement of GADL1 in taurine biosynthesis. However, when the tissue samples were incubated with aspartate, no beta-alanine production was observed. We proposed several possibilities that might explain the inactivation of ADC activity of GADL1 in tissue protein extracts. Although beta-alanine-producing activity was not detected in the supernatant of tissue protein extracts, its potential role in beta-alanine synthesis cannot be excluded. There are several inhibitors of the ADC activity of GADL1 identified. The discovery of GADL1 biochemical activities, in conjunction with its expression and activities in muscles and kidneys, provides some tangible insight toward establishing its physiological function(s).	[Liu, Pingyang; Ding, Haizhen; Li, Jianyong] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Ge, Xiaomei; Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA; [Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Wisconsin System; University of Wisconsin Madison	Li, JY (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Engel Hall 204, Blacksburg, VA 24061 USA.	lij@vt.edu	Liu, Pingyang/G-7796-2014; mo, qin/O-7877-2014	Liu, Pingyang/0000-0001-5060-5807; , Honglin/0000-0001-9540-5788	National Institutes of Health [AI19769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI019769, R37AI019769, R01AI019769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI19769.	Artioli GG, 2010, MED SCI SPORT EXER, V42, P1162, DOI 10.1249/MSS.0b013e3181c74e38; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4; BAKARDJIEV A, 1994, EUR J BIOCHEM, V225, P617, DOI 10.1111/j.1432-1033.1994.00617.x; Battaglioli G, 2003, J NEUROCHEM, V86, P879, DOI 10.1046/j.1471-4159.2003.01910.x; Boldyrev A A, 1995, Vestn Ross Akad Med Nauk, P3; BOLDYREV AA, 1993, INT J BIOCHEM, V25, P1101, DOI 10.1016/0020-711X(93)90587-5; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; BROWN GM, 1982, ADV ENZYMOL RAMB, V53, P345; Bulygina YR, 1995, VOP MED KHIM, V41, P27; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; Decombaz J, 2012, AMINO ACIDS, V43, P67, DOI 10.1007/s00726-011-1169-7; Derave W, 2007, J APPL PHYSIOL, V103, P1736, DOI 10.1152/japplphysiol.00397.2007; Derave W, 2010, SPORTS MED, V40, P247, DOI 10.2165/11530310-000000000-00000; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Fenalti G, 2007, NAT STRUCT MOL BIOL, V14, P280, DOI 10.1038/nsmb1228; Harris RC, 2006, AMINO ACIDS, V30, P279, DOI 10.1007/s00726-006-0299-9; Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje; Hill CA, 2007, AMINO ACIDS, V32, P225, DOI 10.1007/s00726-006-0364-4; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Horning MS, 2000, BRAIN RES, V852, P56, DOI 10.1016/S0006-8993(99)02215-5; Ito T, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S20; Jackson MC, 1996, INFLAMM RES, V45, P132, DOI 10.1007/BF02265166; Kendrick IP, 2008, AMINO ACIDS, V34, P547, DOI 10.1007/s00726-007-0008-3; Kendrick IP, 2009, EUR J APPL PHYSIOL, V106, P131, DOI 10.1007/s00421-009-0998-5; Liu PY, 2013, AMINO ACIDS, V44, P391, DOI 10.1007/s00726-012-1342-7; Liu PY, 2012, INSECT BIOCHEM MOLEC, V42, P396, DOI 10.1016/j.ibmb.2012.02.001; Lohkamp B, 2010, BBA-PROTEINS PROTEOM, V1804, P2198, DOI 10.1016/j.bbapap.2010.08.014; NG RH, 1978, J NEUROCHEM, V30, P187, DOI 10.1111/j.1471-4159.1978.tb07051.x; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Richardson G, 2010, MOL BIOL REP, V37, P3199, DOI 10.1007/s11033-009-9902-y; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Skoldberg F, 2004, J CLIN ENDOCR METAB, V89, P1636, DOI 10.1210/jc.2003-031161; Stellingwerff T, 2012, AMINO ACIDS, V43, P57, DOI 10.1007/s00726-012-1245-7; Trombley PQ, 2000, BIOCHEMISTRY-MOSCOW+, V65, P807; Ubuka T, 2008, AMINO ACIDS, V35, P53, DOI 10.1007/s00726-007-0633-x; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Wu JY, 1998, ADV EXP MED BIOL, V442, P339; WU JY, 1982, P NATL ACAD SCI-BIOL, V79, P4270, DOI 10.1073/pnas.79.14.4270; Zaloga G P, 1996, New Horiz, V4, P26; Zaloga GP, 1997, AM J PHYSIOL-HEART C, V272, pH462, DOI 10.1152/ajpheart.1997.272.1.H462	50	31	36	5	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40898	40906		10.1074/jbc.M112.393728	http://dx.doi.org/10.1074/jbc.M112.393728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038267	hybrid, Green Published			2022-12-25	WOS:000311887600009
J	Barber, AF; Liang, QS; Covarrubias, M				Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel			Novel Activation of Voltage-gated K+ Channels by Sevoflurane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL-ANESTHETICS; POTASSIUM CHANNEL; INHALATIONAL ANESTHETICS; VOLATILE ANESTHETICS; MOLECULAR TARGETS; CALCIUM CURRENT; ISOFLURANE; RECEPTORS; SITE; ALCOHOLS	Voltage-gated ion channels are modulated by halogenated inhaled general anesthetics, but the underlying molecular mechanisms are not understood. Alkanols and halogenated inhaled anesthetics such as halothane and isoflurane inhibit the archetypical voltage-gated Kv3 channel homolog K-Shaw2 by stabilizing the resting/closed states. By contrast, sevoflurane, a more heavily fluorinated ether commonly used in general anesthesia, specifically activates K-Shaw2 currents at relevant concentrations (0.05-1 mM) in a rapid and reversible manner. The concentration dependence of this modulation is consistent with the presence of high and low affinity interactions (K-D = 0.06 and 4 mM, respectively). Sevoflurane (< 1 mM) induces a negative shift in the conductance-voltage relation and increases the maximum conductance. Furthermore, suggesting possible roles in general anesthesia, mammalian Kv1.2 and Kv1.5 channels display similar changes. Quantitative description of the observations by an economical allosteric model indicates that sevoflurane binding favors activation gating and eliminates an unstable inactivated state outside the activation pathway. This study casts light on the mechanism of the novel sevoflurane-dependent activation of Kv channels, which helps explain how closely related inhaled anesthetics achieve specific actions and suggests strategies to develop novel Kv channel activators.	[Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Med Coll, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Barber, Annika F.] Thomas Jefferson Univ, Jefferson Med Coll, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA; [Barber, Annika F.; Liang, Qiansheng; Covarrubias, Manuel] Thomas Jefferson Univ, Jefferson Med Coll, Dept Neurosci, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Covarrubias, M (corresponding author), 900 Walnut St,JHN 417, Philadelphia, PA 19107 USA.	manuel.covarrubias@jefferson.edu	Barber, Annika/AAA-6082-2022	Barber, Annika/0000-0002-5058-939X; Covarrubias, Manuel/0000-0002-0881-4143	NIAAA, National Institutes of Health [AA010615, AA007463]; NINDS, National Institutes of Health [F31 NS077689]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463, R01AA010615] Funding Source: NIH RePORTER	NIAAA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by NIAAA, National Institutes of Health Grants AA010615, AA007463 (to M. C.) and NINDS, National Institutes of Health Grant F31 NS077689 (to A. F. B.).	Barber AF, 2011, BIOPHYS J, V101, P1613, DOI 10.1016/j.bpj.2011.08.026; Bhattacharji A, 2006, MOL PHARMACOL, V70, P1542, DOI 10.1124/mol.106.026187; Bhattacharji A, 2010, BRIT J PHARMACOL, V159, P1475, DOI 10.1111/j.1476-5381.2010.00642.x; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Cacheaux LP, 2005, J PHARMACOL EXP THER, V315, P517, DOI 10.1124/jpet.105.091801; COVARRUBIAS M, 1993, P NATL ACAD SCI USA, V90, P6957, DOI 10.1073/pnas.90.15.6957; COVARRUBIAS M, 1995, J BIOL CHEM, V270, P19408, DOI 10.1074/jbc.270.33.19408; Downie DL, 1996, BRIT J PHARMACOL, V118, P493, DOI 10.1111/j.1476-5381.1996.tb15430.x; Eckenhoff RG, 2011, CURR BIOL, V21, pR985, DOI 10.1016/j.cub.2011.11.012; Eckenhoff RG, 2010, ACS CHEM NEUROSCI, V1, P139, DOI 10.1021/cn900014m; Forman SA, 2011, ANESTHESIOLOGY, V114, P695, DOI 10.1097/ALN.0b013e3181ff72b5; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Friederich P, 2001, ANESTHESIOLOGY, V95, P954, DOI 10.1097/00000542-200110000-00026; Hapfelmeier G, 2001, EUR J ANAESTH, V18, P377, DOI 10.1046/j.0265-0215.2001.00848.x; Harris T, 2000, J BIOL CHEM, V275, P4928, DOI 10.1074/jbc.275.7.4928; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Herold KF, 2009, ANESTHESIOLOGY, V111, P591, DOI 10.1097/ALN.0b013e3181af64d4; HERRINGTON J, 1991, J NEUROSCI, V11, P2226; Horishita T, 2008, ANESTH ANALG, V107, P1579, DOI 10.1213/ane.0b013e318184b966; Jenkins A, 1996, BRIT J PHARMACOL, V117, P1507, DOI 10.1111/j.1476-5381.1996.tb15314.x; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Ouyang W, 2009, ANESTHESIOLOGY, V110, P582, DOI 10.1097/ALN.0b013e318197941e; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; Putzke C, 2007, AM J PHYSIOL-CELL PH, V293, pC1319, DOI 10.1152/ajpcell.00100.2007; Scheller M, 1997, ANESTHESIOLOGY, V86, P118, DOI 10.1097/00000542-199701000-00016; Shiraishi M, 2004, J PHARMACOL EXP THER, V309, P987, DOI 10.1124/jpet.103.064063; Singaram VK, 2011, CURR BIOL, V21, P2070, DOI 10.1016/j.cub.2011.10.042; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Stevens R, 2005, J PHARMACOL EXP THER, V314, P338, DOI 10.1124/jpet.105.085076; Stevens RJN, 2005, ANESTH ANALG, V100, P1696, DOI 10.1213/01.ANE.0000151720.36988.09; Suzuki T, 2002, ANESTHESIOLOGY, V96, P699, DOI 10.1097/00000542-200203000-00028; TAKENOSHITA M, 1991, J NEUROSCI, V11, P1404; Todorovic SM, 2000, MOL PHARMACOL, V58, P98, DOI 10.1124/mol.58.1.98; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; Urban B. W., 2008, V182, P3, DOI 10.1007/978-3-540-74806-9_1; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Wei OY, 2007, ANESTHESIOLOGY, V107, P91, DOI 10.1097/01.anes.0000268390.28362.4a; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	43	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40425	40432		10.1074/jbc.M112.405787	http://dx.doi.org/10.1074/jbc.M112.405787			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038249	Green Published, hybrid			2022-12-25	WOS:000311448800033
J	Cheng, JJ; Goldstein, R; Stec, B; Gershenson, A; Roberts, MF				Cheng, Jiongjia; Goldstein, Rebecca; Stec, Boguslaw; Gershenson, Anne; Roberts, Mary F.			Competition between Anion Binding and Dimerization Modulates Staphylococcus aureus Phosphatidylinositol-specific Phospholipase C Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; X-RAY-DIFFRACTION; PHOSPHATIDYLCHOLINE-ACTIVATION; CRYSTALLOGRAPHY; SYSTEM; TOOL	Staphylococcus aureus phosphatidylinositol-specific phospholipase C (PI-PLC) is a secreted virulence factor for this pathogenic bacterium. A novel crystal structure shows that this PI-PLC can form a dimer via helix B, a structural feature present in all secreted, bacterial PI-PLCs that is important for membrane binding. Despite the small size of this interface, it is critical for optimal enzyme activity. Kinetic evidence, increased enzyme specific activity with increasing enzyme concentration, supports a mechanism where the PI-PLC dimerization is enhanced in membranes containing phosphatidylcholine (PC). Mutagenesis of key residues confirm that the zwitterionic phospholipid acts not by specific binding to the protein, but rather by reducing anionic lipid interactions with a cationic pocket on the surface of the S. aureus enzyme that stabilizes monomeric protein. Despite its structural and sequence similarity to PI-PLCs from other Gram-positive pathogenic bacteria, S. aureus PI-PLC appears to have a unique mechanism where enzyme activity is modulated by competition between binding of soluble anions or anionic lipids to the cationic sensor and transient dimerization on the membrane.	[Cheng, Jiongjia; Goldstein, Rebecca; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Stec, Boguslaw] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Gershenson, Anne] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA	Boston College; Sanford Burnham Prebys Medical Discovery Institute; University of Massachusetts System; University of Massachusetts Amherst	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Cheng, Jiongjia/AAM-9464-2020	Cheng, Jiongjia/0000-0002-0908-3880; Stec, Boguslaw/0000-0002-8696-0349; Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [R01 GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, by National Institutes of Health Grant R01 GM60418 (to M. F. R.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg OG, 2004, BIOCHEMISTRY-US, V43, P2080, DOI 10.1021/bi035063j; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burlak C, 2007, CELL MICROBIOL, V9, P1172, DOI 10.1111/j.1462-5822.2006.00858.x; Chen W, 2009, BIOCHEMISTRY-US, V48, P3578, DOI 10.1021/bi802312d; DAUGHERTY S, 1993, INFECT IMMUN, V61, P5078, DOI 10.1128/IAI.61.12.5078-5089.1993; DYE ES, 1980, INFECT IMMUN, V30, P198, DOI 10.1128/IAI.30.1.198-203.1980; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goldstein R, 2012, BIOCHEMISTRY-US, V51, P2579, DOI 10.1021/bi300057q; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P6835, DOI 10.1021/bi900633p; Pu MM, 2009, J BIOL CHEM, V284, P16099, DOI 10.1074/jbc.M809600200; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi XM, 2009, J BIOL CHEM, V284, P15607, DOI 10.1074/jbc.M901601200; Thompson NL, 1991, TOPICS FLUORESCENCE, P337; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o	30	10	10	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40317	40327		10.1074/jbc.M112.395277	http://dx.doi.org/10.1074/jbc.M112.395277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038258	hybrid, Green Published			2022-12-25	WOS:000311448800023
J	Kikuchi, H; Kuribayashi, F; Imajoh-Ohmi, S; Nishitoh, H; Takami, Y; Nakayama, T				Kikuchi, Hidehiko; Kuribayashi, Futoshi; Imajoh-Ohmi, Shinobu; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo			GCN5 Protects Vertebrate Cells against UV-irradiation via Controlling Gene Expression of DNA Polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HISTONE ACETYLTRANSFERASE; TRANSLESION SYNTHESIS; STAGA COMPLEX; ACETYLATION; ACTIVATION; APOPTOSIS; BINDING; COACTIVATOR; INHIBITORS	By UV-irradiation, cells are subjected to DNA damage followed by mutation, cell death and/or carcinogenesis. DNA repair systems such as nucleotide excision repair (NER) and translesion DNA synthesis (TLS) protect cells against UV-irradiation. To understand the role of histone acetyltransferase GCN5 in regulation of DNA repair, we studied the sensitivity of GCN5-deficient DT40, GCN5(-/-), to various DNA-damaging agents including UV-irradiation, and effects of GCN5-deficiency on the expression of NER- and TLS-related genes. After UV-irradiation, cell death and DNA fragmentation of GCN5(-/-) were appreciably accelerated as compared with those of DT40. Interestingly, GCN5(-/-) showed a remarkable sensitivity to only UV-irradiation but not to other DNA-damaging agents tested. Semiquantitative RT-PCR showed that transcription of DNA polymerase eta (POLH) gene whose deficiency is responsible for a variant form of xeroderma pigmentosum was drastically down-regulated in GCN5(-/-) (to similar to 25%). In addition, ectopic expression of human POLH in GCN5(-/-) dramatically reversed the sensitivity to UV-irradiation of GCN5(-/-) to almost the same level of wild type DT40. Moreover, chromatin immunoprecipitation assay revealed that GCN5 binds to the chicken POLH gene 5'-flanking region that contains a typical CpG island and acetylates Lys-9 of histone H3, but not Lys-14 in vivo. These data suggest that GCN5 takes part in transcription regulation of POLH gene through alterations in the chromatin structure by direct interaction with its 5'-flanking region, and protects vertebrate cells against UV-induced DNA damage via controlling POLH gene expression.	[Kikuchi, Hidehiko; Nishitoh, Hideki; Takami, Yasunari; Nakayama, Tatsuo] Miyazaki Univ, Sect Biochem & Mol Biol, Dept Med Sci, Miyazaki Med Coll, Miyazaki 8891692, Japan; [Kuribayashi, Futoshi] Kawasaki Med Sch, Dept Biochem, Kurashiki, Okayama 7010192, Japan; [Imajoh-Ohmi, Shinobu] Univ Tokyo, Med Prote Lab, Grad Sch Frontier Sci, Inst Med Sci, Tokyo 1088639, Japan	University of Miyazaki; Kawasaki Medical School; University of Tokyo	Kikuchi, H (corresponding author), Miyazaki Univ, Sect Biochem & Mol Biol, Dept Med Sci, Miyazaki Med Coll, 5200 Kihara, Miyazaki 8891692, Japan.	masakari@med.miyazaki-u.ac.jp		Nishitoh, Hideki/0000-0002-8652-4109	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22510203]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 22510203) (to H. K. and T. N.).	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Balajee AS, 2000, GENE, V250, P15, DOI 10.1016/S0378-1119(00)00172-4; Brand M, 2001, EMBO J, V20, P3187, DOI 10.1093/emboj/20.12.3187; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; Furdas SD, 2012, ARCH PHARM, V345, P7, DOI 10.1002/ardp.201100209; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Guo RF, 2011, NUCLEIC ACIDS RES, V39, P1390, DOI 10.1093/nar/gkq983; Hirota K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001151; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; KIKUCHI H, 1995, CELL DEATH DIFFER, V2, P195; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kikuchi H, 2008, GENE, V419, P48, DOI 10.1016/j.gene.2008.04.014; Kikuchi H, 2012, BIOCHEM BIOPH RES CO, V422, P780, DOI 10.1016/j.bbrc.2012.05.099; Kikuchi H, 2011, BIOCHEM BIOPH RES CO, V405, P657, DOI 10.1016/j.bbrc.2011.01.088; Kikuchi H, 2011, J IMMUNOL, V186, P3015, DOI 10.4049/jimmunol.1000364; Kikuchi H, 2009, BBA-MOL CELL RES, V1793, P1304, DOI 10.1016/j.bbamcr.2009.04.016; Kikuchi Hidehiko, 2006, Subcell Biochem, V40, P225; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Steele EJ, 2009, MOL IMMUNOL, V46, P305, DOI 10.1016/j.molimm.2008.10.021; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Teng YM, 2002, J MOL BIOL, V316, P489, DOI 10.1006/jmbi.2001.5383; Waters Raymond, 2008, SEB Exp Biol Ser, V59, P189; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	39	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.406389	http://dx.doi.org/10.1074/jbc.M112.406389			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033487	Green Published, hybrid			2022-12-25	WOS:000311233800052
J	Chen, HJ; Ye, JQ; Xu, KM; Angel, M; Shao, HX; Ferrero, A; Sutton, T; Perez, DR				Chen, Hongjun; Ye, Jianqiang; Xu, Kemin; Angel, Matthew; Shao, Hongxia; Ferrero, Andrea; Sutton, Troy; Perez, Daniel R.			Partial and Full PCR-Based Reverse Genetics Strategy for Influenza Viruses	PLOS ONE			English	Article							POLYMERASE-I PROMOTER; A VIRUS; RNA-POLYMERASE; TRANSFECTION SYSTEM; MOLECULAR ANATOMY; MESSENGER-RNA; 8 PLASMIDS; VIRAL-RNA; REPLICATION; GENERATION	Since 1999, plasmid-based reverse genetics (RG) systems have revolutionized the way influenza viruses are studied. However, it is not unusual to encounter cloning difficulties for one or more influenza genes while attempting to recover virus de novo. To overcome some of these shortcomings we sought to develop partial or full plasmid-free RG systems. The influenza gene of choice is assembled into a RG competent unit by virtue of overlapping PCR reactions containing a cDNA copy of the viral gene segment under the control of RNA polymerase I promoter (pol1) and termination (t1) signals - herein referred to as Flu PCR amplicons. Transfection of tissue culture cells with either HA or NA Flu PCR amplicons and 7 plasmids encoding the remaining influenza RG units, resulted in efficient virus rescue. Likewise, transfections including both HA and NA Flu PCR amplicons and 6 RG plasmids also resulted in efficient virus rescue. In addition, influenza viruses were recovered from a full set of Flu PCR amplicons without the use of plasmids.	[Chen, Hongjun; Ye, Jianqiang; Xu, Kemin; Angel, Matthew; Shao, Hongxia; Ferrero, Andrea; Sutton, Troy; Perez, Daniel R.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Perez, DR (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA.	dperez1@umd.edu	ye, jianqiang/ABH-8988-2020; Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700010C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by contract No HHSN266200700010C from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2009, ARCH MED RES, V40, P643, DOI 10.1016/j.arcmed.2009.10.007; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Feng LQ, 2009, ARCH VIROL, V154, P1151, DOI 10.1007/s00705-009-0422-9; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hoffmann E, 2000, J GEN VIROL, V81, P2843, DOI 10.1099/0022-1317-81-12-2843; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; LOPEZTURISO JA, 1990, VIRUS RES, V16, P325, DOI 10.1016/0168-1702(90)90056-H; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; Perez DR, 1998, VIROLOGY, V249, P52, DOI 10.1006/viro.1998.9318; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shao H, 2011, VIROLOGY; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Suphaphiphat P, 2010, J VIROL, V84, P3721, DOI 10.1128/JVI.01925-09; Vreede FT, 2007, J VIROL, V81, P2196, DOI 10.1128/JVI.02187-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang ZT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-102; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Webby RJ, 2007, CURR TOP MICROBIOL, V315, P67; YAMANAKA K, 1991, P NATL ACAD SCI USA, V88, P5369, DOI 10.1073/pnas.88.12.5369; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Ye JQ, 2010, CLIN VACCINE IMMUNOL, V17, P1363, DOI 10.1128/CVI.00002-10; Yewdell JW, 2012, SCIENCE, V337, P164, DOI 10.1126/science.1225539; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zell R, 2006, EMERG INFECT DIS, V12, P1607, DOI 10.3201/eid1210.060511	36	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46378	10.1371/journal.pone.0046378	http://dx.doi.org/10.1371/journal.pone.0046378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029501	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900148
J	Crespo, I; Tao, H; Nieto, AB; Rebelo, O; Domingues, P; Vital, AL; Patino, MD; Barbosa, M; Lopes, MC; Oliveira, CR; Orfao, A; Tabernero, MD				Crespo, Ines; Tao, Herminio; Belen Nieto, Ana; Rebelo, Olinda; Domingues, Patricia; Vital, Ana Luisa; del Carmen Patino, Maria; Barbosa, Marcos; Lopes, Maria Celeste; Oliveira, Catarina Resende; Orfao, Alberto; Dolores Tabernero, Maria			Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; METHYLTHIOADENOSINE PHOSPHORYLASE; DEREGULATED EXPRESSION; EGFR AMPLIFICATION; MULTIFORME TUMORS; SPLICE VARIANTS; IN-SITU; AMPLICONS; ABERRATIONS; TARGET	Background: Glioblastoma multiforme (GBM) displays multiple amplicons and homozygous deletions that involve relevant pathogenic genes and other genes whose role remains unknown. Methodology: Single-nucleotide polymorphism (SNP)-arrays were used to determine the frequency of recurrent amplicons and homozygous deletions in GBM (n = 46), and to evaluate the impact of copy number alterations (CNA) on mRNA levels of the genes involved. Principal Findings: Recurrent amplicons were detected for chromosomes 7 (50%), 12 (22%), 1 (11%), 4 (9%), 11 (4%), and 17 (4%), whereas homozygous deletions involved chromosomes 9p21 (52%) and 10q (22%). Most genes that displayed a high correlation between DNA CNA and mRNA levels were coded in the amplified chromosomes. For some amplicons the impact of DNA CNA on mRNA expression was restricted to a single gene (e. g., EGFR at 7p11.2), while for others it involved multiple genes (e. g., 11 and 5 genes at 12q14.1-q15 and 4q12, respectively). Despite homozygous del(9p21) and del(10q23.31) included multiple genes, association between these DNA CNA and RNA expression was restricted to the MTAP gene. Conclusions: Overall, our results showed a high frequency of amplicons and homozygous deletions in GBM with variable impact on the expression of the genes involved, and they contributed to the identification of other potentially relevant genes.	[Belen Nieto, Ana; Orfao, Alberto; Dolores Tabernero, Maria] Univ Salamanca, Dept Med, Ctr Canc Res CIC IBMCC CSIC USAL, E-37008 Salamanca, Spain; [Crespo, Ines; Domingues, Patricia; Vital, Ana Luisa; Lopes, Maria Celeste; Oliveira, Catarina Resende] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Crespo, Ines; Domingues, Patricia; Vital, Ana Luisa; Lopes, Maria Celeste] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Tao, Herminio; Barbosa, Marcos] Univ Hosp Coimbra, Neurosurg Serv, Coimbra, Portugal; [Rebelo, Olinda] Univ Hosp Coimbra, Neurol Serv, Neuropathol Lab, Coimbra, Portugal; [del Carmen Patino, Maria] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain; [Barbosa, Marcos; Oliveira, Catarina Resende] Univ Coimbra, Fac Med, Coimbra, Portugal; [Dolores Tabernero, Maria] IECSCYL, Soria, Spain; [Orfao, Alberto; Dolores Tabernero, Maria] Univ Hosp Salamanca, Res Unit, Inst Biosanitario Salamanca IBSAL, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Salamanca; Universidade de Coimbra	Tabernero, MD (corresponding author), Univ Salamanca, Dept Med, Ctr Canc Res CIC IBMCC CSIC USAL, E-37008 Salamanca, Spain.	taberner@usal.es	Orfao, Alberto/B-5801-2017; Lopes, Maria/GXF-7507-2022; Barbosa, Marcos/C-6884-2018	Barbosa, Marcos/0000-0003-3704-4499; Lopes, Maria/0000-0002-6469-0894; Oliveira, Catarina/0000-0001-6942-4328; Barbosa, Marcos/0000-0001-5225-6794; Nieto-Librero, Ana B./0000-0001-6643-247X	Fundacao para a Ciencia e a Tecnologia, Portugal [FCT PIC/IC/83108/2007, SFRH/BD/23086/2005, SFRH/BD/11820/2003]; Fundacion Mutua Madrilena, Madrid, Spain [AP87692011]; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain [RTICC RD06/0020/0035]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacion Mutua Madrilena, Madrid, Spain; Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by Fundacao para a Ciencia e a Tecnologia, Portugal [FCT PIC/IC/83108/2007]; PhD fellowships from Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/23086/2005, SFRH/BD/11820/2003]; Fundacion Mutua Madrilena, Madrid, Spain [AP87692011]; and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion, Madrid, Spain [RTICC RD06/0020/0035]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bralten LBC, 2010, GENE CHROMOSOME CANC, V49, P509, DOI 10.1002/gcc.20760; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christopher SA, 2002, CANCER RES, V62, P6639; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Dahlback HSS, 2009, GENE CHROMOSOME CANC, V48, P908, DOI 10.1002/gcc.20690; Diesel B, 2005, CLIN CANCER RES, V11, P5370, DOI 10.1158/1078-0432.CCR-04-1968; Duncan CD, 2010, ADVANCED CRIME SCENE PHOTOGRAPHY, P1; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Filipski E, 2002, J NATL CANCER I, V94, P690; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Foulquier F, 2012, AM J HUM GENET; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; Gardina PJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-489; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Holtkamp N, 2007, NEURO-ONCOLOGY, V9, P291, DOI 10.1215/15228517-2007-009; Houillier C, 2006, CANCER-AM CANCER SOC, V106, P2218, DOI 10.1002/cncr.21819; Hua H, 2007, CANCER GENE THER, V14, P815, DOI 10.1038/sj.cgt.7701061; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Hung KS, 2000, BIOCHEM BIOPH RES CO, V269, P718, DOI 10.1006/bbrc.2000.2339; Inda MD, 2003, MOL CARCINOGEN, V36, P6, DOI 10.1002/mc.10085; Kanu OO, 2009, CLIN MED INSIGHTS-ON, V3, P39; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Lo KC, 2007, GENE CHROMOSOME CANC, V46, P875, DOI 10.1002/gcc.20474; Lopez-Gines C, 2005, CLIN NEUROPATHOL, V24, P209; Lopez-Gines C, 2010, MODERN PATHOL, V23, P856, DOI 10.1038/modpathol.2010.62; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Lymbouridou R, 2009, EUR J CANCER, V45, P1294, DOI 10.1016/j.ejca.2008.12.028; Maas RM, 2001, CLIN CANCER RES, V7, P868; NAVEILHAN P, 1994, J NEUROSCI RES, V37, P271, DOI 10.1002/jnr.490370212; NOBORI T, 1991, CANCER RES, V51, P3193; Nobusawa S, 2011, NEUROPATHOLOGY, V31, P583, DOI 10.1111/j.1440-1789.2011.01204.x; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ravenall SJ, 2002, EUR J NEUROSCI, V15, P281, DOI 10.1046/j.0953-816x.2001.01862.x; Reifenberger G, 1996, CANCER RES, V56, P5141; Riemenschneider MJ, 2003, INT J CANCER, V104, P752, DOI 10.1002/ijc.11023; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sasaki S, 2003, ONCOGENE, V22, P3792, DOI 10.1038/sj.onc.1206589; Schlierf B, 2007, NEUROPATH APPL NEURO, V33, P621, DOI 10.1111/j.1365-2990.2007.00881.x; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Vital AL, 2010, NEURO-ONCOLOGY, V12, P991, DOI 10.1093/neuonc/noq050; Vital AL, 2010, NEUROGENETICS, V11, P227, DOI 10.1007/s10048-009-0217-x; Vranova V, 2007, ONCOL REP, V17, P457; Wikman H, 2005, GENE CHROMOSOME CANC, V42, P193, DOI 10.1002/gcc.20122; Xia HC, 2010, CAN J NEUROL SCI, V37, P365, DOI 10.1017/S031716710001026X; Yadav AK, 2009, JAMA-J AM MED ASSOC, V302, P276, DOI 10.1001/jama.2009.1022; Yeh KT, 2005, J PATHOL, V206, P111, DOI 10.1002/path.1756; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270	64	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46088	10.1371/journal.pone.0046088	http://dx.doi.org/10.1371/journal.pone.0046088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029397	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900087
J	Davanian, H; Stranneheim, H; Bage, T; Lagervall, M; Jansson, L; Lundeberg, J; Yucel-Lindberg, T				Davanian, Haleh; Stranneheim, Henrik; Bage, Tove; Lagervall, Maria; Jansson, Leif; Lundeberg, Joakim; Yucel-Lindberg, Tulay			Gene Expression Profiles in Paired Gingival Biopsies from Periodontitis-Affected and Healthy Tissues Revealed by Massively Parallel Sequencing	PLOS ONE			English	Article							TNF-ALPHA; AGGRESSIVE PERIODONTITIS; CREVICULAR FLUID; SYNOVIAL TISSUE; OSTEOARTHRITIS; SARCOIDOSIS; PREDICTION; CARTILAGE; CCL18; CELLS	Periodontitis is a chronic inflammatory disease affecting the soft tissue and bone that surrounds the teeth. Despite extensive research, distinctive genes responsible for the disease have not been identified. The objective of this study was to elucidate transcriptome changes in periodontitis, by investigating gene expression profiles in gingival tissue obtained from periodontitis-affected and healthy gingiva from the same patient, using RNA-sequencing. Gingival biopsies were obtained from a disease-affected and a healthy site from each of 10 individuals diagnosed with periodontitis. Enrichment analysis performed among uniquely expressed genes for the periodontitis-affected and healthy tissues revealed several regulated pathways indicative of inflammation for the periodontitis-affected condition. Hierarchical clustering of the sequenced biopsies demonstrated clustering according to the degree of inflammation, as observed histologically in the biopsies, rather than clustering at the individual level. Among the top 50 upregulated genes in periodontitis-affected tissues, we investigated two genes which have not previously been demonstrated to be involved in periodontitis. These included interferon regulatory factor 4 and chemokine (C-C motif) ligand 18, which were also expressed at the protein level in gingival biopsies from patients with periodontitis. In conclusion, this study provides a first step towards a quantitative comprehensive insight into the transcriptome changes in periodontitis. We demonstrate for the first time site-specific local variation in gene expression profiles of periodontitis-affected and healthy tissues obtained from patients with periodontitis, using RNA-seq. Further, we have identified novel genes expressed in periodontitis tissues, which may constitute potential therapeutic targets for future treatment strategies of periodontitis.	[Davanian, Haleh; Bage, Tove; Yucel-Lindberg, Tulay] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden; [Stranneheim, Henrik; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Div Gen Technol, Sci Life Lab, Solna, Sweden; [Lagervall, Maria; Jansson, Leif] Stockholm Cty Council, Dept Periodontol Skanstull, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Stockholm County Council	Davanian, H (corresponding author), Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden.	haleh.davanian@ki.se		Yucel-Lindberg, Tulay/0000-0003-0129-8809	Swedish National Graduate School in Odontological Science, Swedish Research Council [73XD-15005]; Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet	Swedish National Graduate School in Odontological Science, Swedish Research Council; Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet	This study was supported by funds from the Swedish National Graduate School in Odontological Science, Swedish Research Council, project number 73XD-15005, the Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Auer J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2294; Bage T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-241; Beikler T, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-30; COHEN C, 1981, J ORAL SURG, V39, P613; Covani U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/jop.2008.080062, 10.1902/jop.2008.080062 ]; Dasanayake Ananda P, 2010, J Evid Based Dent Pract, V10, P246, DOI 10.1016/j.jebdp.2010.09.006; Davanian H, 2012, CYTOKINE, V57, P406, DOI 10.1016/j.cyto.2011.12.008; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Kim DM, 2006, J PERIODONTOL, V77, P1043, DOI 10.1902/jop.2006.050254; Kurashige Y, 2008, ARCH ORAL BIOL, V53, P437, DOI 10.1016/j.archoralbio.2007.12.005; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Momohara S, 2007, J RHEUMATOL, V34, P266; Moretti AJ, 2007, J PERIODONTOL, V78, P2209, DOI 10.1902/jop.2007.070117; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Papapanou PN, 2004, EUR J ORAL SCI, V112, P216, DOI 10.1111/j.1600-0722.2004.00124.x; Passoja A, 2010, J CLIN PERIODONTOL, V37, P881, DOI 10.1111/j.1600-051X.2010.01602.x; Pradeep AR, 2009, J PERIODONTOL, V80, P1454, DOI 10.1902/jop.2009.090117; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Steinberg T, 2006, J PERIODONTAL RES, V41, P426, DOI 10.1111/j.1600-0765.2006.00884.x; Stranneheim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021910; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suresh L, 2004, J PERIODONTOL, V75, P478, DOI 10.1902/jop.2004.75.3.478; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tu YK, 2004, J PERIODONTOL, V75, P127, DOI 10.1902/jop.2004.75.1.127; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	39	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46440	10.1371/journal.pone.0046440	http://dx.doi.org/10.1371/journal.pone.0046440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029519	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900160
J	Feng, YJ; Cronan, JE				Feng, Youjun; Cronan, John E.			Crosstalk of Escherichia coli FadR with Global Regulators in Expression of Fatty Acid Transport Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ACYL-COENZYME; RECEPTOR PROTEIN; DNA-BINDING; BIOSYNTHESIS; DEGRADATION; GROWTH; SYNTHETASE; REPRESSOR; EXCISION	Escherichia coli FadR plays two regulatory roles in fatty acid metabolism. FadR represses the fatty acid degradation (fad) system and activates the unsaturated fatty acid synthetic pathway. Cross-talk between E. coli FadR and the ArcA-ArcB oxygen-responsive two-component system was observed that resulted in diverse regulation of certain fad regulon beta-oxidation genes. We have extended such analyses to the fadL and fadD genes, the protein products of which are required for long chain fatty acid transport and have also studied the role of a third global regulator, the CRP-cAMP complex. The promoters of both the fadL and fadD genes contain two experimentally validated FadR-binding sites plus binding sites for ArcA and CRP-cAMP. Despite the presence of dual binding sites FadR only modestly regulates expression of these genes, indicating that the number of binding sites does not determine regulatory strength. We report complementary in vitro and in vivo studies indicating that the CRP-cAMP complex directly activates expression of fadL and fadD as well as the beta-oxidation gene, fadH. The physiological relevance of the fadL and fadD transcription data was validated by direct assays of long chain fatty acid transport.	[Feng, Youjun; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Feng, Youjun/I-4134-2012; Cronan, John/V-6626-2019		NIH from National Institute of Allergy and Infectious Diseases [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	NIH from National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI15650 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BLACK PN, 1991, J BACTERIOL, V173, P435, DOI 10.1128/jb.173.2.435-442.1991; BLACK PN, 1994, BBA-LIPID LIPID MET, V1210, P123, DOI 10.1016/0005-2760(94)90113-9; BLACK PN, 1992, J BIOL CHEM, V267, P25513; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cho BK, 2006, MICROBIOL-SGM, V152, P2207, DOI 10.1099/mic.0.28912-0; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Clark D. P., 2005, ECOSAL ESCHERICHIA C; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIRUSSO CC, 1993, MOL MICROBIOL, V7, P311, DOI 10.1111/j.1365-2958.1993.tb01122.x; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; Feng YJ, 2011, MOL MICROBIOL, V80, P195, DOI 10.1111/j.1365-2958.2011.07564.x; Feng YJ, 2011, MOL MICROBIOL, V81, P1020, DOI 10.1111/j.1365-2958.2011.07748.x; Feng YJ, 2010, J BACTERIOL, V192, P4289, DOI 10.1128/JB.00516-10; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; Feng Y, 2009, J BACTERIOL, V191, P6320, DOI 10.1128/JB.00835-09; FULDA M, 1994, MOL GEN GENET, V242, P241, DOI 10.1007/BF00280412; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; HIGASHITANI A, 1993, MOL GEN GENET, V240, P339, DOI 10.1007/BF00280384; Husnain SI, 2009, J BACTERIOL, V191, P6094, DOI 10.1128/JB.00672-09; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Iram SH, 2005, J BIOL CHEM, V280, P32148, DOI 10.1074/jbc.M504054200; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; NUNN WD, 1983, J BACTERIOL, V154, P554, DOI 10.1128/JB.154.2.554-560.1983; PAULI G, 1974, J BACTERIOL, V117, P1178, DOI 10.1128/JB.117.3.1178-1183.1974; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; Zhang Y, 1996, J BACTERIOL, V178, P3614, DOI 10.1128/jb.178.12.3614-3620.1996; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	41	80	81	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46275	10.1371/journal.pone.0046275	http://dx.doi.org/10.1371/journal.pone.0046275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029459	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900123
J	File, AL; Klironomos, J; Maherali, H; Dudley, SA				File, Amanda L.; Klironomos, John; Maherali, Hafiz; Dudley, Susan A.			Plant Kin Recognition Enhances Abundance of Symbiotic Microbial Partner	PLOS ONE			English	Article							MYCORRHIZAL FUNGAL DIVERSITY; COMMUNITY COMPOSITION; EVOLUTION; COOPERATION; SELECTION; TRADE; SPECIALIZATION; COLONIZATION; COMPETITION; MODEL	Background: The stability of cooperative interactions among different species can be compromised by cheating. In the plant-mycorrhizal fungi symbiosis, a single mycorrhizal network may interact with many plants, providing the opportunity for individual plants to cheat by obtaining nutrients from the fungi without donating carbon. Here we determine whether kin selection may favour plant investment in the mycorrhizal network, reducing the incentive to cheat when relatives interact with a single network. Methodology/Principal Findings: We show that mycorrhizal network size and root colonization were greater when Ambrosia artemisiifolia L. was grown with siblings compared to strangers. Soil fungal abundance was positively correlated with group leaf nitrogen, and increased root colonization was associated with a reduced number of pathogen-induced root lesions, indicating greater benefit to plants grown with siblings. Conclusions/Significance: Plants can benefit their relatives through investment in mycorrhizal fungi, and kin selection in plants could promote the persistence of the mycorrhizal symbiosis.	[File, Amanda L.; Dudley, Susan A.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Klironomos, John] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Maherali, Hafiz] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	McMaster University; University of British Columbia; University of Guelph	File, AL (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	fileamanda@gmail.com			NSERC; Canada Foundation for Innovation; Ontario Innovation Trust	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	Funding for this work was supported by NSERC (http://www.nserccrsng.gc.ca/) to H. M, S. D., J.K.; Canada Foundation for Innovation (http://www.innovation.ca/) and Ontario Innovation Trust (http://www.mri.gov.on.ca/) to H. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bever JD, 2009, ECOL LETT, V12, P13, DOI 10.1111/j.1461-0248.2008.01254.x; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Biedrzycki Meredith L, 2010, Commun Integr Biol, V3, P28; Bingham MA, 2009, RANGELAND ECOL MANAG, V62, P60, DOI 10.2111/08-088; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; CHEPLICK GP, 1992, J ECOL, V80, P567, DOI 10.2307/2260699; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; de Mazancourt C, 2010, ECOL LETT, V13, P349, DOI 10.1111/j.1461-0248.2009.01431.x; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Denison RF, 2003, ECOLOGY, V84, P838, DOI 10.1890/0012-9658(2003)084[0838:CITRAT]2.0.CO;2; Donohue K, 2003, AM NAT, V162, P77, DOI 10.1086/375299; Douglas AE, 2008, NEW PHYTOL, V177, P849, DOI 10.1111/j.1469-8137.2007.02326.x; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Ferriere R, 2002, P ROY SOC B-BIOL SCI, V269, P773, DOI 10.1098/rspb.2001.1900; Fumanal B, 2006, MYCORRHIZA, V17, P25, DOI 10.1007/s00572-006-0078-1; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Grman E, 2012, AM NAT, V179, P567, DOI 10.1086/665006; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hausmann NT, 2009, NEW PHYTOL, V183, P1188, DOI 10.1111/j.1469-8137.2009.02882.x; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Johnson D, 2004, NEW PHYTOL, V161, P503, DOI 10.1046/j.1469-8137.2003.00938.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kelly JK, 1996, AM NAT, V147, P899, DOI 10.1086/285885; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LAU TC, 1993, AM J BOT, V80, P763, DOI 10.2307/2445596; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MENGE JA, 1978, NEW PHYTOL, V80, P575, DOI 10.1111/j.1469-8137.1978.tb01589.x; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; MULLEN RB, 1993, OECOLOGIA, V94, P229, DOI 10.1007/BF00341321; Mummey DL, 2005, PLANT SOIL, V271, P83, DOI 10.1007/s11104-004-2066-6; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Omorusi VI, 2011, INT J AGRIC BIOL, V13, P391; Powell JR, 2009, P ROY SOC B-BIOL SCI, V276, P4237, DOI 10.1098/rspb.2009.1015; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ronsheim ML, 2001, OECOLOGIA, V128, P77, DOI 10.1007/s004420000625; Schwartz MW, 1998, ECOLOGY, V79, P1029, DOI 10.1890/0012-9658(1998)079[1029:SARTBM]2.0.CO;2; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Valentine AJ, 2001, SCI HORTIC-AMSTERDAM, V88, P177, DOI 10.1016/S0304-4238(00)00205-3; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Van Dyken JD, 2011, AM NAT, V177, P288, DOI 10.1086/658365; WADE MJ, 1980, BEHAV ECOL SOCIOBIOL, V7, P167, DOI 10.1007/BF00299360; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107	49	43	45	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45648	10.1371/journal.pone.0045648	http://dx.doi.org/10.1371/journal.pone.0045648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029158	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900050
J	Jin, ZD; Zong, CY; Jiang, BC; Zhou, Z; Tong, J; Cao, Y				Jin, Zongda; Zong, Chunyan; Jiang, Bingcheng; Zhou, Zhen; Tong, Jian; Cao, Yi			The Effect of Combined Exposure of 900 MHz Radiofrequency Fields and Doxorubicin in HL-60 Cells	PLOS ONE			English	Article							MICROWAVE-RADIATION; APOPTOSIS; CALCIUM; CANCER; INDUCTION; DAMAGE; RATS	Human promyelocytic leukemia HL-60 cells were pre-exposed to non-ionizing 900 MHz radiofrequency fields (RF) at 12 mu W/cm(2) power density for 1 hour/day for 3 days and then treated with a chemotherapeutic drug, doxorubicin (DOX, 0.125 mg/L). Several end-points related to toxicity, viz., viability, apoptosis, mitochondrial membrane potential (MMP), intracellular free calcium (Ca2+) and Ca2+-Mg2+-ATPase activity were measured. The results obtained in un-exposed and sham-exposed control cells were compared with those exposed to RF alone, DOX alone and RF+DOX. The results indicated no significant differences between un-exposed, sham-exposed control cells and those exposed to RF alone while treatment with DOX alone showed a significant decrease in viability, increased apoptosis, decreased MMP, increased Ca2+ and decreased Ca2+-Mg2+-ATPase activity. When the latter results were compared with cells exposed RF+DOX, the data showed increased cell proliferation, decreased apoptosis, increased MMP, decreased Ca2+ and increased Ca2+-Mg2+-ATPase activity. Thus, RF preexposure appear to protect the HL-60 cells from the toxic effects of subsequent treatment with DOX. These observations were similar to our earlier data which suggested that pre-exposure of mice to 900 MHz RF at 120 mu W/cm(2) power density for 1 hours/day for 14 days had a protective effect in hematopoietic tissue damage induced by subsequent gamma-irradiation.	[Jin, Zongda; Zong, Chunyan; Jiang, Bingcheng; Zhou, Zhen; Tong, Jian; Cao, Yi] Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Cao, Y (corresponding author), Soochow Univ, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China.	yicao@suda.edu.cn			Ministry of Science and Technology, China [2011CB503700]; National Natural Science Foundation [81020108028]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Science and Technology, China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by a grant (973 project: 2011CB503700) from Ministry of Science and Technology, China (http://www.973.gov.cn/Default_3.aspx), a grant (81020108028) from National Natural Science Foundation (http://www.nsfc.gov.cn/Portal0/default106.htm), and The Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SECT CANC INF; [Anonymous], 2012, CANC FACTS 2012; Arcamone F., 1981, DOXORUBICIN ANTICANC; Armstrong JS, 2006, BIOESSAYS, V28, P253, DOI 10.1002/bies.20370; Beer MH, 2006, MERCK MANUAL DIAGNOS; Burkhardt M, 1996, BIOELECTROMAGNETICS, V17, P483, DOI 10.1002/(SICI)1521-186X(1996)17:6<483::AID-BEM8>3.0.CO;2-#; Cao Y, 2011, INT J RADIAT BIOL, V87, P720, DOI 10.3109/09553002.2010.550981; Cao Y, 2010, J TOXICOL ENV HEAL A, V73, P507, DOI 10.1080/15287390903523451; CARTER SK, 1975, J NATL CANCER I, V55, P1265, DOI 10.1093/jnci/55.6.1265; Chakraborti S, 2007, MOL CELL BIOCHEM, V298, P1, DOI 10.1007/s11010-006-9355-8; Chen ZJ, 2010, MUTAT RES-GEN TOX EN, V695, P16, DOI 10.1016/j.mrgentox.2009.10.001; Comparisons F, 2010, DURG FACTS COMP; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Delgado-Coello B, 2006, MOL CELL BIOCHEM, V285, P1, DOI 10.1007/s11010-005-9060-z; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Drexler HG, 2005, DRUG DISCOV TODAY DI, V2, P51; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032040; KLUCK RM, 1994, BBA-MOL CELL RES, V1223, P247, DOI 10.1016/0167-4889(94)90233-X; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Mortazavi SMJ, 2011, IRAN J RADIAT RES, V9, P9; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Persson BRR, 1997, WIREL NETW, V3, P455, DOI 10.1023/A:1019150510840; Rezaei PF, 2011, CYTOTECHNOLOGY, V63, P503, DOI 10.1007/s10616-011-9373-6; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; Sannino A, 2011, INT J RADIAT BIOL, V87, P993, DOI 10.3109/09553002.2011.574779; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Xie SQ, 2008, TOXICOLOGY, V254, P68, DOI 10.1016/j.tox.2008.09.021; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	30	42	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46102	10.1371/journal.pone.0046102	http://dx.doi.org/10.1371/journal.pone.0046102			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029402	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900091
J	Mohiman, N; Argentini, M; Batt, SM; Cornu, D; Masi, M; Eggeling, L; Besra, G; Bayan, N				Mohiman, Niloofar; Argentini, Manuela; Batt, Sarah M.; Cornu, David; Masi, Muriel; Eggeling, Lothar; Besra, Gurdyal; Bayan, Nicolas			The ppm Operon Is Essential for Acylation and Glycosylation of Lipoproteins in Corynebacterium glutamicum	PLOS ONE			English	Article							O-MANNOSYL GLYCANS; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; MONOPHOSPHOMANNOSE SYNTHASE; STREPTOMYCES-COELICOLOR; SORTING SIGNALS; IMMUNE-RESPONSE; MEMBRANE; PROTEIN; ANTIGEN	Background: Due to their contribution to bacterial virulence, lipoproteins and members of the lipoprotein biogenesis pathway represent potent drug targets. Following translocation across the inner membrane, lipoprotein precursors are acylated by lipoprotein diacylglycerol transferase (Lgt), cleaved off their signal peptides by lipoprotein signal peptidase (Lsp) and, in Gram-negative bacteria, further triacylated by lipoprotein N-acyl transferase (Lnt). The existence of an active apolipoprotein N-acyltransferase (Ms-Ppm2) involved in the N-acylation of LppX was recently reported in M. smegmatis. Ms-Ppm2 is part of the ppm operon in which Ppm1, a polyprenol-monophosphomannose synthase, has been shown to be essential in lipoglycans synthesis but whose function in lipoprotein biosynthesis is completely unknown. Results: In order to clarify the role of the ppm operon in lipoprotein biosynthesis, we investigated the post-translational modifications of two model lipoproteins (AmyE and LppX) in C. glutamicum Delta ppm1 and Delta ppm2 mutants. Our results show that both proteins are anchored into the membrane and that their N-termini are N-acylated by Cg-Ppm2. The acylated N-terminal peptide of LppX was also found to be modified by hexose moieties. This O-glycosylation is localized in the N-terminal peptide of LppX and disappeared in the Delta ppm1 mutant. While compromised in the absence of Cg-Ppm2, LppX O-glycosylation could be restored when Cg-Ppm1, Cg-Ppm2 or the homologous Mt-Ppm1 of M. tuberculosis was overexpressed. Conclusion: Together, these results show for the first time that Cg-Ppm1 (Ppm synthase) and Cg-Ppm2 (Lnt) operate in a common biosynthetic pathway in which lipoprotein N-acylation and glycosylation are tightly coupled.	[Mohiman, Niloofar; Masi, Muriel; Bayan, Nicolas] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Mohiman, Niloofar; Masi, Muriel; Bayan, Nicolas] CNRS, UMR 8619, F-91405 Orsay, France; [Argentini, Manuela; Cornu, David] CNRS, Inst Chim Subst Nat, Gif Sur Yvette, France; [Batt, Sarah M.; Besra, Gurdyal] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Eggeling, Lothar] Forschungszentrum Julich, D-52425 Julich, Germany	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Birmingham; Helmholtz Association; Research Center Julich	Bayan, N (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.	nicolas.bayan@u-psud.fr	Bayan, Nicolas/AAI-5034-2020; Masi, Muriel/N-6758-2018	Masi, Muriel/0000-0002-1444-7511; Bayan, Nicolas/0000-0001-7760-0811; Besra, Gurdyal/0000-0002-5605-0395	Agence Nationale pour la Recherche [ANR-07-BLAN-0363]; CNRS; Universite of Paris Sud-XI	Agence Nationale pour la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite of Paris Sud-XI	This work has received financial support from the "Agence Nationale pour la Recherche" grant ANR-07-BLAN-0363, the CNRS and the Universite of Paris Sud-XI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Babu MM, 2006, J BACTERIOL, V188, P2761, DOI 10.1128/JB.188.8.2761-2773.2006; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Brulle JK, BIOCH BIOPHYS RES CO, V391, P679; Chaban B, 2009, J BACTERIOL, V191, P187, DOI 10.1128/JB.00885-08; Cowlishaw DA, 2002, J BACTERIOL, V184, P6081, DOI 10.1128/JB.184.21.6081-6083.2002; Cui JM, 2011, ESSAYS BIOCHEM, V50, P85, DOI [10.1042/BSE0500085, 10.1042/bse0500085]; Denham EL, 2009, MICROBIOL-SGM, V155, P134, DOI 10.1099/mic.0.022061-0; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; Endo T, 2004, GLYCOCONJUGATE J, V21, P3, DOI 10.1023/B:GLYC.0000043740.26062.2c; ESPITIA C, 1989, CLIN EXP IMMUNOL, V77, P378; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Hermann T, 2001, ELECTROPHORESIS, V22, P1712, DOI 10.1002/1522-2683(200105)22:9<1712::AID-ELPS1712>3.0.CO;2-G; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kurokawa K, 2012, J BIOL CHEM; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Nguyen HT, 2010, MOL MICROBIOL, V76, P348, DOI 10.1111/j.1365-2958.2010.07110.x; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Russell-Goldman E, 2008, INFECT IMMUN, V76, P4269, DOI 10.1128/IAI.01735-07; Sartain MJ, 2009, GLYCOBIOLOGY, V19, P38, DOI 10.1093/glycob/cwn102; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Serebryakova MV, 2011, J BIOL CHEM, V286, P22769, DOI 10.1074/jbc.M111.231316; Steyn AJC, 2003, MOL MICROBIOL, V47, P1074, DOI 10.1046/j.1365-2958.2003.03356.x; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Sutcliffe IC, 2012, PROTEIN CELL, V3, P163, DOI 10.1007/s13238-012-2023-8; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Terada M, 2001, J BIOL CHEM, V276, P47690, DOI 10.1074/jbc.M109307200; Tjalsma H, 2005, PROTEOMICS, V5, P4472, DOI 10.1002/pmic.200402080; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Ujihara T, 2008, ANAL BIOCHEM, V374, P429, DOI 10.1016/j.ab.2007.11.014; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Wehmeier S, 2009, MOL MICROBIOL, V71, P421, DOI 10.1111/j.1365-2958.2008.06536.x; Wendisch VF, 1997, THESIS HEINRICH HEIN; Wilkinson KA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-93; Willer T, 2003, CURR OPIN STRUC BIOL, V13, P621, DOI 10.1016/j.sbi.2003.09.003; Wu HC, 1996, CELLULAR MOL BIOL	50	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46225	10.1371/journal.pone.0046225	http://dx.doi.org/10.1371/journal.pone.0046225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029442	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900112
J	Wang, N; Zhu, MF; Tsao, SW; Man, K; Zhang, ZJ; Feng, YB				Wang, Ning; Zhu, Meifen; Tsao, Sai-Wah; Man, Kwan; Zhang, Zhangjin; Feng, Yibin			Up-Regulation of TIMP-1 by Genipin Inhibits MMP-2 Activities and Suppresses the Metastatic Potential of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES-1; INDUCED APOPTOSIS; ACTIVATION; PROTEIN; INVASION; MIGRATION; GENIPOSIDE; AGENT	Aim of the Study: The aim of this study is to investigate the anti-metastatic effect of genipin and its underlying mechanism. Experimental Approach: healing and invasion chamber assays were introduced to examine the anti-migration and anti-invasion action of genipin in human hepatocellular carcinoma cell HepG2 and MHCC97L; orthotopical implantation model was used for in vivo evaluation. Gelatin Zymography, Immunoblotting, quantitative real-time polymerase chain reaction and ELISA assays were used to study the mechanisms underlying genipin's anti-metastatic effect. Key Results: Genipin suppresses the motility and invasiveness of HepG2 and MHCC97L at non-toxic doses, which may be correlated to the inhibition of genipin on MMP-2 activities in the cells. No significant reduced expression of MMP-2 was observed either at mRNA or at protein level. Furthermore, genipin could specifically up-regulate the expression of TIMP-1, the endogenous inhibitor of MMP-2 activities. Silencing of TIMP-1 by RNA interference abolishes genipin's anti-metastaic effect. Activation of p38 MAPK signaling was observed in genipin-treated cells, which is responsible for the TIMP-1 overexpression and MMP-2 inhibition. Presence of SB202190, the p38 MAPK inhibitor, attenuates the anti-metastatic potential of genipin in hepatocellular carcinoma. Orthotopical implantation model showed that genipin could suppress the intrahepatic metastatic as well as tumor expansion in liver without exhibiting potent toxicity. Conclusion: Our findings demonstrated the potential of genipin in suppressing hepatocellular carcinoma metastasis, and p38/TIMP-1/MMP-2 pathway may be involved as the key mechanism of its anti-metastasis effect. Hepatocellular carcinoma is one of the most malignant human cancers with high metastatic potential. The anti-metastatic potential of genipin was evaluated by both cell and animal model. Wound	[Wang, Ning; Zhu, Meifen; Zhang, Zhangjin; Feng, Yibin] Univ Hong Kong, Li Ka Shing Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah; Man, Kwan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah; Man, Kwan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Feng, YB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	yfeng@hku.hk	zhang, zhang/GQZ-6804-2022; zhang, zheng/HCH-9684-2022		research council of University of Hong Kong [10401764]; The Research Grant Committee (RGC) of Hong Kong SAR of China [10500362]	research council of University of Hong Kong; The Research Grant Committee (RGC) of Hong Kong SAR of China	The study was financially supported by grants from the research council of the University of Hong Kong (Project Code: 10401764), The Research Grant Committee (RGC) of Hong Kong SAR of China (RGC General Research Fund, Project Code: 10500362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cao HL, 2010, BIOL PHARM BULL, V33, P1343, DOI 10.1248/bpb.33.1343; Chen YS, 2007, ALLERGY, V62, P66, DOI 10.1111/j.1398-9995.2006.01255.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J., 2001, INT J CANCER, V94, P153; Ho YL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/965846; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jayasankar V, 2004, CIRCULATION, V110, pII180, DOI 10.1161/01.CIR.0000138946.29375.49; Kai HST, 2002, J BIOL CHEM, V277, P48696, DOI 10.1074/jbc.M209177200; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kim ES, 2012, ONCOL REP, V27, P567, DOI 10.3892/or.2011.1508; Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231; Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Li FN, 2012, TOXICOL APPL PHARM, V261, P217, DOI 10.1016/j.taap.2012.04.011; Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pratheeshkumar P, 2011, EUR J PHARMACOL, V668, P450, DOI 10.1016/j.ejphar.2011.07.029; Ramer R, 2007, ONCOGENE, V26, P5822, DOI 10.1038/sj.onc.1210358; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Senthilkumar K, 2011, CELL BIOCHEM FUNCT, V29, P87, DOI 10.1002/cbf.1725; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Suzuki Y, 2001, PLANTA MED, V67, P807, DOI 10.1055/s-2001-18842; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31; Wang N, 2010, INTEGR CANCER THER, V9, P354, DOI 10.1177/1534735410379121; Wang SC, 2008, J CHROMATOGR A, V1212, P68, DOI 10.1016/j.chroma.2008.10.035; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	37	58	62	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46318	10.1371/journal.pone.0046318	http://dx.doi.org/10.1371/journal.pone.0046318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029478	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900133
J	Dibble, KL; Meyerson, LA				Dibble, Kimberly L.; Meyerson, Laura A.			Tidal Flushing Restores the Physiological Condition of Fish Residing in Degraded Salt Marshes	PLOS ONE			English	Article							MUMMICHOG FUNDULUS-HETEROCLITUS; PHRAGMITES-AUSTRALIS INVASION; STABLE-ISOTOPE; HABITAT-USE; PREDATION RISK; GUT CONTENTS; GROWTH; NEKTON; RESTORATION; RESPONSES	Roads, bridges, and dikes constructed across salt marshes can restrict tidal flow, degrade habitat quality for nekton, and facilitate invasion by non-native plants including Phragmites australis. Introduced P. australis contributes to marsh accretion and eliminates marsh surface pools thereby adversely affecting fish by reducing access to intertidal habitats essential for feeding, reproduction, and refuge. Our study assessed the condition of resident fish populations (Fundulus heteroclitus) at four tidally restricted and four tidally restored marshes in New England invaded by P. australis relative to adjacent reference salt marshes. We used physiological and morphological indicators of fish condition, including proximate body composition (% lipid, % lean dry, % water), recent daily growth rate, age class distributions, parasite prevalence, female gravidity status, length-weight regressions, and a common morphological indicator (Fulton's K) to assess impacts to fish health. We detected a significant increase in the quantity of parasites infecting fish in tidally restricted marshes but not in those where tidal flow was restored to reduce P. australis cover. Using fish length as a covariate, we found that unparasitized, non-gravid F. heteroclitus in tidally restricted marshes had significantly reduced lipid reserves and increased lean dry (structural) mass relative to fish residing in reference marshes. Fish in tidally restored marshes were equivalent across all metrics relative to those in reference marshes indicating that habitat quality was restored via increased tidal flushing. Reference marshes adjacent to tidally restored sites contained the highest abundance of young fish (ages 0-1) while tidally restricted marshes contained the lowest. Results indicate that F. heteroclitus residing in physically and hydrologically altered marshes are at a disadvantage relative to fish in reference marshes but the effects can be reversed through ecological restoration.	[Dibble, Kimberly L.; Meyerson, Laura A.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Meyerson, Laura A.] Acad Sci Czech Republ, Inst Bot, Dept Invas Ecol, CS-25243 Pruhonice, Czech Republic	University of Rhode Island; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Dibble, KL (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	klellisdibble@gmail.com	Meyerson, Laura/D-4487-2013; Meyerson, Laura A./S-2979-2019; Meyerson, Laura/K-9013-2012; Meyerson, Laura A./AAN-6688-2020	Meyerson, Laura A./0000-0002-1283-3865	Environmental Protection Agency [FP-91710001-0]; National Oceanic and Atmospheric Administration [NA09NOS4200041]; National Science Foundation [0504103]; Philanthropic Educational Organization [Lellis-Dib3158688]; Northeast Aquatic Plant Management Society; Rhode Island Natural History Survey; Nature Conservancy of Rhode Island [Lellis-Dibble 05-30-09]; University of Rhode Island Agricultural Experiment Station [RI00H-332, 311000-6044]; Direct For Biological Sciences [1050084] Funding Source: National Science Foundation; Division Of Environmental Biology [1049914] Funding Source: National Science Foundation	Environmental Protection Agency(United States Environmental Protection Agency); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Philanthropic Educational Organization; Northeast Aquatic Plant Management Society; Rhode Island Natural History Survey; Nature Conservancy of Rhode Island; University of Rhode Island Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the Environmental Protection Agency Science to Achieve Results Graduate Fellowship Program (FP-91710001-0), National Oceanic and Atmospheric Administration National Estuarine Research Reserve Graduate Fellowship Program (NA09NOS4200041), National Science Foundation Integrative Graduate Education and Research Traineeship Grant to the Coastal Institute at the University of Rhode Island (0504103), the Philanthropic Educational Organization Scholar Award (Lellis-Dib3158688), Northeast Aquatic Plant Management Society Graduate Scholarship Program, Rhode Island Natural History Survey and The Nature Conservancy of Rhode Island Wald Science Grant (Lellis-Dibble 05-30-09), and the University of Rhode Island Agricultural Experiment Station (RI00H-332, 311000-6044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2006, J EXP MAR BIOL ECOL, V335, P177, DOI 10.1016/j.jembe.2006.03.004; Able KW, 2003, ESTUARIES, V26, P484, DOI 10.1007/BF02823725; Adamowicz S.C., 2012, TIDAL MARSH RESTORAT; Adams S. M., 1999, ECOLOGICAL ROLE LIPI, P132; ALLEN EA, 1994, ESTUARIES, V17, P462, DOI 10.2307/1352676; Amara R, 2009, HYDROBIOLOGIA, V627, P87, DOI 10.1007/s10750-009-9717-9; Anisfeld SC, 1999, ESTUARIES, V22, P231, DOI 10.2307/1352980; Anisfeld SC, 1997, ENVIRON SCI TECHNOL, V31, P1650, DOI 10.1021/es960490o; Anisfeld SC, 2012, TIDAL MARSH RESTORAT, P39, DOI DOI 10.5822/978-1-61091-229-7_3; Arneri E, 2000, J FISH BIOL, V56, P1368, DOI 10.1006/jfbi.2000.1255; Balouskus RG, 2012, ESTUAR COAST, V35, P1100, DOI 10.1007/s12237-012-9495-x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; BOESCH DF, 1984, ESTUARIES, V7, P460, DOI 10.2307/1351627; Boumans RMJ, 2002, RESTOR ECOL, V10, P543, DOI 10.1046/j.1526-100X.2002.02032.x; Brawley AH, 1998, ENVIRON MANAGE, V22, P625, DOI 10.1007/s002679900134; Buchsbaum RN, 2006, WETLANDS, V26, P544, DOI 10.1672/0277-5212(2006)26[544:CISMVP]2.0.CO;2; Burdick D.M., 1997, Wetlands Ecology and Management, V4, P129, DOI 10.1007/BF01876233; Burdick D.M, 2012, TIDAL MARSH RESTORAT; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Chambers RM, 2003, ESTUARIES, V26, P398, DOI 10.1007/BF02823716; Chambers RM, 2012, TIDAL MARSH RESTORAT, P81, DOI DOI 10.5822/978-1-61091-229-7_5; Childers DL, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P391; Darnell R. M., 1967, ESTUARIES, P376; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Eberhardt AL, 2011, RESTOR ECOL, V19, P776, DOI 10.1111/j.1526-100X.2010.00721.x; FRITZ ES, 1975, CAN J ZOOL, V53, P361, DOI 10.1139/z75-047; Fry B, 2008, MAR ECOL PROG SER, V369, P193, DOI 10.3354/meps07644; Fulton T. W., 1904, Report of the Fishery Board for Scotland, Vxxii, P141; Gedan KB, 2009, ANNU REV MAR SCI, V1, P117, DOI 10.1146/annurev.marine.010908.163930; Gilliers C, 2004, ENVIRON BIOL FISH, V71, P189, DOI 10.1007/s10641-004-0090-2; Golet F. C., 2012, TIDAL MARSH RESTORAT, P333; Goto D, 2010, CAN J FISH AQUAT SCI, V67, P1566, DOI 10.1139/F10-082; Halpin PM, 2000, MAR ECOL PROG SER, V198, P203, DOI 10.3354/meps198203; Harris CE, 2006, COMP PARASITOL, V73, P72, DOI 10.1654/41716.1; HASSAGER T K, 1991, Dana, V9, P39; Hunter KL, 2006, ESTUAR COAST, V29, P487, DOI 10.1007/BF02784996; Irlandi EA, 1997, OECOLOGIA, V110, P222, DOI 10.1007/s004420050154; James-Pirri MJ, 2001, ESTUAR COAST SHELF S, V53, P205, DOI 10.1006/ecss.2001.0807; Javonillo R, 1997, BIOL BULL, V193, P288, DOI 10.1086/BBLv193n2p288; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; Kelly CJ, 1999, ICES J MAR SCI, V56, P61, DOI 10.1006/jmsc.1998.0426; Kerambrun E, 2012, CHEMOSPHERE, V87, P692, DOI 10.1016/j.chemosphere.2011.12.059; Kneib Ronald T., 1997, Oceanography and Marine Biology an Annual Review, V35, P163; KNEIB RT, 1987, ECOLOGY, V68, P379, DOI 10.2307/1939269; KNEIB RT, 1994, MAR ECOL PROG SER, V106, P227, DOI 10.3354/meps106227; Lafferty KD, 2008, J FISH BIOL, V73, P2083, DOI 10.1111/j.1095-8649.2008.02059.x; Lloret J, 2003, MAR ECOL PROG SER, V248, P197, DOI 10.3354/meps248197; Madon SP, 2001, ECOL MODEL, V136, P149, DOI 10.1016/S0304-3800(00)00416-6; Marcogliese D. J., 2004, ECOHEALTH, V1, P151, DOI DOI 10.1007/S10393-004-0028-3; Marcogliese DJ, 2005, INT J PARASITOL, V35, P705, DOI 10.1016/j.ijpara.2005.01.015; MCIVOR CC, 1988, ECOLOGY, V69, P1341, DOI 10.2307/1941632; McMahon KW, 2005, ESTUARIES, V28, P966, DOI 10.1007/BF02696024; Meyerson L. A., 2000, Wetlands Ecology and Management, V8, P89, DOI 10.1023/A:1008432200133; Milone and MacBroom Inc, 1996, SYB CREEK SALT MARSH; Minello TJ, 2012, ESTUAR COAST, V35, P501, DOI 10.1007/s12237-011-9463-x; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Moreno-Mateos D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001247; MUGIYA Y, 1987, NIPPON SUISAN GAKK, V53, P1979; National Oceanic and Atmospheric Administration, 2003, DRAK ISL MARSH REST; Neilson John D., 1992, Canadian Special Publication of Fisheries and Aquatic Sciences, V117, P115; Nixon S.W., 1980, ESTUAR WETL PROCESS, P437; Odum E.P., 1968, P 2 SEA GRANT C, P63; Osgood DT, 2003, ESTUARIES, V26, P522, DOI 10.1007/BF02823728; Otxotorena U, 2010, FISH RES, V106, P337, DOI 10.1016/j.fishres.2010.09.001; PARRISH DL, 1994, T AM FISH SOC, V123, P601, DOI 10.1577/1548-8659(1994)123<0601:NAAPOD>2.3.CO;2; Pineiro C, 2008, FISH RES, V93, P173, DOI 10.1016/j.fishres.2008.04.001; Portnoy JW, 1997, BIOGEOCHEMISTRY, V36, P275, DOI 10.1023/A:1005715520988; PORTNOY JW, 2003, PARK SCI, V22, P51; Post JR, 2001, ECOLOGY, V82, P1040, DOI 10.1890/0012-9658(2001)082[1040:EASIYF]2.0.CO;2; RADTKE RL, 1982, FISH B-NOAA, V80, P201; Raposa K, 2002, RESTOR ECOL, V10, P665, DOI 10.1046/j.1526-100X.2002.01047.x; Raposa K.B., 2012, TIDAL MARSH RESTORAT, P97; Raposa KB, 2003, ESTUARIES, V26, P98, DOI 10.1007/BF02691697; Raposa KB, 2003, ENVIRON MONIT ASSESS, V81, P239, DOI 10.1023/A:1021389327224; Raposa KB, 2001, WETLANDS, V21, P451, DOI 10.1672/0277-5212(2001)021[0451:SHUPON]2.0.CO;2; Raposa KB, 2008, J COASTAL RES, P180, DOI 10.2112/SI55-015; ROMAN CT, 1984, ENVIRON MANAGE, V8, P141, DOI 10.1007/BF01866935; Roman CT, 2002, RESTOR ECOL, V10, P450, DOI 10.1046/j.1526-100X.2002.01036.x; Rooth J. E., 2003, Estuaries, V26, P475, DOI 10.1007/BF02823724; ROUNTREE RA, 1992, T AM FISH SOC, V121, P765, DOI 10.1577/1548-8659(1992)121<0765:FHGATP>2.3.CO;2; Secor D. H., 1991, BW BARUCH I MAR BIOL; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Simpkins DG, 2003, CAN J ZOOL, V81, P1641, DOI [10.1139/z03-157, 10.1139/Z03-157]; SINICROPE TL, 1990, ESTUARIES, V13, P25, DOI 10.2307/1351429; Slason E, 2000, P 5 BIENN LONG ISL S; Smith SM, 2012, TIDAL MARSH RESTORAT, P59; Smith SM, 2009, RESTOR ECOL, V17, P606, DOI 10.1111/j.1526-100X.2008.00426.x; SPALDING MG, 1993, J WILDLIFE DIS, V29, P237, DOI 10.7589/0090-3558-29.2.237; TAYLOR MH, 1986, AM ZOOL, V26, P159; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Tomas J, 2000, FISH RES, V46, P131, DOI 10.1016/S0165-7836(00)00140-5; VALIELA I, 1977, MAR BIOL, V40, P135, DOI 10.1007/BF00396259; Warren RS, 2002, RESTOR ECOL, V10, P497, DOI 10.1046/j.1526-100X.2002.01031.x; Watzin M. C., 1992, FRAGILE FRINGE COAST; Weinstein MP, 2010, WETLANDS, V30, P1181, DOI 10.1007/s13157-010-0102-2; Weinstein MP, 2009, ESTUAR COAST, V32, P1011, DOI 10.1007/s12237-009-9185-5; Weis J.S., 2009, SALT MARSHES NATURAL; WEISBERG SB, 1981, MAR BIOL, V61, P243, DOI 10.1007/BF00386666; WEISBERG SB, 1982, MAR BIOL, V66, P307, DOI 10.1007/BF00397037; West JM, 2000, ESTUARIES, V23, P699, DOI 10.2307/1352896; Wozniak AS, 2006, ESTUAR COAST, V29, P568, DOI 10.1007/BF02784283	104	32	32	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46161	10.1371/journal.pone.0046161	http://dx.doi.org/10.1371/journal.pone.0046161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029423	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500067
J	Lindhoud, S; Westphal, AH; Borst, JW; van Mierlo, CPM				Lindhoud, Simon; Westphal, Adrie H.; Borst, Jan Willem; van Mierlo, Carlo P. M.			Illuminating the Off-Pathway Nature of the Molten Globule Folding Intermediate of an alpha-beta Parallel Protein	PLOS ONE			English	Article							AZOTOBACTER-VINELANDII; REFRACTIVE-INDEX; FLUORESCENCE DEPOLARIZATION; HYDROGEN-EXCHANGE; ENERGY LANDSCAPE; APOFLAVODOXIN; STATE; AGGREGATION; MECHANISM; CUTINASE	Partially folded protein species transiently form during folding of most proteins. Often, these species are molten globules, which may be on-or off-pathway to the native state. Molten globules are ensembles of interconverting protein conformers that have a substantial amount of secondary structure, but lack virtually all tertiary side-chain packing characteristics of natively folded proteins. Due to solvent-exposed hydrophobic groups, molten globules are prone to aggregation, which can have detrimental effects on organisms. The molten globule observed during folding of the 179-residue apoflavodoxin from Azotobacter vinelandii is off-pathway, as it has to unfold before native protein can form. Here, we study folding of apoflavodoxin and characterize its molten globule using fluorescence spectroscopy and Forster Resonance Energy Transfer (FRET). Apoflavodoxin is site-specifically labeled with fluorescent donor and acceptor dyes, utilizing dye-inaccessibility of Cys69 in cofactor-bound protein. Donor (i.e., Alexa Fluor 488) is covalently attached to Cys69 in all apoflavodoxin variants used. Acceptor (i.e., Alexa Fluor 568) is coupled to Cys1, Cys131 and Cys178, respectively. Our FRET data show that apoflavodoxin's molten globule forms in a non-cooperative manner and that its N-terminal 69 residues fold last. In addition, striking conformational differences between molten globule and native protein are revealed, because the inter-label distances sampled in the 111-residue C-terminal segment of the molten globule are shorter than observed for native apoflavodoxin. Thus, FRET sheds light on the off-pathway nature of the molten globule during folding of an alpha-beta parallel protein.	[Lindhoud, Simon; Westphal, Adrie H.; Borst, Jan Willem; van Mierlo, Carlo P. M.] Wageningen Univ, Biochem Lab, Wageningen, Netherlands; [Westphal, Adrie H.; Borst, Jan Willem] Wageningen Univ, Microspect Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van Mierlo, CPM (corresponding author), Wageningen Univ, Biochem Lab, Wageningen, Netherlands.	carlo.vanmierlo@wur.nl	Borst, Jan Willem/B-1259-2011; Westphal, Adrie Herman/L-3517-2019; vanMierlo, Carlo p/B-4491-2016	Westphal, Adrie Herman/0000-0003-4264-6267; vanMierlo, Carlo p/0000-0002-5358-8392	Netherlands Organization for Scientific Research (NWO) [700.56.002]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organization for Scientific Research (NWO) supported this work (grant number 700.56.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagaratnam S, 2005, PROTEIN SCI, V14, P2284, DOI 10.1110/ps.051582605; AMIR D, 1992, PROTEINS, V13, P162, DOI 10.1002/prot.340130210; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Bollen YJM, 2005, BIOPHYS CHEM, V114, P181, DOI 10.1016/j.bpc.2004.12.005; Bollen YJM, 2005, J BIOL CHEM, V280, P7836, DOI 10.1074/jbc.M412871200; Bollen YJM, 2004, BIOCHEMISTRY-US, V43, P10475, DOI 10.1021/bi049545m; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CHRISTENSEN H, 1991, EUR BIOPHYS J, V19, P221, DOI 10.1007/BF00183530; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Engel R, 2008, J BIOL CHEM, V283, P27383, DOI 10.1074/jbc.M802393200; Fernandez-Recio J, 2001, BIOCHEMISTRY-US, V40, P15234, DOI 10.1021/bi010216t; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Haas E, 2005, CHEMPHYSCHEM, V6, P858, DOI 10.1002/cphc.200400617; Huang F, 2008, PROTEIN ENG DES SEL, V21, P131, DOI 10.1093/protein/gzm069; Jaenicke R, 1997, ADV PROTEIN CHEM, V50, P1, DOI 10.1016/S0065-3233(08)60318-6; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Knox RS, 2002, J PHYS CHEM B, V106, P5289, DOI 10.1021/jp013927+; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Laptenok SP, 2011, BIOCHEMISTRY-US, V50, P3441, DOI 10.1021/bi101965d; Lorenz T, 2008, J MOL BIOL, V381, P443, DOI 10.1016/j.jmb.2008.06.001; Mansoor SE, 2010, BIOCHEMISTRY-US, V49, P9722, DOI 10.1021/bi100907m; Mayhew S. G., 1992, CHEM BIOCH FLAVOENZY, V3, P389; Melo EP, 2003, BIOCHEMISTRY-US, V42, P7611, DOI 10.1021/bi034267x; Nabuurs SM, 2010, EUR BIOPHYS J BIOPHY, V39, P689, DOI 10.1007/s00249-009-0556-4; Nabuurs SM, 2010, J BIOL CHEM, V285, P4165, DOI 10.1074/jbc.M109.087932; Nabuurs SM, 2009, J AM CHEM SOC, V131, P8290, DOI 10.1021/ja9014309; Nabuurs SM, 2009, J AM CHEM SOC, V131, P2739, DOI 10.1021/ja8089476; Nabuurs SM, 2008, J AM CHEM SOC, V130, P16914, DOI 10.1021/ja803841n; Nozaki Y., 1972, PREPARATION GUANIDIN; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Otzen DE, 2007, BBA-PROTEINS PROTEOM, V1774, P323, DOI 10.1016/j.bbapap.2006.11.012; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Ratner V, 2002, BIOCONJUGATE CHEM, V13, P1163, DOI 10.1021/bc025537b; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Steensma E, 1998, PROTEIN SCI, V7, P306; Steensma E, 1998, J MOL BIOL, V282, P653, DOI 10.1006/jmbi.1998.2045; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; SZABO A, 1984, J CHEM PHYS, V81, P150, DOI 10.1063/1.447378; Toptygin D, 2002, J PHYS CHEM B, V106, P3724, DOI 10.1021/jp0133889; van den Berg PAW, 2004, BIOPHYS J, V87, P2577, DOI 10.1529/biophysj.104.040030; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; Visser NV, 2008, BIOPHYS J, V95, P2462, DOI 10.1529/biophysj.108.132001; Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072	56	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45746	10.1371/journal.pone.0045746	http://dx.doi.org/10.1371/journal.pone.0045746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029219	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800090
J	Smith, SEP; Bida, AT; Davis, TR; Sicotte, H; Patterson, SE; Gil, D; Schrum, AG				Smith, Stephen E. P.; Bida, Anya T.; Davis, Tessa R.; Sicotte, Hugues; Patterson, Steven E.; Gil, Diana; Schrum, Adam G.			IP-FCM Measures Physiologic Protein-Protein Interactions Modulated by Signal Transduction and Small-Molecule Drug Inhibition	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; RECOGNITION; CELLS; IDENTIFICATION; SENSITIVITY; COMPLEX; CANCER; IL-2; SELF	Protein-protein interactions (PPI) mediate the formation of intermolecular networks that control biological signaling. For this reason, PPIs are of outstanding interest in pharmacology, as they display high specificity and may represent a vast pool of potentially druggable targets. However, the study of physiologic PPIs can be limited by conventional assays that often have large sample requirements and relatively low sensitivity. Here, we build on a novel method, immunoprecipitation detected by flow cytometry (IP-FCM), to assess PPI modulation during either signal transduction or pharmacologic inhibition by two different classes of small-molecule compounds. First, we showed that IP-FCM can detect statistically significant differences in samples possessing a defined PPI change as low as 10%. This sensitivity allowed IP-FCM to detect a PPI that increases transiently during T cell signaling, the antigen-inducible interaction between ZAP70 and the T cell antigen receptor (TCR)/CD3 complex. In contrast, IP-FCM detected no ZAP70 recruitment when T cells were stimulated with antigen in the presence of the src-family kinase inhibitor, PP2. Further, we tested whether IP-FCM possessed sufficient sensitivity to detect the effect of a second, rare class of compounds called SMIPPI (small-molecule inhibitor of PPI). We found that the first-generation non-optimized SMIPPI, Ro-26-4550, inhibited the IL-2:CD25 interaction detected by IP-FCM. This inhibition was detectable using either a recombinant CD25-Fc chimera or physiologic full-length CD25 captured from T cell lysates. Thus, we demonstrate that IP-FCM is a sensitive tool for measuring physiologic PPIs that are modulated by signal transduction and pharmacologic inhibition.	[Smith, Stephen E. P.; Bida, Anya T.; Davis, Tessa R.; Gil, Diana; Schrum, Adam G.] Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Sicotte, Hugues] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Patterson, Steven E.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Schrum, AG (corresponding author), Mayo Clin Coll Med, Dept Immunol, Rochester, MN 55905 USA.	schrum.adam@mayo.edu		Schrum, Adam/0000-0001-9276-1859	National Institutes of Health [1R56AI084861]; Fraternal Order of Eagles Pilot Project grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI084861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of Eagles Pilot Project grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant 1R56AI084861, a Fraternal Order of Eagles Pilot Project grant, a generous philanthropic gift for research directed toward Alopecia Areata by Mr. Bernard Fineman (AGS), and the Mayo Foundation (DG, AGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bida AT, 2012, METHODS, V56, P154, DOI 10.1016/j.ymeth.2011.09.005; Blazer LL, 2009, NEUROPSYCHOPHARMACOL, V34, P126, DOI 10.1038/npp.2008.151; Colas Pierre, 2008, Curr Drug Discov Technol, V5, P190, DOI 10.2174/157016308785739875; Davis TR, 2010, J VIS EXP; de la Cruz J, 2011, J IMMUNOL, V186, P2282, DOI 10.4049/jimmunol.1003225; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Dietz AB, 2006, TRANSFUSION, V46, P2083, DOI 10.1111/j.1537-2995.2006.01033.x; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Gil D, 2008, J IMMUNOL, V180, P3900, DOI 10.4049/jimmunol.180.6.3900; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Kay BK, 1996, MOL DIVERS, V1, P139, DOI 10.1007/BF01721330; Laudet B, 2008, MOL CELL BIOCHEM, V316, P63, DOI 10.1007/s11010-008-9821-6; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Prasanth SG, 2004, PHILOS T R SOC B, V359, P7, DOI 10.1098/rstb.2003.1360; Raimundo BC, 2004, J MED CHEM, V47, P3111, DOI 10.1021/jm049967u; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schrum A. G., 2007, SCI STKE, P12; Schrum Adam G, 2009, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0509s87; Schrum AG, 2011, J IMMUNOL, V187, P870, DOI 10.4049/jimmunol.1100538; Schrum AG, 2003, IMMUNOL REV, V196, P7, DOI 10.1046/j.1600-065X.2003.00083.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Tilley JW, 1997, J AM CHEM SOC, V119, P7589, DOI 10.1021/ja970702x; Wilson CGM, 2011, CURR TOP MICROBIOL, V348, P25, DOI 10.1007/82_2010_93	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45722	10.1371/journal.pone.0045722	http://dx.doi.org/10.1371/journal.pone.0045722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029201	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800084
J	Tamura, Y; Ono, T; Kuwana, M; Inoue, K; Takei, M; Yamamoto, T; Kawakami, T; Fujita, J; Kataoka, M; Kimura, K; Sano, M; Daida, H; Satoh, T; Fukuda, K				Tamura, Yuichi; Ono, Tomohiko; Kuwana, Masataka; Inoue, Kenji; Takei, Makoto; Yamamoto, Tsunehisa; Kawakami, Takashi; Fujita, Jun; Kataoka, Masaharu; Kimura, Kensuke; Sano, Motoaki; Daida, Hiroyuki; Satoh, Toru; Fukuda, Keiichi			Human Pentraxin 3 (PTX3) as a Novel Biomarker for the Diagnosis of Pulmonary Arterial Hypertension	PLOS ONE			English	Article							RECOGNITION RECEPTOR PTX3; LONG PENTRAXIN; SYSTEMIC-SCLEROSIS; ALTERNATIVE ACTIVATION; VASCULAR INFLAMMATION; INNATE IMMUNITY; HEART-FAILURE; MARKER; EXPRESSION; OUTCOMES	Background: Although inflammation is an important feature of pulmonary arterial hypertension (PAH), the usefulness of local inflammatory markers as biomarkers for PAH is unknown. In this study, we tested whether plasma concentrations of human pentraxin 3 (PTX3), a local inflammatory marker, would be a useful biomarker for detecting PAH. Methods: Plasma PTX3 concentrations were evaluated in 50 PAH patients (27 with idiopathic PAH, 17 with PAH associated with connective tissue disease (CTD-PAH), and six with congenital heart disease), 100 age and sex-matched healthy controls, and 34 disease-matched CTD patients without PAH. Plasma concentrations of B-type natriuretic peptide (BNP) and C-reactive protein (CRP) were also determined. Results: Mean PTX3 levels were significantly higher in all PAH patients than in the healthy controls (4.40 +/- 0.37 vs. 1.94 +/- 0.09 ng/mL, respectively; P<0.001). Using a threshold level of 2.84 ng/mL, PTX3 yielded a sensitivity of 74.0% and a specificity of 84.0% for the detection of PAH. In CTD-PAH patients, mean PTX3 concentrations were significantly higher than in CTD patients without PAH (5.02 +/- 0.69 vs. 2.40 +/- 0.14 ng/mL, respectively; P<0.001). There was no significant correlation between plasma levels of PTX3 and BNP or CRP. Receiver operating characteristic (ROC) curves for screening PAH in patients with CTD revealed that PTX3 (area under the ROC curve 0.866) is superior to BNP. Using a PTX3 threshold of 2.85 ng/mL maximized true-positive and false-negative results (sensitivity 94.1%, specificity 73.5%). Conclusion: Plasma concentrations of PTX3 may be a better biomarker of PAH than BNP, especially in patients with CTD.	[Tamura, Yuichi; Ono, Tomohiko; Takei, Makoto; Yamamoto, Tsunehisa; Kawakami, Takashi; Fujita, Jun; Kimura, Kensuke; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Rheumatol, Tokyo, Japan; [Inoue, Kenji] Juntendo Univ, Nerima Hosp, Dept Cardiol, Tokyo, Japan; [Kataoka, Masaharu; Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Daida, Hiroyuki] Juntendo Univ, Sch Med, Dept Cardiol, Tokyo 113, Japan	Keio University; Keio University; Juntendo University; Kyorin University; Juntendo University	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013; Yamamoto, Tsunehisa/O-2014-2013; Sano, Motoaki/L-3405-2013; Tamura, Yuichi/B-5991-2014; Kuwana, Masataka/L-2918-2013	Yamamoto, Tsunehisa/0000-0002-5241-9482; Tamura, Yuichi/0000-0002-4437-8019				Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Cavagna L, 2010, J RHEUMATOL, V37, P2064, DOI 10.3899/jrheum.090997; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Fisher MR, 2006, ARTHRITIS RHEUM-US, V54, P3043, DOI 10.1002/art.22069; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Hinchcliff M, 2011, J RHEUMATOL, V38, P2172, DOI 10.3899/jrheum.101243; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Ishihara T, 2011, J AM COLL CARDIOL, V57, P1712, DOI 10.1016/j.jacc.2010.10.058; Launay D, 2007, J RHEUMATOL, V34, P1005; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsubara J, 2011, J AM COLL CARDIOL, V57, P861, DOI 10.1016/j.jacc.2010.10.018; Mukerjee D, 2004, RHEUMATOLOGY, V43, P461, DOI 10.1093/rheumatology/keh067; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Nicolls MR, 2005, EUR RESPIR J, V26, P1110, DOI 10.1183/09031936.05.00045705; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Pendergrass SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012106; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Schreiber BE, 2011, ARTHRITIS RHEUM-US, V63, P3531, DOI 10.1002/art.30535; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Williams MH, 2006, EUR HEART J, V27, P1485, DOI 10.1093/eurheartj/ehi891; Yamasaki K, 2009, CLIN CHEM LAB MED, V47, P471, DOI 10.1515/CCLM.2009.110	30	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45834	10.1371/journal.pone.0045834	http://dx.doi.org/10.1371/journal.pone.0045834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029266	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800103
J	Albrecht, M; Arnhold, M; Lingner, S; Mahapatra, S; Bruder, D; Hansen, G; Dittrich, AM				Albrecht, Melanie; Arnhold, Markus; Lingner, Sandra; Mahapatra, Subhashree; Bruder, Dunja; Hansen, Gesine; Dittrich, Anna-Maria			IL-4 Attenuates Pulmonary Epithelial Cell-Mediated Suppression of T Cell Priming	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GITR LIGAND; CYTOKINES; INDUCE; EXPRESSION; ACTIVATION; ANTIGEN; CHEMOKINES; CHILDREN; IMMUNITY	We have previously shown that Th2-polarized airway inflammation facilitates sensitization towards new, protein antigens. In this context, we could demonstrate that IL-4 needs to act on cells of the hematopoetic and the structural compartment in order to facilitate sensitization towards new antigens. We thus aimed to elucidate possible mechanisms of action of IL-4 on structural cells choosing to analyze pulmonary epithelial cells as an important part of the lung's structural system. We used a co-culture system of DC- or APC-dependent in vitro priming of T cells, co-cultivated on a layer of cells of a murine pulmonary epithelial cell line (LA-4) pretreated with or without IL-4. Effects on T cell priming were analyzed via CFSE-dilution and flow cytometric assessment of activation status. Pulmonary epithelial cells suppressed T cell proliferation in vitro but this effect was attenuated by pre-treatment of the epithelial cells with IL-4. Transwell experiments suggest that epithelial-mediated suppression of T cell activation is mostly cell-contact dependent and leads to attenuation in an early naive T cell phenotype. Secretion of soluble factors like TARC, TSLP, GM-CSF and CCL20 by epithelial cells did not change after IL-4 treatment. However, analysis of co-stimulatory expression on pulmonary epithelial cells revealed that pre-treatment of epithelial cells with IL-4 changed expression GITR-L, suggesting a possible mechanism for the effects observed. Our studies provide new insight into the role of IL-4 during the early phases of pulmonary sensitization: The inhibitory activity of pulmonary epithelial cells in homeostasis is reversed in the presence of IL-4, which is secreted in the context of Th2-dominated allergic airway inflammation. This mechanism might serve to explain facilitated sensitization in the clinical context of polysensitization where due to a pre-existing sensitization increased levels of IL-4 in the airways might facilitate T cell priming towards new antigens.	[Albrecht, Melanie; Arnhold, Markus; Lingner, Sandra; Mahapatra, Subhashree; Hansen, Gesine; Dittrich, Anna-Maria] Hannover Med Sch, D-3000 Hannover, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Bruder, Dunja] Univ Magdeburg, Dept Med Microbiol, Res Grp Infect Immunol, D-39106 Magdeburg, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University	Dittrich, AM (corresponding author), Hannover Med Sch, D-3000 Hannover, Germany.	dittrich.anna-maria@mh-hannover.de	Dittrich, Anna/GRY-6738-2022; Dittrich, Anna Maria/M-5640-2013		National Institutes of Health [RO1 HL54450-09]; Deutsche Forschungsgemeinschaft [DI 1224/1-1, SFB 587, N01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (grant RO1 HL54450-09, KB) and the Deutsche Forschungsgemeinschaft (DI 1224/1-1 and SFB 587, N01, AMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne Aideen M, 2009, J Invest Dermatol, V129, P2784, DOI 10.1038/jid.2009.163; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cruickshank SM, 2004, GUT, V53, P678, DOI 10.1136/gut.2003.029967; Culley FJ, 2006, J VIROL, V80, P8151, DOI 10.1128/JVI.00496-06; Cunningham AC, 1997, IMMUNOLOGY, V91, P458, DOI 10.1046/j.1365-2567.1997.d01-2249.x; de Jong AB, 2011, PEDIAT ALLERG IMM-UK, V22, P166, DOI 10.1111/j.1399-3038.2010.00993.x; DesRoches A, 1997, J ALLERGY CLIN IMMUN, V99, P450, DOI 10.1016/S0091-6749(97)70069-1; Dittrich AM, 2008, J IMMUNOL, V181, P7307, DOI 10.4049/jimmunol.181.10.7307; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Gereke M, 2009, AM J RESP CRIT CARE, V179, P344, DOI 10.1164/rccm.200804-592OC; Heijink IH, 2007, AM J RESP CELL MOL, V36, P351, DOI 10.1165/rcmb.2006-0160OC; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kim JD, 2003, GENES IMMUN, V4, P564, DOI 10.1038/sj.gene.6364026; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Lilly CM, 1997, J CLIN INVEST, V99, P1767, DOI 10.1172/JCI119341; Lommatzsch M, 2006, J ALLERGY CLIN IMMUN, V118, P91, DOI 10.1016/j.jaci.2006.02.034; Mahesh SP, 2006, EUR J IMMUNOL, V36, P2128, DOI 10.1002/eji.200635893; Meyer-Hoffert U, 2003, INT ARCH ALLERGY IMM, V131, P264, DOI 10.1159/000072138; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Qiao JO, 2011, IMMUNOL CELL BIOL, V89, P231, DOI 10.1038/icb.2010.85; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; So T, 2006, INT J HEMATOL, V83, P1, DOI 10.1532/IJH97.05120; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stanciu LA, 2006, J INFECT DIS, V193, P404, DOI 10.1086/499275; STONER GD, 1975, CANCER RES, V35, P2177; Thorley AJ, 2005, AM J RESP CELL MOL, V32, P262, DOI 10.1165/rcmb.2004-0196OC; Wang H, 2009, THORAX, V64, P283, DOI 10.1136/thx.2007.094870; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	32	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45916	10.1371/journal.pone.0045916	http://dx.doi.org/10.1371/journal.pone.0045916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029313	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388900110
J	Wales, N; Romero-Navarro, JA; Cappellini, E; Gilbert, MTP				Wales, Nathan; Alberto Romero-Navarro, J.; Cappellini, Enrico; Gilbert, M. Thomas P.			Choosing the Best Plant for the Job: A Cost-Effective Assay to Prescreen Ancient Plant Remains Destined for Shotgun Sequencing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEANDERTHAL GENOME; LEAF DEVELOPMENT; DNA; MAIZE; PCR; CAPTURE; HISTORY; MAMMOTH; NUMBER	DNA extracted from ancient plant remains almost always contains a mixture of endogenous (that is, derived from the plant) and exogenous (derived from other sources) DNA. The exogenous 'contaminant' DNA, chiefly derived from microorganisms, presents significant problems for shotgun sequencing. In some samples, more than 90% of the recovered sequences are exogenous, providing limited data relevant to the sample. However, other samples have far less contamination and subsequently yield much more useful data via shotgun sequencing. Given the investment required for high-throughput sequencing, whenever multiple samples are available, it is most economical to sequence the least contaminated sample. We present an assay based on quantitative real-time PCR which estimates the relative amounts of fungal and bacterial DNA in a sample in comparison to the endogenous plant DNA. Given a collection of contextually-similar ancient plant samples, this low cost assay aids in selecting the best sample for shotgun sequencing.	[Wales, Nathan] Univ Connecticut, Dept Anthropol, Storrs, CT USA; [Wales, Nathan; Alberto Romero-Navarro, J.; Cappellini, Enrico; Gilbert, M. Thomas P.] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Alberto Romero-Navarro, J.] Univ Nacl Autonoma Mexico, Undergrad Program Genom Sci, Cuernavaca 62191, Morelos, Mexico	University of Connecticut; Universidad Nacional Autonoma de Mexico	Wales, N (corresponding author), Univ Connecticut, Dept Anthropol, Storrs, CT USA.	n_wales@hotmail.com	Wales, Nathan/B-4263-2015; Gilbert, Marcus TP/A-8936-2013; Cappellini, Enrico/F-9346-2013	Wales, Nathan/0000-0003-0359-8450; Gilbert, Marcus TP/0000-0002-5805-7195; Cappellini, Enrico/0000-0001-7885-7811	Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship [237227]; American-Scandinavian Foundation; University of Connecticut Open Access Author Fund; Department of Anthropology, University of Connecticut	Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship; American-Scandinavian Foundation; University of Connecticut Open Access Author Fund; Department of Anthropology, University of Connecticut	Funding came from the Danish Council for Independent Research 'Sapere Aude' grant; Danish National Research Foundation 'GeoGenetics' grant; European Union Marie Curie Intra European Fellowship [grant number 237227 allotted to E. C.]; and American-Scandinavian Foundation [dissertation fellowship for N.W.]. Funding for open access charge: University of Connecticut Open Access Author Fund and Department of Anthropology, University of Connecticut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaby R.G., 1997, ANCIENT BIOMOLECULES, V1, P119; Avila-Arcos MC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00074; Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown T. A., 1998, ANCIENT BIOMOLECULES, V2, P185; Bunning SL, 2012, J ARCHAEOL SCI, V39, P2780, DOI 10.1016/j.jas.2012.04.012; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Cappellini E, 2010, NATURWISSENSCHAFTEN, V97, P205, DOI 10.1007/s00114-009-0629-3; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cooper A, 2000, SCIENCE, V289, P1139; Delseny M, 2010, PLANT SCI, V179, P407, DOI 10.1016/j.plantsci.2010.07.019; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Knapp M, 2010, GENES-BASEL, V1, P227, DOI 10.3390/genes1020227; Kudo N, 2001, SEX PLANT REPROD, V13, P279, DOI 10.1007/s004970100066; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lutz KA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-54; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Maliga P, 2011, PLANT PHYSIOL, V155, P1501, DOI 10.1104/pp.110.170969; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, J BIOL CHEM, V264, P9709; Palmer SA, 2012, MOL BIOL EVOL, V29, P2031, DOI 10.1093/molbev/mss070; Palmer SA, 2012, ANN ANAT, V194, P146, DOI 10.1016/j.aanat.2011.03.012; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; POSSINGH.JV, 1969, PLANTA, V86, P186, DOI 10.1007/BF00379826; Pyke K, 2009, PLASTID BIOLOGY, P1, DOI 10.1017/CBO9780511626715; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schlumbaum A, 2008, VEG HIST ARCHAEOBOT, V17, P233, DOI 10.1007/s00334-007-0125-7; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shaver JM, 2006, PLANTA, V224, P72, DOI 10.1007/s00425-005-0195-7; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Smith CI, 2003, J HUM EVOL, V45, P203, DOI 10.1016/S0047-2484(03)00106-4; WAGNER A, 1994, SYST BIOL, V43, P250, DOI 10.2307/2413465; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Zoschke R, 2007, PLANT J, V50, P710, DOI 10.1111/j.1365-313X.2007.03084.x	50	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45644	10.1371/journal.pone.0045644	http://dx.doi.org/10.1371/journal.pone.0045644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029156	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900084
J	Bhattacharya, S; HuangFu, WC; Dong, G; Qian, J; Baker, DP; Karar, J; Koumenis, C; Diehl, JA; Fuchs, SY				Bhattacharya, S.; HuangFu, W-C; Dong, G.; Qian, J.; Baker, D. P.; Karar, J.; Koumenis, C.; Diehl, J. A.; Fuchs, S. Y.			Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses	ONCOGENE			English	Article						interferon; tumor microenvironment; integrated stress response; PERK; GCN2; IFNAR1	I-INTERFERON; PROTEIN-KINASE; DOWN-REGULATION; IFNAR1 CHAIN; ALPHA; HYPOXIA; PERK; PHOSPHORYLATION; DEGRADATION; CELLS	Viral and pharmacological inducers of protein kinase RNA-activated (PKR)-like ER kinase (PERK) were shown to accelerate the phosphorylation-dependent degradation of the IFNAR1 chain of the Type 1 interferon (IFN) receptor and to limit cell sensitivity to IFN. Here we report that hypoxia can elicit these effects in a PERK-dependent manner. The altered fate of IFNAR1 affected by signaling downstream of PERK depends on phosphorylation of eIF2 alpha (eukaryotic translational initiation factor 2-alpha) and ensuing activation of p38 alpha kinase. Activators of other eIF2 alpha kinases such as PKR or GCN2 (general control nonrepressed-2) are also capable of eliminating IFNAR1 and blunting IFN responses. Modulation of constitutive PKR activity in human breast cancer cells stabilizes IFNAR1 and sensitizes these cells to IFNAR1-dependent anti-tumorigenic effects. Although downregulation of IFNAR1 and impaired IFNAR1 signaling can be elicited in response to amino-acid deficit, the knockdown of GCN2 in melanoma cells reverses these phenotypes. We propose that, in cancer cells and the tumor microenvironment, activation of diverse eIF2 alpha kinases followed by IFNAR1 downregulation enables multiple cellular components of tumor tissue to evade the direct and indirect anti-tumorigenic effects of Type 1 IFN.	[Bhattacharya, S.; HuangFu, W-C; Dong, G.; Qian, J.; Fuchs, S. Y.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bhattacharya, S.; HuangFu, W-C; Dong, G.; Qian, J.; Fuchs, S. Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Baker, D. P.] Biogen Idec Inc, Cambridge, MA USA; [Karar, J.; Koumenis, C.] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Diehl, J. A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Biogen; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Fuchs, SY (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu	Koumenis, Constantinos/B-2002-2008	Koumenis, Costas/0000-0001-5945-4726	'Training in Tumor Virology' Grant [2-T32-CA-557726-06]; NIH [CA92900, CA142425, CA94214, CA104838]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA092900, R01CA142425, R01CA094214, P01CA104838] Funding Source: NIH RePORTER	'Training in Tumor Virology' Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Herlyn, R Kaufman, A Koromilas, A Nebreda, D Ron and Z Ronai for reagents, Dr Yong Zhang for technical help, and the members of Fuchs, Diehl and Koumenis labs for discussion. The support to SB from the 'Training in Tumor Virology' Grant 2-T32-CA-557726-06 is greatly appreciated. This work was supported by the NIH Grants CA92900 and CA142425 (to SYF), CA94214 (to CK), CA104838 (to JAD) and by a grant with the Pennsylvania Department of Health (to JAD, CK, and SYF). The Department specifically disclaims responsibility for any analyses, interpretation or conclusions.	Bhattacharya S, 2011, BLOOD, V118, P4179, DOI 10.1182/blood-2010-12-325373; Bhattacharya S, 2011, J BIOL CHEM, V286, P22069, DOI 10.1074/jbc.M111.238766; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Blalock WL, 2010, J CELL PHYSIOL, V223, P572, DOI 10.1002/jcp.22092; Bobrovnikova-Marjon E, 2010, ONCOGENE, V29, P3881, DOI 10.1038/onc.2010.153; Bobrovnikova-Marjon E, 2012, MOL CELL BIOL, V32, P2268, DOI 10.1128/MCB.00063-12; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Eggermont AMM, 2001, EUR J CANCER, V37, P2147, DOI 10.1016/S0959-8049(01)00272-6; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fidler IJ, 2002, DIFFERENTIATION, V70, P498, DOI 10.1046/j.1432-0436.2002.700904.x; Folkman J, 1992, Semin Cancer Biol, V3, P89; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; HuangFu WC, 2012, ONCOGENE, V31, P161, DOI 10.1038/onc.2011.221; Huangfu Wei-Chun, 2010, Genes Cancer, V1, P725, DOI 10.1177/1947601910382901; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Kim SH, 2000, ONCOGENE, V19, P3086, DOI 10.1038/sj.onc.1203632; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Li YZ, 2004, ARCH IMMUNOL THER EX, V52, P156; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu Y, 2010, NEOPLASIA, V12, P61, DOI 10.1593/neo.91354; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Noman MZ, 2011, CRIT REV IMMUNOL, V31, P357, DOI 10.1615/CritRevImmunol.v31.i5.10; Nussbaum JM, 2003, CANCER LETT, V196, P207, DOI 10.1016/S0304-3835(03)00276-3; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; PFEFFER LM, 1980, J CELL BIOL, V85, P9, DOI 10.1083/jcb.85.1.9; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Qian J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002065; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Savinova O, 1999, INT J BIOCHEM CELL B, V31, P175, DOI 10.1016/S1357-2725(98)00140-X; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Zheng H, 2011, BLOOD, V118, P4003, DOI 10.1182/blood-2011-06-359745; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	49	51	51	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4214	4221		10.1038/onc.2012.439	http://dx.doi.org/10.1038/onc.2012.439			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045272	Green Accepted			2022-12-25	WOS:000324168000003
J	Larrouy-Maumus, G; Skovierova, H; Dhouib, R; Angala, SK; Zuberogoitia, S; Pham, H; Villela, AD; Mikusova, K; Noguera, A; Gilleron, M; Valentinova, L; Kordulakova, J; Brennan, PJ; Puzo, G; Nigou, J; Jackson, M				Larrouy-Maumus, Gerald; Skovierova, Henrieta; Dhouib, Rabeb; Angala, Shiva Kumar; Zuberogoitia, Sophie; Ha Pham; Villela, Anne Drumond; Mikusova, Katarina; Noguera, Audrey; Gilleron, Martine; Valentinova, Lucia; Kordulakova, Jana; Brennan, Patrick. J.; Puzo, Germain; Nigou, Jerome; Jackson, Mary			A Small Multidrug Resistance-like Transporter Involved in the Arabinosylation of Arabinogalactan and Lipoarabinomannan in Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL 2-HYBRID SYSTEM; ESCHERICHIA-COLI; O-ANTIGEN; CELL-WALL; FUNCTIONAL-ANALYSIS; LIPID INTERMEDIATE; SHIGELLA-FLEXNERI; BIOSYNTHESIS; TUBERCULOSIS; GENE	The biosynthesis of the major cell envelope glycoconjugates of Mycobacterium tuberculosis is topologically split across the plasma membrane, yet nothing is known of the transporters required for the translocation of lipid-linked sugar donors and oligosaccharide intermediates from the cytoplasmic to the periplasmic side of the membrane in mycobacteria. One of the mechanisms used by prokaryotes to translocate lipid-linked phosphate sugars across the plasma membrane relies on translocases that share resemblance with small multidrug resistance transporters. The presence of an small multidrug resistance-like gene, Rv3789, located immediately upstream from dprE1/dprE2 responsible for the formation of decaprenyl-monophosphoryl-beta-D-arabinose (DPA) in the genome of M. tuberculosis led us to investigate its potential involvement in the formation of the major arabinosylated glycopolymers, lipoarabinomannan (LAM) and arabinogalactan (AG). Disruption of the ortholog of Rv3789 in Mycobacterium smegmatis resulted in a reduction of the arabinose content of both AG and LAM that accompanied the accumulation of DPA in the mutant cells. Interestingly, AG and LAM synthesis was restored in the mutant not only upon expression of Rv3789 but also upon that of the undecaprenyl phosphate aminoarabinose flippase arnE/F genes from Escherichia coli. A bacterial two-hybrid system further indicated that Rv3789 interacts in vivo with the galactosyltransferase that initiates the elongation of the galactan domain of AG. Biochemical and genetic evidence is thus consistent with Rv3789 belonging to an AG biosynthetic complex, where its role is to reorient DPA to the periplasm, allowing this arabinose donor to then be used in the buildup of the arabinan domains of AG and LAM.	[Larrouy-Maumus, Gerald; Zuberogoitia, Sophie; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] CNRS, Dept Mecanismes Mol Infect Mycobacteriennes, IPBS, F-31077 Toulouse, France; [Larrouy-Maumus, Gerald; Zuberogoitia, Sophie; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] Univ Toulouse 3, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Skovierova, Henrieta; Dhouib, Rabeb; Angala, Shiva Kumar; Ha Pham; Villela, Anne Drumond; Brennan, Patrick. J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Skovierova, Henrieta; Mikusova, Katarina; Valentinova, Lucia; Kordulakova, Jana] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Colorado State University; Comenius University Bratislava	Nigou, J (corresponding author), CNRS, Dept Mecanismes Mol Infect Mycobacteriennes, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	Jerome.Nigou@ipbs.fr; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Nigou, Jérôme/D-6802-2019; Jackson, Mary/D-5345-2017; Kordulakova, Jana/I-3887-2014; Mikusova, Katarina/I-3622-2014	Nigou, Jérôme/0000-0002-6233-2487; Jackson, Mary/0000-0002-9212-0258; Kordulakova, Jana/0000-0003-2834-0165; Mikusova, Katarina/0000-0002-0100-4877; Larrouy-Maumus, Gerald/0000-0001-6614-8698; GILLERON, Martine/0000-0002-2581-3302	National Institutes of Health [AI064798]; Slovak Research and Development Agency [RPEU-0012-06]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovak Research and Development Agency(Slovak Research and Development Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064798. This work was also supported by Slovak Research and Development Agency Contract RPEU-0012-06.	Alaimo C, 2006, EMBO J, V25, P967, DOI 10.1038/sj.emboj.7601024; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; De Rossi E, 1998, J BACTERIOL, V180, P6068, DOI 10.1128/JB.180.22.6068-6071.1998; Feldman MF, 1999, J BIOL CHEM, V274, P35129, DOI 10.1074/jbc.274.49.35129; Goude R, 2008, J BACTERIOL, V190, P4335, DOI 10.1128/JB.01825-07; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Hug I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000819; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Kremer L, 2001, J BIOL CHEM, V276, P26430, DOI 10.1074/jbc.M102022200; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Marolda CL, 1999, MICROBIOL-UK, V145, P2485, DOI 10.1099/00221287-145-9-2485; Marolda CL, 2004, MICROBIOL-SGM, V150, P4095, DOI 10.1099/mic.0.27456-0; Marolda CL, 2006, J BACTERIOL, V188, P5124, DOI 10.1128/JB.00461-06; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Mikusova K, 2006, J BACTERIOL, V188, P6592, DOI 10.1128/JB.00489-06; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Ninio S, 2001, J BIOL CHEM, V276, P48250, DOI 10.1074/jbc.M108231200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x; Yan AX, 2007, J BIOL CHEM, V282, P36077, DOI 10.1074/jbc.M706172200	37	18	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.400986	http://dx.doi.org/10.1074/jbc.M112.400986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038254	Green Published, hybrid			2022-12-25	WOS:000311233800061
J	Seddik, R; Jungblut, SP; Silander, OK; Rajalu, M; Fritzius, T; Besseyrias, V; Jacquier, V; Fakler, B; Gassmann, M; Bettler, B				Seddik, Riad; Jungblut, Stefan P.; Silander, Olin K.; Rajalu, Mathieu; Fritzius, Thorsten; Besseyrias, Valerie; Jacquier, Valerie; Fakler, Bernd; Gassmann, Martin; Bettler, Bernhard			Opposite Effects of KCTD Subunit Domains on GABA(B) Receptor-mediated Desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ACID(B) RECEPTORS; GIRK CURRENTS; RGS PROTEINS; K+ CHANNELS; B RECEPTOR; NEURONS; PHOSPHORYLATION; ACTIVATION; INHIBITION	GABA(B) receptors assemble from principle and auxiliary subunits. The principle subunits GABA(B1) and GABA(B2) form functional heteromeric GABA(B(1,2)) receptors that associate with homotetramers of auxiliary KCTD8, -12, -12b, or -16 (named after their K+ channel tetramerization domain) subunits. These auxiliary subunits constitute receptor subtypes with distinct functional properties. KCTD12 and -12b generate desensitizing receptor responses while KCTD8 and -16 generate largely non-desensitizing receptor responses. The structural elements of the KCTDs underlying these differences in desensitization are unknown. KCTDs are modular proteins comprising a T1 tetramerization domain, which binds to GABA(B2), and a H1 homology domain. KCTD8 and -16 contain an additional C-terminal H2 homology domain that is not sequence-related to the H1 domains. No functions are known for the H1 and H2 domains. Here we addressed which domains and sequence motifs in KCTD proteins regulate desensitization of the receptor response. We found that the H1 domains in KCTD12 and -12b mediate desensitization through a particular sequence motif, T/NFLEQ, which is not present in the H1 domains of KCTD8 and -16. In addition, the H2 domains in KCTD8 and -16 inhibit desensitization when expressed C-terminal to the H1 domains but not when expressed as a separate protein in trans. Intriguingly, the inhibitory effect of the H2 domain is sequence-independent, suggesting that the H2 domain sterically hinders desensitization by the H1 domain. Evolutionary analysis supports that KCTD12 and -12b evolved desensitizing properties by liberating their H1 domains from antagonistic H2 domains and acquisition of the T/NFLEQ motif.	[Gassmann, Martin; Bettler, Bernhard] Univ Basel, Dept Biomed, Pharmazentrum, CH-4056 Basel, Switzerland; [Silander, Olin K.] Univ Basel, Core Program Computat & Syst Biol, Biozentrum, CH-4056 Basel, Switzerland; [Fakler, Bernd] Univ Freiburg, Inst Physiol 2, D-79108 Freiburg, Germany; [Fakler, Bernd] Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany	University of Basel; University of Basel; University of Freiburg	Gassmann, M (corresponding author), Univ Basel, Dept Biomed, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	martin.gassmann@unibas.ch; bernhard.bettler@unibas.ch	bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207; Gassmann, Martin/0000-0001-6201-3032; Silander, Olin/0000-0003-4105-8316	Swiss National Science Foundation [3100A0-117816]; National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease"; European Community's Seventh Framework Programme (FP7) [201714]; Ambizione fellowship from the Swiss National Science Foundation; Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease"; European Community's Seventh Framework Programme (FP7)(European Commission); Ambizione fellowship from the Swiss National Science Foundation; Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation	This work was supported by grants from the Swiss National Science Foundation (3100A0-117816), the National Center for Competence in Research (NCCR) "Synapsy, Synaptic Bases of Mental Health Disease" (to B. B.), the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 201714 (to B. B.), an Ambizione fellowship from the Swiss National Science Foundation (to O. K. S.), and a Marie Heim-Vogtlin fellowship from the Swiss National Science Foundation (to V. J.).	Bartoi T, 2010, J BIOL CHEM, V285, P20625, DOI 10.1074/jbc.M109.049700; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Biermann B, 2010, J NEUROSCI, V30, P1385, DOI 10.1523/JNEUROSCI.3172-09.2010; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cruz HG, 2004, NAT NEUROSCI, V7, P153, DOI 10.1038/nn1181; Dittman JS, 2008, J NEUROSCI, V28, P7104, DOI 10.1523/JNEUROSCI.0378-08.2008; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kusunoki H, 1998, BIOCHEMISTRY-US, V37, P4782, DOI 10.1021/bi972756p; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Maity B, 2012, J BIOL CHEM, V287, P4972, DOI 10.1074/jbc.M111.297218; Metz M, 2011, J COMP NEUROL, V519, P1435, DOI 10.1002/cne.22610; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Mutneja M, 2005, PFLUG ARCH EUR J PHY, V450, P61, DOI 10.1007/s00424-004-1367-1; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Pennock RL, 2012, J NEUROSCI, V32, P10192, DOI 10.1523/JNEUROSCI.1227-12.2012; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultheis C, 2011, J NEUROPHYSIOL, V106, P817, DOI 10.1152/jn.00578.2010; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Sickmann T, 2003, J NEUROPHYSIOL, V90, P2494, DOI 10.1152/jn.00112.2003; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Taylor RW, 2011, J NEUROSCI, V31, P9869, DOI 10.1523/JNEUROSCI.0435-11.2011; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Wetherington JP, 2002, J PHYSIOL-LONDON, V544, P459, DOI 10.1113/jphysiol.2002.023093; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wischmeyer E, 1997, MOL CELL NEUROSCI, V9, P194, DOI 10.1006/mcne.1997.0614; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549	46	35	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.412767	http://dx.doi.org/10.1074/jbc.M112.412767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035119	Green Published, hybrid			2022-12-25	WOS:000311233800055
J	Yin, L; Fristedt, R; Herdean, A; Solymosi, K; Bertrand, M; Andersson, MX; Mamedov, F; Vener, AV; Schoefs, B; Spetea, C				Yin, Lan; Fristedt, Rikard; Herdean, Andrei; Solymosi, Katalin; Bertrand, Martine; Andersson, Mats X.; Mamedov, Fikret; Vener, Alexander V.; Schoefs, Benoit; Spetea, Cornelia			Photosystem II Function and Dynamics in Three Widely Used Arabidopsis thaliana Accessions	PLOS ONE			English	Article							REVERSIBLE PROTEIN-PHOSPHORYLATION; PHOTOSYNTHETIC MEMBRANES; CHLOROPHYLL-A; HIGHER-PLANTS; FLUORESCENCE TRANSIENT; THYLAKOID MEMBRANES; PROTEOMIC APPROACH; XANTHOPHYLL CYCLE; COMPLEXES; PIGMENTS	Columbia-0 (Col-0), Wassilewskija-4 (Ws-4), and Landsberg erecta-0 (Ler-0) are used as background lines for many public Arabidopsis mutant collections, and for investigation in laboratory conditions of plant processes, including photosynthesis and response to high-intensity light (HL). The photosystem II (PSII) complex is sensitive to HL and requires repair to sustain its function. PSII repair is a multistep process controlled by numerous factors, including protein phosphorylation and thylakoid membrane stacking. Here we have characterized the function and dynamics of PSII complex under growth-light and HL conditions. Ws-4 displayed 30% more thylakoid lipids per chlorophyll and 40% less chlorophyll per carotenoid than Col-0 and Ler-0. There were no large differences in thylakoid stacking, photoprotection and relative levels of photosynthetic complexes among the three accessions. An increased efficiency of PSII closure was found in Ws-4 following illumination with saturation flashes or continuous light. Phosphorylation of the PSII D1/D2 proteins was reduced by 50% in Ws-4 as compared to Col-0 and Ler-0. An increase in abundance of the responsible STN8 kinase in response to HL treatment was found in all three accessions, but Ws-4 displayed 50% lower levels than Col-0 and Ler-0. Despite this, the HL treatment caused in Ws-4 the lagest extent of PSII inactivation, disassembly, D1 protein degradation, and the largest decrease in the size of stacked thylakoids. The dilution of chlorophyll-protein complexes with additional lipids and carotenoids in Ws-4 may represent a mechanism to facilitate lateral protein traffic in the membrane, thus compensating for the lack of a full complement of STN8 kinase. Nevertheless, additional PSII damage occurs in Ws-4, which exceeds the D1 protein synthesis capacity, thus leading to enhanced photoinhibition. Our findings are valuable for selection of appropriate background line for PSII characterization in Arabidopsis mutants, and also provide the first insights into natural variation of PSII protein phosphorylation.	[Yin, Lan; Herdean, Andrei; Andersson, Mats X.; Spetea, Cornelia] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Fristedt, Rikard; Vener, Alexander V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Solymosi, Katalin] Eotvos Lorand Univ, Dept Plant Anat, H-1088 Budapest, Hungary; [Bertrand, Martine] Natl Inst Marine Sci & Tech, Cnam, Cherbourg Octev, France; [Mamedov, Fikret] Uppsala Univ, Dept Chem, Angstrom Lab, Uppsala, Sweden; [Schoefs, Benoit] Univ Maine, EA2160, LUNAM Univ, F-72017 Le Mans, France	University of Gothenburg; Linkoping University; Eotvos Lorand University; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Uppsala University; Le Mans Universite	Spetea, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	cornelia.spetea.wiklund@bioenv.gu.se	Schoefs, Benoit/AAE-4010-2019; Mamedov, Fikret/A-1761-2016; Herdean, Andrei/C-6093-2018; Andersson, Mats/E-7958-2010; Wiklund, Cornelia Spetea/S-3635-2019	Schoefs, Benoit/0000-0002-7804-8130; Mamedov, Fikret/0000-0002-6218-3039; Herdean, Andrei/0000-0003-2143-0213; Andersson, Mats/0000-0003-4279-6572; Solymosi, Katalin/0000-0001-5246-2547	Swedish Research Council; Swedish Research Council for Environment, Agriculture and Space Planning (Formas); French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche; University of Le Mans	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Space Planning (Formas)(Swedish Research Council Formas); French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche; University of Le Mans	This work was supported by grants from the Swedish Research Council, the Swedish Research Council for Environment, Agriculture and Space Planning (Formas), the French Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche, and University of Le Mans. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MX, 2006, PLANT J, V47, P947, DOI 10.1111/j.1365-313X.2006.02844.x; Andersson MX, 2005, J BIOL CHEM, V280, P27578, DOI 10.1074/jbc.M503273200; Armbruster U, 2011, MOL PLANT, V4, P1, DOI 10.1093/mp/ssq060; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baroli I, 2003, PLANT CELL, V15, P992, DOI 10.1105/tpc.010405; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Danielsson R, 2006, J BIOL CHEM, V281, P14241, DOI 10.1074/jbc.M600634200; Darko E, 2000, J CHROMATOGR A, V876, P111, DOI 10.1016/S0021-9673(00)00141-2; Flood PJ, 2011, TRENDS PLANT SCI, V16, P327, DOI 10.1016/j.tplants.2011.02.005; Fristedt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024565; Fristedt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010963; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Heinemeyer J, 2004, PHYTOCHEMISTRY, V65, P1683, DOI 10.1016/j.phytochem.2004.04.022; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jung HS, 2009, PLANT PHYSIOL, V150, P977, DOI 10.1104/pp.109.137828; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lichtenthaler H.K., 1983, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; MCCOURT P, 1985, PLANT PHYSIOL, V78, P853, DOI 10.1104/pp.78.4.853; Moreau RA, 2008, LIPIDS, V43, P533, DOI 10.1007/s11745-008-3181-6; Moulin P., 2010, HDB PLANT CROP STRES, P407; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Noren H, 1999, BIOSCIENCE REP, V19, P499, DOI 10.1023/A:1020280710067; Pesaresi P, 2011, BBA-BIOENERGETICS, V1807, P887, DOI 10.1016/j.bbabio.2010.08.002; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Rokka A, 2000, PLANT PHYSIOL, V123, P1525, DOI 10.1104/pp.123.4.1525; Ruban AV, 2010, ARCH BIOCHEM BIOPHYS, V504, P78, DOI 10.1016/j.abb.2010.06.034; Schoefs B, 2004, J CHROMATOGR A, V1054, P217, DOI 10.1016/j.chroma.2004.05.105; Schoefs B., 1996, AM BIOTECHNOL LAB, V14, P18; Schwarte S, 2011, MOL BIOL EVOL, V28, P1861, DOI 10.1093/molbev/msr008; Sirpio S, 2011, METHODS MOL BIOL, V775, P19, DOI 10.1007/978-1-61779-237-3_2; Solymosi K, 2012, PLANTA, V235, P1035, DOI 10.1007/s00425-011-1559-9; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; Tsimilli-Michael M, 2000, APPL SOIL ECOL, V15, P169, DOI 10.1016/S0929-1393(00)00093-7; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Welti R, 2003, ANAL BIOCHEM, V314, P149, DOI 10.1016/S0003-2697(02)00623-1; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Willig A, 2011, PLANT PHYSIOL, V157, P2102, DOI 10.1104/pp.111.187328; Yin L, 2010, PLANT PHYSIOL, V153, P666, DOI 10.1104/pp.110.155804	51	23	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46206	10.1371/journal.pone.0046206	http://dx.doi.org/10.1371/journal.pone.0046206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029436	Green Published, gold			2022-12-25	WOS:000309973900107
J	Yang, SM; Chen, W; Guo, WW; Jia, SP; Sun, JH; Liu, HZ; Young, WY; He, DZZ				Yang, Shi-Ming; Chen, Wei; Guo, Wei-Wei; Jia, Shuping; Sun, Jian-He; Liu, Hui-Zhan; Young, Wie-Yen; He, David Z. Z.			Regeneration of Stereocilia of Hair Cells by Forced Atoh1 Expression in the Adult Mammalian Cochlea	PLOS ONE			English	Article							INDUCED HEARING-LOSS; IMPULSE NOISE; MECHANICAL DAMAGE; NERVOUS-SYSTEM; PRONEURAL GENE; GUINEA-PIG; MYOSIN-XVA; IN-VIVO; MATH1; RECOVERY	The hallmark of mechanosensory hair cells is the stereocilia, where mechanical stimuli are converted into electrical signals. These delicate stereocilia are susceptible to acoustic trauma and ototoxic drugs. While hair cells in lower vertebrates and the mammalian vestibular system can spontaneously regenerate lost stereocilia, mammalian cochlear hair cells no longer retain this capability. We explored the possibility of regenerating stereocilia in the noise-deafened guinea pig cochlea by cochlear inoculation of a viral vector carrying Atoh1, a gene critical for hair cell differentiation. Exposure to simulated gunfire resulted in a 60-70 dB hearing loss and extensive damage and loss of stereocilia bundles of both inner and outer hair cells along the entire cochlear length. However, most injured hair cells remained in the organ of Corti for up to 10 days after the trauma. A viral vector carrying an EGFP-labeled Atoh1 gene was inoculated into the cochlea through the round window on the seventh day after noise exposure. Auditory brainstem response measured one month after inoculation showed that hearing thresholds were substantially improved. Scanning electron microscopy revealed that the damaged/lost stereocilia bundles were repaired or regenerated after Atoh1 treatment, suggesting that Atoh1 was able to induce repair/regeneration of the damaged or lost stereocilia. Therefore, our studies revealed a new role of Atoh1 as a gene critical for promoting repair/regeneration of stereocilia and maintaining injured hair cells in the adult mammal cochlea. Atoh1-based gene therapy, therefore, has the potential to treat noise-induced hearing loss if the treatment is carried out before hair cells die.	[Yang, Shi-Ming; Guo, Wei-Wei; Sun, Jian-He; Young, Wie-Yen] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China; [Chen, Wei] PLA AF Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Jia, Shuping; Liu, Hui-Zhan; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Chinese People's Liberation Army General Hospital; Creighton University	Yang, SM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China.	yangsm301@263.net; hed@creighton.edu	, sunjhe/S-5843-2019	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	Major State Basic Research Development Program of China (973 Program) [2011CBA01000]; National Basic Research Program of China (973 Program) [2012CB967900]; National Hi-Tech Research and Development Program of China (863 Program) [2007AA02Z150]; National Natural Science Foundation of China [30871398, 30730040]; National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) [R21 DC 009908, R01 DC 004696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009908, R01DC004696] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program #2011CBA01000), the National Basic Research Program of China (973 Program #2012CB967900), National Hi-Tech Research and Development Program of China (863 Program #2007AA02Z150), the National Natural Science Foundation of China (#30871398, 30730040) to SMY, and by National Institutes of Health (NIH) grants R21 DC 009908 and R01 DC 004696 to DH from the National Institute on Deafness and Other Communication Disorders (NIDCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; CHEATHAM MA, 1993, HEARING RES, V68, P107, DOI 10.1016/0378-5955(93)90069-D; CHEATHAM MA, 1993, PROG BRAIN RES, V97, P13; Chen P, 2002, DEVELOPMENT, V129, P2495; DALLOS P, 1992, J NEUROSCI, V12, P4575; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; HAMERNIK RP, 1988, J ACOUST SOC AM, V84, P941, DOI 10.1121/1.396663; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; HAMERNIK RP, 1987, J ACOUST SOC AM, V81, P1118, DOI 10.1121/1.394632; Harding GW, 2004, J ACOUST SOC AM, V115, P2207, DOI 10.1121/1.1689961; Helms AW, 1998, DEVELOPMENT, V125, P919; HENDERSON D, 1986, J ACOUST SOC AM, V80, P569, DOI 10.1121/1.394052; Hu BH, 2006, HEARING RES, V211, P16, DOI 10.1016/j.heares.2005.08.006; Hu BH, 2008, HEARING RES, V236, P11, DOI 10.1016/j.heares.2007.11.002; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liang Z, 1992, NOISE INDUCED HEARIN, P325; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Manuela M, 2008, J NEUROSCI, V28, P4918; Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; PICKLES JO, 1987, HEARING RES, V25, P173, DOI 10.1016/0378-5955(87)90089-X; Price GR, 2007, HEARING RES, V226, P5, DOI 10.1016/j.heares.2006.08.005; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 1999, J NEUROSCI, V19, P2161	49	20	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46355	10.1371/journal.pone.0046355	http://dx.doi.org/10.1371/journal.pone.0046355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029493	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500095
J	Behrens, MD; Lafferty, KD				Behrens, Michael D.; Lafferty, Kevin D.			Geographic Variation in the Diet of Opaleye (Girella nigricans) with Respect to Temperature and Habitat	PLOS ONE			English	Article							MARINE HERBIVOROUS FISHES; STABLE-ISOTOPES; NITROGEN ISOTOPES; ONTOGENIC CHANGES; REEF COMMUNITIES; TROPHIC POSITION; STOMACH CONTENTS; FOOD SELECTION; ANIMALS; DELTA-N-15	We studied diet variation in an omnivorous fish across its range, which allowed us to test predictions about the effect of ocean temperature and habitat on herbivory. Throughout most of its geographic range, from Southern California to central Baja California, the opaleye (Girella nigricans) fed primarily on red and green algae, but there was significant variation in the amount of algal material in the diet among sites. The proportion of algal material in the diet was related to habitat, with algae making up a larger proportion of a fish's diet in algal-dominated habitats than in urchin barrens. Independent of habitat, the proportion of algal material in the diet increased with environmental temperature. Analyses of stable isotopes revealed similar changes in trophic position and confirmed that these associations with diet persisted over relatively long time scales. The shift to a more herbivorous diet at warmer temperatures is in agreement with past laboratory studies on this species that show a diet-dependent change in performance with temperature and can indicate a diet shift across the species' geographic range to meet its physiological demands. A possible plastic response to herbivory was a longer gut relative to body size. The results of this study are consistent with past findings that associate temperature with increases in the relative diversity of herbivorous fishes in tropical parts of the ocean.	[Lafferty, Kevin D.] Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA; [Behrens, Michael D.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Lafferty, KD (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, US Geol Survey, Western Ecol Res Ctr, Santa Barbara, CA 93106 USA.	kevin_lafferty@lifesci.ucsb.edu	Lafferty, Kevin D./B-3888-2009		United States Geological Survey; David and Lucille Packard Foundation; Andrew W. Mellon Foundation; UC MEXUS (The University of California Institute for Mexico and the United States); UC Marine Council; Fletcher Jones Foundation	United States Geological Survey(United States Geological Survey); David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Andrew W. Mellon Foundation; UC MEXUS (The University of California Institute for Mexico and the United States); UC Marine Council; Fletcher Jones Foundation	This work was supported by the United States Geological Survey, the David and Lucille Packard Foundation, the Andrew W. Mellon Foundation, and UC MEXUS (The University of California Institute for Mexico and the United States). MDB was supported by UC Marine Council and Fletcher Jones Foundation Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; Arrington DA, 2002, ECOLOGY, V83, P2145, DOI 10.1890/0012-9658(2002)083[2145:HODFRO]2.0.CO;2; BARRY JP, 1993, ENVIRON BIOL FISH, V37, P75, DOI 10.1007/BF00000715; Behrens M. D., 2005, THESIS U CALIFORNIA; Behrens MD, 2004, MAR ECOL PROG SER, V281, P307; Behrens MD, 2004, MAR ECOL PROG SER, V279, P129, DOI 10.3354/meps279129; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; BENAVIDES AG, 1994, FUNCT ECOL, V8, P46, DOI 10.2307/2390110; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; DEMARTINI EE, 1981, COPEIA, P785; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Floeter SR, 2005, MAR BIOL, V147, P1435, DOI 10.1007/s00227-005-0027-0; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gonzalez-Bergonzoni I, 2012, ECOSYSTEMS, V15, P492, DOI 10.1007/s10021-012-9524-4; HALLACHER LE, 1985, ENVIRON BIOL FISH, V12, P91, DOI 10.1007/BF00002762; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; HORN MH, 1990, J FISH BIOL, V37, P237, DOI 10.1111/j.1095-8649.1990.tb05855.x; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Lapointe BE, 2010, HARMFUL ALGAE, V9, P1, DOI 10.1016/j.hal.2009.06.001; Lin HJ, 2007, ESTUAR COAST SHELF S, V73, P527, DOI 10.1016/j.ecss.2007.02.013; LOBEL PS, 1981, J FISH BIOL, V19, P365, DOI 10.1111/j.1095-8649.1981.tb05842.x; Lobel PS., 1980, B MAR SCI, V30, P273; Love M, 1996, PROBABLY MORE YOU WA; MITCHELL DF, 1953, AM MIDL NAT, V49, P862, DOI 10.2307/2485213; Mountfort DO, 2002, APPL ENVIRON MICROB, V68, P1374, DOI 10.1128/AEM.68.3.1374-1380.2002; MULLIN MM, 1984, LIMNOL OCEANOGR, V29, P1267, DOI 10.4319/lo.1984.29.6.1267; Munoz AA, 2000, J FISH BIOL, V56, P986, DOI 10.1006/jfbi.1999.1224; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; OWENS NJP, 1987, ADV MAR BIOL, V24, P389; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Raubenheimer D, 2005, ECOLOGY, V86, P2601, DOI 10.1890/04-1472; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; ROBISON BH, 1984, MAR BIOL, V84, P119, DOI 10.1007/BF00392995; *SAS I INC, 2002, JMP STAT GRAPH GUID; Sotka EE, 2009, BIOL BULL-US, V216, P75; TARGETT TE, 1990, MAR ECOL PROG SER, V66, P13, DOI 10.3354/meps066013; Ventura M, 2008, FRESHWATER BIOL, V53, P1434, DOI 10.1111/j.1365-2427.2008.01975.x; Wagner CE, 2009, FUNCT ECOL, V23, P1122, DOI 10.1111/j.1365-2435.2009.01589.x; WILLIAMS GEORGE C, 1955, CALIFORNIA FISH AND GAME, V41, P203; Wolesensky W, 2005, ECOL MODEL, V188, P358, DOI 10.1016/j.ecolmodel.2005.02.017; Zuanon JAS, 2007, COMP BIOCHEM PHYS A, V147, P761, DOI 10.1016/j.cbpa.2006.08.038	47	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45901	10.1371/journal.pone.0045901	http://dx.doi.org/10.1371/journal.pone.0045901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029302	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800115
J	Card, CM; Rutherford, WJ; Ramdahin, S; Yao, XJ; Kimani, M; Wachihi, C; Kimani, J; Plummer, FA; Ball, TB; Fowke, KR				Card, Catherine M.; Rutherford, W. John; Ramdahin, Suzie; Yao, Xiaojian; Kimani, Makobu; Wachihi, Charles; Kimani, Joshua; Plummer, Francis A.; Ball, T. Blake; Fowke, Keith R.			Reduced Cellular Susceptibility to In Vitro HIV Infection Is Associated with CD4+T Cell Quiescence	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; IMMUNE ACTIVATION; SEX WORKERS; TRANSMISSION; REPLICATION; EXPRESSION; PROPAGATION; PROGRESSION; LYMPHOCYTES	Background: HIV preferentially establishes productive infection in activated T cells. Since proportions of activated CD4+ T cells vary between individuals, this study aimed to determine if individuals with a greater proportion of activated CD4+ T cells would be more susceptible to in vitro HIV infection. Methodology/Principal Findings: Unstimulated peripheral blood mononuclear cells (PBMC) from various donors were inoculated with HIVML1956 in vitro. HIV replication was evaluated by HIV p24 ELISA of culture supernatants and intracellular staining for HIV p24, which was detected by flow cytometry. Baseline T cell phenotypes and infected cell phenotypes were also evaluated by flow cytometry. Ex vivo phenotyping at the time of blood draw showed that elevated T cell activation and reduced Tregs were associated with increased cellular susceptibility to in vitro infection. Furthermore, the infected CD4+ T cell population was enriched for activated cells. Conclusion/Significance: These data suggest that CD4+ T cell quiescence provides an environment less conducive to the establishment of HIV infection by limiting the pool of activated target cells.	[Card, Catherine M.; Rutherford, W. John; Ramdahin, Suzie; Yao, Xiaojian; Plummer, Francis A.; Ball, T. Blake; Fowke, Keith R.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kimani, Makobu; Wachihi, Charles; Kimani, Joshua; Ball, T. Blake; Fowke, Keith R.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Fowke, Keith R.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Plummer, Francis A.; Ball, T. Blake] Publ Hlth Agcy Canada, Winnipeg, MB, Canada	University of Manitoba; University of Nairobi; University of Manitoba; Public Health Agency of Canada	Fowke, KR (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada.	fowkekr@cc.umanitoba.ca	Kimani, Makobu/V-6369-2019; Card, Catherine/AFK-2442-2022	Kimani, Makobu/0000-0001-9275-4018; Fowke, Keith/0000-0001-8227-6649; Card, Catherine/0000-0002-2561-9649; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [MOP-86721]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR; www.cihr-irsc.gc.ca), grant #MOP-86721. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Banas B, 2001, FEBS LETT, V509, P207, DOI 10.1016/S0014-5793(01)03182-9; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Camara M, 2010, J INFECT DIS, V201, P835, DOI 10.1086/651000; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Land AM, 2008, AIDS RES HUM RETROV, V24, P865, DOI 10.1089/aid.2007.0200; Lane Jr, 1999, METH MOLEC MED, V17, P3, DOI 10.1385/0-89603-369-4:3; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; McKinnon LR, 2012, CURR OPIN HIV AIDS, V7, P195, DOI 10.1097/COH.0b013e3283504941; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moreno-Fernandez ME, 2011, BLOOD, V117, P5372, DOI 10.1182/blood-2010-12-323162; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Moreno-Fernandez ME, 2011, AIDS RES HUMAN RETRO; Navarro J, 1998, J VIROL, V72, P4712, DOI 10.1128/JVI.72.6.4712-4720.1998; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; Sun Y, 2000, J IMMUNOL, V165, P1755, DOI 10.4049/jimmunol.165.4.1755; TANG SB, 1995, J VIROL, V69, P5659, DOI 10.1128/JVI.69.9.5659-5665.1995; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	39	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45911	10.1371/journal.pone.0045911	http://dx.doi.org/10.1371/journal.pone.0045911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029309	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800118
J	Kudryashova, E; Kalda, C; Kudryashov, DS				Kudryashova, Elena; Kalda, Caitlin; Kudryashov, Dmitri S.			Glutamyl Phosphate Is an Activated Intermediate in Actin Crosslinking by Actin Crosslinking Domain (ACD) Toxin	PLOS ONE			English	Article							CHOLERAE RTX TOXIN; VI-SECRETION-SYSTEM; ACCESSORY TOXINS; ELECTRON CRYOMICROSCOPY; EL-TOR; FILAMENTS; POLYMERIZATION; COLONIZATION; SYNTHETASES; NUCLEOTIDE	Actin Crosslinking Domain (ACD) is produced by several life-threatening Gram-negative pathogenic bacteria as part of larger toxins and delivered into the cytoplasm of eukaryotic host cells via Type I or Type VI secretion systems. Upon delivery, ACD disrupts the actin cytoskeleton by catalyzing intermolecular amide bond formation between E270 and K50 residues of actin, leading to the formation of polymerization-deficient actin oligomers. Ultimately, accumulation of the crosslinked oligomers results in structural and functional failure of the actin cytoskeleton in affected cells. In the present work, we advanced in our understanding of the ACD catalytic mechanism by discovering that the enzyme transfers the gamma-phosphoryl group of ATP to the E270 actin residue, resulting in the formation of an activated acyl phosphate intermediate. This intermediate is further hydrolyzed and the energy of hydrolysis is utilized for the formation of the amide bond between actin subunits. We also determined the pH optimum for the reaction and the kinetic parameters of ACD catalysis for its substrates, ATP and actin. ACD showed sigmoidal, non-Michaelis-Menten kinetics for actin (K-0.5 = 30 mu M) reflecting involvement of two actin molecules in a single crosslinking event. We established that ACD can also utilize Mg2+-GTP to support crosslinking, but the kinetic parameters (K-M = 8 mu M and 50 mu M for ATP and GTP, respectively) suggest that ATP is the primary substrate of ACD in vivo. The optimal pH for ACD activity was in the range of 7.0-9.0. The elucidated kinetic mechanism of ACD toxicity adds to understanding of complex network of host-pathogen interactions.	[Kudryashova, Elena; Kalda, Caitlin; Kudryashov, Dmitri S.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kudryashov, DS (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	kudryashov.1@osu.edu	Kudryashova, Elena/K-8223-2019; Kudryashova, Elena/ADL-6316-2022; Kudryashov, Dmitri/P-9004-2014	Kudryashova, Elena/0000-0002-1646-1229; Kudryashova, Elena/0000-0002-1646-1229; Kudryashov, Dmitri/0000-0003-1782-3305				Bisswanger H, 2004, PRACTICAL ENZYMOLOGY, Vxv; Carlier M F, 1990, Adv Biophys, V26, P51, DOI 10.1016/0065-227X(90)90007-G; Cong Y, 2008, J MOL BIOL, V375, P331, DOI 10.1016/j.jmb.2007.10.027; Cordero CL, 2006, J BIOL CHEM, V281, P32366, DOI 10.1074/jbc.M605275200; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Geissler B, 2009, MOL MICROBIOL, V73, P858, DOI 10.1111/j.1365-2958.2009.06810.x; Goldsmith SC, 2001, J BIOMOL STRUCT DYN, V19, P405, DOI 10.1080/07391102.2001.10506750; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; IYENGAR MR, 1964, BIOCHIM BIOPHYS ACTA, V86, P543, DOI 10.1016/0304-4165(64)90094-7; Kim E, 2000, BIOPHYS CHEM, V86, P191, DOI 10.1016/S0301-4622(00)00143-5; Kudryashov DS, 2008, J BIOL CHEM, V283, P445, DOI 10.1074/jbc.M703910200; Kudryashov DS, 2008, P NATL ACAD SCI USA, V105, P18537, DOI 10.1073/pnas.0808082105; Kudryashov DS, 2003, BIOPHYS J, V85, P2466, DOI 10.1016/S0006-3495(03)74669-4; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; LIPMANN F, 1945, J BIOL CHEM, V161, P415; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007352; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sheahan KL, 2004, P NATL ACAD SCI USA, V101, P9798, DOI 10.1073/pnas.0401104101; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; TSUDA Y, 1971, BIOCHEMISTRY-US, V10, P3186, DOI 10.1021/bi00793a004; WEDLER FC, 1972, J BIOL CHEM, V247, P993; WEINSTOCK JV, 1984, CELL IMMUNOL, V89, P46, DOI 10.1016/0008-8749(84)90196-5; WEISBROD RE, 1973, J BIOL CHEM, V248, P3997; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200	38	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45721	10.1371/journal.pone.0045721	http://dx.doi.org/10.1371/journal.pone.0045721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029200	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800083
J	Piotrzkowski, N; Schillberg, S; Rasche, S				Piotrzkowski, Natalia; Schillberg, Stefan; Rasche, Stefan			Tackling Heterogeneity: A Leaf Disc-Based Assay for the High-Throughput Screening of Transient Gene Expression in Tobacco	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; PROTEIN-PRODUCTION; VIRULENCE GENES; OPTIMIZATION; SPECIFICITY; ATTACHMENT; SYSTEM; PLANTS; TRANSFORMATION; PURIFICATION	Transient Agrobacterium-mediated gene expression assays for Nicotiana tabacum (N. tabacum) are frequently used because they facilitate the comparison of multiple expression constructs regarding their capacity for maximum recombinant protein production. However, for three model proteins, we found that recombinant protein accumulation (rpa) was significantly influenced by leaf age and leaf position effects. The ratio between the highest and lowest amount of protein accumulation (max/min ratio) was found to be as high as 11. Therefore, construct-based impacts on the rpa level that are less than 11-fold will be masked by background noise. To address this problem, we developed a leaf disc-based screening assay and infiltration device that allows the rpa level in a whole tobacco plant to be reliably and reproducibly determined. The prototype of the leaf disc infiltration device allows 14 Agrobacterium-mediated infiltration events to be conducted in parallel. As shown for three model proteins, the average max/min rpa ratio was reduced to 1.4 using this method, which allows for a sensitive comparison of different genetic elements affecting recombinant protein expression.	[Piotrzkowski, Natalia; Schillberg, Stefan; Rasche, Stefan] Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany	Fraunhofer Gesellschaft	Rasche, S (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Aachen, Germany.	stefan.rasche@ime.fraunhofer.de	Schillberg, Stefan/I-5449-2013; Schillberg, Stefan/K-4211-2019	Schillberg, Stefan/0000-0002-1896-4575; Rasche, Stefan/0000-0002-3489-9881	founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" of the German Federal Ministry of Education and Research [PLANT-KBBE, FKZ0315456B]	founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" of the German Federal Ministry of Education and Research	This work was supported by the founding initiative "Transnational PLant Alliance for Novel Technologies - towards implementing the Knowledge-Based Bio-Economy in Europe" (PLANT-KBBE, FKZ0315456B) of the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GC, 1993, PLANT CELL, V5, P603, DOI 10.1105/tpc.5.6.603; ANKENBAUER RG, 1990, J BACTERIOL, V172, P6442, DOI 10.1128/jb.172.11.6442-6446.1990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; Chiera JM, 2008, TRANSGENIC RES, V17, P1143, DOI 10.1007/s11248-008-9192-5; Coelho PS, 2009, EUR J PLANT PATHOL, V125, P179, DOI 10.1007/s10658-009-9469-4; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; De Amicis F, 2007, TRANSGENIC RES, V16, P731, DOI 10.1007/s11248-006-9063-x; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Giddings G, 2001, CURR OPIN BIOTECH, V12, P450, DOI 10.1016/S0958-1669(00)00244-5; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Kapila J, 1997, PLANT SCI, V122, P101, DOI 10.1016/S0168-9452(96)04541-4; Korban SS, 2002, IN VITRO CELL DEV-PL, V38, P231, DOI 10.1079/IVP2002292; LEPETIT M, 1991, PLANT CELL REP, V10, P401, DOI 10.1007/BF00232611; Ma JKC, 2005, EMBO REP, V6, P593, DOI 10.1038/sj.embor.7400470; Matoba N, 2011, METHODS MOL BIOL, V701, P199, DOI 10.1007/978-1-61737-957-4_11; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MELCHERS LS, 1989, MOL MICROBIOL, V3, P969, DOI 10.1111/j.1365-2958.1989.tb00246.x; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Molina A., 2009, Open Biotechnology Journal, V3, P67, DOI 10.2174/1874070700903010067; Petersen A, 1997, ELECTROPHORESIS, V18, P819, DOI 10.1002/elps.1150180528; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Rasche S., 2011, Open Biotechnology Journal, V5, P1; Raven N, 2011, SINGLE USE TECHNOLOG, P252; SANGWAN RS, 1992, PLANTA, V188, P439, DOI 10.1007/BF00192812; Sheludko YV, 2007, BIOTECHNOL BIOENG, V96, P608, DOI 10.1002/bit.21075; SPENCER PA, 1988, PHYTOCHEMISTRY, V27, P2781, DOI 10.1016/0031-9422(88)80663-0; Streatfield SJ, 2007, PLANT BIOTECHNOL J, V5, P2, DOI 10.1111/j.1467-7652.2006.00216.x; SWART S, 1994, PLANT MOL BIOL, V24, P171, DOI 10.1007/BF00040583; Teli NP, 2004, PLANT CELL TISS ORG, V79, P125, DOI 10.1007/s11240-004-0653-0; Villemont E, 1997, PLANTA, V201, P160, DOI 10.1007/BF01007700; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WAGNER VT, 1992, J BACTERIOL, V174, P5999, DOI 10.1128/jb.174.18.5999-6003.1992; Wong C, 2001, CANCER IMMUNOL IMMUN, V50, P93, DOI 10.1007/s002620100174; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yang YN, 2000, PLANT J, V22, P543, DOI 10.1046/j.1365-313x.2000.00760.x; Zhou FY, 2006, APPL MICROBIOL BIOT, V72, P756, DOI 10.1007/s00253-005-0305-2	40	15	16	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45803	10.1371/journal.pone.0045803	http://dx.doi.org/10.1371/journal.pone.0045803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029251	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800100
J	Burgess, A; Lorca, T; Castro, A				Burgess, Andrew; Lorca, Thierry; Castro, Anna			Quantitative Live Imaging of Endogenous DNA Replication in Mammalian Cells	PLOS ONE			English	Article							FACTORIES; CHECKPOINT; DYNAMICS; PCNA	Historically, the analysis of DNA replication in mammalian tissue culture cells has been limited to static time points, and the use of nucleoside analogues to pulse-label replicating DNA. Here we characterize for the first time a novel Chromobody cell line that specifically labels endogenous PCNA. By combining this with high-resolution confocal time-lapse microscopy, and with a simplified analysis workflow, we were able to produce highly detailed, reproducible, quantitative 4D data on endogenous DNA replication. The increased resolution allowed accurate classification and segregation of S phase into early-, mid-, and late-stages based on the unique subcellular localization of endogenous PCNA. Surprisingly, this localization was slightly but significantly different from previous studies, which utilized over-expressed GFP tagged forms of PCNA. Finally, low dose exposure to Hydroxyurea caused the loss of mid- and late-S phase localization patterns of endogenous PCNA, despite cells eventually completing S phase. Taken together, these results indicate that this simplified method can be used to accurately identify and quantify DNA replication under multiple and various experimental conditions.	[Lorca, Thierry; Castro, Anna] Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France; [Lorca, Thierry; Castro, Anna] Univ Montpellier I, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France; [Burgess, Andrew] Univ New S Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Burgess, Andrew] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Program, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of New South Wales Sydney; Garvan Institute of Medical Research	Castro, A (corresponding author), Univ Montpellier 2, Ctr Rech Biochim Macromol, IFR 122, CNRS UMR 5237, Montpellier, France.	a.burgess@garvan.org.au	Burgess, Andrew/C-7952-2009; Burgess, Andrew/H-3339-2019; CASTRO, ANNA/F-4350-2010	Burgess, Andrew/0000-0003-4536-9226; Burgess, Andrew/0000-0003-4536-9226; CASTRO, ANNA/0000-0002-3655-1352; Lorca, Thierry/0000-0003-2007-8924	Ligue Nationale Contre le Cancer (Equipe Labellisee); Agence Nationale de la Recherche (ANR) [2010 BLAN 120701]; Cancer Institute NSW [10/FRL/3-02]	Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Cancer Institute NSW	This work was supported by the Ligue Nationale Contre le Cancer (Equipe Labellisee), and Agence Nationale de la Recherche (ANR) 2010 BLAN 120701, and a Cancer Institute NSW Future Research Leaders Fellowship [10/FRL/3-02][AB]. Funding for open access charge: [Cancer Institute NSW, 10/FRL/3-02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp901; Burgess A, 2008, ONCOGENE, V27, P5554, DOI 10.1038/onc.2008.167; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Ersoy I, 2009, LECT NOTES COMPUT SC, V5762, P617, DOI 10.1007/978-3-642-04271-3_75; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Karnani N, 2011, GENE DEV, V25, P621, DOI 10.1101/gad.2029711; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Muyldermans S, 2001, J Biotechnol, V74, P277; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Nakanishi M, 2010, CHROMOSOME RES, V18, P103, DOI 10.1007/s10577-009-9086-2; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sadoni N, 2004, J CELL SCI, V117, P5353, DOI 10.1242/jcs.01412; Schmidthals K, 2010, ANAL BIOANAL CHEM, V397, P3203, DOI 10.1007/s00216-010-3657-0; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schornack S, 2009, PLANT J, V60, P744, DOI 10.1111/j.1365-313X.2009.03982.x; Shermoen AW, 2010, CURR BIOL, V20, P2067, DOI 10.1016/j.cub.2010.10.021; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; vonMikecz A., 2009, OPEN BIOL J, P193	25	48	49	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45726	10.1371/journal.pone.0045726	http://dx.doi.org/10.1371/journal.pone.0045726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029203	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388900095
J	Choi, JS; Shin, YC; Jung, WH; Jang, JH; Kang, DH; Choi, CH; Choi, SW; Lee, JY; Hwang, JY; Kwon, JS				Choi, Jung-Seok; Shin, Young-Chul; Jung, Wi Hoon; Jang, Joon Hwan; Kang, Do-Hyung; Choi, Chi-Hoon; Choi, Sam-Wook; Lee, Jun-Young; Hwang, Jae Yeon; Kwon, Jun Soo			Altered Brain Activity during Reward Anticipation in Pathological Gambling and Obsessive-Compulsive Disorder	PLOS ONE			English	Article							HUMAN VENTRAL STRIATUM; EVENT-RELATED FMRI; DOPAMINE RELEASE; PREFRONTAL CORTEX; SEX-DIFFERENCES; AMPHETAMINE; ACTIVATION; ADDICTION; RESPONSES; SENSITIVITY	Background: Pathological gambling (PG) and obsessive-compulsive disorder (OCD) are conceptualized as a behavioral addiction, with a dependency on repetitive gambling behavior and rewarding effects following compulsive behavior, respectively. However, no neuroimaging studies to date have examined reward circuitry during the anticipation phase of reward in PG compared with in OCD while considering repetitive gambling and compulsion as addictive behaviors. Methods/Principal Findings: To elucidate the neural activities specific to the anticipation phase of reward, we performed event-related functional magnetic resonance imaging (fMRI) in young adults with PG and compared them with those in patients with OCD and healthy controls. Fifteen male patients with PG, 13 patients with OCD, and 15 healthy controls, group-matched for age, gender, and IQ, participated in a monetary incentive delay task during fMRI scanning. Neural activation in the ventromedial caudate nucleus during anticipation of both gain and loss decreased in patients with PG compared with that in patients with OCD and healthy controls. Additionally, reduced activation in the anterior insula during anticipation of loss was observed in patients with PG compared with that in patients with OCD which was intermediate between that in OCD and healthy controls (healthy controls < PG < OCD), and a significant positive correlation between activity in the anterior insula and South Oaks Gambling Screen score was found in patients with PG. Conclusions: Decreased neural activity in the ventromedial caudate nucleus during anticipation may be a specific neurobiological feature for the pathophysiology of PG, distinguishing it from OCD and healthy controls. Correlation of anterior insular activity during loss anticipation with PG symptoms suggests that patients with PG fit the features of OCD associated with harm avoidance as PG symptoms deteriorate. Our findings have identified functional disparities and similarities between patients with PG and OCD related to the neural responses associated with reward anticipation.	[Choi, Jung-Seok; Jang, Joon Hwan; Kang, Do-Hyung; Lee, Jun-Young; Kwon, Jun Soo] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Choi, Jung-Seok; Lee, Jun-Young; Hwang, Jae Yeon] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Shin, Young-Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Psychiat, Seoul, South Korea; [Jung, Wi Hoon; Kwon, Jun Soo] SNU MRC, Inst Human Behav Med, Seoul, South Korea; [Choi, Chi-Hoon] Natl Med Ctr, Dept Radiol, Seoul, South Korea; [Choi, Sam-Wook] Eulji Univ, Dept Addict Rehabil & Social Welf, Songnam, South Korea; [Hwang, Jae Yeon; Kwon, Jun Soo] SNU, Coll Nat Sci, Brain & Cognit Sci WCU Program, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; National Medical Center - Korea; Eulji University; Seoul National University (SNU)	Kwon, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	kwonjs@snu.ac.kr	Jung, Wi Hoon/J-4033-2019; Kang, Do-Hyung/J-5358-2012; Lee, Jun-Young/J-5604-2012; Kwon, Jun Soo/J-2734-2012; Lee, Jun-Young/N-5963-2019	Lee, Jun-Young/0000-0002-5893-3124; Lee, Jun-Young/0000-0002-5893-3124; Hwang, Jae Yeon/0000-0002-0616-9750; Jung, Wi Hoon/0000-0002-8697-9584	World Class University program through the Korea Science and Engineering Foundation; Ministry of Education, Science and Technology [R31-10089]	World Class University program through the Korea Science and Engineering Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by World Class University program through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (R31-10089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brody AL, 2004, AM J PSYCHIAT, V161, P1211, DOI 10.1176/appi.ajp.161.7.1211; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; de la Fuente-Fernandez R, 2002, BEHAV BRAIN RES, V136, P359, DOI 10.1016/S0166-4328(02)00130-4; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Denys D, 2004, J CLIN PSYCHIAT, V65, P11; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Figee M, 2011, BIOL PSYCHIAT, V69, P867, DOI 10.1016/j.biopsych.2010.12.003; First M. B., 2014, SCID 5 105 STRUCTURE; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Holden C, 2001, SCIENCE, V294, P980, DOI 10.1126/science.294.5544.980; JOFFE RT, 1993, AM J PSYCHIAT, V150, P959; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Knutson B, 2004, NEURON, V43, P261, DOI 10.1016/j.neuron.2004.06.030; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; OLDS ME, 1981, PHARMACOL BIOCHEM BE, V15, P167, DOI 10.1016/0091-3057(81)90172-6; Pallanti S, 2005, J GAMBL STUD, V21, P431, DOI 10.1007/s10899-005-5557-3; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pohjalainen T, 1998, AM J PSYCHIAT, V155, P768; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Tobler PN, 2009, P NATL ACAD SCI USA, V106, P7185, DOI 10.1073/pnas.0809599106; van Holst RJ, 2012, BIOL PSYCHIAT, V71, P741, DOI 10.1016/j.biopsych.2011.12.030	38	56	60	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45938	10.1371/journal.pone.0045938	http://dx.doi.org/10.1371/journal.pone.0045938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PT	23029329	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388900114
J	Matabos, M; Tunnicliffe, V; Juniper, SK; Dean, C				Matabos, Marjolaine; Tunnicliffe, Verena; Juniper, S. Kim; Dean, Courtney			A Year in Hypoxia: Epibenthic Community Responses to Severe Oxygen Deficit at a Subsea Observatory in a Coastal Inlet	PLOS ONE			English	Article							DEEP-WATER RENEWAL; SAANICH INLET; BRITISH-COLUMBIA; DISSOLVED-OXYGEN; ANOXIC FJORD; DYNAMICS; IMPACT; FISH; TOLERANCE; MORTALITY	Changes in ocean ventilation driven by climate change result in loss of oxygen in the open ocean that, in turn, affects coastal areas in upwelling zones such as the northeast Pacific. Saanich Inlet, on the west coast of Canada, is a natural seasonally hypoxic fjord where certain continental shelf species occur in extreme hypoxia. One study site on the VENUS cabled subsea network is located in the hypoxic zone at 104 m depth. Photographs of the same 5 m(2) area were taken with a remotely-controlled still camera every 2/3 days between October 6th 2009 and October 18th 2010 and examined for community composition, species behaviour and microbial mat features. Instruments located on a near-by platform provided high-resolution measurements of environmental variables. We applied multivariate ordination methods and a principal coordinate analysis of neighbour matrices to determine temporal structures in our dataset. Responses to seasonal hypoxia (0.1-1.27 ml/l) and its high variability on short time-scale (hours) varied among species, and their life stages. During extreme hypoxia, microbial mats developed then disappeared as a hippolytid shrimp, Spirontocaris sica, appeared in high densities (200 m(-2)) despite oxygen below 0.2 ml/l. The slender sole Lyopsetta exilis was abundant in severe hypoxia and diminished as oxygen increased in the summer. This planktivore may be responding to changes in the depth of the diurnal migration of zooplankton. While the squat lobster Munida quadrispina was common at all times, juveniles disappeared in fluctuating conditions. Despite low oxygen conditions, animal densities were high indicating that the risk from hypoxia is balanced by factors such as food availability and escape from less tolerant predators. As hypoxia increases on the continental shelf, we expect benthic communities to become dominated by low diversity, hypoxia-tolerant species of low commercial significance.	[Matabos, Marjolaine; Tunnicliffe, Verena; Juniper, S. Kim; Dean, Courtney] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Matabos, Marjolaine; Juniper, S. Kim] Univ Victoria, NEPTUNE Canada, Victoria, BC, Canada; [Tunnicliffe, Verena] Univ Victoria, VENUS, Victoria, BC, Canada	University of Victoria; University of Victoria; University of Victoria	Matabos, M (corresponding author), Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada.	mmatabos@uvic.ca	Tunnicliffe, Verena/D-1056-2014; Juniper, Kim/N-6769-2015	Juniper, Kim/0000-0002-7608-260X; Matabos, Marjolaine/0000-0003-1983-9896	NSERC Canada; Canada Foundation for Innovation (VENUS, University of Victoria); Canadian Healthy Ocean Network (CHONe)	NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (VENUS, University of Victoria); Canadian Healthy Ocean Network (CHONe)	Funding was provided by NSERC Canada (http://www.nserc-crsng.gc.ca/; SK Juniper, V. Tunnicliffe) and the Canada Foundation for Innovation (http://www.innovation.ca/en; VENUS, University of Victoria). M. Matabos was a post-doctoral fellow funded by the Canadian Healthy Ocean Network (CHONe - http://chone.marinebiodiversity.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achberger C, 2011, B AM METEOROL SOC, V92, pS1, DOI 10.1175/1520-0477-92.6.S1; Alin SR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007511; ANDERSON J J, 1973, Estuarine and Coastal Marine Science, V1, P1, DOI 10.1016/0302-3524(73)90052-2; Andreev AG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003103; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Beveridge I, 2007, THESIS U VICTORIA; BlaisStevens A, 1997, CAN J EARTH SCI, V34, P1345, DOI 10.1139/e17-107; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Breitburg DL, 1997, ECOL MONOGR, V67, P489, DOI 10.1890/0012-9615(1997)067[0489:VEOLDO]2.0.CO;2; BURD BJ, 1988, CAN J ZOOL, V66, P2320, DOI 10.1139/z88-346; BURD BJ, 1984, J EXP MAR BIOL ECOL, V81, P1, DOI 10.1016/0022-0981(84)90221-1; Butler T, 1964, J FISHERIES BOARD CA, V21, P219; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Childress JJ, 1998, J EXP BIOL, V201, P1223; Crawford WR, 2010, STATE PHYS BIOL SELE, V2010, P137; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dinning KM, 2013, MAR ECOL-EVOL PERSP, V34, P2, DOI 10.1111/j.1439-0485.2012.00517.x; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Freeland H, 1997, DEEP-SEA RES PT I, V44, P2117, DOI 10.1016/S0967-0637(97)00083-6; FROST TM, 1995, LINKING SPECIES & ECOSYSTEMS, P224; GALLARDO VA, 1994, J CRUSTACEAN BIOL, V14, P665, DOI 10.2307/1548860; Gargett AE, 2003, ESTUAR COAST SHELF S, V56, P1141, DOI 10.1016/S0272-7714(02)00319-0; Gooday AJ, 2009, DEEP-SEA RES PT II, V56, P488, DOI 10.1016/j.dsr2.2008.10.003; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Hansson D, 2011, J GEOPHYS RES, V116, P1; Haselmair A, 2010, MAR ECOL PROG SER, V414, P195, DOI 10.3354/meps08657; HERLINVEAUX RH, 1962, J FISH RES BOARD CAN, V19, P1, DOI 10.1139/f62-001; Hofmann AF, 2011, DEEP-SEA RES PT I, V58, P1212, DOI 10.1016/j.dsr.2011.09.004; Hughes DJ, 2009, DEEP-SEA RES PT II, V56, P434, DOI 10.1016/j.dsr2.2008.05.030; Johannessen SC, 2009, CLIM RES, V40, P1, DOI 10.3354/cr00819; JORGENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1261; Juan-Jorda MJ, 2009, FISH OCEANOGR, V18, P1, DOI 10.1111/j.1365-2419.2008.00489.x; JUNIPER SK, 1986, MAR ECOL PROG SER, V33, P41, DOI 10.3354/meps033041; Karlson K, 2002, OCEANOGR MAR BIOL, V40, P427; Katz T, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003416; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keller AA, 2007, NMFSNSWFSC87 NOAA US; Keller AA, 2010, FISH OCEANOGR, V19, P76, DOI 10.1111/j.1365-2419.2009.00529.x; Kodama K, 2011, MAR POLLUT BULL, V63, P215, DOI 10.1016/j.marpolbul.2011.04.022; Kodama K, 2010, ECOTOXICOLOGY, V19, P479, DOI 10.1007/s10646-009-0438-7; Koslow JA, 2011, MAR ECOL PROG SER, V436, P207, DOI 10.3354/meps09270; Legendre P, 1998, NUMERICAL ECOLOGY; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2009, DEEP-SEA RES PT II, V56, P449, DOI 10.1016/j.dsr2.2008.05.032; Manning CC, 2010, MAR CHEM, V122, P1, DOI 10.1016/j.marchem.2010.08.002; Masson D, 2002, ESTUAR COAST SHELF S, V54, P115, DOI 10.1006/ecss.2001.0833; Matabos M, 2011, J EXP MAR BIOL ECOL, V401, P89, DOI 10.1016/j.jembe.2011.02.041; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Ning X, 2011, J OCEANOGR, V67, P59, DOI 10.1007/s10872-011-0006-7; PEARCY WG, 1978, FISH B-NOAA, V76, P641; Pena MA, 2010, BIOGEOSCIENCES, V7, P933, DOI 10.5194/bg-7-933-2010; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; R Core Team, 2021, R LANG ENV STAT COMP; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Sturdivant SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034539; Timothy DA, 2001, MAR CHEM, V73, P37, DOI 10.1016/S0304-4203(00)00071-2; TUNNICLIFFE V, 1988, MAR ECOL PROG SER, V47, P117, DOI 10.3354/meps047117; Tunnicliffe V, 2000, LIMNOL OCEANOGR, V45, P1380, DOI 10.4319/lo.2000.45.6.1380; Tunnicliffe V, 1981, NATURE, V294, P354, DOI 10.1038/294354a0; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vaquer-Sunyer R, 2010, LIMNOL OCEANOGR, V55, P1075, DOI 10.4319/lo.2010.55.3.1075; Vardaro MF, 2007, DEEP-SEA RES PT I, V54, P1231, DOI 10.1016/j.dsr.2007.05.004; VISMANN B, 1991, OPHELIA, V34, P1, DOI 10.1080/00785326.1991.10429703; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; WICKSTEN M K, 1989, Transactions of the San Diego Society of Natural History, V21, P291; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Yahel G, 2008, MAR ECOL PROG SER, V372, P195, DOI 10.3354/meps07688; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x; Zimmermann M, 2006, CONT SHELF RES, V26, P1005, DOI 10.1016/j.csr.2006.02.013	76	38	39	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45626	10.1371/journal.pone.0045626	http://dx.doi.org/10.1371/journal.pone.0045626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029145	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400114
J	Dieterich, LC; Schiller, P; Huang, H; Wawrousek, EF; Loskog, A; Wanders, A; Moons, L; Dimberg, A				Dieterich, Lothar C.; Schiller, Petter; Huang, Hua; Wawrousek, Eric F.; Loskog, Angelica; Wanders, Alkwin; Moons, Lieve; Dimberg, Anna			alpha B-Crystallin regulates expansion of CD11b(+)Gr-1(+) immature myeloid cells during tumor progression	FASEB JOURNAL			English	Article						heat-shock protein B5; inflammation; cancer; myelopoiesis	HEAT-SHOCK PROTEINS; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; CANCER; INFLAMMATION; EXPRESSION; HSP27; HYPERPROLIFERATION; DIFFERENTIATION; ANGIOGENESIS	The molecular chaperone alpha B-crystallin has emerged as a target for cancer therapy due to its expression in human tumors and its role in regulating tumor angiogenesis. alpha B-crystallin also reduces neuroinflammation, but its role in other inflammatory conditions has not been investigated. Here, we examined whether alpha B-crystallin regulates inflammation associated with tumors and ischemia. We found that CD45(+) leukocyte infiltration is 3-fold increased in tumors and ischemic myocardium in alpha B-crystallin-deficient mice. Notably, alpha B-crystallin is prominently expressed in CD11b(+) Gr-1(+) immature myeloid cells (IMCs), known as regulators of angiogenesis and immune responses, while lymphocytes and mature granulocytes show low alpha B-crystallin expression. alpha B-Crystallin deficiency results in a 3-fold higher accumulation of CD11b(+) Gr-1(+) IMCs in tumors and a significant rise in CD11b(+) Gr-1(+) IMCs in spleen and bone marrow. Similarly, we noted a 2-fold increase in CD11b(+) Gr-1(+) IMCs in chronically inflamed livers in alpha B-crystallin-deficient mice. The effect of alpha B-crystallin on IMC accumulation is limited to pathological conditions, as CD11b(+) Gr-1(+) IMCs are not elevated in naive mice. Through ex vivo differentiation of CD11b(+) Gr-1(+) cells, we provide evidence that alpha B-crystallin regulates systemic expansion of IMCs through a cell-intrinsic mechanism. Our study suggests a key role of alpha B-crystallin in limiting expansion of CD11b(+) Gr-1(+) IMCs in diverse pathological conditions.-Dieterich, L. C., Schiller, P., Huang, H., Wawrousek, E. F., Loskog, A., Wanders, A., Moons, L., Dimberg, A. alpha B-Crystallin regulates expansion of CD11b(+) Gr-1(+) immature myeloid cells during tumor progression. FASEB J. 27, 151-162 (2013). www.fasebj.org	[Dieterich, Lothar C.; Schiller, Petter; Huang, Hua; Loskog, Angelica; Wanders, Alkwin; Dimberg, Anna] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Wawrousek, Eric F.] NEI, NIH, Bethesda, MD 20892 USA; [Moons, Lieve] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Louvain, Belgium	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); KU Leuven	Dimberg, A (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden.	anna.dimberg@igp.uu.se	Wawrousek, Eric/A-4547-2008	Dieterich, Lothar/0000-0001-7908-5710; Dimberg, Anna/0000-0003-4422-9125; Loskog, Angelica/0000-0001-8583-6138; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Schiller, Petter/0000-0002-1790-3711	NATIONAL EYE INSTITUTE [ZICEY000458] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adhikari AS, 2011, BBA-MOL CELL RES, V1813, P1532, DOI 10.1016/j.bbamcr.2011.04.009; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; Boslooper K, 2008, PATHOLOGY, V40, P500, DOI 10.1080/00313020802198010; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chin D, 2005, LARYNGOSCOPE, V115, P1239, DOI 10.1097/01.MLG.0000164715.86240.55; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; De Wilde V, 2009, AM J TRANSPLANT, V9, P2034, DOI 10.1111/j.1600-6143.2009.02757.x; Dieterich L. C., 2012, CURR ANGIOGEN, V1, P39; Dimberg A, 2008, BLOOD, V111, P2015, DOI 10.1182/blood-2007-04-087841; Duda DG, 2011, CLIN CANCER RES, V17, P2074, DOI 10.1158/1078-0432.CCR-10-2636; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Evert M, 2002, CARCINOGENESIS, V23, P697, DOI 10.1093/carcin/23.5.697; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Ho PY, 2013, UROL ONCOL-SEMIN ORI, V31, P1367, DOI 10.1016/j.urolonc.2012.01.015; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Moline-Velazquez V, 2011, BRAIN PATHOL, V21, P678, DOI 10.1111/j.1750-3639.2011.00495.x; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Ria R, 2009, CLIN CANCER RES, V15, P5369, DOI 10.1158/1078-0432.CCR-09-0040; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Ruan Q, 2011, MOL CANCER RES, V9, P1632, DOI 10.1158/1541-7786.MCR-11-0327; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sitterding SM, 2008, ANN DIAGN PATHOL, V12, P33, DOI 10.1016/j.anndiagpath.2007.02.004; van Noort JM, 2012, INT J BIOCHEM CELL B, V44, P1670, DOI 10.1016/j.biocel.2011.12.010; van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636	50	3	3	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					151	162		10.1096/fj.12-213017	http://dx.doi.org/10.1096/fj.12-213017			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23033322	Green Published, Green Accepted			2022-12-25	WOS:000313103200015
J	Medina, B; Paraskevopoulos, K; Boehringer, J; Sznajder, A; Robertson, M; Endicott, J; Gordon, C				Medina, Bethan; Paraskevopoulos, Konstantinos; Boehringer, Jonas; Sznajder, Anna; Robertson, Morag; Endicott, Jane; Gordon, Colin			The Ubiquitin-associated (UBA) 1 Domain of Schizosaccharomyces pombe Rhp23 Is Essential for the Recognition of Ubiquitin-proteasome System Substrates Both in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN CHAIN-BINDING; ANAPHASE-PROMOTING COMPLEX; PROTEIN LIGASE SYSTEM; STRUCTURAL DETERMINANTS; POLYUBIQUITIN CHAINS; FISSION YEAST; SUBUNIT; RAD23; DEGRADATION; CELLS	The ubiquitin-proteasome system is essential for maintaining a functional cell. Not only does it remove incorrectly folded proteins, it also regulates protein levels to ensure their appropriate spatial and temporal distribution. Proteins marked for degradation by the addition of Lys(48)-linked ubiquitin (Ub) chains are recognized by shuttle factors and transported to the 26 S proteasome. One of these shuttle factors, Schizosaccharomyces pombe Rhp23, has an unusual domain architecture. It comprises an N-terminal ubiquitin-like domain that can recognize the proteasome followed by two ubiquitin-associated (UBA) domains, termed UBA1 and UBA2, which can bind Ub. This architecture is conserved up to humans, suggesting that both domains are important for Rhp23 function. Such an extent of conservation raises the question as to why, in contrast to all other shuttle proteins, does Rhp23 require two UBA domains? We performed in vitro Ub binding assays using domain swap chimeric proteins and mutated domains in isolation as well as in the context of the full-length protein to reveal that the Ub binding properties of the UBA domains are context-dependent. In vivo, the internal Rhp23 UBA1 domain provides sufficient Ub recognition for the protein to function without UBA2.	[Medina, Bethan; Paraskevopoulos, Konstantinos; Sznajder, Anna; Robertson, Morag; Gordon, Colin] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Boehringer, Jonas; Endicott, Jane] Univ Oxford, Dept Biochem, Lab Mol Biophys, Oxford OX1 3QU, England	University of Edinburgh; University of Oxford	Endicott, J (corresponding author), No Inst Canc Res, Sch Med, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	jane.endicott@ncl.ac.uk; C.Gordon@hgu.mrc.ac.uk		Endicott, Jane/0000-0003-4868-0116	United Kingdom Medical Research Council; Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence; Wellcome Trust; MRC [G0700053] Funding Source: UKRI; Medical Research Council [G0700053] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the United Kingdom Medical Research Council, Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation (RUBICON) network of excellence, and Wellcome Trust.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Hartmann-Petersen R, 2003, INT J BIOCHEM CELL B, V35, P629, DOI 10.1016/S1357-2725(02)00393-X; Heessen S, 2005, MOL CELL, V18, P225, DOI 10.1016/j.molcel.2005.03.015; Heinen C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1179; HERSHKO A, 1982, J BIOL CHEM, V257, P3964; HERSHKO A, 1986, J BIOL CHEM, V261, P1992; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seeger M, 2003, J BIOL CHEM, V278, P16791, DOI 10.1074/jbc.M208281200; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanderSpek PJ, 1996, NUCLEIC ACIDS RES, V24, P2551, DOI 10.1093/nar/24.13.2551; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Wang Q, 2003, ONCOGENE, V22, P1486, DOI 10.1038/sj.onc.1206224; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilkinson CRM, 2000, J BIOL CHEM, V275, P15182, DOI 10.1074/jbc.275.20.15182; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107	41	4	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42344	42351		10.1074/jbc.M112.419838	http://dx.doi.org/10.1074/jbc.M112.419838			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038266	Green Published, hybrid			2022-12-25	WOS:000312103000069
J	Eischen, CM; Boyd, K				Eischen, Christine M.; Boyd, Kelli			Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53	PLOS ONE			English	Article							MYC-INDUCED LYMPHOMAGENESIS; MICE; SUPPRESSOR; P19(ARF); TUMORIGENESIS; APOPTOSIS; DEFICIENT; SPECTRUM; PATHWAY; CANCER	Inactivation of the Arf-Mdm2-p53 tumor suppressor pathway is a necessary event for tumorigenesis. Arf controls Mdm2, which in turn regulates p53, but Arf and Mdm2 also have p53-independent functions that affect tumor development. Moreover, inhibition of oncogene-induced tumorigenesis relies on Arf and p53, but the requirements of Arf and p53 in tumor development initiated in the absence of overt oncogene overexpression and the role of Mdm2 in this process remain unclear. In a series of genetic experiments in mice with defined deficiencies in Arf, Mdm2 and/or p53, we show Mdm2 haploinsufficiency significantly delayed tumorigenesis in mice deficient in Arf and p53. Mdm2 heterozygosity significantly inhibited tumor development in the absence of Arf, and in contrast to Myc oncogene-driven cancer, this delay in tumorigenesis could not be rescued with the presence of one allele of Arf. Notably, Mdm2 haploinsufficieny blocked the accelerated tumor development in Arf deficient mice caused by p53 heterozygosity. However, tumorigenesis was not inhibited in Mdm2 heterozygous mice lacking both alleles of p53 regardless of Arf status. Surprisingly, loss of Arf accelerated tumor development in p53-null mice. Tumor spectrum was largely dictated by Arf and p53 status with Mdm2 haploinsufficiency only modestly altering the tumor type in some of the genotypes and not the number of primary tumors that arose. Therefore, the significant effects of Mdm2 haploinsufficiency on tumor latency were independent of Arf and required at least one allele of p53, and an Mdm2 deficiency had minor effects on the types of tumors that developed. These data also demonstrate that decreased levels of Mdm2 are protective in the presence of multiple genetic events in Arf and p53 genes that normally accelerate tumorigenesis.	[Eischen, Christine M.; Boyd, Kelli] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA	Vanderbilt University	Eischen, CM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA.	christine.eischen@vanderbilt.edu			National Cancer Institute (NCI) [R01CA117935]; NCI cancer center [P30CA068485]; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA117935] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute (NCI) grant R01CA117935 and the Vanderbilt Translational Pathology Shared Resource supported by the NCI cancer center grant P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eischen CM, 2004, ONCOGENE, V23, P8931, DOI 10.1038/sj.onc.1208052; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; O'Leary KA, 2004, MOL CELL BIOL, V24, P186, DOI 10.1128/MCB.24.1.186-191.2004; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	23	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46148	10.1371/journal.pone.0046148	http://dx.doi.org/10.1371/journal.pone.0046148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029416	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900097
J	Meijering, B; van Rijn, H; Taatgen, NA; Verbrugge, R				Meijering, Ben; van Rijn, Hedderik; Taatgen, Niels A.; Verbrugge, Rineke			What Eye Movements Can Tell about Theory of Mind in a Strategic Game	PLOS ONE			English	Article							DEPTH; ATTRIBUTION; ALLOCATION; CHIMPANZEE; BELIEFS	This study investigates strategies in reasoning about mental states of others, a process that requires theory of mind. It is a first step in studying the cognitive basis of such reasoning, as strategies affect tradeoffs between cognitive resources. Participants were presented with a two-player game that required reasoning about the mental states of the opponent. Game theory literature discerns two candidate strategies that participants could use in this game: either forward reasoning or backward reasoning. Forward reasoning proceeds from the first decision point to the last, whereas backward reasoning proceeds in the opposite direction. Backward reasoning is the only optimal strategy, because the optimal outcome is known at each decision point. Nevertheless, we argue that participants prefer forward reasoning because it is similar to causal reasoning. Causal reasoning, in turn, is prevalent in human reasoning. Eye movements were measured to discern between forward and backward progressions of fixations. The observed fixation sequences corresponded best with forward reasoning. Early in games, the probability of observing a forward progression of fixations is higher than the probability of observing a backward progression. Later in games, the probabilities of forward and backward progressions are similar, which seems to imply that participants were either applying backward reasoning or jumping back to previous decision points while applying forward reasoning. Thus, the game-theoretical favorite strategy, backward reasoning, does seem to exist in human reasoning. However, participants preferred the more familiar, practiced, and prevalent strategy: forward reasoning.	[Meijering, Ben; Taatgen, Niels A.; Verbrugge, Rineke] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands	University of Groningen; University of Groningen	Meijering, B (corresponding author), Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands.	b.meijering@rug.nl	Verbrugge, Rineke/D-3781-2012; Taatgen, Niels/A-3216-2008; van Rijn, Hedderik/L-3685-2014	Verbrugge, Rineke/0000-0003-3829-0106; van Rijn, Hedderik/0000-0002-0461-9850; Taatgen, Niels/0000-0001-7286-3460	Netherlands Organization of Scientific Research (NWO) [227-80-001]	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a Vici grant from the Netherlands Organization of Scientific Research (NWO; http://www.nwo.nl/) that was awarded to Rineke Verbrugge (grant 227-80-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly I. A., 2011, MINDREADERS COGNITIV; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Borst JP, 2010, J EXP PSYCHOL LEARN, V36, P363, DOI 10.1037/a0018106; Brassard G., 1996, FUNDAMENTALS ALGORIT; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Colman AM, 2003, TRENDS COGN SCI, V7, P2, DOI 10.1016/S1364-6613(02)00006-2; Flobbe L., 2008, J LOG LANG INF, V17, P417, DOI [10.1007/s10849-008-9064-7, DOI 10.1007/S10849-008-9064-7]; Fu WT, 2004, COGNITIVE SCI, V28, P901, DOI 10.1016/j.cogsci.2004.03.005; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Ghosh S, 2010, P 3 LOG RES BOUND AG, P15; Ghosh S., 2011, CEUR WORKSHOP P, V751, P79; Goodie AS, 2012, J BEHAV DECIS MAKING, V25, P95, DOI 10.1002/bdm.717; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Hedden T, 2002, COGNITION, V85, P1, DOI 10.1016/S0010-0277(02)00054-9; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson EJ, 2002, J ECON THEORY, V104, P16, DOI 10.1006/jeth.2001.2850; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KELLEY HH, 1980, ANNU REV PSYCHOL, V31, P457, DOI 10.1146/annurev.ps.31.020180.002325; Kong XH, 2010, COGNITIVE SCI, V34, P322, DOI 10.1111/j.1551-6709.2009.01075.x; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; Meijering B., 2011, P 33 ANN C COGN SCI, P2486; Meijering B, 2010, COGNITION IN FLUX, P1423; Nyamsuren E, COGNITIVE S IN PRESS; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Osborne M.J., 1994, COURSE GAME THEORY; Perea A., 2010, GAMES, V1, P168; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, SOC NEUROSCI-UK, V1, P284, DOI 10.1080/17470910601000446; Todd PM, 2000, BEHAV BRAIN SCI, V23, P727, DOI 10.1017/S0140525X00003447; Weber R, 2001, ORGAN SCI, V12, P582, DOI 10.1287/orsc.12.5.582.10090; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zhang J, 2003, TRENDS COGN SCI, V7, P4, DOI 10.1016/S1364-6613(02)00007-4; Zhang J, 2012, COGNITIVE SCI, V36, P560, DOI 10.1111/j.1551-6709.2012.01238.x	39	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45961	10.1371/journal.pone.0045961	http://dx.doi.org/10.1371/journal.pone.0045961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029341	Green Published, gold			2022-12-25	WOS:000309973900068
J	Mochizuki, K; Tachibana, M; Saitou, M; Tokitake, Y; Matsui, Y				Mochizuki, Kentaro; Tachibana, Makoto; Saitou, Mitinori; Tokitake, Yuko; Matsui, Yasuhisa			Implication of DNA Demethylation and Bivalent Histone Modification for Selective Gene Regulation in Mouse Primordial Germ Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PREIMPLANTATION EMBRYOS; EPIGENETIC EVENTS; PATERNAL GENOME; NUCLEAR FACTOR; MICE; EXPRESSION; METHYLATION; SPECIFICATION; DIFFERENTIATION	Primordial germ cells (PGCs) sequentially induce specific genes required for their development. We focused on epigenetic changes that regulate PGC-specific gene expression. mil-1, Blimp1, and Stella are preferentially expressed in PGCs, and their expression is upregulated during PGC differentiation. Here, we first determined DNA methylation status of mil-1, Blimp1, and Stella regulatory regions in epiblast and in PGCs, and found that they were hypomethylated in differentiating PGCs after E9.0, in which those genes were highly expressed. We used siRNA to inhibit a maintenance DNA methyltransferase, Dnmt1, in embryonic stem (ES) cells and found that the flanking regions of all three genes became hypomethylated and that expression of each gene increased 1.5- to 3-fold. In addition, we also found 1.5- to 5-fold increase of the PGC genes in the PGCLCs (PGC-like cells) induced form ES cells by knockdown of Dnmt1. We also obtained evidence showing that methylation of the regulatory region of mil-1 resulted in 2.5-fold decrease in expression in a reporter assay. Together, these results suggested that DNA demethylation does not play a major role on initial activation of the PGC genes in the nascent PGCs but contributed to enhancement of their expression in PGCs after E9.0. However, we also found that repression of representative somatic genes, Hoxa1 and Hoxb1, and a tissue-specific gene, Gfap, in PGCs was not dependent on DNA methylation; their flanking regions were hypomethylated, but their expression was not observed in PGCs at E13.5. Their promoter regions showed the bivalent histone modification in PGCs, that may be involved in repression of their expression. Our results indicated that epigenetic status of PGC genes and of somatic genes in PGCs were distinct, and suggested contribution of epigenetic mechanisms in regulation of the expression of a specific gene set in PGCs.	[Mochizuki, Kentaro; Tokitake, Yuko; Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Tachibana, Makoto] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Kyoto 606, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Med, Dept Anat & Cell Biol, Kyoto, Japan; [Saitou, Mitinori] CREST ERATO, JST, Kyoto, Japan	Tohoku University; Kyoto University; Kyoto University	Matsui, Y (corresponding author), Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	ymatsui@idac.tohoku.ac.jp		Matsui, Yasuhisa/0000-0001-7026-6355	Japan Society for the Promotion of Science for Young Scientists; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	K. Mochizuki was supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Gu PL, 2011, STEM CELLS, V29, P1041, DOI 10.1002/stem.652; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Gure AO, 2002, INT J CANCER, V101, P448, DOI 10.1002/ijc.10634; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Imamura M, 2010, MOL REPROD DEV, V77, P802, DOI 10.1002/mrd.21223; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kehoe SM, 2008, BIOL REPROD, V79, P921, DOI 10.1095/biolreprod.108.067645; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Li SSL, 2006, BIOCHEM BIOPH RES CO, V340, P48, DOI 10.1016/j.bbrc.2005.11.149; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mochizuki K, 2010, DEV GROWTH DIFFER, V52, P517, DOI 10.1111/j.1440-169X.2010.01190.x; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohinata Y, 2008, REPRODUCTION, V136, P503, DOI 10.1530/REP-08-0053; Okamura D, 2008, DEV BIOL, V317, P576, DOI 10.1016/j.ydbio.2008.03.002; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ruggiu M, 1997, NATURE, V389, P73, DOI 10.1038/37987; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seligman J, 1998, BIOCHEM BIOPH RES CO, V245, P878, DOI 10.1006/bbrc.1998.8530; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stallock J, 2003, DEVELOPMENT, V130, P6589, DOI 10.1242/dev.00898; Storre J, 2005, J BIOL CHEM, V280, P41380, DOI 10.1074/jbc.M506797200; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki H, 2008, DEV BIOL, V318, P133, DOI 10.1016/j.ydbio.2008.03.020; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Tanaka SS, 2000, GENE DEV, V14, P841; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; WEBER J, 1994, CANCER RES, V54, P1766; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	63	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46036	10.1371/journal.pone.0046036	http://dx.doi.org/10.1371/journal.pone.0046036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029374	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900075
J	Chang, KH; Chen, YC; Wu, YR; Lee, WF; Chen, CM				Chang, Kuo-Hsuan; Chen, Yi-Chun; Wu, Yih-Ru; Lee, Wan-Fen; Chen, Chiung-Mei			Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; UNCOUPLING PROTEIN-2; GLUCOSE-METABOLISM; BLOOD; EXPRESSION; ABNORMALITIES; DYSFUNCTION; ACTIVATION; BIOMARKER; DAMAGE	Background: Huntington's disease (HD) is caused by expanded CAG repeats encoding a polyglutamine tract in the huntingtin (HTT) protein. A number of differentially-expressed protein molecules have been identified in striatum of HD animal models. Here we examined if the expression changes could be visualized in the peripheral leukocytes of HD patients and pre-symptomatic HD (PreHD) carriers. Methods and findings: The expression levels of 17 candidate genes that differentially expressed in striatum between transgenic HD and wild-type mice in literature were measured in the peripheral leukocytes of 4 PreHD carriers, 16 HD patients and 20 healthy controls. Four genes majorly involved in metabolism and oxidative stress response, including AHCY1, ACO2, OXCT1 and CAP1, demonstrated consistent downregulation in peripheral leukocytes of both PreHD carriers and HD patients, while UCP2 was only down-regulated in HD patients. Conclusion: These results provide potential peripheral biomarkers to indicate disease onset in preclinical stage, and to monitor the efficacy of early treatment. Further studies of a large series of preHD carriers and symptomatic HD patients will be warranted to verify the findings and examine if these markers correlate with clinical features.	[Chang, Kuo-Hsuan; Chen, Yi-Chun; Wu, Yih-Ru; Lee, Wan-Fen; Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, CM (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Academia Sinica, Taiwan [AS-100-TP2-B02-4]; Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3B1381]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital)	This work was supported by Academia Sinica, Taiwan (AS-100-TP2-B02-4) and from Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG3B1381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AN, 2008, BRAIN, V131, P381, DOI 10.1093/brain/awm312; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Chiang MC, 2007, MOL CELL PROTEOMICS, V6, P781, DOI 10.1074/mcp.M600356-MCP200; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feng QP, 2009, J NEUROCHEM, V110, P1806, DOI 10.1111/j.1471-4159.2009.06276.x; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kim J, 2010, BBA-MOL BASIS DIS, V1802, P673, DOI 10.1016/j.bbadis.2010.05.001; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; La Spada AR, 2011, NEUROBIOLOGY HUNTING; Leoni V, 2008, BRAIN, V131, P2851, DOI 10.1093/brain/awn212; Lovrecic L, 2009, MOVEMENT DISORD, V24, P2277, DOI 10.1002/mds.22477; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maglione V, 2005, AM J MED GENET B, V139B, P101, DOI 10.1002/ajmg.b.30223; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Naia L, 2012, REV NEUROSCIENCE, V23, P13, DOI 10.1515/RNS.2011.060; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Tabchy A, 2006, EUR J HUM GENET, V14, P649, DOI 10.1038/sj.ejhg.5201562; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; Zuccato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022966	49	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46492	10.1371/journal.pone.0046492	http://dx.doi.org/10.1371/journal.pone.0046492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029535	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500105
J	Minnicelli, C; Barros, MHM; Klumb, CE; Romano, SO; Zalcberg, IR; Hassan, R				Minnicelli, Carolina; Barros, Mario H. M.; Klumb, Claudete E.; Romano, Sergio O.; Zalcberg, Ilana R.; Hassan, Rocio			Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; NON-HODGKINS-LYMPHOMA; GENOMIC ANCESTRY; GENE; SUSCEPTIBILITY; CHILDREN; DIFFERENTIATION; ASSOCIATION; EXPRESSION; INFECTION	Epstein-Barr virus (EBV) is an important environmental factor associated to the development of Burkitt lymphoma (BL) in endemic and intermediate risk regions. However, little is known about the contribution of genetic constitution to the development and clinical response of the disease. The aim of this work was to investigate the role of EBV and Interleukin 10 (IL10) single nucleotide polymorphisms (-1082A/G, -819C/T, -592C/A) and microsatellites (IL10.R and IL10.G) in susceptibility and clinical outcome in pediatric BL patients, in a region with intermediate EBV association frequency. The frequencies of IL10 promoter Single nucleotide polymorphisms -1082A/G, -819C/T, -592C/A, and IL10.R and IL10.G microsatellites were compared in 62 pediatric patients and 216 healthy donors. IL10 -1082GG and GCC/GCC genotypes were more frequent in patients than in controls, and associated to a higher risk of BL development (GG genotype OR 2.62, 95% CI, 1.25-5.51; P = 0.008; Pc = 0.024). EBV was detected in tumor samples by EBER-ISH in 54.1% of cases. EBV+ patients exhibited a better event free survival (EFS) (P = 0.019) than EBV- patients. Carriers of IL10 R3-GCC had worse EFS (P = 0.028). Our results suggest a risk effect and an independent prognostic value of IL10 polymorphisms and EBV in childhood BL patients.	[Minnicelli, Carolina; Barros, Mario H. M.; Zalcberg, Ilana R.; Hassan, Rocio] Inst Nacl Canc INCA, Bone Marrow Transplantat Ctr CEMO, Rio De Janeiro, Brazil; [Klumb, Claudete E.] Inst Nacl Canc INCA, Hematol Serv, Rio De Janeiro, Brazil; [Romano, Sergio O.] Inst Nacl Canc INCA, Pathol Dept DIPAT, Rio De Janeiro, Brazil	National Cancer Institute (Inca); National Cancer Institute (Inca); National Cancer Institute (Inca)	Hassan, R (corresponding author), Inst Nacl Canc INCA, Bone Marrow Transplantat Ctr CEMO, Rio De Janeiro, Brazil.	rocio.hassan@pq.cnpq.br	Klumb, Claudete/L-2682-2015; Barros, Mario/G-1842-2014	Klumb, Claudete/0000-0002-7672-1088; Barros, Mario/0000-0001-6826-9565	Swissbridge Foundation (Switzerland); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq) (Brazil) [573806/2008-0]; Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (FAPERJ) (Brazil) [E26/170.026/2008]	Swissbridge Foundation (Switzerland); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq) (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (FAPERJ) (Brazil)	This work was supported by the Swissbridge Foundation (Switzerland), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, PensaRio) and Instituto Nacional de Ciencia e Tecnologia (INCT) para Controle do Cancer (Grants Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq 573806/2008-0 and FAPERJ E26/170.026/2008) (Brazil). Sponsors had no involvement in the study design, in the collection, analysis and interpretation of data, in the writing of the manuscript, or in the decision to submit the manuscript for publication.	[Anonymous], PHARMACOGENOMICS ADM; Araujo I, 1996, BLOOD, V87, P5279, DOI 10.1182/blood.V87.12.5279.bloodjournal87125279; Barros MH, 2011, INT J CANCER, V15, P3762; Berglund M, 2005, BLOOD, V105, P4894, DOI 10.1182/blood-2004-12-4814; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; Chan ATC, 2004, J CLIN ONCOL, V22, P1373, DOI 10.1200/JCO.2004.04.185; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Eskdale J, 1999, GENES IMMUN, V1, P151, DOI 10.1038/sj.gene.6363656; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Feng WH, 2004, J VIROL, V78, P1893, DOI 10.1128/JVI.78.4.1893-1902.2004; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Hassan R, 2008, HAEMATOLOGICA, V93, P780, DOI 10.3324/haematol.12424; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Helminen M, 1999, J INFECT DIS, V180, P496, DOI 10.1086/314883; Helminen ME, 2001, J INFECT DIS, V184, P777, DOI 10.1086/322987; HOLLAND G, 1993, CANCER INVEST, V11, P751, DOI 10.3109/07357909309046950; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Keegan THM, 2005, J CLIN ONCOL, V23, P7604, DOI 10.1200/JCO.2005.02.6310; Kitagawa N, 2000, EMBO J, V19, P6742, DOI 10.1093/emboj/19.24.6742; Klumb CE, 2004, J PEDIAT HEMATOL ONC, V26, P462, DOI 10.1097/00043426-200407000-00014; Klumb CE, 2004, INT J CANCER, V108, P66, DOI 10.1002/ijc.11443; Kube D, 2003, GENES IMMUN, V4, P459, DOI 10.1038/sj.gene.6364003; Kube D, 2008, CLIN CANCER RES, V14, P3777, DOI 10.1158/1078-0432.CCR-07-5182; Labrecque LG, 1999, INT J CANCER, V81, P6, DOI 10.1002/(SICI)1097-0215(19990331)81:1&lt;6::AID-IJC2&gt;3.0.CO;2-2; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Magrath I, 1992, Semin Cancer Biol, V3, P285; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moraes MO, 2003, IMMUNOGENETICS, V54, P896, DOI 10.1007/s00251-003-0543-3; Mormann M, 2004, GENES IMMUN, V5, P246, DOI 10.1038/sj.gene.6364073; MURPHY SB, 1980, SEMIN ONCOL, V7, P332; Ogden CA, 2005, J IMMUNOL, V174, P3015, DOI 10.4049/jimmunol.174.5.3015; Oyama T, 2007, CLIN CANCER RES, V13, P5124, DOI 10.1158/1078-0432.CCR-06-2823; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patte C, 2002, BEST PRACT RES CL HA, V15, P695, DOI 10.1053/beha.2002.0231; Pizza M, 2008, HEMATOLOGY, V13, P114, DOI 10.1179/102453308X315942; Queiroga EM, 2008, AM J CLIN PATHOL, V130, P186, DOI 10.1309/2CNAWY6GAR0VQAXX; Reuss E, 2002, GENES IMMUN, V3, P407, DOI 10.1038/sj.gene.6363920; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Skibola CF, 2007, HAEMATOLOGICA, V92, P960, DOI 10.3324/haematol.11011; Stefanoff CG, 2003, DIAGN MOL PATHOL, V12, P79, DOI 10.1097/00019606-200306000-00003; Suarez A, 2003, TRANSPLANTATION, V75, P711, DOI 10.1097/01.TP.0000055216.19866.9A; Suarez-Kurtz G, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00118; Suarez-Kurtz G, 2007, PHARMACOGENET GENOM, V17, P765, DOI 10.1097/FPC.0b013e3281c10e52; Sumba PO, 2010, BRIT J CANCER, V103, P1736, DOI 10.1038/sj.bjc.6605947; Swerdlow E., 2008, WHO CLASSIFICATION T; Tang WH, 2010, CLIN CANCER RES, V16, P2055, DOI 10.1158/1078-0432.CCR-09-2424; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Westendorp RGJ, 1997, LANCET, V349, P170, DOI 10.1016/S0140-6736(96)06413-6	51	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46005	10.1371/journal.pone.0046005	http://dx.doi.org/10.1371/journal.pone.0046005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029361	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500055
J	Robinson, H; Wray, S				Robinson, Hayley; Wray, Susan			A New Slow Releasing, H2S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; K-ATP CHANNELS; SENSITIVE POTASSIUM CHANNELS; CYSTATHIONINE GAMMA-LYASE; HYDROGEN-SULFIDE; SARCOPLASMIC-RETICULUM; METABOLIC INHIBITION; IN-VITRO; INTRACELLULAR CALCIUM; FORCE PRODUCTION	Better tocolytics are required to help prevent preterm labour. The gaseotransmitter Hydrogen sulphide (H2S) has been shown to reduce myometrial contractility and thus is of potential interest. However previous studies used NaHS, which is toxic and releases H2S as a non-physiological bolus and thus alternative H2S donors are sought. GYY4137 has been developed to slowly release H2S and hence better reflect endogenous physiological release. We have examined its effects on spontaneous and oxytocin-stimulated contractility and compared them to NaHS, in human and rat myometrium, throughout gestation. The effects on contractility in response to GYY4137 (1 nM-1 mM) and NaHS (1 mM) were examined on myometrial strips from, biopsies of women undergoing elective caesarean section or hysterectomy, and from nonpregnant, 14, 18, 22 day (term) gestation or labouring rats. In pregnant rat and human myometrium dose-dependent and significant decreases in spontaneous contractions were seen with increasing concentrations of GYY4137, which also reduced underlying Ca transients. GYY4137 and NaHS significantly reduced oxytocin-stimulated and high-K depolarised contractions as well as spontaneous activity. Their inhibitory effects increased as gestation advanced, but were abruptly reversed in labour. Glibenclamide, an inhibitor of ATP-sensitive potassium (K-ATP) channels, abolished the inhibitory effect of GYY4137. These data suggest (i) H2S contributes to uterine quiescence from mid-gestation until labor, (ii) that H2S affects L-type calcium channels and K-ATP channels reducing Ca entry and thereby myometrial contractions, (iii) add to the evidence that H2S plays a physiological role in relaxing myometrium, and thus (iv) H2S is an attractive target for therapeutic manipulation of human myometrial contractility.	[Robinson, Hayley; Wray, Susan] Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Wray, S (corresponding author), Univ Liverpool, Dept Cellular & Mol Physiol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	s.wray@liv.ac.uk	wray, susan/B-1197-2009	Wray, Susan/0000-0002-0086-1359	Wellcome Trust Prize Studentship [WT086736M]	Wellcome Trust Prize Studentship(Wellcome Trust)	H.R. was the recipient of a Wellcome Trust Prize Studentship (Ref. WT086736M, www.wellcome.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson PI, 2006, BRIT J PHARMACOL, V147, P815, DOI 10.1038/sj.bjp.0706644; Al-Magableh MR, 2011, N-S ARCH PHARMACOL, V383, P403, DOI 10.1007/s00210-011-0608-z; Bauer CC, 2010, ATHEROSCLEROSIS, V209, P374, DOI 10.1016/j.atherosclerosis.2009.10.004; BOYARSKY S, 1978, Urology, V12, P134, DOI 10.1016/0090-4295(78)90322-9; Burdyga T, 2007, ANN NY ACAD SCI, V1101, P85, DOI 10.1196/annals.1389.002; Collins PL, 2000, BIOL REPROD, V63, P1262, DOI 10.1095/biolreprod63.5.1262; CRICHTON CA, 1993, J PHYSIOL-LONDON, V465, P629, DOI 10.1113/jphysiol.1993.sp019697; Curley M, 2002, MOL HUM REPROD, V8, P941, DOI 10.1093/molehr/8.10.941; Dawe GS, 2008, NEUROSCIENCE, V152, P169, DOI 10.1016/j.neuroscience.2007.12.008; Dhaese I, 2010, EUR J PHARMACOL, V628, P179, DOI 10.1016/j.ejphar.2009.11.024; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Doeller JE, 2005, ANAL BIOCHEM, V341, P40, DOI 10.1016/j.ab.2005.03.024; Gallyas Jr F, 2012, BR J PHARM; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; HEATON RC, 1993, J PHYSIOL-LONDON, V465, P43, DOI 10.1113/jphysiol.1993.sp019665; Hu R, 2011, GYNECOL ENDOCRINOL, V27, P900, DOI 10.3109/09513590.2010.551563; Hughes MN, 2009, FREE RADICAL BIO MED, V47, P1346, DOI 10.1016/j.freeradbiomed.2009.09.018; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kubo S., 2007, Inflammopharmacology, V15, P288, DOI 10.1007/s10787-007-1590-4; Kubo S, 2007, J PHARMACOL SCI, V104, P392, DOI 10.1254/jphs.SC0070199; Kupittayanant S, 2002, BJOG-INT J OBSTET GY, V109, P289, DOI 10.1016/S1470-0328(02)01110-2; Kupittayanant S, 2001, PFLUG ARCH EUR J PHY, V443, P112, DOI 10.1007/s004240100668; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Lee SW, 2007, BIOCHEM BIOPH RES CO, V358, P1142, DOI 10.1016/j.bbrc.2007.05.063; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Liang GH, 2012, J PHYSL; Longo M, 2003, MOL HUM REPROD, V9, P159, DOI 10.1093/molehr/gag023; Luckas MJM, 2000, BRIT J OBSTET GYNAEC, V107, P1309, DOI 10.1111/j.1471-0528.2000.tb11626.x; Luckas MJM, 1999, AM J OBSTET GYNECOL, V181, P468, DOI 10.1016/S0002-9378(99)70580-6; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Noble K, 2006, J PHYSIOL-LONDON, V570, P29, DOI 10.1113/jphysiol.2005.098475; Olson KR, 2012, ANTIOXID REDOX SIGN, V17, P32, DOI 10.1089/ars.2011.4401; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Patel P, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-10; Quenby S, 2004, OBSTET GYNECOL, V103, P718, DOI 10.1097/01.AOG.0000118306.82556.43; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Shmigol AV, 1998, J PHYSIOL-LONDON, V511, P803, DOI 10.1111/j.1469-7793.1998.803bg.x; Shmigol AV, 2001, J PHYSIOL-LONDON, V531, P707, DOI 10.1111/j.1469-7793.2001.0707h.x; Sidhu R, 2001, PHARMACOL TOXICOL, V88, P198, DOI 10.1034/j.1600-0773.2001.d01-104.x; Sun QX, 2009, J BIOL CHEM, V284, P3076, DOI 10.1074/jbc.M805459200; Sun YG, 2008, CARDIOVASC RES, V79, P632, DOI 10.1093/cvr/cvn140; SZAL SE, 1994, AM J PHYSIOL, V267, pE77, DOI 10.1152/ajpendo.1994.267.1.E77; Taggart MJ, 1997, J PHYSIOL-LONDON, V499, P485, DOI 10.1113/jphysiol.1997.sp021943; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Tian XY, 2012, PHARMACOL RES, V65, P239, DOI 10.1016/j.phrs.2011.11.006; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Webb GD, 2008, J PHARMACOL EXP THER, V324, P876, DOI 10.1124/jpet.107.133538; Wray S, 2008, J NEUROENDOCRINOL, V20, P451, DOI 10.1111/j.1365-2826.2008.01665.x; Wray S, 2005, CELL CALCIUM, V38, P397, DOI 10.1016/j.ceca.2005.06.018; WRAY S, 1992, EXP PHYSIOL, V77, P307, DOI 10.1113/expphysiol.1992.sp003590; Wray S, 2007, EXP PHYSIOL, V92, P621, DOI 10.1113/expphysiol.2007.038125; Xu C, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-35; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; You XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023788; Yu Fang, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P493; Zhang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037073; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	70	32	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46278	10.1371/journal.pone.0046278	http://dx.doi.org/10.1371/journal.pone.0046278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029460	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500081
J	Sadaf, S; Birman, S; Hasan, G				Sadaf, Sufia; Birman, Serge; Hasan, Gaiti			Synaptic Activity in Serotonergic Neurons Is Required for Air-Puff Stimulated Flight in Drosophila melanogaster	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NEUROMODULATOR OCTOPAMINE; TARGETED EXPRESSION; LOCUST FLIGHT; BEHAVIOR; CALCIUM; MODULATION; GROWTH; METAMORPHOSIS; SPECIFICATION	Background: Flight is an integral component of many complex behavioral patterns in insects. The giant fiber circuit has been well studied in several insects including Drosophila. However, components of the insect flight circuit that respond to an air-puff stimulus and comprise the flight central pattern generator are poorly defined. Aminergic neurons have been implicated in locust, moth and Drosophila flight. Here we have investigated the requirement of neuronal activity in serotonergic neurons, during development and in adults, on air-puff induced flight in Drosophila. Methodology/Principal Findings: To target serotonergic neurons specifically, a Drosophila strain that contains regulatory regions from the TRH (Tryptophan Hydroxylase) gene linked to the yeast transcription factor GAL4 was used. By blocking synaptic transmission from serotonergic neurons with a tetanus toxin transgene or by hyperpolarisation with Kir2.1, close to 50% adults became flightless. Temporal expression of a temperature sensitive Dynamin mutant transgene (Shi(ts)) suggests that synaptic function in serotonergic neurons is required both during development and in adults. Depletion of IP3R in serotonergic neurons via RNAi did not affect flight. Interestingly, at all stages a partial requirement for synaptic activity in serotonergic neurons was observed. The status of serotonergic neurons was investigated in the central nervous system of larvae and adults expressing tetanus toxin. A small but significant reduction was observed in serotonergic cell number in adult second thoracic segments from flightless tetanus toxin expressing animals. Conclusions: These studies show that loss of synaptic activity in serotonergic neurons causes a flight deficit. The temporal focus of the flight deficit is during pupal development and in adults. The cause of the flight deficit is likely to be loss of neurons and reduced synaptic function. Based on the partial phenotypes, serotonergic neurons appear to be modulatory, rather than an intrinsic part of the flight circuit.	[Sadaf, Sufia; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Birman, Serge] ParisTech, Ecole Super Phys & Chim Ind, Ctr Natl Rech Sci, Neurobiol Lab, Paris, France	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Hasan, G (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Hasan, Gaiti/P-4107-2019; Hasan, Gaiti/I-5851-2015	Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X; Sadaf, Sufia/0000-0002-0404-7151	Council of Scientific and Industrial research; Department of Biotechnology; Department of Science and Technology; National Centre for Biological Sciences, Tata Institute of Fundamental Research	Council of Scientific and Industrial research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); National Centre for Biological Sciences, Tata Institute of Fundamental Research	This work was supported by research fellowships from the Council of Scientific and Industrial research (http://rdpp.csir.res.in/csir_acsir/Home.aspx) to Sufia Sadaf. The project was supported financially by grants from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), the Department of Science and Technology (http://www.dst.gov.in/), and the National Centre for Biological Sciences, Tata Institute of Fundamental Research (http://www.ncbs.res.in) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2010, J NEUROSCI, V30, P1301, DOI 10.1523/JNEUROSCI.3668-09.2010; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Banerjee S, 2004, J NEUROSCI, V24, P7869, DOI 10.1523/JNEUROSCI.0656-04.2004; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buhl E, 2008, J EXP BIOL, V211, P2346, DOI 10.1242/jeb.017384; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Consoulas C, 2005, J COMP NEUROL, V485, P321, DOI 10.1002/cne.20499; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards JS, 2006, J EXP BIOL, V209, P4411, DOI 10.1242/jeb.02592; Engel JE, 1996, J NEUROSCI, V16, P3486; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fenelon VS, 1998, CURR OPIN NEUROBIOL, V8, P705, DOI 10.1016/S0959-4388(98)80111-6; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Hasan G, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00010; KAMMER AE, 1976, J EXP BIOL, V65, P65; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; PARKER D, 1995, J NEUROPHYSIOL, V73, P923, DOI 10.1152/jn.1995.73.3.923; RAMIREZ JM, 1991, J NEUROPHYSIOL, V66, P1522, DOI 10.1152/jn.1991.66.5.1522; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; SOMBATI S, 1984, J NEUROBIOL, V15, P455, DOI 10.1002/neu.480150606; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Stevenson PA, 1997, J EXP BIOL, V200, P633; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Sykes PA, 2004, CELL TISSUE RES, V317, P327, DOI 10.1007/s00441-004-0940-4; TANOUYE MA, 1983, J EXP BIOL, V105, P241; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Velazquez-Ulloa NA, 2011, J NEUROSCI, V31, P78, DOI 10.1523/JNEUROSCI.3542-10.2011; Venkiteswaran G, 2009, P NATL ACAD SCI USA, V106, P10326, DOI 10.1073/pnas.0902982106; Vierk R, 2010, J COMP PHYSIOL A, V196, P37, DOI 10.1007/s00359-009-0490-z; White BH, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.020.2009	38	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46405	10.1371/journal.pone.0046405	http://dx.doi.org/10.1371/journal.pone.0046405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029511	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500100
J	Wadden, D; Cahill, F; Amini, P; Randell, E; Vasdev, S; Yi, YQ; Zhang, WZ; Sun, G				Wadden, Danny; Cahill, Farrell; Amini, Peyvand; Randell, Edward; Vasdev, Sudesh; Yi, Yanqing; Zhang, Weizhen; Sun, Guang			Serum Acylated Ghrelin Concentrations in Response to Short-Term Overfeeding in Normal Weight, Overweight, and Obese Men	PLOS ONE			English	Article							INCREASES FOOD-INTAKE; PLASMA GHRELIN; INSULIN-RESISTANCE; CIRCULATING GHRELIN; BODY-FAT; RELEASE; HYPERPHAGIA; SECRETION; DECREASE; HORMONES	Background: Ghrelin, an orexigenic gut hormone secreted primarily from the stomach, is involved in energy homeostasis. However, little data is available regarding its response to energy surplus and the development of human obesity. Objective: The present study investigated the response of circulating acylated ghrelin to a 7-day positive energy challenge. Design: A total of 68 healthy young men were overfed 70% more calories than required, for 1-week. Subjects were classified based on percent body fat (measured by dual-energy X-ray absorptiometry) as normal weight, overweight, and obese. Serum acylated ghrelin concentration was measured before and after the positive energy challenge. Additionally, the relationship between acylated ghrelin and obesity-related phenotypes including weight, body mass index, percent body fat, cholesterol, HDL-c, LDL-c, glucose, insulin and homeostasis model assessment of insulin resistance and beta-cell function at baseline and change due to overfeeding, were assessed. Results: Contrary to our expectations, serum acylated ghrelin was significantly increased in response to overfeeding and the increase was independent of obesity status. There was no significant difference in fasting acylated ghrelin between normal weight, overweight, and obese men at baseline. Acylated ghrelin was negatively correlated with weight and BMI for normal weight and with BMI in overweight men. Also ghrelin was correlated with change in weight and BMI in overweight (negative relationship) and obese (positive relationship) groups. Conclusion: Our results showed that circulating acylated ghrelin was increased after a 7-day positive energy challenge regardless of adiposity status. However, acylated ghrelin was correlated with change in weight and BMI in opposing directions, in overweight and obese subjects respectively, thus dependent on obesity status.	[Wadden, Danny; Cahill, Farrell; Amini, Peyvand; Vasdev, Sudesh; Yi, Yanqing; Sun, Guang] Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada; [Randell, Edward] Mem Univ Newfoundland, Discipline Lab Med, St John, NF, Canada; [Zhang, Weizhen] Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Memorial University Newfoundland; Memorial University Newfoundland; Peking University	Sun, G (corresponding author), Mem Univ Newfoundland, Fac Med, Div Med, St John, NF, Canada.	gsun@mun.ca	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798	Canadian Institutes for Health Research (CIHR); Canada Foundation for Innovation (CFI)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by the Canadian Institutes for Health Research (CIHR) and the Canada Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; BRAY GA, 2003, HDB HLTH CARE; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Cahill F, 2011, AM J CLIN NUTR, V93, P741, DOI 10.3945/ajcn.110.003624; Callahan HS, 2004, J CLIN ENDOCR METAB, V89, P1319, DOI 10.1210/jc.2003-031267; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; Druce MR, 2005, INT J OBESITY, V29, P1130, DOI 10.1038/sj.ijo.0803001; Erdmann J, 2003, REGUL PEPTIDES, V116, P101, DOI 10.1016/S0167-0115(03)00195-2; Fagerberg B, 2003, METABOLISM, V52, P1460, DOI 10.1016/S0026-0495(03)00274-9; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Hagobian TA, 2008, METABOLISM, V57, P393, DOI 10.1016/j.metabol.2007.10.016; Hansen TK, 2002, CLIN ENDOCRINOL, V56, P203, DOI 10.1046/j.0300-0664.2001.01456.x; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Hosoda H, 2003, J BIOL CHEM, V278, P64, DOI 10.1074/jbc.M205366200; Iwakura H, 2005, J BIOL CHEM, V280, P15247, DOI 10.1074/jbc.M411358200; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Konturek SJ, 2005, J PHYSIOL PHARMACOL, V56, P507; Korbonits M, 2004, EUR J ENDOCRINOL, V151, pS67, DOI 10.1530/eje.0.151S067; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Matsumoto M, 2001, BIOCHEM BIOPH RES CO, V287, P142, DOI 10.1006/bbrc.2001.5553; MAURIEGE P, 1992, INT J OBESITY, V16, P219; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE347, DOI 10.1152/ajpendo.00615.2004; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Natalucci G, 2005, EUR J ENDOCRINOL, V152, P845, DOI 10.1530/eje.1.01919; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Prince AC, 2009, AM J CLIN NUTR, V89, P755, DOI 10.3945/ajcn.2008.27056; Purnell JQ, 2003, J CLIN ENDOCR METAB, V88, P5747, DOI 10.1210/jc.2003-030513; Qader SS, 2005, REGUL PEPTIDES, V128, P51, DOI 10.1016/j.regpep.2004.12.018; Ravussin E, 2001, J CLIN ENDOCR METAB, V86, P4547, DOI 10.1210/jc.86.9.4547; Robertson MD, 2004, INT J OBESITY, V28, P727, DOI 10.1038/sj.ijo.0802637; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rosicka M, 2003, PHYSIOL RES, V52, P61; Shea J, 2007, AM J CLIN NUTR, V86, P1310, DOI 10.1093/ajcn/86.5.1310; Shea J, 2009, AM J CLIN NUTR, V89, P407, DOI 10.3945/ajcn.2008.25970; Stepien M, 2011, MED SCI MONITOR, V17, pPR13, DOI 10.12659/MSM.882030; Sun G, 2005, AM J CLIN NUTR, V81, P74; Sun G, 2007, AM J CLIN NUTR, V85, P399, DOI 10.1093/ajcn/85.2.399; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Votruba SB, 2009, AM J CLIN NUTR, V89, P801, DOI 10.3945/ajcn.2008.27011; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zwirska-Korczala K, 2007, J PHYSIOL PHARMACOL, V58, P13	53	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45748	10.1371/journal.pone.0045748	http://dx.doi.org/10.1371/journal.pone.0045748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029221	Green Accepted, gold, Green Published			2022-12-25	WOS:000309517500040
J	Virgone, C; Cecchetto, G; Ferrari, A; Bisogno, G; Donofrio, V; Boldrini, R; Collini, P; Dall'Igna, P; Alaggio, R				Virgone, Calogero; Cecchetto, Giovanni; Ferrari, Andrea; Bisogno, Gianni; Donofrio, Vittoria; Boldrini, Renata; Collini, Paola; Dall'Igna, Patrizia; Alaggio, Rita			GATA-4 and FOG-2 Expression in Pediatric Ovarian Sex Cord-Stromal Tumors Replicates Embryonal Gonadal Phenotype: Results from the TREP Project	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-4; MULLERIAN-INHIBITING SUBSTANCE; GRANULOSA-CELL TUMORS; YOLK-SAC TUMORS; RARE TUMORS; PROMOTERS; APOPTOSIS; COFACTOR; FAMILY; CANCER	Aim: GATA proteins are a family of zinc finger transcription factors regulating gene expression, differentiation and proliferation in various tissues. The expression of GATA-4 and FOG-2, one of its modulators, was studied in pediatric Sex Cord-Stromal tumors of the ovary, in order to evaluate their potential role as diagnostic markers and prognostic factors. Materials and Methods: Clinical and histological data of 15 patients, enrolled into the TREP Project since 2000 were evaluated. When available, immunostaines for FOG-2, GATA-4, alpha-Inhibin, Vimentin and Pancytokeratin were also analyzed. Results: In our series there were 6 Juvenile Granulosa Cell Tumors (JGCT), 6 Sertoli-Leydig Cell Tumors (SLCT), 1 Cellular Fibroma, 1 Theca Cell Tumor and 1 Stromal Sclerosing Tumor (SST). Thirteen patients obtained a complete remission (CR), 1 reached a second CR after the removal of a metachronous tumor and 1 died of disease. Inhibin was detectable in 11/15, Vimentin in 13/15, Pancytokeratin in 6/15, GATA-4 in 5/13 and FOG-2 in 11/15. FOG-2 was highly expressed in 5/6 JGCT, while GATA-4 was weakly detectable only in 1 of the cases. SLCT expressed diffusely FOG-2 (4/6) and GATA-4 (3/5). GATA-4 and FOG-2 were detected in fibroma and thecoma but not in the SST. Conclusions: Pediatric granulosa tumors appear to express a FOG-2/GATA-4 phenotype in keeping with primordial ovarian follicles. High expression of GATA-4 does not correlate with aggressive behaviour as seen in adults, but it is probably involved in cell proliferation its absence can be associated with the better outcome of JGCT. SLCTs replicate the phenotype of Sertoli cells during embryogenesis in normal testis. In this group, the lack of expression of FOG-2 in tumors in advanced stages might reveal a hypothetical role in inhibiting GATA-4 cell proliferation pathway. In fibroma/thecoma group GATA-4 and FOG-2 point out the abnormal activation of GATA pathway and might be involved in the onset of these tumors.	[Virgone, Calogero; Cecchetto, Giovanni; Bisogno, Gianni; Dall'Igna, Patrizia] Univ Hosp, Dept Pediat, Padua, Italy; [Virgone, Calogero; Cecchetto, Giovanni; Bisogno, Gianni; Dall'Igna, Patrizia] Univ Hosp, Dept Gynaecol Obstet, Padua, Italy; [Ferrari, Andrea] Ist Nazl Tumori, Pediat Oncol Unit, I-20133 Milan, Italy; [Donofrio, Vittoria] Azienda Osped Rilievo Nazl Santobono Pausillipon, Serv Anat & Istol Patol, Naples, Italy; [Boldrini, Renata] Bambino Gesu Pediat Hosp, Pathol Unit, Rome, Italy; [Collini, Paola] Ist Nazl Tumori, Pathol Unit, I-20133 Milan, Italy; [Alaggio, Rita] Univ Padua, Dept Med & Diagnost Sci & Special Therapies, Pathol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Bambino Gesu; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua	Virgone, C (corresponding author), Univ Hosp, Dept Pediat, Padua, Italy.	calogero.virgone@unipd.it	alaggio, rita/AAC-2348-2019; Ferrari, Andrea/R-1028-2016; Virgone, Calogero/ABB-7432-2020; Collini, Paola/K-7354-2016; Bisogno, Gianni/K-9282-2016	alaggio, rita/0000-0003-3915-3816; Ferrari, Andrea/0000-0002-4724-0517; Collini, Paola/0000-0002-6158-210X; Dall'Igna, Patrizia/0000-0002-3822-3272; Bisogno, Gianni/0000-0003-4462-5523; Virgone, Calogero/0000-0002-3651-9416	Fondazione Cassa Di Risparmio Di Padova e Rovigo; "Fondazione Citta' della Speranza," Padua	Fondazione Cassa Di Risparmio Di Padova e Rovigo(Fondazione Cariparo); "Fondazione Citta' della Speranza," Padua	This paper is partially supported by a Grant from "Fondazione Cassa Di Risparmio Di Padova e Rovigo" and from the "Fondazione Citta' della Speranza," Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2005, J CLIN ENDOCR METAB, V90, P6529, DOI 10.1210/jc.2005-0921; Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Ball Allison, 2011, J Pediatr Adolesc Gynecol, V24, pe5, DOI 10.1016/j.jpag.2010.07.005; Cecchetto G, 2011, PEDIATR BLOOD CANCER, V56, P1062, DOI 10.1002/pbc.22918; Ferrari A, 2007, EUR J CANCER, V43, P654, DOI 10.1016/j.ejca.2006.08.028; Gwin K, 2008, PEDIAT DEV PATHOL, V12, P1; Ketola I, 2000, J CLIN ENDOCR METAB, V85, P3925, DOI 10.1210/jc.85.10.3925; Kyronlahti A, 2008, ENDOCRINOLOGY, V149, P5635, DOI 10.1210/en.2008-0148; Kyronlahti A, 2010, ENDOCR-RELAT CANCER, V17, P709, DOI 10.1677/ERC-10-0041; Laitinen MPE, 2000, J CLIN ENDOCR METAB, V85, P3476, DOI 10.1210/jc.85.9.3476; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Mannisto S, 2005, TUMOR BIOL, V26, P265, DOI 10.1159/000087565; Masiakos PT, 1977, SEMIN PEDIATR SURG, V6, P147; Pastore G, 2009, PEDIATR BLOOD CANCER, V53, P152, DOI 10.1002/pbc.22049; Robert NM, 2002, ENDOCRINOLOGY, V143, P3963, DOI 10.1210/en.2002-220280; Robertson DM, 2004, SEMIN REPROD MED, V 22, P219, DOI 10.1055/s-2004-831897; Robertson DM, 2002, MOL CELL ENDOCRINOL, V191, P97, DOI 10.1016/S0303-7207(02)00060-6; Salonen J, 2010, EUR J ENDOCRINOL, V162, P625, DOI 10.1530/EJE-09-0734; SCULLY RE, 1996, ATLAS TUMOR PATHOLOG; Siltanen S, 1999, AM J PATHOL, V155, P1823, DOI 10.1016/S0002-9440(10)65500-9; Siltanen S, 2003, PEDIATR RES, V54, P542, DOI 10.1203/01.PDR.0000081295.56529.E9; Templeman Claire L, 2005, Semin Pediatr Surg, V14, P93; Tremblay JJ, 1999, MOL ENDOCRINOL, V13, P1388, DOI 10.1210/me.13.8.1388; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Vaskivuo TE, 2001, J CLIN ENDOCR METAB, V86, P3421, DOI 10.1210/jc.86.7.3421; Viger RS, 2004, J ANDROL, V25, P441; Watanabe K, 2000, P NATL ACAD SCI USA, V97, P1624, DOI 10.1073/pnas.97.4.1624; Young RH, 2005, MODERN PATHOL, V18, pS81, DOI 10.1038/modpathol.3800311; YOUNG RH, 1984, AM J SURG PATHOL, V8, P575, DOI 10.1097/00000478-198408000-00002	29	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45914	10.1371/journal.pone.0045914	http://dx.doi.org/10.1371/journal.pone.0045914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029311	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700088
J	Sheng, XY; Wei, Q; Jiang, LP; Li, X; Gao, Y; Wang, L				Sheng, Xianyong; Wei, Qian; Jiang, Liping; Li, Xue; Gao, Yuan; Wang, Li			Different Degree in Proteasome Malfunction Has Various Effects on Root Growth Possibly through Preventing Cell Division and Promoting Autophagic Vacuolization	PLOS ONE			English	Article							INTRACELLULAR PROTEIN-DEGRADATION; UBIQUITIN/PROTEASOME PATHWAY; ARABIDOPSIS; UBIQUITIN; INHIBITION; INDUCTION; ROLES; DEATH; SIZE; OVEREXPRESSION	The ubiquitin/proteasome pathway plays a vital role in plant development. But the effects of proteasome malfunction on root growth, and the mechanism underlying this involvement remains unclear. In the present study, the effects of proteasome inhibitors on Arabidopsis root growth were studied through the analysis of the root length, and meristem size and cell length in maturation zone using FM4-64, and cell-division potential using GFP fusion cyclin B, and accumulation of ubiquitinated proteins using immunofluorescence labeling, and autophagy activity using LysoTracker and MDC. The results indicated that lower concentration of proteasome inhibitors promoted root growth, whereas higher concentration of inhibitors had the opposite effects. The accumulation of cyclin B was linked to MG132-induced decline in meristem size, indicating that proteasome malfunction prevented cell division. Besides, MG132-induced accumulation of the ubiquitinated proteins was associated with the increasing fluorescence signal of LysoTracker and MDC in the elongation zone, revealing a link between the activation of autophagy and proteasome malfunction. These results suggest that weak proteasome malfunction activates moderate autophagy and promotes cell elongation, which compensates the inhibitor-induced reduction of cell division, resulting in long roots. Whereas strong proteasome malfunction induces severe autophagy and disturbs cell elongation, resulting in short roots.	[Sheng, Xianyong; Wei, Qian; Jiang, Liping; Li, Xue; Gao, Yuan] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Sheng, Xianyong] Chinese Acad Sci, Inst Bot, Key Lab Mol Physiol, Beijing, Peoples R China; [Wang, Li] Cent S Univ, Sch Biol Sci & Technol, Changsha, Hunan, Peoples R China	Capital Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Central South University	Sheng, XY (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	xianyong.sheng@163.com			Natural Science Foundation of China [30700039, 30800088]; Scientific Research Project of Beijing Educational Committee [KM201210028017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Project of Beijing Educational Committee	This work was supported by Natural Science Foundation of China (Grant No. 30700039; 30800088) and Scientific Research Project of Beijing Educational Committee (Grant No. KM201210028017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cecconi F, 2007, AUTOPHAGY, V3, P506; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Criqui MC, 2000, PLANT J, V24, P763, DOI 10.1111/j.1365-313X.2000.t01-1-.x; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; Du YL, 2009, AUTOPHAGY, V5, P663, DOI 10.4161/auto.5.5.8377; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Ingvardsen C, 2001, PLANTA, V213, P333, DOI 10.1007/s004250000511; Kim M, 2003, J BIOL CHEM, V278, P19406, DOI 10.1074/jbc.M210539200; Kurepa J, 2008, BIOCHIMIE, V90, P324, DOI 10.1016/j.biochi.2007.07.019; Kurepa J, 2009, PLANT SIGNAL BEHAV, V4, P924, DOI 10.4161/psb.4.10.9469; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li WF, 2010, MOL PLANT, V3, P212, DOI 10.1093/mp/ssp086; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Minnnaugh EG, 2004, MOL CANCER THER, V3, P551; Mitou G., 2009, INT J PLANT GENOMICS; Mizukami Y, 2001, CURR OPIN PLANT BIOL, V4, P533, DOI 10.1016/S1369-5266(00)00212-0; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Moriyasu Y, 2003, PLANT CELL PHYSIOL, V44, P795, DOI 10.1093/pcp/pcg100; Negi S, 2010, MOL PLANT, V3, P854, DOI 10.1093/mp/ssq033; Patel S, 2008, AUTOPHAGY, V4, P20, DOI 10.4161/auto.5056; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Planchais S, 2004, PLANT J, V38, P616, DOI 10.1111/j.0960-7412.2004.02071.x; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sako K, 2010, J PLANT RES, V123, P701, DOI 10.1007/s10265-010-0321-x; Sheng XY, 2010, CELL BIOCHEM FUNCT, V28, P420, DOI 10.1002/cbf.1672; Sheng XY, 2006, PLANT PHYSIOL, V141, P1578, DOI 10.1104/pp.106.081703; Sheng XY, 2011, TREES-STRUCT FUNCT, V25, P407, DOI 10.1007/s00468-010-0515-9; Smalle J, 2002, PLANT CELL, V14, P17, DOI 10.1105/tpc.010381; Speranza A, 2001, PLANT PHYSIOL, V126, P1150, DOI 10.1104/pp.126.3.1150; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Takatsuka C, 2011, PLANT CELL PHYSIOL, V52, P2074, DOI 10.1093/pcp/pcr137; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Ueda M, 2004, DEVELOPMENT, V131, P2101, DOI 10.1242/dev.01096; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wagenknecht B, 2000, J NEUROCHEM, V75, P2288, DOI 10.1046/j.1471-4159.2000.0752288.x; Wang SH, 2011, PLANT CELL, V23, P3412, DOI 10.1105/tpc.111.089920; Wu WKK, 2008, BIOCHEM BIOPH RES CO, V374, P258, DOI 10.1016/j.bbrc.2008.07.031	46	12	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45673	10.1371/journal.pone.0045673	http://dx.doi.org/10.1371/journal.pone.0045673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029176	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800078
J	Moen, SM; Celius, EG; Sandvik, L; Brustad, M; Nordsletten, L; Eriksen, EF; Holmoy, T				Moen, Stine Marit; Celius, Elisabeth Gulowsen; Sandvik, Leiv; Brustad, Magritt; Nordsletten, Lars; Eriksen, Erik Fink; Holmoy, Trygve			Bone Turnover and Metabolism in Patients with Early Multiple Sclerosis and Prevalent Bone Mass Deficit: A Population-Based Case-Control Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MINERAL DENSITY; 25-HYDROXYVITAMIN-D LEVELS; SERUM 25-HYDROXYVITAMIN-D; DOSE GLUCOCORTICOIDS; RISK; ASSOCIATION; WOMEN; HEALTH	Background: Low bone mass is prevalent in ambulatory multiple sclerosis (MS) patients even shortly after clinical onset. The mechanism is not known, but could involve shared etiological risk factors between MS and low bone mass such as hypovitaminosis D operating before disease onset, or increased bone loss after disease onset. The aim of this study was to explore the mechanism of the low bone mass in early-stage MS patients. Methodology/Principal Findings: We performed a population-based case-control study comparing bone turnover (crosslinked N-terminal telopeptide of type 1 collagen; NTX, bone alkaline phosphatase; bALP), metabolism (25-hydroxy-and 1, 25-dihydroxyvitamin D, calcium, phosphate, and parathyroid hormone), and relevant lifestyle factors in 99 patients newly diagnosed with clinically isolated syndrome (CIS) or MS, and in 159 age, sex, and ethnicity matched controls. After adjustment for possible confounders, there were no significant differences in NTX (mean 3.3; 95% CI -6.9, 13.5; p = 0.519), bALP (mean 1.6; 95% CI -0.2, 3.5; p = 0.081), or in any of the parameters related to bone metabolism in patients compared to controls. The markers of bone turnover and metabolism were not significantly correlated with bone mass density, or associated with the presence of osteoporosis or osteopenia within or between the patient and control groups. Intake of vitamin D and calcium, reported UV exposure, and physical activity did not differ significantly. Conclusions/Significance: Bone turnover and metabolism did not differ significantly in CIS and MS patients with prevalent low bone mass compared to controls. These findings indicate that the bone deficit in patients newly diagnosed with MS and CIS is not caused by recent acceleration of bone loss, and are compatible with shared etiological factors between MS and low bone mass.	[Moen, Stine Marit; Celius, Elisabeth Gulowsen] Univ Oslo, Ulleval Hosp, Dept Neurol, Oslo, Norway; [Sandvik, Leiv] Univ Oslo, Ulleval Hosp, Epidemiol & Biostat Sect, Oslo, Norway; [Brustad, Magritt] Univ Tromso, Dept Community Med, Tromso, Norway; [Nordsletten, Lars] Univ Oslo, Ulleval Hosp, Dept Orthoped, Oslo, Norway; [Eriksen, Erik Fink] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Holmoy, Trygve] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Holmoy, Trygve] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Moen, SM (corresponding author), Univ Oslo, Ulleval Hosp, Dept Neurol, Oslo, Norway.	s.m.moen@medisin.uio.no	Celius, Elisabeth Gulowsen/S-1387-2019; Eriksen, Erik Fink/AAF-5056-2020	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; 	South-Eastern Norway Regional Health Authority; Ulleval University Hospital; Odd Fellow Research Foundation for Multiple Sclerosis; Endowment of K. and K. H. Hemsen; Endowment of Fritz and Ingrid Nilsen	South-Eastern Norway Regional Health Authority; Ulleval University Hospital; Odd Fellow Research Foundation for Multiple Sclerosis; Endowment of K. and K. H. Hemsen; Endowment of Fritz and Ingrid Nilsen	Study funding: Supported by research grants from the South-Eastern Norway Regional Health Authority, Ulleval University Hospital, Odd Fellow Research Foundation for Multiple Sclerosis, the Endowment of K. and K. H. Hemsen, and the Endowment of Fritz and Ingrid Nilsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alver K, 2005, OSTEOPOROSIS INT, V16, P623, DOI 10.1007/s00198-004-1722-2; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barnes MS, 2007, MULT SCLER, V13, P670, DOI 10.1177/1352458506072666; Bazelier MT, 2012, MULT SCLER J, V18, P622, DOI 10.1177/1352458511426739; Bazelier MT, 2011, J BONE MINER RES, V26, P2271, DOI 10.1002/jbmr.418; Brustad M, 2004, PUBLIC HEALTH NUTR, V7, P327, DOI 10.1079/PHN2003536; Brustad M, 2004, EUR J CLIN NUTR, V58, P128, DOI 10.1038/sj.ejcn.1601759; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Cosman F, 1998, NEUROLOGY, V51, P1161, DOI 10.1212/WNL.51.4.1161; COSMAN F, 1994, J BONE MINER RES, V9, P1097; Czerny B, 2010, EUR J OBSTET GYN R B, V149, P82, DOI 10.1016/j.ejogrb.2009.12.010; Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164; Edvardsen K, 2009, INT J BIOMETEOROL, V53, P451, DOI 10.1007/s00484-009-0231-6; Gelfand JM, 2011, NEUROLOGY, V76, P1824, DOI 10.1212/WNL.0b013e31821cccf5; Gibson JC, 2011, OSTEOPOROSIS INT, V22, P2935, DOI 10.1007/s00198-011-1644-8; Gilboe IM, 2000, ANN RHEUM DIS, V59, P110, DOI 10.1136/ard.59.2.110; Hawkes CH, 2007, MULT SCLER J, V13, P610, DOI 10.1177/1352458506073501; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hearn AP, 2010, MULT SCLER J, V16, P1031, DOI 10.1177/1352458510368985; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Kragt JJ, 2009, MULT SCLER J, V15, P9, DOI 10.1177/1352458508095920; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lagunova Z, 2009, ANTICANCER RES, V29, P3713, DOI 10.14341/2071-8713-4886; Lilleby V, 2005, ARTHRITIS RHEUM, V52, P2051, DOI 10.1002/art.21115; Lonergan R, 2011, J NEUROL NEUROSUR PS, V82, P317, DOI 10.1136/jnnp.2010.220988; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Minisola S, 2008, J Endocrinol Invest, V31, P28; Mirowska-Guzel D, 2011, J NEUROIMMUNOL, V236, P87, DOI 10.1016/j.jneuroim.2011.04.014; Mirzaei F, 2011, ANN NEUROL, V70, P30, DOI 10.1002/ana.22456; Moen SM, 2011, NEUROLOGY, V77, P151, DOI 10.1212/WNL.0b013e3182242d34; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2009, NEUROLOGY, V73, P1543, DOI 10.1212/WNL.0b013e3181c0d6e0; NIEVES J, 1994, NEUROLOGY, V44, P1687, DOI 10.1212/WNL.44.9.1687; Ozgocmen S, 2005, J BONE MINER METAB, V23, P309, DOI 10.1007/s00774-005-0604-9; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Seibel MJ, 2003, ENDOCRIN METAB CLIN, V32, P83, DOI 10.1016/S0889-8529(02)00077-4; Shaygannejad V, 2010, INT J PREVENTIVE MED, V1, P195; Smestad C, 2008, J NEUROL, V255, P49, DOI 10.1007/s00415-007-0659-8; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; Soilu-Hanninen M, 2008, J NEUROL NEUROSUR PS, V79, P152, DOI 10.1136/jnnp.2006.105320; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Steffensen LH, 2010, J NEUROL, V257, P410, DOI 10.1007/s00415-009-5337-6; Stepan JJ, 2004, CLIN CHIM ACTA, V348, P147, DOI 10.1016/j.cccn.2004.05.012; Sundqvist E, 2010, EUR J HUM GENET, V18, P1349, DOI 10.1038/ejhg.2010.113; Terzi T, 2010, J CLIN NEUROSCI, V17, P1260, DOI 10.1016/j.jocn.2010.01.044; Triantafyllou N, 2012, J NEUROL SCI, V313, P137, DOI 10.1016/j.jns.2011.09.002; Tuzun S, 2003, MULT SCLER, V9, P600, DOI 10.1191/1352458503ms966oa; van der Mei IAF, 2007, J NEUROL, V254, P581, DOI 10.1007/s00415-006-0315-8; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Zikan V, 2011, J OSTEOPOROS, V2011, DOI 10.4061/2011/596294	54	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45703	10.1371/journal.pone.0045703	http://dx.doi.org/10.1371/journal.pone.0045703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029191	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400122
J	Emmenegger, BA; Hwang, EI; Moore, C; Markant, SL; Brun, SN; Dutton, JW; Read, TA; Fogarty, MP; Singh, AR; Durden, DL; Yang, C; McKeehan, WL; Wechsler-Reya, RJ				Emmenegger, B. A.; Hwang, E. I.; Moore, C.; Markant, S. L.; Brun, S. N.; Dutton, J. W.; Read, T-A; Fogarty, M. P.; Singh, A. R.; Durden, D. L.; Yang, C.; McKeehan, W. L.; Wechsler-Reya, R. J.			Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma	ONCOGENE			English	Article						basic FGF; cerebellum; medulloblastoma; granule; sonic hedgehog	HEDGEHOG PATHWAY INHIBITOR; FACTOR RECEPTOR; CELL-PROLIFERATION; STEM-CELLS; SUPPRESSOR; PRECURSORS; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; PROGRESSION	Cerebellar granule neurons are the most abundant neurons in the brain, and a critical element of the circuitry that controls motor coordination and learning. In addition, granule neuron precursors (GNPs) are thought to represent cells of origin for medulloblastoma, the most common malignant brain tumor in children. Thus, understanding the signals that control the growth and differentiation of these cells has important implications for neurobiology and neurooncology. Our previous studies have shown that proliferation of GNPs is regulated by Sonic hedgehog (Shh), and that aberrant activation of the Shh pathway can lead to medulloblastoma. Moreover, we have demonstrated that Shh-dependent proliferation of GNPs and medulloblastoma cells can be blocked by basic fibroblast growth factor (bFGF). But while the mitogenic effects of Shh signaling have been confirmed in vivo, the inhibitory effects of bFGF have primarily been studied in culture. Here, we demonstrate that mice lacking FGF signaling in GNPs exhibit no discernable changes in GNP proliferation or differentiation. In contrast, activation of FGF signaling has a potent effect on tumor growth: treatment of medulloblastoma cells with bFGF prevents them from forming tumors following transplantation, and inoculation of tumor-bearing mice with bFGF markedly inhibits tumor growth in vivo. These results suggest that activators of FGF signaling may be useful for targeting medulloblastoma and other Shh-dependent tumors.	[Emmenegger, B. A.; Markant, S. L.; Brun, S. N.; Wechsler-Reya, R. J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA; [Emmenegger, B. A.; Markant, S. L.; Brun, S. N.; Wechsler-Reya, R. J.] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Durham, NC USA; [Hwang, E. I.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Moore, C.; Markant, S. L.; Brun, S. N.; Wechsler-Reya, R. J.] Sanford Burnham Med Res Inst, Tumor Dev Program, La Jolla, CA 92037 USA; [Dutton, J. W.] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA; [Read, T-A] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Fogarty, M. P.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Singh, A. R.; Durden, D. L.] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Yang, C.; McKeehan, W. L.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA	Duke University; Duke University; Children's National Health System; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; North Carolina State University; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wechsler-Reya, RJ (corresponding author), Sanford Burnham Med Res Inst, Tumor Dev Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rwreya@sanfordburnham.org		Read, Tracy-Ann/0000-0002-5436-1296	National Institute of Mental Health [MH67916]; Pediatric Brain Tumor Foundation of the US; California Institute for Regenerative Medicine [LA1-01747]; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067916] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pediatric Brain Tumor Foundation of the US; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Marcie Kritzik for help with the paper, Kerry Dorr for contributions to the early stages of this work, Albert Basson for helpful discussions, Chuxia Deng, David Ornitz and James Olson for providing mice, Matthias Lauth and Rune Toftgard for Sufu<SUP>-/-</SUP> MEFs, Sam Johnson for help with microscopy, Amanda Conway for help with western blotting, and Mike Cook and Beth Harvat for help with flow cytometry. This work was funded by grant number MH67916 from the National Institute of Mental Health, by funds from the Pediatric Brain Tumor Foundation of the US, and by a Leadership Award (LA1-01747) from the California Institute for Regenerative Medicine.	Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Ballinger MD, 1999, NAT BIOTECHNOL, V17, P1199, DOI 10.1038/70746; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Debinski W, 2009, EXPERT REV NEUROTHER, V9, P1519, DOI 10.1586/ERN.09.99; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FISHELL G, 1991, DEVELOPMENT, V113, P755; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; Goldowitz D, 1998, TRENDS NEUROSCI, V21, P375, DOI 10.1016/S0166-2236(98)01313-7; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hamre KM, 1997, DEVELOPMENT, V124, P4201; Hatton BA, 2008, CANCER RES, V68, P1768, DOI 10.1158/0008-5472.CAN-07-5092; Hsu P, 2001, BRAIN RES, V896, P188, DOI 10.1016/S0006-8993(01)02173-4; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kenigsberg RL, 1997, AM J PATHOL, V151, P867; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kofuji P, 1996, NEURON, V16, P941, DOI 10.1016/S0896-6273(00)80117-8; Komuro H, 1998, J NEUROSCI, V18, P1478; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee Y, 2007, ONCOGENE, V26, P6442, DOI 10.1038/sj.onc.1210467; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Li SZ, 2009, DEV NEUROBIOL, V69, P837, DOI 10.1002/dneu.20740; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; MARES V, 1970, BRAIN RES, V23, P323, DOI 10.1016/0006-8993(70)90060-0; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mullen RJ, 1997, PERSPECT DEV NEUROBI, V5, P43; NICHOLSO.JL, 1972, BRAIN RES, V44, P13, DOI 10.1016/0006-8993(72)90362-9; Nicot A, 2002, J NEUROSCI, V22, P9244; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Olson DC, 1998, CELL GROWTH DIFFER, V9, P557; PASCUALCASTROVIEJO I, 1994, NEUROPEDIATRICS, V25, P183, DOI 10.1055/s-2008-1073020; Pons S, 2001, DEVELOPMENT, V128, P1481; Read TA, 2009, CANCER CELL, V15, P1; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Song BW, 2002, J PHARMACOL EXP THER, V301, P605, DOI 10.1124/jpet.301.2.605; Spassky N, 2008, DEV BIOL, V317, P246, DOI 10.1016/j.ydbio.2008.02.026; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Vachon P, 2004, J NEURO-ONCOL, V67, P139, DOI 10.1023/B:NEON.0000021824.41701.e5; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang VY, 2001, NAT REV NEUROSCI, V2, P484, DOI 10.1038/35081558; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200; Xu XL, 2002, GENESIS, V32, P85, DOI 10.1002/gene.10028; Yaguchi Y, 2009, DEV DYNAM, V238, P2058, DOI 10.1002/dvdy.22013; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yu CD, 2005, J BIOL CHEM, V280, P17707, DOI 10.1074/jbc.M411771200; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	67	22	22	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4181	4188		10.1038/onc.2012.440	http://dx.doi.org/10.1038/onc.2012.440			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	23045271	Green Accepted, Green Submitted			2022-12-25	WOS:000323748500013
J	Friedrich, DC; Santos, SEB; Ribeiro-dos-Santos, AKC; Hutz, MH				Friedrich, Deise C.; Santos, Sidney E. B.; Ribeiro-dos-Santos, Andrea K. C.; Hutz, Mara H.			Several Different Lactase Persistence Associated Alleles and High Diversity of the Lactase Gene in the Admixed Brazilian Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; PHLORHIZIN HYDROLASE GENE; ADULT-TYPE HYPOLACTASIA; HAPLOTYPE RECONSTRUCTION; LINKAGE DISEQUILIBRIUM; VARIANT; EVOLUTION; C/T-13910; UPSTREAM; AFRICA	Adult-type hypolactasia is a common phenotype caused by the lactase enzyme deficiency. The -13910 C>T polymorphism, located 14 Kb upstream of the lactase gene (LCT) in the MCM6 gene was associated with lactase persistence (LP) in Europeans. This polymorphism is rare in Africa but several other variants associated with lactase persistence were observed in Africans. The aims of this study were to identify polymorphisms in the MCM6 region associated with the lactase persistence phenotype and to determine the distribution of LCT gene haplotypes in 981 individuals from North, Northeast and South Brazil. These polymorphisms were genotyped by PCR based methods and sequencing. The -13779*C, -13910*T, -13937*A, -14010*C, -14011*T LP alleles previously described in the MCM6 gene region that acts as an enhancer for the LCT gene were identified in Brazilians. The most common LP allele was -13910*T. Its frequency was highly correlated with European ancestry in the Brazilian populations investigated. The -13910*T was higher (0.295) in southern Brazilians of European ancestry and lower (0.175) in the Northern admixed population. LCT haplotypes were derived from the 10 LCT SNPs genotyped. Overall twenty six haplotypes previously described were identified in the four Brazilian populations studied. The Multidimensional Scaling analysis showed that Belem, in the north, was closer to Amerindians. Northeastern and southern Afro-descendants were more related with Bantu-speaking South Africans whereas the Southern population with European ancestry grouped with Southern and Northern Europeans. This study shows a high variability considering the number of LCT haplotypes observed. Due to the highly admixed nature of the Brazilian populations, the diagnosis of hypolactasia in Brazil, based only in the investigation of the -13910*T allele is an oversimplification.	[Friedrich, Deise C.; Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Santos, Sidney E. B.; Ribeiro-dos-Santos, Andrea K. C.] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Para	Hutz, MH (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	mara.hutz@ufrgs.br	Santos, Ândrea Ribeiro dos/B-6061-2013; Hutz, Mara H/I-4070-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Friedrich, Deise/F-5790-2017	Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Friedrich, Deise/0000-0002-4613-5301; Hutz, Mara/0000-0002-9146-1229	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [470937/2010-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil; grant # 470937/2010-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; BOLL W, 1991, AM J HUM GENET, V48, P889; Bulhoes AC, 2007, BRAZ J MED BIOL RES, V40, P1441, DOI 10.1590/S0100-879X2007001100004; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; De Andrade FM, 2011, NUTR METAB CARDIOVAS, V21, P584, DOI 10.1016/j.numecd.2009.12.013; De Franca E, 2004, HUM BIOL, V76, P267, DOI 10.1353/hub.2004.0030; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2007, WORLD J GASTROENTERO, V13, P3508, DOI 10.3748/wjg.v13.i25.3508; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Everitt BS., 1992, ANAL CONTINGENCY TAB; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fiegenbaum M, 2007, CLIN CHIM ACTA, V380, P175, DOI 10.1016/j.cca.2007.02.007; Friedrich DC, 2012, AM J PHYS ANTHROPOL, V147, P427, DOI 10.1002/ajpa.22010; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Ingram CJE, 2009, J MOL EVOL, V69, P579, DOI 10.1007/s00239-009-9301-y; Jensen TGK, 2011, HUM GENET, V130, P483, DOI 10.1007/s00439-011-0966-0; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Lee MF, 1998, NUTR REV, V56, P1; Lember M, 2006, WORLD J GASTROENTERO, V12, P7329, DOI 10.3748/wjg.v12.i45.7329; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Mattar R, 2008, CLIN BIOCHEM, V41, P628, DOI 10.1016/j.clinbiochem.2008.01.006; Mattar R, 2010, CLINICS, V65, P1399, DOI 10.1590/S1807-59322010001200030; Mattevi VS, 2002, INT J OBESITY, V26, P1179, DOI 10.1038/sj.ijo.0802067; MONTGOMERY RK, 1991, FASEB J, V5, P2824, DOI 10.1096/fasebj.5.13.1916106; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Romero IG, 2012, MOL BIOL EVOL, V29, P248, DOI 10.1093/molbev/msr190; Salzano FM, 2002, EVOLUTION GENETICS L; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tomas G, 2002, HUM BIOL, V74, P397, DOI 10.1353/hub.2002.0036; Torniainen S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-31; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; Wright S., 1969, EVOLUTION GENETICS P; Wright S., 1978, EVOLUTION GENETICS P	50	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46520	10.1371/journal.pone.0046520	http://dx.doi.org/10.1371/journal.pone.0046520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029545	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900181
J	Gautam, P; Nair, SC; Gupta, MK; Sharma, R; Polisetty, RV; Uppin, MS; Sundaram, C; Puligopu, AK; Ankathi, P; Purohit, AK; Chandak, GR; Harsha, HC; Sirdeshmukh, R				Gautam, Poonam; Nair, Sudha C.; Gupta, Manoj Kumar; Sharma, Rakesh; Polisetty, Ravindra Varma; Uppin, Megha S.; Sundaram, Challa; Puligopu, Aneel K.; Ankathi, Praveen; Purohit, Aniruddh K.; Chandak, Giriraj R.; Harsha, H. C.; Sirdeshmukh, Ravi			Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SERUM CARNOSINASE; CHROMOGRANIN-A; EXPRESSION; BRAIN; FERRITIN; MARKERS; CELLS; DIFFERENTIATION; INFLAMMATION	Glioblastomas (GBMs) are the most common and lethal primary tumors of the central nervous system with high level of recurrence despite aggressive therapy. Tumor-associated proteins/peptides may appear in the plasma of these patients as a result of disruption of the blood-brain barrier in them, raising the scope for development of plasma-based tests for diagnosis and monitoring the disease. With this objective, we analyzed the levels of proteins present in the plasma from GBM patients using an iTRAQ based LC-MS/MS approach. Analysis with pooled plasma specimens from the patient and healthy control samples revealed high confidence identification of 296 proteins, of which 61 exhibited a fold-change >= 1.5 in the patient group. Forty-eight of them contained signal sequence. A majority have been reported in the differentially expressed transcript or protein profile of GBM tissues; 6 have been previously studied as plasma biomarkers for GBM and 16 for other types of cancers. Altered levels of three representative proteins-ferritin light chain (FTL), S100A9, and carnosinase 1 (CNDP1)-were verified by ELISA in a test set of ten individual plasma specimens. FTL is an inflammation marker also implicated in cancer, S100A9 is an important member of the Ca2+ signaling cascade reported to be altered in GBM tissue, and CNDP1 has been reported for its role in the regulation of the levels of carnosine, implicated as a potential drug for GBM. These and other proteins in the dataset may form useful starting points for further clinical investigations for the development of plasma-based biomarker panels for GBM.	[Sharma, Rakesh; Harsha, H. C.; Sirdeshmukh, Ravi] Inst Bioinformat, Bangalore, Karnataka, India; [Gautam, Poonam; Nair, Sudha C.; Gupta, Manoj Kumar; Polisetty, Ravindra Varma; Chandak, Giriraj R.; Sirdeshmukh, Ravi] Ctr Cellular & Mol Biol CSIR, Hyderabad, Andhra Pradesh, India; [Uppin, Megha S.; Sundaram, Challa; Puligopu, Aneel K.; Ankathi, Praveen; Purohit, Aniruddh K.] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Nizam's Institute of Medical Sciences	Sirdeshmukh, R (corresponding author), Inst Bioinformat, Bangalore, Karnataka, India.	sirdesh@ibioinformatics.org	Gowda, Harsha/A-8526-2011	Gowda, Harsha/0000-0002-4118-6855; Gupta, Manoj Kumar/0000-0002-1432-9793; Chandak, Giriraj Ratan/0000-0002-3095-9453; Sharma, Rakesh/0000-0002-5306-3457	Council of Scientific and Industrial Research (CSIR), Government of India [NWP 0004, IAP 001]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work reported here was carried out under the Network Project NWP 0004 and IAP 001 supported by the Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belli Susana Haydee, 2009, Acta Gastroenterol Latinoam, V39, P184; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Deininger MH, 2003, ACTA NEUROPATHOL, V106, P271, DOI 10.1007/s00401-003-0727-9; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; GASQUE P, 1992, J IMMUNOL, V149, P1381; Gaunitz F, 2012, AMINO ACIDS, V43, P135, DOI 10.1007/s00726-012-1271-5; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Haapasalo J, 2007, NEURO-ONCOLOGY, V9, P308, DOI 10.1215/15228517-2007-001; Hormigo A, 2006, CLIN CANCER RES, V12, P5698, DOI 10.1158/1078-0432.CCR-06-0181; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Iwamoto FM, 2011, NEURO-ONCOLOGY, V13, P1244, DOI 10.1093/neuonc/nor117; Jarvela S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-104; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Khwaja FW, 2006, PROTEOMICS, V6, P6277, DOI 10.1002/pmic.200600135; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P111, DOI 10.1016/j.ecl.2010.12.001; LENNEY JF, 1983, CLIN CHIM ACTA, V132, P157, DOI 10.1016/0009-8981(83)90243-7; Maenpaa A, 1997, ACTA NEUROPATHOL, V94, P216, DOI 10.1007/s004010050696; MAXIM PE, 1986, CANCER, V57, P305, DOI 10.1002/1097-0142(19860115)57:2<305::AID-CNCR2820570219>3.0.CO;2-D; MCCOMB RD, 1982, J NEUROPATH EXP NEUR, V41, P479; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; MURAKAMI M, 1988, J CLIN INVEST, V82, P177, DOI 10.1172/JCI113568; Nemeth Julia, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P329; NOMURA A, 1992, CANCER EPIDEM BIOMAR, V1, P547; OZAWA H, 1994, PEDIATR NEUROL, V10, P44, DOI 10.1016/0887-8994(94)90066-3; Petrik V, 2008, CLIN CHEM, V54, P713, DOI 10.1373/clinchem.2007.096792; Polisetty RV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013565; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Quaranta M, 2007, TUMORI J, V93, P275; Rajcevic U, 2009, MOL CELL PROTEOMICS, V8, P2595, DOI 10.1074/mcp.M900124-MCP200; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Reynes G, 2011, J NEURO-ONCOL, V102, P35, DOI 10.1007/s11060-010-0290-x; ROTH J, 1993, BLOOD, V82, P1875; Salmaggi A, 1999, CANCER LETT, V146, P169, DOI 10.1016/S0304-3835(99)00255-4; Sato Y, 1998, J NEURO-ONCOL, V40, P47, DOI 10.1023/A:1006078521790; Schneider SW, 2004, ACTA NEUROPATHOL, V107, P272, DOI 10.1007/s00401-003-0810-2; Schoen P, 2003, CLIN CHEM, V49, P1930, DOI 10.1373/clinchem.2003.019398; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WASSIF WS, 1994, CLIN CHIM ACTA, V225, P57, DOI 10.1016/0009-8981(94)90027-2; WEINSTEIN PS, 1984, SCAND J IMMUNOL, V19, P193; Xu G, 2010, INDIAN J BIOCHEM BIO, V47, P211; Zhou M, 2010, CANCER RES, V70, P7534, DOI 10.1158/0008-5472.CAN-10-0815	49	58	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46153	10.1371/journal.pone.0046153	http://dx.doi.org/10.1371/journal.pone.0046153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029420	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900100
J	Li, L; Ban, ZJ; Li, XH; Wu, MY; Wang, AL; Jiang, YQ; Jiang, YH				Li, Li; Ban, Zhao-Jun; Li, Xi-Hong; Wu, Mao-Yu; Wang, Ai-Li; Jiang, Yu-Qian; Jiang, Yun-Hong			Differential Expression of Anthocyanin Biosynthetic Genes and Transcription Factor PcMYB10 in Pears (Pyrus communis L.)	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; FLAVONOID BIOSYNTHESIS; CHALCONE SYNTHASE; COLOR DEVELOPMENT; PYRIFOLIA NAKAI; UV-B; RED; ACCUMULATION; APPLE; BIOCHEMISTRY	Anthocyanin biosynthesis in various plants is affected by environmental conditions and controlled by the transcription level of the corresponding genes. In pears (Pyrus communis cv. 'Wujiuxiang'), anthocyanin biosynthesis is significantly induced during low temperature storage compared with that at room temperature. We further examined the transcriptional levels of anthocyanin biosynthetic genes in 'Wujiuxiang' pears during developmental ripening and temperature-induced storage. The expression of genes that encode flavanone 3-hydroxylase, dihydroflavonol 4-reductase, anthocyanidin synthase, UDPglucose: flavonoid 3-O-glucosyltransferase, and R2R3 MYB transcription factor (PcMYB10) was strongly positively correlated with anthocyanin accumulation in 'Wujiuxiang' pears in response to both developmental and cold-temperature induction. Hierarchical clustering analysis revealed the expression patterns of the set of target genes, of which PcMYB10 and most anthocyanin biosynthetic genes were related to the same cluster. The present work may help explore the molecular mechanism that regulates anthocyanin biosynthesis and its response to abiotic stress at the transcriptional level in plants.	[Li, Li; Li, Xi-Hong; Wang, Ai-Li; Jiang, Yu-Qian] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China; [Ban, Zhao-Jun; Wu, Mao-Yu] All China Federat Supply & Mkt Cooperat, Jinan Fruit Res Inst, Jinan, Shandong, Peoples R China; [Ban, Zhao-Jun] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Xinjiang, Peoples R China; [Jiang, Yun-Hong] Univ Leeds, Sch Proc Environm & Mat Engn, Inst Particle Sci & Engn, Leeds, W Yorkshire, England	Tianjin University Science & Technology; Xinjiang Agricultural University; University of Leeds	Li, XH (corresponding author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Food Nutr & Safety, Tianjin, Peoples R China.	Jimmy.li1011@gmail.com	jiang, yu/HGU-0029-2022; jiang, yunhong/O-9673-2017	jiang, yunhong/0000-0003-3292-8164	Cultivation Foundation from Tianjin University of Science and Technology; Ministry of Education (MOE); Agriculture and Agri-Food Canada (AAFC)	Cultivation Foundation from Tianjin University of Science and Technology; Ministry of Education (MOE); Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada)	The authors are grateful for the financial support provided by the Cultivation Foundation for the Excellent Ph.D. Dissertation from Tianjin University of Science and Technology, and the Ministry of Education (MOE) and Agriculture and Agri-Food Canada (AAFC) for the Ph.D. fellowship, granted for L. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2007, PLANT CELL PHYSIOL, V48, P958, DOI 10.1093/pcp/pcm066; Ban Y, 2009, PLANTA, V230, P871, DOI 10.1007/s00425-009-0993-4; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chagne D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-212; CHRISTIE PJ, 1994, PLANTA, V194, P541, DOI 10.1007/BF00714468; Crifo T, 2012, J AGR FOOD CHEM, V60, P476, DOI 10.1021/jf203891e; de Pascual-Teresa S, 2010, INT J MOL SCI, V11, P1679, DOI 10.3390/ijms11041679; DUSSI MC, 1995, J AM SOC HORTIC SCI, V120, P785, DOI 10.21273/JASHS.120.5.785; Feng SQ, 2010, PLANTA, V232, P245, DOI 10.1007/s00425-010-1170-5; Fischer TC, 2007, TREES-STRUCT FUNCT, V21, P521, DOI 10.1007/s00468-007-0145-z; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; JU ZG, 1995, SCI HORTIC-AMSTERDAM, V63, P175, DOI 10.1016/0304-4238(95)00807-6; Ju ZG, 1997, SCI HORTIC-AMSTERDAM, V70, P31, DOI 10.1016/S0304-4238(97)00040-X; Lancaster JE, 2000, J HORTIC SCI BIOTECH, V75, P142, DOI 10.1080/14620316.2000.11511213; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lister CE, 1996, J SCI FOOD AGR, V71, P313, DOI [10.1002/(SICI)1097-0010(199607)71:3<313::AID-JSFA586>3.0.CO;2-N, 10.1002/(SICI)1097-0010(199607)71:3&lt;313::AID-JSFA586&gt;3.0.CO;2-N]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Piero AR, 2005, J AGR FOOD CHEM, V53, P9083, DOI 10.1021/jf051609s; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; Pierantoni L, 2010, PLANT PHYSIOL BIOCH, V48, P1020, DOI 10.1016/j.plaphy.2010.09.002; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Steyn WJ, 2005, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2005.671.9; Steyn WJ, 2004, J AM SOC HORTIC SCI, V129, P6, DOI 10.21273/JASHS.129.1.0006; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu J. W., 2012, TREE GENET GENOMES, P1; Yu B, 2012, SCI HORTIC-AMSTERDAM, V136, P29, DOI 10.1016/j.scienta.2011.12.026; Zhang B, 2012, PLANT CELL REP, V31, P281, DOI 10.1007/s00299-011-1162-3; Zhang D, 2012, SCI HORTIC-AMSTERDAM, V134, P53, DOI 10.1016/j.scienta.2011.10.025; Zhang XD, 2011, PLANT MOL BIOL REP, V29, P305, DOI 10.1007/s11105-010-0231-z	44	61	68	1	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46070	10.1371/journal.pone.0046070	http://dx.doi.org/10.1371/journal.pone.0046070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029391	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900084
J	Rodova, M; Fu, JS; Watkins, DN; Srivastava, RK; Shankar, S				Rodova, Mariana; Fu, Junsheng; Watkins, Dara Nall; Srivastava, Rakesh K.; Shankar, Sharmila			Sonic Hedgehog Signaling Inhibition Provides Opportunities for Targeted Therapy by Sulforaphane in Regulating Pancreatic Cancer Stem Cell Self-Renewal	PLOS ONE			English	Article							CHEMOPREVENTION; PREVENTION	Dysregulation of the sonic hedgehog (Shh) signaling pathway has been associated with cancer stem cells (CSC) and implicated in the initiation of pancreatic cancer. Pancreatic CSCs are rare tumor cells characterized by their ability to self-renew, and are responsible for tumor recurrence accompanied by resistance to current therapies. The lethality of these incurable, aggressive and invasive pancreatic tumors remains a daunting clinical challenge. Thus, the objective of this study was to investigate the role of Shh pathway in pancreatic cancer and to examine the molecular mechanisms by which sulforaphane (SFN), an active compound in cruciferous vegetables, inhibits self-renewal capacity of human pancreatic CSCs. Interestingly, we demonstrate here that Shh pathway is highly activated in pancreatic CSCs and plays important role in maintaining stemness by regulating the expression of stemness genes. Given the requirement for Hedgehog in pancreatic cancer, we investigated whether hedgehog blockade by SFN could target the stem cell population in pancreatic cancer. In an in vitro model, human pancreatic CSCs derived spheres were significantly inhibited on treatment with SFN, suggesting the clonogenic depletion of the CSCs. Interestingly, SFN inhibited the components of Shh pathway and Gli transcriptional activity. Interference of Shh-Gli signaling significantly blocked SFN-induced inhibitory effects demonstrating the requirement of an active pathway for the growth of pancreatic CSCs. SFN also inhibited downstream targets of Gli transcription by suppressing the expression of pluripotency maintaining factors (Nanog and Oct-4) as well as PDGFR alpha and Cyclin D1. Furthermore, SFN induced apoptosis by inhibition of BCL-2 and activation of caspases. Our data reveal the essential role of Shh-Gli signaling in controlling the characteristics of pancreatic CSCs. We propose that pancreatic cancer preventative effects of SFN may result from inhibition of the Shh pathway. Thus Sulforaphane potentially represents an inexpensive, safe and effective alternative for the management of pancreatic cancer.	[Rodova, Mariana; Fu, Junsheng; Watkins, Dara Nall; Shankar, Sharmila] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Rodova, Mariana; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	sshankar@kumc.edu			Veterans Affairs [I01BX001583] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs)		Cavaleri F, 2003, CELL, V113, P551, DOI 10.1016/S0092-8674(03)00394-5; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Dorado J, 2011, J GASTROENTEROL, V46, P966, DOI 10.1007/s00535-011-0422-x; Gills JJ, 2006, CANCER LETT, V236, P72, DOI 10.1016/j.canlet.2005.05.007; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Hunakova L, 2009, NEOPLASMA, V56, P548, DOI 10.4149/neo_2009_06_548; Jackson SJT, 2004, J NUTR, V134, P2229, DOI 10.1093/jn/134.9.2229; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeong WS, 2004, PHARM RES-DORDR, V21, P661, DOI 10.1023/B:PHAM.0000022413.43212.cf; Kallifatidis G, 2011, MOL THER, V19, P188, DOI 10.1038/mt.2010.216; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kelleher FC, 2010, CARCINOGENESIS; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee CJ, 2008, TRANSL ONCOL, V1, P14, DOI 10.1593/tlo.08013; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; Li Y, 2012, CANC LETT; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Morton JP, 2007, CELL CYCLE, V6, P1553, DOI 10.4161/cc.6.13.4467; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Shankar S, 2008, CLIN CANCER RES, V14, P1; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Srivastava Rakesh K, 2011, Front Biosci (Elite Ed), V3, P515, DOI 10.2741/e266; Srivastava RK, 2010, FRONT BIOSC IN PRESS; Tanaka H, 2009, ANTICANCER RES, V29, P2147; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Ward JW, 2010, J FAM PRACTICE, V59, pS23; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	40	86	92	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46083	10.1371/journal.pone.0046083	http://dx.doi.org/10.1371/journal.pone.0046083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029396	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900086
J	Sakaguchi, H; Takami, T; Yasutani, Y; Maeda, T; Morino, M; Ishii, T; Shiomi, Y; Nishitani, H				Sakaguchi, Hiroki; Takami, Toshihiro; Yasutani, Yoshinori; Maeda, Takeshi; Morino, Masayuki; Ishii, Takashi; Shiomi, Yasushi; Nishitani, Hideo			Checkpoint Kinase ATR Phosphorylates Cdt2, a Substrate Receptor of CRL4 Ubiquitin Ligase, and Promotes the Degradation of Cdt1 following UV Irradiation	PLOS ONE			English	Article							CELL-CYCLE CONTROL; DNA-DAMAGE; S-PHASE; EXCISION-REPAIR; ATAXIA-TELANGIECTASIA; EUKARYOTIC CELLS; LICENSING FACTOR; RE-REPLICATION; PIP BOX; PCNA	The DNA replication-licensing factor Cdt1 is present during the G1 phase of the cell cycle. When cells initiate S phase or are UV-irradiated, Cdt1 is recruited to chromatin-bound PCNA and ubiquitinated by CRL4(Cdt2) for degradation. In both situations, the substrate-recognizing subunit Cdt2 is detected as a highly phosphorylated form. Here, we show that both caffeine-sensitive kinase and MAP kinases are responsible for Cdt2 phosphorylation following UV irradiation. We found that Cdt1 degradation was attenuated in the presence of caffeine. This attenuation was also observed in cells depleted of ATR, but not ATM. Following UV irradiation, Cdt2 was phosphorylated at the S/TQ sites. ATR phosphorylated Cdt2 in vitro, mostly in the C-terminal region. Cdt1 degradation was also induced by DNA damaging chemicals such as methyl methanesulfonate (MMS) or zeocin, depending on PCNA and CRL4-Cdt2, though it was less caffeine-sensitive. These findings suggest that ATR, activated after DNA damage, phosphorylates Cdt2 and promotes the rapid degradation of Cdt1 after UV irradiation in the G1 phase of the cell cycle.	[Sakaguchi, Hiroki; Takami, Toshihiro; Yasutani, Yoshinori; Maeda, Takeshi; Morino, Masayuki; Ishii, Takashi; Shiomi, Yasushi; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Naito Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants in Aid for Scientific Research, Scientific Research in a Priority Area, and the Global Center of Excellence Program from the Ministry of Education, Culture, Sport, Science, and Technology of Japan; and the Naito Foundation; Hyogo Science and Technology Association; and The Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shiomi Y, 2012, MOL CELL BIOL; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Stathopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034621; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46480	10.1371/journal.pone.0046480	http://dx.doi.org/10.1371/journal.pone.0046480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029527	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900168
J	Verant, ML; Boyles, JG; Waldrep, W; Wibbelt, G; Blehert, DS				Verant, Michelle L.; Boyles, Justin G.; Waldrep, William, Jr.; Wibbelt, Gudrun; Blehert, David S.			Temperature-Dependent Growth of Geomyces destructans, the Fungus That Causes Bat White-Nose Syndrome	PLOS ONE			English	Article							EMERGING DISEASE; MODEL; PHYSIOLOGY; SELECTION; PATHOGEN	White-nose syndrome (WNS) is an emergent disease estimated to have killed over five million North American bats. Caused by the psychrophilic fungus Geomyces destructans, WNS specifically affects bats during hibernation. We describe temperature-dependent growth performance and morphology for six independent isolates of G. destructans from North America and Europe. Thermal performance curves for all isolates displayed an intermediate peak with rapid decline in performance above the peak. Optimal temperatures for growth were between 12.5 and 15.8 degrees C, and the upper critical temperature for growth was between 19.0 and 19.8 degrees C. Growth rates varied across isolates, irrespective of geographic origin, and above 12 degrees C all isolates displayed atypical morphology that may have implications for proliferation of the fungus. This study demonstrates that small variations in temperature, consistent with those inherent of bat hibernacula, affect growth performance and physiology of G. destructans, which may influence temperature-dependent progression and severity of WNS in wild bats.	[Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA; [Verant, Michelle L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Boyles, Justin G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Waldrep, William, Jr.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Wibbelt, Gudrun] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; University of Chicago; Leibniz Institut fur Zoo und Wildtierforschung	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI USA.	dblehert@usgs.gov	Boyles, Justin G/A-5152-2010	Blehert, David/0000-0002-1065-9760; Verant, Michelle/0000-0001-6994-6257	US Geological Survey; US Fish and Wildlife Service; Bat Conservation International	US Geological Survey(United States Geological Survey); US Fish and Wildlife Service(US Fish & Wildlife Service); Bat Conservation International	Financial support for this project was provided by the US Geological Survey, the US Fish and Wildlife Service, and Bat Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brack V, 2007, ENVIRON MANAGE, V40, P739, DOI 10.1007/s00267-006-0274-y; Brasier C, 2003, MYCOL RES, V107, P258, DOI 10.1017/S0953756203227660; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Flory AR, 2012, J APPL ECOL; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; HUEY RB, 1979, AM ZOOL, V19, P357; Kasuga T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034728; Lin XR, 2005, EUKARYOT CELL, V4, P1746, DOI 10.1128/EC.4.10.1746-1754.2005; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Oksanen J, 1997, J VEG SCI, V8, P147, DOI 10.2307/3237252; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pikula J, 2012, J WILDLIFE DIS, V48, P207, DOI 10.7589/0090-3558-48.1.207; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puechmaille SJ, 2011, TRENDS ECOL EVOL, V26, P570, DOI 10.1016/j.tree.2011.06.013; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rashid A, 2001, Cutis, V67, P23; Robson GD, 2008, T BRIT MYCOL SOC, P129; Schuler MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020905; Shi PJ, 2010, J THERM BIOL, V35, P225, DOI 10.1016/j.jtherbio.2010.05.005; St-Germain G, 2011, IDENTIFYING FUNGI; TWENTE JW, 1955, ECOLOGY, V36, P706, DOI 10.2307/1931308; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Yazdanparast SA, 2006, J MED MICROBIOL, V55, P1577, DOI 10.1099/jmm.0.46474-0	34	171	173	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46280	10.1371/journal.pone.0046280	http://dx.doi.org/10.1371/journal.pone.0046280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029462	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900124
J	Wielstra, B; Beukema, W; Arntzen, JW; Skidmore, AK; Toxopeus, AG; Raes, N				Wielstra, Ben; Beukema, Wouter; Arntzen, Jan W.; Skidmore, Andrew K.; Toxopeus, Albertus G.; Raes, Niels			Corresponding Mitochondrial DNA and Niche Divergence for Crested Newt Candidate Species	PLOS ONE			English	Article							ABSENCE DATA; MODELS; PHYLOGEOGRAPHY; DELIMITATION; SPECIATION; ECOLOGY; AREAS	Genetic divergence of mitochondrial DNA does not necessarily correspond to reproductive isolation. However, if mitochondrial DNA lineages occupy separate segments of environmental space, this supports the notion of their evolutionary independence. We explore niche differentiation among three candidate species of crested newt (characterized by distinct mitochondrial DNA lineages) and interpret the results in the light of differences observed for recognized crested newt species. We quantify niche differences among all crested newt (candidate) species and test hypotheses regarding niche evolution, employing two ordination techniques (PCA-env and ENFA). Niche equivalency is rejected: all (candidate) species are found to occupy significantly different segments of environmental space. Furthermore, niche overlap values for the three candidate species are not significantly higher than those for the recognized species. As the three candidate crested newt species are, not only in terms of mitochondrial DNA genetic divergence, but also ecologically speaking, as diverged as the recognized crested newt species, our findings are in line with the hypothesis that they represent cryptic species. We address potential pitfalls of our methodology.	[Wielstra, Ben; Arntzen, Jan W.; Raes, Niels] Naturalis Biodivers Ctr, Leiden, Netherlands; [Wielstra, Ben; Beukema, Wouter; Skidmore, Andrew K.; Toxopeus, Albertus G.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands	Naturalis Biodiversity Center; University of Twente	Wielstra, B (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	ben.wielstra@naturalis.nl	Raes, Niels/A-9645-2011; Toxopeus, Albertus/A-3650-2010; Arntzen, Jan/E-7108-2016; Wielstra, Ben/G-3773-2015; Beukema, Wouter/D-6365-2014; Skidmore, Andrew K/C-7441-2011	Raes, Niels/0000-0002-4329-4892; Arntzen, Jan/0000-0003-3229-5993; Wielstra, Ben/0000-0002-7112-5965; Beukema, Wouter/0000-0002-5839-7683; Skidmore, Andrew K/0000-0002-7446-8429				Arntzen JW, 2010, AMPHIBIA-REPTILIA, V31, P311; Arntzen JW, 2003, HDB REPTILIEN AMPHIB, VIIA, P421, DOI DOI 10.2307/1565573; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; BUCCIINNOCENTI S, 1983, COPEIA, P662; Coyne JA, 2004, SPECIATION, V37; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Ivanovic A, ZOOL ANZ IN PRESS; Kidd DM, 2008, MOL ECOL RESOUR, V8, P88, DOI 10.1111/j.1471-8286.2007.01925.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Riddle BR, 2008, PROG PHYS GEOG, V32, P173, DOI 10.1177/0309133308093822; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Team RDC, 2010, R LANG ENV STAT COMP; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; Wielstra B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-162; Wolterstorff W., 1923, BLATTER AQUARIEN TER, V34, P120	31	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46671	10.1371/journal.pone.0046671	http://dx.doi.org/10.1371/journal.pone.0046671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029564	Green Published, Green Accepted, gold			2022-12-25	WOS:000309973900198
J	Barbosa, CMG; Terra, M; de Albuquerque, ALP; Di Giorgi, D; Grupi, C; Negrao, CE; Rondon, MUPB; Martinez, DG; Marcourakis, T; dos Santos, FA; Braga, ALF; Zanetta, DMT; Santos, UD				Galvao Barbosa, Cristiane Maria; Terra-Filho, Mario; Pereira de Albuquerque, Andre Luis; Di Giorgi, Dante; Grupi, Cesar; Negrao, Carlos Eduardo; Pinto Brandao Rondon, Maria Urbana; Martinez, Daniel Godoy; Marcourakis, Tania; dos Santos, Fabiana Almeida; Ferreira Braga, Alfesio Luis; Trevisan Zanetta, Dirce Maria; Santos, Ubiratan de Paula			Burnt Sugarcane Harvesting - Cardiovascular Effects on a Group of Healthy Workers, Brazil	PLOS ONE			English	Article							AIR-POLLUTION; OXIDATIVE STRESS; BLOOD-PRESSURE; EXERCISE; EXPOSURE; HYPONATREMIA; POLLUTANTS; FAILURE; IMPACT; CITY	Background: Brazil is the world's largest producer of sugarcane. Harvest is predominantly manual, exposing workers to health risks: intense physical exertion, heat, pollutants from sugarcane burning. Design: Panel study to evaluate the effects of burnt sugarcane harvesting on blood markers and on cardiovascular system. Methods: Twenty-eight healthy male workers, living in the countryside of Brazil were submitted to blood markers, blood pressure, heart rate variability, cardiopulmonary exercise testing, sympathetic nerve activity evaluation and forearm blood flow measures (venous occlusion plethysmography) during burnt sugarcane harvesting and four months later while they performed other activities in sugar cane culture. Results: Mean participant age was 31 +/- 6.3 years, and had worked for 9.8 +/- 8.4 years on sugarcane work. Work during the harvest period was associated with higher serum levels of Creatine Kinase - 136.5 U/L (IQR: 108.5-216.0) vs. 104.5 U/L (IQR: 77.5-170.5), (p = 0.001); plasma Malondialdehyde-7.5 +/- 1.4 mu M/dl vs. 6.9 +/- 1.0 mu M/dl, (p = 0.058); Glutathione Peroxidase - 55.1 +/- 11.8 Ug/Hb vs. 39.5 +/- 9.5 Ug/Hb, (p < 0.001); Glutathione Transferase- 3.4 +/- 1.3 Ug/Hb vs. 3.0 +/- 1.3 Ug/Hb, (p = 0.001); and 24-hour systolic blood pressure - 120.1 +/- 10.3 mmHg vs. 117.0 +/- 10.0 mmHg, (p = 0.034). In cardiopulmonary exercise testing, rest-to-peak diastolic blood pressure increased by 11.12 mmHg and 5.13 mmHg in the harvest and non-harvest period, respectively. A 10 miliseconds reduction in rMSSD and a 10 burst/min increase in sympathetic nerve activity were associated to 2.2 and 1.8 mmHg rises in systolic arterial pressure, respectively. Conclusion: Work in burnt sugarcane harvesting was associated with changes in blood markers and higher blood pressure, which may be related to autonomic imbalance.	[Galvao Barbosa, Cristiane Maria; Terra-Filho, Mario; Pereira de Albuquerque, Andre Luis; Santos, Ubiratan de Paula] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil; [Galvao Barbosa, Cristiane Maria] FUNDACENTRO, Sao Paulo, Brazil; [Di Giorgi, Dante] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Hypertens Unit, Sao Paulo, Brazil; [Grupi, Cesar] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Electrocardiol Unit, Sao Paulo, Brazil; [Negrao, Carlos Eduardo; Pinto Brandao Rondon, Maria Urbana; Martinez, Daniel Godoy] Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Unit Cardiovasc Rehabil & Exerci, Sao Paulo, Brazil; [Marcourakis, Tania; dos Santos, Fabiana Almeida] Univ Sao Paulo, Pharmacol Sci Sch, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis] Univ Sao Paulo, Fac Med, Dept Pathol, Lab Expt Air Pollut,Environm Epidemiol Study Grp, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis] Univ Catolica Santos, Environm Exposure & Risk Assessment Grp, Sao Paulo, Brazil; [Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Santos; Universidade de Sao Paulo	Santos, UD (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Heart Inst InCor,Pulm Div, Sao Paulo, Brazil.	pneubiratan@incor.usp.br	Zanetta, Dirce M T/G-4950-2013; Martinez, Daniel Godoy/D-9135-2015; Terra-Filho, Mario/H-5806-2012; Martinez, Daniel Godoy/O-6617-2019; Negrao, Carlos E/C-4281-2012; Rondon, Maria Urbana P B/G-5272-2012; Braga, Alfésio L. F./G-6920-2012; Santos, Ubiratan/H-7862-2012; Marcourakis, Tânia/D-6667-2012; Albuquerque, Andre/C-8835-2012	Martinez, Daniel Godoy/0000-0003-0034-7963; Terra-Filho, Mario/0000-0002-8642-5354; Martinez, Daniel Godoy/0000-0003-0034-7963; Rondon, Maria Urbana P B/0000-0002-4134-6126; Braga, Alfésio L. F./0000-0003-3254-3029; Santos, Ubiratan/0000-0003-4919-884X; Marcourakis, Tânia/0000-0002-0076-5017; Zanetta, Dirce Maria/0000-0002-7273-5087; Negrao, Carlos Eduardo/0000-0003-4652-1226; Albuquerque, Andre/0000-0003-3486-5240				ACGIH, 2022, THRESH LIM VAL TLVS; Alperovitch A, 2009, ARCH INTERN MED, V169, P75, DOI 10.1001/archinternmed.2008.512; Alves Francisco, 2006, Saude soc., V15, P90; Anastasakis A, 2005, HEART, V91, P1477, DOI 10.1136/hrt.2004.055053; Anderson J, 2009, ATHEROSCLEROSIS, V10, P1; Arbex MA, 2010, J EPIDEMIOL COMMUN H, V64, P573, DOI 10.1136/jech.2009.094342; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Bankir L, 2007, CLIN J AM SOC NEPHRO, V2, P304, DOI 10.2215/CJN.03401006; Baumgartner J, 2011, ENV HLTH PERSPECT; Bosso RMV, 2006, SCI TOTAL ENVIRON, P382; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Brazilian Society of Cardiology. Brazilian Society of Cardiology. Department of Atherosclerosis Department of Pediatric Cardiology Brazilian Society of Pediatrics Department of Pediatric Endocrinology Department of Pediatric Endocrinology, 2005, ARQ BRAS CARDIOL, V85, P1; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; Cancado JE, 2006, ENVIRON HEALTH PERSP, V114, P725, DOI 10.1289/ehp.8485; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P396, DOI 10.1097/EDE.0b013e3181d5e19b; Donde A, 2012, J OCCUP ENVIRON MED, V54, P466, DOI 10.1097/JOM.0b013e318246f1d4; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033385; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Forbes LJL, 2009, EPIDEMIOLOGY, V20, P245, DOI 10.1097/EDE.0b013e318190ea3f; Fuks K, 2011, ENV HLTH PERSPECT; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; GLINER JA, 1975, J APPL PHYSIOL, V39, P628, DOI 10.1152/jappl.1975.39.4.628; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Goto DM, 2011, ENVIRON RES, V111, P664, DOI 10.1016/j.envres.2011.03.006; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Henderson SB, 2011, ENVIRON HEALTH PERSP, V119, P1266, DOI 10.1289/ehp.1002288; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; Hew-Butler T, 2010, SPORTS MED, V40, P459, DOI 10.2165/11532070-000000000-00000; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Laat EF, 2008, IMPACTOS IND CANAVIE, P36; Lakka TA, 2005, EUR HEART J, V26, P2018, DOI 10.1093/eurheartj/ehi394; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Liao DP, 2004, AM J EPIDEMIOL, V159, P768, DOI 10.1093/aje/kwh109; Marzatico F, 1997, J SPORT MED PHYS FIT, V37, P235; Mazzoli-Rocha F, 2008, ENVIRON RES, V108, P35, DOI 10.1016/j.envres.2008.05.004; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Negrao CE, 2001, AM J PHYSIOL-HEART C, V280, pH1286, DOI 10.1152/ajpheart.2001.280.3.H1286; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Qian ZM, 2008, ENVIRON HEALTH PERSP, V116, P1172, DOI 10.1289/ehp.10847; Ribeiro Helena, 2008, Rev. Saúde Pública, V42, P370, DOI 10.1590/S0034-89102008005000009; Romieu I, 2008, EUR RESPIR J, V31, P179, DOI 10.1183/09031936.00128106; Sangani RG, 2010, INHAL TOXICOL, V22, P621, DOI 10.3109/08958371003599037; Santos, 2006, J BRAS PNEUMOL, V32, pS5, DOI DOI 10.1590/S1806-37132006000800003; Santos UD, 2005, EUR HEART J, V26, P193, DOI 10.1093/eurheartj/ehi035; SHIEH SD, 1992, AM J NEPHROL, V12, P252, DOI 10.1159/000168454; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; SPURR GB, 1977, AM J CLIN NUTR, V30, P1740, DOI 10.1093/ajcn/30.10.1740; Tanskanen M, 2010, J SPORT SCI, V28, P309, DOI 10.1080/02640410903473844; Task Force of Eur Soc Cardiology North Am Society Eletrophysiology, 1996, CIRCULATION, V93, P1043; World Health Organization, 2006, WHO AIR QUAL GUID PA; Yin Z, 2009, AM J PHYSIOL-HEART C, V296, pH1540	57	32	36	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46142	10.1371/journal.pone.0046142	http://dx.doi.org/10.1371/journal.pone.0046142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029413	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500065
J	Ogawa, A; Hayashi, A; Kishihara, E; Yoshino, S; Takeuchi, A; Shichiri, M				Ogawa, Akifumi; Hayashi, Akinori; Kishihara, Eriko; Yoshino, Sonomi; Takeuchi, Akihiro; Shichiri, Masayoshi			New Indices for Predicting Glycaemic Variability	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; GLYCATED ALBUMIN; PLASMA-GLUCOSE; CARDIOVASCULAR MORTALITY; HEMOGLOBIN; COMPLICATIONS; HYPERGLYCEMIA; MELLITUS; HBA1C	Blood glucose variability is known to be associated with increased risk of long-term complications. Reliable indices for predicting hyperglycaemic and hypoglycaemic fluctuations are therefore needed. Glycaemic standard deviation (SD) obtained by continuous glucose monitoring correlates closely with nine previously described glycaemic variability formulas. Here, new indices predictive of glycaemic variability were developed, which can be calculated from laboratory measures based on a single blood draw. The indices included the glycated albumin (GA) to HbA1c ratio (GA/A1c ratio) and the fasting C-peptide immunoreactivity (FCPR) to fasting plasma glucose (FPG) ratio (FCPR index). Predictive values of these indices were assessed in 100 adults with diabetes. GA/A1c ratio and FCPR index showed close associations with glycaemic SD in addition to the nine existing glucose variability formulas. Subjects with a GA/A1c ratio >= 2.8 and FCPR index <3.0 showed the greatest SD and longest durations of hypoglycaemia, while those with a GA/A1c ratio <2.8 and FCPR index >= 3.0 had smaller SDs and little sign of hypoglycaemia. In adults with diabetes, a high GA/A1c ratio and low FCPR index value reflect higher glycaemic excursions, irrespective of diabetes type. Simultaneous measurements of GA, HbA1c, FPG and FCPR may help to identify a group of patients who warrant closer monitoring in relation to glycaemic variability and hypoglycaemia.	[Ogawa, Akifumi; Hayashi, Akinori; Kishihara, Eriko; Yoshino, Sonomi; Shichiri, Masayoshi] Kitasato Univ, Dept Endocrinol Diabet & Metab, Sch Med, Kanagawa, Japan; [Takeuchi, Akihiro] Kitasato Univ, Dept Med Informat, Sch Allied Hlth Sci, Kanagawa, Japan	Kitasato University; Kitasato University	Shichiri, M (corresponding author), Kitasato Univ, Dept Endocrinol Diabet & Metab, Sch Med, Kanagawa, Japan.	shichiri@kitasato-u.ac.jp	Hayashi, Akinori/AAD-2469-2020	Hayashi, Akinori/0000-0002-9946-1004; Shichiri, Masayoshi/0000-0002-5704-1378				Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; DAY JF, 1979, J BIOL CHEM, V254, P9394; Goto A, 2010, ENDOCR J, V57, P237, DOI 10.1507/endocrj.K09E-279; Kisugi R, 2007, CLIN CHIM ACTA, V382, P59, DOI 10.1016/j.cca.2007.04.001; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koga M, 2010, ANN CLIN BIOCHEM, V47, P313, DOI 10.1258/acb.2010.009234; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Kohnert KD, 2007, DIABETES RES CLIN PR, V77, P420, DOI 10.1016/j.diabres.2007.01.021; Kohnert KD, 2009, DIABETES CARE, V32, P1058, DOI 10.2337/dc08-1956; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Nakagami T, 2006, EUR J CARDIOV PREV R, V13, P555, DOI 10.1097/01.hjr.0000183916.28354.69; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Saisho Y, 2011, ENDOCR J, V58, P315, DOI 10.1507/endocrj.K10E-399; SCHLICHTKRULL J, 1965, ACTA MED SCAND, V177, P95; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Weykamp Cas, 2009, J Diabetes Sci Technol, V3, P439; WOJCICKI JM, 1995, HORM METAB RES, V27, P41, DOI 10.1055/s-2007-979906	24	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46517	10.1371/journal.pone.0046517	http://dx.doi.org/10.1371/journal.pone.0046517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029543	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500107
J	Sianglum, W; Srimanote, P; Taylor, PW; Rosado, H; Voravuthikunchai, SP				Sianglum, Wipawadee; Srimanote, Potjanee; Taylor, Peter W.; Rosado, Helena; Voravuthikunchai, Supayang P.			Transcriptome Analysis of Responses to Rhodomyrtone in Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							BACTERIAL-INFECTIONS; ANTIMICROBIAL AGENTS; TEICHOIC-ACID; PEPTIDOGLYCAN; BIOSYNTHESIS; TOMENTOSA; PRODUCTS; LYSINE; DRUG	Rhodomyrtone, purified from Rhodomyrtus tomentosa (Aiton) Hassk, exhibits a high degree of potency against methicillin-resistant Staphylococcus aureus (MRSA). We recently demonstrated that exposure of MRSA to a subinhibitory concentration (0.174 mu g/ml) of rhodomyrtone resulted in the alteration of expression of several functional classes of bacterial proteins. To provide further insight into the antibacterial mode of action of this compound, we determined the impact of exposure to rhodomyrtone on the gene transcriptional profile of MRSA using microarray analysis. Exposure of MRSA to subinhibitory concentrations (0.5MIC; 0.5 mu g/ml) of rhodomyrtone revealed significant modulation of gene expression, with induction of 64 genes and repression of 35 genes. Prominent changes in response to exposure to rhodomyrtone involved genes encoding proteins essential to metabolic pathways and processes such as amino acid metabolism, membrane function, ATP-binding cassette (ABC) transportation and lipoprotein and nucleotide metabolism. Genes involved in the synthesis of the aspartate family of amino acids, in particular proteins encoded by the dap operon were prominent. The diaminopimelate (DAP) biosynthetic pathway is the precursor of lysine synthesis and is essential for peptidoglycan biosynthesis. However, phenotypic analysis of the peptidoglycan amino acid content of rhodomyrtone-treated MRSA did not differ significantly from that extracted from control cells. Genes involved in the biosynthesis of amino acids and peptidoglycan, and a high affinity ATP-driven K ((+)) transport system, were investigated by quantitative reverse transcription-PCR (qRT-PCR) using EMRSA-16 1, 4, or 18 h after exposure to rhodomyrtone and in general the data concurred with that obtained by microarray, highlighting the relevance of the DAP biosynthetic pathway to the mode of action of rhodomyrtone.	[Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand; [Sianglum, Wipawadee; Voravuthikunchai, Supayang P.] Prince Songkla Univ, Nat Prod Res Ctr, Fac Sci, Hat Yai, Thailand; [Srimanote, Potjanee] Thammasat Univ, Fac Allied Hlth Sci, Pathumtanee, Thailand; [Taylor, Peter W.; Rosado, Helena] UCL, Sch Pharm, London, England	Prince of Songkla University; Prince of Songkla University; Thammasat University; University of London; University College London; University of London School of Pharmacy	Voravuthikunchai, SP (corresponding author), Prince Songkla Univ, Dept Microbiol, Fac Sci, Hat Yai, Thailand.	supayang.v@psu.ac.th	Srimanote, Potjanee/W-2221-2019		Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program [PHD/0053/2550]	Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission; Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (http://www.nru.psu.ac.th/) and the Thailand Research Fund through the Royal Golden Jubilee (RGJ) PhD program (http://rgj.trf.or.th/eng/rgje11.asp), grant no. PHD/0053/2550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy DY, 2008, CLIN MICROBIOL INFEC, V14, P411, DOI 10.1111/j.1469-0691.2007.01933.x; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Bradley JS, 2005, CURR OPIN PEDIATR, V17, P71, DOI 10.1097/01.mop.0000151555.17799.41; Brunskill EW, 1997, MICROBIOL-UK, V143, P2877, DOI 10.1099/00221287-143-9-2877; Camargo ILBD, 2008, ANTIMICROB AGENTS CH, V52, P4289, DOI 10.1128/AAC.00417-08; CHAMBERS H F, 1988, Clinical Microbiology Reviews, V1, P173; Clinical and Laboratory Standards Institute, 2005, PERFORMANCE STANDARD, pM100; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Dachriyanus, 2002, AUST J CHEM, V55, P229, DOI 10.1071/CH01194; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Doyle M, 2009, J ANTIMICROB CHEMOTH, V64, P949, DOI 10.1093/jac/dkp325; Eliopoulos GM, 2009, J INFECTION, V59, pS17, DOI 10.1016/S0163-4453(09)60004-9; Formstone A, 2008, J BACTERIOL, V190, P1812, DOI 10.1128/JB.01394-07; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Hiranrat A, 2008, TETRAHEDRON, V64, P11193, DOI 10.1016/j.tet.2008.09.054; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Limsuwan S, 2009, PHYTOMEDICINE, V16, P645, DOI 10.1016/j.phymed.2009.01.010; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; Martin KW, 2003, J ANTIMICROB CHEMOTH, V51, P241, DOI 10.1093/jac/dkg087; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Saising J, 2008, J HEALTH SCI, V54, P589, DOI 10.1248/jhs.54.589; Samy RP, 2008, EVID-BASED COMPL ALT, P283; Sass V, 2008, INT J MED MICROBIOL, V298, P619, DOI 10.1016/j.ijmm.2008.01.011; Shakil S, 2008, J CHEMOTHERAPY, V20, P411, DOI 10.1179/joc.2008.20.4.411; Sianglum W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016628; Sorlozano A, 2010, EUR J CLIN MICROBIOL, V29, P73, DOI 10.1007/s10096-009-0823-4; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; Wenzel RP, 2007, INT J ANTIMICROB AG, V30, P210, DOI 10.1016/j.ijantimicag.2007.04.003; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005	32	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45744	10.1371/journal.pone.0045744	http://dx.doi.org/10.1371/journal.pone.0045744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029218	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500039
J	Chien, WC; Chung, CH; Jaakkola, JJK; Chu, CM; Kao, S; Su, SL; Lai, CH				Chien, Wu-Chien; Chung, Chi-Hsiang; Jaakkola, Jouni J. K.; Chu, Chi-Ming; Kao, Senyeong; Su, Sui-Lung; Lai, Ching-Huang			Risk and Prognostic Factors of Inpatient Mortality Associated with Unintentional Insecticide and Herbicide Poisonings: A Retrospective Cohort Study	PLOS ONE			English	Article							TAIWAN; EPIDEMIOLOGY	Introduction: Pesticide poisoning is an important public health problem worldwide. The study aimed to determine the risk of all-cause and cause-specific inpatient mortality and to identify prognostic factors for inpatient mortality associated with unintentional insecticide and herbicide pesticide poisonings. Methods: We performed a retrospective cohort study of 3,986 inpatients recruited at hospitalization between 1999 and 2008 in Taiwan. We used the International Classification of Disease, 9th ed., Clinical Modification external causes of injury codes to classify poisoning agents into accidental poisoning by insecticides and herbicides. Comparisons in mortality rates were made between insecticide poisoning patients and herbicide poisoning patients by using the Cox proportional hazards models to estimate multivariable-adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs). Results: There were 168 deaths during 21,583 person-days of follow-up evaluation (7.8 per 1,000 person-days). The major causes of mortality for insecticide poisonings were the toxic effect of organophosphate and coma, and the major causes of mortality for herbicide poisonings were the toxic effect of other pesticides and the toxic effect of organophosphate. The mortality for herbicide exposure was fourfold higher than that for insecticide exposure. The factors associated with inpatient mortality were herbicide poisonings (HR = 4.58, 95% CI 3.29 to 6.37) and receiving mechanical ventilation treatment (HR = 3.85, 95% CI 2.73 to 5.42). Conclusions: We demonstrated that herbicides stand out as the dominant agent for poisoning-related fatalities. The control of and limiting access to herbicide agents and developing appropriate therapeutic regimens, including emergency care, should be priorities.	[Chien, Wu-Chien; Chu, Chi-Ming; Kao, Senyeong; Su, Sui-Lung; Lai, Ching-Huang] Natl Def Med Ctr, Dept Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Jaakkola, Jouni J. K.] Univ Oulu, Inst Hlth Sci, Ctr Environm & Resp Hlth Res, Oulu, Finland	National Defense Medical Center; National Defense Medical Center; University of Oulu	Lai, CH (corresponding author), Natl Def Med Ctr, Dept Publ Hlth, 161,Sect 6, Taipei, Taiwan.	lgh@mail.ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021; Jaakkola, Jouni J.K./G-4314-2012; Lai, Ching-Huang/ABF-9274-2021	Su, Sui-Lung/0000-0003-3122-1116; Jaakkola, Jouni/0000-0003-4168-4683; Chu, Cordia/0000-0002-3683-5638; Kao, Senyeong/0000-0002-0209-240X	Academy of Finland [129419, 138691]	Academy of Finland(Academy of Finland)	JJ was supported by Academy of Finland (http://www.aka.fi/eng), grants no. 129419 (SALVE program) and 138691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon WA, 2005, JAMA-J AM MED ASSOC, V294, P455, DOI 10.1001/jama.294.4.455; Bradberry Sally M, 2004, Toxicol Rev, V23, P159, DOI 10.2165/00139709-200423030-00003; [Bureau of Animal and Plant Health Inspection Quarantine EY Taiwan (ROC)], 2012, PEST STAT AN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YH, 2011, LIVER INT, V31, P354, DOI 10.1111/j.1478-3231.2010.02350.x; Chen YJ, 2009, CLIN TOXICOL, V47, P670, DOI 10.1080/15563650903140399; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien, 2011, CHARACTERISTICS TREN; Chou P., 2003, VALIDATION COMORBIDI; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Gawarammana IB, 2011, BR J CLIN PHARM; Jaiprakash H, 2011, FOOD CHEM TOXICOL, V49, P248, DOI 10.1016/j.fct.2010.10.026; Lee CH, 2008, AM J EMERG MED, V26, P275, DOI 10.1016/j.ajem.2007.05.011; Lee HL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-7; Lien YC, 2009, ANN THORAC SURG, V88, P1124, DOI 10.1016/j.athoracsur.2009.06.002; Lin TJ, 2008, CLIN TOXICOL, V46, P794, DOI 10.1080/15563650801986695; Litchfield Melville H, 2005, Toxicol Rev, V24, P271, DOI 10.2165/00139709-200524040-00006; Liu Q, 2009, FORENSIC SCI INT, V193, P88, DOI 10.1016/j.forsciint.2009.09.013; National Health Research Institutes TR, 2011, NAT HLTH INS RES DAT; Senarathna L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-373; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; TOMINACK RL, 1991, J TOXICOL-CLIN TOXIC, V29, P91, DOI 10.3109/15563659109038601; WHO, 2020, WHO REC CLASS PEST H, V2019; Yang CC, 1996, J TOXICOL-CLIN TOXIC, V34, P651, DOI 10.3109/15563659609013825	24	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45627	10.1371/journal.pone.0045627	http://dx.doi.org/10.1371/journal.pone.0045627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029146	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800069
J	Luddington, IA; Kaczmarska, I; Lovejoy, C				Luddington, Ian A.; Kaczmarska, Irena; Lovejoy, Connie			Distance and Character-Based Evaluation of the V4 Region of the 18S rRNA Gene for the Identification of Diatoms (Bacillariophyceae)	PLOS ONE			English	Article							SKELETONEMA-COSTATUM; BARCODING DIATOMS; DNA; DIVERSITY; RDNA; TAXONOMY; UTILITY; MARINE; COX1; RBCL	DNA barcoding is a molecular tool that exploits a unique DNA sequence of a standardized gene or non-coding region for the species identification of unknown individuals. The investigation into a suitable barcode for diatoms is ongoing and there are several promising candidates including mitochondrial, plastidial and nuclear markers. We analyzed 272 sequences from 76 diatoms species in the orders Thalassiosirales, Lithodesmiales and Cymatosirales, using distance and character based approaches, to assess the applicability of a DNA barcode based on the hypervariable V4 region of the nuclear 18S rRNA gene. We show that the proposed V4 barcode separated ca. 97% of all centric diatom taxa tested using a threshold p-distance of 0.02 and that many problem pairs were further separated using a character based approach. The reliability of amplification, extensive reference library and variability seen in the V4 region make it the most promising candidate to date for a barcode marker for diatoms particularly when combined with DNA character analysis.	[Luddington, Ian A.; Kaczmarska, Irena] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Lovejoy, Connie] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada	Mount Allison University; Laval University; Laval University	Luddington, IA (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	ialuddington@mta.ca	Lovejoy, Connie/A-3756-2008	Lovejoy, Connie/0000-0001-8027-2281	NSERC discovery grant; Canadian Healthy Oceans Network	NSERC discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network	This work was supported by NSERC discovery grant (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.aspand) and Canadian Healthy Oceans Network (http://chone.marinebiodiversity.ca/), awarded to Irena Kaczmarska and Connie Lovejoy. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alverson AJ, 2005, J PHYCOL, V41, P1248, DOI 10.1111/j.1529-8817.2005.00136.x; Alverson AJ, 2007, MOL PHYLOGENET EVOL, V45, P193, DOI 10.1016/j.ympev.2007.03.024; Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fryxell G, 1977, NOVA HEDWIGIA BEIH, V54, P67; Geospiza, GEOSP WEBS FINCH TV; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamsher SE, 2011, PROTIST, V162, P405, DOI 10.1016/j.protis.2010.09.005; HASLE G R, 1968, Journal of the Royal Microscopical Society, V88, P357; HASLE GR, 1980, NORW J BOT, V27, P167; HASLE GR, 1978, NORW J BOT, V25, P77; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoppenrath M, 2007, EUR J PHYCOL, V42, P271, DOI 10.1080/09670260701352288; Iwatani N, 2005, POLAR BIOSCIENCES, V18, P35; Kaczmarska I, 2006, J PHYCOL, V42, P121, DOI 10.1111/j.1529-8817.2006.00161.x; Kaczmarska I, 2007, P 1 CENTR EUR DIAT M, P69, DOI DOI 10.3372/CEDIATOM.114; Kaczmarska I, 2009, EUR J PHYCOL, V44, P461, DOI 10.1080/09670260902855873; Lane CE, 2007, MOL PHYLOGENET EVOL, V44, P634, DOI 10.1016/j.ympev.2007.03.016; Lang I, 2011, DIATOM RES, V26, P43, DOI 10.1080/0269249X.2011.573703; Lin SJ, 2006, J PHYCOL, V42, P646, DOI 10.1111/j.1529-8817.2006.00229.x; Lin S, 2009, APPL ENVIRON MICROB, V75, P1279, DOI 10.1128/AEM.01578-08; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; MacGillivary ML, 2012, BOTANY, V90, P205, DOI 10.1139/B11-101; MacGillivary ML, 2011, J EUKARYOT MICROBIOL, V58, P529, DOI 10.1111/j.1550-7408.2011.00585.x; Medlin Linda K., 2010, Diversity, V2, P973, DOI 10.3390/d2070973; MEDLIN LK, 1991, J PHYCOL, V27, P514, DOI 10.1111/j.0022-3646.1991.00514.x; Mills KE, 2006, BOT MAR, V49, P417, DOI 10.1515/BOT.2006.053; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Sar EA, 2011, DIATOM RES, V26, P109, DOI 10.1080/0269249X.2011.573691; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sarno D, 2005, J PHYCOL, V41, P151, DOI 10.1111/j.1529-8817.2005.04067.x; Sarno D, 2007, J PHYCOL, V43, P156, DOI 10.1111/j.1529-8817.2006.00305.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Syvertsen E, 1977, NOVA HEDWIGIA S, V54, P99; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor H, 2012, MOL ECOL RES, V12, DOI [10.1111/j.1755-0998.2012.03119, DOI 10.1111/J.1755-0998.2012.03119]; White T., 1990, PCR PROTOCOLS GUIDE, P315; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	51	48	50	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45664	10.1371/journal.pone.0045664	http://dx.doi.org/10.1371/journal.pone.0045664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029169	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800074
J	Bucharova, A; Munzbergova, Z				Bucharova, Anna; Muenzbergova, Zuzana			Gene Flow among Populations of Two Rare Co-Occurring Fern Species Differing in Ploidy Level	PLOS ONE			English	Article							ATHYRIUM-FILIX-FEMINA; REPRODUCTIVE-BIOLOGY; NATURAL-POPULATIONS; PLANT CONSERVATION; MATING SYSTEM; DIVERSITY; DEPRESSION; HISTORY; RATES; LIFE	Differences in ploidy levels among different fern species have a vast influence on their mating system, their colonization ability and on the gene flow among populations. Differences in the colonization abilities of species with different ploidy levels are well known: tetraploids, in contrast to diploids, are able to undergo intra-gametophytic selfing. Because fertilization is a post-dispersal process in ferns, selfing results in better colonization abilities in tetraploids because of single spore colonization. Considerably less is known about the gene flow among populations of different ploidy levels. The present study examines two rare fern species that differ in ploidy. While it has already been confirmed that tetraploid species are better at colonizing, the present study focuses on the gene flow among existing populations. We analyzed the genetic structure of a set of populations in a 10x10 km study region using isoenzymes. Genetic variation in tetraploid species is distributed mainly among populations; the genetic distance between populations is correlated with the geographical distance, and larger populations host more genetic diversity than smaller populations. In the diploid species, most variability is partitioned within populations; the genetic distance is not related to geographic distance, and the genetic diversity of populations is not related to the population size. This suggests that in tetraploid species, which undergo selfing, gene flow is limited. In contrast, in the diploid species, which experience outcrossing, gene flow is extensive and the whole system behaves as one large population. Our results suggest that in ferns, the ability to colonize new habitats and the gene flow among existing populations are affected by the mating system.	[Bucharova, Anna; Muenzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic; [Bucharova, Anna; Muenzbergova, Zuzana] Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Bucharova, Anna] Univ Tubingen, Inst Evolut & Ecol, Dept Plant Ecol, Tubingen, Germany	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen	Bucharova, A (corresponding author), Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic.	bucharka@email.cz	Bucharova, Anna Lampei/U-5784-2017; Münzbergová, Zuzana/F-6321-2013	Bucharova, Anna Lampei/0000-0002-5468-5426; Münzbergová, Zuzana/0000-0002-4026-6220	MSMT [2B06178]; FRVS [348/2004]; GAUK [176/2006]; GACR [526/09/0549]; RVO [67985939]; institutional resources of MSMT	MSMT(Ministry of Education, Youth & Sports - Czech Republic); FRVS; GAUK; GACR(Grant Agency of the Czech Republic); RVO; institutional resources of MSMT	This work was supported by MSMT [2B06178], FRVS [348/2004], GAUK [176/2006] and GACR [526/09/0549] and partly by RVO 67985939 and institutional resources of MSMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dias PMB, 2008, CROP BREED APPL BIOT, V8, P202, DOI 10.12702/1984-7033.v08n03a04; Bucharova A, 2010, AM J BOT, V97, P1260, DOI 10.3732/ajb.0900351; Dong YH, 2010, ANN BOT FENN, V47, P34, DOI 10.5735/085.047.0104; Duminil J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-177; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; GOVINDARAJU DR, 1988, HEREDITY, V61, P401, DOI 10.1038/hdy.1988.130; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HEJNY S, 1980, FLORA CZECH REPUBLIC; Hood G.M., 2010, POPTOOLS VERSION 3 2; Hooper EA, 1997, AM J BOT, V84, P1664, DOI 10.2307/2446464; Hunt HV, 2009, MOL ECOL, V18, P4940, DOI 10.1111/j.1365-294X.2009.04402.x; Kang M, 2008, DIVERS DISTRIB, V14, P799, DOI 10.1111/j.1472-4642.2008.00484.x; Landergott U, 2001, HEREDITY, V87, P344, DOI 10.1046/j.1365-2540.2001.00912.x; LLOYD RM, 1974, ANN MO BOT GARD, V61, P318, DOI 10.2307/2395060; Lott MS, 2003, AM J BOT, V90, P1144, DOI 10.3732/ajb.90.8.1144; LOVIS JD, 1955, P BOT SOC BR ISLE, V1, P2; Maki M, 1998, HEREDITY, V80, P604; MASUYAMA S, 1990, Plant Species Biology, V5, P13, DOI 10.1111/j.1442-1984.1990.tb00188.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Newman D, 2001, CONSERV BIOL, V15, P1054, DOI 10.1046/j.1523-1739.2001.0150041054.x; PECK JH, 1990, AM FERN J, V80, P126, DOI 10.2307/1547200; Pryor KV, 2001, MOL ECOL, V10, P1881, DOI 10.1046/j.1365-294X.2001.01343.x; R Development Core Team, 2009, R FDN STAT COMP; Ranker TA, 1992, GENETIC DIVERSITY MA; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Schneller J, 2007, AM J BOT, V94, P965, DOI 10.3732/ajb.94.6.965; Schneller JJ, 1996, J VEG SCI, V7, P113, DOI 10.2307/3236423; Schneller JJ, 1996, BIOL J LINN SOC, V59, P281; Schneller JJ, 1997, INT J PLANT SCI, V158, P79, DOI 10.1086/297416; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Soltis D.E., 1989, ISOZYMES PLANT BIOL, P241; SOLTIS DE, 1992, AM J BOT, V79, P97, DOI 10.2307/2445202; SOLTIS PS, 1988, AM J BOT, V75, P248, DOI 10.2307/2443891; Suter M, 2000, INT J PLANT SCI, V161, P233, DOI 10.1086/314258; Tajek P, 2003, THESIS; Tajek P, 2011, ACTA OECOL, V37, P495, DOI 10.1016/j.actao.2011.06.009; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; Tutin TG, 1993, FLORA EUROPAEA; Vogel JC, 1999, BIOL J LINN SOC, V66, P23, DOI 10.1111/j.1095-8312.1999.tb01915.x; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Yeh F., 1997, BELG J BOT, V129, P1	45	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45855	10.1371/journal.pone.0045855	http://dx.doi.org/10.1371/journal.pone.0045855			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029277	gold, Green Published			2022-12-25	WOS:000309388900107
J	Fan, WW; Sun, DD; Liu, JT; Liang, D; Wang, YB; Narsinh, KH; Li, Y; Qin, X; Liang, JM; Tian, J; Cao, F				Fan, Weiwei; Sun, Dongdong; Liu, Junting; Liang, Dong; Wang, Yabin; Narsinh, Kazim H.; Li, Yong; Qin, Xing; Liang, Jimin; Tian, Jie; Cao, Feng			Adipose Stromal Cells Amplify Angiogenic Signaling via the VEGF/mTOR/Akt Pathway in a Murine Hindlimb Ischemia Model: A 3D Multimodality Imaging Study	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; STEM-CELLS; IN-VIVO; BONE-MARROW; REGENERATIVE MEDICINE; CLINICAL TRANSLATION; ENDOTHELIAL-CELLS; TISSUE; SURVIVAL; THERAPY	Although adipose-derived stromal cell (ADSC) transplantation has been demonstrated as a promising therapeutic strategy for peripheral arterial disease (PAD), the mechanism of action behind the observed therapeutic efficacy of ADSCs remains unclear. This study was designed to investigate the long-term outcome and therapeutic behavior of engrafted ADSCs in a murine hindlimb ischemia model using multimodality molecular imaging approaches. ADSCs (1.0x10(7)) were isolated from Tg(Fluc-egfp) mice which constitutively express dual-reporter firefly luciferase and enhanced green fluorescent protein (Fluc(+)-eGFP(+), mADSCs(Fluc+GFP+)), then intramuscularly injected into the hindlimb of BALB/c-nu mice after unilateral femoral artery ligation and excision. Abbreviated survival (similar to 5 weeks) of post-transplant mADSCs within the ischemic hindlimb was longitudinally monitored using noninvasive bioluminescence imaging (BLI), fluorescence imaging (FRI), and bioluminescence tomography with micro-computed tomography (BLT/micro-CT). Use of the BLT/micro-CT system enabled quantitative 3-dimensional (3D) imaging of the cells' distribution and kinetics in vivo. Engrafted mADSCs improved blood perfusion recovery, ambulatory performance and prognosis of the ischemic hindlimb, probably by inducing angiogenesis and formation of collateral vessels, which could be visualized using laser Doppler perfusion imaging (LDPI), micro-CT angiography, vascular-cast imaging, and immunofluorescence. mADSCs augmented activation of the pro-angiogenic VEGF/mTOR/Akt pathway in vivo, even though the cells failed to incorporate into the host microvasculature as functional components. Downregulation of VEGF/mTOR/Akt signaling using small molecule inhibitors counteracted mADSC-induced angiogenesis and perfusion restoration. This study demonstrates for the first time the spatiotemporal kinetics and functional survival of transplanted mADSCs in a PAD model using in vivo 3D multimodality imaging. Our study indicates that mADSCs potentiate pro-angiogenic signal amplification via a VEGF/mTOR/Akt-dependent pathway, and thereby promote recovery from hindlimb ischemia.	[Liu, Junting; Liang, Jimin; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Fan, Weiwei; Sun, Dongdong; Liang, Dong; Wang, Yabin; Qin, Xing; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Mol Imaging Program, Xian 710032, Shaanxi, Peoples R China; [Fan, Weiwei; Sun, Dongdong; Liang, Dong; Wang, Yabin; Qin, Xing; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Narsinh, Kazim H.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Narsinh, Kazim H.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Li, Yong] Fourth Mil Med Univ, Xijing Hosp, Dept Plast Surg, Xian 710032, Shaanxi, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Stanford University; Stanford University; Air Force Military Medical University	Tian, J (corresponding author), Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	tian@ieee.org; wind8828@gmail.com	Liu, Junting/F-3550-2010; Liu, Junting/D-7175-2012; Liang, Jimin/B-5394-2014; Tian, Jie/H-1190-2011; Frank, Viki/GXZ-9902-2022	Liu, Junting/0000-0002-2099-0190; Liang, Jimin/0000-0003-1428-5804; Tian, Jie/0000-0003-0498-0432; 	National Basic Research Program of China [2012CB518101]; National Natural Science Foundation of China [30970845, 81090274, 81090270, 81100579]; China Department of Education [2010CXTD01]; China's Ministry of Science and Technology 863 Program [2012AA02A603]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; China's Ministry of Science and Technology 863 Program	This work was supported by National Basic Research Program of China (2012CB518101); National Natural Science Foundation of China (No. 30970845, No. 81090274, No. 81090270, and No. 81100579); Innovation Team Development Grant by China Department of Education (2010CXTD01); China's Ministry of Science and Technology 863 Program (2012AA02A603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CIRCULATION, V124, P2020; Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao F, 2009, CANCER RES, V69, P2709, DOI 10.1158/0008-5472.CAN-08-4122; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Falcon BL, 2011, CANCER RES, V71, P1573, DOI 10.1158/0008-5472.CAN-10-3126; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Lawall H, 2011, J VASC SURG, V53, P445, DOI 10.1016/j.jvs.2010.08.060; Liu JT, 2010, IEEE T BIO-MED ENG, V57, P2579, DOI 10.1109/TBME.2010.2056370; Liu JT, 2010, OPT EXPRESS, V18, P13102, DOI 10.1364/OE.18.013102; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sheikh AY, 2012, ARTERIOSCL THROM VAS, V32, P92, DOI 10.1161/ATVBAHA.111.238618; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Tirziu D, 2005, CIRCULATION, V112, P2501, DOI 10.1161/CIRCULATIONAHA.105.542829; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Trinh XB, 2009, BRIT J CANCER, V100, P971, DOI 10.1038/sj.bjc.6604921; van der Bogt KEA, 2012, JACC-CARDIOVASC IMAG, V5, P46, DOI 10.1016/j.jcmg.2011.07.011; Xie XY, 2007, CLONING STEM CELLS, V9, P549, DOI 10.1089/clo.2007.0032; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45621	10.1371/journal.pone.0045621	http://dx.doi.org/10.1371/journal.pone.0045621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029141	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900082
J	Zhang, BT; Carrie, C; Ivanova, A; Narsai, R; Murcha, MW; Duncan, O; Wang, Y; Law, SR; Albrecht, V; Pogson, B; Giraud, E; Van Aken, O; Whelan, J				Zhang, Botao; Carrie, Chris; Ivanova, Aneta; Narsai, Reena; Murcha, Monika W.; Duncan, Owen; Wang, Yan; Law, Simon R.; Albrecht, Veronica; Pogson, Barry; Giraud, Estelle; Van Aken, Olivier; Whelan, James			LETM Proteins Play a Role in the Accumulation of Mitochondrially Encoded Proteins in Arabidopsis thaliana and AtLETM2 Displays Parent of Origin Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOLF-HIRSCHHORN-SYNDROME; EMBRYO SAC DEVELOPMENT; ALTERNATIVE OXIDASE; CARRIER PROTEINS; GENE; EXPRESSION; GENOME; BIOGENESIS; RNA; TRANSCRIPTION	The Arabidopsis thaliana genome contains two genes with homology to the mitochondrial protein LETM1 (leucine zipper-EF-hand-containing transmembrane protein). Inactivation of both genes, Atletm1 and Atletm2, together is lethal. Plants that are hemizygous for AtLETM2 and homozygous for Atletm1 (letm1(-/-) LETM2(+/-)) displayed a mild retarded growth phenotype during early seedling growth. It was shown that accumulation of mitochondrial proteins was reduced in hemizygous (letm1(-/-) LETM2(+/-)) plants. Examination of respiratory chain proteins by Western blotting, blue native PAGE, and enzymatic activity assays revealed that the steady state level of ATP synthase was reduced in abundance, whereas the steady state levels of other respiratory chain proteins remained unchanged. The absence of a functional maternal AtLETM2 allele in an Atletm1 mutant background resulted in early seed abortion. Reciprocal crosses revealed that maternally, but not paternally, derived AtLETM2 was absolutely required for seed development. This requirement for a functional maternal allele of AtLETM2 was confirmed using direct sequencing of reciprocal crosses of Col-0 and Ler accessions. Furthermore, AtLETM2 promoter beta-glucuronidase constructs displayed exclusive maternal expression patterns.	[Zhang, Botao; Carrie, Chris; Ivanova, Aneta; Narsai, Reena; Murcha, Monika W.; Duncan, Owen; Wang, Yan; Law, Simon R.; Giraud, Estelle; Van Aken, Olivier; Whelan, James] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia; [Narsai, Reena] Univ Western Australia, Ctr Computat Syst Biol, Crawley, WA 6009, Australia; [Albrecht, Veronica; Pogson, Barry] Australian Natl Univ, Australian Res Council Ctr Excellence Plant Energ, Res Sch Biol, Acton, ACT 2601, Australia	University of Western Australia; University of Western Australia; Australian National University	Whelan, J (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Bayliss Bldg M316,35 Stirling Highway, Crawley, WA 6009, Australia.	jim.whelan@uwa.edu.au	Murcha, Monika W/C-3834-2011; Pogson, Barry J/C-9953-2009; Carrie, Chris/A-2638-2010; Murcha, Monika W/H-5495-2014; Van Aken, Olivier/H-5999-2014; Van Aken, Olivier/A-2607-2010; Zhang, Botao/H-7712-2016; Van Aken, Olivier/B-4633-2019; Whelan, James/F-6402-2011	Pogson, Barry J/0000-0003-1869-2423; Carrie, Chris/0000-0002-4240-4674; Murcha, Monika W/0000-0002-3689-6158; Van Aken, Olivier/0000-0003-4024-968X; Zhang, Botao/0000-0003-3691-7876; Van Aken, Olivier/0000-0003-4024-968X; Whelan, James/0000-0001-5754-025X; Law, Simon/0000-0003-0389-6650; WANG, YAN/0000-0003-1600-2863; Duncan, Owen/0000-0001-6999-1509	Chinese Scholarship Council Scholarship; Australian Research Council Centre of Excellence Program [CEO561495]	Chinese Scholarship Council Scholarship; Australian Research Council Centre of Excellence Program(Australian Research Council)	This work was supported by a Chinese Scholarship Council Scholarship (to B. Z.) and the Australian Research Council Centre of Excellence Program CEO561495.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Carrie C, 2008, FEBS LETT, V582, P3073, DOI 10.1016/j.febslet.2008.07.061; Carrie C, 2010, J BIOL CHEM, V285, P36138, DOI 10.1074/jbc.M110.121202; Carrie C, 2009, PLANT J, V57, P1128, DOI 10.1111/j.1365-313X.2008.03745.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Considine MJ, 2001, PLANT PHYSIOL, V126, P1619, DOI 10.1104/pp.126.4.1619; Cooper H.M., 2009, CURR PROTOC NEUROSCI, DOI [10.1002/0471142301.ns0505s48, DOI 10.1002/0471142301.NS0505S48]; Daley DO, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-110; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Geisler DA, 2012, PLANT CELL, V24, P2792, DOI 10.1105/tpc.112.099424; Giege P, 2005, PLANT CELL, V17, P1497, DOI 10.1105/tpc.104.030254; Giraud E, 2012, PLANT CELL ENVIRON, V35, P271, DOI 10.1111/j.1365-3040.2011.02293.x; Giraud E, 2009, PLANT PHYSIOL, V150, P1286, DOI 10.1104/pp.109.139782; Gleason C, 2011, P NATL ACAD SCI USA, V108, P10768, DOI 10.1073/pnas.1016060108; Gray MW, 2001, GENOME BIOL, V2; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grini PE, 2002, GENETICS, V162, P1911; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Heazlewood JL, 2003, FEBS LETT, V540, P201, DOI 10.1016/S0014-5793(03)00264-3; Herrmann JM, 2012, BIOCH BIOPH IN PRESS; Ikeda Y, 2012, PLANT CELL PHYSIOL, V53, P809, DOI 10.1093/pcp/pcs049; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Karpova OV, 2002, PLANT CELL, V14, P3271, DOI 10.1105/tpc.005603; Klodmann J, 2011, PLANT PHYSIOL, V157, P587, DOI 10.1104/pp.111.182352; Kuhn K, 2011, PLANT J, V67, P1067, DOI 10.1111/j.1365-313X.2011.04658.x; Kuhn K, 2009, PLANT CELL, V21, P2762, DOI 10.1105/tpc.109.068536; LAMATTINA L, 1993, EUR J BIOCHEM, V217, P831, DOI 10.1111/j.1432-1033.1993.tb18311.x; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Lister R, 2007, PLANT CELL, V19, P3739, DOI 10.1105/tpc.107.050534; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Matsushima R, 2011, PLANT CELL, V23, P1608, DOI 10.1105/tpc.111.084012; Meyer EH, 2007, PLANT MOL BIOL, V64, P319, DOI 10.1007/s11103-007-9156-9; Millar AH, 2011, ANNU REV PLANT BIOL, V62, P79, DOI 10.1146/annurev-arplant-042110-103857; Murcha MW, 2005, J BIOL CHEM, V280, P16476, DOI 10.1074/jbc.M413299200; Murcha MW, 2004, J MOL BIOL, V344, P443, DOI 10.1016/j.jmb.2004.09.045; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; Rode C, 2011, J PROTEOMICS, V74, P2214, DOI 10.1016/j.jprot.2011.06.017; Schlickum S, 2004, GENOMICS, V83, P254, DOI 10.1016/j.ygeno.2003.08.013; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Van Aken O, 2009, MOL PLANT, V2, P1310, DOI 10.1093/mp/ssp053; WEBB MC, 1994, SEX PLANT REPROD, V7, P153, DOI 10.1007/BF00228488; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; WHELAN J, 1995, PLANT PHYSIOL, V107, P1469, DOI 10.1104/pp.107.4.1469	66	44	45	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41757	41773		10.1074/jbc.M112.383836	http://dx.doi.org/10.1074/jbc.M112.383836			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23043101	Green Published, hybrid			2022-12-25	WOS:000312103000018
J	Schmid, J; Dussmann, H; Boukes, GJ; Flanagan, L; Lindner, AU; O'Connor, CL; Rehm, M; Prehn, JHM; Huber, HJ				Schmid, Jasmin; Dussmann, Heiko; Boukes, Gerhardt J.; Flanagan, Lorna; Lindner, Andreas U.; O'Connor, Carla L.; Rehm, Markus; Prehn, Jochen H. M.; Huber, Heinrich J.			Systems Analysis of Cancer Cell Heterogeneity in Caspase-dependent Apoptosis Subsequent to Mitochondrial Outer Membrane Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED-INHIBITOR; CYTOCHROME-C; COLORECTAL-CANCER; PROTEASOME INHIBITORS; ACTIVATION; PROTEINS; EXECUTION; RELEASE; MODEL; EXPRESSION	Deregulation of apoptosis is a hallmark of carcinogenesis. We here combine live cell imaging and systems modeling to investigate caspase-dependent apoptosis execution subsequent to mitochondrial outer membrane permeabilization ( MOMP) in several cancer cell lines. We demonstrate that, although most cell lines that underwent MOMP also showed robust and fast activation of executioner caspases and apoptosis, the colorectal cancer cell lines LoVo and HCT-116 Smac(-/-), similar to X-linked inhibitor of apoptosis protein (XIAP)-overexpressing HeLa (HeLa XIAP(Adv)) cells, only showed delayed and often no caspase activation, suggesting apoptosis impairment subsequent to MOMP. Employing APOPTO-CELL, a recently established model of apoptosis subsequent to MOMP, this impairment could be understood by studying the systemic interaction of five proteins that are present in the apoptosis pathway subsequent to MOMP. Using APOPTO-CELL as a tool to study detailed molecular mechanisms during apoptosis execution in individual cell lines, we demonstrate that caspase-9 was the most important regulator in DLD-1, HCT-116, and HeLa cells and identified additional cell line-specific co-regulators. Developing and applying a computational workflow for parameter screening, systems modeling identified that apoptosis execution kinetics are more robust against changes in reaction kinetics in HCT-116 and HeLa than in DLD-1 cells. Our systems modeling study is the first to draw attention to the variability in cell specific protein levels and reaction rates and to the emergent effects of such variability on the efficiency of apoptosis execution and on apoptosis impairment subsequent to MOMP.	[Schmid, Jasmin; Dussmann, Heiko; Boukes, Gerhardt J.; Flanagan, Lorna; Lindner, Andreas U.; O'Connor, Carla L.; Rehm, Markus; Prehn, Jochen H. M.; Huber, Heinrich J.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, Dublin 2, Ireland	Royal College of Surgeons - Ireland	Huber, HJ (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Ctr Syst Med, 123 St Stephens Green, Dublin 2, Ireland.	heinhuber@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Rehm, Markus/C-3398-2012; Schmid, Jasmin/C-3393-2012	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Schmid, Jasmin/0000-0001-5384-2242; Flanagan, Lorna/0000-0001-5616-1055; Dussmann, Heiko/0000-0002-3582-8057; Lindner, Andreas/0000-0003-1590-3547	Science Foundation Ireland [08/IN.1/B1949, 07/RFP/BICF601]; Irish Health Research Board APOCO-LON Grant [TRA/2007/26]; European Union Framework Programme 7 (APO-SYS); European Union Marie Curie action project Oxysense [PIAP-GA-2009-230641]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Health Research Board APOCO-LON Grant; European Union Framework Programme 7 (APO-SYS); European Union Marie Curie action project Oxysense	This research was supported by Science Foundation Ireland Grant 08/IN.1/B1949 (to J. H. M. P. and H. J. H.), Science Foundation Ireland Grant 07/RFP/BICF601 (to M. R.), Irish Health Research Board APOCO-LON Grant TRA/2007/26 (to J. H. M. P.), the European Union Framework Programme 7 (APO-SYS), and the European Union Marie Curie action project Oxysense PIAP-GA-2009-230641 (to J. H. M. P.).	Adams J, 1999, CANCER RES, V59, P2615; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bialik S, 2010, TRENDS BIOCHEM SCI, V35, P556, DOI 10.1016/j.tibs.2010.04.008; Bratton SB, 2002, CELL DEATH DIFFER, V9, P881, DOI 10.1038/sj.cdd.4401069; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; FIDLER IJ, 1985, SEMIN ONCOL, V12, P207; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hector S, 2012, BRIT J CANCER, V106, P1499, DOI 10.1038/bjc.2012.133; Hector S, 2012, GUT, V61, P725, DOI 10.1136/gutjnl-2011-300433; Hector S, 2009, BBA-REV CANCER, V1795, P117, DOI 10.1016/j.bbcan.2008.12.002; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Huber HJ, 2007, BIOINFORMATICS, V23, P648, DOI 10.1093/bioinformatics/btl684; Huber HJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.2; Huber HJ, 2011, BBA-MOL CELL RES, V1813, P608, DOI 10.1016/j.bbamcr.2010.10.004; Huber HJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-9; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kappelhoff JC, 2009, PROTEIN J, V28, P96, DOI 10.1007/s10930-009-9168-1; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; O'Connor CL, 2008, BBA-MOL CELL RES, V1783, P1903, DOI 10.1016/j.bbamcr.2008.05.025; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Peterson QP, 2009, J MED CHEM, V52, P5721, DOI 10.1021/jm900722z; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tamm I, 2004, HEMATOL J, V5, P489, DOI 10.1038/sj.thj.6200549; Teicher BA, 1999, CLIN CANCER RES, V5, P2638; Twiddy D, 2004, J BIOL CHEM, V279, P19665, DOI 10.1074/jbc.M311388200; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Varekova RS, 2011, J CHEM INF MODEL, V51, P1795, DOI 10.1021/ci200133w; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Xiang GA, 2009, J SURG ONCOL, V100, P708, DOI 10.1002/jso.21408; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zlobec I, 2006, CANCER-AM CANCER SOC, V106, P284, DOI 10.1002/cncr.21600	52	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41546	41559		10.1074/jbc.M112.411827	http://dx.doi.org/10.1074/jbc.M112.411827			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038270	Green Published, hybrid			2022-12-25	WOS:000311887600064
J	Chung, JS; Katayama, H; Dircksen, H				Chung, J. Sook; Katayama, Hidekazu; Dircksen, Heinrich			New Functions of Arthropod Bursicon: Inducing Deposition and Thickening of New Cuticle and Hemocyte Granulation in the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							CRUSTACEAN CARDIOACTIVE PEPTIDE; MOLT-INHIBITING HORMONE; GREEN SHORE CRAB; CARCINUS-MAENAS; DEVELOPMENTAL EXPRESSION; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; HYPERGLYCEMIC HORMONE; HARDENING HORMONE; CELL-DEATH	Arthropod growth requires molt-associated changes in softness and stiffness of the cuticle that protects from desiccation, infection and injury. Cuticle hardening in insects depends on the blood-borne hormone, bursicon (Burs), although it has never been determined in hemolymph. Whilst also having Burs, decapod crustaceans reiterate molting many more times during their longer life span and are encased in a calcified exoskeleton, which after molting undergoes similar initial cuticle hardening processes as in insects. We investigated the role of homologous crustacean Burs in cuticular changes and growth in the blue crab, Callinectes sapidus. We found dramatic increases in size and number of Burs cells during development in paired thoracic ganglion complex (TGC) neurons with pericardial organs (POs) as neurohemal release sites. A skewed expression of Burs beta/Burs alpha mRNA in TGC corresponds to protein contents of identified Burs beta homodimer and Burs heterodimer in POs. In hemolymph, Burs is consistently present at similar to 21 pM throughout the molt cycle, showing a peak of similar to 89 pM at ecdysis. Since initial cuticle hardness determines the degree of molt-associated somatic increment (MSI), we applied recombinant Burs in vitro to cuticle explants of late premolt or early ecdysis. Burs stimulates cuticle thickening and granulation of hemocytes. These findings demonstrate novel cuticle-associated functions of Burs during molting, while the unambiguous and constant presence of Burs in cells and hemolymph throughout the molt cycle and life stages may implicate further functions of its homo-and heterodimer hormone isoforms in immunoprotective defense systems of arthropods.	[Chung, J. Sook; Katayama, Hidekazu] Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA; [Dircksen, Heinrich] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Stockholm University	Chung, JS (corresponding author), Univ Maryland, Inst Marine & Environm Technol, Ctr Environm Sci, Baltimore, MD 21201 USA.	chung@umces.edu	Chung, J.Sook/D-3832-2012; Dircksen, Heinrich/C-7704-2013	Chung, J.Sook/0000-0002-9318-304X; Dircksen, Heinrich/0000-0001-7815-4868; Katayama, Hidekazu/0000-0003-3367-9147	NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office [NA17FU2841]; Japan Society for Promotion of Science	NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by a program grant (NA17FU2841) from NOAA (National Oceanic and Atmospheric Administration's) Chesapeake Bay Office to the Blue Crab Advanced Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the blue crab hatchery staff at the Institute of Marine and Environmental Technology (Baltimore, MD, USA) for juvenile crabs, and to Ms. S. Tylor at Cooperative Oxford Laboratory, Center for Coastal Environmental Health & Biomolecular Research at Charleston (CCEHBR) (Oxford, MD, USA) for semi-thin sectioning. Dr. H. Katayama was sponsored by a fellowship from the Japan Society for Promotion of Science. This article is contribution No. 4674 of the University of Maryland Center for Environmental Science and contribution No. 12-236 of the Institute of Marine and Environmental Science.	Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Asano T, 2001, J BIOL CHEM, V276, P11100, DOI 10.1074/jbc.M008426200; Bai H, 2010, DEV BIOL, V344, P248, DOI 10.1016/j.ydbio.2010.05.003; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 2004, DEVELOPMENT, V131, P4751, DOI 10.1242/dev.01312; Chung JS, 1996, EUR J BIOCHEM, V240, P358, DOI 10.1111/j.1432-1033.1996.0358h.x; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Churchill EP, 1919, B US BUR FISH, V36, P95; Dai L, 2008, J COMP NEUROL, V506, P759, DOI 10.1002/cne.21575; DALL W, 1978, J EXP MAR BIOL ECOL, V35, P165, DOI 10.1016/0022-0981(78)90074-6; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; DAVIS NT, 1993, J COMP NEUROL, V338, P612, DOI 10.1002/cne.903380410; DENNELL R, 1947, PROC R SOC SER B-BIO, V134, P485, DOI 10.1098/rspb.1947.0027; Dillaman R, 2005, J MORPHOL, V263, P356, DOI 10.1002/jmor.10311; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; DIRCKSEN H, 1991, CELL TISSUE RES, V263, P439, DOI 10.1007/BF00327278; Dircksen H, 1998, CONSERVED CRUSTACEAN; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Drexler AL, 2007, CELL TISSUE RES, V329, P391, DOI 10.1007/s00441-007-0391-9; Foyle TP, 1989, FIELD TESTING SHELL; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; FRAENKEL G., 1965, J INSECT PHYSIOL, V11, P513, DOI 10.1016/0022-1910(65)90137-X; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; HOSE JE, 1992, BIOL BULL-US, V183, P185, DOI 10.2307/1542206; Keller R, 1970, DEV GENES EVOL, V164, P209; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; Kostron B, 1996, J EXP BIOL, V199, P367; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; MYKLES DL, 1980, J EXP BIOL, V84, P89; Natzle JE, 2008, GENETICS, V180, P885, DOI 10.1534/genetics.108.092908; Ohira T, 1999, BIOSCI BIOTECH BIOCH, V63, P1576, DOI 10.1271/bbb.63.1576; Phillips JE, 1998, LOCUST ION TRANSPORT; Phlippen MK, 2000, J EXP BIOL, V203, P521; Reynolds S.E., 1980, Advances in Insect Physiology, V15, P475, DOI 10.1016/S0065-2806(08)60144-7; Reynolds SE, 1996, ADV INSECT PHYSIOL, V26, P157, DOI 10.1016/S0065-2806(08)60031-4; ROBERTSON JD, 1960, COMP BIOCHEM PHYSIOL, V1, P183, DOI 10.1016/0010-406X(60)90023-2; Sharp JH, 2010, GEN COMP ENDOCR, V169, P65, DOI 10.1016/j.ygcen.2010.07.006; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Suderman RJ, 2006, INSECT BIOCHEM MOLEC, V36, P353, DOI 10.1016/j.ibmb.2006.01.012; TRAVIS DF, 1955, BIOL BULL, V108, P88, DOI 10.2307/1538400; TRUBE A, 1994, J COMP NEUROL, V348, P80, DOI 10.1002/cne.903480104; Truman JW, 2005, VITAM HORM, V73, P1, DOI 10.1016/S0083-6729(05)73001-6; VACCA LL, 1983, BIOL BULL, V165, P758, DOI 10.2307/1541477; WEBSTER SG, 1986, GEN COMP ENDOCR, V61, P237, DOI 10.1016/0016-6480(86)90201-7; Wilcockson DC, 2008, GEN COMP ENDOCR, V156, P113, DOI 10.1016/j.ygcen.2007.12.003; Woodruff EA, 2008, PEPTIDES, V29, P2276, DOI 10.1016/j.peptides.2008.08.023; Yatsu J, 2009, INSECT BIOCHEM MOLEC, V39, P254, DOI 10.1016/j.ibmb.2008.12.005; Zitnan D., 2012, INSECT ENDOCNNOLOGY, P253, DOI DOI 10.1016/B978-0-12-384749-2.10007-X; Zmora N, 2007, BIOL REPROD, V77, P138, DOI 10.1095/biolreprod.106.055483; Zmora O, 2005, AQUACULTURE, V244, P129, DOI 10.1016/j.aquaculture.2004.11.012	56	35	38	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46299	10.1371/journal.pone.0046299	http://dx.doi.org/10.1371/journal.pone.0046299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029467	Green Published, gold			2022-12-25	WOS:000309973900126
J	Davis, E; Tamayo, A; Fernandez, A				Davis, Elizabeth; Tamayo, Aracely; Fernandez, Alicia			"Because Somebody Cared about Me. That's How It Changed Things": Homeless, Chronically Ill Patients' Perspectives on Case Management	PLOS ONE			English	Article							HEALTH-SERVICES RESEARCH; EMERGENCY-DEPARTMENT; ALCOHOL-PROBLEMS; FREQUENT USERS; SOCIAL SUPPORT; URBAN HOMELESS; COSTS; HOSPITALIZATION; POPULATION; LONELINESS	Background: Case management programs for chronically ill, homeless people improve health and resource utilization by linking patients with case managers focused on improving management of medical and psychosocial problems. Little is known about participants' perspectives on case management interventions. Methods: This qualitative study used in-depth, one-on-one interviews to understand the impact of a case management program from the perspective of participants. A standardized interview guide with open-ended questions explored experiences with the case management program and feelings about readiness to leave the program. Results: Four recurrent themes emerged: (1) Participants described profound social isolation prior to case management program enrollment; (2) Participants perceived that caring personal relationships with case managers were key to the program; (3) Participants valued assistance with navigating medical and social systems; and (4) Participants perceived that their health improved through both the interpersonal and the practical aspects of case management. Conclusions: Chronically ill, homeless people enrolled in a case management program perceived that social support from case managers resulted in improved health. Programs for this population should consider explicitly including comprehensive social support interventions. Further research on case management should explore the impact of different types of social support on outcomes for homeless chronically ill patients.	[Davis, Elizabeth; Fernandez, Alicia] Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Tamayo, Aracely] Univ Calif Berkeley, Sch Publ Hlth, Dept Epidemiol, Berkeley, CA 94720 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Davis, E (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA.	elizabeth.davis@ucsf.edu			National Institute of Health Career Development Award [K23-RR018324-01]; Arnold P. Gold Professorship award; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR018324] Funding Source: NIH RePORTER	National Institute of Health Career Development Award; Arnold P. Gold Professorship award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr. Alicia Fernandez was supported by an National Institute of Health Career Development Award (K23-RR018324-01) and by an Arnold P. Gold Professorship award. http://grants.nih.gov/training/careerdevelopmentawards.htm. http://www.humanism-in-medicine.org/index.php/programs_grants/gold_foundation_programs/gold_professorships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggett TP, 2010, AM J PUBLIC HEALTH, V100, P1326, DOI 10.2105/AJPH.2009.180109; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Berry-Millett Rachel, 2009, Synth Proj Res Synth Rep, DOI 52372; BF Crabtree, 1999, DOING QUALITATIVE RE, P33; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Buchanan David, 2009, Am J Public Health, V99 Suppl 3, pS675, DOI 10.2105/AJPH.2008.137810; Buchanan D, 2006, AM J PUBLIC HEALTH, V96, P1278, DOI 10.2105/AJPH.2005.067850; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; Craig C, 2011, IHI INNOVATION SERIE; D'Amore J, 2001, ACAD EMERG MED, V8, P1051, DOI 10.1111/j.1553-2712.2001.tb01114.x; Gelberg L., 1996, CHANGING US HLTH CAR, P273; Glaser B, 1978, DISCOV GROUNDED THEO; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kidder DP, 2007, AM J PUBLIC HEALTH, V97, P2238, DOI 10.2105/AJPH.2006.090209; Kim TW, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-19; Kushel MB, 2006, CLIN INFECT DIS, V43, P234, DOI 10.1086/505212; Kushel MB, 2001, JAMA-J AM MED ASSOC, V285, P200, DOI 10.1001/jama.285.2.200; Kushel MB, 2002, AM J PUBLIC HEALTH, V92, P778, DOI 10.2105/AJPH.92.5.778; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; MARTELL JV, 1992, ANN INTERN MED, V116, P299, DOI 10.7326/0003-4819-116-4-299; Martinez TE, 2006, PSYCHIAT SERV, V57, P992, DOI 10.1176/appi.ps.57.7.992; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Moore G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-320; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Murphy BM, 2008, EUR J CARDIOV PREV R, V15, P210, DOI 10.1097/HJR.0b013e3282f2dc4e; National Coalition for the Homeless, 2009, HLTH CAR HOM; O'Connell J., 2005, PREMATURE MORTALITY; O'Connell J., 1999, UTILIZATION COSTS ME; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Perissinotto CM, 2012, ARCH INTERN MED, V172, P1078, DOI 10.1001/archinternmed.2012.1993; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Rich E., 2012, COORDINATING CARE AD; ROBERTSON MJ, 1986, AM J PUBLIC HEALTH, V76, P561, DOI 10.2105/AJPH.76.5.561; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Salit SA, 1998, NEW ENGL J MED, V338, P1734, DOI 10.1056/NEJM199806113382406; Schneidermann M, 2007, MED MANAGEMENT VULNE, P151; Sorkin D, 2002, ANN BEHAV MED, V24, P290, DOI 10.1207/S15324796ABM2404_05; Thornquist L, 2002, ACAD EMERG MED, V9, P300, DOI 10.1111/j.1553-2712.2002.tb01323.x; Tovbin D, 2001, NEPHRON, V89, P26, DOI 10.1159/000046039; Turnbull J, 2007, CAN MED ASSOC J, V177, P1065, DOI 10.1503/cmaj.071294; Wright NMJ, 2006, BRIT J GEN PRACT, V56, P286	44	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45980	10.1371/journal.pone.0045980	http://dx.doi.org/10.1371/journal.pone.0045980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029350	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900069
J	Elgaaen, BV; Olstad, OK; Sandvik, L; Odegaard, E; Sauer, T; Staff, AC; Gautvik, KM				Elgaaen, Bente Vilming; Olstad, Ole Kristoffer; Sandvik, Leiv; Odegaard, Elin; Sauer, Torill; Staff, Anne Cathrine; Gautvik, Kaare M.			ZNF385B and VEGFA Are Strongly Differentially Expressed in Serous Ovarian Carcinomas and Correlate with Survival	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; LOW-GRADE; CANCER; TUMORS; FOXM1; IDENTIFICATION; ANGIOGENESIS; BEVACIZUMAB; ACTIVATION	Background: The oncogenesis of ovarian cancer is poorly understood. The aim of this study was to identify mRNAs differentially expressed between moderately and poorly differentiated (MD/PD) serous ovarian carcinomas (SC), serous ovarian borderline tumours (SBOT) and superficial scrapings from normal ovaries (SNO), and to correlate these mRNAs with clinical parameters including survival. Methods: Differences in mRNA expression between MD/PD SC, SBOT and SNO were analyzed by global gene expression profiling (n = 23), validated by RT-qPCR (n = 41) and correlated with clinical parameters. Results: Thirty mRNAs differentially expressed between MD/PD SC, SBOT and SNO were selected from the global gene expression analyses, and 21 were verified (p < 0.01) by RT-qPCR. Of these, 13 mRNAs were differentially expressed in MD/PD SC compared with SNO (p, 0.01) and were correlated with clinical parameters. ZNF385B was downregulated (FC = -130.5, p = 1.2 x 10(-7)) and correlated with overall survival (p = 0.03). VEGFA was upregulated (FC = 6.1, p = 6.0 x 10(-6)) and correlated with progression-free survival (p = 0.037). Increased levels of TPX2 and FOXM1 mRNAs (FC = 28.5, p = 2.7 x 10(-10) and FC = 46.2, p = 5.6 x 10(-4), respectively) correlated with normalization of CA125 (p = 0.03 and p = 0.044, respectively). Furthermore, we present a molecular pathway for MD/PD SC, including VEGFA, FOXM1, TPX2, BIRC5 and TOP2A, all significantly upregulated and directly interacting with TP53. Conclusions: We have identified 21 mRNAs differentially expressed (p<0.01) between MD/PD SC, SBOT and SNO. Thirteen were differentially expressed in MD/PD SC, including ZNF385B and VEGFA correlating with survival, and FOXM1 and TPX2 with normalization of CA125. We also present a molecular pathway for MD/PD SC.	[Elgaaen, Bente Vilming; Odegaard, Elin] Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway; [Elgaaen, Bente Vilming; Sandvik, Leiv; Sauer, Torill; Staff, Anne Cathrine; Gautvik, Kaare M.] Univ Oslo, Fac Med, Oslo, Norway; [Olstad, Ole Kristoffer; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Unit Biostat & Epidemiol, Oslo, Norway; [Sauer, Torill] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Staff, Anne Cathrine] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Elgaaen, BV (corresponding author), Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway.	bente.vilming.elgaaen@medisin.uio.no	Sauer, Torill/H-7041-2019		The Women and Children's Division, Oslo University Hospital; The Inger and John Fredriksen Foundation for Ovarian Cancer Research	The Women and Children's Division, Oslo University Hospital; The Inger and John Fredriksen Foundation for Ovarian Cancer Research	This study was funded by The Women and Children's Division, Oslo University Hospital, and The Inger and John Fredriksen Foundation for Ovarian Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed A, 2007, CHEM-BIOL INTERACT, V165, P1, DOI 10.1016/j.cbi.2006.10.003; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cancer in Norway, 2011, CANC THER NORW CANC; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elgaaen BV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013837; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Emmanuel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017617; Gomez-Raposo C, 2010, GYNECOL ONCOL, V118, P88, DOI 10.1016/j.ygyno.2010.03.012; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hata K, 2011, ANTICANCER RES, V31, P731; Ishigami SI, 1998, BRIT J CANCER, V78, P1379, DOI 10.1038/bjc.1998.688; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kommoss S, 2009, VIRCHOWS ARCH, V454, P249, DOI 10.1007/s00428-009-0725-y; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pujade-Lauraine E, 2013, J CLIN ONCOL, V31; Qian XY, 2011, APPL IMMUNOHISTO M M, V19, P126, DOI 10.1097/PAI.0b013e3181e30dcd; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shigeishi H, 2009, ONCOL REP, V21, P341, DOI 10.3892/or_00000227; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Siddiqui GK, 2010, EUR J GYNAECOL ONCOL, V31, P156; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	46	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46317	10.1371/journal.pone.0046317	http://dx.doi.org/10.1371/journal.pone.0046317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029477	gold, Green Published			2022-12-25	WOS:000309973900132
J	Rosario, R; Araki, H; Print, CG; Shelling, AN				Rosario, Roseanne; Araki, Hiromitsu; Print, Cristin G.; Shelling, Andrew N.			The Transcriptional Targets of Mutant FOXL2 in Granulosa Cell Tumours	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; POTENTIAL TARGETS; EXPRESSION; MUTATION; OVARY; ADULT; MOUSE; LINE; IDENTIFICATION; ELEMENT	Background: Despite their distinct biology, granulosa cell tumours (GCTs) are treated the same as other ovarian tumours. Intriguingly, a recurring somatic mutation in the transcription factor Forkhead Box L2 (FOXL2) 402C>G has been found in nearly all GCTs examined. This investigation aims to identify the pathogenicity of mutant FOXL2 by studying its altered transcriptional targets. Methods: The expression of mutant FOXL2 was reduced in the GCT cell line KGN, and wildtype and mutant FOXL2 were overexpressed in the GCT cell line COV434. Total RNA was hybridised to Affymetrix U133 Plus 2 microarrays. Comparisons were made between the transcriptomes of control cells and cells altered by FOXL2 knockdown and overexpression, to detect potential transcriptional targets of mutant FOXL2. Results: The overexpression of wildtype and mutant FOXL2 in COV434, and the silencing of mutant FOXL2 expression in KGN, has shown that mutant FOXL2 is able to differentially regulate the expression of many genes, including two well known FOXL2 targets, StAR and CYP19A. We have shown that many of the genes regulated by mutant FOXL2 are clustered into functional annotations of cell death, proliferation, and tumourigenesis. Furthermore, TGF-beta signalling was found to be enriched when using the gene annotation tools GATHER and GeneSetDB. This enrichment was still significant after performing a robust permutation analysis. Conclusion: Given that many of the transcriptional targets of mutant FOXL2 are known TGF-beta signalling genes, we suggest that deregulation of this key antiproliferative pathway is one way mutant FOXL2 contributes to the pathogenesis of adult-type GCTs. We believe this pathway should be a target for future therapeutic interventions, if outcomes for women with GCTs are to improve.	[Rosario, Roseanne; Shelling, Andrew N.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand; [Araki, Hiromitsu; Print, Cristin G.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Bioinformat Inst New Zealand, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Rosario, R (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand.	r.rosario@auckland.ac.nz		Shelling, Andrew/0000-0002-5300-1934; Print, Cristin/0000-0001-8345-7812	Sladjana M. Crosley Fund for GCT Research; Granulosa Cell Tumour Foundation; University of Auckland; Cancer Society of New Zealand Training Scholarship in Cancer Research	Sladjana M. Crosley Fund for GCT Research; Granulosa Cell Tumour Foundation; University of Auckland; Cancer Society of New Zealand Training Scholarship in Cancer Research	This work is funded by the Sladjana M. Crosley Fund for GCT Research and the Granulosa Cell Tumour Foundation. Roseanne Rosario is supported by a University of Auckland Doctoral Scholarship and the Cancer Society of New Zealand Training Scholarship in Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki H, 2012, FEBS OPEN BIO, V2, P76, DOI 10.1016/j.fob.2012.04.003; Arcellana-Panlilio MY, 2002, GENE CHROMOSOME CANC, V35, P176, DOI 10.1002/gcc.10108; Ayroles JF, 2006, METHOD ENZYMOL, V411, P214, DOI 10.1016/S0076-6879(06)11011-3; Batista F, 2007, P NATL ACAD SCI USA, V104, P3330, DOI 10.1073/pnas.0611326104; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Benayoun BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008789; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Colombo N, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1005; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'Angelo E, 2011, MODERN PATHOL, V24, P1360, DOI 10.1038/modpathol.2011.95; East N, 2005, J OBSTET GYNAECOL CA, V27, P363, DOI 10.1016/S1701-2163(16)30464-9; Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Escudero JM, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-4; Fleming NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014389; Fuller PJ, 2004, TRENDS ENDOCRIN MET, V15, P122, DOI 10.1016/j.tem.2004.02.005; Fuller PJ, 2002, MOL CELL ENDOCRINOL, V191, P89, DOI 10.1016/S0303-7207(02)00059-X; Gittleman AM, 2003, CLIN IMAG, V27, P221, DOI 10.1016/S0899-7071(02)00586-7; Harris SE, 2002, MOL HUM REPROD, V8, P729, DOI 10.1093/molehr/8.8.729; Hes O, 2011, APPL IMMUNOHISTO M M, V19, P347, DOI 10.1097/PAI.0b013e3182039ef2; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Jamieson S, 2010, MODERN PATHOL, V23, P1477, DOI 10.1038/modpathol.2010.145; Kalfa N, 2008, J UROLOGY, V180, P1810, DOI 10.1016/j.juro.2008.03.097; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kim JH, 2011, ONCOGENE, V30, P1653, DOI 10.1038/onc.2010.541; Kim MS, 2010, J PATHOL, V221, P147, DOI 10.1002/path.2688; Kobel M, 2009, CANCER RES, V69, P9160, DOI 10.1158/0008-5472.CAN-09-2669; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Parman C, 2006, AFFYQCREPORTS PACKAG; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Pisarska MD, 2011, ENDOCRINOLOGY, V152, P1199, DOI 10.1210/en.2010-1041; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Schlessinger D, 2010, J ANDROL, V31, P16, DOI 10.2164/jandrol.109.008201; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veitia RA, 2010, BIOESSAYS, V32, P375, DOI 10.1002/bies.200900193; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Zhang H, 2000, MOL HUM REPROD, V6, P146, DOI 10.1093/molehr/6.2.146	51	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46270	10.1371/journal.pone.0046270	http://dx.doi.org/10.1371/journal.pone.0046270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029457	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900121
J	Song, B; Smink, AM; Jones, CV; Callaghan, JM; Firth, SD; Bernard, CA; Laslett, AL; Kerr, PG; Ricardo, SD				Song, Bi; Smink, Alexandra M.; Jones, Christina V.; Callaghan, Judy M.; Firth, Stephen D.; Bernard, Claude A.; Laslett, Andrew L.; Kerr, Peter G.; Ricardo, Sharon D.			The Directed Differentiation of Human iPS Cells into Kidney Podocytes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR PODOCYTES; DNA METHYLATION; SOMATIC-CELLS; FIBROBLASTS; EXPRESSION; PROLIFERATION; PARIETAL; BETA	The loss of glomerular podocytes is a key event in the progression of chronic kidney disease resulting in proteinuria and declining function. Podocytes are slow cycling cells that are considered terminally differentiated. Here we provide the first report of the directed differentiation of induced pluripotent stem (iPS) cells to generate kidney cells with podocyte features. The iPS-derived podocytes share a morphological phenotype analogous with cultured human podocytes. Following 10 days of directed differentiation, iPS podocytes had an up-regulated expression of mRNA and protein localization for podocyte markers including synaptopodin, nephrin and Wilm's tumour protein (WT1), combined with a down-regulation of the stem cell marker OCT3/4. In contrast to human podocytes that become quiescent in culture, iPS-derived cells maintain a proliferative capacity suggestive of a more immature phenotype. The transduction of iPS podocytes with fluorescent labeled-talin that were immunostained with podocin showed a cytoplasmic contractile response to angiotensin II (AII). A permeability assay provided functional evidence of albumin uptake in the cytoplasm of iPS podocytes comparable to human podocytes. Moreover, labeled iPS-derived podocytes were found to integrate into reaggregated metanephric kidney explants where they incorporated into developing glomeruli and co-expressed WT1. This study establishes the differentiation of iPS cells to kidney podocytes that will be useful for screening new treatments, understanding podocyte pathogenesis, and offering possibilities for regenerative medicine.	[Song, Bi; Smink, Alexandra M.; Jones, Christina V.; Bernard, Claude A.; Ricardo, Sharon D.] Monash Univ, MISCL, Clayton, Vic, Australia; [Laslett, Andrew L.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Kerr, Peter G.] Monash Univ, Dept Med, Monash Med Ctr, Clayton, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Monash University	Ricardo, SD (corresponding author), Monash Univ, MISCL, Clayton, Vic, Australia.	Sharon.Ricardo@monash.edu	Laslett, Andrew L/A-9760-2011; Smink, Alexandra/AAP-5285-2021; Kerr, Peter G/I-1461-2013	Laslett, Andrew L/0000-0003-4729-8193; Smink, Alexandra/0000-0002-9714-1779; Ricardo, Sharon/0000-0003-1724-3669; Bernard, Claude Charles Andre/0000-0003-2816-5328	Alport Foundation of Australia; Monash University Strategic Grant; Erdi Fellowship in Neurological Diseases; Baker Foundation	Alport Foundation of Australia; Monash University Strategic Grant(Monash University); Erdi Fellowship in Neurological Diseases; Baker Foundation	This work was supported by the Alport Foundation of Australia and a Monash University Strategic Grant. CA Bernard is a recipient of an Erdi Fellowship in Neurological Diseases and funding from the Baker Foundation. Microscopy was performed with technical expertise from Monash Micro Imaging, Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Humphreys BD, 2007, NEPHROL THER, V3, P3, DOI 10.1016/j.nephro.2006.12.002; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V336, P585, DOI 10.1016/j.bbrc.2005.08.136; Kriz W, 2003, PEDIATR NEPHROL, V18, P617, DOI 10.1007/s00467-003-1172-7; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; LIN SA, 2010, STEM CELLS DEV; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Mae SI, 2010, BIOCHEM BIOPH RES CO, V393, P877, DOI 10.1016/j.bbrc.2010.02.111; MALLIPATTU SK, 2012, J BIOL CHEM; Mene Paolo, 2009, V466, P3, DOI 10.1007/978-1-59745-352-3_1; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; NORGAARD JOR, 1987, LAB INVEST, V57, P277; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Ohtaka A, 2002, NEPHROL DIAL TRANSPL, V17, P11, DOI 10.1093/ndt/17.suppl_9.11; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Ruster C, 2009, AM J NEPHROL, V29, P538, DOI 10.1159/000191467; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Song B, 2011, J AM SOC NEPHROL, V22, P1213, DOI 10.1681/ASN.2010101022; Steenhard BM, 2005, J AM SOC NEPHROL, V16, P1623, DOI 10.1681/ASN.2004070584; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaughan MR, 2005, KIDNEY INT, V68, P133, DOI 10.1111/j.1523-1755.2005.00387.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	50	121	133	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46453	10.1371/journal.pone.0046453	http://dx.doi.org/10.1371/journal.pone.0046453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029522	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900163
J	Lee, AJH; Awano, T; Park, GH; Monani, UR				Lee, Andrew J-H; Awano, Tomoyuki; Park, Gyu-Hwan; Monani, Umrao R.			Limited Phenotypic Effects of Selectively Augmenting the SMN Protein in the Neurons of a Mouse Model of Severe Spinal Muscular Atrophy	PLOS ONE			English	Article							MOTOR-NEURONS; NEUROMUSCULAR-JUNCTIONS; SINGLE NUCLEOTIDE; SKELETAL-MUSCLE; CARDIAC DEFECTS; SURVIVAL; GENE; RESCUE; MICE; IDENTIFICATION	The selective vulnerability of motor neurons to paucity of Survival Motor Neuron (SMN) protein is a defining feature of human spinal muscular atrophy (SMA) and indicative of a unique requirement for adequate levels of the protein in these cells. However, the relative contribution of SMN-depleted motor neurons to the disease process is uncertain and it is possible that their characteristic loss and the overall SMA phenotype is a consequence of low protein in multiple cell types including neighboring spinal neurons and non-neuronal tissue. To explore the tissue-specific requirements for SMN and, especially, the salutary effects of restoring normal levels of the protein to neuronal tissue of affected individuals, we have selectively expressed the protein in neurons of mice that model severe SMA. Expressing SMN pan-neuronally in mutant mice mitigated specific aspects of the disease phenotype. Motor performance of the mice improved and the loss of spinal motor neurons that characterizes the disease was arrested. Proprioceptive synapses on the motor neurons were restored and defects of the neuromuscular junctions mitigated. The improvements at the cellular level were reflected in a four-fold increase in survival. Nevertheless, mutants expressing neuronal SMN did not live beyond three weeks of birth, a relatively poor outcome compared to the effects of ubiquitously restoring SMN. This suggests that although neurons and, in particular, spinal motor neurons constitute critical cellular sites of action of the SMN protein, a truly effective treatment of severe SMA will require restoring the protein to multiple cell types including non-neuronal tissue.	[Lee, Andrew J-H; Awano, Tomoyuki; Monani, Umrao R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Monani, Umrao R.] Columbia Univ, Dept Neurol, New York, NY USA; [Park, Gyu-Hwan] Kyungpook Natl Univ, Dept Neuropharmacol, Taegu, South Korea; [Lee, Andrew J-H; Awano, Tomoyuki; Monani, Umrao R.] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA	Columbia University; Columbia University; Kyungpook National University; Columbia University	Monani, UR (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	um2105@columbia.edu	Lee, Andrew/GVU-2817-2022		National Institutes of Health [NS057482]; Muscular Dystrophy Association of America; Families of SMA; SMA Foundation; Department of Defense [W81XWH-08-1-0009 SC3, W81XWH-09-1-0245]; AFMFrance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Families of SMA; SMA Foundation; Department of Defense(United States Department of Defense); AFMFrance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work described in this article was supported by grants from the National Institutes of Health (NS057482), Muscular Dystrophy Association of America, Families of SMA, SMA Foundation, Department of Defense (W81XWH-08-1-0009 SC3 and W81XWH-09-1-0245) and AFMFrance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BERTINI E, 1989, AM J MED GENET, V33, P328, DOI 10.1002/ajmg.1320330309; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, CURR TREAT OPTION NE, V11, P90, DOI 10.1007/s11940-009-0012-x; Butchbach MER, 2007, NEUROBIOL DIS, V27, P207, DOI 10.1016/j.nbd.2007.04.009; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Gogliotti RG, 2011, NEUROBIOL DIS, V43, P142, DOI 10.1016/j.nbd.2011.03.002; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guettier-Sigrist S, 2001, FUND CLIN PHARMACOL, V15, P31, DOI 10.1046/j.1472-8206.2001.00006.x; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; Maddatu TP, 2005, HUM MOL GENET, V14, P3179, DOI 10.1093/hmg/ddi349; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; MELLINS RB, 1974, PEDIATRICS, V53, P33; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; PIERCE JP, 1993, J NEUROSCI, V13, P4748; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Somers E, 2012, NEUROMUSCULAR DISORD, V22, P435, DOI 10.1016/j.nmd.2011.10.021; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340	61	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46353	10.1371/journal.pone.0046353	http://dx.doi.org/10.1371/journal.pone.0046353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029491	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500094
J	Wang, JT; Chen, YY; Tew, KS; Meng, PJ; Chen, CA				Wang, Jih-Terng; Chen, Yi-Yun; Tew, Kwee Siong; Meng, Pei-Jei; Chen, Chaolun A.			Physiological and Biochemical Performances of Menthol-Induced Aposymbiotic Corals	PLOS ONE			English	Article							ALGA-INVERTEBRATE SYMBIOSIS; CLIMATE-CHANGE; THERMAL TOLERANCE; SEA-ANEMONE; ANTHOPLEURA-ELEGANTISSIMA; SENSORY NEURONS; PHASE-SHIFTS; CELL BIOLOGY; STRESS; ZOOXANTHELLAE	The unique mutualism between corals and their photosynthetic zooxanthellae (Symbiodinium spp.) is the driving force behind functional assemblages of coral reefs. However, the respective roles of hosts and Symbiodinium in this endosymbiotic association, particularly in response to environmental challenges (e.g., high sea surface temperatures), remain unsettled. One of the key obstacles is to produce and maintain aposymbiotic coral hosts for experimental purposes. In this study, a simple and gentle protocol to generate aposymbiotic coral hosts (Isopora palifera and Stylophora pistillata) was developed using repeated incubation in menthol/artificial seawater (ASW) medium under light and in ASW in darkness, which depleted more than 99% of Symbiodinium from the host within 4,8 days. As indicated by the respiration rate, energy metabolism (by malate dehydrogenase activity), and nitrogen metabolism (by glutamate dehydrogenase activity and profiles of free amino acids), the physiological and biochemical performances of the menthol-induced aposymbiotic corals were comparable to their symbiotic counterparts without nutrient supplementation (e.g., for Stylophora) or with a nutrient supplement containing glycerol, vitamins, and a host mimic of free amino acid mixture (e.g., for Isopora). Differences in biochemical responses to menthol-induced bleaching between Stylophora and Isopora were attributed to the former digesting Symbiodinium rather than expelling the algae live as found in the latter species. Our studies showed that menthol could successfully bleach corals and provided aposymbiotic corals for further exploration of coral-alga symbioses.	[Wang, Jih-Terng; Chen, Yi-Yun] Tajen Univ, Grad Inst Biotechnol, Pingtung, Taiwan; [Tew, Kwee Siong; Meng, Pei-Jei] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tew, Kwee Siong; Meng, Pei-Jei] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolut, Pingtung, Taiwan; [Chen, Chaolun A.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Chaolun A.] Acad Sinica, Taiwan Int Grad Program TIGP Biodivers, Taipei 115, Taiwan; [Chen, Chaolun A.] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wang, JT (corresponding author), Tajen Univ, Grad Inst Biotechnol, Pingtung, Taiwan.	jtw@mail.tajen.edu.tw; acropora.chen@gmail.com	Meng, PJ/AAC-3677-2021		Academic Sinica Thematic grant; National Science Council [NSC-96-2628-B-001-004-MY3]	Academic Sinica Thematic grant; National Science Council(Ministry of Science and Technology, Taiwan)	Academic Sinica Thematic grant (2008-2010) to JTW and CAC, and National Science Council (NSC-96-2628-B-001-004-MY3) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, CHANGES MARINE COMMU; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bhagooli R, 2003, J EXP MAR BIOL ECOL, V291, P181, DOI 10.1016/S0022-0981(03)00121-7; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN JT, 1987, PLANT SCI, V48, P195, DOI 10.1016/0168-9452(87)90090-2; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1981, MAR BIOL, V61, P199, DOI 10.1007/BF00386660; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Haeseler G, 2002, EUR J ANAESTH, V19, P571, DOI 10.1017/S0265021502000923; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JONES BN, 1981, J LIQ CHROMATOGR, V4, P565, DOI 10.1080/01483918108059956; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; KRUSKAL J.B., 1978, MULTIDIMENSIONAL SCA; Kuo J, 2010, J EXP MAR BIOL ECOL, V388, P11, DOI 10.1016/j.jembe.2010.03.011; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MOORE SJ, 1989, J MAR BIOL ASSOC UK, V69, P803, DOI 10.1017/S0025315400032173; OECD SIDS, 2003, MENTH, P5; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; REES TAV, 1986, PROC R SOC SER B-BIO, V229, P299, DOI 10.1098/rspb.1986.0087; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Wang JT, 2011, MAR ECOL PROG SER, V422, P51, DOI 10.3354/meps08913; Wang JT, 2012, ZOOL STUD, V51, P137; Wang JT, 1997, PLANT PHYSIOL, V114, P631, DOI 10.1104/pp.114.2.631; Wang JT, 1998, J EXP BIOL, V201, P2445; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Weis VM, 1996, J EXP BIOL, V199, P883	50	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46406	10.1371/journal.pone.0046406	http://dx.doi.org/10.1371/journal.pone.0046406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029512	gold, Green Submitted, Green Published			2022-12-25	WOS:000309517500101
J	Busch, S; Ryden, L; Stal, O; Jirstrom, K; Landberg, G				Busch, Susann; Ryden, Lisa; Stal, Olle; Jirstrom, Karin; Landberg, Goran			Low ERK Phosphorylation in Cancer-Associated Fibroblasts Is Associated with Tamoxifen Resistance in Pre-Menopausal Breast Cancer	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOTHELIAL GROWTH-FACTOR; TUMOR MICROENVIRONMENT; KNOCKOUT MICE; LUNG-CANCER; EXPRESSION; SIGNATURE; ESTROGEN; CELLS; PATHWAY	Purpose: The aim of this study was to evaluate ERK phosphorylation as a stromal biomarker for breast cancer prognosis and tamoxifen treatment prediction within a randomized tamoxifen trial. Patients and Methods: Tissue microarrays of two breast cancer cohorts including in total 743 invasive breast cancer samples were analyzed for ERK phosphorylation (pERK) and smooth muscle actin-alpha expression (SMA alpha) in cancer-associated fibroblasts (CAFs) and links to clinico-pathological data and treatment-predictive values were delineated. Results: By analyzing a unique randomized tamoxifen trial including breast cancer patients receiving no adjuvant treatment we show for the first time that patients low in ERK phosphorylation in CAFs did not respond to tamoxifen treatment despite having estrogen-receptor alpha (ER alpha-positive tumors compared to patients with high pERK levels in CAFs (P = 0.015, multivariate Cox regression interaction analysis). In both clinical materials we further show a significant association between pERK and SMA alpha, a characteristic marker for activated fibroblasts. SMA alpha expression however was not linked to treatment-predictive information but instead had prognostic qualities. Conclusion: The data suggests that the presence of a subpopulation of CAFs, defined by minimal activated ERK signaling, is linked to an impaired tamoxifen response. Thus, this report illustrates the importance of the stroma for monitoring treatment effects in pre-menopausal breast cancer.	[Busch, Susann; Landberg, Goran] Univ Manchester, Breakthrough Breast Canc Res Unit, Sch Canc Enabling Sci & Technol,Christie NHS Fdn, Manchester Acad Hlth Sci Ctr,Paterson Inst Canc R, Manchester, Lancs, England; [Ryden, Lisa] Univ Lund Hosp, Dept Surg, Inst Clin Sci, S-22185 Lund, Sweden; [Stal, Olle] Linkoping Univ, Dept Clin & Expt Med, Div Oncol, Linkoping, Sweden; [Jirstrom, Karin; Landberg, Goran] Lund Univ, Skane Univ Hosp Malmo, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden; [Landberg, Goran] Gothenburg Univ, Sahlgrenska Canc Ctr, Gothenburg, Sweden	Christie NHS Foundation Trust; University of Manchester; Lund University; Skane University Hospital; Linkoping University; Lund University; Skane University Hospital; University of Gothenburg	Landberg, G (corresponding author), Univ Manchester, Breakthrough Breast Canc Res Unit, Sch Canc Enabling Sci & Technol,Christie NHS Fdn, Manchester Acad Hlth Sci Ctr,Paterson Inst Canc R, Manchester, Lancs, England.	glandberg@picr.man.ac.uk			Swedish Cancer Society and Breakthrough Breast Cancer UK; Breast Cancer Now [MAN-Q1] Funding Source: researchfish	Swedish Cancer Society and Breakthrough Breast Cancer UK; Breast Cancer Now	This study was supported by the Swedish Cancer Society and Breakthrough Breast Cancer UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Arendt LM, 2009, SEMIN CELL DEV BIOL; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Bogin L, 2002, CANCER RES, V62, P1948; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Garvin S, 2003, CANCER RES, V63, P8742; Gasparini G, 2000, Oncologist, V5 Suppl 1, P37; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Han SW, 2005, INT J CANCER, V113, P109, DOI 10.1002/ijc.20550; Hattar R, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2220; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Ihn H, 2000, J IMMUNOL, V165, P2149, DOI 10.4049/jimmunol.165.4.2149; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Mandell JW, 2008, HISTOCHEM CELL BIOL, V130, P465, DOI 10.1007/s00418-008-0474-z; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Milde-Langosch K, 2005, BRIT J CANCER, V92, P2206, DOI 10.1038/sj.bjc.6602655; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pages Gilles, 2004, Methods Mol Biol, V250, P155; Petricoin EF, 2004, TRENDS MOL MED, V10, P59, DOI 10.1016/j.molmed.2003.12.006; Pinto MP, 2010, CANCER RES, V70, P2655, DOI 10.1158/0008-5472.CAN-09-4373; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Rajski M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-1; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rudnick JA, 2012, CLIN EXP METASTASIS; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Shekhar MPV, 2007, AM J PATHOL, V170, P1546, DOI 10.2353/ajpath.2007.061004; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wennmalm K, 2009, NAT MED, V15, P237, DOI 10.1038/nm0309-237; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269	46	21	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45669	10.1371/journal.pone.0045669	http://dx.doi.org/10.1371/journal.pone.0045669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029174	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700056
J	Guo, L; Wu, WJ; Liu, LD; Wang, LC; Zhang, Y; Wu, LQ; Guan, Y; Li, QH				Guo, Lei; Wu, Wen-juan; Liu, Long-ding; Wang, Li-chun; Zhang, Ying; Wu, Lian-qiu; Guan, Ying; Li, Qi-han			Herpes Simplex Virus 1 ICP22 Inhibits the Transcription of Viral Gene Promoters by Binding to and Blocking the Recruitment of P-TEFb	PLOS ONE			English	Article							RNA-POLYMERASE-II; EARLY PROTEIN ICP22; CARBOXYL-TERMINAL DOMAIN; INFECTED-CELL PROTEIN; ELONGATION; TYPE-1; ACTIVATION; EXPRESSION; PHOSPHORYLATION; KINASE	ICP22 is a multifunctional herpes simplex virus 1 (HSV-1) immediate early protein that functions as a general repressor of a subset of cellular and viral promoters in transient expression systems. Although the exact mechanism of repression remains unclear, this protein induces a decrease in RNA polymerase II Serine 2 (RNAPII Ser-2) phosphorylation, which is critical for transcription elongation. To characterize the mechanism of transcriptional repression by ICP22, we established an in vivo transient expression reporter system. We found that ICP22 inhibits transcription of the HSV-1 alpha, beta and gamma gene promoters. The viral tegument protein VP16, which plays vital roles in initiation of viral gene expression and viral proliferation, can overcome the inhibitory effect of ICP22 on alpha-gene transcription. Further immunoprecipitation studies indicated that both ICP22 and VP16 bind to positive transcription elongation factor b (P-TEFb) and form a complex with it in vivo. We extended this to show that P-TEFb regulates transcription of the viral alpha-gene promoters and affects transcriptional regulation of ICP22 and VP16 on the alpha-genes. Additionally, ChIP assays demonstrated that ICP22 blocks the recruitment of P-TEFb to the viral promoters, while VP16 reverses this blocking effect by recruiting P-TEFb to the viral alpha-gene promoters through recognition of the TAATGARAT motif. Taken together, our results suggest that ICP22 interacts with and blocks the recruitment of P-TEFb to viral promoter regions, which inhibits transcription of the viral gene promoters. The transactivator VP16 binds to and induces the recruitment of P-TEFb to viral alpha-gene promoters, which counteracts the transcriptional repression of ICP22 on alpha-genes by recruiting p-TEFb to the promoter region.	[Guo, Lei; Wu, Wen-juan; Liu, Long-ding; Wang, Li-chun; Zhang, Ying; Guan, Ying; Li, Qi-han] Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China; [Wu, Wen-juan] Affiliated Hosp 1, Kunming Med Coll, Kunming, Peoples R China; [Wu, Lian-qiu] Chinese Acad Med Sci, Inst Mat Med, Peking Union Med Coll, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Peking Union Medical College	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Peking Union Med Coll, Kunming, Peoples R China.	imbcams.lq@gmail.com	Guo, Lei/AEU-0178-2022; Wu, wenjuan/GPX-6968-2022	Guo, Lei/0000-0003-1733-1802	National Basic Research Program [2012CB518901, 2011CB504903]; National Natural Sciences Foundation of China [31100127]	National Basic Research Program(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by funding from National Basic Research Program, 2012CB518901 and 2011CB504903 (http://www.973.gov.cn/) and National Natural Sciences Foundation of China, grant number 31100127 (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Baringer JR, 1976, SURV OPHTHALMOL, V21, P71; Bowman JJ, 2009, J VIROL, V83, P8733, DOI 10.1128/JVI.00810-09; Bruni R, 1998, J VIROL, V72, P8525, DOI 10.1128/JVI.72.11.8525-8531.1998; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; Chiu YL, 2004, J VIROL, V78, P2517, DOI 10.1128/JVI.78.5.2517-2529.2004; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Cun W, 2006, J BIOCHEM, V140, P67, DOI 10.1093/jb/mvj135; Cun W, 2009, SCI CHINA SER C, V52, P344, DOI 10.1007/s11427-009-0051-2; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Durand LO, 2005, J VIROL, V79, P6757, DOI 10.1128/JVI.79.11.6757-6762.2005; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Fraser KA, 2007, J VIROL, V81, P5091, DOI 10.1128/JVI.00184-07; GAFFNEY DF, 1985, NUCLEIC ACIDS RES, V13, P7847, DOI 10.1093/nar/13.21.7847; Giraud S, 2004, ONCOGENE, V23, P7391, DOI 10.1038/sj.onc.1207972; GODOWSKI PJ, 1986, P NATL ACAD SCI USA, V83, P256, DOI 10.1073/pnas.83.2.256; Hartzog GA, 2007, GENE DEV, V21, P3209, DOI 10.1101/gad.1628707; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Kalamvoki M, 2011, J VIROL, V85, P9472, DOI 10.1128/JVI.00876-11; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lenasi T, 2010, RNA BIOL, V7, P145, DOI 10.4161/rna.7.2.11057; Leopardi R, 1997, J VIROL, V71, P1133, DOI 10.1128/JVI.71.2.1133-1139.1997; Li WJ, 2009, POPUL SPACE PLACE, V15, P1, DOI 10.1002/psp.505; Lin Fu-sen, 2010, Virologica Sinica, V25, P1, DOI 10.1007/s12250-010-3080-x; Long MC, 1999, J VIROL, V73, P5593, DOI 10.1128/JVI.73.7.5593-5604.1999; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Markovitz NS, 2000, J VIROL, V74, P523, DOI 10.1128/JVI.74.1.523-528.2000; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Napolitano G, 2002, INT J ONCOL, V21, P171, DOI 10.3892/ijo.21.1.171; Ogle WO, 1999, J VIROL, V73, P4305, DOI 10.1128/JVI.73.5.4305-4315.1999; OHARE P, 1993, SEMIN VIROL, V4, P145, DOI 10.1006/smvy.1993.1010; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; ProdHon C, 1996, VIROLOGY, V226, P393, DOI 10.1006/viro.1996.0667; PURVES FC, 1993, P NATL ACAD SCI USA, V90, P6701, DOI 10.1073/pnas.90.14.6701; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Rajcani J, 2000, FOLIA MICROBIOL, V45, P7, DOI 10.1007/BF02817445; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Roizman B, 2007, FIELDS VIROLOGY, P3238; SEKULOVICH RE, 1988, J VIROL, V62, P4510, DOI 10.1128/JVI.62.12.4510-4522.1988; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Spencer CA, 1997, J VIROL, V71, P2031, DOI 10.1128/JVI.71.3.2031-2040.1997; Weir JP, 2001, GENE, V271, P117, DOI 10.1016/S0378-1119(01)00512-1; Whitley Richard J, 2002, Semin Pediatr Infect Dis, V13, P6, DOI 10.1053/spid.2002.29752; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhou Q, 1998, EMBO J, V17, P3681, DOI 10.1093/emboj/17.13.3681	58	30	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45749	10.1371/journal.pone.0045749	http://dx.doi.org/10.1371/journal.pone.0045749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029222	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700065
J	Wijayalath, W; Cheesman, S; Tanabe, K; Handunnetti, S; Carter, R; Pathirana, S				Wijayalath, Wathsala; Cheesman, Sandra; Tanabe, Kazuyuki; Handunnetti, Shiroma; Carter, Richard; Pathirana, Sisira			Strain-Specific Protective Effect of the Immunity Induced by Live Malarial Sporozoites under Chloroquine Cover	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; GENETIC DIVERSITY; VIVAX MALARIA; PARASITES; VACCINE; STAGE; IMMUNIZATION; POLYMORPHISM; CYNOMOLGI; INVITRO	The efficacy of a whole-sporozoite malaria vaccine would partly be determined by the strain-specificity of the protective responses against malarial sporozoites and liver-stage parasites. Evidence from previous reports were inconsistent, where some studies have shown that the protective immunity induced by irradiated or live sporozoites in rodents or humans were cross-protective and in others strain-specific. In the present work, we have studied the strain-specificity of live sporozoite-induced immunity using two genetically and immunologically different strains of Plasmodium cynomolgi, Pc746 and PcCeylon, in toque monkeys. Two groups of monkeys were immunized against live sporozoites of either the Pc746 (n = 5), or the PcCeylon (n = 4) strain, by the bites of 2-4 sporozoite-infected Anopheles tessellates mosquitoes per monkey under concurrent treatments with chloroquine and primaquine to abrogate detectable blood infections. Subsequently, a group of non-immunized monkeys (n = 4), and the two groups of immunized monkeys were challenged with a mixture of sporozoites of the two strains by the bites of 2-5 infective mosquitoes from each strain per monkey. In order to determine the strain-specificity of the protective immunity, the proportions of parasites of the two strains in the challenge infections were quantified using an allele quantification assay, Pyrosequencing (TM), based on a single nucleotide polymorphism (SNP) in the parasites' circumsporozoite protein gene. The Pyrosequencing (TM) data showed that a significant reduction of parasites of the immunizing strain in each group of strain-specifically immunized monkeys had occurred, indicating a stronger killing effect on parasites of the immunizing strain. Thus, the protective immunity developed following a single, live sporozoite/chloroquine immunization, acted specifically against the immunizing strain and was, therefore, strain-specific. As our experiment does not allow us to determine the parasite stage at which the strain-specific protective immunity is directed, it is possible that the target of this immunity could be either the pre-erythrocytic stage, or the blood-stage, or both.	[Wijayalath, Wathsala; Pathirana, Sisira] Univ Colombo, Malaria Res Unit, Dept Parasitol, Fac Med, Colombo, Sri Lanka; [Cheesman, Sandra; Carter, Richard] Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Tanabe, Kazuyuki] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Handunnetti, Shiroma] Univ Colombo, Inst Biochem Mol Biol & Biotechnol, Colombo, Sri Lanka	University of Colombo; University of Edinburgh; Osaka University; University of Colombo	Pathirana, S (corresponding author), Univ Colombo, Malaria Res Unit, Dept Parasitol, Fac Med, Colombo, Sri Lanka.	sisira@med.cmb.ac.lk			National Science Foundation, Sri Lanka [RG/2005/HS/14/, NSF/Sch/2004/08]; National Research Council, Sri Lanka [05-66]; Wellcome Trust Programme [544RCX R37984]	National Science Foundation, Sri Lanka(National Science Foundation (NSF)); National Research Council, Sri Lanka; Wellcome Trust Programme(Wellcome Trust)	This investigation received financial support from the National Science Foundation, Sri Lanka (RG/2005/HS/14/) and the National Research Council, Sri Lanka (Research grant-05-66) granted to SP. WW was supported by a post-graduate research scholarship (NSF/Sch/2004/08) granted by the National Science Foundation of Sri Lanka. SC was supported under the Wellcome Trust Programme Grant No. 544RCX R37984, to RC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywickreme W, 1995, THESIS LIVERPOOL SCH; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Cheesman S, 2007, MOL BIOCHEM PARASIT, V152, P213, DOI 10.1016/j.molbiopara.2006.12.008; CLYDE DF, 1990, B WORLD HEALTH ORGAN, V68, P9; Cui LW, 2003, AM J TROP MED HYG, V68, P613, DOI 10.4269/ajtmh.2003.68.613; Culleton RL, 2011, PARASITE IMMUNOL, V33, P73, DOI 10.1111/j.1365-3024.2010.01251.x; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; Farooq U, 2009, J VECTOR DIS, V46, P109; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Good MF, 2010, IMMUNITY, V33, P555, DOI 10.1016/j.immuni.2010.10.005; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Leclerc MC, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-40; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Martinelli A, 2005, P NATL ACAD SCI USA, V102, P814, DOI 10.1073/pnas.0405097102; MILLET P, 1989, PARASITE IMMUNOL, V11, P223, DOI 10.1111/j.1365-3024.1989.tb00661.x; Peters W., 1974, Advances Parasit, V12, P69, DOI 10.1016/S0065-308X(08)60387-5; Renia L, 2008, PARASITE, V15, P379, DOI 10.1051/parasite/2008153379; RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Tanabe K, 2007, MOL BIOCHEM PARASIT, V156, P74, DOI 10.1016/j.molbiopara.2007.07.002; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Wijayalath WAWK, 2008, PARASITE IMMUNOL, V30, P630, DOI 10.1111/j.1365-3024.2008.01065.x; Wijayalath WAWK, 2010, THESIS U COLOMBO; YAYON A, 1983, J PROTOZOOL, V30, P642, DOI 10.1111/j.1550-7408.1983.tb05336.x	25	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45861	10.1371/journal.pone.0045861	http://dx.doi.org/10.1371/journal.pone.0045861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029282	Green Submitted, gold, Green Published			2022-12-25	WOS:000309554700079
J	Amadi-Obi, A; Yu, CR; Dambuza, I; Kim, SH; Marrero, B; Egwuagu, CE				Amadi-Obi, Ahjoku; Yu, Cheng-Rong; Dambuza, Ivy; Kim, Sung-Hye; Marrero, Bernadette; Egwuagu, Charles E.			Interleukin 27 Induces the Expression of Complement Factor H (CFH) in the Retina	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MACULAR DEGENERATION; EPITHELIAL-CELLS; B-CELL; INFLAMMATION; UVEITIS; CYTOKINE; REGION; IRF8; PATHOGENESIS	Complement factor H (CFH) is a central regulator of the complement system and has been implicated in the etiology of age-related macular degeneration (AMD), a leading cause of blindness in the elderly. In view of previous studies showing that reduced expression of CFH in the retina is a risk factor for developing AMD, there is significant interest in understanding how CFH expression is regulated in the retina. In this study, we have shown that the anti-inflammatory cytokine, IL-27, induced CFH expression in mouse retinal cells and human retinal pigmented epithelial cells (RPE) through STAT1-mediated up-regulation of Interferon Regulatory Factor-1 (IRF-1) and IRF-8. We further show that cells in the ganglion and inner-nuclear layers of the retina constitutively express IRF-1 and IRF-8 and enhanced CFH expression in the retina during ocular inflammation correlated with significant increase in the expression of IRF-1, IRF-8 and IL-27 (IL-27p28 and Ebi3). Our data thus reveal a novel role of IL-27 in regulating complement activation through up-regulation of CFH and suggest that defects in IL-27 signaling or expression may contribute to the reduction of CFH expression in the retina of patients with AMD.	[Amadi-Obi, Ahjoku; Yu, Cheng-Rong; Dambuza, Ivy; Kim, Sung-Hye; Marrero, Bernadette; Egwuagu, Charles E.] NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Egwuagu, CE (corresponding author), NEI, Mol Immunol Sect, NIH, Bethesda, MD 20892 USA.	egwuaguc@nei.nih.gov	Dambuza, Ivy/M-2484-2019	Yu, Cheng-Rong/0000-0001-7246-0362	National Eye Institute; National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000372, ZIAEY000262] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Intramural Research Programs of the National Eye Institute and National Institutes of Health provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Dick AD, 2003, J LEUKOCYTE BIOL, V74, P161, DOI 10.1189/jlb.1102535; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Egwuagu CE, 2002, J IMMUNOL, V168, P3181, DOI 10.4049/jimmunol.168.7.3181; Fraczek LA, 2011, MOL IMMUNOL, V49, P201, DOI 10.1016/j.molimm.2011.08.013; Fraczek LA, 2010, MOL IMMUNOL, V48, P9, DOI 10.1016/j.molimm.2010.08.016; GASQUE P, 1992, J IMMUNOL, V149, P1381; Gery Igal, 2002, Int Rev Immunol, V21, P89, DOI 10.1080/08830180212061; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lau LI, 2011, INVEST OPHTH VIS SCI, V52, P6832, DOI 10.1167/iovs.11-7815; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Li WM, 1999, INVEST OPHTH VIS SCI, V40, P976; Li WM, 1999, J BIOL CHEM, V274, P9686, DOI 10.1074/jbc.274.14.9686; Li WM, 1999, DEV BIOL, V210, P44, DOI 10.1006/dbio.1999.9267; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mandal NA, 2006, INVEST OPHTH VIS SCI, V47, P4091, DOI 10.1167/iovs.05-1655; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; MUNOZCANOVES P, 1990, J BIOL CHEM, V265, P20065; NUSSENBLATT RB, 1991, INVEST OPHTH VIS SCI, V32, P3131; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Qi CF, 2009, IMMUNOL RES, V45, P62, DOI 10.1007/s12026-008-8032-2; Taniguchi T, 1997, J CELL PHYSIOL, V173, P128, DOI 10.1002/(SICI)1097-4652(199711)173:2<128::AID-JCP8>3.0.CO;2-P; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Wang HS, 2008, BLOOD, V112, P4028, DOI 10.1182/blood-2008-01-129049; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Williams SA, 1997, SCAND J IMMUNOL, V45, P7, DOI 10.1046/j.1365-3083.1997.d01-364.x; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yu CR, 2011, INVEST OPHTH VIS SCI, V52, P6978, DOI 10.1167/iovs.11-7688; Zhang JD, 2010, J BIOL CHEM, V285, P21269, DOI 10.1074/jbc.M110.100818; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	43	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45801	10.1371/journal.pone.0045801	http://dx.doi.org/10.1371/journal.pone.0045801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029250	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900101
J	Jurgens, CWD; Bell, KA; McQuiston, AR; Guido, W				Jurgens, Chris W. D.; Bell, Karen A.; McQuiston, A. Rory; Guido, William			Optogenetic Stimulation of the Corticothalamic Pathway Affects Relay Cells and GABAergic Neurons Differently in the Mouse Visual Thalamus	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; METABOTROPIC GLUTAMATE RECEPTORS; IN-VITRO; RETICULAR NUCLEUS; DYNAMIC PROPERTIES; FUNCTIONAL-ORGANIZATION; THALAMOCORTICAL NEURONS; POSTSYNAPTIC POTENTIALS; CORTICOFUGAL FEEDBACK; CORTICAL INTERNEURONS	The dorsal lateral geniculate nucleus (dLGN) serves as the primary conduit of retinal information to visual cortex. In addition to retinal input, dLGN receives a large feedback projection from layer VI of visual cortex. Such input modulates thalamic signal transmission in different ways that range from gain control to synchronizing network activity in a stimulus-specific manner. However, the mechanisms underlying such modulation have been difficult to study, in part because of the complex circuitry and diverse cell types this pathway innervates. To address this and overcome some of the technical limitations inherent in studying the corticothalamic (CT) pathway, we adopted a slice preparation in which we were able to stimulate CT terminal arbors in the visual thalamus of the mouse with blue light by using an adeno-associated virus to express the light-gated ion channel, ChIEF, in layer VI neurons. To examine the postsynaptic responses evoked by repetitive CT stimulation, we recorded from identified relay cells in dLGN, as well as GFP expressing GABAergic neurons in the thalamic reticular nucleus (TRN) and intrinsic interneurons of dLGN. Relay neurons exhibited large glutamatergic responses that continued to increase in amplitude with each successive stimulus pulse. While excitatory responses were apparent at postnatal day 10, the strong facilitation noted in adult was not observed until postnatal day 21. GABAergic neurons in TRN exhibited large initial excitatory responses that quickly plateaued during repetitive stimulation, indicating that the degree of facilitation was much larger for relay cells than for TRN neurons. The responses of intrinsic interneurons were smaller and took the form of a slow depolarization. These differences in the pattern of excitation for different thalamic cell types should help provide a framework for understanding how CT feedback alters the activity of visual thalamic circuitry during sensory processing as well as different behavioral or pathophysiological states.	[Jurgens, Chris W. D.; Bell, Karen A.; McQuiston, A. Rory; Guido, William] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Virginia Commonwealth University	Guido, W (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	william.guido@louisville.edu	McQuiston, Adam Rory/A-3072-2008		National Institutes of Health (NIH) [EY012716, MH094626, NS063059]; NIH-NINDS training grant [5T32NS07288-23]; NIH-NINDS Center Core grant [5P30NS047463]; NATIONAL EYE INSTITUTE [R01EY012716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463, T32NS007288, R21NS063059] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINDS training grant; NIH-NINDS Center Core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH), grant numbers EY012716 (W.G.), MH094626 (A.R.M.) and NS063059 (A.R.M.). C.W.J. was supported in part by NIH-NINDS training grant 5T32NS07288-23. Confocal reconstructions were performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility supported in part from NIH-NINDS Center Core grant (5P30NS047463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; Alexander GM, 2006, NEUROSCIENCE, V141, P501, DOI 10.1016/j.neuroscience.2006.03.060; Alexander GM, 2006, NEUROSCIENCE, V137, P367, DOI 10.1016/j.neuroscience.2005.11.012; Alexander GM, 2005, J NEUROPHYSIOL, V94, P163, DOI 10.1152/jn.01198.2004; Andolina IM, 2007, P NATL ACAD SCI USA, V104, P1685, DOI 10.1073/pnas.0609318104; Augustinaite S, 2011, J PHYSIOL-LONDON, V589, P2963, DOI 10.1113/jphysiol.2011.205542; Ayling OGS, 2009, NAT METHODS, V6, P219, DOI [10.1038/NMETH.1303, 10.1038/nmeth.1303]; Bickford ME, 2008, J COMP NEUROL, V508, P264, DOI 10.1002/cne.21671; Bickford ME, 2010, J COMP NEUROL, V518, P622, DOI 10.1002/cne.22223; BLOOMFIELD SA, 1989, P NATL ACAD SCI USA, V86, P3911, DOI 10.1073/pnas.86.10.3911; BOURASSA J, 1995, NEUROSCIENCE, V66, P253, DOI 10.1016/0306-4522(95)00009-8; Briggs F, 2008, CURR OPIN NEUROBIOL, V18, P403, DOI 10.1016/j.conb.2008.09.002; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Casale AE, 2011, J NEUROSCI, V31, P18289, DOI 10.1523/JNEUROSCI.4417-11.2011; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cox CL, 2003, J NEUROSCI, V23, P7642; Cox CL, 1998, NATURE, V394, P478, DOI 10.1038/28855; Cox CL, 2000, NEURON, V27, P597, DOI 10.1016/S0896-6273(00)00069-6; Crandall SR, 2012, J NEUROSCI, V32, P2513, DOI 10.1523/JNEUROSCI.4402-11.2012; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cudeiro J, 1996, J PHYSIOL-LONDON, V490, P481, DOI 10.1113/jphysiol.1996.sp021159; Dingledine R, 1999, PHARMACOL REV, V51, P7; Erisir A, 1997, J COMP NEUROL, V377, P535; Errington AC, 2011, J NEUROSCI, V31, P8669, DOI 10.1523/JNEUROSCI.0317-11.2011; Godwin DW, 1996, J NEUROPHYSIOL, V76, P1800, DOI 10.1152/jn.1996.76.3.1800; Golshani P, 2001, P NATL ACAD SCI USA, V98, P4172, DOI 10.1073/pnas.061013698; Govindaiah G, 2006, J NEUROSCI, V26, P13443, DOI 10.1523/JNEUROSCI.3578-06.2006; Granseth B, 2004, J PHYSIOL-LONDON, V556, P135, DOI 10.1113/jphysiol.2003.052720; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; Granseth B, 2002, J PHYSIOL-LONDON, V544, P477, DOI 10.1113/jphysiol.2002.024703; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; HAMOS JE, 1985, NATURE, V317, P618, DOI 10.1038/317618a0; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kielland A, 2006, J NEUROSCI, V26, P5786, DOI 10.1523/JNEUROSCI.4631-05.2006; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Li JL, 2003, J COMP NEUROL, V460, P394, DOI 10.1002/cne.10646; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MCCORMICK DA, 1992, P NATL ACAD SCI USA, V89, P2774, DOI 10.1073/pnas.89.7.2774; Mohrmann R, 2003, NEUROSCIENCE, V117, P7, DOI 10.1016/S0306-4522(02)00835-7; MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; MONTERO VM, 1985, EXP BRAIN RES, V59, P151; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; NORTON TT, 1992, PROG BRAIN RES, V90, P193; Parent M, 2008, J COMP NEUROL, V511, P678, DOI 10.1002/cne.21868; PARNAVELAS JG, 1977, J COMP NEUROL, V171, P481, DOI 10.1002/cne.901710405; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Przybyszewski AW, 2000, VISUAL NEUROSCI, V17, P485, DOI 10.1017/S0952523800174012; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Schlesinger F, 2005, SYNAPSE, V55, P176, DOI 10.1002/syn.20110; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SILLITO AM, 1994, NATURE, V369, P479, DOI 10.1038/369479a0; SILLITO AM, 1983, BRAIN RES, V277, P63, DOI 10.1016/0006-8993(83)90908-3; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TSUMOTO T, 1978, EXP BRAIN RES, V32, P345; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; UHLRICH DJ, 1988, J NEUROSCI, V8, P4565; VIDNYANSZKY Z, 1994, J COMP NEUROL, V349, P259, DOI 10.1002/cne.903490208; Von Krosigk M, 1999, NEUROSCIENCE, V91, P7, DOI 10.1016/S0306-4522(98)00557-0; Wang ST, 2001, J COMP NEUROL, V440, P321, DOI 10.1002/cne.1389; WEBER AJ, 1989, J COMP NEUROL, V289, P156, DOI 10.1002/cne.902890113; Williams SR, 1996, J PHYSIOL-LONDON, V490, P129, DOI 10.1113/jphysiol.1996.sp021131; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042; Yang YM, 2011, J PHYSIOL-LONDON, V589, P4209, DOI 10.1113/jphysiol.2011.208066; Zhu JJ, 1999, J NEUROSCI, V19, P5721, DOI 10.1523/JNEUROSCI.19-14-05721.1999	77	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45717	10.1371/journal.pone.0045717	http://dx.doi.org/10.1371/journal.pone.0045717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029198	gold, Green Published			2022-12-25	WOS:000309388900093
J	Matsueda, S; Wang, MJ; Weng, JS; Li, Y; Yin, BN; Zou, J; Li, QT; Zhao, W; Peng, WY; Legras, X; Loo, C; Wang, RF; Wang, HY				Matsueda, Satoko; Wang, Mingjun; Weng, Jinsheng; Li, Ying; Yin, Bingnan; Zou, Jia; Li, Qingtian; Zhao, Wei; Peng, Weiyi; Legras, Xavier; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.			Identification of Prostate-Specific G-Protein Coupled Receptor as a Tumor Antigen Recognized by CD8(+) T Cells for Cancer Immunotherapy	PLOS ONE			English	Article							MOLECULAR-CLONING; GENOME-WIDE; EXPRESSION; GENE; HOMOLOGY; PROSTEIN; EPITOPES; LINES; PSGR; RNA	Background: Prostate cancer is the most common cancer among elderly men in the US, and immunotherapy has been shown to be a promising strategy to treat patients with metastatic castration-resistant prostate cancer. Efforts to identify novel prostate specific tumor antigens will facilitate the development of effective cancer vaccines against prostate cancer. Prostate-specific G-protein coupled receptor (PSGR) is a novel antigen that has been shown to be specifically overexpressed in human prostate cancer tissues. In this study, we describe the identification of PSGR-derived peptide epitopes recognized by CD8(+) T cells in an HLA-A2 dependent manner. Methodology/Principal Findings: Twenty-one PSGR-derived peptides were predicted by an immuno-informatics approach based on the HLA-A2 binding motif. These peptides were examined for their ability to induce peptide-specific T cell responses in peripheral blood mononuclear cells (PBMCs) obtained from either HLA-A2(+) healthy donors or HLA-A2(+) prostate cancer patients. The recognition of HLA-A2 positive and PSGR expressing LNCaP cells was also tested. Among the 21 PSGR-derived peptides, three peptides, PSGR3, PSGR4 and PSGR14 frequently induced peptide-specific T cell responses in PBMCs from both healthy donors and prostate cancer patients. Importantly, these peptide-specific T cells recognized and killed LNCaP prostate cancer cells in an HLA class I-restricted manner. Conclusions/Significance: We have identified three novel HLA-A2-restricted PSGR-derived peptides recognized by CD8(+) T cells, which, in turn, recognize HLA-A2(+) and PSGR(+) tumor cells. The PSGR-derived peptides identified may be used as diagnostic markers as well as immune targets for development of anticancer vaccines.	[Matsueda, Satoko; Wang, Mingjun; Weng, Jinsheng; Li, Ying; Zou, Jia; Li, Qingtian; Zhao, Wei; Peng, Weiyi; Legras, Xavier; Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wang, Mingjun; Yin, Bingnan; Zou, Jia; Li, Qingtian; Zhao, Wei; Loo, Christopher; Wang, Rong-Fu; Wang, Helen Y.] Methodist Hosp Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA; [Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Baylor College of Medicine	Wang, HY (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	ywang4@tmhs.org		WANG, MINGJUN/0000-0002-5848-0444	National Cancer Institute, National Institute of Health; Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA090327] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; Methodist Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was in part supported by grants from National Cancer Institute, National Institute of Health and Cancer Research Institute, and The Methodist Hospital Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1981, J EXP MED, V154, P1764, DOI 10.1084/jem.154.6.1764; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Carlsson B, 2007, PROSTATE, V67, P389, DOI 10.1002/pros.20498; Cormier JN, 1998, INT J CANCER, V75, P517, DOI 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.3.CO;2-M; Di Lorenzo G, 2011, NAT REV CLIN ONCOL, V8, P551, DOI 10.1038/nrclinonc.2011.72; Drake CG, 2012, CURRENT OPINION UROL; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Hammond AS, 2005, CLIN EXP IMMUNOL, V140, P109, DOI 10.1111/j.1365-2249.2005.02751.x; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; ISRAELI RS, 1993, CANCER RES, V53, P227; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Joniau S, 2012, EUR UROL, V61, P290, DOI 10.1016/j.eururo.2011.09.020; Kalos M, 2004, PROSTATE, V60, P246, DOI 10.1002/pros.20043; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kawakami M, 1997, CANCER RES, V57, P2321; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Lesterhuis WJ, 2011, NAT REV DRUG DISCOV, V10, P591, DOI 10.1038/nrd3500; LUNDWALL A, 1987, FEBS LETT, V214, P317, DOI 10.1016/0014-5793(87)80078-9; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; OESTERLING JE, 1991, J UROLOGY, V145, P907, DOI 10.1016/S0022-5347(17)38491-4; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; SOLIN T, 1990, BIOCHIM BIOPHYS ACTA, V1048, P72, DOI 10.1016/0167-4781(90)90024-V; SU SL, 1995, CANCER RES, V55, P1441; Tsavaler L, 2001, CANCER RES, V61, P3760; VandenEynde BJ, 1997, INT J CLIN LAB RES, V27, P81, DOI 10.1007/BF02912440; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Weng JS, 2005, INT J CANCER, V113, P811, DOI 10.1002/ijc.20635; Xu JC, 2001, CANCER RES, V61, P1563; Xu LL, 2000, CANCER RES, V60, P6568; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zeng G, 2001, P NATL ACAD SCI USA, V98, P3964, DOI 10.1073/pnas.061507398	37	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45756	10.1371/journal.pone.0045756	http://dx.doi.org/10.1371/journal.pone.0045756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029225	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900097
J	Bravi, A; Green, G; Longtin, A; Seely, AJE				Bravi, Andrea; Green, Geoffrey; Longtin, Andre; Seely, Andrew J. E.			Monitoring and Identification of Sepsis Development through a Composite Measure of Heart Rate Variability	PLOS ONE			English	Article							SEPTIC SHOCK	Tracking the physiological conditions of a patient developing infection is of utmost importance to provide optimal care at an early stage. This work presents a procedure to integrate multiple measures of heart rate variability into a unique measure for the tracking of sepsis development. An early warning system is used to illustrate its potential clinical value. The study involved 17 adults (age median 51 (interquartile range 46-62)) who experienced a period of neutropenia following chemoradiotherapy and bone marrow transplant; 14 developed sepsis, and 3 did not. A comprehensive panel (N = 92) of variability measures was calculated for 5 min-windows throughout the period of monitoring (12 +/- 4 days). Variability measures underwent filtering and two steps of data reduction with the objective of enhancing the information related to the greatest degree of change. The proposed composite measure was capable of tracking the development of sepsis in 12 out of 14 patients. Simulating a real-time monitoring setting, the sum of the energy over the very low frequency range of the composite measure was used to classify the probability of developing sepsis. The composite revealed information about the onset of sepsis about 60 hours (median value) before of sepsis diagnosis. In a real monitoring setting this quicker detection time would be associated to increased efficacy in the treatment of sepsis, therefore highlighting the potential clinical utility of a composite measure of variability.	[Bravi, Andrea; Seely, Andrew J. E.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Green, Geoffrey; Seely, Andrew J. E.] Therapeut Monitoring Syst Inc, Ottawa, ON, Canada; [Longtin, Andre] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Dept Crit Care Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa	Bravi, A (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	a.bravi@uottawa.ca						Ahmad S, 2010, IEEE T INSTRUM MEAS, V59, P2575, DOI 10.1109/TIM.2010.2057571; Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; [Anonymous], CRIT CARE MED; Bravi A, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-90; Brindley PG, 2006, CAN J ANAESTH, V53, P1157, DOI 10.1007/BF03022884; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Gunther A, ACTA NEUROLOGICA SCA; Moorman JR, 2011, J PEDIATR-US, V159, P900, DOI 10.1016/j.jpeds.2011.06.044; Moorman JR, 2006, IEEE T BIO-MED ENG, V53, P126, DOI 10.1109/TBME.2005.859810; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; Saria S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001304; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1	14	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45666	10.1371/journal.pone.0045666	http://dx.doi.org/10.1371/journal.pone.0045666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029171	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400119
J	Head, JA; Kalveram, B; Ikegami, T				Head, Jennifer A.; Kalveram, Birte; Ikegami, Tetsuro			Functional Analysis of Rift Valley Fever Virus NSs Encoding a Partial Truncation	PLOS ONE			English	Article							RECENT COMMON ANCESTRY; IMMUNE-RESPONSES; INFECTED-CELLS; PROTECTS MICE; MOLECULAR EPIDEMIOLOGY; LETHAL INFECTION; GENETIC-EVIDENCE; RHESUS MACAQUES; DOWN-REGULATION; MESSENGER-RNA	Rift Valley fever virus (RVFV), belongs to genus Phlebovirus of the family Bunyaviridae, causes high rates of abortion and fetal malformation in infected ruminants as well as causing neurological disorders, blindness, or lethal hemorrhagic fever in humans. RVFV is classified as a category A priority pathogen and a select agent in the U. S., and currently there are no therapeutics available for RVF patients. NSs protein, a major virulence factor of RVFV, inhibits host transcription including interferon (IFN)-beta mRNA synthesis and promotes degradation of dsRNA-dependent protein kinase (PKR). NSs self-associates at the C-terminus 17 aa., while NSs at aa. 210-230 binds to Sin3A-associated protein (SAP30) to inhibit the activation of IFN-beta promoter. Thus, we hypothesize that NSs function(s) can be abolished by truncation of specific domains, and co-expression of nonfunctional NSs with intact NSs will result in the attenuation of NSs function by dominant-negative effect. Unexpectedly, we found that RVFV NSs truncated at aa. 6-30, 31-55, 56-80, 81-105, 106-130, 131-155, 156-180, 181-205, 206-230, 231-248 or 249-265 lack functions of IFN-b mRNA synthesis inhibition and degradation of PKR. Truncated NSs were less stable in infected cells, while nuclear localization was inhibited in NSs lacking either of aa. 81-105, 106-130, 131155, 156-180, 181-205, 206-230 or 231-248. Furthermore, none of truncated NSs had exhibited significant dominant-negative functions for NSs-mediated IFN-beta suppression or PKR degradation upon co-expression in cells infected with RVFV. We also found that any of truncated NSs except for intact NSs does not interact with RVFV NSs even in the presence of intact C-terminus self-association domain. Our results suggest that conformational integrity of NSs is important for the stability, cellular localization and biological functions of RVFV NSs, and the co-expression of truncated NSs does not exhibit dominant-negative phenotype.	[Kalveram, Birte; Ikegami, Tetsuro] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Head, Jennifer A.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [Ikegami, Tetsuro] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Ikegami, T (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	teikegam@utmb.edu	Ikegami, Tetsuro/H-1329-2013	Ikegami, Tetsuro/0000-0001-8318-2783	Western Regional Center of Excellence [5 U54 AI057156]; National Institutes of Health [R01 AI08764301]; Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB); Institute for Human Infections and Immunity (IHII) at UTMB; James W. McLaughlin Fellowship Fund at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156, R01AI087643] Funding Source: NIH RePORTER	Western Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB); Institute for Human Infections and Immunity (IHII) at UTMB; James W. McLaughlin Fellowship Fund at UTMB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by 5 U54 AI057156 through the Western Regional Center of Excellence, National Institutes of Health grant R01 AI08764301, and funding from Sealy Center for Vaccine Development at The University of Texas Medical Branch (UTMB), and that from Institute for Human Infections and Immunity (IHII) at UTMB. BK was supported by the James W. McLaughlin Fellowship Fund at UTMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000725; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2008, J VIROL, V82, P11152, DOI 10.1128/JVI.01519-08; Bird BH, 2007, J VIROL, V81, P2805, DOI 10.1128/JVI.02095-06; Bird BH, 2011, J VIROL, V85, P12901, DOI 10.1128/JVI.06046-11; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Carroll SA, 2011, J VIROL, V85, P6162, DOI 10.1128/JVI.00335-11; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; de Boer SM, 2010, VACCINE, V28, P2330, DOI 10.1016/j.vaccine.2009.12.062; Dodd KA, 2012, J VIROL, V86, P4204, DOI 10.1128/JVI.07104-11; Dungu B, 2010, VACCINE, V28, P4581, DOI 10.1016/j.vaccine.2010.04.085; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Grobbelaar AA, 2011, EMERG INFECT DIS, V17, P2270, DOI 10.3201/eid1712.111035; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Holman DH, 2009, CLIN VACCINE IMMUNOL, V16, P1624, DOI 10.1128/CVI.00182-09; HOUSE JA, 1992, ANN NY ACAD SCI, V653, P233, DOI 10.1111/j.1749-6632.1992.tb19652.x; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Ito N, 2003, MICROBIOL IMMUNOL, V47, P613, DOI 10.1111/j.1348-0421.2003.tb03424.x; Kalveram B, 2011, JOVE-J VIS EXP, DOI 10.3791/3400; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kawada S, 2008, J VIROL, V82, P4384, DOI 10.1128/JVI.01953-07; KENDE M, 1987, ANTIMICROB AGENTS CH, V31, P986, DOI 10.1128/AAC.31.7.986; KENDE M, 1985, ANTIMICROB AGENTS CH, V27, P903, DOI 10.1128/AAC.27.6.903; Kortekaas J, 2010, VACCINE, V28, P4394, DOI 10.1016/j.vaccine.2010.04.048; Kortekaas J, 2010, VACCINE, V28, P2271, DOI 10.1016/j.vaccine.2010.01.001; Kortekaas J, 2011, J VIROL, V85, P12622, DOI 10.1128/JVI.00841-11; Lagerqvist N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Liao MF, 2005, J CELL BIOL, V171, P111, DOI 10.1083/jcb.200507075; Lorenzo G, 2008, VACCINE, V26, P5255, DOI 10.1016/j.vaccine.2008.07.042; Mandell RB, 2010, HUM VACCIN, P6; Mandell RB, 2010, J VIROL METHODS, V169, P259, DOI 10.1016/j.jviromet.2010.07.015; Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; Miller BR, 2002, EMERG INFECT DIS, V8, P1492, DOI 10.3201/eid0812.020194; MORRILL JC, 1989, RES VIROLOGY, V140, P139, DOI 10.1016/S0923-2516(89)80091-3; Morrill JC, 1997, AM J VET RES, V58, P1110; MORRILL JC, 1987, AM J VET RES, V48, P1042; MORRILL JC, 1991, VACCINE, V9, P35, DOI 10.1016/0264-410X(91)90314-V; Morrill JC, 1997, AM J VET RES, V58, P1104; MORRILL JC, 1989, REV INFECT DIS, V11, pS815; Morrill JC, 2011, J INFECT DIS, V204, P617, DOI 10.1093/infdis/jir354; Morrill JC, 2011, J INFECT DIS, V204, P229, DOI 10.1093/infdis/jir249; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Muller R, 1994, J GEN VIROL; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Naslund J, 2009, VIROLOGY, V385, P409, DOI 10.1016/j.virol.2008.12.012; Papin JF, 2011, P NATL ACAD SCI USA, V108, P14926, DOI 10.1073/pnas.1112149108; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Peters CJ, 1981, HDB SERIES ZOONOSE B, V1403-420; Pichlmair A, 2010, VECTOR-BORNE ZOONOT, V10, P701, DOI 10.1089/vbz.2009.0248; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Rusnak JM, 2011, VACCINE, V29, P3222, DOI 10.1016/j.vaccine.2011.02.037; Sanchez AB, 2005, J VIROL, V79, P7262, DOI 10.1128/JVI.79.11.7262-7268.2005; Scaglioni P, 1996, HEPATOLOGY, V24, P1010; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Soi RK, 2010, CLIN VACCINE IMMUNOL, V17, P1842, DOI 10.1128/CVI.00220-10; Spik K, 2006, VACCINE, V24, P4657, DOI 10.1016/j.vaccine.2005.08.034; SWANEPOEL R, 1977, J GEN VIROL, V34, P557, DOI 10.1099/0022-1317-34-3-557; Swanepoel R., 2004, INFECT DIS LIVESTOCK, V2, P1037; von Teichman B, 2011, VACCINE, V29, P5771, DOI 10.1016/j.vaccine.2011.05.055; Walker RC, 2010, J VIROL, V84, P5201, DOI 10.1128/JVI.02318-09; Wallace DB, 2006, VACCINE, V24, P7181, DOI 10.1016/j.vaccine.2006.06.041; WEBER PC, 1992, J GEN VIROL, V73, P2955, DOI 10.1099/0022-1317-73-11-2955; Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107; Yadani FZ, 1999, J VIROL, V73, P5018, DOI 10.1128/JVI.73.6.5018-5025.1999; Zamoto-Niikura A, 2009, J VIROL, V83, P12779, DOI 10.1128/JVI.01310-09; 2005, FED REG, V70, P13241	80	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45730	10.1371/journal.pone.0045730	http://dx.doi.org/10.1371/journal.pone.0045730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029207	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400125
J	Schafer, C; Rymarczyk, G; Ding, L; Kirber, MT; Bolotina, VM				Schaefer, Claudia; Rymarczyk, Grzegorz; Ding, Lai; Kirber, Michael T.; Bolotina, Victoria M.			Role of Molecular Determinants of Store-operated Ca2+ Entry (Orai1, Phospholipase A2 Group 6, and STIM1) in Focal Adhesion Formation and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCYTE CHEMOTAXIS; PROTEIN-KINASE-A; CALCIUM INFLUX; SMOOTH-MUSCLE; I-CRAC; CHANNELS; ACTIN; DYNAMICS; CALPAIN; FORCE	Store-operated Ca2+ entry and its major determinants are known to be important for cell migration, but the mechanism of their involvement in this complex process is unknown. This study presents a detailed characterization of distinct roles of Orai1, STIM1, and PLA2g6 in focal adhesion (FA) formation and migration. Using HEK293 cells, we discovered that although molecular knockdown of Orai1, STIM1, or PLA2g6 resulted in a similar reduction in migration velocity, there were profound differences in their effects on number, localization, and lifetime of FAs. Knockdown of STIM1 caused an increase in lifetime and number of FAs, their redistribution toward lamellae region, and an increase in cell tail length. In contrast, the number of FAs in Orai1- or PLA2g6-deficient cells was significantly reduced, and FAs accumulated closer to the leading edge. Assembly rate and Vinculin phosphorylation of FAs was similarly reduced in Orai1, PLA2g6, or STIM1-deficient cells. Although Orai1 and PLA2g6 accumulated and co-localized at the leading edge, STIM1 distribution was more complex. We found STIM1 protrusions in lamellipodia, which co-localized with FAs, whereas major accumulation could be seen in central and retracting parts of the cell. Interestingly, knockdown of Orai1 and PLA2g6 produced similar and non-additive effect on migration, whereas knockdown of STIM1 simultaneously with either Orai1 or PLA2g6 produced additional inhibition. Together these data suggest that although Orai1, PLA2g6, and STIM1 play major roles in formation of new FAs at the leading edge, STIM1 may also be involved in Orai1- and PLA2g6-independent disassembly of FAs in the back of cells.	[Schaefer, Claudia; Rymarczyk, Grzegorz; Bolotina, Victoria M.] Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, Boston, MA 02118 USA; [Ding, Lai] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Opt Imaging Core, Boston, MA 02115 USA; [Kirber, Michael T.] Boston Univ, Sch Med, Dept Med, Cellular Imaging Core, Boston, MA 02118 USA	Boston University; Harvard University; Harvard Medical School; Boston University	Bolotina, VM (corresponding author), Boston Univ, Sch Med, Dept Med, Ion Channel & Calcium Signaling Unit, 650 Albany St,X-704, Boston, MA 02118 USA.	bolotina@bu.edu		Kirber, Michael/0000-0001-9009-5776; Bolotina, Victoria/0000-0001-5862-181X	National Institutes of Health [RO1 HL71793, RO1 HL54150]; Department of Medicine; Cellular Imaging Core; Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R01HL071793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine; Cellular Imaging Core; Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL71793 and RO1 HL54150. This work was also supported by the Department of Medicine, the Cellular Imaging Core, and the Evans Center for Interdisciplinary Biomedical Research (Affinity Research Collaborative program on Calcium Homeostasis in Health and Disease) at the Boston University School of Medicine.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bhatt A, 2002, J CELL SCI, V115, P3415; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bolotina V. M., 2012, STORE OPERATED CALCI, P115; Bolotina VM, 2008, J PHYSIOL-LONDON, V586, P3035, DOI 10.1113/jphysiol.2008.154997; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carnevale KA, 2001, J IMMUNOL, V167, P3414, DOI 10.4049/jimmunol.167.6.3414; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clapham DE, 2009, CELL, V136, P814, DOI 10.1016/j.cell.2009.02.022; Clark K, 2008, EUR J CELL BIOL, V87, P631, DOI 10.1016/j.ejcb.2008.01.009; Collins SR, 2009, DEV CELL, V16, P160, DOI 10.1016/j.devcel.2009.01.018; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Fabian A, 2008, PFLUG ARCH EUR J PHY, V457, P475, DOI 10.1007/s00424-008-0515-4; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Gwozdz T, 2008, AM J PHYSIOL-CELL PH, V295, pC1133, DOI 10.1152/ajpcell.00306.2008; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2011, CURR OPIN CELL BIOL, V23, P554, DOI 10.1016/j.ceb.2011.05.006; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Lewis RS, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A003970; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Logue JS, 2011, J BIOL CHEM, V286, P22113, DOI 10.1074/jbc.M111.232660; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rao JN, 2010, AM J PHYSIOL-CELL PH, V299, pC579, DOI 10.1152/ajpcell.00066.2010; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Schafer C, 2009, EXP CELL RES, V315, P1212, DOI 10.1016/j.yexcr.2008.11.008; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Small J.V., 2004, ENCY BIOL CHEM, V1st, P356, DOI [10.1016/B0-12-443710-9/00097-1, DOI 10.1016/B0-12-443710-9/00097-1]; Small JV, 2010, TRENDS CELL BIOL, V20, P628, DOI 10.1016/j.tcb.2010.08.006; SMALL JV, 1981, J CELL BIOL, V91, P695, DOI 10.1083/jcb.91.3.695; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zamir E, 1999, J CELL SCI, V112, P1655	59	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40745	40757		10.1074/jbc.M112.407155	http://dx.doi.org/10.1074/jbc.M112.407155			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043102	Green Published, hybrid			2022-12-25	WOS:000311448800063
J	Ito, H; Takano, H; Arakawa, R; Takahashi, H; Kodaka, F; Takahata, K; Nogami, T; Suzuki, M; Suhara, T				Ito, Hiroshi; Takano, Harumasa; Arakawa, Ryosuke; Takahashi, Hidehiko; Kodaka, Fumitoshi; Takahata, Keisuke; Nogami, Tsuyoshi; Suzuki, Masayuki; Suhara, Tetsuya			Effects of Dopamine D-2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[beta-C-11]DOPA	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HALOPERIDOL; OCCUPANCY; SCHIZOPHRENIA; DECARBOXYLASE; KINETICS; RELEASE; DRUG; PERFORMANCE; RISPERIDONE	Dopamine D-2 receptor partial agonist antipsychotic drugs can modulate dopaminergic neurotransmission as functional agonists or functional antagonists. The effects of antipsychotics on presynaptic dopaminergic functions, such as dopamine synthesis capacity, might also be related to their therapeutic efficacy. Positron emission tomography (PET) was used to examine the effects of the partial agonist antipsychotic drug aripiprazole on presynaptic dopamine synthesis in relation to dopamine D-2 receptor occupancy and the resulting changes in dopamine synthesis capacity in healthy men. On separate days, PET studies with [C-11] raclopride and L-[beta-C-11]DOPA were performed under resting condition and with single doses of aripiprazole given orally. Occupancy of dopamine D-2 receptors corresponded to the doses of aripiprazole, but the changes in dopamine synthesis capacity were not significant, nor was the relation between dopamine D-2 receptor occupancy and these changes. A significant negative correlation was observed between baseline dopamine synthesis capacity and changes in dopamine synthesis capacity by aripiprazole, indicating that this antipsychotic appears to stabilize dopamine synthesis capacity. The therapeutic effects of aripiprazole in schizophrenia might be related to such stabilizing effects on dopaminergic neurotransmission responsivity.	[Ito, Hiroshi; Takano, Harumasa; Arakawa, Ryosuke; Takahashi, Hidehiko; Kodaka, Fumitoshi; Takahata, Keisuke; Nogami, Tsuyoshi; Suzuki, Masayuki; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Ito, H (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	hito@nirs.go.jp		Takahashi, Hidehiko/0000-0002-5102-1982; Takahata, Keisuke/0000-0002-0884-4924; Ito, Hiroshi/0000-0002-3581-4798	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government; Japan Society for the Promotion of Science [21591587]; National Institute of Radiological Sciences	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Radiological Sciences	This study was supported in part by a Grant-in-Aid for Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government, a Grant-in-Aid for Scientific Research (C) (No. 21591587) from the Japan Society for the Promotion of Science, and a grant from the National Institute of Radiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALSARA JJ, 1979, PSYCHOPHARMACOLOGY, V62, P67, DOI 10.1007/BF00426037; BARON JC, 1989, PSYCHOPHARMACOLOGY, V99, P463, DOI 10.1007/BF00589893; Brix G, 1997, J NUCL MED, V38, P1614; BROWN RM, 1979, BRAIN RES, V168, P133, DOI 10.1016/0006-8993(79)90132-X; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cumming P, 1997, J CEREBR BLOOD F MET, V17, P1254, DOI 10.1097/00004647-199711000-00014; Danielsen EH, 2001, SYNAPSE, V41, P172, DOI 10.1002/syn.1071; Der-Ghazarian T, 2010, J NEURAL TRANSM, V117, P573, DOI 10.1007/s00702-010-0396-5; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; GJEDDE A, 1988, PEPTIDE AND AMINO ACID TRANSPORT MECHANISMS IN THE CENTRAL NERVOUS SYSTEM, P209; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grunder G, 2008, AM J PSYCHIAT, V165, P988, DOI 10.1176/appi.ajp.2008.07101574; Grunder G, 2003, NEUROPSYCHOPHARMACOL, V28, P787, DOI 10.1038/sj.npp.1300103; HARTVIG P, 1991, J NEURAL TRANSM-GEN, V86, P25, DOI 10.1007/BF01250373; HICKS PB, 1990, LIFE SCI, V47, P1609, DOI 10.1016/0024-3205(90)90365-X; Ito H, 2007, ANN NUCL MED, V21, P355, DOI 10.1007/s12149-007-0033-z; Ito H, 2006, NUCL MED COMMUN, V27, P723, DOI 10.1097/01.mnm.0000230069.08576.6d; Ito H, 2009, J NEUROSCI, V29, P13730, DOI 10.1523/JNEUROSCI.4172-09.2009; Kegeles LS, 2008, NEUROPSYCHOPHARMACOL, V33, P3111, DOI 10.1038/npp.2008.33; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; KORSGAARD S, 1985, EUR J PHARMACOL, V118, P245, DOI 10.1016/0014-2999(85)90135-9; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; LLOYD KG, 1972, J NEUROCHEM, V19, P1549, DOI 10.1111/j.1471-4159.1972.tb05099.x; Mamo D, 2007, AM J PSYCHIAT, V164, P1411, DOI 10.1176/appi.ajp.2007.06091479; Molden E, 2006, THER DRUG MONIT, V28, P744, DOI 10.1097/01.ftd.0000249944.42859.bf; NYBERG S, 1993, PSYCHOPHARMACOLOGY, V110, P265, DOI 10.1007/BF02251280; Oshibuchi H, 2009, EUR J PHARMACOL, V615, P83, DOI 10.1016/j.ejphar.2009.05.006; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Pehek EA, 2001, BRAIN RES, V888, P51, DOI 10.1016/S0006-8993(00)03004-3; Potkin SG, 2003, ARCH GEN PSYCHIAT, V60, P681, DOI 10.1001/archpsyc.60.7.681; Sparshatt A, 2010, J CLIN PSYCHIAT, V71, P1447, DOI 10.4088/JCP.09r05060gre; Sugaya Y, 2001, NEUROSCIENCE, V104, P1, DOI 10.1016/S0306-4522(01)00008-2; Takahata K, 2012, PSYCHOPHARM IN PRESS; Torstenson R, 1998, NEUROPHARMACOLOGY, V37, P989, DOI 10.1016/S0028-3908(98)00085-9; Vernaleken I, 2006, NEUROIMAGE, V30, P1332, DOI 10.1016/j.neuroimage.2005.11.014; Vernaleken I, 2008, NEUROIMAGE, V40, P1222, DOI 10.1016/j.neuroimage.2007.12.045; Watson CC, 1996, COMP IMAG VIS, V4, P255; Wood MD, 2006, EUR J PHARMACOL, V546, P88, DOI 10.1016/j.ejphar.2006.07.008; Yokoi F, 2002, NEUROPSYCHOPHARMACOL, V27, P248, DOI 10.1016/S0893-133X(02)00304-4	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46488	10.1371/journal.pone.0046488	http://dx.doi.org/10.1371/journal.pone.0046488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029533	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900172
J	Karavitis, J; Hix, LM; Shi, YHH; Schultz, RF; Khazaie, K; Zhang, M				Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Schultz, Rachael F.; Khazaie, Khashayarsha; Zhang, Ming			Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; LUNG-CANCER; IFN-GAMMA; CD8(+); MICROENVIRONMENT; CYTOTOXICITY; SURVEILLANCE; SUPPRESSION; PROGRESSION	Background: The targeting of the immune system through immunotherapies to prevent tumor tolerance and immune suppression are at the front lines of breast cancer treatment and research. Human and laboratory studies have attributed breast cancer progression and metastasis to secondary organs such as the bone, to a number of factors, including elevated levels of prostaglandin E2 (PGE2) and the enzyme responsible for its production, cyclooxygenase 2 (COX2). Due to the strong connection of COX2 with immune function, we focused on understanding how variance in COX2 expression manipulates the immune profile in a syngeneic, and immune-competent, mouse model of breast cancer. Though there have been correlative findings linking elevated levels of COX2 and Tregs in other cancer models, we sought to elucidate the mechanisms by which these immuno-suppressive cells are recruited to breast tumor and the means by which they promote tumor tolerance. Methodology/Principal Findings: To elucidate the mechanisms by which exacerbated COX2 expression potentiates metastasis we genetically manipulated non-metastatic mammary tumor cells (TM40D) to over-express COX2 (TM40D-COX2). Over-expression of COX2 in this mouse breast cancer model resulted in an increase in bone metastasis (an observation that was ablated following suppression of COX2 expression) in addition to an exacerbated Treg recruitment in the primary tumor. Interestingly, other immune-suppressive leukocytes, such as myeloid derived suppressor cells, were not altered in the primary tumor or the circulation. Elevated levels of PGE2 by tumor cells can directly recruit CD4+CD25+ cells through interactions with their EP2 and/or EP4 receptors, an effect that was blocked using anti-PGE2 antibody. Furthermore, increased Treg recruitment to the primary tumor contributed to the greater levels of apoptotic CD8+T cells in the TM40D-COX2 tumors. Conclusion/Significance: Due to the systemic effects of COX2 inhibitors, we propose targeting specific EP receptors as therapeutic interventions to breast cancer progression.	[Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Dept Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Dept Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Schultz, Rachael F.; Khazaie, Khashayarsha; Zhang, Ming] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA.	m-zhang@northwestern.edu			Department of Defense (DOD) [W81XWH-10-1-0685]; Lynn Sage Foundation	Department of Defense (DOD)(United States Department of Defense); Lynn Sage Foundation	This work was supported by the Department of Defense (DOD) W81XWH-10-1-0685, Avon breast cancer award, and Lynn Sage Foundation awarded to M.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; American Cancer Society Inc, 2011, BREAST CANC FACTS FI; Baratelli F, 2010, AM J TRANSL RES, V2, P356; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Huang M, 1998, CANCER RES, V58, P1208; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Khazaie K, 2006, SEMIN CANCER BIOL, V16, P124, DOI 10.1016/j.semcancer.2005.11.006; KITTRELL FS, 1992, CANCER RES, V52, P1924; Klein G, 2005, IMMUNOL LETT, V100, P29, DOI 10.1016/j.imlet.2005.06.024; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Li YS, 2001, CANCER RES, V61, P6906; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Onizuka S, 1999, CANCER RES, V59, P3128; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Rech AJ, 2010, CANCER IMMUNOL IMMUN, V59, P599, DOI 10.1007/s00262-009-0780-x; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Sugihara AQ, 2009, INT J ONCOL, V34, P1533, DOI 10.3892/ijo_00000282; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Thorat MA, 2008, MODERN PATHOL, V21, P15, DOI 10.1038/modpathol.3800970; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Yaqub S, 2008, CANCER IMMUNOL IMMUN, V57, P813, DOI 10.1007/s00262-007-0417-x; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zitvogel L, 2006, CURR TOP MICROBIOL, V298, P157; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46342	10.1371/journal.pone.0046342	http://dx.doi.org/10.1371/journal.pone.0046342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029485	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900138
J	Lintner, M; Weissenbacher, A; Heiss, E				Lintner, Monika; Weissenbacher, Anton; Heiss, Egon			The Oropharyngeal Morphology in the Semiaquatic Giant Asian Pond Turtle, Heosemys grandis, and Its Evolutionary Implications	PLOS ONE			English	Article							DORSAL LINGUAL EPITHELIUM; STERNOTHERUS-ODORATUS CHELONIA; PELUSIOS-CASTANEUS CHELONIA; FEEDING APPARATUS; PREY CAPTURE; TERRAPENE-CAROLINA; CUORA-AMBOINENSIS; FOOD TRANSPORT; FINE-STRUCTURE; BOX-TURTLE	The oropharynx as a functional entity plays a fundamental role in feeding. Transitions from aquatic to terrestrial lifestyles in vertebrates demanded major changes of the oropharynx for the required adaptations to a different feeding environment. Extant turtles evolved terrestrial feeding modes in three families (testudinids, emydids, geoemydids)-independently from other amniotes- and are therefore important model organisms to reconstruct morpho-functional changes behind aquatic-terrestrial transitions. In this study we hypothesized that the oropharyngeal morphology in semiaquatic turtles of the geoemydid family shows parallels to testudinids, the only purely terrestrial extant lineage. We provide an in-depth description of the oropharynx in the semiaquatic geoemydid Heosemys grandis by using a combination of micro computed tomography (micro-CT) and subsequent digital in situ 3-D reconstruction, scanning electron microscopy (SEM), and histology. We show that H. grandis has a large tongue with rough papillose surface and well-developed lingual muscles. The attachment sites of the lingual muscles on the hyolingual skeleton and their courses within the tongue are nearly identical with testudinids. The hyolingual skeleton itself is mainly cartilaginous and shows distinct-but compared to testudinids rather small-anterior extensions of the hyoid body and hypoglossum. Oral glands are well developed in H. grandis but are smaller and simpler than in testudinids. Similarly, oropharyngeal keratinization was minimal and found only in the anterior palate, regions close to the beak, and tongue tip. We conclude that H. grandis shows distinct oropharyngeal morphofunctional adaptations for a terrestrial lifestyle but still retains characters typical for aquatic forms. This makes this species an important example showing the oropharyngeal adaptations behind aquatic-terrestrial transitions in turtles.	[Lintner, Monika; Heiss, Egon] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Weissenbacher, Anton] Zoo Vienna, Vienna, Austria; [Heiss, Egon] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	University of Vienna; University of Antwerp	Heiss, E (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	Egon.Heiss@ua.ac.be		Heiss, Egon/0000-0002-5257-8889	Austrian Science fund FWF [J3186-B17, P20094-B17]	Austrian Science fund FWF(Austrian Science Fund (FWF))	This study was financially supported by the Austrian Science fund FWF (project numbers: J3186-B17 and P20094-B17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2001, AM ZOOL, V41, P1299, DOI 10.1668/0003-1569(2001)041[1299:IMACOF]2.0.CO;2; Anquetin J, 2009, P ROY SOC B-BIOL SCI, V276, P879, DOI 10.1098/rspb.2008.1429; Beisser CJ, 2004, ANAT REC PART A, V277A, P227, DOI 10.1002/ar.a.20008; Beisser CJ, 2001, TISSUE CELL, V33, P63, DOI 10.1054/tice.2000.0156; BEISSER CJ, 1995, J MORPHOL, V226, P267, DOI 10.1002/jmor.1052260303; Beisser CJ, 1998, ANAT REC, V250, P127, DOI 10.1002/(SICI)1097-0185(199802)250:2<127::AID-AR1>3.0.CO;2-0; Bels Vincent, 2008, P187; Bels VL, 1997, J EXP ZOOL, V277, P198, DOI 10.1002/(SICI)1097-010X(19970215)277:3<198::AID-JEZ2>3.0.CO;2-J; Bonin F, 2006, TURTLES WORLD; Bramble D.M., 1985, P230; Deban SM, 2003, EXPTL BIOL REV, P161; Deban SM, 2002, ZOOL J LINN SOC-LOND, V134, P375, DOI 10.1046/j.1096-3642.2002.00004.x; Druzisky KA, 2001, ZOOL-ANAL COMPLEX SY, V104, P143, DOI 10.1078/0944-2006-00015; Fahrenholz C., 1937, P115; Gray JE, 1860, ANN MAG NAT HIST 3, V6, P217; Heiss E, 2008, ANAT REC, V291, P876, DOI 10.1002/ar.20695; Heiss E, 2011, J MORPHOL, V272, P1217, DOI 10.1002/jmor.10978; Heiss E, 2010, ANAT REC, V293, P1416, DOI 10.1002/ar.21185; Heiss E, 2009, J MORPHOL, V270, P892, DOI 10.1002/jmor.10728; Iwasaki S, 2002, J ANAT, V201, P1, DOI 10.1046/j.1469-7580.2002.00073.x; Iwasaki SI, 1996, ANAT REC, V246, P305, DOI 10.1002/(SICI)1097-0185(199611)246:3<305::AID-AR1>3.0.CO;2-X; IWASAKI SI, 1992, J MORPHOL, V211, P125, DOI 10.1002/jmor.1052110202; Joyce WG, 2004, P ROY SOC B-BIOL SCI, V271, P1, DOI 10.1098/rspb.2003.2523; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kiernan JA., 2003, HISTOLOGICAL HISTOCH; Kochva E., 1978, P43; LAUDER GV, 1992, J EXP BIOL, V164, P55; Lemell P, 1997, NETH J ZOOL, V47, P429, DOI 10.1163/156854297X00102; Lemell P, 2000, J MORPHOL, V244, P127, DOI 10.1002/(SICI)1097-4687(200005)244:2<127::AID-JMOR3>3.0.CO;2-U; Lemell P, 2010, AMPHIBIA-REPTILIA, V31, P97, DOI 10.1163/156853810790457803; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lintner M., 2010, THESIS; NALAVADE MN, 1976, FOL HISTOCH CYTOCHEM, V14, P123; Natchev N, 2011, CONTRIB ZOOL, V80, P143, DOI 10.1163/18759866-08002004; Natchev N, 2010, ZOOMORPHOLOGY, V129, P111, DOI 10.1007/s00435-010-0104-x; Natchev N, 2009, ZOOLOGY, V112, P113, DOI 10.1016/j.zool.2008.05.002; PRITCHARD PCH, 1979, ENCY TURTLES; Reisz RR, 2008, NATURE, V456, P450, DOI 10.1038/456450a; Richter S, 2007, AMPHIBIA-REPTILIA, V28, P148, DOI 10.1163/156853807779798983; Romeis B., 1989, MIKROSKOPISCHE TECHN; Schumacher G. H., 1973, P101; Schwenk Kurt, 2001, Bulletin of the Museum of Comparative Zoology, V156, P219; Schwenk Kurt, 2000, P21, DOI 10.1016/B978-012632590-4/50003-4; Stayton CT, 2011, J EXP BIOL, V214, P4083, DOI 10.1242/jeb.060574; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Weisgram J, 1989, PLZEN LEK SBORN S, V59, P117; Werneburg I, 2011, PALAEONTOL ELECTRON, V14; WINOKUR RM, 1988, J MORPHOL, V196, P33, DOI 10.1002/jmor.1051960105; Wocheslander R, 2000, NETH J ZOOL, V50, P445, DOI 10.1163/156854200506080; Wocheslander R, 1999, NETH J ZOOL, V49, P1, DOI 10.1163/156854299X00010	50	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46344	10.1371/journal.pone.0046344	http://dx.doi.org/10.1371/journal.pone.0046344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029486	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900139
J	Varchetta, S; Brunetta, E; Roberto, A; Mikulak, J; Hudspeth, KL; Mondelli, MU; Mavilio, D				Varchetta, Stefania; Brunetta, Enrico; Roberto, Alessandra; Mikulak, Joanna; Hudspeth, Kelly L.; Mondelli, Mario U.; Mavilio, Domenico			Engagement of Siglec-7 Receptor Induces a Pro-Inflammatory Response Selectively in Monocytes	PLOS ONE			English	Article							KILLER-CELL RECEPTOR; SIALIC ACIDS; ERK PHOSPHORYLATION; INHIBITORY RECEPTOR; CYTOKINE PRODUCTION; IMMUNE-SYSTEM; RECOGNITION; IMMUNORECEPTOR; IDENTIFICATION; DECTIN-1	Sialic acid binding immunoglobulin-like lectin-7 (Siglec-7) is a trans-membrane receptor carrying immunoreceptor tyrosine based inhibitory motifs (ITIMs) and delivering inhibitory signals upon ligation with sialylated glycans. This inhibitory function can be also targeted by several pathogens that have evolved to express sialic acids on their surface to escape host immune responses. Here, we demonstrate that cross-linking of Siglec-7 by a specific monoclonal antibody (mAb) induces a remarkably high production of IL-6, IL-1 alpha, CCL4/MIP-1 beta, IL-8 and TNF-alpha. Among the three immune cell subsets known to constitutively express Siglec-7, the production of these pro-inflammatory cytokines and chemokines selectively occurs in monocytes and not in Natural Killer or T lymphocytes. This Siglec-7-mediated activating function is associated with the phosphorylation of the extracellular signal-regulated kinase (ERK) pathway. The present study also shows that sialic acid-free Zymosan yeast particles are able to bind Siglec-7 on monocytes and that this interaction mimics the ability of the anti Siglec-7 mAb to induce the production of pro-inflammatory mediators. Indeed, blocking or silencing Siglec-7 in primary monocytes greatly reduced the production of inflammatory cytokines and chemokines in response to Zymosan, thus confirming that Siglec-7 participates in generating a monocyte-mediated inflammatory outcome following pathogen recognition. The presence of an activating form of Siglec-7 in monocytes provides the host with a new and alternative mechanism to encounter pathogens not expressing sialylated glycans.	[Mavilio, Domenico] Ist Clin Humanitas, IRCCS, Lab Clin & Expt Immunol, Milan, Italy; [Varchetta, Stefania] Fdn San Matteo, IRCCS, Res Labs, Dept Infect Dis, Pavia, Italy; [Varchetta, Stefania] Univ Pavia, I-27100 Pavia, Italy; [Brunetta, Enrico; Roberto, Alessandra; Mikulak, Joanna; Hudspeth, Kelly L.; Mondelli, Mario U.] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy	IRCCS Humanitas Research Hospital; University of Pavia; University of Pavia	Mavilio, D (corresponding author), Ist Clin Humanitas, IRCCS, Lab Clin & Expt Immunol, Milan, Italy.	domenico.mavilio@humanitas.it	Mondelli, Mario U/J-5375-2016; mikulak, joanna/AAB-3070-2022; Varchetta, Stefania/C-9034-2018; Brunetta, Enrico/AAT-6524-2021; Mavilio, Domenico/E-5194-2017	Mondelli, Mario U/0000-0003-1811-3153; mikulak, joanna/0000-0001-8310-9543; Varchetta, Stefania/0000-0002-0289-2896; Roberto, Alessandra/0000-0001-6615-0026; Brunetta, Enrico/0000-0002-0676-1228; Mavilio, Domenico/0000-0001-6147-0952	Intramural Research program of Istituto Clinico Humanitas [20090917]; Italian Ministry of Health [RF-ICH-2009-1299677, RF-ICH-2009-1304134]	Intramural Research program of Istituto Clinico Humanitas; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the Intramural Research program of Istituto Clinico Humanitas (Grant 20090917 to D.M.), and by the Italian Ministry of Health (Ricerca Finalizzata, Bando ISS, Grants RF-ICH-2009-1299677 to D.M. and RF-ICH-2009-1304134 and to J.M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Barclay A. N., 1997, LEUCOCYTE ANTIGEN FA, V2nd; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bliss JM, 1996, MOL MICROBIOL, V21, P221, DOI 10.1046/j.1365-2958.1996.6461357.x; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Carlin AF, 2007, J BACTERIOL, V189, P1231, DOI 10.1128/JB.01155-06; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Chirathaworn C, 2002, J IMMUNOL, V168, P5530, DOI 10.4049/jimmunol.168.11.5530; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2001, IMMUNOLOGY, V103, P137, DOI 10.1046/j.0019-2805.2001.01241.x; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; da Silva FP, 2008, TRENDS IMMUNOL, V29, P366, DOI 10.1016/j.it.2008.05.001; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Dionne MS, 2001, MOL CELL BIOL, V21, P636, DOI 10.1128/MCB.21.2.636-643.2001; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Falco M, 1999, J EXP MED, V190, P793, DOI 10.1084/jem.190.6.793; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gupta S, 2010, BIOCHEM BIOPH RES CO, V402, P301, DOI 10.1016/j.bbrc.2010.10.020; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Ikehara Y, 2004, J BIOL CHEM, V279, P43117, DOI 10.1074/jbc.M403538200; Jacobs T, 2010, EUR J CELL BIOL, V89, P113, DOI 10.1016/j.ejcb.2009.10.006; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; May LT, 2008, INT J BIOCHEM CELL B, V40, P2013, DOI 10.1016/j.biocel.2008.04.001; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Peterson ME, 2008, IMMUNITY, V29, P578, DOI 10.1016/j.immuni.2008.07.014; Pillai S, 2011, ANN REV IMMUNOL; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Soares RMA, 2000, BBA-GEN SUBJECTS, V1474, P262, DOI 10.1016/S0304-4165(00)00003-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vitale C, 2001, P NATL ACAD SCI USA, V98, P5764, DOI 10.1073/pnas.091097198; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200	50	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45821	10.1371/journal.pone.0045821	http://dx.doi.org/10.1371/journal.pone.0045821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029261	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900055
J	Haglund, E; Sulkowska, JI; He, Z; Feng, GS; Jennings, PA; Onuchic, JN				Haglund, Ellinor; Sulkowska, Joanna I.; He, Zhao; Feng, Gen-Sheng; Jennings, Patricia A.; Onuchic, Jose N.			The Unique Cysteine Knot Regulates the Pleotropic Hormone Leptin	PLOS ONE			English	Article							INTRACHAIN DISULFIDE BOND; BODY-WEIGHT REGULATION; STRUCTURE-BASED MODELS; OBESE GENE-PRODUCT; OB PROTEIN; MISSENSE MUTATION; CRYSTAL-STRUCTURE; FOOD-INTAKE; DYNAMICS; INTERLEUKIN-1-BETA	Leptin plays a key role in regulating energy intake/expenditure, metabolism and hypertension. It folds into a four-helix bundle that binds to the extracellular receptor to initiate signaling. Our work on leptin revealed a hidden complexity in the formation of a previously un-described, cysteine-knotted topology in leptin. We hypothesized that this unique topology could offer new mechanisms in regulating the protein activity. A combination of in silico simulation and in vitro experiments was used to probe the role of the knotted topology introduced by the disulphide-bridge on leptin folding and function. Our results surprisingly show that the free energy landscape is conserved between knotted and unknotted protein, however the additional complexity added by the knot formation is structurally important. Native state analyses led to the discovery that the disulphide-bond plays an important role in receptor binding and thus mediate biological activity by local motions on distal receptor-binding sites, far removed from the disulphide-bridge. Thus, the disulphide-bridge appears to function as a point of tension that allows dissipation of stress at a distance in leptin.	[Haglund, Ellinor; Sulkowska, Joanna I.; Jennings, Patricia A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Haglund, Ellinor; Sulkowska, Joanna I.; Jennings, Patricia A.] Univ Calif San Diego, Ctr Theoret Biol Phys CTBP, La Jolla, CA 92093 USA; [He, Zhao; Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [He, Zhao; Feng, Gen-Sheng] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Onuchic, Jose N.] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Onuchic, Jose N.] Rice Univ, Dept Phys & Astron Chem & Biochem & Cell Biol, Houston, TX USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rice University; Rice University	Jennings, PA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	pajennings@ucsd.edu; jonuchic@rice.edu	he, zhao/S-4989-2019		Center for Theoretical Biological Physics; National Science Foundation (NSF) [PHY-0822283]; National Institutes of Health [GM54038]; Cancer Prevention and Research Institute of Texas;  [NSF- MCB-1051438]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054038, R29GM054038] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1212312] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the Center for Theoretical Biological Physics sponsored by the National Science Foundation (NSF) (Grant PHY-0822283) and by NSF- MCB-1051438. National Institutes of Health GM54038 JNO is a CPRIT Scholar in Cancer Research sponsored by the Cancer Prevention and Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A.T HRVaC, 1978, INTRO MATH STAT; Adamczyk M, 1999, RAPID COMMUN MASS SP, V13, P1813, DOI 10.1002/(SICI)1097-0231(19990930)13:18<1813::AID-RCM722>3.0.CO;2-1; Altmann SW, 1995, PROTEIN EXPRES PURIF, V6, P722, DOI 10.1006/prep.1995.0002; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andrews BT, 2008, P NATL ACAD SCI USA, V105, P12283, DOI 10.1073/pnas.0804039105; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin J, 2009, CHEMBIOCHEM, V10, P2663, DOI 10.1002/cbic.200900534; Banky P, 2000, J BIOL CHEM, V275, P35146, DOI 10.1074/jbc.M003961200; Beldarrain A, 1999, BIOCHEMISTRY-US, V38, P7865, DOI 10.1021/bi990287g; Bishop B, 2001, J BIOL CHEM, V276, P33465, DOI 10.1074/jbc.M104494200; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; Boute N, 2004, BIOCHIMIE, V86, P351, DOI 10.1016/j.biochi.2004.06.005; BREMS DN, 1990, J BIOL CHEM, V265, P5504; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Catalano S, 2004, J BIOL CHEM, V279, P19908, DOI 10.1074/jbc.M313191200; Cemazar M, 2008, ANTIOXID REDOX SIGN, V10, P103, DOI 10.1089/ars.2007.1849; CHOI SC, 1969, TECHNOMETRICS, V11, P683, DOI 10.2307/1266892; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Crespi EJ, 2006, P NATL ACAD SCI USA, V103, P10092, DOI 10.1073/pnas.0507519103; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P622; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Denver RJ, 2011, NEUROENDOCRINOLOGY, V94, P21, DOI 10.1159/000328435; Doshi U, 2012, P NATL ACAD SCI USA, V109, P5699, DOI 10.1073/pnas.1117060109; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Fawzi AB, 1996, HORM METAB RES, V28, P694, DOI 10.1055/s-2007-979880; Feng YP, 1996, J MOL BIOL, V259, P524, DOI 10.1006/jmbi.1996.0337; Ferreiro DU, 2007, P NATL ACAD SCI USA, V104, P19819, DOI 10.1073/pnas.0709915104; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; FERRENBERG AM, 1988, PHYS REV LETT, V61, P2635, DOI 10.1103/PhysRevLett.61.2635; Finke JM, 2000, BIOCHEMISTRY-US, V39, P575, DOI 10.1021/bi991518m; Finke JM, 2000, BIOCHEMISTRY-US, V39, P15633, DOI 10.1021/bi001307d; Fischer-Posovszky P, 2010, J CLIN ENDOCR METAB, V95, P2836, DOI 10.1210/jc.2009-2466; Fiser Andras, 2006, NUCL ACIDS RES; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Giese K, 1996, MOL MED, V2, P50, DOI 10.1007/BF03402202; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Haglund E, 2008, J BIOL CHEM, V283, P27904, DOI 10.1074/jbc.M801776200; Haglund E, 2012, J BIOL CHEM, V287, P2731, DOI 10.1074/jbc.M111.312447; Haglund E, 2009, P NATL ACAD SCI USA, V106, P21619, DOI 10.1073/pnas.0907665106; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hamming OJ, 2011, J VIROL, V85, P8181, DOI 10.1128/JVI.00521-11; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Imagawa K, 1998, J BIOL CHEM, V273, P35245, DOI 10.1074/jbc.273.52.35245; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Kurokawa T, 2005, PEPTIDES, V26, P745, DOI 10.1016/j.peptides.2004.12.017; Lago R, 2008, CELL IMMUNOL, V252, P139, DOI 10.1016/j.cellimm.2007.09.004; Lammert H, 2009, PROTEINS, V77, P881, DOI 10.1002/prot.22511; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Lindberg MO, 2006, P NATL ACAD SCI USA, V103, P4083, DOI 10.1073/pnas.0508863103; Lo Verso F, 2007, J PHYS CHEM C, V111, P15803, DOI 10.1021/jp0737606; Marianayagam NJ, 2005, J R SOC INTERFACE, V2, P47, DOI 10.1098/rsif.2004.0025; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Muller G, 1997, J BIOL CHEM, V272, P10585, DOI 10.1074/jbc.272.16.10585; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Niv-Spector L, 2005, BIOCHEM J, V390, P475, DOI 10.1042/BJ20050233; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Noel JK, 2012, J PHYS CHEM B, V116, P8692, DOI 10.1021/jp300852d; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Rees A. R., 1992, PROTEIN ENG PRACTICA; RENTSCH J, 1995, BIOCHEM BIOPH RES CO, V214, P131, DOI 10.1006/bbrc.1995.2266; Rock FL, 1996, HORM METAB RES, V28, P649, DOI 10.1055/s-2007-979871; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shpilman M, 2011, J BIOL CHEM, V286, P4429, DOI 10.1074/jbc.M110.196402; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Sulkowska JI, 2008, BIOPHYS J, V95, P3174, DOI 10.1529/biophysj.107.127233; Sulkowska JI, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.268103; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; TERRY RD, 1980, ANNU REV NEUROSCI, V3, P77, DOI 10.1146/annurev.ne.03.030180.000453; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vaz DC, 2006, PROTEIN SCI, V15, P33, DOI 10.1110/ps.051593306; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yao SG, 2011, BIOCHEMISTRY-US, V50, P2464, DOI 10.1021/bi101810f; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zirah S, 2011, J AM SOC MASS SPECTR, V22, P467, DOI 10.1007/s13361-010-0028-1	96	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45654	10.1371/journal.pone.0045654	http://dx.doi.org/10.1371/journal.pone.0045654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029163	Green Published, gold			2022-12-25	WOS:000309554700055
J	Martelli, D; Luppi, M; Cerri, M; Tupone, D; Perez, E; Zamboni, G; Amici, R				Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto			Waking and Sleeping following Water Deprivation in the Rat	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; LOW AMBIENT-TEMPERATURE; EYE-MOVEMENT SLEEP; REM-SLEEP; COLD-EXPOSURE; DESYNCHRONIZED SLEEP; THERMOREGULATION; VASOPRESSIN; CALCIUM; PATTERN	Wake-sleep (W-S) states are affected by thermoregulation. In particular, REM sleep (REMS) is reduced in homeotherms under a thermal load, due to an impairment of hypothalamic regulation of body temperature. The aim of this work was to assess whether osmoregulation, which is regulated at a hypothalamic level, but, unlike thermoregulation, is maintained across the different W-S states, could influence W-S occurrence. Sprague-Dawley rats, kept at an ambient temperature of 24 degrees C and under a 12 h:12 h light-dark cycle, were exposed to a prolonged osmotic challenge of three days of water deprivation (WD) and two days of recovery in which free access to water was restored. Two sets of parameters were determined in order to assess: i) the maintenance of osmotic homeostasis (water and food consumption; changes in body weight and fluid composition); ii) the effects of the osmotic challenge on behavioral states (hypothalamic temperature (Thy), motor activity, and W-S states). The first set of parameters changed in WD as expected and control levels were restored on the second day of recovery, with the exception of urinary Ca++ that almost disappeared in WD, and increased to a high level in recovery. As far as the second set is concerned, WD was characterized by the maintenance of the daily oscillation of Thy and by a decrease in activity during the dark periods. Changes in W-S states were small and mainly confined to the dark period: i) REMS slightly decreased at the end of WD and increased in recovery; ii) non-REM sleep (NREMS) increased in both WD and recovery, but EEG delta power, a sign of NREMS intensity, decreased in WD and increased in recovery. Our data suggest that osmoregulation interferes with the regulation of W-S states to a much lesser extent than thermoregulation.	[Martelli, Davide; Luppi, Marco; Cerri, Matteo; Tupone, Domenico; Perez, Emanuele; Zamboni, Giovanni; Amici, Roberto] Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy; [Martelli, Davide] Univ Melbourne, Florey Neurosci Inst, Syst Neurophysiol Div, Melbourne, Vic, Australia; [Tupone, Domenico] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA	University of Bologna; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Oregon Health & Science University; Oregon National Primate Research Center	Zamboni, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Human & Gen Physiol, Bologna, Italy.	giovanni.zamboni@unibo.it	Luppi, Marco/AGH-3155-2022; Cerri, Matteo/F-5009-2017; Martelli, Davide/Q-7375-2016; Tupone, Domenico/M-8079-2016	Luppi, Marco/0000-0002-9462-5014; Cerri, Matteo/0000-0003-3556-305X; Tupone, Domenico/0000-0002-4238-1011; Martelli, Davide/0000-0001-6523-9598	University of Bologna	University of Bologna	This work has been funded by Research Funds for Fundamental and Applied Research (RFO Funds) from the University of Bologna (http://www.eng.unibo.it/PortaleEn/Research/Services+for+teachers+and+researchers/National+Regional+and+Local+Funding/default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici R, 2004, BRAIN RES, V996, P9, DOI 10.1016/j.brainres.2003.09.026; Amici R, 2001, BEHAV BRAIN RES, V123, P155, DOI 10.1016/S0166-4328(01)00203-0; AMICI R, 1994, J SLEEP RES, V3, P250, DOI 10.1111/j.1365-2869.1994.tb00139.x; Amici R, 1998, BRAIN RES, V781, P252, DOI 10.1016/S0006-8993(97)01242-0; Amici R, 2008, SLEEP, V31, P708, DOI 10.1093/sleep/31.5.708; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ARNAULD E, 1989, AM J PHYSIOL, V256, pR674, DOI 10.1152/ajpregu.1989.256.3.R674; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; BORN J, 1992, AM J PHYSIOL, V262, pE295, DOI 10.1152/ajpendo.1992.262.3.E295; Caputa M, 1996, J THERM BIOL, V21, P21, DOI 10.1016/0306-4565(95)00016-X; Cerri M, 2005, SLEEP, V28, P694, DOI 10.1093/sleep/28.6.694; Chatelain D, 2003, REGUL PEPTIDES, V110, P249, DOI 10.1016/S0167-0115(02)00217-3; Endres DB, 1994, TIETZ TXB CLIN CHEM, P1887; FRANKEN P, 1993, PHYSIOL BEHAV, V54, P885, DOI 10.1016/0031-9384(93)90297-S; Heller C., 2005, PRINCIPLES PRACTICE, P292, DOI DOI 10.1016/B0-72-160797-7/50031-8; HOLM S, 1979, SCAND J STAT, V6, P65; KOULACK D, 1970, J NERV MENT DIS, V151, P143, DOI 10.1097/00005053-197008000-00008; Kryger MH, 2011, PRINCIPLES PRACTICE, P431, DOI [DOI 10.1016/B978-1-4160-6645-3.00037-2, DOI 10.1016/13978-1-4160-6645-3.00037-2]; Kuznetsov IE, 2000, NEUROSCIENCE, V99, P363, DOI 10.1016/S0306-4522(00)00184-6; Luppi M, 2010, J SLEEP RES, V19, P394, DOI 10.1111/j.1365-2869.2009.00810.x; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; Marenzana M, 2005, BONE, V37, P545, DOI 10.1016/j.bone.2005.04.036; McKinley M, 2008, CLIN EXP PHARMACOL P, V35, P701, DOI 10.1111/j.1440-1681.2007.04833.x; MCKINLEY MJ, 1983, AM J PHYSIOL, V245, pR287, DOI 10.1152/ajpregu.1983.245.2.R287; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mouret J R, 1971, Int J Neurosci, V2, P265, DOI 10.3109/00207457109147009; Parmeggiani P. L., 1994, PRINCIPLES PRACTICE, P194; PARMEGGIANI PL, 1980, ELECTROEN CLIN NEURO, V50, P293, DOI 10.1016/0013-4694(80)90157-1; Parmeggiani PL, 2003, FRONT BIOSCI, V8, pS557, DOI 10.2741/1054; Parmeggiani PL, 2005, PRINCIPLES PRACTICE, V4th, P185; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Simon E, 1999, JPN J PHYSIOL, V49, P297, DOI 10.2170/jjphysiol.49.297; Talmage D. W., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P108; Talmage RV, 2009, GEN COMP ENDOCR, V162, P245, DOI 10.1016/j.ygcen.2009.03.027; Toney GM, 2003, ACTA PHYSIOL SCAND, V177, P43, DOI 10.1046/j.1365-201X.2003.01046.x; Vyazovskiy VV, 2005, BRAIN RES, V1050, P64, DOI 10.1016/j.brainres.2005.05.022; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Watts AG, 1999, PHYSIOL BEHAV, V65, P871; Waynforth H, 1980, EXPT SURGICAL TECHNI, P59; Wotus C, 2003, NEUROENDOCRINOLOGY, V78, P301, DOI 10.1159/000074883; Zamboni G, 2004, BRAIN RES, V1022, P62, DOI 10.1016/j.brainres.2004.07.002; Zamboni G, 2001, BEHAV BRAIN RES, V122, P25, DOI 10.1016/S0166-4328(01)00175-9	42	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46116	10.1371/journal.pone.0046116	http://dx.doi.org/10.1371/journal.pone.0046116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029406	Green Published, gold			2022-12-25	WOS:000309554700116
J	Saxena, N; Hartman, M; Yip, CH; Bhoo-Pathy, N; Khin, LW; Taib, NA; Looi, LM; Lim, SE; Lee, SC; Verkooijen, HM				Saxena, Nakul; Hartman, Mikael; Yip, Cheng-Har; Bhoo-Pathy, Nirmala; Khin, Lay Wai; Taib, Nur Aishah; Looi, Lai-Meng; Lim, Siew-Eng; Lee, Soo-Chin; Verkooijen, Helena M.			Does the Axillary Lymph Node Ratio Have Any Added Prognostic Value over pN Staging for South East Asian Breast Cancer Patients?	PLOS ONE			English	Article							DISSECTION; SURVIVAL; METASTASIS	Introduction: Lymph node ratio (LNR, i.e. the ratio of the number of positive nodes to the total number of nodes excised) is reported to be superior to the absolute number of nodes involved (pN stage) in classifying patients at high versus low risk of death following breast cancer. The added prognostic value of LNR over pN in addition to other prognostic factors has never been assessed. Methods: All patients diagnosed with lymph node positive, non-metastatic invasive breast cancer at the National University Hospital (Singapore) and University of Malaya Medical Center (Kuala Lumpur) between 1990-2007 were included (n = 1589). Overall survival of the patients was estimated by the Kaplan Meier method for LNR [categorized as low (>0 and <0.2), intermediate (0.2-0.65) and high (>0.65-1)] and pN staging [pN1, pN2 and pN3]. Adjusted overall relative mortality risks associated with LNR and pN were calculated by Cox regression. The added prognostic value of LNR over pN was evaluated by comparing the discriminating capacity (as indicated by the c statistic) of two multivariate models, one including pN and one including LNR. Results: LNR was superior to pN in categorizing mortality risks for women >= 60 years, those with ER negative or grade 3 tumors. In combination with other factors (i.e. age, treatment, grade, tumor size and receptor status), substituting pN by LNR did not result in better discrimination of women at high versus low risk of death, neither for the entire cohort (c statistic 0.72 [0.70-0.75] and 0.73 [0.71-0.76] respectively for pN versus LNR), nor for the subgroups mentioned above. Conclusion: In combination with other prognosticators, substitution of pN by LNR did not provide any added prognostic value for South East Asian breast cancer patients.	[Saxena, Nakul; Hartman, Mikael; Verkooijen, Helena M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Yip, Cheng-Har; Taib, Nur Aishah] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Hosp Kuala Lumpur, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Khin, Lay Wai] Natl Univ Singapore, Invest Med Unit, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Looi, Lai-Meng] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Lim, Siew-Eng; Lee, Soo-Chin] Natl Univ Hlth Syst, Dept Hematol Oncol, Natl Univ Canc Inst, Singapore, Singapore; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	National University of Singapore; National University of Singapore; Universiti Malaya; National University of Singapore; Universiti Malaya; National University of Singapore; Utrecht University; Utrecht University Medical Center	Hartman, M (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore.	mikael_hartman@nuhs.edu.sg	Lee, Soo Chin/S-9111-2016; Pathy, Nirmala Bhoo/C-1228-2010; LIM, SIEW ENG/AGO-6654-2022; Yip, Cheng-Har/B-1909-2010; Looi, Lai Meng/AAB-9403-2019; Looi, Lai Meng/A-3382-2009; Taib, Nur Aishah Mohd/B-2370-2010; Hartman, Mikael/B-4324-2011	Lee, Soo Chin/0000-0002-5835-6419; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Hartman, Mikael/0000-0001-5726-9965	HIR Grant Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/06]; European Union through a PhD fellowship grant (AsiaLink program) [MY/AsiaLink/044[128-713]]	HIR Grant Ministry of Higher Education, Malaysia; European Union through a PhD fellowship grant (AsiaLink program)	The Malaysian data was supported by an HIR Grant UM.C/HlR/MOHE/06 from the Ministry of Higher Education, Malaysia. Nirmala Bhoo-Pathy was funded by the European Union through a PhD fellowship grant (AsiaLink program MY/AsiaLink/044[128-713]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2011, BREAST CANCER RES TR, V130, P507, DOI 10.1007/s10549-011-1730-9; Atahan IL, 2008, ACTA ONCOL, V47, P232, DOI 10.1080/02841860701678761; AXELSSON CK, 1992, EUR J CANCER, V28A, P1415, DOI 10.1016/0959-8049(92)90534-9; Boughey JC, 2010, CANCER-AM CANCER SOC, V116, P3322, DOI 10.1002/cncr.25207; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; Edge SB, 2010, AJCC CANC STAGING MA; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hatoum HA, 2009, ANN SURG ONCOL, V16, P3388, DOI 10.1245/s10434-009-0653-8; Keam B, 2009, BREAST CANCER RES TR, V116, P153, DOI 10.1007/s10549-008-0160-9; Lim SE, 2007, WORLD J SURG, V31, P1387, DOI 10.1007/s00268-007-9086-3; MATHIESEN O, 1990, ACTA ONCOL, V29, P721, DOI 10.3109/02841869009092990; Pathy NB, 2011, BREAST, V20, pS75, DOI 10.1016/j.breast.2011.01.015; RECHT A, 1995, CANCER, V76, P1491, DOI 10.1002/1097-0142(19951101)76:9<1491::AID-CNCR2820760902>3.0.CO;2-8; SAEZ RA, 1989, SEMIN SURG ONCOL, V5, P102, DOI 10.1002/ssu.2980050206; Saxena N, 2011, EUR J CANCER, V47, P1186, DOI 10.1016/j.ejca.2010.12.009; Schaapveld M, 2004, J SURG ONCOL, V87, P4, DOI 10.1002/jso.20061; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tausch C, 2012, ANN SURG ONCOL, V19, P1808, DOI 10.1245/s10434-011-2189-y; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Vinh-Hung V, 2003, INT J ONCOL, V22, P697; Vinh-Hung V, 2009, FUTURE ONCOL, V5, P1585, DOI 10.2217/FON.09.129; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Woodward WA, 2006, J CLIN ONCOL, V24, P2910, DOI 10.1200/JCO.2005.03.1526; Yiangou C, 1999, BRIT J CANCER, V80, P1974, DOI 10.1038/sj.bjc.6690629	24	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45809	10.1371/journal.pone.0045809	http://dx.doi.org/10.1371/journal.pone.0045809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029254	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700074
J	de Jager, SCA; Bongaerts, BWC; Weber, M; Kraaijeveld, AO; Rousch, M; Dimmeler, S; van Dieijen-Visser, MP; Cleutjens, KBJM; Nelemans, PJ; van Berkel, TJC; Biessen, EAL				de Jager, Saskia C. A.; Bongaerts, Brenda W. C.; Weber, Michael; Kraaijeveld, Adriaan O.; Rousch, Mat; Dimmeler, Stefanie; van Dieijen-Visser, Marja P.; Cleutjens, Kitty B. J. M.; Nelemans, Patty J.; van Berkel, Theo J. C.; Biessen, Erik A. L.			Chemokines CCL3/MIP1 alpha, CCL5/RANTES and CCL18/PARC are Independent Risk Predictors of Short-Term Mortality in Patients with Acute Coronary Syndromes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; UNSTABLE ANGINA-PECTORIS; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; ARTERY-DISEASE; TROPONIN-T; EXPRESSION; CELLS	Cytokines play an important role in ischemic injury and repair. However, little is known about their prognostic value in cardiovascular disease. The aim of this study was to investigate the prognostic importance of chemokines CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC for the risk of future cardiovascular events in patients with acute coronary syndromes (ACS). Baseline levels of CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC were determined in ACS patients from the Bad Nauheim ACS II registry (n = 609). During the following 200 days, patients were monitored for the occurrence of fatal and non-fatal cardiovascular events. Patients with CCL3/MIP1 alpha, CCL5/RANTES and CCL18/PARC concentrations in the highest tertile were associated with an increased risk of a fatal event during follow-up (HR: 2.19, 95%CI: 1.04-4.61 for CCL3/MIP1 alpha, HR: 3.45, 95%CI: 1.54-7.72 for CCL5/RANTES and HR: 3.14, 95%CI: 1.33-7.46 for CCL18/PARC). This risk was highest for patients with all three biomarkers concentrations in the upper tertile (HR: 2.52, 95%CI: 1.11-5.65). Together with known risk predictors of cardiovascular events, CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC combined improved the c-statistics from 0.74 to 0.81 (p = 0.007). In conclusion, CCL3/MIP-1 alpha, CCL5/RANTES and CCL18/PARC are independently associated with the risk of short-term mortality in ACS patients. Combining all three biomarkers further increased their prognostic value.	[Bongaerts, Brenda W. C.; Rousch, Mat; Cleutjens, Kitty B. J. M.; Biessen, Erik A. L.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands; [de Jager, Saskia C. A.; van Berkel, Theo J. C.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Weber, Michael] Kerckhoff Heart Ctr, Dept Cardiol, Bad Nauheim, Germany; [Kraaijeveld, Adriaan O.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Dimmeler, Stefanie] Goethe Univ Frankfurt, Ctr Mol Med, Inst Cardiovasc Regenerat, Frankfurt, Germany; [van Dieijen-Visser, Marja P.] Maastricht Univ, Med Ctr, Dept Clin Chem, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Maastricht University; Leiden University; Leiden University - Excl LUMC; Kerckhoff Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Goethe University Frankfurt; Maastricht University; Maastricht University	Bongaerts, BWC (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Dept Pathol, Maastricht, Netherlands.	Brenda.Bongaerts@mumc.nl	de+Jager, Saskia/ABC-4264-2020; de+Jager, Saskia/AAE-1132-2022; Van Berkel, Theo/ABD-7677-2021	de Jager, Saskia/0000-0002-5233-0066; Dimmeler, Stefanie/0000-0002-1045-2436; Biessen, Erik/0000-0002-6454-8548	Netherlands Heart Foundation [M93.001]; Netherlands Scientific Organization, (Health Care Efficiency program grant) [170881003]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Scientific Organization, (Health Care Efficiency program grant)	This work was supported by the Netherlands Heart Foundation (grant M93.001, SCAdJ, AOK, TJCvB and EALB) and the Netherlands Scientific Organization, (Health Care Efficiency program grant 170881003 BWCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Butterfield LH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-173; Cavusoglu E, 2007, ARTERIOSCL THROM VAS, V27, P929, DOI 10.1161/01.ATV.0000258789.21585.76; Cha JK, 2000, J KOREAN MED SCI, V15, P273, DOI 10.3346/jkms.2000.15.3.273; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; de Jager SCA, 2008, J MOL CELL CARDIOL, V45, P446, DOI 10.1016/j.yjmcc.2008.06.003; de Jager W, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-52; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Frangogiannis NG, 2004, INFLAMM RES, V53, P585, DOI 10.1007/s00011-004-1298-5; Frangogiannis NG, 2004, CURR VASC PHARMACOL, V2, P163, DOI 10.2174/1570161043476375; Gonzalez-Quesada C, 2009, CURR ATHEROSCLER REP, V11, P131, DOI 10.1007/s11883-009-0021-y; Hagg Daniel A, 2009, Atherosclerosis, V204, pe15, DOI 10.1016/j.atherosclerosis.2008.10.010; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Haumer M, 2005, J VASC SURG, V41, P610, DOI 10.1016/j.jvs.2005.01.013; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Kraaijeveld AO, 2007, CIRCULATION, V116, P1931, DOI 10.1161/CIRCULATIONAHA.107.706986; Kraaijeveld AO, 2007, CURR PHARM DESIGN, V13, P1039, DOI 10.2174/138161207780487584; Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Quinones Marlon P, 2007, Atherosclerosis, V195, pe92, DOI 10.1016/j.atherosclerosis.2007.03.026; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schomig K, 2006, EUR HEART J, V27, P1032, DOI 10.1093/eurheartj/ehi761; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Simeoni E, 2004, EUR HEART J, V25, P1438, DOI 10.1016/j.ehj.2004.05.005; Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690; Tarzami ST, 2003, CIRCULATION, V108, P2387, DOI 10.1161/01.CIR.0000093192.72099.9A; Toor IS, 2008, J VASC SURG, V48, P1504, DOI 10.1016/j.jvs.2008.07.072; Vandervelde S, 2007, CARDIOVASC RES, V73, P783, DOI 10.1016/j.cardiores.2006.11.030; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Vogiatzi K, 2009, THROMB RES, V124, P84, DOI 10.1016/j.thromres.2008.12.043; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Wilcox J N, 1994, J Atheroscler Thromb, V1 Suppl 1, pS10; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	48	42	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45804	10.1371/journal.pone.0045804	http://dx.doi.org/10.1371/journal.pone.0045804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029252	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800101
J	Gao, YF; Chen, L; Cai, YD; Feng, KY; Huang, T; Jiang, Y				Gao, Yu-Fei; Chen, Lei; Cai, Yu-Dong; Feng, Kai-Yan; Huang, Tao; Jiang, Yang			Predicting Metabolic Pathways of Small Molecules and Enzymes Based on Interaction Information of Chemicals and Proteins	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; LOCALIZATION; SEQUENCES; STITCH	Metabolic pathway analysis, one of the most important fields in biochemistry, is pivotal to understanding the maintenance and modulation of the functions of an organism. Good comprehension of metabolic pathways is critical to understanding the mechanisms of some fundamental biological processes. Given a small molecule or an enzyme, how may one identify the metabolic pathways in which it may participate? Answering such a question is a first important step in understanding a metabolic pathway system. By utilizing the information provided by chemical-chemical interactions, chemical-protein interactions, and protein-protein interactions, a novel method was proposed by which to allocate small molecules and enzymes to 11 major classes of metabolic pathways. A benchmark dataset consisting of 3,348 small molecules and 654 enzymes of yeast was constructed to test the method. It was observed that the first order prediction accuracy evaluated by the jackknife test was 79.56% in identifying the small molecules and enzymes in a benchmark dataset. Our method may become a useful vehicle in predicting the metabolic pathways of small molecules and enzymes, providing a basis for some further analysis of the pathway systems.	[Gao, Yu-Fei; Jiang, Yang] Jilin Univ, Dept Surg, China Japan Union Hosp, Changchun 130023, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Feng, Kai-Yan] Shenzhen Beishan Ind Zone, Beijing Genom Inst, Shenzhen, Peoples R China; [Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Jilin University; Shanghai Maritime University; Shanghai University; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Jiang, Y (corresponding author), Jilin Univ, Dept Surg, China Japan Union Hosp, Changchun 130023, Peoples R China.	jy7555@163.com	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Shanghai Municipal Education Commission [12YZ120, 12ZZ087]	National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (No. 12YZ120, No. 12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3626, DOI 10.1093/nar/22.17.3626; Bogdanov P, 2010, IEEE ACM T COMPUT BI, V7, P208, DOI 10.1109/TCBB.2009.81; Cai YD, 2008, MOL DIVERS, V12, P131, DOI 10.1007/s11030-008-9085-9; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen L, 2010, MED CHEM, V6, P388, DOI 10.2174/157340610793563983; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2010, NUCLEIC ACIDS RES, V38, pD552, DOI 10.1093/nar/gkp937; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Lu J, 2009, PROTEIN PEPTIDE LETT, V16, P969, DOI 10.2174/092986609788923374; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Mondal S, 2006, J THEOR BIOL, V243, P252, DOI 10.1016/j.jtbi.2006.06.014; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Shao XJ, 2009, J THEOR BIOL, V258, P289, DOI 10.1016/j.jtbi.2009.01.024; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sun XD, 2006, AMINO ACIDS, V30, P469, DOI 10.1007/s00726-005-0239-0; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028	31	43	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45944	10.1371/journal.pone.0045944	http://dx.doi.org/10.1371/journal.pone.0045944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029334	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800125
J	Rohrer, S; Holsten, L; Weiss, E; Benghezal, M; Fischer, W; Haas, R				Rohrer, Stefanie; Holsten, Lea; Weiss, Evelyn; Benghezal, Mohammed; Fischer, Wolfgang; Haas, Rainer			Multiple Pathways of Plasmid DNA Transfer in Helicobacter pylori	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; TRANSFORMATION COMPETENCE; GENETIC-TRANSFORMATION; NATURAL COMPETENCE; MEMBRANE VESICLES; SYSTEM; RECOMBINATION; RELAXASE; COMPONENTS; EVOLUTION	Many Helicobacter pylori (Hp) strains carry cryptic plasmids of different size and gene content, the function of which is not well understood. A subgroup of these plasmids (e.g. pHel4, pHel12), contain a mobilisation region, but no cognate type IV secretion system (T4SS) for conjugative transfer. Instead, certain H. pylori strains (e. g. strain P12 carrying plasmid pHel12) can harbour up to four T4SSs in their genome (cag-T4SS, comB, tfs3, tfs4). Here, we show that such indigenous plasmids can be efficiently transferred between H. pylori strains, even in the presence of extracellular DNaseI eliminating natural transformation. Knockout of a plasmid-encoded mobA relaxase gene significantly reduced plasmid DNA transfer in the presence of DNaseI, suggesting a DNA conjugation or mobilisation process. To identify the T4SS involved in this conjugative DNA transfer, each individual T4SS was consecutively deleted from the bacterial chromosome. Using a marker-free counterselectable gene deletion procedure (rpsL counterselection method), a P12 mutant strain was finally obtained with no single T4SS (P12 Delta T4SS). Mating experiments using these mutants identified the comB T4SS in the recipient strain as the major mediator of plasmid DNA transfer between H. pylori strains, both in a DNaseI-sensitive (natural transformation) as well as a DNaseI-resistant manner (conjugative transfer). However, transfer of a pHel12::cat plasmid from a P12 Delta T4SS donor strain into a P12 Delta T4SS recipient strain provided evidence for the existence of a third, T4SS-independent mechanism of DNA transfer. This novel type of plasmid DNA transfer, designated as alternate DNaseI-Resistant (ADR) mechanism, is observed at a rather low frequency under in vitro conditions. Taken together, our study describes for the first time the existence of three distinct pathways of plasmid DNA transfer between H. pylori underscoring the importance of horizontal gene transfer for this species.	[Rohrer, Stefanie; Holsten, Lea; Weiss, Evelyn; Fischer, Wolfgang; Haas, Rainer] Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany; [Benghezal, Mohammed] Univ Western Australia, H Pylori Res Lab, Nedlands, WA 6009, Australia; [Benghezal, Mohammed] Ondek Pty Ltd, Nedlands, WA, Australia	University of Munich; University of Western Australia	Haas, R (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	haas@mvp.uni-muenchen.de		Benghezal, Mohammed/0000-0002-4207-0192	Deutsche Forschungsgemeinschaft [HA2697/10-1]; 30 ERA-NET PathoGenoMics 3 HELDIVPAT [0315905C]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 30 ERA-NET PathoGenoMics 3 HELDIVPAT	This work was supported by the Deutsche Forschungsgemeinschaft (HA2697/10-1) and by 30 ERA-NET PathoGenoMics 3 HELDIVPAT (0315905C) to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Backert S, 2005, MICROBIOL-SGM, V151, P3493, DOI 10.1099/mic.0.28250-0; BOYD AC, 1989, MOL GEN GENET, V217, P488; Castillo AR, 2008, INFECT IMMUN, V76, P5632, DOI 10.1128/IAI.00627-08; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; De Ungria MCA, 1999, PLASMID, V41, P97, DOI 10.1006/plas.1998.1383; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; HAAS R, 1993, MOL MICROBIOL, V8, P753, DOI 10.1111/j.1365-2958.1993.tb01618.x; Hofler C, 2004, INT J MED MICROBIOL, V294, P141, DOI 10.1016/j.ijmm.2004.06.021; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Hofreuter D, 2002, J BACTERIOL, V184, P2755, DOI 10.1128/JB.184.10.2755-2766.2002; Hofreuter D, 2001, MOL MICROBIOL, V41, P379, DOI 10.1046/j.1365-2958.2001.02502.x; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; KLEANTHOUS H, 1991, MOL MICROBIOL, V5, P2377, DOI 10.1111/j.1365-2958.1991.tb02084.x; Kuipers EJ, 1998, J BACTERIOL, V180, P2901, DOI 10.1128/JB.180.11.2901-2905.1998; Lin EA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000337; NEDENSKOVSORENSEN P, 1990, J INFECT DIS, V161, P365, DOI 10.1093/infdis/161.2.365; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; PANSEGRAU W, 1994, J BIOL CHEM, V269, P2782; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; PENFOLD SS, 1988, J INFECT DIS, V157, P850, DOI 10.1093/infdis/157.4.850; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMITT W, 1995, MOL GEN GENET, V248, P563, DOI 10.1007/BF02423452; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; SEGAL ED, 1993, BIOTECHNIQUES, V14, P225; Song JY, 2003, PLASMID, V50, P236, DOI 10.1016/S0147-619X(03)00061-1; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Varsaki A, 2003, MOL MICROBIOL, V48, P481, DOI 10.1046/j.1365-2958.2003.03441.x	40	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45623	10.1371/journal.pone.0045623	http://dx.doi.org/10.1371/journal.pone.0045623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029142	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900083
J	Chen, SJ; Yen, CH; Huang, YC; Lee, BJ; Hsia, S; Lin, PT				Chen, Shu-Ju; Yen, Chi-Hua; Huang, Yi-Chia; Lee, Bor-Jen; Hsia, Simon; Lin, Ping-Ting			Relationships between Inflammation, Adiponectin, and Oxidative Stress in Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; INTERLEUKIN-6; OBESITY; PREVALENCE; HYPERTENSION; ASSOCIATION; POPULATION; MARKERS	Metabolic syndrome (MS) represents a cluster of physiological and anthropometric abnormalities. The purpose of this study was to investigate the relationships between the levels of inflammation, adiponectin, and oxidative stress in subjects with MS. The inclusion criteria for MS, according to the Taiwan Bureau of Health Promotion, Department of Health, were applied to the case group (n = 72). The control group (n = 105) comprised healthy individuals with normal blood biochemical values. The levels of inflammatory markers [high sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6), adiponectin, an oxidative stress marker (malondialdehyde), and antioxidant enzymes activities [catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx)] were measured. Subjects with MS had significantly higher concentrations of inflammatory markers and lower adiponectin level, and lower antioxidant enzymes activities than the control subjects. The levels of inflammatory markers and adiponectin were significantly correlated with the components of MS. The level of hs-CRP was significantly correlated with the oxidative stress marker. The IL-6 level was significantly correlated with the SOD and GPx activities, and the adiponectin level was significantly correlated with the GPx activity. A higher level of hs-CRP (>= 1.00 mg/L), or IL-6 (>= 1.50 pg/mL) or a lower level of adiponectin (<7.90 mu g/mL) were associated with a significantly greater risk of MS. In conclusion, subjects suffering from MS may have a higher inflammation status and a higher level of oxidative stress. A higher inflammation status was significantly correlated with decreases in the levels of antioxidant enzymes and adiponectin and an increase in the risk of MS.	[Huang, Yi-Chia; Lee, Bor-Jen; Lin, Ping-Ting] Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan; [Chen, Shu-Ju] Chung Chou Univ Sci & Technol, Dept Hlth Food, Changhua, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yen, Chi-Hua] Chung Shan Med Univ, Ctr Educ & Res Geriatr & Gerontol, Taichung, Taiwan; [Huang, Yi-Chia; Lin, Ping-Ting] Chung Shan Med Univ Hosp, Dept Nutr, Taichung, Taiwan; [Lee, Bor-Jen] Taichung Vet Gen Hosp, Intens Care Unit, Taichung, Taiwan; [Hsia, Simon] HungKuang Univ, Dept Nutr, Taichung, Taiwan; [Hsia, Simon] HungKuang Univ, Inst Biomed Nutr, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taichung Veterans General Hospital; Hungkuang University; Hungkuang University	Lin, PT (corresponding author), Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan.	apt810@csmu.edu.tw	Huang, Yi-Chia/AAS-8877-2021; Stefanadis, Christodoulos/ABH-2232-2020	Huang, Yi-Chia/0000-0003-2234-4464; Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council of Taiwan [NSC 99-2320-B-040-011]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council (NSC 99-2320-B-040-011) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Antoniades C, 2003, HERZ, V28, P628, DOI 10.1007/s00059-003-2417-8; BATAILLE R, 1992, ARTHRITIS RHEUM-US, V35, P982, DOI 10.1002/art.1780350824; CERIELLO A, 1993, DIABETOLOGIA, V36, P265, DOI 10.1007/BF00399961; Choi KM, 2007, DIABETES RES CLIN PR, V75, P235, DOI 10.1016/j.diabres.2006.06.019; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Das UN, 2004, CURR HYPERTENS REP, V6, P66, DOI 10.1007/s11906-004-0014-8; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ford ES, 2003, DIABETES CARE, V26, P575, DOI 10.2337/diacare.26.3.575; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Giugliano D, 2000, NUTR METAB CARDIOVAS, V10, P38; GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Karaouzene N, 2011, NUTR METAB CARDIOVAS, V21, P792, DOI 10.1016/j.numecd.2010.02.007; Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1; Lapenna D, 2001, FREE RADICAL BIO MED, V31, P331, DOI 10.1016/S0891-5849(01)00584-6; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x; Yeh CJ, 2011, ASIA PAC J CLIN NUTR, V20, P292	30	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45693	10.1371/journal.pone.0045693	http://dx.doi.org/10.1371/journal.pone.0045693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029185	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388400121
J	Zhang, D; Cui, JG; Tang, YZ				Zhang, Dian; Cui, Jianguo; Tang, Yezhong			Plasticity of Peripheral Auditory Frequency Sensitivity in Emei Music Frog	PLOS ONE			English	Article							BRAIN-STEM RESPONSES; SONG CONTROL-SYSTEM; SEASONAL PLASTICITY; ADVERTISEMENT CALLS; GROUND-SQUIRRELS; LEOPARD FROG; MIDDLE-EAR; SONGBIRDS; ANDROGEN; NUCLEI	In anurans reproductive behavior is strongly seasonal. During the spring, frogs emerge from hibernation and males vocalize for mating or advertising territories. Female frogs have the ability to evaluate the quality of the males' resources on the basis of these vocalizations. Although studies revealed that central single torus semicircularis neurons in frogs exhibit season plasticity, the plasticity of peripheral auditory sensitivity in frog is unknown. In this study the seasonally plasticity of peripheral auditory sensitivity was test in the Emei music frog Babina daunchina, by comparing thresholds and latencies of auditory brainstem responses (ABRs) evoked by tone pips and clicks in the reproductive and non-reproductive seasons. The results show that both ABR thresholds and latency differ significantly between the reproductive and non-reproductive seasons. The thresholds of tone pip evoked ABRs in the non-reproductive season increased significantly about 10 dB than those in the reproductive season for frequencies from 1 KHz to 6 KHz. ABR latencies to waveform valley values for tone pips for the same frequencies using appropriate threshold stimulus levels are longer than those in the reproductive season for frequencies from 1.5 to 6 KHz range, although from 0.2 to 1.5 KHz range it is shorter in the non-reproductive season. These results demonstrated that peripheral auditory frequency sensitivity exhibits seasonal plasticity changes which may be adaptive to seasonal reproductive behavior in frogs.	[Zhang, Dian] Univ Elect Sci & Technol China, Sch Automat Engn, Chengdu 610054, Sichuan, Peoples R China; [Zhang, Dian; Cui, Jianguo; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Cui, JG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	cuijg@cib.ac.cn; Tangyz@cib.ac.cn			National Natural Science Foundation of China [30900141]; Chinese Academy of Sciences [KSCX2-EW-J-22]; Youth Innovation Promotion Association of Chinese Academy of Sciences [Y2C3011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of Chinese Academy of Sciences	This work was supported by the National Natural Science Foundation of China (30900141), the Chinese Academy of Sciences (KSCX2-EW-J-22) and Youth Innovation Promotion Association of Chinese Academy of Sciences (Y2C3011) to Jianguo Cui. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball GF, 1999, DESIGN OF ANIMAL COMMUNICATION, P213; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Brenowitz EA, 2004, ANN NY ACAD SCI, V1016, P560, DOI 10.1196/annals.1298.006; Brittan-Powell EF, 2010, J ACOUST SOC AM, V128, P787, DOI 10.1121/1.3458813; Buck CL, 2003, HORM BEHAV, V43, P318, DOI 10.1016/S0018-506X(02)00050-8; Chen Q, 2011, J HERPETOL, V45, P406; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; Chu J, 2002, NEUROENDOCRINOLOGY, V76, P18, DOI 10.1159/000063680; Cui JG, 2012, BIOL LETTERS, V8, P337, DOI 10.1098/rsbl.2011.1091; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Freeberg TM, 2007, INFORM CHICK A DEE C, P199; Goense JBM, 2005, J NEUROBIOL, V65, P22, DOI 10.1002/neu.20172; HAMILL NJ, 1989, J COMP PHYSIOL B, V159, P159, DOI 10.1007/BF00691736; Katbamna B, 2006, J COMP PHYSIOL A, V192, P381, DOI 10.1007/s00359-005-0076-3; Lucas JR, 2007, J COMP PHYSIOL A, V193, P201, DOI 10.1007/s00359-006-0180-z; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; Nottebohm F, 1999, DESIGN OF ANIMAL COMMUNICATION, P63; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; RYAN MJ, 1995, SCIENCE, V269, P390, DOI 10.1126/science.269.5222.390; SCHWARTZ JJ, 1989, J COMP PHYSIOL A, V166, P37; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Smith GT, 1997, J NEUROSCI, V17, P6001; Smith GT, 1996, BRAIN RES, V734, P79, DOI 10.1016/S0006-8993(96)00613-0; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Tramontin AD, 2000, TRENDS NEUROSCI, V23, P251, DOI 10.1016/S0166-2236(00)01558-7; Wilczynski W, 2003, J NEUROBIOL, V56, P54, DOI 10.1002/neu.10228; Wollerman L, 1999, ANIM BEHAV, V57, P529, DOI 10.1006/anbe.1998.1013	28	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45792	10.1371/journal.pone.0045792	http://dx.doi.org/10.1371/journal.pone.0045792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029243	Green Submitted, Green Published, gold			2022-12-25	WOS:000311313900169
J	Graziano, V; Mcgrath, WJ; Suomalainen, M; Greber, UF; Freimuth, P; Blainey, PC; Luo, GB; Xie, XS; Mangel, WF				Graziano, Vito; Mcgrath, William J.; Suomalainen, Maarit; Greber, Urs F.; Freimuth, Paul; Blainey, Paul C.; Luo, Guobin; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space I. BINDING TO DNA AND TO HEXON OF THE PRECURSOR TO PROTEIN VI, pVI, OF HUMAN ADENOVIRUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; RESOLUTION; ENTRY; LOCALIZATION; DISRUPTION; TRANSPORT; COFACTORS; TERMINUS; RECEPTOR; COMPLEX	The precursor to adenovirus protein VI, pVI, is a multifunctional protein with different roles early and late in virus infection. Here, we focus on two roles late in infection, binding of pVI to DNA and to the major capsid protein hexon. pVI bound to DNA as a monomer independent of DNA sequence with an apparent equilibrium dissociation constant, K-d(app), of 46 nM. Bound to double-stranded DNA, one molecule of pVI occluded 8 bp. Upon the binding of pVI to DNA, three sodium ions were displaced from the DNA. A Delta G(0)(0) of -4.54 kcal/mol for the nonelectrostatic free energy of binding indicated that a substantial component of the binding free energy resulted from nonspecific interactions between pVI and DNA. The proteolytically processed, mature form of pVI, protein VI, also bound to DNA; its K-d(app) was much higher, 307 nM. The binding assays were performed in 1 mM MgCl2 because in the absence of magnesium, the binding to pVI or protein VI to DNA was too tight to determine a K-d(app). Three molecules of pVI bound to one molecule of the hexon trimer with an equilibrium dissociation constant K-d(app) of 1.1 nM.	[Graziano, Vito; Mcgrath, William J.; Freimuth, Paul; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Suomalainen, Maarit; Greber, Urs F.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Blainey, Paul C.; Luo, Guobin; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; University of Zurich; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	Greber, Urs F/G-9458-2015	Greber, Urs F/0000-0003-2278-120X; McGrath, William/0000-0002-9375-624X; Blainey, Paul/0000-0002-4889-8783	National Institutes of Health; National Science Foundation; National Institutes of Health [R01AI41599]; Swiss National Science Foundation [31003A_125477/1]; Kanton Zurich; Brookhaven National Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Zurich; Brookhaven National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by the National Institutes of Health Director's Pioneer Award and the National Science Foundation (to X. S. X.) and National Institutes of Health R01AI41599 Grant (to W. F. M.). This work was also supported by the Swiss National Science Foundation (Grant 31003A_125477/1) and the Kanton Zurich (to U. F. G.) and by a Laboratory Directed Research and Development grant from Brookhaven National Laboratory (to P. C. F.).	AKUSJARVI G, 1984, J BIOL CHEM, V259, P3976; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Blainey PC, 2013, J BIOL CHEM, V288, P2092, DOI 10.1074/jbc.M112.407460; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Honkavuori KS, 2004, J GEN VIROL, V85, P3367, DOI 10.1099/vir.0.80203-0; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; MATTHEWS DA, 1995, J GEN VIROL, V76, P1959, DOI 10.1099/0022-1317-76-8-1959; MATTHEWS DA, 1994, J GEN VIROL, V75, P3365, DOI 10.1099/0022-1317-75-12-3365; McGrath WJ, 1996, VIROLOGY, V217, P131, DOI 10.1006/viro.1996.0100; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Moyer CL, 2011, J VIROL, V85, P2631, DOI 10.1128/JVI.02321-10; Philipson L, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P1; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Rux John J, 2007, Methods Mol Med, V131, P231; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; San Martin C, 2008, J MOL BIOL, V383, P923, DOI 10.1016/j.jmb.2008.08.054; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808	42	12	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2059	2067		10.1074/jbc.M112.377150	http://dx.doi.org/10.1074/jbc.M112.377150			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043136	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000313751400057
J	Choi, YJ; Jung, J; Chung, HK; Im, E; Rhee, SH				Choi, Yoon Jeong; Jung, Jane; Chung, Hyo Kyun; Im, Eunok; Rhee, Sang Hoon			PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment	FASEB JOURNAL			English	Article						flagellin; inflammatory bowel disease; interleukin 10; epithelial cells	DOMAIN-CONTAINING ADAPTER; TOLL-LIKE RECEPTOR-4; BACTERIAL FLAGELLIN; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; GENE-EXPRESSION; CUTTING EDGE; ACTIVATION; TLR5; IMMUNITY; CELLS	Defective IL-10 allele is a risk factor for intestinal inflammation. Indeed, IL-10(-/-) mice are predisposed to spontaneous colitis in the presence of intestinal microbiota, indicating that microbial factors contribute to developing intestinal inflammation. By recognizing flagellin, TLR5 plays a quintessential role in microbial recognition in intestinal epithelial cells. Here, we treated flagellin (1.0 mu g/mouse/d) in mouse colon and found that it elicited colonic inflammation in IL-10(-/-) mice, characterized with tissue hypertrophy, inflamed epithelium, and enhanced cytokine production in the colon (MPO, KC, IL-6; >= 2-fold; P < 0.05). These inflammatory effects were dramatically inhibited in TLR5(-/-); IL-10(-/-) mice. Intestinal epithelium specific PTEN deletion significantly attenuated flagellin-promoted colonic inflammation in IL-10(-/-) mice. As a molecular mechanism that PTEN deletion inhibited TLR5-elicited responses, we hypothesized that PTEN regulated TLR5-induced responses by controlling the involvement of Mal in TLR5 engagement. Mal interacted with TLR5 on flagellin, and Mal deficiency inhibited flagellin-induced responses in intestinal epithelial cells. Similarly, Mal(-/-); IL-10(-/-) mice showed reduced flagellin-promoted responses. Furthermore, PTEN deletion disrupted Mal-TLR5 interaction, resulting in diminished TLR5-induced responses. PTEN deletion impeded Mal localization at the plasma membrane and suppressed Mal-TLR5 interaction. These results suggest that, by controlling Mal recruitment, PTEN regulates TLR5-induced inflammatory responses.-Choi, Y. J., Jung, J., Chung, H. K., Im, E., Rhee, S. H. PTEN regulates TLR5-induced intestinal inflammation by controlling Mal/TIRAP recruitment. FASEB J. 27, 243-254 (2013). www.fasebj.org	[Choi, Yoon Jeong; Jung, Jane; Chung, Hyo Kyun; Rhee, Sang Hoon] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Im, Eunok] Pusan Natl Univ, Sch Pharm, Pusan, South Korea	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pusan National University	Rhee, SH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, MRL1240,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shrhee@mednet.ucla.edu	Lee, Kee-Joon/AAA-4090-2022		U.S. National Institutes of Health [DK079015]; National Research Foundation (NRF) of Korea; Ministry of Education, Science and Technology [2012R1A1A1042566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079015] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Ruslan M. Medzhitov (Yale University, New Haven, CT, USA) for Mal (TIRAP)<SUP>-/-</SUP> mice, Dr. Vivek M. Rangnekar (University of Kentucky, Lexington, KY, USA) for PTEN-GFP construct, and Dr. Hong Wu (University of California-Los Angeles, Los Angeles, CA, USA) for MEF-PTEN<SUP>-/-</SUP> and MEF-PTEN<SUP>+/+</SUP> cells. This work was supported by the U.S. National Institutes of Health (DK079015, S. H. R.) and by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Education, Science and Technology (2012R1A1A1042566; E. I.). The authors declare no conflicts of interest.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carvalho FA, 2008, INFLAMM BOWEL DIS, V14, P1051, DOI 10.1002/ibd.20423; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; Choi YJ, 2010, J BIOL CHEM, V285, P21382, DOI 10.1074/jbc.M110.115022; CROHN BB, 1958, JAMA-J AM MED ASSOC, V166, P1479, DOI 10.1001/jama.1958.62990120019013; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hakelien AM, 2002, NAT BIOTECHNOL, V20, P460, DOI 10.1038/nbt0502-460; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Im E, 2009, J NUTR, V139, P1848, DOI 10.3945/jn.109.108613; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Letran SE, 2011, J IMMUNOL, V186, P5406, DOI 10.4049/jimmunol.1003576; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Miao EA, 2007, SEMIN IMMUNOPATHOL, V29, P275, DOI 10.1007/s00281-007-0078-z; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	45	27	28	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					243	254		10.1096/fj.12-217596	http://dx.doi.org/10.1096/fj.12-217596			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038756	Green Published			2022-12-25	WOS:000313103200023
J	Kim, M; Kim, S; Lim, JH; Lee, C; Choi, HC; Woo, CH				Kim, Miso; Kim, Suji; Lim, Jae Hyang; Lee, ChuHee; Choi, Hyoung Chul; Woo, Chang-Hoon			Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-5; NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; ANTIOXIDANT RESPONSE; GENE-EXPRESSION; CELLS; ATHEROSCLEROSIS; PHOSPHORYLATION; TRANSCRIPTION; INDUCTION	Atherosclerosis is often observed in areas where disturbed flow is formed, whereas atheroprotective region is found in areas where steady laminar flow is developed. It has been reported that some genes activated by blood flow play important roles in vascular function and pathogenesis of atherosclerosis. Extracellular signal-regulated kinase 5 (ERK5) has been reported to regulate endothelial integrity and protect from vascular dysfunction and disease under laminar flow. Kruppel-like factor 2 (KLF2) and NF-E2-related factor 2 (Nrf2) are major transcriptional factors that contribute to anti-atherogenic responses under laminar flow. Implication of ERK5 in laminar flow-mediated regulation of KLF2-dependent gene has been established, whereas the role of ERK5 in laminar flow-mediated activation of Nrf2 pathway has not been addressed yet. In this study, we found that the blockage of ERK5 either by genetic depletion with siRNA or by biochemical inactivation with a specific chemical compound inhibited laminar flow-induced up-regulation of Nrf2-dependent gene expressions, whereas activation of ERK5 increased transcriptional activity and nuclear translocation of Nrf2, which suggests that ERK5 mediates laminar flow-induced up-regulation of Nrf2-dependent gene expression. Further functional studies showed that ERK5 provides protection against oxidative stress-induced cytotoxicity dependent on Nrf2. Molecular interaction between ERK5 and Nrf2 was further induced by laminar flow. Finally, flow-dependent nuclear localization of Nrf2 was inhibited by BIX02189, a specific inhibitor of MEK5, in aorta of mice in vivo. Collectively, these data demonstrate that laminar flow-induced activation of ERK5-Nrf2 signal pathway plays a critical role for anti-inflammatory and anti-apoptotic mechanism in endothelial cells.	[Kim, Miso; Kim, Suji; Choi, Hyoung Chul; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Dept Pharmacol, Taegu 705717, South Korea; [Lee, ChuHee] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, Taegu 705717, South Korea; [Kim, Miso; Kim, Suji; Choi, Hyoung Chul; Woo, Chang-Hoon] Yeungnam Univ, Coll Med, Aging Associated Vasc Dis Res Ctr, Taegu 705717, South Korea; [Lim, Jae Hyang] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul 158710, South Korea	Yeungnam University; Yeungnam University; Yeungnam University; Ewha Womans University	Woo, CH (corresponding author), Yeungnam Univ, Coll Med, Dept Pharmacol, 317-1 Daemyung Dong, Taegu 705717, South Korea.	changhoon_woo@yu.ac.kr		Lim, Jae Hyang/0000-0003-0972-9271	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korea government [2011-0006184, 2011-0026075]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111345]	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korea government(Korean Government); Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korea government (Grants 2011-0006184 and 2011-0026075) and a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (Grant A111345).	Akaike M, 2004, MOL CELL BIOL, V24, P8691, DOI 10.1128/MCB.24.19.8691-8704.2004; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Cao Y, 2012, J BIOL CHEM, V287, P3029; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Clark PR, 2011, MICROCIRCULATION, V18, P102, DOI 10.1111/j.1549-8719.2010.00071.x; Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Fleming I, 1998, CIRC RES, V82, P686, DOI 10.1161/01.RES.82.6.686; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Lee HH, 2010, ARCH BIOCHEM BIOPHYS, V501, P142, DOI 10.1016/j.abb.2010.06.011; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Nigro P, 2010, BLOOD, V116, P1971, DOI 10.1182/blood-2010-02-269134; Ohnesorge N, 2010, J BIOL CHEM, V285, P26199, DOI 10.1074/jbc.M110.103127; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Takabe W, 2011, ANTIOXID REDOX SIGN, V15, P1379, DOI 10.1089/ars.2010.3645; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Warabi E, 2004, FREE RADICAL BIO MED, V37, P682, DOI 10.1016/j.freeradbiomed.2004.05.020; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Woo CH, 2008, CIRC RES, V102, P538, DOI 10.1161/CIRCRESAHA.107.156877; Woo CH, 2006, J BIOL CHEM, V281, P32164, DOI 10.1074/jbc.M602369200; Yan C, 2001, J BIOL CHEM, V276, P10870, DOI 10.1074/jbc.M009286200; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Young A, 2009, ARTERIOSCL THROM VAS, V29, P1902, DOI 10.1161/ATVBAHA.109.193540; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375	36	51	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40722	40731		10.1074/jbc.M112.381509	http://dx.doi.org/10.1074/jbc.M112.381509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043106	Green Published, hybrid			2022-12-25	WOS:000311448800061
J	Shi, GX; Cai, WK; Andres, DA				Shi, Geng-Xian; Cai, Weikang; Andres, Douglas A.			Rit-mediated Stress Resistance Involves a p38-Mitogen- and Stress-activated Protein Kinase 1 (MSK1)-dependent cAMP Response Element-binding Protein (CREB) Activation Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; P38 MAPK; DEPENDENT TRANSCRIPTION; GENE-TRANSCRIPTION; CELL-DEATH; PHOSPHORYLATION; PATHWAY; SURVIVAL; FAMILY; CONTRIBUTES	The cAMP response element (CRE)-binding protein (CREB) is a key regulatory factor of gene transcription, and plays an essential role in development of the central nervous system and for neuroprotection. Multiple signaling pathways have been shown to contribute to the regulation of CREB-dependent transcription, including both ERK and p38 mitogen-activated protein (MAP) kinases cascades. Recent studies have identified the Ras-related small G-protein, Rit, as a central regulator of a p38-MK2-HSP27 signaling cascade that functions as a critical survival mechanism for cells adapting to stress. Here, we examine the contribution of Rit-p38 signaling to the control of stress-dependent gene transcription. Using a pheochromocytoma cell model, we find that a novel Rit-p38-MSK1/2 pathway plays a critical role in stress-mediated CREB activation. RNAi-mediated Rit silencing, or inhibition of p38 or MSK1/2 kinases, was found to disrupt stress-mediated CREB-dependent transcription, resulting in increased cell death. Furthermore, ectopic expression of active Rit stimulates CREB-Ser133 phosphorylation, induces expression of the anti-apoptotic Bcl-2 and Bcl(XL) proteins, and promotes cell survival. These data indicate that the Rit-p38-MSK1/2 signaling pathway may have an important role in the stress-dependent regulation of CREB-dependent gene expression.	[Shi, Geng-Xian; Cai, Weikang; Andres, Douglas A.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Shi, GX (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, BBSRB Rm B136,741 S Limestone St, Lexington, KY 40536 USA.	gshi2@uky.edu; dandres@uky.edu	Cai, Weikang/K-2394-2019; Shi, Geng-Xian/AAK-6061-2021	Cai, Weikang/0000-0001-5638-0805	United States Public Health Service Grant from the National Institute of Neurological Disorders and Stroke [NS045103]; National Institutes of Health Grant from the National Institute of General Medical Sciences [P20GM103486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS045103, R01NS045103] Funding Source: NIH RePORTER	United States Public Health Service Grant from the National Institute of Neurological Disorders and Stroke; National Institutes of Health Grant from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the United States Public Health Service Grant NS045103 (to D. A. A.) from the National Institute of Neurological Disorders and Stroke and in part by National Institutes of Health Grant P20GM103486 from the National Institute of General Medical Sciences.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andres DA, 2008, J NEUROCHEM, V107, P1436, DOI 10.1111/j.1471-4159.2008.05708.x; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cai WK, 2011, MOL BIOL CELL, V22, P3231, DOI 10.1091/mbc.E11-05-0400; Caivano M, 2000, J IMMUNOL, V164, P3018, DOI 10.4049/jimmunol.164.6.3018; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Lein PJ, 2007, J NEUROSCI, V27, P4725, DOI 10.1523/JNEUROSCI.5633-06.2007; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Ronkina N, 2011, NUCLEIC ACIDS RES, V39, P2503, DOI 10.1093/nar/gkq1178; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2011, MOL CELL BIOL, V31, P1938, DOI 10.1128/MCB.01380-10; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Spencer ML, 2002, J BIOL CHEM, V277, P20160, DOI 10.1074/jbc.M201092200; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Walton M, 1999, J NEUROCHEM, V73, P1836; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386	48	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.384248	http://dx.doi.org/10.1074/jbc.M112.384248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038261	Green Published, hybrid			2022-12-25	WOS:000311233800054
J	Yu, SN; Maillard, RA; Gribenko, AV; Lee, JC				Yu, Shaoning; Maillard, Rodrigo A.; Gribenko, Alexey V.; Lee, J. Ching			The N-terminal Capping Propensities of the D-helix Modulate the Allosteric Activation of the Escherichia coli cAMP Receptor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DNA COMPLEX; SINGLE-SITE MUTATIONS; CYCLIC-AMP; HINGE REORIENTATION; ANGSTROM RESOLUTION; GLOBULAR-PROTEINS; LIGAND-BINDING; AMINO-ACID; M-VALUES; NUCLEOTIDE	Transduction of biological signals at the molecular level involves the activation and/or inhibition of allosteric proteins. In the transcription factor cAMP receptor protein (CRP) from Escherichia coli, the allosteric activation, or apo-holo transition, involves rigid body motions of domains and structural rearrangements within the hinge region connecting the cAMP- and DNA-binding domains. During this apo-holo transition, residue 138 is converted as part of the elongated D-helix to the position of the N-terminal capping residue of a shorter D-helix. The goal of the current study is to elucidate the role of residue 138 in modulating the allostery between cAMP and DNA binding. By systematically mutating residue 138, we found that mutants with higher N-terminal capping propensities lead to increased cooperativity of cAMP binding and a concomitant increase in affinity for lac-DNA. Furthermore, mutants with higher N-terminal capping propensity correlate with properties characteristic of holo-CRP, particularly, increase in protein structural dynamics. Overall, our results provide a quantitative characterization of the role of residue 138 in the isomerization equilibrium between the apo and holo forms of CRP, and in turn the thermodynamic underpin to the molecular model of allostery revealed by the high resolution structural studies.	[Yu, Shaoning; Maillard, Rodrigo A.; Gribenko, Alexey V.; Lee, J. Ching] Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Lee, JC (corresponding author), Univ Texas Med Branch Galveston, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	jclee@utmb.edu		Gribenko, Alexey/0000-0002-4285-4608	National Institutes of Health [GM-77551]; Robert A. Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-77551. This work was also supported by the Robert A. Welch Foundation.	Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Auton M, 2004, BIOCHEMISTRY-US, V43, P1329, DOI 10.1021/bi035908r; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; Auton M, 2007, P NATL ACAD SCI USA, V104, P15317, DOI 10.1073/pnas.0706251104; Barksdale A D, 1982, Methods Biochem Anal, V28, P1, DOI 10.1002/9780470110485.ch1; Baskakov IV, 1998, BIOCHEMISTRY-US, V37, P18010, DOI 10.1021/bi981849j; Chen SF, 2001, J MOL BIOL, V314, P75, DOI 10.1006/jmbi.2001.5090; Cheng XD, 1998, J BIOL CHEM, V273, P705, DOI 10.1074/jbc.273.2.705; Cheng XD, 1998, BIOCHEMISTRY-US, V37, P51, DOI 10.1021/bi9719455; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; CHENG XD, 1994, J BIOL CHEM, V269, P30781; DONG AC, 1994, METHOD ENZYMOL, V232, P139; Dong AC, 2002, BIOCHEMISTRY-US, V41, P6660, DOI 10.1021/bi020036z; EILEN E, 1977, J MOL BIOL, V114, P47, DOI 10.1016/0022-2836(77)90282-0; Gekko K, 2004, BIOCHEMISTRY-US, V43, P3844, DOI 10.1021/bi036271e; HEYDUK E, 1992, BIOCHEMISTRY-US, V31, P3682, DOI 10.1021/bi00129a017; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HEYDUK T, 1989, BIOCHEMISTRY-US, V28, P6914, DOI 10.1021/bi00443a021; KIM J, 1992, P NATL ACAD SCI USA, V89, P9700, DOI 10.1073/pnas.89.20.9700; Kumar S, 1998, PROTEINS, V31, P460, DOI 10.1002/(SICI)1097-0134(19980601)31:4<460::AID-PROT12>3.0.CO;2-D; Lin SH, 2002, BIOCHEMISTRY-US, V41, P14935, DOI 10.1021/bi026756n; Lin SH, 2002, BIOCHEMISTRY-US, V41, P11857, DOI 10.1021/bi026099z; Lin SH, 2002, BIOCHEMISTRY-US, V41, P2946, DOI 10.1021/bi0119215; MCKAY DB, 1982, J BIOL CHEM, V257, P9518; O'Brien EP, 2009, BIOCHEMISTRY-US, V48, P3743, DOI 10.1021/bi8021119; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; SIXL F, 1990, BIOCHEM J, V266, P545, DOI 10.1042/bj2660545; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; WEBER IT, 1987, J MOL BIOL, V198, P311, DOI 10.1016/0022-2836(87)90315-9; WU CW, 1974, BIOCHEMISTRY-US, V13, P2573, DOI 10.1021/bi00709a016; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166	38	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.404806	http://dx.doi.org/10.1074/jbc.M112.404806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035121	Green Published, hybrid			2022-12-25	WOS:000311233800012
J	Bshary, A; Bshary, R				Bshary, Andrea; Bshary, Redouan			Individual Differences in Foraging Strategies of Parasitic Sabre-Tooth Blennies	PLOS ONE			English	Article							VOLUNTEERS DILEMMA; BEHAVIORAL SYNDROMES; FLOWER CONSTANCY; NATIONAL-PARK; COOPERATION; PUNISHMENT; EVOLUTION; FREQUENCY; SPECIALIZATION; BENEFITS	Originally, evolutionary game theory typically predicted that optimal behaviour in a given situation is uniform or bimodal. However, the growing evidence that animals behave more variably while individuals may differ consistently in their behaviour, has led to the development of models that predict a distribution of strategies. Here we support the importance of such models in a study on a coral reef fish host-parasite system. Parasitic blennies (Plagiotremus sp.) regularly attack other fishes to bite off scales and mucus. Individuals of some victim species react to being bitten with punishing the parasite through aggressive chasing. Our field observations and laboratory experiments show that individual blennies differ markedly in how they incorporate being punished into their foraging decisions. We discuss how these differences may affect the payoff structure and hence the net effect of punishment on punishers and on the appearance of a public good for look-alikes.	[Bshary, Andrea; Bshary, Redouan] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of Neuchatel	Bshary, A (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	andrea.bshary@unine.ch		Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council fellowship [NER/A/S/2002/00898]; Swiss Science Foundation [3100A0-120552/1]; Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was financed by grant number NER/A/S/2002/00898 by the Natural Environment Research Council fellowship (http://www.nerc.ac.uk/) to Rufus Johnstone and R.B. and grant number 3100A0-120552/1 by the Swiss Science Foundation (http://www.snf.ch/E/Pages/default.aspx) to R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, J EVOLUTION BIOL, V22, P2192, DOI 10.1111/j.1420-9101.2009.01835.x; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2011, EVOLUTION, V65, P885, DOI 10.1111/j.1558-5646.2010.01176.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; AVISE JC, 1986, EVOLUTION, V40, P1051, DOI 10.1111/j.1558-5646.1986.tb00572.x; Bergmuller R, 2010, PHILOS T R SOC B, V365, P2751, DOI 10.1098/rstb.2010.0124; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bshary A, 2010, CURR BIOL, V20, P2032, DOI 10.1016/j.cub.2010.10.027; Bshary A, 2010, ETHOLOGY, V116, P681, DOI 10.1111/j.1439-0310.2010.01781.x; Bshary R, 2003, J ANIM ECOL, V72, P169, DOI 10.1046/j.1365-2656.2003.00683.x; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Cisarovsky G, 2012, ETHOLOGY, V118, P850, DOI 10.1111/j.1439-0310.2012.02075.x; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Darlington RB, 2008, SIGN TEST TABLE; Davies NB, 2012, INTRO BEHAV ECOLOGY; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Gigerenzer G., 2002, BOUNDED RATIONALITY; Hamblin S, 2009, ANIM BEHAV, V78, P1343, DOI 10.1016/j.anbehav.2009.09.001; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; HOPPEDOMINIK B, 1984, MAMMALIA, V48, P477, DOI 10.1515/mamm.1984.48.4.477; HORI M, 1993, SCIENCE, V260, P216, DOI 10.1126/science.260.5105.216; Ishii Y, 2010, POPUL ECOL, V52, P27, DOI 10.1007/s10144-009-0185-x; Johnson ML, 2006, MAR BIOL, V148, P889, DOI 10.1007/s00227-005-0118-y; KREBS JR, 1978, NATURE, V275, P27, DOI 10.1038/275027a0; Maynard Smith J., 1982, pi; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; NSHOMBO M, 1994, ENVIRON BIOL FISH, V39, P59, DOI 10.1007/BF00004757; OLLASON JG, 1980, THEOR POPUL BIOL, V18, P44, DOI 10.1016/0040-5809(80)90039-8; Preacher KJ, 2001, CALCULATION CHI SQUA; Raihani NJ, 2011, EVOLUTION, V65, P2725, DOI 10.1111/j.1558-5646.2011.01383.x; Rana JS, 2002, J ANIM ECOL, V71, P15, DOI 10.1046/j.0021-8790.2001.00574.x; Schindler DE, 1997, OECOLOGIA, V110, P592, DOI 10.1007/s004420050200; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; Sherratt TN, 2009, FRONT BIOSCI-LANDMRK, V14, P4557, DOI 10.2741/3548; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith-Vaniz W.F., 1976, MONOGRAPH ACAD NATUR, V19, p[i, 1]; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2011, P ROY SOC B-BIOL SCI, V278, P440, DOI 10.1098/rspb.2010.1051	47	1	1	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45998	10.1371/journal.pone.0045998	http://dx.doi.org/10.1371/journal.pone.0045998			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029356	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900071
J	Silva, MA; Lucas, TG; Salgueiro, CA; Gomes, CM				Silva, Marta A.; Lucas, Tania G.; Salgueiro, Carlos A.; Gomes, Claudio M.			Protein Folding Modulates the Swapped Dimerization Mechanism of Methyl-Accepting Chemotaxis Heme Sensors	PLOS ONE			English	Article							C-TYPE HEME; SIGNAL-TRANSDUCTION; GEOBACTER-SULFURREDUCENS; BIOPHYSICAL PROPERTIES; BACTERIAL CHEMOTAXIS; STABILITY; DOMAIN; LACTOPEROXIDASE; FERREDOXIN; PLASTICITY	The periplasmic sensor domains GSU0582 and GSU0935 are part of methyl accepting chemotaxis proteins in the bacterium Geobacter sulfurreducens. Both contain one c-type heme group and their crystal structures revealed that these domains form swapped dimers with a PAS fold formed from the two protein chains. The swapped dimerization of these sensors is related to the mechanism of signal transduction and the formation of the swapped dimer involves significant folding changes and conformational rearrangements within each monomeric component. However, the structural changes occurring during this process are poorly understood and lack a mechanistic framework. To address this issue, we have studied the folding and stability properties of two distinct heme-sensor PAS domains, using biophysical spectroscopies. We observed substantial differences in the thermodynamic stability (Delta G = 14.6 kJ. mol(-1) for GSU0935 and Delta G = 26.3 kJ. mol(-1) for GSU0582), and demonstrated that the heme moiety undergoes conformational changes that match those occurring at the global protein structure. This indicates that sensing by the heme cofactor induces conformational changes that rapidly propagate to the protein structure, an effect which is directly linked to the signal transduction mechanism. Interestingly, the two analyzed proteins have distinct levels of intrinsic disorder (25% for GSU0935 and 13% for GSU0582), which correlate with conformational stability differences. This provides evidence that the sensing threshold and intensity of the propagated allosteric effect is linked to the stability of the PAS-fold, as this property modulates domain swapping and dimerization. Analysis of the PAS-domain shows that disorder segments are found either at the hinge region that controls helix motions or in connecting segments of the beta-sheet interface. The latter is known to be widely involved in both intra-and intermolecular interactions, supporting the view that it's folding and stability are at the basis of the specificity and regulation of many types of PAS-containing signaling proteins.	[Lucas, Tania G.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Silva, Marta A.; Salgueiro, Carlos A.] UNL, FCT, Dept Quim, CQFB, Caparica, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	gomes@itqb.unl.pt	Silva, Marta A./P-2221-2019; Gomes, Cláudio M./A-8152-2008; Lucas, Tânia/B-6144-2018; Salgueiro, Carlos/A-4522-2013	Silva, Marta A./0000-0002-4994-5473; Gomes, Cláudio M./0000-0003-4662-6933; Lucas, Tânia/0000-0002-3967-6476; Salgueiro, Carlos/0000-0003-1136-809X	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PEst-OE/EQB/LA0004/2011, SFRH/BD/61952/2009];  [PTDC/BIA-PRO/74498/2006];  [PTDC/QUI/70101/2006]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); ; 	This work was supported by project grants PTDC/BIA-PRO/74498/2006 (to CAS), PTDC/QUI/70101/2006 (to CMG) and by the strategic grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado) from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). MAS acknowledges Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) for the doctoral grant SFRH/BD/61952/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 2003, ACCOUNTS CHEM RES, V36, P825, DOI 10.1021/ar020097p; Boscolo B, 2007, BBA-PROTEINS PROTEOM, V1774, P1164, DOI 10.1016/j.bbapap.2007.07.003; Boscolo B, 2009, BBA-PROTEINS PROTEOM, V1794, P1041, DOI 10.1016/j.bbapap.2009.03.003; Brunori M, 2003, BIOPHYS CHEM, V100, P409, DOI 10.1016/S0301-4622(02)00295-8; Catarino T, 2010, J PHYS CHEM B, V114, P11251, DOI 10.1021/jp1029882; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Ferguson PL, 2002, BIOCHEMISTRY-US, V41, P3637, DOI 10.1021/bi0118052; FU RD, 1994, J BACTERIOL, V176, P344, DOI 10.1128/JB.176.2.344-350.1994; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gomes CM, 1998, J BIOL INORG CHEM, V3, P499, DOI 10.1007/s007750050260; GRANT SK, 1992, BIOCHEMISTRY-US, V31, P9491, DOI 10.1021/bi00154a023; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Leal SS, 2004, J BIOL INORG CHEM, V9, P987, DOI 10.1007/s00775-004-0599-z; Leal SS., 2010, PROTEIN FOLDING META, P81; Londer YY, 2006, FEMS MICROBIOL LETT, V258, P173, DOI 10.1111/j.1574-6968.2006.00220.x; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pace C N, 1986, Methods Enzymol, V131, P266; Pfeil W, 1997, J MOL BIOL, V272, P591, DOI 10.1006/jmbi.1997.1278; Pokkuluri PR, 2008, J MOL BIOL, V377, P1498, DOI 10.1016/j.jmb.2008.01.087; Roberts GP, 2001, PROG NUCLEIC ACID RE, V67, P35, DOI 10.1016/S0079-6603(01)67024-7; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tompa P., 2010, STRUCTURE FUNCTION I; Tsaprailis G, 1998, BIOCHEMISTRY-US, V37, P2004, DOI 10.1021/bi971032a; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352	32	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46328	10.1371/journal.pone.0046328	http://dx.doi.org/10.1371/journal.pone.0046328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029480	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900135
J	Vimont, S; Boyd, A; Bleibtreu, A; Bens, M; Goujon, JM; Garry, L; Clermont, O; Denamur, E; Arlet, G; Vandewalle, A				Vimont, Sophie; Boyd, Anders; Bleibtreu, Alexandre; Bens, Marcelle; Goujon, Jean-Michel; Garry, Louis; Clermont, Olivier; Denamur, Erick; Arlet, Guillaume; Vandewalle, Alain			The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities	PLOS ONE			English	Article							SEQUENCE TYPE ST131; SPECTRUM BETA-LACTAMASES; COMPLETE GENOME SEQUENCE; UNITED-STATES; PHYLOGENETIC GROUP; E. COLI; VIRULENCE; STRAINS; COMMUNITY; CTX-M-15	Increasing numbers of pyelonephritis-associated uropathogenic Escherichia coli (UPEC) are exhibiting high resistance to antibiotic therapy. They include a particular clonal group, the CTX-M-15-producing O25b:H4-ST131 clone, which has been shown to have a high dissemination potential. Here we show that a representative isolate of this E. coli clone, referred to as TN03, has enhanced metabolic capacities, acts as a potent intestine-colonizing strain, and displays the typical features of UPEC strains. In a modified streptomycin-treated mouse model of intestinal colonization where streptomycin was stopped 5 days before inoculation, we show that TN03 outcompetes the commensal E. coli strains K-12 MG1655, IAI1, and ED1a at days 1 and 7. Using an experimental model of ascending UTI in C3H/HeN mice, we then show that TN03 colonized the urinary tract. One week after the transurethral inoculation of the TN03 isolates, the bacterial loads in the bladder and kidneys were significantly greater than those of two other UPEC strains (CFT073 and HT7) belonging to the same B2 phylogenetic group. The differences in bacterial loads did not seem to be directly linked to differences in the inflammatory response, since the intrarenal expression of chemokines and cytokines and the number of polymorphonuclear neutrophils attracted to the site of inflammation was the same in kidneys colonized by TN03, CFT073, or HT7. Lastly, we show that in vitro TN03 has a high maximum growth rate in both complex (Luria-Bertani and human urine) and minimum media. In conclusion, our findings indicate that TN03 is a potent UPEC strain that colonizes the intestinal tract and may persist in the kidneys of infected hosts.	[Vimont, Sophie; Arlet, Guillaume] Hop Univ Est Parisien Site Tenon, AP HP, Serv Bacteriol, Paris, France; [Vimont, Sophie; Boyd, Anders; Arlet, Guillaume] Univ Paris 06, Paris, France; [Boyd, Anders] INSERM, U707, Paris, France; [Bleibtreu, Alexandre; Bens, Marcelle; Garry, Louis; Clermont, Olivier; Denamur, Erick; Vandewalle, Alain] Univ Paris Diderot, Paris, France; [Bleibtreu, Alexandre; Garry, Louis; Clermont, Olivier; Denamur, Erick] INSERM, U722, Paris, France; [Bens, Marcelle; Vandewalle, Alain] INSERM, U773, Paris, France; [Goujon, Jean-Michel] Univ Poitiers, Unite Pathol Ultrastruct & Expt, Ctr Hosp & Univ Poitiers, Poitiers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers	Vimont, S (corresponding author), Hop Univ Est Parisien Site Tenon, AP HP, Serv Bacteriol, Paris, France.	sophie.vimont@tnn.aphp.fr	Arlet, Guillaume/AAW-4918-2020; Arlet, Guillaume/P-2990-2017; Boyd, Anders/GLQ-8906-2022; alexandre, bleibtreu/I-6214-2019	Boyd, Anders/0000-0001-9512-8928; alexandre, bleibtreu/0000-0001-5145-4174	French National Research Agency [ANR-08-MIE-030]; Contrat Hospitalier de Recherche Translationnelle; "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale"	French National Research Agency(French National Research Agency (ANR)); Contrat Hospitalier de Recherche Translationnelle; "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale"	This work was funded in part by a grant from the French National Research Agency under reference ANR-08-MIE-030 (to GA, and AV). AV was in receipt of a "Contrat Hospitalier de Recherche Translationnelle" (CHRP, INSERM-APHP, 2010). A. B. was supported by a "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chassin C, 2007, J EXP MED, V204, P2837, DOI 10.1084/jem.20071032; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; Chassin C, 2008, J AM SOC NEPHROL, V19, P2364, DOI 10.1681/ASN.2007121273; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hang L, 1999, J IMMUNOL, V162, P3037; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lavollay M, 2006, ANTIMICROB AGENTS CH, V50, P2433, DOI 10.1128/AAC.00150-06; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Leflon-Guibout V, 2008, J CLIN MICROBIOL, V46, P3900, DOI 10.1128/JCM.00734-08; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Lescat M, 2012, COMMENSAL ESCHERICHI; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P935; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Song J, 2008, EUR J CLIN INVEST, V38, P21, DOI 10.1111/j.1365-2362.2008.02005.x; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	56	70	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46547	10.1371/journal.pone.0046547	http://dx.doi.org/10.1371/journal.pone.0046547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029548	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900184
J	Takagi, M; Ishii, T; Inokuchi, M; Amano, N; Narumi, S; Asakura, Y; Muroya, K; Hasegawa, Y; Adachi, M; Hasegawa, T				Takagi, Masaki; Ishii, Tomohiro; Inokuchi, Mikako; Amano, Naoko; Narumi, Satoshi; Asakura, Yumi; Muroya, Koji; Hasegawa, Yukihiro; Adachi, Masanori; Hasegawa, Tomonobu			Gradual Loss of ACTH Due to a Novel Mutation in LHX4: Comprehensive Mutation Screening in Japanese Patients with Congenital Hypopituitarism	PLOS ONE			English	Article							PITUITARY-HORMONE DEFICIENCY; 2-BASE PAIR DELETION; GENE; CHILDREN; PROP1; POU1F1	Mutations in transcription factors genes, which are well regulated spatially and temporally in the pituitary gland, result in congenital hypopituitarism (CH) in humans. The prevalence of CH attributable to transcription factor mutations appears to be rare and varies among populations. This study aimed to define the prevalence of CH in terms of nine CH-associated genes among Japanese patients. We enrolled 91 Japanese CH patients for DNA sequencing of POU1F1, PROP1, HESX1, LHX3, LHX4, SOX2, SOX3, OTX2, and GLI2. Additionally, gene copy numbers for POU1F1, PROP1, HESX1, LHX3, and LHX4 were examined by multiplex ligation-dependent probe amplification. The gene regulatory properties of mutant LHX4 proteins were characterized in vitro. We identified two novel heterozygous LHX4 mutations, namely c.249-1G>A, p.V75I, and one common POU1F1 mutation, p.R271W. The patient harboring the c.249-1G>A mutation exhibited isolated growth hormone deficiency at diagnosis and a gradual loss of ACTH, whereas the patient with the p.V75I mutation exhibited multiple pituitary hormone deficiency. In vitro experiments showed that both LHX4 mutations were associated with an impairment of the transactivation capacities of POU1F1 and alpha GSU, without any dominant-negative effects. The total mutation prevalence in Japanese CH patients was 3.3%. This study is the first to describe, a gradual loss of ACTH in a patient carrying an LHX4 mutation. Careful monitoring of hypothalamic-pituitary -adrenal function is recommended for CH patients with LHX4 mutations.	[Takagi, Masaki; Ishii, Tomohiro; Inokuchi, Mikako; Amano, Naoko; Narumi, Satoshi; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Takagi, Masaki; Hasegawa, Yukihiro] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Asakura, Yumi; Muroya, Koji; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Kanagawa, Japan	Keio University; Tokyo Metropolitan Children's Medical Center	Hasegawa, T (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.	thaseg@a6.keio.jp	Ishii, Tomohiro/B-8711-2019; Hasegawa, Tomonobu/L-3331-2013; Muroya, Koji/J-1304-2016	Ishii, Tomohiro/0000-0001-7360-2465; Muroya, Koji/0000-0002-1810-9894; ASAKURA, YUMI/0000-0001-7242-8354	Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan [014]; Foundation for Growth Science, Japan	Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan; Foundation for Growth Science, Japan	This work was supported by Health and Labour Sciences Research Grant for Research on Applying Health Technology (Jitsuyoka (Nanbyo) - Ippan - 014). This work was supported by a grant from the Foundation for Growth Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asteria C, 2000, EUR J ENDOCRINOL, V143, P347, DOI 10.1530/eje.0.1430347; Bonfig W, 2011, EUR J PEDIATR, V170, P1017, DOI 10.1007/s00431-011-1393-x; Castinetti F, 2008, J CLIN ENDOCR METAB, V93, P2790, DOI 10.1210/jc.2007-2389; Cogan JD, 1998, J CLIN ENDOCR METAB, V83, P3346, DOI 10.1210/jc.83.9.3346; Crofton PM, 2004, HORM RES, V61, P92, DOI 10.1159/000075339; Dateki S, 2010, J CLIN ENDOCR METAB, V95, P4043, DOI 10.1210/jc.2010-0150; de Graaff LCG, 2010, HORM RES PAEDIAT, V73, P363, DOI 10.1159/000308169; FUJIEDA K, 1996, CLIN ENDOCRINOL TOKY, V44, P1229; Ito J, 1993, J JPN PEDIAT SOC, V97, P1789; *JAP PUBL HLTH ASS, 1996, NORM BIOCH VAL JAP C; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Machinis K, 2005, J CLIN ENDOCR METAB, V90, P5456, DOI 10.1210/jc.2004-2332; Machinis K, 2001, AM J HUM GENET, V69, P961, DOI 10.1086/323764; McLennan K, 2003, CLIN ENDOCRINOL, V58, P785, DOI 10.1046/j.1365-2265.2003.01781.x; Mendonca BB, 1999, J CLIN ENDOCR METAB, V84, P942, DOI 10.1210/jc.84.3.942; Pernasetti F, 2000, J CLIN ENDOCR METAB, V85, P390, DOI 10.1210/jc.85.1.390; Pfaffle R, 2011, BEST PRACT RES CL EN, V25, P43, DOI 10.1016/j.beem.2010.10.014; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Rainbow LA, 2005, CLIN ENDOCRINOL, V62, P163, DOI 10.1111/j.1365-2265.2004.02189.x; Reynaud R, 2006, J CLIN ENDOCR METAB, V91, P3329, DOI 10.1210/jc.2005-2173; Romero CJ, 2009, TRENDS ENDOCRIN MET, V20, P506, DOI 10.1016/j.tem.2009.06.005; Tajima T, 2010, EXP CLIN ENDOCR DIAB, V118, P405, DOI 10.1055/s-0029-1225612; Tajima T, 2007, ENDOCR J, V54, P637, DOI 10.1507/endocrj.K06-200	24	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46008	10.1371/journal.pone.0046008	http://dx.doi.org/10.1371/journal.pone.0046008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029363	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700105
J	Martin, LS; Cerda, F; Jimenez, V; Fuentealba, J; Munoz, B; Aguayo, LG; Guzman, L				San Martin, Loreto; Cerda, Fabian; Jimenez, Veronica; Fuentealba, Jorge; Munoz, Braulio; Aguayo, Luis G.; Guzman, Leonardo			Inhibition of the Ethanol-induced Potentiation of alpha 1 Glycine Receptor by a Small Peptide That Interferes with G beta gamma Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MOUSE SPINAL NEURONS; SYNAPTIC-TRANSMISSION; MOLECULAR-DYNAMICS; SYNTHETIC PEPTIDES; HEART-FAILURE; ION-CHANNEL; SUBUNITS; MODULATION; RAT	Previous studies indicate that ethanol can modulate glycine receptors (GlyR), in part, through G beta gamma interaction with basic residues in the intracellular loop. In this study, we show that a seven-amino acid peptide (RQH(C7)), which has the primary structure of a motif in the large intracellular loop of GlyR (GlyR-IL), was able to inhibit the ethanol-elicited potentiation of this channel from 47 +/- 2 to 16 +/- 4%, without interfering with the effect of G beta gamma on GIRK (G protein activated inwardly rectifying potassium channel) activation. RQH(C7) displayed a concentration-dependent effect on ethanol action in evoked and synaptic currents. A fragment of GlyR-IL without the basic amino acids did not interact with G beta gamma or inhibit ethanol potentiation of GlyR. In silico analysis using docking and molecular dynamics allowed to identify a region of similar to 350 angstrom(2) involving aspartic acids 186, 228, and 246 in G beta gamma where we propose that RQH(C7) binds and exerts its blocking action on the effect of ethanol in GlyR.	[San Martin, Loreto; Cerda, Fabian; Fuentealba, Jorge; Munoz, Braulio; Aguayo, Luis G.; Guzman, Leonardo] Univ Concepcion, Fac Biol Sci, Dept Physiol, Concepcion 403901, Chile; [Jimenez, Veronica] Univ Concepcion, Fac Chem Sci, Dept Organ Chem, Concepcion 403901, Chile	Universidad de Concepcion; Universidad de Concepcion	Guzman, L (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Physiol, Casilla 160-C, Concepcion 403901, Chile.	joseguzman@udec.cl	Munoz, Braulio/F-2493-2018; Jiménez, Verónica A/B-8789-2017; Guzman, Jose/AAM-7649-2020	Munoz, Braulio/0000-0003-4442-975X; Guzman, Jose/0000-0001-9596-5494	Fondecyt [11080145]; National Institutes of Health [R01AA 15150]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Fondecyt Grant 11080145 and National Institutes of Health Grant R01AA 15150.	Aguayo LG, 1996, J PHARMACOL EXP THER, V279, P1116; Aguayo LG, 2004, BRAIN RES REV, V47, P33, DOI 10.1016/j.brainresrev.2004.06.007; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Camacho CJ, 2005, BIOINFORMATICS, V21, P2534, DOI 10.1093/bioinformatics/bti322; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Goubaeva F, 2003, J BIOL CHEM, V278, P19634, DOI 10.1074/jbc.M300052200; Gu YP, 1998, J PHYSIOL-LONDON, V506, P331, DOI 10.1111/j.1469-7793.1998.331bw.x; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kamal FA, 2011, J MOL CELL CARDIOL, V51, P462, DOI 10.1016/j.yjmcc.2011.01.006; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; KONIG B, 1994, BBA-MOL CELL RES, V1223, P261, DOI 10.1016/0167-4889(94)90235-6; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; Kubota M, 2008, J PEPT SCI, V14, P998, DOI 10.1002/psc.1034; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; Melzer N, 2010, J BIOL CHEM, V285, P3730, DOI 10.1074/jbc.M109.030460; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Min BI, 1996, BRAIN RES, V734, P72; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Molander A, 2005, ALCOHOL CLIN EXP RES, V29, P38, DOI 10.1097/01.ALC.0000150009.78622.E0; Molander A, 2007, ALCOHOL ALCOHOLISM, V42, P11, DOI 10.1093/alcalc/ag1085; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Shpakov A O, 2010, Ross Fiziol Zh Im I M Sechenova, V96, P1062; Shpakov AO, 2011, J AMINO ACIDS; Singer JH, 1998, J NEUROPHYSIOL, V80, P2608, DOI 10.1152/jn.1998.80.5.2608; Smrcka AV, 2002, METHOD ENZYMOL, V344, P557; SONG Y, 1990, NATURE, V348, P242, DOI 10.1038/348242a0; Stern CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018114; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; van Zundert B, 2005, BRAIN RES, V1050, P40, DOI 10.1016/j.brainres.2005.05.014; van Zundert B, 2002, J NEUROPHYSIOL, V87, P640, DOI 10.1152/jn.00455.2001; WADE SM, 1994, MOL PHARMACOL, V45, P1191; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	52	8	8	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40713	40721		10.1074/jbc.M112.393603	http://dx.doi.org/10.1074/jbc.M112.393603			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035114	hybrid, Green Published			2022-12-25	WOS:000311448800060
J	Haining, EJ; Yang, J; Bailey, RL; Khan, K; Collier, R; Tsai, S; Watson, SP; Frampton, J; Garcia, P; Tomlinson, MG				Haining, Elizabeth J.; Yang, Jing; Bailey, Rebecca L.; Khan, Kabir; Collier, Richard; Tsai, Schickwann; Watson, Steve P.; Frampton, Jon; Garcia, Paloma; Tomlinson, Michael G.			The TspanC8 Subgroup of Tetraspanins Interacts with A Disintegrin and Metalloprotease 10 (ADAM10) and Regulates Its Maturation and Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; GROWTH-FACTOR; ENDOPLASMIC-RETICULUM; PLATELET TETRASPANIN; ADHERENT LEUKOCYTES; MEMBRANE-PROTEINS; IN-VIVO; ALPHA; CD151; ERYTHROPOIESIS	A disintegrin and metalloprotease 10 (ADAM10) is a ubiquitous transmembrane metalloprotease that cleaves the extracellular regions from over 40 different transmembrane target proteins, including Notch and amyloid precursor protein. ADAM10 is essential for embryonic development and is also important in inflammation, cancer, and Alzheimer disease. However, ADAM10 regulation remains poorly understood. ADAM10 is compartmentalized into membrane microdomains formed by tetraspanins, which are a superfamily of 33 transmembrane proteins in humans that regulate clustering and trafficking of certain other transmembrane "partner" proteins. This is achieved by specific tetraspanin-partner interactions, but it is not clear which tetraspanins specifically interact with ADAM10. The aims of this study were to identify which tetraspanins interact with ADAM10 and how they regulate this metalloprotease. Co-immunoprecipitation identified specific ADAM10 interactions with Tspan5, Tspan10, Tspan14, Tspan15, Tspan17, and Tspan33/Penumbra. These are members of the largely unstudied TspanC8 subgroup of tetraspanins, all six of which promoted ADAM10 maturation. Different cell types express distinct repertoires of TspanC8 tetraspanins. Human umbilical vein endothelial cells express relatively high levels of Tspan14, the knockdown of which reduced ADAM10 surface expression and activity. Mouse erythrocytes express predominantly Tspan33, and ADAM10 expression was substantially reduced in the absence of this tetraspanin. In contrast, ADAM10 expression was normal on Tspan33-deficient mouse platelets in which Tspan14 is the major TspanC8 tetraspanin. These results define TspanC8 tetraspanins as essential regulators of ADAM10 maturation and trafficking to the cell surface. This finding has therapeutic implications because focusing on specific TspanC8-ADAM10 complexes may allow cell type- and/or substrate-specific ADAM10 targeting.	[Haining, Elizabeth J.; Yang, Jing; Bailey, Rebecca L.; Khan, Kabir; Collier, Richard; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England; [Watson, Steve P.] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Frampton, Jon; Garcia, Paloma] Univ Birmingham, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Tsai, Schickwann] Univ Utah, Dept Med, Div Hematol, Salt Lake City, UT 84132 USA	University of Birmingham; University of Birmingham; University of Birmingham; Utah System of Higher Education; University of Utah	Tomlinson, MG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England.	m.g.tomlinson@bham.ac.uk	Garcia, Paloma/AFO-2595-2022; Watson, Stephen P/Q-6292-2016; Khan, Kabir/U-8350-2018	Watson, Stephen P/0000-0002-7846-7423; Khan, Kabir/0000-0001-8453-3485; Tomlinson, Michael/0000-0002-1189-0091; Garcia, Paloma/0000-0001-5582-8575	two Biotechnology and Biological Sciences Research Council studentships; British Heart Foundation (BHF) chair; Science City Research Alliance fellowship; BHF Senior Research Fellowship [FS/08/062/25797]; British Heart Foundation [FS/08/062/25797] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	two Biotechnology and Biological Sciences Research Council studentships(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation (BHF) chair(British Heart Foundation); Science City Research Alliance fellowship; BHF Senior Research Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by two Biotechnology and Biological Sciences Research Council studentships (to E. J. H. and R. L. B.), a British Heart Foundation (BHF) chair (to S. P. W.), a Science City Research Alliance fellowship (to P. G.), and BHF Senior Research Fellowship FS/08/062/25797 (to M. G. T.).	Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bender M, 2010, BLOOD, V116, P3347, DOI 10.1182/blood-2010-06-289108; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x; Glomski K, 2011, BLOOD, V118, P1163, DOI 10.1182/blood-2011-04-348557; Goschnick MW, 2006, BLOOD, V108, P1911, DOI 10.1182/blood-2006-02-004267; Haining EJ, 2011, BIOCHEM SOC T, V39, P518, DOI 10.1042/BST0390518; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Heikens MJ, 2007, BLOOD, V109, P3244, DOI 10.1182/blood-2006-09-046672; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lewandrowski U, 2009, BLOOD, V114, pE10, DOI 10.1182/blood-2009-02-203828; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Orlowski E, 2009, J THROMB HAEMOST, V7, P2074, DOI 10.1111/j.1538-7836.2009.03612.x; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Protty MB, 2009, BIOCHEM J, V417, P391, DOI 10.1042/BJ20081126; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Takeda Y, 2008, J BIOL CHEM, V283, P26089, DOI 10.1074/jbc.M801902200; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tomlinson MG, 2009, J THROMB HAEMOST, V7, P2070, DOI 10.1111/j.1538-7836.2009.03613.x; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Zelm MC, 2010, J CLIN INVEST, V120, P1265, DOI 10.1172/JCI39748; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Zhang C, 2010, DEV DYNAM, V239, P2594, DOI 10.1002/dvdy.22391	45	109	118	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416503	http://dx.doi.org/10.1074/jbc.M112.416503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035126	hybrid, Green Published			2022-12-25	WOS:000311233800044
J	Edinger, RS; Bertrand, CA; Rondandino, C; Apodaca, GA; Johnson, JP; Butterworth, MB				Edinger, Robert S.; Bertrand, Carol A.; Rondandino, Christine; Apodaca, Gerard A.; Johnson, John P.; Butterworth, Michael B.			The Epithelial Sodium Channel (ENaC) Establishes a Trafficking Vesicle Pool Responsible for Its Regulation	PLOS ONE			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; CELL-SURFACE EXPRESSION; COLLECTING DUCT CELLS; NA+ CHANNELS; UREA TRANSPORTERS; PLASMA-MEMBRANE; SERINE PROTEASES; AQUAPORIN-2 TRAFFICKING; ACCESSORY PROTEINS; APICAL MEMBRANE	The epithelial sodium channel (ENaC) is the rate-limiting step for sodium reabsorption across tight epithelia. Cyclic-AMP (cAMP) stimulation promotes ENaC trafficking to the apical surface to increase channel number and transcellular Na+ transport. Removal of corticosteroid supplementation in a cultured cortical collecting duct cell line reduced ENaC expression. Concurrently, the number of vesicles trafficked in response to cAMP stimulation, as measured by a change in membrane capacitance, also decreased. Stimulation with aldosterone restored both the basal and cAMP-stimulated ENaC activity and increased the number of exocytosed vesicles. Knocking down ENaC directly decreased both the cAMP-stimulated short-circuit current and capacitance response in the presence of aldosterone. However, constitutive apical recycling of the Immunoglobulin A receptor was unaffected by alterations in ENaC expression or trafficking. Fischer Rat Thyroid cells, transfected with alpha,beta,gamma-mENaC had a significantly greater membrane capacitance response to cAMP stimulation compared to non-ENaC controls. Finally, immunofluorescent labeling and quantitation revealed a smaller number of vesicles in cells where ENaC expression was reduced. These findings indicate that ENaC is not a passive passenger in regulated epithelial vesicle trafficking, but plays a role in establishing and maintaining the pool of vesicles that respond to cAMP stimulation.	[Bertrand, Carol A.; Apodaca, Gerard A.; Johnson, John P.; Butterworth, Michael B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Edinger, Robert S.; Rondandino, Christine; Apodaca, Gerard A.; Johnson, John P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterworth, MB (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	michael7@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Rondanino, Christine/S-6880-2018	Rondanino, Christine/0000-0002-1100-9401; Butterworth, Michael/0000-0002-2173-8333	National Institutes of Health [R00DK078917, R37DK54425, R01DK077777, R01DK047874, P30DK079307]; CFF grant [BERTRA12G0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047874, R01DK077777, R01DK054814, P30DK079307, R37DK054425, R00DK078917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following grants: National Institutes of Health grants R00DK078917 to MBB, R37DK54425 and R01DK077777 to GAA and R01DK047874 to JPP and by P30DK079307 for imaging and electrophysiological cores. CFF grant BERTRA12G0 to CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; APODACA G, 1993, J BIOL CHEM, V268, P23712; Bagnasco SM, 2005, PFLUG ARCH EUR J PHY, V450, P217, DOI 10.1007/s00424-005-1403-9; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Christensen BM, 1998, AM J PHYSIOL-RENAL, V275, pF285, DOI 10.1152/ajprenal.1998.275.2.F285; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Ecelbarger CA, 1999, FASEB J, V13, pA392; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fosch H, 2008, CURR OPIN CELL BIOL, V20, P208, DOI 10.1016/j.ceb.2008.01.003; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Frokiaer J, 2005, J AM SOC NEPHROL, V16, P2827, DOI 10.1681/ASN.2005080850; Gormley K, 2003, BIOCHEM J, V371, P1, DOI 10.1042/BJ20021375; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Inoue T, 1999, AM J PHYSIOL-RENAL, V276, pF559, DOI 10.1152/ajprenal.1999.276.4.F559; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Leung SM, 2000, MOL BIOL CE IN PRESS; Liang X, 2008, J BIOL CHEM; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu L, 2002, HYPERTENSION, V39, P860, DOI 10.1161/01.HYP.0000013055.48885.8D; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Noda Y, 2005, BIOL CELL, V97, P885; Ohara M, 2002, BIOCHEM BIOPH RES CO, V299, P285, DOI 10.1016/S0006-291X(02)02634-7; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2000, CURR OPIN NEPHROL HY, V9, P529, DOI 10.1097/00041552-200009000-00012; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SONG WX, 1994, J BIOL CHEM, V269, P29474; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang WD, 2006, AM J PHYSIOL-RENAL, V290, pF530, DOI 10.1152/ajprenal.00070.2005; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhou R, 2007, J BIOLCHEM; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2010, J BIOL CHEM, V285, P30523, DOI 10.1074/jbc.M110.150755	81	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46593	10.1371/journal.pone.0046593	http://dx.doi.org/10.1371/journal.pone.0046593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029554	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000309973900188
J	Kroepil, F; Fluegen, G; Totikov, Z; Baldus, SE; Vay, C; Schauer, M; Topp, SA; Esch, JSA; Knoefel, WT; Stoecklein, NH				Kroepil, Feride; Fluegen, Georg; Totikov, Zaurbek; Baldus, Stephan E.; Vay, Christian; Schauer, Matthias; Topp, Stefan A.; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Stoecklein, Nikolas H.			Down-Regulation of CDH1 Is Associated with Expression of SNAI1 in Colorectal Adenomas	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; N-CADHERIN; CELLS DISSEMINATE; REPRESSOR SNAIL; BONE-MARROW; STEM-CELLS; CANCER; OVEREXPRESSION; PROGRESSION	Introduction: Down-regulation of E-cadherin (CDH1) and epithelial-mesenchymal transition (EMT) are considered critical events for invasion and metastasis of colorectal carcinoma. Here we tested whether the important regulators of E-cadherin expression SNAI1 and TWIST1 are already detectable in human colorectal adenomas. Methods: RNA was extracted from a set of randomly selected formalin-fixed and paraffin-embedded (FFPE) colorectal adenomas (n = 41) and normal colon mucosa (n = 10). Subsequently mRNA expression of CDH1, CDH2, SNAI1 and TWIST1 was analysed by quantitative RT-PCR analysis. CDH1 as well as SNAI1 protein expression were assessed by immunohistochemistry (IHC). Results: SNAI1 mRNA was expressed in 78% (n = 32/41), TWIST1 mRNA in 41% (n = 17/41) and CDH2 mRNA in 41% (n = 17/41) of the colorectal adenoma tissue, while normal colon mucosa was negative for these transcription factors. We found a significant correlation between reduced CDH1 and the presence of SNAI1 mRNA expression and for combined SNAI1 and TWIST1 mRNA expression, respectively. A correlation between CDH2 mRNA expression and reduced CDH1 expression was not observed. We confirmed the relationship between SNAI1 expression and reduced E-cadherin expression on the protein level via IHC. Conclusion: Our data show that SNAI1 and Twist1 are already expressed in benign precursor lesions of colorectal cancer and that SNAI1 expression was significantly correlated with lower expression of CDH1. Whether these findings reflect true EMT and/or are a sign of a more aggressive biology need to be investigated in further studies.	[Kroepil, Feride; Fluegen, Georg; Totikov, Zaurbek; Vay, Christian; Schauer, Matthias; Topp, Stefan A.; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Baldus, Stephan E.] Univ Hosp Dusseldorf, Inst Pathol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Stoecklein, NH (corresponding author), Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany.	nikolas.stoecklein@uni-duesseldorf.de	Esch, Jan Schulte am/AAL-9904-2021; Kroepil, Feride/M-9755-2013	Esch, Jan Schulte am/0000-0002-2101-5012; 	Forschungskommission der Medizinischen Fakultat Dusseldorf [9772354]; Rudolf Bartling Stiftung [II/89]	Forschungskommission der Medizinischen Fakultat Dusseldorf; Rudolf Bartling Stiftung	This study was supported by a grant from the Forschungskommission (grant number 9772354) der Medizinischen Fakultat Dusseldorf (to F. Kroepil, S.E. Baldus and N.H. Stoecklein) and by a grant from the Rudolf Bartling Stiftung (II/89)(to N.H. Stoecklein). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; GAGLIARDI G, 1995, VIRCHOWS ARCH, V426, P149; Gomez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018023; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao XP, 1997, ANTICANCER RES, V17, P2241; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Larriba MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010221; Jungck M, 2004, INT J COLORECTAL DIS, V19, P438, DOI 10.1007/s00384-003-0575-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Marsman WA, 2005, GUT, V54, P1821, DOI 10.1136/gut.2005.078774; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Pantel K, 2011, CLIN CHEM; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Risio M, 2010, BEST PRACT RES CL GA, V24, P397, DOI 10.1016/j.bpg.2010.08.002; Rosivatz E, 2004, INT J CANCER, V111, P711, DOI 10.1002/ijc.20317; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Roy HK, 2005, DIGEST DIS SCI, V50, P42, DOI 10.1007/s10620-005-1275-z; Sanger N, 2011, INT J CANC; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schmelzle M, 2011, PROSTAG OTH LIPID M, V94, P25, DOI 10.1016/j.prostaglandins.2010.12.001; Steinert R, 2005, GUT, V54, P1045, DOI 10.1136/gut.2004.062216; Tannapfel A, 2010, DTSCH ARZTEBL INT, V107, P760, DOI 10.3238/arztebl.2010.0760; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Valizadeh A, 1997, AM J PATHOL, V150, P1977	38	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46665	10.1371/journal.pone.0046665	http://dx.doi.org/10.1371/journal.pone.0046665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029563	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900197
J	Tirado-Velez, JM; Joumady, I; Saez-Benito, A; Cozar-Castellano, I; Perdomo, G				Manuel Tirado-Velez, Jose; Joumady, Insaf; Saez-Benito, Ana; Cozar-Castellano, Irene; Perdomo, German			Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation	PLOS ONE			English	Article							INSULIN SENSITIVITY; CYCLE PROGRESSION; MULTIPLE-MYELOMA; LIPID-METABOLISM; BETA-OXIDATION; CANCER; ETOMOXIR; SYNTHASE; APOPTOSIS; ORLISTAT	Multiple myeloma is a haematological malignancy characterized by the clonal proliferation of plasma cells. It has been proposed that targeting cancer cell metabolism would provide a new selective anticancer therapeutic strategy. In this work, we tested the hypothesis that inhibition of beta-oxidation and de novo fatty acid synthesis would reduce cell proliferation in human myeloma cells. We evaluated the effect of etomoxir and orlistat on fatty acid metabolism, glucose metabolism, cell cycle distribution, proliferation, cell death and expression of G1/S phase regulatory proteins in myeloma cells. Etomoxir and orlistat inhibited beta-oxidation and de novo fatty acid synthesis respectively in myeloma cells, without altering significantly glucose metabolism. These effects were associated with reduced cell viability and cell cycle arrest in G0/G1. Specifically, etomoxir and orlistat reduced by 40-70% myeloma cells proliferation. The combination of etomoxir and orlistat resulted in an additive inhibitory effect on cell proliferation. Orlistat induced apoptosis and sensitized RPMI-8226 cells to apoptosis induction by bortezomib, whereas apoptosis was not altered by etomoxir. Finally, the inhibitory effect of both drugs on cell proliferation was associated with reduced p21 protein levels and phosphorylation levels of retinoblastoma protein. In conclusion, inhibition of fatty acid metabolism represents a potential therapeutic approach to treat human multiple myeloma.	[Manuel Tirado-Velez, Jose; Cozar-Castellano, Irene; Perdomo, German] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Joumady, Insaf; Saez-Benito, Ana] Hosp Univ Puerta del Mar, Clin Lab Dept, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Perdomo, G (corresponding author), Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain.	perdomogm@yahoo.com	Cozar-Castellano, Irene/B-5625-2015; Godino, Ana Saez-Benito/K-6357-2013; Tirado-Velez, JM/K-2317-2014; Perdomo, German/K-6703-2014	Cozar-Castellano, Irene/0000-0002-6065-5362; Godino, Ana Saez-Benito/0000-0002-7864-9147; Tirado-Velez, JM/0000-0002-6654-4735; Perdomo, German/0000-0002-2301-0012	Carlos III Health Institute [CP08/00106]; Spanish Ministry of Science and Innovation [SAF2009-11282]; European Community through the regional development funding program (FEDER); "Puerta del Mar Foundation'' (Spain);  [IRG-247835]	Carlos III Health Institute(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community through the regional development funding program (FEDER); "Puerta del Mar Foundation'' (Spain); 	This work was supported by grants from the Carlos III Health Institute (CP08/00106), the Spanish Ministry of Science and Innovation (SAF2009-11282) and the FP7-PEOPLE-2009-RG (PIRG06-GA-2009-25369) to GP, and the FP7-PEOPLE-2009-RG (IRG-247835) to ICC. The authors' Research Unit facilities at the HUPM received support from the European Community through the regional development funding program (FEDER). JMTV was supported by the "Puerta del Mar Foundation'' (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berge K, 2003, J LIPID RES, V44, P118, DOI 10.1194/jlr.M200312-JLR200; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bristow M, 2000, LANCET, V356, P1621, DOI 10.1016/S0140-6736(00)03149-4; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; HUBINGER A, 1992, HORM METAB RES, V24, P115, DOI 10.1055/s-2007-1003271; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Hungria VTM, 2004, CANCER CHEMOTH PHARM, V53, P51, DOI 10.1007/s00280-003-0692-y; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Tirado-Velez JM, 2012, ANN HEMATOL, V91, P83, DOI 10.1007/s00277-011-1246-8; Menendez JA, 2005, ANN ONCOL, V16, P1253, DOI 10.1093/annonc/mdi239; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Quinn J, 2011, BLOOD, V117, P890, DOI 10.1182/blood-2010-01-264424; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schmidt-Schweda S, 2000, CLIN SCI, V99, P27, DOI 10.1042/CS19990235; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tirado-Velez JM, 2011, ANN HEMATOL; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Wang WQ, 2008, J ZHEJIANG UNIV-SC B, V9, P441, DOI 10.1631/jzus.B0740640; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yecies JL, 2010, CELL, V140, P28, DOI 10.1016/j.cell.2009.12.037; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	36	79	83	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46484	10.1371/journal.pone.0046484	http://dx.doi.org/10.1371/journal.pone.0046484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029529	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900169
J	Fang, TC; Pang, CY; Chiu, SC; Ding, DC; Tsai, RK				Fang, Te-Chao; Pang, Cheng-Yoong; Chiu, Sheng-Chun; Ding, Dah-Ching; Tsai, Rong-Kung			Renoprotective Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Immunodeficient Mice Suffering from Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; OPTIC-NERVE CRUSH; FACTOR G-CSF; BONE-MARROW; TUBULAR EPITHELIUM; RICH SOURCE; REPAIR; DIFFERENTIATION; TRANSPLANTATION; BLOOD	It is unknown whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can improve the renal function of patients suffering from acute kidney injury. Moreover, before beginning clinical trials, it is necessary to investigate this renoprotective effect of hUC-MSCs in a xenogeneic model of acute kidney injury. However, no previous studies have examined the application of hUC-MSCs to immunodeficient mice suffering from acute kidney injury. The objectives of this study were to examine whether hUC-MSCs could improve renal function in nonobese diabetic-severe combined immune deficiency (NOD-SCID) mice suffering from acute kidney injury, and to investigate the mechanism(s) for hUC-MSCs to improve renal function in this xenogeneic model. Early (3 hr) and late (12 hr) administrations of hUC-MSCs (10(6) cells) were performed via the external jugular vein into NOD-SCID mice suffering from either folic acid (FA) (250 mg/kg body weight) or vehicle. The results showed that early administration of hUC-MSCs improved the renal function of NOD-SCID mice suffering from FA-induced acute kidney injury, as evidenced by decreased serum urea nitrogen and serum creatinine levels, as well as a reduced tubular injury score. The beneficial effects of hUC-MSCs were through reducing apoptosis and promoting proliferation of renal tubular cells. These benefits were independent of inflammatory cytokine effects and transdifferentiation. Furthermore, this study is the first one to show that the reduced apoptosis of renal tubular cells by hUC-MSCs in this xenogeneic model is mediated through the mitochondrial pathway, and through the increase of Akt phosphorylation.	[Fang, Te-Chao; Pang, Cheng-Yoong; Chiu, Sheng-Chun; Ding, Dah-Ching; Tsai, Rong-Kung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Fang, Te-Chao] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Fang, Te-Chao] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Pang, Cheng-Yoong; Chiu, Sheng-Chun] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Ding, Dah-Ching] Buddhist Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien, Taiwan; [Tsai, Rong-Kung] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Fang, TC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	fangtechao@yahoo.com.tw	DING, DAH-CHING/Y-3592-2019; Pang, Cheng-Yoong/R-4990-2019; Chiu, Sheng-Chun/F-9493-2015; Pang, Cheng-Yoong/AFO-1562-2022	Pang, Cheng-Yoong/0000-0002-9063-2858; Chiu, Sheng-Chun/0000-0002-5927-8088	National Science Council, Taiwan [NSC 95-2745-B-303-001]; Tzu Chi General Hospital, Hualien, Taiwan [TCRD 98-24, TCRD 99-17]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi General Hospital, Hualien, Taiwan	This study was supported by research grants from the National Science Council, Taiwan (NSC 95-2745-B-303-001) to TCF, and from the Tzu Chi General Hospital, Hualien, Taiwan (TCRD 98-24 and TCRD 99-17) to TCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cao HL, 2010, BIOTECHNOL LETT, V32, P725, DOI 10.1007/s10529-010-0207-y; Capelli C, 2011, CYTOTHERAPY, V13, P786, DOI 10.3109/14653249.2011.563294; Chen YA, 2011, STEM CELLS DEV, V20, P103, DOI 10.1089/scd.2009.0495; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fang Te-Chao, 2003, Birth Defects Research, V69, P238, DOI 10.1002/bdrc.10019; Fernandez M, 2004, J MOL ENDOCRINOL, V33, P155, DOI 10.1677/jme.0.0330155; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; Gupta A, 2012, EXP TOXICOL PATHOL, V64, P225, DOI 10.1016/j.etp.2010.08.010; Herrera MB, 2004, INT J MOL MED, V14, P1035; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kim JW, 2004, ANN HEMATOL, V83, P733, DOI 10.1007/s00277-004-0918-z; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lataillade JJ, 2006, HAEMATOLOGICA, V91, p1009A; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; Nangaku M, 1998, J AM SOC NEPHROL, V9, P590; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Terai S, 2003, J BIOCHEM, V134, P551, DOI 10.1093/jb/mvg173; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Tsai RK, 2010, EXP EYE RES, V90, P537, DOI 10.1016/j.exer.2010.01.004; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x	45	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46504	10.1371/journal.pone.0046504	http://dx.doi.org/10.1371/journal.pone.0046504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029541	gold, Green Published, Green Submitted			2022-12-25	WOS:000309517500106
J	Wagegg, M; Gaber, T; Lohanatha, FL; Hahne, M; Strehl, C; Fangradt, M; Tran, CL; Schonbeck, K; Hoff, P; Ode, A; Perka, C; Duda, GN; Buttgereit, F				Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Ode, Andrea; Perka, Carsten; Duda, Georg N.; Buttgereit, Frank			Hypoxia Promotes Osteogenesis but Suppresses Adipogenesis of Human Mesenchymal Stromal Cells in a Hypoxia-Inducible Factor-1 Dependent Manner	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; OXYGEN; DIFFERENTIATION; CAPACITY; THERAPY; BIOLOGY; REPAIR; HIF	Background: Bone fracture initiates a series of cellular and molecular events including the expression of hypoxia-inducible factor (HIF)-1. HIF-1 is known to facilitate recruitment and differentiation of multipotent human mesenchymal stromal cells (hMSC). Therefore, we analyzed the impact of hypoxia and HIF-1 on the competitive differentiation potential of hMSCs towards adipogenic and osteogenic lineages. Methodology/Principal Findings: Bone marrow derived primary hMSCs cultured for 2 weeks either under normoxic (app. 18% O-2) or hypoxic (less than 2% O-2) conditions were analyzed for the expression of MSC surface markers and for expression of the genes HIF1A, VEGFA, LDHA, PGK1, and GLUT1. Using conditioned medium, adipogenic or osteogenic differentiation as verified by Oil-Red-O or von-Kossa staining was induced in hMSCs under either normoxic or hypoxic conditions. The expression of HIF1A and VEGFA was measured by qPCR. A knockdown of HIF-1 alpha by lentiviral transduction was performed, and the ability of the transduced hMSCs to differentiate into adipogenic and osteogenic lineages was analyzed. Hypoxia induced HIF-1 alpha and HIF-1 target gene expression, but did not alter MSC phenotype or surface marker expression. Hypoxia (i) suppressed adipogenesis and associated HIF1A and PPARG gene expression in hMSCs and (ii) enhanced osteogenesis and associated HIF1A and RUNX2 gene expression. shRNA-mediated knockdown of HIF-1 alpha enhanced adipogenesis under both normoxia and hypoxia, and suppressed hypoxia-induced osteogenesis. Conclusions/Significance: Hypoxia promotes osteogenesis but suppresses adipogenesis of human MSCs in a competitive and HIF-1-dependent manner. We therefore conclude that the effects of hypoxia are crucial for effective bone healing, which may potentially lead to the development of novel therapeutic approaches.	[Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Buttgereit, Frank] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Buttgereit, Frank] German Arthrit Res Ctr, Berlin, Germany; [Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Ode, Andrea; Duda, Georg N.; Buttgereit, Frank] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Ode, Andrea; Duda, Georg N.] Charite, Julius Wolff Inst, Berlin, Germany; [Ode, Andrea; Duda, Georg N.] Charite, Ctr Musculoskeletal Surg, Berlin, Germany; [Perka, Carsten] Charite, Dept Orthopaed, Berlin, Germany; [Hahne, Martin] Charite, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gaber, T (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany.	gaber@drfz.de	Perka, Carsten/ABG-6505-2021; Duda, Georg N/H-2085-2016; Ode, Andrea/B-6805-2015	Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X; Buttgereit, Frank/0000-0003-2534-550X	Bundesministerium fur Bildung und Forschung (BMBF); State of Berlin, BCRT-Grant II; European Commission [2/2010-1/2014]; Deutsche Forschungsgemeinschaft (DFG) through Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Berlin, BCRT-Grant II; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG) through Berlin-Brandenburg School for Regenerative Therapies(German Research Foundation (DFG))	This work has been supported in part by the Bundesministerium fur Bildung und Forschung (BMBF) and the State of Berlin, BCRT-Grant II to FB and TG. MW and TG have been supported in part by the project NMP4-LA-2009-228929 ("Nanosciences, Nanotechnologies, Materials and new Production Technologies''; 2/2010-1/2014) funded by the European Commission through the 7th Framework Programme for Research. MH has been supported by Deutsche Forschungsgemeinschaft (DFG) funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Ham AW, 1930, J BONE JOINT SURG, V12, P827; Hoff P, 2011, IMMUNOL RES; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Muller J, 2011, CELL TRANSPLANT; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Ontiveros C, 2004, J CELL PHYSIOL, V200, P169, DOI 10.1002/jcp.20054; Park JH, 2002, MOL CELL ENDOCRINOL, V192, P197, DOI 10.1016/S0303-7207(02)00036-9; Polykandriotis E, 2006, HANDCHIR MIKROCHIR P, V38, P217, DOI 10.1055/s-2006-924419; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schmidt-Bleek K., 2012, J TISSUE ENG REGEN M; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x	34	138	147	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46483	10.1371/journal.pone.0046483	http://dx.doi.org/10.1371/journal.pone.0046483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029528	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500103
J	Cameron, MJ; Kelvin, AA; Leon, AJ; Cameron, CM; Ran, LS; Xu, LL; Chu, YK; Danesh, A; Fang, Y; Li, QJ; Anderson, A; Couch, RC; Paquette, SG; Fomukong, NG; Kistner, O; Lauchart, M; Rowe, T; Harrod, KS; Jonsson, CB; Kelvin, DJ				Cameron, Mark J.; Kelvin, Alyson A.; Leon, Alberto J.; Cameron, Cheryl M.; Ran, Longsi; Xu, Luoling; Chu, Yong-Kyu; Danesh, Ali; Fang, Yuan; Li, Qianjun; Anderson, Austin; Couch, Ronald C.; Paquette, Stephane G.; Fomukong, Ndingsa G.; Kistner, Otfried; Lauchart, Manfred; Rowe, Thomas; Harrod, Kevin S.; Jonsson, Colleen B.; Kelvin, David J.			Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; IMMUNE-RESPONSES; INFLUENZA-VIRUS; MICE; PATHOGENESIS; MECHANISMS; CYTOKINES; EVENTS; FAMILY; ISG15	In terms of its highly pathogenic nature, there remains a significant need to further define the immune pathology of SARS-coronavirus (SARS-CoV) infection, as well as identify correlates of immunity to help develop vaccines for severe coronaviral infections. Here we use a SARS-CoV infection-reinfection ferret model and a functional genomics approach to gain insight into SARS immunopathogenesis and to identify correlates of immune protection during SARS-CoV-challenge in ferrets previously infected with SARS-CoV or immunized with a SARS virus vaccine. We identified gene expression signatures in the lungs of ferrets associated with primary immune responses to SARS-CoV infection and in ferrets that received an identical second inoculum. Acute SARS-CoV infection prompted coordinated innate immune responses that were dominated by antiviral IFN response gene (IRG) expression. Reinfected ferrets, however, lacked the integrated expression of IRGs that was prevalent during acute infection. The expression of specific IRGs was also absent upon challenge in ferrets immunized with an inactivated, Al(OH)(3)-adjuvanted whole virus SARS vaccine candidate that protected them against SARS-CoV infection in the lungs. Lack of IFN-mediated immune enhancement in infected ferrets that were previously inoculated with, or vaccinated against, SARS-CoV revealed 9 IRG correlates of protective immunity. This data provides insight into the molecular pathogenesis of SARS-CoV and SARS-like-CoV infections and is an important resource for the development of CoV antiviral therapeutics and vaccines.	[Cameron, Mark J.; Leon, Alberto J.; Cameron, Cheryl M.; Ran, Longsi; Xu, Luoling; Danesh, Ali; Fang, Yuan; Paquette, Stephane G.; Rowe, Thomas; Kelvin, David J.] Toronto Gen Hosp, Div Expt Therapeut, Res Inst, Univ Hlth Network, Toronto, ON, Canada; [Paquette, Stephane G.; Kelvin, David J.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON M5S 1A1, Canada; [Danesh, Ali; Fang, Yuan; Kelvin, David J.] Univ Toronto, Dept Immunol, Fac Med, Toronto, ON, Canada; [Leon, Alberto J.; Kelvin, David J.] Shantou Univ, Int Inst Infect & Immun, Coll Med, Shantou, Guangdong, Peoples R China; [Chu, Yong-Kyu; Li, Qianjun; Anderson, Austin] So Res Inst, Dept Biochem & Mol Biol, Birmingham, AL 35255 USA; [Couch, Ronald C.; Fomukong, Ndingsa G.; Harrod, Kevin S.; Kelvin, David J.] Lovelace Resp Res Inst, Albuquerque, NM USA; [Jonsson, Colleen B.] Ctr Predict Med, Louisville, KY USA; [Kistner, Otfried; Lauchart, Manfred] Baxter Innovat GmbH, Vienna, Austria; [Kelvin, Alyson A.] Immune Diagnost & Res, Toronto, ON, Canada; [Kelvin, David J.] Univ Sassari, Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, I-07100 Sassari, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Shantou University; Lovelace Respiratory Research Institute; Baxter International Inc; Baxter Innovations GmbH; University of Sassari	Kelvin, DJ (corresponding author), Toronto Gen Hosp, Div Expt Therapeut, Res Inst, Univ Hlth Network, Toronto, ON, Canada.	dkelvin@uhnres.utoronto.ca	Jonsson, Colleen/GPC-4424-2022; Rowe, Thomas/AAW-4899-2020; Jonsson, Colleen/X-2360-2019; Cameron, Mark/O-6775-2019	Jonsson, Colleen/0000-0002-2640-7672; Cameron, Mark/0000-0003-4768-4094; Harrod, Kevin/0000-0003-0780-9470	Canadian Institutes of Health Research (CIHR); Baxter Innovations GmbH; National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID) [N01-AI-30063, 03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Baxter Innovations GmbH; National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Canadian Institutes of Health Research (CIHR), and Baxter Innovations GmbH and the National Institutes of Health and National Institute of Allergy and Infectious Disease (NIH/NIAID) through Contract No. N01-AI-30063 Task Order No. 03. The CIHR and NIH/NIAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Baxter supplied the SARS vaccine and were involved in the design of vaccination study.	Banner D, 2012, J INFECT DEV COUNTR, V6, P465; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Cameron MJ, 2008, VIRUS RES, V133, P13, DOI 10.1016/j.virusres.2007.02.014; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Chan M C W, 2011, Hong Kong Med J, V17 Suppl 6, P31; Chu YK, 2008, VIROLOGY, V374, P151, DOI 10.1016/j.virol.2007.12.032; Czub M, 2005, VACCINE, V23, P2273, DOI 10.1016/j.vaccine.2005.01.033; Danesh A, 2011, VIROLOGY, V409, P102, DOI 10.1016/j.virol.2010.10.002; Darnell MER, 2007, J INFECT DIS, V196, P1329, DOI 10.1086/522431; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849; Ghai R, 2007, IMMUNOBIOLOGY, V212, P253, DOI 10.1016/j.imbio.2006.11.001; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hogan RJ, 2004, J VIROL, V78, P11416, DOI 10.1128/JVI.78.20.11416-11421.2004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Kelvin AA, 2012, INTECH IMMUNOASSAYS; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kobinger GP, 2007, VACCINE, V25, P5220, DOI 10.1016/j.vaccine.2007.04.065; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Le Goff B, 2010, JOINT BONE SPINE, V77, P201, DOI 10.1016/j.jbspin.2010.03.002; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006; Lu HC, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-3; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Peiris J. S. Malik, 2008, V454, P61, DOI 10.1007/978-1-59745-181-9_6; Peltola VT, 2006, INFECT IMMUN, V74, P2562, DOI 10.1128/IAI.74.5.2562-2567.2006; Roberts A, 2005, J VIROL, V79, P503, DOI 10.1128/JVI.79.1.503-511.2005; Roberts A, 2005, J VIROL, V79, P5833, DOI 10.1128/JVI.79.9.5833-5838.2005; Rockx B, 2009, J VIROL, V83, P7062, DOI 10.1128/JVI.00127-09; Rowe T, 2010, J GEN VIROL, V91, P2898, DOI 10.1099/vir.0.024323-0; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; See RH, 2008, J GEN VIROL, V89, P2136, DOI 10.1099/vir.0.2008/001891-0; Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10; Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Totura AL, 2012, CURR OPIN VIROL, V2, P264, DOI 10.1016/j.coviro.2012.04.004; Vega VB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-32; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Weingartl H, 2004, J VIROL, V78, P12672, DOI 10.1128/JVI.78.22.12672-12676.2004; Wentworth DE, 2004, EMERG INFECT DIS, V10, P1293, DOI 10.3201/eid1007.031119; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	52	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45842	10.1371/journal.pone.0045842	http://dx.doi.org/10.1371/journal.pone.0045842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029269	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700077
J	Hashemi, H; Pouyanfard, S; Bandehpour, M; Noroozbabaei, Z; Kazemi, B; Saelens, X; Mokhtari-Azad, T				Hashemi, Hamidreza; Pouyanfard, Somayeh; Bandehpour, Mojgan; Noroozbabaei, Zahra; Kazemi, Bahram; Saelens, Xavier; Mokhtari-Azad, Talat			Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge	PLOS ONE			English	Article							ANTIGENIC PEPTIDE VACCINE; MATRIX PROTEIN-2; M2 PROTEIN; MONOCLONAL-ANTIBODY; PHAGE DISPLAY; EXTRACELLULAR DOMAIN; EFFICIENT INDUCTION; CAPSID SURFACE; BACTERIOPHAGE-T4; RESPONSES	Considering the emergence of highly pathogenic influenza viruses and threat of worldwide pandemics, there is an urgent need to develop broadly-protective influenza vaccines. In this study, we demonstrate the potential of T7 bacteriophage-based nanoparticles with genetically fused ectodomain of influenza A virus M2 protein (T7-M2e) as a candidate universal flu vaccine. Immunization of mice with non-adjuvanted T7-M2e elicited M2e-specific serum antibody responses that were similar in magnitude to those elicited by M2e peptide administered in Freund's adjuvant. Comparable IgG responses directed against T7 phage capsomers were induced following vaccination with wild type T7 or T7-M2e. T7-M2e immunization induced balanced amounts of IgG(1) and IgG(2a) antibodies and these antibodies specifically recognized native M2 on the surface of influenza A virus-infected mammalian cells. The frequency of IFN-gamma-secreting T cells induced by T7-M2e nanoparticles was comparable to those elicited by M2e peptide emulsified in Freund's adjuvant. Emulsification of T7-M2e nanoparticles in Freund's adjuvant, however, induced a significantly stronger T cell response. Furthermore, T7-M2e-immunized mice were protected against lethal challenge with an H1N1 or an H3N2 virus, implying the induction of heterosubtypic immunity in our mouse model. T7-M2e-immunized mice displayed considerable weight loss and had significantly reduced viral load in their lungs compared to controls. We conclude that display of M2e on the surface of T7 phage nanoparticles offers an efficient and economical opportunity to induce cross-protective M2e-based immunity against influenza A.	[Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran; [Pouyanfard, Somayeh] Tarbiat Modares Univ, Dept Virol, Tehran, Iran; [Hashemi, Hamidreza; Noroozbabaei, Zahra; Mokhtari-Azad, Talat] Univ Tehran Med Sci, Dept Virol, Tehran, Iran; [Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Dept Biotechnol, Sch Med, Tehran, Iran; [Saelens, Xavier] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Shahid Beheshti University Medical Sciences; Tarbiat Modares University; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Flanders Institute for Biotechnology (VIB); Ghent University	Kazemi, B (corresponding author), Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran.	kazemi@sbmu.ac.ir; Mokhtari@Sina.tums.ac.ir	Kazemi, Bahram/F-2785-2016; bandehpour, mojgan/O-9744-2019; Saelens, Xavier/N-5728-2015; Kazemi, Bahram/GRR-9838-2022	Kazemi, Bahram/0000-0002-3072-8831; bandehpour, mojgan/0000-0002-5479-2846; , Xavier/0000-0002-3861-6965	Tehran University of Medical Sciences [15786]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was part of a Ph.D thesis supported by Tehran University of Medical Sciences, grant number 15786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballea S, 2007, VALUE HEALTH, V10, P98, DOI 10.1111/j.1524-4733.2006.00157.x; Adams MH, 1959, BACTERIOPHAGES; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Chackerian B, 1999, P NATL ACAD SCI USA, V96, P2373, DOI 10.1073/pnas.96.5.2373; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Couch R B, 1975, Dev Biol Stand, V28, P295; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; De Berardinis P, 2000, NAT BIOTECHNOL, V18, P873, DOI 10.1038/78490; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; DENKERS EY, 1985, J IMMUNOL, V135, P2183; Di Giovine M, 2001, VIROLOGY, V282, P102, DOI 10.1006/viro.2000.0809; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Fang JB, 2005, VACCINE, V23, P4860, DOI 10.1016/j.vaccine.2005.05.024; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Franke ED, 1997, J IMMUNOL, V159, P3424; Gamage LNA, 2009, VACCINE, V27, P6595, DOI 10.1016/j.vaccine.2009.08.019; GETHING MJ, 1980, NATURE, V287, P301, DOI 10.1038/287301a0; Gupta A, 2003, J MOL BIOL, V334, P241, DOI 10.1016/j.jmb.2003.09.033; Hayes S, 2010, VACCINE, V28, P6789, DOI 10.1016/j.vaccine.2010.07.047; Herrmann S, 2007, J VIROL METHODS, V141, P133, DOI 10.1016/j.jviromet.2006.11.041; HEUSSER CH, 1977, J EXP MED, V145, P1316, DOI 10.1084/jem.145.5.1316; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; JACKSON DC, 1991, ARCH VIROL, V118, P199, DOI 10.1007/BF01314030; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Jiang J, 1997, INFECT IMMUN, V65, P4770, DOI 10.1128/IAI.65.11.4770-4777.1997; JOU WM, 1980, CELL, V19, P683, DOI 10.1016/S0092-8674(80)80045-6; Kouskoff V, 2000, SCIENCE, V287, P2501, DOI 10.1126/science.287.5462.2501; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LAMB RA, 1981, VIROLOGY, V112, P729, DOI 10.1016/0042-6822(81)90317-2; Markine-Goriaynoff D, 2002, J VIROL, V76, P432, DOI 10.1128/JVI.76.1.432-435.2002; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Morrot A, 2006, INFECT IMMUN, V74, P2495, DOI 10.1128/IAI.74.4.2495-2497.2006; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Park EK, 1998, J VIROL, V72, P2449, DOI 10.1128/JVI.72.3.2449-2455.1998; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Ren SX, 2009, ACTA PHARMACOL SIN, V30, P637, DOI 10.1038/aps.2009.44; Ren SX, 2011, VACCINE, V29, P5802, DOI 10.1016/j.vaccine.2011.03.051; Ren ZJ, 2008, VACCINE, V26, P1471, DOI 10.1016/j.vaccine.2007.12.053; Rosenberg AGK, 1996, NOVAGEN NEWSLETTER, P1; Sathaliyawala T, 2006, J VIROL, V80, P7688, DOI 10.1128/JVI.00235-06; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Shivachandra SB, 2007, VACCINE, V25, P1225, DOI 10.1016/j.vaccine.2006.10.010; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Tan GH, 2005, J MED VIROL, V77, P475, DOI 10.1002/jmv.20479; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Towbin H, 1992, Biotechnology, V24, P145; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Ulivieri C, 2008, IMMUNOL LETT, V119, P62, DOI 10.1016/j.imlet.2008.04.004; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P6095, DOI 10.1016/j.vaccine.2008.11.037; Wu JM, 2007, J VIROL METHODS, V139, P50, DOI 10.1016/j.jviromet.2006.09.017; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9	75	64	67	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45765	10.1371/journal.pone.0045765	http://dx.doi.org/10.1371/journal.pone.0045765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029232	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700068
J	Lenart, N; Szegedi, V; Juhasz, G; Kasztner, A; Horvath, J; Bereczki, E; Toth, ME; Penke, B; Santha, M				Lenart, Nikolett; Szegedi, Viktor; Juhasz, Gabor; Kasztner, Aniko; Horvath, Janos; Bereczki, Erika; Toth, Melinda E.; Penke, Botond; Santha, Miklos			Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice	PLOS ONE			English	Article							GAMMA-MUTANT MICE; ALZHEIMERS-DISEASE; PKC-GAMMA; NEUROFIBRILLARY DEGENERATION; APOLIPOPROTEIN-B; NILE RED; A-BETA; PROTEIN; BRAIN; MOUSE	Aims: ApoB-100 is the major protein component of cholesterol- and triglyceride-rich LDL and VLDL lipoproteins in the serum. Previously, we generated and partially described transgenic mice overexpressing the human ApoB-100 protein. Here, we further characterize this transgenic strain in order to reveal a possible link between hypeprlipidemia and neurodegeneration. Methods and Results: We analyzed the serum and cerebral lipid profiles, tau phosphorylation patterns, amyloid plaque-formation, neuronal apoptosis and synaptic plasticity of young (3 month old), adult (6 month old) and aging (10-11 month old) transgenic mice. We show that ApoB-100 transgenic animals present i) elevated serum and cerebral levels of triglycerides and ApoB-100, ii) increased cerebral tau phosphorylation at phosphosites Ser(199), Ser(199/202), Ser(396) and Ser(404). Furthermore, we demonstrate, that tau hyperphosphorylation is accompanied by impaired presynaptic function, long-term potentiation and widespread hippocampal neuronal apoptosis. Conclusions: The results presented here indicate that elevated ApoB-100 level and the consequent chronic hypertriglyceridemia may lead to impaired neuronal function and neurodegeneration, possibly via hyperphosphorylation of tau protein. On account of their specific phenotype, ApoB-100 transgenic mice may be considered a versatile model of hyperlipidemia-induced age-related neurodegeneration.	[Lenart, Nikolett; Kasztner, Aniko; Bereczki, Erika; Toth, Melinda E.; Santha, Miklos] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Szegedi, Viktor; Juhasz, Gabor; Penke, Botond] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary; [Horvath, Janos; Penke, Botond] Univ Szeged, Inst Med Chem, Fac Med, Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Santha, M (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	santha@brc.hu	Bereczki, Erika/GSD-4808-2022; Santha, Miklos/F-4772-2013	Bereczki, Erika/0000-0002-0373-7417; Lenart, Nikolett/0000-0002-7456-949X; Juhasz, Gabor/0000-0001-6912-5109; Szegedi, Viktor/0000-0003-4191-379X	National Office for Research and Technology [TAMOP-4.2.2-08/1-2008-0002, TAMOP 4.2.1B-1/9-KONV, GOP 1.1.1-11-2011-0003]; NKTH [TAMOP-4.2.2/B-10/1-2010-0012]	National Office for Research and Technology(National Office for Research and TechnologyTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NKTH(National Office for Research and Technology)	This work was supported by the National Office for Research and Technology grants (TAMOP-4.2.2-08/1-2008-0002 to BP and MS, TAMOP 4.2.1B-1/9-KONV to BP and GOP 1.1.1-11-2011-0003 to MS). NL was a participant of the PhD Support Program for Talented Students at University of Szeged, supported by NKTH (TAMOP-4.2.2/B-10/1-2010-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Antonios N, 2008, EUR NEUROL, V60, P269, DOI 10.1159/000157880; Bjelik A, 2006, NEUROCHEM INT, V49, P393, DOI 10.1016/j.neuint.2006.01.026; CALLOW MJ, 1994, P NATL ACAD SCI USA, V91, P2130, DOI 10.1073/pnas.91.6.2130; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chan A, 2006, J ALZHEIMERS DIS, V9, P399; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cromwell William C, 2009, Curr Cardiol Rep, V11, P468; Csont T, 2007, CARDIOVASC RES, V76, P100, DOI 10.1016/j.cardiores.2007.06.006; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; FOWLER SD, 1985, J HISTOCHEM CYTOCHEM, V33, P833, DOI 10.1177/33.8.4020099; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Panza F, 2006, BRAIN RES REV, V51, P275, DOI 10.1016/j.brainresrev.2005.11.007; Pei JJ, 2008, CURR OPIN PSYCHIATR, V21, P555, DOI 10.1097/YCO.0b013e328314b78b; Pelech Steven, 2003, Methods Mol Biol, V218, P99; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Sabbagh M, 2004, J ALZHEIMERS DIS, V6, P585; Saito N, 2002, J BIOCHEM, V132, P683, DOI 10.1093/oxfordjournals.jbchem.a003274; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; SPARKS DL, 1995, NEUROSCI LETT, V187, P142, DOI 10.1016/0304-3940(95)11357-6; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Sule Z, 2009, LIFE SCI, V84, P935, DOI 10.1016/j.lfs.2009.04.011; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Wang DY, 2011, J BIOL CHEM, V286, P31852, DOI 10.1074/jbc.M111.244335; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Watanabe T, 2004, METABOLISM, V53, P476, DOI 10.1016/j.metabol.2003.11.020; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46007	10.1371/journal.pone.0046007	http://dx.doi.org/10.1371/journal.pone.0046007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029362	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000309554700104
J	Meisner, JK; Song, J; Price, RJ				Meisner, Joshua K.; Song, Ji; Price, Richard J.			Arteriolar and Venular Remodeling Are Differentially Regulated by Bone Marrow-Derived Cell-Specific CX3CR1 and CCR2 Expression	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MONOCYTES; ARTERIOGENESIS; MACROPHAGE; HETEROGENEITY; ANGIOGENESIS; MIGRATION; ISCHEMIA; SUBSETS	The chemokine receptors CCR2 and CX3CR1 are critical for the recruitment of "inflammatory" and "resident" monocytes, respectively, subpopulations that differentially affect vascular remodeling in atherosclerosis. Here, we tested the hypothesis that bone marrow-derived cell (BMC)-specific CCR2 and CX3CR1 differentially control venular and arteriolar remodeling. Venular and arteriolar lumenal remodeling were observed by intravital microscopy in mice with either CCR2 or CX3CR1 deficient BMCs after implantation of a dorsal skinfold window chamber, a model in which arterioles and venules lumenally enlarge in wild-type (WT) mice. Arteriolar remodeling was abolished in mice with either CCR2 or CX3CR1-deficient BMCs. In contrast, the loss of CX3CR1 from BMCs, but not CCR2, significantly reduced small venule remodeling compared to WT controls. We conclude that microvascular remodeling is differentially regulated by BMC-expressed chemokine receptors. Both CCR2 and CX3CR1 regulate arteriole growth; however, only BMC-expressed CX3CR1 impacts small venule growth. These findings may provide a basis for additional investigations aimed at determining how patterns of monocyte subpopulation recruitment spatially influence microvascular remodeling.	[Meisner, Joshua K.; Price, Richard J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Song, Ji; Price, Richard J.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Price, Richard J.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Price, RJ (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.	rprice@virginia.edu		Meisner, Joshua/0000-0003-1049-8351	National Heart Lung and Blood Institute [R01 HL074082]; American Heart Association [10GRNT3490001, 09PRE2060385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Heart Lung and Blood Institute Grant R01 HL074082, American Heart Association Grant-In-Aid 10GRNT3490001, and American Heart Association Pre-Doctoral Fellowhip 09PRE2060385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Doyle ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032815; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Nickerson MM, 2009, ARTERIOSCL THROM VAS, V29, P1794, DOI 10.1161/ATVBAHA.109.194019; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Rege A, 2012, ANGIOGENESIS, V15, P87, DOI 10.1007/s10456-011-9245-x; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Swirski FK, 2011, ARTERIOSCL THROM VAS, V31, P1517, DOI 10.1161/ATVBAHA.110.221150; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Uchida Y, 2012, INT HEART J, V53, P54, DOI 10.1536/ihj.53.54; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46312	10.1371/journal.pone.0046312	http://dx.doi.org/10.1371/journal.pone.0046312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029475	gold, Green Published			2022-12-25	WOS:000309554700121
J	Chang, YM; Chen, CKM; Chang, YC; Jeng, WY; Hou, MH; Wang, AHJ				Chang, Yu-Ming; Chen, Cammy K. -M.; Chang, Yuan-Chih; Jeng, Wen-Yih; Hou, Ming-Hon; Wang, Andrew H. -J.			Functional Studies of ssDNA Binding Ability of MarR Family Protein TcaR from Staphylococcus epidermidis	PLOS ONE			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; DNA-BINDING; BACTERIOPHAGE THERAPY; REGULATOR; REPRESSOR; MECHANISM; STABILITY; LIGAND; TRANSCRIPTION	The negative transcription regulator of the ica locus, TcaR, regulates proteins involved in the biosynthesis of poly-N-acetylglucosamine (PNAG). Absence of TcaR increases PNAG production and promotes biofilm formation in Staphylococci. Previously, the 3D structure of TcaR in its apo form and its complex structure with several antibiotics have been analyzed. However, the detailed mechanism of multiple antibiotic resistance regulator (MarR) family proteins such as TcaR is unclear and only restricted on the binding ability of double-strand DNA (dsDNA). Here we show by electrophoretic mobility shift assay (EMSA), electron microscopy (EM), circular dichroism (CD), and Biacore analysis that TcaR can interact strongly with single-stranded DNA (ssDNA), thereby identifying a new role in MarR family proteins. Moreover, we show that TcaR preferentially binds 33-mer ssDNA over double-stranded DNA and inhibits viral ssDNA replication. In contrast, such ssDNA binding properties were not observed for other MarR family protein and TetR family protein, suggesting that the results from our studies are not an artifact due to simple charge interactions between TcaR and ssDNA. Overall, these results suggest a novel role for TcaR in regulation of DNA replication. We anticipate that the results of this work will extend our understanding of MarR family protein and broaden the development of new therapeutic strategies for Staphylococci.	[Chang, Yu-Ming; Chen, Cammy K. -M.; Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Jeng, Wen-Yih; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw	CHANG, Yuan-Chih/J-2609-2016	CHANG, Yuan-Chih/0000-0002-0289-3768; Hou, Ming-hon/0000-0003-4170-1527	Academia Sinica and National Science Council (Taiwan) [NSC96-3114-P-001-004, NSC97-3114-P-001-001, NSC99-3113-B-001-001]; Institute of Biological Chemistry at Academia Sinica and; National Research Program for Biopharmaceuticals	Academia Sinica and National Science Council (Taiwan); Institute of Biological Chemistry at Academia Sinica and; National Research Program for Biopharmaceuticals	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC96-3114-P-001-004, NSC97-3114-P-001-001, and NSC99-3113-B-001-001 (to AH-JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We, the authors, acknowledge the support of grants from the Institute of Biological Chemistry at Academia Sinica and National Research Program for Biopharmaceuticals. We are also grateful for the use of the Tecnai F20 in the Cryo-EM Core Facility, Scientific Instrument Center at Academia Sinica.	Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Alekshun MN, 1999, J BACTERIOL, V181, P4669, DOI 10.1128/JB.181.15.4669-4672.1999; Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Anderson SD, 2008, ANN PHARMACOTHER, V42, P806, DOI 10.1345/aph.1L016; [Anonymous], 1983, LANCET, V2, P1287; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Brandenberger M, 2000, BBA-GEN SUBJECTS, V1523, P135, DOI 10.1016/S0304-4165(00)00133-1; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267; Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Chin KH, 2006, PROTEINS, V65, P239, DOI 10.1002/prot.21017; Christensen J, 2002, J VIROL, V76, P6518, DOI 10.1128/JVI.76.13.6518-6531.2002; Corbin-Lickfett KA, 2009, NUCLEIC ACIDS RES, V37, P7290, DOI 10.1093/nar/gkp793; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Guerra AJ, 2011, J AM CHEM SOC, V133, P19614, DOI 10.1021/ja2080532; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hou MH, 2008, BIOCHEMISTRY-US, V47, P5493, DOI 10.1021/bi701915f; Hou MH, 2009, BIOCHEMISTRY-US, V48, P4691, DOI 10.1021/bi900092w; Huang CY, 2009, PROTEIN SCI, V18, P2209, DOI 10.1002/pro.225; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Llull D, 2011, J BACTERIOL, V193, P1919, DOI 10.1128/JB.01109-10; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Mattey M, 2008, CURR OPIN BIOTECH, V19, P608, DOI 10.1016/j.copbio.2008.09.001; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Miller PF, 1996, MOL MICROBIOL, V21, P441, DOI 10.1111/j.1365-2958.1996.tb02553.x; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Palm GJ, 2012, NUCL ACIDS RES; Pirisi A, 2000, LANCET, V356, P1418, DOI 10.1016/S0140-6736(05)74059-9; Saridakis V, 2008, J MOL BIOL, V377, P655, DOI 10.1016/j.jmb.2008.01.001; Sitohy M, 2006, J AGR FOOD CHEM, V54, P3800, DOI 10.1021/jf0531757; Smith HO, 2003, P NATL ACAD SCI USA, V100, P15440, DOI 10.1073/pnas.2237126100; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Traktman Paula, 2004, Methods Mol Biol, V269, P169; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wu JG, 2007, NUCLEIC ACIDS RES, V35, P2390, DOI 10.1093/nar/gkm149	52	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45665	10.1371/journal.pone.0045665	http://dx.doi.org/10.1371/journal.pone.0045665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029170	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800075
J	Di Milia, L; Rogers, NL; Akerstedt, T				Di Milia, Lee; Rogers, Naomi L.; Akerstedt, Torbjorn			Sleepiness, Long Distance Commuting and Night Work as Predictors of Driving Performance	PLOS ONE			English	Article							SHIFT-WORK; FATIGUE; ACCIDENTS; ALERTNESS; DISORDERS; SLEEPY; HEALTH; RISK	Few studies have examined the effect of working night shift and long distance commuting. We examined the association between several sleep related and demographic variables, commuting distance, night work and use of mobile phones on driving performance. We used a prospective design to recruit participants and conducted a telephone survey (n = 649). The survey collected demographic and journey details, work and sleep history and driving performance concerning the day the participant was recruited. Participants also completed the Karolinska Sleepiness Scale and the Epworth Sleepiness Scale. Night workers reported significantly more sleepiness, shorter sleep duration and commuting longer distances. Seven variables were significant predictors of lane crossing. The strongest predictor was acute sleepiness (OR = 5.25, CI, 1.42-19.49, p < 0.01) followed by driving >= 150 kms (OR = 3.61, CI, 1.66-7.81, p < 0.001), obtaining less than 10 hours sleep in the previous 48 hours (OR = 2.58, CI, 1.03-6.46, p < 0.05), driving after night shift (OR = 2.19, CI, 1.24-3.88, p < 0.001), being <43 years old (OR = 1.95, CI, 1.11-3.41, p < 0.05) and using mobile phones during the journey (OR = 1.90, CI, 1.10-3.27, p < 0.05). Sleep related variables, long-distance commuting and night work have a major impact on lane crossing. Several interventions should be considered to reduce the level of sleepiness in night workers.	[Di Milia, Lee] Cent Queensland Univ, Sch Management, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Rogers, Naomi L.] Cent Queensland Univ, Chronobiol & Sleep Unit, Rockhampton, Qld 4702, Australia; [Akerstedt, Torbjorn] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Central Queensland University; Central Queensland University; Stockholm University	Di Milia, L (corresponding author), Cent Queensland Univ, Sch Management, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia.	v.dimilia@cqu.edu.au	Di Milia, Lee/A-6810-2008; Rogers, Naomi/G-3538-2013	Di Milia, Lee/0000-0001-7681-5589; Rogers, Naomi/0000-0002-0536-9814; Akerstedt, Torbjorn/0000-0001-8049-8504	Department of Transport and Main Roads, QLD, Australia	Department of Transport and Main Roads, QLD, Australia	The study was funded by the Department of Transport and Main Roads, QLD, Australia. The funders had no role in study design, data collection and analysis, decision to submit or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; Akerstedt T, 2005, J SLEEP RES, V14, P17, DOI 10.1111/j.1365-2869.2004.00437.x; Akerstedt T, 2002, J PSYCHOSOM RES, V53, P585, DOI 10.1016/S0022-3999(02)00447-6; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Basner M, 2012, SLEEP, V35, P193, DOI 10.5665/sleep.1620; Bjorvatn B, 2006, SLEEP, V29, P821, DOI 10.1093/sleep/29.6.821; Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Cummings P, 2001, Inj Prev, V7, P194, DOI 10.1136/ip.7.3.194; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Czeisler CA, 2009, MAYO CLIN PROC, V84, P958, DOI 10.1016/S0025-6196(11)60666-6; Dawson D, 2005, SLEEP MED REV, V9, P365, DOI 10.1016/j.smrv.2005.03.002; Di Milia L, 2006, TRANSPORT RES F-TRAF, V9, P278, DOI 10.1016/j.trf.2006.01.006; GOLD DR, 1992, AM J PUBLIC HEALTH, V82, P1011, DOI 10.2105/AJPH.82.7.1011; Horne J, 1999, BRIT MED J, V310, P565; Jermakian JS, 2011, ACCIDENT ANAL PREV, V43, P732, DOI 10.1016/j.aap.2010.10.020; Lowden A, 2012, CHRONOBIOL INT, V29, P641, DOI 10.3109/07420528.2012.675850; Muller R, 2008, ANN OCCUP HYG, V52, P63, DOI 10.1093/annhyg/mem058; Nabi H, 2006, BRIT MED J, V333, P75, DOI 10.1136/bmj.38863.638194.AE; National Sleep Foundation, 2011, 2011 SLEEP AM POLL C; Ohayon MM, 2002, J PSYCHOSOM RES, V53, P577, DOI 10.1016/S0022-3999(02)00438-5; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Pilcher JJ, 2000, SLEEP, V23, P155; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Richardson G S, 1989, Alcohol Drugs Driving, V5-6, P265; Rogers A, 2001, J Hum Ergol (Tokyo), V30, P131; Rogers NL, 2003, FRONT BIOSCI-LANDMRK, V8, pS1056, DOI 10.2741/1174; ROSA RR, 1991, WORK STRESS, V5, P107, DOI 10.1080/02678379108257008; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; Sagberg F, 1999, ACCIDENT ANAL PREV, V31, P639, DOI 10.1016/S0001-4575(99)00023-8; Siskind V, 2011, ACCIDENT ANAL PREV, V43, P1082, DOI 10.1016/j.aap.2010.12.016; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Ting PH, 2008, PHYSIOL BEHAV, V94, P448, DOI 10.1016/j.physbeh.2008.02.015; Tziotis N, 2005, APR27305; Waage S, 2012, SLEEP MED, V13, P64, DOI 10.1016/j.sleep.2011.04.009; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	40	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45856	10.1371/journal.pone.0045856	http://dx.doi.org/10.1371/journal.pone.0045856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029278	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800106
J	Li, J; Mo, ML; Chen, Z; Chen, Z; Sheng, Q; Mu, H; Zhang, F; Zhang, Y; Zhi, XY; Li, H; He, BA; Zhou, HM				Li, Jie; Mo, Minli; Chen, Zhao; Chen, Zhe; Sheng, Qing; Mu, Hang; Zhang, Fang; Zhang, Yi; Zhi, Xiu-Yi; Li, Hui; He, Biao; Zhou, Hai-Meng			Adenoviral Delivery of the EMX2 Gene Suppresses Growth in Human Gastric Cancer	PLOS ONE			English	Article							ONCOLYTIC ADENOVIRUS; FUNCTION LEADS; VIRAL VECTORS; EXPRESSION; THERAPY; SURGERY; CELLS; P53; ADENOCARCINOMA; PROLIFERATION	Background: EMX2 is a human orthologue of the Drosophila empty spiracles homeobox gene that has been implicated in embryogenesis. Recent studies suggest possible involvement of EMX2 in human cancers; however, the role of EMX2 in carcinogenesis needs further exploration. Results: In this study, we reported that down-regulation of EMX2 expression was significantly correlated with EMX2 promoter hypermethylation in gastric cancer. Restoring EMX2 expression using an adenovirus delivery system in gastric cancer cell lines lacking endogenous EMX2 expression led to inhibition of cell proliferation and Wnt signaling pathway both in vitro and in a gastric cancer xenograft model in vivo. In addition, we observed that animals treated with the adenoviral EMX2 expression vector had significantly better survival than those treated with empty adenoviral vector. Conclusion: Our study suggests that EMX2 is a putative tumor suppressor in human gastric cancer. The adenoviral-EMX2 may have potential as a novel gene therapy for the treatment of patients with gastric cancer.	[Li, Hui; He, Biao] Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Li, Jie; Mo, Minli; Chen, Zhao; Chen, Zhe; Mu, Hang; Zhou, Hai-Meng] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Sheng, Qing] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Mu, Hang; Zhang, Fang; Zhou, Hai-Meng] Tsinghua Univ, Yangtze Delta Reg Inst, Zhejiang Prov Key Lab Appl Enzymol, Jiaxing, Zhejiang, Peoples R China; [Zhang, Yi; Zhi, Xiu-Yi] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tsinghua University; Zhejiang Sci-Tech University; Tsinghua University; Capital Medical University	He, BA (corresponding author), Univ Calif San Francisco, Dept Surg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	biao.he@ucsfmedctr.org; zhm-dbs@tsinghua.edu.cn	Chen, Zhe/E-4278-2015; Chen, Zhe/H-1417-2016	Chen, Zhe/0000-0002-8209-0999; 	National Key Basic Research and Development (973) Program of China [2011CB910800, 2012CB917304]; National Natural Science Foundation of China [31170732]; Natural Science Foundation of Zhejiang Province [Y2101329]; Postdoctoral Science Foundation of Zhejiang Province [2010-BSH-031]	National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Postdoctoral Science Foundation of Zhejiang Province(China Postdoctoral Science Foundation)	This work was supported by funds from the National Key Basic Research and Development (973) Program of China (2011CB910800 and 2012CB917304), the National Natural Science Foundation of China (31170732), the Natural Science Foundation of Zhejiang Province (Y2101329), and the Postdoctoral Science Foundation of Zhejiang Province (2010-BSH-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Appledorn DM, 2008, CONTRIB NEPHROL, V159, P47, DOI 10.1159/000125581; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Galli R, 2002, DEVELOPMENT, V129, P1633; Galm Oliver, 2005, V113, P279, DOI 10.1385/1-59259-916-8:279; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Idogawa M, 2009, CLIN CANCER RES, V15, P3725, DOI 10.1158/1078-0432.CCR-08-2396; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Ligon KL, 2003, DEVELOPMENT, V130, P2275, DOI 10.1242/dev.00421; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Makower D, 2003, CLIN CANCER RES, V9, P693; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mo ML, 2010, INT J BIOL MARKER, V25, P236, DOI 10.5301/JBM.2010.6088; Nishimura S, 2001, CANCER RES, V61, P7009; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Noonan FC, 2001, GENOMICS, V76, P37, DOI 10.1006/geno.2001.6590; Okamoto J, 2010, ONCOGENE, V29, P5969, DOI 10.1038/onc.2010.330; Okamoto J, 2011, CLIN LUNG CANCER, V12, P237, DOI 10.1016/j.cllc.2011.03.025; Park CY, 2008, INVEST OPHTH VIS SCI, V49, P399, DOI 10.1167/iovs.07-0619; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Roukos D, 2009, ANN SURG ONCOL, V16, P795, DOI 10.1245/s10434-009-0317-8; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Sheridan C, 2011, NAT BIOTECHNOL, V29, P121, DOI 10.1038/nbt.1769; Taylor HS, 2005, MOL ENDOCRINOL, V19, P2839, DOI 10.1210/me.2005-0130; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wu KC, 2009, J GASTROEN HEPATOL, V24, P37, DOI 10.1111/j.1440-1746.2008.05753.x; Yoshida M, 1997, DEVELOPMENT, V124, P101	43	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45970	10.1371/journal.pone.0045970	http://dx.doi.org/10.1371/journal.pone.0045970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029345	Green Submitted, Green Published, gold			2022-12-25	WOS:000309392800126
J	Schellingerhout, D; LeRoux, LG; Hobbs, BP; Bredow, S				Schellingerhout, Dawid; LeRoux, Lucia G.; Hobbs, Brian P.; Bredow, Sebastian			Impairment of Retrograde Neuronal Transport in Oxaliplatin-Induced Neuropathy Demonstrated by Molecular Imaging	PLOS ONE			English	Article							SPINAL-CORD PLASTICITY; ROOT GANGLION NEURONS; NERVE GROWTH-FACTOR; TETANUS TOXIN; AXONAL-TRANSPORT; C-FRAGMENT; ESCHERICHIA-COLI; BINDING-SITE; CISPLATIN; NEUROTOXICITY	Background and Purpose: The purpose of our study was to utilize a molecular imaging technology based on the retrograde axonal transport mechanism (neurography), to determine if oxaliplatin-induced neurotoxicity affects retrograde axonal transport in an animal model. Materials and Methods: Mice (n = 8/group) were injected with a cumulative dose of 30 mg/kg oxaliplatin (sufficient to induce neurotoxicity) or dextrose control injections. Intramuscular injections of Tetanus Toxin C-fragment (TTc) labeled with Alexa 790 fluorescent dye were done (15 ug/20 uL) in the left calf muscles, and in vivo fluorescent imaging performed (0-60 min) at baseline, and then weekly for 5 weeks, followed by 2-weekly imaging out to 9 weeks. Tissues were harvested for immunohistochemical analysis. Results: With sham treatment, TTc transport causes fluorescent signal intensity over the thoracic spine to increase from 0 to 60 minutes after injection. On average, fluorescence signal increased 722%+/-117% (Mean+/-SD) from 0 to 60 minutes. Oxaliplatin treated animals had comparable transport at baseline (787%+/-140%), but transport rapidly decreased through the course of the study, falling to 363%+/-88%, 269%+/-96%, 191%+/-58%, 121%+/-39%, 75%+/-21% with each successive week and stabilizing around 57% (+/-15%) at 7 weeks. Statistically significant divergence occurred at approximately 3 weeks (p <= 0.05, linear mixed-effects regression model). Quantitative immuno-fluorescence histology with a constant cutoff threshold showed reduced TTc in the spinal cord at 7 weeks for treated animals versus controls (5.2 Arbitrary Units +/-0.52 vs 7.1 AU +/-1.38, p<0.0004, T-test). There was no significant difference in neural cell mass between the two groups as shown with NeuN staining (10.2+/-1.21 vs 10.5 AU +/-1.53, p>0.56, T-test). Conclusion: We show-for the first time to our knowledge-that neurographic in vivo molecular imaging can demonstrate imaging changes in a model of oxaliplatin-induced neuropathy. Impaired retrograde neural transport is suggested to be an important part of the pathophysiology of oxaliplatin-induced neuropathy.	[Schellingerhout, Dawid] Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA; [Schellingerhout, Dawid; LeRoux, Lucia G.; Bredow, Sebastian] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Hobbs, Brian P.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Schellingerhout, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiol, Houston, TX 77030 USA.	Dawid.schellingerhout@mdanderson.org		Le Roux, Lucia/0000-0002-6053-2194	Mike Hogg Fund; MD Anderson Cancer Center Institutional Research Grant; John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging; National Institute of Neurologic Disorders and Stroke [R01NS070742]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070742] Funding Source: NIH RePORTER	Mike Hogg Fund; MD Anderson Cancer Center Institutional Research Grant; John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging; National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The support of the Mike Hogg Fund, MD Anderson Cancer Center Institutional Research Grant, John S. Dunn, Sr. Distinguished Chair in Diagnostic Imaging and Award Number R01NS070742 National Institute of Neurologic Disorders and Stroke are gratefully acknowledged. The content of this paper is the sole responsibility of the authors, and does not necessarily reflect the official views of our funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; APFEL SC, 1992, ANN NEUROL, V31, P76, DOI 10.1002/ana.410310114; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Binder A, 2007, EUR J CANCER, V43, P2658, DOI 10.1016/j.ejca.2007.07.030; BIZZINI B, 1980, BRAIN RES, V193, P221, DOI 10.1016/0006-8993(80)90959-2; BIZZINI B, 1977, J NEUROCHEM, V28, P529, DOI 10.1111/j.1471-4159.1977.tb10423.x; BIZZINI B, 1981, BRAIN RES, V210, P291, DOI 10.1016/0006-8993(81)90902-1; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; CAVALETTI G, 1992, CANCER-AM CANCER SOC, V69, P203, DOI 10.1002/1097-0142(19920101)69:1<203::AID-CNCR2820690133>3.0.CO;2-1; CAVALETTI G, 1991, INT J TISSUE REACT, V13, P151; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Cersosimo RJ, 2005, ANN PHARMACOTHER, V39, P128, DOI 10.1345/aph.1E319; Chen XY, 2002, J NEUROPHYSIOL, V87, P645, DOI 10.1152/jn.00391.2001; Egashira N, 2010, J PHARMACOL SCI, V112, P473, DOI 10.1254/jphs.10012SC; EISEL U, 1986, EMBO J, V5, P2495, DOI 10.1002/j.1460-2075.1986.tb04527.x; FAIRWEATHER NF, 1986, J BACTERIOL, V165, P21, DOI 10.1128/jb.165.1.21-27.1986; FAIRWEATHER NF, 1986, NUCLEIC ACIDS RES, V14, P7809, DOI 10.1093/nar/14.19.7809; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; FISHMAN PS, 1987, BRAIN RES, V406, P275, DOI 10.1016/0006-8993(87)90792-X; Grafstein B, 1999, BRAIN RES BULL, V50, P311, DOI 10.1016/S0361-9230(99)00157-4; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Konya D, 2008, REGEN MED, V3, P309, DOI 10.2217/17460751.3.3.309; Kottschade LA, 2010, SUPPORT CAR IN PRESS; Kurniali PC, 2010, ONCOLOGY-NY, V24, P289; Louch HA, 2002, BIOCHEMISTRY-US, V41, P13644, DOI 10.1021/bi020291j; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Park SB, 2008, CURR MED CHEM, V15, P3081, DOI 10.2174/092986708786848569; Parker AR, 2010, MOL CANCER THER, V9, P2558, DOI 10.1158/1535-7163.MCT-10-0300; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Raynaud M, 1967, Prog Immunobiol Stand, V3, P244; Saif M Wasif, 2005, Ther Clin Risk Manag, V1, P249; Schellingerhout D, 2009, MOL IMAGING, V8, P319, DOI 10.2310/7290.2009.00029; SCHMIDT Y, 1995, EXP NEUROL, V132, P16, DOI 10.1016/0014-4886(95)90054-3; Scuteri A, 2010, NEUROSCI LETT, V486, P141, DOI 10.1016/j.neulet.2010.09.028; Sinha K, 2000, MOL MICROBIOL, V37, P1041, DOI 10.1046/j.1365-2958.2000.02091.x; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Stockel K, 1975, EXPT BRAIN RES S, V23; Ta LE, 2006, NEUROTOXICOLOGY, V27, P992, DOI 10.1016/j.neuro.2006.04.010; Ta LE, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-9; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P1; Wolpaw JR, 2006, PROG NEUROBIOL, V78, P233, DOI 10.1016/j.pneurobio.2006.03.001; Wolpaw JR, 2006, LEARN MEMORY, V13, P208, DOI 10.1101/lm.92706; Wu SN, 2009, NEUROTOXICOLOGY, V30, P677, DOI 10.1016/j.neuro.2009.04.010; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Xu YD, 2012, J NUCL MED, V53, P312, DOI 10.2967/jnumed.111.094623; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45776	10.1371/journal.pone.0045776	http://dx.doi.org/10.1371/journal.pone.0045776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029238	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900098
J	Teixeira, PJPL; Thomazella, DPT; Vidal, RO; do Prado, PFV; Reis, O; Baroni, RM; Franco, SF; Mieczkowski, P; Pereira, GAG; Mondego, JMC				Teixeira, Paulo J. P. L.; Thomazella, Daniela P. T.; Vidal, Ramon O.; do Prado, Paula F. V.; Reis, Osvaldo; Baroni, Renata M.; Franco, Sulamita F.; Mieczkowski, Piotr; Pereira, Goncalo A. G.; Mondego, Jorge M. C.			The Fungal Pathogen Moniliophthora perniciosa Has Genes Similar to Plant PR-1 That Are Highly Expressed during Its Interaction with Cacao	PLOS ONE			English	Article							RICH SECRETORY PROTEIN; WITCHES-BROOM DISEASE; VENOM ALLERGEN; CRINIPELLIS-PERNICIOSA; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; THEOBROMA-CACAO; CAUSAL AGENT; MELOIDOGYNE-INCOGNITA; BIOTROPHIC-LIKE	The widespread SCP/TAPS superfamily (SCP/Tpx-1/Ag5/PR-1/Sc7) has multiple biological functions, including roles in the immune response of plants and animals, development of male reproductive tract in mammals, venom activity in insects and reptiles and host invasion by parasitic worms. Plant Pathogenesis Related 1 (PR-1) proteins belong to this superfamily and have been characterized as markers of induced defense against pathogens. This work presents the characterization of eleven genes homologous to plant PR-1 genes, designated as MpPR-1, which were identified in the genome of Moniliophthora perniciosa, a basidiomycete fungus responsible for causing the devastating witches' broom disease in cacao. We describe gene structure, protein alignment and modeling analyses of the MpPR-1 family. Additionally, the expression profiles of MpPR-1 genes were assessed by qPCR in different stages throughout the fungal life cycle. A specific expression pattern was verified for each member of the MpPR-1 family in the conditions analyzed. Interestingly, some of them were highly and specifically expressed during the interaction of the fungus with cacao, suggesting a role for the MpPR-1 proteins in the infective process of this pathogen. Hypothetical functions assigned to members of the MpPR-1 family include neutralization of plant defenses, antimicrobial activity to avoid competitors and fruiting body physiology. This study provides strong evidence on the importance of PR-1-like genes for fungal virulence on plants.	[Teixeira, Paulo J. P. L.; Thomazella, Daniela P. T.; Vidal, Ramon O.; do Prado, Paula F. V.; Reis, Osvaldo; Baroni, Renata M.; Franco, Sulamita F.; Pereira, Goncalo A. G.] Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil; [Vidal, Ramon O.] Lab Nacl Biociencias, Sao Paulo, Brazil; [Baroni, Renata M.; Mondego, Jorge M. C.] Inst Agron Campinas, Ctr Pesquisa & Desenvolvimento Recursos Genet Veg, Sao Paulo, Brazil; [Mieczkowski, Piotr] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA	Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Pereira, GAG (corresponding author), Univ Estadual Campinas, Dept Genet Evolucao & Bioagentes, Sao Paulo, Brazil.	goncalo@unicamp.br	Thomazella, Daniela Paula de Toledo/D-2750-2012; Teixeira, Paulo/C-1546-2013; Pereira, Gonçalo A. G./B-7944-2012	Teixeira, Paulo/0000-0002-0776-5044; Mieczkowski, Piotr/0000-0003-2418-0096; Favoretti Vital do Prado, Paula/0000-0002-3427-2229	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/53553-3, 2007/50262-0, 2009/51018-1, 2009/50119-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2006/53553-3, 2007/50262-0, 2009/51018-1 and 2009/50119-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Asojo OA, 2005, J MOL BIOL, V346, P801, DOI 10.1016/j.jmb.2004.12.023; Braun BR, 2000, GENETICS, V156, P31; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Cantacessi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031164; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding X, 2000, INT J PARASITOL, V30, P77, DOI 10.1016/S0020-7519(99)00165-4; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandez C, 1997, J MOL BIOL, V266, P576, DOI 10.1006/jmbi.1996.0772; FRIAS GA, 1995, PLANT DIS, V79, P787, DOI 10.1094/PD-79-0787; Gao B, 2001, INT J PARASITOL, V31, P1617, DOI 10.1016/S0020-7519(01)00300-9; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Kang JS, 2012, INT J PARASITOL, V42, P63, DOI 10.1016/j.ijpara.2011.10.006; Kiba A, 2007, PLANT BIOTECHNOL-NAR, V24, P247, DOI 10.5511/plantbiotechnology.24.247; King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lozano J, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P28, DOI 10.1079/9781845936877.0028; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; LU G, 1993, J IMMUNOL, V150, P2823; Meinhardt LW, 2006, CURR MICROBIOL, V52, P191, DOI 10.1007/s00284-005-0182-z; Meinhardt LW, 2008, MOL PLANT PATHOL, V9, P577, DOI 10.1111/J.1364-3703.2008.00496.X; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; MIZUKI N, 1992, MAMM GENOME, V3, P274, DOI 10.1007/BF00292155; MOCHCAMORALES J, 1990, TOXICON, V28, P299, DOI 10.1016/0041-0101(90)90065-F; Mondego JMC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-548; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Oeser B, 2009, MOL PLANT PATHOL, V10, P665, DOI [10.1111/j.1364-3703.2009.00560.x, 10.1111/J.1364-3703.2009.00560.X]; Perfect SE, 2001, MOL PLANT PATHOL, V2, P101, DOI 10.1046/j.1364-3703.2001.00055.x; Pires ABL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-158; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573; Rauscher M, 1999, PLANT J, V19, P625, DOI 10.1046/j.1365-313x.1999.00545.x; REALINI C, 1994, FEBS LETT, V348, P109, DOI 10.1016/0014-5793(94)00569-9; REALINI C, 1995, J BIOL CHEM, V270, P29664; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rincones J, 2008, MOL PLANT MICROBE IN, V21, P891, DOI 10.1094/MPMI-21-7-0891; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Scarpari LM, 2005, J EXP BOT, V56, P865, DOI 10.1093/jxb/eri079; SCHUREN FHJ, 1993, J GEN MICROBIOL, V139, P2083, DOI 10.1099/00221287-139-9-2083; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; Thomazella DPT, 2012, NEW PHYTOL, V194, P1025, DOI 10.1111/j.1469-8137.2012.04119.x; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Wang X, 2007, EXP PARASITOL, V117, P133, DOI 10.1016/j.exppara.2007.03.017; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu F, 2012, BIOTECHNOL LETT; Zuniga S, 1999, GENE, V233, P141, DOI 10.1016/S0378-1119(99)00145-6	62	23	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45929	10.1371/journal.pone.0045929	http://dx.doi.org/10.1371/journal.pone.0045929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029323	Green Published, gold			2022-12-25	WOS:000309388900113
J	Ajay, AK; Saikumar, J; Bijol, V; Vaidya, VS				Ajay, Amrendra Kumar; Saikumar, Janani; Bijol, Vanesa; Vaidya, Vishal S.			Heterozygosity for Fibrinogen Results in Efficient Resolution of Kidney Ischemia Reperfusion Injury	PLOS ONE			English	Article							LEUKOCYTE-ENDOTHELIUM INTERACTION; DEFICIENT MICE; MYOCARDIAL-INFARCTION; PLASMA-FIBRINOGEN; ADHESION; DISEASE; ACTIVATION; FIBROSIS; RECOGNITION; EXPRESSION	Fibrinogen (Fg) has been recognized to play a central role in coagulation, inflammation and tissue regeneration. Several studies have used Fg deficient mice (Fg(-/-)) in comparison with heterozygous mice (Fg(+/-)) to point the proinflammatory role of Fg in diverse pathological conditions and disease states. Although Fg(+/-) mice are considered 'ormal', plasma Fg is reduced to similar to 75% of the normal circulating levels present in wild type mice (Fg(+/+)). We report that this reduction in Fg protein production in the Fg(+/-) mice is enough to protect them from kidney ischemia reperfusion injury (IRI) as assessed by tubular injury, kidney dysfunction, necrosis, apoptosis and inflammatory immune cell infiltration. Mechanistically, we observed binding of Fg to ICAM-1 in kidney tissues of Fg(+/+) mice at 24 h following IRI as compared to a complete absence of binding observed in the Fg(+/-) and Fg(-/-) mice. Raf-1 and ERK were highly activated as evident by significantly higher phosphorylation in the Fg(+/+) kidneys at 24 h following IRI as compared to Fg(+/-) and Fg(-/-) mice kidneys. On the other hand Cyclin D1 and pRb, indicating higher cell proliferation, were significantly increased in the Fg(+/-) and Fg(-/-) as compared to Fg(+/+) kidneys. These data suggest that Fg heterozygosity allows maintenance of a critical balance of Fg that enables regression of initial injury and promotes faster resolution of kidney damage.	[Ajay, Amrendra Kumar; Saikumar, Janani; Vaidya, Vishal S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA; [Bijol, Vanesa] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Vaidya, VS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Renal,Dept Med, Boston, MA 02115 USA.	vvaidya@partners.org	Saikumar, Janani/AAE-9461-2021; Ajay, Amrendra K/D-7431-2016	Ajay, Amrendra K/0000-0003-2790-5726; Saikumar, Janani/0000-0002-8930-2472	National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award [ES017543]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017543] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work in Vaidya laboratory was supported by National Institutes of Health/National Institute of Environmental Health Sciences Outstanding New Environmental Scientist Award (ES017543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101; ALTIERI DC, 1995, J BIOL CHEM, V270, P696, DOI 10.1074/jbc.270.2.696; Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Cruz-Topete D, 2006, J PATHOL, V210, P325, DOI 10.1002/path.2060; Degen JL, 2001, ANN NY ACAD SCI, V936, P276; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Drew AF, 2001, AM J PHYSIOL-RENAL, V281, pF1157, DOI 10.1152/ajprenal.0002.2001; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; Iacoviello L, 2001, HYPERTENSION, V38, P1199, DOI 10.1161/hy1101.099478; Iwaki T, 2006, BLOOD, V107, P3883, DOI 10.1182/blood-2005-09-3780; Jeong HJ, 1998, TRANSPLANT P, V30, P2953, DOI 10.1016/S0041-1345(98)00884-7; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Krishnamoorthy A, 2010, TOXICOL SCI, V118, P298, DOI 10.1093/toxsci/kfq240; LANGUINO LR, 1995, P NATL ACAD SCI USA, V92, P1505, DOI 10.1073/pnas.92.5.1505; LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y; Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198; Peyvandi F, 2006, J THROMB HAEMOST, V4, P1634, DOI 10.1111/j.1538-7836.2006.02014.x; Reinhart WH, 2003, VASC MED, V8, P211, DOI 10.1191/1358863x03vm494ra; SCARABIN PY, 1993, ARTERIOSCLER THROMB, V13, P886, DOI 10.1161/01.ATV.13.6.886; Sorensen I, 2011, KIDNEY INT, V80, P1035, DOI 10.1038/ki.2011.214; Sorensen I, 2011, J AM SOC NEPHROL, V22, P1887, DOI 10.1681/ASN.2011010031; Steinbrecher KA, 2010, CANCER RES, V70, P2634, DOI 10.1158/0008-5472.CAN-09-3465; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Vidal B, 2008, GENE DEV, V22, P1747, DOI 10.1101/gad.465908; Wilberding JA, 2001, ANN NY ACAD SCI, V936, P542	30	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45628	10.1371/journal.pone.0045628	http://dx.doi.org/10.1371/journal.pone.0045628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029147	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400115
J	Finlayson, C; Brown, K; Blasco, R; Rosell, J; Negro, JJ; Bortolotti, GR; Finlayson, G; Marco, AS; Pacheco, FG; Vidal, JR; Carrion, JS; Fa, DA; Llanes, JMR				Finlayson, Clive; Brown, Kimberly; Blasco, Ruth; Rosell, Jordi; Jose Negro, Juan; Bortolotti, Gary R.; Finlayson, Geraldine; Sanchez Marco, Antonio; Giles Pacheco, Francisco; Rodriguez Vidal, Joaquin; Carrion, Jose S.; Fa, Darren A.; Llanes, Jose M. Rodriguez			Birds of a Feather: Neanderthal Exploitation of Raptors and Corvids	PLOS ONE			English	Article							SOUTH-AFRICA; SMALL-GAME; EVOLUTION	The hypothesis that Neanderthals exploited birds for the use of their feathers or claws as personal ornaments in symbolic behaviour is revolutionary as it assigns unprecedented cognitive abilities to these hominins. This inference, however, is based on modest faunal samples and thus may not represent a regular or systematic behaviour. Here we address this issue by looking for evidence of such behaviour across a large temporal and geographical framework. Our analyses try to answer four main questions: 1) does a Neanderthal to raptor-corvid connection exist at a large scale, thus avoiding associations that might be regarded as local in space or time?; 2) did Middle (associated with Neanderthals) and Upper Palaeolithic (associated with modern humans) sites contain a greater range of these species than Late Pleistocene paleontological sites?; 3) is there a taphonomic association between Neanderthals and corvids-raptors at Middle Palaeolithic sites on Gibraltar, specifically Gorham's, Vanguard and Ibex Caves? and; 4) was the extraction of wing feathers a local phenomenon exclusive to the Neanderthals at these sites or was it a geographically wider phenomenon?. We compiled a database of 1699 Pleistocene Palearctic sites based on fossil bird sites. We also compiled a taphonomical database from the Middle Palaeolithic assemblages of Gibraltar. We establish a clear, previously unknown and widespread, association between Neanderthals, raptors and corvids. We show that the association involved the direct intervention of Neanderthals on the bones of these birds, which we interpret as evidence of extraction of large flight feathers. The large number of bones, the variety of species processed and the different temporal periods when the behaviour is observed, indicate that this was a systematic, geographically and temporally broad, activity that the Neanderthals undertook. Our results, providing clear evidence that Neanderthal cognitive capacities were comparable to those of Modern Humans, constitute a major advance in the study of human evolution.	[Blasco, Ruth; Rosell, Jordi] Univ Rovira & Virgili, Area Prehist, Tarragona, Spain; [Finlayson, Clive] Univ Toronto, Dept Social Sci, Toronto, ON, Canada; [Blasco, Ruth; Rosell, Jordi] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Jose Negro, Juan] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Bortolotti, Gary R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Sanchez Marco, Antonio] Inst Catala Paleontol, Area Neogene & Quaternary Faunas, Cerdanyola Del Valles, Spain; [Rodriguez Vidal, Joaquin] Univ Huelva, Fac Ciencias Expt, Depto Geodinam & Paleontol, Huelva, Spain; [Carrion, Jose S.] Univ Murcia, Dept Plant Biol, Murcia, Spain; [Llanes, Jose M. Rodriguez] Univ Catholique Louvain 30, CRED, Inst Hlth & Soc, Brussels, Belgium	Universitat Rovira i Virgili; University of Toronto; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Saskatchewan; Institut Catala de Paleontologia Miquel Crusafont (ICP); Universidad de Huelva; University of Murcia	Blasco, R (corresponding author), Univ Rovira & Virgili, Area Prehist, Tarragona, Spain.	rblascolopez@gmail.com	Negro, Juan Jose/I-2653-2015; Fa, Darren A./F-1863-2015; Rosell, Jordi/G-8705-2015; Rodriguez-Llanes, Jose Manuel/L-4537-2019; Carrion, Jose S/A-8983-2015; Blasco, Ruth/AAG-8200-2019; Marco, Antonio Sánchez/F-9837-2010; Fa, Darren/Z-4376-2019	Negro, Juan Jose/0000-0002-8697-5647; Fa, Darren A./0000-0002-5900-9814; Rosell, Jordi/0000-0002-6758-6291; Rodriguez-Llanes, Jose Manuel/0000-0003-3736-736X; Carrion, Jose S/0000-0002-6949-4382; Blasco, Ruth/0000-0001-9804-739X; Marco, Antonio Sánchez/0000-0003-0654-1935; Fa, Darren/0000-0002-5900-9814; Rodriguez-Vidal, Joaquin/0000-0002-9475-3307	Government of Gibraltar; European Community - Program Interreg [IIIB: 2002-02-4, 1-U-048 -]; Generalitat de Catalunya [2009 SGR 188]; Spanish Goverment [CGL2009-12703-C03-02, CGL2011-28681]	Government of Gibraltar; European Community - Program Interreg; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Goverment(Spanish Government)	The excavations and scientific research associated with Gorham's Cave have been funded by the Government of Gibraltar and, additionally between 2002-04, by the European Community - Program Interreg IIIB: 2002-02-4, 1-U-048 -. R. Blasco and J. Rosell are part of the following projects: 2009 SGR 188 of Generalitat de Catalunya and CGL2009-12703-C03-02 of the Spanish Goverment. A. Sanchez Marco belongs to the CGL2011-28681 project of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biebuyk DP, 1984, POWER HEADDRESSES CR; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Bovy KM, 2002, J ARCHAEOL SCI, V29, P965, DOI 10.1006/jasc.2001.0795; Bovy KM, 2012, J ARCHAEOL SCI, V39, P2049, DOI 10.1016/j.jas.2012.02.028; Brown K, 2011, INTERD CONTRIB ARCH, P247, DOI 10.1007/978-1-4419-8219-3_10; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; Ferraro-Dorta S, 2000, PLUMARIA INDIGENA BR; Finlayson C., 2011, AVIAN SURVIVORS HIST; Finlayson C., 2004, NEANDERTHALS MODERN; Grande JM, 2004, ARDEOLA, V51, P375; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guthrie R. D., 2005, NATURE PALEOLITHIC A; Hiroa TR, 1944, J POLYNESIAN SOC, V53, P1; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Klein RG, 2001, J ANTHROPOL RES, V57, P1; Klein RG, 2008, P NATL ACAD SCI USA, V105, pE115, DOI 10.1073/pnas.0809985106; Levi-Strauss Claude, 1967, STRUCTURAL ANTHR; Livingston SD, 1988, THESIS U WASHINGTON; Lyman RL, 2003, REPORTS ARCHAEOLOGY, P235; Mails TE, 1972, MYSTIC WARRIORS PLAI; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; McBrearty S, 2007, RETHINKING HUMAN REV, P133; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Mundy P., 1992, VULTURES AFRICA; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Renfrew C., 2007, PREHISTORY MAKING HU; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; SCHAFER W, 1972, ECOLOGY PALEOECOLOGY; Serjeantson D., 2009, BIRDS CAMBRIDGE MANU; Soressi M., 2008, SOCIETE PREHISTORIQU, P95; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 2000, CURR ANTHROPOL, V41, P39, DOI 10.1086/300102; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Tattersall I, 2011, HUMAN BRAIN EVOLUTIO, P1; Tyrberg T., 1998, PUBLICATIONS NUTTALL, V27; Tyrberg T, 2008, ONLINE SUPPLEMENT PL; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	43	154	156	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2012	7	9							e45927	10.1371/journal.pone.0045927	http://dx.doi.org/10.1371/journal.pone.0045927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	019MC	23029321	Green Published, Green Submitted, gold			2022-12-25	WOS:000309742800066
J	Canton, I; Massignani, M; Patikarnmonthon, N; Chierico, L; Robertson, J; Renshaw, SA; Warren, NJ; Madsen, JP; Armes, SP; Lewis, AL; Battaglia, G				Canton, Irene; Massignani, Marzia; Patikarnmonthon, Nisa; Chierico, Luca; Robertson, James; Renshaw, Stephen A.; Warren, Nicholas J.; Madsen, Jeppe P.; Armes, Steven P.; Lewis, Andrew L.; Battaglia, Giuseppe			Fully synthetic polymer vesicles for intracellular delivery of antibodies in live cells	FASEB JOURNAL			English	Article						immunotargeting; protein; antibody; nanovector	NF-KAPPA-B; IN-VITRO; GENE DELIVERY; DNA; LOCALIZATION; COMPLEXES; SELECTION; CYTOKINE; THERAPY; MODEL	There is an emerging need both in pharmacology and within the biomedical industry to develop new tools to target intracellular mechanisms. The efficient delivery of functionally active proteins within cells is potentially a powerful research strategy, especially through the use of antibodies. In this work, we report on a nanovector for the efficient encapsulation and delivery of antibodies into live cells with no significant loss of cell viability or any deleterious effect on cell metabolic activity. This delivery system is based on poly[2-(methacryloyloxy) ethyl phosphorylcholine]-block-[2-(diisopropylamino) ethyl methacrylate] (PMPC-PDPA), a pH-sensitive diblock copolymer that self-assembles to form nanometer-sized vesicles, also known as polymersomes, at physiological pH. Polymersomes can successfully deliver relatively high antibody payloads within different types of live cells. We demonstrate that these antibodies can target their respective epitope showing immunolabeling of gamma-tubulin, actin, Golgi protein, and the transcription factor NF-kappa B in live cells. Finally, we demonstrate that intracellular delivery of antibodies can control specific subcellular events, as well as modulate cell activity and proinflammatory processes.-Canton, I., Massignani, M., Patikarnmonthon, N., Chierico, L., Robertson, J., Renshaw, S. A., Warren, N. J., Madsen, J. P., Armes, S P., Lewis, A. L., Battaglia, G. Fully synthetic polymer vesicles for intracellular delivery of antibodies in live cells. FASEB J. 27, 98-108 (2013). www.fasebj.org	[Canton, Irene; Massignani, Marzia; Patikarnmonthon, Nisa; Chierico, Luca; Robertson, James; Renshaw, Stephen A.; Madsen, Jeppe P.; Battaglia, Giuseppe] Univ Sheffield, Krebs Inst, Sheffield S10 2TN, S Yorkshire, England; [Canton, Irene; Patikarnmonthon, Nisa; Chierico, Luca; Robertson, James; Madsen, Jeppe P.; Battaglia, Giuseppe] Univ Sheffield, Ctr Membrane Interact & Dynam, Sheffield S10 2TN, S Yorkshire, England; [Canton, Irene; Massignani, Marzia; Patikarnmonthon, Nisa; Chierico, Luca; Robertson, James; Warren, Nicholas J.; Madsen, Jeppe P.; Battaglia, Giuseppe] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Robertson, James; Renshaw, Stephen A.] Univ Sheffield, MRC, Ctr Dev & Biomed Genet, Sheffield S10 2TN, S Yorkshire, England; [Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Sheffield S10 2TN, S Yorkshire, England; [Warren, Nicholas J.; Madsen, Jeppe P.; Armes, Steven P.] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England; [Lewis, Andrew L.] Biocompatibles UK Ltd, Farnham, Surrey, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; Biocompatibles International PLC	Battaglia, G (corresponding author), Univ Sheffield, Dept Biomed Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	g.battaglia@sheffield.ac.uk	Patikarnmonthon, Nisa/AAF-3078-2020; Madsen, Jeppe/A-3184-2015; Battaglia, Giuseppe/I-2142-2013; Renshaw, Steve/E-6192-2010; Warren, Nicholas J/I-1588-2013; Warren, Nicholas/AAE-9388-2021	Patikarnmonthon, Nisa/0000-0001-5787-0785; Madsen, Jeppe/0000-0001-7625-9498; Battaglia, Giuseppe/0000-0003-3349-6770; Renshaw, Steve/0000-0003-1790-1641; Warren, Nicholas J/0000-0002-8298-1417; Warren, Nicholas/0000-0002-8298-1417; Canton, Irene/0000-0003-2768-4425; Lewis, Andrew/0000-0001-5779-5631; Armes, Steven/0000-0002-8289-6351; Robertson, James/0000-0002-9961-0073	MRC [G0701932] Funding Source: UKRI; Medical Research Council [G0701932] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andreakos E, 2003, ARTHRITIS RHEUM, V48, P1901, DOI 10.1002/art.11044; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baron S, 2000, J IMMUNOL METHODS, V242, P115, DOI 10.1016/S0022-1759(00)00242-8; BATRA RK, 1994, GENE THER, V1, P255; Battaglia G, 2005, J AM CHEM SOC, V127, P8757, DOI 10.1021/ja050742y; Bell S, 2003, CELL SIGNAL, V15, P1, DOI 10.1016/S0898-6568(02)00080-3; Biswas A, 2011, ACS NANO, V5, P1385, DOI 10.1021/nn1031005; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548; CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Du JZ, 2005, J AM CHEM SOC, V127, P17982, DOI 10.1021/ja056514l; Ferguson LR, 2007, MUTAT RES-FUND MOL M, V623, P14, DOI 10.1016/j.mrfmmm.2007.03.014; Giacomelli C, 2006, BIOMACROMOLECULES, V7, P817, DOI 10.1021/bm0508921; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hoog G, 2011, FASEB J, V25, P3815, DOI 10.1096/fj.11-187484; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Kondo Y, 2008, J IMMUNOL METHODS, V332, P10, DOI 10.1016/j.jim.2007.12.008; Kuriyama R, 2009, J CELL SCI, V122, P2014, DOI 10.1242/jcs.036715; Lesca C, 2005, ONCOGENE, V24, P5165, DOI 10.1038/sj.onc.1208723; Li GH, 2009, INT J PHARMACEUT, V368, P109, DOI 10.1016/j.ijpharm.2008.10.008; Li HH, 2007, MUTAT RES-FUND MOL M, V623, P98, DOI 10.1016/j.mrfmmm.2007.03.013; Lomas H, 2008, FARADAY DISCUSS, V139, P143, DOI 10.1039/b717431d; Lomas H, 2007, ADV MATER, V19, P4238, DOI 10.1002/adma.200700941; LoPresti C, 2011, ACS NANO, V5, P1775, DOI 10.1021/nn102455z; LoPresti C, 2009, J MATER CHEM, V19, P3576, DOI 10.1039/b818869f; Massignani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010459; Massignani M, 2009, SMALL, V5, P2424, DOI 10.1002/smll.200900578; Murdoch C, 2010, NANOMEDICINE-UK, V5, P1025, DOI 10.2217/NNM.10.97; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Perfetto B, 2003, RES MICROBIOL, V154, P337, DOI 10.1016/S0923-2508(03)00084-6; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rahmanzadeh R, 2010, CANCER RES, V70, P9234, DOI 10.1158/0008-5472.CAN-10-1190; Raynaud-Messina B, 2007, CURR OPIN CELL BIOL, V19, P24, DOI 10.1016/j.ceb.2006.12.008; Raz-Prag D, 2010, P NATL ACAD SCI USA, V107, P12710, DOI 10.1073/pnas.0913472107; Robinson KL, 2002, J MATER CHEM, V12, P890, DOI 10.1039/b200348c; Sidhu SS, 2006, NAT CHEM BIOL, V2, P682, DOI 10.1038/nchembio843; Visintin M, 2008, J BIOTECHNOL, V135, P1, DOI 10.1016/j.jbiotec.2008.02.012; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	41	59	62	0	120	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					98	108		10.1096/fj.12-212183	http://dx.doi.org/10.1096/fj.12-212183			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23033321				2022-12-25	WOS:000313103200011
J	Rezende, LF; Santos, GJ; Carneiro, EM; Boschero, AC				Rezende, Luiz F.; Santos, Gustavo J.; Carneiro, Everardo M.; Boschero, Antonio C.			Ciliary Neurotrophic Factor Protects Mice Against Streptozotocin-induced Type 1 Diabetes through SOCS3 THE ROLE OF STAT1/STAT3 RATIO IN beta-CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; CYTOKINE SIGNALING-3; INSULIN-RESISTANCE; BODY-WEIGHT; STAT1 GENE; SUPPRESSOR; CNTF; EXPRESSION; APOPTOSIS; PATHWAY	Type 1 diabetes is characterized by a loss of islet beta-cells. Ciliary neurotrophic factor (CNTF) protects pancreatic islets against cytokine-induced apoptosis. For this reason, we assessed whether CNTF protects mice against streptozotocin-induced diabetes (a model of type 1 diabetes) and the mechanism for this protection. WT and SOCS3 knockdown C57BL6 mice were treated for 5 days with citrate buffer or 0.1 mg/kg CNTF before receiving 80 mg/kg streptozotocin. Glycemia in non-fasted mice was measured weekly from days 0-28 after streptozotocin administration. Diabetes was defined as a blood glucose > 11.2 mmol/liter. Wild-type (WT) and SOCS3 knockdown MIN6 cells were cultured with CNTF, IL1 beta, or both. CNTF reduced diabetes incidence and islet apoptosis in WT but not in SOCS3kd mice. Likewise, CNTF inhibited apoptosis in WT but not in SOCS3kd MIN6 cells. CNTF increased STAT3 phosphorylation in WT and SOCS3kd mice and MIN6 cells but reduced STAT1 phosphorylation only in WT mice, in contrast to streptozotocin and IL1 beta. Moreover, CNTF reduced NF kappa B activation and required down-regulation of inducible NO synthase expression to exert its protective effects. In conclusion, CNTF protects mice against streptozotocin-induced diabetes by increasing pancreatic islet survival, and this protection depends on SOCS3. In addition, SOCS3 expression and beta-cell fate are dependent on STAT1/STAT3 ratio.	[Rezende, Luiz F.; Santos, Gustavo J.; Carneiro, Everardo M.; Boschero, Antonio C.] State Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, BR-13083865 Campinas, SP, Brazil	Universidade Estadual de Campinas	Rezende, LF (corresponding author), State Univ Campinas UNICAMP, Dept Struct & Funct Biol, Inst Biol, POB 6109, BR-13083865 Campinas, SP, Brazil.	luizbio@gmail.com	Carneiro, Everardo/D-4758-2012; Santos, Gustavo/L-6419-2013; Boschero, Antonio/O-7525-2014	Santos, Gustavo/0000-0001-9135-7184; Boschero, Antonio/0000-0003-3829-8570	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Instituto Nacional de Obesidade e Diabetes	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Obesidade e Diabetes	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and Instituto Nacional de Obesidade e Diabetes.	Ahima RS, 2006, NAT MED, V12, P511, DOI 10.1038/nm0506-511; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Borjesson A, 2011, IMMUNOL LETT, V136, P74, DOI 10.1016/j.imlet.2010.12.007; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chandra J, 2001, DIABETES, V50, pS44, DOI 10.2337/diabetes.50.2007.S44; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Del Prato S, 2004, DIABETES OBES METAB, V6, P319; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826; Fasler-Kan E, 2010, BRAIN RES, V1354, P15, DOI 10.1016/j.brainres.2010.07.077; Flodstrom M, 1999, DIABETES, V48, P706, DOI 10.2337/diabetes.48.4.706; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Jiang JJ, 2003, J GENE MED, V5, P977, DOI 10.1002/jgm.433; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kim JY, 2010, CELL SIGNAL, V22, P1669, DOI 10.1016/j.cellsig.2010.06.007; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Laubner K, 2005, DIABETES, V54, P3410, DOI 10.2337/diabetes.54.12.3410; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindberg K, 2005, J MOL ENDOCRINOL, V35, P231, DOI 10.1677/jme.1.01840; Liu QS, 2007, BASIC CLIN PHARMACOL, V101, P78, DOI 10.1111/j.1742-7843.2007.00092.x; Mandrup-Poulsen T, 2003, ANN NY ACAD SCI, V1005, P32, DOI 10.1196/annals.1288.005; Matthews VB, 2008, J MOL MED-JMM, V86, P353, DOI 10.1007/s00109-007-0286-y; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Moore F, 2011, J BIOL CHEM, V286, P929, DOI 10.1074/jbc.M110.162131; Mori H, 2007, BIOCHEM BIOPH RES CO, V359, P952, DOI 10.1016/j.bbrc.2007.05.198; Nakata M, 2007, BIOCHEM BIOPH RES CO, V353, P1046, DOI 10.1016/j.bbrc.2006.12.134; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; Rajan P, 1996, J NEUROSCI RES, V43, P403, DOI 10.1002/(SICI)1097-4547(19960215)43:4<403::AID-JNR2>3.0.CO;2-J; Rezende ACS, 2008, BRAZ J MED BIOL RES, V41, P1024, DOI 10.1590/S0100-879X2008005000052; Rezende LF, 2012, DIABETOLOGIA, V55, P1495, DOI 10.1007/s00125-012-2493-5; Rezende LF, 2007, J ENDOCRINOL, V195, P157, DOI 10.1677/JOE-07-0016; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Ronn SG, 2008, DIABETOLOGIA, V51, P1873, DOI 10.1007/s00125-008-1090-0; Santos GJ, 2011, CELL SIGNAL, V23, P1669, DOI 10.1016/j.cellsig.2011.06.001; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Steinberg GR, 2009, DIABETES, V58, P829, DOI 10.2337/db08-0659; Stephanou A, 2005, GROWTH FACTORS, V23, P177, DOI 10.1080/08977190500178745; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wadt KAW, 1998, DIABETES, V47, P1602, DOI 10.2337/diabetes.47.10.1602; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; WINTER CG, 1995, P NATL ACAD SCI USA, V92, P5865, DOI 10.1073/pnas.92.13.5865; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Yasuda H, 2009, DIABETES RES CLIN PR, V83, P200, DOI 10.1016/j.diabres.2008.11.029	51	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41628	41639		10.1074/jbc.M112.358788	http://dx.doi.org/10.1074/jbc.M112.358788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038263	Green Published, hybrid			2022-12-25	WOS:000312103000007
J	Gil, JE; Kim, E; Kim, IS; Ku, B; Park, WS; Oh, BH; Ryu, SH; Cho, W; Heo, WD				Gil, Jung-Eun; Kim, Eui; Kim, Il-Shin; Ku, Bonsu; Park, Wei Sun; Oh, Byung-Ha; Ryu, Sung Ho; Cho, Wonhwa; Heo, Won Do			Phosphoinositides Differentially Regulate Protrudin Localization through the FYVE Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; MEMBRANE TRAFFICKING; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; EARLY ENDOSOME; LIVING CELLS; PROTEIN; BINDING; 4,5-BISPHOSPHATE; RECOGNITION	Protrudin is a FYVE (Fab 1, YOTB, Vac 1, and EEA1) domain-containing protein involved in transport of neuronal cargoes and implicated in the onset of hereditary spastic paraplegia. Our image-based screening of the lipid binding domain library revealed novel plasma membrane localization of the FYVE domain of protrudin unlike canonical FYVE domains that are localized to early endosomes. The membrane binding study by surface plasmon resonance analysis showed that this FYVE domain preferentially binds phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2), phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P-2), and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) unlike canonical FYVE domains that specifically bind phosphatidylinositol 3-phosphate (PtdIns(3) P). Furthermore, we found that these phosphoinositides (PtdInsP) differentially regulate shuttling of protrudin between endosomes and plasma membrane via its FYVE domain. Protrudin mutants with reduced PtdInsP-binding affinity failed to promote neurite outgrowth in primary cultured hippocampal neurons. These results suggest that novel PtdInsP selectivity of the protrudin-FYVE domain is critical for its cellular localization and its role in neurite outgrowth.	[Gil, Jung-Eun; Ku, Bonsu; Park, Wei Sun; Oh, Byung-Ha; Heo, Won Do] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury KIB, Taejon 305701, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea; [Kim, Il-Shin; Ryu, Sung Ho] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, Kyungbook, South Korea; [Kim, Eui; Cho, Wonhwa] Pohang Univ Sci & Technol, Div Integrat Biosci & Bioengn, Pohang 790784, Kyungbook, South Korea; [Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cho, W (corresponding author), Univ Illinois, Dept Chem MC 111, 845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu; wdheo@kaist.ac.kr	Heo, Won-Do/C-1696-2011; Oh, Byung-Ha/C-2061-2011	Ryu, Sung Ho/0000-0003-0913-3048; Ku, Bonsu/0000-0003-1784-8975	Ministry of Health & Welfare, Republic of Korea [A101204]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Healthcare Technology R&D Project, Ministry of Health & Welfare, Republic of Korea Grant A101204.	Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Corvera S, 1999, CURR OPIN CELL BIOL, V11, P460, DOI 10.1016/S0955-0674(99)80066-0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Estrada L, 2001, HUM MOL GENET, V10, P485, DOI 10.1093/hmg/10.5.485; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gaullier JM, 2000, J BIOL CHEM, V275, P24595, DOI 10.1074/jbc.M906554199; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Heo WD, 2003, CELL, V113, P315; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/nmeth.1428, 10.1038/NMETH.1428]; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Manna D, 2007, J BIOL CHEM, V282, P32093, DOI 10.1074/jbc.M703517200; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Maroun CR, 2003, MOL BIOL CELL, V14, P1691, DOI 10.1091/mbc.E02-06-0352; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; Misra S, 2001, CELL, V107, P559, DOI 10.1016/S0092-8674(01)00594-3; Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Murray JT, 2002, TRAFFIC, V3, P416, DOI 10.1034/j.1600-0854.2002.30605.x; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Pantakani DVK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029584; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ridley SH, 2001, J CELL SCI, V114, P3991; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; TOKER A, 1995, J BIOL CHEM, V270, P29525, DOI 10.1074/jbc.270.49.29525; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yu M, 2006, J IMMUNOL, V176, P2421, DOI 10.4049/jimmunol.176.4.2421	52	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41268	41276		10.1074/jbc.M112.419127	http://dx.doi.org/10.1074/jbc.M112.419127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043110	hybrid, Green Published			2022-12-25	WOS:000311887600041
J	Hollands, A; Gonzalez, D; Leire, E; Donald, C; Gallo, RL; Sanderson-Smith, M; Dorrestein, PC; Nizet, V				Hollands, Andrew; Gonzalez, David; Leire, Emma; Donald, Cortny; Gallo, Richard L.; Sanderson-Smith, Martina; Dorrestein, Pieter C.; Nizet, Victor			A Bacterial Pathogen Co-opts Host Plasmin to Resist Killing by Cathelicidin Antimicrobial Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; EXPRESSION; VIRULENCE; PROTECTS; STAPHYLOKINASE; INHIBITOR; INDUCTION; SKIN	The bacterial pathogen Group A Streptococcus (GAS) colonizes epithelial and mucosal surfaces and can cause a broad spectrum of human disease. Through the secreted plasminogen activator streptokinase (Ska), GAS activates human plasminogen into plasmin and binds it to the bacterial surface. The resulting surface plasmin protease activity has been proposed to play a role in disrupting tissue barriers, promoting invasive spread of the bacterium. We investigated whether this surface protease activity could aid the immune evasion role through degradation of the key innate antimicrobial peptide LL-37, the human cathelicidin. Cleavage products of plasmin-degraded LL-37 were analyzed by matrix-assisted laser desorption ionization mass spectrometry. Ska-deficient GAS strains were generated by targeted allelic exchange mutagenesis and confirmed to lack surface plasmin activity after growth in human plasma or media supplemented with plasminogen and fibrinogen. Loss of surface plasmin activity left GAS unable to efficiently degrade LL-37 and increased bacterial susceptibility to killing by the antimicrobial peptide. When mice infected with GAS were simultaneously treated with the plasmin inhibitor aprotinin, a significant reduction in the size of necrotic skin lesions was observed. Together these data reveal a novel immune evasion strategy of the human pathogen: co-opting the activity of a host protease to evade peptide-based innate host defenses.	[Nizet, Victor] Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, Dept Pediat, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Donald, Cortny; Sanderson-Smith, Martina] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Donald, Cortny; Sanderson-Smith, Martina] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wollongong; University of Wollongong	Nizet, V (corresponding author), Univ Calif San Diego, Div Pediat Pharmacol & Drug Discovery, Dept Pediat, 9500 Gilman Dr,Mail Code 0687, La Jolla, CA 92093 USA.	vnizet@ucsd.edu	Nizet, Victor/AAF-3190-2019; Sanderson-Smith, Martina L/H-9614-2013; Gallo, Richard L/A-8931-2009; Dorrestein, Pieter/ABF-2930-2020; Sanderson-Smith, Martina/O-9387-2019; Leire, Emma/B-8026-2016	Sanderson-Smith, Martina L/0000-0002-6366-4993; Gallo, Richard L/0000-0002-1401-7861; Leire, Emma/0000-0001-9161-0442; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health [AI077780, AI052453, AR052728]; National Health and Medical Research Council of Australia (NHMRC) [635218]; NHMRC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780, R01AI052453, R37AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM068524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077780 (to V.N.), AI052453 (to R. L. G. and V.N.), and AR052728 (to R. L. G. and V.N.). This work was also supported by National Health and Medical Research Council of Australia (NHMRC) Grant 635218 (to M. S.).; The recipient of a Career development fellowship from the NHMRC.	Bergman P, 2006, INFECT IMMUN, V74, P6982, DOI 10.1128/IAI.01043-06; Braff MH, 2007, J INFECT DIS, V195, P1365, DOI 10.1086/513277; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Jin T, 2004, J IMMUNOL, V172, P1169, DOI 10.4049/jimmunol.172.2.1169; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	28	32	33	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40891	40897		10.1074/jbc.M112.404582	http://dx.doi.org/10.1074/jbc.M112.404582			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038245	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000311887600008
J	Lien, CF; Mohanta, SK; Frontczak-Baniewicz, M; Swinny, JD; Zablocka, B; Gorecki, DC				Lien, Chun Fu; Mohanta, Sarajo Kumar; Frontczak-Baniewicz, Malgorzata; Swinny, Jerome D.; Zablocka, Barbara; Gorecki, Dariusz C.			Absence of Glial alpha-Dystrobrevin Causes Abnormalities of the Blood-Brain Barrier and Progressive Brain Edema	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC MDX MICE; CELLS IN-VITRO; ENDOTHELIAL-CELLS; SYNTROPHIN-BINDING; POTASSIUM CHANNEL; BETA-DYSTROBREVIN; EXPRESSION; PROTEIN; MOUSE; WATER	The blood-brain barrier (BBB) plays a key role in maintaining brain functionality. Although mammalian BBB is formed by endothelial cells, its function requires interactions between endotheliocytes and glia. To understand the molecular mechanisms involved in these interactions is currently a major challenge. We show here that alpha-dystrobrevin (alpha-DB), a protein contributing to dystrophin-associated protein scaffolds in astrocytic endfeet, is essential for the formation and functioning of BBB. The absence of alpha-DB in null brains resulted in abnormal brain capillary permeability, progressively escalating brain edema, and damage of the neurovascular unit. Analyses in situ and in two-dimensional and three-dimensional in vitro models of BBB containing alpha-DB-null astrocytes demonstrated these abnormalities to be associated with loss of aquaporin-4 water and Kir4.1 potassium channels from glial endfeet, formation of intracellular vacuoles in alpha-DB-null astrocytes, and defects of the astrocyte-endothelial interactions. These caused deregulation of tight junction proteins in the endothelia. Importantly, alpha-DB but not dystrophins showed continuous expression throughout development in BBB models. Thus, alpha-DB emerges as a central organizer of dystrophin-associated protein in glial endfeet and a rare example of a glial protein with a role in maintaining BBB function. Its abnormalities might therefore lead to BBB dysfunction.	[Lien, Chun Fu; Mohanta, Sarajo Kumar; Swinny, Jerome D.; Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; [Zablocka, Barbara] Mossakowski Med Res Ctr, Mol Biol Unit, PL-02106 Warsaw, Poland	University of Portsmouth; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Gorecki, DC (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.	darek.gorecki@port.ac.uk	Mohanta, Sarajo/L-1355-2019; Mohanta, Sarajo K/J-5441-2015	Mohanta, Sarajo/0000-0001-6144-4092; Mohanta, Sarajo K/0000-0001-6144-4092; Zablocka, Barbara/0000-0003-3116-7295; Gorecki, Dariusz/0000-0003-3584-1654; Swinny, Jerome/0000-0002-8194-5481	European Union (EU)	European Union (EU)(CGIAREuropean Commission)	This work was supported in part by European Union (EU) Interreg AdMiN and TC2N grants (to D. C. G.).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Al Ahmad A, 2011, J CEREBR BLOOD F MET, V31, P693, DOI 10.1038/jcbfm.2010.148; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Banerjee S, 2007, ANNU REV NEUROSCI, V30, P235, DOI 10.1146/annurev.neuro.30.051606.094345; Blake DJ, 1998, P NATL ACAD SCI USA, V95, P241, DOI 10.1073/pnas.95.1.241; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Bohm SV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-85; Bragg AD, 2006, GLIA, V53, P879, DOI 10.1002/glia.20347; Bragg AD, 2010, NEUROREPORT, V21, P695, DOI 10.1097/WNR.0b013e32833b0a3b; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chow J, 2001, DEV BRAIN RES, V130, P123, DOI 10.1016/S0165-3806(01)00220-6; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Crocker SJ, 2008, GLIA, V56, P1187, DOI 10.1002/glia.20689; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Guadagno E, 2004, GLIA, V47, P138, DOI 10.1002/glia.20039; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hartmann C, 2007, EXP CELL RES, V313, P1318, DOI 10.1016/j.yexcr.2007.01.024; Haseloff RF, 2005, CELL MOL NEUROBIOL, V25, P25, DOI 10.1007/s10571-004-1375-x; Hazai D, 2008, BRAIN RES, V1201, P52, DOI 10.1016/j.brainres.2008.01.046; Imamura M, 1998, P NATL ACAD SCI USA, V95, P6139, DOI 10.1073/pnas.95.11.6139; Liebner S, 2005, BLOOD BRAIN BARRIER, P1; Lien CF, 2004, GENE EXPR PATTERNS, V4, P583, DOI 10.1016/j.modgep.2004.01.015; Lien CF, 2007, CELL TISSUE RES, V327, P67, DOI 10.1007/s00441-006-0241-1; Lien CF, 2012, BIOMACROMOLECULES, V13, P1067, DOI 10.1021/bm201790s; Marriott DR, 1995, NEURAL CELL CULTURE, P85; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Ment LR, 1997, IN VITRO CELL DEV-AN, V33, P684; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; Newey SE, 2001, J BIOL CHEM, V276, P6645, DOI 10.1074/jbc.M008305200; Nico B, 2005, CURR NEUROVASC RES, V2, P47, DOI 10.2174/1567202052773481; Nico B, 2004, NEUROSCIENCE, V125, P921, DOI 10.1016/j.neuroscience.2004.02.008; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Noel G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017559; Peters MF, 1997, J BIOL CHEM, V272, P31561, DOI 10.1074/jbc.272.50.31561; Rees MLJ, 2007, NEUROMUSCULAR DISORD, V17, P123, DOI 10.1016/j.nmd.2006.11.003; Reichenbach A, 2007, GRAEF ARCH CLIN EXP, V245, P627, DOI 10.1007/s00417-006-0516-y; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Vajda Z, 2002, P NATL ACAD SCI USA, V99, P13131, DOI 10.1073/pnas.192457099; Wilcock DM, 2009, NEUROSCIENCE, V159, P1055, DOI 10.1016/j.neuroscience.2009.01.023; Wolburg H, 2011, INT REV CEL MOL BIO, V287, P1, DOI 10.1016/B978-0-12-386043-9.00001-3; Yoder EJ, 2002, GLIA, V38, P137, DOI 10.1002/glia.10016; Zea-Aragon Z, 2004, J NEUROSCI METH, V138, P89, DOI 10.1016/j.jneumeth.2004.03.018; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	56	48	52	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41374	41385		10.1074/jbc.M112.400044	http://dx.doi.org/10.1074/jbc.M112.400044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043099	Green Published, hybrid			2022-12-25	WOS:000311887600050
J	Kim, HJ; Jeong, MY; Na, U; Winge, DR				Kim, Hyung J.; Jeong, Mi-Young; Na, Un; Winge, Dennis R.			Flavinylation and Assembly of Succinate Dehydrogenase Are Dependent on the C-terminal Tail of the Flavoprotein Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; COMPLEX-II; UBIQUINONE OXIDOREDUCTASE; COVALENT ATTACHMENT; MITOCHONDRIA; GENE; YEAST; FAD; MUTATION; PARAGANGLIOMA	The enzymatic function of succinate dehydrogenase (SDH) is dependent on covalent attachment of FAD on the similar to 70-kDa flavoprotein subunit Sdh1. We show presently that flavinylation of the Sdh1 subunit of succinate dehydrogenase is dependent on a set of two spatially close C-terminal arginine residues that are distant from the FAD binding site. Mutation of Arg(582) in yeast Sdh1 precludes flavinylation as well as assembly of the tetrameric enzyme complex. Mutation of Arg(638) compromises SDH function only when present in combination with a Cys(630) substitution. Mutations of either Arg(582) or Arg(638)/Cys(630) do not markedly destabilize the Sdh1 polypeptide; however, the steady-state level of Sdh5 is markedly attenuated in the Sdh1 mutant cells. With each mutant Sdh1, second-site Sdh1 suppressor mutations were recovered in Sdh1 permitting flavinylation, stabilization of Sdh5 and SDH tetramer assembly. SDH assembly appears to require FAD binding but not necessarily covalent FAD attachment. The Arg residues may be important not only for Sdh5 association but also in the recruitment and/or guidance of FAD and or succinate to the substrate site for the flavinylation reaction. The impaired assembly of SDH with the C-terminal Sdh1 mutants suggests that FAD binding is important to stabilize the Sdh1 conformation enabling association with Sdh2 and the membrane anchor subunits.	[Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu			NIEHS, National Institutes of Health [ES03817]; Huntsman Cancer Institute [P30 CA042014]; National Institutes of Health [R24DK092784-01]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092784, T32DK007115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Huntsman Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant ES03817 from the NIEHS, National Institutes of Health (to D. R. W.), funding from the Huntsman Cancer Institute (P30 CA042014), and support from the National Institutes of Health (R24DK092784-01).	Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Fraaije MW, 2000, J BIOL CHEM, V275, P38654, DOI 10.1074/jbc.M004753200; Giancaspero TA, 2008, FEBS J, V275, P1103, DOI 10.1111/j.1742-4658.2008.06270.x; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HAGERHALL C, 1995, BBA-BIOENERGETICS, V1229, P356, DOI 10.1016/0005-2728(95)00023-C; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maklashina E, 2010, BBA-BIOENERGETICS, V1797, P747, DOI 10.1016/j.bbabio.2010.01.019; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Oyedotun KS, 2001, J BIOL CHEM, V276, P16936, DOI 10.1074/jbc.M100184200; Robinson KM, 1996, J BIOL CHEM, V271, P4055; Robinson KM, 1995, METHOD ENZYMOL, V260, P34, DOI 10.1016/0076-6879(95)60128-7; ROBINSON KM, 1994, EUR J BIOCHEM, V222, P983, DOI 10.1111/j.1432-1033.1994.tb18949.x; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sitkin Y, 2007, BBA-BIOENERGETICS, V1767, P143, DOI 10.1016/j.bbabio.2006.11.017; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tomasiak TM, 2008, J BIOL CHEM, V283, P15460, DOI 10.1074/jbc.M801372200; Tzagoloff A, 1996, J BIOL CHEM, V271, P7392, DOI 10.1074/jbc.271.13.7392; WU M, 1995, MOL CELL BIOL, V15, P264, DOI 10.1128/MCB.15.1.264	27	31	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40670	40679		10.1074/jbc.M112.405704	http://dx.doi.org/10.1074/jbc.M112.405704			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043141	hybrid, Green Published			2022-12-25	WOS:000311448800056
J	Alasaari, JS; Lagus, M; Ollila, HM; Toivola, A; Kivimaki, M; Vahtera, J; Kronholm, E; Harma, M; Puttonen, S; Paunio, T				Alasaari, Jukka S.; Lagus, Markus; Ollila, Hanna M.; Toivola, Auli; Kivimaki, Mika; Vahtera, Jussi; Kronholm, Erkki; Harma, Mikko; Puttonen, Sampsa; Paunio, Tiina			Environmental Stress Affects DNA Methylation of a CpG Rich Promoter Region of Serotonin Transporter Gene in a Nurse Cohort	PLOS ONE			English	Article							EPIGENETIC REGULATION; SLC6A4 METHYLATION; DEPRESSION; EXPRESSION; BEHAVIOR; RISK; POLYMORPHISM; METAANALYSIS; ASSOCIATION; DISEASE	Background: Shift-working nurses are exposed to a stressful work environment, which puts them at an increased risk for burnout and depression. We explored the effect of environmental stress on serotonin transporter gene (SLC6A4) promoter methylation among nurses from high and low work stress environments. Methodology: Using bisulfite sequencing, we investigated the methylation status of five CpG residues of a CpG-rich region in the promoter of SLC6A4 by comparing female shift working nurses from a high work stress environment (n = 24) to low work stress environment (n = 25). We also analyzed the association of 5-HTTLPR polymorphism at 59 end of SLC6A4. Work stress was assessed by the Karasek's Model and possible signs of burnout or depression were measured by the Maslach Burnout Index General Survey and Beck Depression Index. Methylation levels were assessed by bisulfite sequencing of DNA extracted from peripheral blood leucocytes. Restriction enzyme treatment followed by standard PCR was used to identify 5-HTTLPR genotypes. Principal Findings: We found that nurses in the high stress environment had significantly lower promoter methylation levels at all five CpG residues compared to nurses in the low stress environment (p < 0.01). There was no significant interaction of 5-HTTLPR genotype and work stress with methylation (p = 0.58). In unadjusted (bivariate) analysis, burnout was not significantly associated to methylation levels. However, when mutually adjusted for both, burnout and work stress were significant contributors (p = 0.038 and p < 0.0001 respectively) to methylation levels. Conclusions: Our findings show that environmental stress is concurrent with decreased methylation of the SLC6A4 promoter. This may lead to increased transcriptional activity of the gene, increased reuptake of serotonin from synaptic clefts, and termination of the activity of serotonin. This could present a possible coping mechanism for environmental stress in humans that could eventually increase risk for disturbed functional capability and experience of depressed mood in long-term stress.	[Alasaari, Jukka S.; Lagus, Markus; Ollila, Hanna M.; Toivola, Auli; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Kivimaki, Mika; Vahtera, Jussi; Harma, Mikko; Puttonen, Sampsa] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kivimaki, Mika; Vahtera, Jussi] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kronholm, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Turku, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, Cent Hosp, SF-00180 Helsinki, Finland	Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; University of London; University College London; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Paunio, T (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland.	tiina.paunio@thl.fi	Kivimaki, Mika/B-3607-2012; Ollila, Hanna M/I-8552-2017; Vahtera, Jussi/J-3271-2013; Ollila, Hanna M/GQA-6308-2022	Kivimaki, Mika/0000-0002-4699-5627; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [124404]; Helsinki University Central Hospital [TYH2010306]; Sigrid and Arne Juselius Foundation; Academy of Finland; Finnish Work Environment Fund; European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme; United States National Institutes of Health [AG034454, HL036310]; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G8802774, G0902037] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Helsinki University Central Hospital; Sigrid and Arne Juselius Foundation; Academy of Finland(Academy of Finland); Finnish Work Environment Fund; European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was financially supported by the Academy of Finland (WORK grant number 124404), Helsinki University Central Hospital (TYH2010306) and Sigrid and Arne Juselius Foundation (to TP). MK is supported by the Academy of Finland, the Finnish Work Environment Fund, the European Union New Occupational Safety and Health (OSH) European Research Area (ERA) research programme, and the United States National Institutes of Health (AG034454 & HL036310). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beach SRH, 2011, PSYCHOSOM MED, V73, P83, DOI 10.1097/PSY.0b013e3181fdd074; Beach SRH, 2010, AM J MED GENET B, V153B, P710, DOI 10.1002/ajmg.b.31028; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chorbov VM, 2007, AM J MED GENET B, V144B, P830, DOI 10.1002/ajmg.b.30534; Conroy J, 2004, MOL PSYCHIATR, V9, P587, DOI 10.1038/sj.mp.4001459; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gorwood Philip, 2004, Am J Pharmacogenomics, V4, P9, DOI 10.2165/00129785-200404010-00002; Haenisch B, 2010, PHARMACOL THERAPEUT, V129, P352, DOI DOI 10.1016/J.PHARMTHERA.2010.12.002; Han WG, 2006, ANAL BIOCHEM, V355, P50, DOI 10.1016/j.ab.2006.05.010; Hu XZ, 2004, BIOL PSYCHIAT, V55, p191S; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Karasek R.A., 1998, ENCY OCCUPATIONAL HL, p34.36; Kinnally EL, 2010, GENES BRAIN BEHAV, V9, P575, DOI 10.1111/j.1601-183X.2010.00588.x; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Koenen KC, 2011, DEPRESS ANXIETY, V28, P639, DOI 10.1002/da.20825; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd ed., P19; Shen LL, 2007, BIOTECHNIQUES, V42, P48, DOI 10.2144/000112312; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Ijzendoorn MH, 2010, BIOL PSYCHIAT, V68, P405, DOI 10.1016/j.biopsych.2010.05.008; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	44	70	73	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45813	10.1371/journal.pone.0045813	http://dx.doi.org/10.1371/journal.pone.0045813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029256	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900054
J	Garcia-Gonzalez, MA; Nicolas-Perez, D; Lanas, A; Bujanda, L; Carrera, P; Benito, R; Strunk, M; Sopena, F; Santolaria, S; Piazuelo, E; Jimenez, P; Campo, R; Espinel, J; Manzano, M; Geijo, F; Pellise, M; Gonzalez-Huix, F; Espinos, J; Zaballa, M; Tito, L; Barranco, L; Pazo, R; Quintero, E				Asuncion Garcia-Gonzalez, Maria; Nicolas-Perez, David; Lanas, Angel; Bujanda, Luis; Carrera, Patricia; Benito, Rafael; Strunk, Mark; Sopena, Federico; Santolaria, Santos; Piazuelo, Elena; Jimenez, Pilar; Campo, Rafael; Espinel, Jesus; Manzano, Marisa; Geijo, Fernando; Pellise, Maria; Gonzalez-Huix, Ferran; Espinos, Jorge; Zaballa, Manuel; Tito, Llucia; Barranco, Luis; Pazo, Roberto; Quintero, Enrique			Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; PEPTIC-ULCER DISEASE; CELL LUNG-CANCER; COLORECTAL-CANCER; GASTROESOPHAGEAL CANCER; POOR-PROGNOSIS; BREAST-CANCER; POLYMORPHISMS; CARCINOMA	Background: Genetic factors influencing the prognosis of gastric adenocarcinoma (GAC) are not well known. Given the relevance of cytokines and other pro-inflammatory mediators in cancer progression and invasiveness, we aimed to assess the prognostic role of several functional cytokine and cyclooxygenase gene polymorphisms in patients with GAC. Methodology: Genomic DNA from 380 Spanish Caucasian patients with primary GAC was genotyped for 23 polymorphisms in pro-inflammatory (IL1B, TNFA, LTA, IL6, IL12p40), anti-inflammatory (IL4, IL1RN, IL10, TGFB1) cytokine, and cyclooxygenase (PTGS1 and PTGS2) genes by PCR, RFLP and TaqMan assays. Clinical and histological information was collected prospectively. Survival curves were estimated by the Kaplan-Meier method and compared using the log rank test. Outcome was determined by analysis of Cox proportional hazards, adjusting for confounding factors. Results: The median follow-up period and median overall survival (OS) time were 9.9 months (range 0.4-120.3) and 10.9 months (95% CI: 8.9-14.1), respectively. Multivariate analysis identified tumor stages III (HR, 3.23; 95% CI: 2-5.22) and IV (HR, 5.5; 95% CI: 3.51-8.63) as independent factors associated with a significantly reduced OS, whereas surgical treatment (HR: 0.44; 95% CI: 0.3-0.6) was related to a better prognosis of the disease. Concerning genetic factors, none of the 23 polymorphisms evaluated in the current study did influence survival. Moreover, no gene-environment interactions on GAC prognosis were observed. Conclusions: Our results show that, in our population, the panel of selected pro-and anti-inflammatory cytokine, and cyclooxygenase gene polymorphisms are not relevant in determining the prognosis of gastric adenocarcinoma.	[Asuncion Garcia-Gonzalez, Maria; Lanas, Angel; Strunk, Mark; Sopena, Federico; Piazuelo, Elena] IIS Aragon, Zaragoza, Spain; [Asuncion Garcia-Gonzalez, Maria; Lanas, Angel; Bujanda, Luis; Carrera, Patricia; Benito, Rafael; Strunk, Mark; Sopena, Federico; Piazuelo, Elena; Jimenez, Pilar] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Nicolas-Perez, David; Quintero, Enrique] Hosp Univ Canarias, Dept Gastroenterol, Tenerife, Spain; [Lanas, Angel; Benito, Rafael] Univ Zaragoza, Fac Med, Zaragoza, Spain; [Lanas, Angel; Sopena, Federico] Hosp Clin Univ, Dept Gastroenterol, Zaragoza, Spain; [Bujanda, Luis] Univ Basque Country, Fac Med, Hosp Donostia, Dept Gastroenterol, San Sebastian, Spain; [Benito, Rafael] Hosp Clin Univ Lozano Blesa, Dept Microbiol, Zaragoza, Spain; [Santolaria, Santos] Hosp San Jorge, Dept Gastroenterol, Huesca, Spain; [Campo, Rafael] Hosp Parc Tauli, Dept Gastroenterol, Sabadell, Spain; [Espinel, Jesus] Complejo Hosp Leon, Dept Gastroenterol, Leon, Spain; [Manzano, Marisa] Hosp 12 Octubre, Dept Gastroenterol, E-28041 Madrid, Spain; [Geijo, Fernando] Hosp Clin Univ, Dept Gastroenterol, Salamanca, Spain; [Pellise, Maria] Hosp Clin Barcelona, Dept Gastroenterol, Barcelona, Spain; [Gonzalez-Huix, Ferran] Hosp Josep Trueta, Dept Gastroenterol, Girona, Spain; [Espinos, Jorge] Hosp Mutua Terrassa, Dept Gastroenterol, Terrassa, Spain; [Zaballa, Manuel] Hosp Cruces, Dept Gastroenterol, Baracaldo, Spain; [Tito, Llucia] Hosp Mataro, Dept Gastroenterol, Mataro, Spain; [Barranco, Luis] Hosp del Mar, Dept Gastroenterol, Barcelona, Spain; [Pazo, Roberto] Hosp Miguel Servet, Dept Oncol, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de la Laguna; University of Zaragoza; Universidad de la Laguna; University Hospital Donostia; University of Basque Country; Lozano Blesa University Clinical Hospital; Hospital Universidad San Jorge; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Universidad de Leon; Hospital de Leon; Hospital Universitario 12 de Octubre; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Universitario Mutua Terrassa; Hospital Universitario Cruces; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Miguel Servet University Hospital	Garcia-Gonzalez, MA (corresponding author), IIS Aragon, Zaragoza, Spain.	asgarcia@unizar.es	CARRERA-LASFUENTES, PATRICIA/ABG-6300-2020; Barranco Priego, Luis/AFV-2437-2022; Pellise, Maria/ABC-3246-2021; Strunk, Mark/I-2423-2017; Quintero, Enrique/C-3841-2017; Bujanda, Luis/AAB-2485-2021; ESPINEL, JESUS/GVT-4480-2022; Benito, Rafael/AAH-9885-2019; García-González, María Asunción/D-9821-2018; Strunk, Mark HP/K-3597-2014	CARRERA-LASFUENTES, PATRICIA/0000-0002-8848-709X; Barranco Priego, Luis/0000-0002-7352-7415; Strunk, Mark/0000-0002-8619-3979; Quintero, Enrique/0000-0002-7244-8125; Bujanda, Luis/0000-0002-4353-9968; García-González, María Asunción/0000-0002-8906-2683; Strunk, Mark HP/0000-0002-8619-3979; Pellise, Maria/0000-0001-9739-4998; Piazuelo, Elena/0000-0001-5813-3445; Santolaria, Santos/0000-0003-4414-2361	Spanish "Fondo de Investigaciones Sanitarias" [PI05/0405, PS09/00213]; Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas)	Spanish "Fondo de Investigaciones Sanitarias"; Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas)(Instituto de Salud Carlos III)	This study was supported by the Spanish "Fondo de Investigaciones Sanitarias" (grants PI05/0405 and PS09/00213), and Instituto de Salud Carlos III (CIBER de enfermedades hepaticas y digestivas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Canzian F, 2008, EUR J CANCER PREV, V17, P178, DOI 10.1097/CEJ.0b013e3282b6fd88; Castillejo A, 2009, INT J CANCER, V124, P608, DOI 10.1002/ijc.24013; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chulada PC, 2000, CANCER RES, V60, P4705; Church RD, 2004, BRIT J CANCER, V91, P1015, DOI 10.1038/sj.bjc.6602119; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Coghill AE, 2011, CLIN CANCER RES, V17, P7139, DOI 10.1158/1078-0432.CCR-11-1134; Cox DG, 2004, BRIT J CANCER, V91, P339, DOI 10.1038/sj.bjc.6601906; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Deans C, 2007, ANN SURG ONCOL, V14, P329, DOI 10.1245/s10434-006-9122-9; Degiuli M, 2004, BRIT J CANCER, V90, P1727, DOI 10.1038/sj.bjc.6601761; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fujimura T, 2006, WORLD J GASTROENTERO, V12, P1336, DOI 10.3748/wjg.v12.i9.1336; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Gawron AJ, 2011, SCAND J GASTROENTERO, V46, P333, DOI 10.3109/00365521.2010.537679; Gonzalez-Conejero R, 2005, STROKE, V36, P276, DOI 10.1161/01.STR.0000151362.65339.f9; Graziano F, 2005, J CLIN ONCOL, V23, P2339, DOI 10.1200/JCO.2005.02.345; Guan XX, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-94; Gupta RA, 2003, CANCER RES, V63, P906; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Hobsley M, 2007, GASTROENTEROLOGY, V132, P2076, DOI 10.1053/j.gastro.2007.03.088; Hou L, 2007, ANTICANCER RES, V27, P4243; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Huang XE, 2000, NUTR CANCER, V38, P30, DOI 10.1207/S15327914NC381_5; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Iglesias D, 2009, CANCER CAUSE CONTROL, V20, P1421, DOI 10.1007/s10552-009-9368-1; Inui A, 2002, CA-CANCER J CLIN, V52, P72, DOI 10.3322/canjclin.52.2.72; KABIR S, 1995, CANCER LETT, V95, P207, DOI 10.1016/0304-3835(95)03895-4; Kawaguchi T, 2010, J THORAC ONCOL, V5, P1001, DOI 10.1097/JTO.0b013e3181e2f607; Kooby DA, 2003, ANN SURG, V237, P828, DOI 10.1097/00000658-200306000-00011; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu JL, 2010, WORLD J GASTROENTERO, V16, P5510, DOI 10.3748/wjg.v16.i43.5510; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Maehara Y, 1999, J CLIN ONCOL, V17, P607, DOI 10.1200/JCO.1999.17.2.607; MALEFYT RD, 1991, J EXP MED, V174, P915; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Marrelli D, 2009, CANCER, V115, P2071, DOI 10.1002/cncr.24253; Meimarakis G, 2006, LANCET ONCOL, V7, P211, DOI 10.1016/S1470-2045(06)70586-1; MORISAKI T, 1994, CANCER RES, V54, P1113; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Pereira C, 2009, EUR J GASTROEN HEPAT, V21, P76, DOI 10.1097/MEG.0b013e32830ce7ba; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; Qiu HB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-374; Rad R, 2006, LANCET ONCOL, V7, P364, DOI 10.1016/S1470-2045(06)70672-6; RASHID SA, 1982, BRIT J CANCER, V45, P390, DOI 10.1038/bjc.1982.66; Ristimaki A, 1997, CANCER RES, V57, P1276; Santolaria S, 2001, MED CLIN-BARCELONA, V116, P641, DOI 10.1016/S0025-7753(01)71935-5; Saxena A, 2008, WORLD J GASTROENTERO, V14, P1498, DOI 10.3748/wjg.14.1498; Shibata M, 2002, J CLIN GASTROENTEROL, V34, P416, DOI 10.1097/00004836-200204000-00006; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2005, ALCOHOL, V35, P259, DOI 10.1016/j.alcohol.2005.04.007; Shiraishi N, 2007, J SURG ONCOL, V96, P14, DOI 10.1002/jso.20631; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; SIEWERT JR, 1987, CHIRURG, V58, P25; Soria JC, 2003, CLIN CANCER RES, V9, P1785; Tahara T, 2011, CLIN EXP MED, V11, P211, DOI 10.1007/s10238-010-0129-y; Takeda H, 2003, CANCER RES, V63, P4872; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; von Rahden BHA, 2005, CANCER RES, V65, P5038, DOI 10.1158/0008-5472.CAN-04-1107; Wang KS, 2006, ACTA BIOCH BIOPH SIN, V38, P179, DOI 10.1111/j.1745-7270.2006.00151.x; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Yamada Y, 1998, J BONE MINER RES, V13, P1569, DOI 10.1359/jbmr.1998.13.10.1569; Zhang XM, 2011, MOL CARCINOGEN, V50, P876, DOI 10.1002/mc.20784	67	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46179	10.1371/journal.pone.0046179	http://dx.doi.org/10.1371/journal.pone.0046179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029430	Green Published, gold			2022-12-25	WOS:000309973900103
J	Eberle, D; Kurth, T; Santos-Ferreira, T; Wilson, J; Corbeil, D; Ader, M				Eberle, Dominic; Kurth, Thomas; Santos-Ferreira, Tiago; Wilson, John; Corbeil, Denis; Ader, Marius			Outer Segment Formation of Transplanted Photoreceptor Precursor Cells	PLOS ONE			English	Article							RETINAL STEM-CELLS; RED FLUORESCENT PROTEIN; MOUSE RETINA; RCS RATS; GENERATION; MICE; DIFFERENTIATE; EXPRESSION; EPITHELIUM; RHODOPSIN	Transplantation of photoreceptor precursor cells (PPCs) into the retina represents a promising treatment for cell replacement in blinding diseases characterized by photoreceptor loss. In preclinical studies, we and others demonstrated that grafted PPCs integrate into the host outer nuclear layer (ONL) and develop into mature photoreceptors. However, a key feature of light detecting photoreceptors, the outer segment (OS) with natively aligned disc membrane staples, has not been studied in detail following transplantation. Therefore, we used as donor cells PPCs isolated from neonatal double transgenic reporter mice in which OSs are selectively labeled by green fluorescent protein while cell bodies are highlighted by red fluorescent protein. PPCs were enriched using CD73-based magnetic associated cell sorting and subsequently transplanted into either adult wild-type or a model of autosomal-dominant retinal degeneration mice. Three weeks post-transplantation, donor photoreceptors were identified based on fluorescent-reporter expression and OS formation was monitored at light and electron microscopy levels. Donor cells that properly integrated into the host wild-type retina developed OSs with the formation of a connecting cilium and well-aligned disc membrane staples similar to the surrounding native cells of the host. Surprisingly, the majority of not-integrated PPCs that remained in the sub-retinal space also generated native-like OSs in wild-type mice and those affected by retinal degeneration. Moreover, they showed an improved photoreceptor maturation and OS formation by comparison to donor cells located on the vitreous side suggesting that environmental cues influence the PPC differentiation and maturation. We conclude that transplanted PPCs, whether integrated or not into the host ONL, are able to generate the cellular structure for effective light detection, a phenomenon observed in wild-type as well as in degenerated retinas. Given that patients suffering from retinitis pigmentosa lose almost all photoreceptors, our findings are of utmost importance for the development of cell-based therapies.	[Eberle, Dominic; Kurth, Thomas; Santos-Ferreira, Tiago; Corbeil, Denis; Ader, Marius] Cluster Excellence TU Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [Corbeil, Denis] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Wilson, John] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Technische Universitat Dresden; Technische Universitat Dresden; Baylor College of Medicine	Ader, M (corresponding author), Cluster Excellence TU Dresden, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany.	marius.ader@crt-dresden.de	Ader, Marius/E-7535-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/A-6519-2010; Corbeil, Denis/L-2340-2019	Ader, Marius/0000-0001-9467-7677; Corbeil, Denis/0000-0003-1181-3659; Eberle, Dominic/0000-0003-0369-6042; Ferreira, Tiago/0000-0002-2065-6440; Kurth, Thomas/0000-0001-5624-1717	Deutsche Forschungsgemeinschaft; CRTD [043_264030]; Fundacao Para a Ciencia e Tecnologia [SFRH/BD/60787/2009]; charity ProRetina E.V. stipend [060_3229];  [SFB 655]; NATIONAL EYE INSTITUTE [R01EY011731] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CRTD; Fundacao Para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); charity ProRetina E.V. stipend; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de), CRTD seed grant #043_264030 (http://www.crt-dresden.de), SFB 655 (http://www.sfb655.de), Fundacao Para a Ciencia e Tecnologia #SFRH/BD/60787/2009 (http://www.fct.pt), and the charity ProRetina E.V. stipend #060_3229 (http://www.pro-retina-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Barber AC, 2011, ARVO M, V52, P4019; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Comyn O, 2010, CURR OPIN NEUROL, V23, P4, DOI 10.1097/WCO.0b013e3283352f96; Eberle D, 2011, INVEST OPHTH VIS SCI, V52, P6462, DOI 10.1167/iovs.11-7399; Fabig G, 2012, METHOD CELL BIOL, V111, P75, DOI 10.1016/B978-0-12-416026-2.00005-4; GAUR VP, 1992, EXP EYE RES, V54, P645, DOI 10.1016/0014-4835(92)90020-S; GOURAS P, 1992, INVEST OPHTH VIS SCI, V33, P2579; GOURAS P, 1994, INVEST OPHTH VIS SCI, V35, P3145; GOURAS P, 1991, INVEST OPHTH VIS SCI, V32, P3167; GOURAS P, 1991, INVEST OPHTH VIS SCI, V32, P1704; GOURAS P, 1991, Journal of Neural Transplantation and Plasticity, V2, P91; Hippert C, 2012, ARVO M, V53, P2010; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Lakowski J, 2011, STEM CELLS, V29, P1391, DOI 10.1002/stem.694; Lakowski J, 2010, HUM MOL GENET, V19, P4545, DOI 10.1093/hmg/ddq378; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Lin N, 1996, CURR EYE RES, V15, P1069, DOI 10.3109/02713689609017657; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Merhi-Soussi F, 2006, STEM CELLS, V24, P2060, DOI 10.1634/stemcells.2005-0311; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Pearson RA, 2012, NATURE; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Schwarz H, 2009, HDB CRYOPREPARATION, P537; Schwarz Heinz, 2007, Methods Mol Biol, V369, P229; Sheedlo HJ, 1998, DEV BRAIN RES, V107, P57, DOI 10.1016/S0165-3806(97)00219-8; STIEMKE MM, 1994, DEV BIOL, V162, P169, DOI 10.1006/dbio.1994.1076; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Vicidomini G, 2008, TRAFFIC, V9, P1828, DOI 10.1111/j.1600-0854.2008.00815.x; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095	36	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46305	10.1371/journal.pone.0046305	http://dx.doi.org/10.1371/journal.pone.0046305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029471	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900129
J	Gao, JY; Tan, MY; Gu, MX; Marshall, C; Ding, J; Hu, G; Xiao, M				Gao, Junying; Tan, Meiyun; Gu, Minxia; Marshall, Charles; Ding, Jiong; Hu, Gang; Xiao, Ming			Cellular Localization of Aquaporin-1 in the Human and Mouse Trigeminal Systems	PLOS ONE			English	Article							IMMUNOREACTIVE ENTERIC NEURONS; PERIPHERAL NERVOUS-SYSTEM; WATER CHANNEL; SENSORY NEURONS; CHOROID-PLEXUS; GLIAL-CELLS; RAT-BRAIN; EXPRESSION; IDENTIFICATION; TRANSPORT	Previous studies reported that a subpopulation of mouse and rat trigeminal neurons express water channel aquaporin-1 (AQP1). In this study we make a comparative investigation of AQP1 localization in the human and mouse trigeminal systems. Immunohistochemistry and immunofluorescence results showed that AQP1 was localized to the cytoplasm and cell membrane of some medium and small-sized trigeminal neurons. Additionally, AQP1 was found in numerous peripheral trigeminal axons of humans and mice. In the central trigeminal root and brain stem, AQP1 was specifically expressed in astrocytes of humans, but was restricted to nerve fibers within the central trigeminal root and spinal trigeminal tract and nucleus in mice. Furthermore, AQP1 positive nerve fibers were present in the mucosal and submucosal layers of human and mouse oral tissues, but not in the muscular and subcutaneous layers. Fluorogold retrograde tracing demonstrated that AQP1 positive trigeminal neurons innervate the mucosa but not skin of cheek. These results reveal there are similarities and differences in the cellular localization of AQP1 between the human and mouse trigeminal systems. Selective expression of AQP1 in the trigeminal neurons innervating the oral mucosa indicates an involvement of AQP1 in oral sensory transduction.	[Gao, Junying; Tan, Meiyun; Gu, Minxia; Ding, Jiong; Hu, Gang; Xiao, Ming] Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China; [Marshall, Charles] Univ Kentucky, Dept Rehabil Sci, Ctr Excellence Rural Hlth, Hazard, KY USA	Nanjing Medical University; University of Kentucky	Xiao, M (corresponding author), Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	mingx@njmu.edu.cn		Xiao, Ming/0000-0001-5528-9102	National Natural Science Foundation of China [30971020]; Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine; PAPD Foundation of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine; PAPD Foundation of Jiangsu Higher Education Institutions	Funding was provided by the National Natural Science Foundation of China (30971020), the Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine, and the PAPD Foundation of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Arciszewski MB, 2011, ANN ANAT, V193, P81, DOI 10.1016/j.aanat.2010.11.003; Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Borsani E, 2010, ACTA HISTOCHEM, V112, P444, DOI 10.1016/j.acthis.2009.04.006; Borsani E, 2009, NEUROSCI LETT, V449, P183, DOI 10.1016/j.neulet.2008.11.014; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; de Araujo IET, 2003, J NEUROPHYSIOL, V90, P1865, DOI 10.1152/jn.00297.2003; Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRIGERI A, 1995, J CELL SCI, V108, P2993; Galeano RM, 2000, NEUROSCI LETT, V279, P89, DOI 10.1016/S0304-3940(99)00950-7; Gao HW, 2006, GLIA, V53, P783, DOI 10.1002/glia.20336; Gilbertson Timothy A., 2006, Journal of Water and Health, V4, P35; Hou MY, 2003, BRAIN RES, V964, P179, DOI 10.1016/S0006-8993(02)03927-6; Ichikawa H, 2006, BRAIN RES, V1082, P67, DOI 10.1016/j.brainres.2006.01.092; Ishihara E, 2008, AUTON NEUROSCI-BASIC, V138, P31, DOI 10.1016/j.autneu.2007.09.002; Larsen HS, 2009, EUR J ORAL SCI, V117, P655, DOI 10.1111/j.1600-0722.2009.00695.x; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; Ma TH, 2011, ACTA PHARMACOL SIN, V32, P711, DOI 10.1038/aps.2011.63; Matsumoto I, 2004, MOL BRAIN RES, V126, P98, DOI 10.1016/j.molbrainres.2004.03.024; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Nagahama M, 2006, NEUROSCI LETT, V395, P206, DOI 10.1016/j.neulet.2005.10.092; Nandasena BGTL, 2007, BRAIN RES, V1157, P32, DOI 10.1016/j.brainres.2007.04.033; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nielsen S, 1997, J NEUROSCI, V17, P171; Nieuwenhuys R., 1988, HUMAN CENTRAL NERVOU; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Shields SD, 2010, J COMP NEUROL, V518, P4329, DOI 10.1002/cne.22459; Thi MM, 2008, J NEUROSCI RES, V86, P448, DOI 10.1002/jnr.21496; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Wen H, 1999, EUR J NEUROSCI, V11, P935, DOI 10.1046/j.1460-9568.1999.00502.x; Wu Q, 1998, AM J PHYSIOL-CELL PH, V275, pC1565, DOI 10.1152/ajpcell.1998.275.6.C1565; Zhang H, 2010, J BIOL CHEM, V285, P5896, DOI 10.1074/jbc.M109.090233	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46379	10.1371/journal.pone.0046379	http://dx.doi.org/10.1371/journal.pone.0046379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029502	Green Published, gold			2022-12-25	WOS:000309973900149
J	Hamadah, A; Schreiber, Y; Toye, B; McDiarmid, S; Huebsch, L; Bredeson, C; Tay, J				Hamadah, Aziz; Schreiber, Yoko; Toye, Baldwin; McDiarmid, Sheryl; Huebsch, Lothar; Bredeson, Christopher; Tay, Jason			The Use of Intravenous Antibiotics at the Onset of Neutropenia in Patients Receiving Outpatient-Based Hematopoietic Stem Cell Transplants	PLOS ONE			English	Article							HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; HEART-RATE-VARIABILITY; INFECTIOUS COMPLICATIONS; ANTIBACTERIAL PROPHYLAXIS; RECIPIENTS; LEVOFLOXACIN; METAANALYSIS; RESISTANCE; MORTALITY	Empirical antibiotics at the onset of febrile neutropenia are one of several strategies for management of bacterial infections in patients undergoing Hematopoietic Stem Cell Transplant (HSCT) (empiric strategy). Our HSCT program aims to perform HSCT in an outpatient setting, where an empiric antibiotic strategy was employed. HSCT recipients began receiving intravenous antibiotics at the onset of neutropenia in the absence of fever as part of our institutional policy from 01 Jan 2009; intravenous Prophylactic strategy. A prospective study was conducted to compare two consecutive cohorts [Year 2008 (Empiric strategy) vs. Year 2009 (Prophylactic strategy)] of patients receiving HSCT. There were 238 HSCTs performed between 01 Jan 2008 and 31 Dec 2009 with 127 and 111 in the earlier and later cohorts respectively. Infection-related mortality pre-engraftment was similar with a prophylactic compared to an empiric strategy (3.6% vs. 7.1%; p = 0.24), but reduced among recipients of autologous HSCT (0% vs. 6.8%; p = 0.03). Microbiologically documented, blood stream infections and clinically documented infections pre-engraftment were reduced in those receiving a prophylactic compared to an empiric strategy, (11.7% vs. 28.3%; p = 0.001), (9.9% vs. 24.4%; p = 0.003) and (18.2% vs. 33.9% p = 0.007) respectively. The prophylactic use of intravenous once-daily ceftriaxone in patients receiving outpatient based HSCT is safe and may be particularly effective in patients receiving autologous HSCT. Further studies are warranted to study the impact of this Prophylactic strategy in an outpatient based HSCT program.	[Hamadah, Aziz; McDiarmid, Sheryl; Huebsch, Lothar; Bredeson, Christopher; Tay, Jason] Ottawa Hosp, Blood & Marrow Programme, Ottawa, ON, Canada; [Schreiber, Yoko; Toye, Baldwin] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Tay, J (corresponding author), Ottawa Hosp, Blood & Marrow Programme, Ottawa, ON, Canada.	jtay@ottawahospital.on.ca	Tay, Jason/J-5061-2019	Tay, Jason/0000-0002-5969-9755; Schreiber, Yoko/0000-0003-4981-3486				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Ahmad S, 2009, CRIT CARE, V13, DOI 10.1186/cc8132; AVRIL M, 1994, PEDIATR HEMAT ONCOL, V11, P63; BEARMAN SI, 1988, J CLIN ONCOL, V6, P1562, DOI 10.1200/JCO.1988.6.10.1562; Bow EJ, 2011, CURR OPIN INFECT DIS, V24, P545, DOI 10.1097/QCO.0b013e32834cf054; Bucaneve G, 2005, NEW ENGL J MED, V353, P977, DOI 10.1056/NEJMoa044097; Craig M, 2007, BONE MARROW TRANSPL, V39, P477, DOI 10.1038/sj.bmt.1705591; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dekker A, 2006, J CLIN ONCOL, V24, P5207, DOI 10.1200/JCO.2006.06.1663; Engels EA, 1999, CLIN INFECT DIS, V28, P256, DOI 10.1086/515103; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Gafter-Gvili A, 2007, J ANTIMICROB CHEMOTH, V59, P5, DOI 10.1093/jac/dkl425; Gluck S, 1997, BONE MARROW TRANSPL, V20, P431, DOI 10.1038/sj.bmt.1700901; Gooley TA, 2010, NEW ENGL J MED, V363, P2091, DOI 10.1056/NEJMoa1004383; Guthrie KA, 2010, BONE MARROW TRANSPL, V45, P675, DOI 10.1038/bmt.2009.216; Jagannath S, 1997, BONE MARROW TRANSPL, V20, P445, DOI 10.1038/sj.bmt.1700900; Kimura SI, 2010, BIOL BLOOD MARROW TR, V16, P1355, DOI 10.1016/j.bbmt.2010.04.012; Liu CY, 2011, BONE MARROW TRANSPL, V46, P1231, DOI 10.1038/bmt.2010.286; McDiarmid S, 2010, BONE MARROW TRANSPL, V45, P1220, DOI 10.1038/bmt.2009.330; Meisenberg BR, 1997, J CLIN ONCOL, V15, P11, DOI 10.1200/JCO.1997.15.1.11; Meisenberg BR, 1998, BONE MARROW TRANSPL, V21, P927, DOI 10.1038/sj.bmt.1701191; Mikulska M, 2009, BIOL BLOOD MARROW TR, V15, P47, DOI 10.1016/j.bbmt.2008.10.024; Park SH, 2006, J KOREAN MED SCI, V21, P199, DOI 10.3346/jkms.2006.21.2.199; Pasquini M, 2011, CURRENT USE OUTCOME; PETERSEN F, 1988, INFECTION, V16, P199, DOI 10.1007/BF01650752; Roberts AW, 1993, AUSTR NZ J MED, V141; Slavin MA, 2007, BONE MARROW TRANSPL, V40, P157, DOI 10.1038/sj.bmt.1705686; Slavin MA, 2011, INTERN MED J, V41, P102, DOI 10.1111/j.1445-5994.2010.02341.x; Spellman S, 2008, BIOL BLOOD MARROW TR, V14, P37, DOI 10.1016/j.bbmt.2008.05.001; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Therriault BL, 2010, MAYO CLIN PROC, V85, P711, DOI 10.4065/mcp.2010.0006; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Woolfrey A, 2010, BIOL BLOOD MARROW TR, V16, P1382, DOI 10.1016/j.bbmt.2010.03.024	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46220	10.1371/journal.pone.0046220	http://dx.doi.org/10.1371/journal.pone.0046220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029441	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900111
J	Ji, LJ; Zhou, JL; Zafar, R; Kantorovich, S; Jiang, RX; Carney, PR; Jiang, HB				Ji, Lijun; Zhou, Junli; Zafar, Rabia; Kantorovich, Svetlana; Jiang, Ruixin; Carney, Paul R.; Jiang, Huabei			Cortical Neurovascular Coupling Driven by Stimulation of Channelrhodopsin-2	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OPTICAL CONTROL; HEMODYNAMIC SIGNALS; OXYGEN-METABOLISM; BOLD RESPONSE; TELL US; BRAIN; ACTIVATION; FREQUENCY; TISSUE	While functional imaging is widely used in studies of the brain, how well the hemodynamic signal represents the underlying neural activity is still unclear. And there is a debate on whether hemodynamic signal is more tightly related to synaptic activity or action potentials. This study intends to address these questions by examining neurovascular coupling driven by pyramidal cells in the motor cortex of rats. Pyramidal cells in the motor cortex of rats were selectively transduced with the light sensitive cation channel channelrhodopsin-2 (ChR2). Electrophysiological recordings and optical intrinsic signal imaging were performed simultaneously and synchronously to capture the neural activity and hemodynamics induced by optical stimulation of ChR2-expressing pyramidal cells. Our results indicate that both synaptic activity (local field potential, LFP) and action potentials (multi-unit activity, MUA) are tightly related to hemodynamic signals. While LFPs in c band are better in predicting hemodynamic signals elicited by short stimuli, MUA has better predictions to hemodynamic signals elicited by long stimuli. Our results also indicate that strong nonlinearity exists in neurovascular coupling.	[Ji, Lijun; Jiang, Ruixin; Carney, Paul R.; Jiang, Huabei] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Zhou, Junli; Zafar, Rabia; Kantorovich, Svetlana; Carney, Paul R.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Zhou, Junli; Carney, Paul R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Zhou, Junli; Carney, Paul R.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Carney, Paul R.] Univ Florida, BJ & Eve Wilder Ctr Excellence Epilepsy Res, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jiang, HB (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	hjiang@bme.ufl.edu			J. Crayton Pruitt Family Endowment; B.J and Eve Wilder Endowment; University of Florida Computational Biology Seed Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	J. Crayton Pruitt Family Endowment; B.J and Eve Wilder Endowment; University of Florida Computational Biology Seed Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by the J. Crayton Pruitt Family Endowment (to HJ), B.J and Eve Wilder Endowment (to PRC), and the University of Florida Computational Biology Seed Grant (to PRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DIRNAGL U, 1994, AM J PHYSIOL, V267, pH296, DOI 10.1152/ajpheart.1994.267.1.H296; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Kahn I, 2011, J NEUROSCI, V31, P15086, DOI 10.1523/JNEUROSCI.0007-11.2011; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Li B, 2007, J NEUROSCI, V27, P10223, DOI 10.1523/JNEUROSCI.1505-07.2007; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Martindale J, 2005, J CEREBR BLOOD F MET, V25, P651, DOI 10.1038/sj.jcbfm.9600060; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Scott NA, 2012, PLOS ONE, V7, P176, DOI 10.1371/journal.pone.0029859; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Soltysik DA, 2004, NEUROIMAGE, V22, P1117, DOI 10.1016/j.neuroimage.2004.03.024; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Thompson JK, 2004, NAT NEUROSCI, V7, P919, DOI 10.1038/nn1308; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vazquez AL, 1998, NEUROIMAGE, V7, P108, DOI 10.1006/nimg.1997.0316; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46607	10.1371/journal.pone.0046607	http://dx.doi.org/10.1371/journal.pone.0046607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029556	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900190
J	Kwei, KA; Baker, JB; Pelham, RJ				Kwei, Kevin A.; Baker, Joffre B.; Pelham, Robert J.			Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; O-GLCNAC TRANSFERASE; INSULIN-RESISTANCE; DRUG-SENSITIVITY; AKT ACTIVATION; MESSENGER-RNA; CANCER-CELLS; PATHWAY; KINASE; POTENT	The phosphoinositide 3-kinase (PI3K) signaling pathway is significantly altered in a wide variety of human cancers, driving cancer cell growth and survival. Consequently, a large number of PI3K inhibitors are now in clinical development. To begin to improve the selection of patients for treatment with PI3K inhibitors and to identify de novo determinants of patient response, we sought to identify and characterize candidate genomic and phosphoproteomic biomarkers predictive of response to the selective PI3K inhibitor, GDC-0941, using the NCI-60 human tumor cell line collection. In this study, sixty diverse tumor cell lines were exposed to GDC-0941 and classified by GI(50) value as sensitive or resistant. The most sensitive and resistant cell lines were analyzed for their baseline levels of gene expression and phosphorylation of key signaling nodes. Phosphorylation or activation status of both the PI3K-Akt signaling axis and PARP were correlated with in vitro response to GDC-0941. A gene expression signature associated with in vitro sensitivity to GDC-0941 was also identified. Furthermore, in vitro siRNA-mediated silencing of two genes in this signature, OGT and DDN, validated their role in modulating sensitivity to GDC-0941 in numerous cell lines and begins to provide biological insights into their role as chemosensitizers. These candidate biomarkers will offer useful tools to begin a more thorough understanding of determinants of patient response to PI3K inhibitors and merit exploration in human cancer patients treated with PI3K inhibitors.	[Kwei, Kevin A.; Baker, Joffre B.; Pelham, Robert J.] Genom Hlth Inc, Redwood City, CA USA	Genomic Health	Pelham, RJ (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	rpelham@genomichealth.com			Genomic Health, Inc.	Genomic Health, Inc.	Genomic Health, Inc. provided funding for this work. The funders had no role in study design, data collection and analysis, or preparation of the manuscript but approved the decision to publish.	Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Harradine KA, 2011, MOL CANCER RES, V9, P173, DOI 10.1158/1541-7786.MCR-10-0412; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; O'Brien C, 2010, CLIN CANC RES; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	43	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46518	10.1371/journal.pone.0046518	http://dx.doi.org/10.1371/journal.pone.0046518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029544	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900180
J	Mortillaro, JM; Rigal, F; Rybarczyk, H; Bernardes, M; Abril, G; Meziane, T				Mortillaro, Jean-Michel; Rigal, Francois; Rybarczyk, Herve; Bernardes, Marcelo; Abril, Gwenael; Meziane, Tarik			Particulate Organic Matter Distribution along the Lower Amazon River: Addressing Aquatic Ecology Concepts Using Fatty Acids	PLOS ONE			English	Article							FLOODPLAIN LAKE; CARBON-DIOXIDE; SPATIAL PROCESSES; LIPID BIOMARKERS; ENERGY-SOURCES; LAGO GRANDE; VEGETATION; DYNAMICS; ESTUARY; PHYTOPLANKTON	One of the greatest challenges in understanding the Amazon basin functioning is to ascertain the role played by floodplains in the organic matter (OM) cycle, crucial for a large spectrum of ecological mechanisms. Fatty acids (FAs) were combined with environmental descriptors and analyzed through multivariate and spatial tools (asymmetric eigenvector maps, AEM and principal coordinates of neighbor matrices, PCNM). This challenge allowed investigating the distribution of suspended particulate organic matter (SPOM), in order to trace its seasonal origin and quality, along a 800 km section of the Amazon river-floodplain system. Statistical analysis confirmed that large amounts of saturated FAs (15: 0, 18: 0, 24: 0, 25: 0 and 26: 0), an indication of refractory OM, were concomitantly recorded with high pCO(2) in rivers, during the high water season (HW). Contrastingly, FAs marker which may be attributed in this ecosystem to aquatic plants (18:2 omega 6 and 18:3 omega 3) and cyanobacteria (16:1 omega 7), were correlated with higher O-2, chlorophyll a and pheopigments in floodplains, due to a high primary production during low waters (LW). Decreasing concentrations of unsaturated FAs, that characterize labile OM, were recorded during HW, from upstream to downstream. Furthermore, using PCNM and AEM spatial methods, FAs compositions of SPOM displayed an upstream-downstream gradient during HW, which was attributed to OM retention and the extent of flooded forest in floodplains. Discrimination of OM quality between the Amazon River and floodplains corroborate higher autotrophic production in the latter and transfer of OM to rivers at LW season. Together, these gradients demonstrate the validity of FAs as predictors of spatial and temporal changes in OM quality. These spatial and temporal trends are explained by 1) downstream change in landscape morphology as predicted by the River Continuum Concept; 2) enhanced primary production during LW when the water level decreased and its residence time increased as predicted by the Flood Pulse Concept.	[Mortillaro, Jean-Michel; Rigal, Francois; Rybarczyk, Herve; Meziane, Tarik] MNHN, Dept Milieux & Peuplements Aquat, BOREA, UMR CNRS IRD UPMC 7208, Paris, France; [Rigal, Francois] Univ Acores, Azorean Biodivers Grp, Angra Do Heroismo, Terceira, Portugal; [Bernardes, Marcelo] Univ Fed Fluminense, Inst Quim, Programa Geoquim, Rio De Janeiro, Brazil; [Abril, Gwenael] Univ Bordeaux 1, EPOC, UMR CNRS 5805, F-33405 Talence, France; [Abril, Gwenael] Univ Fed Amazonas, IRD, GET, Lab Potamol Amazon, Manaus, Amazonas, Brazil	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universidade dos Acores; Universidade Federal Fluminense; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; Universidade Federal de Amazonas	Mortillaro, JM (corresponding author), MNHN, Dept Milieux & Peuplements Aquat, BOREA, UMR CNRS IRD UPMC 7208, CP 53, Paris, France.	mortillaro@mnhn.fr	Abril, Gwenaël/C-7835-2011; mortillaro, Jean-Michel/A-2496-2012; Bernardes, Marcelo C/H-7869-2012; Meziane, Tarik/A-5465-2009; Meziane, Tarik/AAF-7906-2020	Abril, Gwenaël/0000-0002-4914-086X; mortillaro, Jean-Michel/0000-0003-1911-9338; Bernardes, Marcelo C/0000-0002-4338-4353; Meziane, Tarik/0000-0003-2142-6441; Meziane, Tarik/0000-0003-2142-6441; Rigal, Francois/0000-0001-6882-1591	French National Agency for Research (ANR)	French National Agency for Research (ANR)(French National Research Agency (ANR))	This research is a contribution to the CARBAMA project, supported by the French National Agency for Research (ANR), and conducted within an international cooperation agreement between the National Council for Scientific and Technological Development - Brazil (CNPq) and the Institute for Research and Development - France (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2006, SCI TOTAL ENVIRON, V354, P246, DOI 10.1016/j.scitotenv.2004.12.051; Abril G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019714; AGUSTI S, 1992, LIMNOL OCEANOGR, V37, P434, DOI 10.4319/lo.1992.37.2.0434; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Arts M.T., 1999, LIPIDS FRESHWATER EC; Aufdenkampe AK, 2007, ORG GEOCHEM, V38, P337, DOI 10.1016/j.orggeochem.2006.06.003; Battin TJ, 2009, NAT GEOSCI, V2, P595, DOI 10.1038/ngeo602; Bechtel A, 2009, ORG GEOCHEM, V40, P441, DOI 10.1016/j.orggeochem.2009.01.011; Bernardes MC, 2004, ECOL APPL, V14, pS263; Bianchi TS, 2009, P NATL ACAD SCI USA, V106, P8085, DOI 10.1073/pnas.0812878106; Blanchet F., 2010, AEM TOOLS CONSTRUCT; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnet MP, 2008, J HYDROL, V349, P18, DOI 10.1016/j.jhydrol.2007.10.055; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Canuel EA, 2001, ORG GEOCHEM, V32, P563, DOI 10.1016/S0146-6380(00)00195-9; Caraco N, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P301; Dray S, 2009, PACKFOR FORWARD SELE, P46; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; FORSBERG BR, 1988, LIMNOL OCEANOGR, V33, P41, DOI 10.4319/lo.1988.33.1.0041; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; FURCH K, 1993, ARCH HYDROBIOL, V128, P277; Goulding M, 2003, SMITHSONIAN ATLAS AM; HAMILTON SK, 1987, LIMNOL OCEANOGR, V32, P1277, DOI 10.4319/lo.1987.32.6.1277; Hawkes H.A., 1975, RIVER ECOLOGY; Hedges JI, 2000, LIMNOL OCEANOGR, V45, P1449, DOI 10.4319/lo.2000.45.7.1449; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743, DOI 10.4319/lo.1994.39.4.0743; HEDGES JI, 1986, LIMNOL OCEANOGR, V31, P717, DOI 10.4319/lo.1986.31.4.0717; Hess LL, 2003, REMOTE SENS ENVIRON, V87, P404, DOI 10.1016/j.rse.2003.04.001; Hu JF, 2006, ESTUAR COAST SHELF S, V66, P346, DOI 10.1016/j.ecss.2005.09.009; HUMPHRIES SE, 1988, LIMNOL OCEANOGR, V33, P79, DOI 10.4319/lo.1988.33.1.0079; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W. J., 1997, CENTRAL AMAZON FLOOD; Junk W.J., 1984, AMAZON LIMNOLOGY LAN, P269, DOI [10.1007/978-94-009-6542-3_10, DOI 10.1007/978-94-009-6542-3, DOI 10.1007/978-94-009-6542-3_10]; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2010, RDATEST CANONICAL RE; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leite RG, 2002, ECOL FRESHW FISH, V11, P56, DOI 10.1034/j.1600-0633.2002.110106.x; Martinez JM, 2007, REMOTE SENS ENVIRON, V108, P209, DOI 10.1016/j.rse.2006.11.012; Maurice Bourgoin L, 2007, J HYDROL, V335, P140, DOI 10.1016/j.jhydrol.2006.11.023; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; Melack J.M., 2010, AMAZONIAN FLOODPLAIN, P43, DOI DOI 10.1007/978-90-481-8725-6_3; MERTES LAK, 1995, GEOMORPHOLOGY, V13, P215, DOI 10.1016/0169-555X(95)00038-7; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; MEYERS PA, 1993, ORG GEOCHEM, V20, P47, DOI 10.1016/0146-6380(93)90080-U; Meziane T, 2007, MAR BIOL, V150, P1103, DOI 10.1007/s00227-006-0424-z; Moreira-Turcq P, 2004, PALAEOGEOGR PALAEOCL, V214, P27, DOI 10.1016/j.palaeo.2004.06.013; Moreira-Turcq P, 2003, HYDROL PROCESS, V17, P1329, DOI 10.1002/hyp.1287; Moreira-Turcq PF, 2003, HYDROL PROCESS, V17, P1393, DOI 10.1002/hyp.1291; Mortillaro JM, 2011, ORG GEOCHEM, V42, P1159, DOI 10.1016/j.orggeochem.2011.08.011; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Nesterov VN, 2009, RUSS J PLANT PHYSL+, V56, P85, DOI 10.1134/S1021443709010130; Oksanen J, 2010, VEGAN COMUNITY ECOLO; Oliveira ACB, 2006, AQUAT SCI, V68, P229, DOI 10.1007/s00027-006-0808-7; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Phlips EJ, 2008, FUND APPL LIMNOL, V172, P99, DOI 10.1127/1863-9135/2008/0172-0099; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Raymond PA, 1997, ESTUARIES, V20, P381, DOI 10.2307/1352351; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Richey JE, 1989, GLOBAL BIOGEOCHEM CY, V3, P191, DOI 10.1029/GB003i003p00191; Rozentsvet OA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P351, DOI 10.1023/A:1014892601961; Saliot A, 2001, BIOGEOCHEMISTRY, V53, P79, DOI 10.1023/A:1010754022594; SEDELL J R, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P49; SETARO FV, 1984, LIMNOL OCEANOGR, V29, P972, DOI 10.4319/lo.1984.29.5.0972; Sioli H, 1984, AMAZON LIMNOLOGY LAN, DOI 10.1007/978-94-009-6542-3; Thorp JH, 1998, OECOLOGIA, V117, P551, DOI 10.1007/s004420050692; THORP JH, 1994, OIKOS, V70, P305, DOI 10.2307/3545642; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Waichman AV, 1996, HYDROBIOLOGIA, V341, P27, DOI 10.1007/BF00012300; Wakeham SG, 1995, DEEP-SEA RES PT I, V42, P1749, DOI 10.1016/0967-0637(95)00074-G; Waterson EJ, 2008, ORG GEOCHEM, V39, P422, DOI 10.1016/j.orggeochem.2008.01.011; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Xu Y, 2007, MAR ENVIRON RES, V64, P666, DOI 10.1016/j.marenvres.2007.07.004	79	17	17	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46141	10.1371/journal.pone.0046141	http://dx.doi.org/10.1371/journal.pone.0046141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029412	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900094
J	Sharma, R; Florea, M; Nau, WM; Swaminathan, K				Sharma, Reetu; Florea, Mara; Nau, Werner M.; Swaminathan, Kunchithapadam			Validation of Drug-Like Inhibitors against Mycobacterium Tuberculosis L-Aspartate alpha-Decarboxylase Using Nuclear Magnetic Resonance (H-1 NMR)	PLOS ONE			English	Article							TANDEM ENZYME ASSAYS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MASS-SPECTROMETRY; BETA-ALANINE; BIOSYNTHESIS; PURIFICATION; SPECTROSCOPY; PANTOTHENATE; BINDING	The catalytic activity of L-aspartate alpha-decarboxylase (ADC) is essential for the growth of several micro-organisms, including Mycobacterium tuberculosis (Mtb), and has triggered efforts for the development of pharmaceutically active compounds against tuberculosis. The present study is a continuation of our recent chemoinformatics-based design approach for identifying potential drug-like inhibitors against MtbADC. We report an NMR-based protocol that allows label-free and direct monitoring of enzymatic conversion, which we have combined with a systematic testing of reported and newly identified potential inhibitors against MtbADC. Quantification of enzymatic conversion in the absence and presence of inhibitors allowed for a relative measure of the inhibitory effect (k(rel)). Among the newly identified compounds, D-tartrate, L-tartrate, and 2,4-dihydroxypyrimidine-5-carboxylate were found to inhibit the enzyme with k(rel) values of 0.36, 0.38, and 0.54, respectively. In addition to the identification of potential building blocks for the development of therapeutic agents, the current study highlights the importance of electrostatic interactions governing enzyme-inhibitor binding.	[Florea, Mara; Nau, Werner M.] Jacobs Univ, Sch Sci & Engn, Bremen, Germany; [Sharma, Reetu; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Jacobs University; National University of Singapore	Nau, WM (corresponding author), Jacobs Univ, Sch Sci & Engn, Bremen, Germany.	w.nau@jacobs-university.de; dbsks@nus.edu.sg	mo, qin/O-7877-2014; Nau, Werner/E-6686-2011	Nau, Werner/0000-0002-7654-6232; Sharma, Reetu/0000-0002-3300-9832	Ministry of Education [R154-000-439-112, R154-000-491-112]; Biomedical Research Council of Singapore [R154-000-424-305]; National University of Singapore; Fonds der Chemischen Industrie; Jacobs University Bremen	Ministry of Education; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Jacobs University Bremen	KS acknowledges the funding support of the Ministry of Education (Grants R154-000-439-112 and R154-000-491-112) and the Biomedical Research Council (Grant R154-000-424-305) of Singapore. The graduate research scholarship for RS is provided by National University of Singapore. MF and WMN acknowledge the support from the Fonds der Chemischen Industrie (doctoral stipend for MF) and Jacobs University Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL LM, 1988, BIOCHEMISTRY-US, V27, P5933, DOI 10.1021/bi00416a017; Albert A, 1998, NAT STRUCT BIOL, V5, P289, DOI 10.1038/nsb0498-289; Belliveau KA, 2010, NAT PROD RES, V24, P24, DOI 10.1080/14786410802278285; Chopra S, 2002, PROTEIN EXPRES PURIF, V25, P533, DOI 10.1016/S1046-5928(02)00039-6; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; CRONAN JE, 1980, J BACTERIOL, V141, P1291, DOI 10.1128/JB.141.3.1291-1297.1980; de Villiers J, 2010, CHEM-EUR J, V16, P10030, DOI 10.1002/chem.201000622; Dsouza RN, 2012, CHEM-EUR J, V18, P3444, DOI 10.1002/chem.201103364; Ghale G, 2011, J AM CHEM SOC, V133, P7528, DOI 10.1021/ja2013467; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Gopalan G, 2006, PROTEINS, V65, P796, DOI 10.1002/prot.21126; Lee B, 2004, J MOL BIOL, V340, P1, DOI 10.1016/j.jmb.2004.04.049; MAAS WK, 1950, J BACTERIOL, V60, P733, DOI 10.1128/JB.60.6.733-745.1950; Ramjee MK, 1997, BIOCHEM J, V323, P661, DOI 10.1042/bj3230661; RAVEL JM, 1946, J BIOL CHEM, V166, P407; Sahoo H, 2007, J AM CHEM SOC, V129, P15927, DOI 10.1021/ja074975w; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sharma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033521; SHIVE W, 1946, J BIOL CHEM, V162, P451; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; VANDENBERG JI, 1986, ANAL BIOCHEM, V155, P38, DOI 10.1016/0003-2697(86)90221-6; Webb ME, 2004, NAT PROD REP, V21, P695, DOI 10.1039/b316419p; Webb ME, 2003, CHEM COMMUN, P2416, DOI 10.1039/b308182f; WILLIAMSON JM, 1979, J BIOL CHEM, V254, P8074	24	8	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45947	10.1371/journal.pone.0045947	http://dx.doi.org/10.1371/journal.pone.0045947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029336	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900066
J	Downing, AS; van Nes, EH; Mooij, WM; Scheffer, M				Downing, Andrea S.; van Nes, Egbert H.; Mooij, Wolf M.; Scheffer, Marten			The Resilience and Resistance of an Ecosystem to a Collapse of Diversity	PLOS ONE			English	Article							LAKE VICTORIA; STABLE STATES; EAST-AFRICA; CORAL-REEFS; NILE PERCH; FOOD-WEB; BIODIVERSITY; PRODUCTIVITY; COMMUNITIES; POPULATIONS	Diversity is expected to increase the resilience of ecosystems. Nevertheless, highly diverse ecosystems have collapsed, as did Lake Victoria's ecosystem of cichlids or Caribbean coral reefs. We try to gain insight to this paradox, by analyzing a simple model of a diverse community where each competing species inflicts a small mortality pressure on an introduced predator. High diversity strengthens this feedback and prevents invasion of the introduced predator. After a gradual loss of native species, the introduced predator can escape control and the system collapses into a contrasting, invaded, low-diversity state. Importantly, we find that a diverse system that has high complementarity gains in resilience, whereas a diverse system with high functional redundancy gains in resistance. Loss of resilience can display early-warning signals of a collapse, but loss of resistance not. Our results emphasize the need for multiple approaches to studying the functioning of ecosystems, as managing an ecosystem requires understanding not only the threats it is vulnerable to but also pressures it appears resistant to.	[Downing, Andrea S.; van Nes, Egbert H.; Mooij, Wolf M.; Scheffer, Marten] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Downing, AS (corresponding author), Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands.	andrea.downing@wur.nl	downing, andrea s./H-4465-2012; Mooij, Wolf M/C-2677-2008; van Nes, Egbert H/F-2681-2011; Scheffer, Marten/C-1852-2012; KNAW, NIOO-KNAW/A-4320-2012	downing, andrea s./0000-0002-5206-9355; Mooij, Wolf M/0000-0001-5586-8200; KNAW, NIOO-KNAW/0000-0002-3835-159X; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization for Scientific Research (NWO/WOTRO) [W01.65.304.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the integrated project "Exploitation or eutrophication as threats for fisheries? Disentangling social and ecological drivers of ecosystem changes in Lake Victoria (SEDEC)", supported by the Netherlands Organization for Scientific Research (NWO/WOTRO) grant number W01.65.304.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.1890/1540-9295(2003)001[0376:ASSIE]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Downing AS, 2012, ECOL APPL, V22, P229, DOI 10.1890/11-0941.1; DRAKE JA, 1990, TRENDS ECOL EVOL, V5, P159, DOI 10.1016/0169-5347(90)90223-Z; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Elton C. S., 1958, ECOLOGY INVASIONS AN; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Goudswaard KPC, 2008, ENVIRON BIOL FISH, V81, P127, DOI 10.1007/s10641-006-9180-7; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kitchell JF, 1997, ECOL APPL, V7, P653; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Schroder A, 2009, P NATL ACAD SCI USA, V106, P2671, DOI 10.1073/pnas.0808279106; Schroder A, 2012, OIKOS, V121, P417, DOI 10.1111/j.1600-0706.2011.19764.x; Steneck RS, 2011, CONSERV BIOL, V25, P904, DOI 10.1111/j.1523-1739.2011.01717.x; Stromayer KAK, 1997, WILDLIFE SOC B, V25, P227; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van de Wolfshaar K, 2006, POPULATION PERSISTEN; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Whiteside JH, 2011, GEOLOGY, V39, P99, DOI 10.1130/G31401.1; WITTE F, 1992, ENVIRON BIOL FISH, V34, P1, DOI 10.1007/BF00004782; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	43	54	54	2	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46135	10.1371/journal.pone.0046135	http://dx.doi.org/10.1371/journal.pone.0046135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029410	Green Published, gold			2022-12-25	WOS:000309517500063
J	Mandalos, N; Saridaki, M; Harper, JL; Kotsoni, A; Yang, P; Economides, AN; Remboutsika, E				Mandalos, Nikolaos; Saridaki, Marannia; Harper, Jessica Lea; Kotsoni, Anastasia; Yang, Peter; Economides, Aris N.; Remboutsika, Eumorphia			Application of a Novel Strategy of Engineering Conditional Alleles to a Single Exon Gene, Sox2	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIAL EXPRESSION; REGULATORY REGION; INTRONLESS GENES; MESSENGER-RNAS; MOUSE GENOME; IN-VITRO; DNA; SEQUENCE; NEUROGENESIS	Background: The Conditional by Inversion (COIN) method for engineering conditional alleles relies on an invertible optimized gene trap-like element, the COIN module, for imparting conditionality. The COIN module contains an optimized 3' splice site-polyadenylation signal pair, but is inserted antisense to the target gene and therefore does not alter transcription, until it is inverted by Cre recombinase. In order to make COIN applicable to all protein-coding genes, the COIN module has been engineered within an artificial intron, enabling insertion into an exon. Methodology/Principal Findings: Therefore, theoretically, the COIN method should be applicable to single exon genes, and to test this idea we engineered a COIN allele of Sox2. This single exon gene presents additional design challenges, in that its proximal promoter and coding region are entirely contained within a CpG island, and are also spanned by an overlapping transcript, Sox2Ot, which contains mmu-miR1897. Here, we show that despite disruption of the CpG island by the COIN module intron, the COIN allele of Sox2 (Sox2(COIN)) is phenotypically wild type, and also does not interfere with expression of Sox2Ot and miR1897. Furthermore, the inverted COIN allele of Sox2, Sox2(INV) is functionally null, as homozygotes recapitulate the phenotype of Sox2(beta geo/beta geo) mice, a well-characterized Sox2 null. Lastly, the benefit of the eGFP marker embedded in the COIN allele is demonstrated as it mirrors the expression pattern of Sox2. Conclusions/Significance: Our results demonstrate the applicability of the COIN technology as a method of choice for targeting single exon genes.	[Harper, Jessica Lea; Yang, Peter; Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Mandalos, Nikolaos; Saridaki, Marannia; Harper, Jessica Lea; Kotsoni, Anastasia; Remboutsika, Eumorphia] Biomed Sci Res Ctr Alexander Fleming, Stem Cell Biol Lab, Inst Mol Biol & Genet, Vari, Greece	Regeneron; Alexander Fleming Biomedical Sciences Research Center	Economides, AN (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	aris.economides@regeneron.com; remboutsika@gmail.com	Remboutsika, Eumorphia/L-2718-2019	Remboutsika, Eumorphia/0000-0002-1243-9569; Economides, Aris/0000-0002-6508-8942	General Secretariat of Research and Technology [NON-EU82]; REGENERON Pharmaceuticals Inc., New York, USA	General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); REGENERON Pharmaceuticals Inc., New York, USA	This work was financially supported by BILATERAL COOPERATION GRANT (NON-EU82) from the General Secretariat of Research and Technology and it was performed under the auspices of a collaboration agreement with REGENERON Pharmaceuticals Inc., New York, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Three authors (Jessica Lea Harper, Peter Yang and Aris N. Economides) have the affiliation to the commercial funders of this research REGENERON Pharmaceuticals Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Alonso MM, PLOS ONE, V6; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barrand S, BIOCH BIOPHYS RES CO, V391, P762; Barrand S, 2010, BIOCHEM BIOPH RES CO, V401, P611, DOI 10.1016/j.bbrc.2010.09.116; Behbahaninia M, 2011, NEUROSURGERY, V69, pN19, DOI 10.1227/01.neu.0000405596.78460.20; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Donner AL, 2007, DEV BIOL, V303, P784, DOI 10.1016/j.ydbio.2006.10.047; Economides AN, 2012, CONDITIONALS BY INVE; Ekonomou A, 2005, PLOS BIOL, V3, P1111, DOI 10.1371/journal.pbio.0030186; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Funabashi H, 2010, BIOCHEM BIOPH RES CO, V400, P554, DOI 10.1016/j.bbrc.2010.08.098; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hill AE, 2006, FEBS LETT, V580, P4303, DOI 10.1016/j.febslet.2006.06.051; Huang YQ, 1997, P NATL ACAD SCI USA, V94, P10104, DOI 10.1073/pnas.94.19.10104; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Kamachi Y, 2009, P JPN ACAD B-PHYS, V85, P55, DOI 10.2183/pjab.85.55; Kirby PJ, 2002, CYTOGENET GENOME RES, V98, P96, DOI 10.1159/000068539; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Remboutsika E, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00016; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Sakharkar KR, 2006, FEBS LETT, V580, P1472, DOI 10.1016/j.febslet.2006.01.070; Sakharkar Meena Kishore, 2005, In Silico Biology, V5, P221; SCHILHAM MW, 1993, NUCLEIC ACIDS RES, V21, P2009, DOI 10.1093/nar/21.8.2009; Seoighe C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S16; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Swinburne IA, 2008, GENE DEV, V22, P2342, DOI 10.1101/gad.1696108; Swinburne IA, 2008, DEV CELL, V14, P324, DOI 10.1016/j.devcel.2008.02.002; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45768	10.1371/journal.pone.0045768	http://dx.doi.org/10.1371/journal.pone.0045768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029233	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500043
J	Yan, L; Gao, Y; Zhang, Y; Tildesley, M; Liu, LQ; Zhang, Y; Wen, LY; Wang, W; Li, XD; Hu, Y; Bai, T; Wang, M; Zeng, YH; Wang, DM; Wang, XJ; Lan, Y; Wang, SW; Shu, YL				Yan, Lei; Gao, Yan; Zhang, Yong; Tildesley, Michael; Liu, Liqi; Zhang, Ye; Wen, Leying; Wang, Wei; Li, Xiaodan; Hu, Ying; Bai, Tian; Wang, Min; Zeng, Yuhong; Wang, Dingming; Wang, Xianjun; Lan, Yu; Wang, Shiwen; Shu, Yuelong			Epidemiological and Virological Characteristics of Pandemic Influenza A (H1N1) School Outbreaks in China in 2009	PLOS ONE			English	Article							INFECTION; VIRUS; CALIFORNIA; ENGLAND; ADULT; DEATH	Background: During the 2009 pandemic influenza H1N1 (2009) virus (pH1N1) outbreak, school students were at an increased risk of infection by the pH1N1 virus. However, the estimation of the attack rate showed significant variability. Methods: Two school outbreaks were investigated in this study. A questionnaire was designed to collect information by interview. Throat samples were collected from all the subjects in this study 6 times and sero samples 3 times to confirm the infection and to determine viral shedding. Data analysis was performed using the software STATA 9.0. Findings: The attack rate of the pH1N1 outbreak was 58.3% for the primary school, and 52.9% for the middle school. The asymptomatic infection rates of the two schools were 35.8% and 37.6% respectively. Peak virus shedding occurred on the day of ARI symptoms onset, followed by a steady decrease over subsequent days (p = 0.026). No difference was found either in viral shedding or HI titer between the symptomatic and the asymptomatic infectious groups. Conclusions: School children were found to be at a high risk of infection by the novel virus. This may be because of a heightened risk of transmission owing to increased mixing at boarding school, or a lack of immunity owing to socioeconomic status. We conclude that asymptomatically infectious cases may play an important role in transmission of the pH1N1 virus.	[Yan, Lei; Gao, Yan; Liu, Liqi; Zhang, Ye; Wen, Leying; Wang, Wei; Li, Xiaodan; Hu, Ying; Bai, Tian; Wang, Min; Zeng, Yuhong; Lan, Yu; Wang, Shiwen; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Yong] Beijing Normal Univ, Sch Math Sci, Beijing 100875, Peoples R China; [Tildesley, Michael] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England; [Tildesley, Michael] US Natl Inst Hlth, Fogarty Int Ctr, Bethesda, MD USA; [Wang, Dingming] Ctr Dis Control & Prevent Guizhou Prov, Guiyang, Peoples R China; [Wang, Xianjun] Ctr Dis Control & Prevent Shandong Prov, Jinan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Beijing Normal University; University of Warwick; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wang, SW (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wangshiwencdc@163.com; yshu@cnic.org.cn		Tildesley, Michael/0000-0002-6875-7232	National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases [2008ZX10004-012]; NIH/NIAID [5-U54-AI-057157-08]; Wellcome Trust; RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) Fund for the Special Program for Prevention and Control of Infectious Diseases (Grant No. 2008ZX10004-012), and NIH/NIAID Grant 5-U54-AI-057157-08 (Epidemiology and Molecular Mechanism of Highly Pathogenic Avian Influenza H5N1 and Pandemic Influenza H1N1). MT is supported by the Wellcome Trust, the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, LANCET, V374, P2032, DOI 10.1016/S0140-6736(09)61916-4; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chan M., 2009, WORLD NOW START 2009; Chan M, 2010, H1N1 POSTPANDEMIC PE; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gurav YK, 2010, INDIAN J MED RES, V132, P67; Huai Y, 2010, INFLUENZA OTHER RESP, V4, P259, DOI 10.1111/j.1750-2659.2010.00150.x; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kendal AP, 1982, WHO COLLABORATING CT, pB17; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; ROSS T, 2010, PLOS CURR INFLUENZA; San Diego County Health and Human Svcs Imperial County Public Health Dept California Dept of Public Health Dallas County Health and Human Svcs Texas Dept of State Health Svcs, 2009, MMWR-MORBID MORTAL W, V58, P435; Wang Wei, 2009, Chinese Journal of Virology, V25, P4; WHO, 2005, REC LAB TESTS ID AV; WHO CDC, WHO CDC PROT REAL TI; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization (WHO), WHO MAN AN INFL DIAG; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; [张欣 ZHANG Xin], 2011, [中华传染病杂志, Chinese Journal of Infections Diseases], V29, P154; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	29	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45898	10.1371/journal.pone.0045898	http://dx.doi.org/10.1371/journal.pone.0045898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029300	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500045
J	Bories, C; Guitton, MJ; Julien, C; Tremblay, C; Vandal, M; Msaid, M; De Koninck, Y; Calon, F				Bories, Cyril; Guitton, Matthieu J.; Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; De Koninck, Yves; Calon, Frederic			Sex-Dependent Alterations in Social Behaviour and Cortical Synaptic Activity Coincide at Different Ages in a Model of Alzheimer's Disease	PLOS ONE			English	Article							DEVELOPMENTAL-GENETIC ANALYSIS; MEDIAL PREFRONTAL CORTEX; MILD COGNITIVE IMPAIRMENT; APPSWE/PS1 BIGENIC MODEL; TRANSGENIC MOUSE MODEL; A-BETA; AGGRESSIVE-BEHAVIOR; NEUROPSYCHIATRIC SYMPTOMS; MICE; APATHY	Besides memory deficits, Alzheimer's disease (AD) patients suffer from neuropsychiatric symptoms, including alterations in social interactions, which are subject of a growing number of investigations in transgenic models of AD. Yet the biological mechanisms underlying these behavioural alterations are poorly understood. Here, a social interaction paradigm was used to assess social dysfunction in the triple-transgenic mouse model of AD (3xTg-AD). We observed that transgenic mice displayed dimorphic behavioural abnormalities at different ages. Social disinhibition was observed in 18 months old 3xTg-AD males compared to age and sex-matched control mice. In 3xTg-AD females, social disinhibition was present at 12 months followed by reduced social interactions at 18 months. These dimorphic behavioural alterations were not associated with alterations in AD neuropathological markers such as A beta or tau levels in the frontal cortex. However, patch-clamp recordings revealed that enhanced social interactions coincided temporally with an increase in both excitatory and inhibitory basal synaptic inputs to layer 2-3 pyramidal neurons in the prefrontal cortex. These findings uncover a novel pattern of occurrence of psychiatric-like symptoms between sexes in an AD model. Our results also reveal that functional alterations in synapse activity appear as a potentially significant substrate underlying behavioural correlates of AD.	[Guitton, Matthieu J.; Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Bories, Cyril; Guitton, Matthieu J.; De Koninck, Yves] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Julien, Carl; Tremblay, Cyntia; Vandal, Milene; Msaid, Meriem; Calon, Frederic] CHU Laval, Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Bories, Cyril; Guitton, Matthieu J.; De Koninck, Yves] Quebec Mental Hlth Inst, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Calon, F (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	frederic.calon@crchul.ulaval.ca	Calon, Frederic/AAF-4390-2020; Bories, Cyril/O-9869-2019; Julien, Carl/AAU-5309-2021; De Koninck, Yves/C-2659-2008	De Koninck, Yves/0000-0002-5779-9330; Bories, Cyril/0000-0003-0811-5219; Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [MOP74443]; Alzheimer Society Canada [ASC 0516, 0823]; Canada Foundation for Innovation [10307]; "Fonds de la Recherche en Sante du Quebec" (FRSQ); FRSQ; Laval University "Fonds d'Enseignement et de Recherche"; Clinical Research Initiative; CIHR Institute of Aging [CAN-76833]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); "Fonds de la Recherche en Sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Laval University "Fonds d'Enseignement et de Recherche"; Clinical Research Initiative; CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR))	Grants to FC from the Canadian Institutes of Health Research (CIHR) (MOP74443), the Alzheimer Society Canada (ASC 0516 and 0823) and the Canada Foundation for Innovation (10307) supported this work. MJG and YDK are supported by Career Awards from the "Fonds de la Recherche en Sante du Quebec" (FRSQ). CJ held studentships from the Alzheimer Society Canada, the FRSQ, and Laval University "Fonds d'Enseignement et de Recherche". FC was supported by a New Investigator Award from the Clinical Research Initiative and the CIHR Institute of Aging(CAN-76833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; CAIRNS RB, 1983, J COMP PSYCHOL, V97, P69, DOI 10.1037/0735-7036.97.1.69; Callahan MJ, 2001, AM J PATHOL, V158, P1173, DOI 10.1016/S0002-9440(10)64064-3; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; Cooke BM, 2005, J NEUROSCI, V25, P10759, DOI 10.1523/JNEUROSCI.2919-05.2005; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Craig D, 2005, AM J GERIAT PSYCHIAT, V13, P460, DOI 10.1176/appi.ajgp.13.6.460; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Filali M, 2009, GENES BRAIN BEHAV, V8, P143, DOI 10.1111/j.1601-183X.2008.00453.x; Filali M, 2012, BEHAV BRAIN RES, V234, P334, DOI 10.1016/j.bbr.2012.07.004; Filali M, 2011, PHYSIOL BEHAV, V104, P880, DOI 10.1016/j.physbeh.2011.05.023; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; GARIEPY JL, 1988, J COMP PSYCHOL, V102, P392, DOI 10.1037/0735-7036.102.4.392; Gimenez-Llort L, 2007, NEUROSCI BIOBEHAV R, V31, P125, DOI 10.1016/j.neubiorev.2006.07.007; Guitton MJ, 2008, BEHAV BRAIN RES, V191, P148, DOI 10.1016/j.bbr.2008.03.022; Guitton MJ, 2009, J PSYCHOSOM RES, V67, P273, DOI 10.1016/j.jpsychores.2008.10.017; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hirata-Fukae C, 2008, BRAIN RES, V1216, P92, DOI 10.1016/j.brainres.2008.03.079; HOOD KE, 1988, BEHAV GENET, V18, P605, DOI 10.1007/BF01082312; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; JULIEN C, 2008, NEUROBIOL AGING; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lechowski L, 2009, INT J GERIATR PSYCH, V24, P341, DOI 10.1002/gps.2125; Li SC, 2002, NEUROSCI BIOBEHAV R, V26, P795, DOI 10.1016/S0149-7634(02)00066-0; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lueken U, 2007, AM J GERIAT PSYCHIAT, V15, P376, DOI 10.1097/JGP.0b013e3180437db3; MARIN RS, 1991, J NEUROPSYCH CLIN N, V3, P243; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Mizrahi R, 2007, DRUG AGING, V24, P547, DOI 10.2165/00002512-200724070-00003; Mizuno K, 2010, TRENDS NEUROSCI, V33, P285, DOI 10.1016/j.tins.2010.03.001; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nikulina EM, 2004, NEUROSCIENCE, V123, P857, DOI 10.1016/j.neuroscience.2003.10.029; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pietropaolo S, 2011, NEUROBIOL AGING; Pietropaolo S, 2009, BEHAV NEUROSCI, V123, P181, DOI 10.1037/a0013607; Preuss UW, 2010, AM J GERIAT PSYCHIAT, V18, P821, DOI 10.1097/JGP.0b013e3181ca3a13; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Stack A, 2010, NEUROPSYCHOPHARMACOL, V35, P570, DOI 10.1038/npp.2009.163; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Teng E, 2007, DEMENT GERIATR COGN, V24, P253, DOI 10.1159/000107100; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tremblay C, 2007, J ALZHEIMERS DIS, V12, P377; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Wu LJ, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-9; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zahs KR, 2010, TRENDS NEUROSCI	64	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46111	10.1371/journal.pone.0046111	http://dx.doi.org/10.1371/journal.pone.0046111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YB	23029404	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700115
J	Balada, E; Castro-Marrero, J; Felip, L; Ordi-Ros, J; Vilardell-Tarres, M				Balada, Eva; Castro-Marrero, Jesus; Felip, Lledo; Ordi-Ros, Josep; Vilardell-Tarres, Miquel			Associations between the Expression of Epigenetically Regulated Genes and the Expression of DNMTs and MBDs in Systemic Lupus Erythematosus	PLOS ONE			English	Article							CD4(+) T-CELLS; ABNORMAL DNA METHYLATION; NATURAL-KILLER-CELLS; SOLUBLE CD40 LIGAND; ELEMENTS CONTRIBUTES; SYNGENEIC MICE; OVEREXPRESSION; DEMETHYLATION; METHYLTRANSFERASE; HYPOMETHYLATION	Objectives: We determined the expression of ITGAL, PRF1, KIR2DL4, CD70, and CD40LG in patients with SLE and performed correlations with the global DNA methylation status and the levels of three DNA methylation enzymes and two methyl CpG-binding domain (MBD) proteins. Patients and Methods: CD4(+) T cells were isolated from 35 SLE patients and 30 healthy controls. DNA deoxymethylcytosine content was measured by an enzyme-linked immunosorbent assay (ELISA). Transcript levels of ITGAL, PRF1, KIR2DL4, CD70, CD40LG, DNMT1, DNMT3A, DNMT3B, MBD2, and MBD4 were quantified by real-time reverse-transcription polymerase chain reaction (RT-PCR). Results: SLE patients had significantly elevated transcript levels of ITGAL (18.61+/-22.17 vs. 7.33+/-9.17, p = 0.042), PRF1 (21.67+/-26.34 vs. 10.67+/-11.65, p = 0.039), and CD70 (1.45+/-1.63 vs. 0.67+/-0.28, p = 0.011). A positive correlation was observed between transcript levels of CD40LG and ITGAL (r = 0.477, p = 0.004) as well as between CD40LG and PRF1 (r = 0.557, p = 0.001). Transcript levels of KIR2DL4 were higher than controls' but it did not reach statistical significance (1.36+/-3.52 vs. 0.22+/-0.79, p = 0.560). A tight relationship with global DNA hypomethylation as well as with the expression of most of the DNA methylation-related genes was observed, especially for ITGAL, PRF1, and CD40LG. Conclusions: ITGAL, PRF1, and CD70 are overexpressed in SLE CD4(+) T cells. The tight association of CD40LG with ITGAL and PRF1 leads us to infer that it probably contributes to the pathogenesis of the disease. The apparent simultaneous regulation between their expression and the global DNA hypomethylation as well as with the transcription of many DNA methylation-related enzymes, reinforces the idea that epigenetic mechanisms are responsible for the deregulation of ITGAL, PRF1, and CD40LG.	[Balada, Eva; Castro-Marrero, Jesus; Felip, Lledo; Ordi-Ros, Josep; Vilardell-Tarres, Miquel] Univ Autonoma Barcelona, Hosp Vall dHebron, Vall dHebron Res Inst, Res Unit Syst Autoimmune Dis, E-08193 Barcelona, Spain	Autonomous University of Barcelona	Balada, E (corresponding author), Univ Autonoma Barcelona, Hosp Vall dHebron, Vall dHebron Res Inst, Res Unit Syst Autoimmune Dis, E-08193 Barcelona, Spain.	eva.balada@vhir.org		Castro-Marrero, Jesus/0000-0002-2481-3052				Balada E, 2008, IMMUNOLOGY, V124, P339, DOI 10.1111/j.1365-2567.2007.02771.x; Balada E, 2007, J LEUKOCYTE BIOL, V81, P1609, DOI 10.1189/jlb.0107064; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Basu D, 2009, J IMMUNOL, V183, P3481, DOI 10.4049/jimmunol.0900034; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Kaplan MJ, 2004, J IMMUNOL, V172, P3652, DOI 10.4049/jimmunol.172.6.3652; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kozlowska A, 2010, J RHEUMATOL, V37, P53, DOI 10.3899/jrheum.090424; Lei W, 2009, SCAND J RHEUMATOL, V38, P369, DOI 10.1080/03009740902758875; Li GJ, 2008, J LEUKOCYTE BIOL, V84, P824, DOI 10.1189/jlb.0807583; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Lu Q, 2007, J IMMUNOL, V179, P6352, DOI 10.4049/jimmunol.179.9.6352; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Luo Y, 2008, BRIT J DERMATOL, V159, P827, DOI 10.1111/j.1365-2133.2008.08758.x; Luo Y, 2010, CLIN EXP DERMATOL, V35, P425, DOI 10.1111/j.1365-2230.2009.03611.x; Mizugaki M, 1997, CLIN EXP IMMUNOL, V110, P265; Oelke K, 2004, ARTHRITIS RHEUM-US, V50, P1850, DOI 10.1002/art.20255; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Perez OD, 2004, BLOOD, V104, P1083, DOI 10.1182/blood-2003-08-2652; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; RICHARDSON B, 1994, ARTHRITIS RHEUM, V37, P1363, DOI 10.1002/art.1780370915; RICHARDSON BC, 1992, ARTHRITIS RHEUM, V35, P647, DOI 10.1002/art.1780350608; Shi WM, 2009, J DERMATOL SCI, V53, P236, DOI 10.1016/j.jdermsci.2008.09.007; Shoshan Y, 2001, J IMMUNOL, V167, P5963, DOI 10.4049/jimmunol.167.10.5963; Urquizu-Padilla M, 2009, J RHEUMATOL, V36, P953, DOI 10.3899/jrheum.080978; Vollmann J, 1996, BRIT MED J, V313, P1445, DOI 10.1136/bmj.313.7070.1445; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yung R, 1996, J CLIN INVEST, V97, P2866, DOI 10.1172/JCI118743; Zhao M, 2010, J AUTOIMMUN, V35, P58, DOI 10.1016/j.jaut.2010.02.002; Zhao S, 2011, ARTHRITIS RHEUM-US, V63, P1376, DOI 10.1002/art.30196; Zhou Y, 2011, LUPUS; Zhou Y, 2009, CLIN IMMUNOL, V132, P362, DOI 10.1016/j.clim.2009.05.011; Zhu B, 2000, NUCLEIC ACIDS RES, V28, P4157, DOI 10.1093/nar/28.21.4157; Zhu XH, 2011, INT J DERMATOL, V50, P697, DOI 10.1111/j.1365-4632.2010.04804.x	43	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45897	10.1371/journal.pone.0045897	http://dx.doi.org/10.1371/journal.pone.0045897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029299	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800114
J	Baysinger, AN; Kent, BA; Brown, TH				Baysinger, Amber N.; Kent, Brianne A.; Brown, Thomas H.			Muscarinic Receptors in Amygdala Control Trace Fear Conditioning	PLOS ONE			English	Article							GRADED PERSISTENT ACTIVITY; LONG-TERM POTENTIATION; ENTORHINAL CORTEX; MEMORY CONSOLIDATION; FUNCTIONAL NEUROANATOMY; CHOLINERGIC MODULATION; PARAHIPPOCAMPAL REGION; VENTRAL HIPPOCAMPUS; CELLULAR MECHANISM; PERIRHINAL CORTEX	Intelligent behavior requires transient memory, which entails the ability to retain information over short time periods. A newly-emerging hypothesis posits that endogenous persistent firing (EPF) is the neurophysiological foundation for aspects or types of transient memory. EPF is enabled by the activation of muscarinic acetylcholine receptors (mAChRs) and is triggered by suprathreshold stimulation. EPF occurs in several brain regions, including the lateral amygdala (LA). The present study examined the role of amygdalar mAChRs in trace fear conditioning, a paradigm that requires transient memory. If mAChR-dependent EPF selectively supports transient memory, then blocking amygdalar mAChRs should impair trace conditioning, while sparing delay and context conditioning, which presumably do not rely upon transient memory. To test the EPF hypothesis, LA was bilaterally infused, prior to trace or delay conditioning, with either a mAChR antagonist (scopolamine) or saline. Computerized video analysis quantified the amount of freezing elicited by the cue and by the training context. Scopolamine infusion profoundly reduced freezing in the trace conditioning group but had no significant effect on delay or context conditioning. This pattern of results was uniquely anticipated by the EPF hypothesis. The present findings are discussed in terms of a systems-level theory of how EPF in LA and several other brain regions might help support trace fear conditioning.	[Baysinger, Amber N.; Kent, Brianne A.; Brown, Thomas H.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Brown, Thomas H.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University	Brown, TH (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	thomas.brown@yale.edu		Kent, Brianne/0000-0003-0074-028X	National Science and Engineering Research Council Fellowship; National Science Foundation Graduate Research Fellowship [DGE-0644492]; Yale University;  [MH58405]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058405] Funding Source: NIH RePORTER	National Science and Engineering Research Council Fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Yale University; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by MH58405 to THB, National Science and Engineering Research Council Fellowship to BAK, National Science Foundation Graduate Research Fellowship Grant DGE-0644492 to ANB, and Yale University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2008, J NEUROSCI METH, V171, P30, DOI 10.1016/j.jneumeth.2008.01.033; ALONSO JR, 1995, J COMP NEUROL, V355, P135, DOI 10.1002/cne.903550202; Bang SJ, 2009, J NEUROSCI, V29, P4346, DOI 10.1523/JNEUROSCI.0069-09.2009; Barnet RC, 2005, LEARN BEHAV, V33, P437, DOI 10.3758/BF03193182; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Brandao ML, 2008, BEHAV BRAIN RES, V188, P1, DOI 10.1016/j.bbr.2007.10.018; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; BROWN TH, 2004, CELLULAR MOL NEUROSC, P499; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Edeline JM, 2002, NEUROBIOL LEARN MEM, V78, P100, DOI 10.1006/nlme.2001.4035; Egorov AV, 2006, EUR J NEUROSCI, V24, P3183, DOI 10.1111/j.1460-9568.2006.05200.x; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; FANSELOW MS, 1994, BEHAV NEUROSCI, V108, P210, DOI 10.1037/0735-7044.108.1.210; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Furtak SC, 2007, HIPPOCAMPUS, V17, P709, DOI 10.1002/hipo.20314; Gilmartin MR, 2012, NEUROBIOL LEARN MEM, V97, P452, DOI 10.1016/j.nlm.2012.03.009; Goosens KA, 2000, BEHAV BRAIN RES, V114, P145, DOI 10.1016/S0166-4328(00)00224-2; Guimarais M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00089; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hasselmo ME, 2006, TRENDS COGN SCI, V10, P487, DOI 10.1016/j.tics.2006.09.005; Hasselmo ME, 2011, NEUROPSYCHOPHARMACOL, V36, P52, DOI 10.1038/npp.2010.104; HEBB D. O., 1949; Huang CH, 2010, BRAIN RES, V1326, P143, DOI 10.1016/j.brainres.2010.02.033; Ivkovich D, 2001, NEUROBIOL LEARN MEM, V76, P426, DOI 10.1006/nlme.2001.4027; Ivkovich D, 2000, DEV PSYCHOBIOL, V36, P148, DOI 10.1002/(SICI)1098-2302(200003)36:2<148::AID-DEV6>3.0.CO;2-L; Jochems A, 2012, FENS ABSTR; KELSO SR, 1986, SCIENCE, V232, P85, DOI 10.1126/science.3952501; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; Kent BA, 2012, HIPPOCAMPUS, V22, P2068, DOI 10.1002/hipo.22058; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Kholodar-Smith DB, 2008, NEUROBIOL LEARN MEM, V90, P537, DOI 10.1016/j.nlm.2008.06.006; Klink R, 1997, J NEUROPHYSIOL, V77, P1813, DOI 10.1152/jn.1997.77.4.1813; Knauer B, 2012, FENS ABSTR; Kwapis JL, 2011, LEARN MEMORY, V18, P728, DOI 10.1101/lm.023945.111; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HJ, 2001, J NEUROSCI, V21, P4116, DOI 10.1523/JNEUROSCI.21-11-04116.2001; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Maddox SA, 2011, LEARN MEMORY, V18, P24, DOI 10.1101/lm.1980211; Majchrzak M, 2006, HIPPOCAMPUS, V16, P114, DOI 10.1002/hipo.20138; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8; Moyer JR, 2006, BEHAV NEUROSCI, V120, P612, DOI 10.1037/0735-7044.120.3.612; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Navaroli VL, 2012, HIPPOCAMPUS, V22, P1392, DOI 10.1002/hipo.20975; Pang MH, 2010, NEUROBIOL LEARN MEM, V94, P206, DOI 10.1016/j.nlm.2010.05.008; Parikh V, 2008, ANN NY ACAD SCI, V1129, P225, DOI 10.1196/annals.1417.021; Parikh V, 2007, NEURON, V56, P141, DOI 10.1016/j.neuron.2007.08.025; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; Raybuck JD, 2010, NEUROBIOL LEARN MEM, V94, P353, DOI 10.1016/j.nlm.2010.08.001; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Reboreda A, 2007, J NEUROPHYSIOL, V97, P3937, DOI 10.1152/jn.01233.2006; Reboreda A, 2011, ADV EXP MED BIOL, V704, P595, DOI 10.1007/978-94-007-0265-3_32; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Schafe GE, 2000, J NEUROSCI, V20, P8177; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Woodruff-Pak DS, 2008, TRENDS NEUROSCI, V31, P105, DOI 10.1016/j.tins.2007.11.006; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Yoon T, 2007, NEUROBIOL LEARN MEM, V87, P464, DOI 10.1016/j.nlm.2006.12.006; Yoshida M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00010; Yoshida M, 2009, J NEUROSCI, V29, P4945, DOI 10.1523/JNEUROSCI.5154-08.2009; Zaborszky L, 2002, PROG BRAIN RES, V136, P359; Zhang ZZ, 2011, HIPPOCAMPUS, V21, P386, DOI 10.1002/hipo.20755; Zhang ZZ, 2010, CEREB CORTEX, V20, P2948, DOI 10.1093/cercor/bhq043	78	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45720	10.1371/journal.pone.0045720	http://dx.doi.org/10.1371/journal.pone.0045720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029199	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800082
J	Liu, LW; Sun, XF; Yan, PF; Wang, LM; Chen, HG				Liu, Liangwei; Sun, Xiaofeng; Yan, Pengfei; Wang, Linmin; Chen, Hongge			Non-Structured Amino-Acid Impact on GH11 Differs from GH10 Xylanase	PLOS ONE			English	Article							TRICHODERMA-REESEI ENDO-1,4-BETA-XYLANASE-II; DISULFIDE BRIDGE; ENZYMATIC-ACTIVITY; THERMAL-STABILITY; SUBSTRATE-BINDING; THERMOSTABILITY; COMBINATION; DELETION; DOMAINS; REGION	The Aspergillus niger xylanase (Xyn) was used as a model to investigate impacts of un-structured residues on GH11 family enzyme, because the beta-jelly roll structure has five residues (Ser1Ala2Gly3Ile4Asn5) at N-terminus and two residues (Ser183Ser184) at C-terminus that do not form to helix or strand. The N- or/and C-terminal residues were respectively deleted to construct three mutants. The optimal temperatures of Xyn Delta N, Xyn Delta C, and Xyn Delta NC were 46, 50, and 46 degrees C, and the thermostabilities were 15.7, 73.9, 15.5 min at 50 degrees C, respectively, compared to 48 degrees C and 33.9 min for the Xyn. After kinetic analysis, the substrate-binding affinities for birch-wood xylan decreased in the order Xyn Delta C>Xyn>Xyn Delta NC>Xyn Delta N, while the K-cat values increased in the order Xyn Delta C<Xyn Delta NC<Xyn<Xyn Delta N. The C-terminal deletion increased the GH11 xylanase thermostability and T-opt, while the N- and NC-terminal deletions decreased its thermostability and optimal temperature. The C-terminal residues created more impact on enzyme thermal property, while the N-terminal residues created more impact on its catalytic efficiency and substrate-binding affinity. The impact of non-structured residues on GH11 xylanase was different from that of similar residues on GH10 xylanase, and the difference is attributed to structural difference between GH11 jelly-roll and GH10 (beta/alpha)(8).	[Liu, Liangwei; Sun, Xiaofeng; Yan, Pengfei; Wang, Linmin; Chen, Hongge] Henan Agr Univ, Life Sci Coll, Zhengzhou, Henan, Peoples R China; [Wang, Linmin; Chen, Hongge] Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Ministry of Agriculture & Rural Affairs	Liu, LW (corresponding author), Henan Agr Univ, Life Sci Coll, Zhengzhou, Henan, Peoples R China.	LLW321@yahoo.com.cn		liu, liangwei/0000-0002-1896-8437	Natural Science Foundation of China [30972123]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (30972123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HG, 2006, J MICROBIOL BIOTECHN, V16, P1132; Fenel F, 2004, J BIOTECHNOL, V108, P137, DOI 10.1016/j.jbiotec.2003.11.002; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; Hamana H, 1999, J BIOCHEM-TOKYO, V125, P109, DOI 10.1093/oxfordjournals.jbchem.a022246; Huang BH, 1996, BIOCHEMISTRY-US, V35, P12164, DOI 10.1021/bi960234o; Jeong MY, 2007, J BIOTECHNOL, V127, P300, DOI 10.1016/j.jbiotec.2006.07.005; KAUFMANN E, 1984, FEBS LETT, V170, P81, DOI 10.1016/0014-5793(84)81373-3; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Krengel U, 1996, ACTA CRYSTALLOGR D, V52, P571, DOI 10.1107/S0907444995014740; Liu LW, 2011, J BIOL CHEM, V286, P44710, DOI 10.1074/jbc.M111.269753; Liu LW, 2011, PROCESS BIOCHEM, V46, P395, DOI 10.1016/j.procbio.2010.07.026; Liu LW, 2008, J BIOTECHNOL, V136, pS201, DOI 10.1016/j.jbiotec.2008.07.423; Lo Leggio L, 1999, PROTEINS, V36, P295; Ma YF, 2000, BIOCHEMISTRY-US, V39, P13350, DOI 10.1021/bi000688s; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Niu D, 2010, BIOTECHNOL LETT, V32, P963, DOI 10.1007/s10529-010-0241-9; Phannachet K, 2010, CURR MICROBIOL, V61, P549, DOI 10.1007/s00284-010-9651-0; Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; Wang Q, 2008, APPL BIOCHEM BIOTECH, V144, P273, DOI 10.1007/s12010-007-8016-z; Wang S, 2009, PLOS ONE, V4, P1; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Wassenberg D, 1997, PROTEIN SCI, V6, P1718, DOI 10.1002/pro.5560060812; Wen TN, 2005, BIOCHEMISTRY-US, V44, P9197, DOI 10.1021/bi0500630; Xiong HR, 2004, EXTREMOPHILES, V8, P393, DOI 10.1007/s00792-004-0400-9; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159	26	6	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45762	10.1371/journal.pone.0045762	http://dx.doi.org/10.1371/journal.pone.0045762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029229	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800093
J	Wei, Y; Zhao, LQ; Qi, BZ; Xiao, X; He, L; Zhou, GQ; Chen, SW; Li, HL; Ruan, L; Zhang, CT; Liu, SW				Wei, Yong; Zhao, Li-qun; Qi, Bao-zhen; Xiao, Xing; He, Li; Zhou, Gen-qing; Chen, Song-wen; Li, Hong-li; Ruan, Lei; Zhang, Cun-tai; Liu, Shao-wen			Lysophosphatidic Acid Increases the Electrophysiological Instability of Adult Rabbit Ventricular Myocardium by Augmenting L-Type Calcium Current	PLOS ONE			English	Article							LONG-QT SYNDROME; CARDIAC MYOCYTES; ARRHYTHMIC RISK; LPA RECEPTORS; IDENTIFICATION; HYPERTROPHY; MODULATION; ACTIVATION; MECHANISMS; CELLS	Lysophosphatidic acid (LPA) has diverse actions on the cardiovascular system and is widely reported to modulate multiple ion currents in some cell types. However, little is known about its electrophysiological effects on cardiac myocytes. This study investigated whether LPA has electrophysiological effects on isolated rabbit myocardial preparations. The results indicate that LPA prolongs action potential duration at 90% repolarization (APD(90)) in a concentration- and frequency-dependent manner in isolated rabbit ventricular myocytes. The application of extracellular LPA significantly increases the coefficient of APD(90) variability. LPA increased L-type calcium current (I-Ca,I-L) density without altering its activation or deactivation properties. In contrast, LPA has no effect on two other ventricular repolarizing currents, the transient outward potassium current (I-to) and the delayed rectifier potassium current (I-K). In arterially perfused rabbit left ventricular wedge preparations, the monophasic action potential duration, QT interval, and Tpeak-end are prolonged by LPA. LPA treatment also significantly increases the incidence of ventricular tachycardia induced by S1S2 stimulation. Notably, the effects of LPA on action potentials and I-Ca,I-L are PTX-sensitive, suggesting LPA action requires a G(i)-type G protein. In conclusion, LPA prolongs APD and increases electrophysiological instability in isolated rabbit myocardial preparations by increasing I-Ca,I-L in a G(i) protein-dependent manner.	[Wei, Yong; Zhao, Li-qun; Qi, Bao-zhen; Zhou, Gen-qing; Chen, Song-wen; Li, Hong-li; Liu, Shao-wen] Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Wei, Yong] Shanghai Songjiang Ctr Hosp, Dept Cardiol, Shanghai, Peoples R China; [Xiao, Xing; He, Li; Ruan, Lei; Zhang, Cun-tai] Huazhong Univ Sci & Technol, Dept Geratol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Shanghai Jiao Tong University; Huazhong University of Science & Technology	Liu, SW (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	shaowen.liu@hotmail.com	Chen, Songwen/AAI-4389-2020; Liu, Shaowen/AAJ-4121-2020	Chen, Songwen/0000-0002-6492-5702; Zhou, Genqing/0000-0003-4506-7658	Shanghai Jiao Tong University School of Medicine [BXJ201135]	Shanghai Jiao Tong University School of Medicine	This research was supported by the Doctoral Students' Innovation Fund of Shanghai Jiao Tong University School of Medicine (grant number: BXJ201135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA T, 1994, CIRCULATION, V90, P469, DOI 10.1161/01.CIR.90.1.469; Chang YJ, 2007, PROSTAG OTH LIPID M, V83, P268, DOI 10.1016/j.prostaglandins.2007.01.014; Chemin J, 2005, J BIOL CHEM, V280, P4415, DOI 10.1074/jbc.M408246200; Chen JH, 2008, J CELL BIOCHEM, V103, P1718, DOI 10.1002/jcb.21564; Chen X, 2003, SCAND J CLIN LAB INV, V63, P497, DOI 10.1080/00365510310003265; Cohen A, 2009, MOL CELL NEUROSCI, V40, P382, DOI 10.1016/j.mcn.2008.12.004; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Cremers B, 2003, J MOL CELL CARDIOL, V35, P71, DOI 10.1016/S0022-2828(02)00279-1; de Jong JSSG, 2011, J MOL CELL CARDIOL, V51, P347, DOI 10.1016/j.yjmcc.2011.05.016; Fukushima N, 2001, PROSTAG OTH LIPID M, V64, P21, DOI 10.1016/S0090-6980(01)00105-8; Hilal-Dandan R, 2004, J MOL CELL CARDIOL, V36, P481, DOI 10.1016/j.yjmcc.2003.12.010; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; Kaufman ES, 2011, J ELECTROCARDIOL, V44, P645, DOI 10.1016/j.jelectrocard.2011.07.023; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohata H, 2011, EXP PHYSIOL, V96, P468, DOI 10.1113/expphysiol.2011.056416; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Parrill AL, 2004, SEMIN CELL DEV BIOL, V15, P467, DOI 10.1016/j.semcdb.2004.05.006; Rancoule C, 2011, EXPERT OPIN INV DRUG, V20, P657, DOI 10.1517/13543784.2011.566864; Shimizu W, 2004, J AM COLL CARDIOL, V44, P117, DOI 10.1016/j.jacc.2004.03.043; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Spector AA, 2003, CIRCULATION, V108, P641, DOI 10.1161/01.CIR.0000082307.85449.1D; Swarthout JT, 2000, CELL MOL LIFE SCI, V57, P1978, DOI 10.1007/PL00000678; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tigyi G, 2003, PROG LIPID RES, V42, P498, DOI 10.1016/S0163-7827(03)00035-3; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; Tomar A, 2009, J BIOL CHEM, V284, P35278, DOI 10.1074/jbc.C109.060830; Wang J, 2002, INVEST OPHTH VIS SCI, V43, P3202; Wei L, 2004, J MOL CELL CARDIOL, V36, P465, DOI 10.1016/j.yjmcc.2004.02.006; Xu Yan-Jun, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P109, DOI 10.1177/107424840200700207; Xu YJ, 2005, CELL CALCIUM, V38, P569, DOI 10.1016/j.ceca.2005.08.001; Yan GX, 2001, CIRCULATION, V103, P2851; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45862	10.1371/journal.pone.0045862	http://dx.doi.org/10.1371/journal.pone.0045862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029283	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800109
J	Deguines, N; Julliard, R; de Flores, M; Fontaine, C				Deguines, Nicolas; Julliard, Romain; de Flores, Mathieu; Fontaine, Colin			The Whereabouts of Flower Visitors: Contrasting Land-Use Preferences Revealed by a Country-Wide Survey Based on Citizen Science	PLOS ONE			English	Article							GLOBAL BIODIVERSITY INDICATORS; POLLINATOR DECLINES; PLANTS; CONSERVATION; DIVERSITY; URBANIZATION; ENVIRONMENTS; COMMUNITIES; BUTTERFLIES; EXTINCTION	Background: In the past decade, accumulating evidence of pollinator decline has raised concerns regarding the functioning of terrestrial ecosystems and the sustainability of crop production. Although land-use changes have been advanced as the major causes, the affinities of most wild pollinators with the main land-use types remain unknown. Filling this gap in our knowledge is a prerequisite to improving conservation and management programmes. Methodology/Principal Findings: We estimated the affinity of flower visitors with urban, agricultural and natural land-uses using data from a country-wide scale monitoring scheme based on citizen science (Spipoll). We tested whether the affinities differed among insect orders and according to insect frequency (frequent or infrequent). Our results indicate that the affinities with the three land-use types differed among insect orders. Apart from Hymenopterans, which appeared tolerant to the different land-uses, all flower visitors presented a negative affinity with urban areas and a positive affinity with agricultural and natural areas. Additionally, infrequent taxa displayed a lower affinity with urban areas and a higher affinity with natural areas than did frequent taxa. Within frequent taxa, Hymenoptera and Coleoptera included specialists of the three land-use types whereas Diptera and Lepidoptera contained specialists of all but urban areas. Conclusions/Significance: Our approach allowed the first standardised evaluation of the affinity of flower visitors with the main land-use types across a broad taxonomical range and a wide geographic scope. Our results suggest that the most detrimental land-use change for flower visitor communities is urbanisation. Moreover, our findings highlight the fact that agricultural areas have the potential to host highly diverse pollinator communities. We suggest that policy makers should, therefore, focus on the implementation of pollinator-friendly practices in agricultural lands. This may be a win-win strategy, as both biodiversity and crop production may benefit from healthier communities of flower visitors in these areas.	[Deguines, Nicolas; Julliard, Romain; Fontaine, Colin] Museum Natl Hist Nat, MNHN CNRS UPMC, UMR CERSP 7204, F-75231 Paris, France; [de Flores, Mathieu] Off Insectes & Environm, Guyancourt, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Deguines, N (corresponding author), Museum Natl Hist Nat, MNHN CNRS UPMC, UMR CERSP 7204, F-75231 Paris, France.	deguines@mnhn.fr	Deguines, Nicolas/N-7818-2018; Fontaine, Colin/N-6469-2015	Deguines, Nicolas/0000-0001-6930-916X; Fontaine, Colin/0000-0001-5367-5675	l'Agence Nationale de la Recherche [ANR-09-RPDOC-020-01]	l'Agence Nationale de la Recherche(French National Research Agency (ANR))	This study was funded by l'Agence Nationale de la Recherche (Grant number ANR-09-RPDOC-020-01; URL http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; [Anonymous], 2009, NATURE, V457, P8, DOI 10.1038/457008a; Barfod AS, 2011, ANN BOT-LONDON, V108, P1503, DOI 10.1093/aob/mcr192; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Bellmann H., 1999, GUIDE ABEILLES BOURD; Bergerot B, 2011, LANDSCAPE ECOL, V26, P83, DOI 10.1007/s10980-010-9537-3; Bergerot B, 2010, LANDSCAPE URBAN PLAN, V96, P98, DOI 10.1016/j.landurbplan.2010.02.007; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Bossard M, 2006, CORINE LAND COVER; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cane James H., 2005, P109; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Canty A., FUNCTIONS, V1; Carvalheiro LG, 2008, J APPL ECOL, V45, P1419, DOI 10.1111/j.1365-2664.2008.01518.x; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Crawley MJ., 2007, R BOOK; DALLWITZ MJ, 1980, TAXON, V29, P41, DOI 10.2307/1219595; Dallwitz MJ, 1999, USERS GUIDE DELTA ED; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Dias B, 1999, REC WORKSH CONS SUST, DOI DOI 10.1093/SYSBI0/33.1.69; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Dupont YL, 2009, J ANIM ECOL, V78, P346, DOI 10.1111/j.1365-2656.2008.01501.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fattorini S, 2011, BIOL CONSERV, V144, P370, DOI 10.1016/j.biocon.2010.09.014; Ferreira LB, 2005, BIODIVERS CONSERV, V14, P1809, DOI 10.1007/s10531-004-0701-4; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Goujon P, 2010, SYSTEME IDENTIFICATI; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Jonason D, 2011, J APPL ECOL, V48, P543, DOI 10.1111/j.1365-2664.2011.01989.x; Jones JPG, 2011, CONSERV BIOL, V25, P450, DOI 10.1111/j.1523-1739.2010.01605.x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Krell FT, 2004, BIODIVERS CONSERV, V13, P795, DOI 10.1023/B:BIOC.0000011727.53780.63; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; Mayer C., 2011, Journal of Pollination Ecology, V3, P8; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merckx T, 2009, AGR ECOSYST ENVIRON, V130, P177, DOI 10.1016/j.agee.2009.01.006; Mulieri PR, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.9101; National Research Council, 2007, STAT POLL N AM; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Ollerton J, 2003, ANN BOT-LONDON, V92, P807, DOI 10.1093/aob/mcg206; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Palmieri A., 2011, LAND QUALITY LAND US, P59; Potts SG, 2009, J APPL ECOL, V46, P369, DOI 10.1111/j.1365-2664.2009.01609.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schmidt KA, 2003, ECOLOGY, V84, P406, DOI 10.1890/0012-9658(2003)084[0406:SPIFEP]2.0.CO;2; Silvertown J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018927; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; SOeS, 2010, ENV FRANC ED 2010; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Tonietto R, 2011, LANDSCAPE URBAN PLAN, V103, P102, DOI 10.1016/j.landurbplan.2011.07.004; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; UNEP/COP/CBD, 2011, 10 M C PART CONV BIO; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Winfree R, 2011, ANNU REV ECOL EVOL S, V42, P1, DOI 10.1146/annurev-ecolsys-102710-145042	68	81	83	2	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45822	10.1371/journal.pone.0045822	http://dx.doi.org/10.1371/journal.pone.0045822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029262	Green Published, Green Submitted, gold			2022-12-25	WOS:000309388400134
J	Crooks, DR; Jeong, SY; Tong, WH; Ghosh, MC; Olivierre, H; Haller, RG; Rouault, TA				Crooks, Daniel R.; Jeong, Suh Young; Tong, Wing-Hang; Ghosh, Manik C.; Olivierre, Hayden; Haller, Ronald G.; Rouault, Tracey A.			Tissue Specificity of a Human Mitochondrial Disease DIFFERENTIATION-ENHANCED MIS-SPLICING OF THE Fe-S SCAFFOLD GENE ISCU RENDERS PATIENT CELLS MORE SENSITIVE TO OXIDATIVE STRESS IN ISCU MYOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER BIOGENESIS; SUCCINATE-DEHYDROGENASE; LACTIC-ACIDOSIS; PAROXYSMAL MYOGLOBINURIA; ACONITASE DEFICIENCY; HEREDITARY MYOPATHY; IRON HOMEOSTASIS; MAMMALIAN-CELLS; INTRON MUTATION; SKELETAL-MUSCLE	Iron-sulfur (Fe-S) cluster cofactors are formed on the scaffold protein ISCU. ISCU myopathy is a disease caused by an intronic mutation that leads to abnormally spliced ISCU mRNA. We found that two predominant mis-spliced ISCU mRNAs produce a truncated and short-lived ISCU protein product in multiple patient cell types. Expression of the muscle-specific transcription factor MyoD further diminished normal splicing of ISCU mRNA in patient myoblasts, demonstrating that the process of muscle differentiation enhances the loss of normal ISCU mRNA splicing. ISCU protein was nearly undetectable in patient skeletal muscle, but was higher in patient myoblasts, fibroblasts, and lymphoblasts. We next treated patient cells with pro-oxidants to mimic the oxidative stress associated with muscle activity. Brief hydrogen peroxide treatment or incubation in an enriched oxygen atmosphere led to a marked further reduction of ISCU protein levels, which could be prevented by pretreatment with the antioxidant ascorbate. Thus, we conclude that skeletal muscle differentiation of patient cells causes a higher degree of abnormal ISCU splicing and that oxidative stress resulting from skeletal muscle work destabilizes the small amounts of normal ISCU protein generated in patient skeletal muscles.	[Crooks, Daniel R.] Georgetown Univ, Dept Biochem Mol & Cellular Biol, Med Ctr, Washington, DC 20057 USA; [Crooks, Daniel R.; Jeong, Suh Young; Tong, Wing-Hang; Ghosh, Manik C.; Olivierre, Hayden; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Mol Med, NIH, Bethesda, MD 20892 USA; [Haller, Ronald G.] Texas Hlth Presbyterian Hosp, Neuromuscular Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; [Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Haller, Ronald G.] N Texas VA Med Ctr, Div Neurol, Dallas, TX 75216 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Rouault, TA (corresponding author), Bldg 18T,Rm 101,9000 Rockville Pike, Bethesda, MD 20892 USA.	rouault@helix.nih.gov		Jeong, Suh Young/0000-0002-6376-7001	National Institutes of Health through the NICHD Intramural Research Program; NIAMS [R01 AR050597]; Veterans Affairs Merit Review; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008814] Funding Source: NIH RePORTER	National Institutes of Health through the NICHD Intramural Research Program; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs Merit Review(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health through the NICHD Intramural Research Program (to T. A. R.) and NIAMS Grant R01 AR050597 (to R. G. H.). This work was also supported by a Veterans Affairs Merit Review (to R. G. H.).	ALESSIO HM, 1988, AM J PHYSIOL, V255, pC874, DOI 10.1152/ajpcell.1988.255.6.C874; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Bitoun JP, 2008, BIOMETALS, V21, P693, DOI 10.1007/s10534-008-9154-7; Crooks DR, 2007, J NEUROSCI RES, V85, P1797, DOI 10.1002/jnr.21321; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; DRUGGE U, 1995, J MED GENET, V32, P344, DOI 10.1136/jmg.32.5.344; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Holloszy JO, 1996, ANNU REV NUTR, V16, P121, DOI 10.1146/annurev.nu.16.070196.001005; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kavazis AN, 2009, FREE RADICAL BIO MED, V46, P842, DOI 10.1016/j.freeradbiomed.2009.01.002; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kollberg G, 2011, NEUROMUSCULAR DISORD, V21, P115, DOI 10.1016/j.nmd.2010.11.010; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; LINDERHOLM H, 1969, ACTA MED SCAND, V185, P153; LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x; Liu XF, 2008, J VIROL, V82, P11568, DOI 10.1128/JVI.01318-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Martelli A, 2012, DIS MODEL MECH, V5, P165, DOI 10.1242/dmm.008706; MEYDANI M, 1993, AM J PHYSIOL, V264, pR992, DOI 10.1152/ajpregu.1993.264.5.R992; MEYDANI M, 1992, ANN NY ACAD SCI, V669, P363; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Nordin A, 2012, HUM MUTAT, V33, P467, DOI 10.1002/humu.22002; Nordin A, 2011, HUM GENET, V129, P371, DOI 10.1007/s00439-010-0931-3; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; SEN CK, 1995, J APPL PHYSIOL, V79, P675, DOI 10.1152/jappl.1995.79.3.675; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Shoubridge E A, 1996, Methods Enzymol, V264, P465, DOI 10.1016/S0076-6879(96)64042-7; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906	48	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40119	40130		10.1074/jbc.M112.418889	http://dx.doi.org/10.1074/jbc.M112.418889			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035118	hybrid, Green Published			2022-12-25	WOS:000311448800003
J	Hill, KE; Wu, S; Motley, AK; Stevenson, TD; Winfrey, VP; Capecchi, MR; Atkins, JF; Burk, RF				Hill, Kristina E.; Wu, Sen; Motley, Amy K.; Stevenson, Teri D.; Winfrey, Virginia P.; Capecchi, Mario R.; Atkins, John F.; Burk, Raymond F.			Production of Selenoprotein P (Sepp1) by Hepatocytes Is Central to Selenium Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTOR-2; WHOLE-BODY SELENIUM; MOUSE-BRAIN; SELENOCYSTEINE; RAT; LIVER; GENE; MICE; EXCRETION; DELETION	Sepp1 is a widely expressed extracellular protein that in humans and mice contains 10 selenocysteine residues in its primary structure. Extra-hepatic tissues take up plasma Sepp1 for its selenium via apolipoprotein E receptor-2 (apoER2)-mediated endocytosis. The role of Sepp1 in the transport of selenium from liver, a rich source of the element, to peripheral tissues was studied using mice with selective deletion of Sepp1 in hepatocytes (Sepp1(c/c)/ alb-cre(+/-) mice). Deletion of Sepp1 in hepatocytes lowered plasma Sepp1 concentration to 10% of that in Sepp1(c/c) mice (controls) and increased urinary selenium excretion, decreasing whole-body and tissue selenium concentrations. Under selenium-deficient conditions, Sepp1(c/c)/alb-cre(+/-) mice accumulated selenium in the liver at the expense of extra-hepatic tissues, severely worsening clinical manifestations of dietary selenium deficiency. These findings are consistent with there being competition for metabolically available hepatocyte selenium between the synthesis of selenoproteins and the synthesis of selenium excretory metabolites. In addition, selenium deficiency down-regulated the mRNA of the most abundant hepatic selenoprotein, glutathione peroxidase-1 (Gpx1), to 15% of the selenium-replete value, while reducing Sepp1 mRNA, the most abundant hepatic selenoprotein mRNA, only to 61%. This strongly suggests that Sepp1 synthesis is favored in the liver over Gpx1 synthesis when selenium supply is limited, directing hepatocyte selenium to peripheral tissues in selenium deficiency. We conclude that production of Sepp1 by hepatocytes is central to selenium homeostasis in the organism because it promotes retention of selenium in the body and effects selenium distribution from the liver to extra-hepatic tissues, especially under selenium-deficient conditions.	[Hill, Kristina E.; Motley, Amy K.; Stevenson, Teri D.; Winfrey, Virginia P.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Wu, Sen; Capecchi, Mario R.; Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Atkins, John F.] Univ Coll, BioSci Inst, Cork, Ireland	Vanderbilt University; Utah System of Higher Education; University of Utah; University College Cork	Burk, RF (corresponding author), Vanderbilt Univ Sch Med, 1030C Med Res Bldg 4, Nashville, TN 37232 USA.	raymond.burk@vanderbilt.edu		Atkins, John/0000-0001-7933-0165	National Institutes of Health [R37 ES002497, 5P30 DK058404, 5P30 ES000267]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R37ES002497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 ES002497, 5P30 DK058404, and 5P30 ES000267.	Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Burk RF, 2006, BBA-GEN SUBJECTS, V1760, P1789, DOI 10.1016/j.bbagen.2006.08.010; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; BURK RF, 1973, P SOC EXP BIOL MED, V142, P214, DOI 10.3181/00379727-142-36991; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; ESAKI N, 1982, J BIOL CHEM, V257, P4386; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; KATO T, 1992, AM J PHYSIOL, V262, pG854, DOI 10.1152/ajpgi.1992.262.5.G854; Kobayashi Y, 2002, P NATL ACAD SCI USA, V99, P15932, DOI 10.1073/pnas.252610699; KOH TS, 1983, J ASSOC OFF ANA CHEM, V66, P918; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; MCCONNELL KP, 1952, J BIOL CHEM, V195, P277; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Okuno T, 2006, BIOL TRACE ELEM RES, V109, P155, DOI 10.1385/BTER:109:2:155; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; SHEEHAN TMT, 1990, CLIN CHEM, V36, P2124; Shiobara Y, 1999, ANALYST, V124, P1237, DOI 10.1039/a902922b; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; WALLACE E, 1983, GAMETE RES, V7, P377, DOI 10.1002/mrd.1120070409; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; Yang XG, 2000, BBA-GEN SUBJECTS, V1474, P390, DOI 10.1016/S0304-4165(00)00035-0; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200	40	100	104	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40414	40424		10.1074/jbc.M112.421404	http://dx.doi.org/10.1074/jbc.M112.421404			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038251	Green Published, hybrid			2022-12-25	WOS:000311448800032
J	King, BS; Cooper, KL; Liu, KJ; Hudson, LG				King, Brenee S.; Cooper, Karen L.; Liu, Ke Jian; Hudson, Laurie G.			Poly(ADP-ribose) Contributes to an Association between Poly(ADP-ribose) Polymerase-1 and Xeroderma Pigmentosum Complementation Group A in Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; BINDING-PROTEINS; MACRO DOMAIN; XPA PROTEIN; PARP-1; IDENTIFICATION; RECRUITMENT; INHIBITORS; MOTIFS; FAMILY	Exposure to ultraviolet radiation (UVR) promotes the formation of UVR-induced, DNA helix distorting photolesions such as (6-4) pyrimidine-pyrimidone photoproducts and cyclobutane pyrimidine dimers. Effective repair of such lesions by the nucleotide excision repair (NER) pathway is required to prevent DNA mutations and chromosome aberrations. Poly(ADP-ribose) polymerase-1 (PARP-1) is a zinc finger protein with well documented involvement in base excision repair. PARP-1 is activated in response to DNA damage and catalyzes the formation of poly(ADP-ribose) subunits that assist in the assembly of DNA repair proteins at sites of damage. In this study, we present evidence for PARP-1 contributions to NER, extending the knowledge of PARP-1 function in DNA repair beyond the established role in base excision repair. Silencing the PARP-1 protein or inhibiting PARP activity leads to retention of UVR-induced photolesions. PARP activation following UVR exposure promotes association between PARP-1 and XPA, a central protein in NER. Administration of PARP inhibitors confirms that poly(ADP-ribose) facilitates PARP-1 association with XPA in whole cell extracts, in isolated chromatin complexes, and in vitro. Furthermore, inhibition of PARP activity decreases UVR-stimulated XPA chromatin association, illustrating that these relationships occur in a meaningful context for NER. These results provide a mechanistic link for PARP activity in the repair of UVR-induced photoproducts.	[King, Brenee S.; Cooper, Karen L.; Liu, Ke Jian; Hudson, Laurie G.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA	University of New Mexico	Hudson, LG (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, MSC09 5360,1 Univ New Mexico, Albuquerque, NM 87131 USA.	LHudson@salud.unm.edu	King, Brenee/C-8100-2013; King, Brenee/L-1197-2013	King, Brenee/0000-0002-3313-799X	National Institutes of Health [RO1ES015826, F31ES019823]; University of New Mexico Initiative [R25GM060201]; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F31ES019823, R01ES015826, R01ES021100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1ES015826 (to L. G. H. and K. J. L.) and F31ES019823 (to B. S. K.).; This work was also supported by University of New Mexico Initiative to Maximize Student Diversity Grant R25GM060201.	ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Bartels CL, 2007, BIOCHEM BIOPH RES CO, V356, P219, DOI 10.1016/j.bbrc.2007.02.125; Burkle A, 2001, BIOESSAYS, V23, P795, DOI 10.1002/bies.1115; Camenisch U, 2008, ADV EXP MED BIOL, V637, P28; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Ghodgaonkar MM, 2008, DNA REPAIR, V7, P617, DOI 10.1016/j.dnarep.2008.01.001; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Han WD, 2011, MUTAT RES-REV MUTAT, V727, P86, DOI 10.1016/j.mrrev.2011.03.001; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hunter JE, 2012, ONCOGENE, V31, P251, DOI 10.1038/onc.2011.229; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kimbung S, 2012, CANCER LETT, V319, P232, DOI 10.1016/j.canlet.2012.01.015; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Malanga M, 1998, J BIOL CHEM, V273, P11839, DOI 10.1074/jbc.273.19.11839; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moroni F, 2001, CELL DEATH DIFFER, V8, P921, DOI 10.1038/sj.cdd.4400884; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Plummer R, 2008, CLIN CANCER RES, V14, P7917, DOI 10.1158/1078-0432.CCR-08-1223; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Qin XJ, 2008, TOXICOL APPL PHARM, V232, P41, DOI 10.1016/j.taap.2008.05.019; Schmitz AAP, 1998, BIOCHEMISTRY-US, V37, P9520, DOI 10.1021/bi973063b; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Schwerdtle T, 2010, CHEM RES TOXICOL, V23, P432, DOI 10.1021/tx900444w; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SUTO MJ, 1991, ANTI-CANCER DRUG DES, V6, P107; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	43	54	57	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.393504	http://dx.doi.org/10.1074/jbc.M112.393504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038248	Green Published, hybrid			2022-12-25	WOS:000311233800050
J	Lohman, AW; Weaver, JL; Billaud, M; Sandilos, JK; Griffiths, R; Straub, AC; Penuela, S; Leitinger, N; Laird, DW; Bayliss, DA; Isakson, BE				Lohman, Alexander W.; Weaver, Janelle L.; Billaud, Marie; Sandilos, Joanna K.; Griffiths, Rachael; Straub, Adam C.; Penuela, Silvia; Leitinger, Norbert; Laird, Dale W.; Bayliss, Douglas A.; Isakson, Brant E.			S-Nitrosylation Inhibits Pannexin 1 Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; ATP RELEASE; NITRIC-OXIDE; HEMICHANNELS; EXPRESSION; ERYTHROCYTES; PERMEABILITY; STRESS; FAMILY	S-Nitrosylation is a post-translational modification on cysteine(s) that can regulate protein function, and pannexin 1 (Panx1) channels are present in the vasculature, a tissue rich in nitric oxide (NO) species. Therefore, we investigated whether Panx1 can be S-nitrosylated and whether this modification can affect channel activity. Using the biotin switch assay, we found that application of the NO donor S-nitrosoglutathione (GSNO) or diethylammonium (Z)-1-1(N, N-diethylamino) diazen-1-ium-1,2-diolate (DEA NONOate) to human embryonic kidney (HEK) 293T cells expressing wild type (WT) Panx1 and mouse aortic endothelial cells induced Panx1 S-nitrosylation. Functionally, GSNO and DEA NONOate attenuated Panx1 currents; consistent with a role for S-nitrosylation, current inhibition was reversed by the reducing agent dithiothreitol and unaffected by 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one, a blocker of guanylate cyclase activity. In addition, ATP release was significantly inhibited by treatment with both NO donors. To identify which cysteine residue(s) was S-nitrosylated, we made single cysteine-to-alanine substitutions in Panx1 (Panx1(C40A), Panx1(C346A), and Panx1(C426A)). Mutation of these single cysteines did not prevent Panx1 S-nitrosylation; however, mutation of either Cys-40 or Cys-346 prevented Panx1 current inhibition and ATP release by GSNO. This observation suggested that multiple cysteines may be S-nitrosylated to regulate Panx1 channel function. Indeed, we found that mutation of both Cys-40 and Cys-346 (Panx1(C40A/C346A)) prevented Panx1 S-nitrosylation by GSNO as well as the GSNO-mediated inhibition of Panx1 current and ATP release. Taken together, these results indicate that S-nitrosylation of Panx1 at Cys-40 and Cys-346 inhibits Panx1 channel currents and ATP release.	[Isakson, Brant E.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Lohman, Alexander W.; Billaud, Marie; Isakson, Brant E.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Weaver, Janelle L.; Sandilos, Joanna K.; Griffiths, Rachael; Leitinger, Norbert; Bayliss, Douglas A.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	University of Virginia; University of Virginia; University of Virginia; Western University (University of Western Ontario)	Isakson, BE (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	brant@virginia.edu	Laird, Dale W/AAL-2407-2020; Penuela, Silvia/A-6961-2010; Billaud, Marie/N-7609-2017; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; Penuela, Silvia/0000-0003-4829-5517; Billaud, Marie/0000-0002-7591-0362; Straub, Adam/0000-0003-0542-9466; Weaver, Janelle/0000-0001-8677-8312	National Institutes of Health [HL088554, HL107963, HL112904-1, NS033583]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL107963, K99HL112904, R01HL088554, R00HL112904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, T32GM008136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088554 (to B. E. I.), HL107963 (to B. E. I.), HL112904-1 (to A. C. S.), and NS033583 (to D. A. B.). This work was also supported by an American Heart Association postdoctoral fellowship (to M. B.) and an American Heart Association predoctoral fellowship (to A. W. L.).	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Asada K, 2009, J BIOL CHEM, V284, P6014, DOI 10.1074/jbc.M807158200; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bunse S, 2011, J MEMBRANE BIOL, V244, P21, DOI 10.1007/s00232-011-9393-3; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Burnstock Geoffrey, 2011, World J Gastrointest Pathophysiol, V2, P31, DOI 10.4291/wjgp.v2.i2.31; Burnstock G, 2011, CELL MOL LIFE SCI, V68, P1369, DOI 10.1007/s00018-010-0614-1; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Iwabuchi S, 2011, NEUROCHEM INT, V58, P376, DOI 10.1016/j.neuint.2010.12.013; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Li S, 2011, ENDOCRINOLOGY, V152, P2342, DOI 10.1210/en.2010-1216; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Ransford GA, 2009, AM J RESP CELL MOL, V41, P525, DOI 10.1165/rcmb.2008-0367OC; Ray A, 2006, CEREBELLUM, V5, P189, DOI 10.1080/14734220500530082; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Rumjahn SM, 2009, BRIT J CANCER, V100, P1465, DOI 10.1038/sj.bjc.6604998; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Seminario-Vidal L, 2011, J BIOL CHEM, V286, P26277, DOI 10.1074/jbc.M111.260562; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Swayne LA, 2010, J BIOL CHEM, V285, P24977, DOI 10.1074/jbc.M110.130054; Wang JJ, 2010, J GEN PHYSIOL, V136, P515, DOI 10.1085/jgp.201010440; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Woehrle T, 2010, J LEUKOCYTE BIOL, V88, P1181, DOI 10.1189/jlb.0410211; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang L, 2008, J NEUROSCI RES, V86, P2281, DOI 10.1002/jnr.21675	43	79	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.397976	http://dx.doi.org/10.1074/jbc.M112.397976			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033481	Green Published, hybrid			2022-12-25	WOS:000311233800030
J	Potet, F; Lorinc, AN; Chaigne, S; Hopkins, CR; Venkataraman, R; Stepanovic, SZ; Lewis, LM; Days, E; Sidorov, VY; Engers, DW; Zou, BY; Afshartous, D; George, AL; Campbell, CM; Balser, JR; Li, M; Baudenbacher, FJ; Lindsley, CW; Weaver, CD; Kupershmidt, S				Potet, Franck; Lorinc, Amanda N.; Chaigne, Sebastien; Hopkins, Corey R.; Venkataraman, Raghav; Stepanovic, Svetlana Z.; Lewis, L. Michelle; Days, Emily; Sidorov, Veniamin Y.; Engers, Darren W.; Zou, Beiyan; Afshartous, David; George, Alfred L., Jr.; Campbell, Courtney M.; Balser, Jeffrey R.; Li, Min; Baudenbacher, Franz J.; Lindsley, Craig W.; Weaver, C. David; Kupershmidt, Sabina			Identification and Characterization of a Compound That Protects Cardiac Tissue from Human Ether-a-go-go-related Gene (hERG)-related Drug-induced Arrhythmias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-CHANNEL BLOCK; HERG POTASSIUM CHANNEL; MOLECULAR DETERMINANTS; K+ CHANNELS; QT SYNDROME; XENOPUS-OOCYTES; AFFINITY; BINDING; PROLONGATION; RECTIFIER	The human Ether-a-go-go-related gene (hERG)-encoded K+ current, I-Kr is essential for cardiac repolarization but is also a source of cardiotoxicity because unintended hERG inhibition by diverse pharmaceuticals can cause arrhythmias and sudden cardiac death. We hypothesized that a small molecule that diminishes IKr block by a known hERG antagonist would constitute a first step toward preventing hERG-related arrhythmias and facilitating drug discovery. Using a high-throughput assay, we screened a library of compounds for agents that increase the IC70 of dofetilide, a well characterized hERG blocker. One compound, VU0405601, with the desired activity was further characterized. In isolated, Langendorff-perfused rabbit hearts, optical mapping revealed that dofetilide-induced arrhythmias were reduced after pretreatment with VU0405601. Patch clamp analysis in stable hERG-HEK cells showed effects on current amplitude, inactivation, and deactivation. VU0405601 increased the IC50 of dofetilide from 38.7 to 76.3 nM. VU0405601 mitigates the effects of hERG blockers from the extracellular aspect primarily by reducing inactivation, whereas most clinically relevant hERG inhibitors act at an inner pore site. Structure-activity relationships surrounding VU0405601 identified a 3-pyridiyl and a naphthyridine ring system as key structural components important for preventing hERG inhibition by multiple inhibitors. These findings indicate that small molecules can be designed to reduce the sensitivity of hERG to inhibitors.	[Kupershmidt, Sabina] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Res, Nashville, TN 37232 USA; [Hopkins, Corey R.; Engers, Darren W.; Lindsley, Craig W.] Vanderbilt Univ, Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Venkataraman, Raghav; Sidorov, Veniamin Y.; Baudenbacher, Franz J.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA; [Lewis, L. Michelle; Days, Emily; Weaver, C. David] Vanderbilt Univ, Inst Biol Chem, Nashville, TN 37232 USA; [Afshartous, David] Vanderbilt Univ, Dept Biostat, Nashville, TN 37232 USA; [George, Alfred L., Jr.; Campbell, Courtney M.; Kupershmidt, Sabina] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Zou, Beiyan; Li, Min] Johns Hopkins Univ, Sch Med, Johns Hopkins Ion Channel Ctr, Baltimore, MD 21205 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Johns Hopkins University	Kupershmidt, S (corresponding author), Vanderbilt Univ, Sch Med, Dept Anesthesiol, Div Res, P-445 MRBIV Langford,13th Floor, Nashville, TN 37232 USA.	sabina.kupershmidt@vanderbilt.edu	Kupershmidt, Sabina/AAO-5464-2021; Chaigne, Sebastien/AFN-4672-2022	Kupershmidt, Sabina/0000-0002-8119-2723; Campbell, Courtney/0000-0002-0803-0429	National Institutes of Health [1RO1HL090790, RO3MH084820, 1 U54 MH074427, U54MH084659]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL107066, R01HL090790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659, R03MH084820, U54MH074427] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1HL090790 and RO3MH084820 (to S.K.), 1 U54 MH074427 (to C.D.W.), and U54MH084659 (to C.W.L.).; Supported in part by a Scientist Development Grant from the American Heart Association.	Aiba T, 2005, J AM COLL CARDIOL, V45, P300, DOI 10.1016/j.jacc.2004.09.069; BASSANI JWM, 1995, BIOPHYS J, V68, P1453, DOI 10.1016/S0006-3495(95)80318-8; Brugada R, 2005, CAN MED ASSOC J, V173, P1349, DOI 10.1503/cmaj.050596; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; De Cicco M, 1999, CRIT CARE MED, V27, P332, DOI 10.1097/00003246-199902000-00040; Drolet B, 1999, J CARDIOVASC ELECTR, V10, P1597, DOI 10.1111/j.1540-8167.1999.tb00224.x; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Hondeghem LM, 2003, J CARDIOVASC ELECTR, V14, P287, DOI 10.1046/j.1540-8167.2003.02466.x; Hondeghem LM, 2001, CIRCULATION, V103, P2004; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Kamiya K, 2006, MOL PHARMACOL, V69, P1709, DOI 10.1124/mol.105.020990; Kamiya K, 2001, MOL PHARMACOL, V60, P244, DOI 10.1124/mol.60.2.244; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kiehn J, 1996, CIRCULATION, V94, P2572, DOI 10.1161/01.CIR.94.10.2572; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; McPate MJ, 2008, BRIT J PHARMACOL, V155, P957, DOI 10.1038/bjp.2008.325; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Milnes JT, 2003, BRIT J PHARMACOL, V139, P887, DOI 10.1038/sj.bjp.0705335; Mitcheson JS, 2000, J GEN PHYSIOL, V115, P229, DOI 10.1085/jgp.115.3.229; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mitcheson JS, 2003, CURR OPIN DRUG DISC, V6, P667; Nattel S, 2008, PROG BIOPHYS MOL BIO, V98, P328, DOI 10.1016/j.pbiomolbio.2008.10.009; Perrin MJ, 2008, MOL PHARMACOL, V74, P1443, DOI 10.1124/mol.108.049056; Perry M, 2006, MOL PHARMACOL, V69, P509, DOI 10.1124/mol.105.016741; Potet F, 2001, J PHARMACOL EXP THER, V299, P1007; Ridley JM, 2006, J MOL CELL CARDIOL, V40, P107, DOI 10.1016/j.yjmcc.2005.09.017; Ridley JM, 2004, J MOL CELL CARDIOL, V36, P701, DOI 10.1016/j.yjmcc.2004.02.009; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Sanchez-Chapula JA, 2004, N-S ARCH PHARMACOL, V370, P484, DOI 10.1007/s00210-004-0995-5; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; Sanchez-Chapula JA, 2002, J BIOL CHEM, V277, P23587, DOI 10.1074/jbc.M200448200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schmalhofer WA, 2010, ASSAY DRUG DEV TECHN, V8, P714, DOI 10.1089/adt.2010.0351; Shah RR, 2007, DRUG SAFETY, V30, P1093, DOI 10.2165/00002018-200730120-00003; Snyders DJ, 1996, MOL PHARMACOL, V49, P949; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Woosley RL, 1996, ANNU REV PHARMACOL, V36, P233, DOI 10.1146/annurev.pa.36.040196.001313; Wynia-Smith SL, 2008, J GEN PHYSIOL, V132, P507, DOI 10.1085/jgp.200810083; Yang T, 2001, J CARDIOVASC PHARM, V38, P737, DOI 10.1097/00005344-200111000-00010; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zou AR, 1998, J PHYSIOL-LONDON, V509, P129, DOI 10.1111/j.1469-7793.1998.129bo.x; Zou BY, 2010, ASSAY DRUG DEV TECHN, V8, P743, DOI 10.1089/adt.2010.0339	52	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.380162	http://dx.doi.org/10.1074/jbc.M112.380162			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23033485	hybrid, Green Published			2022-12-25	WOS:000311233800031
J	Taniguchi, M; Kitatani, K; Kondo, T; Hashimoto-Nishimura, M; Asano, S; Hayashi, A; Mitsutake, S; Igarashi, Y; Umehara, H; Takeya, H; Kigawa, J; Okazaki, T				Taniguchi, Makoto; Kitatani, Kazuyuki; Kondo, Tadakazu; Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Hayashi, Akira; Mitsutake, Susumu; Igarashi, Yasuyuki; Umehara, Hisanori; Takeya, Hiroyuki; Kigawa, Junzo; Okazaki, Toshiro			Regulation of Autophagy and Its Associated Cell Death by "Sphingolipid Rheostat" RECIPROCAL ROLE OF CERAMIDE AND SPHINGOSINE 1-PHOSPHATE IN THE MAMMALIAN TARGET OF RAPAMYCIN PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; INDUCED APOPTOSIS; ER STRESS; PROTEIN PHOSPHATASE-2A; CERAMIDE ACCUMULATION; S1P(3) RECEPTOR; LEUKEMIA-CELLS; HL-60 CELLS; KINASE-B; SPHINGOSINE-1-PHOSPHATE	The role of "sphingolipid rheostat" by ceramide and sphingosine 1-phosphate (S1P) in the regulation of autophagy remains unclear. In human leukemia HL-60 cells, amino acid deprivation (AA(-)) caused autophagy with an increase in acid sphingomy-leinase (SMase) activity and ceramide, which serves as an autophagy inducing lipid. Knockdown of acid SMase significantly suppressed the autophagy induction. S1P treatment counteracted autophagy induction by AA(-) or C-2-ceramide. AA(-) treatment promoted mammalian target of rapamycin (mTOR) dephosphorylation/inactivation, inducing autophagy. S1P treatment suppressed mTOR inactivation and autophagy induction by AA(-). S1P exerts biological actions via cell surface receptors, and S1P(3) among five S1P receptors was predominantly expressed in HL-60 cells. We evaluated the involvement of S1P(3) in suppressing autophagy induction. S1P treatment of CHO cells had no effects on mTOR inactivation and autophagy induction by AA(-) or C-2-ceramide. Whereas S1P treatment of S1P(3) overexpressing CHO cells resulted in activation of the mTOR pathway, preventing cells from undergoing autophagy induced by AA(-) or C-2-ceramide. These results indicate that S1P-S1P(3) plays a role in counteracting ceramide signals that mediate mTOR-controlled autophagy. In addition, we evaluated the involvement of ceramide-activated protein phosphatases (CAPPs) in ceramide-dependent inactivation of the mTOR pathway. Inhibition of CAPP by okadaic acid in AA(-)- or C-2-ceramide-treated cells suppressed dephosphorylation/inactivation of mTOR, autophagy induction, and autophagy-associated cell death, indicating a novel role of ceramide-CAPPs in autophagy induction. Moreover, S1P(3) engagement by S1P counteracted cell death. Taken together, these results indicated that sphingolipid rheostat in ceramide-CAPPs and S1P-S1P(3) signaling modulates autophagy and its associated cell death through regulation of the mTOR pathway.	[Taniguchi, Makoto; Kitatani, Kazuyuki; Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Okazaki, Toshiro] Tottori Univ, Div Clin Lab Med, Fac Med, Yonago, Tottori 6838503, Japan; [Hashimoto-Nishimura, Mayumi; Asano, Satoshi; Kigawa, Junzo] Tottori Univ, Tottori Univ Hosp, Ctr Canc, Yonago, Tottori 6838503, Japan; [Hayashi, Akira; Takeya, Hiroyuki] Tottori Univ, Div Pathol Biochem, Dept Biomed Sci, Fac Med, Yonago, Tottori 6838503, Japan; [Hayashi, Akira; Umehara, Hisanori; Okazaki, Toshiro] Kanazawa Med Univ, Dept Hematol & Immunol, Uchinada, Ishikawa 9200293, Japan; [Kondo, Tadakazu] Kyoto Univ, Dept Hematol & Oncol, Grad Sch Med, Kyoto 6068507, Japan; [Kitatani, Kazuyuki] Tohoku Univ, Dept Biobank, Tohoku Med Megabank Org, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Taniguchi, Makoto] Kanazawa Med Univ, Dept Life Sci, Med Res Inst, Uchinada, Ishikawa 9200293, Japan; [Mitsutake, Susumu; Igarashi, Yasuyuki] Hokkaido Univ, Lab Biomembrane & Biofunct Chem, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0010021, Japan	Tottori University; Tottori University; Tottori University; Kanazawa Medical University; Kyoto University; Tohoku University; Kanazawa Medical University; Hokkaido University	Okazaki, T (corresponding author), Kanazawa Med Univ, Dept Med, Div Hematol Immunol, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	toshiroo@kanazawa-med.ac.jp	Asano, Satoshi/AAQ-3817-2020; Kitatani, Kazuyuki/H-7100-2019; Mitsutake, Susumu/A-4082-2012; Taniguchi, Makoto/L-5757-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; Taniguchi, Makoto/0000-0001-5920-8285; Asano, Satoshi/0000-0003-1537-4307	Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science [21890144]; Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology [22249041]; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Kanazawa Medical University Research Foundation	This work was supported in part by grants from the Sapporo Biocluster "Bio-S," the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (Japan), the Japan Society for the Promotion of Science (Grant-in-Aid for Young Scientists 21890144) (to K. K.), the Sumitomo Foundation (to K. K.), the Japanese Ministry of Education, Culture, Sports, Science and Technology 22249041 (to H. U.), the Uehara Memorial Foundation (to H. U.), the Vehicle Racing Commemorative Foundation (to H. U.), and the Kanazawa Medical University Research Foundation (to H. U).	Akao Y, 2002, BIOCHEM BIOPH RES CO, V294, P363, DOI 10.1016/S0006-291X(02)00462-X; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Banno Y, 2001, J BIOL CHEM, V276, P35622, DOI 10.1074/jbc.M105673200; Bektas M, 2005, ONCOGENE, V24, P178, DOI 10.1038/sj.onc.1208019; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Blazquez C, 2008, CANCER RES, V68, P1945, DOI 10.1158/0008-5472.CAN-07-5176; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chang CL, 2009, AM J PHYSIOL-CELL PH, V297, pC451, DOI 10.1152/ajpcell.00586.2008; Deng QL, 2007, MOL PHARMACOL, V71, P724, DOI 10.1124/mol.106.029223; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kohno T, 2003, J BIOCHEM, V134, P667, DOI 10.1093/jb/mvg191; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Kondo T, 2000, J BIOL CHEM, V275, P8872, DOI 10.1074/jbc.275.12.8872; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Lavieu G, 2006, J BIOL CHEM, V281, P8518, DOI 10.1074/jbc.M506182200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okajima F, 1996, FEBS LETT, V379, P260, DOI 10.1016/0014-5793(95)01526-4; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Potteck H, 2010, CELL PHYSIOL BIOCHEM, V26, P67, DOI 10.1159/000315107; Pyne S, 2002, BBA-MOL CELL BIOL L, V1582, P121, DOI 10.1016/S1388-1981(02)00146-4; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sato K, 1998, BIOCHEM BIOPH RES CO, V253, P253, DOI 10.1006/bbrc.1998.9745; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, LEUKEMIA, V16, P1596, DOI 10.1038/sj.leu.2402611; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; STRUM JC, 1994, J BIOL CHEM, V269, P15493; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	66	103	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.416552	http://dx.doi.org/10.1074/jbc.M112.416552			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035115	hybrid, Green Published			2022-12-25	WOS:000311233800058
J	Delorme, V; Diomande, SV; Dedieu, L; Cavalier, JF; Carriere, F; Kremer, L; Leclaire, J; Fotiadu, F; Canaan, S				Delorme, Vincent; Diomande, Sadia V.; Dedieu, Luc; Cavalier, Jean-Francois; Carriere, Frederic; Kremer, Laurent; Leclaire, Julien; Fotiadu, Frederic; Canaan, Stephane			MmPPOX Inhibits Mycobacterium tuberculosis Lipolytic Enzymes Belonging to the Hormone-Sensitive Lipase Family and Alters Mycobacterial Growth	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; FUSARIUM-SOLANI-PISI; GENOME SEQUENCE; IN-VITRO; TRIACYLGLYCEROL; IDENTIFICATION; ESTERASE; TETRAHYDROLIPSTATIN; EXPRESSION; MODEL	Lipid metabolism plays an important role during the lifetime of Mycobacterium tuberculosis, the causative agent of tuberculosis. Although M. tuberculosis possesses numerous lipolytic enzymes, very few have been characterized yet at a biochemical/pharmacological level. This study was devoted to the M. tuberculosis lipolytic enzymes belonging to the Hormone-Sensitive Lipase (HSL) family, which encompasses twelve serine hydrolases closely related to the human HSL. Among them, nine were expressed, purified and biochemically characterized using a broad range of substrates. In vitro enzymatic inhibition studies using the recombinant HSL proteins, combined with mass spectrometry analyses, revealed the potent inhibitory activity of an oxadiazolone compound, named MmPPOX. In addition, we provide evidence that MmPPOX alters mycobacterial growth. Overall, these findings suggest that the M. tuberculosis HSL family displays important metabolic functions, thus opening the way to further investigations linking the involvement of these enzymes in mycobacterial growth.	[Delorme, Vincent; Diomande, Sadia V.; Dedieu, Luc; Cavalier, Jean-Francois; Carriere, Frederic; Canaan, Stephane] Aix Marseille Univ, CNRS, UMR 7282, Marseille, France; [Delorme, Vincent; Leclaire, Julien; Fotiadu, Frederic] Univ Paul Cezanne, CNRS, UMR 7313, Ecole Cent Marseille,Equipe Chirosci, Marseille, France; [Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, INSERM,UMR 5235, Montpellier, France; [Kremer, Laurent] INSERM, DIMNP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Canaan, S (corresponding author), Aix Marseille Univ, CNRS, UMR 7282, Marseille, France.	canaan@imm.cnrs.fr	Cavalier, JF/ABB-6445-2020; Kremer, Laurent/M-4935-2017; Carrière, Frédéric/E-8408-2010; Leclaire, Julien/AAD-8263-2020	Cavalier, JF/0000-0003-0864-8314; Kremer, Laurent/0000-0002-6604-4458; Carrière, Frédéric/0000-0003-4848-9418; Leclaire, Julien/0000-0001-7984-9055; Delorme, Vincent/0000-0001-5235-7069	Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Agence Nationale de la Recherche Francaise [ANR PCV 2007-184840 PHELIN, ANR MIEN 2009-00904 FOAMY_TUB]; LISA Carnot Institute (Convention ANR) [07-CARN-009-01]; EGIDE	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche Francaise(French National Research Agency (ANR)); LISA Carnot Institute (Convention ANR)(French National Research Agency (ANR)); EGIDE	V. Delorme was funded by a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by the CNRS, the Agence Nationale de la Recherche Francaise (ANR PCV 2007-184840 PHELIN, ANR MIEN 2009-00904 FOAMY_TUB), by the LISA Carnot Institute (Convention ANR no07-CARN-009-01) and by EGIDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ali Y, 2006, BIOCHEMISTRY-US, V45, P14183, DOI 10.1021/bi0613978; Ben Ali Y, 2012, BIOCHIMIE, V94, P137, DOI 10.1016/j.biochi.2011.09.028; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Cavalier J-F, 2011, Patent No. [EP 11 305 911.7, 11305911]; Chakroborty Amitabha, 2011, Inflammopharmacology, V19, P131, DOI 10.1007/s10787-010-0072-2; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotes K, 2008, APPL MICROBIOL BIOT, V78, P741, DOI 10.1007/s00253-008-1397-2; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dedieu L, 2012, BIOCHIMIE IN PRESS; Delorme V, 2011, PHARM RES-DORDR, V28, P1831, DOI 10.1007/s11095-010-0362-9; Dhouib R, 2011, FEBS J, V278, P97, DOI 10.1111/j.1742-4658.2010.07936.x; Dhouib R, 2011, BBA-MOL CELL BIOL L, V1811, P234, DOI 10.1016/j.bbalip.2011.01.001; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Low KL, 2010, J BIOL CHEM, V285, P21662, DOI 10.1074/jbc.M110.135731; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; Ransac S, 1997, METHOD ENZYMOL, V286, P190; RANSAC S, 1990, BIOCHIM BIOPHYS ACTA, V1043, P57, DOI 10.1016/0005-2760(90)90110-J; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schoenafinger K, 2001, Patent No. [WO/2001/066, 531, 2001066531]; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Shen GM, 2012, INFECT IMMUN, V80, P243, DOI 10.1128/IAI.05541-11; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Tiss A, 2009, J MOL CATAL B-ENZYM, V58, P41, DOI 10.1016/j.molcatb.2008.11.003; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Verger R, 2006, Patent No. [WO/2006/085, 009, 2006085009]; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f; Zhang M, 2005, PROTEIN EXPRES PURIF, V42, P59, DOI 10.1016/j.pep.2005.03.022	58	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46493	10.1371/journal.pone.0046493	http://dx.doi.org/10.1371/journal.pone.0046493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029536	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900174
J	Li, J; Ma, XS; Yu, W; Lou, ZQ; Mu, DL; Wang, Y; Shen, BZ; Qi, SH				Li, Jun; Ma, Xuesong; Yu, Wei; Lou, Zhangqun; Mu, Dunlan; Wang, Ying; Shen, Baozhong; Qi, Sihua			Reperfusion Promotes Mitochondrial Dysfunction following Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							DENSITY GRADIENT CENTRIFUGATION; SUPEROXIDE-DISMUTASE DEFICIENCY; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; CELL-DEATH; OXIDATIVE STRESS; NEURONAL DEATH; CYCLOPHILIN-D; MOLECULAR MECHANISMS; BRAIN MITOCHONDRIA	Background and Purpose: Mitochondrial dysfunction has been implicated in the cell death observed after cerebral ischemia, and several mechanisms for this dysfunction have been proposed. Reperfusion after transient cerebral ischemia may cause continued and even more severe damage to the brain. Many lines of evidence have shown that mitochondria suffer severe damage in response to ischemic injury. The purpose of this study was to observe the features of mitochondrial dysfunction in isolated mitochondria during the reperfusion period following focal cerebral ischemia. Methods: Male Wistar rats were subjected to focal cerebral ischemia. Mitochondria were isolated using Percoll density gradient centrifugation. The isolated mitochondria were fixed for electron microscopic examination; calcium-induced mitochondrial swelling was quantified using spectrophotometry. Cyclophilin D was detected by Western blotting. Fluorescent probes were used to selectively stain mitochondria to measure their membrane potential and to measure reactive oxidative species production using flow cytometric analysis. Results: Signs of damage were observed in the mitochondrial morphology after exposure to reperfusion. The mitochondrial swelling induced by Ca2+ increased gradually with the increasing calcium concentration, and this tendency was exacerbated as the reperfusion time was extended. Cyclophilin D protein expression peaked after 24 hours of reperfusion. The mitochondrial membrane potential was decreased significantly during the reperfusion period, with the greatest decrease observed after 24 hours of reperfusion. The surge in mitochondrial reactive oxidative species occurred after 2 hours of reperfusion and was maintained at a high level during the reperfusion period. Conclusions: Reperfusion following focal cerebral ischemia induced significant mitochondrial morphological damage and Ca2+-induced mitochondrial swelling. The mechanism of this swelling may be mediated by the upregulation of the Cyclophilin D protein, the destruction of the mitochondrial membrane potential and the generation of excessive reactive oxidative species.	[Shen, Baozhong] Mol Imaging Key Lab Gen Univ & Coll Heilongjiang, Harbin, Peoples R China; [Li, Jun; Ma, Xuesong; Yu, Wei; Lou, Zhangqun; Mu, Dunlan; Wang, Ying; Qi, Sihua] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin, Peoples R China	Harbin Medical University	Qi, SH (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin, Peoples R China.	baozhongshen1961@163.com; sihuaqi2009@hotmail.com			Natural Science Foundation of Heilongjiang Province [ZD201017]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This project was supported by grants from the Natural Science Foundation of Heilongjiang Province (ZD201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; BROWN AW, 1972, J NEUROL SCI, V16, P59, DOI 10.1016/0022-510X(72)90102-5; Canevari L, 1997, J CEREBR BLOOD F MET, V17, P1166, DOI 10.1097/00004647-199711000-00005; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Feng ZC, 1998, RESUSCITATION, V37, P33, DOI 10.1016/S0300-9572(98)00031-8; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; GARCIA JH, 1978, ACTA NEUROPATHOL, V43, P85; GARCIA JH, 1975, HUM PATHOL, V6, P583, DOI 10.1016/S0046-8177(75)80043-8; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hou ST, 2002, INT REV CYTOL, V221, P93; Iijima T, 2003, NEUROCHEM INT, V43, P263, DOI 10.1016/S0197-0186(02)00228-0; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Iijima T, 2006, NEUROSCI RES, V55, P234, DOI 10.1016/j.neures.2006.04.005; KALIMO H, 1977, VIRCHOWS ARCH B, V25, P207; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lust WD, 2002, METAB BRAIN DIS, V17, P113, DOI 10.1023/A:1015420222334; MCGEERUSSELL SM, 1970, BRAIN RES, V20, P193, DOI 10.1016/0006-8993(70)90288-X; Murakami K, 1998, J NEUROSCI, V18, P205; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; MYERS KM, 1995, J NEUROCHEM, V65, P2432; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Peinado MA, 1997, ANAT REC, V247, P420; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Schild L, 2005, FEBS J, V272, P3593, DOI 10.1111/j.1742-4658.2005.04781.x; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SIMS NR, 1995, INT J BIOCHEM CELL B, V27, P531, DOI 10.1016/1357-2725(95)00026-L; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; Solenski NJ, 1997, STROKE, V28, P2545, DOI 10.1161/01.STR.28.12.2545; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Zaidan E, 1997, BRAIN RES, V772, P23, DOI 10.1016/S0006-8993(97)00833-0; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	52	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46498	10.1371/journal.pone.0046498	http://dx.doi.org/10.1371/journal.pone.0046498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029539	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900177
J	Murakami, H; Nakao, T; Matsunaga, M; Kasuya, Y; Shinoda, J; Yamada, J; Ohira, H				Murakami, Hiroki; Nakao, Takashi; Matsunaga, Masahiro; Kasuya, Yukinori; Shinoda, Jun; Yamada, Jitsuhiro; Ohira, Hideki			The Structure of Mindful Brain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER; AMYGDALA; EMOTION; SUPPRESSION; THERAPY; VOLUME	Mindfulness is currently attracting a great deal of attention as a psychotherapy technique. It is defined as bringing one's complete attention to the experiences occurring in the present moment in a nonjudgmental or accepting way. The Five Facet Mindfulness Questionnaire (FFMQ) was developed to assess individual differences in mindfulness states. The FFMQ is composed of five facets representing elements of mindfulness: non-reactivity to inner experience, non-judging, acting with awareness, describing, and observing. In the present study, we applied voxel-based morphometry to investigate the relationship between the brain structure and each facet as measured by the FFMQ. The results showed a positive association between the describing facet of mindfulness on the FFMQ and gray matter volume in the right anterior insula and the right amygdala. In conclusion, mindfulness was related with development in parts of the somatic marker circuit of the brain.	[Murakami, Hiroki] Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan; [Nakao, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Matsunaga, Masahiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Dept Cerebral Res, Okazaki, Aichi 444, Japan; [Kasuya, Yukinori; Shinoda, Jun; Yamada, Jitsuhiro] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Japan; [Ohira, Hideki] Nagoya Univ, Dept Psychol, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	National Center for Neurology & Psychiatry - Japan; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nagoya University	Murakami, H (corresponding author), Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan.	hmurakami@ncnp.go.jp	nakao, takashi/U-7188-2017	nakao, takashi/0000-0002-2227-4526	Japan Society for the Promotion of Science [20330148];  [208551];  [20821]; Grants-in-Aid for Scientific Research [22530743] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 208551 and No. 20821) and by a Grant-in-Aid for Scientific Research (B) (No. 20330148) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hayes AM, 2004, CLIN PSYCHOL-SCI PR, V11, P255, DOI 10.1093/clipsy/bph080; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sugiura Y, 2012, MINDFULNESS, V3, P85, DOI 10.1007/s12671-011-0082-1; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013	27	47	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46377	10.1371/journal.pone.0046377	http://dx.doi.org/10.1371/journal.pone.0046377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029500	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900147
J	Patnaik, SK; Yendamuri, S; Kannisto, E; Kucharczuk, JC; Singhal, S; Vachani, A				Patnaik, Santosh K.; Yendamuri, Sai; Kannisto, Eric; Kucharczuk, John C.; Singhal, Sunil; Vachani, Anil			MicroRNA Expression Profiles of Whole Blood in Lung Adenocarcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; PERIPHERAL-BLOOD; CIRCULATING MICRORNAS; MICROARRAY DATA; CANCER-PATIENTS; BIOMARKERS; SIGNATURES; SERUM; MIRNA; RNA	The association of lung cancer with changes in microRNAs in plasma shown in multiple studies suggests a utility for circulating microRNA biomarkers in non-invasive detection of the disease. We examined if presence of lung cancer is reflected in whole blood microRNA expression as well, possibly because of a systemic response. Locked nucleic acid microarrays were used to quantify the global expression of microRNAs in whole blood of 22 patients with lung adenocarcinoma and 23 controls, ten of whom had a radiographically detected non-cancerous lung nodule and the other 13 were at high risk for developing lung cancer because of a smoking history of >20 pack-years. Cases and controls differed significantly for age with a mean difference of 10.7 years, but not for gender, race, smoking history, blood hemoglobin, platelet count, or white blood cell count. Of 1282 quantified human microRNAs, 395 (31%) were identified as expressed in the study's subjects, with 96 (24%) differentially expressed between cases and controls. Classification analyses of microRNA expression data were performed using linear kernel support vector machines (SVM) and top-scoring pairs (TSP) methods, and classifiers to identify presence of lung adenocarcinoma were internally cross-validated. In leave-one-out cross-validation, the TSP classifiers had sensitivity and specificity of 91% and 100%, respectively. The values with SVM were both 91%. In a Monte Carlo cross-validation, average sensitivity and specificity values were 86% and 97%, respectively, with TSP, and 88% and 89%, respectively, with SVM. MicroRNAs miR-190b, miR-630, miR-942, and miR-1284 were the most frequent constituents of the classifiers generated during the analyses. These results suggest that whole blood microRNA expression profiles can be used to distinguish lung cancer cases from clinically relevant controls. Further studies are needed to validate this observation, including in non-adenocarcinomatous lung cancers, and to clarify upon the confounding effect of age.	[Vachani, Anil] Univ Penn, Abramson Res Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Patnaik, Santosh K.; Yendamuri, Sai; Kannisto, Eric] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Kucharczuk, John C.; Singhal, Sunil] Univ Penn, Div Thorac Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Roswell Park Cancer Institute; University of Pennsylvania	Vachani, A (corresponding author), Univ Penn, Abramson Res Ctr, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	avachani@mail.med.upenn.edu		Yendamuri, Sai/0000-0001-6654-3487	National Cancer Institute [1R21CA156087-01A1]; NCI [K07CA111952]; Thoracic Surgery Foundation for Research and Education; State University of New York at Buffalo; NATIONAL CANCER INSTITUTE [K07CA111952, R21CA156087, P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Thoracic Surgery Foundation for Research and Education; State University of New York at Buffalo; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Cancer Institute research grant 1R21CA156087-01A1 and Career Development Award K07CA111952 from the NCI (http://www.nci.gov) to Anil Vachani, and a research award from the Thoracic Surgery Foundation for Research and Education (http://www.tsfre.org), and Buswell Fellowship award from the State University of New York at Buffalo to Sai Yendamuri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bauer AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034151; Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chal V, 2005, J CLIN LAB ANAL, V19, P182, DOI 10.1002/jcla.20075; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dudoit S, 2003, INTERDISC STAT, P93; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Foss KM, 2011, J THORAC ONCOL, V6, P482, DOI 10.1097/JTO.0b013e318208c785; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Hamilton AJ, 2010, BIOCHEM SOC T, V38, P229, DOI 10.1042/BST0380229; Hammerle-Fickinger A, 2010, BIOTECHNOL LETT, V32, P35, DOI 10.1007/s10529-009-0130-2; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Jeong HC, 2011, MOL MED REP, V4, P383, DOI 10.3892/mmr.2011.430; Kagedal B, 2005, CLIN CHEM LAB MED, V43, P1190, DOI 10.1515/CCLM.2005.206; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Leek JT, 2009, BIOINFORMATICS, V25, P1203, DOI 10.1093/bioinformatics/btp126; Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Maertzdorf J, 2012, P NATL ACAD SCI US; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morandi E, 2009, RADIAT RES, V172, P500, DOI 10.1667/RR1545.1; Muller MC, 2002, LEUKEMIA, V16, P2395, DOI 10.1038/sj.leu.2402734; Orlova IA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-195; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Ost DE, 2012, AM J RESP CRIT CARE, V185, P363, DOI 10.1164/rccm.201104-0679CI; Patnaik SK, 2010, ANAL BIOCHEM, V407, P147, DOI 10.1016/j.ab.2010.08.004; Pirker Robert, 2003, Clin Lung Cancer, V5, P90, DOI 10.3816/CLC.2003.n.022; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Rykova EY, 2006, ANN NY ACAD SCI, V1075, P328, DOI 10.1196/annals.1368.044; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; SHOENFELD Y, 1986, J CANCER RES CLIN, V111, P54, DOI 10.1007/BF00402777; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tomita M, 2010, ANTICANCER RES, V30, P3099; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Zander T, 2011, CLIN CANCER RES, V17, P3360, DOI 10.1158/1078-0432.CCR-10-0533; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575	71	83	85	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46045	10.1371/journal.pone.0046045	http://dx.doi.org/10.1371/journal.pone.0046045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029380	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900079
J	Roger, F; Lamy, B; Jumas-Bilak, E; Kodjo, A; Marchandin, H				Roger, Frederic; Lamy, Brigitte; Jumas-Bilak, Estelle; Kodjo, Angeli; Marchandin, Helene		colBVH Study Grp	Ribosomal Multi-Operon Diversity: An Original Perspective on the Genus Aeromonas	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; SHARMANA SP-NOV.; RNA GENE; PHYLOGENETIC ANALYSIS; INTRAGENOMIC HETEROGENEITY; GENOME SEQUENCE; COPY NUMBER; IDENTIFICATION; EVOLUTION; STRAINS	16S rRNA gene (rrs) is considered of low taxonomic interest in the genus Aeromonas. Here, 195 Aeromonas strains belonging to populations structured by multilocus phylogeny were studied using an original approach that considered Ribosomal Multi-Operon Diversity. This approach associated pulsed-field gel electrophoresis (PFGE) to assess rrn operon number and distribution across the chromosome and PCR-temporal temperature gel electrophoresis (TTGE) to assess rrs V3 region heterogeneity. Aeromonads harbored 8 to 11 rrn operons, 10 operons being observed in more than 92% of the strains. Intraspecific variability was low or nul except for A. salmonicida and A. aquariorum suggesting that large chromosomic rearrangements might occur in these two species while being extremely rarely encountered in the evolution of other taxa. rrn operon number at 8 as well as PFGE patterns were shown valuable for taxonomic purpose allowing resolution of species complexes. PCR-TTGE revealed a high rate of strains (41.5%) displaying intragenomic rrs heterogeneity. Strains isolated from human samples more frequently displayed intragenomic heterogeneity than strains recovered from non-human and environmental specimens. Intraspecific variability ranged from 0 to 76.5% of the strains. The observation of species-specific TTGE bands, the recovery of identical V3 regions in different species and the variability of intragenomic heterogeneity (1-13 divergent nucleotides) supported the occurrence of mutations and horizontal transfer in aeromonad rrs evolution. Altogether, the presence of a high number of rrn operon, the high proportion of strains harboring divergent rrs V3 region and the previously demonstrated high level of genetic diversity argued in favor of highly adaptative capabilities of aeromonads. Outstanding features observed for A. caviae supported the ongoing process of adaptation to a specialized niche represented by the gut, previously hypothesized. 16S rRNA gene is an informative marker in the genus Aeromonas for both evolutionary and polyphasic taxonomic studies provided that multi-operon fingerprinting approaches are used.	[Roger, Frederic; Lamy, Brigitte; Jumas-Bilak, Estelle; Marchandin, Helene] Univ Montpellier I, UFR Sci Pharmaceut & Biol, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France; [Lamy, Brigitte; Marchandin, Helene] Ctr Hosp Reg Univ Montpellier, Hop Arnaud Villeneuve, Bacteriol Lab, Montpellier, France; [Lamy, Brigitte; Kodjo, Angeli] Aeromonas GFA, Grp Etude Francais, Lyon, France; [Jumas-Bilak, Estelle] Ctr Hosp Reg Univ Montpellier, Lab Hygiene Hosp, Montpellier, France; [Kodjo, Angeli] Univ Claude Bernard Lyon 1, CNRS, UMR Ecol Microbienne 5557, Marcy Ietoile, France; [colBVH Study Grp] Virol & Hyg Hop Generaux, ColBVH, Coll Bacteriol, Le Chesnay, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marchandin, H (corresponding author), Univ Montpellier I, UFR Sci Pharmaceut & Biol, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France.	helene.marchandin@univ-montp1.fr	MARCHANDIN, Hélène/AAM-8288-2021; Lamy, Brigitte/A-8401-2015; Roger, Frédéric/ABC-3458-2021	MARCHANDIN, Hélène/0000-0003-2130-6335; Lamy, Brigitte/0000-0003-2370-8186; Roger, Frédéric/0000-0001-7884-2791; Kodjo, Angeli/0000-0002-7247-9765; Auvray, Christelle/0000-0001-9782-170X	Association des Biologistes de l'Ouest; ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique Pharmacie)	Association des Biologistes de l'Ouest; ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique Pharmacie)	This work was supported by the Association des Biologistes de l'Ouest and by ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique & Pharmacie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Alperi A, 2010, INT J SYST EVOL MICR, V60, P72, DOI 10.1099/ijs.0.011643-0; Aujoulat F, 2012, GENES-BASEL, V3, P191, DOI 10.3390/genes3020191; Borrell N, 1997, J CLIN MICROBIOL, V35, P1671, DOI 10.1128/JCM.35.7.1671-1674.1997; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Dikow RB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-237; Dodd HN, 1998, MICROBIOL-SGM, V144, P3087, DOI 10.1099/00221287-144-11-3087; Figueras MJ, 2011, INT J SYST EVOL MICR, V61, P242, DOI 10.1099/ijs.0.016139-0; Figueras MJ, 2000, J CLIN MICROBIOL, V38, P2023; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Graf J, 1999, J CLIN MICROBIOL, V37, P3194, DOI 10.1128/JCM.37.10.3194-3197.1999; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holt HM, 2005, CLIN MICROBIOL INFEC, V11, P347, DOI 10.1111/j.1469-0691.2005.01108.x; Huys G, 2001, SYST APPL MICROBIOL, V24, P177, DOI 10.1078/0723-2020-00038; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jensen S, 2009, FEMS MICROBIOL LETT, V294, P207, DOI 10.1111/j.1574-6968.2009.01567.x; Jumas-Bilak E, 2005, INT J SYST EVOL MICR, V55, P2471, DOI 10.1099/ijs.0.63715-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Lamy B, 2009, J CLIN MICROBIOL, V47, P1234, DOI 10.1128/JCM.00155-09; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li YX, 2011, J BACTERIOL, V193, P3389, DOI 10.1128/JB.00347-11; Liu SL, 1999, J BACTERIOL, V181, P6747, DOI 10.1128/JB.181.21.6747-6755.1999; LUCCHINI GM, 1992, INT J SYST BACTERIOL, V42, P384; Marchandin H, 2003, INT J SYST EVOL MICR, V53, P547, DOI 10.1099/ijs.0.02378-0; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; Martinez-Murcia AJ, 2007, INT MICROBIOL, V10, P61, DOI 10.2436/20.1501.01.9; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; MARTINEZMURCIA AJ, 1992, INT J SYST BACTERIOL, V42, P412, DOI 10.1099/00207713-42-3-412; Martino ME, 2011, APPL ENVIRON MICROB, V77, P4986, DOI 10.1128/AEM.00708-11; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; Minana-Galbis D, 2010, SYST APPL MICROBIOL, V33, P15, DOI 10.1016/j.syapm.2009.11.002; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Pidiyar VJ, 2003, DNA SEQUENCE, V14, P183, DOI 10.1080/1042517031000101257; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Roger F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-62; Saavedra MJ, 2007, ANTON LEEUW INT J G, V91, P159, DOI 10.1007/s10482-006-9107-5; Saha P, 2006, INT J SYST EVOL MICR, V56, P1905, DOI 10.1099/ijs.0.63972-0; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sharma Krishna Kanchan, 2010, J Lab Physicians, V2, P61, DOI 10.4103/0974-2727.72150; Silver AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016751; SNEATH PHA, 1993, INT J SYST BACTERIOL, V43, P626, DOI 10.1099/00207713-43-3-626; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Tacao M, 2005, FEMS MICROBIOL LETT, V246, P11, DOI 10.1016/j.femsle.2005.03.033; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Umelo E, 1998, MICROBIOL-SGM, V144, P2141, DOI 10.1099/00221287-144-8-2141; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Zheng JF, 2006, J ENVIRON SCI-CHINA, V18, P530	55	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46268	10.1371/journal.pone.0046268	http://dx.doi.org/10.1371/journal.pone.0046268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23032081	Green Submitted, gold, Green Published			2022-12-25	WOS:000309517500080
J	Okamoto, Y; Vricella, LA; Moss, WJ; Griffin, DE				Okamoto, Yukari; Vricella, Luca A.; Moss, William J.; Griffin, Diane E.			Immature CD4(+)CD8(+) Thymocytes Are Preferentially Infected by Measles Virus in Human Thymic Organ Cultures	PLOS ONE			English	Article							LYMPHOCYTIC ACTIVATION MOLECULE; WILD-TYPE MEASLES; BLOOD MONONUCLEAR-CELLS; LYMPHOID-TISSUES; CELLULAR RECEPTOR; GAMMA-INTERFERON; DENDRITIC CELLS; TERMINAL DIFFERENTIATION; IMMUNE-RESPONSES; EPITHELIAL-CELLS	Cells of the human immune system are important target cells for measles virus (MeV) infection and infection of these cells may contribute to the immunologic abnormalities and immune suppression that characterize measles. The thymus is the site for production of naive T lymphocytes and is infected during measles. To determine which populations of thymocytes are susceptible to MeV infection and whether strains of MeV differ in their ability to infect thymocytes, we used ex vivo human thymus organ cultures to assess the relative susceptibility of different subpopulations of thymocytes to infection with wild type and vaccine strains of MeV. Thymocytes were susceptible to MeV infection with the most replication in immature CD4(+)CD8(+) double positive cells. Susceptibility correlated with the level of expression of the MeV receptor CD150. Wild type strains of MeV infected thymocytes more efficiently than the Edmonston vaccine strain. Thymus cultures from children >= 3 years of age were less susceptible to MeV infection than cultures from children 5 to 15 months of age. Resistance in one 7 year-old child was associated with production of interferon-gamma suggesting that vaccination may result in MeV-specific memory T cells in the thymus. We conclude that immature thymocytes are susceptible to MeV infection and thymocyte infection may contribute to the immunologic abnormalities associated with measles.	[Okamoto, Yukari; Moss, William J.; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Moss, William J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Vricella, Luca A.] Johns Hopkins Univ, Sch Med, Dept Cardiac Surg, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Griffin, DE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.	dgriffin@jhsph.edu			National Institutes of Health [R01 AI23047]; Bill and Melinda Gates Foundation [RG3522]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health R01 AI23047; The Bill and Melinda Gates Foundation RG3522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akramuzzaman SM, 2000, AM J EPIDEMIOL, V151, P723, DOI 10.1093/oxfordjournals.aje.a010267; ARNEBORN P, 1983, INFECT IMMUN, V39, P29, DOI 10.1128/IAI.39.1.29-37.1983; Auwaerter PG, 1999, J INFECT DIS, V180, P950, DOI 10.1086/314993; Auwaerter PG, 1996, J VIROL, V70, P3734, DOI 10.1128/JVI.70.6.3734-3740.1996; Aversa G, 1997, J IMMUNOL, V158, P4036; Bartz R, 1998, J GEN VIROL, V79, P1015, DOI 10.1099/0022-1317-79-5-1015; BECKFORD AP, 1985, S AFR MED J, V68, P858; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; Condack C, 2007, J INFECT DIS, V196, P541, DOI 10.1086/519689; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Erlenhoefer C, 2001, J VIROL, V75, P4499, DOI 10.1128/JVI.75.10.4499-4505.2001; FINKE D, 1995, J VIROL, V69, P5469, DOI 10.1128/JVI.69.9.5469-5474.1995; Gagneur A, 2008, CLIN VACCINE IMMUNOL, V15, P1845, DOI 10.1128/CVI.00229-08; Grais RF, 2007, PLOS MED, V4, P122, DOI 10.1371/journal.pmed.0040016; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Hahm B, 2003, J VIROL, V77, P3505, DOI 10.1128/JVI.77.6.3505-3515.2003; HIRSCH RL, 1984, CLIN IMMUNOL IMMUNOP, V31, P1, DOI 10.1016/0090-1229(84)90184-3; Hsu EC, 2001, VIROLOGY, V279, P9, DOI 10.1006/viro.2000.0711; ILONEN J, 1988, J GEN VIROL, V69, P247, DOI 10.1099/0022-1317-69-1-247; JOHNSON RT, 1984, NEW ENGL J MED, V310, P137, DOI 10.1056/NEJM198401193100301; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Kruse M, 2001, J IMMUNOL, V167, P1989, DOI 10.4049/jimmunol.167.4.1989; LEOPARDI R, 1992, APMIS, V100, P125, DOI 10.1111/j.1699-0463.1992.tb00850.x; LISZEWSKI MK, 1992, CURR TOP MICROBIOL, V178, P45; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; McQuaid S, 2002, LAB INVEST, V82, P403, DOI 10.1038/labinvest.3780434; MOENCH TR, 1988, J INFECT DIS, V158, P433, DOI 10.1093/infdis/158.2.433; Moss WJ, 2006, NAT REV MICROBIOL, V4, P900, DOI 10.1038/nrmicro1550; Mrkic B, 2000, J VIROL, V74, P1364, DOI 10.1128/JVI.74.3.1364-1372.2000; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; NOZAWA Y, 1994, PATHOL INT, V44, P442, DOI 10.1111/j.1440-1827.1994.tb01708.x; Obojes K, 2005, J VIROL, V79, P7768, DOI 10.1128/JVI.79.12.7768-7776.2005; Ohgimoto K, 2007, VIRUS RES, V123, P1, DOI 10.1016/j.virusres.2006.07.006; Ohno S, 2007, J VIROL, V81, P1650, DOI 10.1128/JVI.02134-06; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Patterson CE, 2002, J VIROL, V76, P4497, DOI 10.1128/JVI.76.9.4497-4506.2002; Permar SR, 2003, J VIROL, V77, P7872, DOI 10.1128/JVI.77.14.7872-7879.2003; Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006; ROTA JS, 1992, VIROLOGY, V188, P135, DOI 10.1016/0042-6822(92)90742-8; Ryon JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P994, DOI 10.1128/CDLI.9.5.994-1003.2002; SAKAGUCHI M, 1986, MICROBIOL IMMUNOL, V30, P1067, DOI 10.1111/j.1348-0421.1986.tb03036.x; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; SMARON MF, 1991, J VIROL METHODS, V33, P223, DOI 10.1016/0166-0934(91)90022-R; Sprent J, 2009, IMMUNOL CELL BIOL, V87, P46, DOI 10.1038/icb.2008.88; STARR S, 1964, NEW ENGL J MED, V270, P386, DOI 10.1056/NEJM196402202700802; Takeuchi K, 2005, J VIROL, V79, P7838, DOI 10.1128/JVI.79.12.7838-7844.2005; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Valentin H, 1999, J VIROL, V73, P2212, DOI 10.1128/JVI.73.3.2212-2221.1999; Vidalain PO, 2002, J VIROL, V76, P6415, DOI 10.1128/JVI.76.13.6415-6424.2002; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; WARD BJ, 1991, CLIN IMMUNOL IMMUNOP, V61, P236, DOI 10.1016/S0090-1229(05)80027-3; Watanabe A, 2010, J VIROL, V84, P4183, DOI 10.1128/JVI.02168-09; Welstead GG, 2005, P NATL ACAD SCI USA, V102, P16415, DOI 10.1073/pnas.0505945102; WHITE RG, 1973, CLIN EXP IMMUNOL, V13, P343; YAMANOUC.K, 1973, J INFECT DIS, V128, P795, DOI 10.1093/infdis/128.6.795	64	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45999	10.1371/journal.pone.0045999	http://dx.doi.org/10.1371/journal.pone.0045999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029357	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700103
J	Kateete, DP; Katabazi, FA; Okeng, A; Okee, M; Musinguzi, C; Asiimwe, BB; Kyobe, S; Asiimwe, J; Boom, WH; Joloba, ML				Kateete, David Patrick; Katabazi, Fred Ashaba; Okeng, Alfred; Okee, Moses; Musinguzi, Conrad; Asiimwe, Benon Byamugisha; Kyobe, Samuel; Asiimwe, Jeniffer; Boom, W. Henry; Joloba, Moses Lutaakome			Rhomboids of Mycobacteria: Characterization Using an aarA Mutant of Providencia stuartii and Gene Deletion in Mycobacterium smegmatis	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; FAMILY; IDENTIFICATION; MECHANISM; PROTEINS; GENOME; BCG	Background: Rhomboids are ubiquitous proteins with unknown roles in mycobacteria. However, bioinformatics suggested putative roles in DNA replication pathways and metabolite transport. Here, mycobacterial rhomboid-encoding genes were characterized; first, using the Providencia stuartii null-rhomboid mutant and then deleted from Mycobacterium smegmatis for additional insight in mycobacteria. Methodology/Principal Findings: Using in silico analysis we identified in M. tuberculosis genome the genes encoding two putative rhomboid proteins; Rv0110 (referred to as "rhomboid protease 1") and Rv1337 ("rhomboid protease 2"). Genes encoding orthologs of these proteins are widely represented in all mycobacterial species. When transformed into P. stuartii null-rhomboid mutant (Delta aarA), genes encoding mycobacterial orthologs of "rhomboid protease 2" fully restored AarA activity (AarA is the rhomboid protein of P. stuartii). However, most genes encoding mycobacterial "rhomboid protease 1" orthologs did not. Furthermore, upon gene deletion in M. smegmatis, the Delta MSMEG_4904 single mutant (which lost the gene encoding MSMEG_4904, orthologous to Rv1337, "rhomboid protease 2") formed the least biofilms and was also more susceptible to ciprofloxacin and novobiocin, antimicrobials that inhibit DNA gyrase. However, the Delta MSMEG_5036 single mutant (which lost the gene encoding MSMEG_5036, orthologous to Rv0110, "rhomboid protease 1") was not as susceptible. Surprisingly, the double rhomboid mutant Delta MSMEG_4904-Delta MSMEG_5036 (which lost genes encoding both homologs) was also not as susceptible suggesting compensatory effects following deletion of both rhomboid-encoding genes. Indeed, transforming the double mutant with a plasmid encoding MSMEG_5036 produced phenotypes of the Delta MSMEG_4904 single mutant (i.e. susceptibility to ciprofloxacin and novobiocin). Conclusions/Significance: Mycobacterial rhomboid-encoding genes exhibit differences in complementing aarA whereby it's only genes encoding "rhomboid protease 2" orthologs that fully restore AarA activity. Additionally, gene deletion data suggests inhibition of DNA gyrase by MSMEG_4904; however, the ameliorated effect in the double mutant suggests occurrence of compensatory mechanisms following deletion of genes encoding both rhomboids.	[Kateete, David Patrick; Katabazi, Fred Ashaba; Okeng, Alfred; Okee, Moses; Musinguzi, Conrad; Asiimwe, Benon Byamugisha; Kyobe, Samuel; Asiimwe, Jeniffer; Joloba, Moses Lutaakome] Makerere Univ, Coll Hlth Sci MakCHS, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Asiimwe, Jeniffer] Makerere Univ, Coll Vet Med Anim Resources & Biosecur CoVAB, Kampala, Uganda; [Boom, W. Henry; Joloba, Moses Lutaakome] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Makerere University; Makerere University; Case Western Reserve University	Joloba, ML (corresponding author), Makerere Univ, Coll Hlth Sci MakCHS, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.	mlj10@case.edu	Kateete, David Patrick/HCH-5603-2022	Joloba, Moses/0000-0002-0334-9983; Kateete, David Patrick/0000-0001-8075-3069	National Institutes of Health [R03 AI062849, R01 AI075637]; Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases; United States National Institutes of Health and Human Services [NO1-AI-95383, HHSN266200700022C/NO1-AI-70022]; Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala [U2RTW006879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI062849, R01AI075637, N01AI095383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tuberculosis Research Unit (TBRU); United States National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part by the National Institutes of Health (Grants # R03 AI062849 and R01 AI075637); the Tuberculosis Research Unit (TBRU), established with Federal funds from the United States National Institutes of Allergy and Infectious Diseases and the United States National Institutes of Health and Human Services, under Contract Nos. NO1-AI-95383 and HHSN266200700022C/NO1-AI-70022; and with training support to DPK from the Fogarty International Center through Clinical Operational and Health Services Research (COHRE Uganda) at the JCRC, Kampala (award # U2RTW006879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Bischoff E, 2000, MOL MICROBIOL, V35, P1005, DOI 10.1046/j.1365-2958.2000.01788.x; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Clemmer KM, 2006, J BACTERIOL, V188, P3415, DOI 10.1128/JB.188.9.3415-3419.2006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cook GM, 2009, ADV MICROB PHYSL, V55, P318; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Freeman M, 2009, SEMIN CELL DEV BIOL, V20, P231, DOI 10.1016/j.semcdb.2008.10.006; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Garcia MJ, 2008, BIOINFORMATICS TROPI; Harth G, 2005, MOL MICROBIOL, V58, P1157, DOI 10.1111/j.1365-2958.2005.04899.x; Hill RB, 2010, SEMIN CELL DEV BIOL, V21, P582, DOI 10.1016/j.semcdb.2009.12.011; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Kana BD, 2004, TUBERCULOSIS, V84, P63, DOI 10.1016/j.tube.2003.08.006; Kateete DP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-272; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Okuni JB, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-99; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; Posey JE, 2006, J BACTERIOL, V188, P1332, DOI 10.1128/JB.188.4.1332-1340.2006; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Sambrook J, 2001, MOL CLONING LAB MANU; Sander P, 2001, Methods Mol Med, V54, P93, DOI 10.1385/1-59259-147-7:093; Song HH, 2007, GENE, V399, P112, DOI 10.1016/j.gene.2007.05.005; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Stephan J, 2004, GENE, V343, P181, DOI 10.1016/j.gene.2004.08.028; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Stinear TP, 2007, GENOME RES, V17, P192, DOI 10.1101/gr.5942807; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45741	10.1371/journal.pone.0045741	http://dx.doi.org/10.1371/journal.pone.0045741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029216	Green Submitted, gold, Green Published			2022-12-25	WOS:000309392800089
J	Sniegula, S; Nilsson-Ortman, V; Johansson, F				Sniegula, Szymon; Nilsson-Ortman, Viktor; Johansson, Frank			Growth Pattern Responses to Photoperiod across Latitudes in a Northern Damselfly	PLOS ONE			English	Article							LIFE-HISTORY PLASTICITY; BODY-SIZE; TIME CONSTRAINTS; EVOLUTIONARY SIGNIFICANCE; SEASONAL ENVIRONMENT; DEVELOPMENTAL RATE; SPERM COMPETITION; REACTION NORMS; CLIMATE-CHANGE; TEMPERATURE	Background: Latitudinal clines in temperature and seasonality impose strong seasonal constraints on ectotherms. Studies of population differentiation in phenotypic plasticity of life history traits along latitudinal gradients are important for understanding how organisms have adapted to seasonal environments and predict how they respond to climate changes. Such studies have been scarce for species with a northern distribution. Methodology/Principle Finding: Larvae of the northern damselfly Coenagrion johanssoni originating from semivoltine central, partivoltine northern, and partivoltine northernmost Swedish populations were reared in the laboratory. To investigate whether larvae use photoperiodic cues to induce compensatory growth along this latitudinal gradient, larvae were reared under two different photoperiods corresponding to a northern and southern latitude. In addition, field adult size was assessed to test the strength of possible compensatory growth mechanisms under natural conditions and hatchling size was measured to test for maternal effects. We hypothesized that populations originating from lower latitudes would be more time constrained than high-latitude populations because they have a shorter life cycle. The results showed that low-latitude populations had higher growth rates in summer/fall. In general northern photoperiods induced higher growth rates, but this plastic response to photoperiod was strongest in the southernmost populations and negligible in the northernmost population. During spring, central populations grew faster under the southern rather than the northern photoperiod. On the other hand, northern and northernmost populations did not differ between each other and grew faster in the northern rather than in the southern photoperiod. Field sampled adults did not differ in size across the studied regions. Conclusion/Significance: We found a significant differentiation in growth rate across latitudes and latitudinal difference in growth rate response to photoperiod. Importantly, growth responses measured at a single larval developmental stage in one season may not always generalize to other developmental stages or seasons.	[Sniegula, Szymon] Polish Acad Sci, Inst Nat Conservat, Dept Ecosyst Conservat, Krakow, Poland; [Nilsson-Ortman, Viktor; Johansson, Frank] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Johansson, Frank] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	Polish Academy of Sciences; Umea University; Uppsala University	Sniegula, S (corresponding author), Polish Acad Sci, Inst Nat Conservat, Dept Ecosyst Conservat, Krakow, Poland.	szymon.sniegula@gmail.com	Sniegula, Szymon/E-9588-2015; /AAG-2132-2019	Sniegula, Szymon/0000-0003-1459-3751; /0000-0003-1459-3751	Polish State Committee for Scientific Research grant [N N304 294237]; Swedish Research Council; Swedish Research Council FORMAS	Polish State Committee for Scientific Research grant(Polish State Committee for Scientific Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	We wish to thank Maria Golab for her great help with the laboratory work and Elzbieta Sniegula for her help in the field collection. We are very grateful to Prof. Gordon Pritchard and Kamila Zloty and two anonymous reviewers for helpful comments on the earlier version of the manuscript. SS is funded by a Polish State Committee for Scientific Research grant (Project No. N N304 294237).; Funding was provided by the Polish State Committee for Scientific Research grant (Project No. N N304 294237), Swedish Research Council, and Swedish Research Council FORMAS. SS is funded by a Polish State Committee for Scientific Research grant (Project No. N N304 294237). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Addo-Bediako A, 2002, FUNCT ECOL, V16, P332, DOI 10.1046/j.1365-2435.2002.00634.x; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BRADFORD MJ, 1995, OECOLOGIA, V103, P319, DOI 10.1007/BF00328620; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; CANNINGS SG, 1997, INSECTS YUKON, P169; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Cooper G, 1996, P ROY SOC B-BIOL SCI, V263, P1343, DOI 10.1098/rspb.1996.0197; Corbet P.S., 1972, Acta Arctica, V18, P1; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2003, Journal of the Entomological Society of British Columbia, V100, P3; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; CORBET PS, 1969, SCIENCE, V166, P865, DOI 10.1126/science.166.3907.865; Danks HV, 1987, INSECT DORMANCY ECOL; De Block M, 2003, J EVOLUTION BIOL, V16, P986, DOI 10.1046/j.1420-9101.2003.00581.x; De Block M, 2008, ECOGRAPHY, V31, P115, DOI 10.1111/j.2007.0906-7590.05313.x; Dijkstra K.-D.-B., 2006, FIELD GUIDE DRAGONFL; Dmitriew CM, 2011, BIOL REV, V86, P97, DOI 10.1111/j.1469-185X.2010.00136.x; FINCKE OM, 1984, BEHAV ECOL SOCIOBIOL, V14, P235, DOI 10.1007/BF00299623; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gotthard K, 2001, EXPTL BIOL REV, P287; GOTTHARD K, 1995, OIKOS, V74, P3, DOI 10.2307/3545669; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; Johansson F., 1994, Odonatologica, V23, P355; Johansson F, 1999, ECOLOGY, V80, P1242, DOI 10.2307/177071; Johansson F, 2010, ODONATOLOGICA, V39, P97; Johansson F, 2001, ECOLOGY, V82, P1857, DOI 10.1890/0012-9658(2001)082[1857:LHPIAD]2.0.CO;2; Kidokoro T, 1978, JPN J ECOL, V29, P291; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; Lowe CD, 2009, ECOLOGY, V90, P2202, DOI 10.1890/08-1780.1; LUTZ PE, 1964, BIOL BULL, V127, P304, DOI 10.2307/1539228; Nicieza A, 2009, OECOLOGIA, V159, P27, DOI 10.1007/s00442-008-1194-8; Nilsson-Ortman V, 2012, ECOLOGY, V93, P1340; Norling U., 1984, Advances in Odonatology, V2, P127; NORLING U, 1984, Odonatologica, V13, P429; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pritchard G, 1996, BIOL J LINN SOC, V58, P221, DOI 10.1111/j.1095-8312.1996.tb01432.x; Pritchard G., 1982, Advances in Odonatology, V1, P227; PROCTER DLC, 1973, CAN J ZOOL, V51, P1165, DOI 10.1139/z73-169; R Development Core Team, 2008, R LANG ENG STAT COMP; Ragland GJ, 2007, J EVOLUTION BIOL, V20, P2144, DOI 10.1111/j.1420-9101.2007.01428.x; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Roff Derek, 2002, pi; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Shama LNS, 2011, MOL ECOL, V20, P2929, DOI 10.1111/j.1365-294X.2011.05156.x; Sniegula S, 2012, OIKOS, V121, P1073, DOI 10.1111/j.1600-0706.2011.20015.x; Sniegula S, 2010, ECOL ENTOMOL, V35, P149, DOI 10.1111/j.1365-2311.2009.01164.x; Sokolovska N, 2000, ECOL ENTOMOL, V25, P239, DOI 10.1046/j.1365-2311.2000.00251.x; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Stoks R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016935; Strobbe F, 2004, BIOL J LINN SOC, V83, P187, DOI 10.1111/j.1095-8312.2004.00379.x; Thompson DJ, 2011, ECOL LETT, V14, P905, DOI 10.1111/j.1461-0248.2011.01655.x; Thompson DJ, 2002, ECOL ENTOMOL, V27, P378, DOI 10.1046/j.1365-2311.2002.00419.x; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Van Doorslaer W, 2005, OIKOS, V111, P599, DOI 10.1111/j.1600-0706.2005.14335.x; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	65	25	26	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46024	10.1371/journal.pone.0046024	http://dx.doi.org/10.1371/journal.pone.0046024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029371	Green Published, gold			2022-12-25	WOS:000309392800131
J	Correa, RFT; Ardisson-Araujo, DMP; Monnerat, RG; Ribeiro, BM				Teixeira Correa, Roberto Franco; Pereira Ardisson-Araujo, Daniel Mendes; Monnerat, Rose Gomes; Ribeiro, Bergmann Morais			Cytotoxicity Analysis of Three Bacillus thuringiensis Subsp israelensis delta-Endotoxins towards Insect and Mammalian Cells	PLOS ONE			English	Article							MOSQUITO-LARVICIDAL ACTIVITY; CRYSTAL PROTEINS; CYTOLYTIC TOXIN; GENE; TOXICITY; CRY11A; IDENTIFICATION; ESTABLISHMENT; ORGANIZATION; PARASPORIN	Three members of the delta-endotoxin group of toxins expressed by Bacillus thuringiensis subsp. israelensis, Cyt2Ba, Cry4Aa and Cry11A, were individually expressed in recombinant acrystalliferous B. thuringiensis strains for in vitro evaluation of their toxic activities against insect and mammalian cell lines. Both Cry4Aa and Cry11A toxins, activated with either trypsin or Spodoptera frugiperda gastric juice (GJ), resulted in different cleavage patterns for the activated toxins as seen by SDS-PAGE. The GJ-processed proteins were not cytotoxic to insect cell cultures. On the other hand, the combination of the trypsinactivated Cry4Aa and Cry11A toxins yielded the highest levels of cytotoxicity to all insect cells tested. The combination of activated Cyt2Ba and Cry11A also showed higher toxic activity than that of toxins activated individually. When activated Cry4Aa, Cry11A and Cyt2Ba were used simultaneously in the same assay a decrease in toxic activity was observed in all insect cells tested. No toxic effect was observed for the trypsin-activated Cry toxins in mammalian cells, but activated Cyt2Ba was toxic to human breast cancer cells (MCF-7) when tested at 20 mu g/mL.	[Teixeira Correa, Roberto Franco; Pereira Ardisson-Araujo, Daniel Mendes; Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Monnerat, Rose Gomes] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Ribeiro, BM (corresponding author), Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil.	bergmann@unb.br	Ribeiro, Bergmann Morais/C-7114-2015; Ardisson-Araújo, Daniel Mendes Pereira/AAM-6320-2020	Ribeiro, Bergmann Morais/0000-0002-1061-196X; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; Fundacao de Apoio a Pesquisa do Distrito	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (www.cnpq.br) and Fundacao de Apoio a Pesquisa do Distrito Federal-FAPDF (www.fap.df.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGSUTHANASOMBAT C, 1992, FEMS MICROBIOL LETT, V94, P63, DOI 10.1111/j.1574-6968.1992.tb05290.x; Angsuthanasombat C, 2004, J BIOCHEM MOL BIOL, V37, P304; BENDOV E, 1995, J BACTERIOL, V177, P2851, DOI 10.1128/jb.177.10.2851-2857.1995; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Bravo A, 2001, METODOLOGIAS UTILIZA; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Butko P, 2003, APPL ENVIRON MICROB, V69, P2415, DOI 10.1128/AEM.69.5.2415-2422.2003; Carmona D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019952; CHANG C, 1993, APPL ENVIRON MICROB, V59, P815, DOI 10.1128/AEM.59.3.815-821.1993; Cheong HS, 1997, APPL ENVIRON MICROB, V63, P3254, DOI 10.1128/AEM.63.8.3254-3260.1997; CHILCOTT CN, 1988, J GEN MICROBIOL, V134, P2551; CHRISTELLER JT, 1990, INSECT BIOCHEM, V20, P157, DOI 10.1016/0020-1790(90)90008-I; COOK RJ, 1993, ANNU REV PHYTOPATHOL, V31, P53, DOI 10.1146/annurev.py.31.090193.000413; Crickmore N, 2006, J APPL MICROBIOL, V101, P616, DOI 10.1111/j.1365-2672.2006.02936.x; CRICKMORE N, 1990, BIOCHEM J, V270, P133, DOI 10.1042/bj2700133; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Estruch JJ, 1997, NAT BIOTECHNOL, V15, P137, DOI 10.1038/nbt0297-137; Finney D.J., 1971, PROBIT ANAL; Gerber D, 2000, J BIOL CHEM, V275, P23602, DOI 10.1074/jbc.M002596200; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GRACE TDC, 1967, NATURE, V216, P613, DOI 10.1038/216613a0; Gringorten JL, 1999, IN VITRO CELL DEV-AN, V35, P299, DOI 10.1007/s11626-999-0075-8; Guerchicoff A, 1997, APPL ENVIRON MICROB, V63, P2716, DOI 10.1128/AEM.63.7.2716-2721.1997; HOFTE H, 1989, MICROBIOL REV, V53, P242; Hughes PA, 2005, J INVERTEBR PATHOL, V88, P34, DOI 10.1016/j.jip.2004.10.004; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; KNOWLES BH, 1992, P ROY SOC B-BIOL SCI, V248, P1, DOI 10.1098/rspb.1992.0035; Li J, 1996, J MOL BIOL, V257, P129, DOI 10.1006/jmbi.1996.0152; MCCLINTOCK JT, 1986, J VIROL, V57, P197, DOI 10.1128/JVI.57.1.197-204.1986; Mizuki E, 1999, J APPL MICROBIOL, V86, P477, DOI 10.1046/j.1365-2672.1999.00692.x; Mizuki E, 2000, CLIN DIAGN LAB IMMUN, V7, P625, DOI 10.1128/CDLI.7.4.625-634.2000; Moreira Beltrao HDB, 2007, FEMS MICROBIOL LETT, V266, P163, DOI 10.1111/j.1574-6968.2006.00527.x; Ohba M, 2009, ANTICANCER RES, V29, P427; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; PONCET S, 1995, J INVERTEBR PATHOL, V66, P131, DOI 10.1006/jipa.1995.1075; Pootanakit K, 2003, J BIOCHEM MOL BIOL, V36, P508; Promdonkoy B, 2003, CURR MICROBIOL, V46, P94, DOI 10.1007/s00284-002-3823-5; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauka DH, 2007, J INVERTEBR PATHOL, V94, P125, DOI 10.1016/j.jip.2006.09.002; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; THOMAS WE, 1983, J CELL SCI, V60, P181; Uawithya P, 1998, BIOCHEM MOL BIOL INT, V44, P825; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Vilchez S, 2004, APPL ENVIRON MICROB, V70, P6587, DOI 10.1128/AEM.70.11.6587-6594.2004; WARD ES, 1987, NUCLEIC ACIDS RES, V15, P7195, DOI 10.1093/nar/15.17.7195; WHO, 1996, WORLD HLTH REP 1996, P46; Wirth MC, 1997, P NATL ACAD SCI USA, V94, P10536, DOI 10.1073/pnas.94.20.10536; Wirth MC, 2005, APPL ENVIRON MICROB, V71, P185, DOI 10.1128/AEM.71.1.185-189.2005; Xu Y, 2001, APPL ENVIRON MICROB, V67, P3010, DOI 10.1128/AEM.67.7.3010-3015.2001; Yamagiwa M, 2004, BIOSCI BIOTECH BIOCH, V68, P523, DOI 10.1271/bbb.68.523; Yousten A A, 1984, Adv Biotechnol Processes, V3, P315	56	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e46121	10.1371/journal.pone.0046121	http://dx.doi.org/10.1371/journal.pone.0046121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029407	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800134
J	Sarkis, J; Vie, V; Winder, SJ; Renault, A; Le Rumeur, E; Hubert, JF				Sarkis, Joe; Vie, Veronique; Winder, Steve J.; Renault, Anne; Le Rumeur, Elisabeth; Hubert, Jean-Francois			Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness	FASEB JOURNAL			English	Article						actin-binding domain; rheology; spectrin-like repeats; lipid-protein interactions	CYTOPLASMIC GAMMA-ACTIN; ROD DOMAIN; LIPID MONOLAYERS; BINDING DOMAIN; SHEAR RHEOLOGY; UTROPHIN; STABILITY; MUSCLE; MODEL; FILAMENTS	Dystrophin is an essential part of a membrane protein complex that provides flexible support to muscle fiber membranes. Loss of dystrophin function leads to membrane fragility and muscle-wasting disease. Given the importance of cytoskeletal interactions in strengthening the sarcolemma, we have focused on actin-binding domain 2 of human dystrophin, constituted by repeats 11 to 15 of the central domain (DYS R11-15). We previously showed that DYS R11-15 also interacts with membrane lipids. We investigated the shear elastic constant (mu) and the surface viscosity (eta(s)) of Langmuir phospholipid monolayers mimicking the inner leaflet of the sarcolemma in the presence of DYS R11-15 and actin. The initial interaction of 100 nM DYS R11-15 with the monolayers slightly modifies their rheological properties. Injection of 0.125 mu M filamentous actin leads to a strong increase of mu and eta(s), from 0 to 5.5 mN/m and 2.4 x 10(-4) N . s/m, respectively. These effects are specific to DYS R11-15, require filamentous actin, and depend on phospholipid nature and lateral surface pressure. These findings suggest that the central domain of dystrophin contributes significantly to the stiffness and the stability of the sarcolemma through its simultaneous interactions with the cytoskeleton and lipid membrane. This mechanical link is likely to be a major contributing factor to the shock absorber function of dystrophin and muscle sarcolemmal integrity on mechanical stress.-Sarkis, J., Vie, V., Winder, S. J., Renault, A., Le Rumeur, E., Hubert, J.-F. Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness. FASEB J. 27, 359-367 (2013). www.fasebj.org	[Sarkis, Joe; Vie, Veronique; Renault, Anne; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Europeenne Bretagne, Rennes, France; [Sarkis, Joe; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Fac Med, CNRS, UMR, Inst Genet Dev Rennes, F-35043 Rennes, France; [Sarkis, Joe; Vie, Veronique; Renault, Anne; Le Rumeur, Elisabeth; Hubert, Jean-Francois] Univ Rennes 1, Rennes, France; [Sarkis, Joe; Vie, Veronique; Renault, Anne] Inst Phys Rennes, CNRS, UMR, Rennes, France; [Winder, Steve J.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); University of Sheffield	Hubert, JF (corresponding author), Fac Med, CNRS, UMR 6290, Equipe Struct & Interact Mol, CS 34317,2 Av Pr Leon Bernard, F-35043 Rennes, France.	jfhubert@univ-rennes1.fr		Sarkis, Joe/0000-0002-9342-7198	Association Francaise contre les Myopathies; GIS-BRESMAT-Conseil Regional de Bretagne; French Minister of Research	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); GIS-BRESMAT-Conseil Regional de Bretagne(Region Bretagne); French Minister of Research	The authors thank Dr. Isabelle Cantat for help with the theoretical data treatment and for critically reading the manuscript. This work was supported by the Association Francaise contre les Myopathies and by GIS-BRESMAT-Conseil Regional de Bretagne. J.S. was the recipient of a doctoral fellowship from the French Minister of Research. The authors thank Christophe Tascon, Angelique Cheron, Adam Smith, Ellen Allwood, Gilles Paboeuf, and Estelle Robert for technical assistance; Aurelie Nicolas for the Becker Muscular Dystrophy database; the Centre de Biochimie des Proteines (UMR-CNRS 6290; Rennes, France); and the Centre de Microscopie Electronique (Biosit, University of Rennes 1, Rennes, France).	Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Deme B, 2000, EUR PHYS J E, V2, P125, DOI 10.1007/s101890050046; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; Espinosa G, 2011, P NATL ACAD SCI USA, V108, P6008, DOI 10.1073/pnas.1018572108; FIEHN W, 1971, J BIOL CHEM, V246, P5617; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Hanft LM, 2006, P NATL ACAD SCI USA, V103, P5385, DOI 10.1073/pnas.0600980103; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Helfer E, 2000, PHYS REV LETT, V85, P457, DOI 10.1103/PhysRevLett.85.457; Henderson DM, 2012, J MOL BIOL, V416, P414, DOI 10.1016/j.jmb.2011.12.040; Henderson DM, 2011, HUM MOL GENET, V20, P2955, DOI 10.1093/hmg/ddr199; Isanta S, 2011, SOFT MATTER, V7, P3100, DOI 10.1039/c0sm00880j; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Le Floch-Fouere C, 2010, FOOD HYDROCOLLOID, V24, P275, DOI 10.1016/j.foodhyd.2009.10.006; Le Rumeur E, 2003, J BIOL CHEM, V278, P5993, DOI 10.1074/jbc.M207321200; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Legardinier S, 2008, BBA-PROTEINS PROTEOM, V1784, P672, DOI 10.1016/j.bbapap.2007.12.014; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Legrand B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023819; Limozin L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178101; Limozin L, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.168103; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Lodish H, 2000, MOL CELL BIOL; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Marsh D, 2006, BIOPHYS J, V91, P227, DOI 10.1529/biophysj.105.079004; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; Roberts SA, 2005, INT J PHARM, V300, P48, DOI 10.1016/j.ijpharm.2005.05.003; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2005, J BIOL CHEM, V280, P23018, DOI 10.1074/jbc.M502530200; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Rybakova IN, 1997, J BIOL CHEM, V272, P28771, DOI 10.1074/jbc.272.45.28771; Sarkis J, 2011, J BIOL CHEM, V286, P30481, DOI 10.1074/jbc.M111.243881; Sengupta K, 2006, LANGMUIR, V22, P5776, DOI 10.1021/la053310+; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Venien-Bryan C, 1998, BIOPHYS J, V74, P2649, DOI 10.1016/S0006-3495(98)77970-6; Vie V, 2010, BBA-BIOMEMBRANES, V1798, P1503, DOI 10.1016/j.bbamem.2010.04.005; WEGNER A, 1982, J MOL BIOL, V161, P607, DOI 10.1016/0022-2836(82)90411-9; WINDER SJ, 1995, J CELL SCI, V108, P63; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S	44	13	13	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					359	367		10.1096/fj.12-208967	http://dx.doi.org/10.1096/fj.12-208967			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23033320				2022-12-25	WOS:000313103200034
J	Kir, S; Zhang, Y; Gerard, RD; Kliewer, SA; Mangelsdorf, DJ				Kir, Serkan; Zhang, Yuan; Gerard, Robert D.; Kliewer, Steven A.; Mangelsdorf, David J.			Nuclear Receptors HNF4 alpha and LRH-1 Cooperate in Regulating Cyp7a1 in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID BIOSYNTHESIS; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; NEGATIVE FEEDBACK-REGULATION; HETERODIMER PARTNER; LIPID HOMEOSTASIS; FACTOR 4-ALPHA; X-RECEPTOR; SHP; TRANSCRIPTION; LIVER	Fibroblast growth factor 19 (FGF19) is a postprandial enterokine induced by the nuclear bile acid receptor, FXR, in ileum. FGF19 inhibits bile acid synthesis in liver through transcriptional repression of cholesterol 7 alpha-hydroxylase (CYP7A1) via a mechanism involving the nuclear receptor SHP. Here, in a series of loss-of-function studies, we show that the nuclear receptors HNF4 alpha and LRH-1 have dual roles in regulating Cyp7a1 in vivo. First, they cooperate in maintaining basal Cyp7a1 expression. Second, they enable SHP binding to the Cyp7a1 promoter and facilitate FGF19-mediated repression of bile acid synthesis. HNF4 alpha and LRH-1 promote active transcription histone marks on the Cyp7a1 promoter that are reversed by FGF19 in a SHP-dependent manner. These findings demonstrate that both HNF4 alpha and LRH-1 are important regulators of Cyp7a1 transcription in vivo.	[Kir, Serkan; Zhang, Yuan; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kliewer, SA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu		Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute; National Institutes of Health [DK67158, DK62434]; Robert A. Welch Foundation [I-1275, I-1588]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067158, U19DK062434] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Howard Hughes Medical Institute (to D. J. M.), the National Institutes of Health (Grants DK67158 and DK62434, to S. A. K. and D. J. M.), and the Robert A. Welch Foundation (I-1275, to D. J. M. and I-1588, to S. A. K.).	Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200; del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Fang SS, 2007, MOL CELL BIOL, V27, P1407, DOI 10.1128/MCB.00944-06; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Kemper JK, 2004, MOL CELL BIOL, V24, P7707, DOI 10.1128/MCB.24.17.7707-7719.2004; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200; Kir S, 2011, COLD SH Q B, V76, P139, DOI 10.1101/sqb.2011.76.010710; Lee FY, 2006, TRENDS BIOCHEM SCI, V31, P572, DOI 10.1016/j.tibs.2006.08.002; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660; Potthoff MJ, 2011, CELL METAB, V13, P729, DOI 10.1016/j.cmet.2011.03.019; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stroup D, 2000, J LIPID RES, V41, P1; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9	29	92	99	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41334	41341		10.1074/jbc.M112.421834	http://dx.doi.org/10.1074/jbc.M112.421834			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23038264	Green Published, hybrid			2022-12-25	WOS:000311887600047
J	Cardoso, S; Lau, W; Dias, JE; Fevereiro, P; Maniatis, N				Cardoso, Silvana; Lau, Winston; Dias, Jose Eiras; Fevereiro, Pedro; Maniatis, Nikolas			A Candidate-Gene Association Study for Berry Colour and Anthocyanin Content in Vitis vinifera L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; PROANTHOCYANIDIN BIOSYNTHESIS; TRANSCRIPTION FACTOR; POPULATION-STRUCTURE; GRAPE BERRIES; MIXED-MODEL; EXPRESSION; PATHWAY; DISEASE; FRUIT	Anthocyanin content is a trait of major interest in Vitis vinifera L. These compounds affect grape and wine quality, and have beneficial effects on human health. A candidate-gene approach was used to identify genetic variants associated with anthocyanin content in grape berries. A total of 445 polymorphisms were identified in 5 genes encoding transcription factors and 10 genes involved in either the biosynthetic pathway or transport of anthocyanins. A total of 124 SNPs were selected to examine association with a wide range of phenotypes based on RP-HPLC analysis and visual characterization. The phenotypes were total skin anthocyanin (TSA) concentration but also specific types of anthocyanins and relative abundance. The visual assessment was based on OIV (Organisation Internationale de la Vigne et du Vin) descriptors for berry and skin colour. The genes encoding the transcription factors MYB11, MYBCC and MYCB were significantly associated with TSA concentration. UFGT and MRP were associated with several different types of anthocyanins. Skin and pulp colour were associated with nine genes (MYB11, MYBCC, MYCB, UFGT, MRP, DFR, LDOX, CHI and GST). Pulp colour was associated with a similar group of 11 genes (MYB11, MYBCC, MYCB, MYCA, UFGT, MRP, GST, DFR, LDOX, CHI and CHSA). Statistical interactions were observed between SNPs within the transcription factors MYB11, MYBCC and MYCB. SNPs within LDOX interacted with MYB11 and MYCB, while SNPs within CHI interacted with MYB11 only. Together, these findings suggest the involvement of these genes in anthocyanin content and on the regulation of anthocyanin biosynthesis. This work forms a benchmark for replication and functional studies.	[Cardoso, Silvana; Fevereiro, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Plant Cell Biotechnol, Oeiras, Portugal; [Cardoso, Silvana; Lau, Winston; Maniatis, Nikolas] UCL, Dept Genet Evolut & Environm, London, England; [Dias, Jose Eiras] Inst Nacl Recursos Biol, Inst Nacl Invest Agr, Dois Portos, Portugal	Universidade Nova de Lisboa; University of London; University College London	Cardoso, S (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Plant Cell Biotechnol, Oeiras, Portugal.	silvana@itqb.unl.pt	Fevereiro, Pedro/A-2447-2010; Eiras-Dias, José J.E./B-5382-2016	Fevereiro, Pedro/0000-0003-1311-8406; Eiras-Dias, José J.E./0000-0001-7997-8199; Maniatis, Nikolas/0000-0002-6567-5936; Lau, Winston/0000-0001-5501-4619	Fundacao para a Ciencia e a Tecnolgia [SFRH/BD/29379/2006]; European Commission 6th Framework Programme for research [ERA-PG 074B GRASP GRAPE WINE]	Fundacao para a Ciencia e a Tecnolgia; European Commission 6th Framework Programme for research	This work was supported by the Fundacao para a Ciencia e a Tecnolgia (grant number SFRH/BD/29379/2006) and by the European Commission 6th Framework Programme for research (grant number ERA-PG 074B GRASP GRAPE WINE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageorges A, 2006, PLANT SCI, V170, P372, DOI 10.1016/j.plantsci.2005.09.007; Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; [Anonymous], 1998, BUSINESS MEDIA, DOI DOI 10.1007/978-94-009-5570-7; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Brouillard R., 1982, ANTHOCYANINS FOOD CO, P1, DOI [10.1016/b978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.50005-6, DOI 10.1016/B978-0-12-472550-8.X5001-X]; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; CHAKRABORTY R, 1993, HUM BIOL, V65, P875; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cortell JM, 2006, J AGR FOOD CHEM, V54, P8510, DOI 10.1021/jf0616560; Cutanda-Perez MC, 2009, PLANT MOL BIOL, V69, P633, DOI 10.1007/s11103-008-9446-x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Doligez A, 2006, MOL BREEDING, V18, P109, DOI 10.1007/s11032-006-9016-3; Doligez A, 2002, THEOR APPL GENET, V105, P780, DOI 10.1007/s00122-002-0951-z; Downey MO, 2006, AM J ENOL VITICULT, V57, P257; Eder A, 2000, FOOD ANAL HPLC, P845; Evanno G RS, 2005, MOL ECOL, V14, P10; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fournier-Level A, 2009, GENETICS, V183, P1127, DOI 10.1534/genetics.109.103929; Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gollop R, 2002, J EXP BOT, V53, P1397, DOI 10.1093/jexbot/53.373.1397; Gollop R, 2001, PLANT SCI, V161, P579, DOI 10.1016/S0168-9452(01)00445-9; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kobayashi S, 2001, PLANT SCI, V160, P543, DOI 10.1016/S0168-9452(00)00425-8; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; MANTEL N, 1967, CANCER RES, V27, P209; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; OIV, 2009, REC METH INT AN VINS; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2009, DOCUMENTATION STRUCT; Quattrocchio F, 1998, PLANT J, V13, P475, DOI 10.1046/j.1365-313X.1998.00046.x; Ribereau-Gayon P., 1982, ANTHOCYANINS FOOD CO, P209; Ritland K, 1996, EVOLUTION, V50, P1062, DOI [10.2307/2410647, 10.1111/j.1558-5646.1996.tb02347.x]; Rozen S, 2000, Methods Mol Biol, V132, P365; Saito K, 2002, NEW PHYTOL, V155, P9, DOI 10.1046/j.1469-8137.2002.00440.x; Salmaso M, 2008, THEOR APPL GENET, V116, P1129, DOI 10.1007/s00122-008-0741-3; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Stuber CW, 1999, CROP SCI, V39, P1571, DOI 10.2135/cropsci1999.3961571x; Terrier N, 2009, PLANT PHYSIOL, V149, P1028, DOI 10.1104/pp.108.131862; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2009, BRIEF BIOINFORM, V10, P664, DOI 10.1093/bib/bbp050; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	57	29	31	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46021	10.1371/journal.pone.0046021	http://dx.doi.org/10.1371/journal.pone.0046021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029369	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900073
J	Castro, OW; Santos, VR; Pun, RYK; McKlveen, JM; Batie, M; Holland, KD; Gardner, M; Garcia-Cairasco, N; Herman, JP; Danzer, SC				Castro, Olagide W.; Santos, Victor R.; Pun, Raymund Y. K.; McKlveen, Jessica M.; Batie, Matthew; Holland, Katherine D.; Gardner, Margaret; Garcia-Cairasco, Norberto; Herman, James P.; Danzer, Steve C.			Impact of Corticosterone Treatment on Spontaneous Seizure Frequency and Epileptiform Activity in Mice with Chronic Epilepsy	PLOS ONE			English	Article							SPONTANEOUS RECURRENT SEIZURES; LOW-DOSE CORTICOSTERONE; TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; CHRONIC STRESS; MINERALOCORTICOID RECEPTORS; KINDLING EPILEPTOGENESIS; GLUCOCORTICOID-RECEPTORS; STRUCTURAL PLASTICITY	Stress is the most commonly reported precipitating factor for seizures in patients with epilepsy. Despite compelling anecdotal evidence for stress-induced seizures, animal models of the phenomena are sparse and possible mechanisms are unclear. Here, we tested the hypothesis that increased levels of the stress-associated hormone corticosterone ( CORT) would increase epileptiform activity and spontaneous seizure frequency in mice rendered epileptic following pilocarpine-induced status epilepticus. We monitored video-EEG activity in pilocarpine-treated mice 24/7 for a period of four or more weeks, during which animals were serially treated with CORT or vehicle. CORT increased the frequency and duration of epileptiform events within the first 24 hours of treatment, and this effect persisted for up to two weeks following termination of CORT injections. Interestingly, vehicle injection produced a transient spike in CORT levels - presumably due to the stress of injection - and a modest but significant increase in epileptiform activity. Neither CORT nor vehicle treatment significantly altered seizure frequency; although a small subset of animals did appear responsive. Taken together, our findings indicate that treatment of epileptic animals with exogenous CORT designed to mimic chronic stress can induce a persistent increase in interictal epileptiform activity.	[McKlveen, Jessica M.; Herman, James P.; Danzer, Steve C.] Univ Cincinnati, Program Neurosci, Cincinnati, OH 45221 USA; [Castro, Olagide W.; Santos, Victor R.; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Physiol, BR-14049 Ribeirao Preto, SP, Brazil; [Batie, Matthew] Cincinnati Childrens Hosp, Med Ctr, Div Clin Engn, Cincinnati, OH USA; [Holland, Katherine D.] Cincinnati Childrens Hosp, Med Ctr, Div Neurol, Cincinnati, OH USA; [Pun, Raymund Y. K.; Danzer, Steve C.] Cincinnati Childrens Hosp, Med Ctr, Dept Anesthesia, Cincinnati, OH USA; [Gardner, Margaret; Danzer, Steve C.] Univ Cincinnati, Mol & Dev Biol Program, Cincinnati, OH USA; [McKlveen, Jessica M.; Herman, James P.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Anesthesia, Cincinnati, OH USA; [Danzer, Steve C.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Universidade de Sao Paulo; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Danzer, SC (corresponding author), Univ Cincinnati, Program Neurosci, Cincinnati, OH 45221 USA.	Steve.Danzer@cchmc.org	Santos, Victor R/Y-3257-2018; Herman, James P/D-4960-2015; Castro, Olagide/C-6781-2015; Cairasco, Norberto Garcia/E-3250-2015	Santos, Victor R/0000-0003-4979-3120; Herman, James P/0000-0003-3571-2406; Castro, Olagide/0000-0002-1874-509X; Cairasco, Norberto Garcia/0000-0001-8857-3775	Charles L. Shor Foundation for Epilepsy Research; National Institute of Neurological Disorders and Stroke [R01NS065020, R01NS062806]; Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062806, R01NS065020] Funding Source: NIH RePORTER	Charles L. Shor Foundation for Epilepsy Research; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Charles L. Shor Foundation for Epilepsy Research, the National Institute of Neurological Disorders and Stroke (SCD, Award Numbers R01NS065020 and R01NS062806) and the Brazilian foundations Programa de Excelencia Academica - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PROEX-CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2011, EXP GERONTOL, V46, P90, DOI 10.1016/j.exger.2010.08.023; Bajorat R, 2011, EPILEPSIA, V52, pE118, DOI 10.1111/j.1528-1167.2011.03200.x; Benkovic SA, 2009, NEUROTOXICOLOGY, V30, P965, DOI 10.1016/j.neuro.2009.07.005; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; Chang PS, 2011, J NEUROSCI METH, V201, P106, DOI 10.1016/j.jneumeth.2011.07.018; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Danzer SC, 2010, HIPPOCAMPUS, V20, P113, DOI 10.1002/hipo.20589; Drude S, 2011, LAB ANIMAL, V40, P119, DOI 10.1038/laban0411-119; EHLERS CL, 1979, ELECTROEN CLIN NEURO, V47, P404, DOI 10.1016/0013-4694(79)90156-1; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Engel J, 2003, NEUROLOGY, V60, P538, DOI 10.1212/01.WNL.0000055086.35806.2D; Erbayat-Altay E, 2007, EPILEPSIA, V48, P1470, DOI 10.1111/j.1528-1167.2007.01110.x; Evanson NK, 2010, J NEUROENDOCRINOL, V22, P846, DOI 10.1111/j.1365-2826.2010.02000.x; FUXE K, 1985, ENDOCRINOLOGY, V117, P1803, DOI 10.1210/endo-117-5-1803; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Goosens K.A., 2007, SOURCEBRAIN AGING MO; Hall CB, 2009, EPILEPSY BEHAV, V14, P472, DOI 10.1016/j.yebeh.2008.12.011; Haut SR, 2007, NEUROLOGY, V69, P1905, DOI 10.1212/01.wnl.0000278112.48285.84; Haut SR, 2012, EPILEPSY BEHAV, V23, P415, DOI 10.1016/j.yebeh.2012.02.007; Haut SR, 2009, NEUROL CLIN, V27, P925, DOI 10.1016/j.ncl.2009.06.002; Haut SR, 2003, EPILEPSY BEHAV, V4, P511, DOI 10.1016/S1525-5050(03)00182-3; Heinrichs SC, 2010, PROG NEURO-PSYCHOPH, V34, P808, DOI 10.1016/j.pnpbp.2009.11.002; HERMAN JP, 1993, CELL MOL NEUROBIOL, V13, P349, DOI 10.1007/BF00711577; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; HERMAN JP, 1989, MOL ENDOCRINOL, V3, P1886, DOI 10.1210/mend-3-11-1886; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Karst H, 1999, EUR J NEUROSCI, V11, P889, DOI 10.1046/j.1460-9568.1999.00495.x; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Lightman SL, 2008, J NEUROENDOCRINOL, V20, P880, DOI 10.1111/j.1365-2826.2008.01711.x; Longordo F, 2011, SLEEP, V34, P679, DOI 10.1093/sleep/34.5.679; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; MEANEY MJ, 1985, BRAIN RES, V328, P176, DOI 10.1016/0006-8993(85)91340-X; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003; Pavlides C, 1996, BRAIN RES, V738, P229, DOI 10.1016/S0006-8993(96)00776-7; Pavlides C, 2002, HIPPOCAMPUS, V12, P245, DOI 10.1002/hipo.1116; Pineda E, 2010, EPILEPSIA, V51, P110, DOI 10.1111/j.1528-1167.2010.02623.x; PRITCHARD PB, 1991, EPILEPSIA, V32, pS46; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RAO ML, 1989, NEUROENDOCRINOLOGY, V49, P33, DOI 10.1159/000125088; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Roberts AJ, 1995, PSYCHONEUROENDOCRINO, V20, P891, DOI 10.1016/0306-4530(95)00016-X; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; Sawyer NT, 2010, J CLIN NEUROPHYSIOL, V27, P445, DOI 10.1097/WNP.0b013e3181fe0573; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schridde U, 2004, PHARMACOL BIOCHEM BE, V78, P369, DOI 10.1016/j.pbb.2004.04.012; Selassie GRH, 2010, EPILEPSY BEHAV, V18, P267, DOI 10.1016/j.yebeh.2010.04.015; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; Taher TR, 2005, NEUROPSYCHOPHARMACOL, V30, P1610, DOI 10.1038/sj.npp.1300709; Talmi M, 1995, BRAIN RES, V704, P97, DOI 10.1016/0006-8993(95)01123-4; TEMKIN NR, 1984, EPILEPSIA, V25, P450, DOI 10.1111/j.1528-1157.1984.tb03442.x; Tolmacheva EA, 2012, HORM BEHAV, V61, P706, DOI 10.1016/j.yhbeh.2012.03.004; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Vyas A, 2002, J NEUROSCI, V22, P6810; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WEISS GK, 1993, NEUROSCI LETT, V157, P91, DOI 10.1016/0304-3940(93)90650-A; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Williams P, 2006, J NEUROSCI METH, V155, P39, DOI 10.1016/j.jneumeth.2005.12.035; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wolff M, 2005, EPILEPSIA, V46, P1661, DOI 10.1111/j.1528-1167.2005.00255.x; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	75	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46044	10.1371/journal.pone.0046044	http://dx.doi.org/10.1371/journal.pone.0046044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029379	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900078
J	Gui, J; Yue, Y; Chen, RZ; Xu, W; Xiong, SD				Gui, Jun; Yue, Yan; Chen, Ruizhen; Xu, Wei; Xiong, Sidong			A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-kappa B Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VIRAL MYOCARDITIS; VIRUS-INFECTION; ENZYME A20; COXSACKIEVIRUS; MICE; CARDIOMYOPATHY; INFLAMMATION; RESPONSES; CELLS	Background: Viral myocarditis, which is most prevalently caused by Coxsackievirus B3 (CVB3) infection, is a serious clinical condition characterized by cardiac inflammation. However, efficient therapies targeting inflammation are still lacking and much needed. A20, also known as tumor necrosis factor alpha induced protein 3 (TNFAIP3) is a key negative regulator of inflammation. But whether A20 may affect cardiac inflammation during acute viral myocarditis remains to be elucidated. The aim of this study was to investigate the potential protective effect of A20 on CVB3-induced myocarditis. Methodology/Principal Findings: Mice were intraperitoneally inoculated with CVB3 to establish acute viral myocarditis model. We found that the expression of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6 and monocyte chemotactic protein-1 (MCP-1) were markedly and persistently increased during the progression of CVB3-induced myocarditis, and positively correlated with the disease severity. Notably, intravenous injection in vivo with adenovirus expressed A20 (Ad-A20) remarkably reduced CVB3-induced pro-inflammatory cytokines production and alleviated the severity of myocarditis. Further, we observed that nuclear factor-kappaB (NF-kappa B) signaling which mediates inflammatory response was significantly inhibited in CVB3-infected mice with Ad-A20 treatment. Finally, we revealed that A20 was required to inhibit CVB3-induced NF-kappa B signaling by restricting TNF receptor associated factor 6 (TRAF6) ubiquitylation. Conclusion/Significance: This study demonstrates the protective role of A20 against CVB3-induced myocarditis, which may provide a new therapeutic strategy for the treatment of viral myocarditis.	[Gui, Jun; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yue, Yan; Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Yue, Yan; Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Chen, Ruizhen] Fudan Univ, Key Lab Viral Heart Dis, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Soochow University - China; Soochow University - China; Fudan University	Xiong, SD (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sdxiongfd@126.com		Gui, Jun/0000-0002-8022-1203	National Natural Science Foundation of China [81072413, 31070786, 30890141]; Jiangsu "Pan-Deng" Project [BK2010004]; Major State Basic Research Development Program of China [2013CB530501]; Shanghai Science and Technology Commission [10JC1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; Major State Basic Research Development Program of China(National Basic Research Program of China); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants of National Natural Science Foundation of China (81072413, 31070786, 30890141), Jiangsu "Pan-Deng" Project (BK2010004), Major State Basic Research Development Program of China (2013CB530501), Shanghai Science and Technology Commission grant (10JC1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badorff C, 2000, CIRCULATION, V102, P2276; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Calabrese F, 2003, CARDIOVASC RES, V60, P11, DOI 10.1016/S0008-6363(03)00475-9; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Corsten MF, 2012, TRENDS MOL MED, V18, P426, DOI 10.1016/j.molmed.2012.05.005; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Esfandiarei M, 2007, CELL MICROBIOL, V9, P2358, DOI 10.1111/j.1462-5822.2007.00964.x; Fairweather D, 2007, METHODS, V41, P118, DOI 10.1016/j.ymeth.2006.07.009; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Garmaroudi FS, 2010, P NATL ACAD SCI USA, V107, P17053, DOI 10.1073/pnas.1006478107; Gay RT, 2006, P NATL ACAD SCI USA, V103, P13825, DOI 10.1073/pnas.0605507103; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Kang NI, 2009, J IMMUNOL, V183, P1488, DOI 10.4049/jimmunol.0900163; KLINGEL K, 1993, SCAND J INFECT DIS, P79; Kupfer R, 2002, J IMMUNOL METHODS, V266, P155, DOI 10.1016/S0022-1759(02)00146-1; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leipner C, 2000, HERZ, V25, P245, DOI 10.1007/s000590050014; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; MATSUMORI A, 1994, BRIT HEART J, V72, P561; Matsumori A, 2004, EUR J HEART FAIL, V6, P137, DOI 10.1016/j.ejheart.2003.10.007; Onose A, 2006, EUR J PHARMACOL, V541, P198, DOI 10.1016/j.ejphar.2006.03.073; Pankuweit S, 2004, HERZ, V29, P788, DOI 10.1007/s00059-004-2626-9; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; YAMADA T, 1994, CIRCULATION, V89, P846, DOI 10.1161/01.CIR.89.2.846; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Yue Y, 2011, MOL IMMUNOL, V48, P706, DOI 10.1016/j.molimm.2010.11.018	49	56	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46515	10.1371/journal.pone.0046515	http://dx.doi.org/10.1371/journal.pone.0046515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029542	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900179
J	Valenza, F; Pizzocri, M; Salice, V; Chevallard, G; Fossali, T; Coppola, S; Froio, S; Polli, F; Gatti, S; Fortunato, F; Comi, GP; Gattinoni, L				Valenza, Franco; Pizzocri, Marta; Salice, Valentina; Chevallard, Giorgio; Fossali, Tommaso; Coppola, Silvia; Froio, Sara; Polli, Federico; Gatti, Stefano; Fortunato, Francesco; Comi, Giacomo P.; Gattinoni, Luciano			Sodium Bicarbonate Treatment during Transient or Sustained Lactic Acidemia in Normoxic and Normotensive Rats	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; BLOOD LACTATE LEVELS; METABOLIC-ACIDOSIS; SEPTIC SHOCK; PH; HEMODYNAMICS; HYPERLACTATEMIA; SUBSTRATE; VARIABLES; INCREASE	Introduction: Lactic acidosis is a frequent cause of poor outcome in the intensive care settings. We set up an experimental model of lactic acid infusion in normoxic and normotensive rats to investigate the systemic effects of lactic acidemia per se without the confounding factor of an underlying organic cause of acidosis. Methodology: Sprague Dawley rats underwent a primed endovenous infusion of L(+) lactic acid during general anesthesia. Normoxic and normotensive animals were then randomized to the following study groups (n = 8 per group): S) sustained infusion of lactic acid, S+B) sustained infusion+sodium bicarbonate, T) transient infusion, T+B transient infusion+sodium bicarbonate. Hemodynamic, respiratory and acid-base parameters were measured over time. Lactate pharmacokinetics and muscle phosphofructokinase enzyme's activity were also measured. Principal Findings: Following lactic acid infusion blood lactate rose (P<0.05), pH (P<0.05) and strong ion difference (P<0.05) drop. Some rats developed hemodynamic instability during the primed infusion of lactic acid. In the normoxic and normotensive animals bicarbonate treatment normalized pH during sustained infusion of lactic acid (from 7.22 +/- 0.02 to 7.36 +/- 0.04, P<0.05) while overshoot to alkalemic values when the infusion was transient (from 7.24 +/- 0.01 to 7.53 +/- 0.03, P<0.05). When acid load was interrupted bicarbonate infusion affected lactate wash-out kinetics (P<0.05) so that blood lactate was higher (2.9 +/- 1 mmol/l vs. 1.0 +/- 0.2, P<0.05, group T vs. T+B respectively). The activity of phosphofructokinase enzyme was correlated with blood pH (R2 = 0.475, P<0.05). Conclusions: pH decreased with acid infusion and rose with bicarbonate administration but the effects of bicarbonate infusion on pH differed under a persistent or transient acid load. Alkalization affected the rate of lactate disposal during the transient acid load.	[Valenza, Franco; Pizzocri, Marta; Salice, Valentina; Chevallard, Giorgio; Fossali, Tommaso; Coppola, Silvia; Froio, Sara; Polli, Federico; Gattinoni, Luciano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Anestesia Rianimaz Intens & Subinten, Milan, Italy; [Gatti, Stefano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Ric Chirurg Preclin, Milan, Italy; [Fortunato, Francesco; Comi, Giacomo P.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Sci Neurol, Ctr Dino Ferrari, Milan, Italy; [Valenza, Franco; Gatti, Stefano; Comi, Giacomo P.; Gattinoni, Luciano] Univ Milan, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Valenza, F (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Dipartimento Anestesia Rianimaz Intens & Subinten, Milan, Italy.	franco.valenza@unimi.it	Polli, Federico/AAB-9868-2022; Comi, Giacomo P/K-5702-2016; Fossali, Tommaso/HGD-3325-2022; Gatti, Stefano/AAE-3281-2022; Pizzocri, Marta/AAB-5888-2021; Gatti, Stefano/M-1780-2015	Comi, Giacomo P/0000-0002-1383-5248; Gatti, Stefano/0000-0003-2209-4338; Pizzocri, Marta/0000-0002-9058-5457; Gatti, Stefano/0000-0003-2209-4338; Valenza, Franco/0000-0003-0634-2282; Gattinoni, Luciano/0000-0001-5380-2494; Coppola, Silvia/0000-0001-9290-5090	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy	The study was funded by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUROMEH S, 1986, AM J PHYSIOL, V250, pF702, DOI 10.1152/ajprenal.1986.250.4.F702; ARIEFF AI, 1982, AM J PHYSIOL, V242, pF586, DOI 10.1152/ajprenal.1982.242.6.F586; Arieff AI, 1996, CURR ANAES CRIT CARE, V7, P182; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; BARON PG, 1978, CLIN SCI MOL MED, V55, P175, DOI 10.1042/cs0550175; BENJAMIN E, 1994, CRIT CARE MED, V22, P1616; Boyd JH, 2008, CURR OPIN CRIT CARE, V14, P379, DOI 10.1097/MCC.0b013e3283069d5c; BRODER G, 1964, SCIENCE, V143, P1457, DOI 10.1126/science.143.3613.1457; Cady L D Jr, 1973, Crit Care Med, V1, P75, DOI 10.1097/00003246-197303000-00003; Chiolero R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009; Chrusch C, 2002, J CRIT CARE, V17, P188, DOI 10.1053/jcrc.2002.35816; Chrusch C, 2000, AM J RESP CRIT CARE, V161, P517, DOI 10.1164/ajrccm.161.2.9902403; COOPER DJ, 1990, ANN INTERN MED, V112, P492, DOI 10.7326/0003-4819-112-7-492; COOPER DJ, 1993, AM REV RESPIR DIS, V148, P317, DOI 10.1164/ajrccm/148.2.317; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; DRUML W, 1991, CRIT CARE MED, V19, P1120, DOI 10.1097/00003246-199109000-00005; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; Gattinoni L, 2006, MINERVA ANESTESIOL, V72, P551; GRAF H, 1985, AM J PHYSIOL, V249, pF630, DOI 10.1152/ajprenal.1985.249.5.F630; GRAF H, 1985, SCIENCE, V227, P754, DOI 10.1126/science.3969564; Gunnerson KJ, 2006, CRIT CARE, V10, DOI 10.1186/cc3987; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; Hood VL, 1998, NEW ENGL J MED, V339, P819, DOI 10.1056/NEJM199809173391207; HOOD VL, 1983, MINER ELECTROL METAB, V9, P317; Jansen TC, 2008, CRIT CARE, V12, DOI 10.1186/cc7159; Khosravani H, 2009, CRIT CARE, V13, DOI 10.1186/cc7918; Kitano T, 2002, LIFE SCI, V72, P557, DOI 10.1016/S0024-3205(02)02251-8; Kraut Jeffrey A, 2006, Clin Exp Nephrol, V10, P111, DOI 10.1007/s10157-006-0408-9; Leverve X M, 1999, Curr Opin Clin Nutr Metab Care, V2, P165, DOI 10.1097/00075197-199903000-00013; Leverve XM, 2001, CURR OPIN CLIN NUTR, V4, P137, DOI 10.1097/00075197-200103000-00010; Levraut J, 2000, INTENS CARE MED, V26, P558, DOI 10.1007/s001340051204; Ling K H, 2010, METHOD ENZYMOL, P306; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHIEU D, 1991, CRIT CARE MED, V19, P1352, DOI 10.1097/00003246-199111000-00008; Miller BF, 2002, J PHYSIOL-LONDON, V544, P963, DOI 10.1113/jphysiol.2002.027128; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; OKAMOTO H, 1995, ACTA ANAESTH SCAND, V39, P79, DOI 10.1111/j.1399-6576.1995.tb05596.x; PAGLIASSOTTI MJ, 1990, AM J PHYSIOL, V258, pR903, DOI 10.1152/ajpregu.1990.258.4.R903; PARK R, 1982, J CLIN INVEST, V70, P853, DOI 10.1172/JCI110682; Pellerin L, 2003, NEUROCHEM INT, V43, P331, DOI 10.1016/S0197-0186(03)00020-2; Rachoin JS, 2011, J HOSP MED, V6, pE1, DOI 10.1002/jhm.703; RHEE KH, 1993, CHEST, V104, P913, DOI 10.1378/chest.104.3.913; ROTH DA, 1990, ARCH BIOCHEM BIOPHYS, V279, P386, DOI 10.1016/0003-9861(90)90506-T; SESTOFT L, 1986, CLIN SCI, V70, P19, DOI 10.1042/cs0700019; Tanaka M, 1996, BRIT J ANAESTH, V77, P408, DOI 10.1093/bja/77.3.408; Tanaka M, 1997, ANAESTH INTENS CARE, V25, P615, DOI 10.1177/0310057X9702500603; Valenza F, 2005, CRIT CARE, V9, P588, DOI 10.1186/cc3818; VITEK V, 1971, ANN SURG, V173, P308, DOI 10.1097/00000658-197102000-00021; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989	50	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46035	10.1371/journal.pone.0046035	http://dx.doi.org/10.1371/journal.pone.0046035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029373	Green Published, gold			2022-12-25	WOS:000309973900074
J	van Gent, M; Bart, MJ; van der Heide, HGJ; Heuvelman, KJ; Mooi, FR				van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.			Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; III SECRETION; VIRULENCE FACTORS; NEUTROPHIL RECRUITMENT; COMPARATIVE GENOMICS; PROTEIN PERTACTIN; TEMPORAL TRENDS; DISEASE BURDEN; GENE LOSS; VACCINE	Bordetella pertussis is the causative agent of pertussis, a highly contagious disease of the human respiratory tract. Despite high vaccination coverage, pertussis has resurged and has become one of the most prevalent vaccine-preventable diseases in developed countries. We have proposed that both waning immunity and pathogen adaptation have contributed to the persistence and resurgence of pertussis. Allelic variation has been found in virulence-associated genes coding for the pertussis toxin A subunit (ptxA), pertactin (prn), serotype 2 fimbriae (fim2), serotype 3 fimbriae (fim3) and the promoter for pertussis toxin (ptxP). In this study, we investigated how more than 60 years of vaccination has affected the Dutch B. pertussis population by combining data from phylogeny, genomics and temporal trends in strain frequencies. Our main focus was on the ptxA, prn, fim3 and ptxP genes. However, we also compared the genomes of 11 Dutch strains belonging to successful lineages. Our results showed that, between 1949 and 2010, the Dutch B. pertussis population has undergone as least four selective sweeps that were associated with small mutations in ptxA, prn, fim3 and ptxP. Phylogenetic analysis revealed a stepwise adaptation in which mutations accumulated clonally. Genomic analysis revealed a number of additional mutations which may have a contributed to the selective sweeps. Five large deletions were identified which were fixed in the pathogen population. However, only one was linked to a selective sweep. No evidence was found for a role of gene acquisition in pathogen adaptation. Our results suggest that the B. pertussis gene repertoire is already well adapted to its current niche and required only fine tuning to persist in the face of vaccination. Further, this work shows that small mutations, even single SNPs, can drive large changes in the populations of bacterial pathogens within a time span of six to 19 years.	[van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Mooi, FR (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	frits.mooi@rivm.nl						Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, INFECT IMMUN, V77, P1182, DOI 10.1128/IAI.01150-08; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2004, VACCINE, V22, P2122, DOI 10.1016/j.vaccine.2003.12.006; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; He QS, 2003, J INFECT DIS, V187, P1200, DOI 10.1086/368412; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hijnen M, 2007, VACCINE, V25, P5902, DOI 10.1016/j.vaccine.2007.05.039; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallonen T, 2011, INFECT GENET EVOL; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kerr JR, 1999, MICROB PATHOGENESIS, V27, P349, DOI 10.1006/mpat.1999.0307; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Lam C, 2012, INFECT GENET EVOL; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Martcheva M, 2008, J R SOC INTERFACE, V5, P3, DOI 10.1098/rsif.2007.0236; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Moerman L, 2006, ISRAEL MED ASSOC J, V8, P308; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Octavia S, 2011, MOL BIOL EVOL, V28, P707, DOI 10.1093/molbev/msq245; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Petersen RF, 2012, EMERG INFEC IN PRESS; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; Restif O, 2007, J R SOC INTERFACE, V4, P143, DOI 10.1098/rsif.2006.0167; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Streefland M, 2007, VACCINE, V25, P2994, DOI 10.1016/j.vaccine.2007.01.015; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; van Loo IHM, 1999, J INFECT DIS, V179, P915, DOI 10.1086/314690; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; Watanabe M, 2002, J HEALTH SCI, V48, P560, DOI 10.1248/jhs.48.560; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; Williamson P, 1996, FEMS IMMUNOL MED MIC, V13, P169, DOI 10.1016/0928-8244(95)00123-9; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11	78	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46407	10.1371/journal.pone.0046407	http://dx.doi.org/10.1371/journal.pone.0046407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029513	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900155
J	Sheng, XW; Reppel, M; Nguemo, F; Mohammad, FI; Kuzmenkin, A; Hescheler, J; Pfannkuche, K				Sheng, Xiaowu; Reppel, Michael; Nguemo, Filomain; Mohammad, Farooq Ibrahem; Kuzmenkin, Alexey; Hescheler, Juergen; Pfannkuche, Kurt			Human Pluripotent Stem Cell-Derived Cardiomyocytes: Response to TTX and Lidocain Reveals Strong Cell to Cell Variability	PLOS ONE			English	Article							CARDIAC MYOCYTES; HUMAN FIBROBLASTS; SODIUM CURRENT; NA+ CURRENT; GENERATION; MOUSE; INDUCTION; DIFFERENTIATION; TRANSPLANTATION; INTEGRATION	Stem cell derived cardiomyocytes generated either from human embryonic stem cells (hESC-CMs) or human induced pluripotent stem cells (hiPSC-CMs) hold great promise for the investigation of early developmental processes in human cardiomyogenesis and future cell replacement strategies. We have analyzed electrophysiological properties of hESC-CMs (HES2) and hiPSC-CMs, derived from reprogrammed adult foreskin fibroblasts that have previously been found to be highly similar in terms of gene expression. In contrast to the similarity found in the expression profile we found substantial differences in action potentials (APs) and sodium currents at late stage (day 60) of in vitro differentiation with higher sodium currents in hiPSC-CMs. Sensitivity to lidocain was considerably reduced in hESC-CMs as compared to hiPSC-CMs, and the effect could not be explained by differences in beating frequency. In contrast, sensitivity to tetrodotoxin (TTX) was higher in hESC-CMs suggesting different contributions of TTX-sensitive and TTX-resistant sodium channels to AP generation. These data point to physiological differences that are not necessarily detected by genomics. We conclude that novel pharmacological screening-assays using hiPSC-CMs need to be applied with some caution.	[Sheng, Xiaowu; Nguemo, Filomain; Mohammad, Farooq Ibrahem; Kuzmenkin, Alexey; Hescheler, Juergen; Pfannkuche, Kurt] Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany; [Sheng, Xiaowu] Huazhong Univ Sci & Technol, Coll Med, Dept Physiol, Wuhan 430074, Peoples R China; [Sheng, Xiaowu] Huazhong Univ Sci & Technol, Coll Med, German Chinese Stem Cell Ctr, Wuhan 430074, Peoples R China; [Reppel, Michael] Univ Lubeck, Med Clin 2, Lubeck, Germany; [Mohammad, Farooq Ibrahem] Al Nahrain Univ, Biotechnol Res Ctr, Baghdad, Iraq; [Pfannkuche, Kurt] Univ Cologne, Clin & Polyclin Paedriatr Cardiol, D-50931 Cologne, Germany	University of Cologne; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Lubeck; Al-Nahrain University; University of Cologne	Pfannkuche, K (corresponding author), Univ Cologne, Inst Neurophysiol, D-50931 Cologne, Germany.	kurt.pfannkuche@uni-koeln.de		Pfannkuche, Kurt Paul/0000-0002-4284-774X; Nguemo, Filomain/0000-0002-2236-6797	North Rhine Westphalian Stem Cell Network [314-40001110]; Maria Pesch Foundation	North Rhine Westphalian Stem Cell Network; Maria Pesch Foundation	This project was supported by a grant from The North Rhine Westphalian Stem Cell Network (Grant No. 314-40001110) to Kurt Pfannkuche and a grant from the Maria Pesch Foundation to Alexei Kuzmenkin and by Koln Fortune. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JL, 2000, J MOL CELL CARDIOL, V32, P1169, DOI 10.1006/jmcc.2000.1155; BKAILY G, 1991, J MOL CELL CARDIOL, V23, P25, DOI 10.1016/0022-2828(91)90036-L; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gupta MK, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-98; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Jonsson M.K., 2012, J MOL CELL CARDIOL; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lin XM, 2011, HEART RHYTHM, V8, P1923, DOI 10.1016/j.hrthm.2011.07.016; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Maltsev VA, 1998, CIRCULATION, V98, P2545, DOI 10.1161/01.CIR.98.23.2545; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Singla DK, 2011, MOL PHARMACEUT, V8, P1573, DOI 10.1021/mp2001704; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Laake LW, 2010, CELL MOL LIFE SCI, V67, P277, DOI 10.1007/s00018-009-0179-z; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	48	46	46	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45963	10.1371/journal.pone.0045963	http://dx.doi.org/10.1371/journal.pone.0045963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029342	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500049
J	Yilmaz, A; Zhang, XY; Chung, JT; Tan, SL; Holzer, H; Ao, A				Yilmaz, Ahmet; Zhang, Xiao Yun; Chung, Jin-Tae; Tan, Seang Lin; Holzer, Hananel; Ao, Asangla			Chromosome Segregation Analysis in Human Embryos Obtained from Couples Involving Male Carriers of Reciprocal or Robertsonian Translocation	PLOS ONE			English	Article							PREIMPLANTATION GENETIC DIAGNOSIS; IN-SITU HYBRIDIZATION; MEIOTIC SEGREGATION; MALE-INFERTILITY; CLEAVAGE DIVISIONS; SPERM; ABNORMALITIES; CYCLES; FISH; MOSAICISM	The objective of this study was to investigate the frequency and type of chromosome segregation patterns in cleavage stage embryos obtained from male carriers of Robertsonian (ROB) and reciprocal (REC) translocations undergoing preimplantation genetic diagnosis (PGD) at our reproductive center. We used FISH to analyze chromosome segregation in 308 day 3 cleavage stage embryos obtained from 26 patients. The percentage of embryos consistent with normal or balanced segregation (55.1% vs. 27.1%) and clinical pregnancy (62.5% vs. 19.2%) rates were higher in ROB than the REC translocation carriers. Involvement of non-acrocentric chromosome(s) or terminal breakpoint(s) in reciprocal translocations was associated with an increase in the percent of embryos consistent with adjacent 1 but with a decrease in 3: 1 segregation. Similar results were obtained in the analysis of nontransferred embryos donated for research. 3:1 segregation was the most frequent segregation type in both day 3 (31%) and spare (35%) embryos obtained from carriers of t(11;22)(q23;q11), the only non-random REC with the same breakpoint reported in a large number of unrelated families mainly identified by the birth of a child with derivative chromosome 22. These results suggest that chromosome segregation patterns in day 3 and nontransferred embryos obtained from male translocation carriers vary with the type of translocation and involvement of acrocentric chromosome(s) or terminal breakpoint(s). These results should be helpful in estimating reproductive success in translocation carriers undergoing PGD.	[Ao, Asangla] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Yilmaz, Ahmet; Zhang, Xiao Yun; Chung, Jin-Tae; Tan, Seang Lin; Holzer, Hananel] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Ao, A (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	asangla.ao@muhc.mcgill.ca	ao, asangla/Q-5454-2019; Holzer, Hananel/AAJ-1059-2020	Holzer, Hananel/0000-0001-8565-6145; Yilmaz, Ahmet/0000-0002-4010-8599				Alves C, 2002, PRENATAL DIAG, V22, P1153, DOI 10.1002/pd.503; Armstrong SJ, 2000, AM J HUM GENET, V67, P601, DOI 10.1086/303052; Benet J, 2005, CYTOGENET GENOME RES, V111, P281, DOI 10.1159/000086901; Bielanska M, 2002, HUM REPROD, V17, P413, DOI 10.1093/humrep/17.2.413; Bielanska M, 2005, FERTIL STERIL, V84, P336, DOI 10.1016/j.fertnstert.2005.03.031; Bint SM, 2011, HUM REPROD, V26, P1575, DOI 10.1093/humrep/der080; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Colls P, 2012, REPROD BIOMED ONLINE, V24, P621, DOI 10.1016/j.rbmo.2012.02.006; Conn CM, 1998, HUM GENET, V102, P117, DOI 10.1007/s004390050663; Coonen E, 2000, MOL HUM REPROD, V6, P199, DOI 10.1093/molehr/6.3.199; Delhanty JDA, 1995, HUM REPROD UPDATE, V1, P201, DOI 10.1093/humupd/1.3.201; Delhanty JDA, 1997, HUM GENET, V99, P755, DOI 10.1007/s004390050443; Dohle GR, 2005, EUR UROL, V48, P703, DOI 10.1016/j.eururo.2005.06.002; Escudero T, 2003, FERTIL STERIL, V79, P1528, DOI 10.1016/S0015-0282(03)00252-8; Escudero T, 2000, PRENATAL DIAG, V20, P599, DOI 10.1002/1097-0223(200007)20:7<599::AID-PD883>3.3.CO;2-H; Estop AM, 1999, HUM GENET, V104, P412, DOI 10.1007/s004390050977; Frydman N, 2001, HUM REPROD, V16, P2274, DOI 10.1093/humrep/16.11.2274; Gardner RJM, 2004, CHROMOSOME ABNORMALI, P388; Harper JC, 2010, HUM REPROD, V25, P2685, DOI 10.1093/humrep/deq228; Huang J, 2009, PRENATAL DIAG, V29, P1167, DOI 10.1002/pd.2376; Irvine DS, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.suppl_1.33; Iwarsson E, 2000, PRENATAL DIAG, V20, P1038, DOI 10.1002/1097-0223(200012)20:13<1038::AID-PD976>3.3.CO;2-#; Jin H, 2010, FERTIL STERIL, V93, P1061, DOI 10.1016/j.fertnstert.2008.11.020; Ko DS, 2010, AM J MED GENET A, V152A, P1428, DOI 10.1002/ajmg.a.33368; Kovaleva NV, 2003, AM J MED GENET A, V121A, P180, DOI 10.1002/ajmg.a.20156; Lim CK, 2008, FERTIL STERIL, V90, P2144, DOI 10.1016/j.fertnstert.2007.10.035; Lledo B, 2010, HUM REPROD, V25, P1843, DOI 10.1093/humrep/deq111; Morel F, 2004, INT J ANDROL, V27, P200, DOI 10.1111/j.1365-2605.2004.00490.x; Munne S, 1997, HUM REPROD, V12, P780, DOI 10.1093/humrep/12.4.780; Munne S, 2005, CYTOGENET GENOME RES, V111, P305, DOI 10.1159/000086904; Munne S, 1998, HUM REPROD UPDATE, V4, P842, DOI 10.1093/humupd/4.6.842; Munne Santiago, 2002, Reprod Biomed Online, V4, P183; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; Ogilvie CM, 2002, EUR J HUM GENET, V10, P801, DOI 10.1038/sj.ejhg.5200895; Poongothai J, 2009, SINGAP MED J, V50, P336; Raghavan M, 2005, CANCER RES, V65, P375; Roux C, 2005, CYTOGENET GENOME RES, V111, P291, DOI 10.1159/000086902; Scriven PN, 1998, PRENATAL DIAG, V18, P1437, DOI 10.1002/(SICI)1097-0223(199812)18:13<1437::AID-PD497>3.3.CO;2-G; Scriven PN, 2001, HUM REPROD, V16, P2267, DOI 10.1093/humrep/16.11.2267; Shi QH, 2001, REPRODUCTION, V121, P655, DOI 10.1530/rep.0.1210655; Tease C, 1998, CHROMOSOMA, V107, P549, DOI 10.1007/s004120050341; Traversa MV, 2010, MOL HUM REPROD, V16, P329, DOI 10.1093/molehr/gaq013; Treff NR, 2011, FERTIL STERIL, V95, P1606, DOI 10.1016/j.fertnstert.2010.11.004; Van Assche E, 1999, MOL HUM REPROD, V5, P682, DOI 10.1093/molehr/5.7.682; Ye YH, 2012, REPROD BIOMED ONLINE, V24, P83, DOI 10.1016/j.rbmo.2011.08.012; Zhang XY, 2010, REPROD BIOMED ONLINE, V21, P552, DOI 10.1016/j.rbmo.2010.05.002	46	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46046	10.1371/journal.pone.0046046	http://dx.doi.org/10.1371/journal.pone.0046046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029381	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500057
J	Juss, JK; Hayhoe, RP; Owen, CE; Bruce, I; Walmsley, SR; Cowburn, AS; Kulkarni, S; Boyle, KB; Stephens, L; Hawkins, PT; Chilvers, ER; Condliffe, AM				Juss, Jatinder K.; Hayhoe, Richard P.; Owen, Charles E.; Bruce, Ian; Walmsley, Sarah R.; Cowburn, Andrew S.; Kulkarni, Suhasini; Boyle, Keith B.; Stephens, Len; Hawkins, Phillip T.; Chilvers, Edwin R.; Condliffe, Alison M.			Functional Redundancy of Class I Phosphoinositide 3-Kinase (PI3K) Isoforms in Signaling Growth Factor-Mediated Human Neutrophil Survival	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RESPIRATORY-DISTRESS-SYNDROME; PHOSPHATIDYLINOSITOL 3-KINASE; KINASE INHIBITORS; DISTINCT ROLES; CELL-SURVIVAL; APOPTOSIS; PI3K-GAMMA; ACTIVATION; GAMMA	We have investigated the contribution of individual phosphoinositide 3-kinase (PI3K) Class I isoforms to the regulation of neutrophil survival using (i) a panel of commercially available small molecule isoform-selective PI3K Class I inhibitors, (ii) novel inhibitors, which target single or multiple Class I isoforms (PI3K alpha, PI3K beta, PI3K delta, and PI3K gamma), and (iii) transgenic mice lacking functional PI3K isoforms (p110 delta(KO)gamma(KO) or p110 gamma(KO)). Our data suggest that there is considerable functional redundancy amongst Class I PI3Ks (both Class IA and Class IB) with regard to GM-CSF-mediated suppression of neutrophil apoptosis. Hence pharmacological inhibition of any 3 or more PI3K isoforms was required to block the GM-CSF survival response in human neutrophils, with inhibition of individual or any two isoforms having little or no effect. Likewise, isolated blood neutrophils derived from double knockout PI3K p110 delta(KO)gamma(KO) mice underwent normal time-dependent constitutive apoptosis and displayed identical GM-CSF mediated survival to wild type cells, but were sensitized to pharmacological inhibition of the remaining PI3K isoforms. Surprisingly, the pro-survival neutrophil phenotype observed in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) was resilient to inactivation of the PI3K pathway.	[Juss, Jatinder K.; Hayhoe, Richard P.; Cowburn, Andrew S.; Chilvers, Edwin R.; Condliffe, Alison M.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Juss, Jatinder K.; Hayhoe, Richard P.; Cowburn, Andrew S.; Chilvers, Edwin R.; Condliffe, Alison M.] Papworth Hosp, Cambridge CB3 8RE, England; [Juss, Jatinder K.; Kulkarni, Suhasini; Boyle, Keith B.; Stephens, Len; Hawkins, Phillip T.] Babraham Inst, Inositide Lab, Cambridge, England; [Owen, Charles E.; Bruce, Ian] Novartis, Horsham Res Ctr, Horsham, W Sussex, England; [Walmsley, Sarah R.] Univ Sheffield, Sch Med, Acad Unit Resp Med, Sheffield, S Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Novartis; University of Sheffield	Condliffe, AM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England.	amc46@medschl.cam.ac.uk		Walmsley, Sarah/0000-0001-9584-174X; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Hayhoe, Richard/0000-0002-7335-2715; Cowburn, Andrew/0000-0001-9145-4275; condliffe, alison/0000-0002-6697-8648; Chilvers, Edwin/0000-0002-4230-9677	NIHR Cambridge Biomedical Research Centre; Biotechnogy and Biological Science Research Council (BBSRC); Papworth Hospital RD Department; BBSRC [BBS/E/B/000C0411, BBS/E/B/0000H111, BBS/E/B/0000M211] Funding Source: UKRI; MRC [G0600840] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H111, BBS/E/B/000C0411, BBS/E/B/0000M211] Funding Source: researchfish; Medical Research Council [G0600840] Funding Source: researchfish	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnogy and Biological Science Research Council (BBSRC); Papworth Hospital RD Department; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in this manuscript was funded by the NIHR Cambridge Biomedical Research Centre (fellowship for Dr Jatinder Juss), the Biotechnogy and Biological Science Research Council (BBSRC) and Papworth Hospital R&D Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Ameriks MK, 2009, CURR TOP MED CHEM, V9, P738, DOI 10.2174/156802609789044434; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; Cowburn AS, 2011, AM J RESP CELL MOL, V44, P879, DOI 10.1165/rcmb.2010-0101OC; Cowburn AS, 2002, BLOOD, V100, P2607, DOI 10.1182/blood-2001-11-0122; de Frias M, 2010, BRIT J HAEMATOL, V150, P108, DOI 10.1111/j.1365-2141.2010.08151.x; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154; Foukas LC, 2010, P NATL ACAD SCI USA, V107, P11381, DOI 10.1073/pnas.0906461107; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; HASLETT C, 1989, CURR OPIN IMMUNOL, V2, P10, DOI 10.1016/0952-7915(89)90091-5; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Johnson C, 2007, ONCOGENE, V26, P7049, DOI 10.1038/sj.onc.1210504; King AG, 2001, BLOOD, V97, P1534, DOI 10.1182/blood.V97.6.1534; Kobayashi SD, 2005, J LEUKOCYTE BIOL, V78, P1408, DOI 10.1189/jlb.0605289; Kong DX, 2010, EUR J CANCER, V46, P1111, DOI 10.1016/j.ejca.2010.01.005; Kulkarni S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001617; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu LX, 2007, BLOOD, V110, P1191, DOI 10.1182/blood-2006-11-060103; Maier U, 1999, J BIOL CHEM, V274, P29311, DOI 10.1074/jbc.274.41.29311; Matute-Bello G, 2000, CRIT CARE MED, V28, P1, DOI 10.1097/00003246-200001000-00001; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Pletz MWR, 2004, EUR RESPIR J, V23, P532, DOI 10.1183/09031936.04.00089004; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Vanhaesebroeck B, 2011, CURR TOP MICROBIOL, V347, P1, DOI 10.1007/82_2010_65; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Xu YF, 2010, P NATL ACAD SCI USA, V107, P2950, DOI 10.1073/pnas.0912717107; Yang KY, 2003, CELL SIGNAL, V15, P225, DOI 10.1016/S0898-6568(02)00063-3	43	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45933	10.1371/journal.pone.0045933	http://dx.doi.org/10.1371/journal.pone.0045933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029326	Green Published, Green Accepted, gold			2022-12-25	WOS:000309554700090
J	Marcilla, A; Trelis, M; Cortes, A; Sotillo, J; Cantalapiedra, F; Minguez, MT; Valero, ML; del Pino, MMS; Munoz-Antoli, C; Toledo, R; Bernal, D				Marcilla, Antonio; Trelis, Maria; Cortes, Alba; Sotillo, Javier; Cantalapiedra, Fernando; Teresa Minguez, Maria; Luz Valero, Maria; Sanchez del Pino, Manuel Mateo; Munoz-Antoli, Carla; Toledo, Rafael; Bernal, Dolores			Extracellular Vesicles from Parasitic Helminths Contain Specific Excretory/Secretory Proteins and Are Internalized in Intestinal Host Cells	PLOS ONE			English	Article							ECHINOSTOMA-FRIEDI TREMATODA; FASCIOLA-HEPATICA; LEUCINE AMINOPEPTIDASE; SECRETORY PRODUCTS; MOLECULAR-CLONING; EXOSOMES; IDENTIFICATION; INFECTIONS; CAPRONI; ENOLASE	The study of host-parasite interactions has increased considerably in the last decades, with many studies focusing on the identification of parasite molecules (i.e. surface or excretory/secretory proteins (ESP)) as potential targets for new specific treatments and/or diagnostic tools. In parallel, in the last few years there have been significant advances in the field of extracellular vesicles research. Among these vesicles, exosomes of endocytic origin, with a characteristic size ranging from 30-100 nm, carry several atypical secreted proteins in different organisms, including parasitic protozoa. Here, we present experimental evidence for the existence of exosome-like vesicles in parasitic helminths, specifically the trematodes Echinostoma caproni and Fasciola hepatica. These microvesicles are actively released by the parasites and are taken up by host cells. Trematode extracellular vesicles contain most of the proteins previously identified as components of ESP, as confirmed by proteomic, immunogold labeling and electron microscopy studies. In addition to parasitic proteins, we also identify host proteins in these structures. The existence of extracellular vesicles explains the secretion of atypical proteins in trematodes, and the demonstration of their uptake by host cells suggests an important role for these structures in host-parasite communication, as described for other infectious agents.	[Marcilla, Antonio; Trelis, Maria; Cortes, Alba; Sotillo, Javier; Cantalapiedra, Fernando; Munoz-Antoli, Carla; Toledo, Rafael] Univ Valencia, Area Parasitol, Dept Biol Celular & Parasitol, Valencia, Spain; [Teresa Minguez, Maria; Luz Valero, Maria] Univ Valencia, Serv Cent Soporte Invest Expt SCSIE, Valencia, Spain; [Luz Valero, Maria] Ctr Invest Principe Felipe, Serv Prote, Valencia, Spain; [Sanchez del Pino, Manuel Mateo; Bernal, Dolores] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	University of Valencia; University of Valencia; Prince Felipe Research Center; University of Valencia	Marcilla, A (corresponding author), Univ Valencia, Area Parasitol, Dept Biol Celular & Parasitol, Valencia, Spain.	antonio.marcilla@uv.es	Toledo, Rafael/AAA-5052-2020; Villanueva, María MTV Trelis/K-6021-2014; del Pino, Manuel M. Sánchez/I-3977-2015; Bernal, Dolores/K-7769-2014; Toledo, Rafael/G-6741-2016; marcilla, antonio/F-9996-2010; Muñoz-Antoli, Carla/ABF-6047-2020; Sotillo, Javier/B-7354-2014	Villanueva, María MTV Trelis/0000-0002-5977-3337; del Pino, Manuel M. Sánchez/0000-0001-9696-7600; Bernal, Dolores/0000-0003-4627-8393; Toledo, Rafael/0000-0003-2651-9794; marcilla, antonio/0000-0003-0004-0531; Sotillo, Javier/0000-0002-1443-7233; Cantalapiedra, Fernando/0000-0003-3021-3296; Cortes Carbonell, Alba/0000-0002-9027-8780	Spanish Ministry of Science and Innovation [FIS09/02355, SAF2010-16236]; FEDER; Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain) [PROMETEO/2009/081]; Universitat de Valencia (Valencia, Spain) [UV-AE-10-23739]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain); Universitat de Valencia (Valencia, Spain)	Funding was provided by FIS09/02355 and SAF2010-16236 from the Spanish Ministry of Science and Innovation and FEDER; PROMETEO/2009/081 from Conselleria d'Educacio, Generalitat Valenciana (Valencia, Spain), and UV-AE-10-23739 from the Universitat de Valencia (Valencia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2008, MOL BIOCHEM PARASIT, V158, P52, DOI 10.1016/j.molbiopara.2007.11.011; ANDRESEN K, 1989, INT J PARASITOL, V19, P111, DOI 10.1016/0020-7519(89)90028-3; Bernal D, 2006, PROTEOMICS, V6, P2835, DOI 10.1002/pmic.200500571; Bernal D, 2004, FEBS LETT, V563, P203, DOI 10.1016/S0014-5793(04)00306-0; Bobrie A, 2011, TRAFFIC; Clayton C, 2010, ADV EXP MED BIOL, V702, P39, DOI 10.1007/978-1-4419-7841-7_4; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Dalton JP, 2003, INT J PARASITOL, V33, P621, DOI 10.1016/S0020-7519(03)00057-2; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Gehrmann U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021480; Geiger A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-20; Giuliani A, 2010, METHODS MOL BIOL, V618, P137, DOI 10.1007/978-1-60761-594-1_10; Guillou F, 2007, MOL BIOCHEM PARASIT, V155, P45, DOI 10.1016/j.molbiopara.2007.05.009; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Izquierdo-Useros N, 2011, CELL MICROBIOL, V13, P10, DOI 10.1111/j.1462-5822.2010.01542.x; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Liu F, 2009, MOL CELL PROTEOMICS, V8, P1236, DOI 10.1074/mcp.M800538-MCP200; Marcilla A, 2008, CLIN VACCINE IMMUNOL, V15, P95, DOI 10.1128/CVI.00338-07; Marcilla A, 2007, EXP PARASITOL, V117, P57, DOI 10.1016/j.exppara.2007.03.011; Marcilla A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001513; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morphew RM, 2007, MOL CELL PROTEOMICS, V6, P963, DOI 10.1074/mcp.M600375-MCP200; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Robinson MW, 2010, TRENDS PARASITOL, V26, P371, DOI 10.1016/j.pt.2010.05.004; Robinson MW, 2009, PHILOS T R SOC B, V364, P2763, DOI 10.1098/rstb.2009.0089; Robinson MW, 2009, MOL CELL PROTEOMICS, V8, P1891, DOI 10.1074/mcp.M900045-MCP200; Rodrigues ML, 2011, MYCOPATHOLOGIA; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Silverman JM, 2011, CELL MICROBIOL, V13, P1, DOI 10.1111/j.1462-5822.2010.01537.x; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sotillo J, 2008, PARASITE IMMUNOL, V30, P271, DOI 10.1111/j.1365-3024.2007.01019.x; Sotillo J, 2010, PARASITOL RES, V107, P691, DOI 10.1007/s00436-010-1923-x; Stack C, 2011, ADV EXP MED BIOL, V712, P116, DOI 10.1007/978-1-4419-8414-2_8; Thery C, 2011, SCIENTIST, V25, P36; THREADGOLD LT, 1963, Q J MICROSC SCI, V104, P505; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; Toledo R, 2005, TRENDS PARASITOL, V21, P251, DOI 10.1016/j.pt.2005.04.006; Toledo R, 2003, PARASITOLOGY, V126, P433, DOI 10.1017/S0031182003213068; Toledo R, 2012, EUR J CLIN MICROBIOL; Toledo R, 2011, J PROTEOMICS, V74, P1485, DOI 10.1016/j.jprot.2011.03.029; Wang XY, 2011, MOL BIOCHEM PARASIT, V177, P135, DOI 10.1016/j.molbiopara.2011.02.011; Wilson RA, 2011, INT J PARASITOL, V41, P1347, DOI 10.1016/j.ijpara.2011.08.003	52	229	241	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45974	10.1371/journal.pone.0045974	http://dx.doi.org/10.1371/journal.pone.0045974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029346	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700099
J	Chang, S; Ross, EM				Chang, Seungwoo; Ross, Elliott M.			Activation Biosensor for G Protein-Coupled Receptors: A FRET-Based m1 Muscarinic Activation Sensor That Regulates G(q)	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CHOLINERGIC-RECEPTOR; RHODOPSIN; BINDING; CRYSTALLOGRAPHY; ENVIRONMENT; MOVEMENT; AGONISTS	We describe the design, construction and validation of a fluorescence sensor to measure activation by agonist of the m1 muscarinic cholinergic receptor, a prototypical class I G(q)-coupled receptor. The sensor uses an established general design in which Forster resonance energy transfer (FRET) from a circularly permuted CFP mutant to FlAsH, a selectively reactive fluorescein, is decreased 15-20% upon binding of a full agonist. Notably, the sensor displays essentially wild-type capacity to catalyze activation of G alpha(q), and the purified and reconstituted sensor displays appropriate regulation of affinity for agonists by G(q). We describe the strategies used to increase the agonist-driven change in FRET while simultaneously maintaining regulatory interactions with G alpha(q), in the context of the known structures of Class I G protein-coupled receptors. The approach should be generally applicable to other Class I receptors which include numerous important drug targets.	[Chang, Seungwoo; Ross, Elliott M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Green Ctr Syst Biol, Dallas, TX 75390 USA.	ross@utsw.swmed.edu			National Institutes of Health [R01GM030355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from National Institutes of Health R01GM030355, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams S, 2002, FORBES, V169, P124; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Ambrosio M, 2012, MOL PHARMACOL, V81, P770, DOI 10.1124/mol.112.077693; ARDEN JR, 1992, BIOCHEM BIOPH RES CO, V188, P1111, DOI 10.1016/0006-291X(92)91346-R; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Granier S, 2009, METHODS MOL BIOL, V552, P253, DOI 10.1007/978-1-60327-317-6_18; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Harikumar KG, 2002, J BIOL CHEM, V277, P18552, DOI 10.1074/jbc.M201164200; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; HOGGER P, 1995, J BIOL CHEM, V270, P7405; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Ilien B, 2003, J NEUROCHEM, V85, P768, DOI 10.1046/j.1471-4159.2003.01717.x; Inglese J, 1998, BIOCHEMISTRY-US, V37, P2372, DOI 10.1021/bi972161u; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; JOU WM, 1980, CELL, V19, P683, DOI 10.1016/S0092-8674(80)80045-6; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LAMEH J, 1992, J BIOL CHEM, V267, P13406; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Martikkala E, 2009, ANAL BIOCHEM, V392, P103, DOI 10.1016/j.ab.2009.05.022; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; Middleton RJ, 2005, CURR OPIN CHEM BIOL, V9, P517, DOI 10.1016/j.cbpa.2005.08.016; MINTA A, 1989, J BIOL CHEM, V264, P8171; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; PARKER EM, 1991, J BIOL CHEM, V266, P519; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Weiss JM, 1996, J THEOR BIOL, V178, P169, DOI 10.1006/jtbi.1996.0015; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Ziegler N, 2011, BIOORGAN MED CHEM, V19, P1048, DOI 10.1016/j.bmc.2010.07.060	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45651	10.1371/journal.pone.0045651	http://dx.doi.org/10.1371/journal.pone.0045651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029161	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388900085
J	Peyre, M; Stemmer-Rachamimov, A; Clermont-Taranchon, E; Quentin, S; El-Taraya, N; Walczak, C; Volk, A; Niwa-Kawakita, M; Karboul, N; Giovannini, M; Kalamarides, M				Peyre, M.; Stemmer-Rachamimov, A.; Clermont-Taranchon, E.; Quentin, S.; El-Taraya, N.; Walczak, C.; Volk, A.; Niwa-Kawakita, M.; Karboul, N.; Giovannini, M.; Kalamarides, M.			Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation	ONCOGENE			English	Article						meningioma; adenovirus; NF2; CDKN2AB; mouse model	TUMOR-SUPPRESSOR; MALIGNANT PROGRESSION; DCE-MRI; P16(INK4A); GENE; SENESCENCE; BENIGN; RECURRENCE; P15(INK4B); REGRESSION	Aggressive variants of meningiomas (WHO grade II and III) represent up to 30% of those tumors that are among the most common primary central nervous system tumors in adults. Currently, there is no effective treatment for grade-II and -III meningiomas, the main treatment remaining surgical excision. Genetic studies have highlighted two main events associated with meningioma progression: an increase of chromosomal instability in tumors with NF2 inactivation and homozygous deletions or point mutations of the CDKN2AB locus. In this study we demonstrated that in mice, in addition to bi-allelic Nf2 inactivation, homozygous and heterozygous Adenovirus Cre-mediated Cdkn2ab deletions lead to increased meningioma frequency (72% and 50%, respectively) with a shorter latency (3.5 and 7.8 months, respectively) compared with control cohorts and induce grade II/III meningioma progression with an incidence of 34% and 28%, respectively. Moreover, Cdkn2ab inactivation in arachnoidal cells was associated with decreased senescence compared with Nf2(-/-) and wild-type arachnoidal cells in vitro. We have established three mouse meningioma cell lines and generated a syngenic orthotopic meningioma mouse model with 50-100% grade-II/III meningiomas after reimplantation. Comparative genomic hybridization of four meningiomas from Cdkn2ab homozygous mice and three cell cultures revealed the absence of unbalanced chromosomal segments in tumors and several chromosome imbalances in cell cultures. In addition, we were able to detect meningiomas by using bioluminescence and to evaluate tumor vascular permeability by dynamic magnetic resonance imaging. These results show that Nf2 and Cdkn2ab cooperate to promote meningioma progression in mice. The short latency of tumor development and the ability to derive grade II/III meningioma cell cultures are key aspects of this model to promote its use in pre-clinical drug testing.	[Peyre, M.; Kalamarides, M.] Hop Beaujon, AP HP, Dept Neurosurg, F-92110 Clichy, France; [Peyre, M.; Clermont-Taranchon, E.; Niwa-Kawakita, M.; Karboul, N.; Kalamarides, M.] Univ Paris 07, Paris, France; [Peyre, M.; Clermont-Taranchon, E.; Niwa-Kawakita, M.; Karboul, N.; Kalamarides, M.] Fdn Jean Dausset, Unite Inserm U674, Paris, France; [Stemmer-Rachamimov, A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neuropathol, Boston, MA USA; [Quentin, S.] Inst Univ Hematol, INSERM, U944, Paris, France; [El-Taraya, N.; Walczak, C.; Volk, A.] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [El-Taraya, N.; Walczak, C.; Volk, A.] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Giovannini, M.] House Res Inst, Los Angeles, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Kalamarides, M (corresponding author), Hop Beaujon, AP HP, Dept Neurosurg, 100 Blvd Gen Leclerc, F-92110 Clichy, France.	michel.kalamarides@bjn.aphp.fr	Volk, Andreas/A-8474-2019	Volk, Andreas/0000-0003-0915-5458; Kawakita, Michiko/0000-0002-9450-583X; Peyre, Matthieu/0000-0001-8470-9516	Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer-comite Paris; Fondation Anber; Association Neurofibromatoses et Recklinghausen; Inserm	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer-comite Paris; Fondation Anber; Association Neurofibromatoses et Recklinghausen; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank A Berns for Ink4ab<SUP>-/+</SUP> mutant mice, M Pla and staff of the Institut Universitaire d'Hematologie (IUH), Universite Paris 7, for mouse housing. We also thank J Calderaro and G Morcrette for their help in additional pathological analyses. This work was supported by Grants from the Association pour la Recherche sur le Cancer (subvention fixe and funding to MP), Ligue Nationale contre le Cancer-comite Paris, Fondation Anber, Association Neurofibromatoses et Recklinghausen (to ECT and NK) and Inserm.	Aghi MK, 2009, NEUROSURGERY, V64, P56, DOI 10.1227/01.NEU.0000330399.55586.63; Al-Mefty O, 2004, J NEUROSURG, V101, P210, DOI 10.3171/jns.2004.101.2.0210; Bostrom J, 2001, AM J PATHOL, V159, P661, DOI 10.1016/S0002-9440(10)61737-3; Buschges R, 2002, BRAIN PATHOL, V12, P145; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Evans DGR, 2006, J MED GENET, V43, P289, DOI 10.1136/jmg.2005.036319; Gaya A, 2008, BRIT J CANCER, V99, P321, DOI 10.1038/sj.bjc.6604426; Goutagny S, 2011, ANN ONCOL, V22, P990, DOI 10.1093/annonc/mdr012; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; Hanft S, 2010, J NEURO-ONCOL, V99, P433, DOI 10.1007/s11060-010-0348-9; James MF, 2008, NEUROBIOL DIS, V29, P278, DOI 10.1016/j.nbd.2007.09.002; Jongsma J, 2008, CANCER CELL, V13, P261, DOI 10.1016/j.ccr.2008.01.030; Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302; Kalamarides M, 2008, BRAIN PATHOL, V18, P62, DOI 10.1111/j.1750-3639.2007.00105.x; Kamijo T, 1999, CANCER RES, V59, P2217; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Korshunov A, 2003, INT J CANCER, V104, P728, DOI 10.1002/ijc.11013; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Lamszus K, 2000, J NEUROPATH EXP NEUR, V59, P504, DOI 10.1093/jnen/59.6.504; Leone PE, 1999, ONCOGENE, V18, P2231, DOI 10.1038/sj.onc.1202531; Lopez-Gines C, 2004, CANCER GENET CYTOGEN, V148, P123, DOI 10.1016/S0165-4608(03)00279-6; Lou E, 2012, J NEURO-ONCOL, V109, P63, DOI 10.1007/s11060-012-0861-0; Loveless ME, 2012, NEOPLASIA, V14, P54, DOI 10.1593/neo.111478; Lyons SK, 2003, CANCER RES, V63, P7042; Menon AG, 1997, ONCOGENE, V14, P611, DOI 10.1038/sj.onc.1200853; Mihaila D, 2003, CLIN CANCER RES, V9, P4443; Morrison JP, 2007, TOXICOL PATHOL, V35, P838, DOI 10.1080/01926230701584130; Perry A, 2002, BRAIN PATHOL, V12, P183; Pistolesi S, 2004, NEUROPATH APPL NEURO, V30, P118, DOI 10.1046/j.0305-1846.2003.00516.x; Puchner MJA, 2010, ANN ONCOL, V21, P2445, DOI 10.1093/annonc/mdq634; Ragel BT, 2008, SURG NEUROL, V70, P295, DOI 10.1016/j.surneu.2007.06.031; Riemenschneider MJ, 2006, LANCET NEUROL, V5, P1045, DOI 10.1016/S1474-4422(06)70625-1; Romagosa C, 2011, ONCOGENE, V30, P2087, DOI 10.1038/onc.2010.614; RUTTLEDGE MH, 1994, NAT GENET, V6, P180, DOI 10.1038/ng0294-180; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Simon M, 2001, J NEURO-ONCOL, V55, P149, DOI 10.1023/A:1013863630293; Sotillo R, 2009, CANCER CELL, V16, P451, DOI 10.1016/j.ccr.2009.11.014; The WHO, 2020, CLASSIFICATION TUMOU; Vautier J, 2010, MAGN RESON MED, V64, P313, DOI 10.1002/mrm.22396; Weber RG, 1997, P NATL ACAD SCI USA, V94, P14719, DOI 10.1073/pnas.94.26.14719	41	26	26	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4264	4272		10.1038/onc.2012.436	http://dx.doi.org/10.1038/onc.2012.436			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23045274				2022-12-25	WOS:000324168000008
J	Lanaspa, MA; Sanchez-Lozada, LG; Choi, YJ; Cicerchi, C; Kanbay, M; Roncal-Jimenez, CA; Ishimoto, T; Li, NX; Marek, G; Duranay, M; Schreiner, G; Rodriguez-Iturbe, B; Nakagawa, T; Kang, DH; Sautin, YY; Johnson, RJ				Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Choi, Yea-Jin; Cicerchi, Christina; Kanbay, Mehmet; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Li, Nanxing; Marek, George; Duranay, Murat; Schreiner, George; Rodriguez-Iturbe, Bernardo; Nakagawa, Takahiko; Kang, Duk-Hee; Sautin, Yuri Y.; Johnson, Richard J.			Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; RISK-FACTOR; CELL-PROLIFERATION; DIETARY FRUCTOSE; FILTRATION-RATE; DISEASE; HYPERURICEMIA; ASSOCIATION; ALLOPURINOL; HOMEOSTASIS	Metabolic syndrome represents a collection of abnormalities that includes fatty liver, and it currently affects one-third of the United States population and has become a major health concern worldwide. Fructose intake, primarily from added sugars in soft drinks, can induce fatty liver in animals and is epidemiologically associated with nonalcoholic fatty liver disease in humans. Fructose is considered lipogenic due to its ability to generate triglycerides as a direct consequence of the metabolism of the fructose molecule. Here, we show that fructose also stimulates triglyceride synthesis via a purine-degrading pathway that is triggered from the rapid phosphorylation of fructose by fructokinase. Generated AMP enters into the purine degradation pathway through the activation of AMP deaminase resulting in uric acid production and the generation of mitochondrial oxidants. Mitochondrial oxidative stress results in the inhibition of aconitase in the Krebs cycle, resulting in the accumulation of citrate and the stimulation of ATP citrate lyase and fatty-acid synthase leading to de novo lipogeneis. These studies provide new insights into the pathogenesis of hepatic fat accumulation under normal and diseased states.	[Cicerchi, Christina; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Li, Nanxing; Nakagawa, Takahiko; Johnson, Richard J.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80045 USA; [Sanchez-Lozada, Laura G.] Inst Nacl Cardiol Ignacio Chavez, Dept Med, Lab Renal Physiopathol & Nephrol, Mexico City 14339, DF, Mexico; [Choi, Yea-Jin; Kang, Duk-Hee] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Nephrol,Ehwa Med Res Ctr, Seoul 120750, South Korea; [Kanbay, Mehmet; Duranay, Murat] Kayseri Training & Res Hosp, Div Nephrol, Dept Med, TR-38039 Kayseri, Turkey; [Marek, George; Sautin, Yuri Y.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32611 USA; [Schreiner, George] Cardero Therapeut Inc, Menlo Pk, CA 94085 USA; [Rodriguez-Iturbe, Bernardo] Inst Venezolano Invest Cient Zulia, Maracaibo 4001 A, Venezuela; [Rodriguez-Iturbe, Bernardo] Univ Hosp, Maracaibo 4001 A, Venezuela; [Rodriguez-Iturbe, Bernardo] Univ Zulia, Maracaibo 4001 A, Venezuela	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institute of Cardiology - Mexico; Ewha Womans University; Kayseri Training & Research Hospital; State University System of Florida; University of Florida		Miguel.lanaspagarcia@ucdenver.edu	1, 1/L-6277-2019; Ishimoto, Takuji/M-4873-2014; Sanchez-Lozada, Laura/AAS-2104-2021; Lanaspa, Miguel/AAO-4971-2020	Ishimoto, Takuji/0000-0002-9861-5331; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Sautin, Yuri/0000-0003-3618-5134	National Institutes of Health [HL-68607, RC4 DK090869-01]; Amway; Cardero; Danone; Questcor; University of Colorado; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant [A101742]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amway; Cardero; Danone(Danone Nutricia); Questcor; University of Colorado; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-68607 and RC4 DK090869-01 (to R. J. J.). This work was also supported by Amway, Cardero, Danone, and Questcor (to R. J. J.) and by startup funds from the University of Colorado (to R. J. J.) and Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant A101742 (to D.-H. K.). M. A. L., T. I., and R. J. J. are listed as inventors on a patent application from the University of Colorado related to developing isoform-specific fructokinase inhibitors in the treatment of disorders associated with obesity and insulin resistance. T. N. and R. J. J. are listed as inventors on several patent applications related to lowering uric acid as a means to prevent or treat metabolic syndrome. Dr. Johnson also has a patent with the University of Washington and Merck for the use of allopurinol to treat hypertension. Dr. Johnson also discloses that he has consulted for Ardea, Astellas, Danone, and Novartis, that he is on the scientific board of Amway. R. J. J. and T. N. have patent applications related to lowering uric acid as a means to prevent fatty liver and metabolic syndrome. R. J. J., T. I., and M. L. also have patent applications related to blocking fructose metabolism as a means for preventing or treating metabolic syndrome. Dr. Johnson has also consulted for Novartis, Danone, Ardea, Mitsubishi Tanabe, and Astellas. Dr. Johnson also has two lay books on sugar, including the Sugar Fix (Rodale, 2008) and the Fat Switch (Mercola.com, 2012).	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abdelmalek MF, 2007, HEPATOLOGY, V46, p293A; Ackerman Z, 2005, HYPERTENSION, V45, P1012, DOI 10.1161/01.HYP.0000164570.20420.67; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Argalious MY, 2012, BRIT J ANAESTH, V109, P161, DOI 10.1093/bja/aes143; Baldini PM, 2004, CELL DEATH DIFFER, V11, pS210, DOI 10.1038/sj.cdd.4401520; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; CHANEY AL, 1962, CLIN CHEM, V8, P130; Choi JWJ, 2008, ARTHRIT RHEUM-ARTHR, V59, P109, DOI 10.1002/art.23245; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Cox CL, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-68; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2008, JAMA-J AM MED ASSOC, V300, P924, DOI 10.1001/jama.300.8.924; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Kanbay M, 2011, CLIN J AM SOC NEPHRO, V6, P1887, DOI 10.2215/CJN.11451210; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lee JW, 2010, GUT LIVER, V4, P378, DOI 10.5009/gnl.2010.4.3.378; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Nikkila E A, 1969, Adv Lipid Res, V7, P63; NIKKILA EA, 1972, ACTA MED SCAND, P221; ODIEVRE M, 1978, AM J DIS CHILD, V132, P605, DOI 10.1001/archpedi.1978.02120310069014; Ogino K, 2010, CIRC-HEART FAIL, V3, P73, DOI 10.1161/CIRCHEARTFAILURE.109.868604; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; PERHEENT.J, 1967, LANCET, V2, P528; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; REISER S, 1989, AM J CLIN NUTR, V49, P832, DOI 10.1093/ajcn/49.5.832; Roncal-Jimenez CA, 2011, METABOLISM, V60, P1259, DOI 10.1016/j.metabol.2011.01.008; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Sirota J. C., 2012, METABOLISM, P7; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; VANDENBERGHE G, 1977, BIOCHEM J, V162, P601, DOI 10.1042/bj1620601; Xu CF, 2010, HEPATOLOGY, V52, P1865, DOI 10.1002/hep.23798; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918; Yamada T, 2010, ACTA GASTRO-ENT BELG, V73, P12; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d	53	409	425	5	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40732	40744		10.1074/jbc.M112.399899	http://dx.doi.org/10.1074/jbc.M112.399899			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23035112	Green Published, hybrid			2022-12-25	WOS:000311448800062
J	Doherty, MT; Kang, YS; Lee, C; Stumph, WE				Doherty, Matthew T.; Kang, Yoon Soon; Lee, Cheryn; Stumph, William E.			Architectural Arrangement of the Small Nuclear RNA (snRNA)-activating Protein Complex 190 Subunit (SNAP190) on U1 snRNA Gene Promoter DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROXIMAL-SEQUENCE-ELEMENT; MYB-DOMAIN PROTEIN; TRANSCRIPTION FACTOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; POLYMERASE-II; RECOGNITION; IDENTIFICATION; MODEL; TBP	Myb repeats similar to 52 amino acid residues in length were first characterized in the oncogenic Myb transcription factor, which contains three tandem Myb repeats in its DNA-binding domain. Proteins of this family normally contain either one, two, or three tandem Myb repeats that are involved in protein-DNA interactions. The small nuclear RNA (snRNA)-activating protein complex (SNAPc) is a heterotrimeric transcription factor that is required for expression of small nuclear RNA genes. This complex binds to an essential promoter element, the proximal sequence element, centered similar to 50 base pairs upstream of the transcription start site of snRNA genes. SNAP190, the largest subunit of SNAPc, uncharacteristically contains 4.5 tandem Myb repeats. Little is known about the arrangement of the Myb repeats in the SNAPc-DNA complex, and it has not been clear whether all 4.5 Myb repeats contact the DNA. By using a site-specific protein-DNA photo-cross-linking assay, we have now mapped specific nucleotides where each of the Myb repeats of Drosophila melanogaster SNAP190 interacts with a U1 snRNA gene proximal sequence element. The results reveal the topological arrangement of the 4.5 SNAP190 Myb repeats relative to the DNA and to each other when SNAP190 is bound to a U1 promoter as a subunit of SNAPc.	[Kang, Yoon Soon; Lee, Cheryn; Stumph, William E.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA; [Doherty, Matthew T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University; California State University System; San Diego State University	Stumph, WE (corresponding author), San Diego State Univ, Dept Chem & Biochem, 5500 Campanile Dr, San Diego, CA 92182 USA.	wstumph@sciences.sdsu.edu			National Science Foundation [MCB-0641350, MCB-1157549]; California Metabolic Research Foundation	National Science Foundation(National Science Foundation (NSF)); California Metabolic Research Foundation	This work was supported by National Science Foundation Grants MCB-0641350 and MCB-1157549 and in part by the California Metabolic Research Foundation.	Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Crimmins D. L., 1996, CURR PROTOC PROTEIN, V4, P111411; Das A, 2005, MOL CELL BIOL, V25, P7314, DOI 10.1128/MCB.25.16.7314-7322.2005; Das A, 2003, P NATL ACAD SCI USA, V100, P80, DOI 10.1073/pnas.262609399; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Hardin SB, 2000, NUCLEIC ACIDS RES, V28, P2771, DOI 10.1093/nar/28.14.2771; HENRY RW, 1995, NATURE, V374, P653, DOI 10.1038/374653a0; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hung KH, 2011, CRIT REV BIOCHEM MOL, V46, P11, DOI 10.3109/10409238.2010.518136; Hung KH, 2009, J BIOL CHEM, V284, P22568, DOI 10.1074/jbc.M109.027961; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim MK, 2010, MOL CELL BIOL, V30, P2411, DOI 10.1128/MCB.01508-09; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1998, NUCLEIC ACIDS RES, V26, P1731, DOI 10.1093/nar/26.7.1731; Lai HT, 2008, FEBS LETT, V582, P3734, DOI 10.1016/j.febslet.2008.09.059; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Ma BC, 2002, MOL CELL BIOL, V22, P8067, DOI 10.1128/MCB.22.22.8067-8078.2002; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; OGATA K, 1995, NAT STRUCT BIOL, V2, P309, DOI 10.1038/nsb0495-309; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; Schimanski B, 2005, MOL CELL BIOL, V25, P7303, DOI 10.1128/MCB.25.16.7303-7313.2005; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; TANIKAWA J, 1993, P NATL ACAD SCI USA, V90, P9320, DOI 10.1073/pnas.90.20.9320; WALDSCHMIDT R, 1991, EMBO J, V10, P2595, DOI 10.1002/j.1460-2075.1991.tb07801.x; WANANDI I, 1993, J BIOL CHEM, V268, P6629; Wang Y, 1998, MOL CELL BIOL, V18, P1570, DOI 10.1128/MCB.18.3.1570; Wong MW, 1998, MOL CELL BIOL, V18, P368, DOI 10.1128/MCB.18.1.368; YOON JB, 1995, MOL CELL BIOL, V15, P2019; Yu EY, 2000, J BIOL CHEM, V275, P24208, DOI 10.1074/jbc.M003250200	38	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.407775	http://dx.doi.org/10.1074/jbc.M112.407775			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23038247	Green Published, hybrid			2022-12-25	WOS:000311233800009
J	Belotti, E; Puvirajesinghe, TM; Audebert, S; Baudelet, E; Camoin, L; Pierres, M; Lasvaux, L; Ferracci, G; Montcouquiol, M; Borg, JP				Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Pierres, Michel; Lasvaux, Lea; Ferracci, Geraldine; Montcouquiol, Mireille; Borg, Jean-Paul			Molecular Characterisation of Endogenous Vangl2/Vangl1 Heteromeric Protein Complexes	PLOS ONE			English	Article							PLANAR CELL-POLARITY; NEURAL-TUBE DEFECTS; LOOP-TAIL; TISSUE POLARITY; VANGL2; MOUSE; GENE; STRABISMUS; IDENTIFICATION; DROSOPHILA	Background: Mutations in the Planar Cell Polarity (PCP) core gene Vangl2 cause the most severe neural tube defects (NTD) in mice and humans. Genetic studies show that the Vangl2 gene genetically interacts with a close homologue Vangl1. How precisely Vangl2 and Vangl1 proteins interact and crosstalk has remained a difficult issue to address, with the main obstacle being the accurate discrimination of the two proteins, which share close sequence homology. Experimental evidence previously presented has been sparse and addressed with ectopically expressed proteins or with antibodies unable to biochemically discriminate Vangl1 from Vangl2, therefore giving rise to unclear results. Methodology and Main Findings: A highly specific monoclonal anti-Vangl2 antibody was generated and rigorously tested on both recombinant and extracted Vangl2 using surface plasmon resonance (SPR) analysis, western blot, and immunoprecipitation experiments. This antibody efficiently affinity-purified Vangl2 from cell lysates and allowed the unambiguous identification of endogenous Vangl2 by proteomic analysis. Vangl1 was also present in Vangl2 immunoprecipitates, establishing the first biochemical evidence for the existence of Vangl2/Vangl1 heterodimers at an endogenous level. Epitope-tagged Vangl2 and Vangl1 confirmed that both proteins interact and colocalize at the plasma membrane. The Vangl2 antibody is able to acutely assess differential expression levels of Vangl2 protein in culture cell lines, as corroborated with gene expression analysis. We characterised Vangl2 expression in the cochlea of homozygous and heterozygous Lp mutant mice bearing a point mutation within the C-terminal Vangl2 region that leads to profound PCP defects. Our antibody could detect much lower levels of Vangl2(Lp) protein in mutant mice compared to the wild type mice. Conclusion: Our results provide an in-depth biochemical characterisation of the interaction observed between Vangl paralogues.	[Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] INSERM, U1068, CRCM, F-13258 Marseille, France; [Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] CNRS UMR7258, CRCM, Marseille, France; [Belotti, Edwige; Puvirajesinghe, Tania M.; Audebert, Stephane; Baudelet, Emilie; Camoin, Luc; Borg, Jean-Paul] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Ferracci, Geraldine] Aix Marseille Univ, CNRS, CRN2M UMR7286, Marseille, France; [Pierres, Michel] CNRS, Ctr Immunol Marseille Luminy, UMR INSERM 6102, Marseille, France; [Lasvaux, Lea; Montcouquiol, Mireille] Bordeaux Univ, Neuroctr Magendie, Planar Polar & Plast Grp, INSERM,U862, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Borg, JP (corresponding author), INSERM, U1068, CRCM, F-13258 Marseille, France.	jean-paul.borg@inserm.fr	Puvirajesinghe, Tania/AAD-9137-2020; Camoin, Luc/AAB-3856-2019; montcouquiol, mireille/L-6199-2017; Borg, Jean-Paul/AAX-8096-2020	Camoin, Luc/0000-0002-1230-4787; montcouquiol, mireille/0000-0001-8739-6519; Borg, Jean-Paul/0000-0001-8418-3382; Puvirajesinghe, Tania/0000-0002-8304-9824; Belotti, Edwige/0000-0002-0496-2309; Audebert, Stephane/0000-0002-9409-2588	Foundation of Medical Research (FRM, France); Association pour la Recherche contre le Cancer (ARC); La Ligue Contre le Cancer (Label Ligue JPB); EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)); INCa (L'Institut National du Cancer); IBiSA (Infrastructures Biologie Sante et Agronomie) [ANR-08-MNPS-040-01]; Region Regional Aquitaine	Foundation of Medical Research (FRM, France); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); La Ligue Contre le Cancer (Label Ligue JPB); EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)); INCa (L'Institut National du Cancer); IBiSA (Infrastructures Biologie Sante et Agronomie); Region Regional Aquitaine	This work was supported by grants from the Foundation of Medical Research (FRM, France), Association pour la Recherche contre le Cancer (ARC) and La Ligue Contre le Cancer (Label Ligue JPB), EUCAAD-FP7 program (European Consortium for Anticancer Antibody Development, Seventh Framework Programme: HEALTH)), INCa (L'Institut National du Cancer) and IBiSA (Infrastructures Biologie Sante et Agronomie), ANR-08-MNPS-040-01(MM), Region Regional Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gravel M, 2010, BIOCHEMISTRY-US, V49, P3445, DOI 10.1021/bi902180m; Iliescu A, 2011, BIOCHEMISTRY-US, V50, P2274, DOI 10.1021/bi101767a; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Jessen JR, 2004, GENE EXPR PATTERNS, V4, P339, DOI 10.1016/j.modgep.2003.09.012; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Lake BB, 2009, J CELL BIOL, V185, P59, DOI 10.1083/jcb.200807073; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Taylor J, 1998, GENETICS, V150, P199; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wolff T, 1998, DEVELOPMENT, V125, P1149; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988	30	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46213	10.1371/journal.pone.0046213	http://dx.doi.org/10.1371/journal.pone.0046213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029439	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900109
J	Chen, J; Cai, QP; Shen, PJ; Yan, RL; Wang, CM; Yang, DJ; Fu, HB; Chen, XY				Chen, Ji; Cai, Qing-ping; Shen, Pi-jie; Yan, Rong-lin; Wang, Chang-ming; Yang, De-jun; Fu, Hong-bing; Chen, Xue-yun			Netrin-1 Protects against L-Arginine-Induced Acute Pancreatitis in Mice	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SURVIVAL; INFLAMMATION; EXPRESSION; SEVERITY; RECEPTORS; MIGRATION; INHIBITION; MECHANISMS; CYTOKINES	Acute pancreatitis (AP) is a common inflammatory disease mediated by damage to acinar cells and subsequent pancreatic inflammation with infiltration of leukocytes. The neuronal guidance protein, netrin-1, has been shown to control leukocyte trafficking and modulate inflammatory responses in several inflammation-based diseases. The present study was aimed toward investigating the effects of netrin-1 in an in vivo model of AP in mice. AP was induced in C57BL/6 mice by administration of two intraperitoneal injections of L-Arginine (4 g/kg). Mice were treated with recombinant mouse netrin-1 at a dose of 1 mu g/mouse or vehicle (0.1% BSA) intravenously through the tail vein immediately after the second injection of L-Arginine, and every 24 h thereafter. Mice were sacrificed at several time intervals from 0 to 96 h after the induction of pancreatitis. Blood and tissue samples of pancreas and lung were collected and processed to determine the severity of pancreatitis biochemically and histologically. Immunohistochemical staining demonstrated that netrin-1 was mainly expressed in the islet cells of the normal pancreas and the AP model pancreas, and the pancreatic expression of netrin-1 was down-regulated at both the mRNA and protein levels during the course of AP. Exogenous netrin-1 administration significantly reduced plasma amylase levels, myeloperoxidase activity, pro-inflammatory cytokine production, and pancreas and lung tissue damages. Furthermore, netrin-1 administration did not cause significant inhibition of nuclear factor-kappa B activation in the pancreas of L-Arginine-induced AP. In conclusion, our novel data suggest that netrin-1 is capable of improving damage of pancreas and lung, and exerting anti-inflammatory effects in mice with severe acute pancreatitis. Thus, our results indicate that netrin-1 may constitute a novel target in the management of AP.	[Chen, Ji; Cai, Qing-ping; Shen, Pi-jie; Yan, Rong-lin; Wang, Chang-ming; Yang, De-jun; Fu, Hong-bing; Chen, Xue-yun] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China	Naval Medical University	Yan, RL (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China.	yanronglin@163.com			Shanghai Municipal Science and Technology commission [10JC1412700]; Natural Science Foundation of China [30901770, 81150110493]	Shanghai Municipal Science and Technology commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by Shanghai Municipal Science and Technology commission (no. 10JC1412700) and the Natural Science Foundation of China (no. 30901770 and no. 81150110493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2011, GUT, V10, P1136; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Bhatia M, 1998, INT J PANCREATOL, V24, P77; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Dawra R, 2007, AM J PHYSIOL-GASTR L, V292, pG1009, DOI 10.1152/ajpgi.00167.2006; De Breuck S, 2003, DIABETOLOGIA, V46, P926, DOI 10.1007/s00125-003-1125-5; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Gravante G, 2009, PANCREATOLOGY, V9, P601, DOI 10.1159/000212097; Hughes CB, 1996, AM J SURG, V171, P274, DOI 10.1016/S0002-9610(97)89568-2; INOUE S, 1995, ARCH SURG-CHICAGO, V130, P93; JAVIER P, 2004, ANN SURG, V240, P108; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Link BC, 2007, ANN SURG ONCOL, V14, P2591, DOI 10.1245/s10434-007-9469-6; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; NORMAN J, 1995, SURGERY, V117, P648, DOI 10.1016/S0039-6060(95)80008-5; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Paradisi A, 2009, P NATL ACAD SCI USA, V106, P17146, DOI 10.1073/pnas.0901767106; Pereda J, 2006, CURR MED CHEM, V13, P2775, DOI 10.2174/092986706778522011; Pezzilli R, 2009, EXPERT OPIN PHARMACO, V10, P2999, DOI 10.1517/14656560903382630; Rakonczay Z, 2003, FREE RADICAL BIO MED, V34, P696, DOI 10.1016/S0891-5849(02)01373-4; Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sandoval D, 1996, GASTROENTEROLOGY, V111, P1081, DOI 10.1016/S0016-5085(96)70077-X; Satoh A, 1999, GUT, V44, P253, DOI 10.1136/gut.44.2.253; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Steinle AU, 1999, GASTROENTEROLOGY, V116, P420, DOI 10.1016/S0016-5085(99)70140-X; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Tang XL, 2008, NAT CELL BIOL, V10, P698, DOI 10.1038/ncb1732; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; Vonlaufen A, 2008, J GASTROEN HEPATOL, V23, P1339, DOI 10.1111/j.1440-1746.2008.05520.x; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Wang WW, 2009, AM J PHYSIOL-RENAL, V296, pF723, DOI 10.1152/ajprenal.90686.2008; Werner J, 1998, ANN SURG, V227, P86, DOI 10.1097/00000658-199801000-00013; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Yang YHC, 2011, DIABETOLOGIA, V54, P828, DOI 10.1007/s00125-010-2012-5; Zhou XL, 2009, PANCREAS, V38, P752, DOI 10.1097/MPA.0b013e3181a86b74	45	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46201	10.1371/journal.pone.0046201	http://dx.doi.org/10.1371/journal.pone.0046201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029434	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500071
J	Huang, SX; Zhu, XM; Liu, YF; Tao, YX; Feng, GY; He, L; Guo, XZ; Ma, G				Huang, Sixia; Zhu, Xuming; Liu, Yanfang; Tao, Yixin; Feng, Guoyin; He, Lin; Guo, Xizhi; Ma, Gang			Wls Is Expressed in the Epidermis and Regulates Embryonic Hair Follicle Induction in Mice	PLOS ONE			English	Article							SONIC HEDGEHOG; WNT LIGANDS; MORPHOGENESIS; SECRETION; WNTLESS; PROTEIN; DIFFERENTIATION; INITIATION; AXIS	Wnt proteins are secreted molecules that play multiple roles during hair follicle development and postnatal hair cycling. Wntless (Wls) is a cargo protein required for the secretion of various Wnt ligands. However, its role during hair follicle development and hair cycling remains unclear. Here, we examined the expression of Wls during hair follicle induction and postnatal hair cycling. We also conditionally deleted Wls with K14-cre to investigate its role in hair follicle induction. K14-cre;Wls(c/c) mice exhibited abnormal hair follicle development, which is possibly caused by impaired canonical Wnt signaling. Meanwhile, Wnt5a is also expressed in embryonic epidermis, but Wnt5a null mice showed no significant defect in embryonic hair follicle morphogenesis. Therefore, Wls may regulate hair follicle induction by mediating the Wnt/beta-catenin pathway.	[Huang, Sixia; Zhu, Xuming; Liu, Yanfang; Tao, Yixin; Feng, Guoyin; He, Lin; Guo, Xizhi; Ma, Gang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Guo, XZ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	xzguo2005@gmail.com; magang2004@gmail.com	Zhu, Xuming/ABC-6380-2021; liu, yan/HCI-5542-2022	Zhu, Xuming/0000-0003-1148-4162; Huang, Sixia/0000-0003-3591-1085; Guo, Xizhi/0000-0001-8047-6049	973 Program [2011CBA00803, 2010CB529600, 2012CB966900]; National Key Technology Research and Development Program [2012BAI01B09]; National Nature Science Foundation of China [81121001]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]	973 Program(National Basic Research Program of China); National Key Technology Research and Development Program(National Key Technology R&D Program); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The study was supported by the 973 Program (2011CBA00803, 2010CB529600,2012CB966900), the National Key Technology Research and Development Program (2012BAI01B09), the National Nature Science Foundation of China (81121001), the Shanghai Municipal Commission of Science and Technology Program (09DJ1400601), and the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hu B, 2010, GENE DEV, V24, P1519, DOI 10.1101/gad.1886910; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim H, 2009, MOL CELL BIOL, V29, P2118, DOI 10.1128/MCB.01503-08; Lindner G, 1997, AM J PATHOL, V151, P1601; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yu HMI, 2010, DEV DYNAM, V239, P2102, DOI 10.1002/dvdy.22336; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	24	30	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45904	10.1371/journal.pone.0045904	http://dx.doi.org/10.1371/journal.pone.0045904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029304	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700087
J	Niu, HJ; Wang, JH; Zhao, TD; Shu, N; He, Y				Niu, Haijing; Wang, Jinhui; Zhao, Tengda; Shu, Ni; He, Yong			Revealing Topological Organization of Human Brain Functional Networks with Resting-State Functional near Infrared Spectroscopy	PLOS ONE			English	Article							SMALL-WORLD; MODULAR ORGANIZATION; CORTICAL NETWORKS; LARGE-SCALE; CONNECTIVITY; LANGUAGE; INFANTS; CORTEX; ARCHITECTURE; BEHAVIOR	Background: The human brain is a highly complex system that can be represented as a structurally interconnected and functionally synchronized network, which assures both the segregation and integration of information processing. Recent studies have demonstrated that a variety of neuroimaging and neurophysiological techniques such as functional magnetic resonance imaging (MRI), diffusion MRI and electroencephalography/magnetoencephalography can be employed to explore the topological organization of human brain networks. However, little is known about whether functional near infrared spectroscopy (fNIRS), a relatively new optical imaging technology, can be used to map functional connectome of the human brain and reveal meaningful and reproducible topological characteristics. Results: We utilized resting-state fNIRS (R-fNIRS) to investigate the topological organization of human brain functional networks in 15 healthy adults. Brain networks were constructed by thresholding the temporal correlation matrices of 46 channels and analyzed using graph-theory approaches. We found that the functional brain network derived from R-fNIRS data had efficient small-world properties, significant hierarchical modular structure and highly connected hubs. These results were highly reproducible both across participants and over time and were consistent with previous findings based on other functional imaging techniques. Conclusions: Our results confirmed the feasibility and validity of using graph-theory approaches in conjunction with optical imaging techniques to explore the topological organization of human brain networks. These results may expand a methodological framework for utilizing fNIRS to study functional network changes that occur in association with development, aging and neurological and psychiatric disorders.	[Niu, Haijing; Wang, Jinhui; Zhao, Tengda; Shu, Ni; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	He, Y (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	yong.he@bnu.edu.cn	He, Yong/C-2161-2009; He, Yong/Q-5756-2018; Wang, jinhui/AAF-8668-2019	He, Yong/0000-0002-7039-2850	Natural Science Foundation of China [81030028, 81201122]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant numbers 81030028 and 81201122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Duan L, 2012, NEUROIMAGE, V60, P2008, DOI 10.1016/j.neuroimage.2012.02.014; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; He Y, 2010, CURR OPIN NEUROL, V23, P341, DOI 10.1097/WCO.0b013e32833aa567; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2003, PSYCHOPHYSIOLOGY, V40, P511, DOI 10.1111/1469-8986.00053; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Lu CM, 2010, J NEUROSCI METH, V186, P242, DOI 10.1016/j.jneumeth.2009.11.010; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; Nakano T, 2009, CEREB CORTEX, V19, P455, DOI 10.1093/cercor/bhn096; Niu HJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3561687; Niu HJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462986; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2011, NEUROIMAGE IN PRESS; Stam CJ, 2010, J NEUROL SCI, V289, P128, DOI 10.1016/j.jns.2009.08.028; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White BR, 2012, NEUROIMAGE, V59, P2529, DOI 10.1016/j.neuroimage.2011.08.094; White BR, 2009, NEUROIMAGE, V47, P148, DOI 10.1016/j.neuroimage.2009.03.058; Xia M, 2011, BRAIN CONNE IN PRESS; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang H, 2011, NEUROIMAGE, V55, P607, DOI 10.1016/j.neuroimage.2010.12.007; Zhang H, 2010, NEUROIMAGE, V51, P1150, DOI 10.1016/j.neuroimage.2010.02.080; Zhang YJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3462973; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	64	64	65	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45771	10.1371/journal.pone.0045771	http://dx.doi.org/10.1371/journal.pone.0045771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029235	Green Published, gold			2022-12-25	WOS:000309554700070
J	Saito, S; Furuno, A; Sakurai, J; Park, HR; Shin-ya, K; Tomida, A				Saito, Sakae; Furuno, Aki; Sakurai, Junko; Park, Hae-Ryong; Shin-ya, Kazuo; Tomida, Akihiro			Compound C Prevents the Unfolded Protein Response during Glucose Deprivation through a Mechanism Independent of AMPK and BMP Signaling	PLOS ONE			English	Article							KINASE INHIBITORS; CHEMICAL GENOMICS; CELL-SURVIVAL; MESSENGER-RNA; ATF6; STRESS; PROLIFERATION; PROTEOLYSIS; ACTIVATION; RESISTANCE	Inhibiting the unfolded protein response (UPR) can be a therapeutic approach, especially for targeting the tumor microenvironment. Here, we show that compound C (also known as dorsomorphin), a small-molecule inhibitor of AMP-activated protein kinase (AMPK) and bone morphogenetic protein (BMP) signaling, inhibit the UPR-induced transcription program depending on the glucose deprivation conditions. We found that compound C prevented UPR marker glucose-regulated protein 78 (GRP78) accumulation and exerted enhanced cytotoxicity during glucose deprivation. Gene expression profiling, together with biochemical analysis, revealed that compound C had a unique mode of action to suppress the transcriptional activation of UPR-targeted genes, as compared with the classic UPR inhibitors versipelostatin and biguanides. Surprisingly, the UPR-inhibiting activity of compound C was not associated with either AMPK or BMP signaling inhibition. We further found that combination treatments of compound C and the classic UPR inhibitors resulted in synergistic cell death with UPR suppression during glucose deprivation. Our findings demonstrate that compound C could be a unique tool for developing a UPR-targeted antitumor therapy.	[Saito, Sakae; Furuno, Aki; Sakurai, Junko; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan; [Park, Hae-Ryong] Kyungnam Univ, Dept Food Sci & Biotechnol, Masan, South Korea; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Kyungnam University; National Institute of Advanced Industrial Science & Technology (AIST)	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan.	akihiro.tomida@jfcr.or.jp	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661	Ministry of Education, Culture, Sports, Science and Technology of Japan [22300342, 23701067]; National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare [21-3-1]; Kobayashi Foundation for Cancer Research; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [24650626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research (B) (22300342; AT) and a Grant-in-Aid for Young Scientists (B) (23701067; SS), from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the National Cancer Center Research and Development Fund (21-3-1) (AT) from the Ministry of Health, Labour and Welfare; a grant from Kobayashi Foundation for Cancer Research (AT); and from the Vehicle Racing Commemorative Foundation (AT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Dan S, 2002, CANCER RES, V62, P1139; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DILMAN VM, 1979, CANCER LETT, V7, P357, DOI 10.1016/S0304-3835(79)80066-X; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Haga N, 2010, CANCER SCI, V101, P1125, DOI 10.1111/j.1349-7006.2010.01525.x; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Matsuo J, 2009, CANCER SCI, V100, P327, DOI 10.1111/j.1349-7006.2008.01036.x; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogiso Y, 2000, CANCER RES, V60, P2429; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito S, 2011, METHOD ENZYMOL, V491, P327, DOI 10.1016/B978-0-12-385928-0.00018-3; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45845	10.1371/journal.pone.0045845	http://dx.doi.org/10.1371/journal.pone.0045845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029271	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700078
J	Wang, XP; Deng, XL; Zhang, XC				Wang, Xinping; Deng, Xuliang; Zhang, Xichen			Identification of a Novel Splicing Form of Amelogenin Gene in a Reptile, Ctenosaura similis	PLOS ONE			English	Article							PRIMARY RNA TRANSCRIPT; MESSENGER-RNAS; DNA-SEQUENCE; RAT INCISOR; CDNA SEQUENCE; IN-VIVO; PROTEIN; ENAMEL; CLONING; EXPRESSION	Amelogenin, the major enamel matrix protein in tooth development, has been demonstrated to play a significant role in tooth enamel formation. Previous studies have identified the alternative splicing of amelogenin in many mammalian vertebrates as one mechanism for amelogenin heterogeneous expression in teeth. While amelogenin and its splicing forms in mammalian vertebrates have been cloned and sequenced, the amelogenin gene, especially its splicing forms in non-mammalian species, remains largely unknown. To better understand the mechanism underlying amelogenin evolution, we previously cloned and characterized an amelogenin gene sequence from a squamate, the green iguana. In this study, we employed RT-PCR to amplify the amelogenin gene from the black spiny-tailed iguana Ctenosaura similis teeth, and discovered a novel splicing form of the amelogenin gene. The transcript of the newly identified iguana amelogenin gene (named C. Similis-T2L) is 873 nucleotides long encoding an expected polypeptide of 206 amino acids. The C. Similis-T2L contains a unique exon denominated exon X, which is located between exon 5 and exon 6. The C. Similis-T2L contains 7 exons including exon 1, 2, 3, 5, X, 6, and 7. Analysis of the secondary and tertiary structures of T2L amelogenin protein demonstrated that exon X has a dramatic effect on the amelogenin structures. This is the first report to provide definitive evidence for the amelogenin alternative splicing in non-mammalian vertebrates, revealing a unique exon X and the splicing form of the amelogenin gene transcript in Ctenosaura similis.	[Wang, Xinping; Zhang, Xichen] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China; [Deng, Xuliang] Beijing Univ, Sch Stomatol, Beijing 100871, Peoples R China	Jilin University; Peking University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376	Jilin University [4305050102Q6, 4305050102O1]; National Basic Research Program of China [2012CB933904]; National Natural Science Foundation of China [81171000]	Jilin University(Jilin University); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Jilin University (4305050102Q6 and 4305050102O1) to Xinping Wang; the National Basic Research Program of China (2012CB933904), the National Natural Science Foundation of China (No. 81171000) to Xuliang Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOBA T, 1989, J DENT RES, V68, P1331, DOI 10.1177/00220345890680090901; Baba O, 2002, J HISTOCHEM CYTOCHEM, V50, P1229, DOI 10.1177/002215540205000910; BONASS WA, 1994, BIOCHEM BIOPH RES CO, V198, P755, DOI 10.1006/bbrc.1994.1109; BONASS WA, 1994, BBA-GENE STRUCT EXPR, V1219, P690, DOI 10.1016/0167-4781(94)90228-3; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; DENBESTEN PK, 1992, ARCH ORAL BIOL, V37, P1097, DOI 10.1016/0003-9969(92)90043-8; DIEKWISCH T, 1993, DEVELOPMENT, V117, P471; GIBSON C, 1991, BIOCHEMISTRY-US, V30, P1075, DOI 10.1021/bi00218a028; Hu CC, 1996, J DENT RES, V75, P1728, DOI 10.1177/00220345960750100401; Hu CC, 1996, J DENT RES, V75, P1735, DOI 10.1177/00220345960750100501; Hu CC, 1997, J DENT RES, V76, P641, DOI 10.1177/00220345970760020401; Ishiyama M, 1998, ARCH HISTOL CYTOL, V61, P467, DOI 10.1679/aohc.61.467; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; Li R, 1995, J DENT RES, V74, P1880, DOI 10.1177/00220345950740121101; Li W, 1998, ARCH ORAL BIOL, V43, P497, DOI 10.1016/S0003-9969(98)00013-2; Lyaruu DM, 1998, EUR J ORAL SCI, V106, P299, DOI 10.1111/j.1600-0722.1998.tb02190.x; LYNGSTADAAS SP, 1995, EMBO J, V14, P5224, DOI 10.1002/j.1460-2075.1995.tb00207.x; Mathur Ajay Kishore, 2000, Journal of Mammalian Evolution, V7, P23, DOI 10.1023/A:1009413632741; SALIDO EC, 1992, AM J HUM GENET, V50, P303; Shimokawa H, 1987, Adv Dent Res, V1, P293; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; SNEAD ML, 1985, BIOCHEM BIOPH RES CO, V129, P812, DOI 10.1016/0006-291X(85)91964-3; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; Veis A, 2003, CELL MOL LIFE SCI, V60, P38, DOI 10.1007/s000180300003; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Wang XP, 2006, J EXP ZOOL PART B, V306B, P393, DOI 10.1002/jez.b.21096; Wang XP, 2005, J EXP ZOOL PART B, V304B, P177, DOI 10.1002/jez.b.21035; Wood C. B., 1999, Journal of Mammalian Evolution, V6, P177, DOI 10.1023/A:1020624222324; Zhang X, 2011, PLOS ONE, V6, P1	32	6	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45871	10.1371/journal.pone.0045871	http://dx.doi.org/10.1371/journal.pone.0045871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029286	Green Submitted, gold, Green Published			2022-12-25	WOS:000309554700080
J	Ofran, Y; Paltiel, O; Pelleg, D; Rowe, JM; Yom-Tov, E				Ofran, Yishai; Paltiel, Ora; Pelleg, Dan; Rowe, Jacob M.; Yom-Tov, Elad			Patterns of Information-Seeking for Cancer on the Internet: An Analysis of Real World Data	PLOS ONE			English	Article							HEALTH INFORMATION; INTERVENTION; PROGNOSIS	Although traditionally the primary information sources for cancer patients have been the treating medical team, patients and their relatives increasingly turn to the Internet, though this source may be misleading and confusing. We assess Internet searching patterns to understand the information needs of cancer patients and their acquaintances, as well as to discern their underlying psychological states. We screened 232,681 anonymous users who initiated cancer-specific queries on the Yahoo Web search engine over three months, and selected for study users with high levels of interest in this topic. Searches were partitioned by expected survival for the disease being searched. We compared the search patterns of anonymous users and their contacts. Users seeking information on aggressive malignancies exhibited shorter search periods, focusing on disease-and treatment-related information. Users seeking knowledge regarding more indolent tumors searched for longer periods, alternated between different subjects, and demonstrated a high interest in topics such as support groups. Acquaintances searched for longer periods than the proband user when seeking information on aggressive (compared to indolent) cancers. Information needs can be modeled as transitioning between five discrete states, each with a unique signature representing the type of information of interest to the user. Thus, early phases of information-seeking for cancer follow a specific dynamic pattern. Areas of interest are disease dependent and vary between probands and their contacts. These patterns can be used by physicians and medical Web site authors to tailor information to the needs of patients and family members.	[Ofran, Yishai] Rambam Med Ctr, Dept Hematol & Bone Marrow Transplantat, Haifa, Israel; [Ofran, Yishai] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Paltiel, Ora] Hadassah Univ Hosp, Dept Hematol, IL-91120 Jerusalem, Israel; [Paltiel, Ora] Hadassah Univ Hosp, Sch Publ Hlth, IL-91120 Jerusalem, Israel; [Pelleg, Dan] Yahoo Res, Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Jerusalem, Israel; [Yom-Tov, Elad] Yahoo Res, New York, NY USA	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Yom-Tov, E (corresponding author), Microsoft Res, New York, NY USA.	eladyt@microsoft.com		Yom-Tov, Elad/0000-0002-2380-4584; Ofran, Yishai/0000-0002-5521-1337				Breyer BN, 2010, EPIDEMIOLOGY, V21, P584, DOI 10.1097/EDE.0b013e3181e080cd; Butow PN, 1997, ANN ONCOL, V8, P857, DOI 10.1023/A:1008284006045; Bylund CL, 2009, PSYCHO-ONCOLOGY, V18, P1139, DOI 10.1002/pon.1511; Castleton K, 2011, SUPPORT CARE CANCER, V19, P1183, DOI 10.1007/s00520-010-0935-5; Chou WYS, 2011, J CANCER SURVIV, V5, P263, DOI 10.1007/s11764-011-0179-5; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1315, DOI 10.1038/nbt1004-1315; Gage EA, 2011, SOCIOL HLTH ILLN, V2011; Gencer D, 2011, ONKOLOGIE, V34, P435, DOI 10.1159/000330940; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Howlader N, 2011, SEER CANC STAT REV 1; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Imes RS, 2008, HEALTH COMMUN, V23, P538, DOI 10.1080/10410230802460580; INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604; James N, 2007, CLIN ONCOL-UK, V19, P356, DOI 10.1016/j.clon.2007.02.005; Kubler-Ross E., 1973, DEATH DYING; Lee SJ, 2003, BIOL BLOOD MARROW TR, V9, P389, DOI 10.1016/S1083-8791(03)00103-4; Lopez-Gomez M, 2011, ANN ONCOL, V2011; Nagler RH, 2010, PATIENT EDUC COUNS, V81, pS54, DOI 10.1016/j.pec.2010.09.010; Partin MR, 2003, J CLIN EPIDEMIOL, V56, P867, DOI 10.1016/S0895-4356(03)00061-1; Paul MJ, 2011, ICWSM 2011; Quin J, 2010, J SURG RES, V160, P35, DOI 10.1016/j.jss.2008.10.004; Russ H, 2011, ISR MED ASSOC J, V13, P220; Shiffman S, 2009, HEALTH PSYCHOL, V28, P519, DOI 10.1037/a0015197; Smith-McLallen A, 2011, J HLTH COMM, V1, P1; Snow R., 2008, P C EMP METH NAT LAN, P254, DOI DOI 10.3115/1613715.1613751; Sogaard AJ, 2004, INT J EQUITY HLTH, V3; Stehl ML, 2009, J PEDIATR PSYCHOL, V34, P803, DOI 10.1093/jpepsy/jsn130; Temel JS, 2011, J CLIN ONCOL, V29, P2319, DOI 10.1200/JCO.2010.32.4459; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; WEISMAN AD, 1976, INT J PSYCHIAT MED, V7, P1, DOI 10.2190/UQ2G-UGV1-3PPC-6387; White R. W., 2009, P CIKM; White RW, 2009, ACM T INFORM SYST, P271; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; YANG H, 2010, P ACM SIGIR, P459; Yom-Tov E, 2011, SIGIR, P385	37	46	46	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45921	10.1371/journal.pone.0045921	http://dx.doi.org/10.1371/journal.pone.0045921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029317	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800121
J	Qian, J; Yao, DM; Lin, J; Qian, W; Wang, CZ; Chai, HY; Yang, J; Li, Y; Deng, ZQ; Ma, JC; Chen, XX				Qian, Jun; Yao, Dong-ming; Lin, Jiang; Qian, Wei; Wang, Cui-zhu; Chai, Hai-yan; Yang, Jing; Li, Yun; Deng, Zhao-qun; Ma, Ji-chun; Chen, Xing-xing			U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome	PLOS ONE			English	Article							MECHANISMS; MACHINERY; PATHWAY; DISEASE; IMPACT; CYCLE	Somatic mutations of U2AF1 gene have recently been identified in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this study, we analyzed the frequency and clinical impact of U2AF1 mutations in a cohort of 452 Chinese patients with myeloid neoplasms. Mutations in U2AF1 were found in 2.5% (7/275) of AML and 6.3% (6/96) of MDS patients, but in none of 81 CML. All mutations were heterozygous missense mutations affecting codon S34 or Q157. There was no significant association of U2AF1 mutation with blood parameters, FAB subtypes, karyotypes and other gene mutations in AML. The overall survival (OS) of AML patients with U2AF1 mutation (median 3 months) was shorter than those without mutation (median 7 months) (P = 0.035). No difference in the OS was observed between MDS patients with and without U2AF1 mutations. Our data show that U2AF1 mutation is a recurrent event at a low frequency in AML and MDS.	[Qian, Jun; Lin, Jiang; Wang, Cui-zhu; Chai, Hai-yan; Yang, Jing; Li, Yun; Ma, Ji-chun; Chen, Xing-xing] Jiangsu Univ, Affiliated Peoples Hosp, Dept Haematol, Zhenjiang, Jiangsu, Peoples R China; [Lin, Jiang; Qian, Wei; Deng, Zhao-qun] Jiangsu Univ, Affiliated Peoples Hosp, Lab Ctr, Zhenjiang, Jiangsu, Peoples R China; [Yao, Dong-ming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Lin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Haematol, Zhenjiang, Jiangsu, Peoples R China.	linjiangmail@sina.com; dwqian@yahoo.com			Science and Technology Special Project in Clinical Medicine of Jiangsu Province [BL2012056]; National Natural Science foundation of China [81172592]; 333 Project of Jiangsu Province [BRA2011085]; Natural Science foundation of Jiangsu Province [BK2009206]	Science and Technology Special Project in Clinical Medicine of Jiangsu Province; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by Science and Technology Special Project in Clinical Medicine of Jiangsu Province (BL2012056), National Natural Science foundation of China (81172592), 333 Project of Jiangsu Province (BRA2011085) and Natural Science foundation of Jiangsu Province (BK2009206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Damm F, 2012, BLOOD, V119, P3211, DOI 10.1182/blood-2011-12-400994; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ding WQ, 2002, CANCER RES, V62, P947; Dohner H, 2011, HEMATOL-AM SOC HEMAT, P36, DOI 10.1182/asheducation-2011.1.36; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Huntly BJP, 2005, NATURE, V435, P1169, DOI 10.1038/4351169a; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lin J, 2012, ANN HEMATOL, V91, P519, DOI 10.1007/s00277-011-1352-7; Lin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026906; Makishima H, 2012, BLOOD, V119, P3203, DOI 10.1182/blood-2011-12-399774; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Qian J, 2010, CLIN CHIM ACTA, V411, P2097, DOI 10.1016/j.cca.2010.08.020; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Swerdlow E., 2008, WHO CLASSIFICATION T; Szankasi P, 2008, J MOL DIAGN, V10, P236, DOI 10.2353/jmoldx.2008.070167; Thol F, 2012, BLOOD, V119, P3578, DOI 10.1182/blood-2011-12-399337; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x	25	68	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45760	10.1371/journal.pone.0045760	http://dx.doi.org/10.1371/journal.pone.0045760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029227	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388400129
J	Ruiz, OE; Nikolova, LS; Metzstein, MM				Ruiz, Oscar E.; Nikolova, Linda S.; Metzstein, Mark M.			Drosophila Zpr1 (Zinc Finger Protein 1) Is Required Downstream of Both EGFR And FGFR Signaling in Tracheal Subcellular Lumen Formation	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; CELL-MIGRATION; BRANCHING MORPHOGENESIS; ECTOPIC EXPRESSION; RECEPTOR HOMOLOG; GENE ENCODES; SMN PROTEIN; SYSTEM; MELANOGASTER; PATTERN	The cellular and molecular cues involved in creating branched tubular networks that transport liquids or gases throughout an organism are not well understood. To identify factors required in branching and lumen formation of Drosophila tracheal terminal cells, a model for branched tubular networks, we performed a forward genetic-mosaic screen to isolate mutations affecting these processes. From this screen, we have identified the first Drosophila mutation in the gene Zpr1 (Zinc finger protein 1) by the inability of Zpr1-mutant terminal cells to form functional, gas-filled lumens. We show that Zpr1 defective cells initiate lumen formation, but are blocked from completing the maturation required for gas filling. Zpr1 is an evolutionarily conserved protein first identified in mammalian cells as a factor that binds the intracellular domain of the unactivated epidermal growth factor receptor (EGFR). We show that down-regulation of EGFR in terminal cells phenocopies Zpr1 mutations and that Zpr1 is epistatic to ectopic lumen formation driven by EGFR overexpression. However, while Zpr1 mutants are fully penetrant, defects observed when reducing EGFR activity are only partially penetrant. These results suggest that a distinct pathway operating in parallel to the EGFR pathway contributes to lumen formation, and this pathway is also dependent on Zpr1. We provide evidence that this alternative pathway may involve fibroblast growth factor receptor (FGFR) signaling. We suggest a model in which Zpr1 mediates both EGFR and FGFR signal transduction cascades required for lumen formation in terminal cells. To our knowledge, this is the first genetic evidence placing Zpr1 downstream of EGFR signaling, and the first time Zpr1 has been implicated in FGFR signaling. Finally, we show that down-regulation of Smn, a protein known to interact with Zpr1 in mammalian cells, shows defects similar to Zpr1 mutants.	[Ruiz, Oscar E.; Nikolova, Linda S.; Metzstein, Mark M.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Metzstein, MM (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	markm@genetics.utah.edu		Ruiz, Oscar/0000-0002-5426-260X	Kirschstein-NRSA predoctoral institutional training grant at the University of Utah [NIH 5T32GM007464-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM084947] Funding Source: NIH RePORTER	Kirschstein-NRSA predoctoral institutional training grant at the University of Utah; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	OER was supported by a Kirschstein-NRSA predoctoral institutional training grant at the University of Utah (NIH 5T32GM007464-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Ahmad S, 2012, HUM MOL GENET, V21, P2745, DOI 10.1093/hmg/dds102; Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088; BIER E, 1989, GENE DEV, V3, P1273, DOI 10.1101/gad.3.9.1273; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; CHOU TB, 1992, GENETICS, V131, P643; CLIFFORD RJ, 1989, GENETICS, V123, P771; Doran B, 2006, P NATL ACAD SCI USA, V103, P7471, DOI 10.1073/pnas.0602057103; Egginton S, 2011, ACTA PHYSIOL, V202, P225, DOI 10.1111/j.1748-1716.2010.02194.x; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Galcheva-Gargova Z, 1998, MOL BIOL CELL, V9, P2963, DOI 10.1091/mbc.9.10.2963; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Gangwani L, 2005, MOL CELL BIOL, V25, P2744, DOI 10.1128/MCB.25.7.2744-2756.2005; Gangwani L, 2001, NAT CELL BIOL, V3, P376, DOI 10.1038/35070059; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Gangwani L, 2006, J BIOL CHEM, V281, P40330, DOI 10.1074/jbc.M608165200; Gervais L, 2010, CURR BIOL, V20, P359, DOI 10.1016/j.cub.2009.12.043; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Ghabrial AS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002087; GLAZER L, 1991, GENE DEV, V5, P697, DOI 10.1101/gad.5.4.697; Guillemin K, 1996, DEVELOPMENT, V122, P1353; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Jeon M, 2009, DEVELOPMENT, V136, P3121, DOI 10.1242/dev.033597; JONES T, 2011, AGENDA, V45, P153, DOI DOI 10.1534/GENETICS.111.130351; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Llimargas M, 1999, DEV GENES EVOL, V209, P174, DOI 10.1007/s004270050241; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miguel-Aliaga I, 2000, FEBS LETT, V486, P99, DOI 10.1016/S0014-5793(00)02243-2; Mishra AK, 2007, P NATL ACAD SCI USA, V104, P13930, DOI 10.1073/pnas.0704915104; Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Rajendra TK, 2007, J CELL BIOL, V176, P831, DOI 10.1083/jcb.200610053; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rozen S, 2000, Methods Mol Biol, V132, P365; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schottenfeld-Roames J, 2012, NAT CELL BIOL, V14, P386, DOI 10.1038/ncb2454; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; Shim K, 2001, DEVELOPMENT, V128, P4923; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vanhecke D, 2008, METHOD CELL BIOL, V88, P151, DOI 10.1016/S0091-679X(08)00409-3; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wilk R, 2000, DEV BIOL, V219, P183, DOI 10.1006/dbio.2000.9619; XU T, 1993, DEVELOPMENT, V117, P1223	55	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45649	10.1371/journal.pone.0045649	http://dx.doi.org/10.1371/journal.pone.0045649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029159	Green Submitted, gold, Green Published			2022-12-25	WOS:000311313900165
J	Asthana, J; Kuchibhatla, A; Jana, SC; Ray, K; Panda, D				Asthana, Jayant; Kuchibhatla, Anuradha; Jana, Swadhin Chandra; Ray, Krishanu; Panda, Dulal			Dynein Light Chain 1 (LC8) Association Enhances Microtubule Stability and Promotes Microtubule Bundling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; FISSION YEAST; IN-VIVO; KINETIC STABILIZATION; DYNAMIC MICROTUBULES; MITOTIC SPINDLE; CROSS-LINKERS; MYOSIN-V; PROTEIN; DROSOPHILA	Dynein light chain 1 (LC8), a highly conserved protein, is known to bind to a variety of different polypeptides. It functions as a dimer, which is inactivated through phosphorylation at the Ser-88 residue. A loss of LC8 function causes apoptosis in Drosophila embryos, and its overexpression induces malignant transformation of breast cancer cells. Here we show that LC8 binds to tubulin, promotes microtubule assembly, and induces the bundling of reconstituted microtubules in vitro. Furthermore, LC8 decorates microtubules both in Drosophila embryos and in HeLa cells, increases the microtubule stability, and promotes microtubule bundling in these cells. Microtubule stability influences a number of different cellular functions including mitosis and cell differentiation. The LC8 overexpression reduces the susceptibility of microtubules to cold and nocodazole-induced depolymerization in tissue-cultured cells and increases microtubule acetylation, suggesting that LC8 stabilizes microtubules. We also show that LC8 knockdown or transfection with inhibitory peptides destabilizes microtubules and inhibits bipolar spindle assembly in HeLa cells. In addition, LC8 knockdown leads to the mitotic block in HeLa cells. Furthermore, molecular docking analysis using the crystal structures of tubulin and LC8 dimer indicated that the latter may bind at alpha-beta tubulin junction in a protofilament at sites distinct from the kinesin and dynein binding sites. Together, we provide the first evidence of a novel microtubule-associated protein-like function of LC8 that could explain its reported roles in cellular metastasis and differentiation.	[Asthana, Jayant; Kuchibhatla, Anuradha; Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Jana, Swadhin Chandra; Ray, Krishanu] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Tata Institute of Fundamental Research (TIFR)	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in	Asthana, Jayant/AFQ-7879-2022	Ray, Krishanu/0000-0001-6406-3199; Asthana, Dr. Jayant/0000-0002-8961-6308; Jana, Swadhin/0000-0002-8311-3849	Department of Atomic Energy (DAE) Science Research Council, Government of India; Tata Institute of Fundamental Research, DAE	Department of Atomic Energy (DAE) Science Research Council, Government of India; Tata Institute of Fundamental Research, DAE	This work was supported by a grant from the Department of Atomic Energy (DAE) Science Research Council, Government of India (to D. P.) and by intramural funds of the Tata Institute of Fundamental Research, DAE (to K. R.).	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Asakawa K, 2005, EMBO REP, V6, P1194, DOI 10.1038/sj.embor.7400540; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Diaz-Rodriguez E, 2008, P NATL ACAD SCI USA, V105, P16719, DOI 10.1073/pnas.0803504105; Dick T, 1996, MOL CELL BIOL, V16, P1966; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Ghosh-Roy A, 2004, MOL BIOL CELL, V15, P2470, DOI 10.1091/mbc.E03-11-0848; Glotzer M, 2009, CURR BIOL, V19, pR162, DOI 10.1016/j.cub.2008.12.028; Goldstone S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010634; Graf ER, 2011, J NEUROSCI, V31, P15026, DOI 10.1523/JNEUROSCI.2024-11.2011; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Herzig RP, 2000, J CELL SCI, V113, P4263; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; Lippens G, 2007, PRION, V1, P21, DOI 10.4161/pri.1.1.4055; Liu B, 2003, MOL MICROBIOL, V47, P291, DOI 10.1046/j.1365-2958.2003.03285.x; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Mayer C, 2006, CELL CYCLE, V5, P1456, DOI 10.4161/cc.5.13.2912; Mohan PMK, 2006, PROTEIN SCI, V15, P335, DOI 10.1110/ps.051854906; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Musch A, 2004, TRAFFIC, V5, P1, DOI 10.1046/j.1600-0854.2003.00149.x; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; PELLMAN D, 1995, J CELL BIOL, V130, P1373, DOI 10.1083/jcb.130.6.1373; Peterman EJG, 2009, CURR BIOL, V19, pR1089, DOI 10.1016/j.cub.2009.10.047; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang D, 2007, REPRODUCTION, V133, P685, DOI 10.1530/rep.1.01167	67	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40793	40805		10.1074/jbc.M112.394353	http://dx.doi.org/10.1074/jbc.M112.394353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038268	Green Published, hybrid			2022-12-25	WOS:000311448800067
J	Lee, JH; Fischer, JA				Lee, Ji-Hoon; Fischer, Janice A.			Drosophila Tel2 Is Expressed as a Translational Fusion with EpsinR and Is a Regulator of Wingless Signaling	PLOS ONE			English	Article							ENTH-DOMAIN PROTEIN; RETROMER COMPLEX; LIQUID FACETS; BETA-CATENIN; FAT-FACETS; E-CADHERIN; BINDING; ENDOCYTOSIS; ACTIVATION; SECRETION	Tel2, a protein conserved from yeast to vertebrates, is an essential regulator of diverse cellular processes including telomere maintenance, DNA damage checkpoints, DNA repair, biological clocks, and cell signaling. The Drosophila Tel2 protein is produced as a translational fusion with EpsinR, a Clathrin adapter that facilitates vesicle trafficking between the Golgi and endosomes. EpsinR and Tel2 are encoded by a Drosophila gene called lqfR. lqfR is required for viability, and its specific roles include cell growth, proliferation, and planar cell polarity. We find that all of these functions of lqfR are attributed entirely to Tel2, not EpsinR. In addition, we find that Drosophila LqfR/Tel2 is a component of one or more protein complexes that contain E-cadherin and Armadillo. Moreover, Tel2 modulates E-cadherin and Armadillo cellular dynamics. We propose that at least one of the functions of Drosophila Tel2 is regulation of Wingless signaling.	[Lee, Ji-Hoon; Fischer, Janice A.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fischer, JA (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Austin, TX 78712 USA.	jaf@mail.utexas.edu			National Institute of Child Health and Human Development (NICHD) [RO1-HD30680]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030680] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (NICHD) Grant RO1-HD30680. The funders had no role in study design, data collection and alaysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V103, P4116; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Anderson CM, 2008, CELL CYCLE, V7, P3695, DOI 10.4161/cc.7.23.7154; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Benard C, 2001, DEVELOPMENT, V128, P4045; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kemler R, 1992, Semin Cell Biol, V3, P149; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Leventis PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025466; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Overstreet E, 2005, THESIS U TEXAS AUSTI; Parker DS, 2002, DEVELOPMENT, V129, P2565; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Seppa MJ, 2008, DEV BIOL, V318, P1, DOI 10.1016/j.ydbio.2008.02.022; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Xie XH, 2012, DEV BIOL, V363, P399, DOI 10.1016/j.ydbio.2012.01.004; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	59	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46357	10.1371/journal.pone.0046357	http://dx.doi.org/10.1371/journal.pone.0046357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029494	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900142
J	Scala, C; Tian, XJ; Mehdiabadi, NJ; Smith, MH; Saxer, G; Stephens, K; Buzombo, P; Strassmann, JE; Queller, DC				Scala, Clea; Tian, Xiangjun; Mehdiabadi, Natasha J.; Smith, Margaret H.; Saxer, Gerda; Stephens, Katie; Buzombo, Prince; Strassmann, Joan E.; Queller, David C.			Amino Acid Repeats Cause Extraordinary Coding Sequence Variation in the Social Amoeba Dictyostelium discoideum	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; TRINUCLEOTIDE REPEATS; SELF-INCOMPATIBILITY; COMPARATIVE GENOMICS; MICROSATELLITES; EVOLUTION; SELECTION; DNA; GENES; RECOMBINATION	Protein sequences are normally the most conserved elements of genomes owing to purifying selection to maintain their functions. We document an extraordinary amount of within-species protein sequence variation in the model eukaryote Dictyostelium discoideum stemming from triplet DNA repeats coding for long strings of single amino acids. D. discoideum has a very large number of such strings, many of which are polyglutamine repeats, the same sequence that causes various human neurological disorders in humans, like Huntington's disease. We show here that D. discoideum coding repeat loci are highly variable among individuals, making D. discoideum a candidate for the most variable proteome. The coding repeat loci are not significantly less variable than similar non-coding triplet repeats. This pattern is consistent with these amino-acid repeats being largely non-functional sequences evolving primarily by mutation and drift.	[Tian, Xiangjun; Strassmann, Joan E.; Queller, David C.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Scala, Clea; Mehdiabadi, Natasha J.; Smith, Margaret H.; Stephens, Katie; Buzombo, Prince] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA; [Saxer, Gerda] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA	Washington University (WUSTL); Rice University; Rice University	Queller, DC (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	queller@wustl.edu		Strassmann, Joan/0000-0003-0638-8440; Smith, Margaret/0000-0002-3523-0979	National Science Foundation [DEB-0918931]; Division Of Environmental Biology [0949689] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation under Grant No. DEB-0918931 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 1996, NAT GENET, V13, P390, DOI 10.1038/ng0896-390; Awadalla P, 1999, GENETICS, V152, P413; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Clark AG, 1993, EVOLUTIONARY INFEREN; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Fondon JW, 2008, TRENDS NEUROSCI, V31, P328, DOI 10.1016/j.tins.2008.03.006; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Guillaudeux T, 1998, P NATL ACAD SCI USA, V95, P9494, DOI 10.1073/pnas.95.16.9494; Haerty W, 2010, GENOME RES, V20, P755, DOI 10.1101/gr.101246.109; Hancock JM, 1996, BIOESSAYS, V18, P421, DOI 10.1002/bies.950180512; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1964, GENETICS, V49, P725; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Lewis PO, 2001, GENETIC DATA ANAL GD; Li W. H, 1997, MOL EVOLUTION; LI WH, 1991, FUNDAMENTALS MOL EVO; LITT M, 1989, AM J HUM GENET, V44, P397; McConnell R, 2007, GENETICS, V177, P1499, DOI 10.1534/genetics.107.076067; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; Metzgar D, 2000, GENOME RES, V10, P72; Michalakis Y, 1996, GENETICS, V143, P1713; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Nei M, 1979, P NATL ACAD SCI USA, V76, P362; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Richman AD, 2000, PLANT MOL BIOL, V42, P169, DOI 10.1023/A:1006336206637; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SPUDICH JA, 1982, METHOD CELL BIOL, V25, P359, DOI 10.1016/S0091-679X(08)61433-8; Sucgang R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r20; Tian XJ, 2011, MOL BIOL EVOL, V28, P899, DOI 10.1093/molbev/msq266; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Wierdl M, 1997, GENETICS, V146, P769	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46150	10.1371/journal.pone.0046150	http://dx.doi.org/10.1371/journal.pone.0046150			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029418	Green Published, gold			2022-12-25	WOS:000309973900098
J	Sulaiman, L; Haglund, F; Hashemi, J; Obara, T; Nordenstrom, J; Larsson, C; Juhlin, CC				Sulaiman, Luqman; Haglund, Felix; Hashemi, Jamileh; Obara, Takao; Nordenstrom, Jorgen; Larsson, Catharina; Juhlin, C. Christofer			Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors	PLOS ONE			English	Article							FAMILIAL ISOLATED HYPERPARATHYROIDISM; NUCLEAR-LOCALIZATION; SUPPRESSOR PROTEIN; HRPT2 GENE; HUMAN PAF1; PARAFIBROMIN; MUTATIONS; EXPRESSION; GERMLINE; HYBRIDIZATION	Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin protein have been established in the majority of parathyroid carcinomas and in subsets of parathyroid adenomas. While it is known that CDC73-mutated parathyroid tumors display specific gene expression changes compared to CDC73 wild-type cases, the molecular cytogenetic profile in CDC73-mutated cases compared to unselected adenomas (with an expected very low frequency of CDC73 mutations) remains unknown. For this purpose, nine parathyroid tumors with established CDC73 gene inactivating mutations (three carcinomas, one atypical adenoma and five adenomas) were analyzed for copy number alterations and loss of heterozygosity using array-comparative genomic hybridization (a-CGH) and single nucleotide polymorphism (SNP) microarrays, respectively. Furthermore, CDC73 gene promoter methylation levels were assessed using bisulfite Pyrosequencing. The panel included seven tumors with single mutation and three with double mutations of the CDC73 gene. The carcinomas displayed copy number alterations in agreement with previous studies, whereas the CDC73-mutated adenomas did not display the same pattern of alterations at loci frequently deleted in unselected parathyroid tumors. Furthermore, gross losses of chromosomal material at 1p and 13 were significantly (p = 0.012) associated with parathyroid carcinomas as opposed to adenomas. Quantitative PCR-based copy number loss regarding CDC73 was observed in three adenomas, while all the carcinomas were diploid or showed copy number gain for CDC73 gene. Hypermethylation of the CDC73 gene promoter was not observed. Our data could suggest that CDC73-mutated parathyroid adenomas exhibit a partly unique cytogenetic profile in addition to that of carcinomas and unselected adenomas. Furthermore, CDC73-mutated carcinomas displayed losses at 1p and 13 which are not seen in CDC73-mutated adenomas, making these regions of interest for further studies regarding malignant properties in tumors from CDC73-mutated cases. However, due to the small sample size, validation of the results in a larger cohort is warranted.	[Sulaiman, Luqman; Juhlin, C. Christofer] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Haglund, Felix; Hashemi, Jamileh; Larsson, Catharina] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Med Genet Unit, Stockholm, Sweden; [Obara, Takao] Tokyo Womens Med Univ Hosp, Dept Endocrine Surg, Tokyo, Japan; [Nordenstrom, Jorgen] Karolinska Univ Hosp, Karolinska Inst, Endocrine Surg Unit, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Tokyo Women's Medical University; Karolinska Institutet; Karolinska University Hospital	Sulaiman, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Luqman.Sulaiman@ki.se; Catharina.Larsson@ki.se	Juhlin, Carl Christofer/C-1125-2016	Juhlin, Carl Christofer/0000-0002-5945-9081	Swedish Cancer Society; Swedish Research Council [5210-2010-3518]; Gustav V Jubilee Foundation; Karolinska Institutet; Stockholm County Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustav V Jubilee Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was financially supported by Swedish Cancer Society, Swedish Research Council (No. 5210-2010-3518), Gustav V Jubilee Foundation, Karolinska Institutet and Stockholm County Council. LS is supported by a research stipend donated from Mr. Ahmad Ismail Nanakaly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1998, CANCER GENET CYTOGEN, V106, P30, DOI 10.1016/S0165-4608(98)00049-1; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; Bradley KJ, 2006, CLIN ENDOCRINOL, V64, P299, DOI 10.1111/j.1365-2265.2006.02460.x; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cavaco BM, 2004, J CLIN ENDOCR METAB, V89, P1747, DOI 10.1210/jc.2003-031016; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Cetani F, 2007, EUR J ENDOCRINOL, V156, P547, DOI 10.1530/EJE-06-0720; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; CRYNS VL, 1995, GENE CHROMOSOME CANC, V13, P9, DOI 10.1002/gcc.2870130103; Farber LJ, 2010, MOL CARCINOGEN, V49, P215, DOI 10.1002/mc.20591; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Gill AJ, 2006, AM J SURG PATHOL, V30, P1140; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Haven CJ, 2004, CANCER RES, V64, P7405, DOI 10.1158/0008-5472.CAN-04-2063; Howell VM, 2003, J MED GENET, V40, P657, DOI 10.1136/jmg.40.9.657; Juhlin C, 2006, ENDOCR-RELAT CANCER, V13, P509, DOI 10.1677/erc.1.01058; Juhlin CC, 2007, ENDOCR-RELAT CANCER, V14, P501, DOI 10.1677/ERC-07-0021; Juhlin CC, 2011, VIRCHOWS ARCH, V459, P47, DOI 10.1007/s00428-010-1032-3; Juhlin CC, 2010, ENDOCR PATHOL, V21, P166, DOI 10.1007/s12022-010-9121-z; Juhlin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009472; Krebs LJ, 2005, J CLIN ENDOCR METAB, V90, P5015, DOI 10.1210/jc.2005-0717; Kytola S, 2000, AM J PATHOL, V157, P579, DOI 10.1016/S0002-9440(10)64568-3; Lin L, 2007, MOL CANCER RES, V5, P183, DOI 10.1158/1541-7786.MCR-06-0129; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Palanisamy N, 1998, J CLIN ENDOCR METAB, V83, P1766, DOI 10.1210/jc.83.5.1766; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Simonds WF, 2004, J CLIN ENDOCR METAB, V89, P96, DOI 10.1210/jc.2003-030675; Sulaiman L, 2012, ENDOCRINE RELATED CA; Valimaki S, 2002, INT J ONCOL, V21, P727; Villablanca A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012369; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yi Y, 2008, GENE CHROMOSOME CANC, V47, P639, DOI 10.1002/gcc.20565	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46325	10.1371/journal.pone.0046325	http://dx.doi.org/10.1371/journal.pone.0046325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029479	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900134
J	de Celles, MD; Salomon, J; Marinier, A; Lawrence, C; Gaillard, JL; Herrmann, JL; Guillemot, D				de Celles, Matthieu Domenech; Salomon, Jerome; Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis; Guillemot, Didier			Identifying More Epidemic Clones during a Hospital Outbreak of Multidrug-Resistant Acinetobacter baumannii	PLOS ONE			English	Article							HEALTH-CARE WORKERS; STAPHYLOCOCCUS-AUREUS; TRANSMISSION; STRAINS; ROUTES	Infections caused by multidrug-resistant bacteria are a major concern in hospitals. Current infection-control practices legitimately focus on hygiene and appropriate use of antibiotics. However, little is known about the intrinsic abilities of some bacterial strains to cause outbreaks. They can be measured at a population level by the pathogen's transmission rate, i.e. the rate at which the pathogen is transmitted from colonized hosts to susceptible hosts, or its reproduction number, counting the number of secondary cases per infected/colonized host. We collected data covering a 20-month surveillance period for carriage of multidrug-resistant Acinetobacter baumannii (MDRAB) in a surgery ward. All isolates were subjected to molecular fingerprinting, and a cluster analysis of profiles was performed to identify clonal groups. We then applied stochastic transmission models to infer transmission rates of MDRAB and each MDRAB clone. Molecular fingerprinting indicated that 3 clonal complexes spread in the ward. A first model, not accounting for different clones, quantified the level of in-ward cross-transmission, with an estimated transmission rate of 0.03/day (95% credible interval [0.012-0.049]) and a single-admission reproduction number of 0.61 [0.30-1.02]. The second model, accounting for different clones, suggested an enhanced transmissibility of clone 3 (transmission rate 0.047/day [0.018-0.091], with a single-admission reproduction number of 0.81 [0.30-1.56]). Clones 1 and 2 had comparable transmission rates (respectively, 0.016 [0.001-0.045], 0.014 [0.001-0.045]). The method used is broadly applicable to other nosocomial pathogens, as long as surveillance data and genotyping information are available. Building on these results, more epidemic clones could be identified, and could lead to follow-up studies dissecting the functional basis for variation in transmissibility of MDRAB lineages.	[de Celles, Matthieu Domenech; Salomon, Jerome; Guillemot, Didier] Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France; [de Celles, Matthieu Domenech; Salomon, Jerome; Guillemot, Didier] Inst Natl Sante & Rech Med, U657, Paris, France; [de Celles, Matthieu Domenech] Univ Paris 06, Cellule Pasteur UPMC, Paris, France; [Salomon, Jerome] Conservatoire Natl Arts & Metiers, Lab Modelisat & Surveillance Risques Securite San, Paris, France; [Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis] Hop Raymond Poincare, AP HP, Lab Microbiol, Garches, France; [Marinier, Anne; Lawrence, Christine; Gaillard, Jean-Louis; Herrmann, Jean-Louis] Univ Versailles St Quentin En Yvelines, EA 3647, Versailles, France; [de Celles, Matthieu Domenech; Guillemot, Didier] Univ Versailles St Quentin En Yvelines, EA 4499, Versailles, France; [Guillemot, Didier] Hop Raymond Poincare, AP HP, Unite Fonct Sante Publ, Garches, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	de Celles, MD (corresponding author), Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France.	domenech@pasteur.fr	Guillemot, Didier/AAN-3051-2020; SALOMON, JEROME/AGY-7338-2022	Herrmann, Jean-Louis/0000-0003-2347-6418; Domenech de Celles, Matthieu/0000-0002-9302-4858; Guillemot, Didier/0000-0002-8497-1765				ANDERSON R M, 1991; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Charbonneau P, 2006, CLIN INFECT DIS, V42, P778, DOI 10.1086/500319; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2008, AM J EPIDEMIOL, V168, P548, DOI 10.1093/aje/kwn176; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fontana C, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-79; Forrester ML, 2007, BIOSTATISTICS, V8, P383, DOI 10.1093/biostatistics/kxl017; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kaki R, 2011, J ANTIMICROB CHEMOTH, V66, P1223, DOI 10.1093/jac/dkr137; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kretzschmar M, 2010, TRENDS MICROBIOL, V18, P406, DOI 10.1016/j.tim.2010.06.008; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rosenthal VD, 2010, AM J INFECT CONTROL, V38, P95, DOI 10.1016/j.ajic.2009.12.004; Saeed S, 2006, INFECT CONT HOSP EP, V27, P981, DOI 10.1086/507286; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Tenorio AR, 2001, CLIN INFECT DIS, V32, P826, DOI 10.1086/319214; Trampuz A, 2004, MAYO CLIN PROC, V79, P109, DOI 10.4065/79.1.109; Villalon P, 2011, J CLIN MICROBIOL, V49, P875, DOI 10.1128/JCM.01026-10; Wisplinghoff H, 2007, J HOSP INFECT, V66, P174, DOI 10.1016/j.jhin.2007.02.016	37	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45758	10.1371/journal.pone.0045758	http://dx.doi.org/10.1371/journal.pone.0045758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029226	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500042
J	Dicksved, J; Schreiber, O; Willing, B; Petersson, J; Rang, S; Phillipson, M; Holm, L; Roos, S				Dicksved, Johan; Schreiber, Olof; Willing, Ben; Petersson, Joel; Rang, Sara; Phillipson, Mia; Holm, Lena; Roos, Stefan			Lactobacillus reuteri Maintains a Functional Mucosal Barrier during DSS Treatment Despite Mucus Layer Dysfunction	PLOS ONE			English	Article							CROHNS-DISEASE; ESCHERICHIA-COLI; ILEAL MUCOSA; MICROBIOTA; IMBALANCES; DYSBIOSIS; ADHERENCE; BACTERIA; STRAINS; MODEL	Treatment with the probiotic bacterium Lactobacillus reuteri has been shown to prevent dextran sodium sulfate (DSS)-induced colitis in rats. This is partly due to reduced P-selectin-dependent leukocyte-and platelet-endothelial cell interactions, however, the mechanism behind this protective effect is still unknown. In the present study a combination of culture dependent and molecular based T-RFLP profiling was used to investigate the influence of L. reuteri on the colonic mucosal barrier of DSS treated rats. It was first demonstrated that the two colonic mucus layers of control animals had different bacterial community composition and that fewer bacteria resided in the firmly adherent layer. During DSS induced colitis, the number of bacteria in the inner firmly adherent mucus layer increased and bacterial composition of the two layers no longer differed. In addition, induction of colitis dramatically altered the microbial composition in both firmly and loosely adherent mucus layers. Despite protecting against colitis, treatment with L. reuteri did not improve the integrity of the mucus layer or prevent distortion of the mucus microbiota caused by DSS. However, L. reuteri decreased the bacterial translocation from the intestine to mesenteric lymph nodes during DSS treatment, which might be an important part of the mechanisms by which L. reuteri ameliorates DSS induced colitis.	[Dicksved, Johan; Willing, Ben; Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Schreiber, Olof; Petersson, Joel; Rang, Sara; Phillipson, Mia; Holm, Lena] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Willing, Ben] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Rang, Sara] Lund Univ, Ctr Chem & Chem Engn, Lund, Sweden	Swedish University of Agricultural Sciences; Uppsala University; University of British Columbia; Lund University	Roos, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Box 7025, S-75007 Uppsala, Sweden.	stefan.roos@slu.se		Dicksved, Johan/0000-0002-7515-4480; Roos, Stefan/0000-0002-1606-1794; Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [04X-08646, 57P-20680-01-4, 57x-20675-01-4]; Swedish Research Council for Environment, Agricultural Science and Spatial Planning [222-2006-454]; Nanna Svartz Foundation; Ruth and Richard Julins Foundation; Biogaia AB Stockholm, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Science and Spatial Planning(Swedish Research Council Formas); Nanna Svartz Foundation; Ruth and Richard Julins Foundation; Biogaia AB Stockholm, Sweden	The study was supported by grants from the Swedish Research Council (04X-08646, 57P-20680-01-4, 57x-20675-01-4), http://www.vr.se/; Swedish Research Council for Environment, Agricultural Science and Spatial Planning (222-2006-454), http://www.formas.se/; Nanna Svartz Foundation, http://www.uadm.uu.se/resursen/utlys/utlysning.php?uid = 758&col = 2&dir = 0&offset = 0; Ruth and Richard Julins Foundation, http://ki.se/ki/jsp/polopoly.jsp?d = 20152&a = 134578&l = en; and Biogaia AB Stockholm, Sweden, http://www.biogaia.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; COOPER HS, 1993, LAB INVEST, V69, P238; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Jager S, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/910283; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lamine F, 2004, SCAND J GASTROENTERO, V39, P1250, DOI 10.1080/00365520410007953; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schreiber O, 2009, AM J PHYSIOL-GASTR L, V296, pG534, DOI 10.1152/ajpgi.90470.2008; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442	27	88	92	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46399	10.1371/journal.pone.0046399	http://dx.doi.org/10.1371/journal.pone.0046399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029509	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500099
J	Navarro, G; Chokpaiboon, S; De Muylder, G; Bray, WM; Nisam, SC; McKerrow, JH; Pudhom, K; Linington, RG				Navarro, Gabriel; Chokpaiboon, Supchar; De Muylder, Geraldine; Bray, Walter M.; Nisam, Sean C.; McKerrow, James H.; Pudhom, Khanitha; Linington, Roger G.			Hit-to-Lead Development of the Chamigrane Endoperoxide Merulin A for the Treatment of African Sleeping Sickness	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; NORSESQUITERPENE PEROXIDES; PLASMODIUM-FALCIPARUM; ARTEMISININ; FUNGUS; DERIVATIVES; DISCOVERY; DRUGS	Background: Human African trypanosomiasis (HAT) is an infectious disease with a large global health burden occurring primarily in Central and Eastern Africa. Most current treatments have poor blood brain barrier (BBB) penetration, which prevent them from targeting the most lethal stage of the infection. In addition, current therapeutics suffer from a variety of limitations ranging from serious side effects to difficulties with treatment administration. Therefore it is of crucial importance to find new treatments that are safe, affordable, and effective against both sub-species of Trypanosoma brucei. Methods: Semi-synthetic derivatization of the fungally-derived natural product merulin A (1) has led to the discovery of new development candidates for the protozoan parasite T. brucei, the causative agent of HAT. Creation of an initial SAR library based around the merulin scaffold revealed several key features required for activity, including the endoperoxide bridge, as well as one position suitable for further derivatization. Subsequent synthesis of a 20-membered analogue library, guided by the addition of acyl groups that improve the drug-like properties of the merulin A core, resulted in the development of compound 12 with an IC50 of 60 nM against T. brucei, and a selectivity index greater than 300-fold against HeLa and immortalized glial cells. Significance: We report the semi-synthetic optimization of the merulin class of endoperoxide natural products as development candidates against T. brucei. We have identified compounds with low nM antiparasitic activities and high selectivity indices against HeLa cells. These compounds can be produced economically in large quantities via a one step derivatization from the microbial fermentation broth isolate, making them encouraging lead candidates for further development.	[Navarro, Gabriel; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Chokpaiboon, Supchar; Pudhom, Khanitha] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok, Thailand; [De Muylder, Geraldine; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94143 USA; [Bray, Walter M.; Nisam, Sean C.] Univ Calif Santa Cruz, Chem Screening Ctr, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Chulalongkorn University; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz	Linington, RG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu	Linington, Roger/ABD-5582-2021	Linington, Roger/0000-0003-1818-4971	Sandler Center for Drug Discovery; Sandler Foundation; NIAID [R56 AI085177-01A1, U01AI075641]; Belgian American Education Foundation; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI085177, U01AI075641] Funding Source: NIH RePORTER	Sandler Center for Drug Discovery; Sandler Foundation; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Belgian American Education Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported with funding from the Sandler Center for Drug Discovery, funded by the Sandler Foundation (RGL and JHM), NIAID grant R56 AI085177-01A1 (RGL), the Belgian American Education Foundation (GDM) NIAID grant U01AI075641 (JHM), and from a National Science Foundation Predoctoral Fellowship (GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM MH, 1994, J PHARM SCI-US, V83, P1257, DOI 10.1002/jps.2600830915; Alexander MD, 2006, CHEMBIOCHEM, V7, P409, DOI 10.1002/cbic.200500466; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Chokpaiboon S, 2011, J NAT PROD, V74, P2290, DOI 10.1021/np200491g; Chokpaiboon S, 2010, J NAT PROD, V73, P1005, DOI 10.1021/np100103j; Crespo MD, 2008, ANTIMICROB AGENTS CH, V52, P98, DOI 10.1128/AAC.00609-07; Diamond JM, 1969, P ROY SOC LOND B BIO, V171, P273; Feng YJ, 2010, J NAT PROD, V73, P716, DOI 10.1021/np900535z; Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Holla H, 2011, BIOORG MED CHEM LETT, V21, P4793, DOI 10.1016/j.bmcl.2011.06.059; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; KARARLI TT, 1989, CRIT REV THER DRUG, V6, P39; Kumar S, 2004, IND CROP PROD, V19, P77, DOI 10.1016/j.indcrop.2003.07.003; Li HX, 2011, J NAT PROD, V74, P1230, DOI 10.1021/np200164k; Liu DZ, 2010, TETRAHEDRON LETT, V51, P3152, DOI 10.1016/j.tetlet.2010.04.048; Mackey ZB, 2006, CHEM BIOL DRUG DES, V67, P355, DOI 10.1111/j.1747-0285.2006.00389.x; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; Oguri H, 2011, J AM CHEM SOC, V133, P7096, DOI 10.1021/ja200374q; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Rubio BK, 2009, J NAT PROD, V72, P218, DOI 10.1021/np800711a; Schmid C, 2004, LANCET, V364, P789, DOI 10.1016/S0140-6736(04)16940-7; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; Torreele E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000923; WILS P, 1994, J PHARMACOL EXP THER, V269, P654; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	27	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46172	10.1371/journal.pone.0046172	http://dx.doi.org/10.1371/journal.pone.0046172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029428	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500070
J	Guo, WJ; Liu, W; Hong, SC; Liu, HL; Qian, C; Shen, Y; Wu, XF; Sun, Y; Xu, Q				Guo, Wenjie; Liu, Wen; Hong, Shaocheng; Liu, Hailiang; Qian, Cheng; Shen, Yan; Wu, Xuefeng; Sun, Yang; Xu, Qiang			Mitochondria-Dependent Apoptosis of Con A-Activated T Lymphocytes Induced by Asiatic Acid for Preventing Murine Fulminant Hepatitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELL-CYCLE ARREST; CONCANAVALIN-A; LIVER-INJURY; DEATH; MICE; MECHANISMS; MODEL; PROLIFERATION; PATHWAYS	Selectively facilitating apoptosis of activated T cells is essential for the clearance of pathogenic injurious cells and subsequent efficient resolution of inflammation. However, few chemicals have been reported to trigger apoptosis of activated T cells for the treatment of hepatitis without affecting quiescent T cells. In the present study, we found that asiatic acid, a natural triterpenoid, selectively triggered apoptosis of concanavalin A (Con A)-activated T cells in a mitochondria-dependent manner indicated by the disruption of the mitochondrial transmembrane potential, release of cytochrome c from mitochondria to cytosol, caspases activation, and cleavage of PARP. In addition, asiatic acid also induced the cleavage of caspase 8 and Bid and augmented Fas expression in Con A-activated T cells. However, following activation of T cells from MRLlpr/lpr mice with mutation of Fas demonstrated a similar susceptibility to asiatic acid-induced apoptosis compared with normal T cells, suggesting that Fas-mediated death-receptor apoptotic pathway does not mainly contribute to asiatic acid-induced cell death. Furthermore, asiatic acid significantly alleviated Con A-induced T cell-dependent fulminant hepatitis in mice, as assessed by reduced serum transaminases, pro-inflammatory cytokines, and pathologic parameters. Consistent with the in vitro results, asiatic acid also induced apoptosis of activated CD4(+) T cells in vivo. Taken together, our results demonstrated that the ability of asiatic acid to induce apoptosis of activated T cells and its potential use in the treatment of T-cell-mediated inflammatory diseases.	[Guo, Wenjie; Liu, Wen; Hong, Shaocheng; Liu, Hailiang; Qian, Cheng; Shen, Yan; Wu, Xuefeng; Sun, Yang; Xu, Qiang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Sun, Y (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	sunyangnju@163.com; molpharm@163.com	Qian, Cheng/ACI-6931-2022; Guo, Wenjie/AAQ-7553-2020	Qian, Cheng/0000-0001-7573-3717; 	Science Fund for Creative Research Groups of NSFC [81121062]; National Natural Science Foundation of China [30973920, 81173070, 90913023]; National Science & Technology Major Project [2012ZX09304-001]; National Fundamental Fund of Personnel Training in Biology [J1103512]	Science Fund for Creative Research Groups of NSFC(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project; National Fundamental Fund of Personnel Training in Biology	This work was supported by Science Fund for Creative Research Groups of NSFC (No. 81121062), National Natural Science Foundation of China (Nos. 30973920, 81173070 and 90913023), National Science & Technology Major Project (No. 2012ZX09304-001) and National Fundamental Fund of Personnel Training in Biology (No. J1103512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Gao J, 2004, J PHARM PHARMACOL, V56, P1449, DOI 10.1211/0022357044733; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Gerspach J, 2011, RECENT PAT ANTI-CANC, V6, P294, DOI 10.2174/157489211796957739; Gong FY, 2008, EXP BIOL MED, V233, P1124, DOI 10.3181/0801-RM-15; Hildeman DA, 2002, CURR OPIN IMMUNOL, V14, P354, DOI 10.1016/S0952-7915(02)00335-7; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Kanuri G, 2011, J NUTR BIOCHEM, V22, P527, DOI 10.1016/j.jnutbio.2010.04.007; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Kuzuhara H, 2000, EUR J PHARMACOL, V391, P175, DOI 10.1016/S0014-2999(99)00931-0; Lee MK, 2009, NAT PROD COMMUN, V4, P765; Lee MK, 2000, RES COMMUN MOL PATH, V108, P75; Lettau M, 2011, EUR J CELL BIOL, V90, P456, DOI 10.1016/j.ejcb.2010.10.006; Luo QO, 2011, TOXICOL APPL PHARM, V251, P130, DOI 10.1016/j.taap.2010.12.011; Ma K, 2000, EUR J PHARMACOL, V603, P98; Santucci L, 2000, HEPATOLOGY, V31, P399, DOI 10.1002/hep.510310220; Sturm A, 2008, CURR DRUG TARGETS, V9, P381, DOI 10.2174/138945008784221198; Sun Y, 2010, BIOCHEM PHARMACOL, V79, P229, DOI 10.1016/j.bcp.2009.08.014; Sun Y, 2009, BIOCHEM PHARMACOL, V77, P1717, DOI 10.1016/j.bcp.2009.03.002; Sun Y, 2009, INT IMMUNOPHARMACOL, V9, P978, DOI 10.1016/j.intimp.2009.04.006; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Urayama S, 2001, J LAB CLIN MED, V138, P11, DOI 10.1067/mlc.2001.115938; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Xiong YY, 2009, NEUROCHEM RES, V34, P746, DOI 10.1007/s11064-008-9844-0; Zhang XN, 2012, EUR J PHARMACOL, V679, P51, DOI 10.1016/j.ejphar.2012.01.006	31	22	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46018	10.1371/journal.pone.0046018	http://dx.doi.org/10.1371/journal.pone.0046018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029367	gold, Green Published, Green Submitted			2022-12-25	WOS:000309554700107
J	Loot, AE; Moneke, I; Keseru, B; Oelze, M; Syzonenko, T; Daiber, A; Fleming, I				Loot, Annemarieke E.; Moneke, Isabelle; Keserue, Benjamin; Oelze, Matthias; Syzonenko, Tetyana; Daiber, Andreas; Fleming, Ingrid			11,12-EET Stimulates the Association of BK Channel alpha and beta(1) Subunits in Mitochondria to Induce Pulmonary Vasoconstriction	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; SOLUBLE EPOXIDE HYDROLASE; VASCULAR SMOOTH-MUSCLE; EPOXYEICOSATRIENOIC ACIDS; LARGE-CONDUCTANCE; HYPERPOLARIZING FACTOR; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; BETA-1 SUBUNIT; HYPOXIA	In the systemic circulation, 11,12-epoxyeicosatrienoic acid (11,12-EET) elicits nitric oxide (NO)- and prostacyclin-independent vascular relaxation, partially through the activation of large conductance Ca2+-activated potassium (BK) channels. However, in the lung 11,12-EET contributes to hypoxia-induced pulmonary vasoconstriction. Since pulmonary artery smooth muscle cells also express BK channels, we assessed the consequences of BK beta(1) subunit deletion on pulmonary responsiveness to 11,12-EET as well as to acute hypoxia. In buffer-perfused mouse lungs, hypoxia increased pulmonary artery pressure and this was significantly enhanced in the presence of NO synthase (NOS) and cyclooxygenase (COX) inhibitors. Under these conditions the elevation of tissue EET levels using an inhibitor of the soluble epoxide hydrolase (sEH-I), further increased the hypoxic contraction. Direct administration of 11,12-EET also increased pulmonary artery pressure, and both the sEH-I and 11,12-EET effects were prevented by iberiotoxin and absent in BK beta(-/-)(1) mice. In pulmonary artery smooth muscle cells treated with NOS and COX inhibitors and loaded with the potentiometric dye, di-8-ANEPPS, 11,12-EET induced depolarization while the BK channel opener NS1619 elicited hyperpolarization indicating there was no effect of the EET on classical plasma membrane BK channels. In pulmonary artery smooth muscle cells a subpopulation of BK channels is localized in mitochondria. In these cells, 11,12-EET elicited an iberiotoxin-sensitive loss of mitochondrial membrane potential (JC-1 fluorescence) leading to plasma membrane depolarization, an effect not observed in BK beta(-/-)(1) cells. Mechanistically, stimulation with 11,12-EET time-dependently induced the association of the BK alpha and beta(1) subunits. Our data indicate that in the absence of NO and prostacyclin 11,12-EET contributes to pulmonary vasoconstriction by stimulating the association of the alpha and beta(1) subunits of mitochondrial BK channels. The 11,12-EET-induced activation of BK channels results in loss of the mitochondrial membrane potential and depolarization of the pulmonary artery smooth muscle cells.	[Loot, Annemarieke E.; Moneke, Isabelle; Keserue, Benjamin; Syzonenko, Tetyana; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany; [Oelze, Matthias; Daiber, Andreas] Johannes Gutenberg Univ Mainz, Dept Cardiol, Med Clin 2, Mainz, Germany	Goethe University Frankfurt; Johannes Gutenberg University of Mainz	Fleming, I (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/L-1225-2014; Fleming, Ingrid/AAB-6123-2022	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635	Deutsche Forschungsgemeinschaft [Exzellenzcluster 147 "Cardio-Pulmonary Systems"] [GRK 757]; European Vascular Genomics Network, a Network of Excellence; European Community [LSHM-CT-2003-503254]	Deutsche Forschungsgemeinschaft [Exzellenzcluster 147 "Cardio-Pulmonary Systems"](German Research Foundation (DFG)); European Vascular Genomics Network, a Network of Excellence; European Community(European Commission)	This study was supported by the Deutsche Forschungsgemeinschaft [GRK 757, Exzellenzcluster 147 "Cardio-Pulmonary Systems"] and by the European Vascular Genomics Network, a Network of Excellence supported by the European Community's sixth Framework Program [Contract No LSHM-CT-2003-503254]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YT, 2012, AM J PHYSIOL-LUNG C, V302, pL352, DOI 10.1152/ajplung.00302.2011; Bauersachs J, 1996, CIRCULATION, V94, P3341, DOI 10.1161/01.CIR.94.12.3341; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Fike CD, 2005, J APPL PHYSIOL, V98, P1111, DOI 10.1152/japplphysiol.00810.2004; FLEMING I, 1994, CIRC RES, V74, P1220, DOI 10.1161/01.RES.74.6.1220; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Fukao M, 2001, MOL PHARMACOL, V59, P16, DOI 10.1124/mol.59.1.16; Gauthier KM, 2002, CIRC RES, V90, P1028, DOI 10.1161/01.RES.0000018162.87285.F8; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Keseru B, 2010, CARDIOVASC RES, V85, P232, DOI 10.1093/cvr/cvp281; Keserue B, 2008, FASEB J, V22, P4306, DOI 10.1096/fj.08-112821; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kiss L, 2008, ANAL BIOANAL CHEM, V390, P697, DOI 10.1007/s00216-007-1718-9; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Loot AE, 2011, J CARDIOVASC PHARM, V57, P140, DOI 10.1097/FJC.0b013e3181ed088d; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Michaelis UR, 2003, FASEB J, V17, P770, DOI 10.1096/fj.02-0640fje; Michelakis EV, 2004, J MOL CELL CARDIOL, V37, P1119, DOI 10.1016/j.yjmcc.2004.09.007; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Potente M, 2003, J BIOL CHEM, V278, P29619, DOI 10.1074/jbc.M305385200; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Roth M, 2009, AM J RESP CRIT CARE, V180, P353, DOI 10.1164/rccm.200806-848OC; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Sommer N, 2008, EUR RESPIR J, V32, P1639, DOI 10.1183/09031936.00013908; SPEAR RK, 1978, ANAL BIOCHEM, V90, P211, DOI 10.1016/0003-2697(78)90025-8; Sweet TB, 2009, J GEN PHYSIOL, V133, P139, DOI 10.1085/jgp.200810129; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Weir EK, 2006, CARDIOVASC RES, V71, P630, DOI 10.1016/j.cardiores.2006.04.014; Weissmann N, 2004, RESP PHYSIOL NEUROBI, V139, P191, DOI 10.1016/j.resp.2003.10.003; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Weissmann N, 2006, CARDIOVASC RES, V71, P620, DOI 10.1016/j.cardiores.2006.04.009; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yang A, 2010, VASC PHARMACOL, V53, P122, DOI 10.1016/j.vph.2010.05.001	45	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46065	10.1371/journal.pone.0046065	http://dx.doi.org/10.1371/journal.pone.0046065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029390	Green Published, gold			2022-12-25	WOS:000309554700112
J	Al-Salih, G; Al-Attar, N; Delbosc, S; Louedec, L; Corvazier, E; Loyau, S; Michel, JB; Pidard, D; Duval, X; Meilhac, O				Al-Salih, Ghada; Al-Attar, Nawwar; Delbosc, Sandrine; Louedec, Liliane; Corvazier, Elisabeth; Loyau, Stephane; Michel, Jean-Baptiste; Pidard, Dominique; Duval, Xavier; Meilhac, Olivier			Role of Vegetation-Associated Protease Activity in Valve Destruction in Human Infective Endocarditis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ANTIPLATELET THERAPY; EMBOLIC EVENTS; MURAL THROMBUS; INVOLVEMENT; ACTIVATION; PATHOGENS; APOPTOSIS; PLASMIN; COAGULATION	Aims: Infective endocarditis (IE) is characterized by septic thrombi (vegetations) attached on heart valves, consisting of microbial colonization of the valvular endocardium, that may eventually lead to congestive heart failure or stroke subsequent to systemic embolism. We hypothesized that host defense activation may be directly involved in tissue proteolytic aggression, in addition to pathogenic effects of bacterial colonization. Methods and Results: IE valve samples collected during surgery (n = 39) were dissected macroscopically by separating vegetations (VG) and the surrounding damaged part of the valve from the adjacent, apparently normal (N) valvular tissue. Corresponding conditioned media were prepared separately by incubation in culture medium. Histological analysis showed an accumulation of platelets and polymorphonuclear neutrophils (PMNs) at the interface between the VG and the underlying tissue. Apoptotic cells (PMNs and valvular cells) were abundantly detected in this area. Plasminogen activators (PA), including urokinase (uPA) and tissue (tPA) types were also associated with the VG. Secreted matrix metalloproteinase (MMP) 9 was also increased in VG, as was leukocyte elastase and myeloperoxidase (MPO). The presence of neutrophil extracellular traps (NETs) associating MPO and externalized nucleosomes, was shown by immunostaining in the VG. Both MPO and cell-free DNA were released in larger amounts by VG than N samples, suggesting bacterial activation of PMNs within the vegetation. Finally, evidence of proteolytic tissue damage was obtained by the release of fragments of extracellular matrix components such as fibrinogen and fibronectin, as well as protease-sensitive receptors such as the uPA receptor. Conclusion: Our data obtained using human IE valves suggest that septic vegetations represent an important source of proteases originating from massive leukocyte recruitment and activation of the host plasminergic system. The latter forms a potential therapeutic target to minimize valvular tissue degradation independently from that induced by bacterial proteases.	[Al-Salih, Ghada; Delbosc, Sandrine; Louedec, Liliane; Corvazier, Elisabeth; Loyau, Stephane; Michel, Jean-Baptiste; Pidard, Dominique; Meilhac, Olivier] INSERM, U698, Paris, France; [Al-Attar, Nawwar] Hop Xavier Bichat, AP HP, Dept Cardiovasc Surg, Paris, France; [Al-Attar, Nawwar; Michel, Jean-Baptiste; Meilhac, Olivier] Univ Paris Diderot, Paris, France; [Pidard, Dominique] CNRS, Inst Natl Sci Vivant, Paris, France; [Duval, Xavier] INSERM, CIC 007, Paris, France; [Meilhac, Olivier] AP HP, Bichat Stroke Ctr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Meilhac, O (corresponding author), INSERM, U698, Paris, France.	olivier.meilhac@inserm.fr	Meilhac, Olivier/N-4385-2017; DELBOSC, Sandrine/ABB-4618-2021; Michel, Jean-Baptiste/AAH-9336-2020	Meilhac, Olivier/0000-0002-3740-7539; Loyau, stephane/0000-0001-8748-501X; Pidard, Dominique/0000-0002-5732-3279; Delbosc, Sandrine/0000-0001-8076-6927				Anavekar NS, 2007, CLIN INFECT DIS, V44, P1180, DOI 10.1086/513197; Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Beaufort N, 2011, CELL MICROBIOL, V13, P1149, DOI 10.1111/j.1462-5822.2011.01606.x; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Bonnefoy A, 2000, THROMB RES, V98, P323, DOI 10.1016/S0049-3848(99)00242-X; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BUITING AGM, 1989, THROMB HAEMOSTASIS, V62, P1029; Chan KL, 2003, J AM COLL CARDIOL, V42, P775, DOI 10.1016/S0735-1097(03)00829-5; DELAHAYE F, 1995, EUR HEART J, V16, P394, DOI 10.1093/oxfordjournals.eurheartj.a060923; Delbosc S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018679; Fitzgerald JR, 2006, NAT REV MICROBIOL, V4, P445, DOI 10.1038/nrmicro1425; Fontaine V, 2004, AM J PATHOL, V164, P2077, DOI 10.1016/S0002-9440(10)63766-2; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Hippenstiel S, 2003, THROMB HAEMOSTASIS, V89, P18; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; JETT BD, 1994, CLIN MICROBIOL REV, V7, P462, DOI 10.1128/CMR.7.4.462-478.1994; Kochtebane N, 2010, J PATHOL, V221, P37, DOI 10.1002/path.2681; Kupferwasser LI, 1999, CIRCULATION, V99, P2791, DOI 10.1161/01.CIR.99.21.2791; Leclercq A, 2007, J LEUKOCYTE BIOL, V82, P1420, DOI 10.1189/jlb.1106671; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; McKittrick IB, 2011, AM J PHYSIOL-RENAL, V301, pF1326, DOI 10.1152/ajprenal.00267.2011; Meilhac O, 2003, FASEB J, V17, P1301, DOI 10.1096/fj.02-0687fje; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Moreillon P, 2002, INFECT DIS CLIN N AM, V16, P297, DOI 10.1016/S0891-5520(01)00009-5; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mtairag EM, 2002, ARTERIOSCL THROM VAS, V22, P1824, DOI 10.1161/01.ATV.0000037102.31086.F4; Neumann FJ, 1999, J AM COLL CARDIOL, V34, P1420, DOI 10.1016/S0735-1097(99)00350-2; Ovechkin AV, 2005, J APPL PHYSIOL, V99, P2398, DOI 10.1152/japplphysiol.00442.2005; Pepin J, 2009, CLIN MICROBIOL INFEC, V15, P193, DOI 10.1111/j.1469-0691.2008.02665.x; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Thurlow LR, 2010, INFECT IMMUN, V78, P4936, DOI 10.1128/IAI.01118-09; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45695	10.1371/journal.pone.0045695	http://dx.doi.org/10.1371/journal.pone.0045695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029186	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900090
J	Lin, CH; Su, CH; Tseng, DY; Ding, FC; Hwang, PP				Lin, Chia-Hao; Su, Che-Hsien; Tseng, Deng-Yu; Ding, Feng-Chun; Hwang, Pung-Pung			Action of Vitamin D and the Receptor, VDRa, in Calcium Handling in Zebrafish (Danio rerio)	PLOS ONE			English	Article							1,25-DIHYDROXYVITAMIN D-3; PARATHYROID-HORMONE; NUCLEAR RECEPTOR; ION REGULATION; RAINBOW-TROUT; EXPRESSION; FISH; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; 25-HYDROXYCHOLECALCIFEROL; PUFFERFISH	The purpose of the present study was to use zebrafish as a model to investigate how vitamin D and its receptors interact to control Ca2+ uptake function. Low-Ca2+ fresh water stimulated Ca2+ influx and expressions of epithelial calcium channel (ecac), vitamin D-25-hydroxylase (cyp2r1), vitamin D receptor a (vdra), and vdrb in zebrafish. Exogenous vitamin D increased Ca2+ influx and expressions of ecac and 25-hydroxyvitamin D3-24-hydroxylase (cyp24a1), but downregulated 1 alpha-OHase (cyp27b1) with no effects on other Ca2+ transporters. Morpholino oligonucleotide knockdown of VDRa, but not VDRb, was found as a consequence of calcium uptake inhibition by knockdown of ecac, and ossification of vertebrae is impaired. Taken together, vitamin D-VDRa signaling may stimulate Ca2+ uptake by upregulating ECaC in zebrafish, thereby clarifying the Ca2+-handling function of only a VDR in teleosts. Zebrafish may be useful as a model to explore the function of vitamin D-VDR signaling in Ca2+ homeostasis and the related physiological processes in vertebrates.	[Lin, Chia-Hao; Su, Che-Hsien; Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Su, Che-Hsien; Ding, Feng-Chun; Hwang, Pung-Pung] Natl Taiwan Univ, Inst Fishery Sci, Taipei 10764, Taiwan; [Tseng, Deng-Yu] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National University Tainan	Hwang, PP (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	pphwang@gate.sinica.edu.tw	Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; Hwang, Pung-Pung/AAH-1538-2022; Lin, Chia-Hao/AHC-6514-2022		National Science Council, Taiwan, R.O.C.	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was financially supported by the grant to P.P.H. from the National Science Council, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink W, 2007, J ENDOCRINOL, V193, P473, DOI 10.1677/JOE-06-0164; Barletta F, 2004, AM J PHYSIOL-ENDOC M, V286, pE598, DOI 10.1152/ajpendo.00214.2003; Chen YY, 2003, J EXP ZOOL PART A, V295A, P127, DOI 10.1002/jez.a.10195; Cheng W, 2006, DEV BIOL, V294, P482, DOI 10.1016/j.ydbio.2006.03.018; Chou MY, 2011, CELL MOL LIFE SCI, V68, P2797, DOI 10.1007/s00018-010-0593-2; Craig TA, 2008, J BONE MINER RES, V23, P1486, DOI 10.1359/jbmr.080403; DUBOIS MB, 1988, GEN COMP ENDOCR, V71, P1, DOI 10.1016/0016-6480(88)90288-2; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; HAYES ME, 1986, GEN COMP ENDOCR, V64, P143, DOI 10.1016/0016-6480(86)90040-7; Henry H. L., 1997, Vitamin D., P57; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Hwang PP, 2007, COMP BIOCHEM PHYS A, V148, P479, DOI 10.1016/j.cbpa.2007.06.416; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Hwang PP, 2010, FISH PHYSIOL, V29, P311, DOI 10.1016/S1546-5098(10)02908-0; Hwang PP, 2009, J EXP BIOL, V212, P1745, DOI 10.1242/jeb.026054; Krasowski MD, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-5; Lafont AG, 2011, J BONE MINER RES, V26, P1072, DOI 10.1002/jbmr.301; Lechner D, 2007, MOL CELL ENDOCRINOL, V263, P55, DOI 10.1016/j.mce.2006.08.009; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023689; Lock EJ, 2007, J ENDOCRINOL, V193, P459, DOI 10.1677/JOE-06-0198; Lynch M, 2000, GENETICS, V154, P459; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Murayama A, 1999, ENDOCRINOLOGY, V140, P2224, DOI 10.1210/en.140.5.2224; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; Patschan D, 2001, BONE, V29, P498, DOI 10.1016/S8756-3282(01)00610-X; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Qiu AD, 2004, GENE, V342, P113, DOI 10.1016/j.gene.2004.07.041; Qiu A, 2007, AQUAT TOXICOL, V84, P142, DOI 10.1016/j.aquatox.2007.02.020; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; SUNDELL K, 1993, GEN COMP ENDOCR, V91, P344, DOI 10.1006/gcen.1993.1135; SWARUP K, 1991, COMP BIOCHEM PHYS A, V100, P445, DOI 10.1016/0300-9629(91)90497-Z; TAKEUCHI A, 1991, LIFE SCI, V48, P275, DOI 10.1016/0024-3205(91)90355-F; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; Vanoevelen J, 2011, FASEB J, V25, P3197, DOI 10.1096/fj.11-183145; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Whitfield GK, 2003, ENDOCRINOLOGY, V144, P2704, DOI 10.1210/en.2002-221101; Zierold C, 2003, J CELL BIOCHEM, V88, P234, DOI 10.1002/jcb.10341	44	44	44	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45650	10.1371/journal.pone.0045650	http://dx.doi.org/10.1371/journal.pone.0045650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029160	Green Submitted, gold, Green Published			2022-12-25	WOS:000309388400117
J	Po, C; Kalthoff, D; Kim, YB; Nelles, M; Hoehn, M				Po, Chrystelle; Kalthoff, Daniel; Kim, Young Beom; Nelles, Melanie; Hoehn, Mathias			White Matter Reorganization and Functional Response after Focal Cerebral Ischemia in the Rat	PLOS ONE			English	Article							EXPERIMENTAL STROKE; NERVOUS-SYSTEM; DIFFUSION; MRI; RECOVERY; CONNECTIVITY; TISSUE; FMRI	After stroke, the brain has shown to be able to achieve spontaneous functional recovery despite severe cerebral damage. This phenomenon is poorly understood. To address this issue, focal transient ischemia was induced by 60 min middle cerebral artery occlusion in Wistar rats. The evolution of stroke was followed using two magnetic resonance imaging modalities: diffusion spectrum imaging (acquired before, one and four weeks after stroke) and functional magnetic resonance imaging (acquired before and five weeks after stroke). To confirm the imaging observations, immunohistochemical staining for myelin, astrocytes and macrophages/microglia was added. At four weeks after stroke, a focal alteration of the diffusion anisotropy was observed between the ipsilesional ventricle and the lesion area. Using tractography this perturbation was identified as reorganization of the ipsilesional internal capsule. Functional imaging at five weeks after ischemia demonstrated activation of the primary sensorimotor cortex in both hemispheres in all rats except one animal lacking a functional response in the ipsilesional cortex. Furthermore, fiber tracking showed a transhemispheric fiber connection through the corpus callosum, which-in the rat without functional recovery-was lost. Our study shows the influence of the internal capsule reorganization, combined with inter-hemispheric connections though the corpus callosum, on the functional activation of the brain from stroke. In conclusion, tractography opens a new door to non-invasively investigate the structural correlates of lack of functional recovery after stroke.	[Po, Chrystelle; Kalthoff, Daniel; Kim, Young Beom; Nelles, Melanie; Hoehn, Mathias] Max Planck Inst Neurol Res, In Vivo NMR Lab, D-50931 Cologne, Germany	Max Planck Society	Hoehn, M (corresponding author), Max Planck Inst Neurol Res, In Vivo NMR Lab, Gleueler Str 50, D-50931 Cologne, Germany.	mathias@nf.mpg.de		Po, Chrystelle/0000-0001-9785-9572	EU [HEALTH-F5-2008-201842 (ENCITE)]; German Federal Ministry of Education and Research [BMBF-0314104]	EU(European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded by the EU project HEALTH-F5-2008-201842 (ENCITE) and by a grant from the German Federal Ministry of Education and Research BMBF-0314104 (Biomarkers of Brain Ageing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; CHEN CN, 1993, MAGNET RESON MED, V29, P386, DOI 10.1002/mrm.1910290316; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Farr TD, 2011, NMR BIOMED, V24, P35, DOI 10.1002/nbm.1553; Granziera C, 2007, Open Neuroimag J, V1, P10, DOI 10.2174/1874440000701010010; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Jiang Q, 2006, NEUROIMAGE, V32, P1080, DOI 10.1016/j.neuroimage.2006.05.025; Kim YB, 2012, NMR BIOMED, V25, P943, DOI 10.1002/nbm.1815; Kleiser R, 2010, NEURORADIOLOGY, V52, P37, DOI 10.1007/s00234-009-0539-2; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Koizumi JYY, 1986, JPN J STROKE, V8, P1, DOI [DOI 10.3995/JSTROKE.8.1, DOI 10.3995/jstroke.8.1]; Kreisel SH, 2007, CEREBROVASC DIS, V23, P243, DOI 10.1159/000098323; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Norris DG, 2001, J MAGN RESON IMAGING, V13, P486, DOI 10.1002/jmri.1072; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Ramos-Cabrer P, 2005, NMR BIOMED, V18, P440, DOI 10.1002/nbm.978; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Tang PF, 2010, AM J NEURORADIOL, V31, P1023, DOI 10.3174/ajnr.A1981; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; van Meer MPA, 2010, J CEREBR BLOOD F MET, V30, P1707, DOI 10.1038/jcbfm.2010.124; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Weber R, 2006, NEUROIMAGE, V29, P1303, DOI 10.1016/j.neuroimage.2005.08.028; Weber R, 2008, J NEUROSCI, V28, P1022, DOI 10.1523/JNEUROSCI.4147-07.2008; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Ween JE, 2008, J NEUROIMAGING, V18, P227, DOI 10.1111/j.1552-6569.2007.00180.x; Wegener S, 2006, J CEREBR BLOOD F MET, V26, P38, DOI 10.1038/sj.jcbfm.9600166; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087	35	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45629	10.1371/journal.pone.0045629	http://dx.doi.org/10.1371/journal.pone.0045629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029148	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900164
J	Wu, ZQ; Sun, HB; Zeng, WX; He, JC; Mao, XM				Wu, Ziqing; Sun, Huabin; Zeng, Weixia; He, Jincan; Mao, Xiangming			Upregulation of MircoRNA-370 Induces Proliferation in Human Prostate Cancer Cells by Downregulating the Transcription Factor FOXO1	PLOS ONE			English	Article							ANDROGEN RECEPTOR; TUMOR SUPPRESSION; BIOCHEMICAL RECURRENCE; FACTOR FKHR; EXPRESSION; INHIBITION; APOPTOSIS; GENE; PHOSPHORYLATION; ACTIVATION	Forkhead box protein O1 (FOXO1), a key member of the FOXO family of transcription factors, acts as a tumor suppressor and has been associated with various key cellular functions, including cell growth, differentiation, apoptosis and angiogenesis. Therefore, it is puzzling why FOXO protein expression is downregulated in cancer cells. MicroRNAs, non-coding 20 similar to 22 nucleotide single-stranded RNAs, result in translational repression or degradation and gene silencing of their target genes, and significantly contribute to the regulation of gene expression. In the current study, we report that miR-370 expression was significantly upregulated in five prostate cancer cell lines, compared to normal prostatic epithelial (PrEC) cells. Ectopic expression of miR-370 induced proliferation and increased the anchorage-independent growth and colony formation ability of DU145 and LNCaP prostate cancer cells, while inhibition of miR-370 reduced proliferation, anchorage-independent growth and colony formation ability. Furthermore, upregulation of miR-370 promoted the entry of DU145 and LNCaP prostate cancer cells into the G1/S cell cycle transition, which was associated with downregulation of the cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) and p21(Cip1), and upregulation of the cell-cycle regulator cyclin D1 mRNA. Additionally, we demonstrated that miR-370 can downregulate expression of FOXO1 by directly targeting the FOXO1 3'-untranslated region. Taken together, our results suggest that miR-370 plays an important role in the proliferation of human prostate cancer cells, by directly suppressing the tumor suppressor FOXO1.	[He, Jincan; Mao, Xiangming] So Med Univ, Dept Urol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Ziqing] So Med Univ, Dept Pathol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Wu, Ziqing] So Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Sun, Huabin] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 5, Zhuhai, Guangdong, Peoples R China; [Zeng, Weixia] Laura Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Sun Yat Sen University	Mao, XM (corresponding author), So Med Univ, Dept Urol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	xmmao2012@sina.cn						Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Huang HJ, 2004, J BIOL CHEM, V279, P13866, DOI 10.1074/jbc.M314143200; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; ISAACS WB, 1995, CANCER SURV, V23, P19; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim KW, 2012, ENVIRON GEOCHEM HLTH, V34, P1, DOI 10.1007/s10653-011-9402-6; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Li L, 2005, PROSTATE CANCER P D, V8, P108, DOI 10.1038/sj.pcan.4500776; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Lu HR, 2011, NEOPLASIA, V13, P854, DOI 10.1593/neo.11594; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Roehrborn CG, 2011, BJU INT, V108, P806, DOI 10.1111/j.1464-410X.2011.10365.x; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wu LH, 2012, FEBS LETT, V586, P1038, DOI 10.1016/j.febslet.2012.02.050; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang HT, 2010, PROSTATE, V70, P1265, DOI 10.1002/pros.21162	55	74	81	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e45825	10.1371/journal.pone.0045825	http://dx.doi.org/10.1371/journal.pone.0045825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23029264	Green Published, Green Submitted, gold			2022-12-25	WOS:000311313900170
J	Kosicka, A; Cunliffe, AD; Mackenzie, R; Zariwala, MG; Perretti, M; Flower, RJ; Renshaw, D				Kosicka, Anna; Cunliffe, Adam D.; Mackenzie, Richard; Zariwala, M. Gulrez; Perretti, Mauro; Flower, Roderick J.; Renshaw, Derek			Attenuation of plasma annexin A1 in human obesity	FASEB JOURNAL			English	Article						anti-inflammatory; adipocytes; adipocytokines; SGBS cells; inflammation	AIR-DISPLACEMENT PLETHYSMOGRAPHY; BODY-MASS INDEX; NF-KAPPA-B; ADIPOSE-TISSUE; DIABETES-MELLITUS; ANTHROPOMETRIC INDEXES; WAIST CIRCUMFERENCE; INSULIN SENSITIVITY; SUBCUTANEOUS FAT; INFLAMMATION	Obesity-related metabolic disorders are characterized by mild chronic inflammation, leukocyte infiltration, and tissue fibrosis as a result of adipocytokine production from the expanding white adipose tissue. Annexin A1 (AnxA1) is an endogenous glucocorticoid regulated protein, which modulates systemic anti-inflammatory processes and, therefore, may be altered with increasing adiposity in humans. Paradoxically, we found that plasma AnxA1 concentrations inversely correlated with BMI, total percentage body fat, and waist-to-hip ratio in human subjects. Plasma AnxA1 was also inversely correlated with plasma concentrations of the acute-phase protein, C-reactive protein (CRP), and the adipocytokine leptin, suggesting that as systemic inflammation increases, anti-inflammatory AnxA1 is reduced. In addition, AnxA1 gene expression and protein were significantly up-regulated during adipogenesis in a human adipocyte cell line compared to vehicle alone, demonstrating for the first time that AnxA1 is expressed and excreted from human adipocytes. These data demonstrate a failure in the endogenous anti-inflammatory system to respond to increasing systemic inflammation resulting from expanding adipose tissue, a condition strongly linked to the development of type 2 diabetes and cardiovascular disease. These data raise the possibility that a reduction in plasma AnxA1 may contribute to the chronic inflammatory phenotype observed in human obesity.-Kosicka, A., Cunliffe, A. D., Mackenzie, R., Gulrez Zariwala, M., Perretti, M., Flower, R. J., Renshaw, D. Attenuation of plasma annexin A1 in human obesity. FASEB J. 27, 368-378 (2013). www.fasebj.org	[Kosicka, Anna; Mackenzie, Richard; Zariwala, M. Gulrez; Renshaw, Derek] Univ Westminster, Sch Life Sci, Dept Human & Hlth Sci, London W1W 6UW, England; [Cunliffe, Adam D.] London S Bank Univ, Dept Appl Sci, London, England; [Perretti, Mauro; Flower, Roderick J.] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Ctr Biochem Pharmacol, London, England	Roehampton University; University of Westminster; London South Bank University; University of London; Queen Mary University London	Renshaw, D (corresponding author), Univ Westminster, Sch Life Sci, Dept Human & Hlth Sci, 115 New Cavendish St, London W1W 6UW, England.	renshad@wmin.ac.uk		Zariwala, Mohammed Gulrez/0000-0001-9944-8451; Renshaw, Derek/0000-0002-2759-0229	Human and Health Sciences Department, School of Life Sciences, University of Westminster (London, UK); Society for Endocrinology	Human and Health Sciences Department, School of Life Sciences, University of Westminster (London, UK); Society for Endocrinology	A.K. was supported by a 2-yr scholarship from the Human and Health Sciences Department, School of Life Sciences, University of Westminster (London, UK). D.R. was supported by an Early Career grant from the Society for Endocrinology. The authors thank Dr. Niloufar Moradi-Bidhendi for proofreading the manuscript.	Ahmed M, 2010, OBESITY, V18, P27, DOI 10.1038/oby.2009.208; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Babbin BA, 2008, J IMMUNOL, V181, P5035, DOI 10.4049/jimmunol.181.7.5035; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Barac A, 2012, J CLIN HYPERTENS, V14, P13, DOI 10.1111/j.1751-7176.2011.00560.x; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; Borai A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-158; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Cheuk BLY, 2011, EUR J VASC ENDOVASC, V41, P364, DOI 10.1016/j.ejvs.2010.11.021; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; D'Acquisto F, 2008, RHEUMATOLOGY, V47, P636, DOI 10.1093/rheumatology/ken062; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Dalli J, 2010, AM J PATHOL, V177, P176, DOI 10.2353/ajpath.2010.091149; DAVIDSON J, 1991, BRIT J PHARMACOL, V102, P7, DOI 10.1111/j.1476-5381.1991.tb12122.x; DeLoach Stephanie, 2011, Ther Adv Cardiovasc Dis, V5, P149, DOI 10.1177/1753944711408757; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Do MS, 2006, YONSEI MED J, V47, P729, DOI 10.3349/ymj.2006.47.5.729; Doyle SL, 2012, P NUTR SOC, V71, P181, DOI 10.1017/S002966511100320X; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; GARN SM, 1986, AM J CLIN NUTR, V44, P996, DOI 10.1093/ajcn/44.6.996; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; GOULDING NJ, 1990, LANCET, V335, P1416, DOI 10.1016/0140-6736(90)91445-G; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; Guven SF, 2012, SLEEP BREATH, V16, P217, DOI 10.1007/s11325-011-0492-2; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hockley T., 2007, EUROPEAN CHOLESTEROL; HORTOBAGYI T, 1994, EUR J CLIN NUTR, V48, P369; Hyatt TC, 2009, OBESITY, V17, P276, DOI 10.1038/oby.2008.549; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Kim SY, 2011, EPIDEMIOL HEALTH, V33, DOI 10.4178/epih/e2011007; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Kuo SM, 2011, INT J OBESITY, V35, P1487, DOI 10.1038/ijo.2011.20; Lam JCM, 2012, RESPIROLOGY, V17, P223, DOI 10.1111/j.1440-1843.2011.02081.x; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lee SW, 2011, YONSEI MED J, V52, P939, DOI 10.3349/ymj.2011.52.6.939; Life Measurement Inc., 2005, CUST TRAIN BOD COMP; Lockner DW, 2000, ANN NY ACAD SCI, V904, P72; LOHMAN TG, 1997, HLTH FITNESS J, V1, P30; Maderna P, 2005, J IMMUNOL, V174, P3727, DOI 10.4049/jimmunol.174.6.3727; MASFERRER JL, 1992, P NATL ACAD SCI USA, V89, P3917, DOI 10.1073/pnas.89.9.3917; McArthur S, 2010, J IMMUNOL, V185, P6317, DOI 10.4049/jimmunol.1001095; McCrory MA, 1998, J APPL PHYSIOL, V84, P1475, DOI 10.1152/jappl.1998.84.4.1475; Mulla A, 2005, J CLIN ENDOCR METAB, V90, P557, DOI 10.1210/jc.2004-1230; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Nevill AM, 2006, AM J PHYS ANTHROPOL, V129, P151, DOI 10.1002/ajpa.20262; Nishimura Satoshi, 2009, Discov Med, V8, P55; Organization WH, 1998, WELLB MEAS PRIM HLTH; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Parkin D. M., 2011, BR J CANC S2, V105, pS34; PEERS SH, 1993, BRIT J PHARMACOL, V108, P66, DOI 10.1111/j.1476-5381.1993.tb13441.x; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Perretti M, 2003, NEWS PHYSIOL SCI, V18, P60, DOI 10.1152/nips.01424.2002; Perretti M, 1996, NAT MED, V2, P1259, DOI 10.1038/nm1196-1259; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Pupjalis D, 2011, EMBO MOL MED, V3, P102, DOI 10.1002/emmm.201000113; Raynal P., 1993, BIOCH J 3, V292, P759; Renshaw D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012771; Rhodes D, 2011, INFLAMM RES, V60, P261; Rosales JL, 1997, J IMMUNOL, V159, P6195; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Schreiner PJ, 1996, AM J EPIDEMIOL, V144, P335, DOI 10.1093/oxfordjournals.aje.a008934; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shafer KJ, 2008, NUTRITION, V24, P148, DOI 10.1016/j.nut.2007.10.015; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Solito E, 1998, CYTOKINE, V10, P514, DOI 10.1006/cyto.1997.0325; Sudlow AW, 1996, BRIT J PHARMACOL, V117, P1449, DOI 10.1111/j.1476-5381.1996.tb15305.x; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Tsuriya D, 2011, INTERNAL MED, V50, P2767, DOI 10.2169/internalmedicine.50.5908; Uwaifo GI, 2002, J CLIN ENDOCR METAB, V87, P2899, DOI 10.1210/jc.87.6.2899; Vazzana N, 2011, CURR MED CHEM, V18, P5267, DOI 10.2174/092986711798184299; WABITSCH M, 1995, J CLIN ENDOCR METAB, V80, P3469, DOI 10.1210/jc.80.12.3469; Wagner DR, 2000, MED SCI SPORT EXER, V32, P1339, DOI 10.1097/00005768-200007000-00023; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang ZM, 2011, J ETHNOPHARMACOL, V137, P774, DOI 10.1016/j.jep.2011.06.037; Warne JP, 2006, AM J PHYSIOL-ENDOC M, V291, pE1264, DOI 10.1152/ajpendo.00655.2005; Wauters M, 2000, METABOLISM, V49, P724, DOI 10.1053/meta.2000.6255; Wilson JP, 2012, AM J CLIN NUTR, V95, P25, DOI 10.3945/ajcn.111.019273; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Yazid S, 2009, BIOCHEM PHARMACOL, V77, P1814, DOI 10.1016/j.bcp.2009.03.010; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2011, CURR DIABETES REP, V11, P203, DOI 10.1007/s11892-011-0183-1; Yudkin JS, 2007, HORM METAB RES, V39, P707, DOI 10.1055/s-2007-985898; Yudkin JS, 2003, INT J OBESITY, V27, pS25, DOI 10.1038/sj.ijo.0802496; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005; Zhang ZQ, 2010, CANCER RES, V70, P2379, DOI 10.1158/0008-5472.CAN-09-4204; Zhao YM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-14	101	36	36	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					368	378		10.1096/fj.12-213728	http://dx.doi.org/10.1096/fj.12-213728			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038751				2022-12-25	WOS:000313103200035
J	Murray, J; Auwerx, J; Huss, JM				Murray, Jennifer; Auwerx, Johan; Huss, Janice M.			Impaired myogenesis in estrogen-related receptor gamma (ERR gamma)-deficient skeletal myocytes due to oxidative stress	FASEB JOURNAL			English	Article						orphan nuclear receptors; differentiation; metabolism; reactive oxygen species	NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; NECROSIS-FACTOR-ALPHA; MUSCLE ATROPHY; ERR-ALPHA; MYOBLAST DIFFERENTIATION; GENE-EXPRESSION; MITOCHONDRIAL BIOGENESIS; PROTEIN-KINASE; CELL-SURVIVAL	Specialized contractile function and increased mitochondrial number and oxidative capacity are hallmark features of myocyte differentiation. The estrogen-related receptors (ERRs) can regulate mitochondrial biogenesis or mitochondrial enzyme expression in skeletal muscle, suggesting that ERRs may have a role in promoting myogenesis. Therefore, we characterized myogenic programs in primary myocytes isolated from wild-type (M-ERR gamma WT) and muscle-specific ERR gamma(-/-) (M-ERR gamma(-/-)) mice. Myotube maturation and number were decreased throughout differentiation in M-ERR gamma(-/-) primary myocytes, resulting in myotubes with reduced mitochondrial content and sarcomere assembly. Compared with M-ERR gamma WT myocytes at the same differentiation stage, the glucose oxidation rate was reduced by 30% in M-ERR gamma(-/-) myotubes, while medium-chain fatty acid oxidation was increased by 34% in M-ERR gamma(-/-) myoblasts and 36% in M-ERR gamma(-/-) myotubes. Concomitant with increased reliance on mitochondrial beta-oxidation, H2O2 production was significantly increased by 40% in M-ERR gamma(-/-) myoblasts and 70% in M-ERR gamma(-/-) myotubes compared to M-ERR gamma WT myocytes. ROS activation of FoxO and NF-kappa B and their downstream targets, atrogin-1 and MuRF1, was observed in M-ERR gamma(-/-) myocytes. The antioxidant N-acetyl cysteine rescued myotube formation and atrophy gene induction in M-ERR gamma(-/-) myocytes. These results suggest that loss of ERR gamma causes metabolic defects and oxidative stress that impair myotube formation through activation of skeletal muscle atrophy pathways.-Murray, J., Auwerx, J., Huss, J. M. Impaired myogenesis in estrogen-related receptor gamma (ERR gamma)-deficient skeletal myocytes due to oxidative stress. FASEB J. 27, 135-150 (2013). www.fasebj.org	[Huss, Janice M.] City Hope Natl Med Ctr, Dept Diabet & Metab Dis Res, Leslie & Susan Gonda Goldschmied Diabet & Genet R, Div Cellular & Mol Diabet Res,Beckman Res Inst, Duarte, CA 91010 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland	City of Hope; Beckman Research Institute of City of Hope; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Huss, JM (corresponding author), City Hope Natl Med Ctr, Dept Diabet & Metab Dis Res, Leslie & Susan Gonda Goldschmied Diabet & Genet R, Div Cellular & Mol Diabet Res,Beckman Res Inst, Rm 2132,1500 E Duarte Rd, Duarte, CA 91010 USA.	jhuss@coh.org	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK074700]; Beckman Research Institute (City of Hope); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074700] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Beckman Research Institute (City of Hope); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Marisa McDonald for technical assistance. The authors acknowledge assistance from the Light Microscopy and Digital Imaging Core and the Animal Resources Center (Department of Comparative Medicine, City of Hope). This work is supported by U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases funding (R01DK074700; to J. M. H.) and the Beckman Research Institute (City of Hope). The authors declare no conflicts of interest.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Barja G, 1999, J BIOENERG BIOMEMBR, V31, P347, DOI 10.1023/A:1005427919188; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Campbell KJ, 2004, BIOCHEM SOC T, V32, P1087, DOI 10.1042/BST0321087; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Cuschieri J, 2005, CRIT CARE MED, V33, pS417, DOI 10.1097/01.CCM.0000191714.39495.A6; DENYER GS, 1991, PFLUG ARCH EUR J PHY, V419, P115, DOI 10.1007/BF00372995; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Gomes-Marcondes MCC, 2002, CANCER LETT, V180, P69, DOI 10.1016/S0304-3835(02)00006-X; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Malinska D, 2012, MITOCHONDRION, V12, P144, DOI 10.1016/j.mito.2011.06.015; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Zhou LZH, 2001, FREE RADICAL BIO MED, V31, P1405, DOI 10.1016/S0891-5849(01)00719-5	62	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2013	27	1					135	150		10.1096/fj.12-212290	http://dx.doi.org/10.1096/fj.12-212290			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23038752	Green Published			2022-12-25	WOS:000313103200014
J	Duan, D; Jia, ZM; Joshi, M; Brunton, J; Chan, M; Drew, D; Davis, D; Allingham, JS				Duan, Da; Jia, Zhimeng; Joshi, Monika; Brunton, Jacqueline; Chan, Michelle; Drew, Doran; Davis, Darlene; Allingham, John S.			Neck Rotation and Neck Mimic Docking in the Noncatalytic Kar3-associated Protein Vik1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; CRYSTAL-STRUCTURE; KINESIN MOTOR; DOMAIN; KAR3; SPINDLE; CIK1; MOTIF; NCD	It is widely accepted that movement of kinesin motor proteins is accomplished by coupling ATP binding, hydrolysis, and product release to conformational changes in the microtubule-binding and force-generating elements of their motor domain. Therefore, understanding how the Saccharomyces cerevisiae proteins Cik1 and Vik1 are able to function as direct participants in movement of Kar3Cik1 and Kar3Vik1 kinesin complexes presents an interesting challenge given that their motor homology domain (MHD) cannot bind ATP. Our crystal structures of the Vik1 ortholog from Candida glabrata may provide insight into this mechanism by showing that its neck and neck mimic-like element can adopt several different conformations reminiscent of those observed in catalytic kinesins. We found that when the neck is alpha-helical and interacting with the MHD core, the C terminus of CgVik1 docks onto the central beta-sheet similarly to the ATP-bound form of Ncd. Alternatively, when neck-core interactions are broken, the Cterminus is disordered. Mutations designed to impair neck rotation, or some of the neck-MHD interactions, decreased microtubule gliding velocity and steady state ATPase rate of CgKar3Vik1 complexes significantly. These results strongly suggest that neck rotation and neck mimic docking in Vik1 and Cik1 may be a structural mechanism for communication with Kar3.	[Duan, Da; Jia, Zhimeng; Joshi, Monika; Brunton, Jacqueline; Drew, Doran; Davis, Darlene; Allingham, John S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Chan, Michelle] Univ British Columbia, Dept Cellular & Dev Biol, Vancouver, BC V6T 1Z3, Canada	Queens University - Canada; University of British Columbia	Allingham, JS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St,Rm 652, Kingston, ON K7L 3N6, Canada.	allinghj@queensu.ca	Jia, Zhimeng/GRI-9437-2022; Allingham, John/AAW-9262-2020; Jia, Zhimeng/AAS-9450-2021	Jia, Zhimeng/0000-0001-8156-5553; Jia, Zhimeng/0000-0001-8156-5553	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada and Canadian Institutes of Health Research (to J. S. A.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Deavours BE, 1998, CELL MOTIL CYTOSKEL, V40, P408, DOI 10.1002/(SICI)1097-0169(1998)40:4<408::AID-CM8>3.0.CO;2-6; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duan D, 2012, PROTEINS, V80, P1016, DOI 10.1002/prot.24004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Gladfelter A, 2009, NAT REV MICROBIOL, V7, P875, DOI 10.1038/nrmicro2249; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Heuston E, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-19; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khalil AS, 2008, P NATL ACAD SCI USA, V105, P19247, DOI 10.1073/pnas.0805147105; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sherwood RK, 2008, EUKARYOT CELL, V7, P1460, DOI 10.1128/EC.00138-08; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Szczesna E, 2012, FEBS LETT, V586, P854, DOI 10.1016/j.febslet.2012.02.011; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vinogradova MV, 2009, P NATL ACAD SCI USA, V106, P8175, DOI 10.1073/pnas.0811131106; Vinogradova MV, 2004, J BIOL CHEM, V279, P23504, DOI 10.1074/jbc.M400741200; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	44	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40292	40301		10.1074/jbc.M112.416529	http://dx.doi.org/10.1074/jbc.M112.416529			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23043140	hybrid, Green Published			2022-12-25	WOS:000311448800021
J	Mailloux, RJ; Fu, A; Robson-Doucette, C; Allister, EM; Wheeler, MB; Screaton, R; Harper, ME				Mailloux, Ryan J.; Fu, Accalia; Robson-Doucette, Christine; Allister, Emma M.; Wheeler, Michael B.; Screaton, Robert; Harper, Mary-Ellen			Glutathionylation State of Uncoupling Protein-2 and the Control of Glucose-stimulated Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; OXYGEN SPECIES PRODUCTION; S-GLUTATHIONYLATION; MITOCHONDRIAL-MEMBRANE; OXIDATIVE STRESS; MUSCLE-CELLS; PROTON LEAK; RELEASE; ISLETS; CONDUCTANCE	The role of reactive oxygen species (ROS) in glucose-stimulated insulin release remains controversial because ROS have been shown to both amplify and impede insulin release. In regard to preventing insulin release, ROS activates uncoupling protein-2 (UCP2), a mitochondrial inner membrane protein that negatively regulates glucose-stimulated insulin secretion (GSIS) by uncoupling oxidative phosphorylation. With our recent discovery that the UCP2-mediated proton leak is modulated by reversible glutathionylation, a process responsive to small changes in ROS levels, we resolved to determine whether glutathionylation is required for UCP2 regulation of GSIS. Using Min6 cells and pancreatic islets, we demonstrate that induction of glutathionylation not only deactivates UCP2-mediated proton leak but also enhances GSIS. Conversely, an increase in mitochondrial matrix ROS was found to deglutathionylate and activate UCP2 leak and impede GSIS. Glucose metabolism also decreased the total amount of cellular glutathionylated proteins and increased the cellular glutathione redox ratio (GSH/GSSG). Intriguingly, the provision of extracellular ROS (H2O2, 10 mu M) amplified GSIS and also activated UCP2. Collectively, our findings indicate that the glutathionylation status of UCP2 contributes to the regulation of GSIS, and different cellular sites and inducers of ROS can have opposing effects on GSIS, perhaps explaining some of the controversy surrounding the role of ROS in GSIS.	[Mailloux, Ryan J.; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Fu, Accalia; Screaton, Robert] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Robson-Doucette, Christine; Allister, Emma M.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto	Harper, ME (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	mharper@uottawa.ca		Doucette, Christine/0000-0002-5070-2639; Harper, Mary-Ellen/0000-0003-3864-5886; Wheeler, Michael B./0000-0002-7480-7267; Mailloux, Ryan/0000-0003-3986-9830; Fu, Accalia/0000-0002-1110-8039	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research Canadian Institutes of Health Research (to M. E. H.).; Supported by a postdoctoral fellowship provided by the Canadian Institutes of Health Research.; Supported by a doctoral training fellowship from the Canadian Diabetes Association.	Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; AMMON HPT, 1980, DIABETES, V29, P830, DOI 10.2337/diabetes.29.10.830; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gray JP, 2010, TOXICOL MECH METHOD, V20, P167, DOI 10.3109/15376511003695181; Heart E, 2012, TOXICOL APPL PHARM, V258, P216, DOI 10.1016/j.taap.2011.11.002; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; JANJIC D, 1992, EUR J BIOCHEM, V210, P297, DOI 10.1111/j.1432-1033.1992.tb17421.x; Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kushnareva YE, 2000, ARCH BIOCHEM BIOPHYS, V376, P377, DOI 10.1006/abbi.2000.1730; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Liedhegner EAS, 2012, ANTIOXID REDOX SIGN, V16, P543, DOI 10.1089/ars.2011.4119; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MACDONALD MJ, 1991, BIOSCIENCE REP, V11, P165, DOI 10.1007/BF01182485; MACDONALD MJ, 1990, ARCH BIOCHEM BIOPHYS, V279, P104, DOI 10.1016/0003-9861(90)90468-E; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004; Mailloux RJ, 2012, FASEB J, V26, P363, DOI 10.1096/fj.11-189639; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; MASON RP, 1990, ENVIRON HEALTH PERSP, V87, P237, DOI 10.2307/3431031; Mertz RJ, 1996, J BIOL CHEM, V271, P4838, DOI 10.1074/jbc.271.9.4838; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Parker N, 2008, BIOCHEM J, V412, P131, DOI 10.1042/BJ20080006; Pi J, 2010, DIABETES OBES METAB, V12, P141, DOI 10.1111/j.1463-1326.2010.01269.x; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Porterfield DM, 2000, DIABETES, V49, P1511, DOI 10.2337/diabetes.49.9.1511; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Spacek T, 2008, INT J BIOCHEM CELL B, V40, P1522, DOI 10.1016/j.biocel.2007.11.015; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010	48	53	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.393538	http://dx.doi.org/10.1074/jbc.M112.393538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035124	Green Published, hybrid			2022-12-25	WOS:000311233800037
J	Jono, CMA; Pavoine, S				Jono, Clementine M. A.; Pavoine, Sandrine			Threat Diversity Will Erode Mammalian Phylogenetic Diversity in the Near Future	PLOS ONE			English	Article							EXTINCTION RISK; CONSERVATION PRIORITIZATION; AUSTRALIAN MARSUPIALS; BIODIVERSITY; IMPACT; PROBABILITIES; SELECTIVITY; HISTORY; DECLINE; BATS	To reduce the accelerating rate of phylogenetic diversity loss, many studies have searched for mechanisms that could explain why certain species are at risk, whereas others are not. In particular, it has been demonstrated that species might be affected by both extrinsic threat factors as well as intrinsic biological traits that could render a species more sensitive to extinction; here, we focus on extrinsic factors. Recently, the International Union for Conservation of Nature developed a new classification of threat types, including climate change, urbanization, pollution, agriculture and aquaculture, and harvesting/hunting. We have used this new classification to analyze two main factors that could explain the expected future loss of mammalian phylogenetic diversity: 1. differences in the type of threats that affect mammals and 2. differences in the number of major threats that accumulate for a single species. Our results showed that Cetartiodactyla, Diprotodontia, Monotremata, Perissodactyla, Primates, and Proboscidea could lose a high proportion of their current phylogenetic diversity in the coming decades. In contrast, Chiroptera, Didelphimorphia, and Rodentia could lose less phylogenetic diversity than expected if extinctions were random. Some mammalian clades, including Marsupiala, Chiroptera, and a subclade of Primates, are affected by particular threat types, most likely due solely to their geographic locations and associations with particular habitats. However, regardless of the geography, habitat, and taxon considered, it is not the threat type, but the threat diversity that determines the extinction risk for species and clades. Thus, some mammals might be randomly located in areas subjected to a large diversity of threats; they might also accumulate detrimental traits that render them sensitive to different threats, which is a characteristic that could be associated with large body size. Any action reducing threat diversity is expected to have a significant impact on future mammalian phylogeny.	[Jono, Clementine M. A.; Pavoine, Sandrine] UMR CNRS UPMC 7204, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, Paris, France; [Pavoine, Sandrine] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Oxford	Jono, CMA (corresponding author), UMR CNRS UPMC 7204, Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, Paris, France.	clementine.jono@gmail.com						Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Baillie J. E., 2004, GLOBAL SPECIES ASSES; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Cardillo M, 2001, CONSERV BIOL, V15, P1435, DOI 10.1046/j.1523-1739.2001.00286.x; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Elliott W.R., 2004, ENCY CAVES, P428; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Greenacre M.J., 1984, THEORY APPL CORRES A; Gros G, 1982, BIOMETR PRAX, V22, P117; Hall LS, 1997, WILDLIFE SOC B, V25, P173; Hayward MW, 2009, CONSERV BIOL, V23, P1568, DOI 10.1111/j.1523-1739.2009.01260.x; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15, DOI DOI 10.2305/IUCN.CH.2009.17.EN; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; *INT UN CONS NAT, 2012, IUCN RED LIST CAT CR; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2019, IUCN RED LIST THREAT; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; Johnson CN, 2002, ANIM CONSERV, V5, P135, DOI 10.1017/S1367943002002196; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; KRAJEWSKI C, 1991, SCIENCE, V254, P918, DOI 10.1126/science.254.5034.918-a; Lapointe FJ, 2001, J CLASSIF, V18, P109, DOI 10.1007/s00357-001-0007-0; MACE GM, 2000, FUTURE PRIORITIES CO, P27; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; Meijaard E, 2008, BIOTROPICA, V40, P76, DOI 10.1111/j.1744-7429.2007.00340.x; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Mooers AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003700; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Parhar RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023528; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Rodriguez JP, 2000, NATURE, V403, P241, DOI 10.1038/35002183; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sodhi N. S., 2009, PRINCET GUIDE ECOL, P514, DOI DOI 10.1515/9781400833023.514; Vie J-C, 2009, WILDLIFE CHANGING WO; Wilson D. E., 2005, MAMMAL SPECIES WORLD	61	20	20	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46235	10.1371/journal.pone.0046235	http://dx.doi.org/10.1371/journal.pone.0046235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029443	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900113
J	Loyola, RD; Lemes, P; Faleiro, FV; Trindade, J; Machado, RB				Loyola, Rafael D.; Lemes, Priscila; Faleiro, Frederico V.; Trindade-Filho, Joaquim; Machado, Ricardo B.			Severe Loss of Suitable Climatic Conditions for Marsupial Species in Brazil: Challenges and Opportunities for Conservation	PLOS ONE			English	Article							MODELS; IMPACTS	A wide range of evidences indicate climate change as one the greatest threats to biodiversity in the 21st century. The impacts of these changes, which may have already resulted in several recent species extinction, are species-specific and produce shifts in species phenology, ecological interactions, and geographical distributions. Here we used cutting-edge methods of species distribution models combining thousands of model projections to generate a complete and comprehensive ensemble of forecasts that shows the likely impacts of climate change in the distribution of all 55 marsupial species that occur in Brazil. Consensus projections forecasted range shifts that culminate with high species richness in the southeast of Brazil, both for the current time and for 2050. Most species had a significant range contraction and lost climate space. Turnover rates were relatively high, but vary across the country. We also mapped sites retaining climatic suitability. They can be found in all Brazilian biomes, especially in the pampas region, in the southern part of the Brazilian Atlantic Forest, in the north of the Cerrado and Caatinga, and in the northwest of the Amazon. Our results provide a general overview on the likely effects of global climate change on the distribution of marsupials in the country as well as in the patterns of species richness and turnover found in regional marsupial assemblages.	[Loyola, Rafael D.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil; [Lemes, Priscila; Faleiro, Frederico V.; Trindade-Filho, Joaquim] Univ Fed Goias, Grad Program Ecol & Evolut, Goiania, Go, Brazil; [Machado, Ricardo B.] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Brasilia	Loyola, RD (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	rdiasloyola@gmail.com	Machado, Ricardo/GXM-8198-2022; Machado, Ricardo Bomfim/J-5894-2012; Faleiro, Frederico V/B-8250-2016; Loyola, Rafael/A-4425-2008; Loyola, Rafael/S-3978-2019; Lemes, Priscila/I-5877-2013; Filho, Joaquim Trindade/AAP-1545-2021	Machado, Ricardo Bomfim/0000-0002-6508-9005; Faleiro, Frederico V/0000-0002-4183-6897; Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Lemes, Priscila/0000-0002-0918-5158; TRINDADE FILHO, JOAQUIM/0000-0001-5429-3193	CNPq [304703/2011-7]; CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	R.D.L. received a research productivity scholarship from the CNPq (grant #304703/2011-7). P. L. received a PhD scholarship from CNPq. F. V. F. and J.T.-F. received PhD scholarships from CAPES. Conservation Biogeography Lab research has been continuously supported by the CNPq, CAPES, Conservation International Brazil, and MCT-Rede CLIMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caceres N.C., 2006, MARSUPIAIS BRASIL BI, V1; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eastman JR, 2009, IDRISI KILIMANJARO G; Diniz JAF, 2009, NAT CONSERVACAO, V7, P100; Fernandez Fernando A.S., 2006, P191; Franklin J, 2009, MAPPING SPECIES DIST; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Garcia RA, 2012, GLOBAL CHANGE BIOL, V18, P1253, DOI 10.1111/j.1365-2486.2011.02605.x; Gardner A.L., 2008, MAMMALS S AM MARSUPI, V1; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hastie T.J., 2017, STAT SCI; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Lawler JJ, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P271, DOI 10.1007/978-1-4419-7390-0_14; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lewinsohn TM, 2005, CONSERV BIOL, V19, P619, DOI 10.1111/j.1523-1739.2005.00680.x; Loyola RD, 2012, MAMIFEROS B IN PRESS; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Parry ML, 2007, CLIMATE CHANGE 2007; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pimm SL, 2010, NAT CONSERVACAO, V8, P71, DOI 10.4322/natcon.00801011; Prevedello JA, 2011, J ZOOL, V284, P53, DOI 10.1111/j.1469-7998.2010.00783.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Puettker Thomas, 2008, BMC Ecology, V8, P9, DOI 10.1186/1472-6785-8-9; Rossi R. V., 2006, MAMIFEROS BRASIL, P27; Salazar LF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029695; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x	36	42	42	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46257	10.1371/journal.pone.0046257	http://dx.doi.org/10.1371/journal.pone.0046257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029452	gold, Green Published, Green Submitted			2022-12-25	WOS:000309973900118
J	Zhang, H; Yan, HM; Kendrick, KM; Li, CY				Zhang, Hao; Yan, Hong-Mei; Kendrick, Keith M.; Li, Chao-Yi			Both Lexical and Non-Lexical Characters Are Processed during Saccadic Eye Movements	PLOS ONE			English	Article							TIME; COMPRESSION; SUPPRESSION; SPACE	On average our eyes make 3-5 saccadic movements per second when we read, although their neural mechanism is still unclear. It is generally thought that saccades help redirect the retinal fovea to specific characters and words but that actual discrimination of information only occurs during periods of fixation. Indeed, it has been proposed that there is active and selective suppression of information processing during saccades to avoid experience of blurring due to the high-speed movement. Here, using a paradigm where a string of either lexical (Chinese) or non-lexical (alphabetic) characters are triggered by saccadic eye movements, we show that subjects can discriminate both while making saccadic eye movement. Moreover, discrimination accuracy is significantly better for characters scanned during the saccadic movement to a fixation point than those not scanned beyond it. Our results showed that character information can be processed during the saccade, therefore saccades during reading not only function to redirect the fovea to fixate the next character or word but allow pre-processing of information from the ones adjacent to the fixation locations to help target the next most salient one. In this way saccades can not only promote continuity in reading words but also actively facilitate reading comprehension.	[Zhang, Hao; Yan, Hong-Mei; Kendrick, Keith M.; Li, Chao-Yi] Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yan, HM (corresponding author), Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	hmyan@uestc.edu.cn		Kendrick, Keith/0000-0002-0371-5904	Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60972108, 91120013, 61075109]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Program (2007CB311001), and the Natural Science Foundations of China (90820301, 60972108, 91120013, 61075109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binda P, 2009, J NEUROSCI, V29, P13147, DOI 10.1523/JNEUROSCI.3723-09.2009; BRIDGEMAN B, 1995, PSYCHOL RES-PSYCH FO, V58, P163, DOI 10.1007/BF00419631; Brockmole JR, 2002, PERCEPT PSYCHOPHYS, V64, P867, DOI 10.3758/BF03196792; Burr DC, 2011, PHILOS T R SOC B, V366, P504, DOI 10.1098/rstb.2010.0244; Burr DC, 2010, TRENDS COGN SCI, V14, P528, DOI 10.1016/j.tics.2010.09.005; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Hall NJ, 2011, PHILOS T R SOC B, V366, P528, DOI 10.1098/rstb.2010.0248; Ibbotson MR, 2007, CEREB CORTEX, V17, P1129, DOI 10.1093/cercor/bhl022; Ibbotson MR, 2009, CURR BIOL, V19, pR493, DOI 10.1016/j.cub.2009.05.010; Irwin D. E., 2004, INTERFACE LANGUAGE V, P105; Irwin DE, 2007, PERCEPT PSYCHOPHYS, V69, P450, DOI 10.3758/BF03193765; Irwin DE, 2004, PSYCHOL SCI, V15, P467, DOI 10.1111/j.0956-7976.2004.00703.x; Irwin DE, 2000, PSYCHON B REV, V7, P654, DOI 10.3758/BF03213003; Irwin DE, 1998, COGNITIVE PSYCHOL, V36, P1, DOI 10.1006/cogp.1998.0682; Knoll J, 2011, J VISION, V11, DOI 10.1167/11.14.15; Lappe M, 2006, J VISION, V6, P1282, DOI 10.1167/6.11.11; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Morrone C, 2008, COGNITIVE NEUROSCIEN; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Potter M.C., 1984, NEW METHODS READING, P91; Radach R, 2004, EUR J COGN PSYCHOL, V16, P3, DOI 10.1080/09541440340000295; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Thilo KV, 2004, NAT NEUROSCI, V7, P13, DOI 10.1038/nn1171; Vonk W, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P291, DOI 10.1016/B978-044451020-4/50017-7; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Yatabe K, 2009, PSYCHON B REV, V16, P62, DOI 10.3758/PBR.16.1.62	31	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46383	10.1371/journal.pone.0046383	http://dx.doi.org/10.1371/journal.pone.0046383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029504	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900151
J	Geng, QR; Xu, DZ; He, LJ; Lu, JB; Zhou, ZW; Zhan, YQ; Lu, Y				Geng, Qi-Rong; Xu, Da-Zhi; He, Long-Jun; Lu, Jia-Bing; Zhou, Zhi-Wei; Zhan, You-Qing; Lu, Yue			Beclin-1 Expression Is a Significant Predictor of Survival in Patients with Lymph Node-Positive Gastric Cancer	PLOS ONE			English	Article							AUTOPHAGY; STATISTICS	Background: Beclin 1 is a main actor of autophagy. The expression of Beclin 1 and its prognostic role in gastric cancer is largely unexplored. The purpose of the present study is to investigate the expression of beclin 1 in gastric cancer cells, tissues and its relationship with prognosis. Methods: The expression of Beclin 1 was detected in 271 specimens of lymph-node positive gastric cancer patients by immunohistochemistry. The correlation of Beclin 1 expression to clinicopathologic features and survival of gastric cancer was studied. Beclin-1 expression in gastric cancer cell lines and clinical specimens is also detected using reverse transcription-PCR and Western blotting. Results: Beclin 1 is up-regulated at both mRNA and protein levels in six gastric cancer cell lines compared with those in normal gastric mucosa cell line (GES-1). The expression of Beclin-1 in gastric clinical specimens is also higher than those in the adjacent noncancerous tissues. Of the 271 patients, 229 (84.5%) were Beclin 1 high expression tumors by immunohistochemistry. Beclin 1 expression is closely associated with intravascular embolus. Kaplan-Meier analysis showed high beclin 1 expression was associated with longer overall survival. Both univariate analysis and multivariate analysis revealed that Beclin 1 expression were independent prognostic factors in the patients with node-positive gastric cancer. Conclusions: Our findings strongly suggest that Beclin 1 has a potential role in tumorigenesis of gastric cancer and could be a promising biomarker for predicting the prognosis of patients with lymph node-positive gastric cancer. It might also serve as a novel therapeutic target for gastric cancer treatment.	[Geng, Qi-Rong; Xu, Da-Zhi; He, Long-Jun; Lu, Jia-Bing; Zhou, Zhi-Wei; Zhan, You-Qing; Lu, Yue] State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China; [Geng, Qi-Rong; Lu, Yue] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Da-Zhi; Zhou, Zhi-Wei; Zhan, You-Qing] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [He, Long-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Jia-Bing] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xu, DZ (corresponding author), State Key Lab Oncol S China, Guangzhou, Guangdong, Peoples R China.	xudzh@sysucc.org.cn; lvyue@sysucc.org.cn			Medical Science Foundation of Guangdong Province [2010B031600071]	Medical Science Foundation of Guangdong Province	This work was supported by the Medical Science Foundation of Guangdong Province (No. 2010B031600071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Bang YJ, 2010, LANCET, V376, P1302; Chen N, 2009, BBA-MOL CELL RES, V1793, P1516, DOI 10.1016/j.bbamcr.2008.12.013; Cui MH, 2010, MED ONCOL, V27, P632, DOI 10.1007/s12032-009-9260-6; Daniel F, 2007, CANCER INVEST, V25, P226, DOI 10.1080/07357900701206323; Dong LW, 2011, AUTOPHAGY, V7, P1222, DOI 10.4161/auto.7.10.16610; Galizia G, 2006, J SURG ONCOL, V93, P241, DOI 10.1002/jso.20402; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Holden J, 2011, LANCET ONCOL, V12, P16, DOI 10.1016/S1470-2045(10)70276-X; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang XH, 2001, CANCER RES, V61, P3443; Lordick F, 2011, FUTURE ONCOL, V7, P187, DOI 10.2217/FON.10.178; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Saito H, 2010, J SURG ONCOL, V101, P622, DOI 10.1002/jso.21562; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Sobin LH., 2010, TNM CLASSIFICATION M; Sutter AP, 2004, ONKOLOGIE, V27, P17, DOI 10.1159/000075600; TAGLIABUE E, 1991, INT J CANCER, V47, P933, DOI 10.1002/ijc.2910470625; Wan XM, 2011, INT J CANCER, V129, P1087, DOI 10.1002/ijc.25771; Wang ZH, 2007, GYNECOL ONCOL, V107, P107, DOI 10.1016/j.ygyno.2007.05.034; Xing R, 2012, GUT, V61, P43, DOI 10.1136/gut.2010.230623; Xu DZ, 2004, WORLD J GASTROENTERO, V10, P2727, DOI 10.3748/wjg.v10.i18.2727; Xu DZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-536; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4; Yamaguchi T, 2001, JPN J CLIN ONCOL, V31, P153, DOI 10.1093/jjco/hye035	34	28	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45968	10.1371/journal.pone.0045968	http://dx.doi.org/10.1371/journal.pone.0045968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029344	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500050
J	Green, JA; Gu, C; Mykytyn, K				Green, Jill A.; Gu, Chen; Mykytyn, Kirk			Heteromerization of Ciliary G Protein-Coupled Receptors in the Mouse Brain	PLOS ONE			English	Article							NEURONAL CILIA; ADENYLYL-CYCLASE; SIGNALING CENTER; LEPTIN ACTION; DOPAMINE D1; MICE LEADS; SOMATOSTATIN; LOCALIZATION; DISEASE; MEMORY	Nearly every cell type in the mammalian body projects from its cell surface a primary cilium that provides important sensory and signaling functions. Defects in the formation or function of primary cilia have been implicated in the pathogenesis of many human developmental disorders and diseases, collectively termed ciliopathies. Most neurons in the brain possess cilia that are enriched for signaling proteins such as G protein-coupled receptors and adenylyl cyclase type 3, suggesting neuronal cilia sense neuromodulators in the brain and contribute to non-synaptic signaling. Indeed, disruption of neuronal cilia or loss of neuronal ciliary signaling proteins is associated with obesity and learning and memory deficits. As the functions of primary cilia are defined by the signaling proteins that localize to the ciliary compartment, identifying the complement of signaling proteins in cilia can provide important insights into their physiological roles. Here we report for the first time that different GPCRs can colocalize within the same cilium. Specifically, we found the ciliary GPCRs, melanin-concentrating hormone receptor 1 (Mchr1) and somatostatin receptor 3 (Sstr3) colocalizing within cilia in multiple mouse brain regions. In addition, we have evidence suggesting Mchr1 and Sstr3 form heteromers. As GPCR heteromerization can affect ligand binding properties as well as downstream signaling, our findings add an additional layer of complexity to neuronal ciliary signaling.	[Green, Jill A.; Mykytyn, Kirk] Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA; [Gu, Chen] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mykytyn, K (corresponding author), Ohio State Univ, Coll Med, Dept Pharmacol, Columbus, OH 43210 USA.	mykytyn.1@osu.edu	Mykytyn, Kirk/E-3723-2011	Mykytyn, Kirk/0000-0002-0158-4592	National Institutes of Health/National Institute of General Medical Sciences [R01 GM083120]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS062720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062720] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by R01 GM083120 from the National Institutes of Health/National Institute of General Medical Sciences (K.M.) and R01 NS062720 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (C.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Chung SJ, 2011, J MOL NEUROSCI, V43, P115, DOI 10.1007/s12031-010-9411-4; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Domire JS, 2009, METHOD CELL BIOL, V91, P111, DOI 10.1016/S0091-679X(08)91006-2; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Green JA, 2010, CELL MOL LIFE SCI, V67, P3287, DOI 10.1007/s00018-010-0425-4; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Kokkotou EG, 2001, ENDOCRINOLOGY, V142, P680, DOI 10.1210/en.142.2.680; Kolakowski LF, 1996, FEBS LETT, V398, P253, DOI 10.1016/S0014-5793(96)01160-X; Lee SP, 2004, J BIOL CHEM, V279, P35671, DOI 10.1074/jbc.M401923200; Marcellino D, 2008, J BIOL CHEM, V283, P26016, DOI 10.1074/jbc.M710349200; Monzon ME, 1999, PEPTIDES, V20, P1517, DOI 10.1016/S0196-9781(99)00164-3; Pachoud B, 2010, J NEUROPHYSIOL, V104, P1417, DOI 10.1152/jn.01052.2009; Pfeiffer M, 2001, J BIOL CHEM, V276, P14027, DOI 10.1074/jbc.M006084200; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rozenfeld R, 2011, BIOCHEM J, V433, P11, DOI 10.1042/BJ20100458; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Stanic D, 2009, BRAIN RES, V1249, P101, DOI 10.1016/j.brainres.2008.10.024; Stengel A, 2010, J PHYSIOL PHARMACOL, V61, P399; Stepanyan Z, 2007, J NEUROCHEM, V100, P468, DOI 10.1111/j.1471-4159.2006.04219.x; Veland IR, 2009, NEPHRON PHYSIOL, V111, P39, DOI 10.1159/000208212; Wang ZS, 2011, J NEUROSCI, V31, P5557, DOI 10.1523/JNEUROSCI.6561-10.2011; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010	35	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46304	10.1371/journal.pone.0046304	http://dx.doi.org/10.1371/journal.pone.0046304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029470	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500086
J	Laakkonen, JP; Engler, T; Romero, IA; Weksler, B; Couraud, PO; Kreppel, F; Kochanek, S				Laakkonen, Johanna P.; Engler, Tatjana; Romero, Ignacio A.; Weksler, Babette; Couraud, Pierre-Olivier; Kreppel, Florian; Kochanek, Stefan			Transcellular Targeting of Fiber- and Hexon-Modified Adenovirus Vectors across the Brain Microvascular Endothelial Cells In Vitro	PLOS ONE			English	Article							TRANSGENE EXPRESSION; DRUG TRANSPORT; ADULT BRAIN; BARRIER; GENE; TRANSCYTOSIS; RECEPTOR; MODEL; TRAFFICKING	In central nervous system (CNS)-directed gene therapy, efficient targeting of brain parenchyma through the vascular route is prevented by the endothelium and the epithelium of the blood-brain and the blood-cerebrospinal fluid barriers, respectively. In this study, we evaluated the feasibility of the combined genetic and chemical adenovirus capsid modification technology to enable transcellular delivery of targeted adenovirus (Ad) vectors across the blood-brain barrier (BBB) in vitro models. As a proof-of-principle ligand, maleimide-activated full-length human transferrin (hTf) was covalently attached to cysteine-modified Ad serotype 5 vectors either to its fiber or hexon protein. In transcytosis experiments, hTf-coupled vectors were shown to be redirected across the BBB models, the transcytosis activity of the vectors being dependent on the location of the capsid modification and the in vitro model used. The transduction efficiency of hTf-targeted vectors decreased significantly in confluent, polarized cells, indicating that the intracellular route of the vectors differed between unpolarized and polarized cells. After transcellular delivery the majority of the hTf-modified vectors remained intact and partly capable of gene transfer. Altogether, our results demonstrate that i) covalent attachment of a ligand to Ad capsid can mediate transcellular targeting across the cerebral endothelium in vitro, ii) the attachment site of the ligand influences its transcytosis efficiency and iii) combined genetic/chemical modification of Ad vector can be used as a versatile platform for the development of Ad vectors for transcellular targeting.	[Laakkonen, Johanna P.; Engler, Tatjana; Kreppel, Florian; Kochanek, Stefan] Univ Ulm, Dept Gene Therapy, Ulm, Germany; [Romero, Ignacio A.; Weksler, Babette; Couraud, Pierre-Olivier] Cochin Inst, INSERM, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Kochanek, S (corresponding author), Univ Ulm, Dept Gene Therapy, Ulm, Germany.	stefan.kochanek@uni-ulm.de		Romero, Ignacio/0000-0002-0322-9180; Laakkonen, Johanna/0000-0002-8556-9727	Academy of Finland [130242]; Finnish Cultural Foundation [00107022]; EU (NoE Clinigene) [LSHB-CT-2006-018933]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); EU (NoE Clinigene)	This work was supported by Academy of Finland (130242), Finnish Cultural Foundation (00107022) and the EU (NoE Clinigene - LSHB-CT-2006-018933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Batista L, 2010, NEUROBIOL DIS, V37, P656, DOI 10.1016/j.nbd.2009.12.001; Campos SK, 2006, VIROLOGY, V349, P453, DOI 10.1016/j.virol.2006.01.032; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Corjon S, 2008, MOL THER, V16, P1813, DOI 10.1038/mt.2008.174; Cudkowicz A, 1984, Prog Clin Biol Res, V165, P509; DEHOUCK MP, 1992, J NEUROCHEM, V58, P1790, DOI 10.1111/j.1471-4159.1992.tb10055.x; Di Pasquale G, 2006, MOL THER, V13, P506, DOI 10.1016/j.ymthe.2005.11.007; Espenlaub S, 2010, HUM GENE THER, V21, P1155, DOI 10.1089/hum.2009.171; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Franke H, 1999, BRAIN RES, V818, P65, DOI 10.1016/S0006-8993(98)01282-7; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Georgieva JV, 2011, MOL THER, V19, P318, DOI 10.1038/mt.2010.236; Glasgow JN, 2006, CANCER GENE THER, V13, P830, DOI 10.1038/sj.cgt.7700928; Goldsmith ME, 2003, CLIN CANCER RES, V9, P5394; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kreppel F, 2005, MOL THER, V12, P107, DOI 10.1016/j.ymthe.2005.03.006; Lichota J, 2010, J NEUROCHEM, V113, P1, DOI [10.1111/j.1471-4159.2009.06544, 10.1111/j.1471-4159.2009.06544.x]; Lindemann D, 2009, THROMB HAEMOSTASIS, V102, P1135, DOI 10.1160/TH09-10-0724; Manfredsson FP, 2010, DISCOV MED, V9, P204; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Nitz T, 2003, BRAIN RES, V981, P30, DOI 10.1016/S0006-8993(03)02834-8; Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725; Pardridge WM, 1998, J NEUROCHEM, V70, P1781; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Prill JM, 2011, MOL THER, V19, P83, DOI 10.1038/mt.2010.229; Pulzova L, 2009, FEMS IMMUNOL MED MIC, V57, P203, DOI 10.1111/j.1574-695X.2009.00594.x; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Smith-Arica JR, 2000, MOL THER, V2, P579, DOI 10.1006/mthe.2000.0215; Tang Y, 2007, GENE THER, V14, P523, DOI 10.1038/sj.gt.3302888; Thomas CE, 2002, J VIROL, V76, P3452, DOI 10.1128/JVI.76.7.3452-3460.2002; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Xia HB, 2000, J VIROL, V74, P11359, DOI 10.1128/JVI.74.23.11359-11366.2000	40	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45977	10.1371/journal.pone.0045977	http://dx.doi.org/10.1371/journal.pone.0045977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029348	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500051
J	Chen, GW; Tsao, KC; Huang, CG; Gong, YN; Chang, SC; Liu, YC; Wu, HH; Yang, SL; Lin, TY; Huang, YC; Shih, SR				Chen, Guang-Wu; Tsao, Kuo-Chien; Huang, Chung-Guei; Gong, Yu-Nong; Chang, Shih-Cheng; Liu, Yi-Chun; Wu, Hsiao-Han; Yang, Shu-Li; Lin, Tzou-Yien; Huang, Yhu-Chering; Shih, Shin-Ru			Amino Acids Transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011	PLOS ONE			English	Article							INFLUENZA-A; NEURAMINIDASE INHIBITORS; OSELTAMIVIR RESISTANCE; VIRUS; SURVEILLANCE; MUTATIONS; EMERGENCE; SELECTION; WORLDWIDE; DRUG	A swine-origin influenza A was detected in April 2009 and soon became the 2009 H1N1 pandemic strain (H1N1pdm). The current study revealed the genetic diversity of H1N1pdm, based on 77 and 70 isolates which we collected, respectively, during the 2009/2010 and 2010/2011 influenza seasons in Taiwan. We focused on tracking the amino acid transitioning of hemagglutinin (HA) and neuraminidase (NA) genes in the early diversification of the virus and compared them with H1N1pdm strains reported worldwide. We identified newly emerged mutation markers based on A/California/04/2009, described how these markers shifted from the first H1N1pdm season to the one that immediately followed, and discussed how these observations may relate to antigenicity, receptor-binding, and drug susceptibility. It was found that the amino acid mutation rates of H1N1pdm were elevated, from 9.29 x 10(-3) substitutions per site in the first season to 1.46 x 10(-2) in the second season in HA, and from 5.23 x 10(-3) to 1.10 x 10(-2) in NA. Many mutation markers were newly detected in the second season, including 11 in HA and 8 in NA, and some were found having statistical correlation to disease severity. There were five noticeable HA mutations made to antigenic sites. No significant titer changes, however, were detected based on hemagglutination inhibition tests. Only one isolate with H275Y mutation known to reduce susceptibility to NA inhibitors was detected. As limited Taiwanese H1N1pdm viruses were isolated after our sampling period, we gathered 8,876 HA and 6,017 NA H1N1pdm sequences up to April 2012 from NCBI to follow up the dynamics of mentioned HA mutations. While some mutations described in this study seemed to either settle in or die out in the 2011-2012 season, a number of them still showed signs of transitioning, prompting the importance of continuous monitoring of this virus for more seasons to come.	[Chen, Guang-Wu; Tsao, Kuo-Chien; Huang, Chung-Guei; Chang, Shih-Cheng; Lin, Tzou-Yien; Shih, Shin-Ru] Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan; [Chen, Guang-Wu] Chang Gung Univ, Dept Comp Sci & Informat Engn, Tao Yuan, Taiwan; [Tsao, Kuo-Chien; Huang, Chung-Guei; Chang, Shih-Cheng; Shih, Shin-Ru] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Gong, Yu-Nong] Chang Gung Univ, Grad Inst Elect Engn, Tao Yuan, Taiwan; [Tsao, Kuo-Chien; Huang, Chung-Guei; Liu, Yi-Chun; Wu, Hsiao-Han; Yang, Shu-Li; Shih, Shin-Ru] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Lin, Tzou-Yien; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsao, KC (corresponding author), Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan, Taiwan.	kctsao@adm.cgmh.org.tw	Chen, Guang-Wu/M-6768-2016; liu, yi/GXE-9662-2022; Shih, Shin-Ru/M-9711-2016	Chen, Guang-Wu/0000-0002-5322-4839; Gong, Yu-Nong/0000-0002-6799-1561; Shih, Shin-Ru/0000-0003-4874-401X	Chang Gung Memorial Hospital [CMRPG390601, CMRPG390602, CMRPG320018, CMRPD180213]; National Science Council, Taiwan [NSC97-2221-E-182-034-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Grants from Chang Gung Memorial Hospital: CMRPG390601, CMRPG390602, CMRPG320018, CMRPD180213. http://www.cgmh.org.tw. Grants from National Science Council, Taiwan: NSC97-2221-E-182-034-MY3. http://www.nsc.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Deyde VM, 2009, ANTIVIR RES, V81, P16, DOI 10.1016/j.antiviral.2008.08.008; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hurt A, 2011, EURO SURVEILL, V16; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyicheva T, 2011, INFECT GENET EVOL, V11, P2107, DOI 10.1016/j.meegid.2011.05.002; Maurer-Stroh S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-18; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Pan CE, 2010, PLOS ONE, V5, pA31, DOI 10.1371/journal.pone.0009549; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Renaud C, 2011, J CLIN VIROL, V52, P70, DOI 10.1016/j.jcv.2011.05.019; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Ujike M, 2011, EMERG INFECT DIS, V17, P470, DOI 10.3201/eid1703.101188; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905; Yang JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028288	24	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45946	10.1371/journal.pone.0045946	http://dx.doi.org/10.1371/journal.pone.0045946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029335	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700094
J	Shin, IS; Lee, MY; Lim, HS; Ha, H; Seo, CS; Kim, JC; Shin, HK				Shin, In Sik; Lee, Mee Young; Lim, Hye Sun; Ha, Hyekyung; Seo, Chang Seob; Kim, Jong-Choon; Shin, Hyeun Kyoo			An Extract of Crataegus pinnatifida Fruit Attenuates Airway Inflammation by Modulation of Matrix Metalloproteinase-9 in Ovalbumin Induced Asthma	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; MURINE MODEL; TOLUENE DIISOCYANATE; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; IN-VITRO; EXPRESSION; MIGRATION; EOSINOPHILS; MECHANISMS	Background: Crataegus pinnatifida (Chinese hawthorn) has long been used as a herbal medicine in Asia and Europe. It has been used for the treatment of various cardiovascular diseases such as myocardial weakness, tachycardia, hypertension and arteriosclerosis. In this study, we investigated the anti-inflammatory effects of Crataegus pinnatifida ethanolic extracts (CPEE) on Th2-type cytokines, eosinophil infiltration, expression of matrix metalloproteinase (MMP)-9, and other factors, using an ovalbumin (OVA)-induced murine asthma model. Methods/Principal Finding: Airways of OVA-sensitized mice exposed to OVA challenge developed eosinophilia, mucus hypersecretion and increased cytokine levels. CPEE was applied 1 h prior to OVA challenge. Mice were administered CPEE orally at doses of 100 and 200 mg/kg once daily on days 18-23. Bronchoalveolar lavage fluid (BALF) was collected 48 h after the final OVA challenge. Levels of interleukin (IL)-4 and IL-5 in BALF were measured using enzyme-linked immunosorbent (ELISA) assays. Lung tissue sections 4 mm in thickness were stained with Mayer's hematoxylin and eosin for assessment of cell infiltration and mucus production with PAS staining, in conjunction with ELISA, and Western blot analyses for the expression of MMP-9, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 protein expression. CPEE significantly decreased the Th2 cytokines including IL-4 and IL-5 levels, reduced the number of inflammatory cells in BALF and airway hyperresponsiveness, suppressed the infiltration of eosinophil-rich inflammatory cells and mucus hypersecretion and reduced the expression of ICAM-1, VCAM-1 and MMP-9 and the activity of MMP-9 in lung tissue of OVA-challenged mice. Conclusions: These results showed that CPEE can protect against allergic airway inflammation and can act as an MMP-9 modulator to induce a reduction in ICAM-1 and VCAM-1 expression. In conclusion, we strongly suggest the feasibility of CPEE as a therapeutic drug for allergic asthma.	[Shin, In Sik; Lee, Mee Young; Lim, Hye Sun; Ha, Hyekyung; Seo, Chang Seob; Shin, Hyeun Kyoo] Korea Inst Oriental Med, Basic Herbal Med Res Grp, Taejon, South Korea; [Shin, In Sik; Kim, Jong-Choon] Chonnam Natl Univ, Coll Vet Med, Kwangju, South Korea	Korea Institute of Oriental Medicine (KIOM); Chonnam National University	Shin, HK (corresponding author), Korea Inst Oriental Med, Basic Herbal Med Res Grp, Taejon, South Korea.	toxkim@chonnam.ac.kr; hkshin@kiom.re.kr			Korea Research Council of Fundamental Science and Technology of the Republic of Korea	Korea Research Council of Fundamental Science and Technology of the Republic of Korea	This research was supported by grants from the Korea Research Council of Fundamental Science and Technology of the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel M, 2008, J IMMUNOL, V180, P3543, DOI 10.4049/jimmunol.180.5.3543; BOSCHETTO P, 1987, J ALLERGY CLIN IMMUN, V80, P261, DOI 10.1016/0091-6749(87)90028-5; BurkeGaffney A, 1996, BRIT J PHARMACOL, V119, P1149, DOI 10.1111/j.1476-5381.1996.tb16017.x; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Di Girolamo N, 2006, J IMMUNOL, V177, P2638, DOI 10.4049/jimmunol.177.4.2638; Gueders MM, 2008, BIOCHEM PHARMACOL, V75, P514, DOI 10.1016/j.bcp.2007.09.012; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V104, P356, DOI 10.1016/S0091-6749(99)70379-9; Kao ES, 2005, J AGR FOOD CHEM, V53, P430, DOI 10.1021/jf040231f; Kim CH, 2004, AM J PHYSIOL-LUNG C, V288, P307; Kong Ying-Jun, 2008, Zhonghua Jiehe He Huxi Zazhi, V31, P129; Korenblat PE, 2001, ANN ALLERG ASTHMA IM, V86, P31, DOI 10.1016/S1081-1206(10)62309-5; Kumagai K, 1999, J IMMUNOL, V162, P4212; Lee KS, 2003, J ALLERGY CLIN IMMUN, V111, P1278, DOI 10.1067/mai.2003.1501; Lee MY, 2010, INT IMMUNOPHARMACOL, V10, P474, DOI 10.1016/j.intimp.2010.01.008; Lee YC, 2001, J ALLERGY CLIN IMMUN, V108, P1021, DOI 10.1067/mai.2001.120132; Liu LY, 2002, AM J RESP CRIT CARE, V165, P1062, DOI 10.1164/ajrccm.165.8.2109065; Liu ZY, 2005, BIOMED PHARMACOTHER, V59, P481, DOI 10.1016/j.biopha.2005.06.009; Locke NR, 2007, AM J RESP CELL MOL, V36, P625, DOI 10.1165/rcmb.2006-0083OC; Lynch KR, 1999, NATURE, V399, P789; MAPP CE, 1987, B EUR PHYSIOPATH RES, V23, P583; MONTEFORT S, 1994, J CLIN INVEST, V93, P1411, DOI 10.1172/JCI117118; Niu CS, 2011, HORM METAB RES, V43, P625, DOI 10.1055/s-0031-1283147; OHKAWARA Y, 1995, AM J RESP CELL MOL, V12, P4, DOI 10.1165/ajrcmb.12.1.7529029; Okada S, 1997, AM J RESP CELL MOL, V17, P519, DOI 10.1165/ajrcmb.17.4.2877; Punithavathi VR, 2010, CARDIOVASC TOXICOL, V10, P181, DOI 10.1007/s12012-010-9077-8; Rosseau S, 2000, J IMMUNOL, V164, P427, DOI 10.4049/jimmunol.164.1.427; Scholz D, 1996, CELL TISSUE RES, V284, P415, DOI 10.1007/s004410050602; Sergejeva S, 2005, AM J RESP CELL MOL, V33, P248, DOI 10.1165/rcmb.2004-0213OC; Shan G, 2007, J SEP SCI, V30, P717; Soberon JR, 2010, J ETHNOPHARMACOL, V130, P329, DOI 10.1016/j.jep.2010.05.015; Tadic VM, 2008, J AGR FOOD CHEM, V56, P7700, DOI 10.1021/jf801668c; Wagner JG, 2000, PHARMACOL REV, V52, P349; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Wang T, 2011, J AGR FOOD CHEM, V59, P4987, DOI 10.1021/jf1049062; Wills-Karp M, 2004, SCIENCE, V305, P1726, DOI 10.1126/science.1104134	36	30	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45734	10.1371/journal.pone.0045734	http://dx.doi.org/10.1371/journal.pone.0045734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029210	Green Submitted, gold, Green Published			2022-12-25	WOS:000309392800087
J	Waldeck-Weiermair, M; Alam, MR; Khan, MJ; Deak, AT; Vishnu, N; Karsten, F; Imamura, H; Graier, WF; Malli, R				Waldeck-Weiermair, Markus; Alam, Muhammad Rizwan; Khan, Muhammad Jadoon; Deak, Andras T.; Vishnu, Neelanjan; Karsten, Felix; Imamura, Hiromi; Graier, Wolfgang F.; Malli, Roland			Spatiotemporal Correlations between Cytosolic and Mitochondrial Ca2+ Signals Using a Novel Red-Shifted Mitochondrial Targeted Cameleon	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEINS; INSULIN-SECRETION; CALCIUM DYNAMICS; CELL PHYSIOLOGY; ATP SYNTHESIS; FRET; INDICATORS; METABOLISM; MEMBRANE; MOTILITY	The transfer of Ca2+ from the cytosol into the lumen of mitochondria is a crucial process that impacts cell signaling in multiple ways. Cytosolic Ca2+ ([Ca2+](cyto)) can be excellently quantified with the ratiometric Ca2+ probe fura-2, while genetically encoded Forster resonance energy transfer (FRET)-based fluorescent Ca2+ sensors, the cameleons, are efficiently used to specifically measure Ca2+ within organelles. However, because of a significant overlap of the fura-2 emission with the spectra of the cyan and yellow fluorescent protein of most of the existing cameleons, the measurement of fura-2 and cameleons within one given cell is a complex task. In this study, we introduce a novel approach to simultaneously assess [Ca2+](cyto) and mitochondrial Ca2+ ([Ca2+](mito)) signals at the single cell level. In order to eliminate the spectral overlap we developed a novel red-shifted cameleon, D1GO-Cam, in which the green and orange fluorescent proteins were used as the FRET pair. This ratiometric Ca2+ probe could be successfully targeted to mitochondria and was suitable to be used simultaneously with fura-2 to correlate [Ca2+](cyto) and [Ca2+](mito) within same individual cells. Our data indicate that depending on the kinetics of [Ca2+](cyto) rises there is a significant lag between onset of [Ca2+](cyto) and [Ca2+](mito) signals, pointing to a certain threshold of [Ca2+](cyto) necessary to activate mitochondrial Ca2+ uptake. The temporal correlation between [Ca2+](mito) and [Ca2+](cyto) as well as the efficiency of the transfer of Ca2+ from the cytosol into mitochondria varies between different cell types. Moreover, slow mitochondrial Ca2+ extrusion and a desensitization of mitochondrial Ca2+ uptake cause a clear difference in patterns of mitochondrial and cytosolic Ca2+ oscillations of pancreatic beta-cells in response to D-glucose.	[Waldeck-Weiermair, Markus; Alam, Muhammad Rizwan; Khan, Muhammad Jadoon; Deak, Andras T.; Vishnu, Neelanjan; Karsten, Felix; Graier, Wolfgang F.; Malli, Roland] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; [Imamura, Hiromi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci, Tokyo, Japan	Medical University of Graz; Japan Science & Technology Agency (JST)	Malli, R (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria.	roland.malli@medunigraz.at	Alam, Muhammad Rizwan/AAE-2266-2019; Imamura, Hiromi/AAD-5109-2019; Graier, Wolfgang F./B-7052-2008; Khan, Muhammad Jadoon/AAG-5484-2019; Waldeck-Weiermair, Markus/AAV-5193-2020	Alam, Muhammad Rizwan/0000-0002-1578-5723; Imamura, Hiromi/0000-0002-1896-0443; Graier, Wolfgang F./0000-0003-1871-3298; Waldeck-Weiermair, Markus/0000-0002-5792-6766; Vishnu, Neelanjan/0000-0001-6395-4686; Malli, Roland/0000-0001-6327-8729	Austrian Science Funds, FWF [P21857-B18, P22553-B18]; FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz; FWF within the DKplus Metabolic and Cardiovascular Disease [W1226-B18]; Austrian Science Fund (FWF) [P 22553, P 21857] Funding Source: researchfish; Grants-in-Aid for Scientific Research [24657101] Funding Source: KAKEN	Austrian Science Funds, FWF(Austrian Science Fund (FWF)); FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz; FWF within the DKplus Metabolic and Cardiovascular Disease; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Austrian Science Funds (http://www.fwf.ac.at/, FWF, P21857-B18 and P22553-B18). M.J.K., M. R. A. and A. T. D. are funded by the FWF within the PhD-programs Molecular Medicine and Neuroscience at the Medical University of Graz. N.V. is supported by the FWF within the DKplus Metabolic and Cardiovascular Disease (W1226-B18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Adamikova L, 2004, MOL BIOL CELL, V15, P1969, DOI 10.1091/mbc.E03-09-0675; Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Collins TJ, 2001, J BIOL CHEM, V276, P26411, DOI 10.1074/jbc.M101101200; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Davidson SM, 2012, METHODS MOL BIOL, V810, P219, DOI 10.1007/978-1-61779-382-0_14; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Filippin L, 2005, CELL CALCIUM, V37, P129, DOI 10.1016/j.ceca.2004.08.002; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; Jacobo SMP, 2009, J PHARMACOL EXP THER, V331, P724, DOI 10.1124/jpet.109.158519; Jean-Quartier C, 2012, MOL CELL ENDOCRINOL, V353, P114, DOI 10.1016/j.mce.2011.10.033; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; Khan MJ, 2012, J BIOL CHEM; Knot HJ, 2005, MOL INTERV, V5, P112, DOI 10.1124/mi.5.2.8; Maechler P, 1998, J BIOL CHEM, V273, P20770, DOI 10.1074/jbc.273.33.20770; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Malli R, 2010, FEBS LETT, V584, P1942, DOI 10.1016/j.febslet.2010.01.010; McCombs JE, 2008, METHODS, V46, P152, DOI 10.1016/j.ymeth.2008.09.015; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Moreau B, 2008, CURR BIOL, V18, P855, DOI 10.1016/j.cub.2008.05.026; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; PAPACONSTANTINOU J, 1961, J BIOL CHEM, V236, P285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Piljic A, 2008, ACS CHEM BIOL, V3, P156, DOI 10.1021/cb700247q; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Tarasov AI, 2012, CELL CALCIUM; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Waldeck-Weiermair M, 2010, CELL CALCIUM, V47, P433, DOI 10.1016/j.ceca.2010.03.004; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; WARBURG O, 1956, SCIENCE, V124, P269; Wei AC, 2012, J GEN PHYSIOL, V139, P465, DOI 10.1085/jgp.201210784; Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Yang XF, 2005, BIOCHEM BIOPH RES CO, V330, P914, DOI 10.1016/j.bbrc.2005.03.054; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zecchini Erika, 2007, Ital J Biochem, V56, P235	67	35	35	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45917	10.1371/journal.pone.0045917	http://dx.doi.org/10.1371/journal.pone.0045917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029314	gold, Green Published, Green Submitted			2022-12-25	WOS:000309392800119
J	Mahankali, M; Henkels, KM; Alter, G; Gomez-Cambronero, J				Mahankali, Madhu; Henkels, Karen M.; Alter, Gerald; Gomez-Cambronero, Julian			Identification of the Catalytic Site of Phospholipase D2 (PLD2) Newly Described Guanine Nucleotide Exchange Factor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAC2; CHEMOTAXIS; PROTEINS; GEF; PHOSPHORYLATION; STIMULATION; FIBROBLASTS; ACTIVATION; RECEPTOR; FAMILY	We have demonstrated that phospholipase D2 (PLD2) is a guanine nucleotide exchange factor (GEF) for Rac2 and determined the PLD2 domains and amino acid site(s) responsible for its GEF activity. Experiments using GST fusion proteins or GST-free counterparts, purified proteins revealed that the PX domain is sufficient to exert GEF activity similar to full-length PLD2. The PLD2-GEF catalytic site is formed by a hydrophobic pocket of residues Phe-107, Phe-129, Leu-166, and Leu-173, all of which are in the PX domain. A nearby Arg-172 is also important in the overall activity. PX mutants altering any of those five amino acids fail to have GEF activity but still bind to Rac2, while their lipase activity was mostly unaffected. In addition to the PX domain, a region in the pleckstrin homology domain (Ile-306-Ala-310) aids in the PX-mediated GEF activity by providing a docking site to hold Rac2 in place during catalysis. We conclude that PLD2 is a unique GEF, with the PX being the major catalytic domain for its GEF activity, whereas the pleckstrin homology domain assists in the PX-mediated activity. The physiological relevance of this novel GEF in cell biology is demonstrated here in chemotaxis and phagocytosis of leukocytes, as the specific PX and and PH mutants abolished cell function. Thus, this study reveals for the first time the catalytic site that forms the basis for the mechanism behind the GEF activity of PLD2.	[Mahankali, Madhu; Henkels, Karen M.; Alter, Gerald; Gomez-Cambronero, Julian] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Wright State Univ, Sch Med, Dept Biochem & Mol Biol, 3640 Colonel Glenn Hwy, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health Grant [HL056653]; Boonshoft School of Medicine Grant [229102]; State of Ohio Research Incentive Grant [668372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056653, R01HL056653] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boonshoft School of Medicine Grant; State of Ohio Research Incentive Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL056653 (to J. G.-C.). This work was also supported by Boonshoft School of Medicine Grant 229102 and State of Ohio Research Incentive Grant 668372 (to J. G.-C.).	Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Di Fulvio M, 2007, J MOL BIOL, V367, P814, DOI 10.1016/j.jmb.2007.01.021; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gomez-Cambronero J, 2011, CELL SIGNAL, V23, P1885, DOI 10.1016/j.cellsig.2011.06.017; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Houle MG, 1999, BBA-MOL CELL BIOL L, V1439, P135, DOI 10.1016/S1388-1981(99)00090-6; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Kantonen S, 2011, MOL CELL BIOL, V31, P4524, DOI 10.1128/MCB.05684-11; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Kwofie MA, 2008, J BIOL CHEM, V283, P3088, DOI 10.1074/jbc.M705170200; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Lu ZM, 2000, MOL CELL BIOL, V20, P462, DOI 10.1128/MCB.20.2.462-467.2000; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Ming WY, 2007, MOL CELL BIOL, V27, P312, DOI 10.1128/MCB.00985-06; Morris AJ, 1997, BIOCHEM SOC T, V25, P1151, DOI 10.1042/bst0251151; Oshimoto H, 2003, ONCOL RES, V14, P31, DOI 10.3727/000000003108748586; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Peng HJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206672; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Slaaby R, 1998, J BIOL CHEM, V273, P33722, DOI 10.1074/jbc.273.50.33722; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu LM, 2011, J BIOL CHEM, V286, P25477, DOI 10.1074/jbc.M111.249631; Zhang H, 2009, J IMMUNOL, V183, P2718, DOI 10.4049/jimmunol.0900849; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	28	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41417	41431		10.1074/jbc.M112.383596	http://dx.doi.org/10.1074/jbc.M112.383596			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23035122	Green Published, hybrid			2022-12-25	WOS:000311887600054
J	Liu, B; Wang, XL; Chen, QC; Dong, QW; Lan, X				Liu, Bin; Wang, Xiaolong; Chen, Qingcai; Dong, Qiwen; Lan, Xun			Using Amino Acid Physicochemical Distance Transformation for Fast Protein Remote Homology Detection	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; DISCRIMINATIVE METHOD; FOLD RECOGNITION; STRUCTURAL CLASS; STRING KERNELS; PREDICTION; SERVER; SIMILARITY; ACCURATE; DATABASE	Protein remote homology detection is one of the most important problems in bioinformatics. Discriminative methods such as support vector machines (SVM) have shown superior performance. However, the performance of SVM-based methods depends on the vector representations of the protein sequences. Prior works have demonstrated that sequence-order effects are relevant for discrimination, but little work has explored how to incorporate the sequence-order information along with the amino acid physicochemical properties into the prediction. In order to incorporate the sequence-order effects into the protein remote homology detection, the physicochemical distance transformation (PDT) method is proposed. Each protein sequence is converted into a series of numbers by using the physicochemical property scores in the amino acid index (AAIndex), and then the sequence is converted into a fixed length vector by PDT. The sequence-order information can be efficiently included into the feature vector with little computational cost by this approach. Finally, the feature vectors are input into a support vector machine classifier to detect the protein remote homologies. Our experiments on a well-known benchmark show the proposed method SVM-PDT achieves superior or comparable performance with current state-of-the-art methods and its computational cost is considerably superior to those of other methods. When the evolutionary information extracted from the frequency profiles is combined with the PDT method, the profile-based PDT approach can improve the performance by 3.4% and 11.4% in terms of ROC score and ROC50 score respectively. The local sequence-order information of the protein can be efficiently captured by the proposed PDT and the physicochemical properties extracted from the amino acid index are incorporated into the prediction. The physicochemical distance transformation provides a general framework, which would be a valuable tool for protein-level study.	[Liu, Bin; Wang, Xiaolong; Chen, Qingcai] Harbin Inst Technol, Sch Comp Sci & Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Liu, Bin; Wang, Xiaolong; Chen, Qingcai] Harbin Inst Technol, Key Lab Network Oriented Intelligent Computat, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Dong, Qiwen] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Lan, Xun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Fudan University; University System of Ohio; Ohio State University	Liu, B (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China.	bliu@insun.hit.edu.cn	Liu, Bin/E-9480-2013	Lan, Xun/0000-0002-6523-046X; Liu, Bin/0000-0002-8520-8374	National Natural Science Foundation of China [61173075, 61003090, 60973076]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2013103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology)	This work was supported by the National Natural Science Foundation of China (No. 61173075, 61003090 and 60973076) and the Project HIT.NSRIF.2013103 supported by Natural Scientific Research Innovation Foundation in Harbin Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben-Hur A, 2003, BIOINFORMATICS, V19, pi26, DOI 10.1093/bioinformatics/btg1002; Bernardes JS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-83; Brandt BW, 2009, NUCLEIC ACIDS RES, V37, pW48, DOI 10.1093/nar/gkp279; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Dong QW, 2005, PROCEEDINGS OF 2005 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-9, P3363; Dong QW, 2006, BIOINFORMATICS, V22, P285, DOI 10.1093/bioinformatics/bti801; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Grigoriev IV, 1999, P NATL ACAD SCI USA, V96, P14318, DOI 10.1073/pnas.96.25.14318; Handstad T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-23; Hochreiter S, 2007, BIOINFORMATICS, V23, P1728, DOI 10.1093/bioinformatics/btm247; Homaeian L, 2007, PROTEINS, V69, P486, DOI 10.1002/prot.21527; Hou Y, 2003, BIOINFORMATICS, V19, P2294, DOI 10.1093/bioinformatics/btg317; Hou YN, 2004, PROTEINS, V57, P518, DOI 10.1002/prot.20221; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kedarisetti KD, 2006, BIOCHEM BIOPH RES CO, V348, P981, DOI 10.1016/j.bbrc.2006.07.141; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Lee MM, 2008, PROTEINS, V71, P1409, DOI 10.1002/prot.21830; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Lin Z, 2001, J PROTEIN CHEM, V20, P217, DOI 10.1023/A:1010967008838; Lingner T, 2006, BIOINFORMATICS, V22, P2224, DOI 10.1093/bioinformatics/btl376; Lingner T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-259; Liu B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-510; Liu X, 2011, COMPUT BIOL MED, V41, P640, DOI 10.1016/j.compbiomed.2011.05.015; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Margelevicius M, 2010, BIOINFORMATICS, V26, P1905, DOI 10.1093/bioinformatics/btq306; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; Noble WS, 2005, FEBS J, V272, P5119, DOI 10.1111/j.1742-4658.2005.04947.x; Ogul H, 2007, BIOSYSTEMS, V87, P75, DOI 10.1016/j.biosystems.2006.03.006; Qian B, 2004, BIOINFORMATICS, V20, P2175, DOI 10.1093/bioinformatics/bth181; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Sadreyev RI, 2009, NUCLEIC ACIDS RES, V37, pW90, DOI 10.1093/nar/gkp360; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Shah AR, 2008, BIOINFORMATICS, V24, P783, DOI 10.1093/bioinformatics/btn028; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Vapnik V., 1998, STAT LEARNING THEORY; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Webb-Robertson BJ, 2005, COMPUT BIOL CHEM, V29, P440, DOI 10.1016/j.compbiolchem.2005.09.006; Webb-Robertson BJM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-145; Yang YC, 2008, J THEOR BIOL, V252, P145, DOI 10.1016/j.jtbi.2008.01.028	49	85	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46633	10.1371/journal.pone.0046633	http://dx.doi.org/10.1371/journal.pone.0046633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029559	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900193
J	Liu, Y; Zhou, YJ; Zhu, KQ				Liu, Yu; Zhou, Yijiang; Zhu, Keqing			Inhibition of Glioma Cell Lysosome Exocytosis Inhibits Glioma Invasion	PLOS ONE			English	Article							CATHEPSIN-B; SECRETORY LYSOSOMES; TUMOR-GROWTH; EXPRESSION; EFFECTORS; RAB27; ANGIOGENESIS; RELEASE; GENE; RNA	Cancer cells invade by secreting enzymes that degrade the extracellular matrix and these are sequestered in lysosomal vesicles. In this study, the effects of the selective lysosome lysing drug GPN and the lysosome exocytosis inhibitor vacuolin-1 on lysosome exocytosis were studied to determine their effect on glioma cell migration and invasion. Both GPN and vacuolin-1 evidently inhibited migration and invasion in transwell experiments and scratch experiments. There are more lysosomes located on the cell membrane of glioma cells than of astrocytes. GPN decreased the lysosome number on the cell membrane. We found that rab27A was expressed in glioma cells, and colocalized with cathepsin D in lysosome. RNAi-Rab27A inhibited lysosome cathepsin D exocytosis and glioma cell invasion in an in vitro assay. Inhibition of cathepsin D inhibited glioma cell migration. The data suggest that the inhibition of lysosome exocytosis from glioma cells plays an important modulatory role in their migration and invasion.	[Liu, Yu; Zhou, Yijiang; Zhu, Keqing] Zhejiang Univ, Sch Med, Dept Neurobiol, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, KQ (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	zhukeqing@zju.edu.cn			Zhejiang Provincial National Science Foundation of China [Y2080213]; National Natural Science Foundation of China [30770677]	Zhejiang Provincial National Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Zhejiang Provincial National Science Foundation of China (Y2080213) and by the National Natural Science Foundation of China (30770677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Fukuda ME, 2005, CANCER RES, V65, P5190, DOI 10.1158/0008-5472.CAN-04-4134; Goishi K, 2004, BIOCHEM BIOPH RES CO, V324, P294, DOI 10.1016/j.bbrc.2004.09.050; Handley MTW, 2007, J CELL SCI, V120, P973, DOI 10.1242/jcs.03406; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Izumi T, 2007, ENDOCR J, V54, P649, DOI 10.1507/endocrj.KR-78; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Levicar N, 2002, J NEURO-ONCOL, V58, P21, DOI 10.1023/A:1015892911420; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mohanam S, 2001, ONCOGENE, V20, P3665, DOI 10.1038/sj.onc.1204480; Shaik GM, 2009, CELL SIGNAL, V21, P1337, DOI 10.1016/j.cellsig.2009.04.001; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620	22	44	45	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45910	10.1371/journal.pone.0045910	http://dx.doi.org/10.1371/journal.pone.0045910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029308	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900063
J	Thakur, D; Saxena, R; Singh, V; Haq, W; Katti, SB; Singh, BN; Tripathi, RK				Thakur, Dharamsheela; Saxena, Reshu; Singh, Vandana; Haq, Wahajul; Katti, S. B.; Singh, Bhupendra Narain; Tripathi, Raj Kamal			Human Beta Casein Fragment (54-59) Modulates M. bovis BCG Survival and Basic Transcription Factor 3 (BTF3) Expression in THP-1 Cell Line	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VIRULENT MYCOBACTERIUM-TUBERCULOSIS; TOXIN-1 AND/OR LIPOPOLYSACCHARIDES; ALVEOLAR MACROPHAGES; PHAGOCYTE OXIDASE; ADJUVANT ACTIVITY; APOPTOSIS; IDENTIFICATION; INFECTION; STRAINS	Immunostimulatory peptides potentiate the immune system of the host and are being used as a viable adjunct to established therapeutic modalities in treatment of cancer and microbial infections. Several peptides derived from milk protein have been reported to induce immunostimulatory activity. Human beta-casein fragment (54-59), natural sequence peptide (NS) carrying the Val-Glu-Pro-Ile-Pro-Tyr amino acid residues, was reported to activate the macrophages and impart potent immunostimulatory activity. In present study, we found that this peptide increases the clearance of M. bovis BCG from THP-1 cell line in vitro. The key biomolecules, involved in the clearance of BCG from macrophage like, nitric oxide, pro-inflammatory cytokines and chemokines, were not found to be significantly altered after peptide treatment in comparison to the untreated control. Using proteomic approach we found that BTF3a, an isoform of the Basic Transcription Factor, BTF3, was down regulated in THP-1 cell line after peptide treatment. This was reconfirmed by real time RT-PCR and western blotting. We report the BTF3a as a novel target of this hexapeptide. Based on the earlier findings and the results from the present studies, we suggest that the down regulation of BTF3a following the peptide treatment may augment the M. bovis BCG mediated apoptosis resulting in enhanced clearance of M. bovis BCG from THP-1 cell line.	[Singh, Vandana; Singh, Bhupendra Narain] Cent Drug Res Inst, Div Microbiol, Lucknow 226001, Uttar Pradesh, India; [Thakur, Dharamsheela; Saxena, Reshu; Tripathi, Raj Kamal] Cent Drug Res Inst, Div Toxicol, Lucknow 226001, Uttar Pradesh, India; [Haq, Wahajul; Katti, S. B.] Cent Drug Res Inst, Div Med & Proc Chem, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Singh, BN (corresponding author), Cent Drug Res Inst, Div Microbiol, Lucknow 226001, Uttar Pradesh, India.	bnsingh@cdri.res.in; rk_tripathi@cdri.res.in	Saxena, Reshu/AAU-3178-2021	Singh, Bhupendra Narain/0000-0002-8197-5381	Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI); Alternative Animal Model project [NWP0034]	Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI); Alternative Animal Model project	We are thankful to the "Council of Scientific and Indistrial Research (CSIR)- Central Drug Research Institute (CDRI)" for providing the institutional funding and Alternative Animal Model project (NWP0034) for providing the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1974, BIOCHEM BIOPH RES CO, V56, P561, DOI 10.1016/0006-291X(74)90640-8; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Bringans S, 2008, RAPID COMMUN MASS SP, V22, P3450, DOI 10.1002/rcm.3752; Brockstedt E, 1999, J PROTEIN CHEM, V18, P225, DOI 10.1023/A:1020636308270; CAVALLINI B, 1988, NATURE, V334, P77, DOI 10.1038/334077a0; CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; DENG JM, 1995, TRANSGENIC RES, V4, P264, DOI 10.1007/BF01969120; DING AH, 1988, J IMMUNOL, V141, P2407; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fratazzi C, 1997, J IMMUNOL, V158, P4320; Harrison LM, 2005, MICROB PATHOGENESIS, V38, P63, DOI 10.1016/j.micpath.2004.12.003; Harrison LM, 2005, INFECT IMMUN, V73, P403, DOI 10.1128/IAI.73.1.403-412.2005; KANNO M, 1992, GENE, V117, P219, DOI 10.1016/0378-1119(92)90732-5; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kusumawidjaja G, 2007, CANCER BIOL THER, V6, P367, DOI 10.4161/cbt.6.3.3704; Li Rong, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P323; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; LOWY I, 1977, CELL IMMUNOL, V29, P195, DOI 10.1016/0008-8749(77)90288-X; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; OBRIEN L, 1994, INFECT IMMUN, V62, P5187, DOI 10.1128/IAI.62.11.5187-5190.1994; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; PARKER F, 1984, EUR J BIOCHEM, V145, P677, DOI 10.1111/j.1432-1033.1984.tb08609.x; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Rysz J, 2000, Acta Pol Pharm, V57 Suppl, P11; Sharma P, 2004, PEPTIDES, V25, P1873, DOI 10.1016/j.peptides.2004.06.011; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; SUGIMURA K, 1979, CELL IMMUNOL, V43, P137, DOI 10.1016/0008-8749(79)90157-6; Thiede B, 2001, J BIOL CHEM, V276, P26044, DOI 10.1074/jbc.M101062200; ZHENG XM, 1990, NATURE, V344, P556, DOI 10.1038/344556a0; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	35	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45905	10.1371/journal.pone.0045905	http://dx.doi.org/10.1371/journal.pone.0045905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029305	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900061
J	Wang, HG; Chen, YH; Zhu, HJ; Wang, S; Zhang, XW; Xu, DJ; Cao, KJ; Zou, JG				Wang, Hegui; Chen, Yanhong; Zhu, Hongjun; Wang, Sen; Zhang, Xiwen; Xu, Dongjie; Cao, Kejiang; Zou, Jiangang			Increased Response to beta(2)-Adrenoreceptor Stimulation Augments Inhibition of I-Kr in Heart Failure Ventricular Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-A; RECTIFIER POTASSIUM CURRENT; GUINEA-PIG HEART; RAPID COMPONENT; BETA(2)-ADRENERGIC STIMULATION; DEPENDENT PATHWAYS; ION-CHANNEL; ACTIVATION; CURRENTS; CANINE	Background: Increasing evidence indicates that the rapid component of delayed rectifier potassium current (I-Kr) is modulated by alpha- and beta-adrenergic stimulation. However, the role and mechanism regulating I-Kr through beta(2)-adrenoreceptor (beta-AR) stimulation in heart failure (HF) are unclear. Methodology/Principal Findings: In the present study, we investigated the effects of fenoterol, a highly selective beta(2)-AR agonist, on I-Kr in left ventricular myocytes obtained from control and guinea pigs with HF induced by descending aortic banding. I-Kr was measured by using whole cell patch clamp technique. In control myocytes, superfusion of fenoterol (10 mu M) caused a 17% decrease in I-Kr. In HF myocytes, the same concentration of fenoterol produced a significantly greater decrease (33%) in I-Kr. These effects were not modified by the incubation of myocytes with CGP-20712A, a beta(1)-AR antagonist, but were abolished by pretreatment of myocytes with ICI-118551, a beta(2)-AR antagonist. An inhibitory cAMP analog, Rp-cAMPS and PKA inhibitor significantly attenuated fenoterol-induced inhibition of I-Kr in HF myocytes. Moreover, fenoterol markedly prolonged action potential durations at 90% (APD(90)) repolarization in HF ventricular myocytes. Conclusions: The results indicate that inhibition of I-Kr induced by beta(2)-AR stimulation is increased in HF. The inhibitory effect is likely to be mediated through a cAMP/PKA pathway in HF ventricular myocytes.	[Chen, Yanhong; Zhu, Hongjun; Wang, Sen; Zhang, Xiwen; Xu, Dongjie; Cao, Kejiang; Zou, Jiangang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Hegui] Wannan Med Coll, Yijishan Hosp, Dept Cardiol, Wuhu, Peoples R China	Nanjing Medical University; Wannan Medical College	Zou, JG (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	jgzou@njmu.edu.cn			National Nature Science Foundation of China [81170162]; University Nature Science Foundation of Jiangsu Province [09KJB320008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Nature Science Foundation of Jiangsu Province	This work was supported by the National Nature Science Foundation of China (81170162) http://www.nsfc.gov.cn/Portal0/default166.htm) and University Nature Science Foundation of Jiangsu Province (09KJB320008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULD RA, 1995, CIRCULATION, V92, P1612, DOI 10.1161/01.CIR.92.6.1612; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Duan DY, 2009, J PHYSIOL-LONDON, V587, P2163, DOI 10.1113/jphysiol.2008.165860; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Harmati G, 2011, BRIT J PHARMACOL, V162, P890, DOI 10.1111/j.1476-5381.2010.01092.x; James AF, 1996, CIRC RES, V79, P201, DOI 10.1161/01.RES.79.2.201; Karle CA, 2002, CARDIOVASC RES, V53, P355, DOI 10.1016/S0008-6363(01)00509-0; KIUCHI K, 1993, J CLIN INVEST, V91, P907, DOI 10.1172/JCI116312; Li Y, 2008, J MEMBRANE BIOL, V223, P107, DOI 10.1007/s00232-008-9118-4; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Pelzer S, 1997, AM J PHYSIOL-HEART C, V273, pH2539, DOI 10.1152/ajpheart.1997.273.6.H2539; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Tamargo J, 2004, CARDIOVASC RES, V62, P9, DOI 10.1016/j.cardiores.2003.12.026; Thomas D, 2006, CURR PHARM DESIGN, V12, P2271, DOI 10.2174/138161206777585102; Thomas D, 2004, BASIC RES CARDIOL, V99, P279, DOI 10.1007/s00395-004-0474-7; Thomas D, 1999, J BIOL CHEM, V274, P27457, DOI 10.1074/jbc.274.39.27457; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Vittorio TJ, 2008, J CARDIOVASC PHARM T, V13, P51, DOI 10.1177/1074248407312629; VOSS HP, 1994, J PHARMACOL EXP THER, V271, P386; Wang S, 2009, EUR J PHARMACOL, V608, P1, DOI 10.1016/j.ejphar.2009.02.017; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Zankov DP, 2009, HEART RHYTHM, V6, P1038, DOI 10.1016/j.hrthm.2009.02.045; Zhang ZS, 2001, J PHARMACOL EXP THER, V298, P188; Zicha S, 2003, AM J PHYSIOL-HEART C, V285, pH1641, DOI 10.1152/ajpheart.00346.2003	32	0	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46186	10.1371/journal.pone.0046186	http://dx.doi.org/10.1371/journal.pone.0046186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029432	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900105
J	Hintzsche, H; Jastrow, C; Kleine-Ostmann, T; Karst, U; Schrader, T; Stopper, H				Hintzsche, Henning; Jastrow, Christian; Kleine-Ostmann, Thomas; Kaerst, Uwe; Schrader, Thorsten; Stopper, Helga			Terahertz Electromagnetic Fields (0.106 THz) Do Not Induce Manifest Genomic Damage In Vitro	PLOS ONE			English	Article							SPINDLE DISTURBANCES; BIOLOGICAL-SYSTEMS; HUMAN-LYMPHOCYTES; OXIDATIVE STRESS; RADIATION; CELLS; EXPOSURE; FREQUENCY; VIVO; TECHNOLOGY	Terahertz electromagnetic fields are non-ionizing electromagnetic fields in the frequency range from 0.1 to 10 THz. Potential applications of these electromagnetic fields include the whole body scanners, which currently apply millimeter waves just below the terahertz range, but future scanners will use higher frequencies in the terahertz range. These and other applications will bring along human exposure to these fields. Up to now, only a limited number of investigations on biological effects of terahertz electromagnetic fields have been performed. Therefore, research is strongly needed to enable reliable risk assessment. Cells were exposed for 2 h, 8 h, and 24 h with different power intensities ranging from 0.04 mW/cm(2) to 2 mW/cm(2), representing levels below, at, and above current safety limits. Genomic damage on the chromosomal level was measured as micronucleus formation. DNA strand breaks and alkali-labile sites were quantified with the comet assay. No DNA strand breaks or alkali-labile sites were observed as a consequence of exposure to terahertz electromagnetic fields in the comet assay. The fields did not cause chromosomal damage in the form of micronucleus induction.	[Hintzsche, Henning; Stopper, Helga] Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany; [Jastrow, Christian; Kleine-Ostmann, Thomas; Schrader, Thorsten] Phys Tech Bundesanstalt, Braunschweig, Germany; [Kaerst, Uwe] Helmholtz Zentrum Infekt Forsch, Braunschweig, Germany	University of Wurzburg; Physikalisch-Technische Bundesanstalt (PTB); Helmholtz Association; Helmholtz-Center for Infection Research	Stopper, H (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany.	Stopper@toxi.uni-wuerzburg.de			German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz); German Research Foundation (DFG); University of Wuerzburg	German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was funded by the German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz). The publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2011, BIOMED OPT EXPRESS, V2, P2679, DOI 10.1364/BOE.2.002679; Ammari M, 2008, TOXICOLOGY, V250, P70, DOI 10.1016/j.tox.2008.05.019; Berry E, 2003, J LASER APPL, V15, P192, DOI 10.2351/1.1585079; Bock J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015806; BOLLER K, 1970, HUMANGENETIK, V11, P35, DOI 10.1007/BF00296302; Dickhoff R, 2011, CHARACTERIZATION THZ, P1; Doria A, 2004, INFRARED PHYS TECHN, V45, P339, DOI 10.1016/j.infrared.2004.01.014; Feychting M, 2011, PROG BIOPHYS MOL BIO; Foster KR, 2000, IEEE T PLASMA SCI, V28, P15, DOI 10.1109/27.842819; Gallerano G. P., 2004, TERA HERTZ RAD BIOL; Guney M, 2007, TOXICOL IND HEALTH, V23, P411, DOI 10.1177/0748233707080906; Hintzsche H, 2011, RADIAT RES, V175, P569, DOI 10.1667/RR2406.1; Hintzsche H, 2012, CRIT REV ENV SCI TEC, V42, P2408, DOI 10.1080/10643389.2011.574206; Hintzsche H, 2010, TOXICOL LETT, V193, P124, DOI 10.1016/j.toxlet.2009.12.016; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; Huang TQ, 2008, INT J RADIAT BIOL, V84, P909, DOI 10.1080/09553000802460123; Jastrow C, 2010, ADV RADIO SCI, V8, P1, DOI 10.5194/ars-8-1-2010; Khurana VG, 2008, MED PHYS, V35, P5203, DOI 10.1118/1.3013548; Korenstein-Ilan A, 2008, RADIAT RES, V170, P224, DOI 10.1667/RR0944.1; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Ramundo-Orlando A, 2007, BIOELECTROMAGNETICS, V28, P587, DOI 10.1002/bem.20343; Ramundo-Orlando A, 2010, J INFRARED MILLIM TE, V31, P1400, DOI 10.1007/s10762-010-9731-z; Scarfi MR, 2003, J BIOL PHYS, V29, P171, DOI 10.1023/A:1024440708943; Schrader T, 2011, BIOELECTROMAGNETICS, V32, P291, DOI 10.1002/bem.20634; Schrader T, 2008, BIOELECTROMAGNETICS, V29, P626, DOI 10.1002/bem.20428; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI 10.1109/TMTT.2004.835916; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Wilmink GJ, 2010, LASERS SURG MED; Yadav AS, 2008, MUTAT RES-GEN TOX EN, V650, P175, DOI 10.1016/j.mrgentox.2007.11.005; Zeni O, 2007, HEALTH PHYS, V92, P349, DOI 10.1097/01.HP.0000251248.23991.35	32	33	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46397	10.1371/journal.pone.0046397	http://dx.doi.org/10.1371/journal.pone.0046397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029508	Green Published, Green Submitted, gold			2022-12-25	WOS:000309517500098
J	Testoni, S; Bartolone, E; Rossi, M; Patrignani, A; Bruggmann, R; Lichtner, P; Tetens, J; Gentile, A; Drogemuller, C				Testoni, Stefania; Bartolone, Elena; Rossi, Marco; Patrignani, Andrea; Bruggmann, Remy; Lichtner, Peter; Tetens, Jens; Gentile, Arcangelo; Droegemueller, Cord			KDM2B Is Implicated in Bovine Lethal Multi-Organic Developmental Dysplasia	PLOS ONE			English	Article							HISTONE DEMETHYLATION; GENE; ASSOCIATION	In the last decade breeders of Romagnola cattle observed an outbreak of a new congenital anomaly. This lethal multi-organ developmental dysplasia is mainly characterized by facial deformities, ascites and hepatic fibrosis. Affected stillborn calves were inbred to a single founder sire suggesting autosomal monogenic recessive inheritance. We localized the causative mutation to a 1.2 Mb interval on BTA 17 by genome-wide association and identical by descent mapping. A solution-based method for targeted DNA capture combined with massively parallel sequencing was used to analyze the entire critical region containing 24 genes. Homozygosity for two non-synonymous coding sequence variants affecting the RNF34 and KDM2B genes was detected by evaluating one affected calf. Here we show that the disease phenotype is associated with a KDM2B missense mutation (c.2503G>A) leading to an amino acid exchange (p.D835N) in an evolutionary strongly conserved domain. In addition, the genetic makeup of three inbred cattle strongly supports the causality of the KDM2B mutation. This report of a naturally-occurring spontaneous mutation of a JmjC domain containing histone demethylase gene provides evidence for their important role in the endo-and mesodermal organ development.	[Bartolone, Elena; Rossi, Marco; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Testoni, Stefania] Univ Padua, Dept Vet Clin Sci, Padua, Italy; [Bartolone, Elena; Rossi, Marco; Gentile, Arcangelo] Univ Bologna, Vet Clin Dept, Bologna, Italy; [Patrignani, Andrea; Bruggmann, Remy] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Bruggmann, Remy] Univ Bern, Dept Biol, Bern, Switzerland; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; University of Padua; University of Bologna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch		Partigiani, Andrea/0000-0001-8019-3911; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X; Bruggmann, Remy/0000-0001-5629-6363	region of Emilia Romagna (Italy)	region of Emilia Romagna (Italy)(Regione Emilia Romagna)	The authors thank the region of Emilia Romagna (Italy) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HOMEPAGE BOS TAURUS; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Drogemuller C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001079; Drogemuller C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018931; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Testoni S, 2009, VET REC, V164, P693, DOI 10.1136/vr.164.22.693; Thompson PN, 2006, J ANIM SCI, V84, P2629, DOI 10.2527/jas.2005-774; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Verrier L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001390; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	20	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e45634	10.1371/journal.pone.0045634	http://dx.doi.org/10.1371/journal.pone.0045634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029151	Green Published, gold, Green Accepted			2022-12-25	WOS:000309517500036
J	Tewari-Singh, N; Jain, AK; Inturi, S; Agarwal, C; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Chapla; White, Carl W.; Agarwal, Rajesh			Silibinin Attenuates Sulfur Mustard Analog-Induced Skin Injury by Targeting Multiple Pathways Connecting Oxidative Stress and Inflammation	PLOS ONE			English	Article							SULFIDE-INDUCED SKIN; SKH-1 HAIRLESS MICE; MOUSE SKIN; MOLECULAR-MECHANISMS; INDUCED TOXICITY; DNA-DAMAGE; CELLS; EFFICACY; CYTOKINE; CANCER	Chemical warfare agent sulfur mustard (HD) inflicts delayed blistering and incapacitating skin injuries. To identify effective countermeasures against HD-induced skin injuries, efficacy studies were carried out employing HD analog 2-chloroethyl ethyl sulfide (CEES)-induced injury biomarkers in skin cells and SKH-1 hairless mouse skin. The data demonstrate strong therapeutic efficacy of silibinin, a natural flavanone, in attenuating CEES-induced skin injury and oxidative stress. In skin cells, silibinin (10 mu M) treatment 30 min after 0.35/0.5 mM CEES exposure caused a significant (p<0.05) reversal in CEES-induced decrease in cell viability, apoptotic and necrotic cell death, DNA damage, and an increase in oxidative stress. Silibinin (1 mg) applied topically to mouse skin 30 min post-CEES exposure (2 mg), was effective in reversing CEES-induced increases in skin bi-fold (62%) and epidermal thickness (85%), apoptotic cell death (70%), myeloperoxidase activity (complete reversal), induction of iNOS, COX-2, and MMP-9 protein levels (>90%), and activation of transcription factors NF-kappa B and AP-1 (complete reversal). Similarly, silibinin treatment was also effective in attenuating CEES-induced oxidative stress measured by 4-hydroxynonenal and 5,5-dimethyl-2-(8-octanoic acid)-1-pyrolline N-oxide protein adduct formation, and 8-oxo-2-deoxyguanosine levels. Since our previous studies implicated oxidative stress, in part, in CEES-induced toxic responses, the reversal of CEES-induced oxidative stress and other toxic effects by silibinin in this study indicate its pleiotropic therapeutic efficacy. Together, these findings support further optimization of silibinin in HD skin toxicity model to develop a novel effective therapy for skin injuries by vesicants.	[Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Chapla; Agarwal, Rajesh] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [White, Carl W.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	Rajesh.Agarwal@ucdenver.edu			CounterACT Program, Office of the Director, National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES-015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	CounterACT Program, Office of the Director, National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the CounterACT Program, Office of the Director, National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), Grant Number [U54 ES-015678]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo CM, 2003, PHARMACOL TOXICOL, V92, P204, DOI 10.1034/j.1600-0773.2003.920503.x; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; Black AT, 2010, TOXICOL APPL PHARM, V245, P352, DOI 10.1016/j.taap.2010.04.001; Chittezhath M, 2008, MOL CANCER THER, V7, P1817, DOI 10.1158/1535-7163.MCT-08-0256; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Deep G, 2010, CANCER METAST REV, V29, P447, DOI 10.1007/s10555-010-9237-0; Dhanalakshmi S, 2004, CARCINOGENESIS, V25, P99, DOI 10.1093/carcin/bgg188; Dhanalakshmi S, 2005, J BIOL CHEM, V280, P20375, DOI 10.1074/jbc.M414640200; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Gould NS, 2009, J PHARMACOL EXP THER, V328, P732, DOI 10.1124/jpet.108.145037; Graham John S, 2005, J Burns Wounds, V4, pe1; Graham JS, 2009, TOXICOLOGY, V263, P47, DOI 10.1016/j.tox.2008.07.067; Gu M, 2005, CARCINOGENESIS, V26, P1404, DOI 10.1093/carcin/bgi096; Gu M, 2005, CANCER EPIDEM BIOMAR, V14, P1344, DOI 10.1158/1055-9965.EPI-04-0664; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Gu M, 2010, MOL CARCINOGEN, V49, P1, DOI 10.1002/mc.20560; Hakkinen Lari, 2001, Methods in Cell Science, V23, P189, DOI 10.1023/A:1016385109922; Henemyre-Harris Claudia L, 2008, Eplasty, V8, pe16; Inturi S, 2011, FREE RADIC BIOL MED; Jain AK, 2011, TOXICOL LETT, V205, P293, DOI 10.1016/j.toxlet.2011.06.019; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Jowsey PA, 2009, TOXICOLOGY, V257, P105, DOI 10.1016/j.tox.2008.12.001; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P12, DOI 10.1016/j.tox.2009.01.019; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Kehe Kai, 2008, Eplasty, V8, pe32; Laskin JD, 2010, ANN NY ACAD SCI, V1203, P92, DOI 10.1111/j.1749-6632.2010.05605.x; LINDSAY CD, 1995, HUM EXP TOXICOL, V14, P580, DOI 10.1177/096032719501400705; Mallikarjuna G, 2004, CANCER RES, V64, P6349, DOI 10.1158/0008-5472.CAN-04-1632; Matijasevic Z, 2001, CARCINOGENESIS, V22, P661, DOI 10.1093/carcin/22.4.661; Pal A, 2009, FREE RADICAL BIO MED, V47, P1640, DOI 10.1016/j.freeradbiomed.2009.09.011; Paromov V, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/109516; Paromov Victor, 2007, J Burns Wounds, V7, pe7; Ray R, 2000, J APPL TOXICOL, V21, pS87; Rowell M, 2009, TOXICOLOGY, V263, P9, DOI 10.1016/j.tox.2009.05.015; Sabourin CLK, 2002, J BIOCHEM MOL TOXIC, V16, P263, DOI 10.1002/jbt.10050; Sabourin CLK, 2000, J BIOCHEM MOL TOXIC, V14, P291, DOI 10.1002/1099-0461(2000)14:6<291::AID-JBT1>3.0.CO;2-B; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Singh RP, 2009, CLIN DERMATOL, V27, P479, DOI 10.1016/j.clindermatol.2009.05.012; Singh RP, 2005, EUR J CANCER, V41, P1969, DOI 10.1016/j.ejca.2005.03.033; Smith WJ, 2009, TOXICOLOGY, V263, P70, DOI 10.1016/j.tox.2008.09.012; Tewari-Singh N, 2011, J PHARMACOL EXP THER, V336, P450, DOI 10.1124/jpet.110.173708; Tewari-Singh N, 2010, CHEM RES TOXICOL, V23, P1034, DOI 10.1021/tx100038b; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Tyagi A, 2011, MOL CARCINOG; VOGT RF, 1984, FUND APPL TOXICOL, V4, pS71, DOI 10.1016/0272-0590(84)90139-8	47	55	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46149	10.1371/journal.pone.0046149	http://dx.doi.org/10.1371/journal.pone.0046149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029417	Green Published, gold, Green Submitted			2022-12-25	WOS:000309517500066
J	de Oliveira, GAP; Pereira, EG; Dias, CV; Souza, TLF; Ferretti, GDS; Cordeiro, Y; Camillo, LR; Cascardo, J; Almeida, FC; Valente, AP; Silva, JL				de Oliveira, Guilherme A. P.; Pereira, Elen G.; Dias, Cristiano V.; Souza, Theo L. F.; Ferretti, Giulia D. S.; Cordeiro, Yraima; Camillo, Luciana R.; Cascardo, Julio; Almeida, Fabio C.; Valente, Ana Paula; Silva, Jerson L.			Moniliophthora perniciosa Necrosis- and Ethylene-Inducing Protein 2 (MpNep2) as a Metastable Dimer in Solution: Structural and Functional Implications	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; WITCHES-BROOM; NEP1-LIKE PROTEINS; CAUSAL AGENT; CRINIPELLIS-PERNICIOSA; IDENTIFICATION; EXPRESSION; CAROTOVORA; DEFENSE; DISEASE	Understanding how Nep-like proteins (NLPs) behave during the cell cycle and disease progression of plant pathogenic oomycetes, fungi and bacteria is crucial in light of compelling evidence that these proteins play a role in Witches Broom Disease (WBD) of Theobroma cacao, one of the most important phytopathological problems to afflict the Southern Hemisphere. The crystal structure of MpNep2, a member of the NLP family and the causal agent of WBD, revealed the key elements for its activity. This protein has the ability to refold after heating and was believed to act as a monomer in solution, in contrast to the related homologs MpNep1 and NPP from the oomyceteous fungus Phytophthora parasitica. Here, we identify and characterize a metastable MpNep2 dimer upon over-expression in Escherichia coli using different biochemical and structural approaches. We found using ultra-fast liquid chromatography that the MpNep2 dimer can be dissociated by heating but not by dilution, oxidation or high ionic strength. Small-angle X-ray scattering revealed a possible tail-to-tail interaction between monomers, and nuclear magnetic resonance measurements identified perturbed residues involved in the putative interface of interaction. We also explored the ability of the MpNep2 monomer to refold after heating or chemical denaturation. We observed that MpNep2 has a low stability and cooperative fold that could be an explanation for its structure and activity recovery after stress. These results can provide new insights into the mechanism for MpNep2's action in dicot plants during the progression of WBD and may open new avenues for the involvement of NLP-oligomeric species in phytopathological disorders.	[de Oliveira, Guilherme A. P.; Pereira, Elen G.; Ferretti, Giulia D. S.; Almeida, Fabio C.; Valente, Ana Paula; Silva, Jerson L.] Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil; [Dias, Cristiano V.; Camillo, Luciana R.; Cascardo, Julio] Univ Estadual Santa Cruz, Ctr Biotecnol & Genet, Lab Proteom, Ilheus, BA, Brazil; [Dias, Cristiano V.] Mars Ctr Cocoa Sci, Itajuipe, BA, Brazil; [Souza, Theo L. F.; Cordeiro, Yraima] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual de Santa Cruz; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Ctr Nacl Ressonancia Magnet Nucl Jiri Jonas, Inst Nacl Biol Estrutural & Bioimagem, Programa Biol Estrutural,Inst Bioquim Med, Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	de Souza, Theo LF/E-1705-2017; Silva, Jerson/J-8984-2014; Cordeiro, Yraima/J-7619-2012; Pereira, Elen/H-9585-2013; de Oliveira, Guilherme A. P./O-1192-2013; Valente, Ana Paula/J-3010-2017; Almeida, Fabio/O-4989-2018; SILVA, JERSON Lima/GRF-1442-2022	de Souza, Theo LF/0000-0002-0109-0357; Silva, Jerson/0000-0001-9523-9441; Cordeiro, Yraima/0000-0003-4278-212X; Pereira, Elen/0000-0001-8073-7931; de Oliveira, Guilherme A. P./0000-0002-0063-5888; Valente, Ana Paula/0000-0001-7219-1123; Almeida, Fabio/0000-0001-6046-7006; SILVA, JERSON Lima/0000-0001-9523-9441; Diniz da Silva Ferretti, Giulia/0000-0002-1205-6090	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian Synchrotron Light Laboratory (LNLS) [SAXS1-10895, SAXS1-11698]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Synchrotron Light Laboratory (LNLS); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (CNPq INCT Program) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to J.L.S. This research was also supported by the Brazilian Synchrotron Light Laboratory (LNLS) under proposals SAXS1-10895 and SAXS1-11698. G.A.P.O. is the recipient of a graduate fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; Bae H, 2006, PLANT PHYSIOL, V141, P1056, DOI 10.1104/pp.106.076869; Bae HH, 2005, MYCOL RES, V109, P1373, DOI 10.1017/S0953756205003941; Bailey BA, 1997, CAN J MICROBIOL, V43, P45, DOI 10.1139/m97-007; Bailey Bryan A., 1995, Phytopathology, V85, P1250, DOI 10.1094/Phyto-85-1250; Cechin AL, 2008, PLANT SIGNAL BEHAV, V3, P906, DOI 10.4161/psb.3.10.6643; EVANS HC, 1980, T BRIT MYCOL SOC, V74, P515, DOI 10.1016/S0007-1536(80)80051-9; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; FRIAS GA, 1991, PLANT DIS, V75, P552, DOI 10.1094/PD-75-0552; Garcia O, 2007, MYCOL RES, V111, P443, DOI 10.1016/j.mycres.2007.01.017; Gijzen M, 2006, PHYTOCHEMISTRY, V67, P1800, DOI 10.1016/j.phytochem.2005.12.008; Jennings JC, 2000, WEED SCI, V48, P7, DOI 10.1614/0043-1745(2000)048[0007:IOEBAN]2.0.CO;2; Keates SE, 2003, PLANT PHYSIOL, V132, P1610, DOI 10.1104/pp.102.019836; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kufner I, 2009, PLANT SIGNAL BEHAV, V4, P977, DOI 10.4161/psb.4.10.9669; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; Mattinen L, 2004, MOL PLANT MICROBE IN, V17, P1366, DOI 10.1094/MPMI.2004.17.12.1366; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Pace C N, 1986, Methods Enzymol, V131, P266; Pemberton CL, 2005, MOL PLANT MICROBE IN, V18, P343, DOI 10.1094/MPMI-18-0343; Pemberton CL, 2004, MOL PLANT PATHOL, V5, P353, DOI 10.1111/j.1364-3703.2004.00235.x; Penman D, 2000, MYCOL RES, V104, P671, DOI 10.1017/S0953756299001689; Purdy LH, 1996, ANNU REV PHYTOPATHOL, V34, P573, DOI 10.1146/annurev.phyto.34.1.573; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Romano SA, 2009, FASEB J, V23, P4308, DOI 10.1096/fj.09-138974; Schouten A, 2008, NEW PHYTOL, V177, P493, DOI 10.1111/j.1469-8137.2007.02274.x; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Veit S, 2001, PLANT PHYSIOL, V127, P832, DOI 10.1104/pp.010350; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weber G, 1992, PROTEIN INTERACTIONS; Zaparoli G, 2011, BIOCHEMISTRY-US, V50, P9901, DOI 10.1021/bi201253b	36	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45620	10.1371/journal.pone.0045620	http://dx.doi.org/10.1371/journal.pone.0045620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029140	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700053
J	Harris, JA; Koyama, A; Maeda, S; Ho, K; Devidze, N; Dubal, DB; Yu, GQ; Masliah, E; Mucke, L				Harris, Julie A.; Koyama, Akihiko; Maeda, Sumihiro; Ho, Kaitlyn; Devidze, Nino; Dubal, Dena B.; Yu, Gui-Qiu; Masliah, Eliezer; Mucke, Lennart			Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MOUSE; MUTANT-TAU; P301L TAU; MEMORY; MODEL; MICE; PROTEIN; TANGLE; PARAHIPPOCAMPAL	Accumulation of hyperphosphorylated tau in the entorhinal cortex (EC) is one of the earliest pathological hallmarks in patients with Alzheimer's disease (AD). It can occur before significant A beta deposition and appears to "spread" into anatomically connected brain regions. To determine whether this early-stage pathology is sufficient to cause disease progression and cognitive decline in experimental models, we overexpressed mutant human tau (hTauP301L) predominantly in layer II/III neurons of the mouse EC. Cognitive functions remained normal in mice at 4, 8, 12 and 16 months of age, despite early and extensive tau accumulation in the EC. Perforant path (PP) axon terminals within the dentate gyrus (DG) contained abnormal conformations of tau even in young EC-hTau mice, and phosphorylated tau increased with age in both the EC and PP. In old mice, ultrastructural alterations in presynaptic terminals were observed at PP-to-granule cell synapses. Phosphorylated tau was more abundant in presynaptic than postsynaptic elements. Human and pathological tau was also detected within hippocampal neurons of this mouse model. Thus, hTauP301L accumulation predominantly in the EC and related presynaptic pathology in hippocampal circuits was not sufficient to cause robust cognitive deficits within the age range analyzed here.	[Harris, Julie A.; Koyama, Akihiko; Maeda, Sumihiro; Ho, Kaitlyn; Devidze, Nino; Dubal, Dena B.; Yu, Gui-Qiu; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Harris, Julie A.; Maeda, Sumihiro; Dubal, Dena B.; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Diego	Mucke, L (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	lmucke@gladstone.ucsf.edu	Maeda, Sumihiro/W-9146-2019; Dubal, Dena/AAL-2091-2021		National Institutes of Health (NIH) [AG011385, AG022074, AG023501, NS065780, AG18440, AG5131, NS044233]; Bristol-Myers Squibb; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG011385, R01AG011385, R37AG018440, P01AG022074, P50AG023501, R01AG018440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants AG011385, AG022074, AG023501 and NS065780 to L.M. and AG18440, AG5131 and NS044233 to E.M., and by a gift from the S.D. Bechtel, Jr. Foundation to L.M. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; Dr. Mucke is a member of the scientific advisory boards of AgeneBio, iPierian, ProBiodrug and Neuropore Therapies. He has received research funding for other projects and consulting fees from Bristol-Myers Squibb. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P35; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; CALLAHAN LM, 1994, NEUROBIOL AGING, V15, P381, DOI 10.1016/0197-4580(94)90041-8; Chin J, 2004, NEUROBIOL AGING, V25, pS18, DOI 10.1016/S0197-4580(04)80058-7; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Dayton RD, 2012, EXP NEUROL, V233, P807, DOI 10.1016/j.expneurol.2011.12.002; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deipolyi AR, 2007, NEUROLOGY, V69, P986, DOI 10.1212/01.wnl.0000271376.19515.c6; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kremer A, 2011, J NEUROSCI, V31, P18036, DOI 10.1523/JNEUROSCI.4859-11.2011; Lee SJ, 2011, NEUROSCI RES, V70, P339, DOI 10.1016/j.neures.2011.05.008; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Masdeu JC, 2005, J NEUROL SCI, V236, P55, DOI 10.1016/j.jns.2005.05.001; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Monacelli AM, 2003, NEUROLOGY, V61, P1491, DOI 10.1212/WNL.61.11.1491; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Murakami T, 2006, AM J PATHOL, V169, P1365, DOI 10.2353/ajpath.2006.051250; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Reed LA, 2001, NEUROBIOL AGING, V22, P89, DOI 10.1016/S0197-4580(00)00202-5; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schindowski K, 2006, AM J PATHOL, V169, P599, DOI 10.2353/ajpath.2006.060002; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Spencer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016575; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Sun AY, 2002, J HISTOCHEM CYTOCHEM, V50, P463, DOI 10.1177/002215540205000403; Sydow A, 2010, NEURODEGENER DIS, V7, P28, DOI 10.1159/000283479; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tatebayashi Y, 2002, P NATL ACAD SCI USA, V99, P13896, DOI 10.1073/pnas.202205599; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004	66	86	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45881	10.1371/journal.pone.0045881	http://dx.doi.org/10.1371/journal.pone.0045881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029293	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700084
J	Spencer-Smith, R; Varkey, EM; Fielder, MD; Snyder, LAS				Spencer-Smith, Russell; Varkey, Eldho M.; Fielder, Mark D.; Snyder, Lori A. S.			Sequence Features Contributing to Chromosomal Rearrangements in Neisseria gonorrhoeae	PLOS ONE			English	Article							REPEAT-ENCLOSED ELEMENTS; GENOME; MENINGITIDIS; STRAIN; DNA; PHASE; VISUALIZATION; PROPHAGE; FAMILY	Through whole genome sequence alignments, breakpoints in chromosomal synteny can be identified and the sequence features associated with these determined. Alignments of the genome sequences of Neisseria gonorrhoeae strain FA1090, N. gonorrhoeae strain NCCP11945, and N. gonorrhoeae strain TCDC-NG08107 reveal chromosomal rearrangements that have occurred. Based on these alignments and dot plot pair-wise comparisons, the overall chromosomal arrangement of strain NCCP11945 and TCDC-NG08107 are very similar, with no large inversions or translocations. The insertion of the Gonococcal Genetic Island in strain NCCP11945 is the most prominent distinguishing feature differentiating these strains. When strain NCCP11945 is compared to strain FA1090, however, 14 breakpoints in chromosomal synteny are identified between these gonococcal strains. The majority of these, 11 of 14, are associated with a prophage, IS elements, or IS-like repeat enclosed elements which appear to have played a role in the rearrangements observed. Additional rearrangements of small regions of the genome are associated with pilin genes. Evidence presented here suggests that the rearrangements of blocks of sequence are mediated by activation of prophage and associated IS elements and reintegration elsewhere in the genome or by homologous recombination between IS-like elements that have generated inversions.	[Spencer-Smith, Russell; Varkey, Eldho M.; Fielder, Mark D.; Snyder, Lori A. S.] Kingston Univ, Sch Life Sci, Kingston Upon Thames, Surrey, England	Kingston University	Snyder, LAS (corresponding author), Kingston Univ, Sch Life Sci, Kingston Upon Thames, Surrey, England.	l.snyder@kingston.ac.uk		Spencer-Smith, Russell/0000-0002-8865-0520; Snyder, Lori/0000-0003-3172-3984	Kingston University	Kingston University	RS-S and this work were supported by a Kingston University award to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; BHAT KS, 1991, MOL MICROBIOL, V5, P1889, DOI 10.1111/j.1365-2958.1991.tb00813.x; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Carbonnelle E, 2009, VACCINE, V27, pB78, DOI 10.1016/j.vaccine.2009.04.069; Chen CC, 2011, J BACTERIOL, V193, P1788, DOI 10.1128/JB.00007-11; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davidsen T, 2006, NAT REV MICROBIOL, V4, P11, DOI 10.1038/nrmicro1324; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; ELKINS C, 1991, J BACTERIOL, V173, P3911, DOI 10.1128/JB.173.12.3911-3913.1991; Gibbs CP, 1996, FEMS MICROBIOL LETT, V145, P173, DOI 10.1016/S0378-1097(96)00404-1; Jordan P, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-23; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; Kawai M, 2006, GENE, V383, P52, DOI 10.1016/j.gene.2006.07.013; Klee SR, 2000, INFECT IMMUN, V68, P2082, DOI 10.1128/IAI.68.4.2082-2095.2000; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Liu SV, 2002, J BACTERIOL, V184, P6163, DOI 10.1128/JB.184.22.6163-6173.2002; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Masignani V, 2001, INFECT IMMUN, V69, P2580, DOI 10.1128/IAI.69.4.2580-2588.2001; Mazzone M, 2001, GENE, V278, P211, DOI 10.1016/S0378-1119(01)00725-9; MEYER TF, 1982, CELL, V30, P45, DOI 10.1016/0092-8674(82)90010-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; NACHAMKIN I, 1981, INFECT IMMUN, V32, P641, DOI 10.1128/IAI.32.2.641-648.1981; Piekarowicz A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-66; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; SEGAL E, 1985, CELL, V40, P293, DOI 10.1016/0092-8674(85)90143-6; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Skaar EP, 2005, J BACTERIOL, V187, P1276, DOI 10.1128/JB.187.4.1276-1286.2005; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Snyder LAS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-70; STERN A, 1987, MOL MICROBIOL, V1, P5, DOI 10.1111/j.1365-2958.1987.tb00520.x; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46023	10.1371/journal.pone.0046023	http://dx.doi.org/10.1371/journal.pone.0046023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029370	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309554700108
J	Jia, ZQ; Zhu, YJ; Liu, LY				Jia, Zhiqing; Zhu, Yajuan; Liu, Liying			Different Water Use Strategies of Juvenile and Adult Caragana intermedia Plantations in the Gonghe Basin, Tibet Plateau	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; COLORADO PLATEAU; STABLE-ISOTOPES; DESERT PLANTS; CHINA; SHRUBS; POPULATION; COMMUNITY; ECOSYSTEM; SUMMER	Background: In a semi-arid ecosystem, water is one of the most important factors that affect vegetation dynamics, such as shrub plantation. A water use strategy, including the main water source that a plant species utilizes and water use efficiency (WUE), plays an important role in plant survival and growth. The water use strategy of a shrub is one of the key factors in the evaluation of stability and sustainability of a plantation. Methodology/Principal Findings: Caragana intermedia is a dominant shrub of sand-binding plantations on sand dunes in the Gonghe Basin in northeastern Tibet Plateau. Understanding the water use strategy of a shrub plantation can be used to evaluate its sustainability and long-term stability. We hypothesized that C. intermedia uses mainly deep soil water and its WUE increases with plantation age. Stable isotopes of hydrogen and oxygen were used to determine the main water source and leaf carbon isotope discrimination was used to estimate long-term WUE. The root system was investigated to determine the depth of the main distribution. The results showed that a 5-year-old C. intermedia plantation used soil water mainly at a depth of 0-30 cm, which was coincident with the distribution of its fine roots. However, 9- or 25-year-old C. intermedia plantations used mainly 0-50 cm soil depth water and the fine root system was distributed primarily at soil depths of 0-50 cm and 0-60 cm, respectively. These sources of soil water are recharged directly by rainfall. Moreover, the long-term WUE of adult plantations was greater than that of juvenile plantations. Conclusions: The C. intermedia plantation can change its water use strategy over time as an adaptation to a semi-arid environment, including increasing the depth of soil water used for root growth, and increasing long-term WUE.	[Jia, Zhiqing; Zhu, Yajuan; Liu, Liying] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Jia, Zhiqing; Zhu, Yajuan] Qinghai Gonghe Desert Ecosyst Res Stn, Gonghe Cty, Qinghai Provinc, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF	Zhu, YJ (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.	zhuyajuan80@gmail.com			Forestry Public Benefit Scientific Research Special Project of P.R. China [201204203]; Research Institute of Forestry, Chinese Academy of Forestry [ZD200908]	Forestry Public Benefit Scientific Research Special Project of P.R. China; Research Institute of Forestry, Chinese Academy of Forestry	This research was supported by the Forestry Public Benefit Scientific Research Special Project of P.R. China (201204203) and the Key Project of the Research Institute of Forestry, Chinese Academy of Forestry (ZD200908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casper BB, 2005, OECOLOGIA, V145, P541, DOI 10.1007/s00442-005-0162-9; Cheng XR, 2009, PLANT SOIL, V315, P149, DOI 10.1007/s11104-008-9739-5; Cheng XL, 2006, PLANT ECOL, V184, P1, DOI 10.1007/s11258-005-9047-6; Chimner RA, 2004, PLANT SOIL, V260, P225, DOI 10.1023/B:PLSO.0000030190.70085.e9; Darrouzet-Nardi A, 2006, PLANT SOIL, V285, P31, DOI 10.1007/s11104-005-4453-z; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; DONOVAN LA, 1994, OECOLOGIA, V100, P347, DOI 10.1007/BF00316964; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Fu K, 1992, FLORA REPUBLICAE POP, P47; Gebauer RLE, 2000, ECOLOGY, V81, P1415, DOI 10.1890/0012-9658(2000)081[1415:WANUPF]2.0.CO;2; Li G, 2007, J HYDROL, V333, P109; Li S, 2001, DESERTIFICATION SUST, P253; Ohte N, 2003, ECOL APPL, V13, P337, DOI 10.1890/1051-0761(2003)013[0337:WUONAP]2.0.CO;2; Schwinning S, 2005, J ARID ENVIRON, V60, P547, DOI 10.1016/j.jaridenv.2004.07.003; Schwinning S, 2003, OECOLOGIA, V136, P252, DOI 10.1007/s00442-003-1255-y; Schwinning S, 2002, OECOLOGIA, V130, P345, DOI 10.1007/s00442-001-0817-0; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; Yang H, 2010, PLANT SOIL, V340, P141; Zhao LJ, 2006, ENVIRON GEOL, V50, P285, DOI 10.1007/s00254-006-0209-1; Zhu Y.J., 2011, ACTA ECOL SIN, V31, P341, DOI [10.1016/j.chnaes.2011.09.004, DOI 10.1016/J.CHNAES.2011.09.004]; Zhu YJ, 2011, J FOOD AGRIC ENVIRON, V9, P832; Zhu YaJuan, 2010, Scientia Silvae Sinicae, V46, P15	23	25	47	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45902	10.1371/journal.pone.0045902	http://dx.doi.org/10.1371/journal.pone.0045902			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029303	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800116
J	Schurman, SH; Dunn, CA; Greaves, R; Yu, BB; Ferrucci, L; Croteau, DL; Seidman, MM; Bohr, VA				Schurman, Shepherd H.; Dunn, Christopher A.; Greaves, Rebecca; Yu, Binbing; Ferrucci, Luigi; Croteau, Deborah L.; Seidman, Michael M.; Bohr, Vilhelm A.			Age-Related Disease Association of Endogenous gamma-H2AX Foci in Mononuclear Cells Derived from Leukapheresis	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; OBSTRUCTIVE SLEEP-APNEA; OXIDATIVE DNA-DAMAGE; MOLECULAR MARKER; HISTONE H2AX; VITAMIN-D; REPAIR; HYPERTENSION; LYMPHOCYTES; CANCER	The phosphorylated form of histone H2AX (gamma-H2AX) forms immunohistochemically detectable foci at DNA double strand breaks. In peripheral blood mononuclear cells (PBMCs) derived from leukapheresis from patients enrolled in the Baltimore Longitudinal Study of Aging, gamma-H2AX foci increased in a linear fashion with regards to age, peaking at similar to 57 years. The relationship between the frequency of gamma-H2AX foci and age-related pathologies was assessed. We found a statistically significant (p = 0.023) 50% increase in foci in PBMCs derived from patients with a known history of vitamin D deficiency. In addition, there were trends toward increased gamma-H2AX foci in patients with cataracts (34% increase, p<0.10) and in sleep apnea patients (44%, p<0.10). Among patients >= 57 y/o, we found a significant (p = 0.037) 36% increase in the number of gamma-H2AX foci/cell for patients with hypertension compared to non-hypertensive patients. Our results support a role for increased DNA damage in the morbidity of age-related diseases. gamma-H2AX may be a biomarker for human morbidity in age-related diseases.	[Schurman, Shepherd H.; Dunn, Christopher A.; Greaves, Rebecca; Croteau, Deborah L.; Seidman, Michael M.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Yu, Binbing] NIA, Lab Epidemiol Demog & Biometry, NIH, Baltimore, MD 21224 USA; [Ferrucci, Luigi] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Croteau, Deb/AAP-5933-2020; Schurman, Shepherd/ABF-8125-2021; Bohr, Vilhelm/AAP-5931-2020	Schurman, Shepherd/0000-0002-9133-7906; Dunn, Christopher/0000-0001-7899-0110; Croteau, Deborah/0000-0002-6094-4084	National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by the Intramural Progam of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Bhogal N, 2009, INT J RADIAT BIOL, V85, P732, DOI 10.1080/09553000902785791; Chatterjee M, 2001, MUTAT RES-FUND MOL M, V475, P69, DOI 10.1016/S0027-5107(01)00080-X; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; DEWITZ TS, 1979, BLOOD CELLS, V5, P499; Dielis AWJH, 2005, HYPERTENSION, V46, P1236, DOI 10.1161/01.HYP.0000193538.20705.23; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kontogianni K, 2007, ENVIRON MOL MUTAGEN, V48, P722, DOI 10.1002/em.20351; Lerman PM., 1980, APPL STATIST, V29, P77, DOI [DOI 10.2307/2346413, 10.2307/2346413]; Love CC, 2005, THERIOGENOLOGY, V63, P1584, DOI 10.1016/j.theriogenology.2004.05.030; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mah LJ, 2010, EPIGENETICS-US, V5, P129, DOI 10.4161/epi.5.2.11080; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Prasad K, 2011, J MED SYST; R Development Core Team, 2012, R LANG ENV STAT COMP; Redon CE, 2011, METHODS MOL BIOL, V682, P249, DOI 10.1007/978-1-60327-409-8_18; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Shock N.W., 1984, NORMAL HUMAN AGING B; Sobol RW, 2003, DNA REPAIR, V2, P609, DOI 10.1016/S1568-7864(03)00026-0; Subash P, 2010, J HUM HYPERTENS, V24, P475, DOI 10.1038/jhh.2009.100; Tremezaygues L, 2009, DERM-ENDOCRINOL, V1, P239, DOI 10.4161/derm.1.4.9705; Tremezaygues L, 2010, J STEROID BIOCHEM, V121, P324, DOI 10.1016/j.jsbmb.2010.03.007; Yamauchi M, 2005, CHEST, V127, P1674, DOI 10.1378/chest.127.5.1674; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Yildiz A, 2008, TURK KARDIYOL DERN A, V36, P231; Zwicker F, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-62	36	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45728	10.1371/journal.pone.0045728	http://dx.doi.org/10.1371/journal.pone.0045728			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029205	gold, Green Submitted, Green Published			2022-12-25	WOS:000309392800085
J	Munoz-Martinez, F; Garcia-Fontana, C; Rico-Jimenez, M; Alfonso, C; Krell, T				Munoz-Martinez, Francisco; Garcia-Fontana, Cristina; Rico-Jimenez, Miriam; Alfonso, Carlos; Krell, Tino			Genes Encoding Cher-TPR Fusion Proteins Are Predominantly Found in Gene Clusters Encoding Chemosensory Pathways with Alternative Cellular Functions	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MYXOCOCCUS-XANTHUS; PSEUDOMONAS-AERUGINOSA; BACTERIAL CHEMOTAXIS; SELF-ASSOCIATION; TETRATRICOPEPTIDE REPEAT; AZOSPIRILLUM-BRASILENSE; METHYLTRANSFERASE CHER; ENVIRONMENTAL SIGNALS; TWITCHING MOTILITY	Chemosensory pathways correspond to major signal transduction mechanisms and can be classified into the functional families flagellum-mediated taxis, type four pili-mediated taxis or pathways with alternative cellular functions (ACF). CheR methyltransferases are core enzymes in all of these families. CheR proteins fused to tetratricopeptide repeat (TPR) domains have been reported and we present an analysis of this uncharacterized family. We show that CheR-TPRs are widely distributed in GRAM-negative but almost absent from GRAM-positive bacteria. Most strains contain a single CheR-TPR and its abundance does not correlate with the number of chemoreceptors. The TPR domain fused to CheR is comparatively short and frequently composed of 2 repeats. The majority of CheR-TPR genes were found in gene clusters that harbor multidomain response regulators in which the REC domain is fused to different output domains like HK, GGDEF, EAL, HPT, AAA, PAS, GAF, additional REC, HTH, phosphatase or combinations thereof. The response regulator architectures coincide with those reported for the ACF family of pathways. Since the presence of multidomain response regulators is a distinctive feature of this pathway family, we conclude that CheR-TPR proteins form part of ACF type pathways. The diversity of response regulator output domains suggests that the ACF pathways form a superfamily which regroups many different regulatory mechanisms, in which all CheR-TPR proteins appear to participate. In the second part we characterize WspC of Pseudomonas putida, a representative example of CheR-TPR. The affinities of WspC-Pp for S-adenosylmethionine and S-adenosylhomocysteine were comparable to those of prototypal CheR, indicating that WspC-Pp activity is in analogy to prototypal CheRs controlled by product feed-back inhibition. The removal of the TPR domain did not impact significantly on the binding constants and consequently not on the product feed-back inhibition. WspC-Pp was found to be monomeric, which rules out a role of the TPR domain in self-association.	[Munoz-Martinez, Francisco; Garcia-Fontana, Cristina; Rico-Jimenez, Miriam; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, Granada, Spain; [Alfonso, Carlos] Ctr Invest Biol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, Environm Protect Dept, Granada, Spain.	tino.krell@eez.csic.es	Fontana, Cristina Garcia/AAJ-4536-2021; Krell, Tino/G-7296-2015; Alfonso, Carlos/K-1316-2014; Fontana, Cristina Garcia/L-8184-2014	Fontana, Cristina Garcia/0000-0002-9328-6022; Krell, Tino/0000-0002-9040-3166; Alfonso, Carlos/0000-0001-7165-4800; Fontana, Cristina Garcia/0000-0002-9328-6022; Rico Jimenez, Miriam/0000-0002-0126-1478; Munoz-Martinez, Francisco/0000-0001-8416-0092	Andalusian regional government Junta de Andalucia [P09-RNM-4509, CVI-7335]; Spanish Ministry for Economy and Competitiveness [Bio2010-16937]; BBVA Foundation [BIOCON08 185/09]	Andalusian regional government Junta de Andalucia(Junta de Andalucia); Spanish Ministry for Economy and Competitiveness(Spanish Government); BBVA Foundation(BBVA Foundation)	This work has been funded by research projects from the Andalusian regional government Junta de Andalucia (grants P09-RNM-4509 and CVI-7335 to T. K.), the Spanish Ministry for Economy and Competitiveness (grant Bio2010-16937 to T. K.) and from the BBVA Foundation (grant BIOCON08 185/09 to T. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As part of its activities, the BBVA Foundation funds research projects in the area of environmental protection. Tino Krell has been granted the research project entitled "Biodegradation: challenging the constrains" (please see for further information http://www.fbbva.es/TLFU/tlfu/ing/areas/medioamb/investigacion/fichainves/index.jsp?codigo = 351). This project contains basic research to increase the efficiency of biodegradation. A major strategy in increasing the efficiency of biodegradation is to optimize chemotaxis of different Pseudomonas strains towards environmental contaminants. In this context CheR methyltransferases are of importance. This project covers expenses for hiring a post-doctoral researcher during 2 years, expenses for traveling and general expenses for running a research laboratory. Apart from this research project there is no other interaction between Tino Krell and the BBVA Foundation such as consultancy. This project will finish by the end of June and no patents will be deposited that are the result of this project. There are no products on the market or will be developed. In summary, the interaction between T. K. and the BBVA Foundation is purely scientific. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Alexandre G, 2004, FEMS MICROBIOL REV, V28, P113, DOI 10.1016/j.femsre.2003.10.003; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; Berleman JE, 2005, MOL MICROBIOL, V56, P1457, DOI 10.1111/j.1365-2958.2005.04646.x; Bible AN, 2008, J BACTERIOL, V190, P6365, DOI 10.1128/JB.00734-08; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Cole JL, 2004, METHOD ENZYMOL, V384, P212; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Eckler SA, 2005, NEUROSCIENCE, V131, P661, DOI 10.1016/j.neuroscience.2004.11.035; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Harighi B, 2009, MICROBIOL RES, V164, P634, DOI 10.1016/j.micres.2008.11.001; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Kanungpean D, 2011, MICROBIOL-SGM, V157, P1279, DOI 10.1099/mic.0.047399-0; Kennelly PJ, 2002, FEMS MICROBIOL LETT, V206, P1, DOI 10.1016/S0378-1097(01)00479-7; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JR, 2009, P NATL ACAD SCI USA, V106, P5978, DOI 10.1073/pnas.0811231106; Luciano J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002268; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MCCLEARY WR, 1990, J BACTERIOL, V172, P4877, DOI 10.1128/jb.172.9.4877-4887.1990; Nan B, 2011, ANNU REV GENET, V45, P21, DOI 10.1146/annurev-genet-110410-132547; Nan BY, 2010, MOL MICROBIOL, V76, P1539, DOI 10.1111/j.1365-2958.2010.07184.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Perez E, 2007, MOL MICROBIOL, V63, P363, DOI 10.1111/j.1365-2958.2006.05518.x; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; RodriguezSoto JP, 1997, J BACTERIOL, V179, P4361, DOI 10.1128/jb.179.13.4361-4371.1997; Schreiber A, 2011, NATURE, V470, P227, DOI 10.1038/nature09756; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott AE, 2008, MOL MICROBIOL, V69, P724, DOI 10.1111/j.1365-2958.2008.06323.x; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; Stephens BB, 2006, J BACTERIOL, V188, P4759, DOI 10.1128/JB.00267-06; STOCK JB, 1981, CELL, V27, P37, DOI 10.1016/0092-8674(81)90358-5; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Terada S, 2010, EMBO J, V29, P843, DOI 10.1038/emboj.2009.389; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yi X, 2002, BBA-PROTEIN STRUCT M, V1596, P28, DOI 10.1016/S0167-4838(01)00314-4; Zeytuni N, 2011, P NATL ACAD SCI USA, V108, P480; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	62	6	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45810	10.1371/journal.pone.0045810	http://dx.doi.org/10.1371/journal.pone.0045810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029255	Green Published, gold			2022-12-25	WOS:000309388900103
J	Wardhaugh, CW; Stork, NE; Edwards, W; Grimbacher, PS				Wardhaugh, Carl W.; Stork, Nigel E.; Edwards, Will; Grimbacher, Peter S.			The Overlooked Biodiversity of Flower-Visiting Invertebrates	PLOS ONE			English	Article							LOWLAND RAIN-FOREST; PLANT-POLLINATOR INTERACTIONS; INSECT HERBIVORES; TROPICAL FORESTS; SPECIES RICHNESS; PHYTOPHAGOUS BEETLES; INORDINATE FONDNESS; HOST-SPECIFICITY; GUILD STRUCTURE; TREES	Estimates suggest that perhaps 40% of all invertebrate species are found in tropical rainforest canopies. Extrapolations of total diversity and food web analyses have been based almost exclusively on species inhabiting the foliage, under the assumption that foliage samples are representative of the entire canopy. We examined the validity of this assumption by comparing the density of invertebrates and the species richness of beetles across three canopy microhabitats (mature leaves, new leaves and flowers) on a one hectare plot in an Australian tropical rainforest. Specifically, we tested two hypotheses: 1) canopy invertebrate density and species richness are directly proportional to the amount of resource available; and 2) canopy microhabitats represent discrete resources that are utilised by their own specialised invertebrate communities. We show that flowers in the canopy support invertebrate densities that are ten to ten thousand times greater than on the nearby foliage when expressed on a per-unit resource biomass basis. Furthermore, species-level analyses of the beetle fauna revealed that flowers support a unique and remarkably rich fauna compared to foliage, with very little species overlap between microhabitats. We reject the hypothesis that the insect fauna on mature foliage is representative of the greater canopy community even though mature foliage comprises a very large proportion of canopy plant biomass. Although the significance of the evolutionary relationship between flowers and insects is well known with respect to plant reproduction, less is known about the importance of flowers as resources for tropical insects. Consequently, we suggest that this constitutes a more important piece of the 'diversity jigsaw puzzle' than has been previously recognised and could alter our understanding of the evolution of plant-herbivore interactions and food web dynamics, and provide a better foundation for accurately estimating global species richness.	[Wardhaugh, Carl W.; Edwards, Will] James Cook Univ, Sch Marine & Trop Biol, Smithfield, Qld, Australia; [Stork, Nigel E.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Grimbacher, Peter S.] Univ Melbourne, Dept Resource Management & Geog, Richmond, Vic, Australia	James Cook University; Griffith University; University of Melbourne	Wardhaugh, CW (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Smithfield, Qld, Australia.	carl.wardhaugh@my.jcu.edu.au	Edwards, Will/M-6652-2015; Wardhaugh, Carl W/K-6474-2015; Edwards, Will/GRS-5509-2022	Edwards, Will/0000-0001-8981-7479; Wardhaugh, Carl W/0000-0002-1628-8163; Stork, Nigel/0000-0001-7812-2452	MTSRF grant; Skyrail Rainforest Foundation; Australian Postgraduate Award	MTSRF grant; Skyrail Rainforest Foundation; Australian Postgraduate Award(Australian Government)	Financial support for fieldwork was provided by a MTSRF grant. CWW was supported by a grant from the Skyrail Rainforest Foundation and an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Armbruster WS, 1997, ECOLOGY, V78, P1661; BASSET Y, 1991, OECOLOGIA, V87, P388, DOI 10.1007/BF00634596; BASSET Y, 1992, ECOL ENTOMOL, V17, P310, DOI 10.1111/j.1365-2311.1992.tb01063.x; Basset Y, 2001, OECOLOGIA, V129, P253, DOI 10.1007/s004420100724; BAWA KS, 1985, AM J BOT, V72, P346, DOI 10.2307/2443527; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; Carisey N, 1997, ENTOMOL EXP APPL, V85, P17, DOI 10.1023/A:1003097429242; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Colwell RK, 2013, ESTIMATES STAT ESTIM; Condon MA, 2008, SCIENCE, V320, P928, DOI 10.1126/science.1155832; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Ellwood MDF, 2004, NATURE, V429, P549, DOI 10.1038/nature02560; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Feinstein J, 2007, BIOTROPICA, V39, P549, DOI 10.1111/j.1744-7429.2007.00279.x; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Frame D, 2003, TAXON, V52, P681, DOI 10.2307/3647343; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GOTTSBERGER G, 1989, PLANT SYST EVOL, V167, P189, DOI 10.1007/BF00936405; Gribel R, 1999, J TROP ECOL, V15, P247, DOI 10.1017/S0266467499000796; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grove SJ, 2000, INVERTEBR TAXON, V14, P733, DOI 10.1071/IT00023; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hammond Peter M., 1996, Ecotropica, V2, P99; Hopkins MS, 1996, J BIOGEOGR, V23, P737, DOI 10.1111/j.1365-2699.1996.tb00035.x; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Kitching RL, 2006, SCIENCE, V313, P1055, DOI 10.1126/science.1131117; Laidlaw M, 2007, AUSTRAL ECOL, V32, P10, DOI 10.1111/j.1442-9993.2007.01739.x; Lawrence JF., 2000, BEETLES WORLD; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; LOUDA SM, 1982, OECOLOGIA, V55, P185, DOI 10.1007/BF00384486; LOWMAN MD, 1992, ECOLOGY, V73, P129, DOI 10.2307/1938726; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Morais HC, 2009, BIOTROPICA, V41, P401, DOI 10.1111/j.1744-7429.2009.00534.x; MORAN VC, 1982, J ANIM ECOL, V51, P289, DOI 10.2307/4325; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, ECOL LETT, V7, P1090, DOI 10.1111/j.1461-0248.2004.00666.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Odegaard F, 2004, ECOL ENTOMOL, V29, P76, DOI 10.1111/j.0307-6946.2004.00580.x; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Pratt PD, 2005, ECOL ENTOMOL, V30, P316, DOI 10.1111/j.0307-6946.2005.00691.x; REGAL PJ, 1977, SCIENCE, V196, P622, DOI 10.1126/science.196.4290.622; Romero GQ, 2004, ECOLOGY, V85, P446, DOI 10.1890/02-0327; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; SIMPSON BB, 1981, ANN MO BOT GARD, V68, P301, DOI 10.2307/2398800; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; STORK NE, 1987, ECOL ENTOMOL, V12, P69, DOI 10.1111/j.1365-2311.1987.tb00986.x; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Stork NE, 2007, AUSTRAL ECOL, V32, P4, DOI 10.1111/j.1442-9993.2007.01740.x; Stork NE, 2006, P ROY SOC B-BIOL SCI, V273, P1969, DOI 10.1098/rspb.2006.3521; Strauss SY, 1999, EVOLUTION, V53, P1105, DOI [10.2307/2640815, 10.1111/j.1558-5646.1999.tb04525.x]; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; Teichert H, 2011, PLANT SYST EVOL, V291, P25, DOI 10.1007/s00606-010-0367-1; THOMAS CD, 1990, ECOLOGY, V71, P610, DOI 10.2307/1940314; Tracey JG, 1982, VEGETATION HUMID TRO; van Dulmen A, 2001, PLANT ECOL, V153, P73, DOI 10.1023/A:1017577305193; Wackers FL, 2007, ANNU REV ENTOMOL, V52, P301, DOI 10.1146/annurev.ento.52.110405.091352; Walter DE, 1998, AUST J ECOL, V23, P501, DOI 10.1111/j.1442-9993.1998.tb00760.x; Wardhaugh CW, 2012, J ANIM ECOL, V81, P1086, DOI 10.1111/j.1365-2656.2012.01988.x; Wardhaugh CW, 2012, INSECT CONS IN PRESS	69	30	30	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45796	10.1371/journal.pone.0045796	http://dx.doi.org/10.1371/journal.pone.0045796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029246	gold, Green Accepted, Green Published			2022-12-25	WOS:000309388400131
J	Shimizu, T; Takaya, N; Nakamura, A				Shimizu, Tetsu; Takaya, Naoki; Nakamura, Akira			An L-glucose Catabolic Pathway in Paracoccus Species 43P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; BACILLUS-SUBTILIS; ACID CATABOLISM; D-SUGARS; IDENTIFICATION; METABOLISM; GLYCERALDEHYDE; DERIVATIVES; OXIDATION; BACTERIA	AnL-glucose-utilizing bacterium, Paracoccus sp. 43P, was isolated from soil by enrichment cultivation in a minimal medium containing L-glucose as the sole carbon source. In cell-free extracts from this bacterium, NAD(+)-dependent L-glucose dehydrogenase was detected as having sole activity toward L-glucose. This enzyme, LgdA, was purified, and the lgdA gene was found to be located in a cluster of putative inositol catabolic genes. LgdA showed similar dehydrogenase activity toward scyllo-and myo-inositols. L-Gluconate dehydrogenase activity was also detected in cell-free extracts, which represents the reaction product of LgdA activity toward L-glucose. Enzyme purification and gene cloning revealed that the corresponding gene resides in a nine-gene cluster, the lgn cluster, which may participate in aldonate incorporation and assimilation. Kinetic and reaction product analysis of each gene product in the cluster indicated that they sequentially metabolize L-gluconate to glycolytic intermediates, D-glyceraldehyde-3-phosphate, and pyruvate through reactions of C-5 epimerization by dehydrogenase/reductase, dehydration, phosphorylation, and aldolase reaction, using a pathway similar to L-galactonate catabolism in Escherichia coli. Gene disruption studies indicated that the identified genes are responsible for L-glucose catabolism.	[Shimizu, Tetsu; Takaya, Naoki; Nakamura, Akira] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Nakamura, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	nakamura.akira.fm@u.tsukuba.ac.jp		Nakamura, Akira/0000-0001-7250-7175	Noda Institute for Scientific Research, Japan; Japan Society for Promotion of Science	Noda Institute for Scientific Research, Japan; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by NISR Research Grant from the Noda Institute for Scientific Research, Japan, and grants-in-aid for scientific research (B) from Japan Society for Promotion of Science.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Bausch C, 1998, J BACTERIOL, V180, P3704, DOI 10.1128/JB.180.14.3704-3710.1998; Breslow R, 2010, P NATL ACAD SCI USA, V107, P5723, DOI 10.1073/pnas.1001639107; COOPER RA, 1979, FEBS LETT, V103, P216, DOI 10.1016/0014-5793(79)81330-7; COOPER RA, 1980, FEBS LETT, V115, P63, DOI 10.1016/0014-5793(80)80727-7; De Groeve MRM, 2009, BIOTECHNOL LETT, V31, P1873, DOI 10.1007/s10529-009-0087-1; Hemker M, 2001, J BACTERIOL, V183, P4484, DOI 10.1128/JB.183.15.4484-4492.2001; Hilditch S, 2007, J BIOL CHEM, V282, P26195, DOI 10.1074/jbc.M704401200; HOWE AF, 1964, ANAL BIOCHEM, V9, P443, DOI 10.1016/0003-2697(64)90205-2; KALYANANDA MKGS, 1987, J BACTERIOL, V169, P2488, DOI 10.1128/jb.169.6.2488-2493.1987; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuorelahti S, 2006, MOL MICROBIOL, V61, P1060, DOI 10.1111/j.1365-2958.2006.05294.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIVESEY G, 1995, J NUTR, V125, P3020; Lobanok AG, 1998, WORLD J MICROB BIOT, V14, P259, DOI 10.1023/A:1008850601037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moore S, 1940, J BIOL CHEM, V133, P293; Morinaga T, 2010, MICROBIOL-SGM, V156, P1538, DOI 10.1099/mic.0.037499-0; OCHMAN H, 1988, GENETICS, V120, P621; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; RAMALEY R, 1979, J BIOL CHEM, V254, P7684; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; RUDNEY HARRY, 1940, SCIENCE, V92, P112, DOI 10.1126/science.92.2379.112; SASAJIMA KI, 1979, BIOCHIM BIOPHYS ACTA, V571, P120, DOI 10.1016/0005-2744(79)90232-8; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sun HJ, 2009, ASTROBIOLOGY, V9, P443, DOI 10.1089/ast.2008.0315; WONG TY, 1994, APPL ENVIRON MICROB, V60, P2065, DOI 10.1128/AEM.60.6.2065-2068.1994; Yoshida KI, 2008, J BIOL CHEM, V283, P10415, DOI 10.1074/jbc.M708043200; Zhang LS, 2011, FUNGAL GENET BIOL, V48, P990, DOI 10.1016/j.fgb.2011.06.002	32	32	33	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40448	40456		10.1074/jbc.M112.403055	http://dx.doi.org/10.1074/jbc.M112.403055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23038265	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000311448800036
J	Xu, M; Liu, K; Swaroop, M; Porter, FD; Sidhu, R; Finkes, S; Ory, DS; Marugan, JJ; Xiao, JB; Southall, N; Pavan, WJ; Davidson, C; Walkley, SU; Remaley, AT; Baxa, U; Sun, W; McKew, JC; Austin, CP; Zheng, W				Xu, Miao; Liu, Ke; Swaroop, Manju; Porter, Forbes D.; Sidhu, Rohini; Finkes, Sally; Ory, Daniel S.; Marugan, Juan J.; Xiao, Jingbo; Southall, Noel; Pavan, William J.; Davidson, Cristin; Walkley, Steven U.; Remaley, Alan T.; Baxa, Ulrich; Sun, Wei; McKew, John C.; Austin, Christopher P.; Zheng, Wei			delta-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOCOPHEROL; VITAMIN-E; DISEASE; EXOCYTOSIS; PLASMA; SUPPLEMENTATION; TOCOTRIENOLS; FIBROBLASTS; METABOLISM; TISSUE	Niemann-Pick disease type C (NPC) and Wolman disease are two members of a family of storage disorders caused by mutations of genes encoding lysosomal proteins. Deficiency in function of either the NPC1 or NPC2 protein in NPC disease or lysosomal acid lipase in Wolman disease results in defective cellular cholesterol trafficking. Lysosomal accumulation of cholesterol and enlarged lysosomes are shared phenotypic characteristics of both NPC and Wolman cells. Utilizing a phenotypic screen of an approved drug collection, we found that delta-tocopherol effectively reduced lysosomal cholesterol accumulation, decreased lysosomal volume, increased cholesterol efflux, and alleviated pathological phenotypes in both NPC1 and Wolman fibroblasts. Reduction of these abnormalities may be mediated by a delta-tocopherol-induced intracellular Ca2+ response and subsequent enhancement of lysosomal exocytosis. Consistent with a general mechanism for reduction of lysosomal lipid accumulation, we also found that delta-tocopherol reduces pathological phenotypes in patient fibroblasts from other lysosomal storage diseases, including NPC2, Batten (ceroid lipofuscinosis, neuronal 2, CLN2), Fabry, Farber, Niemann-Pick disease type A, Sanfilippo type B (mucopolysaccharidosis type IIIB, MPSIIIB), and Tay-Sachs. Our data suggest that regulated exocytosis may represent a potential therapeutic target for reduction of lysosomal storage in this class of diseases.	[Xu, Miao; Liu, Ke; Swaroop, Manju; Marugan, Juan J.; Xiao, Jingbo; Southall, Noel; Sun, Wei; McKew, John C.; Austin, Christopher P.; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Porter, Forbes D.] Eunice Kennedy Shriver NICHD, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Sidhu, Rohini; Finkes, Sally; Ory, Daniel S.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Davidson, Cristin; Walkley, Steven U.] Albert Einstein Coll Med, Rose F Kennedy Ctr, Sidney Weisner Lab Genet Neurol Dis, Bronx, NY 10461 USA; [Remaley, Alan T.] NHLBI, Lab Lipoprot Metab, NIH, Bethesda, MD 20892 USA; [Xu, Miao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China; [Baxa, Ulrich] NCI, Electron Microscopy Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr,MSC 3370, Bethesda, MD 20892 USA.	wzheng@mail.nih.gov	Davidson, Cristin/F-4889-2017; Zheng, Wei/J-8889-2014; Southall, Noel T/H-8991-2012; Sander-Effron, Samuel/AAX-2231-2020; Davidson, Cristin/AAA-2733-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; xu, miao/U-1176-2017; Zheng, Wei/GOE-5990-2022; Sidhu, Rohini/G-3547-2012	Davidson, Cristin/0000-0002-5508-8113; Zheng, Wei/0000-0003-1034-0757; Southall, Noel T/0000-0003-4500-880X; Davidson, Cristin/0000-0002-5508-8113; Sidhu, Rohini/0000-0003-1703-2167; Sun, Wei/0000-0002-1306-3946; Baxa, Ulrich/0000-0002-7263-5078; Pavan, William/0000-0001-8281-5120; Swaroop, Manju/0000-0002-0576-1664	National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Human Genome Research Institute; Intramural Research Program of the Eunice Kennedy Shriver NICHD; NCI, National Institutes of Health [HHSN26120080001E]; Ara Parseghian Medical Research Foundation; National Institutes of Health [P60 DK020579]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593, R01HD045561, ZIAHD008824] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000002] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences; Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the Eunice Kennedy Shriver NICHD; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ara Parseghian Medical Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences, by the Intramural Research Program of the National Human Genome Research Institute, by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, and by NCI, National Institutes of Health, Contract HHSN26120080001E. This work was also supported by a grant from the Ara Parseghian Medical Research Foundation.; We thank Support of Accelerated Research for Niemann-Pick Disease Type C (SOAR-NPC) for fostering a collaborative research environment and stimulating discussion. Mass spectrometry analysis was performed in the Washington University Metabolomics Facility, supported by National Institutes of Health Grant P60 DK020579. We thank Dr. Yiannis A. Ioannou (Mount Sinai School of Medicine) for technical assistance with the exocytosis assays and Ferri Soheilian and Christina Burks for assistance with electron microscopy.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Bascunan-Castillo Eric C., 2004, Journal of Applied Genetics, V45, P461; Baxter LL, 2012, NUTRIENTS, V4, P467, DOI 10.3390/nu4060467; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUSTANY RMN, 1990, PEDIATR NEUROL, V6, P177, DOI 10.1016/0887-8994(90)90059-A; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Du H, 2008, J LIPID RES, V49, P1646, DOI 10.1194/jlr.M700482-JLR200; Eggermont E, 2006, EUR J PEDIATR, V165, P429, DOI 10.1007/s00431-006-0084-5; Fielding CJ, 1997, J LIPID RES, V38, P1503; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Gohil K, 2010, MOL NUTR FOOD RES, V54, P693, DOI 10.1002/mnfr.200900575; Han XL, 2004, ANAL BIOCHEM, V330, P317, DOI 10.1016/j.ab.2004.04.004; Hemmerling J, 2010, MOL NUTR FOOD RES, V54, P652, DOI 10.1002/mnfr.200900462; Huang HY, 2003, J NUTR, V133, P3137, DOI 10.1093/jn/133.10.3137; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Klein D, 2005, BIOCHEM BIOPH RES CO, V327, P663, DOI 10.1016/j.bbrc.2004.12.054; KRUTH HS, 1986, J BIOL CHEM, V261, P6769; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Manor D, 2007, VITAM HORM, V76, P45, DOI 10.1016/S0083-6729(07)76003-X; Martins RM, 2011, CELL MICROBIOL, V13, P943, DOI 10.1111/j.1462-5822.2011.01590.x; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Nagashima K, 2011, METHODS MOL BIOL, V697, P83, DOI 10.1007/978-1-60327-198-1_8; NORMAN AW, 1972, J BIOL CHEM, V247, P1918; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pani A, 2009, J ALZHEIMERS DIS, V18, P829, DOI 10.3233/JAD-2009-1193; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Perez-Poyato MS, 2011, CURR PHARM BIOTECHNO, V12, P897, DOI 1389-2010/11 $58.00+.00; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Ravaglia G, 2008, AM J CLIN NUTR, V87, P1306, DOI 10.1093/ajcn/87.5.1306; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Royer MC, 2009, J BIOL CHEM, V284, P15826, DOI 10.1074/jbc.M808641200; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Sen CK, 2006, LIFE SCI, V78, P2088, DOI 10.1016/j.lfs.2005.12.001; Sethi AA, 2008, J BIOL CHEM, V283, P32273, DOI 10.1074/jbc.M804461200; Sontag TJ, 2007, J LIPID RES, V48, P1090, DOI 10.1194/jlr.M600514-JLR200; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Tietge UJF, 2001, HUM GENE THER, V12, P279, DOI 10.1089/10430340150218413; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; WOLMAN M, 1995, CLIN PEDIATR, V34, P207, DOI 10.1177/000992289503400406; Yancey PG, 2003, ARTERIOSCL THROM VAS, V23, P712, DOI 10.1161/01.ATV.0000057572.97137.DD	49	87	95	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.357707	http://dx.doi.org/10.1074/jbc.M112.357707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	23035117	Green Published, hybrid			2022-12-25	WOS:000311233800007
J	Jallow, M; Casals-Pascual, C; Ackerman, H; Walther, B; Walther, M; Pinder, M; Sisay-Joof, F; Usen, S; Jallow, M; Abubakar, I; Olaosebikan, R; Jobarteh, A; Conway, DJ; Bojang, K; Kwiatkowski, D				Jallow, Muminatou; Casals-Pascual, Climent; Ackerman, Hans; Walther, Brigitte; Walther, Michael; Pinder, Margaret; Sisay-Joof, Fatou; Usen, Stanley; Jallow, Mariatou; Abubakar, Ismaela; Olaosebikan, Rasaq; Jobarteh, Aminata; Conway, David J.; Bojang, Kalifa; Kwiatkowski, Dominic			Clinical Features of Severe Malaria Associated with Death: A 13-Year Observational Study in The Gambia	PLOS ONE			English	Article							SEVERE FALCIPARUM-MALARIA; AFRICAN CHILDREN; CEREBRAL MALARIA; TRANSMISSION; INDICATORS; MORBIDITY	Background: Severe malaria (SM) is a major cause of death in sub-Saharan Africa. Identification of both specific and sensitive clinical features to predict death is needed to improve clinical management. Methods: A 13-year observational study was conducted from 1997 through 2009 of 2,901 children with SM enrolled at the Royal Victoria Teaching Hospital in The Gambia to identify sensitive and specific predictors of poor outcome in Gambian children with severe malaria between the ages 4 months to 14 years. We have measured the sensitivity and specificity of clinical features that predict death or development of neurological sequelae. Findings: Impaired consciousness (odds ratio {OR} 4.4 [95% confidence interval {CI}, 2.7-7.3]), respiratory distress (OR 2.4 [95% CI, 1.7-3.2]), hypoglycemia (OR 1.7 [95%CI, 1.2-2.3]), jaundice (OR 1.9 [95%CI, 1.2-2.9]) and renal failure (OR 11.1 [95%CI, 3.3-36.5]) were independently associated with death in children with SM. The clinical features that showed the highest sensitivity and specificity to predict death were respiratory distress (area under the curve 0.63 [95% CI, 0.60-0.65]) and impaired consciousness (AUC 0.61[95% CI, 0.59-0.63]), which were comparable to the ability of hyperlactatemia (blood lactate>5 mM) to predict death (AUC 0.64 [95% CI, 0.55-0.72]). A Blantyre coma score (BCS) of 2 or less had a sensitivity of 74% and specificity of 67% to predict death (AUC 0.70 [95% C.I. 0.68-0.72]), and sensitivity and specificity of 74% and 69%, respectively to predict development of neurological sequelae (AUC 0.72 [95% CI, 0.67-0.76]). The specificity of this BCS threshold to identify children at risk of dying improved in children less than 3 years of age (AUC 0.74, [95% C.I 0.71-0.76]). Conclusion: The BCS is a quantitative predictor of death. A BCS of 2 or less is the most sensitive and specific clinical feature to predict death or development of neurological sequelae in children with SM.	[Casals-Pascual, Climent; Kwiatkowski, Dominic] Wellcome Trust Ctr Human Genet, Oxford, England; [Jallow, Muminatou; Walther, Brigitte; Pinder, Margaret; Sisay-Joof, Fatou; Usen, Stanley; Abubakar, Ismaela; Olaosebikan, Rasaq; Jobarteh, Aminata; Bojang, Kalifa] MRC Labs, Malaria Programme, Banjul, Gambia; [Ackerman, Hans; Walther, Michael] NIAID, Lab Malaria & Vector Res, Rockville, MD USA; [Conway, David J.] London Sch Hyg & Trop Med, London WC1, England; [Jallow, Muminatou; Jallow, Mariatou] Royal Victoria Teaching Hosp, Banjul, Gambia	University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; London School of Hygiene & Tropical Medicine	Casals-Pascual, C (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	ccasals@well.ox.ac.uk	Casals-Pascual, Climent/N-7692-2018; Ackerman, Hans/U-9621-2019	Casals-Pascual, Climent/0000-0002-0867-8954; Ackerman, Hans/0000-0003-4940-3305; Olaosebikan, Rasaq/0000-0002-3244-2212; Kwiatkowski, Dominic/0000-0002-5023-0176; Conway, David/0000-0002-8711-3037	Wellcome Trust [077383/Z/05/Z, 075491/Z/04]; Bill & Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health initiative [566]; Medical Research Council [G0701885]; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001150] Funding Source: NIH RePORTER; Medical Research Council [G19/9, MC_UP_A900_1118, MC_U190081993, G0600230, G0600718] Funding Source: researchfish; MRC [MC_UP_A900_1118, G19/9, G0600718, G0600230, G0701885, MC_U190081993] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Bill & Melinda Gates Foundation through the Foundation for the National Institutes of Health as part of the Grand Challenges in Global Health initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institutes of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust [grant number 077383/Z/05/Z] [grant number 075491/Z/04] and by the Bill & Melinda Gates Foundation, through the Foundation for the National Institutes of Health (grant number 566) as part of the Grand Challenges in Global Health initiative. CC-P is supported by the Medical Research Council (Clinician Scientist Fellowship: G0701885). HA is supported by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bejon P, 2007, PLOS MED, V4, P1333, DOI 10.1371/journal.pmed.0040251; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MOLYNEUX ME, 1989, Q J MED, V71, P441; Newton CRJC, 2005, CLIN INFECT DIS, V41, P948, DOI 10.1086/432941; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; von Seidlein L, 2012, CLIN INFECT DIS, V54, P1080, DOI 10.1093/cid/cis034; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2006, WHO CHILD GROWTH STA	22	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e45645	10.1371/journal.pone.0045645	http://dx.doi.org/10.1371/journal.pone.0045645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029157	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000309973900049
J	Sangwan, N; Lata, P; Dwivedi, V; Singh, A; Niharika, N; Kaur, J; Anand, S; Malhotra, J; Jindal, S; Nigam, A; Lal, D; Dua, A; Saxena, A; Garg, N; Verma, M; Kaur, J; Mukherjee, U; Gilbert, JA; Dowd, SE; Raman, R; Khurana, P; Khurana, JP; Lal, R				Sangwan, Naseer; Lata, Pushp; Dwivedi, Vatsala; Singh, Amit; Niharika, Neha; Kaur, Jasvinder; Anand, Shailly; Malhotra, Jaya; Jindal, Swati; Nigam, Aeshna; Lal, Devi; Dua, Ankita; Saxena, Anjali; Garg, Nidhi; Verma, Mansi; Kaur, Jaspreet; Mukherjee, Udita; Gilbert, Jack A.; Dowd, Scot E.; Raman, Rajagopal; Khurana, Paramjit; Khurana, Jitendra P.; Lal, Rup			Comparative Metagenomic Analysis of Soil Microbial Communities across Three Hexachlorocyclohexane Contamination Levels	PLOS ONE			English	Article							GAMMA-HEXACHLOROCYCLOHEXANE; SPHINGOMONAS-PAUCIMOBILIS; LIN GENES; REDUCTIVE DECHLORINATION; BACTERIAL DIVERSITY; RAST SERVER; SP NOV.; DEGRADATION; HCH; SEQUENCE	This paper presents the characterization of the microbial community responsible for the in-situ bioremediation of hexachlorocyclohexane (HCH). Microbial community structure and function was analyzed using 16S rRNA amplicon and shotgun metagenomic sequencing methods for three sets of soil samples. The three samples were collected from a HCH-dumpsite (450 mg HCH/g soil) and comprised of a HCH/soil ratio of 0.45, 0.0007, and 0.00003, respectively. Certain bacterial; (Chromohalobacter, Marinimicrobium, Idiomarina, Salinosphaera, Halomonas, Sphingopyxis, Novosphingobium, Sphingomonas and Pseudomonas), archaeal; (Halobacterium, Haloarcula and Halorhabdus) and fungal (Fusarium) genera were found to be more abundant in the soil sample from the HCH-dumpsite. Consistent with the phylogenetic shift, the dumpsite also exhibited a relatively higher abundance of genes coding for chemotaxis/motility, chloroaromatic and HCH degradation (lin genes). Reassembly of a draft pangenome of Chromohalobacter salaxigenes sp. (similar to 8X coverage) and 3 plasmids (pISP3, pISP4 and pLB1; 13X coverage) containing lin genes/clusters also provides an evidence for the horizontal transfer of HCH catabolism genes.	[Sangwan, Naseer; Lata, Pushp; Dwivedi, Vatsala; Singh, Amit; Niharika, Neha; Kaur, Jasvinder; Anand, Shailly; Malhotra, Jaya; Jindal, Swati; Nigam, Aeshna; Lal, Devi; Dua, Ankita; Saxena, Anjali; Garg, Nidhi; Verma, Mansi; Kaur, Jaspreet; Mukherjee, Udita; Raman, Rajagopal; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Dowd, Scot E.] Mol Res LP, MR DNA, Shallowater, TX USA; [Khurana, Paramjit; Khurana, Jitendra P.] Univ Delhi, Interdisciplinary Ctr Plant Genom, New Delhi, India; [Khurana, Paramjit; Khurana, Jitendra P.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Delhi; United States Department of Energy (DOE); Argonne National Laboratory; University of Delhi; University of Delhi; University of Chicago	Lal, R (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	ruplal@gmail.com	Lal, Devi/GXN-0410-2022; Lal, Rup/AFP-1009-2022; Gilbert, Jack/AAF-3270-2019; Dowd, Scot E/M-5386-2017; Kaur, Jasvinder/ABQ-2529-2022	Dowd, Scot E/0000-0002-6296-1427; Kaur, Jasvinder/0000-0003-1163-5039; Kumar Singh, Amit/0000-0002-9517-7786; Lal, Devi/0000-0002-6480-4249; verma, mansi/0000-0003-3170-9576; Sangwan, Naseer/0000-0002-2407-769X	University of Delhi/Department of Science and Technology PURSE Program; Department of Biotechnology, Government of India [BT/PR3301/BCE/8/875/2011]; Application of microorganisms and allied sector [AMAAS/2006-07/NBAIM/CIR]; United States Department of Energy [DE-AC02-06CH11357]	University of Delhi/Department of Science and Technology PURSE Program; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Application of microorganisms and allied sector; United States Department of Energy(United States Department of Energy (DOE))	This work was supported by grants under University of Delhi/Department of Science and Technology PURSE Program and grants from Department of Biotechnology, Government of India under project BT/PR3301/BCE/8/875/2011 and Application of microorganisms and allied sector F. No.AMAAS/2006-07/NBAIM/CIR. This work was also supported in part by the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arahal DR, 2001, INT J SYST EVOL MICR, V51, P1443, DOI 10.1099/00207713-51-4-1443; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barker MS, 2010, EVOL BIOINFORM, V6, P143, DOI 10.4137/EBO.S5861; Barker MS, 2009, BIOINFORMATICS, V25, P535, DOI 10.1093/bioinformatics/btp011; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Boltner D, 2005, ENVIRON MICROBIOL, V7, P1329, DOI 10.1111/j.1462-5822.2005.00820.x; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Canovas D, 1996, J BACTERIOL, V178, P7221, DOI 10.1128/jb.178.24.7221-7226.1996; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Ceremonie H, 2006, FEMS MICROBIOL LETT, V257, P243, DOI 10.1111/j.1574-6968.2006.00188.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cui ZJ, 2012, J BIOSCI BIOENG, V113, P765, DOI 10.1016/j.jbiosc.2012.01.006; Dadhwal M, 2009, J APPL MICROBIOL, V106, P381, DOI 10.1111/j.1365-2672.2008.03982.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Desai N, 2012, CURR OPIN BIOTECH, V23, P72, DOI 10.1016/j.copbio.2011.12.017; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dogra C, 2004, J BACTERIOL, V186, P2225, DOI 10.1128/JB.186.8.2225-2235.2004; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Endo R, 2007, J BACTERIOL, V189, P3712, DOI 10.1128/JB.01883-06; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jit S, 2011, ENVIRON SCI POLLUT R, V18, P586, DOI 10.1007/s11356-010-0401-4; Kalantzi OI, 2004, CARCINOGENESIS, V25, P613, DOI 10.1093/carcin/bgh048; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; Kumari R, 2002, APPL ENVIRON MICROB, V68, P6021, DOI 10.1128/AEM.68.12.6021-6028.2002; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; Le Borgne S, 2008, J MOL MICROB BIOTECH, V15, P74, DOI 10.1159/000121323; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MACRAE IC, 1969, NATURE, V221, P859, DOI 10.1038/221859a0; Malhotra Shweta, 2007, Indian Journal of Microbiology, V47, P271, DOI 10.1007/s12088-007-0050-6; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Middeldorp PJM, 2005, BIODEGRADATION, V16, P283, DOI 10.1007/s10532-004-1573-8; Miyauchi K, 2002, APPL ENVIRON MICROB, V68, P1803, DOI 10.1128/AEM.68.4.1803-1807.2002; Miyazaki R, 2006, APPL ENVIRON MICROB, V72, P6923, DOI 10.1128/AEM.01531-06; Mohn WW, 2006, ENVIRON MICROBIOL, V8, P60, DOI 10.1111/j.1462-2920.2005.00865.x; Mwangi K, 2010, AFR J MICROBIOL RES, V4, P185; Nagata Y, 2006, FEMS MICROBIOL LETT, V256, P112, DOI 10.1111/j.1574-6968.2005.00096.x; Nagata Y, 2011, ENZYME MICROB TECH, V49, P499, DOI 10.1016/j.enzmictec.2011.10.005; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Phillips TM, 2005, BIODEGRADATION, V16, P363, DOI 10.1007/s10532-004-2413-6; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raina V, 2008, BIODEGRADATION, V19, P27, DOI 10.1007/s10532-007-9112-z; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Sagar V, 2011, WORLD J MICROB BIOT, V27, P1747, DOI 10.1007/s11274-010-0628-8; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Siddique T, 2003, J ENVIRON QUAL, V32, P47, DOI 10.2134/jeq2003.0047; Suar M, 2005, APPL ENVIRON MICROB, V71, P8514, DOI 10.1128/AEM.71.12.8514-8518.2005; Tabata M, 2011, BIOSCI BIOTECH BIOCH, V75, P466, DOI 10.1271/bbb.100652; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Doesburg W, 2005, FEMS MICROBIOL ECOL, V54, P87, DOI 10.1016/j.femsec.2005.03.003; Vega FA, 2007, J ENVIRON QUAL, V36, P272, DOI 10.2134/jeq2006.0053; Vijgen J., 2006, LEGACY LINDANE HCH I; Vijgen J, 2011, ENVIRON SCI POLLUT R, V18, P152, DOI 10.1007/s11356-010-0417-9; Waino M, 2000, INT J SYST EVOL MICR, V50, P183, DOI 10.1099/00207713-50-1-183; Walker A, 2001, ENVIRON POLLUT, V111, P407, DOI 10.1016/S0269-7491(00)00092-0; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Yeo A, 1998, J EXP BOT, V49, P915, DOI 10.1093/jexbot/49.323.915; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	75	66	69	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46219	10.1371/journal.pone.0046219	http://dx.doi.org/10.1371/journal.pone.0046219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029440	gold, Green Submitted, Green Published			2022-12-25	WOS:000309973900110
J	Le Guillou, S; Sdassi, N; Laubier, J; Passet, B; Vilotte, M; Castille, J; Laloe, D; Polyte, J; Bouet, S; Jaffrezic, F; Cribiu, EP; Vilotte, JL; Le Provost, F				Le Guillou, Sandrine; Sdassi, Nezha; Laubier, Johann; Passet, Bruno; Vilotte, Marthe; Castille, Johan; Laloe, Denis; Polyte, Jacqueline; Bouet, Stephan; Jaffrezic, Florence; Cribiu, Edmond-Paul; Vilotte, Jean-Luc; Le Provost, Fabienne			Overexpression of miR-30b in the Developing Mouse Mammary Gland Causes a Lactation Defect and Delays Involution	PLOS ONE			English	Article							STEM-CELL ANTIGEN-1; DOWN-REGULATION; MESSENGER-RNA; CANCER-CELLS; MESENCHYMAL TRANSITION; TRANSGENIC MICE; FAMILY-MEMBERS; KNOCKOUT MICE; EXPRESSION; MICRORNAS	Background: MicroRNA (miRNA) are negative regulators of gene expression, capable of exerting pronounced influences upon the translation and stability of mRNA. They are potential regulators of normal mammary gland development and of the maintenance of mammary epithelial progenitor cells. This study was undertaken to determine the role of miR-30b on the establishment of a functional mouse mammary gland. miR-30b is a member of the miR-30 family, composed of 6 miRNA that are highly conserved in vertebrates. It has been suggested to play a role in the differentiation of several cell types. Methodology/Principal Findings: The expression of miR-30b was found to be regulated during mammary gland development. Transgenic mice overexpressing miR-30b in mammary epithelial cells were used to investigate its role. During lactation, mammary histological analysis of the transgenic mice showed a reduction in the size of alveolar lumen, a defect of the lipid droplets and a growth defect of pups fed by transgenic females. Moreover some mammary epithelial differentiated structures persisted during involution, suggesting a delay in the process. The genes whose expression was affected by the overexpression of miR-30b were characterized by microarray analysis. Conclusion/ Significance: Our data suggests that miR-30b is important for the biology of the mammary gland and demonstrates that the deregulation of only one miRNA could affect lactation and involution.	[Le Guillou, Sandrine; Sdassi, Nezha; Laubier, Johann; Passet, Bruno; Vilotte, Marthe; Castille, Johan; Laloe, Denis; Polyte, Jacqueline; Bouet, Stephan; Jaffrezic, Florence; Cribiu, Edmond-Paul; Vilotte, Jean-Luc; Le Provost, Fabienne] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Le Provost, F (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	Fabienne.LeProvost@jouy.inra.fr	Vilotte, Jean-Luc/AAF-4688-2019; Laloe, Denis/O-7045-2019	Laloe, Denis/0000-0001-8359-0760				Avril-Sassen S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-548; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batts TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027841; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennasser Y, 2011, NAT STRUCT MOL BIOL, V18, P323, DOI 10.1038/nsmb.1987; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; Bockmeyer CL, 2011, METHODS MOL BIOL, V755, P85, DOI 10.1007/978-1-61779-163-5_7; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cheng CW, 2012, BREAST CANCER RES TR, V134, P1081, DOI 10.1007/s10549-012-2034-4; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cizkova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015647; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Epting CL, 2008, J CELL PHYSIOL, V217, P250, DOI 10.1002/jcp.21500; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ichikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031422; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77; Kho Y, 2008, BIOSCI BIOTECH BIOCH, V72, P70, DOI 10.1271/bbb.70374; Lambert AW, 2012, ONCOL; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Lin J, 2011, LEUKEMIA, V25, P145, DOI 10.1038/leu.2010.230; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Lu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006159; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Neve R, 1998, FASEB J, V12, P1541, DOI 10.1096/fasebj.12.14.1541; R Development Core Team, 2012, R LANG ENV STAT COMP; Raymond K, 2012, SEMIN CELL DEV BIOL; Saidi S, 2007, GENE, V401, P97, DOI 10.1016/j.gene.2007.06.023; Schwertfeger KL, 2003, J LIPID RES, V44, P1100, DOI 10.1194/jlr.M300045-JLR200; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VALIVULLAH HM, 1986, INT J BIOCHEM, V18, P799, DOI 10.1016/0020-711X(86)90056-X; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhang JC, 2012, BIOCHEM BIOPH RES CO, V417, P1100, DOI 10.1016/j.bbrc.2011.12.121; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	64	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45727	10.1371/journal.pone.0045727	http://dx.doi.org/10.1371/journal.pone.0045727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029204	Green Published, gold, Green Submitted			2022-12-25	WOS:000309554700062
J	Logge, W; Cheng, D; Chesworth, R; Bhatia, S; Garner, B; Kim, WS; Karl, T				Logge, Warren; Cheng, David; Chesworth, Rose; Bhatia, Surabhi; Garner, Brett; Kim, Woojin Scott; Karl, Tim			Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases	PLOS ONE			English	Article							CASSETTE TRANSPORTER A7; NEUREGULIN-1 MUTANT MICE; HIGH-DENSITY-LIPOPROTEIN; OBJECT RECOGNITION; ALZHEIMERS-DISEASE; CELLULAR CHOLESTEROL; PREPULSE INHIBITION; AMYLOID DEPOSITION; KNOCKOUT MICE; MEMORY	ATP-binding cassette transporters of the subfamily A (ABCA) are responsible for the translocation of lipids including cholesterol, which is crucial for neurological function. Recent studies suggest that the ABC transporter ABCA7 may play a role in the development of brain disorders such as schizophrenia and Alzheimer's disease. However, Abca7's role in cognition and other behaviours has not been investigated. Therefore, we characterised homozygous Abca7 knockout mice in a battery of tests for baseline behaviours (i.e. physical exam, baseline locomotion and anxiety) and behaviours relevant to schizophrenia (i.e. prepulse inhibition and locomotor response to psychotropic drugs) and Alzheimer's disease (i.e. cognitive domains). Knockout mice had normal motor functions and sensory abilities and performed the same as wild type-like animals in anxiety tasks. Short-term spatial memory and fear-associated learning was also intact in Abca7 knockout mice. However, male knockout mice exhibited significantly impaired novel object recognition memory. Task acquisition was unaffected in the cheeseboard task. Female mice exhibited impaired spatial reference memory. This phenomenon was more pronounced in female Abca7 null mice. Acoustic startle response, sensorimotor gating and baseline locomotion was unaltered in Abca7 knockout mice. Female knockouts showed a moderately increased motor response to MK-801 than control mice. In conclusion, Abca7 appears to play only a minor role in behavioural domains with a subtle sex-specific impact on particular cognitive domains.	[Logge, Warren; Cheng, David; Chesworth, Rose; Bhatia, Surabhi; Garner, Brett; Kim, Woojin Scott; Karl, Tim] Neurosci Res Australia, Randwick, NSW, Australia; [Cheng, David; Bhatia, Surabhi; Kim, Woojin Scott; Karl, Tim] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Logge, Warren; Chesworth, Rose; Karl, Tim] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Karl, Tim] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Wollongong; University of Wollongong; University of New South Wales Sydney	Karl, T (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	t.karl@neura.edu.au	Karl, Tim/E-2088-2011	Karl, Tim/0000-0001-9904-8482; Chesworth, Rose/0000-0002-3758-9598; Logge, Warren/0000-0003-0777-3033	National Health and Medical Research Council (NHMRC) [510148]; Schizophrenia Research Institute (SRI); New South Wales Health; National Health and Medical Research Council Career Development Award [568752]; National Alliance for Research on Schizophrenia and Depression (Young Investigator Award); Motor Neuron Disease Research Institute of Australia; Australian Research Council [FT0991986]; National Health and Medical Research Council [1003886, 630445]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute (SRI); New South Wales Health; National Health and Medical Research Council Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); National Alliance for Research on Schizophrenia and Depression (Young Investigator Award)(NARSAD); Motor Neuron Disease Research Institute of Australia; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by a project grant to BG from the National Health and Medical Research Council (NHMRC: 510148) and the Schizophrenia Research Institute (SRI) utilizing infrastructure funding from New South Wales Health. TK is supported by a National Health and Medical Research Council Career Development Award (568752), by the National Alliance for Research on Schizophrenia and Depression (Young Investigator Award), and the Motor Neuron Disease Research Institute of Australia. BG is supported by a Fellowship from the Australian Research Council (FT0991986) and is an honorary National Health and Medical Research Council Senior Research Fellow (630445). BG and TK are also supported by a National Health and Medical Research Council project grant (1003886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Abe-Dohmae S, 2004, J BIOL CHEM, V279, P604, DOI 10.1074/jbc.M309888200; Bimonte HA, 2000, PHYSIOL BEHAV, V70, P311, DOI 10.1016/S0031-9384(00)00259-6; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Bryan KJ, 2009, FRONT NEUROSCI, P1; Chan SL, 2008, J NEUROCHEM, V106, P793, DOI 10.1111/j.1471-4159.2008.05433.x; Chen XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006875; Chesworth R, 2012, BEHAV BRAIN RES, V226, P218, DOI 10.1016/j.bbr.2011.09.019; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; D'Souza DN, 2002, J APPL PHYSIOL, V92, P493, DOI 10.1152/japplphysiol.00565.2001; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; Frick KM, 2000, NEUROSCIENCE, V95, P293; Geyer MA, 2003, CURR PROTOC NEUROSCI; Ghi P, 1999, PHARMACOL BIOCHEM BE, V64, P761, DOI 10.1016/S0091-3057(99)00143-4; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gresack JE, 2007, NEUROBIOL LEARN MEM, V88, P393, DOI 10.1016/j.nlm.2007.07.015; Harburger LL, 2008, BEHAV BRAIN RES, V194, P174, DOI 10.1016/j.bbr.2008.07.014; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ikeda Y, 2003, BIOCHEM BIOPH RES CO, V311, P313, DOI 10.1016/j.bbrc.2003.10.002; Iwamoto N, 2006, J LIPID RES, V47, P1915, DOI 10.1194/jlr.M600127-JLR200; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Kaminski WE, 2000, BIOCHEM BIOPH RES CO, V273, P532, DOI 10.1006/bbrc.2000.2954; Karasinska JM, 2009, J NEUROSCI, V29, P3579, DOI 10.1523/JNEUROSCI.4741-08.2009; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Karl T, 2012, BEHAV BRAIN RES, V228, P392, DOI 10.1016/j.bbr.2011.12.021; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; Kim WS, 2008, J NEUROCHEM, V104, P1145, DOI 10.1111/j.1471-4159.2007.05099.x; Kim WS, 2005, J BIOL CHEM, V280, P3989, DOI 10.1074/jbc.M412602200; Kobayashi DT, 2005, GENES BRAIN BEHAV, V4, P173, DOI 10.1111/j.1601-183X.2005.00124.x; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Lin TT, 2006, CELL RES, V16, P857, DOI 10.1038/sj.cr.7310107; Lopez LL, 2010, BEHAV BRAIN RES, V209, P85, DOI 10.1016/j.bbr.2010.01.020; Nie T, 2001, BEHAV NEUROSCI, V115, P951, DOI 10.1037//0735-7044.115.4.951; Parkinson PF, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-5; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Stolzing A, 2004, FASEB J, V18, P743, DOI 10.1096/fj.03-0374fje; Tanaka N, 2011, J ATHEROSCLER THROMB, V18, P274, DOI 10.5551/jat.6726; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200	54	36	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45959	10.1371/journal.pone.0045959	http://dx.doi.org/10.1371/journal.pone.0045959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029339	gold, Green Published			2022-12-25	WOS:000309554700096
J	Oliveira, JM; Segurado, P; Santos, JM; Teixeira, A; Ferreira, MT; Cortes, RV				Oliveira, Joao M.; Segurado, Pedro; Santos, Jose M.; Teixeira, Amilcar; Ferreira, Maria T.; Cortes, Rui V.			Modelling Stream-Fish Functional Traits in Reference Conditions: Regional and Local Environmental Correlates	PLOS ONE			English	Article							FRESH-WATER FISH; TROUT SALMO-TRUTTA; SEINE RIVER-BASIN; ASSEMBLAGE STRUCTURE; SPECIES RICHNESS; LAND-USE; TERRESTRIAL INVERTEBRATES; LONGITUDINAL PATTERNS; RELATIVE INFLUENCES; COMMUNITY STRUCTURE	Identifying the environmental gradients that control the functional structure of biological assemblages in reference conditions is fundamental to help river management and predict the consequences of anthropogenic stressors. Fish metrics (density of ecological guilds, and species richness) from 117 least disturbed stream reaches in several western Iberia river basins were modelled with generalized linear models in order to investigate the importance of regional-and local-scale abiotic gradients to variation in functional structure of fish assemblages. Functional patterns were primarily associated with regional features, such as catchment elevation and slope, rainfall, and drainage area. Spatial variations of fish guilds were thus associated with broad geographic gradients, showing (1) pronounced latitudinal patterns, affected mainly by climatic factors and topography, or (2) at the basin level, strong upstream-downstream patterns related to stream position in the longitudinal gradient. Maximum native species richness was observed in midsize streams in accordance with the river continuum concept. The findings of our study emphasized the need to use a multi-scale approach in order to fully assess the factors that govern the functional organization of biotic assemblages in 'natural' streams, as well as to improve biomonitoring and restoration of fluvial ecosystems.	[Oliveira, Joao M.; Cortes, Rui V.] Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal; [Oliveira, Joao M.; Segurado, Pedro; Santos, Jose M.; Ferreira, Maria T.] Univ Tecn Lisboa, CEF, P-1100 Lisbon, Portugal; [Teixeira, Amilcar] Inst Politecn Braganca, Ctr Invest Montanha CIMO, Escola Super Agr, Braganca, Portugal	University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Instituto Politecnico de Braganca	Oliveira, JM (corresponding author), Univ Tras Os Montes & Alto Douro, CITAB, Vila Real, Portugal.	jmoliveira@utad.pt	Ferreira, Teresa/C-9785-2012; Oliveira, João M./ADT-6348-2022; Segurado, Pedro/A-1145-2011; Oliveira, João M./K-3130-2013; Santos, José Maria/F-9022-2010; Cortes, Rui Manuel Vitor/K-1896-2013	Ferreira, Teresa/0000-0002-3900-1460; Oliveira, João M./0000-0002-7048-5096; Segurado, Pedro/0000-0002-5917-7893; Oliveira, João M./0000-0002-7048-5096; Santos, José Maria/0000-0003-1232-2560; Cortes, Rui Manuel Vitor/0000-0002-8602-7663; Teiga Teixeira, Amilcar Antonio/0000-0001-5336-1174	National Forest Authority (AFN) under project AQUARIPORT; Foundation for Science and Technology (FCT) [SFRH/BPD/44624/2008, SFRH/BPD/39067/2007]	National Forest Authority (AFN) under project AQUARIPORT; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financially supported by the National Forest Authority (AFN) (http://www.afn.min-agricultura.pt) under project AQUARIPORT, and post-doctoral grants from the Foundation for Science and Technology (FCT) (http://www.fct.pt) (JMO - SFRH/BPD/44624/2008; PS - SFRH/BPD/39067/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts BGW, 2003, HYDROBIOLOGIA, V500, P157, DOI 10.1023/A:1024638726162; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Allan JD, 2003, CAN J FISH AQUAT SCI, V60, P309, DOI 10.1139/F03-019; [Anonymous], 2010, R LANG ENV STAT COMP; BALON EK, 1986, ENVIRON BIOL FISH, V15, P243; Belliard J, 1997, ENVIRON BIOL FISH, V50, P133, DOI 10.1023/A:1007353527126; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carmona JA, 1999, ENVIRON BIOL FISH, V54, P371, DOI 10.1023/A:1007535200837; CEN (Comite Europeen de Normalisation), 2003, 140112003E CEN EN; Chappaz R, 1996, HYDROBIOLOGIA, V331, P63, DOI 10.1007/BF00025408; Clavero M, 2005, AQUAT CONSERV, V15, P415, DOI 10.1002/aqc.679; Coelho M.M., 1997, Fisheries Management and Ecology, V4, P83, DOI 10.1046/j.1365-2400.1997.d01-165.x; Doadrio I., 2002, ATLAS LIBRO ROJO PEC; ELLIOTT JM, 1975, J ANIM ECOL, V44, P823, DOI 10.2307/3721; Esselman PC, 2010, ECOL FRESHW FISH, V19, P439, DOI 10.1111/j.1600-0633.2010.00430.x; Fame Consortium, 2005, MAN APPL EUR FISH IN; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Ferreira MT, 2007, ECOL FRESHW FISH, V16, P504, DOI 10.1111/j.1600-0633.2007.00241.x; Ferreira T, 2007, FISHERIES MANAG ECOL, V14, P519, DOI 10.1111/j.1365-2400.2007.00581.x; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gehrke PC, 2000, MAR FRESHWATER RES, V51, P165, DOI 10.1071/MF99061; Gido KB, 2006, AM FISH S S, V48, P265; Godinho FN, 1998, ENVIRON BIOL FISH, V51, P41, DOI 10.1023/A:1007412714605; Goldstein RM, 2005, N AM J FISH MANAGE, V25, P180, DOI 10.1577/M04-042.1; Goldstein RM, 2004, T AM FISH SOC, V133, P971, DOI 10.1577/T03-080.1; Grant EHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034170; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; Grubaugh JW, 1996, CAN J FISH AQUAT SCI, V53, P896, DOI 10.1139/cjfas-53-4-896; Higgins CL, 2009, AQUAT ECOL, V43, P1133, DOI 10.1007/s10452-009-9233-z; Hoeinghaus DJ, 2007, J BIOGEOGR, V34, P324, DOI 10.1111/j.1365-2699.2006.01587.x; HORWITZ RJ, 1978, ECOL MONOGR, V48, P307, DOI 10.2307/2937233; Huet M., 1949, Schweizerische Zeitschrift fuer Hydrologie Basle, V11, P332, DOI 10.1007/BF02503356; Hynes H., 1975, INT VER THEOR ANGEW, V19, P1, DOI DOI 10.1080/03680770.1974.11896033; Ibanez C, 2009, ECOGRAPHY, V32, P658, DOI 10.1111/j.1600-0587.2008.05591.x; INAG, 2008, MAN AV BIOL QUAL AG; JACKSON DA, 1989, ECOLOGY, V70, P1472, DOI 10.2307/1938206; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Lasne E, 2007, RIVER RES APPL, V23, P877, DOI 10.1002/rra.1030; Lawton JH, 1999, OIKOS, V84, P177, DOI 10.2307/3546712; Logez M, 2010, J N AM BENTHOL SOC, V29, P1310, DOI 10.1899/09-125.1; MAGALHAES MF, 1993, OECOLOGIA, V96, P253, DOI 10.1007/BF00317739; Magalhaes MF, 2002, FRESHWATER BIOL, V47, P1015, DOI 10.1046/j.1365-2427.2002.00830.x; Marsh-Matthews E, 2000, ECOL FRESHW FISH, V9, P9, DOI 10.1034/j.1600-0633.2000.90103.x; MASON CF, 1982, FRESHWATER BIOL, V12, P305, DOI 10.1111/j.1365-2427.1982.tb00624.x; Matthews W. J., 1998, PATTERNS FRESHWATER; McCullagh P, 1989, GEN LINEAR MODELS; McGarvey DJ, 2008, FRESHWATER BIOL, V53, P2206, DOI 10.1111/j.1365-2427.2008.02046.x; McGarvey DJ, 2008, COPEIA, P311, DOI 10.1643/CE-07-020; MCNEELY DL, 1986, SOUTHWEST NAT, V31, P375, DOI 10.2307/3671842; Melcher A, 2007, FISHERIES MANAG ECOL, V14, P453, DOI 10.1111/j.1365-2400.2007.00583.x; Montgomery DR, 1999, J AM WATER RESOUR AS, V35, P397, DOI 10.1111/j.1752-1688.1999.tb03598.x; Noble RAA, 2007, FISHERIES MANAG ECOL, V14, P381, DOI 10.1111/j.1365-2400.2007.00575.x; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; OBERDORFF T, 1993, HYDROBIOLOGIA, V259, P157, DOI 10.1007/BF00006595; Oliveira JM, 2009, N AM J FISH MANAGE, V29, P1466, DOI 10.1577/M08-175.1; Pires AM, 1999, J FISH BIOL, V54, P235; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; Pont D, 2007, FISHERIES MANAG ECOL, V14, P427, DOI 10.1111/j.1365-2400.2007.00577.x; Pont D, 2006, J APPL ECOL, V43, P70, DOI 10.1111/j.1365-2664.2005.01126.x; Pont D, 2005, CAN J FISH AQUAT SCI, V62, P163, DOI 10.1139/F04-183; Poole GC, 2002, FRESHWATER BIOL, V47, P641, DOI 10.1046/j.1365-2427.2002.00922.x; Pouilly M, 2006, J FISH BIOL, V68, P137, DOI 10.1111/j.0022-1112.2006.00883.x; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Pusey BJ, 1996, MAR FRESHWATER RES, V47, P563, DOI 10.1071/MF9960563; Quinn GP, 2003, EXPT DESIGN DATA ANA; Quist MC, 2004, CAN J ZOOL, V82, P1554, DOI [10.1139/z04-134, 10.1139/Z04-134]; Ribeiro F, 2009, FISHERIES MANAG ECOL, V16, P255, DOI 10.1111/j.1365-2400.2009.00659.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Rivas-Martinez S., 2004, BIOBLIMATIC MAP EURO; RIVAS-MARTINEZ S., 1996, FOLIA BOT MATRITENSI, V16, P1; Roni P, 2008, N AM J FISH MANAGE, V28, P856, DOI 10.1577/M06-169.1; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Roset N, 2007, FISHERIES MANAG ECOL, V14, P393, DOI 10.1111/j.1365-2400.2007.00589.x; Sandin L, 2009, FUND APPL LIMNOL, V174, P75, DOI 10.1127/1863-9135/2009/0174-0075; Santos JM, 2011, AQUAT SCI, V73, P233, DOI 10.1007/s00027-010-0172-5; Schlosser I.J., 1987, P17; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; Smith K. G., 2006, STATUS DISTRIBUTION; Stanford JA, 1996, REGUL RIVER, V12, P391, DOI 10.1002/(SICI)1099-1646(199607)12:4/5&lt;391::AID-RRR436&gt;3.0.CO;2-4; Tomanova S, 2007, FUND APPL LIMNOL, V170, P233, DOI 10.1127/1863-9135/2007/0170-0233; Vadas RL, 2001, T AM FISH SOC, V130, P217, DOI 10.1577/1548-8659(2001)130<0217:FOHSMF>2.0.CO;2; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters DM, 2003, FRESHWATER BIOL, V48, P1950, DOI 10.1046/j.1365-2427.2003.01137.x; Wang LZ, 2003, CAN J FISH AQUAT SCI, V60, P491, DOI 10.1139/F03-043; Wang LZ, 2002, J AM WATER RESOUR AS, V38, P663, DOI 10.1111/j.1752-1688.2002.tb00988.x; Warren C.E., 1971, BIOL WATER POLLUTION; [No title captured]; [No title captured]	91	30	30	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45787	10.1371/journal.pone.0045787	http://dx.doi.org/10.1371/journal.pone.0045787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029242	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700073
J	Svistounov, D; Warren, A; McNerney, GP; Owen, DM; Zencak, D; Zykova, SN; Crane, H; Huser, T; Quinn, RJ; Smedsrod, B; Le Couteur, DG; Cogger, VC				Svistounov, Dmitri; Warren, Alessandra; McNerney, Gregory P.; Owen, Dylan M.; Zencak, Dusan; Zykova, Svetlana N.; Crane, Harry; Huser, Thomas; Quinn, Ronald J.; Smedsrod, Bard; Le Couteur, David G.; Cogger, Victoria C.			The Relationship between Fenestrations, Sieve Plates and Rafts in Liver Sinusoidal Endothelial Cells	PLOS ONE			English	Article							ACTIN MICROFILAMENTS; MEMBRANE RAFTS; GROWTH-FACTOR; LINE TENSION; LIPID RAFTS; RAT-LIVER; CYTOSKELETON; CAVEOLIN-1; AGE; PERMEABILITY	Fenestrations are transcellular pores in endothelial cells that facilitate transfer of substrates between blood and the extravascular compartment. In order to understand the regulation and formation of fenestrations, the relationship between membrane rafts and fenestrations was investigated in liver sinusoidal endothelial cells where fenestrations are grouped into sieve plates. Three dimensional structured illumination microscopy, scanning electron microscopy, internal reflectance fluorescence microscopy and two-photon fluorescence microscopy were used to study liver sinusoidal endothelial cells isolated from mice. There was an inverse distribution between sieve plates and membrane rafts visualized by structured illumination microscopy and the fluorescent raft stain, Bodipy FL C5 ganglioside GM1. 7-ketocholesterol and/or cytochalasin D increased both fenestrations and lipid-disordered membrane, while Triton X-100 decreased both fenestrations and lipid-disordered membrane. The effects of cytochalasin D on fenestrations were abrogated by co-administration of Triton X-100, suggesting that actin disruption increases fenestrations by its effects on membrane rafts. Vascular endothelial growth factor (VEGF) depleted lipid-ordered membrane and increased fenestrations. The results are consistent with a sieve-raft interaction, where fenestrations form in non-raft lipid-disordered regions of endothelial cells once the membrane-stabilizing effects of actin cytoskeleton and membrane rafts are diminished.	[Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia; [Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Univ Sydney, ANZAC Med Res Inst, Sydney, NSW 2006, Australia; [Svistounov, Dmitri; Warren, Alessandra; Zykova, Svetlana N.; Crane, Harry; Le Couteur, David G.; Cogger, Victoria C.] Concord Hosp, Sydney, NSW, Australia; [McNerney, Gregory P.; Huser, Thomas] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Owen, Dylan M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Zencak, Dusan; Quinn, Ronald J.] Griffith Univ, Eskitis Inst, Brisbane, Qld 4111, Australia; [Smedsrod, Bard] Univ Tromso, Dept Med Biol, Tromso, Norway	University of Sydney; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; National Science Foundation (NSF); University of California System; University of California Davis; University of New South Wales Sydney; Griffith University; UiT The Arctic University of Tromso	Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2006, Australia.	david.lecouteur@sydney.edu.au	Huser, Thomas/K-7291-2019; Quinn, Ronald J/A-7931-2008; Research Institute, ANZAC/CAE-9030-2022; Zencak, Dusan/K-8383-2012	Huser, Thomas/0000-0003-2348-7416; Quinn, Ronald J/0000-0002-4022-2623; Le Couteur, David/0000-0002-4227-5817; Crane, Harry/0000-0001-5001-3123	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney); National Health and Medical Research Foundation of Australia [570937]; Tromso, Research Foundation	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney); National Health and Medical Research Foundation of Australia(National Health and Medical Research Council (NHMRC) of Australia); Tromso, Research Foundation	Ageing and Alzheimers Research Foundation (a Division the Sydney Medical School Foundation of the University of Sydney http://www.cera.usyd.edu.au/news_aarf.html), National Health and Medical Research Foundation of Australia (nhmrc.gov.au grant number 570937) and the Tromso, Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicout DJ, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.060101; Braet F, 1998, P NATL ACAD SCI USA, V95, P13635, DOI 10.1073/pnas.95.23.13635; Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Cogger VC, 2009, LIVER BIOL PATHOBIOL, P387; Cogger VC, 2008, AM J PHYSIOL-GASTR L, V295, pG137, DOI 10.1152/ajpgi.00069.2008; Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025; Cogger VC, 2010, J STRUCT BIOL, V171, P382, DOI 10.1016/j.jsb.2010.06.001; Funyu J, 2001, BIOCHEM BIOPH RES CO, V280, P481, DOI 10.1006/bbrc.2000.4148; Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937; Kahn E, 2011, CYTOM PART A, V79A, P293, DOI 10.1002/cyto.a.21017; Kahn E, 2010, INT J NANOMED, V5, P185; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004; Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553; Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loison C, 2004, J CHEM PHYS, V121, P1890, DOI 10.1063/1.1752884; Mrowczynska L, 2011, CELL BIOL INT, V35, P991, DOI 10.1042/CBI20100786; O'Reilly JN, 2010, J ELECTRON MICROSC, V59, P65, DOI 10.1093/jmicro/dfp039; Owen DM, 2010, IMMUNOLOGY, V131, P1, DOI 10.1111/j.1365-2567.2010.03319.x; Owen DM, 2010, MICROSC RES TECHNIQ, V73, P618, DOI 10.1002/jemt.20801; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Rubtsova SN, 1998, FEBS LETT, V430, P353, DOI 10.1016/S0014-5793(98)00692-9; STEFFAN AM, 1987, HEPATOLOGY, V7, P1230, DOI 10.1002/hep.1840070610; Vind-Kezunovic D, 2008, BBA-BIOMEMBRANES, V1778, P2480, DOI 10.1016/j.bbamem.2008.05.015; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; Warren A, 2010, MICROCIRCULATION, V17, P32, DOI 10.1111/j.1549-8719.2009.00004.x; Yokomori H, 2004, LAB INVEST, V84, P857, DOI 10.1038/labinvest.3700114; Yokomori H, 2003, LIVER INT, V23, P467, DOI 10.1111/j.1478-3231.2003.00880.x; Yokomori H, 2001, LIVER, V21, P198, DOI 10.1034/j.1600-0676.2001.021003198.x	36	55	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46134	10.1371/journal.pone.0046134	http://dx.doi.org/10.1371/journal.pone.0046134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029409	Green Submitted, Green Published, gold			2022-12-25	WOS:000309554700117
J	Boddy, LM; Thomas, NE; Fairclough, SJ; Tolfrey, K; Brophy, S; Rees, A; Knox, G; Baker, JS; Stratton, G				Boddy, Lynne M.; Thomas, Non E.; Fairclough, Stuart J.; Tolfrey, Keith; Brophy, Sinead; Rees, Anwen; Knox, Gareth; Baker, Julien S.; Stratton, Gareth			ROC Generated Thresholds for Field-Assessed Aerobic Fitness Related to Body Size and Cardiometabolic Risk in Schoolchildren	PLOS ONE			English	Article							METABOLIC RISK; CHILDREN; FATNESS; OBESITY; ADOLESCENTS; CHILDHOOD; WORLDWIDE	Objectives: 1. to investigate whether 20 m multi-stage shuttle run performance (20mSRT), an indirect measure of aerobic fitness, could discriminate between healthy and overweight status in 9-10.9 yr old schoolchildren using Receiver Operating Characteristic (ROC) analysis; 2. Investigate if cardiometabolic risk differed by aerobic fitness group by applying the ROC cut point to a second, cross-sectional cohort. Design: Analysis of cross-sectional data. Participants: 16,619 9-10.9 year old participants from SportsLinx project and 300 11-13.9 year old participants from the Welsh Schools Health and Fitness Study. Outcome Measures: SportsLinx; 20mSRT, body mass index (BMI), waist circumference, subscapular and superilliac skinfold thicknesses. Welsh Schools Health and Fitness Study; 20mSRT performance, waist circumference, and clustered cardiometabolic risk. Analyses: Three ROC curve analyses were completed, each using 20mSRT performance with ROC curve 1 related to BMI, curve 2 was related to waist circumference and 3 was related to skinfolds (estimated % body fat). These were repeated for both girls and boys. The mean of the three aerobic fitness thresholds was retained for analysis. The thresholds were subsequently applied to clustered cardiometabolic risk data from the Welsh Schools study to assess whether risk differed by aerobic fitness group. Results: The diagnostic accuracy of the ROC generated thresholds was higher than would be expected by chance (all models AUC>0.7). The mean thresholds were 33 and 25 shuttles for boys and girls respectively. Participants classified as 'fit' had significantly lower cardiometabolic risk scores in comparison to those classed as unfit (p<0.001). Conclusion: The use of the ROC generated cut points by health professionals, teachers and coaches may provide the opportunity to apply population level 'risk identification and stratification' processes and plan for "at-risk" children to be referred onto intervention services.	[Boddy, Lynne M.; Fairclough, Stuart J.; Stratton, Gareth] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England; [Thomas, Non E.; Brophy, Sinead] Swansea Univ, Coll Human & Hlth Sci, Ctr Children & Young Peoples Well Being, Swansea, W Glam, Wales; [Tolfrey, Keith] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Leicester, Leics, England; [Rees, Anwen; Knox, Gareth] Cardiff Metropolitan Univ, Cardiff Sch Sport, Cardiff, S Glam, Wales; [Knox, Gareth] Univ W England, Hartpury Coll, Dept Business & Appl Sport Sci, Gloucester, England; [Stratton, Gareth] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Stratton, Gareth] Univ Western Australia, Sch Sports Sci Exercise & Hlth, Perth, WA 6009, Australia	Liverpool John Moores University; Swansea University; Loughborough University; Cardiff Metropolitan University; University of West England; Swansea University; University of Western Australia	Boddy, LM (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England.	L.M.Boddy@ljmu.ac.uk	Fairclough, Stuart/AAE-8512-2020; Fairclough, Stuart/F-8900-2015; stratton, Gareth/Z-5471-2019	Fairclough, Stuart/0000-0001-8358-1979; Fairclough, Stuart/0000-0001-8358-1979; stratton, Gareth/0000-0001-5618-0803; Brophy, Sinead/0000-0001-7417-2858; Tolfrey, Keith/0000-0001-6269-1538; Boddy, Lynne/0000-0002-7477-4389	Liverpool John Moores University; Liverpool City Council; Liverpool Primary Care Trust; National Institute for Social Care and Health Research within the Welsh Assembly Government.; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI	Liverpool John Moores University; Liverpool City Council; Liverpool Primary Care Trust; National Institute for Social Care and Health Research within the Welsh Assembly Government.; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The SportsLinx study was funded by Liverpool John Moores University, Liverpool City Council, and Liverpool Primary Care Trust. The Welsh Schools Health and Fitness study was funded by the National Institute for Social Care and Health Research within the Welsh Assembly Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 1998, EUROFIT EUROPEAN TES; Adegboye ARA, 2011, BRIT J SPORT MED, V45, P722, DOI 10.1136/bjsm.2009.068346; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; Berthoin S., 2010, CHILDREN EXERCISE 25, P213; Boddy LM, 2010, J HUM NUTR DIET, V23, P254, DOI 10.1111/j.1365-277X.2009.01025.x; Boddy LM, 2012, MED SCI SPORT EXER, V44, P481, DOI 10.1249/MSS.0b013e3182300267; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Department of Health, 2011, START ACT STAY ACT R; Department of Health, 2009, ANN REP CHIEF MED OF; Eisenmann JC, 2007, INT J PEDIATR OBES, P1; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Rees A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-86; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; TAYLOR S, 2004, ED HLTH, V22, P3; Welk GJ, 2011, AM J PREV MED, V41, pS111, DOI 10.1016/j.amepre.2011.07.007; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358	22	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45755	10.1371/journal.pone.0045755	http://dx.doi.org/10.1371/journal.pone.0045755			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029224	gold, Green Published			2022-12-25	WOS:000309392800092
J	Duarte, A; Poderoso, C; Cooke, M; Soria, G; Maciel, FC; Gottifredi, V; Podesta, EJ				Duarte, Alejandra; Poderoso, Cecilia; Cooke, Mariana; Soria, Gaston; Maciel, Fabiana Cornejo; Gottifredi, Vanesa; Podesta, Ernesto J.			Mitochondrial Fusion Is Essential for Steroid Biosynthesis	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; ACYL-COA SYNTHETASE-4; RAT ADRENAL-GLAND; ARACHIDONIC-ACID; STAR PROTEIN; STIMULATED STEROIDOGENESIS; LH/CHORIONIC GONADOTROPIN; CHOLESTEROL TRANSPORT; REGULATORY PROTEIN; CELLS	Although the contribution of mitochondrial dynamics (a balance in fusion/fission events and changes in mitochondria subcellular distribution) to key biological process has been reported, the contribution of changes in mitochondrial fusion to achieve efficient steroid production has never been explored. The mitochondria are central during steroid synthesis and different enzymes are localized between the mitochondria and the endoplasmic reticulum to produce the final steroid hormone, thus suggesting that mitochondrial fusion might be relevant for this process. In the present study, we showed that the hormonal stimulation triggers mitochondrial fusion into tubular-shaped structures and we demonstrated that mitochondrial fusion does not only correlate-with but also is an essential step of steroid production, being both events depend on PKA activity. We also demonstrated that the hormone-stimulated relocalization of ERK1/2 in the mitochondrion, a critical step during steroidogenesis, depends on mitochondrial fusion. Additionally, we showed that the SHP2 phosphatase, which is required for full steroidogenesis, simultaneously modulates mitochondrial fusion and ERK1/2 localization in the mitochondrion. Strikingly, we found that mitofusin 2 (Mfn2) expression, a central protein for mitochondrial fusion, is upregulated immediately after hormone stimulation. Moreover, Mfn2 knockdown is sufficient to impair steroid biosynthesis. Together, our findings unveil an essential role for mitochondrial fusion during steroidogenesis. These discoveries highlight the importance of organelles' reorganization in specialized cells, prompting the exploration of the impact that organelle dynamics has on biological processes that include, but are not limited to, steroid synthesis.	[Duarte, Alejandra; Poderoso, Cecilia; Cooke, Mariana; Maciel, Fabiana Cornejo; Podesta, Ernesto J.] Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Biomed INBIOMED,CONICET, Buenos Aires, DF, Argentina; [Soria, Gaston; Gottifredi, Vanesa] Univ Buenos Aires, Fdn Inst Leloir, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Podesta, EJ (corresponding author), Univ Buenos Aires, Sch Med, Dept Human Biochem, Inst Invest Biomed INBIOMED,CONICET, Buenos Aires, DF, Argentina.	biohrdc@fmed.uba.ar	Cooke, Mariana/ABD-5051-2021; Gottifredi, Vanesa/AAI-1788-2019; Cooke, Mariana/V-1375-2019	Gottifredi, Vanesa/0000-0001-9656-5951; CORNEJO MACIEL, MARIA FABIANA/0000-0003-0685-9038; Cooke, Mariana/0000-0001-9300-8447	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) to E.J.P., V.G. and C.P.; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to E.J.P.; and Universidad de Buenos Aires (UBA) to E.J.P., F.C.M. and C.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; CHAN YL, 1987, J BIOL CHEM, V262, P1111; Cooke M, 2011, MOL CELL ENDOCRINOL, V336, P63, DOI 10.1016/j.mce.2010.11.030; CRIVELLO JF, 1980, J BIOL CHEM, V255, P8144; de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Garren L D, 1971, Recent Prog Horm Res, V27, P433; Hall PF, 1997, MICROSC RES TECHNIQ, V36, P463, DOI 10.1002/(SICI)1097-0029(19970315)36:6<463::AID-JEMT4>3.0.CO;2-J; Han JD, 1996, J BIOL CHEM, V271, P29211, DOI 10.1074/jbc.271.46.29211; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046; King SR, 1999, J STEROID BIOCHEM, V69, P143, DOI 10.1016/S0960-0760(98)00152-6; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Maciel FC, 2005, J MOL ENDOCRINOL, V34, P655, DOI 10.1677/jme.1.01691; Maciel FC, 2001, J ENDOCRINOL, V170, P403, DOI 10.1677/joe.0.1700403; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Maloberti P, 2002, EUR J BIOCHEM, V269, P5599, DOI 10.1046/j.1432-1033.2002.03267.x; Manes S, 1999, MOL CELL BIOL, V19, P3125; Martin SJ, 2011, DEV CELL, V20, P142, DOI 10.1016/j.devcel.2011.01.016; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mikkola R, 1999, EUR J BIOCHEM, V263, P112, DOI 10.1046/j.1432-1327.1999.00476.x; Nakada K, 2001, BIOCHEM BIOPH RES CO, V288, P743, DOI 10.1006/bbrc.2001.5838; Paz C, 2002, J ENDOCRINOL, V175, P793, DOI 10.1677/joe.0.1750793; Paz C, 1999, EUR J BIOCHEM, V265, P911, DOI 10.1046/j.1432-1327.1999.00759.x; Poderoso C, 2002, ENDOCR RES, V28, P413, DOI 10.1081/ERC-120016816; Poderoso C, 2009, MOL CELL ENDOCRINOL, V300, P37, DOI 10.1016/j.mce.2008.10.009; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; RAE PA, 1979, P NATL ACAD SCI USA, V76, P1896, DOI 10.1073/pnas.76.4.1896; Rocchi S, 2000, BIOCHEM J, V352, P483, DOI 10.1042/0264-6021:3520483; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Schimmer B P, 1979, Methods Enzymol, V58, P570; Schimmer B P, 1980, Adv Cyclic Nucleotide Res, V13, P181; SIMPSON ER, 1983, CAN J BIOCHEM CELL B, V61, P692, DOI 10.1139/o83-088; Wang XJ, 2003, J STEROID BIOCHEM, V85, P159, DOI 10.1016/S0960-0760(03)00189-4; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	51	79	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45829	10.1371/journal.pone.0045829	http://dx.doi.org/10.1371/journal.pone.0045829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029265	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800102
J	Ottenhoff, THM; Dass, RH; Yang, NH; Zhang, MZM; Wong, HEE; Sahiratmadja, E; Khor, CC; Alisjahbana, B; van Crevel, R; Marzuki, S; Seielstad, M; van de Vosse, E; Hibberd, ML				Ottenhoff, Tom H. M.; Dass, Ranjeeta Hari; Yang, Ninghan; Zhang, Mingzi M.; Wong, Hazel E. E.; Sahiratmadja, Edhyana; Khor, Chiea Chuen; Alisjahbana, Bachti; van Crevel, Reinout; Marzuki, Sangkot; Seielstad, Mark; van de Vosse, Esther; Hibberd, Martin L.			Genome-Wide Expression Profiling Identifies Type 1 Interferon Response Pathways in Active Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INFECTION; DISEASE; CELLS; PATTERNS; GENES; ISG15	Tuberculosis (TB), caused by Mycobacterium tuberculosis (M.tb), remains the leading cause of mortality from a single infectious agent. Each year around 9 million individuals newly develop active TB disease, and over 2 billion individuals are latently infected with M.tb worldwide, thus being at risk of developing TB reactivation disease later in life. The underlying mechanisms and pathways of protection against TB in humans, as well as the dynamics of the host response to M.tb infection, are incompletely understood. We carried out whole-genome expression profiling on a cohort of TB patients longitudinally sampled along 3 time-points: during active infection, during treatment, and after completion of curative treatment. We identified molecular signatures involving the upregulation of type-1 interferon (alpha/beta\) mediated signaling and chronic inflammation during active TB disease in an Indonesian population, in line with results from two recent studies in ethnically and epidemiologically different populations in Europe and South Africa. Expression profiles were captured in neutrophil-depleted blood samples, indicating a major contribution of lymphocytes and myeloid cells. Expression of type-1 interferon (alpha/beta) genes mediated was also upregulated in the lungs of M.tb infected mice and in infected human macrophages. In patients, the regulated gene expression-signature normalized during treatment, including the type-1 interferon mediated signaling and a concurrent opposite regulation of interferon-gamma. Further analysis revealed IL15RA, UBE2L6 and GBP4 as molecules involved in the type-I interferon response in all three experimental models. Our data is highly suggestive that the innate immune type-I interferon signaling cascade could be used as a quantitative tool for monitoring active TB disease, and provide evidence that components of the patient's blood gene expression signature bear similarities to the pulmonary and macrophage response to mycobacterial infection.	[Ottenhoff, Tom H. M.; van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Dass, Ranjeeta Hari; Yang, Ninghan; Zhang, Mingzi M.; Wong, Hazel E. E.; Khor, Chiea Chuen; Seielstad, Mark; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Marzuki, Sangkot] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Sahiratmadja, Edhyana; Alisjahbana, Bachti] Padjadjaran State Univ, Hlth Res Unit, Hasan Sadikin Hosp, Fac Med, Bandung, Indonesia; [van Crevel, Reinout] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Eijkman Institute; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; Radboud University Nijmegen	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	t.h.m.ottenhoff@lumc.nl; hibberdml@gis.a-star.edu.sg	van Crevel, reinout/A-6636-2010; Hibberd, Martin L/D-5050-2009; van de Vosse, Esther/HDO-0723-2022; van de Vosse, Esther/B-7285-2009; Seielstad, Mark/T-7841-2019	van Crevel, reinout/0000-0002-6233-6410; van de Vosse, Esther/0000-0001-5199-3426; Hibberd, Martin/0000-0001-8587-1849; Zhang, Mingzi/0000-0002-1213-3340; Khor, Chiea Chuen/0000-0002-1128-4729; Seielstad, Mark/0000-0001-5783-1401; Sahiratmadja, Edhyana/0000-0001-9092-5848	Netherlands' Organization of Scientific Research (NWO); Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP [GC6 74]; Bill and Melinda Gates Foundation Grand Challenges in Global Health; Netherlands Leprosy Relief Foundation; Q.M. Gastmann Wichers Foundation; European Union's Seventh Framework Programme [FP7] for project NEWTBVAC; European Union's Seventh Framework Programme [FP7] for project IDEA; European Union's Seventh Framework Programme [FP7] for project ADITEC [280873]	Netherlands' Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP; Bill and Melinda Gates Foundation Grand Challenges in Global Health(Bill & Melinda Gates Foundation); Netherlands Leprosy Relief Foundation; Q.M. Gastmann Wichers Foundation; European Union's Seventh Framework Programme [FP7] for project NEWTBVAC; European Union's Seventh Framework Programme [FP7] for project IDEA; European Union's Seventh Framework Programme [FP7] for project ADITEC	The authors gratefully acknowledge the support of the following organizations: the Netherlands' Organization of Scientific Research (NWO); the Royal Netherlands' Academy of Arts and Sciences (KNAW); WOTRO/NACCAP; the Bill and Melinda Gates Foundation Grand Challenges in Global Health (grant GC6#74); the Netherlands Leprosy Relief Foundation; the Q.M. Gastmann Wichers Foundation. The research also received funding from the European Union's Seventh Framework Programme [FP7/2007-2013] for projects NEWTBVAC; IDEA; and ADITEC (No: 280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2010, EUR J IMMUNOL, V40, P291, DOI 10.1002/eji.200939856; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; de Jong R, 1998, SCIENCE, V280, P1435; de Paus RA, 2012, INHIBITION TYP UNPUB; DECKER T, 1991, MOL CELL BIOL, V11, P5147, DOI 10.1128/MCB.11.10.5147; Desvignes L, 2012, J IMMUNOL, V188, P6205, DOI 10.4049/jimmunol.1200255; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jeon YJ, 2009, EMBO REP, V10, P374, DOI 10.1038/embor.2009.23; Joosten SA, 2012, GENES IMMUN, V13, P71, DOI 10.1038/gene.2011.64; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kuchtey J, 2006, IMMUNOLOGY, V118, P39, DOI 10.1111/j.1365-2567.2006.02337.x; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Levin M, 2000, MICROBES INFECT, V2, P1549, DOI 10.1016/S1286-4579(00)01310-1; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; Ottenhoff THM, 2012, TRENDS MICROBIOL, V2012; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Ottenhoff THM, 2012, TUBERCULOSIS, V92, pS17, DOI 10.1016/S1472-9792(12)70007-0; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Raviglione MC, 2003, TUBERCULOSIS, V83, P4, DOI 10.1016/S1472-9792(02)00071-9; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schafer G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008448; Schuck SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005590; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; van de Wetering D, 2011, CLIN IMMUNOL, V138, P282, DOI 10.1016/j.clim.2010.12.005; Wong RL, 2011, PROTEIN ENG DES SEL, V24, P373, DOI 10.1093/protein/gzq116; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101	39	165	168	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45839	10.1371/journal.pone.0045839	http://dx.doi.org/10.1371/journal.pone.0045839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029268	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000309392800104
J	Wang, Y; Guo, TT; Zhao, SY; Li, ZX; Mao, YQ; Li, H; Wang, X; Wang, R; Xu, W; Song, RJ; Jin, L; Li, XL; Irwin, DM; Niu, G; Tan, HR				Wang, Yi; Guo, Tingting; Zhao, Shuyong; Li, Zhixin; Mao, Yiqing; Li, Hui; Wang, Xi; Wang, Rong; Xu, Wei; Song, Rongjing; Jin, Ling; Li, Xiuli; Irwin, David M.; Niu, Gang; Tan, Huanran			Expression of the Human Glucokinase Gene: Important Roles of the 5 ' Flanking and Intron 1 Sequences	PLOS ONE			English	Article							I-HYPERSENSITIVE SITES; ELEMENT-BINDING PROTEIN-1C; GENOMIC DNA-SEQUENCES; MAMMALIAN GLUCOKINASE; PRIMARY HEPATOCYTES; LIVER; INSULIN; IDENTIFICATION; TRANSCRIPTION; INDUCTION	Background: Glucokinase plays important tissue-specific roles in human physiology, where it acts as a sensor of blood glucose levels in the pancreas, and a few other cells of the gut and brain, and as the rate-limiting step in glucose metabolism in the liver. Liver-specific expression is driven by one of the two tissue-specific promoters, and has an absolute requirement for insulin. The sequences that mediate regulation by insulin are incompletely understood. Methodology/Principal Findings: To better understand the liver-specific expression of the human glucokinase gene we compared the structures of this gene from diverse mammals. Much of the sequence located between the 5' pancreatic beta-cell-specific and downstream liver-specific promoters of the glucokinase genes is composed of repetitive DNA elements that were inserted in parallel on different mammalian lineages. The transcriptional activity of the liver-specific promoter 5' flanking sequences were tested with and without downstream intronic sequences in two human liver cells lines, HepG2 and L-02. While glucokinase liver-specific 5' flanking sequences support expression in liver cell lines, a sequence located about 2000 bases 3' to the liver-specific mRNA start site represses gene expression. Enhanced reporter gene expression was observed in both cell lines when cells were treated with fetal calf serum, but only in the L-02 cells was expression enhanced by insulin. Conclusions/Significance: Our results suggest that the normal liver L-02 cell line may be a better model to understand the regulation of the liver-specific expression of the human glucokinase gene. Our results also suggest that sequences downstream of the liver-specific mRNA start site have important roles in the regulation of liver-specific glucokinase gene expression.	[Wang, Yi; Guo, Tingting; Zhao, Shuyong; Li, Zhixin; Mao, Yiqing; Li, Hui; Wang, Xi; Wang, Rong; Xu, Wei; Song, Rongjing; Jin, Ling; Irwin, David M.; Tan, Huanran] Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China; [Li, Xiuli] Chifeng Coll, Dept Pharmacol, Chifeng, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Niu, Gang] Beijing N&N Genetech Co, Beijing, Peoples R China	Peking University; Chifeng University; University of Toronto	Irwin, DM (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Pharmacol, Beijing 100871, Peoples R China.	david.irwin@utoronto.ca; tanlab@bjmu.edu.cn		Irwin, David/0000-0001-6131-4933; Jin, Ling/0000-0002-0687-9234	National Natural Science Foundation of China (NSFC) [30772603]; National Key Technologies RD Program [2006BAF07B01, 2009BAK61B01, 2009BAK61B04]; National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative [81061120525, CCI-109605]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from the National Natural Science Foundation of China (NSFC) Grant Number 30772603, National Key Technologies R&D Program (Grant Numbers 2006BAF07B01, 2009BAK61B01, and 2009BAK61B04), and a grant from the National Science Foundation of China - Canadian Institutes of Health Research China-Canada Joint Health Research Initiative (Grant Numbers 81061120525 and CCI-109605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Berrougui H, 2012, REJUV RES, V12, P117; BOSSARD P, 1993, EUR J BIOCHEM, V215, P883, DOI 10.1111/j.1432-1033.1993.tb18106.x; Cha JY, 2001, EXP MOL MED, V33, P59, DOI 10.1038/emm.2001.11; D'Alessio JA, 2011, P NATL ACAD SCI USA, V108, P3906, DOI 10.1073/pnas.1100640108; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029; Gregori C, 2006, FEBS LETT, V580, P410, DOI 10.1016/j.febslet.2005.12.032; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Hansmannel F, 2006, BIOCHEM J, V399, P275, DOI 10.1042/BJ20060811; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Iynedjian PB, 1996, J BIOL CHEM, V271, P29113, DOI 10.1074/jbc.271.46.29113; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lannoy VJ, 2002, DIABETOLOGIA, V45, P1136, DOI 10.1007/s00125-002-0856-z; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Parsa R, 1996, EUR J BIOCHEM, V236, P214, DOI 10.1111/j.1432-1033.1996.00214.x; POSTIC C, 1995, GENOMICS, V29, P740, DOI 10.1006/geno.1995.9943; Postic C, 2001, RECENT PROG HORM RES, V56, P195, DOI 10.1210/rp.56.1.195; Poupeau A, 2011, BBA-MOL BASIS DIS, V1812, P995, DOI 10.1016/j.bbadis.2011.03.015; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Sawka-Verhelle D, 2000, ENDOCRINOLOGY, V141, P1977, DOI 10.1210/en.141.6.1977; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; SHELTON KD, 1992, MOL CELL BIOL, V12, P4578, DOI 10.1128/MCB.12.10.4578; Smit A, 1996, REPEATMASKER OPEN 30; Steck AK, 2011, CURR OPIN ENDOCRINOL, V18, P252, DOI 10.1097/MED.0b013e3283488275; TANIZAWA Y, 1992, MOL ENDOCRINOL, V6, P1070, DOI 10.1210/me.6.7.1070; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; URETA T, 1981, COMP BIOCHEM PHYS B, V70, P225, DOI 10.1016/0305-0491(81)90038-9; YEH HJ, 1980, ACTA BIOL EXP SINICA, V13, P361; Zhu LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE1210, DOI 10.1152/ajpendo.00633.2009	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45824	10.1371/journal.pone.0045824	http://dx.doi.org/10.1371/journal.pone.0045824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029263	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900105
J	Sopel, MJ; Rosin, NL; Falkenham, AG; Bezuhly, M; Esmon, CT; Lee, TDG; Liwski, RS; Legare, JF				Sopel, Mryanda J.; Rosin, Nicole L.; Falkenham, Alec G.; Bezuhly, Michael; Esmon, Charles T.; Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois			Treatment with Activated Protein C (aPC) Is Protective during the Development of Myocardial Fibrosis: An Angiotensin II Infusion Model in Mice	PLOS ONE			English	Article							SEVERE SEPSIS; CIRCULATING FIBROCYTES; ISCHEMIA-REPERFUSION; CELLULAR MECHANISMS; PERIPHERAL-BLOOD; MEDIATE FIBROSIS; TRIAL ENHANCE; RECEPTOR; EXPRESSION; SURVIVAL	Aims: Myocardial fibrosis contributes to the development of heart failure. Activated Protein C (aPC) is a circulating anticoagulant with anti-inflammatory and cytoprotective properties. Using a model of myocardial fibrosis second to Angiotensin II (AngII) infusion, we investigated the novel therapeutic function aPC in the development of fibrosis. Methods and Results: C57Bl/6 and Tie2-EPCR mice were infused with AngII (2.0 mu g/kg/min), AngII and aPC (0.4 mu g/kg/min) or saline for 3d. Hearts were harvested and processed for analysis or used for cellular isolation. Basic histology and collagen deposition were assessed using histologic stains. Transcript levels of molecular mediators were analyzed by quantitative RTPCR. Mice infused with AngII exhibited multifocal areas of myocardial cellular infiltration associated with significant collagen deposition compared to saline control animals (p<0.01). AngII-aPC infusion inhibited this cellular infiltration and the corresponding collagen deposition. AngII-aPC infusion also inhibited significant expression of the pro-fibrotic cytokines TGF-beta 1, CTGF and PDGF found in AngII only infused animals (p<0.05). aPC signals through its receptor, EPCR. Using Tie2-EPCR animals, where endothelial cells over-express EPCR and exhibit enhanced aPC-EPCR signaling, no significant reduction in cellular infiltration or fibrosis was evident with AngII infusion suggesting aPC-mediate protection is endothelial cell independent. Isolated infiltrating cells expressed significant EPCR transcripts suggesting a direct effect on infiltrating cells. Conclusions: This data indicates that aPC treatment abrogates the fibrogenic response to AngII. aPC does not appear to confer protection by stimulating the endothelium but by acting directly on the infiltrating cells, potentially inhibiting migration or activation.	[Sopel, Mryanda J.; Rosin, Nicole L.; Falkenham, Alec G.; Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Bezuhly, Michael; Lee, Timothy D. G.; Legare, Jean-Francois] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada; [Lee, Timothy D. G.; Liwski, Robert S.; Legare, Jean-Francois] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA; [Esmon, Charles T.] Cardiovasc Biol Res Program, Oklahoma City, OK USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Dalhousie University; Dalhousie University; Dalhousie University; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Liwski, RS (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	rliwski@dal.ca; jean.legare@cdha.nshealth.ca		Bezuhly, Michael/0000-0002-7356-5147	Nova Scotia Health Research Foundation [42311]; Canadian Institute of Health Research [44122]; Astellas [43742]	Nova Scotia Health Research Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Astellas(Astellas Pharmaceuticals)	This work was supported by a grant from the Nova Scotia Health Research Foundation (#42311 to J.F.L. http://www.nshrf.ca/); the Canadian Institute of Health Research (#44122 to J.F.L. http://www.cihr-irsc.gc.ca/e/193.html); and an investigator initiated research grant from Astellas (#43742 to R.S.L. http://www.astellas.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bezuhly M, 2009, PLAST RECONSTR SURG, V123, P502, DOI 10.1097/PRS.0b013e318196b87f; Bezuhly M, 2009, BLOOD, V113, P3371, DOI 10.1182/blood-2008-05-159434; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Chesney J, 1998, J IMMUNOL, V160, P419; Chu PY, 2010, AM J PATHOL, V176, P1735, DOI 10.2353/ajpath.2010.090574; Dillon JP, 2005, J ORTHOP RES, V23, P1454, DOI 10.1016/j.orthres.2005.04.009; Ding JW, 2010, J KOREAN MED SCI, V25, P1609, DOI 10.3346/jkms.2010.25.11.1609; Doughty RN, 1997, EUR HEART J, V18, P560; Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35; Fabris B, 2007, J HYPERTENS, V25, P1481, DOI 10.1097/HJH.0b013e328121aae7; Galligan L, 2001, BRIT J HAEMATOL, V115, P408, DOI 10.1046/j.1365-2141.2001.03187.x; Gillibert-Duplantier J, 2010, WORLD J GASTROENTERO, V16, P210, DOI 10.3748/wjg.v16.i2.210; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hoffmann JN, 2004, CRIT CARE MED, V32, P1011, DOI 10.1097/01.CCM.0000120058.88975.42; Ireland H, 1997, CIRCULATION, V96, P15; Kelly DJ, 2004, HYPERTENSION, V44, P195, DOI 10.1161/01.HYP.0000132883.20764.12; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kim S, 2000, PHARMACOL REV, V52, P11; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198; Marian AJ, 2009, J CARDIOVASC TRANSL, V2, P483, DOI 10.1007/s12265-009-9132-7; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Mizutani A, 2000, BLOOD, V95, P3781; Neyrinck AP, 2009, BRIT J PHARMACOL, V158, P1034, DOI 10.1111/j.1476-5381.2009.00251.x; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pirat B, 2007, CORONARY ARTERY DIS, V18, P61, DOI 10.1097/MCA.0b013e328010a44a; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; SAMANI NJ, 1994, LANCET, V344, P1709, DOI 10.1016/S0140-6736(94)90495-2; Sopel M, 2012, INT J EXP PATHOL, V93, P115, DOI 10.1111/j.1365-2613.2011.00797.x; Sopel M, 2010, J INVEST SURG, V23, P79, DOI 10.3109/08941930903469425; Sturn DH, 2003, BLOOD, V102, P1499, DOI 10.1182/blood-2002-12-3880; van Sluis GL, 2011, CANCER LETT, V306, P106, DOI 10.1016/j.canlet.2011.02.038; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Xue ML, 2007, ANN RHEUM DIS, V66, P1574, DOI 10.1136/ard.2006.068239; Yasui H, 2001, AM J RESP CRIT CARE, V163, P1660, DOI 10.1164/ajrccm.163.7.9911068	39	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e45663	10.1371/journal.pone.0045663	http://dx.doi.org/10.1371/journal.pone.0045663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23029168	Green Submitted, Green Published, gold			2022-12-25	WOS:000309388400118
J	Blainey, PC; Graziano, V; Perez-Berna, AJ; McGrath, WJ; Flint, SJ; Martin, CS; Xie, XS; Mangel, WF				Blainey, Paul C.; Graziano, Vito; Perez-Berna, Ana J.; McGrath, William J.; Flint, S. Jane; San Martin, Carmen; Xie, X. Sunney; Mangel, Walter F.			Regulation of a Viral Proteinase by a Peptide and DNA in One-dimensional Space IV. VIRAL PROTEINASE SLIDES ALONG DNA TO LOCATE AND PROCESS ITS SUBSTRATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ADENOVIRUS PROTEINASE; BINDING; PROTEASE; PERFORMANCE; ACTIVATION; DIFFUSION; COFACTORS; DYNAMICS; CONTACT; LINKING	Precursor proteins used in the assembly of adenovirus virions must be processed by the virally encoded adenovirus proteinase (AVP) before the virus particle becomes infectious. An activated adenovirus proteinase, the AVP-pVIc complex, was shown to slide along viral DNA with an extremely fast one-dimensional diffusion constant, 21.0 +/- 1.9 x 10(6) bp(2)/s. In principle, one-dimensional diffusion can provide a means for DNA-bound proteinases to locate and process DNA-bound substrates. Here, we show that this is correct. In vitro, AVP-pVIc complexes processed a purified virion precursor protein in a DNA-dependent reaction; in a quasi in vivo environment, heat-disrupted ts-1 virions, AVP-pVIc complexes processed five different precursor proteins in DNA-dependent reactions. Sliding of AVP-pVIc complexes along DNA illustrates a new biochemical mechanism by which a proteinase can locate its substrates, represents a new paradigm for virion maturation, and reveals a new way of exploiting the surface of DNA.	[Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Graziano, Vito; McGrath, William J.; Mangel, Walter F.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Perez-Berna, Ana J.; San Martin, Carmen] CSIC, CNB, Dept Macromol Struct, E-28049 Madrid, Spain; [Flint, S. Jane] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Harvard University; United States Department of Energy (DOE); Brookhaven National Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Princeton University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu; mangel@bnl.gov	San Martín, Carmen/A-4074-2010; Perez-Berna, Ana/G-2789-2016	San Martín, Carmen/0000-0001-9799-175X; McGrath, William/0000-0002-9375-624X; Perez-Berna, Ana/0000-0003-4145-532X; Blainey, Paul/0000-0002-4889-8783	National Institutes of Health [R01AI41599, GM037705]; National Institutes of Health; National Science Foundation; Ministerio de Ciencia e Innovacion of Spain [BFU2010-16382, FIS2010-10552-E]; Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041599, R21AI113565] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037705] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva from the Ministerio de Ciencia e Innovacion of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI41599 (to W. F. M.) and GM037705 (to S. J. F.) and the National Institutes of Health Director's Pioneer Award and a National Science Foundation (to X. S. X.) This work was also supported by Grants BFU2010-16382 and FIS2010-10552-E from the Ministerio de Ciencia e Innovacion of Spain (to C. S. M.).; The recipient of a Juan de la Cierva postdoctoral contract from the Ministerio de Ciencia e Innovacion of Spain.	Bagchi B, 2008, J PHYS CHEM B, V112, P6282, DOI 10.1021/jp077568f; Bajpayee NS, 2005, BIOCHEMISTRY-US, V44, P8721, DOI 10.1021/bi0502240; Baniecki ML, 2001, BIOCHEMISTRY-US, V40, P12349, DOI 10.1021/bi0109008; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Brown MT, 1996, FEBS LETT, V388, P233, DOI 10.1016/0014-5793(96)00569-8; Casjens S., 1997, STRUCTURAL BIOL VIRU, P3; CHATTERJEE PK, 1986, J MOL BIOL, V188, P23, DOI 10.1016/0022-2836(86)90477-8; Cooper M, 2004, J FLUORESC, V14, P145, DOI 10.1023/B:JOFL.0000016286.62641.59; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Doyle PS, 2000, PHYS REV LETT, V84, P4769, DOI 10.1103/PhysRevLett.84.4769; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gowers DM, 2005, P NATL ACAD SCI USA, V102, P15883, DOI 10.1073/pnas.0505378102; Graziano V, 2013, J BIOL CHEM, V288, P2059, DOI 10.1074/jbc.M112.377150; Graziano V, 2013, J BIOL CHEM, V288, P2068, DOI 10.1074/jbc.M112.407312; Greber UF, 1998, REV MED VIROL, V8, P213; Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m; Gupta S, 2004, MOL CELL PROTEOMICS, V3, P950, DOI 10.1074/mcp.M400037-MCP200; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Komazin-Meredith G, 2008, P NATL ACAD SCI USA, V105, P10721, DOI 10.1073/pnas.0802676105; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; Mangel WF, 1996, J BIOL CHEM, V271, P536, DOI 10.1074/jbc.271.1.536; Mangenot S, 2003, BIOPHYS J, V85, P1817, DOI 10.1016/S0006-3495(03)74610-4; McGrath WJ, 2002, VIROLOGY, V296, P234, DOI 10.1006/viro.2002.1394; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P13237, DOI 10.1021/bi0111653; McGrath WJ, 2001, BIOCHEMISTRY-US, V40, P14468, DOI 10.1021/bi011562d; MURPHY LD, 1995, BIOPHYS CHEM, V57, P71, DOI 10.1016/0301-4622(95)00047-2; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Russell W C, 1967, J Gen Virol, V1, P509, DOI 10.1099/0022-1317-1-4-509; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; Schroeder C. M., 2008, SINGLE MOL TECHNIQUE, P461; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1994, J VIROL, V68, P7292, DOI 10.1128/JVI.68.11.7292-7300.1994; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; Zimmerman SB, 2006, J STRUCT BIOL, V156, P255, DOI 10.1016/j.jsb.2006.03.022	51	37	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2092	2102		10.1074/jbc.M112.407460	http://dx.doi.org/10.1074/jbc.M112.407460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23043138	Green Published, hybrid			2022-12-25	WOS:000313751400060
J	Grassian, AR; Lin, F; Barrett, R; Liu, Y; Jiang, W; Korpal, M; Astley, H; Gitterman, D; Henley, T; Howes, R; Levell, J; Korn, JM; Pagliarini, R				Grassian, Alexandra R.; Lin, Fallon; Barrett, Rosemary; Liu, Yue; Jiang, Wei; Korpal, Manav; Astley, Holly; Gitterman, Daniel; Henley, Thomas; Howes, Rob; Levell, Julian; Korn, Joshua M.; Pagliarini, Raymond			Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; MIR-200 FAMILY; E-CADHERIN; ONCOMETABOLITE 2-HYDROXYGLUTARATE; REPRESSORS ZEB1; CANCER-CELLS; MUTANT IDH1; STEM-CELLS; GENE; EXPRESSION	Mutations in the genes encoding isocitrate dehydrogenase 1 and 2 (IDH1/2) occur in a variety of tumor types, resulting in production of the proposed oncometabolite, 2-hydroxyglutarate (2-HG). How mutant IDH and 2-HG alter signaling pathways to promote cancer, however, remains unclear. Additionally, there exist relatively few cell lines with IDH mutations. To examine the effect of endogenous IDH mutations and 2-HG, we created a panel of isogenic epithelial cell lines with either wild-type IDH1/2 or clinically relevant IDH1/2 mutations. Differences were noted in the ability of IDH mutations to cause robust 2-HG accumulation. IDH1/2 mutants that produce high levels of 2-HG cause an epithelial-mesenchymal transition (EMT)-like phenotype, characterized by changes in EMT-related gene expression and cellular morphology. 2-HG is sufficient to recapitulate aspects of this phenotype in the absence of an IDH mutation. In the cells types examined, mutant IDH-induced EMT is dependent on up-regulation of the transcription factor ZEB1 and down-regulation of the miR-200 family of microRNAs. Furthermore, sustained knockdown of IDH1 in IDH1 R132H mutant cells is sufficient to reverse many characteristics of EMT, demonstrating that continued expression of mutant IDH is required to maintain this phenotype. These results suggest mutant IDH proteins can reversibly deregulate discrete signaling pathways that contribute to tumorigenesis.	[Grassian, Alexandra R.; Lin, Fallon; Barrett, Rosemary; Liu, Yue; Jiang, Wei; Korpal, Manav; Levell, Julian; Korn, Joshua M.; Pagliarini, Raymond] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Astley, Holly; Gitterman, Daniel; Henley, Thomas; Howes, Rob] Horizon Discovery Ltd, Cambridge CB25 9TL, England	Novartis	Pagliarini, R (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	raymond.pagliarini@novartis.com	Jiang, Wei/F-2521-2010		Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	Recipients of presidential postdoctoral fellowships from Novartis Institutes for Biomedical Research.	Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Arai M, 2012, BRAIN TUMOR PATHOL, V29, P201, DOI 10.1007/s10014-012-0085-1; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Duncan C. G., 2012, GENOME RES IN PRESS; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Ghiam AF, 2012, ONCOGENE, V31, P3826, DOI 10.1038/onc.2011.546; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hayden JT, 2009, CELL CYCLE, V8, P1806, DOI 10.4161/cc.8.11.8594; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lopez GY, 2010, BIOCHEM BIOPH RES CO, V398, P585, DOI 10.1016/j.bbrc.2010.06.125; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oishi N, 2012, HEPATOLOGY, V56, P1792, DOI 10.1002/hep.25890; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Sellner L, 2010, EUR J HAEMATOL, V85, P457, DOI 10.1111/j.1600-0609.2010.01505.x; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395; Yen KE, 2012, ONCOLOGIST, V17, P5, DOI 10.1634/theoncologist.2011-0429; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	66	69	71	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42180	42194		10.1074/jbc.M112.417832	http://dx.doi.org/10.1074/jbc.M112.417832			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23038259	hybrid, Green Published			2022-12-25	WOS:000312103000055
J	Mi, RJ; Song, LN; Wang, YC; Ding, XK; Zeng, JW; Lehoux, S; Aryal, RP; Wang, JM; Crew, VK; van Die, I; Chapman, AB; Cummings, RD; Ju, TZ				Mi, Rongjuan; Song, Lina; Wang, Yingchun; Ding, Xiaokun; Zeng, Junwei; Lehoux, Sylvain; Aryal, Rajindra P.; Wang, Jianmei; Crew, Vanja K.; van Die, Irma; Chapman, Arlene B.; Cummings, Richard D.; Ju, Tongzhong			Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN O-GLYCOSYLATION; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; IGA NEPHROPATHY; DNA METHYLATION; X-CHROMOSOME; GENE; BETA-1,3-GALACTOSYLTRANSFERASE; CANCER; DEFICIENCY; MUTATIONS	Cosmc is the specific molecular chaperone in the endoplasmic reticulum for T-synthase, a Golgi beta 3-galactosyltransferase that generates the core 1 O-glycan, Gal beta 1-3GalNAc alpha-Ser/Thr, in glycoproteins. Dysfunctional Cosmc results in the formation of inactive T-synthase and consequent expression of the Tn antigen (GalNAc alpha 1-Ser/Thr), which is associated with several human diseases. However, the molecular regulation of expression of Cosmc, which is encoded by a single gene on Xq24, is poorly understood. Here we show that epigenetic silencing of Cosmc through hypermethylation of its promoter leads to loss of Cosmc transcripts in Tn4 cells, an immortalized B cell line from a male patient with a Tn-syndrome-like phenotype. These cells lack T-synthase activity and express the Tn antigen. Treatment of cells with 5-aza-2'-deoxycytidine causes restoration of Cosmc transcripts, restores T-synthase activity, and reduces Tn antigen expression. Bisulfite sequencing shows that CG dinucleotides in the Cosmc core promoter are hypermethylated. Interestingly, several other X-linked genes associated with glycosylation are not silenced in Tn4 cells, and we observed no correlation of a particular DNA methyltransferase to aberrant methylation of Cosmc in these cells. Thus, hypermethylation of the Cosmc promoter in Tn4 cells is relatively specific. Epigenetic silencing of Cosmc provides another mechanism underlying the abnormal expression of the Tn antigen, which may be important in understanding aberrant Tn antigen expression in human diseases, including IgA nephropathy and cancer.	[Mi, Rongjuan; Song, Lina; Wang, Yingchun; Ding, Xiaokun; Zeng, Junwei; Lehoux, Sylvain; Aryal, Rajindra P.; Cummings, Richard D.; Ju, Tongzhong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Chapman, Arlene B.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Crew, Vanja K.] Natl Hlth Serv Blood & Transplant, Bristol Inst Transfus Sci, Bristol BS34 7QG, Avon, England; [van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Emory University; Emory University; NHS Blood & Transplant (NHSBT); Vrije Universiteit Amsterdam	Ju, TZ (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE,Rm 4029, Atlanta, GA 30322 USA.	tju@emory.edu	Wang, Jianmei/HHZ-0585-2022; Mi, Rongjuan/O-2564-2013	Ju, Tongzhong/0000-0002-4429-1976; Aryal, Rajindra P/0000-0001-8718-636X	National Institutes of Health [R01DK80876]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK80876 (to T. J.).	Aller CT, 1996, AM J HEMATOL, V52, P29, DOI 10.1002/(SICI)1096-8652(199605)52:1<29::AID-AJH5>3.0.CO;2-8; Aryal RP, 2012, J BIOL CHEM, V287, P15317, DOI 10.1074/jbc.M111.312587; Aryal RP, 2010, J BIOL CHEM, V285, P2456, DOI 10.1074/jbc.M109.065169; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Brodsky RA, 2008, BLOOD REV, V22, P65, DOI 10.1016/j.blre.2007.10.002; Bronner C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001764; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Chachadi VB, 2011, INT J BIOCHEM CELL B, V43, P586, DOI 10.1016/j.biocel.2010.12.015; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Crew VK, 2008, BRIT J HAEMATOL, V142, P657, DOI 10.1111/j.1365-2141.2008.07215.x; Desai PR, 2000, TRANSFUS MED REV, V14, P312, DOI 10.1053/tmrv.2000.16229; Felner KM, 1998, BBA-MOL BASIS DIS, V1406, P115; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Inoue T, 2011, ADV OTO-RHINO-LARYNG, V72, P71, DOI 10.1159/000324610; Inoue T, 2010, CLIN IMMUNOL, V136, P447, DOI 10.1016/j.clim.2010.05.009; Jin Bilian, 2011, Genes Cancer, V2, P607, DOI 10.1177/1947601910393957; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2008, CANCER RES, V68, P1636, DOI 10.1158/0008-5472.CAN-07-2345; Ju TZ, 2011, GLYCOBIOLOGY, V21, P352, DOI 10.1093/glycob/cwq168; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Nai HS, 2012, COMB CHEM HIGH T SCR, V15, P216; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Patra SK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P613, DOI 10.1134/S0006297909060042; Qin W, 2005, J INTERN MED, V258, P467, DOI 10.1111/j.1365-2796.2005.01558.x; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Qin Wei, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P762; ROXBY DJ, 1992, TRANSFUSION, V32, P834, DOI 10.1046/j.1537-2995.1992.32993110755.x; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; THURNHER M, 1993, J CLIN INVEST, V91, P2103, DOI 10.1172/JCI116434; WALLNER M, 1985, BLUT, V51, P355, DOI 10.1007/BF00320046; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xie LS, 2010, CLIN INVEST MED, V33, pE5; Yamada K, 2010, NEPHROL DIAL TRANSPL, V25, P3890, DOI 10.1093/ndt/gfq325; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yoo NJ, 2008, APMIS, V116, P154, DOI 10.1111/j.1600-0463.2008.00965.x	53	50	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41523	41533		10.1074/jbc.M112.371989	http://dx.doi.org/10.1074/jbc.M112.371989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23035125	Green Published, hybrid			2022-12-25	WOS:000311887600062
J	Perche-Letuvee, P; Kathirvelu, V; Berggren, G; Clemancey, M; Latour, JM; Maurel, V; Douki, T; Armengaud, J; Mulliez, E; Fontecave, M; Garcia-Serres, R; Gambarelli, S; Atta, M				Perche-Letuvee, Phanelie; Kathirvelu, Velavan; Berggren, Gustav; Clemancey, Martin; Latour, Jean-Marc; Maurel, Vincent; Douki, Thierry; Armengaud, Jean; Mulliez, Etienne; Fontecave, Marc; Garcia-Serres, Ricardo; Gambarelli, Serge; Atta, Mohamed			4-Demethylwyosine Synthase from Pyrococcus abyssi Is a Radical-S-adenosyl-L-methionine Enzyme with an Additional [4Fe-4S](+2) Cluster That Interacts with the Pyruvate Co-substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4FE-4S CLUSTER; MODIFIED NUCLEOSIDES; INHIBITOR BINDING; BASE FORMATION; ADENOSYLMETHIONINE; RNA; SAM; BIOSYNTHESIS; COORDINATION; SPECTROSCOPY	Wybutosine and its derivatives are found in position 37 of tRNA encoding Phe in eukaryotes and archaea. They are believed to play a key role in the decoding function of the ribosome. The second step in the biosynthesis of wybutosine is catalyzed by TYW1 protein, which is a member of the well established class of metalloenzymes called "Radical-SAM." These enzymes use a [4Fe-4S] cluster, chelated by three cysteines in a CX3CX2C motif, and S-adenosyl-L-methionine (SAM) to generate a 5'-deoxyadenosyl radical that initiates various chemically challenging reactions. Sequence analysis of TYW1 proteins revealed, in the N-terminal half of the enzyme beside the Radical-SAM cysteine triad, an additional highly conserved cysteine motif. In this study we show by combining analytical and spectroscopic methods including UV-visible absorption, Mossbauer, EPR, and HYSCORE spectroscopies that these additional cysteines are involved in the coordination of a second [4Fe-4S] cluster displaying a free coordination site that interacts with pyruvate, the second substrate of the reaction. The presence of two distinct iron-sulfur clusters on TYW1 is reminiscent of MiaB, another tRNA-modifying metalloenzyme whose active form was shown to bind two iron-sulfur clusters. A possible role for the second [4Fe-4S] cluster in the enzyme activity is discussed.	[Kathirvelu, Velavan; Clemancey, Martin; Latour, Jean-Marc; Garcia-Serres, Ricardo] Univ Grenoble 1, Lab Chim & Biol Met,UMR 5249, Equipe Physicochim Met Biol,CEA Grenoble,CNRS, Inst Rech Technol & Sci Vivant,iRTSV LCBM Pmb,CEA, F-38054 Grenoble 09, France; [Perche-Letuvee, Phanelie; Kathirvelu, Velavan; Berggren, Gustav; Mulliez, Etienne; Fontecave, Marc; Atta, Mohamed] Univ Grenoble 1, Lab Chim & Biol Met, Equipe Biocatalyse,UMR 5249,CEA,CNRS,CEA Grenoble, Inst Rech Technol & Sci Vivant,iRTSV LCBM Biocat, F-38054 Grenoble 09, France; [Kathirvelu, Velavan; Maurel, Vincent; Gambarelli, Serge] Univ Grenoble 1, Lab Resonance Magnet, Inst Nanosci & Cryogenie, CEA,SCIB,UME E3, F-38054 Grenoble 09, France; [Douki, Thierry] Univ Grenoble 1, Lab Les Acides Nucl, Inst Nanosci & Cryogenie, CEA,SCIB,UME E3, F-38054 Grenoble 09, France; [Armengaud, Jean] IBEB, SBTN, LBSP, F-30207 Bagnols Sur Ceze, France; [Fontecave, Marc] Coll France, F-75231 Paris 05, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; PSL Research University Paris; College de France	Garcia-Serres, R (corresponding author), Univ Grenoble 1, Lab Chim & Biol Met,UMR 5249, Equipe Physicochim Met Biol,CEA Grenoble,CNRS, Inst Rech Technol & Sci Vivant,iRTSV LCBM Pmb,CEA, F-38054 Grenoble 09, France.	ricardo.garcia@cea.fr; serge.gambarelli@cea.fr; mohamed.atta@cea.fr	García-Serres, Ricardo/E-4344-2012; Kathirvelu, Velavan/ABD-4854-2021; Thierry, Douki/H-2108-2018; Berggren, Gustav/H-8659-2013	García-Serres, Ricardo/0000-0001-5203-0568; Kathirvelu, Velavan/0000-0003-0232-1425; Thierry, Douki/0000-0002-5022-071X; Berggren, Gustav/0000-0002-6717-6612; ARMENGAUD, Jean/0000-0003-1589-445X	GIS (Groupement d'interet scientifique)-CNRS; ANR Blanc Grant INSERAD; Region Rhone-Alpes Grants CIBLE; Stiftelsen Bengt Lundqvist minne; Swedish Research Council FORMAS; Royal Swedish Academy of Sciences	GIS (Groupement d'interet scientifique)-CNRS; ANR Blanc Grant INSERAD(French National Research Agency (ANR)); Region Rhone-Alpes Grants CIBLE(Region Auvergne-Rhone-Alpes); Stiftelsen Bengt Lundqvist minne; Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Sciences	This work was supported by a GIS (Groupement d'interet scientifique)-CNRS fellowship PP-L, <SUP>1,2,3</SUP>ANR Blanc-2010 Grant INSERAD (to P. P.-L. and V. K.), and Region Rhone-Alpes Grants CIBLE 2007-2010, 2008-2011, and 2011-2014.; Supported by Stiftelsen Bengt Lundqvist minne, the Swedish Research Council FORMAS, and the Royal Swedish Academy of Sciences.	Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; Ahrens-Botzong A, 2011, ANGEW CHEM INT EDIT, V50, P11976, DOI 10.1002/anie.201104562; Atta M, 2009, DNA RNA MODIFICATION, P347; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Chan A, 2012, ANGEW CHEM INT EDIT, V51, P7711, DOI 10.1002/anie.201202261; Chandor A, 2007, CR CHIM, V10, P756, DOI 10.1016/j.crci.2007.02.019; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Cosper MM, 2002, J AM CHEM SOC, V124, P14006, DOI 10.1021/ja0283044; de Crecy-Lagard V, 2010, MOL BIOL EVOL, V27, P2062, DOI 10.1093/molbev/msq096; EMPTAGE MH, 1983, P NATL ACAD SCI-BIOL, V80, P4674, DOI 10.1073/pnas.80.15.4674; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Fontecave M, 2004, TRENDS BIOCHEM SCI, V29, P243, DOI 10.1016/j.tibs.2004.03.007; Gambarelli S, 2005, CHEMBIOCHEM, V6, P1960, DOI 10.1002/cbic.200500182; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; Goto-Ito S, 2007, ACTA CRYSTALLOGR D, V63, P1059, DOI 10.1107/S0907444907040668; Grosjean H., 2009, DNA RNA MODIFICATION; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; KASAI H, 1976, BIOCHEMISTRY-US, V15, P898, DOI 10.1021/bi00649a027; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Lees NS, 2009, J AM CHEM SOC, V131, P9184, DOI 10.1021/ja903978u; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Seemann M, 2009, J AM CHEM SOC, V131, P13184, DOI 10.1021/ja9012408; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Suzuki Y, 2007, J MOL BIOL, V372, P1204, DOI 10.1016/j.jmb.2007.07.024; Tyryshkin AM, 1999, J AM CHEM SOC, V121, P3396, DOI 10.1021/ja982085y; Urbonavicius J., 2009, DNA RNA MODIFICATION, P423; Waas WF, 2005, J BIOL CHEM, V280, P37616, DOI 10.1074/jbc.M506939200; Young AP, 2011, BIOCHEMISTRY-US, V50, P10573, DOI 10.1021/bi2015053	31	40	42	2	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41174	41185		10.1074/jbc.M112.405019	http://dx.doi.org/10.1074/jbc.M112.405019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23043105	Green Published, hybrid			2022-12-25	WOS:000311887600033
J	Gaidet, N; El Mamy, ABO; Cappelle, J; Caron, A; Cumming, GS; Grosbois, V; Gil, P; Hammoumi, S; de Almeida, RS; Fereidouni, SR; Cattoli, G; Abolnik, C; Mundava, J; Fofana, B; Ndlovu, M; Diawara, Y; Hurtado, R; Newman, SH; Dodman, T; Balanca, G				Gaidet, Nicolas; El Mamy, Ahmed B. Ould; Cappelle, Julien; Caron, Alexandre; Cumming, Graeme S.; Grosbois, Vladimir; Gil, Patricia; Hammoumi, Saliha; de Almeida, Renata Servan; Fereidouni, Sasan R.; Cattoli, Giovanni; Abolnik, Celia; Mundava, Josphine; Fofana, Bouba; Ndlovu, Mduduzi; Diawara, Yelli; Hurtado, Renata; Newman, Scott H.; Dodman, Tim; Balanca, Gilles			Investigating Avian Influenza Infection Hotspots in Old-World Shorebirds	PLOS ONE			English	Article							WILD AQUATIC BIRDS; A VIRUSES; SURVEILLANCE; DYNAMICS; PATTERNS; GENE; TRANSMISSION; STRATEGIES; MIGRATION; WATERFOWL	Heterogeneity in the transmission rates of pathogens across hosts or environments may produce disease hotspots, which are defined as specific sites, times or species associations in which the infection rate is consistently elevated. Hotspots for avian influenza virus (AIV) in wild birds are largely unstudied and poorly understood. A striking feature is the existence of a unique but consistent AIV hotspot in shorebirds (Charadriiformes) associated with a single species at a specific location and time (ruddy turnstone Arenaria interpres at Delaware Bay, USA, in May). This unique case, though a valuable reference, limits our capacity to explore and understand the general properties of AIV hotspots in shorebirds. Unfortunately, relatively few shorebirds have been sampled outside Delaware Bay and they belong to only a few shorebird families; there also has been a lack of consistent oropharyngeal sampling as a complement to cloacal sampling. In this study we looked for AIV hotspots associated with other shorebird species and/or with some of the larger congregation sites of shorebirds in the old world. We assembled and analysed a regionally extensive dataset of AIV prevalence from 69 shorebird species sampled in 25 countries across Africa and Western Eurasia. Despite this diverse and extensive coverage we did not detect any new shorebird AIV hotspots. Neither large shorebird congregation sites nor the ruddy turnstone were consistently associated with AIV hotspots. We did, however, find a low but widespread circulation of AIV in shorebirds that contrast with the absence of AIV previously reported in shorebirds in Europe. A very high AIV antibody prevalence coupled to a low infection rate was found in both first-year and adult birds of two migratory sandpiper species, suggesting the potential existence of an AIV hotspot along their migratory flyway that is yet to be discovered.	[Gaidet, Nicolas; Cappelle, Julien; Caron, Alexandre; Grosbois, Vladimir; Balanca, Gilles] UPR AGIRS, CIRAD ES, Montpellier, France; [El Mamy, Ahmed B. Ould] Ctr Natl Elevage & Rech Vet, Nouakchott, Mauritania; [Gil, Patricia; Hammoumi, Saliha; de Almeida, Renata Servan] INRA CMAEE, UMR CIRAD, CIRAD BIOS, Montpellier, France; [Cumming, Graeme S.; Ndlovu, Mduduzi] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7925 Cape Town, South Africa; [Fereidouni, Sasan R.] Friedrich Loeffler Inst, Insel Riems, Germany; [Cattoli, Giovanni] Ist Zooprofilatt Sperle Venezie, OIE FAO Reference Lab Avian Influenza & Newcastle, Legnaro, Italy; [Abolnik, Celia] Univ Pretoria, Fac Vet Sci, ARC Onderstepoort Vet Inst, ZA-0110 Onderstepoort, South Africa; [Abolnik, Celia] Univ Pretoria, Fac Vet Sci, Dept Prod Anim Studies, ZA-0110 Onderstepoort, South Africa; [Mundava, Josphine] Natl Univ Sci & Technol, Bulawayo, Zimbabwe; [Fofana, Bouba] Direct Natl Eaux & Forets Mali, Bamako, Mali; [Hurtado, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Hurtado, Renata] Univ Sao Paulo, Fac Vet Med, Dept Prevent Med & Anim Hlth, Sao Paulo, Brazil; [Newman, Scott H.] EMPRES Anim Hlth, Wildlife Hlth & Ecol Unit, Food & Agr Org United Nat, Rome, Italy; [Dodman, Tim] Wetlands Int, Wageningen, Netherlands	CIRAD; CIRAD; INRAE; National Research Foundation - South Africa; University of Cape Town; Friedrich Loeffler Institute; IZS delle Venezie; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria; University of Pretoria; National University of Science & Technology - Zimbabwe; Universidade de Sao Paulo; Universidade de Sao Paulo; Food & Agriculture Organization of the United Nations (FAO)	Gaidet, N (corresponding author), UPR AGIRS, CIRAD ES, Montpellier, France.	nicolas.gaidet@cirad.fr	Caron, Alexandre/F-8969-2010; Gaidet, Niccolas/H-8122-2013; Ndlovu, Mduduzi/B-1300-2019; Abolnik, Celia/N-9324-2014; Dodman, Tim/AAM-9817-2021; Cumming, Graeme S./B-6551-2008	Caron, Alexandre/0000-0002-5213-3273; Ndlovu, Mduduzi/0000-0002-2997-9430; Cumming, Graeme S./0000-0002-3678-1326; Mundava, Josephine/0000-0003-2062-3216; Fereidouni, Sasan/0000-0002-3508-991X; Cappelle, Julien/0000-0001-7668-1971; Abolnik, Celia/0000-0003-3044-465X	French Ministry of Foreign Affairs; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of France; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of Sweden; USAID - and Wildlife Conservation Society; EU	French Ministry of Foreign Affairs; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of France; Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through government of Sweden; USAID - and Wildlife Conservation Society(United States Agency for International Development (USAID)); EU(European Commission)	This survey was conducted under four international programmes including the GRIPAVI project sponsored by grants from the French Ministry of Foreign Affairs, the Technical Cooperation Programme of the Food and Agricultural Organization of the United Nations (UN-FAO) through additional financial resources from the government of France and Sweden, the USAID - and Wildlife Conservation Society - sponsored Global Avian Influenza Network for Surveillance (GAINS), and the EU-funded New Flubird project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BIRDS N AM CORNELL L, DOI DOI 10.2173/BOW.ROSGOO.01; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; BARBOSA A, 1995, J AVIAN BIOL, V26, P182, DOI 10.2307/3677317; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Brown LH, 1982, BIRDS AFRICA, VI; Caron A, 2011, ECOHEALTH, V8, P109, DOI 10.1007/s10393-010-0356-4; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; CLARK KE, 1993, CONDOR, V95, P694, DOI 10.2307/1369612; Costa TP, 2011, AVIAN PATHOL, V40, P119, DOI 10.1080/03079457.2010.540002; Cramp S., 1983, BIRDS W PALEARCTIC, VIII; Cumming GS, 2011, ECOHEALTH, V8, P4, DOI 10.1007/s10393-011-0684-z; Delany S., 2009, ATLAS WADER POPULATI; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Gaidet N, 2012, P ROY SOC B-BIOL SCI, V279, P1131, DOI 10.1098/rspb.2011.1417; Gaidet N, 2007, J WILDLIFE DIS, V43, pS22; Ghersi BM, 2009, EMERG INFECT DIS, V15, P935, DOI 10.3201/eid1506.080981; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Gillings S, 2007, J ANIM ECOL, V76, P503, DOI 10.1111/j.1365-2656.2007.01229.x; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hlinak A, 2006, J VET MED B, V53, P105, DOI 10.1111/j.1439-0450.2006.00935.x; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Jindal N, 2010, AVIAN DIS, V54, P115, DOI 10.1637/9032-082109-Reg.1; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Matrosovich M, 2009, REV SCI TECH OIE, V28, P203, DOI 10.20506/rst.28.1.1870; Maxted AM, 2012, J WILDLIFE DIS, V48, P322, DOI 10.7589/0090-3558-48.2.322; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Piersma T, 2007, J ORNITHOL, V148, pS45, DOI 10.1007/s10336-007-0240-3; Sivay Mariya V., 2011, Chinese Birds, V2, P140; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; ZWARTS L, 1990, ARDEA, V78, P39	44	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46049	10.1371/journal.pone.0046049	http://dx.doi.org/10.1371/journal.pone.0046049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029383	Green Published, Green Accepted, gold			2022-12-25	WOS:000309973900080
J	Smith, AB; Lopez-Villarejo, J; Diago-Navarro, E; Mitchenall, LA; Barendregt, A; Heck, AJ; Lemonnier, M; Maxwell, A; Diaz-Orejas, R				Smith, Andrew B.; Lopez-Villarejo, Juan; Diago-Navarro, Elizabeth; Mitchenall, Lesley A.; Barendregt, Arjan; Heck, Albert J.; Lemonnier, Marc; Maxwell, Anthony; Diaz-Orejas, Ramon			A Common Origin for the Bacterial Toxin-Antitoxin Systems parD and ccd, Suggested by Analyses of Toxin/Target and Toxin/Antitoxin Interactions	PLOS ONE			English	Article							PLASMID ADDICTION SYSTEM; ESCHERICHIA-COLI; DNA GYRASE; CRYSTAL-STRUCTURE; KID TOXIN; PROTEIN; R1; ANTIDOTE; STABILITY; CLEAVAGE	Bacterial toxin-antitoxin (TA) systems encode two proteins, a potent inhibitor of cell proliferation (toxin) and its specific antidote (antitoxin). Structural data has revealed striking similarities between the two model TA toxins CcdB, a DNA gyrase inhibitor encoded by the ccd system of plasmid F, and Kid, a site-specific endoribonuclease encoded by the parD system of plasmid R1. While a common structural fold seemed at odds with the two clearly different modes of action of these toxins, the possibility of functional crosstalk between the parD and ccd systems, which would further point to their common evolutionary origin, has not been documented. Here, we show that the cleavage of RNA and the inhibition of protein synthesis by the Kid toxin, two activities that are specifically counteracted by its cognate Kis antitoxin, are altered, but not inhibited, by the CcdA antitoxin. In addition, Kis was able to inhibit the stimulation of DNA gyrase-mediated cleavage of DNA by CcdB, albeit less efficiently than CcdA. We further show that physical interactions between the toxins and antitoxins of the different systems do occur and define the stoichiometry of the complexes formed. We found that CcdB did not degrade RNA nor did Kid have any reproducible effect on the tested DNA gyrase activities, suggesting that these toxins evolved to reach different, rather than common, cellular targets.	[Smith, Andrew B.; Mitchenall, Lesley A.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Lopez-Villarejo, Juan; Diago-Navarro, Elizabeth; Lemonnier, Marc; Diaz-Orejas, Ramon] CSIC, Dept Mol Microbiol, Ctr Invest Biol, Madrid, Spain; [Barendregt, Arjan; Heck, Albert J.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Barendregt, Arjan; Heck, Albert J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Utrecht University; Utrecht University	Diaz-Orejas, R (corresponding author), CSIC, Dept Mol Microbiol, Ctr Invest Biol, Madrid, Spain.	ramondiaz@cib.csic.es	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Diago Navarro, Elizabeth/0000-0001-7117-1796; Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430; Lemonnier, Marc/0000-0002-8587-9864	Spanish MICINN [BFU 2008-01566/BMC y, CSD2008-00013]; PRIME-XS project [262067]; European Union 7th Framework Programme; Basque Country Government; BBSRC (UK); BBSRC-CASE studentship; BBSRC; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PRIME-XS project; European Union 7th Framework Programme; Basque Country Government(Basque Government); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RDO acknowledges financial support from the Spanish MICINN (Granted projects BFU 2008-01566/BMC y and CSD2008-00013). EDN acknowledges support from the PRIME-XS project, grant agreement number 262067, funded by the European Union 7th Framework Programme and from the Basque Country Government. AM acknowledges support from the BBSRC (UK); ABS was supported by a BBSRC-CASE studentship, funded by the BBSRC and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; BRAVO A, 1987, MOL GEN GENET, V210, P101, DOI 10.1007/BF00337764; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Chatterji M, 2001, J ANTIMICROB CHEMOTH, V48, P479, DOI 10.1093/jac/48.4.479; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Diago-Navarro E, 2010, FEBS J, V277, P3097, DOI 10.1111/j.1742-4658.2010.07722.x; Diago-Navarro E, 2009, FEBS J, V276, P4973, DOI 10.1111/j.1742-4658.2009.07199.x; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kamphuis MB, 2007, PROTEINS; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Maxwell A, 1999, METH MOL B, V94, P135; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Munoz-Gomez AJ, 2005, J BACTERIOL, V187, P3151, DOI 10.1128/JB.187.9.3151-3157.2005; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; RUIZECHEVARRIA MJ, 1991, MOL MICROBIOL, V5, P2685, DOI 10.1111/j.1365-2958.1991.tb01977.x; RUIZECHEVARRIA MJ, 1991, MOL GEN GENET, V225, P355, DOI 10.1007/BF00261674; SALMON MA, 1994, MOL GEN GENET, V244, P530, DOI 10.1007/BF00583904; Santos-Sierra S, 2002, FEMS MICROBIOL LETT, V206, P115, DOI 10.1111/j.1574-6968.2002.tb10995.x; Sierra SS, 1998, FEMS MICROBIOL LETT, V168, P51; Smith AB, 2006, NUCLEIC ACIDS RES, V34, P4667, DOI 10.1093/nar/gkl636; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200	38	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46499	10.1371/journal.pone.0046499	http://dx.doi.org/10.1371/journal.pone.0046499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029540	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900178
J	Sung, CK; Yim, H; Gu, HC; Li, DW; Andrews, E; Duraisamy, S; Li, C; Drapkin, R; Benjamin, T				Sung, Chang Kyoo; Yim, Hyungshin; Gu, Hongcang; Li, Dawei; Andrews, Erik; Duraisamy, Sekhar; Li, Cheng; Drapkin, Ronny; Benjamin, Thomas			The Polyoma Virus Large T Binding Protein p150 Is a Transcriptional Repressor of c-MYC	PLOS ONE			English	Article							RADIAL RAY SYNDROME; OVARIAN; EXPRESSION; MUTATIONS; P150(SAL2); NUMBER; SALL4; GENE; P53	p150, product of the SALL2 gene, is a binding partner of the polyoma virus large T antigen and a putative tumor suppressor. p150 binds to the nuclease hypersensitive element of the c-MYC promoter and represses c-MYC transcription. Overexpression of p150 in human ovarian surface epithelial cells leads to decreased expression, and downregulation to increased expression, of c-MYC. c-MYC is repressed upon restoration of p150 to ovarian carcinoma cells. Induction of apoptosis by etoposide results in recruitment of p150 to the c-MYC promoter and to repression of c-MYC. Analysis of data in The Cancer Genome Atlas shows negative correlations between SALL2 and c-MYC expression in four common solid tumor types.	[Sung, Chang Kyoo; Yim, Hyungshin; Gu, Hongcang; Li, Dawei; Andrews, Erik; Benjamin, Thomas] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Duraisamy, Sekhar; Drapkin, Ronny] Ctr Mol Oncol Pathol, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Li, Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Drapkin, Ronny] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Benjamin, T (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	thomas_benjamin@hms.harvard.edu	Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; Gu, Hongcang/0000-0002-1439-7606	National Cancer Institute [RO1 CA 092520]; NIH [R01 GM077122, P50 CA105009, K08 CA108748]; Ovarian Cancer Research Fund; Robert and Debra First Fund; Dana-Farber Women's Executive Council Genetic Fingerprinting Award; NATIONAL CANCER INSTITUTE [R01CA092520, K08CA108748, P50CA105009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Robert and Debra First Fund; Dana-Farber Women's Executive Council Genetic Fingerprinting Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Cancer Institute RO1 CA 092520 to TB, NIH grant R01 GM077122 to CL, and grants P50 CA105009 and K08 CA108748, the Ovarian Cancer Research Fund, the Robert and Debra First Fund, and the Dana-Farber Women's Executive Council Genetic Fingerprinting Award to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Darcy KM, 2009, GYNECOL ONCOL, V114, P472, DOI 10.1016/j.ygyno.2009.05.012; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Gu HC, 2011, BBA-GENE REGUL MECH, V1809, P276, DOI 10.1016/j.bbagrm.2011.02.002; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Howley PM, 2009, VIROLOGY, V384, P256, DOI 10.1016/j.virol.2008.12.006; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 1999, AM J HUM GENET, V64, P435, DOI 10.1086/302238; Li DW, 2004, MOL CELL BIOL, V24, P3885, DOI 10.1128/MCB.24.9.3885-3893.2004; Li DW, 2001, P NATL ACAD SCI USA, V98, P14619, DOI 10.1073/pnas.251447198; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Ma YP, 2001, J BIOL CHEM, V276, P48223, DOI 10.1074/jbc.M106468200; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Parroche P, 2011, VIROLOGY, V417, P443, DOI 10.1016/j.virol.2011.05.016; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sung CK, 2011, FASEB J, V25, P1275, DOI 10.1096/fj.10-173674; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46486	10.1371/journal.pone.0046486	http://dx.doi.org/10.1371/journal.pone.0046486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029531	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900170
J	Wu, D; Wang, M; Wang, XG; Yin, NB; Song, T; Li, HD; Zhang, F; Zhang, YB; Ye, ZQ; Yu, J; Wang, DM; Zhao, ZM				Wu, Di; Wang, Mei; Wang, Xingang; Yin, Ningbei; Song, Tao; Li, Haidong; Zhang, Feng; Zhang, Yongbiao; Ye, Zhenqing; Yu, Jun; Wang, Duen-Mei; Zhao, Zhenmin			Maternal Transmission Effect of a PDGF-C SNP on Nonsyndromic Cleft Lip with or without Palate from a Chinese Population	PLOS ONE			English	Article							LONG ARM; SCAN; GENE; EPIDEMIOLOGY; ASSOCIATION; SEQUENCE; MARKERS; ORIGIN; MAP	Cleft lip with or without palate (CL/P) is a common congenital anomaly with a high birth prevalence in China. Based on a previous linkage signal of nonsyndromic CL/P (NSCL/P) on the chromosomal region 4q31-q32 from the Chinese populations, we screened the 4q31-q32 region for susceptibility genes in 214 trios of Han Chinese. PDGF-C, an important developmental factor, resides in the region and has been implicated in NSCL/P. However, in our family-based association test (transmission disequilibrium test; TDT), we could not conclude an association between PDGF-C and NSCL/P as previously suggested. Instead, we found strong evidence for parent-of-origin effect at a PDGF-C SNP, rs17035464, by a likelihood ratio test (unadjusted p-value = 0.0018; I-m = 2.46). The location of rs17035464 is 13 kb downstream of a previously reported, NSCL/P-associated SNP, rs28999109. Furthermore, a patient from our sample trios was observed with a maternal segmental uniparental isodisomy (UPD) in a region containing rs17035464. Our findings support the involvement of PDGF-C in the development of oral clefts; moreover, the UPD case report contributes to the collective knowledge of rare variants in the human genome.	[Wang, Mei; Zhang, Feng; Zhang, Yongbiao; Ye, Zhenqing; Yu, Jun; Wang, Duen-Mei] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wu, Di; Yin, Ningbei; Song, Tao; Li, Haidong; Zhao, Zhenmin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Di; Yin, Ningbei; Song, Tao; Li, Haidong; Zhao, Zhenmin] Chinese Acad Med Sci, Dept Cleft Lip & Palate, Plast Surg Hosp, Beijing 100730, Peoples R China; [Wang, Mei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xingang] Capital Univ Med Sci, Dept Stomatol, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Zhenmin] Peoples Hosp Jincheng City, Jincheng, Shanxi, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University	Wang, DM (corresponding author), Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	dmwang@usa.net; zhaozhenmin0098@gmail.com	Ye, Zhenqing/L-7954-2019; Ye, Zhenqing/ABF-1433-2020		Doctoral Program Foundation of Institutions of Higher Education of China [200800230021]; Beijing Municipal Natural Science Foundation [7092087]; National Basic Research Program of China [2007CB511901]; Chinese Academy of Sciences	Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Doctoral Program Foundation of Institutions of Higher Education of China (200800230021), Beijing Municipal Natural Science Foundation (7092087), National Basic Research Program of China (Grant No. 2007CB511901) and 100 Talents Program of the Chinese Academy of Sciences to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEIRAGHI S, 1994, CLIN GENET, V46, P255; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Choi SJ, 2008, EUR J HUM GENET; Cooper ME, 2000, CLEFT PALATE-CRAN J, V37, P274, DOI 10.1597/1545-1569(2000)037<0274:DEONCL>2.3.CO;2; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Eberhart JK, 2007, NATURE GENETICS; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grun K, 2005, EUR HEART J, V26, P728, DOI 10.1093/eurheartj/ehi168; Harville EW, 2007, EUR J EPIDEMIOL, V22, P389, DOI 10.1007/s10654-007-9129-y; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LIN AE, 1988, AM J MED GENET, V31, P533, DOI 10.1002/ajmg.1320310308; Lipsky RH, 2003, ANN NY ACAD SCI, V1003, P22, DOI 10.1196/annals.1300.003; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paredes M, 1999, REV MED CHILE, V127, P1431; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prescott NJ, 2002, J MED GENET, V39, P368, DOI 10.1136/jmg.39.5.368; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Reigstad LJ, 2003, J BIOL CHEM, V278, P17114, DOI 10.1074/jbc.M301728200; Salahshourifar I, 2010, AM J MED GENET A, V152A, P1818, DOI 10.1002/ajmg.a.33526; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Song R, 2003, CLEFT LIP PALATE REP; Sowpati DT, 2008, MECH DEVELOP, V125, P963, DOI 10.1016/j.mod.2008.08.002; Sull J, 2009, HUMAN GENETICS; Sull JW, 2008, GENET EPIDEMIOL, V32, P505, DOI 10.1002/gepi.20323; Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Wu X, 2007, GENESIS, V45, P653, DOI 10.1002/dvg.20339; Wyszynski DF, 2003, AM J MED GENET A, V123A, P140, DOI 10.1002/ajmg.a.20283; Zhao JH, 2007, J STAT SOFTW, V23	43	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46477	10.1371/journal.pone.0046477	http://dx.doi.org/10.1371/journal.pone.0046477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029525	Green Published, Green Submitted, gold			2022-12-25	WOS:000309973900166
J	Blanco, F; Matute, H; Vadillo, MA				Blanco, Fernando; Matute, Helena; Vadillo, Miguel A.			Mediating Role of Activity Level in the Depressive Realism Effect	PLOS ONE			English	Article							CONTINGENCY JUDGMENTS; INTERTRIAL INTERVAL; COLLEGE-STUDENTS; ILLUSION; WISER; REINFORCEMENT; HELPLESSNESS; INFORMATION; SYMPTOMS; INTERNET	Several classic studies have concluded that the accuracy of identifying uncontrollable situations depends heavily on depressive mood. Nondepressed participants tend to exhibit an optimistic illusion of control, whereas depressed participants tend to better detect a lack of control. Recently, we suggested that the different activity levels (measured as the probability of responding during a contingency learning task) exhibited by depressed and nondepressed individuals is partly responsible for this effect. The two studies presented in this paper provide further support for this mediational hypothesis, in which mood is the distal cause of the illusion of control operating through activity level, the proximal cause. In Study 1, the probability of responding, P(R), was found to be a mediator variable between the depressive symptoms and the judgments of control. In Study 2, we intervened directly on the mediator variable: The P(R) for both depressed and nondepressed participants was manipulated through instructions. Our results confirm that P(R) manipulation produced differences in the participants' perceptions of uncontrollability. Importantly, the intervention on the mediator variable cancelled the effect of the distal cause; the participants' judgments of control were no longer mood dependent when the P(R) was manipulated. This result supports the hypothesis that the so-called depressive realism effect is actually mediated by the probability of responding.	[Blanco, Fernando; Matute, Helena; Vadillo, Miguel A.] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Blanco, F (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	fblanco81@gmail.com	Vadillo, Miguel A./A-8702-2011; Blanco, Fernando/E-8941-2010; Matute, Helena/A-8256-2011	Vadillo, Miguel A./0000-0001-8421-816X; Blanco, Fernando/0000-0003-1283-8313; Matute, Helena/0000-0001-7221-1366	Direccion General de Investigacion of the Spanish Government [PSI2011-26965]; Departamento de Educacion, Universidades e Investigacion of the Basque Government [PI2012-56]	Direccion General de Investigacion of the Spanish Government; Departamento de Educacion, Universidades e Investigacion of the Basque Government	Support for this research was provided by the Direccion General de Investigacion of the Spanish Government (Grant PSI2011-26965) and the Departamento de Educacion, Universidades e Investigacion of the Basque Government (Grant PI2012-56). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN R, 1991, CLIN PSYCHOL REV, V11, P565, DOI 10.1016/0272-7358(91)90004-E; Aeschleman SR, 2003, BEHAV PROCESS, V61, P37, DOI 10.1016/S0376-6357(02)00158-4; Allan LG, 2007, Q J EXP PSYCHOL, V60, P482, DOI 10.1080/17470210601002686; Alloy L. B., 1988, COGNITIVE PROCESS; ALLOY LB, 1992, J ABNORM PSYCHOL, V101, P234, DOI 10.1037/0021-843X.101.2.234; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BENASSI VA, 1985, J PERS SOC PSYCHOL, V49, P1323, DOI 10.1037/0022-3514.49.5.1323; Birnbaum MH, 2005, HANDBOOK OF HUMAN FACTORS IN WEB DESIGN, P471; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2009, PSYCHOL REC, V59, P551, DOI 10.1007/BF03395681; COHEN J, 1968, PSYCHOL BULL, V70, P426, DOI 10.1037/h0026714; Conde V, 1976, REV PSICOLOGIA GEN A, V31, P496; Consejo General de Colegios Oficiales de Psicologos, 2010, COD DEONT; DOBSON K, 1989, Canadian Journal of Behavioural Science, V21, P419, DOI 10.1037/h0079839; FRANKEL MS, 1999, WORKSH CONV AM ASS A; Hannah SD, 2009, CAN J EXP PSYCHOL, V63, P59, DOI 10.1037/a0013403; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; Kraut R, 2003, PSYCHOL RES ONLINE O; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; LEWINSOHN PM, 1980, PSYCHOTHER-THEOR RES, V17, P322, DOI 10.1037/h0085929; Lewinsohn PM, 1974, PSYCHOL DEPRESSION C, P176; MATUTE H, 1995, Q J EXP PSYCHOL-B, V48, P142; MATUTE H, 1994, LEARN MOTIV, V25, P216, DOI 10.1006/lmot.1994.1012; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; MATUTE H, 2007, P EUR COGN SCI C, P341; Matute H, 2007, CYBERPSYCHOL BEHAV, V10, P176, DOI 10.1089/cpb.2006.9971; MISCHEL W, 1979, AM PSYCHOL, V34, P740, DOI 10.1037/0003-066X.34.9.740; Moore MT, 2012, CLIN PSYCHOL REV, V32, P496, DOI 10.1016/j.cpr.2012.05.004; Msetfi RM, 2007, Q J EXP PSYCHOL, V60, P461, DOI 10.1080/17470210601002595; Msetfi RM, 2005, J EXP PSYCHOL GEN, V134, P10, DOI 10.1037/0096-3445.134.1.10; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Presson PK, 2003, SOC BEHAV PERSONAL, V31, P483, DOI 10.2224/sbp.2003.31.5.483; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Rudski JM, 1999, PSYCHOL REC, V49, P245, DOI 10.1007/BF03395319; Sloman S., 2005, CAUSAL MODELS PEOPLE; Sobel ME., 1982, SOCIOL METHODOL, V13, P290, DOI [DOI 10.2307/270723, 10.2307/270723]; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Taylor SE, 1988, PSYCHOL BULL, V103, P192, DOI [10.1037/0033-2909.103.2.193, DOI 10.1037/0033-2909.103.2.193]; WASON PC, 1960, Q J EXP PSYCHOL, V12, P129, DOI 10.1080/17470216008416717; Wasserman EA, 1996, PSYCHOL LEARN MOTIV, V34, P207, DOI 10.1016/S0079-7421(08)60562-9; White PA, 2002, EUR J SOC PSYCHOL, V32, P667, DOI 10.1002/ejsp.115	45	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46203	10.1371/journal.pone.0046203	http://dx.doi.org/10.1371/journal.pone.0046203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23029435	Green Submitted, Green Published, gold			2022-12-25	WOS:000309517500072
J	Berguer, PM; Alzogaray, VA; Rossi, AH; Mundinano, J; Piazzon, I; Goldbaum, FA				Berguer, Paula M.; Alzogaray, Vanina A.; Hugo Rossi, Andres; Mundinano, Juliana; Piazzon, Isabel; Goldbaum, Fernando A.			A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants	PLOS ONE			English	Article							T-CELL RESPONSES; SPP. LUMAZINE SYNTHASE; CROSS-PRESENTATION; IN-VIVO; ENDOPLASMIC-RETICULUM; SELECTIVE EXPRESSION; ANTIGEN PRESENTATION; CYTOPLASMIC PROTEIN; PROTECTIVE IMMUNITY; BACTERIAL PROTEIN	Lumazine synthase from Brucella spp. (BLS) is a highly immunogenic decameric protein. It is possible to insert foreign peptides or proteins at its ten-amino acid termini. These chimeras elicit systemic and oral immunity without adjuvants, which are commonly needed in the formulation of subunit-based vaccines. Here, we show that BLS induces the cross presentation of a covalently attached peptide OVA(257-264) and a specific cytotoxic response to this peptide in the absence of adjuvants. Unlike other subunit-based vaccines, this chimera induces rapid activation of CTLs and a specific cytotoxic response, making this polymeric protein an ideal antigen carrier for vaccine development. Adoptive transfer of transgenic OT-I T cells revealed efficient cross presentation of BLS-OVA(257-264) in vivo. BLS-OVA(257-264) immunization induced the proliferation of OVA(257-264)-specific CD8+ lymphocytes and also increased the percentage of OVA(257-264)-specific CD8+ cells expressing the early activation marker CD69; after 5 days, the percentage of OVA(257-264)-specific CD8+ cells expressing high levels of CD44 increased. This cell subpopulation showed decreased expression of IL-7R alpha, indicating that BLS-OVA(257-264) induced the generation of CD8+ effector cells. BLS-OVA(257-264) was cross presented in vitro independently of the presence of a functional TLR4 in the DCs. Finally, we show that immunization of wild type mice with the chimera BLS-OVA(257-264) without adjuvants induced a strong OVA(257-264)-specific effector cytotoxic response. This cytotoxicity is dependent on TLR4 as is not induced in mice lacking a functional receptor. These data show that TLR4 signaling is necesary for the induction of a cytotoxic response but not for antigen cross presentation.	[Berguer, Paula M.; Alzogaray, Vanina A.; Hugo Rossi, Andres; Goldbaum, Fernando A.] Consejo Nacl Invest Cient & Tecn CONICET, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Mundinano, Juliana; Piazzon, Isabel] Acad Nacl Med Buenos Aires, Lab Med Expt, IMEX CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental	Berguer, PM (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina.	pau_berguer@yahoo.com	Berguer, Paula/AAI-6353-2020	Goldbaum, Fernando/0000-0001-6235-3002	Howard Hughes Medical Institute; Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT(ANPCyT)	This work was supported in part by grants from the Howard Hughes Medical Institute to F.A.G. (http://www.hhmi.org/grants) and from the Agencia Nacional para la Promocion Cientifica y Tecnologica ANPCyT (http://www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Baldi PC, 1996, CLIN DIAGN LAB IMMUN, V3, P472, DOI 10.1128/CDLI.3.4.472-476.1996; Basta S, 2005, J IMMUNOL, V175, P796, DOI 10.4049/jimmunol.175.2.796; Bellido D, 2009, VACCINE, V27, P136, DOI 10.1016/j.vaccine.2008.10.018; Bergner PM, 2006, J IMMUNOL, V176, P2366, DOI 10.4049/jimmunol.176.4.2366; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Braden BC, 2000, J MOL BIOL, V297, P1031, DOI 10.1006/jmbi.2000.3640; Buseyne F, 2001, NAT MED, V7, P344, DOI 10.1038/85493; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Cox MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/159152; Craig PO, 2005, PROTEINS, V61, P1089, DOI 10.1002/prot.20635; Fierer J, 2000, J INFECT DIS, V181, P681, DOI 10.1086/315256; Freigang S, 2007, P NATL ACAD SCI USA, V104, P13426, DOI 10.1073/pnas.0704423104; Goldbaum FA, 1999, J MED MICROBIOL, V48, P833, DOI 10.1099/00222615-48-9-833; GOLDBAUM FA, 1993, J CLIN MICROBIOL, V31, P2141, DOI 10.1128/JCM.31.8.2141-2145.1993; HAVRAN WL, 1988, J IMMUNOL, V140, P1034; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heit A, 2005, J IMMUNOL, V174, P4373, DOI 10.4049/jimmunol.174.7.4373; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Koniaras C, 1997, INT IMMUNOL, V9, P1601, DOI 10.1093/intimm/9.10.1601; Laplagne DA, 2004, PROTEINS, V57, P820, DOI 10.1002/prot.20248; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; MERUELO D, 1982, P NATL ACAD SCI-BIOL, V79, P7460, DOI 10.1073/pnas.79.23.7460; Nelson D, 2000, J IMMUNOL, V165, P6123, DOI 10.4049/jimmunol.165.11.6123; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Oh JZ, 2010, J IMMUNOL, V185, P4602, DOI 10.4049/jimmunol.1001892; Reimann J, 1999, IMMUNOL REV, V172, P131, DOI 10.1111/j.1600-065X.1999.tb01362.x; Sanchez PJ, 2012, VACCINE, V30, P1154, DOI 10.1016/j.vaccine.2011.12.017; Schirmbeck R, 1996, INTERVIROLOGY, V39, P111, DOI 10.1159/000150482; Schirmbeck R, 2003, J IMMUNOL, V171, P5198, DOI 10.4049/jimmunol.171.10.5198; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sciutto E, 2005, VACCINE, V23, P2784, DOI 10.1016/j.vaccine.2004.11.043; Shaw CA, 2008, INFECT IMMUN, V76, P1214, DOI 10.1128/IAI.01208-07; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Storni T, 2004, J IMMUNOL, V172, P1777, DOI 10.4049/jimmunol.172.3.1777; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Velikovsky CA, 2000, J IMMUNOL METHODS, V244, P1, DOI 10.1016/S0022-1759(00)00244-1; Velikovsky CA, 2003, INFECT IMMUN, V71, P5750, DOI 10.1128/IAI.71.10.5750-5755.2003; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Weck MM, 2007, BLOOD, V109, P3890, DOI 10.1182/blood-2006-04-015719; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	59	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45705	10.1371/journal.pone.0045705	http://dx.doi.org/10.1371/journal.pone.0045705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029192	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700060
J	Gil-Humanes, J; Piston, F; Gimenez, MJ; Martin, A; Barro, F				Gil-Humanes, Javier; Piston, Fernando; Gimenez, Maria J.; Martin, Antonio; Barro, Francisco			The Introgression of RNAi Silencing of gamma-Gliadins into Commercial Lines of Bread Wheat Changes the Mixing and Technological Properties of the Dough	PLOS ONE			English	Article							WEIGHT GLUTENIN SUBUNIT; SDS-SEDIMENTATION TEST; MAKING QUALITY; FUNCTIONAL-PROPERTIES; ALLELIC VARIATION; GEL-ELECTROPHORESIS; TRANSGENIC LINES; OMEGA-GLIADINS; PROTEINS; GENES	In the present work the effects on dough quality by the down-regulation of gamma-gliadins in different genetic backgrounds of bread wheat were investigated. RNAi-mediated silencing of gamma-gliadins was introgressed by conventional crossing into three commercial bread wheat lines (namely 'Gazul', 'Podenco' and 'Arpain'), and along with the transgenic line A1152 (cv. Bobwhite) compared with their respective wild types. The protein fractions were quantified by RP-HPLC, whereas the technological and mixing properties were assessed by SDSS test and by the Mixograph instrument. Principal component analysis (PCA) was carried out for both the wild types and the transgenic lines, showing differences in the factors affecting the technological and mixing properties of the dough as a consequence of the reduction of the gamma-gliadins. In transgenic lines, the alpha- and omega-gliadins, and total gliadins negatively affected the dough strength and tolerance to over-mixing, whereas the L/H ratio showed the opposite effect, positively influencing the dough quality. The increase of the SDSS volume in the transgenic lines of 'Gazul', 'Podenco' and 'Arpain' indicates increased gluten strength and quality respect to the wild types. SDSS volume was found to be positively influenced by the amount of glutenins, which were also increased in the transgenic lines. In addition, a positive effect was observed in the MT, PR1 and RBD in some of the transgenic lines of 'Podenco' and 'Arpain'. In conclusion, the down-regulation of gamma-gliadins resulted in stronger doughs and a better tolerance to over-mixing in some transgenic lines. Although the reduction of gamma-gliadins seems not to have a direct effect on the mixing and bread-making properties, the compensatory effect on the synthesis of the other prolamins may result in stronger doughs with improved over-mixing resistance.	[Gil-Humanes, Javier; Piston, Fernando; Gimenez, Maria J.; Martin, Antonio; Barro, Francisco] Inst Sustainable Agr CSIC, Dept Plant Breeding, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Gil-Humanes, J (corresponding author), Inst Sustainable Agr CSIC, Dept Plant Breeding, Cordoba, Spain.	javigil@ias.csic.es	Piston, Fernando/AAD-6975-2020; Gil-Humanes, Javier/AAU-4381-2020; Barro, Francisco/E-8572-2017; Barro, Francisco/J-3254-2014; Martin, Antonio/K-6547-2017	Barro, Francisco/0000-0002-7652-229X; Martin, Antonio/0000-0002-9755-9278; Piston, Fernando/0000-0002-5496-0205; Gimenez, Maria Jose/0000-0003-3854-5746; Gil Humanes, Javier/0000-0002-7283-6945	Spanish Ministerio de Economia y Competitividad [AGL2010-19643-C02-02, TRA2009_0047]; European Regional Development Fund (FEDER); Junta de Andalucia [P09-AGR-4783]	Spanish Ministerio de Economia y Competitividad(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia)	This work was supported by the Spanish Ministerio de Economia y Competitividad (AGL2010-19643-C02-02 and TRA2009_0047), the European Regional Development Fund (FEDER) and Junta de Andalucia (Project P09-AGR-4783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC, 1999, 5440A AACC, P1; Altpeter F, 1996, NAT BIOTECHNOL, V14, P1155, DOI 10.1038/nbt0996-1155; Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; AYOUB M, 1993, CAN J PLANT SCI, V73, P995, DOI 10.4141/cjps93-130; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Becker D, 2006, SILENCING ALPHA GLIA, P86; BRANLARD G, 1985, J CEREAL SCI, V3, P329, DOI 10.1016/S0733-5210(85)80006-0; Carter BP, 1999, CEREAL CHEM, V76, P907, DOI 10.1094/CCHEM.1999.76.6.907; ECKERT B, 1993, Z LEBENSM UNTERS FOR, V196, P122, DOI 10.1007/BF01185570; Fido RJ, 1997, J CEREAL SCI, V26, P271, DOI 10.1006/jcrs.1997.0138; Gil-Humanes J, 2012, J CEREAL SCI; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; GUPTA RB, 1994, J CEREAL SCI, V19, P19, DOI 10.1006/jcrs.1994.1004; Hamer RJ, 2009, WHEAT CHEM TECHNOLOG; HOSENEY RC, 1969, CEREAL CHEM, V46, P117; Hsia CC, 2001, THEOR APPL GENET, V103, P37, DOI 10.1007/s00122-001-0552-2; ICC, 1994, 1052 ICC INT ASS CER; ICC, 1994, 1231 ICC INT ASS CER; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kasarda D.D., 1989, WHEAT UNIQUE, V277, P302; KASARDA DD, 1983, BIOCHIM BIOPHYS ACTA, V747, P138, DOI 10.1016/0167-4838(83)90132-2; KHAN K, 1985, CEREAL CHEM, V62, P310; KHAN K, 1989, CEREAL CHEM, V66, P391; Khatkar BS, 2002, J CEREAL SCI, V35, P299, DOI 10.1006/jcrs.2001.0429; KOLSTER P, 1993, CEREAL FOOD WORLD, V38, P76; Leon E, 2009, J CEREAL SCI, V49, P148, DOI 10.1016/j.jcs.2008.08.002; LORENZO A, 1987, CROP SCI, V27, P247, DOI 10.2135/cropsci1987.0011183X002700020025x; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; Masci S, 2003, MOL BREEDING, V12, P209, DOI 10.1023/A:1026346823301; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1984, THEOR APPL GENET, V67, P235, DOI 10.1007/BF00317044; PAYNE PI, 1987, J CEREAL SCI, V6, P103, DOI 10.1016/S0733-5210(87)80047-4; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; Piston F, 2011, PLOS ONE, V6; Rakszegi M, 2008, J CEREAL SCI, V47, P310, DOI 10.1016/j.jcs.2007.04.010; Rakszegi M, 2005, J CEREAL SCI, V42, P15, DOI 10.1016/j.jcs.2005.02.006; Shewry P R, 1995, Methods Mol Biol, V49, P399; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; SHEWRY PR, 1989, OXFORD SURV PLANT MO, V6, P163; Sissons MJ, 1998, CEREAL CHEM, V75, P30, DOI 10.1094/CCHEM.1998.75.1.30; Tosi P, 2005, MOL BREEDING, V16, P113, DOI 10.1007/s11032-005-5912-1; Uthayakumaran S, 2001, CEREAL CHEM, V78, P138, DOI 10.1094/CCHEM.2001.78.2.138; Uthayakumaran S, 2000, CEREAL CHEM, V77, P737, DOI 10.1094/CCHEM.2000.77.6.737; WEEGELS PL, 1994, J CEREAL SCI, V20, P253, DOI 10.1006/jcrs.1994.1065; Wieser H, 1998, CEREAL CHEM, V75, P644, DOI 10.1094/CCHEM.1998.75.5.644; Wieser H, 2006, CHARACTERIZATION WHE, P13; Williams R, 1988, 4 ICARDA; Yue SJ, 2008, J CEREAL SCI, V47, P153, DOI 10.1016/j.jcs.2007.03.006	50	38	41	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45937	10.1371/journal.pone.0045937	http://dx.doi.org/10.1371/journal.pone.0045937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029328	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700091
J	Tandon, R; Giret, MTM; SenGupta, D; York, VA; Wiznia, AA; Rosenberg, MG; Kallas, EG; Ndhlovu, LC; Nixon, DF				Tandon, Ravi; Giret, Maria T. M.; SenGupta, Devi; York, Vanessa A.; Wiznia, Andrew A.; Rosenberg, Michael G.; Kallas, Esper G.; Ndhlovu, Lishomwa C.; Nixon, Douglas F.			Age-Related Expansion of Tim-3 Expressing T Cells in Vertically HIV-1 Infected Children	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; DISEASE PROGRESSION; REPLICATIVE SENESCENCE; CD38 EXPRESSION; VIRUS-INFECTION; UNITED-KINGDOM; RNA LEVELS; CD4(+)	As perinatally HIV-1-infected children grow into adolescents and young adults, they are increasingly burdened with the long-term consequences of chronic HIV-1 infection, with long-term morbidity due to inadequate immunity. In progressive HIV-1 infection in horizontally infected adults, inflammation, T cell activation, and perturbed T cell differentiation lead to an "immune exhaustion'', with decline in T cell effector functions. T effector cells develop an increased expression of CD57 and loss of CD28, with an increase in co-inhibitory receptors such as PD-1 and Tim-3. Very little is known about HIV-1 induced T cell dysfunction in vertical infection. In two perinatally antiretroviral drug treated HIV-1-infected groups with median ages of 11.2 yr and 18.5 yr, matched for viral load, we found no difference in the proportion of senescent CD28(-)CD57(+)CD8(+) T cells between the groups. However, the frequency of Tim-3(+)CD8(+) and Tim-3(+)CD4(+) exhausted T cells, but not PD-1(+) T cells, was significantly increased in the adolescents with longer duration of infection compared to the children with shorter duration of HIV-1 infection. PD-1(+)CD8(+) T cells were directly associated with T cell immune activation in children. The frequency of Tim-3(+)CD8(+) T cells positively correlated with HIV-1 plasma viral load in the adolescents but not in the children. These data suggest that Tim-3 upregulation was driven by both HIV-1 viral replication and increased age, whereas PD-1 expression is associated with immune activation. These findings also suggest that the Tim-3 immune exhaustion phenotype rather than PD-1 or senescent cells plays an important role in age-related T cell dysfunction in perinatal HIV-1 infection. Targeting Tim-3 may serve as a novel therapeutic approach to improve immune control of virus replication and mitigate age related T cell exhaustion.	[Tandon, Ravi; Ndhlovu, Lishomwa C.] Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Honolulu, HI 96822 USA; [SenGupta, Devi; York, Vanessa A.; Nixon, Douglas F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Giret, Maria T. M.; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Wiznia, Andrew A.; Rosenberg, Michael G.] Albert Einstein Coll Med, Bronx, NY 10467 USA	University of Hawaii System; University of California System; University of California San Francisco; Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine	Tandon, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Hawaii Ctr AIDS, Dept Trop Med, Honolulu, HI 96822 USA.	rtandon@hawaii.edu	n, l/AAX-3992-2020; Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786; Ndhlovu, Lishomwa/0000-0001-5427-4187; Kallas, Esper/0000-0003-2026-6925	National Institute of Allergy and Infectious Diseases [R56AI083112]; National Institutes of Health grant [AI60397]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI083112, R21AI060397, P30AI027763] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Award Number R56AI083112 from the National Institute of Allergy and Infectious Diseases supported this work (http://www.niaid.nih.gov/Pages/default.aspx). The project was also supported by National Institutes of Health grant (AI60397)(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000321; Agarwal A, 2007, J CLIN VIROL, V40, P301, DOI 10.1016/j.jcv.2007.08.020; Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Amaya RA, 2002, PEDIATR INFECT DIS J, V21, P405, DOI 10.1097/00006454-200205000-00011; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Baitsch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030852; Banerjee P, 2007, J VIROL, V81, P9707, DOI 10.1128/JVI.00887-07; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brugnoni D, 1997, CLIN EXP IMMUNOL, V109, P412, DOI 10.1046/j.1365-2249.1997.4871386.x; Cao W, 2009, JAIDS-J ACQ IMM DEF, V50, P137, DOI 10.1097/QAI.0b013e3181926c28; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Desai Seema, 2010, Curr HIV/AIDS Rep, V7, P4, DOI 10.1007/s11904-009-0038-4; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gibb DM, 2003, BMJ-BRIT MED J, V327, P1019, DOI 10.1136/bmj.327.7422.1019; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Goulder PJR, 2011, ADV EXP MED BIOL, V719, P25, DOI 10.1007/978-1-4614-0204-6_3; Harrison L, 2012, AIDS BEHAV; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kahana SY, 2012, AIDS BEHAV; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kassu A, 2011, AIDS RES HUM RETROV, V27, P1, DOI 10.1089/aid.2010.0156; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Legrand FA, 2005, AIDS, V19, P1575, DOI 10.1097/01.aids.0000186816.99993.8e; Leonard EG, 2003, PEDIATR INFECT DIS J, V22, P77, DOI 10.1097/00006454-200301000-00018; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; McElhaney JE, 2009, EXPERT REV VACCINES, V8, P593, DOI 10.1586/ERV.09.12; Mekmullica J, 2009, CLIN INFECT DIS, V48, P338, DOI 10.1086/595885; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Merino J, 1998, CLIN EXP IMMUNOL, V112, P48; MJ O, 1994, VERTICALLY ACQUIRED; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Nociari MM, 1999, J IMMUNOL, V162, P3327; Paul ME, 2005, J ALLERGY CLIN IMMUN, V115, P848, DOI 10.1016/j.jaci.2004.11.054; Prendergast A, 2011, AIDS RES HUMAN RETRO; Reddi Anand, 2007, BMC Pediatr, V7, P13, DOI 10.1186/1471-2431-7-13; Resino S, 2004, CLIN INFECT DIS, V38, P412, DOI 10.1086/380793; Romeiro Juliana Ribeiro, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P164, DOI 10.1177/1545109711421642; Sabin CA, 2008, AIDS, V22, P1463; SADATSOWTI B, 1991, EUR J IMMUNOL, V21, P737, DOI 10.1002/eji.1830210329; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Shimada Y, 2009, EXP GERONTOL, V44, P517, DOI 10.1016/j.exger.2009.05.003; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Tandon R, 2011, J VIROL, V85, P11526, DOI 10.1128/JVI.05418-11; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; van Baarle D, 2002, AIDS, V16, P2001, DOI 10.1097/00002030-200210180-00004; van Baarle D, 2002, TRENDS IMMUNOL, V23, P586, DOI 10.1016/S1471-4906(02)02326-8; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	65	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45733	10.1371/journal.pone.0045733	http://dx.doi.org/10.1371/journal.pone.0045733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029209	Green Published, Green Submitted, gold			2022-12-25	WOS:000309554700063
J	Bueno, CR; Pantaleao, LC; Voltarelli, VA; Bozi, LHM; Brum, PC; Zatz, M				Bueno Junior, Carlos R.; Pantaleao, Lucas C.; Voltarelli, Vanessa A.; Bozi, Luiz Henrique M.; Brum, Patricia Chakur; Zatz, Mayana			Combined Effect of AMPK/PPAR Agonists and Exercise Training in mdx Mice Functional Performance	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; CREATINE-KINASE; HEART-FAILURE; ANIMAL-MODELS; MOUSE; EXPRESSION; IMPROVES; DISEASES	The present investigation was undertaken to test whether exercise training (ET) associated with AMPK/PPAR agonists (EM) would improve skeletal muscle function in mdx mice. These drugs have the potential to improve oxidative metabolism. This is of particular interest because oxidative muscle fibers are less affected in the course of the disease than glycolitic counterparts. Therefore, a cohort of 34 male congenic C57Bl/10J mdx mice included in this study was randomly assigned into four groups: vehicle solution (V), EM [AICAR (AMPK agonist, 50 mg/Kg-1.day-1, ip) and GW 1516 (PPAR delta agonist, 2.5 mg/Kg-1.day-1, gavage)], ET (voluntary running on activity wheel) and EM+ET. Functional performance (grip meter and rotarod), aerobic capacity (running test), muscle histopathology, serum creatine kinase (CK), levels of ubiquitined proteins, oxidative metabolism protein expression (AMPK, PPAR, myoglobin and SCD) and intracellular calcium handling (DHPR, SERCA and NCX) protein expression were analyzed. Treatments started when the animals were two months old and were maintained for one month. A significant functional improvement (p<0.05) was observed in animals submitted to the combination of ET and EM. CK levels were decreased and the expression of proteins related to oxidative metabolism was increased in this group. There were no differences among the groups in the intracellular calcium handling protein expression. To our knowledge, this is the first study that tested the association of ET with EM in an experimental model of muscular dystrophy. Our results suggest that the association of ET and EM should be further tested as a potential therapeutic approach in muscular dystrophies.	[Bueno Junior, Carlos R.; Zatz, Mayana] Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil; [Pantaleao, Lucas C.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Voltarelli, Vanessa A.; Bozi, Luiz Henrique M.; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Zatz, M (corresponding author), Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil.	mayazatz@usp.br	Bozi, Luiz H M/K-5259-2012; Zatz, Mayana/M-5338-2015; Junior, Carlos Bueno/K-3440-2016; Cetgen, Inct/I-2412-2013; Voltarelli, Vanessa Azevedo/J-3419-2015; Bozi, Luiz/AAT-6126-2020; Voltarelli, Vanessa Azevedo/AAB-8897-2021; humano, Cepid Genoma/I-4067-2013; Brum, Patricia C/E-6605-2011	Bozi, Luiz H M/0000-0002-5698-1181; Zatz, Mayana/0000-0003-3970-8025; Junior, Carlos Bueno/0000-0002-2228-0758; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Brum, Patricia C/0000-0002-4750-6506	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP - CEPID 98/14254-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia (INCT)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia (INCT)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - CEPID 98/14254-2), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and the Instituto Nacional de Ciencia e Tecnologia (INCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KD, 2004, EXP NEUROL, V190, P184, DOI 10.1016/j.expneurol.2004.06.029; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Baltgalvis KA, 2012, MED SCI SPO IN PRESS; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Call JA, 2008, J APPL PHYSIOL, V105, P923, DOI 10.1152/japplphysiol.00028.2008; Call JA, 2010, MUSCLE NERVE, V42, P871, DOI 10.1002/mus.21764; Carter GT, 2002, AM J PHYS MED REHAB, V81, pS151, DOI 10.1097/00002060-200211001-00016; CARTER GT, 1995, NEUROMUSCULAR DISORD, V5, P323, DOI 10.1016/0960-8966(94)00063-F; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008; Dubowitz V., 1985, MUSCLE BIOPSY PRACTI; DUPONTVERSTEEGDEN EE, 1994, J APPL PHYSIOL, V77, P1736, DOI 10.1152/jappl.1994.77.4.1736; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Garrood P, 2008, NEUROMUSCULAR DISORD, V18, P71, DOI 10.1016/j.nmd.2007.07.006; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; Hayes A, 1996, J APPL PHYSIOL, V80, P670, DOI 10.1152/jappl.1996.80.2.670; Hayes A, 1998, AM J PHYSIOL-CELL PH, V274, pC1138, DOI 10.1152/ajpcell.1998.274.4.C1138; Kreuz S, 2009, DIABETES-METAB RES, V25, P577, DOI 10.1002/dmrr.997; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Li ZF, 2008, J NEUROL SCI, V264, P77, DOI 10.1016/j.jns.2007.07.027; Markert CD, 2011, MUSCLE NERVE, V43, P464, DOI 10.1002/mus.21987; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Thomson M, 2007, AM J PHYSIOL-ENDOC M, V292, pE196, DOI 10.1152/ajpendo.00366.2006; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Vainzof M, 2008, J MOL NEUROSCI, V34, P241, DOI 10.1007/s12031-007-9023-9; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wilson JM, 2012, J STRENGTH COND RES, V26, P2293, DOI 10.1519/JSC.0b013e31823a3e2d; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I; ZATZ M, 1976, J GENET HUM, V24, P153	42	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45699	10.1371/journal.pone.0045699	http://dx.doi.org/10.1371/journal.pone.0045699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029189	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800081
J	Murray, JE; Judge, M; Chen, Y				Murray, Janice E.; Judge, Madeline; Chen, Yan			Ignored Faces Produce Figural Face Aftereffects	PLOS ONE			English	Article							SPATIAL ATTENTION; ADAPTATION; RACE; COMPETITION; DISTINCT; GENDER; INFORMATION	Following adaptation to faces with contracted (or expanded) internal features, faces previously perceived as normal appear distorted in the opposite direction. This figural face aftereffect suggests face-coding mechanisms adapt to changes in the spatial relations of features and/or the global structure of faces. Here, we investigated whether the figural aftereffect requires spatial attention. Participants ignored a distorted adapting face and performed a highly demanding letter-count task. Before and after adaptation, participants rated the normality of morphed distorted faces ranging from 50% contracted through undistorted to 50% expanded. A robust aftereffect was observed. These results suggest that the figural face aftereffect can occur in the absence of spatial attention, even when the attentional demands of the relevant task are high.	[Murray, Janice E.; Judge, Madeline; Chen, Yan] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Murray, JE (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	jmur@psy.otago.ac.nz	Judge, Madeline/AAI-1572-2021; Chen, Yan/L-2855-2015; Chen, Yan/X-3108-2018	Judge, Madeline/0000-0001-5215-9353; Chen, Yan/0000-0002-1665-9294; Chen, Yan/0000-0002-1665-9294	Department of Psychology, University of Otago	Department of Psychology, University of Otago	Supported by the Department of Psychology, University of Otago. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Beselmeyer PEG, 2008, COGNITION, V107, P353; Bindemann M, 2005, COGNITION, V98, P177, DOI 10.1016/j.cognition.2004.11.004; Boynton GM, 2004, NAT NEUROSCI, V7, P8, DOI 10.1038/nn0104-8; Finkbeiner M, 2009, PSYCHOL SCI, V20, P42, DOI 10.1111/j.1467-9280.2008.02256.x; Fox E, 2012, EMOTION, V12, P236, DOI 10.1037/a0025321; Hsu SM, 2004, VIS COGN, V11, P871, DOI 10.1080/13506280444000030; Jacques C, 2004, NEUROREPORT, V15, P2417, DOI 10.1097/00001756-200410250-00023; Jacques C, 2007, CEREB CORTEX, V17, P1055, DOI 10.1093/cercor/bhl015; Jaquet E, 2008, VIS COGN, V16, P734, DOI 10.1080/13506280701350647; Jaquet E, 2008, J EXP PSYCHOL HUMAN, V34, P101, DOI 10.1037/0096-1523.34.1.101; Jaquet E, 2007, Q J EXP PSYCHOL, V60, P1457, DOI 10.1080/17470210701467870; Jeffery L, 2006, PSYCHOL SCI, V17, P501, DOI 10.1111/j.1467-9280.2006.01735.x; Jenkins R, 2003, PERCEPT PSYCHOPHYS, V65, P298, DOI 10.3758/BF03194801; Jenkins R, 2002, COGNITION, V86, pB43, DOI 10.1016/S0010-0277(02)00172-5; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Lavie N, 2003, PSYCHOL SCI, V14, P510, DOI 10.1111/1467-9280.03453; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Little AC, 2005, P ROY SOC B-BIOL SCI, V272, P2283, DOI 10.1098/rspb.2005.3220; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Murray JE, 2011, PSYCHOL RES-PSYCH FO, V75, P324, DOI 10.1007/s00426-010-0310-7; Pegna AJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00088; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G., 2011, OXFORD HDB FACE PERC, P263, DOI DOI 10.1093/OXFORDHB/9780199559053.001.0001; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; Schneider W., 2002, E PRIME USERS GUIDE; Shin K, 2009, ATTEN PERCEPT PSYCHO, V71, P1507, DOI 10.3758/APP.71.7.1507; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Susilo T, 2010, J VISION, V10, DOI 10.1167/10.13.1; Suzuki S., 2005, FITTING MIND WORLD A, V2, P135, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0006; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24; Yates A, 2010, EMOTION, V10, P822, DOI 10.1037/a0020325; Zhao L, 2001, VISION RES, V41, P2979, DOI 10.1016/S0042-6989(01)00202-4	41	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45928	10.1371/journal.pone.0045928	http://dx.doi.org/10.1371/journal.pone.0045928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23029322	Green Published, gold			2022-12-25	WOS:000309392800122
J	Qin, WS; Xu, ZX; Lu, YZ; Zeng, CH; Zheng, CX; Wang, SY; Liu, ZH				Qin, Weisong; Xu, Zhongxiu; Lu, Yizhou; Zeng, Caihong; Zheng, Chunxia; Wang, Shengyu; Liu, Zhihong			Mixed Organic Solvents Induce Renal Injury in Rats	PLOS ONE			English	Article							CHRONIC GLOMERULONEPHRITIS; HYDROCARBON EXPOSURE; OXIDATIVE STRESS; NEPHROTOXICITY; TRICHLOROETHYLENE; DISEASE; TOLUENE; CELL; NEPHROPATHY; MECHANISMS	To investigate the injury effects of organic solvents on kidney, an animal model of Sprague-Dawley (SD) rats treated with mixed organic solvents via inhalation was generated and characterized. The mixed organic solvents consisted of gasoline, dimethylbenzene and formaldehyde (GDF) in the ratio of 2: 2: 1, and were used at 12,000 PPM to treat the rats twice a day, each for 3 hours. Proteinuria appeared in the rats after exposure for 5-6 weeks. The incidences of proteinuria in male and female rats after exposure for 12 weeks were 43.8% (7/16) and 25% (4/16), respectively. Urinary N-Acetyl-beta-(D)-Glucosaminidase (NAG) activity was increased significantly after exposure for 4 weeks. Histological examination revealed remarkable injuries in the proximal renal tubules, including tubular epithelial cell detachment, cloud swelling and vacuole formation in the proximal tubular cells, as well as proliferation of parietal epithelium and tubular reflux in glomeruli. Ultrastructural examination found that brush border and cytoplasm of tubular epithelial cell were dropped, that tubular epithelial cells were partially disintegrated, and that the mitochondria of tubular epithelial cells were degenerated and lost. In addition to tubular lesions, glomerular damages were also observed, including segmental foot process fusion and loss of foot process covering on glomerular basement membrane (GBM). Immunofluorescence staining indicated that the expression of nephrin and podocin were both decreased after exposure of GDF. In contrast, increased expression of desmin, a marker of podocyte injury, was found in some areas of a glomerulus. TUNEL staining showed that GDF induced apoptosis in tubular cells and glomerular cells. These studies demonstrate that GDF can induce both severe proximal tubular damage and podocyte injury in rats, and the tubular lesions appear earlier than that of glomeruli.	[Qin, Weisong; Xu, Zhongxiu; Zeng, Caihong; Zheng, Chunxia; Wang, Shengyu; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Lu, Yizhou] Cent Hosp Zhabei Dist, Dept Nephrol, Shanghai, Peoples R China	Nanjing University	Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	zhihong-liu@hotmail.com	Liu, Zhihong/ABB-6918-2021	Liu, Zhihong/0000-0001-6093-0726	National Basic Research Program of China 973 program [2012CB517600, 2012CB517605]; National Natural Science Foundation of China [81270811]	National Basic Research Program of China 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517605) and National Natural Science Foundation of China (no. 81270811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi SS, 2004, DRUG CHEM TOXICOL, V27, P425, DOI 10.1081/DCT-200039782; Al-Ghamdi SS, 2003, TOXICOL IN VITRO, V17, P335, DOI 10.1016/S0887-2333(03)00021-3; Bemis JC, 2000, NEUROTOXICOLOGY, V21, P1123; Bolt HM, 2003, INT ARCH OCC ENV HEA, V76, P174, DOI 10.1017/s00420-002-0407-4; Chu I, 2005, J APPL TOXICOL, V25, P193, DOI 10.1002/jat.1051; COMMANDEUR JNM, 1990, CHEM RES TOXICOL, V3, P171, DOI 10.1021/tx00015a001; DANIELL WE, 1988, JAMA-J AM MED ASSOC, V259, P2280; Endou H, 1998, TOXICOL LETT, V103, P29, DOI 10.1016/S0378-4274(98)00275-6; FLOEGE J, 1992, LAB INVEST, V67, P486; Gonzalez-Yebra AL, 2006, INT ARCH OCC ENV HEA, V79, P259, DOI 10.1007/s00420-005-0001-7; Gradden CW, 2001, QJM-MON J ASSOC PHYS, V94, P79, DOI 10.1093/qjmed/94.2.79; HARMAN JW, 1971, J PATHOL, V104, P119, DOI 10.1002/path.1711040206; INOUE O, 1988, INT ARCH OCC ENV HEA, V60, P15, DOI 10.1007/BF00409373; Jakab MG, 2010, MUTAT RES-GEN TOX EN, V698, P11, DOI 10.1016/j.mrgentox.2010.02.015; KLEINKNECHT D, 1980, ARCH INTERN MED, V140, P230, DOI 10.1001/archinte.140.2.230; Kum C, 2007, TOXICOL IND HEALTH, V23, P115, DOI 10.1177/0748233707078218; LOW LK, 1989, TOXICOL IND HEALTH, V5, P85, DOI 10.1177/074823378900500108; McDermott C, 2008, TOXICOL SCI, V101, P263, DOI 10.1093/toxsci/kfm274; Mensing T, 2002, TOXICOL LETT, V128, P243, DOI 10.1016/S0378-4274(01)00545-8; Mutti A, 1999, RENAL FAILURE, V21, P369, DOI 10.3109/08860229909085101; NAKAJIMA H, 1982, Osaka City Medical Journal, V28, P59; Nanez A, 2005, AM J PHYSIOL-RENAL, V289, pF1291, DOI 10.1152/ajprenal.00107.2005; NELSON NA, 1990, AM J NEPHROL, V10, P10, DOI 10.1159/000168048; NUYTS GD, 1995, LANCET, V346, P7, DOI 10.1016/S0140-6736(95)92648-8; PORRO A, 1992, BRIT J IND MED, V49, P738; Radican L, 2006, J OCCUP ENVIRON MED, V48, P1, DOI 10.1097/01.jom.0000190300.51629.e0; Rankin GO, 2008, TOXICOLOGY, V245, P123, DOI 10.1016/j.tox.2007.12.014; RAVNSKOV U, 1979, ACTA MED SCAND, V205, P575; Ravnskov U, 2000, AM J IND MED, V37, P599, DOI 10.1002/(SICI)1097-0274(200006)37:6<599::AID-AJIM4>3.0.CO;2-X; Ravnskov Uffe, 2005, BMC Nephrol, V6, P15, DOI 10.1186/1471-2369-6-15; Skowron J, 2001, Int J Occup Saf Ergon, V7, P35; STACEY NH, 1989, TOXICOL IND HEALTH, V5, P441, DOI 10.1177/074823378900500305; STEENLAND NK, 1990, AM J PUBLIC HEALTH, V80, P153, DOI 10.2105/AJPH.80.2.153; STENGEL B, 1995, INT J EPIDEMIOL, V24, P427, DOI 10.1093/ije/24.2.427; Thier R, 2003, INT J HYG ENVIR HEAL, V206, P149, DOI 10.1078/1438-4639-00209; YAQOOB M, 1993, Q J MED, V86, P165; ZIMMERMAN SW, 1975, LANCET, V2, P199	37	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45873	10.1371/journal.pone.0045873	http://dx.doi.org/10.1371/journal.pone.0045873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029287	Green Published, gold, Green Submitted			2022-12-25	WOS:000309392800112
J	Manktelow, BN; Seaton, SE				Manktelow, Bradley N.; Seaton, Sarah E.			Specifying the Probability Characteristics of Funnel Plot Control Limits: An Investigation of Three Approaches	PLOS ONE			English	Article							STATISTICAL PROCESS-CONTROL; HOSPITAL MORTALITY; CARE	Background: Emphasis is increasingly being placed on the monitoring and comparison of clinical outcomes between healthcare providers. Funnel plots have become a standard graphical methodology to identify outliers and comprise plotting an outcome summary statistic from each provider against a specified 'target' together with upper and lower control limits. With discrete probability distributions it is not possible to specify the exact probability that an observation from an 'in-control' provider will fall outside the control limits. However, general probability characteristics can be set and specified using interpolation methods. Guidelines recommend that providers falling outside such control limits should be investigated, potentially with significant consequences, so it is important that the properties of the limits are understood. Methods: Control limits for funnel plots for the Standardised Mortality Ratio (SMR) based on the Poisson distribution were calculated using three proposed interpolation methods and the probability calculated of an 'in-control' provider falling outside of the limits. Examples using published data were shown to demonstrate the potential differences in the identification of outliers. Results: The first interpolation method ensured that the probability of an observation of an 'in control' provider falling outside either limit was always less than a specified nominal probability (p). The second method resulted in such an observation falling outside either limit with a probability that could be either greater or less than p, depending on the expected number of events. The third method led to a probability that was always greater than, or equal to, p. Conclusion: The use of different interpolation methods can lead to differences in the identification of outliers. This is particularly important when the expected number of events is small. We recommend that users of these methods be aware of the differences, and specify which interpolation method is to be used prior to any analysis.	[Manktelow, Bradley N.; Seaton, Sarah E.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Leicester	Manktelow, BN (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	brad.manktelow@le.ac.uk	Manktelow, Bradley N/G-2794-2011; Seaton, Sarah/S-6875-2019	Manktelow, Bradley N/0000-0002-3264-0323; Seaton, Sarah/0000-0001-8711-4817	National Institute for Health Research; National Institute for Health Research [MET-08-05-101] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Sarah Seaton is funded by a Research Methods Fellowship award from the National Institute for Health Research. This report is independent research arising from a Research Methods Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Association of Public Health Observatories, 2009, STAT PROC CONTR METH; Aziz O, 2011, ANN ROY COLL SURG, V93, P193, DOI 10.1308/003588411X563411; Berry G, 1995, STATISTICIAN, V44, P417, DOI 10.2307/2348891; Black N, 2010, BMJ-BRIT MED J, V340, P933; Field D, 2010, NEONATAL SURVEY REPO; Forni S, 2009, FUNNEL PLOT I COMP F; Hart Marilyn K, 2007, Qual Manag Health Care, V16, P123; Healthcare Commission, 2009, INV MID STAFF NHS FD; Henderson GR, 2008, QUAL SAF HEALTH CARE, V17, P301, DOI 10.1136/qshc.2006.020784; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jones HE, 2008, J CLIN EPIDEMIOL, V61, P232, DOI 10.1016/j.jclinepi.2007.04.017; Kirkham JJ, 2008, J TRAUMA, V65, P1494, DOI 10.1097/TA.0b013e31815ebabf; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Mayer EK, 2009, ANN SURG, V249, P376, DOI 10.1097/SLA.0b013e31819a47b1; Morris EJA, 2011, GUT, V60, P806, DOI 10.1136/gut.2010.232181; National Clinical Audit Advisory Group, 2011, DET MAN OUTL; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NHS, 2012, NHS SUMM HOSP LEV MO; NHS, 2010, REV PAED CARD SERV O; NHS Department of Health, 2010, NHS OUTC FARM 2011 1; Penfold Robert B, 2008, Healthc Pap, V8, P8; Scott IA, 2011, MED J AUSTRALIA, V194, P645, DOI 10.5694/j.1326-5377.2011.tb03150.x; Seaton SE, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-98; Shojania KG, 2008, CAN MED ASSOC J, V179, P153, DOI 10.1503/cmaj.080010; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45723	10.1371/journal.pone.0045723	http://dx.doi.org/10.1371/journal.pone.0045723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029202	Green Published, gold, Green Submitted			2022-12-25	WOS:000309388900094
J	Ning, DL; Wang, H				Ning, Daliang; Wang, Hui			Involvement of Cytochrome P450 in Pentachlorophenol Transformation in a White Rot Fungus Phanerochaete chrysosporium	PLOS ONE			English	Article							ORGANOCHLORINE PESTICIDES; P450 MONOOXYGENASES; PHLEBIA-RADIATA; DEGRADATION; BIODEGRADATION; PCP; BINDING; SOIL; PENTACHLOROANISOLE; DECHLORINATION	The occurrence of cytochrome P450 and P450-mediated pentachlorophenol oxidation in a white rot fungus Phanerochaete chrysosporium was demonstrated in this study. The carbon monoxide difference spectra indicated induction of P450 (103 +/- 13 pmol P450 per mg protein in the microsomal fraction) by pentachlorophenol. The pentachlorophenol oxidation by the microsomal P450 was NADPH-dependent at a rate of 19.0 +/- 1.2 pmol min(-1) (mg protein)(-1), which led to formation of tetrachlorohydroquinone and was significantly inhibited by piperonyl butoxide (a P450 inhibitor). Tetrachlorohydroquinone was also found in the cultures, while the extracellular ligninases which were reported to be involved in tetrachlorohydroquinone formation were undetectable. The formation of tetrachlorohydroquinone was not detectable in the cultures added with either piperonyl butoxide or cycloheximide (an inhibitor of de novo protein synthesis). These results revealed the pentachlorophenol oxidation by induced P450 in the fungus, and it should be the first time that P450-mediated pentachlorophenol oxidation was demonstrated in a microorganism. Furthermore, the addition of the P450 inhibitor to the cultures led to obvious increase of pentachlorophenol, suggesting that the relationship between P450 and pentachlorophenol methylation is worthy of further research.	[Ning, Daliang; Wang, Hui] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China	Tsinghua University	Wang, H (corresponding author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.	wanghui@tsinghua.edu.cn	Ning, Daliang/AAT-2601-2021; Wang, Hui/G-8744-2012		National Nature Science Foundation of China [31000066, 30970098, 20737001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (Admission No. 31000066, 30970098 and 20737001. http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken BS, 1996, BIODEGRADATION, V7, P175, DOI 10.1007/BF00058177; Barakat AO, 2002, MAR POLLUT BULL, V44, P1426, DOI 10.1016/S0025-326X(02)00313-2; Barque JP, 2002, BIOCHEM BIOPH RES CO, V298, P277, DOI 10.1016/S0006-291X(02)02439-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campoy S, 2009, ENVIRON MICROBIOL, V11, P99, DOI 10.1111/j.1462-2920.2008.01744.x; Chigu NL, 2010, APPL MICROBIOL BIOT, V87, P1907, DOI 10.1007/s00253-010-2616-1; Da-Liang N, 2007, CHEM J CHINESE U, V28, P1469; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; Dubois M, 1997, BIOMARKERS, V2, P17, DOI 10.1080/135475097231922; Fisher B., 1991, J PESTICIDE REFORM, V11, P2; GILBERT FI, 1990, ARCH ENVIRON CON TOX, V19, P603, DOI 10.1007/BF01059082; Goswami M, 2007, ENVIRON MICROBIOL, V9, P2512, DOI 10.1111/j.1462-2920.2007.01370.x; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Ichinose H, 2012, ARCH BIOCHEM BIOPHYS, V518, P8, DOI 10.1016/j.abb.2011.12.010; Jiang X, 2000, CHEMOSPHERE, V41, P901, DOI 10.1016/S0045-6535(99)00435-X; Kamada F, 2002, MICROBIOL-SGM, V148, P1939, DOI 10.1099/00221287-148-6-1939; Laugero C, 1997, CAN J MICROBIOL, V43, P378, DOI 10.1139/m97-052; Livingstone DR, 1998, COMP BIOCHEM PHYS A, V120, P43, DOI 10.1016/S1095-6433(98)10008-9; Luykx DMAM, 2003, BIOCHEM BIOPH RES CO, V312, P373, DOI 10.1016/j.bbrc.2003.10.128; Machado KMG, 2005, WORLD J MICROB BIOT, V21, P297, DOI 10.1007/s11274-004-3693-z; Mahmood S, 2005, ENVIRON MICROBIOL, V7, P1349, DOI 10.1111/j.1462-2920.2005.00822.x; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Masaphy S, 1996, FEMS MICROBIOL LETT, V135, P51; McLellan L, 2007, J ENVIRON MONITOR, V9, P1055, DOI 10.1039/b701436h; Mehmood Z, 1996, CHEMOSPHERE, V33, P759, DOI 10.1016/0045-6535(96)00212-3; Miller GP, 1999, FASEB J, V13, pA1346; MURRAY M, 1990, PHARMACOL REV, V42, P85; NEILSON AH, 1988, APPL ENVIRON MICROB, V54, P524, DOI 10.1128/AEM.54.2.524-530.1988; NIKUPAAVOLA ML, 1988, BIOCHEM J, V254, P877, DOI 10.1042/bj2540877; Ning Da-liang, 2009, China Environmental Science, V29, P407; Ning Da-liang, 2009, Huanjing Kexue, V30, P2485; Ning DL, 2010, BIODEGRADATION, V21, P889, DOI 10.1007/s10532-010-9349-9; Ning DL, 2010, BIODEGRADATION, V21; Omura T, 1999, BIOCHEM BIOPH RES CO, V266, P690, DOI 10.1006/bbrc.1999.1887; OMURA T, 1964, J BIOL CHEM, V239, P2370; PALM H, 1991, CHEMOSPHERE, V23, P263, DOI 10.1016/0045-6535(91)90182-D; PASZCZYNSKI A, 1988, METHOD ENZYMOL, V161, P264; Pedroza AM, 2007, CHEMOSPHERE, V67, P793, DOI 10.1016/j.chemosphere.2006.10.015; Peng Dan, 2008, Huanjing Kexue, V29, P3568; Reddy GVB, 2000, MICROBIOL-UK, V146, P405, DOI 10.1099/00221287-146-2-405; Reddy GVB, 1998, J BACTERIOL, V180, P5159, DOI 10.1128/JB.180.19.5159-5164.1998; Rubilar O, 2011, BIODEGRADATION, V22, P31, DOI 10.1007/s10532-010-9373-9; Sei K, 2008, J ENVIRON SCI HEAL A, V43, P53, DOI 10.1080/10934520701750397; Subramanian V, 2009, APPL ENVIRON MICROB, V75, P5570, DOI 10.1128/AEM.02942-08; Suwanchaichinda C, 2001, PESTIC BIOCHEM PHYS, V70, P63, DOI 10.1006/pest.2001.2544; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Szewczyk R, 2009, INT BIODETER BIODEGR, V63, P123, DOI 10.1016/j.ibiod.2008.08.001; Teramoto H, 2004, APPL MICROBIOL BIOT, V66, P312, DOI 10.1007/s00253-004-1637-z; TIEN M, 1988, METHOD ENZYMOL, V161, P238; Uotila J S, 1991, Biodegradation, V2, P25, DOI 10.1007/BF00122422; Walter M, 2004, J ENVIRON MANAGE, V71, P361, DOI 10.1016/j.jenvman.2004.04.002; WITTLINGER R, 1990, FRESEN J ANAL CHEM, V336, P193, DOI 10.1007/BF00332252; XUN LY, 1991, J BACTERIOL, V173, P4447, DOI 10.1128/JB.173.14.4447-4453.1991; Yu Z, 2011, PROCESS BIOCHEM, V46, P1285, DOI 10.1016/j.procbio.2011.02.018; YUAN JH, 1993, XENOBIOTICA, V23, P427, DOI 10.3109/00498259309057031; Zhang JB, 2007, INT BIODETER BIODEGR, V59, P307, DOI 10.1016/j.ibiod.2006.09.003; Zhou Wen-Min, 1990, ENV MONITORING CHINA, V6, p1 ~ 3	58	23	24	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2012	7	9							e45887	10.1371/journal.pone.0045887	http://dx.doi.org/10.1371/journal.pone.0045887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PT	23029295	gold, Green Published, Green Submitted			2022-12-25	WOS:000309388900108
J	Zhao, ZG; Wang, ZL; Li, QB; Li, WM; You, Y; Zou, P				Zhao, Zhigang; Wang, Zhenling; Li, Qiubai; Li, Weiming; You, Yong; Zou, Ping			The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TGF-BETA; BONE-MARROW; IMMUNOSUPPRESSIVE THERAPY; DENDRITIC CELLS; RESPONSES; SUPPRESSION; EXPANSION; INHIBIT	Myelodysplastic syndrome (MDS) are a group of progressive, clonal, neoplastic bone marrow disorders characterized by hematopoietic stem cell dysregulation and abnormalities in the immune system. Mesenchymal stem cells (MSC) have gained further interests after the demonstration of an immunoregulatory role. Nevertheless, the immunoregulatory function of MDS bone marrow derived MSC (MDS-MSC) remains poorly defined. In addition, it is not clear whether there are differences in the regulatory functions between low-risk and high-risk MDS-MSC. In this study, we obtain and expand MSC from bone marrow of patients with MDS. Our results show that there are significant differences in the immunoregulatory functions between low-risk and high-risk MDS-MSC. Compare to low-risk MDS-MSC, high-risk MDS-MSC is associated with the presence of increased TGF-beta 1, higher apoptosis, higher immunosuppressive rate and a poor ability of hematopoietic support. In addition, our results find that there are great differences in the CD4+CD25+Foxp3+Tregs inducible rate between high-risk MDS-MSC and low-risk MDS-MSC. Compared to high-risk MDS-MSC, the inducible rate of CD4+CD25+Foxp3+Tregs of low-risk MDS-MSC is lower. At last, we find that MDS-MSC derived TGF-beta 1 is largely responsible for the increase in CD4+CD25+Foxp3+Tregs based on knockdown studies. These results elucidate the different immunoregulatory role of MSC in low-risk and high-risk MDS, which may be important for understand the pathogenesis of MDS and the development of novel immunomodulatory strategies for the treatment of MDS.	[Zhao, Zhigang; Wang, Zhenling] Tianjin Med Univ, Oncol Hosp, Dept Hematol, Tianjin, Peoples R China; [Li, Qiubai; Li, Weiming; You, Yong; Zou, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Hematol, Dept Hematol, Wuhan 430074, Peoples R China	Tianjin Medical University; Huazhong University of Science & Technology	Zhao, ZG (corresponding author), Tianjin Med Univ, Oncol Hosp, Dept Hematol, Tianjin, Peoples R China.	zhaodor001@gmail.com	Li, Qiubai/GWQ-9911-2022		National Natural Science Foundation [30801051, 81172833]; Tianjin Application Foundation; Advanced Technology Research Program [08JCYBJC06500, 09JCYBJC11000]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Application Foundation; Advanced Technology Research Program	This work is supported by grants from the National Natural Science Foundation (No. 30801051; No. 81172833) and the Tianjin Application Foundation and Advanced Technology Research Program (08JCYBJC06500; 09JCYBJC11000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aggarwal S, 2011, BRIT J HAEMATOL, V153, P568, DOI 10.1111/j.1365-2141.2011.08683.x; Asano Y, 2001, ANN HEMATOL, V80, P634; Bacigalupo A, 2005, EXP HEMATOL, V33, P819, DOI 10.1016/j.exphem.2005.05.006; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Buck MB, 2006, ANN NY ACAD SCI, V1089, P119, DOI 10.1196/annals.1386.024; Chen Wanjun, 2002, Curr Dir Autoimmun, V5, P62; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Devine SM, 2000, CURR OPIN HEMATOL, V7, P358, DOI 10.1097/00062752-200011000-00007; Epperson DE, 2001, LEUKEMIA RES, V25, P1075, DOI 10.1016/S0145-2126(01)00083-2; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Guo H, 2003, EXP HEMATOL, V31, P650, DOI 10.1016/S0301-472X(03)00087-0; Han Q, 2007, LEUKEMIA RES, V31, P1369; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Klaus M, 2010, STEM CELLS DEV, V19, P1043, DOI 10.1089/scd.2009.0286; Kordasti SY, 2007, BLOOD, V110, P847, DOI 10.1182/blood-2007-01-067546; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4; Saunthararajah Y, 2003, BLOOD, V102, P3025, DOI 10.1182/blood-2002-11-3325; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wang J, 2005, INT J HEMATOL, V82, P152, DOI 10.1532/IJH97.A10505; Wlodarski MW, 2006, BLOOD, V108, P2632, DOI 10.1182/blood-2005-09-3902; Wlodarski MW, 2005, BLOOD, V106, P2769, DOI 10.1182/blood-2004-10-4045; Yamazaki S, 2007, BLOOD, V110, P4293, DOI 10.1182/blood-2007-05-088831; Zhao ZG, 2008, IMMUNOL INVEST, V37, P726, DOI 10.1080/08820130802349940; Zhi-Gang Z, 2008, LEUKEMIA LYMPHOMA, V49, P2187, DOI 10.1080/10428190802455875	32	100	103	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45675	10.1371/journal.pone.0045675	http://dx.doi.org/10.1371/journal.pone.0045675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014RG	23029178	Green Published, Green Submitted, gold			2022-12-25	WOS:000309392800079
J	Yan, P; Zhu, XZ; Li, HM; Shrubsole, MJ; Shi, HM; Zhang, MZ; Harris, RC; Hao, CM; Dai, Q				Yan, Ping; Zhu, Xiangzhu; Li, Haiming; Shrubsole, Martha J.; Shi, Haiming; Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming; Dai, Qi			Association of High Blood Pressure with Renal Insufficiency: Role of Albuminuria, from NHANES, 1999-2006	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; POSITION STATEMENT; HYPERTENSION; PROGRESSION; PROTEINURIA; PREVALENCE; MORTALITY	Background: The relationship between hypertension and kidney disease is complicated. Clinical trials found intense blood pressure control was not associated with alterations in glomerular filtration rate (GFR) in all patients but did slow the rate of GFR decline among those with a higher baseline proteinuria. However, the underlying mechanism has been unclear. Methods: We tested the hypothesis that the association between high blood pressure and renal function is modified by albuminuria status by conducting analyses in a cross-sectional study with 12,440 adult participants without known kidney diseases, diabetes or cardiovascular diseases, participating in the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Results: 1226 out of 12440 were found to have unknown high blood pressure and 4494 were found to have reduced renal function. Overall, a moderate association was found between high blood pressure and renal function insufficiency in all participants analyzed. However, among participants with albuminuria, the prevalence of moderate-severe renal insufficiency substantially and progressively increased from normal subjects to prehypertensive and undiagnosed hypertensive subjects (1.43%, 3.44%, 10.96%, respectively, P for trend <0.0001); on the other hand, the prevalence of undiagnosed hypertension was also significantly higher among subjects with moderate-severe renal insufficiency than those with mild renal insufficiency (35.54% Vs 19.09%, P value <0.05), supporting an association between hypertension and renal function damage. In contrast, no association between hypertension and renal insufficiency was observed among those without albuminuria in this population. Similar findings were observed when the CKD-EPI equation was used. Conclusions: The association between high blood pressure and reduced renal function could be dependent upon the albuminuria status. This finding may provide a possible explanation for results observed in clinical trials of intensive blood pressure control. Further studies are warranted to confirm our findings.	[Yan, Ping; Shi, Haiming] Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Li, Haiming; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Yan, Ping; Zhu, Xiangzhu; Shrubsole, Martha J.; Dai, Qi] Vanderbilt Univ, Sch Med, Dept Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Zhang, Ming-zhi; Harris, Raymond C., Jr.; Hao, Chuan-Ming] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN USA	Fudan University; Fudan University; Vanderbilt University; Vanderbilt University	Yan, P (corresponding author), Fudan Univ, Dept Cardiol, Huashan Hosp, Shanghai 200433, Peoples R China.	qi.dai@vanderbilt.edu	Shrubsole, Martha J/K-5052-2015; Zhu, Xiangzhu/ABB-5787-2021; Zhu, Xiao-Shan/B-2179-2015	Shrubsole, Martha J/0000-0002-5591-7575; Zhu, Xiangzhu/0000-0002-4462-8815; Zhu, Xiao-Shan/0000-0003-1223-1415	International Society of Nephrology; Vanderbilt Epidemiology Center	International Society of Nephrology; Vanderbilt Epidemiology Center	This work is partially supported by the International Fellowship Program of the International Society of Nephrology (HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Drs. Qi Dai and Xiangzhu Zhu's effort was supported by the Vanderbilt Epidemiology Center's development fund. No additional external funding received for this study.	[Anonymous], 2004, AM J KIDNEY DIS, V43, pS14, DOI 10.1053/j/ajkd.2004.03.004; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Bidani AK, 2011, NAT REV NEPHROL, V7, P128, DOI 10.1038/nrneph.2010.168; CHAVERS BM, 1984, KIDNEY INT, V25, P576, DOI 10.1038/ki.1984.57; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gansevoort RT, 2010, CURR OPIN NEPHROL HY, V19, P308, DOI 10.1097/MNH.0b013e328337bbbe; Hamm LL, 2010, AM J MED SCI, V340, P30, DOI 10.1097/MAJ.0b013e3181e590f0; Islam TM, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-17; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; Kalaitzidis RG, 2010, KIDNEY INT, V77, P194, DOI 10.1038/ki.2009.439; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Center for Health Statistics. Centers for Disease Control and Prevention, CTR DIS CONTR PREV N; National Health and Nutrition Examination Survey, 2003, PHYS EX PROC MAN; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Peralta CA, 2012, ARCH INTERN MED, V172, P41, DOI 10.1001/archinternmed.2011.619; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Population Division US Census Bureau, 2007, NCEST200601 US BUR C; Rao MV, 2008, AM J KIDNEY DIS, V51, pS30, DOI 10.1053/j.ajkd.2007.12.012; Sabanayagam C, 2011, ASIA-PAC J PUBLIC HE, V23, P936, DOI 10.1177/1010539510361637; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Segura J, 2011, ADV CHRONIC KIDNEY D, V18, P23, DOI 10.1053/j.ackd.2010.11.001; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Udani S, 2011, NAT REV NEPHROL, V7, P11, DOI 10.1038/nrneph.2010.154; Upadhyay A, 2011, ANN INTERN MED, V154, P541, DOI 10.7326/0003-4819-154-8-201104190-00335; Wang TJ, 2007, HYPERTENSION, V49, P432, DOI 10.1161/01.HYP.0000256956.61872.aa; Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; You L, 2011, ENVIRON HEALTH PERSP, V119, P527, DOI 10.1289/ehp.1002572	46	81	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2012	7	7							e37837	10.1371/journal.pone.0037837	http://dx.doi.org/10.1371/journal.pone.0037837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	971EQ	23029464	gold, Green Published, Green Submitted			2022-12-25	WOS:000306186900001
J	Yang, HC; Liang, YJ; Chen, JW; Chiang, KM; Chung, CM; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Leu, HB; Yin, WH; Chiu, TY; Chern, CI; Lin, SJ; Tomlinson, B; Guo, YL; Sham, PC; Cherny, SS; Lam, TH; Thomas, N; Pan, WH				Yang, Hsin-Chou; Liang, Yu-Jen; Chen, Jaw-Wen; Chiang, Kuang-Mao; Chung, Chia-Min; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Leu, Hsin-Bang; Yin, Wei-Hsian; Chiu, Ting-Yu; Chern, Ching-Iuan; Lin, Shing-Jong; Tomlinson, Brian; Guo, Youling; Sham, Pak C.; Cherny, Stacey S.; Lam, Tai Hing; Thomas, Neil; Pan, Wen-Harn			Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as Hypertension Susceptibility Genes in Han Chinese with a Genome-Wide Gene-Based Association Study	PLOS ONE			English	Article							FACTOR-I GENE; BLOOD-PRESSURE; PROMOTER REGION; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; GROWTH; POLYMORPHISM; LINKAGE; MICE; LOCUS	Hypertension is a complex disorder with high prevalence rates all over the world. We conducted the first genome-wide gene-based association scan for hypertension in a Han Chinese population. By analyzing genome-wide single-nucleotide-polymorphism data of 400 matched pairs of young-onset hypertensive patients and normotensive controls genotyped with the Illumina HumanHap550-Duo BeadChip, 100 susceptibility genes for hypertension were identified and also validated with permutation tests. Seventeen of the 100 genes exhibited differential allelic and expression distributions between patient and control groups. These genes provided a good molecular signature for classifying hypertensive patients and normotensive controls. Among the 17 genes, IGF1, SLC4A4, WWOX, and SFMBT1 were not only identified by our gene-based association scan and gene expression analysis but were also replicated by a gene-based association analysis of the Hong Kong Hypertension Study. Moreover, cis-acting expression quantitative trait loci associated with the differentially expressed genes were found and linked to hypertension. IGF1, which encodes insulin-like growth factor 1, is associated with cardiovascular disorders, metabolic syndrome, decreased body weight/size, and changes of insulin levels in mice. SLC4A4, which encodes the electrogenic sodium bicarbonate cotransporter 1, is associated with decreased body weight/size and abnormal ion homeostasis in mice. WWOX, which encodes the WW domain-containing protein, is related to hypoglycemia and hyperphosphatemia. SFMBT1, which encodes the scm-like with four MBT domains protein 1, is a novel hypertension gene. GRB14, TMEM56 and KIAA1797 exhibited highly significant differential allelic and expressed distributions between hypertensive patients and normotensive controls. GRB14 was also found relevant to blood pressure in a previous genetic association study in East Asian populations. TMEM56 and KIAA1797 may be specific to Taiwanese populations, because they were not validated by the two replication studies. Identification of these genes enriches the collection of hypertension susceptibility genes, thereby shedding light on the etiology of hypertension in Han Chinese populations.	[Yang, Hsin-Chou; Liang, Yu-Jen] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chiang, Kuang-Mao; Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liang, Yu-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chiang, Kuang-Mao] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Ho, Hung-Yun; Ting, Chih-Tai] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Wei-Chuan; Chen, Jyh-Hong] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Yin, Wei-Hsian] Cheng Hsin Rehabil Med Ctr, Div Cardiol, Taipei, Taiwan; [Chiu, Ting-Yu; Chern, Ching-Iuan] Min Sheng Gen Hosp, Div Cardiol, Tao Yuan, Taiwan; [Tomlinson, Brian] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Guo, Youling; Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Thomas, Neil] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Birmingham; National Health Research Institutes - Taiwan	Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	pan@ibms.sinica.edu.tw	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	National Research Program for Genomic Medicine [NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, NSC 99-3112-B-001-029]; National Science Council of Taiwan [NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, NSC 100-2319-B-010002]; Career Development Award of Academia Sinica [AS-100-CDA-M03]; Academia Sinica Genomics and Proteomics Program [521023-92-81, 521023-93-81, 521023-94-19, 30-34-GSK]; Academia Sinica Genomic Medicine Multicenter Studies [40-05-GMM]; Wellcome Trust Funding Source: Medline	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Career Development Award of Academia Sinica; Academia Sinica Genomics and Proteomics Program; Academia Sinica Genomic Medicine Multicenter Studies; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Research Program for Genomic Medicine (NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, and NSC 99-3112-B-001-029), National Science Council grants (NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, and NSC 100-2319-B-010002) of Taiwan, the Career Development Award of Academia Sinica (AS-100-CDA-M03), the Academia Sinica Genomics and Proteomics Program (2003-2006) (521023-92-81, 521023-93-81, 521023-94-19 and 30-34-GSK), and the Academia Sinica Genomic Medicine Multicenter Studies (2007-present) (40-05-GMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fang YJ, 2010, J HYPERTENS, V28, P1203, DOI 10.1097/HJH.0b013e3283384b07; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Funke-Kaiser H, 2003, HUM MOL GENET, V12, P423, DOI 10.1093/hmg/ddg040; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Hanasaki H, 2009, HYPERTENS RES, V32, P261, DOI 10.1038/hr.2009.2; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Horio T, 2010, J HUM HYPERTENS, V24, P320, DOI 10.1038/jhh.2009.73; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt SC, 2006, HYPERTENSION, V47, P532, DOI 10.1161/01.HYP.0000196949.26088.3c; Jakobsson J, 2004, PHARMACOGENOMICS J, V4, P245, DOI 10.1038/sj.tpj.6500236; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Knight J, 2006, BEHAV GENET, V36, P665, DOI 10.1007/s10519-005-9016-9; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Landmann E, 2006, PEDIATRICS, V118, P2374, DOI 10.1542/peds.2006-0146; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; PICKERING G, 1978, AM J MED, V65, P561, DOI 10.1016/0002-9343(78)90839-2; Pineda LL, 2003, PATHOL INT, V53, P390, DOI 10.1046/j.1440-1827.2003.01486.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld I, 2006, EUR J ENDOCRINOL, V154, P715, DOI 10.1530/eje.1.02144; Rietveld I, 2004, CLIN ENDOCRINOL, V61, P195, DOI 10.1111/j.1365-2265.2004.02078.x; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Roy D, 2011, BLOOD, V118, pE32, DOI 10.1182/blood-2010-12-323659; Ruigrok YM, 2005, J NEUROL, V252, P417, DOI 10.1007/s00415-005-0661-y; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schut AFC, 2003, STROKE, V34, P1623, DOI 10.1161/01.STR.0000076013.00240.B0; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Sweeney C, 2005, CANCER EPIDEM BIOMAR, V14, P1802, DOI 10.1158/1055-9965.EPI-05-0149; t Hart LM, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.2007.S26; Taylor JY, 2009, BIOL RES NURS, V11, P53, DOI 10.1177/1099800409334817; te Velde Saskia J, 2005, BMC Endocr Disord, V5, P5, DOI 10.1186/1472-6823-5-5; Telgmann R, 2009, FASEB J, V23, P1303, DOI 10.1096/fj.08-116863; Ueki I, 2000, P NATL ACAD SCI USA, V97, P6868, DOI 10.1073/pnas.120172697; Voorhoeve PG, 2006, EUR J ENDOCRINOL, V154, P379, DOI 10.1530/eje.1.02101; Wallace C, 2006, AM J HUM GENET, V79, P323, DOI 10.1086/506370; Wang K, 2011, PLOS ONE, V6; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Yang Hsin-Chou, 2009, BMC Proc, V3 Suppl 7, pS135; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yazdanpanah M, 2006, AM J CARDIOL, V97, P1274, DOI 10.1016/j.amjcard.2005.11.069; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang MC, 2008, IMMUNOGENETICS, V60, P599, DOI 10.1007/s00251-008-0320-4	96	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32907	10.1371/journal.pone.0032907	http://dx.doi.org/10.1371/journal.pone.0032907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23029496	gold, Green Published			2022-12-25	WOS:000304523400009
J	Lan, GY; Getzin, S; Wiegand, T; Hu, YH; Xie, GS; Zhu, H; Cao, M				Lan, Guoyu; Getzin, Stephan; Wiegand, Thorsten; Hu, Yuehua; Xie, Guishui; Zhu, Hua; Cao, Min			Spatial Distribution and Interspecific Associations of Tree Species in a Tropical Seasonal Rain Forest of China	PLOS ONE			English	Article							DENSITY-DEPENDENCE; DISTRIBUTION PATTERNS; HABITAT ASSOCIATIONS; NEOTROPICAL FOREST; XISHUANGBANNA; DIVERSITY; VEGETATION; RECRUITMENT; MAINTENANCE; POPULATIONS	Studying the spatial pattern and interspecific associations of plant species may provide valuable insights into processes and mechanisms that maintain species coexistence. Point pattern analysis was used to analyze the spatial distribution patterns of twenty dominant tree species, their interspecific spatial associations and changes across life stages in a 20-ha permanent plot of seasonal tropical rainforest in Xishuangbanna, China, to test mechanisms maintaining species coexistence. Torus-translation tests were used to quantify positive or negative associations of the species to topographic habitats. The results showed: (1) fourteen of the twenty tree species were negatively (or positively) associated with one or two of the topographic variables, which evidences that the niche contributes to the spatial pattern of these species. (2) Most saplings of the study species showed a significantly clumped distribution at small scales (0-10 m) which was lost at larger scales (10-30 m). (3) The degree of spatial clumping deceases from saplings, to poles, to adults indicates that density-dependent mortality of the offspring is ubiquitous in species. (4) It is notable that a high number of positive small-scale interactions were found among the twenty species. For saplings, 42.6% of all combinations of species pairs showed positive associations at neighborhood scales up to five meters, but only 38.4% were negative. For poles and adults, positive associations at these distances still made up 45.5% and 29.5%, respectively. In conclusion, there is considerable evidence for the presence of positive interactions among the tree species, which suggests that species herd protection may occur in our plot. In addition, niche assembly and limited dispersal (likely) contribute to the spatial patterns of tree species in the tropical seasonal rain forest in Xishuangbanna, China.	[Lan, Guoyu; Hu, Yuehua; Zhu, Hua; Cao, Min] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Lan, Guoyu; Xie, Guishui] Chinese Acad Trop Agr Sci, Rubber Res Inst, Danzhou City, Hainan Province, Peoples R China; [Getzin, Stephan; Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Tropical Agricultural Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Cao, M (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.	caom@xtbg.ac.cn	Hua, Zhu/AFO-6233-2022; Wiegand, Thorsten/AAP-9709-2021; Wiegand, Thorsten/H-5877-2016	Wiegand, Thorsten/0000-0002-3721-2248; Wiegand, Thorsten/0000-0002-3721-2248	National Science Foundation of China [31061160188-03]; National Science & Technology Pillar Program of China [2008BAC39B02]; Environmental Research Center [233066]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China; Environmental Research Center	This project was supported by a grant from the National Science Foundation of China (31061160188-03) and a grant from the National Science & Technology Pillar Program of China (2008BAC39B02). SG was supported by the Environmental Research Center Advanced Grant "SpatioDiversity" (grant number 233066) to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunyavejchewin S, 2003, FOREST ECOL MANAG, V175, P87, DOI 10.1016/S0378-1127(02)00126-3; Cao M, 1997, BIODIVERS CONSERV, V6, P995, DOI 10.1023/A:1018367630923; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Condit R, 1998, TROPICAL FOREST CENS, P17; CONNELL J H, 1971, P298; Donnelly K, 1978, SIMULATION STUDIES A, P91; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Getzin S, 2011, J TROP ECOL, V27, P93, DOI 10.1017/S0266467410000453; Grubb PJ, 1977, BIOL REV CAMBRIDGE; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hua Z., 2006, FOR STUD CHINA, V8, P1, DOI [10.1007/s11632-006-0014-7, DOI 10.1007/S11632-006-0014-7]; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; King DA, 2006, FOREST ECOL MANAG, V223, P152, DOI 10.1016/j.foreco.2005.10.066; KOHYAMA T, 1993, J ECOL, V81, P131, DOI 10.2307/2261230; Lan GY, 2011, FOREST ECOL MANAG, V262, P1507, DOI 10.1016/j.foreco.2011.06.052; Lan GY, 2009, ECOL RES, V24, P1117, DOI 10.1007/s11284-009-0590-9; Lan GY, 2012, J FOR RES; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Liu JX, 2008, THESIS QUPU NORMAL U, P1; Liu Y, 2002, J PLANT ECOL, V26, P427; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, PLANT ECOL, V192, P193, DOI 10.1007/s11258-007-9328-3; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Stoyan D., 1994, FRACTALS RANDOM SHAP; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, AM NAT, V170, pE77, DOI 10.1086/521240; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WILLS C, 1995, IMMUNOL REV, V143, P263, DOI 10.1111/j.1600-065X.1995.tb00679.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang Xiao-Fei, 2010, Acta Botanica Yunnanica, V32, P367, DOI 10.3724/SP.J.1143.2010.10064; YIN SH, 1990, ACTA BOT YUNNANICA, V12, P415; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	49	42	67	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46074	10.1371/journal.pone.0046074	http://dx.doi.org/10.1371/journal.pone.0046074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	29294477	Green Published, gold, Green Submitted			2022-12-25	WOS:000309973900085
J	Yang, HY; Zhang, W; Pan, H; Feldser, HG; Lainez, E; Miller, C; Leung, S; Zhong, Z; Zhao, HZ; Sweitzer, S; Considine, T; Riera, T; Suri, V; White, B; Ellis, JL; Vlasuk, GP; Loh, C				Yang, Hongying; Zhang, Wei; Pan, Heng; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Leung, Stewart; Zhong, Zhong; Zhao, Huizhen; Sweitzer, Sharon; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine			SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-kappa B Activity	PLOS ONE			English	Article							SMALL-MOLECULE ACTIVATORS; DEPENDENT GENE-EXPRESSION; CELL-SURVIVAL; NEGATIVE REGULATION; CYTOKINE RELEASE; IN-VIVO; ACETYLATION; PHOSPHORYLATION; P53; RESVERATROL	Chronic inflammation is a major contributing factor in the pathogenesis of many age-associated diseases. One central protein that regulates inflammation is NF-kappa B, the activity of which is modulated by post-translational modifications as well as by association with co-activator and co-repressor proteins. SIRT1, an NAD+-dependent protein deacetylase, has been shown to suppress NF-kappa B signaling through deacetylation of the p65 subunit of NF-kappa B resulting in the reduction of the inflammatory responses mediated by this transcription factor. The role of SIRT1 in the regulation of NF-kappa B provides the necessary validation for the development of pharmacological strategies for activating SIRT1 as an approach for the development of a new class of anti-inflammatory therapeutics. We report herein the development of a quantitative assay to assess compound effects on acetylated p65 protein in the cell. We demonstrate that small molecule activators of SIRT1 (STACs) enhance deacetylation of cellular p65 protein, which results in the suppression of TNF alpha-induced NF-kappa B transcriptional activation and reduction of LPS-stimulated TNF alpha secretion in a SIRT1-dependent manner. In an acute mouse model of LPS-induced inflammation, the STAC SRTCX1003 decreased the production of the proinflammatory cytokines TNF alpha and IL-12. Our studies indicate that increasing SIRT1-mediated NF-kappa B deacetylation using small molecule activating compounds is a novel approach to the development of a new class of therapeutic anti-inflammatory agents.	[Yang, Hongying; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine] Sirtris, Cambridge, MA USA; [Zhang, Wei; Pan, Heng; Leung, Stewart; Zhong, Zhong] GlaxoSmithKline R&D China, Shanghai, Peoples R China; [Zhao, Huizhen; Sweitzer, Sharon] GlaxoSmithKline, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Yang, HY (corresponding author), Sirtris, Cambridge, MA USA.	Hongying.2.yang@gsk.com	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aulakh R, 2008, INDIAN J PEDIATR, V75, P1067, DOI 10.1007/s12098-008-0211-6; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Camu F, 1996, Acta Anaesthesiol Belg, V47, P143; Chen J, 2005, J BIOL CHEM; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Disch JS, 2010, 240 ACS NAT M MEDI, P70; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Robers MB, 2011, MOL BIOSYST, V7, P59, DOI 10.1039/c0mb00026d; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Satoh A, 2012, HDB EXP PHARM, V206, P125; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; van der Meer AJ, 2011, INFLAMM RES, V60, P82; vanderPoll T, 1997, J IMMUNOL, V158, P1971; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vu C. B., 2010, Patent Appl., Patent No. [PCT WO 2010/003048, 2010003048]; Vu C. B., 2010, WO Patent, Patent No. [2010037129A1, 2010037129, PCT WO 2010/037129]; YAMAZAKI Y, 2009, AM J PHYSL ENDOCRINO; Yang Baichun, 2008, BMC Pharmacology, V8, P7, DOI 10.1186/1471-2210-8-7; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	65	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46364	10.1371/journal.pone.0046364	http://dx.doi.org/10.1371/journal.pone.0046364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029496	Green Submitted, Green Published, gold			2022-12-25	WOS:000309973900143
J	Wu, JY; Wang, YH; Wang, GJ; Ho, ML; Wang, CZ; Yeh, ML; Chen, CH				Wu, Jyun-Yi; Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen; Yeh, Ming-Long; Chen, Chia-Hsin			Low-Power GaAlAs Laser Irradiation Promotes the Proliferation and Osteogenic Differentiation of Stem Cells via IGF1 and BMP2	PLOS ONE			English	Article							RAT CALVARIAL CELLS; BONE-MARROW; IN-VITRO; GENE-EXPRESSION; THERAPY; OSTEOBLASTS; OSTEOPOROSIS; TGF-BETA-1; CULTURE; ARREST	Low-power laser irradiation (LPLI) has been found to induce various biological effects and cellular processes. Also, LPLI has been shown to promote fracture repair. Until now, it has been unclear how LPLI promotes bone formation and fracture healing. The aim of this study was to investigate the potential mechanism of LPLI-mediated enhancement of bone formation using mouse bone marrow mesenchymal stem cells (D1 cells). D1 cells were irradiated daily with a gallium-aluminum-arsenide (GaAlAs) laser at dose of 0, 1, 2, or 4 J/cm(2). The lactate dehydrogenase (LDH) assay showed no cytotoxic effects of LPLI on D1 cells, and instead, LPLI at 4 J/cm(2) significantly promoted D1 cell proliferation. LPLI also enhanced osteogenic differentiation in a dose-dependent manner and moderately increased expression of osteogenic markers. The neutralization experiments indicated that LPLI regulated insulin-like growth factor 1 (IGF1) and bone morphogenetic protein 2 (BMP2) signaling to promote cell proliferation and/or osteogenic differentiation. In conclusion, our study suggests that LPLI may induce IGF1 expression to promote both the proliferation and osteogenic differentiation of D1 cells, whereas it may induce BMP2 expression primarily to enhance osteogenic differentiation.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Dept Orthopaed, Coll Med, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Dept Phys Med & Rehabil, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Virginia; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Wu, JY (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020; Wang, Yan-Hsiung/C-8792-2009; Zhu, Zhi/D-3721-2011	Wang, Yan-Hsiung/0000-0001-8161-7472; Zhu, Zhi/0000-0002-3287-4920; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Science Council [NSC 96-2221-E-006-259, NSC 96-2314-B-037-059]; National Health Research Institutes, Taiwan [NHRI-EX97-9615EP]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by two grants from the National Science Council (NSC 96-2221-E-006-259, NSC 96-2314-B-037-059) and a grant from the National Health Research Institutes (NHRI-EX97-9615EP) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9; Bouvet-Gerbettaz S, 2009, LASER SURG MED, V41, P291, DOI 10.1002/lsm.20759; Cen Shiqiang, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P84; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Coombe A R, 2001, Clin Orthod Res, V4, P3, DOI 10.1034/j.1600-0544.2001.040102.x; Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Fukuhara E, 2006, CALCIFIED TISSUE INT, V79, P443, DOI 10.1007/s00223-006-0072-9; Gal P, 2009, LASER MED SCI, V24, P539, DOI 10.1007/s10103-008-0604-9; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; IIJIMA K, 1989, CLIN J PAIN, V5, P271; Jin Dong-mei, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P55; Khadra M, 2005, BIOMATERIALS, V26, P3503, DOI 10.1016/j.biomaterials.2004.09.033; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Mehler PS, 2009, INT J EAT DISORDER, V42, P195, DOI 10.1002/eat.20593; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Oliveira DAAP, 2008, PHOTOMED LASER SURG, V26, P401, DOI 10.1089/pho.2007.2101; Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; Schindl A, 2003, BRIT J DERMATOL, V148, P334, DOI 10.1046/j.1365-2133.2003.05070.x; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stein E, 2008, WIEN KLIN WOCHENSCHR, V120, P112, DOI 10.1007/s00508-008-0932-6; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Totosy de Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI 10.1682/JRRD.2008.09.0136; Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492; Wang YH, 2009, MOL THER, V17, P302, DOI 10.1038/mt.2008.267; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Xu M, 2009, PHOTOMED LASER SURG, V27, P309, DOI 10.1089/pho.2008.2283	41	76	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44027	10.1371/journal.pone.0044027	http://dx.doi.org/10.1371/journal.pone.0044027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	23029506	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600024
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-25	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-25	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-25	WOS:000309973900115
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-25	WOS:000305335500028
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
